PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Larkin, HD				Larkin, Howard D.			Next-Generation Monoclonal Antibody Blocks Malaria in Early Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					916	917		10.1001/jama.2022.14704	http://dx.doi.org/10.1001/jama.2022.14704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098739	Bronze			2022-12-28	WOS:000855222400005
J	Daifotis, AG				Daifotis, Anastasia G.			Risks to the 340B Drug Pricing Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Daifotis, Anastasia G.] Janssen Sci Affairs LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA	Johnson & Johnson; Janssen Pharmaceuticals	Daifotis, AG (corresponding author), Janssen Sci Affairs LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA.	adaifoti@its.jnj.com						[Anonymous], 2021, NOVARTIS PHARM CORPO; [Anonymous], 2022, JOHNSON JOHNSON 0321; Fein AJ., 2021, DRUG CHANNELS 0616; King R., 2021, FIERCE HEALTHCA 1108; Knox RP, 2022, JAMA-J AM MED ASSOC, V327, P1647, DOI 10.1001/jama.2022.5959	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11								10.1001/jama.2022.12753	http://dx.doi.org/10.1001/jama.2022.12753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125477				2022-12-28	WOS:000862909200028
J	Ye, XY; Liu, YM				Ye, Xianyun; Liu, Yueming			Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ye, Xianyun; Liu, Yueming] Zhejiang Prov Peoples Hosp, Urol & Nephrol Ctr, Hangzhou, Peoples R China	Zhejiang Provincial People's Hospital	Liu, YM (corresponding author), Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Affiliated Peoples Hosp, Urol & Nephrol Ctr,Dept Nephrol, 58 Shangtang Rd, Hangzhou 310014, Peoples R China.	lyman6136@126.com						Lv JC, 2022, JAMA-J AM MED ASSOC, V327, P1888, DOI 10.1001/jama.2022.5368; Messiaen PE, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12651; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Urakami T, 2021, J INFECT CHEMOTHER, V27, P1193, DOI 10.1016/j.jiac.2021.03.015; Zhang H, 2021, SEMIN IMMUNOPATHOL, V43, P707, DOI 10.1007/s00281-021-00884-7	5	0	0	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11								10.1001/jama.2022.12709	http://dx.doi.org/10.1001/jama.2022.12709			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125478				2022-12-28	WOS:000862909200026
J	Stolz, D; Mkorombindo, T; Schumann, DM; Agusti, A; Ash, SY; Bafadhel, M; Bai, CX; Chalmers, JD; Gerard, JC; Dharmage, SC; Franssen, FME; Frey, U; Han, ML; Hansel, NN; Hawkins, NM; Kalhan, R; Konigshoff, M; Ko, FW; Parekh, TM; Powell, P; Rutten-van Molken, M; Simpson, J; Sin, DD; Song, YL; Suki, B; Troosters, T; Washko, GR; Welte, T; Dransfield, MT				Stolz, Daiana; Mkorombindo, Takudzwa; Schumann, Desiree M.; Agusti, Alvar; Ash, Samuel Y.; Bafadhel, Mona; Bai, Chunxue; Chalmers, James D.; Gerard, J. Criner; Dharmage, Shyamali C.; Franssen, Frits M. E.; Frey, Urs; Han, MeiLan; Hansel, Nadia N.; Hawkins, Nathaniel M.; Kalhan, Ravi; Konigshoff, Melanie; Ko, Fanny W.; Parekh, Trisha M.; Powell, Pippa; Rutten-van Molken, Maureen; Simpson, Jodie; Sin, Don D.; Song, Yuanlin; Suki, Bela; Troosters, Thierry; Washko, George R.; Welte, Tobias; Dransfield, Mark T.			Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission	LANCET			English	Review							TOBACCO-SMOKE EXPOSURE; SMALL AIRWAY DISEASE; LUNG-FUNCTION TRAJECTORIES; PATIENT-REPORTED OUTCOMES; COMPUTED-TOMOGRAPHY; ACUTE EXACERBATIONS; MATERNAL SMOKING; NEVER-SMOKERS; RISK-FACTORS; RESPIRATORY SYMPTOMS		[Stolz, Daiana; Schumann, Desiree M.] Univ Hosp Basel, Clin Resp Med & Pulm Cell Res, Basel, Switzerland; [Stolz, Daiana] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland; [Stolz, Daiana] Univ Freiburg, Clin Resp Med, Freiburg, Germany; [Stolz, Daiana] Univ Freiburg, Fac Med, Freiburg, Germany; [Mkorombindo, Takudzwa; Parekh, Trisha M.; Dransfield, Mark T.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, Lung Hlth Ctr, Birmingham, AL USA; [Agusti, Alvar] Univ Barcelona IDIBAPS, Resp Inst, CIBERES, Hosp Clin, Barcelona, Spain; [Ash, Samuel Y.; Washko, George R.] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA; [Bafadhel, Mona] Kings Coll London, Sch Immunol & Microbial Sci, Fac Life Sci & Med, London, England; [Bafadhel, Mona] Univ Oxford, Nuffield Dept Med, Dept Resp Med, Oxford, England; [Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China; [Chalmers, James D.] Univ Dundee, Scottish Ctr Resp Res, Dundee, Scotland; [Gerard, J. Criner] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA USA; [Dharmage, Shyamali C.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Franssen, Frits M. E.] CIRO, Dept Res & Educ, Horn, Netherlands; [Franssen, Frits M. E.] Maastricht Univ, Dept Resp Med, Med Ctr, Maastricht, Netherlands; [Frey, Urs] Univ Childrens Hosp Basel, Basel, Switzerland; [Han, MeiLan] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA; [Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Pulm & Crit Care Med, Baltimore, MD USA; [Hawkins, Nathaniel M.] Univ British Columbia, Ctr Cardiovasc Innovat, Vancouver, BC, Canada; [Kalhan, Ravi] Northwestern Univ, Dept Prevent Med, Dept Med, Feinberg Sch Med, Chicago, IL USA; [Kalhan, Ravi] Northwestern Univ, Div Pulm & Crit Care Med, Dept Med, Feinberg Sch Med, Chicago, IL USA; [Konigshoff, Melanie] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Ko, Fanny W.] Chinese Univ Hong Kong, Hong Kong, Peoples R China; [Powell, Pippa] European Lung Fdn, Sheffield, England; [Rutten-van Molken, Maureen] Erasmus Univ, Erasmus Sch Hlth & Policy Management, Rotterdam, Netherlands; [Rutten-van Molken, Maureen] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [Simpson, Jodie] Univ Newcastle, Fac Hlth & Med, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Sin, Don D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Vancouver, BC, Canada; [Sin, Don D.] Univ British Columbia, St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Song, Yuanlin] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China; [Song, Yuanlin] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Song, Yuanlin] Shanghai Resp Res Inst, Shanghai, Peoples R China; [Song, Yuanlin] Fudan Univ, Jinshan Hosp, Shanghai, Peoples R China; [Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA USA; [Troosters, Thierry] Katholieke Univ Leuven, Dept Rehabil Sci, Res Grp Rehabil Internal Disorders, Leuven, Belgium; [Welte, Tobias] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Welte, Tobias] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis, Hannover, Germany; [Dransfield, Mark T.] Birmingham VA Med Ctr, Birmingham, AL USA	University of Basel; University of Basel; University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; University of Oxford; Fudan University; University of Dundee; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Melbourne; Maastricht University; University of Basel; University of Michigan System; University of Michigan; Johns Hopkins University; University of British Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Erasmus University Rotterdam; Erasmus University Rotterdam; University of Newcastle; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Fudan University; Fudan University; Fudan University; Boston University; KU Leuven; Hannover Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Dransfield, MT (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Heersink Sch Med, 1900 Univ Blvd, Birmingham, AL 35294 USA.	mdransfield@uabmc.edu		Bafadhel, Mona/0000-0002-9993-2478; Stolz, Daiana/0000-0003-0099-882X	University Hospital Basel, Switzerland; Swiss Respiratory Society; Lung Health Center, Heersink School of Medicine, University of Alabama at Birmingham	University Hospital Basel, Switzerland; Swiss Respiratory Society; Lung Health Center, Heersink School of Medicine, University of Alabama at Birmingham	The Commission has been supported by the University Hospital Basel, Switzerland, the Swiss Respiratory Society, and the Lung Health Center, Heersink School of Medicine, University of Alabama at Birmingham. The European Respiratory Society provided logistic support for meetings during annual conferences. The US National Institutes of Health provided logistic support and space for a meeting of the Commission. We thank the European Lung Foundation for participation, and Sonja Burger for her help with illustrations.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Accordini S, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.02791-2020; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; Adeloye D, 2022, LANCET RESP MED, V10, P447, DOI 10.1016/S2213-2600(21)00511-7; Agusti A, 2022, LANCET RESP MED, V10, P512, DOI 10.1016/S2213-2600(21)00555-5; Agusti A, 2019, LANCET RESP MED, V7, P358, DOI 10.1016/S2213-2600(18)30529-0; Agusti A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01655-2017; Agusti A, 2017, LANCET RESP MED, V5, P935, DOI 10.1016/S2213-2600(17)30434-4; Agusti A, 2016, EUR RESPIR J, V47, P410, DOI 10.1183/13993003.01359-2015; Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Albert P, 2012, THORAX, V67, P701, DOI 10.1136/thoraxjnl-2011-201458; ALBERT RK, 1980, ANN INTERN MED, V92, P753, DOI 10.7326/0003-4819-92-6-753; Allen J, 2003, AM J RESP CRIT CARE, V168, P356, DOI 10.1164/rccm.168.3.356; Allen JL, 2019, PEDIATR INVEST, V3, P236, DOI 10.1002/ped4.12165; Alotaibi NM, 2019, INT J CHRONIC OBSTR, V14, P311, DOI 10.2147/COPD.S188186; Amaral AFS, 2016, EUR RESPIR J, V47, P352, DOI 10.1183/13993003.01366-2015; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Aukland SM, 2006, AM J ROENTGENOL, V187, P1012, DOI 10.2214/AJR.05.0383; Bafadhel M, 2020, LANCET RESP MED, V8, P133, DOI 10.1016/S2213-2600(19)30414-X; Bafadhel M, 2018, LANCET RESP MED, V6, P117, DOI 10.1016/S2213-2600(18)30006-7; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Balasubramanian V, 2012, CURR OPIN PULM MED, V18, P112, DOI 10.1097/MCP.0b013e32834feb37; Balbirsingh V, 2022, THORAX, V77, P939, DOI 10.1136/thoraxjnl-2021-218333; Baldwin GC, 1997, AM J RESP CRIT CARE, V156, P1606, DOI 10.1164/ajrccm.156.5.9704146; Balmes JR, 2019, J ALLERGY CLIN IMMUN, V143, P1979, DOI 10.1016/j.jaci.2019.04.016; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Barker BL, 2015, CHEST, V147, P46, DOI 10.1378/chest.14-0764; Bellisario V, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16204048; Bhatt SP, 2022, ANN AM THORAC SOC, V19, P332, DOI 10.1513/AnnalsATS.202104-419RL; Bhatt SP, 2019, JAMA-J AM MED ASSOC, V321, P2438, DOI 10.1001/jama.2019.7233; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Bhatta DN, 2020, AM J PREV MED, V58, P182, DOI 10.1016/j.amepre.2019.07.028; Bhattarai P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092778; Bigna JJ, 2018, LANCET GLOB HEALTH, V6, pE182, DOI 10.1016/S2214-109X(17)30451-5; Blackstock FC, 2016, ANN AM THORAC SOC, V13, P317, DOI 10.1513/AnnalsATS.201509-600PS; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bodduluri S, 2018, ANN AM THORAC SOC, V15, P281, DOI 10.1513/AnnalsATS.201705-377FR; Boeck L, 2016, CHEST, V150, P1091, DOI 10.1016/j.chest.2016.05.019; Bolton C E, 2007, COPD, V4, P121, DOI 10.1080/15412550701341053; Boucher RC, 2019, NEW ENGL J MED, V380, P1941, DOI 10.1056/NEJMra1813799; Brasier AR, 2018, EXPERT REV RESP MED, V12, P931, DOI 10.1080/17476348.2018.1526677; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buhl R, 2022, J ALLER CL IMM-PRACT, V10, P422, DOI 10.1016/j.jaip.2021.10.059; Bui DS, 2022, LANCET RESP MED, V10, P478, DOI 10.1016/S2213-2600(21)00508-7; Bui DS, 2020, LANCET RESP MED, V9, P387, DOI 10.1016/S2213-2600(20)30413-6; Bui DS, 2018, ANN AM THORAC SOC, V15, P1057, DOI 10.1513/AnnalsATS.201806-374OC; Bui DS, 2018, LANCET RESP MED, V6, P535, DOI 10.1016/S2213-2600(18)30100-0; Bui DS, 2017, AM J RESP CRIT CARE, V196, P39, DOI [10.1164/rccm.201606-1272oc, 10.1164/rccm.201606-1272OC]; BusinessWire, 2014, BUSINESSWIRE; Calle EA, 2014, IEEE T BIO-MED ENG, V61, P1482, DOI 10.1109/TBME.2014.2314261; Camp PG, 2014, EUR RESPIR J, V43, P725, DOI 10.1183/09031936.00206112; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Carreras G, 2021, PEDIATR RES, V90, P216, DOI 10.1038/s41390-020-01223-6; Celli BR, 2021, AM J RESP CRIT CARE, V204, P1251, DOI 10.1164/rccm.202108-1819PP; Chalmers JD, 2020, NEW ENGL J MED, V383, P2127, DOI 10.1056/NEJMoa2021713; Chang HY, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.577673; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Chen XG, 2011, ENVIRON RES, V111, P1215, DOI 10.1016/j.envres.2011.08.003; Cho MH, 2022, LANCET RESP MED, V10, P485, DOI 10.1016/S2213-2600(21)00510-5; Cordova FC, 2016, TELEMED E-HEALTH, V22, P114, DOI 10.1089/tmj.2015.0035; Correia JC, 2021, B WORLD HEALTH ORGAN, V99, P209, DOI 10.2471/BLT.19.250068; Criner GJ, 2019, NEW ENGL J MED, V381, P1023, DOI 10.1056/NEJMoa1905248; Criner GJ, 2022, COPD-J COPD FDN, V9, DOI 10.15326/jcopdf.2022.0296; Criner GJ, 2015, CHEST, V147, P894, DOI 10.1378/chest.14-1676; Crisafulli E, 2020, SEMIN RESP CRIT CARE, V41, P817, DOI 10.1055/s-0040-1702196; Cuttica MJ, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.010672, 10.1161/jaha.118.010672]; Dai X, 2019, CHEST, V155, P94, DOI 10.1016/j.chest.2018.08.1079; Dash S, 2021, J PUBLIC HEALTH POL, V42, P501, DOI 10.1057/s41271-021-00287-w; De Matteis S, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0080-2017; De Santis MM, 2021, ADV MATER, V33, DOI 10.1002/adma.202005476; Decrue F, 2022, AM J RESP CRIT CARE, V205, P99, DOI 10.1164/rccm.202102-0272OC; Delgado-Eckert E, 2021, J ALLERGY CLIN IMMUN, V148, P407, DOI 10.1016/j.jaci.2020.12.652; Deutz NE, 2021, CLIN NUTR, V40, P1388, DOI 10.1016/j.clnu.2020.08.031; Dicker AJ, 2021, J ALLERGY CLIN IMMUN, V147, P158, DOI 10.1016/j.jaci.2020.02.040; DiGiulio A, 2020, MMWR-MORBID MORTAL W, V69, P155, DOI 10.15585/mmwr.mm6906a2; Dimasuay KG, 2018, CLIN SCI, V132, P1711, DOI 10.1042/CS20180337; Ding YP, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.773; Donohue JF, 2018, PULM PHARMACOL THER, V49, P11, DOI 10.1016/j.pupt.2017.12.005; Donovan C, 2016, TRENDS PHARMACOL SCI, V37, P252, DOI 10.1016/j.tips.2016.01.004; Donovan T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013432.pub2; Dournes G, 2015, AM J RESP CRIT CARE, V191, P63, DOI 10.1164/rccm.201408-1423OC; Drake P, 2018, CIGARETTE SMOKING PR; Dransfield M, 2022, AM J RESP CRIT CARE, V205, P631, DOI 10.1164/rccm.202109-2064TR; Dransfield M, 2019, LANCET, V393, P1786, DOI 10.1016/S0140-6736(19)30950-X; Dransfield MT, 2021, ANN AM THORAC SOC, V18, P788, DOI 10.1513/AnnalsATS.202002-096OC; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Drummond MB, 2016, SEMIN RESP CRIT CARE, V37, P277, DOI 10.1055/s-0036-1578801; Dumont EF, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.02267-19; Dvir T, 2011, NANO LETT, V11, P4411, DOI 10.1021/nl2025882; Saul EE, 2020, NAT CANCER, V1, P1140, DOI 10.1038/s43018-020-00142-z; Ejike CO, 2021, AM J RESP CRIT CARE, V203, P987, DOI 10.1164/rccm.202002-0253OC; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; El-Boraie A, 2021, CLIN PHARMACOL THER, V110, P599, DOI 10.1002/cpt.2345; Elliot J, 1998, AM J RESP CRIT CARE, V158, P802, DOI 10.1164/ajrccm.158.3.9709055; Elowsson Rendin L, 2021, FRONT PHARMACOL, V12; Ernst P, 2015, EUR RESPIR J, V45, P525, DOI 10.1183/09031936.00128914; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Evans-Polce R, 2020, AM J PUBLIC HEALTH, V110, P163, DOI 10.2105/AJPH.2019.305421; Faber T, 2017, LANCET PUBLIC HEALTH, V2, pE420, DOI 10.1016/S2468-2667(17)30144-5; Filippone M, 2009, JAMA-J AM MED ASSOC, V302, P1418, DOI 10.1001/jama.2009.1419; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fligiel SEG, 1997, CHEST, V112, P319, DOI 10.1378/chest.112.2.319; Flor LS, 2021, NAT MED, V27, P239, DOI 10.1038/s41591-020-01210-8; Frei A, 2016, CHEST, V150, P860, DOI 10.1016/j.chest.2016.06.031; Galdi F, 2021, RESP RES, V22, DOI 10.1186/s12931-020-01610-x; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Ghasemiesfe M, 2018, ANN INTERN MED, V169, P106, DOI [10.7326/M18-0522, 10.7326/m18-0522]; Ghosh A, 2018, AM J RESP CRIT CARE, V198, P67, DOI 10.1164/rccm.201710-2033OC; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; Gingo MR, 2018, ANN AM THORAC SOC, V15, P192, DOI 10.1513/AnnalsATS.201606-492OC; Government of Canada, 2021, CAN CANN SURV 2020 S; Gray DM, 2017, AM J RESP CRIT CARE, V195, P212, DOI [10.1164/rccm.201601-0188OC, 10.1164/rccm.201601-01880C]; Greulich T, 2017, RESP MED, V132, P132, DOI 10.1016/j.rmed.2017.10.007; Groot E, 2019, INT J OCCUP MED ENV, V32, P121, DOI 10.13075/ijomeh.1896.01326; Gruss I, 2021, J PATIENT-REP OUTCOM, V5, DOI 10.1186/s41687-021-00399-7; Guiedem E, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-00381-w; Han MLK, 2021, AM J RESP CRIT CARE, V203, P414, DOI 10.1164/rccm.202008-3328PP; Han MLK, 2016, LANCET RESP MED, V4, P473, DOI 10.1016/S2213-2600(16)00094-1; Hansel NN, 2022, AM J RESP CRIT CARE, V205, P421, DOI 10.1164/rccm.202103-0604OC; Hansel NN, 2013, AM J RESP CRIT CARE, V187, P1085, DOI 10.1164/rccm.201211-1987OC; Hanson C, 2016, CLIN NUTR, V35, P169, DOI 10.1016/j.clnu.2015.01.020; Hartinger SM, 2013, INDOOR AIR, V23, P342, DOI 10.1111/ina.12027; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Hartman JE, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0281-2020; Hassoun PM, 2021, NEW ENGL J MED, V385, P2361, DOI 10.1056/NEJMra2000348; HEYOB KM, 2019, J PHYSL LUNG CELL MO, V317, pL16, DOI DOI 10.1152/AJPLUNG.00331.2018; Ho SY, 2007, ANN EPIDEMIOL, V17, P126, DOI 10.1016/j.annepidem.2006.06.010; Hoffer-Hawlik M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254222; Hoffman TW, 2018, CURR OPIN PULM MED, V24, P269, DOI 10.1097/MCP.0000000000000475; Hoffmann B, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.1604465; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Holland AE, 2021, ANN AM THORAC SOC, V18, pE12, DOI 10.1513/AnnalsATS.202102-146ST; Holloway RA, 2013, CURR OPIN PULM MED, V19, P95, DOI 10.1097/MCP.0b013e32835cfff5; Holverda S, 2020, LANCET RESP MED, V8, pE25, DOI 10.1016/S2213-2600(20)30123-5; Hoogendoorn M, 2019, VALUE HEALTH, V22, P313, DOI 10.1016/j.jval.2018.10.008; Hutchinson SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093220; Iyer AS, 2022, ANN AM THORAC SOC, V19, P143, DOI 10.1513/AnnalsATS.202103-240RL; Jia J, 2016, AM J PHYSIOL-LUNG C, V311, pL602, DOI 10.1152/ajplung.00124.2016; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jolliffe DA, 2019, THORAX, V74, P337, DOI 10.1136/thoraxjnl-2018-212092; Jones P, 2012, INT J CHRONIC OBSTR, V7, P697, DOI 10.2147/COPD.S32675; Kalhan R, 2018, AM J RESP CRIT CARE, V197, P1616, DOI 10.1164/rccm.201710-2108OC; Karakioulaki M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0124-2019; Keogh E, 2021, RESP MED, V176, DOI 10.1016/j.rmed.2020.106248; Kim T, 2020, COPD, V17, P49, DOI 10.1080/15412555.2019.1698530; Kim VL, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00853-2017; King GG, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00753-2019; Konietzke P, 2018, RESPIRATION, V96, P231, DOI 10.1159/000489177; Kordinas V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090060; Krings JG, 2021, J ALLERGY CLIN IMMUN, V148, P752, DOI 10.1016/j.jaci.2021.01.029; Kunzli N, 2006, AM J RESP CRIT CARE, V174, P1221, DOI 10.1164/rccm.200604-519OC; Lakner C, 2020, UPDATED ESTIMATES IM; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; Lee K, 2009, GLOB INST, P1; Leijten FRM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021072; Lemoine Chantal, 2020, Ann Am Thorac Soc, V17, P378, DOI 10.1513/AnnalsATS.201910-740RL; Lenferink A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02134-2018; Li DM, 2020, PREV MED, V139, DOI 10.1016/j.ypmed.2020.106215; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Liu JC, 2017, AM J EPIDEMIOL, V186, P730, DOI 10.1093/aje/kwx141; Liu YY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00342; Lodge CJ, 2014, AM J RESP CRIT CARE, V189, P1351, DOI 10.1164/rccm.201308-1487OC; Lovasi GS, 2010, AM J EPIDEMIOL, V171, P54, DOI 10.1093/aje/kwp358; Lowe KE, 2019, COPD-J COPD FDN, V6, P384, DOI 10.15326/jcopdf.6.5.2019.0149; Lopez-Campos JL, 2014, COPD, V11, P591, DOI 10.3109/15412555.2014.898035; MacDonald MI, 2016, LANCET RESP MED, V4, P138, DOI 10.1016/S2213-2600(15)00509-3; Magnus MC, 2018, INT J EPIDEMIOL, V47, P1855, DOI 10.1093/ije/dyy221; Carro LM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102210; Man WH, 2019, LANCET RESP MED, V7, P417, DOI [10.1016/S2213-2600(18)30449-1, 10.1016/s2213-2600(18)30449-1]; Mantey DS, 2021, NICOTINE TOB RES, V23, P1327, DOI 10.1093/ntr/ntaa222; Martin EM, 2016, AM J PHYSIOL-LUNG C, V311, pL135, DOI 10.1152/ajplung.00170.2016; Martinez FJ, 2015, LANCET, V385, P857, DOI 10.1016/S0140-6736(14)62410-7; Martinez-Baz I, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-08952-0; Matin S, 2018, INT J CHRONIC OBSTR, V13, P1449, DOI 10.2147/COPD.S155985; Mayhew D, 2018, THORAX, V73, P422, DOI 10.1136/thoraxjnl-2017-210408; McDonald MLN, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1073-3; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Menzies-Gow A, 2021, NEW ENGL J MED, V384, P1800, DOI 10.1056/NEJMoa2034975; Gutierrez-Mariscal FM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217870; Miller J, 2013, RESP MED, V107, P1376, DOI 10.1016/j.rmed.2013.05.001; Mohan A, 2010, RESPIROLOGY, V15, P536, DOI 10.1111/j.1440-1843.2010.01722.x; Mohan SS, 2015, CLIN ENDOCRINOL, V83, P268, DOI 10.1111/cen.12738; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; Mwasuku C, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.congress-2021.PA1805; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; National Centers for Environmental Information, 2022, JUN 2022 WILDF REP; Negrini S, 2021, EUR J PHYS REHAB MED, V57, P478, DOI 10.23736/S1973-9087.21.07075-1; Denetdale JN, 2007, NEW MEX HIST REV, V82, P295; Nyilas S, 2016, J APPL PHYSIOL, V121, P324, DOI 10.1152/japplphysiol.00086.2016; O'Toole J, 2022, ANN AM THORAC SOC, V19, P171, DOI 10.1513/AnnalsATS.202009-1187OC; Olofson J, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00383-2021; Orhon FS, 2009, EUR J PEDIATR, V168, P975, DOI 10.1007/s00431-008-0873-0; Ortega VE, 2020, AM J RESP CRIT CARE, V201, P540, DOI 10.1164/rccm.201904-0769OC; Osei AD, 2020, AM J PREV MED, V58, P336, DOI 10.1016/j.amepre.2019.10.014; Papakonstantinou E, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01941-2018; Papakonstantinou E, 2015, CHEST, V148, P1497, DOI 10.1378/chest.15-0153; Park HY, 2020, THORAX, V75, P506, DOI 10.1136/thoraxjnl-2019-213732; Pascoe S, 2019, LANCET RESP MED, V7, P745, DOI 10.1016/S2213-2600(19)30190-0; Paulin LM, 2018, ANN AM THORAC SOC, V15, P1411, DOI 10.1513/AnnalsATS.201802-150OC; Pavord ID, 2017, NEW ENGL J MED, V377, P1613, DOI 10.1056/NEJMoa1708208; Perez MF, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203938; Perez-Padilla R, 2014, CHRON OBSTR PULM DIS, V1, P23, DOI 10.15326/jcopdf.1.1.2013.0004; Perret JL, 2020, THORAX, V75, P28, DOI 10.1136/thoraxjnl-2019-213389; Perret JL, 2016, RESPIROLOGY, V21, P911, DOI 10.1111/resp.12750; Pesci A, 1998, RESP MED, V92, P863, DOI 10.1016/S0954-6111(98)90389-4; Pignatti P, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1111-1; Polverino F, 2018, AM J MED, V131, pS1, DOI 10.1016/j.amjmed.2018.05.001; Pope D, 2017, ENVIRON INT, V101, P7, DOI 10.1016/j.envint.2017.01.012; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Rabe Klaus F, 2021, Lancet Respir Med, V9, P1288, DOI 10.1016/S2213-2600(21)00167-3; Rabe KF, 2020, NEW ENGL J MED, V383, P35, DOI 10.1056/NEJMoa1916046; Rajappan A, 2017, PEDIATR PULM, V52, P1291, DOI 10.1002/ppul.23779; Raju SV, 2017, AM J RESP CELL MOL, V56, P99, DOI 10.1165/rcmb.2016-0226OC; Raju SV, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-18; Raju SV, 2013, AM J RESP CRIT CARE, V188, P1321, DOI 10.1164/rccm.201304-0733OC; Raju S, 2019, AM J RESP CRIT CARE, V199, P961, DOI 10.1164/rccm.201807-1374OC; Ramsheh MY, 2021, LANCET MICROBE, V2, pE300, DOI 10.1016/S2666-5247(21)00035-5; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Rennard SI, 2015, AM J RESP CRIT CARE, V191, P1001, DOI 10.1164/rccm.201405-0992OC; Reyfman PA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-053342; Reyfman PA, 2021, AM J RESP CRIT CARE, V203, P1435, DOI 10.1164/rccm.202011-4150LE; Reyfman PA, 2018, AM J RESP CRIT CARE, V198, P440, DOI 10.1164/rccm.201801-0120PP; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Rochester CL, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00085-2018; Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST; Rock J, 2012, AM J RESP CRIT CARE, V186, P1213, DOI 10.1164/rccm.201207-1151PP; Roscioli E, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0945-2; Rothnie KJ, 2016, HEART, V102, P1442, DOI 10.1136/heartjnl-2016-309359; Rutten-van Molken M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3367-4; Sadhra S, 2017, INT J CHRONIC OBSTR, V12, P725, DOI 10.2147/COPD.S125980; Saglani S, 2005, AM J RESP CRIT CARE, V171, P722, DOI 10.1164/rccm.200410-1404OC; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Sandberg CEJ, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13309; Sarna M, 2018, THORAX, V73, P969, DOI 10.1136/thoraxjnl-2017-210233; Schumann DM, 2019, CHEST, V156, P456, DOI 10.1016/j.chest.2019.04.012; Schumann DM, 2018, CHEST, V154, P798, DOI 10.1016/j.chest.2018.06.028; Segal LN, 2017, THORAX, V72, P13, DOI 10.1136/thoraxjnl-2016-208599; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Sethi Sanjay, 2008, N Engl J Med, V359, P2355, DOI 10.1056/NEJMra0800353; Shaddick G, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-020-0124-2; Shukla SD, 2022, INFLAMMOPHARMACOLOGY, V30, P725, DOI 10.1007/s10787-022-00968-2; Siddharthan T, 2020, INT J CHRONIC OBSTR, V15, P2769, DOI 10.2147/COPD.S268076; Siddharthan T, 2018, AM J RESP CRIT CARE, V197, P611, DOI 10.1164/rccm.201709-1861OC; Silver SR, 2021, AM J IND MED, V64, P26, DOI 10.1002/ajim.23196; Simpson SJ, 2018, LANCET CHILD ADOLESC, V2, P350, DOI 10.1016/S2352-4642(18)30064-6; Singh D, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01482-1; Singh D, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00164-2019; Sivapalan P, 2019, LANCET RESP MED, V7, P699, DOI 10.1016/S2213-2600(19)30176-6; Slovis BH, 2017, J AM MED INFORM ASSN, V24, P30, DOI 10.1093/jamia/ocw035; Smith BM, 2020, JAMA-J AM MED ASSOC, V323, P2268, DOI 10.1001/jama.2020.6918; Smith Hopkins J, 2017, INVISIBLE HAZARD AFF; Soriano JB, 2020, LANCET RESP MED, V8, P585, DOI 10.1016/S2213-2600(20)30105-3; Southworth T, 2021, J CELL MOL MED, V25, P2203, DOI 10.1111/jcmm.16206; Squassoni SD, 2021, INT J CHRONIC OBSTR, V16, P3561, DOI 10.2147/COPD.S332613; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Stanley SE, 2016, ANN AM THORAC SOC, V13, pS447, DOI 10.1513/AnnalsATS.201609-718AW; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Stolz D, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00407-2019; Stolz D, 2018, AM J RESP CRIT CARE, V197, P1136, DOI 10.1164/rccm.201709-1807OC; Stolz D, 2017, CHEST, V151, P47, DOI 10.1016/j.chest.2016.08.1440; Strange C, 2020, CLIN CHEST MED, V41, P339, DOI 10.1016/j.ccm.2020.05.003; Sumida K, 2017, AM J KIDNEY DIS, V70, P675, DOI 10.1053/j.ajkd.2017.05.021; Tan JY, 2021, THORAX, V76, P512, DOI 10.1136/thoraxjnl-2020-216083; Tan WC, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00826-2019; Tattan-Birch H, 2022, LANCET REG HEALTH-EU, V15, DOI 10.1016/j.lanepe.2022.100315; Taylor SL, 2021, PAEDIATR RESPIR REV, V40, P15, DOI 10.1016/j.prrv.2021.05.003; Thomsen M, 2013, LANCET RESP MED, V1, P543, DOI 10.1016/S2213-2600(13)70137-1; Thygesen K, 2018, CIRCULATION, V138, pE618, DOI 10.1161/CIR.0000000000000617; Tiew PY, 2020, EUR RESPIR J, V57; Topalovic M, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0252-0; Triplette M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170857; Troosters T, 2018, AM J RESP CRIT CARE, V198, P1021, DOI 10.1164/rccm.201706-1288OC; Tsai CL, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.586900; UNICEF WHO World Bank Group, 2018, LEV TRENDS CHILD MAL; Upton MN, 2004, AM J RESP CRIT CARE, V169, P479, DOI 10.1164/rccm.200211-1357OC; Urs R, 2018, PAEDIATR RESPIR REV, V28, P87, DOI 10.1016/j.prrv.2018.04.001; US Centers for Disease Control and Prevention, 2021, DAT BRIEF 427 MORT; US Environmental Protection Agency, IND AIR QUAL TOOLS S; US Environmental Protection Agency, NATL AIR QUAL STAT T; US National Institutes of Health, 2022, EST FUND VAR RES CON; Usemann J, 2019, ENVIRON INT, V126, P682, DOI 10.1016/j.envint.2018.12.019; van Gemert F, 2019, NPJ PRIM CARE RESP M, V29, DOI 10.1038/s41533-019-0144-8; van Haarst A, 2019, CLIN PHARMACOL THER, V106, P1222, DOI 10.1002/cpt.1540; Vanfleteren LEGW, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01696-2016; Vanoverschelde A, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2020-000823; Vardavas CI, 2016, EUR RESPIR J, V48, P115, DOI 10.1183/13993003.01016-2015; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Verberkt CA, 2020, JAMA INTERN MED, V180, P1306, DOI 10.1001/jamainternmed.2020.3134; Vogelmeier C, 2012, COPD, V9, P111, DOI 10.3109/15412555.2011.641803; Voynow JA, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081065; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; Wan ES, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0089-y; Wang XT, 2021, J MOL CELL BIOL, V13, P128, DOI 10.1093/jmcb/mjaa079; Wang Z, 2021, AM J RESP CRIT CARE, V203, P1488, DOI 10.1164/rccm.202009-3448OC; Wechsler ME, 2021, NEW ENGL J MED, V385, P1656, DOI 10.1056/NEJMoa2024257; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Wells JM, 2019, ANN AM THORAC SOC, V16, P439, DOI 10.1513/AnnalsATS.201807-441OC; Wen Yudong, 2010, Int J Chron Obstruct Pulmon Dis, V5, P327, DOI 10.2147/COPD.S11343; WHO, 1990, ACUTE RESP INFECT; WHO, 2018, GLOB STRAT WOM CHILD; WHO, 2018, PRET BIRTH; WHO Department of Data and Analytics, 2020, GLOB HLTH EST 2019 D; Winkler T, 2021, J ALLERGY CLIN IMMUN, V148, P710, DOI 10.1016/j.jaci.2021.07.010; Wood-Baker RR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub2; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; World Health Organization, 2019, WHO REP GLOB TOB EP; Yakar HI, 2017, INT J CHRONIC OBSTR, V12, P323, DOI 10.2147/COPD.S116086; Yang IA, 2022, LANCET RESP MED, V10, P497, DOI 10.1016/S2213-2600(21)00506-3; Yong PC, 2020, CHEST, V157, P236, DOI 10.1016/j.chest.2019.08.2176; Young RP, 2018, TRANSL LUNG CANCER R, V7, P347, DOI 10.21037/tlcr.2018.05.04; Zhao DX, 2018, RESPIROLOGY, V23, P198, DOI 10.1111/resp.13176; Zhao Q, 2019, THORAX, V74, P1031, DOI 10.1136/thoraxjnl-2019-213486; Zhou JJ, 2013, AM J RESP CRIT CARE, V188, P941, DOI 10.1164/rccm.201302-0263OC; Zhou YM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001621; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	325	1	1	11	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					921	972		10.1016/S0140-6736(22)01273-9	http://dx.doi.org/10.1016/S0140-6736(22)01273-9			52	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36075255				2022-12-28	WOS:000890180700025
J	Mechali, M				Mechali, Marcel			Replication timing and genetic instability	SCIENCE			English	Editorial Material							DNA; ORIGINS; DOMAINS; SITES; MYC		[Mechali, Marcel] Univ Montpellier, CNRS, Inst Human Genet, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), Univ Montpellier, CNRS, Inst Human Genet, Montpellier, France.	marcel.mechali@igh.cnrs.fr						Akerman I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18527-0; Alavi S, 2021, J BIOCHEM, V169, P1, DOI 10.1093/jb/mvaa128; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Bisso A, 2019, IMMUNOL REV, V288, P178, DOI 10.1111/imr.12734; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Montefiori L, 2016, CELL REP, V14, P896, DOI 10.1016/j.celrep.2015.12.083; Parker MW, 2019, ELIFE, V8, DOI 10.7554/eLife.48562; Peycheva M., 2022, SCIENCE, V377; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Waltz SE, 1996, NUCLEIC ACIDS RES, V24, P1887, DOI 10.1093/nar/24.10.1887; Wiedemann EM, 2016, CELL REP, V17, P2927, DOI 10.1016/j.celrep.2016.11.041	14	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1259	1260		10.1126/science.ade4734	http://dx.doi.org/10.1126/science.ade4734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108000				2022-12-28	WOS:000887933500021
J	Fukamachi, D; Okumura, Y				Fukamachi, Daisuke; Okumura, Yasuo			Giant Coronary-Artery Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Giant Coronary-Artery Aneurysm A 79-year-old woman was referred to the cardiovascular outpatient clinic because of an abnormal radiographic finding along the left border of her heart. Cardiac catheterization is shown in a video.	[Fukamachi, Daisuke; Okumura, Yasuo] Nihon Univ, Sch Med, Tokyo, Japan	Nihon University	Fukamachi, D (corresponding author), Nihon Univ, Sch Med, Tokyo, Japan.	fukamachi.daisuke@nihon-u.ac.jp							0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11							e23	10.1056/NEJMicm2119409	http://dx.doi.org/10.1056/NEJMicm2119409			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36103416				2022-12-28	WOS:000865415300001
J	Kapil, V; Schran, C; Zen, A; Chen, J; Pickard, CJ; Michaelides, A				Kapil, Venkat; Schran, Christoph; Zen, Andrea; Chen, Ji; Pickard, Chris J.; Michaelides, Angelos			The first-principles phase diagram of monolayer nanoconfined water	NATURE			English	Article							TRANSPORT; FRICTION; ICE	Water in nanoscale cavities is ubiquitous and of central importance to everyday phenomena in geology and biology. However, the properties of nanoscale water can be substantially different from those of bulk water, as shown, for example, by the anomalously low dielectric constant of water in nanochannels(1), near frictionless water flow(2) or the possible existence of a square ice phase(3). Such properties suggest that nanoconfined water could be engineered for technological applications in nanofluidics(4), electrolyte materials(5) and water desalination(6). Unfortunately, challenges in experimentally characterizing water at the nanoscale and the high cost of first-principles simulations have prevented the molecular-level understanding required to control the behaviour of water. Here we combine a range of computational approaches to enable a first-principles-level investigation of a single layer of water within a graphene-like channel. We find that monolayer water exhibits surprisingly rich and diverse phase behaviour that is highly sensitive to temperature and the van der Waals pressure acting within the nanochannel. In addition to multiple molecular phases with melting temperatures varying non-monotonically by more than 400 kelvins with pressure, we predict a hexatic phase, which is an intermediate between a solid and a liquid, and a superionic phase with a high electrical conductivity exceeding that of battery materials. Notably, this suggests that nanoconfinement could be a promising route towards superionic behaviour under easily accessible conditions.	[Kapil, Venkat; Schran, Christoph; Michaelides, Angelos] Univ Cambridge, Yusuf Hamied Dept Chem, Cambridge, England; [Schran, Christoph; Michaelides, Angelos] UCL, Dept Phys & Astron, London, England; [Schran, Christoph; Michaelides, Angelos] London Ctr Nanotechnol, Thomas Young Ctr, London, England; [Zen, Andrea] Univ Napoli Federico II, Dipartimento Fis Ettore Pancini, Naples, Italy; [Zen, Andrea] UCL, Dept Earth Sci, London, England; [Chen, Ji] Peking Univ, Interdisciplinary Inst Light Element Quantum Mat, Sch Phys, Beijing, Peoples R China; [Chen, Ji] Peking Univ, Frontiers Sci Ctr Nanooptoelect, Beijing, Peoples R China; [Pickard, Chris J.] Univ Cambridge, Dept Mat Sci & Met, Cambridge, England; [Pickard, Chris J.] Tohoku Univ, Adv Inst Mat Res, Sendai, Miyagi, Japan	University of Cambridge; University of London; University College London; University of London; University College London; University of Naples Federico II; University of London; University College London; Peking University; Peking University; University of Cambridge; Tohoku University	Kapil, V; Schran, C; Michaelides, A (corresponding author), Univ Cambridge, Yusuf Hamied Dept Chem, Cambridge, England.; Schran, C; Michaelides, A (corresponding author), UCL, Dept Phys & Astron, London, England.; Schran, C; Michaelides, A (corresponding author), London Ctr Nanotechnol, Thomas Young Ctr, London, England.	vk380@cam.ac.uk; cs2121@cam.ac.uk; am452@cam.ac.uk	Zen, Andrea/O-3076-2019	Zen, Andrea/0000-0002-7648-4078; Michaelides, Angelos/0000-0002-9169-169X	Engineering and Physical Sciences Research Council [EP/P020259/1, EP/P020194/1, EP/T022213/1]; Swiss National Science Foundation (SNSF) [P2ELP2_191678]; Ernest Oppenheimer Fund [s1000]; Churchill College, University of Cambridge; Alexander von Humboldt Stiftung; Leverhulme Trust [RPG-2020-038]; Science and Technology Facilities Council; National Natural Science Foundation of China [11974024]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB33000000]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Ernest Oppenheimer Fund; Churchill College, University of Cambridge(University of Cambridge); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Leverhulme Trust(Leverhulme Trust); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank D. Frenkel for discussions; D. M. Wilkins for providing the code to study the angular orientation of water; F. L. Thiemann for help with hydrogen bond analysis; M. Davies for help with visualization and graphics; P. Ravindra for reading the manuscript; and the staff at the UK Materials and Molecular Modelling Hub for computational resources, which is partially funded by Engineering and Physical Sciences Research Council (grants EP/P020194/1 and EP/T022213/1). V.K. acknowledges funding from the Swiss National Science Foundation (SNSF) under project P2ELP2_191678 and the Ernest Oppenheimer Fund, allocation of CPU hours by CSCS under Project ID s1000 and support from Churchill College, University of Cambridge. C.S. acknowledges financial support from the Alexander von Humboldt Stiftung. A.Z. acknowledges financial support from the Leverhulme Trust (grant number RPG-2020-038). Calculations were also performed on the Cambridge Service for Data Driven Discovery (CSD3) operated by the University of Cambridge Research Computing Service (www.csd3.cam.ac.uk), provided by Dell EMC and Intel using Tier-2 funding from the Engineering and Physical Sciences Research Council (capital grant EP/P020259/1), and DiRAC funding from the Science and Technology Facilities Council (www.dirac.ac.uk).J.C.acknowledges funding from the National Natural Science Foundation of China under grant no. 11974024, and the Strategic Priority Research Program of Chinese Academy of Sciences under grant no. XDB33000000.	Algara-Siller G, 2015, NATURE, V519, P443, DOI 10.1038/nature14295; Behler J, 2021, CHEM REV, V121, P10037, DOI 10.1021/acs.chemrev.0c00868; Bjorkman T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235502; Brandenburg JG, 2019, J PHYS CHEM LETT, V10, P358, DOI 10.1021/acs.jpclett.8b03679; Chen J, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.220102; Chen J, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.025501; Cheng BQ, 2019, P NATL ACAD SCI USA, V116, P1110, DOI 10.1073/pnas.1815117116; Conde MM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824627; Corsetti F, 2016, SCI REP-UK, V6, DOI 10.1038/srep18651; Ferguson AL, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755750; Fumagalli L, 2018, SCIENCE, V360, P1339, DOI 10.1126/science.aat4191; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Grasselli F, 2019, NAT PHYS, V15, P967, DOI 10.1038/s41567-019-0562-0; Larsen AH, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa680e; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jiang J, 2021, J AM CHEM SOC, V143, P8177, DOI 10.1021/jacs.1c03243; Kapil V, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2111769119; Kapil V, 2019, COMPUT PHYS COMMUN, V236, P214, DOI 10.1016/j.cpc.2018.09.020; Kavokine N, 2022, NATURE, V602, P84, DOI 10.1038/s41586-021-04284-7; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; Kuhne TD, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0007045; Li SJ, 2019, PHYS CHEM CHEM PHYS, V21, P17640, DOI 10.1039/c9cp00849g; Marsalek O, 2017, J PHYS CHEM LETT, V8, P1545, DOI 10.1021/acs.jpclett.7b00391; Millot M, 2019, NATURE, V569, P251, DOI 10.1038/s41586-019-1114-6; Millot M, 2018, NAT PHYS, V14, P297, DOI 10.1038/s41567-017-0017-4; MITAS L, 1991, J CHEM PHYS, V95, P3467, DOI 10.1063/1.460849; Munoz-Santiburcio D, 2021, CHEM REV, V121, P6293, DOI 10.1021/acs.chemrev.0c01292; Needs RJ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/023201; Nigues A, 2014, NAT MATER, V13, P688, DOI [10.1038/NMAT3985, 10.1038/nmat3985]; Pickard CJ, 2007, NAT PHYS, V3, P473, DOI 10.1038/nphys625; Pickard CJ, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/5/053201; Radha B, 2016, NATURE, V538, P222, DOI 10.1038/nature19363; Schran C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2110077118; Schran C, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0016004; Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315; Singraber A, 2019, J CHEM THEORY COMPUT, V15, P1827, DOI 10.1021/acs.jctc.8b00770; Sugimura E, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766816; Surwade SP, 2015, NAT NANOTECHNOL, V10, P459, DOI [10.1038/nnano.2015.37, 10.1038/NNANO.2015.37]; Vilanova O., 2011, ARXIV; Zamborlini G, 2015, NANO LETT, V15, P6162, DOI 10.1021/acs.nanolett.5b02475; Zen A, 2018, P NATL ACAD SCI USA, V115, P1724, DOI 10.1073/pnas.1715434115; Zhu YB, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4979478	43	1	1	71	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					512	+		10.1038/s41586-022-05036-x	http://dx.doi.org/10.1038/s41586-022-05036-x		SEP 2022	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104556	Green Submitted			2022-12-28	WOS:000854742300002
J	Rukhlenko, OS; Halasz, M; Rauch, N; Zhernovkov, V; Prince, T; Wynne, K; Maher, S; Kashdan, E; MacLeod, K; Carragher, NO; Kolch, W; Kholodenko, BN				Rukhlenko, Oleksii S.; Halasz, Melinda; Rauch, Nora; Zhernovkov, Vadim; Prince, Thomas; Wynne, Kieran; Maher, Stephanie; Kashdan, Eugene; MacLeod, Kenneth; Carragher, Neil O.; Kolch, Walter; Kholodenko, Boris N.			Control of cell state transitions	NATURE			English	Article							PROTEIN; QUANTIFICATION; NETWORKS; EXPRESSION; INHIBITOR; DYNAMICS; SYNERGY; TRKA	Understanding cell state transitions and purposefully controlling them is a longstanding challenge in biology. Here we present cell state transition assessment and regulation (cSTAR), an approach for mapping cell states, modelling transitions between them and predicting targeted interventions to convert cell fate decisions. cSTAR uses omics data as input, classifies cell states, and develops a work flow that transforms the input data into mechanistic models that identify a core signalling network, which controls cell fate transitions by influencing whole-cell networks. By integrating signalling and phenotypic data, cSTAR models how cells manoeuvre in Waddington's landscape' and make decisions about which cell fate to adopt. Notably, cSTAR devises interventions to control the movement of cells in Waddington's landscape. Testing cSTAR in a cellular model of differentiation and proliferation shows a high correlation between quantitative predictions and experimental data. Applying cSTARto different types of perturbation and omics datasets, including single-cell data, demonstrates its flexibility and scalability and provides new biological insights. The ability of cSTAR to identify targeted perturbations that interconvert cell fates will enable designer approaches for manipulating cellular development pathways and mechanistically underpinned therapeutic interventions.	[Rukhlenko, Oleksii S.; Halasz, Melinda; Rauch, Nora; Zhernovkov, Vadim; Prince, Thomas; Wynne, Kieran; Maher, Stephanie; Kashdan, Eugene; Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Sch Med, Syst Biol Ireland, Dublin, Ireland; [Halasz, Melinda; Kolch, Walter; Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst BiomoL & Biomed Res, Dublin, Ireland; [MacLeod, Kenneth; Carragher, Neil O.] Univ Edinburgh, Canc Res UK Edinburgh Ctr, Inst Genet & Canc, Edinburgh, Midlothian, Scotland; [Kholodenko, Boris N.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	University College Dublin; University College Dublin; University of Edinburgh; Yale University	Kholodenko, BN (corresponding author), Univ Coll Dublin, Sch Med, Syst Biol Ireland, Dublin, Ireland.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Conway Inst BiomoL & Biomed Res, Dublin, Ireland.; Kholodenko, BN (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	boris.kholodenko@ucd.ie	Admin, SBI/HGB-2738-2022; MacLeod, Kenneth/GWU-8940-2022	Maher, Stephanie/0000-0002-8159-3922; Zhernovkov, Vadim/0000-0001-8903-1142; Rauch, Nora/0000-0001-6009-5177	NIH/NCI [R01CA244660]; CRUK/Brain Tumour Charity grant [C42454/A28596]; IRC grant [GOIPG/2020/1361]; Science Foundation Ireland [14/IA/2395, 18/SPP/3522]; Children's Health Foundation; EU NanoCommons grant [731032]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CRUK/Brain Tumour Charity grant; IRC grant; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Health Foundation; EU NanoCommons grant	This work was supported by NIH/NCI grant R01CA244660, CRUK/Brain Tumour Charity grant C42454/A28596, EU NanoCommons grant 731032, IRC grant GOIPG/2020/1361 and Science Foundation Ireland grants 14/IA/2395 and 18/SPP/3522, the latter together with the Children's Health Foundation. We thank T. Santra for advising on Bayesian statistics, P. Cotter for IT assistance and C. Sander, B. Bodenmiller and S. Krishnaswamy for providing raw RPPA and CYTOF data.	Aron C, 2020, SCIPOST PHYS, V8, DOI 10.21468/SciPostPhys.8.5.074; Aygun N, 2018, CURR PEDIATR REV, V14, P73, DOI 10.2174/1573396314666180129101627; Bastiaens P, 2015, NAT BIOTECHNOL, V33, P336, DOI 10.1038/nbt.3185; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brackston RD, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006405; Chen WS, 2020, NAT METHODS, V17, P302, DOI 10.1038/s41592-019-0689-z; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Choy C, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0844-3; Cook DP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16066-2; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Ederer M, 2007, BIOPHYS J, V92, P1846, DOI 10.1529/biophysj.106.094094; Fey D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0990; GRECO WR, 1995, PHARMACOL REV, V47, P331; HAKEN H, 2004, SYNERGETICS INTRO AD; Halasz M, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0535; Holbeck SL, 2017, CANCER RES, V77, P3564, DOI 10.1158/0008-5472.CAN-17-0489; Hormoz S, 2016, CELL SYST, V3, P419, DOI 10.1016/j.cels.2016.10.015; Jeong J, 2016, P NATL ACAD SCI USA, V113, pE282, DOI 10.1073/pnas.1516138113; Jung EJ, 2010, MOL CELLS, V30, P121, DOI 10.1007/s10059-010-0096-x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelstrup CD, 2018, J PROTEOME RES, V17, P727, DOI 10.1021/acs.jproteome.7b00602; Kennedy SP, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1127-y; KHOLODENKO B N, 1980, Pharmaceutical Chemistry Journal (English Translation of Khimiko-Farmatsevticheskii Zhurnal), V14, P287; Kholodenko BN, 1997, FEBS LETT, V414, P430, DOI 10.1016/S0014-5793(97)01018-1; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kholodenko BN, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109157; Kholodenko BN, 2015, CELL REP, V12, P1939, DOI 10.1016/j.celrep.2015.08.014; Korkut A, 2015, ELIFE, V4, DOI 10.7554/eLife.04640; Krishna A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1154; Kuznetsov, 2013, ELEMENTS APPL BIFURC; LANDAU L., 1980, STAT PHYS, Vthird, P446; Lange M, 2022, NAT METHODS, V19, P159, DOI 10.1038/s41592-021-01346-6; Macleod KG, 2017, METHODS MOL BIOL, V1647, P153, DOI 10.1007/978-1-4939-7201-2_10; Mitra ED, 2019, ISCIENCE, V19, P1012, DOI 10.1016/j.isci.2019.08.045; Needham EJ, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau8645; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qiu XJ, 2022, CELL, V185, P690, DOI 10.1016/j.cell.2021.12.045; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rukhlenko OS, 2018, CELL SYST, V7, P161, DOI 10.1016/j.cels.2018.06.002; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Santra T., 2018, CURR OPIN SYST BIOL, V9, P11, DOI [10.1016/j.coisb.2018.02.003, DOI 10.1016/J.COISB.2018.02.003, DOI 10.1016/J.C0ISB.2018.02.003]; Santra T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-57; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Sethna JP, 2006, STAT MECH ENTROPY OR; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Thomaseth C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34353-3; Tsyganov MA, 2012, MOL BIOSYST, V8, P730, DOI 10.1039/c2mb05375f; Vaishnavi A, 2015, CANCER DISCOV, V5, P25, DOI 10.1158/2159-8290.CD-14-0765; WADDINGTON C. H., 1940; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Xicoy H, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0149-0; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yalamanchili N, 2006, IEE P SYST BIOL, V153, P236, DOI 10.1049/ip-syb:20050090; Yoneyama Y, 2018, ISCIENCE, V5, P1, DOI 10.1016/j.isci.2018.06.006; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	63	0	0	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					975	+		10.1038/s41586-022-05194-y	http://dx.doi.org/10.1038/s41586-022-05194-y		SEP 2022	43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z2JJ	36104561				2022-12-28	WOS:000854788200003
J	Xu, XY; Wang, TX; Chen, PC; Zhou, C; Ma, JA; Wei, DZ; Wang, HJ; Niu, B; Fang, XY; Wu, D; Zhu, SN; Gu, M; Xiao, M; Zhang, Y				Xu, Xiaoyi; Wang, Tianxin; Chen, Pengcheng; Zhou, Chao; Ma, Jianan; Wei, Dunzhao; Wang, Huijun; Niu, Ben; Fang, Xinyuan; Wu, Di; Zhu, Shining; Gu, Min; Xiao, Min; Zhang, Yong			Femtosecond laser writing of lithium niobate ferroelectric nanodomains	NATURE			English	Article							2ND-HARMONIC GENERATION; OPTICAL-PROPERTIES; LINBO3; RESONATORS; CRYSTALS; WAVES	Lithium niobate (LiNbO3) is viewed as a promising material for optical communications and quantum photonic chips(1,2). Recent breakthroughs in LiNbO3 nanophotonics have considerably boosted the development of high-speed electro-optic modulators(3-5), frequency combs(6,7) and broadband spectrometers(8). However, the traditional method of electrical poling for ferroelectric domain engineering in optic(9-13), acoustic(14-17) and electronic applications(18,19) is limited to two-dimensional space and micrometre-scale resolution. Here we demonstrate a non-reciprocal near-infrared laser-writing technique for reconfigurable three-dimensional ferroelectric domain engineering in LiNbO3 with nanoscale resolution. The proposed method is based on a laser-induced electric field that can either write or erase domain structures in the crystal, depending on the laser-writing direction. This approach offers a pathway for controllable nanoscale domain engineering in LiNbO3 and other transparent ferroelectric crystals, which has potential applications in high-efficiency frequency mixing(20,21), high-frequency acoustic resonators(14-17) and high-capacity non-volatile ferroelectric memory(19,22).	[Xu, Xiaoyi; Wang, Tianxin; Chen, Pengcheng; Zhou, Chao; Ma, Jianan; Wei, Dunzhao; Wang, Huijun; Niu, Ben; Wu, Di; Zhu, Shining; Xiao, Min; Zhang, Yong] Nanjing Univ, Coll Engn & Appl Sci, Collaborat Innovat Ctr Adv Microstruct, Natl Lab Solid State Microstruct,Sch Phys, Nanjing, Peoples R China; [Wei, Dunzhao] Sun Yat Sen Univ, Sch Phys, Guangzhou, Peoples R China; [Fang, Xinyuan; Gu, Min] Univ Shanghai Sci & Technol, Inst Photon Chips, Shanghai, Peoples R China; [Fang, Xinyuan; Gu, Min] Univ Shanghai Sci & Technol, Ctr Artificial Intelligence Nanophoton, Sch Opt Elect & Comp Engn, Shanghai, Peoples R China; [Wu, Di] Nanjing Univ, Jiangsu Key Lab Artificial Funct Mat, Nanjing, Peoples R China; [Xiao, Min] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Wang, Huijun] Univ Southampton, Southampton, Hants, England	Nanjing University; Sun Yat Sen University; University of Shanghai for Science & Technology; University of Shanghai for Science & Technology; Nanjing University; University of Arkansas System; University of Arkansas Fayetteville; University of Southampton	Zhang, Y (corresponding author), Nanjing Univ, Coll Engn & Appl Sci, Collaborat Innovat Ctr Adv Microstruct, Natl Lab Solid State Microstruct,Sch Phys, Nanjing, Peoples R China.	zhangyong@nju.edu.cn	Zhang, Yong/A-7792-2012; Xiao, Min/F-6184-2013; Wu, Di/B-1147-2008	Zhang, Yong/0000-0003-1158-2248; Wu, Di/0000-0003-3619-1411	National Key R&D Programme of China [2021YFA1400803, 2017YFA0303703]; National Natural Science Foundation of China (NSFC) [91950206, 92163216, 11874213, 51725203, U1932115, 51721001, 62005164]; Science and Technology Commission of Shanghai Municipality [21DZ1100500]; Shanghai Municipal Science and Technology Major Project; Shanghai Frontiers Science Centre Programme [2021-2025, 20]; Zhangjiang National Innovation Demonstration Zone [ZJ2019-ZD-005]; Shanghai Rising-Star Program [20QA1404100]; National Key Scientific Instrument and Equipment Development Project [61927814]; Fundamental Research Funds for the Central Universities [021314380191]	National Key R&D Programme of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Science and Technology Major Project; Shanghai Frontiers Science Centre Programme; Zhangjiang National Innovation Demonstration Zone; Shanghai Rising-Star Program; National Key Scientific Instrument and Equipment Development Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key R&D Programme of China (grant nos. 2021YFA1400803 and 2017YFA0303703), the National Natural Science Foundation of China (NSFC) (grant nos. 91950206, 92163216, 11874213, 51725203, U1932115, 51721001 and 62005164), the Science and Technology Commission of Shanghai Municipality (grant no. 21DZ1100500), the Shanghai Municipal Science and Technology Major Project, the Shanghai Frontiers Science Centre Programme (grant no. 2021-2025 No. 20), the Zhangjiang National Innovation Demonstration Zone (grant no. ZJ2019-ZD-005), the Shanghai Rising-Star Program (grant no. 20QA1404100), the National Key Scientific Instrument and Equipment Development Project (grant no. 61927814) and the Fundamental Research Funds for the Central Universities (grant no. 021314380191).	Anhorn M., 1987, IEEE 1987 Ultrasonics Symposium Proceedings (Cat. No.87CH2492-7), P279; ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Ashcroft N.W., 1976, SOLID STATE PHYS; Bartnick M, 2021, PHYS REV APPL, V15, DOI 10.1103/PhysRevApplied.15.024028; Bhatt R, 2005, FERROELECTRICS, V323, P165, DOI 10.1080/00150190500309148; Bo HF, 2018, APPL PHYS A-MATER, V124, DOI 10.1007/s00339-018-2114-3; Canalias C, 2007, NAT PHOTONICS, V1, P459, DOI 10.1038/nphoton.2007.137; Cao B, 2021, OPT EXPRESS, V29, P21615, DOI 10.1364/OE.426575; Chai XJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16623-9; Chen X, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4932199; Ellenbogen T, 2009, NAT PHOTONICS, V3, P395, DOI 10.1038/NPHOTON.2009.95; Fridkin VM, 2001, PHYS SOLID STATE+, V43, P1320, DOI 10.1134/1.1386472; Gattass RR, 2008, NAT PHOTONICS, V2, P219, DOI 10.1038/nphoton.2008.47; He MB, 2019, NAT PHOTONICS, V13, P359, DOI 10.1038/s41566-019-0378-6; He Y, 2019, OPTICA, V6, P1138, DOI 10.1364/OPTICA.6.001138; Huang XY, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa9258; Huang XJ, 2020, NAT PHOTONICS, V14, P82, DOI 10.1038/s41566-019-0538-8; Imbrock J, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5053870; Ishizuki H, 2003, APPL PHYS LETT, V82, P4062, DOI 10.1063/1.1582371; Jankowski M, 2020, OPTICA, V7, P40, DOI 10.1364/OPTICA.7.000040; Jia KP, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.213902; Jin H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103601; KOGELNIK H, 1966, APPL OPTICS, V5, P1550, DOI 10.1364/AO.5.001550; KOSOROTOV VF, 1986, FERROELECTRICS, V70, P27, DOI 10.1080/00150198608221418; LEE WH, 1979, APPL OPTICS, V18, P3661, DOI 10.1364/AO.18.003661; Lehr D, 2015, NANO LETT, V15, P1025, DOI 10.1021/nl5038819; Li MX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17950-7; Lu YQ, 1999, SCIENCE, V284, P1822, DOI 10.1126/science.284.5421.1822; Maekawa S., 2004, PHYS TRANSITION META; Marpaung D, 2019, NAT PHOTONICS, V13, P80, DOI 10.1038/s41566-018-0310-5; Meier D, 2022, NAT REV MATER, V7, P157, DOI 10.1038/s41578-021-00375-z; Pohl D, 2020, NAT PHOTONICS, V14, P24, DOI 10.1038/s41566-019-0529-9; Reddy JNB, 2009, OPT MATER, V31, P1022, DOI 10.1016/j.optmat.2008.11.013; Rodenas A, 2019, NAT PHOTONICS, V13, P105, DOI 10.1038/s41566-018-0327-9; Rosenman G, 2003, APPL PHYS LETT, V82, P103, DOI 10.1063/1.1534410; Saltiel SM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.083902; Saravi S, 2021, ADV OPT MATER, V9, DOI 10.1002/adom.202100789; Shapira A, 2012, OPT LETT, V37, P2136, DOI 10.1364/OL.37.002136; Sharma P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700512; Sheng Y, 2010, OPT EXPRESS, V18, P16539, DOI 10.1364/OE.18.016539; Shur VY, 2015, APPL PHYS REV, V2, DOI 10.1063/1.4928591; Shur VY, 2008, FERROELECTRICS, V373, P1, DOI 10.1080/00150190802408457; Shur VY, 2021, ACTA MATER, V219, DOI 10.1016/j.actamat.2021.117270; Shur VY, 2020, J APPL PHYS, V127, DOI 10.1063/1.5130951; Soergel E, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/46/464003; Solntsev AS, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031007; Steigerwald H, 2010, APPL PHYS B-LASERS O, V101, P535, DOI 10.1007/s00340-010-4209-1; Sun DH, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-00434-0; Sun J., 2020, CRYSTALS, V49, P947, DOI DOI 10.16553/J.CNKI; Wang C, 2018, NATURE, V562, P101, DOI 10.1038/s41586-018-0551-y; Wang J, 2015, OPT EXPRESS, V23, P23072, DOI 10.1364/OE.23.023072; Wei DZ, 2018, NAT PHOTONICS, V12, P596, DOI 10.1038/s41566-018-0240-2; Xu TX, 2018, NAT PHOTONICS, V12, P590, DOI 10.1038/s41566-018-0225-1; YAMADA M, 1991, ELECTRON LETT, V27, P828, DOI 10.1049/el:19910519; Yang WJ, 2008, NAT PHOTONICS, V2, P99, DOI 10.1038/nphoton.2007.276; Yin RC, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3476350; Ying CYJ, 2012, LASER PHOTONICS REV, V6, P526, DOI 10.1002/lpor.201100022; Yuan S, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.153901; Yudistira D, 2010, OPT EXPRESS, V18, P27181, DOI 10.1364/OE.18.027181; Yudistira D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599569; Yudistira D, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3190518; Zhang M, 2019, NATURE, V568, P373, DOI 10.1038/s41586-019-1008-7; Zhang Y, 2021, OPTICA, V8, P372, DOI 10.1364/OPTICA.416619; Zhao J, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.163603; Zhu B, 2020, OPT LETT, V45, P220, DOI 10.1364/OL.45.000220; Zhu D, 2021, ADV OPT PHOTONICS, V13, P242, DOI 10.1364/AOP.411024; Zhu S, 1997, SCIENCE, V278, P843, DOI 10.1126/science.278.5339.843; Zhu YY, 1996, MATER LETT, V28, P503, DOI 10.1016/0167-577X(96)00118-8	68	3	3	96	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					496	+		10.1038/s41586-022-05042-z	http://dx.doi.org/10.1038/s41586-022-05042-z		SEP 2022	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104554				2022-12-28	WOS:000854742300008
J	Sarkar, S				Sarkar, Sonia			Asia's "twindemic": dengue fever cases rocket as covid-19 rages on	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												26.sarkar@gmail.com						[Anonymous], 2022, OUTBREAK NEWS TODAY; [Anonymous], 2021, WHO DENGUE SITUATION; [Anonymous], 2019, WHO REGION AM RECORD; Associated Press, 2022, WHO REPORT; European Centre for Disease Prevention and Control, 2022, DENG WORLDW OV; Lu XT, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009778; Nicolelis MAL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92263-3; Saipen A, 2021, WEST PAC SURVEILL RE, V12, DOI 10.5365/wpsar.2020.11.3.016; Sarao Z, 2020, INQUIRER; Wee LE, 2022, TROP MED INFECT DIS, V7, DOI 10.3390/tropicalmed7050068; Wilder-Smith A, 2020, AM J TROP MED HYG, V103, P570, DOI 10.4269/ajtmh.20-0480	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2090	10.1136/bmj.o2090	http://dx.doi.org/10.1136/bmj.o2090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096518	Bronze			2022-12-28	WOS:000863219000008
J	Zhang, XD; Liu, YL; Han, JC; Kivshar, Y; Song, QH				Zhang, Xudong; Liu, Yilin; Han, Jiecai; Kivshar, Yuri; Song, Qinghai			Chiral emission from resonant metasurfaces	SCIENCE			English	Article							ROOM-TEMPERATURE; VORTEX	Ultracompact sources of circularly polarized light are important for classical and quantum optical information processing. Conventional approaches for generating chiral emission are restricted to excitation power ranges and fail to provide high-quality radiation with perfect polarization conversion. We used the physics of chiral quasi-bound states in the continuum to demonstrate the efficient and controllable emission of circularly polarized light from resonant metasurfaces. Exploiting intrinsic chirality and giant field enhancement, we revealed how to simultaneously modify and control spectra, radiation patterns, and spin angular momentum of photoluminescence and lasing without any spin injection. The superior characteristics of chiral emission and lasing promise multiple applications in nanophotonics and quantum optics.	[Zhang, Xudong; Liu, Yilin; Song, Qinghai] Harbin Inst Technol, Minist Ind & Informat Technol, Key Lab Micronano Optoelect Informat Syst, Shenzhen 518055, Peoples R China; [Han, Jiecai] Harbin Inst Technol, Natl Key Lab Sci & Technol Adv Composites Special, Harbin 150080, Peoples R China; [Kivshar, Yuri] Australian Natl Univ, Res Sch Phys, Nonlinear Phys Ctr, Canberra, ACT 2601, Australia; [Song, Qinghai] Pengcheng Lab, Shenzhen 518055, Peoples R China; [Song, Qinghai] Shanxi Univ, Collaborat Innovat Ctr Extreme Opt, Taiyuan 030006, Shanxi, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Australian National University; Shanxi University	Song, QH (corresponding author), Harbin Inst Technol, Minist Ind & Informat Technol, Key Lab Micronano Optoelect Informat Syst, Shenzhen 518055, Peoples R China.; Kivshar, Y (corresponding author), Australian Natl Univ, Res Sch Phys, Nonlinear Phys Ctr, Canberra, ACT 2601, Australia.; Song, QH (corresponding author), Pengcheng Lab, Shenzhen 518055, Peoples R China.; Song, QH (corresponding author), Shanxi Univ, Collaborat Innovat Ctr Extreme Opt, Taiyuan 030006, Shanxi, Peoples R China.	yuri.kivshar@anu.edu.au; qinghai.song@hit.edu.cn		song, qinghai/0000-0003-1048-411X	National Key Research and Development Project [2021YFA1400802]; Australian Research Council [DP210101292]; International Technology Center Indo-Pacific (ITC IPAC); Army Research Office [FA520921P0034]; National Natural Science Foundation of China [11934012, 12025402, 62125501]; Shenzhen Fundamental Research Projects [JCYJ20210324120402006]; Fundamental Research Funds for Central Universities	National Key Research and Development Project; Australian Research Council(Australian Research Council); International Technology Center Indo-Pacific (ITC IPAC); Army Research Office; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research Projects; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Project 2021YFA1400802 (Q.S.); Australian Research Council, grant DP210101292 (Y.K.); International Technology Center Indo-Pacific (ITC IPAC) and Army Research Office (contract No. FA520921P0034) (Y.K.); National Natural Science Foundation of China 12025402 (Q.S.); National Natural Science Foundation of China 62125501 (Q.S.); National Natural Science Foundation of China 11934012 (Q.S.); Shenzhen Fundamental Research Projects JCYJ20210324120402006 (Q.S.); and Fundamental Research Funds for Central Universities (Q.S.).	[Anonymous], MAT METHODS ARE AVAI; Chen Y, 2022, NAT REV PHYS, V4, P113, DOI 10.1038/s42254-021-00391-6; Dixon J, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.123201; Doeleman HM, 2018, NAT PHOTONICS, V12, P397, DOI 10.1038/s41566-018-0177-5; Dorrah AH, 2022, SCIENCE, V376, P367, DOI 10.1126/science.abi6860; Forbes A, 2021, NAT PHOTONICS, V15, P253, DOI 10.1038/s41566-021-00780-4; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Gorkunov MV, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.093903; Huang C, 2020, SCIENCE, V367, P1018, DOI 10.1126/science.aba4597; Huang YQ, 2021, NAT PHOTONICS, V15, P475, DOI 10.1038/s41566-021-00786-y; Hubener H, 2021, NAT MATER, V20, P438, DOI 10.1038/s41563-020-00801-7; Iba S, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3554760; Kim YH, 2021, SCIENCE, V371, P1129, DOI 10.1126/science.abf5291; Kodigala A, 2017, NATURE, V541, P196, DOI 10.1038/nature20799; Konishi K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057402; Koshelev K, 2020, SCIENCE, V367, P288, DOI 10.1126/science.aaz3985; Kruk SS, 2014, ACS PHOTONICS, V1, P1218, DOI 10.1021/ph500288u; Liu WZ, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.116104; Maksimov AA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045316; Ni JC, 2021, ACS NANO, V15, P2893, DOI 10.1021/acsnano.0c08941; Nishizawa N, 2017, P NATL ACAD SCI USA, V114, P1783, DOI 10.1073/pnas.1609839114; Novotny L., 2012, PRINCIPLES NANOOPTIC; Overvig A, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.073001; Seo IC, 2021, ACS NANO, V15, P13781, DOI 10.1021/acsnano.1c05421; Tang YQ, 2011, SCIENCE, V332, P333, DOI 10.1126/science.1202817; Tian JY, 2022, ADV MATER, V34, DOI 10.1002/adma.202109157; Wu CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4892; Yesilkoy F, 2019, NAT PHOTONICS, V13, P390, DOI 10.1038/s41566-019-0394-6; Yin XF, 2020, NATURE, V580, P467, DOI 10.1038/s41586-020-2181-4; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Zhen B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.257401	31	2	2	53	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1215	+		10.1126/science.abq7870	http://dx.doi.org/10.1126/science.abq7870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074858				2022-12-28	WOS:000887933400046
J	Kayrouz, CM; Huang, J; Hauser, N; Seyedsayamdost, MR				Kayrouz, Chase M.; Huang, Jonathan; Hauser, Nicole; Seyedsayamdost, Mohammad R.			Biosynthesis of selenium-containing small molecules in diverse microorganisms	NATURE			English	Article							ESCHERICHIA-COLI; SULFOXIDE SYNTHASE; ERGOTHIONEINE; IDENTIFICATION; METABOLISM; EVOLUTION; COMPOUND; REVEALS; ENZYMES; ACID	Selenium is an essential micronutrient in diverse organisms. Two routes are known for its insertion into proteins and nucleic acids, via selenocysteine and 2-selenouridine, respectively(1). However, despite its importance, pathways for specific incorporation of selenium into small molecules have remained elusive. Here we use a genome-mining strategy in various microorganisms to uncover a widespread three-gene cluster that encodes a dedicated pathway for producing selenoneine, the selenium analogue of the multifunctional molecule ergothioneine(2,3). We elucidate the reactions of all three proteins and uncover two novel selenium-carbon bond-forming enzymes and the biosynthetic pathway for production of a selenosugar, which is an unexpected intermediate en route to the final product. Our findings expand the scope of biological selenium utilization, suggest that the selenometabolome is more diverse than previously thought, and set the stage for the discovery of other selenium-containing natural products.	[Kayrouz, Chase M.; Huang, Jonathan; Hauser, Nicole; Seyedsayamdost, Mohammad R.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Seyedsayamdost, Mohammad R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Seyedsayamdost, MR (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Seyedsayamdost, MR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	mrseyed@princeton.edu	Hauser, Nicole/ABA-7851-2021	Hauser, Nicole/0000-0001-5455-0102	Life Sciences Research Foundation Postdoctoral Fellowship - Open Philanthropy Project; Swiss National Science Foundation Early "Postdoc Mobility" Fellowship [P2EZP2_187995]; National Science Foundation CAREER Award [1847932]; US National Institutes of Health [GM129496]; Edward C. Taylor 3rd Year Fellowship in Chemistry	Life Sciences Research Foundation Postdoctoral Fellowship - Open Philanthropy Project; Swiss National Science Foundation Early "Postdoc Mobility" Fellowship; National Science Foundation CAREER Award(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward C. Taylor 3rd Year Fellowship in Chemistry	We thank Andy K. L. Nguy for helpful discussions and the Edward C. Taylor 3rd Year Fellowship in Chemistry (to C.M.K.), the Life Sciences Research Foundation Postdoctoral Fellowship sponsored by the Open Philanthropy Project (to J.H.), the Swiss National Science Foundation Early "Postdoc Mobility" Fellowship (no. P2EZP2_187995 to N.H.), the National Science Foundation CAREER Award (no. 1847932 to M.R.S.), and the US National Institutes of Health (GM129496 to M.R.S.) for financial support.	Aachmann FL, 2010, J BIOL CHEM, V285, P33315, DOI 10.1074/jbc.M110.132308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Goncharenko KV, 2020, CHEM-EUR J, V26, P1328, DOI 10.1002/chem.201903898; Goncharenko KV, 2015, ANGEW CHEM INT EDIT, V54, P2821, DOI 10.1002/anie.201410045; HE SH, 1989, J BIOL CHEM, V264, P2678; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIM IY, 1992, J BIOL CHEM, V267, P19650; Kumar AA, 2012, CARBOHYD RES, V360, P8, DOI 10.1016/j.carres.2012.07.012; Lim D, 2019, ANGEW CHEM INT EDIT, V58, P15026, DOI 10.1002/anie.201908967; Lin J, 2015, GENOME BIOL EVOL, V7, P664, DOI 10.1093/gbe/evv022; McCulloch KM, 2008, BIOCHEMISTRY-US, V47, P3810, DOI 10.1021/bi800041h; Naowarojna N, 2019, ACS CATAL, V9, P6955, DOI 10.1021/acscatal.9b02054; Pluskal T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097774; PRAVDIC N, 1967, J ORG CHEM, V32, P1806, DOI 10.1021/jo01281a022; Reich HJ, 2016, ACS CHEM BIOL, V11, P821, DOI 10.1021/acschembio.6b00031; REICH HJ, 1975, J AM CHEM SOC, V97, P5434, DOI 10.1021/ja00852a019; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Song H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11870; Stampfli AR, 2019, J AM CHEM SOC, V141, P5275, DOI 10.1021/jacs.8b13023; STONE MJ, 1992, MOL MICROBIOL, V6, P29, DOI 10.1111/j.1365-2958.1992.tb00834.x; Tareen A, 2020, BIOINFORMATICS, V36, P2272, DOI 10.1093/bioinformatics/btz921; VERES Z, 1994, J BIOL CHEM, V269, P10597; Vit A, 2015, CHEMBIOCHEM, V16, P1490, DOI 10.1002/cbic.201500168; Vit A, 2015, CHEMBIOCHEM, V16, P119, DOI 10.1002/cbic.201402522; Weekley CM, 2013, CHEM SOC REV, V42, P8870, DOI 10.1039/c3cs60272a; WITTWER AJ, 1984, BIOCHEMISTRY-US, V23, P4650, DOI 10.1021/bi00315a021; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200; Yamashita M, 2015, SPRINGER HANDBOOK OF MARINE BIOTECHNOLOGY, P1059; Yamashita Y, 2011, FISHERIES SCI, V77, P679, DOI 10.1007/s12562-011-0360-9; Yamashita Y, 2010, J BIOL CHEM, V285, P18134, DOI 10.1074/jbc.C110.106377; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	38	3	3	70	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2022	610	7930					199	+		10.1038/s41586-022-05174-2	http://dx.doi.org/10.1038/s41586-022-05174-2		SEP 2022	12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5C6KA	36071162				2022-12-28	WOS:000852585300003
J	Tan, JXJ; Finkel, T				Tan, Jay Xiaojun; Finkel, Toren			A phosphoinositide signalling pathway mediates rapid lysosomal repair	NATURE			English	Article							PHOSPHATIDYLSERINE TRANSPORT; PROTEIN; MECHANISMS; COMPLEX; PI(4)P; DRIVEN; ORP9	Lysosomal dysfunction has been increasingly linked to disease and normal ageing(1,2). Lysosomal membrane permeabilization (LMP), a hallmark of lysosome-related diseases, can be triggered by diverse cellular stressors(3). Given the damaging contents of lysosomes, LMP must be rapidly resolved, although the underlying mechanisms are poorly understood. Here, using an unbiased proteomic approach, we show that LMP stimulates a phosphoinositide-initiated membrane tethering and lipid transport (PITT) pathway for rapid lysosomal repair. Upon LMP, phosphatidylinositol-4 kinase type 2 alpha (PI4K2A) accumulates rapidly on damaged lysosomes, generating high levels of the lipid messenger phosphatidylinositol-4-phosphate. Lysosomal phosphatidylinositol-4-phosphate in turn recruits multiple oxysterol-binding protein (OSBP)-related protein (ORP) family members, including ORP9, ORP10, ORP11 and OSBP, to orchestrate extensive new membrane contact sites between damaged lysosomes and the endoplasmic reticulum. The ORPs subsequently catalyse robust endoplasmic reticulum-to-lysosome transfer of phosphatidylserine and cholesterol to support rapid lysosomal repair. Finally, the lipid transfer protein ATG2 is also recruited to damaged lysosomes where its activity is potently stimulated by phosphatidylserine. Independent of macroautophagy, ATG2 mediates rapid membrane repair through direct lysosomal lipid transfer. Together, our findings identify that the PITT pathway maintains lysosomal membrane integrity, with important implications for numerous age-related diseases characterized by impaired lysosomal function.	[Tan, Jay Xiaojun; Finkel, Toren] Univ Pittsburgh, Aging Inst, Sch Med, Pittsburgh, PA 15260 USA; [Tan, Jay Xiaojun; Finkel, Toren] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Tan, Jay Xiaojun] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15260 USA; [Finkel, Toren] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tan, JXJ; Finkel, T (corresponding author), Univ Pittsburgh, Aging Inst, Sch Med, Pittsburgh, PA 15260 USA.; Tan, JXJ; Finkel, T (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.; Tan, JXJ (corresponding author), Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15260 USA.; Finkel, T (corresponding author), Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA 15260 USA.	jay.tan@pitt.edu; finkelt@pitt.edu	Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240	Competitive Medical Research Fund (CMRF) of the University of Pittsburgh Medical Center (UPMC) Health System; National Institutes of Health (NIH) grants [1K01AG075142, 1R01HL142663, 1R01HL142589, U54AG075931, P30AG024827]	Competitive Medical Research Fund (CMRF) of the University of Pittsburgh Medical Center (UPMC) Health System; National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Aging Institute at the University of Pittsburgh for helpful discussions and reagents; K. Zhang, G. Shang and M. Hanna for discussions on protein purification and liposome preparation; Z. Wang, H. G. Wang and P. L. Opresko for sharing reagents; MS Bioworks for mass spectrometry services; G. D. Fairn for providing the mCherry-D4H plasmid; V. Olkkonen for the ORP10 plasmid; A. Y. Ting for the TurboID DNA; T. Levine for the OSBP-PH plasmid; G. Du for the LAMP1-GFP-Twin-Strep plasmid; M. Kampmann the eGFP-galectin-3 and Tau.K18(P301L/V337M)-mRuby2 plasmid; C. Rosenmund for the lyso-pHluorin plasmid; T. Balla for the GFP-P4M plasmid; R. Parton for the 2xFYVE_hrs plasmid; S. Grinstein for the Lact-C2 plasmid; C. Tomasetto for the VAPA WT and KD/MD plasmids; and W. Hahn and D. Root for the PI4K2B cDNA. This work was supported by Competitive Medical Research Fund (CMRF) of the University of Pittsburgh Medical Center (UPMC) Health System (J.X.T.) and National Institutes of Health (NIH) grants 1K01AG075142 (J.X.T.), 1R01HL142663 (T.F.), 1R01HL142589 (T.F.), U54AG075931 (T.F.) and P30AG024827 (T.F.). Figs. 1a, 2d, 2j, 3a, 3e and 4d and Extended Data Figs. 5n, 7n and 10 were generated using Biorender.	Antonny B, 2018, ANNU REV BIOCHEM, V87, P809, DOI 10.1146/annurev-biochem-061516-044924; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gibbons GS, 2019, JAMA NEUROL, V76, P101, DOI 10.1001/jamaneurol.2018.2505; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; Gomez-Sintes R, 2016, AGEING RES REV, V32, P150, DOI 10.1016/j.arr.2016.02.009; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kawasaki A, 2021, J CELL BIOL, V221, DOI 10.1083/jcb.202103141; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li PQ, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001161; Lim CY, 2019, NAT CELL BIOL, V21, P1206, DOI 10.1038/s41556-019-0391-5; Liu XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108368; Lopez-Jimenez AT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007501; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Maeda S, 2019, ELIFE, V8, DOI 10.7554/eLife.45777; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Miao GY, 2021, DEV CELL, V56, P427, DOI 10.1016/j.devcel.2020.12.010; Mirza M, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.859; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Opalinski L, 2011, EMBO J, V30, P5, DOI 10.1038/emboj.2010.299; Osawa T, 2020, GENES CELLS, V25, P65, DOI 10.1111/gtc.12733; Osawa T, 2019, NAT STRUCT MOL BIOL, V26, P281, DOI 10.1038/s41594-019-0203-4; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Platt FM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0025-4; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Radulovic M, 2018, EMBO J, V37, DOI 10.15252/embj.201899753; Rost BR, 2015, NAT NEUROSCI, V18, P1845, DOI 10.1038/nn.4161; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Simons JP, 2009, P NATL ACAD SCI USA, V106, P11535, DOI 10.1073/pnas.0903011106; Skowyra ML, 2018, SCIENCE, V360, P49, DOI 10.1126/science.aar5078; Subczynski WK, 2017, CELL BIOCHEM BIOPHYS, V75, P369, DOI 10.1007/s12013-017-0792-7; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; Xiong J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.235390; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552; Zhou Y, 2010, EXP CELL RES, V316, P3304, DOI 10.1016/j.yexcr.2010.06.008	55	5	5	43	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					815	+		10.1038/s41586-022-05164-4	http://dx.doi.org/10.1038/s41586-022-05164-4		SEP 2022	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36071159	Bronze, Green Published			2022-12-28	WOS:000852585300002
J	Wingerchuk, DM; Lucchinetti, CF				Wingerchuk, Dean M.; Lucchinetti, Claudia F.			Neuromyelitis Optica Spectrum Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; CLINICAL-COURSE; DOUBLE-BLIND; AQUAPORIN-4; MULTICENTER; EFFICACY; LESIONS; SAFETY; SATRALIZUMAB	Neuromyelitis Optica and Its Spectrum Formerly known as Devic's disease, this relapsing, demyelinating disorder of the central nervous system encompasses six syndromes and is associated with aquaporin-4 autoantibodies. Effective treatment prevents relapses.	[Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Lucchinetti, Claudia F.] Mayo Clin, Dept Neurol, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Wingerchuk, DM (corresponding author), Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu						Ajmera MR, 2018, J NEUROL SCI, V384, P96, DOI 10.1016/j.jns.2017.11.022; Aktas O, 2021, ANN NEUROL, V89, P895, DOI 10.1002/ana.26067; Bar-Or A, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000277; Bennett JL, 2017, J NEURO-OPHTHALMOL, V37, P291, DOI 10.1097/WNO.0000000000000508; Burt RK, 2019, NEUROLOGY, V93, pE1732, DOI 10.1212/WNL.0000000000008394; Chitnis T, 2016, NEUROLOGY, V86, P245, DOI 10.1212/WNL.0000000000002283; Ciccarelli O, 2019, LANCET NEUROL, V18, P185, DOI 10.1016/S1474-4422(18)30460-5; Cotzomi E, 2019, BRAIN, V142, P1598, DOI 10.1093/brain/awz106; Cree BAC, 2019, LANCET, V394, P1352, DOI 10.1016/S0140-6736(19)31817-3; Devic E., 1894, B MED PARIS, V8, P1033; Duan TJ, 2020, BRAIN PATHOL, V30, P13, DOI 10.1111/bpa.12793; Estrada K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04332-3; Flanagan EP, 2016, ANN NEUROL, V79, P775, DOI 10.1002/ana.24617; Flanagan EP, 2015, JAMA NEUROL, V72, P81, DOI 10.1001/jamaneurol.2014.2137; Graves J, 2014, NEUROLOGY, V83, P1923, DOI 10.1212/WNL.0000000000001001; Guo Y, 2022, BRAIN, V145, P1379, DOI 10.1093/brain/awab394; Guo Y, 2014, JAMA NEUROL, V71, P1025, DOI 10.1001/jamaneurol.2014.775; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jiao YJ, 2013, NEUROLOGY, V81, P1197, DOI 10.1212/WNL.0b013e3182a6cb5c; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Kim SH, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000000947; Kim SH, 2018, NEUROLOGY, V91, pE2089, DOI 10.1212/WNL.0000000000006574; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Kleiter I, 2016, ANN NEUROL, V79, P206, DOI 10.1002/ana.24554; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levy M, 2021, LANCET NEUROL, V20, P60, DOI 10.1016/S1474-4422(20)30392-6; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lucchinetti CF, 2014, BRAIN PATHOL, V24, P83, DOI 10.1111/bpa.12099; Mao-Draayer Y, 2020, NAT REV NEUROL, V16, P154, DOI 10.1038/s41582-020-0313-y; Marignier R, 2021, LANCET NEUROL, V20, P762, DOI 10.1016/S1474-4422(21)00218-0; Matiello M, 2010, NEUROLOGY, V75, P310, DOI 10.1212/WNL.0b013e3181ea9f15; Mealy MA, 2014, JAMA NEUROL, V71, P324, DOI 10.1001/jamaneurol.2013.5699; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Misu T, 2005, NEUROLOGY, V65, P1479, DOI 10.1212/01.wnl.0000183151.19351.82; Narumi Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-3997-2; Papp V, 2021, NEUROLOGY, V96, P59, DOI 10.1212/WNL.0000000000011153; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Pittock SJ, 2022, MULT SCLER J, V28, P480, DOI 10.1177/13524585211038291; Pittock SJ, 2016, ANN NY ACAD SCI, V1366, P20, DOI 10.1111/nyas.12794; Poupart J, 2020, NEUROLOGY, V94, pE1645, DOI [10.1212/WNL.0000000000009247, 10.1212/WNL.0000000000009245]; Redenbaugh V, 2021, MULT SCLER J-EXP TRA, V7, DOI 10.1177/20552173211052656; Rensel M, 2022, MULT SCLER J, V28, P925, DOI 10.1177/13524585211047223; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Shosha E, 2018, NEUROLOGY, V91, pE1642, DOI 10.1212/WNL.0000000000006392; Tahara M, 2020, LANCET NEUROL, V19, P298, DOI 10.1016/S1474-4422(20)30066-1; Takai Y, 2021, BRAIN, V144, P2401, DOI 10.1093/brain/awab102; Traboulsee A, 2020, LANCET NEUROL, V19, P402, DOI 10.1016/S1474-4422(20)30078-8; Tradtrantip L, 2020, EXPERT OPIN THER TAR, V24, P219, DOI 10.1080/14728222.2020.1732927; Waters P, 2016, J NEUROL NEUROSUR PS, V87, P1005, DOI 10.1136/jnnp-2015-312601; Weiss D, 2022, J NEUROL, V269, P2778, DOI 10.1007/s00415-021-10913-y; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2021, ANN NEUROL, V89, P1088, DOI 10.1002/ana.26049; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yamamura T, 2019, NEW ENGL J MED, V381, P2114, DOI 10.1056/NEJMoa1901747; Yao XM, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0462-4; Zhang C, 2020, LANCET NEUROL, V19, P391, DOI 10.1016/S1474-4422(20)30070-3	60	0	0	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2022	387	7					631	639		10.1056/NEJMra1904655	http://dx.doi.org/10.1056/NEJMra1904655		AUG 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4D8EB	36070711				2022-12-28	WOS:000883681200011
J	Brown, CD; Chang, SW; Schwarz, MN; Leung, TH; Kozii, V; Avdoshkin, A; Moore, JE; Stamper-Kurn, D				Brown, Charles D.; Chang, Shao-Wen; Schwarz, Malte N.; Leung, Tsz-Him; Kozii, Vladyslav; Avdoshkin, Alexander; Moore, Joel E.; Stamper-Kurn, Dan			Direct geometric probe of singularities in band structure	SCIENCE			English	Article							CONICAL INTERSECTIONS; PHASE; DYNAMICS	A quantum system's energy landscape may have points where multiple energy surfaces are degenerate and that exhibit singular geometry of the wave function manifold, with major consequences for the system's properties. Ultracold atoms in optical lattices have been used to indirectly characterize such points in the band structure. We measured the non-Abelian transformation produced by transport directly through the singularities. We accelerated atoms along a quasi-momentum trajectory that enters, turns, and then exits the singularities at linear and quadratic band-touching points of a honeycomb lattice. Measurements after transport identified the topological winding numbers of these singularities to be 1 and 2, respectively. Our work introduces a distinct method for probing singularities that enables the study of non-Dirac singularities in ultracold-atom quantum simulators.	[Brown, Charles D.; Chang, Shao-Wen; Schwarz, Malte N.; Leung, Tsz-Him; Kozii, Vladyslav; Avdoshkin, Alexander; Moore, Joel E.; Stamper-Kurn, Dan] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Brown, Charles D.; Chang, Shao-Wen; Schwarz, Malte N.; Leung, Tsz-Him; Stamper-Kurn, Dan] Univ Calif Berkeley, Challenge Inst Quantum Computat, Berkeley, CA 94720 USA; [Kozii, Vladyslav; Moore, Joel E.; Stamper-Kurn, Dan] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Brown, Charles D.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Kozii, Vladyslav] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Yale University; Carnegie Mellon University	Brown, CD; Stamper-Kurn, D (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Brown, CD; Stamper-Kurn, D (corresponding author), Univ Calif Berkeley, Challenge Inst Quantum Computat, Berkeley, CA 94720 USA.; Stamper-Kurn, D (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Brown, CD (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	charles.d.brown@yale.edu; dmsk@berkeley.edu	; Stamper-Kurn, Dan/B-5442-2015	/0000-0002-0695-6500; Stamper-Kurn, Dan/0000-0002-4845-5835; Leung, Tsz Him/0000-0002-2591-4381	NSF QLCI program [OMA-2016245]; NSF [DMR1918065, PHY-1806362]; ARO through the MURI program [W911NF-17-1-0323]; US Department of Energy [DE-AC02-05CH11231]; Kavli ENSI fellowship; Simons Investigatorship	NSF QLCI program; NSF(National Science Foundation (NSF)); ARO through the MURI program; US Department of Energy(United States Department of Energy (DOE)); Kavli ENSI fellowship; Simons Investigatorship	We acknowledge support from the NSF QLCI program through grant OMA-2016245 and also NSF grant PHY-1806362, and from the ARO through the MURI program (grant W911NF-17-1-0323). C.D.B. acknowledges support from the National Academies of Science, Engineering, and Medicine Ford Postdoctoral Fellowship program. V.K. and J.E.M. were supported by the Quantum Materials program at LBNL, funded by the US Department of Energy under contract DE-AC02-05CH11231. A.A. and J.E.M. acknowledge support from the NSF under grant DMR1918065 and from a Kavli ENSI fellowship. J.E.M. acknowledges support from a Simons Investigatorship.	[Anonymous], 2003, TEXT MONOGR; Bansil A, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.021004; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Brown C. D., 2022, DATASET DIRECT GEOME; Domcke W, 2012, ANNU REV PHYS CHEM, V63, P325, DOI 10.1146/annurev-physchem-032210-103522; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Flaschner N, 2016, SCIENCE, V352, P1091, DOI 10.1126/science.aad4568; Hejazi K, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.035115; Hejazi K, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.035111; Hwang Y, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.L241102; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Leung TH, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.133001; Li T, 2016, SCIENCE, V352, P1094, DOI 10.1126/science.aad5812; Majorana E., 1932, NUOVO CIMENTO, V9, P43, DOI DOI 10.1007/BF02960953; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; McCann E, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/5/056503; Murray JM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.201110; Pujari S, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.086404; Rhim JW, 2020, NATURE, V584, P59, DOI 10.1038/s41586-020-2540-1; Schuurman MS, 2018, ANNU REV PHYS CHEM, V69, P427, DOI 10.1146/annurev-physchem-052516-050721; Shah J, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.195118; SIMON B, 1983, PHYS REV LETT, V51, P2167, DOI 10.1103/PhysRevLett.51.2167; Sun K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046811; Sun K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245122; Tarnowski M, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.240403; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Worth GA, 2004, ANNU REV PHYS CHEM, V55, P127, DOI 10.1146/annurev.physchem.55.091602.094335; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yarkony DR, 2001, J PHYS CHEM A, V105, P6277, DOI 10.1021/jp003731u; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	33	1	1	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1319	1322		10.1126/science.abm6442	http://dx.doi.org/10.1126/science.abm6442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108029	Green Submitted			2022-12-28	WOS:000887933500040
J	Waters, A				Waters, Adele			Trainees face wait till January to sit exams after last minute cancellation for royal funeral	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2022	378								o2259	10.1136/bmj.o2259	http://dx.doi.org/10.1136/bmj.o2259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V6QL	36113873				2022-12-28	WOS:000877352500010
J	Nordling, L; Huang, CC				Nordling, Linda; Huang, Chuchu			'Fungi are amazing': turning mushrooms into vegan leather and meat	NATURE			English	Editorial Material						Careers; Biotechnology; Industry			[Huang, Chuchu] Mycorena, Gothenburg, Sweden		Huang, CC (corresponding author), Mycorena, Gothenburg, Sweden.								0	0	0	19	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					646	646		10.1038/d41586-022-02922-2	http://dx.doi.org/10.1038/d41586-022-02922-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M1LB	36097059	Bronze			2022-12-28	WOS:000853088800010
J	Phelps, CM; Meisel, M				Phelps, Catherine M.; Meisel, Marlies			Team victory, yellow helmets for a computational tour de force	CELL			English	Editorial Material							MICROBIOTA; BACTERIA	Changes in the gut microbiota are associated with the etiopathogenesis of complex diseases, such as mul-tiple sclerosis. In this issue of Cell, the international Multiple Sclerosis Microbiome Study consortium de-ployed a multi-omics approach to profile the composition and function of the gut microbiome in an extensive cohort of MS patients.	[Phelps, Catherine M.; Meisel, Marlies] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Meisel, Marlies] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Meisel, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.; Meisel, M (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	marlies@pitt.edu		Meisel, Marlies/0000-0001-5156-8067	Department of Immunology, University of Pittsburgh School of Medicine; NIH/NIDDK [R01 DK130897]; NIH/NCI [R21 CA259636]; Melanoma Research Alliance award [820677]	Department of Immunology, University of Pittsburgh School of Medicine; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance award	We thank M.J. Bender and A.C. McPherson for critical proofreading. Image was generated using BioRender. This work was supported by an Investigator Start-up Fund, Department of Immunology, University of Pittsburgh School of Medicine, a NIH/NIDDK R01 DK130897, a NIH/NCI R21 CA259636, and a Melanoma Research Alliance award https://doi.org/10.48050/pc.gr.143738 (820677) to M.M.	Baranzini SE, 2022, CELL, V185, P3467, DOI 10.1016/j.cell.2022.08.021; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Cox LM, 2021, ANN NEUROL, V89, P1195, DOI 10.1002/ana.26084; Duscha A, 2020, CELL, V180, P1067, DOI 10.1016/j.cell.2020.02.035; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Wang J, 2020, CELL, V183, P1264, DOI 10.1016/j.cell.2020.09.054; Zhou XY, 2021, MULT SCLER J, V27, P366, DOI 10.1177/1352458520924594	10	0	0	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3459	3461		10.1016/j.cell.2022.08.013	http://dx.doi.org/10.1016/j.cell.2022.08.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4Z5ET	36113423				2022-12-28	WOS:000862232500001
J	Van Noorden, R				Van Noorden, Richard			The researchers using AI to analyse peer review	NATURE			English	Editorial Material																		Buljan I, 2020, ELIFE, V9, DOI 10.7554/eLife.53249; Eve M.P., 2021, READING PEER REV PLO; Severin A, 2022, PREPRINT; Squazzoni F, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd0299; Superchi C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035604; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5	6	0	0	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					455	455						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M5CY	36050529	Bronze			2022-12-28	WOS:000853342100010
J	Tang, D; Jia, YX; Zhang, JZ; Li, HB; Cheng, L; Wang, P; Bao, ZG; Liu, ZH; Feng, SS; Zhu, XJ; Li, DW; Zhu, GT; Wang, HR; Zhou, Y; Zhou, YF; Bryan, GJ; Buell, CR; Zhang, CZ; Huang, SW				Tang, Die; Jia, Yuxin; Zhang, Jinzhe; Li, Hongbo; Cheng, Lin; Wang, Pei; Bao, Zhigui; Liu, Zhihong; Feng, Shuangshuang; Zhu, Xijian; Li, Dawei; Zhu, Guangtao; Wang, Hongru; Zhou, Yao; Zhou, Yongfeng; Bryan, Glenn J.; Buell, C. Robin; Zhang, Chunzhi; Huang, Sanwen			Genome evolution and diversity of wild and cultivated potatoes (Sep, 10.1038/s41586-022-04822-x, 2022)	NATURE			English	Correction												huangsanwen@caas.cn	jia, yu/HHR-9047-2022	Zhang, Jinzhe/0000-0003-3127-4488; Buell, C Robin/0000-0002-6727-4677; Bao, Zhigui/0000-0003-3601-460X; Li, Hongbo/0000-0003-1579-4600; Tang, Die/0000-0003-3992-9573				Martin-Trillo M, 2011, PLANT J, V67, P701, DOI 10.1111/j.1365-313X.2011.04629.x; Nicolas M, 2022, NAT PLANTS, V8, P281, DOI 10.1038/s41477-022-01112-2	2	0	0	27	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					E14	E14		10.1038/s41586-022-05298-5	http://dx.doi.org/10.1038/s41586-022-05298-5		SEP 2022	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z2JJ	36100670	hybrid, Green Published			2022-12-28	WOS:000853462700001
J	Li, MT; Tan, HE; Lu, ZY; Tsang, KS; Chung, AJ; Zuker, CS				Li, Mengtong; Tan, Hwei-Ee; Lu, Zhengyuan; Tsang, Katherine S.; Chung, Ashley J.; Zuker, Charles S.			Gut-brain circuits for fat preference	NATURE			English	Article							VAGAL SENSORY NEURONS; ENTEROENDOCRINE CELLS; MAMMALIAN SWEET; CHOLECYSTOKININ; ACID; RECEPTORS; MICE; PHARMACOLOGY; GPR40	The perception of fat evokes strong appetitive and consummatory responses(1). Here we show that fat stimuli can induce behavioural attraction even in the absence of a functional taste system(2,3). We demonstrate that fat acts after ingestion via the gut-brain axis to drive preference for fat. Using single-cell data, we identified the vagal neurons responding to intestinal delivery of fat, and showed that genetic silencing of this gut-to-brain circuit abolished the development of fat preference. Next, we compared the gut-to-brain pathways driving preference for fat versus sugar(4), and uncovered two parallel systems, one functioning as a general sensor of essential nutrients, responding to intestinal stimulation with sugar, fat and amino acids, whereas the other is activated only by fat stimuli. Finally, we engineered mice lacking candidate receptors to detect the presence of intestinal fat, and validated their role as the mediators of gut-to-brain fat-evoked responses. Together, these findings reveal distinct cells and receptors that use the gut-brain axis as a fundamental conduit for the development of fat preference.	[Li, Mengtong; Tan, Hwei-Ee; Tsang, Katherine S.; Chung, Ashley J.; Zuker, Charles S.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Li, Mengtong; Tan, Hwei-Ee; Tsang, Katherine S.; Chung, Ashley J.; Zuker, Charles S.] Dept Biochem & Mol Biophys, Chevy Chase, MD 20815 USA; [Li, Mengtong; Lu, Zhengyuan; Tsang, Katherine S.; Chung, Ashley J.; Zuker, Charles S.] Columbia Univ, Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA; [Lu, Zhengyuan] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Zuker, Charles S.] Columbia Univ, Dept Neurosci, Vagetos Coll Phys & Surg, New York, NY 10032 USA; [Tan, Hwei-Ee] Agencyfor Sci Technol & Res, Singapore, Singapore	Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University	Zuker, CS (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Zuker, CS (corresponding author), Dept Biochem & Mol Biophys, Chevy Chase, MD 20815 USA.; Zuker, CS (corresponding author), Columbia Univ, Zuckerman Mind Brain & Behav Inst, New York, NY 10027 USA.; Zuker, CS (corresponding author), Columbia Univ, Dept Neurosci, Vagetos Coll Phys & Surg, New York, NY 10032 USA.	cz2195@columbia.edu		Lu, Zhengyuan/0000-0002-4262-1193; Tan, Hwei Ee/0000-0001-5832-5973; LI, MENGTONG/0000-0001-6967-7237	Agency for Science, Technology and Research; Russell Berrie Foundation program in the neurobiology of obesity; National Medical Research Council of Singapore	Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Russell Berrie Foundation program in the neurobiology of obesity; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We thank members of the Zuker laboratory for valuable comments and suggestions; A. Balian, J. Li and B. McTyre, who participated in this work; L. Luo for the gift of TRAP mice; A. Sisti for the generation of SGLT1-knockout mice; H. Jin for general advice with figures and experiments; Z. Wu for help generating the genetically engineered mice; and L. Rickman for expert help with figures. H.-E.T. was supported by Agency for Science, Technology and Research and National Medical Research Council of Singapore. Research reported in this publication was supported in part by the Russell Berrie Foundation program in the neurobiology of obesity (to C.S.Z. and R. Leibel). C.S.Z. is an investigator of the Howard Hughes Medical Institute. Figures were generated with the help of BioRender.com. This article is subject to HHMI's Open Access to Publications policy. HHMI laboratory heads have previously granted a nonexclusive CC BY 4.0 license to the public and a sublicensable license to HHMI in their research articles. Pursuant to those licenses, the author-accepted manuscript of this article can be made freely available under a CC BY 4.0 license immediately upon publication.	Allen IC, 2013, METHODS MOL BIOL, V1032, pV; [Anonymous], 2020, FOOD BALANCES; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bai L, 2022, ELIFE, V11, DOI 10.7554/eLife.74964; Bai L, 2019, CELL, V179, P1129, DOI 10.1016/j.cell.2019.10.031; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Berthoud HR, 2021, INT J OBESITY, V45, P2156, DOI 10.1038/s41366-021-00894-3; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Buchanan KL, 2022, NAT NEUROSCI, V25, P191, DOI 10.1038/s41593-021-00982-7; CHANG RSL, 1986, P NATL ACAD SCI USA, V83, P4923, DOI 10.1073/pnas.83.13.4923; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; de Araujo IE, 2020, ANNU REV PSYCHOL, V71, P139, DOI 10.1146/annurev-psych-122216-011643; DeNardo LA, 2019, NAT NEUROSCI, V22, P460, DOI 10.1038/s41593-018-0318-7; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Goldstein N, 2021, CELL METAB, V3, P676, DOI 10.1016/j.cmet.2020.12.018; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Han WF, 2018, CELL, V175, P665, DOI [10.1016/j.cell.2018.08.049, 10.1016/j.cell.2018.10.018]; Hansen KB, 2021, PHARMACOL REV, V73, P298, DOI 10.1124/pharmrev.120.000131; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Ichiki T, 2022, NATURE, V602, P468, DOI 10.1038/s41586-021-04359-5; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Keemink SW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21640-2; Kupari J, 2019, CELL REP, V27, P2508, DOI 10.1016/j.celrep.2019.04.096; Lacourse KA, 1997, BIOCHEM BIOPH RES CO, V236, P630, DOI 10.1006/bbrc.1997.7030; Lee H, 2017, NATURE, V548, P330, DOI 10.1038/nature23299; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Liddle RA, 1997, ANNU REV PHYSIOL, V59, P221, DOI 10.1146/annurev.physiol.59.1.221; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Pnevmatikakis EA, 2017, J NEUROSCI METH, V291, P83, DOI 10.1016/j.jneumeth.2017.07.031; Prescott SL, 2022, NEURON, V110, P579, DOI 10.1016/j.neuron.2021.12.020; Prescott SL, 2020, CELL, V181, P574, DOI 10.1016/j.cell.2020.03.004; Raab M, 2007, INT REV CYTOL, V256, P223, DOI 10.1016/S0074-7696(07)56007-9; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sclafani A, 2022, PHYSIOL BEHAV, V246, DOI 10.1016/j.physbeh.2022.113695; Sclafani A, 2016, AM J PHYSIOL-REG I, V310, pR631, DOI 10.1152/ajpregu.00432.2015; Sclafani A, 2015, CHEM SENSES, V40, P245, DOI 10.1093/chemse/bjv002; Sclafani A, 2014, PHYSIOL BEHAV, V126, P25, DOI 10.1016/j.physbeh.2013.12.003; Sclafani A, 2013, AM J PHYSIOL-REG I, V305, pR1490, DOI 10.1152/ajpregu.00440.2013; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Smilowitz J.T., 2010, FAT DETECTION TASTE; Su ZW, 2017, CELL REP, V21, P2724, DOI 10.1016/j.celrep.2017.11.036; Tan HE, 2020, NATURE, V580, P511, DOI 10.1038/s41586-020-2199-7; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Ueno A, 2012, NAT PROTOC, V7, P771, DOI 10.1038/nprot.2012.014; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yoneda T, 2007, PHYSIOL BEHAV, V91, P304, DOI 10.1016/j.physbeh.2007.03.006; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	63	3	3	68	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					722	+		10.1038/s41586-022-05266-z	http://dx.doi.org/10.1038/s41586-022-05266-z		SEP 2022	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36070796	Green Published, hybrid			2022-12-28	WOS:000866361800001
J	Hoffmann, HM				Hoffmann, Hanne M.			Boosting cognition with a hormone	SCIENCE			English	Editorial Material									[Hoffmann, Hanne M.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Michigan State University	Hoffmann, HM (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	hanne@msu.edu						Antonarakis SE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0143-7; Casoni F, 2016, DEVELOPMENT, V143, P3969, DOI 10.1242/dev.139444; Hall JE, 2000, J CLIN ENDOCR METAB, V85, P1794, DOI 10.1210/jc.85.5.1794; Han TS, 2012, HANDBOOK OF NEUROENDOCRINOLOGY, P597, DOI 10.1016/B978-0-12-375097-6.10027-7; Jacobs EG, 2016, J NEUROSCI, V36, P10163, DOI 10.1523/JNEUROSCI.0951-16.2016; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Manfredi-Lozano M, 2022, SCIENCE, V377; Meethal SV, 2005, ENDOCRINE, V26, P317, DOI 10.1385/ENDO:26:3:317; Schang AL, 2011, ENDOCRINOLOGY, V152, P568, DOI 10.1210/en.2010-0840; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; URBAN RJ, 1988, J CLIN INVEST, V81, P1020, DOI 10.1172/JCI113412	11	0	0	5	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1042	1043		10.1126/science.add9456	http://dx.doi.org/10.1126/science.add9456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048939				2022-12-28	WOS:000887933200030
J	Jiang, Q; Tong, JH; Xian, YM; Kerner, RA; Dunfield, SP; Xiao, CX; Scheidt, RA; Kuciauskas, D; Wang, XM; Hautzinger, MP; Tirawat, R; Beard, MC; Fenning, DP; Berry, JJ; Larson, BW; Yan, YF; Zhu, K				Jiang, Qi; Tong, Jinhui; Xian, Yeming; Kerner, Ross A.; Dunfield, Sean P.; Xiao, Chuanxiao; Scheidt, Rebecca A.; Kuciauskas, Darius; Wang, Xiaoming; Hautzinger, Matthew P.; Tirawat, Robert; Beard, Matthew C.; Fenning, David P.; Berry, Joseph J.; Larson, Bryon W.; Yan, Yanfa; Zhu, Kai			Surface reaction for efficient and stable inverted perovskite solar cells	NATURE			English	Article							STABILITY; FILMS	Perovskite solar cells (PSCs) with an inverted structure (often referred to as the p-i-n architecture) are attractive for future commercialization owing to their easily scalable fabrication, reliable operation and compatibility with a wide range of perovskite-based tandem device architectures(1,2). However, the power conversion efficiency (PCE) of p-i-n PSCs falls behind that of n-i-p (or normal) structure counterparts(3-6). This large performance gap could undermine efforts to adopt p-i-n architectures, despite their other advantages. Given the remarkable advances in perovskite bulk materials optimization over the past decade, interface engineering has become the most important strategy to push PSC performance to its limit(7,8). Here we report a reactive surface engineering approach based on a simple post-growth treatment of 3-(aminomethyl)pyridine (3-APy) on top of a perovskite thin film. First, the 3-APy molecule selectively reacts with surface formamidinium ions, reducing perovskite surface roughness and surface potential fluctuations associated with surface steps and terraces. Second, the reaction product on the perovskite surface decreases the formation energy of charged iodine vacancies, leading to effective n-type doping with a reduced work function in the surface region. With this reactive surface engineering, the resulting p-i-n PSCs obtained a PCE of over 25 per cent, along with retaining 87 per cent of the initial PCE after over 2,400 hours of 1-sun operation at about 55 degrees Celsius in air.	[Jiang, Qi; Tong, Jinhui; Kerner, Ross A.; Scheidt, Rebecca A.; Kuciauskas, Darius; Hautzinger, Matthew P.; Tirawat, Robert; Beard, Matthew C.; Larson, Bryon W.; Zhu, Kai] Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA; [Xian, Yeming; Wang, Xiaoming; Yan, Yanfa] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Xian, Yeming; Wang, Xiaoming; Yan, Yanfa] Univ Toledo, Wright Ctr Photovotta Innovat & Commercializat, Toledo, OH 43606 USA; [Dunfield, Sean P.; Fenning, David P.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Dunfield, Sean P.; Xiao, Chuanxiao; Berry, Joseph J.] Natl Renewable Energy Lab, Mat Sci Ctr, Golden, CO USA; [Berry, Joseph J.] Univ Colorado, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Berry, Joseph J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of California System; University of California San Diego; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Zhu, K (corresponding author), Natl Renewable Energy Lab, Chem & Nanosci Ctr, Golden, CO 80401 USA.; Yan, YF (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.; Yan, YF (corresponding author), Univ Toledo, Wright Ctr Photovotta Innovat & Commercializat, Toledo, OH 43606 USA.	Yanfa.Yan@utoledo.edu; Kai.Zhu@nrel.gov	Xian, Yeming/GVU-8890-2022; Zhu, Kai/AAF-1940-2019	Kuciauskas, Darius/0000-0001-8091-5718; Dunfield, Sean/0000-0002-2855-4457	US Department of Energy [DE-AC36-08GO28308]; Alliance for Sustainable Energy, Limited Liability Company (LLC); National Renewable Energy Laboratory; Office of Basic Energy Sciences, Office of Science within the US Department of Energy; Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory; 3-APy surface treatment; corresponding device fabrication and characterizations [DE-FOA-0002064, DE-EE0008790]; Advanced Perovskite Cells and Modules programme of the National Center for Photovoltaics - US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office; California Energy Commission EPIC programme [EPC-19-004]; National Science Foundation through the UC Irvine Materials Research Science and Engineering Center [DMR-2011967]; National Science Foundation Major Research Instrumentation Program [CHE-1338173]	US Department of Energy(United States Department of Energy (DOE)); Alliance for Sustainable Energy, Limited Liability Company (LLC); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Office of Science within the US Department of Energy(United States Department of Energy (DOE)); Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory(United States Department of Energy (DOE)); 3-APy surface treatment; corresponding device fabrication and characterizations; Advanced Perovskite Cells and Modules programme of the National Center for Photovoltaics - US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office(United States Department of Energy (DOE)); California Energy Commission EPIC programme; National Science Foundation through the UC Irvine Materials Research Science and Engineering Center; National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work was partially supported by the US Department of Energy under contract number DE-AC36-08GO28308 with Alliance for Sustainable Energy, Limited Liability Company (LLC), the Manager and Operator of the National Renewable Energy Laboratory. We acknowledge the support on first-principle calculations, surface reaction analysis, synthesis of 3-APyI2 and optoelectronic characterizations (for example, transient reflection and time-resolved microwave conductivity), from the Center for Hybrid Organic-Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the Office of Basic Energy Sciences, Office of Science within the US Department of Energy. A portion of the research was performed using computational resources sponsored by the Department of Energy's Office of Energy Efficiency and Renewable Energy and located at the National Renewable Energy Laboratory. We acknowledge the support on 3-APy surface treatment and the corresponding device fabrication and characterizations from DE-FOA-0002064 and award number DE-EE0008790, and the support on the general device and thin-film perovskite fabrication and characterizations from the Advanced Perovskite Cells and Modules programme of the National Center for Photovoltaics, funded by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office. This work was also supported in part by the California Energy Commission EPIC programme, EPC-19-004. We acknowledge the use of facilities and instrumentation at the UC Irvine Materials Research Institute (IMRI), which is supported in part by the National Science Foundation through the UC Irvine Materials Research Science and Engineering Center (DMR-2011967). XPS and UPS were performed in part using instrumentation funded in part by the National Science Foundation Major Research Instrumentation Program under grant number CHE-1338173. We thank I. Tran for assistance with collecting the XPS and UPS data; and S. M. Rowland and L. M. Laurens for conducting the mass spectrometry measurements and structure assignments at the NREL Bioenergy Science Technologies directorate. The views expressed in the article do not necessarily represent the views of the DOE or the US Government.	Al-Ashouri A, 2020, SCIENCE, V370, P1300, DOI 10.1126/science.abd4016; Al-Ashouri A, 2019, ENERG ENVIRON SCI, V12, P3356, DOI 10.1039/c9ee02268f; [Anonymous], 2022, BEST RES CELL EFF CH; Azmi R, 2022, SCIENCE, V376, P73, DOI 10.1126/science.abm5784; Bai S, 2019, NATURE, V571, P245, DOI 10.1038/s41586-019-1357-2; Chen C, 2020, ACS ENERGY LETT, V5, P2560, DOI 10.1021/acsenergylett.0c01350; Chen H, 2022, NAT PHOTONICS, V16, P352, DOI 10.1038/s41566-022-00985-1; Deng YH, 2021, NAT ENERGY, V6, P633, DOI 10.1038/s41560-021-00831-8; Gabka G, 2014, PHYS CHEM CHEM PHYS, V16, P23082, DOI 10.1039/c4cp03850a; Hou Y, 2020, SCIENCE, V367, P1135, DOI 10.1126/science.aaz3691; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Jang YW, 2021, NAT ENERGY, V6, P63, DOI 10.1038/s41560-020-00749-7; Jeon Nam Joong, 2014, Nat Mater, V13, P897, DOI 10.1038/nmat4014; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Kim M, 2022, SCIENCE, V375, P302, DOI 10.1126/science.abh1885; Kuciauskas D, 2018, APPL PHYS LETT, V112, DOI 10.1063/1.5030870; Li XD, 2022, SCIENCE, V375, P434, DOI 10.1126/science.abl5676; Li Z, 2022, SCIENCE, V376, P416, DOI 10.1126/science.abm8566; Lin RX, 2022, NATURE, V603, P73, DOI 10.1038/s41586-021-04372-8; Lin XS, 2020, ENERG ENVIRON SCI, V13, P3823, DOI 10.1039/d0ee02017f; Luo DY, 2020, NAT REV MATER, V5, P44, DOI 10.1038/s41578-019-0151-y; Martins NCT, 2016, APPL CATAL B-ENVIRON, V193, P67, DOI 10.1016/j.apcatb.2016.04.016; McGott DL, 2021, JOULE, V5, P1057, DOI 10.1016/j.joule.2021.03.015; Min H, 2021, NATURE, V598, P444, DOI 10.1038/s41586-021-03964-8; Osadchii DY, 2017, LANGMUIR, V33, P14278, DOI 10.1021/acs.langmuir.7b02929; Park NG, 2020, NAT REV MATER, V5, P333, DOI 10.1038/s41578-019-0176-2; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rabchinskii MK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63935-3; Reid OG, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa9559; Sarritzu V, 2017, SCI REP-UK, V7, DOI 10.1038/srep44629; Shallcross RC, 2017, J AM CHEM SOC, V139, P4866, DOI 10.1021/jacs.7b00516; Stecker C, 2019, ACS NANO, V13, P12127, DOI 10.1021/acsnano.9b06585; Tong JH, 2022, NAT ENERGY, V7, P642, DOI 10.1038/s41560-022-01046-1; Wang X, 2020, CHEM-US, V6, P1369, DOI 10.1016/j.chempr.2020.02.016; Xiao CX, 2017, ACS APPL MATER INTER, V9, P38373, DOI 10.1021/acsami.7b08582; Yang Y, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2016.207; Yin WJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864778; Zhao Y, 2022, SCIENCE, V377, P531, DOI 10.1126/science.abp8873	39	11	11	216	216	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 10	2022	611	7935					278	+		10.1038/s41586-022-05268-x	http://dx.doi.org/10.1038/s41586-022-05268-x		SEP 2022	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6H0KM	36049505				2022-12-28	WOS:000867593600001
J	Kuehn, BM				Kuehn, Bridget M.			Growing Role of Gabapentin in Opioid-Related Overdoses Highlights Misuse Potential and Off-label Prescribing Practices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material															Denver Health and Hospital Authority; National Institute on Drug Abuse	Denver Health and Hospital Authority; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	reported receiving research funding from Denver Health and Hospital Authority and the National Institute on Drug Abuse; consulting for the United Way of Broward County Commission on Behavioral Health and Drug Prevention; and receiving an honorarium to speak at the Researched Abuse, Diversion and Addiction-Related Surveillance System annual meeting. Dr Ellis reported that he is a member of the Scientific Advisory Group for the National Drug EarlyWarning System. DrWebster reported receiving payments from pharmaceutical and technology companies BDSI, CognifiSense, Ensysce, Neurana, Pharmacom, Salix, Kempharm, Elysium, and Shinogi for consulting fees, honoraria for CME presentations or other speaking engagements, travel expense reimbursement, expert testimony, and clinical research. DrWebster also reported that he is associate editor of the special populations section of Pain Medicine; chief medical officer of PainScript, a company that makes a digital tool for managing patients with pain and addiction; and author of a book and coproducer of a documentary, both about pain. No other disclosures were reported.		0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2022	328	13					1283	1285		10.1001/jama.2022.13659	http://dx.doi.org/10.1001/jama.2022.13659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5F6GU	36069924				2022-12-28	WOS:000866412700001
J	Diener, HC; Rothwell, PM				Diener, Hans Christoph; Rothwell, Peter M.			Antithrombotic drugs in secondary stroke prevention: still some way to go	LANCET			English	Editorial Material							ORAL ANTICOAGULANTS; CEREBRAL-ISCHEMIA; ASPIRIN		[Diener, Hans Christoph] Univ Duisburg Essen, Dept Neuroepidemiol, Inst Med Informat Biometry & Epidemiol IMIBE, Med Fac, D-45147 Essen, Germany; [Rothwell, Peter M.] Nuffield Dept Clin Neurosci, Dept Neurol, Oxford, England; [Rothwell, Peter M.] Univ Oxford, Wolfson Ctr Prevent Stroke & Dementia, Oxford, England	University of Duisburg Essen; University of Oxford; University of Oxford	Diener, HC (corresponding author), Univ Duisburg Essen, Dept Neuroepidemiol, Inst Med Informat Biometry & Epidemiol IMIBE, Med Fac, D-45147 Essen, Germany.	hans.diener@uk-essen.de						Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Diener HC, 2020, EUR HEART J SUPPL, V22, pI13, DOI 10.1093/eurheartj/suaa104; Diener HC, 2020, J AM COLL CARDIOL, V75, P1804, DOI 10.1016/j.jacc.2019.12.072; Duga S, 2009, SEMIN THROMB HEMOST, V35, P416, DOI 10.1055/s-0029-1225764; Franke CL, 1997, ANN NEUROL, V42, P857; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Shoamanesh A, 2022, LANCET, V400, P997, DOI 10.1016/S0140-6736(22)01588-4; Trifan G, 2021, CIRCULATION, V143, P2441, DOI 10.1161/CIRCULATIONAHA.121.053782	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					974	975		10.1016/S0140-6736(22)01703-2	http://dx.doi.org/10.1016/S0140-6736(22)01703-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3HP	36063822				2022-12-28	WOS:000888763000002
J	Moss, WJ				Moss, William J.			The Seeds of Ignorance - Consequences of a Booming Betel-Nut Economy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access									[Moss, William J.] Commonwealth Healthcare Corp, Div Otolaryngol Head & Neck Surg, Dept Surg, Saipan, CM 96950 USA		Moss, WJ (corresponding author), Commonwealth Healthcare Corp, Div Otolaryngol Head & Neck Surg, Dept Surg, Saipan, CM 96950 USA.			Moss, William/0000-0002-3971-9296				[Anonymous], 2020, ECONOMIST 1003; [Anonymous], 2014, NEW HUMANITARIA 0131; Bhattacharya A., 2022, QUARTZ INDIA; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; Yang YH, 2020, ORAL ONCOL, V108, DOI 10.1016/j.oraloncology.2020.104915	5	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2203571	http://dx.doi.org/10.1056/NEJMp2203571		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4U3WR	36121043	Bronze			2022-12-28	WOS:000858728800001
J	Nehra, R; Sekine, R; Ledezma, L; Guo, QS; Gray, RM; Roy, A; Marandi, A				Nehra, Rajveer; Sekine, Ryoto; Ledezma, Luis; Guo, Qiushi; Gray, Robert M.; Roy, Arkadev; Marandi, Alireza			Few-cycle vacuum squeezing in nanophotonics	SCIENCE			English	Article							QUANTUM; GENERATION; OPTICS; NOISE	One of the most fundamental quantum states of light is the squeezed vacuum, in which noise in one of the quadratures is less than the standard quantum noise limit. In nanophotonics, it remains challenging to generate, manipulate, and measure such a quantum state with the performance required for a wide range of scalable quantum information systems. Here, we report the development of a lithium niobate-based nanophotonic platform to demonstrate the generation and all-optical measurement of squeezed states on the same chip. The generated squeezed states span more than 25 terahertz of bandwidth supporting just a few optical cycles. The measured 4.9 decibels of squeezing surpass the requirements for a wide range of quantum information systems, demonstrating a practical path toward scalable ultrafast quantum nanophotonics.	[Nehra, Rajveer; Sekine, Ryoto; Ledezma, Luis; Guo, Qiushi; Gray, Robert M.; Roy, Arkadev; Marandi, Alireza] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Ledezma, Luis] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Nehra, R; Marandi, A (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	rnehra@caltech.edu; marandi@caltech.edu		Marandi, Alireza/0000-0002-0470-0050; Ledezma, Luis/0000-0002-0365-1672; Sekine, Ryoto/0000-0001-6135-8581	ARO [W911NF-18-1-0285]; NSF [1846273, 1918549]; AFOSR [FA9550-20-1-0040]; President's and Director's Research and Development Fund of Caltech; JPL; NASA/JPL	ARO; NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); President's and Director's Research and Development Fund of Caltech; JPL; NASA/JPL(National Aeronautics & Space Administration (NASA))	The authors gratefully acknowledge support from ARO grant W911NF-18-1-0285, NSF grants 1846273 and 1918549, AFOSR award FA9550-20-1-0040, and NASA/JPL. This project was funded in part by the President's and Director's Research and Development Fund of Caltech and JPL.	Arrazola JM, 2021, NATURE, V591, P54, DOI 10.1038/s41586-021-03202-1; Asavanant W, 2019, SCIENCE, V366, P373, DOI 10.1126/science.aay2645; Bourassa JE, 2021, QUANTUM-AUSTRIA, V5, DOI 10.22331/q-2021-02-04-392; Casacio CA, 2021, NATURE, V594, P201, DOI 10.1038/s41586-021-03528-w; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Chen M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.120505; Frascella G, 2021, NPJ QUANTUM INFORM, V7, DOI 10.1038/s41534-021-00407-0; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Horoshko DB, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033806; Hu YW, 2021, NATURE, V599, P587, DOI 10.1038/s41586-021-03999-x; Jankowski M, 2020, OPTICA, V7, P40, DOI 10.1364/OPTICA.7.000040; Javid UA, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.183601; Kanter GS, 2002, OPT EXPRESS, V10, P177, DOI 10.1364/OE.10.000177; Kizmann M, 2019, NAT PHYS, V15, P960, DOI 10.1038/s41567-019-0560-2; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Larsen MV, 2019, SCIENCE, V366, P369, DOI 10.1126/science.aay4354; Ledezma L, 2022, OPTICA, V9, P303, DOI 10.1364/OPTICA.442332; Nehra R., 2022, FIGSHARE, DOI [10.6084/m9.figshare.20100140.v1, DOI 10.6084/M9.FIGSHARE.20100140.V1]; O'Brien JL, 2009, NAT PHOTONICS, V3, P687, DOI 10.1038/nphoton.2009.229; Chen PK, 2022, OPT LETT, V47, P1506, DOI 10.1364/OL.447695; Peace D., 2022, ARXIV; Roslund J, 2014, NAT PHOTONICS, V8, P109, DOI [10.1038/nphoton.2013.340, 10.1038/NPHOTON.2013.340]; Shaked Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03083-5; Takanashi N, 2020, OPT EXPRESS, V28, P34916, DOI 10.1364/OE.405832; Tasker JF, 2021, NAT PHOTONICS, V15, P11, DOI 10.1038/s41566-020-00715-5; Vaidya VD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba9186; Vigliar C, 2021, NAT PHYS, V17, P1137, DOI 10.1038/s41567-021-01333-w; WERNER MJ, 1995, PHYS REV A, V52, P4202, DOI 10.1103/PhysRevA.52.4202; Yu HC, 2020, NATURE, V583, P43, DOI 10.1038/s41586-020-2420-8; Zheng PX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg0363; Zhu D, 2021, ADV OPT PHOTONICS, V13, P242, DOI 10.1364/AOP.411024	31	0	0	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1333	1337		10.1126/science.abo6213	http://dx.doi.org/10.1126/science.abo6213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108022	Green Submitted, Green Accepted			2022-12-28	WOS:000887933500043
J	Kreier, F				Kreier, Freda			FISHING GEAR FROM JUST A FEW PLACES FILLS OCEAN 'GARBAGE PATCH'	NATURE			English	News Item																		Lebreton L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22939-w; Lebreton L, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-16529-0	2	0	0	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					454	454						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M5CY	36068408	Bronze			2022-12-28	WOS:000853342100009
J	Griffin, S				Griffin, Shaun			Covid-19: Commission describes "massive global failures" of pandemic response	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, LANCET, V400, P1171, DOI 10.1016/S0140-6736(22)01761-5; Sachs JD, 2022, LANCET, V400, P1224, DOI 10.1016/S0140-6736(22)01585-9; Thacker PD, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2414	3	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								o2237	10.1136/bmj.o2237	http://dx.doi.org/10.1136/bmj.o2237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104067	Bronze			2022-12-28	WOS:000862323900005
J	Halldorsson, SA; Marshall, EW; Caracciolo, A; Matthews, S; Bali, E; Rasmussen, MB; Ranta, E; Robin, JG; Gudfinnsson, GH; Sigmarsson, O; Maclennan, J; Jackson, MG; Whitehouse, MJ; Jeon, H; van der Meer, QHA; Mibei, GK; Kalliokoski, MH; Repczynska, MM; Runarsdottir, RH; Sigurdsson, G; Pfeffer, MA; Scott, SW; Kjartansdottir, R; Kleine, BI; Oppenheimer, C; Aiuppa, A; Ilyinskaya, E; Bitetto, M; Giudice, G; Stefansson, A				Halldorsson, Saemundur A.; Marshall, Edward W.; Caracciolo, Alberto; Matthews, Simon; Bali, Eniko; Rasmussen, Maja B.; Ranta, Eemu; Robin, Johann Gunnarsson; Gudfinnsson, Gudmundur H.; Sigmarsson, Olgeir; Maclennan, John; Jackson, Matthew G.; Whitehouse, Martin J.; Jeon, Heejin; van der Meer, Quinten H. A.; Mibei, Geoffrey K.; Kalliokoski, Maarit H.; Repczynska, Maria M.; Runarsdottir, Rebekka Hlin; Sigurdsson, Gylfi; Pfeffer, Melissa Anne; Scott, Samuel W.; Kjartansdottir, Rikey; Kleine, Barbara, I; Oppenheimer, Clive; Aiuppa, Alessandro; Ilyinskaya, Evgenia; Bitetto, Marcello; Giudice, Gaetano; Stefansson, Andri			Rapid shifting of a deep magmatic source at Fagradalsfjall volcano, Iceland	NATURE			English	Article							MIDOCEAN RIDGE BASALTS; REYKJANES PENINSULA; PRESSURES; CONSTRAINTS; SOLUBILITY; GENERATION; EVOLUTION; INSIGHTS; ERUPTION; OLIVINE	Recent Icelandic rifting events have illuminated the roles of centralized crustal magma reservoirs and lateral magma transport(1-4), important characteristics of mid-ocean ridge magmatism(1,5). A consequence of such shallow crustal processing of magmas(4,5) is the overprinting of signatures that trace the origin, evolution and transport of melts in the uppermost mantle and lowermost crust(6,7). Here we present unique insights into processes occurring in this zone from integrated petrologic and geochemical studies of the 2021 Fagradalsfjall eruption on the Reykjanes Peninsula in Iceland. Geochemical analyses of basalts erupted during the first 50 days of the eruption, combined with associated gas emissions, reveal direct sourcing from a near-Moho magma storage zone. Geochemical proxies, which signify different mantle compositions and melting conditions, changed at a rate unparalleled for individual basaltic eruptions globally. Initially, the erupted lava was dominated by melts sourced from the shallowest mantle but over the following three weeks became increasingly dominated by magmas generated at a greater depth. This exceptionally rapid trend in erupted compositions provides an unprecedented temporal record of magma mixing that filters the mantle signal, consistent with processing in near-Moho melt lenses containing 10(7)-10(8) m(3) of basaltic magma. Exposing previously inaccessible parts of this key magma processing zone to near-real-time investigations provides new insights into the timescales and operational mode of basaltic magma systems.	[Halldorsson, Saemundur A.; Marshall, Edward W.; Caracciolo, Alberto; Matthews, Simon; Bali, Eniko; Rasmussen, Maja B.; Ranta, Eemu; Robin, Johann Gunnarsson; Gudfinnsson, Gudmundur H.; Sigmarsson, Olgeir; van der Meer, Quinten H. A.; Mibei, Geoffrey K.; Kalliokoski, Maarit H.; Repczynska, Maria M.; Runarsdottir, Rebekka Hlin; Sigurdsson, Gylfi; Scott, Samuel W.; Kjartansdottir, Rikey; Kleine, Barbara, I; Stefansson, Andri] Univ Iceland, Nordic VoLcanol Ctr, Inst Earth Sci, Reykjavik, Iceland; [Sigmarsson, Olgeir] Univ Clermont Auvergne, Lab Magmas & Volcans, Aubiere, France; [Maclennan, John] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Jackson, Matthew G.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Whitehouse, Martin J.; Jeon, Heejin] Swedish Museum Nat Hist, Dept Geosci, Stockholm, Sweden; [Pfeffer, Melissa Anne] IceLand Meteorl Off, Reykjavik, Iceland; [Oppenheimer, Clive] Univ Cambridge, Dept Geog, Cambridge, England; [Aiuppa, Alessandro; Bitetto, Marcello] Univ Palermo, Dipartimento Sci Terra & Mare, Palermo, Italy; [Ilyinskaya, Evgenia] Univ Leeds, Sch Earth & Environm, COMET, Leeds, W Yorkshire, England; [Giudice, Gaetano] Ist Nazl Geofis & Vulcanol, Catania, Italy; [Rasmussen, Maja B.] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1350 Copenhagen, Denmark	University of Iceland; Universite Clermont Auvergne (UCA); University of Cambridge; University of California System; University of California Santa Barbara; Swedish Museum of Natural History; University of Cambridge; University of Palermo; University of Leeds; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Copenhagen	Halldorsson, SA (corresponding author), Univ Iceland, Nordic VoLcanol Ctr, Inst Earth Sci, Reykjavik, Iceland.	saemiah@hi.is	Pfeffer, Melissa Anne/GWC-1875-2022; Bali, Eniko/E-7231-2011; Halldorsson, Saemundur Ari/L-9560-2015	BITETTO, Marcello/0000-0003-0460-9772; Rasmussen, Maja Bar/0000-0002-1579-2966; Gudfinnsson, Gudmundur/0000-0003-3275-9866; Bali, Eniko/0000-0001-7289-6393; Ranta, Eemu/0000-0003-3685-334X; Halldorsson, Saemundur Ari/0000-0002-9311-7704	Swedish Research Council [2017-00671]; Swedish Museum of Natural History; University of Iceland; European Commission [731070]; Icelandic Research Fund [228933-051]; Italian Ministero Istruzione Universita e Ricerca (Miur) [PRIN2017-2017LMNLAW]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Museum of Natural History; University of Iceland; European Commission(European CommissionEuropean Commission Joint Research Centre); Icelandic Research Fund; Italian Ministero Istruzione Universita e Ricerca (Miur)(Ministry of Education, Universities and Research (MIUR))	We are grateful for the analytical help of C. Bosq and D. Auclair during the Sr and Nd isotope measurements. We thank G. Pedersen for providing shape-files of the lavas and M. T. Guomundsson, H. Geirsson, F. Sigmundsson, B. Brandsdottir, P. Einarsson, K. Gronvold, N. Oskarsson and K. Saemundsson for helpful discussions and support. We thank S. Johnson, H. Runarsdottir and A. Asmundsdottir for assistance with sample preparation. The NordSIMS ion microprobe facility acknowledges support by the Swedish Research Council (grant no. 2017-00671), the Swedish Museum of Natural History and the University of Iceland; this is NordSIMS publication no. 713. The involvement of S.A.H. was partly in relation to H2020 project EUROVOLC, funded by the European Commission (grant no. 731070). This work was supported by the Icelandic Research Fund, grant no. 228933-051. We gratefully acknowledge constructive comments provided by A. Kent and K. Rubin that helped to improve this work. A.A. ackowledges funding from Italian Ministero Istruzione Universita e Ricerca (Miur), grant PRIN2017-2017LMNLAW.	Aiuppa A, 2021, NAT GEOSCI, V14, P697, DOI 10.1038/s41561-021-00797-y; Aiuppa A, 2009, J VOLCANOL GEOTH RES, V182, P221, DOI 10.1016/j.jvolgeores.2008.09.013; Baker J, 2004, CHEM GEOL, V211, P275, DOI 10.1016/j.chemgeo.2004.06.030; Bergmanis EC, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001742; Burton M, 2007, SCIENCE, V317, P227, DOI 10.1126/science.1141900; Caracciolo A, 2022, GEOLOGY, V50, P796, DOI 10.1130/G49874.1; Caracciolo A, 2020, LITHOS, V352, DOI 10.1016/j.lithos.2019.105234; Cashman KV, 2017, SCIENCE, V355, DOI 10.1126/science.aag3055; Clague DA, 2018, GEOCHEM GEOPHY GEOSY, V19, P2915, DOI 10.1029/2018GC007708; Colman A, 2016, J PETROL, V57, P981, DOI 10.1093/petrology/egw032; Edmonds M, 2008, PHILOS T R SOC A, V366, P4559, DOI 10.1098/rsta.2008.0185; Flovenz OG, 2022, NAT GEOSCI, V15, P397, DOI 10.1038/s41561-022-00930-5; Gansecki C, 2019, SCIENCE, V366, P1212, DOI 10.1126/science.aaz0147; Ghiorso MS, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1141-8; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Goss AR, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002977; Greene AR, 2013, GEOCHEM GEOPHY GEOSY, V14, P4849, DOI 10.1002/ggge.20285; Gregg PM, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006100; Halldorsson SA, 2018, CONTRIB MINERAL PETR, V173, DOI 10.1007/s00410-018-1487-9; Hartley ME, 2018, CONTRIB MINERAL PETR, V173, DOI 10.1007/s00410-017-1435-0; Herzberg C, 2004, J PETROL, V45, P2389, DOI 10.1093/petrology/egh040; Hill E, 2011, CONTRIB MINERAL PETR, V161, P423, DOI 10.1007/s00410-010-0540-0; Iacono-Marziano G, 2012, GEOCHIM COSMOCHIM AC, V97, P1, DOI 10.1016/j.gca.2012.08.035; Iacovino K, 2021, EARTH SPACE SCI, V8, DOI 10.1029/2020EA001584; Ilyinskaya E, 2015, GEOCHIM COSMOCHIM AC, V159, P80, DOI 10.1016/j.gca.2015.01.013; Jackson MD, 2018, NATURE, V564, P405, DOI 10.1038/s41586-018-0746-2; Jackson MG, 2008, EARTH PLANET SC LETT, V276, P175, DOI 10.1016/j.epsl.2008.09.023; Kamber BS, 2009, GEOSTAND GEOANAL RES, V33, P169, DOI 10.1111/j.1751-908X.2009.00911.x; Koornneef JM, 2012, J PETROL, V53, P127, DOI 10.1093/petrology/egr059; Liu EJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9103; Maclennan J, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2000JB000142; Maclennan J, 2019, PHILOS T R SOC A, V377, DOI 10.1098/rsta.2018.0021; Maclennan J, 2017, GEOCHEM GEOPHY GEOSY, V18, P597, DOI 10.1002/2016GC006633; Matthews S, 2021, GEOCHIM COSMOCHIM AC, V293, P525, DOI 10.1016/j.gca.2020.09.030; MCKENZIE D, 1995, J PETROL, V36, P133, DOI 10.1093/petrology/36.1.133; MCKENZIE D, 1991, J PETROL, V32, P1021, DOI 10.1093/petrology/32.5.1021; Mutch EJF, 2019, NAT GEOSCI, V12, P569, DOI 10.1038/s41561-019-0376-9; Neave DA, 2019, J PETROL, V60, P1653, DOI 10.1093/petrology/egz042; Neave DA, 2019, EARTH PLANET SC LETT, V520, P199, DOI 10.1016/j.epsl.2019.06.003; Neave DA, 2017, AM MINERAL, V102, P777, DOI 10.2138/am-2017-5968; Nikolaev GS, 2016, GEOCHEM INT+, V54, P301, DOI 10.1134/S0016702916040078; Oppenheimer C, 2008, J VOLCANOL GEOTH RES, V177, P743, DOI 10.1016/j.jvolgeores.2007.08.022; Peate DW, 2009, CONTRIB MINERAL PETR, V157, P359, DOI 10.1007/s00410-008-0339-4; Pedersen GBM, 2022, GEOPHYS RES LETT, V49, DOI 10.1029/2021GL097125; Perfit MR, 1996, EARTH PLANET SC LETT, V141, P91, DOI 10.1016/0012-821X(96)00052-0; Pin C, 2014, J ANAL ATOM SPECTROM, V29, P1858, DOI 10.1039/c4ja00169a; Presnall DC, 2002, GEOCHIM COSMOCHIM AC, V66, P2073, DOI 10.1016/S0016-7037(02)00890-6; Putirka K, 1999, CONTRIB MINERAL PETR, V135, P151, DOI 10.1007/s004100050503; Putirka KD, 2003, AM MINERAL, V88, P1542, DOI 10.2138/am-2003-1017; Putirka KD, 2008, REV MINERAL GEOCHEM, V69, P61, DOI 10.2138/rmg.2008.69.3; Rubin KH, 2009, NAT GEOSCI, V2, P321, DOI 10.1038/NGEO504; Saemundsson K., 2016, GEOLOGICAL MAP SW IC, V1; Saemundsson K, 2020, J VOLCANOL GEOTH RES, V391, DOI 10.1016/j.jvolgeores.2018.11.022; Shishkina TA, 2010, CHEM GEOL, V277, P115, DOI 10.1016/j.chemgeo.2010.07.014; Shishkina TA, 2014, CHEM GEOL, V388, P112, DOI 10.1016/j.chemgeo.2014.09.001; Shorttle O, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003748; Sigmundsson F, 2016, GEOPHYS RES LETT, V43, P12423, DOI 10.1002/2016GL071884; Sigmundsson F, 2015, NATURE, V517, P191, DOI 10.1038/nature14111; SIGURDSSON H, 1978, NATURE, V274, P126, DOI 10.1038/274126a0; Sinton J, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC001021; Smith PM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000816; Spiegelman M, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000336; van der Meer QHA, 2021, J PETROL, V62, DOI 10.1093/petrology/egab057; Vlastelic I, 2016, ACTIVE VOLCANO WORLD, P185, DOI 10.1007/978-3-642-31395-0_11; Weir NRW, 2001, J GEOPHYS RES-SOL EA, V106, P6347, DOI 10.1029/2000JB900358; Weis D, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001283; Wieser P. E., 2021, EARTH SPACE SCI; Wright TJ, 2012, NAT GEOSCI, V5, P242, DOI [10.1038/ngeo1428, 10.1038/NGEO1428]	69	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					529	+		10.1038/s41586-022-04981-x	http://dx.doi.org/10.1038/s41586-022-04981-x		SEP 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104557	Green Accepted, hybrid			2022-12-28	WOS:000854742300003
J	Mehta, HB; Li, S; An, HJ; Goodwin, JS; Alexander, GC; Segal, JB				Mehta, Hemalkumar B.; Li, Shuang; An, Huijun; Goodwin, James S.; Alexander, G. Caleb; Segal, Jodi B.			Development and Validation of the Summary Elixhauser Comorbidity Score for Use With ICD-10-CM-Coded Data Among Older Adults	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE; INDEX; RISK; ADJUSTMENT; PROGNOSIS; MORTALITY; MODEL	Background: Older adults have many comorbidities contributing to mortality. Objective: To develop a summary Elixhauser (S-Elixhauser) comorbidity score to predict 30-day, in-hospital, and 1-year mortality in older adults using the 38 comorbidities operationalized by the Agency for Healthcare Research and Quality (AHRQ). Design: Retrospective cohort study. Setting: Medicare beneficiaries from 2017 to 2019. Patients: Persons hospitalized in 2018 (n = 899 844) and 3 disease-specific hospitalized cohorts. Measurements: Weights were derived for 38 comorbidities to predict 30-day, in-hospital, and 1-year mortality. The S-Elixhauser score was internally validated and calibrated. Individual Elixhauser comorbidity indicators (38 comorbidities), the modified application of the AHRQ-derived Elixhauser summary score, the Charlson comorbidity indicators (17 comorbidities), and the Charlson summary score were externally validated. The c-statistic was used to evaluate discrimination of a comorbidity score model. Results: The S-Elixhauser score was well calibrated and internally validated, with a c-statistic of 0.705 (95% CI, 0.703 to 0.707) in predicting 30-day mortality, 0.654 (CI, 0.651 to 0.657) for in-hospital mortality, and 0.743 (CI, 0.741 to 0.744) for 1-year mortality. In external validation of other comorbidity indices for 30-day mortality, the c-statistic was 0.711 (CI, 0.709 to 0.713) for the individual Elixhauser comorbidity indicators, 0.688 (CI, 0.686 to 0.690) for the AHRQ Elixhauser score, 0.696 (CI, 0.694 to 0.698) for the Charlson comorbidity indicators, and 0.690 (CI, 0.688 to 0.693) for the Charlson summary score. In 3 disease-specific populations, the discrimination of the S-Elixhauser score in predicting 30-day mortality ranged from 0.657 to 0.732. Limitation: Validation of the S-Elixhauser comorbidity score and head-to-head comparison with other comorbidity scores in an external population are needed to evaluate comparative performance. Conclusion: The S-Elixhauser comorbidity score is well calibrated and internally validated but its advantage over the AHRQ Elixhauser and Charlson summary scores is unclear. Primary Funding Source: National Institute on Aging.	[Mehta, Hemalkumar B.; An, Huijun; Alexander, G. Caleb; Segal, Jodi B.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD 21205 USA; [Mehta, Hemalkumar B.; An, Huijun; Alexander, G. Caleb; Segal, Jodi B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St E7640, Baltimore, MD 21205 USA; [Li, Shuang; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Galveston, TX 77555 USA; [Alexander, G. Caleb; Segal, Jodi B.] Johns Hopkins Med, Div Gen Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins Medicine	Mehta, HB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St E7640, Baltimore, MD 21205 USA.	hbmehta@jhu.edu	Mehta, Hemalkumar/GXV-4110-2022		National Institute on Aging (NIA) [1K01AG070329, K24AG049306]; National Cancer Institute [5K05CA134923]	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By National Institute on Aging (NIA) grant 1K01AG070329 (Dr. Mehta). National Cancer Institute grant 5K05CA134923 (Dr. Goodwin), and NIA grant K24AG049306 (Dr. Segal).	Agency for Healthcare Research and Quality, 2022, ICD10CM AG HEALTHC R; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Brewer MJ, 2016, METHODS ECOL EVOL, V7, P679, DOI 10.1111/2041-210X.12541; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleiss JL, 2003, STAT METHODS RATES P, P340; Garibaldi BT, 2021, ANN INTERN MED, V174, P33, DOI 10.7326/M20-3905; Gilbert EA, 2017, HEALTH SERV OUTCOME, V17, P237, DOI 10.1007/s10742-017-0171-2; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Mehta HB, 2016, J CLIN EPIDEMIOL, V79, P22, DOI 10.1016/j.jclinepi.2016.03.031; Mehta HB, 2016, MED CARE, V54, P180, DOI 10.1097/MLR.0000000000000465; Moore BJ, 2017, MED CARE, V55, P698, DOI 10.1097/MLR.0000000000000735; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Research Data Assistance Center (ResDAC), 2021, DEATH INF RES ID MED; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Steyerberg EW, 2018, J CLIN EPIDEMIOL, V103, P131, DOI 10.1016/j.jclinepi.2018.07.010; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thompson NR, 2015, MED CARE, V53, P374, DOI 10.1097/MLR.0000000000000326; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Varadhan R, 2013, DEV PROTOCOL OBSERVA	27	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1423	+		10.7326/M21-4204	http://dx.doi.org/10.7326/M21-4204		SEP 2022	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36095314				2022-12-28	WOS:000857104100001
J	Shen, YF; Yan, J; Cai, GL				Shen, Yanfei; Yan, Jing; Cai, Guolong			Early vs Standard Approach to Tracheostomy and Functional Outcome Among Patients With Severe Stroke Receiving Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Shen, Yanfei; Yan, Jing; Cai, Guolong] Zhejiang Hosp, Dept Intens Care, 12 Linyin Rd, Hangzhou 310013, Peoples R China		Cai, GL (corresponding author), Zhejiang Hosp, Dept Intens Care, 12 Linyin Rd, Hangzhou 310013, Peoples R China.							Bosel J, 2022, JAMA-J AM MED ASSOC, V327, P1899, DOI 10.1001/jama.2022.4798; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Robba C, 2020, INTENS CARE MED, V46, P983, DOI 10.1007/s00134-020-05935-5; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10												3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098729				2022-12-28	WOS:000855222400028
J	Walli-Attaei, M; Rosengren, A; Rangarajan, S; Breet, Y; Abdul-Razak, S; Al Sharief, W; Alhabib, KF; Avezum, A; Chifamba, J; Diaz, R; Gupta, R; Hu, B; Iqbal, R; Ismail, R; Kelishadi, R; Khatib, R; Lang, XY; Li, SD; Lopez-Jaramillo, P; Mohan, V; Oguz, A; Palileo-Villanueva, LM; Poltyn-Zaradna, K; Sreelakshmi, PR; Pinnaka, LVM; Seron, P; Teo, K; Verghese, ST; Wielgosz, A; Yeates, K; Yusuf, R; Anand, SS; Yusuf, S				Walli-Attaei, Marjan; Rosengren, Annika; Rangarajan, Sumathy; Breet, Yolandi; Abdul-Razak, Suraya; Al Sharief, Wadeia; Alhabib, Khalid F.; Avezum, Alvaro; Chifamba, Jephat; Diaz, Rafael; Gupta, Rajeev; Hu, Bo; Iqbal, Romaina; Ismail, Rosnah; Kelishadi, Roya; Khatib, Rasha; Lang, Xinyue; Li, Sidong; Lopez-Jaramillo, Patricio; Mohan, Viswanathan; Oguz, Aytekin; Palileo-Villanueva, Lia M.; Poltyn-Zaradna, Katarzyna; Sreelakshmi, P. R.; Pinnaka, Lakshmi V. M.; Seron, Pamela; Teo, Koon; Verghese, Sejil T.; Wielgosz, Andreas; Yeates, Karen; Yusuf, Rita; Anand, Sonia S.; Yusuf, Salim			Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study	LANCET			English	Article							CORONARY-HEART-DISEASE; SMOKING; METAANALYSIS; MORTALITY; SEX	Background There is a paucity of data on the prevalence of risk factors and their associations with incident cardiovascular disease in women compared with men, especially from low-income and middle-income countries. Methods In the Prospective Urban Rural Epidemiological (PURE) study, we enrolled participants from the general population from 21 high-income, middle-income, and low-income countries and followed them up for approximately 10 years. We recorded information on participants' metabolic, behavioural, and psychosocial risk factors. For this analysis, we included participants aged 35-70 years at baseline without a history of cardiovascular disease, with at least one follow-up visit. The primary outcome was a composite of major cardiovascular events (cardiovascular disease deaths, myocardial infarction, stroke, and heart failure). We report the prevalence of each risk factor in women and men, their hazard ratios (HRs), and population-attributable fractions (PAFs) associated with major cardiovascular disease. The PURE study is registered with ClinicalTrials.gov, NCT03225586. Findings In this analysis, we included 155 724 participants enrolled and followed-up between Jan 5, 2005, and Sept 13, 2021, (90 934 [58.4%] women and 64 790 [41.6%] men), with a median follow-up of 10.1 years (IQR 8.5-12.0). At study entry, the mean age of women was 49.8 years (SD 9.7) compared with 50.8 years (9.8) in men. As of data cutoff (Sept 13, 2021), 4280 major cardiovascular disease events had occurred in women (age-standardised incidence rate of 5.0 events [95% CI 4.9-5.2] per 1000 person-years) and 4911 in men (8.2 [8.0-8.4] per 1000 person-years). Compared with men, women presented with a more favourable cardiovascular risk profile, especially at younger ages. The HRs for metabolic risk factors were similar in women and men, except for non-HDL cholesterol, for which high non-HDL cholesterol was associated with an HR for major cardiovascular disease of 1.11 (95% CI 1.01-1.21) in women and 1.28 (1.19-1.39) in men, with a consistent pattern for higher risk among men than among women with other lipid markers. Symptoms of depression had a HR of 1.09 (0.98-1.21) in women and 1.42 (1.25-1.60) in men. By contrast, consumption of a diet with a PURE score of 4 or lower (score ranges from 0 to 8), was more strongly associated with major cardiovascular disease in women (1.17 [1.08-1.26]) than in men (1.07 [0.99-1.15]). The total PAFs associated with behavioural and psychosocial risk factors were greater in men (15.7%) than in women (8.4%) predominantly due to the larger contribution of smoking to PAFs in men (ie, 1.3% [95% CI 0.5-2.1] in women vs 107% [8.8-12.6] in men). Interpretation Lipid markers and depression are more strongly associated with the risk of cardiovascular disease in men than in women, whereas diet is more strongly associated with the risk of cardiovascular disease in women than in men. The similar associations of other risk factors with cardiovascular disease in women and men emphasise the importance of a similar strategy for the prevention of cardiovascular disease in men and women. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Walli-Attaei, Marjan; Rangarajan, Sumathy; Teo, Koon; Anand, Sonia S.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Walli-Attaei, Marjan; Rangarajan, Sumathy; Teo, Koon; Anand, Sonia S.; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Breet, Yolandi] North West Univ, Hypertens Africa Res Team HART, Potchefstroom, South Africa; [Breet, Yolandi] North West Univ, MRC Res Unit Hypertens & Cardiovasc Dis, Potchefstroom, South Africa; [Abdul-Razak, Suraya] Univ Teknol MARA UiTM, Cardiovasc & Lungs Res Inst CaVaLRI, PhD Fac Med, Shah Alam, Selangor, Malaysia; [Al Sharief, Wadeia] Univ Sharjah, Med Coll, Med Educ & Res Dept, Sharjah, U Arab Emirates; [Alhabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Avezum, Alvaro] Hosp Alemao Oswald Cruz, Int Res Ctr, Sao Paulo, Brazil; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Physiol Dept, Harare, Zimbabwe; [Diaz, Rafael] Estudios Clin Latinoamer ECLA, Rosario, Santa Fe, Argentina; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Hu, Bo; Lang, Xinyue; Li, Sidong] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Beijing, Peoples R China; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Ismail, Rosnah] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Community Hlth, Kuala Lumpur, Malaysia; [Kelishadi, Roya] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Lopez-Jaramillo, Patricio] Univ Santander UDES, Med Sch, Masira Res Inst, Bucaramanga, Colombia; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Chennai, Tamil Nadu, India; [Oguz, Aytekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Palileo-Villanueva, Lia M.] Univ Philippines Manila, Coll Med, Manila, Philippines; [Poltyn-Zaradna, Katarzyna] Wroclaw Med Univ, Dept Populat Hlth, Wroclaw, Poland; [Sreelakshmi, P. R.] SUT Acad Med Sci, Trivandrum, Kerala, India; [Pinnaka, Lakshmi V. M.] Postgrad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India; [Pinnaka, Lakshmi V. M.] Postgrad Inst Med Educ & Res PGIMER, Sch Publ Hlth, Chandigarh, India; [Seron, Pamela] Univ La Frontera, Fac Med, Temuco, Chile; [Verghese, Sejil T.] St Johns Med Coll & Hosp, Dept Physiol, Bangalore, Karnataka, India; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh	McMaster University; Population Health Research Institute; McMaster University; University of Gothenburg; Sahlgrenska University Hospital; North West University - South Africa; North West University - South Africa; Universiti Teknologi MARA; University of Sharjah; King Saud University; University of Zimbabwe; Eternal Heart Care Centre & Research Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Aga Khan University; Universiti Kebangsaan Malaysia; Isfahan University Medical Science; Birzeit University; Universidad Industrial de Santander; Madras Diabetes Research Foundation; Istanbul Medeniyet University; University of the Philippines System; University of the Philippines Manila; Wroclaw Medical University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Universidad de La Frontera; St. John's National Academy of Health Sciences; St. John's Medical College; University of Ottawa; Queens University - Canada; Independent University Bangladesh (IUB)	Walli-Attaei, M (corresponding author), Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada.; Walli-Attaei, M (corresponding author), McMaster Univ, David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	marjan.walli-attaei@PHRI.ca		Verghese, Sejil/0000-0001-8434-6700	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and LongTerm Care; AstraZeneca (Canada); SanofiAventis (France); SanofiAventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Fundacion ECLA (Estudios Clinicos Latino America); Independent University; Mitra and Associates; Hospital Alemao Oswaldo Cruz, Sao Paulo; Dairy Farmers of Canada; National Dairy Council (US); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de La Frontera [EXD05-0003]; National Center for Cardiovascular Diseases; ThinkTank Research Center for Health Development; Colciencias [6566-04-18062, 6517-777-58228]; Indian Council of Medical Research; Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 [13/2007], 07-05-IFN-BPH 010]; Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 [2/2011]]; Universiti Teknologi MARA; Biostatistics & Data Repository Sector; National Institute of Health, Setia Alam; National Registration Department (JPN), Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; United Nations Relief and Works Agency for Palestine Refugees in the Near East; International Development Research Centre, Canada; Philippine Council for Health Research and Development; Polish Ministry of Science and Higher Education, Wroclaw Medical University [290/W-PURE/2008/0]; Saudi Heart Association; Dr Mohammad Alfagih Hospital; Deanship of Scientific Research at King Saud University [RG -1436-013]; Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University; North-West University; Netherlands Programme for Alternative Development; National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association; Faculty of Community and Health Sciences; Swedish state under the Agreement concerning research and education of doctors; Swedish Heart and Lung Foundation; Swedish Research Council [2018-02527]; Swedish Council for Health, Working Life and Welfare; King Gustaf V:s and Queen Victoria Freemason's Foundation; AFA Insurance; Metabolic Syndrome Society; AstraZeneca; Sanofi Aventis; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research (Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (ON, Canada); Ontario Ministry of Health and LongTerm Care(Ministry of Health and Long-Term Care, Ontario); AstraZeneca (Canada)(AstraZeneca); SanofiAventis (France)(Sanofi-Aventis); SanofiAventis (Canada)(Sanofi-Aventis); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Fundacion ECLA (Estudios Clinicos Latino America); Independent University; Mitra and Associates; Hospital Alemao Oswaldo Cruz, Sao Paulo; Dairy Farmers of Canada; National Dairy Council (US); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de La Frontera; National Center for Cardiovascular Diseases; ThinkTank Research Center for Health Development; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Universiti Teknologi MARA; Biostatistics & Data Repository Sector; National Institute of Health, Setia Alam; National Registration Department (JPN), Universiti Kebangsaan Malaysia; United Nations Relief and Works Agency for Palestine Refugees in the Near East; International Development Research Centre, Canada(CGIAR); Philippine Council for Health Research and Development; Polish Ministry of Science and Higher Education, Wroclaw Medical University; Saudi Heart Association; Dr Mohammad Alfagih Hospital; Deanship of Scientific Research at King Saud University(King Saud University); Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University; North-West University; Netherlands Programme for Alternative Development; National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association; Faculty of Community and Health Sciences; Swedish state under the Agreement concerning research and education of doctors; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Health, Working Life and Welfare; King Gustaf V:s and Queen Victoria Freemason's Foundation; AFA Insurance; Metabolic Syndrome Society; AstraZeneca(AstraZeneca); Sanofi Aventis(Sanofi-Aventis); Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	The PURE study is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research (including through the Strategy for Patient-Oriented Research via the Ontario SPOR Support Unit), the Heart and Stroke Foundation (ON, Canada), and the Ontario Ministry of Health and LongTerm Care. The study was also funded by unrestricted grants from the following pharmaceutical companies: AstraZeneca (Canada), SanofiAventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma. And the study was also funded by several national and local organisations in participating countries as follows: Argentina: Fundacion ECLA (Estudios Clinicos Latino America); Bangladesh: Independent University and Mitra and Associates; Brazil: Hospital Alemao Oswaldo Cruz, Sao Paulo; Canada: an unrestricted grant from Dairy Farmers of Canada and the National Dairy Council (US), Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera (EXD05-0003); China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Biostatistics & Data Repository Sector, National Institute of Health, Setia Alam, and National Registration Department (JPN), Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); the Middle East: the United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre, Canada; The Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (research group number: RG -1436-013), Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University; South Africa: The North-West University, and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council (2018-02527), the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, and AFA Insurance; Turkiye: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority, Dubai. Further details on the funding and participating countries and institutions, and on collaborating staff, are shown in the appendix (pp 3-8).	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Bragg F, 2017, JAMA-J AM MED ASSOC, V317, P280, DOI 10.1001/jama.2016.19720; Burke GM, 2017, AM J CARDIOL, V120, P1787, DOI 10.1016/j.amjcard.2017.07.087; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; de Jong M, 2020, DIABETES CARE, V43, P2050, DOI 10.2337/dc19-2363; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; Ferguson J, 2018, STAT METHODS MED RES, V27, P1141, DOI 10.1177/0962280216655374; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gnatiuc L, 2018, LANCET DIABETES ENDO, V6, P538, DOI 10.1016/S2213-8587(18)30079-2; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Joseph P, 2022, EUR HEART J, V43, P2831; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kjeldsen EW, 2022, LANCET REG HEALTH-EU, V19, DOI DOI 10.1016/j.lanepe.2022.100419; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; Meng RW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21043; Millett ERC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4247; Peters SAE, 2016, ATHEROSCLEROSIS, V248, P123, DOI 10.1016/j.atherosclerosis.2016.03.016; Peters SAE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005663; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Rajan S, 2020, JAMA PSYCHIAT, V77, P1052, DOI 10.1001/jamapsychiatry.2020.1351; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Sathish T, 2022, LANCET GLOB HEALTH, V10, pE216, DOI 10.1016/S2214-109X(21)00509-X; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thurston RC, 2018, MENOPAUSE, V25, P849, DOI 10.1097/GME.0000000000001143; Vogel B, 2021, LANCET, V397, P2385, DOI 10.1016/S0140-6736(21)00684-X; Woodward M, 2019, HEART, V105, P1701, DOI 10.1136/heartjnl-2019-315299; Yang LL, 2016, STAT MED, V35, P1299, DOI 10.1002/sim.6754; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2020, LANCET, V395, P795, DOI 10.1016/S0140-6736(19)32008-2; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	35	2	2	8	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					811	821		10.1016/S0140-6736(22)01441-6	http://dx.doi.org/10.1016/S0140-6736(22)01441-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088949				2022-12-28	WOS:000877580600020
J	Essien, UR; Washington, DL; Fine, MJ				Essien, Utibe R.; Washington, Donna L.; Fine, Michael J.			Beyond Detecting and Understanding Disparities in Novel Diabetes Treatment Need for a Major Shift in Pharmacoequity Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Essien, Utibe R.; Fine, Michael J.] VA Pittsburgh Healthcare Syst, VA HSR&D Ctr Hlth Equ Res & Promot, 3609 Forbes Ave,Ste 2, Pittsburgh, PA 15213 USA; [Essien, Utibe R.; Fine, Michael J.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA USA; [Washington, Donna L.] VA Greater Los Angeles Healthcare Syst, VA HSR&D Ctr Study Healthcare Innovat Implementat, Los Angeles, CA USA; [Washington, Donna L.] Univ Calif Los Angeles, Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Essien, UR (corresponding author), VA Pittsburgh Healthcare Syst, VA HSR&D Ctr Hlth Equ Res & Promot, 3609 Forbes Ave,Ste 2, Pittsburgh, PA 15213 USA.	uessien@pitt.edu						American Diabetes Association, 2022, Clin Diabetes, V40, P10, DOI 10.2337/cd22-as01; Centers for Disease Control and Prevention, NAT DIAB STAT REP; Cheng YLJ, 2019, JAMA-J AM MED ASSOC, V322, P2389, DOI 10.1001/jama.2019.19365; Eberly LA, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.4182; Eberly LA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6139; Essien Utibe R, 2022, Circ Cardiovasc Qual Outcomes, V15, pe008389, DOI 10.1161/CIRCOUTCOMES.121.008389; Essien UR, 2021, JAMA-J AM MED ASSOC, V326, P1793, DOI 10.1001/jama.2021.17764; Essien UR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.14234; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; Lamprea-Montealegre JA, 2022, JAMA-J AM MED ASSOC, V328, P861, DOI 10.1001/jama.2022.13885; Marso SP, 2017, NEW ENGL J MED, V376, P891, DOI 10.1056/NEJMc1615712; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Thomas SB, 2011, ANNU REV PUBL HEALTH, V32, P399, DOI 10.1146/annurev-publhealth-031210-101136; US Department of Veterans Affairs, 2022, VA HLTH CAR COP RAT; Washington DL, 2008, J GEN INTERN MED, V23, P685, DOI 10.1007/s11606-007-0481-0	15	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					836	838						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066540				2022-12-28	WOS:000855171700019
J	O'Connor, DA; Glasziou, P; Maher, CG; McCaffery, KJ; Schram, D; Maguire, B; Ma, R; Billot, L; Gorelik, A; Traeger, AC; Albarqouni, L; Checketts, J; Vyas, P; Clark, B; Buchbinder, R				O'Connor, Denise A.; Glasziou, Paul; Maher, Christopher G.; McCaffery, Kirsten J.; Schram, Dina; Maguire, Brigit; Ma, Robert; Billot, Laurent; Gorelik, Alexandra; Traeger, Adrian C.; Albarqouni, Loai; Checketts, Juliet; Vyas, Parima; Clark, Brett; Buchbinder, Rachelle			Effect of an Individualized Audit and Feedback Intervention on Rates of Musculoskeletal Diagnostic Imaging Requests by Australian General Practitioners A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES; REFERRALS; CARE	IMPORTANCE Audit and feedback can improve professional practice, but few trials have evaluated its effectiveness in reducing potential overuse of musculoskeletal diagnostic imaging in general practice. OBJECTIVE To evaluate the effectiveness of audit and feedback for reducing musculoskeletal imaging by high-requesting Australian general practitioners (GPs). DESIGN, SETTING, AND PARTICIPANTS This factorial cluster-randomized clinical trial included 2271 general practices with at least 1 GP who was in the top 20% of referrers for 11 imaging tests (of the lumbosacral or cervical spine, shoulder, hip, knee, and ankle/hind foot) and for at least 4 individual tests between January and December 2018. Only high-requesting GPs within participating practices were included. The trial was conducted between November 2019 and May 2021, with final follow-up on May 8, 2021. INTERVENTIONS Eligible practices were randomized in a 1:1:1:1:1 ratio to 1of 4 different individualized written audit and feedback interventions (n = 3055 GPs) that varied factorially by (1) frequency of feedback (once vs twice) and (2) visual display (standard vs enhanced display highlighting highly requested tests) or to a control condition of no intervention (n = 764 GPs). Participants were not masked. MAIN OUTCOMES AND MEASURES The primary outcome was the overall rate of requests for the 11 targeted imaging tests per 1000 patient consultations over 12 months, assessed using routinely collected administrative data. Primary analyses included all randomized GPs who had at least 1 patient consultation during the study period and were performed by statisticians masked to group allocation. RESULTS A total of 3819 high-requesting GPs from 2271 practices were randomized, and 3660 GPs (95.8%; n = 727 control, n = 2933 intervention) were included in the primary analysis. Audit and feedback led to a statistically significant reduction in the overall rate of imaging requests per 1000 consultations compared with control over 12 months (adjusted mean, 27.7 [95% CI. 27.5-28.0] vs 30.4 [95% CI, 29.8-30.9], respectively; adjusted mean difference. -2.66 [95% CI. -3.24 to -2.07]; P < .001). CONCLUSIONS AND RELEVANCE Among Australian general practitioners known to frequently request musculoskeletal diagnostic imaging, an individualized audit and feedback intervention, compared with no intervention, significantly decreased the rate of targeted musculoskeletal imaging tests ordered over 12 months.	[O'Connor, Denise A.; Gorelik, Alexandra; Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [O'Connor, Denise A.; Gorelik, Alexandra; Buchbinder, Rachelle] Cabrini Hlth, Monash Cabrini Dept Musculoskeletal Hlth & Clin E, 553 St Kilda Rd, Malvern, Vic 3004, Australia; [Glasziou, Paul; Albarqouni, Loai] Bond Univ, Fac Hlth Sci & Med, Inst Evidence Based Healthcare, Robina, Qld, Australia; [Maher, Christopher G.; Traeger, Adrian C.] Sydney Local Hlth Dist & Univ Sydney, Inst Musculoskeletal Hlth, Camperdown, NSW, Australia; [McCaffery, Kirsten J.] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney Hlth Literacy Lab, Camperdown, NSW, Australia; [Schram, Dina; Maguire, Brigit; Ma, Robert; Checketts, Juliet; Vyas, Parima; Clark, Brett] Australian Govt Dept Hlth & Aged Care, Canberra, ACT, Australia; [Billot, Laurent] Univ New South Wales, Fac Med & Hlth, George Inst Global Hlth, Newtown, NSW, Australia	Monash University; Cabrini Health; Bond University; University of Sydney; George Institute for Global Health; University of New South Wales Sydney; University of Sydney	O'Connor, DA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.; O'Connor, DA (corresponding author), Cabrini Hlth, Monash Cabrini Dept Musculoskeletal Hlth & Clin E, 553 St Kilda Rd, Malvern, Vic 3004, Australia.	denise.oconnor@monash.edu	Maher, Christopher/AAC-6267-2019; Glasziou, Paul/A-7832-2008	Maher, Christopher/0000-0002-1628-7857; Albarqouni, Loai/0000-0002-4114-9106; Glasziou, Paul/0000-0001-7564-073X; Billot, Laurent/0000-0002-4975-9793	Australian Government Department of Health and Aged Care; Australian National Health and Medical Research Council (NHMRC) Program [APP1113532]; Australian NHMRC Translating Research Into Practice (TRIP) Fellowship [APP1168749]; Australian NHMRC Investigator Fellowship [APP1194483, APP1155009, APP1194283]; Australian NHMRC Early Career Fellowship [APP1144026]	Australian Government Department of Health and Aged Care(Australian GovernmentDepartment of Health & Ageing); Australian National Health and Medical Research Council (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Translating Research Into Practice (TRIP) Fellowship; Australian NHMRC Investigator Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian Government Department of Health and Aged Care and supported by Australian National Health and Medical Research Council (NHMRC) Program Grant APP1113532. Dr O'Connor is supported by an Australian NHMRC Translating Research Into Practice (TRIP) Fellowship (grant APP1168749). Dr Glasziou is supported by an Australian NHMRC Investigator Fellowship (grant APP1155009). Dr Maher is supported by an Australian NHMRC Investigator Fellowship (grant APP1194283). Dr Traeger is supported by an Australian NHMRC Early Career Fellowship (grant APP1144026). Dr Buchbinder is supported by an Australian NHMRC Investigator Fellowship (grant APP1194483).	Billot L, 2021, PREPRINT, DOI [10.31219/osf.io/prnd2, DOI 10.31219/OSF.IO/PRND2]; Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Brown B, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0883-5; CARVER CS, 1982, PSYCHOL BULL, V92, P111, DOI 10.1037/0033-2909.92.1.111; Downie A, 2020, BRIT J SPORT MED, V54, P642, DOI 10.1136/bjsports-2018-100087; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Jenkins HJ, 2018, SPINE J, V18, P2266, DOI 10.1016/j.spinee.2018.05.004; Kerry S, 2000, FAM PRACT, V17, P46, DOI 10.1093/fampra/17.1.46; Lin I, 2020, BRIT J SPORT MED, V54, P79, DOI 10.1136/bjsports-2018-099878; Maher CG, 2019, INT J RHEUM DIS, V22, P1957, DOI 10.1111/1756-185X.13710; Morrisroe K, 2018, INTERN MED J, V48, P135, DOI 10.1111/imj.13654; Muskens JLJM, 2022, BMJ QUAL SAF, V31, P54, DOI 10.1136/bmjqs-2020-012576; NHMRC, 2018, NAT STAT ETH COND HU; Robling MR, 2002, CLIN RADIOL, V57, P402, DOI 10.1053/crad.2001.0864; Safiri S, 2021, ARTHRITIS RHEUMATOL, V73, P702, DOI 10.1002/art.41571; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Vos T, 2020, LANCET, V396, P1562; WINKENS RAG, 1995, LANCET, V345, P498, DOI 10.1016/S0140-6736(95)90588-X	21	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					850	860		10.1001/jama.2022.14587	http://dx.doi.org/10.1001/jama.2022.14587			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066518				2022-12-28	WOS:000855171700021
J	Cullen, JP; Russ, S; Russell, HA				Cullen, John P.; Russ, Savanah; Russell, Holly Ann			Theater for Vaccine Hesitancy-Setting the Stage for Difficult Conversations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Arts and Medicine feature describes use of improvisational theater techniques to train health care workers to have persuasive and respectful conversations with vaccine-hesitant patients about accepting COVID-19 vaccination.	[Cullen, John P.] Univ Rochester, Med Ctr, Clin & Translat Sci Inst, 601 Elmwood Ave,Box 708, Rochester, NY 14642 USA; [Cullen, John P.] Univ Rochester, Susan B Anthony Ctr, Rochester, NY 14642 USA; [Russ, Savanah] Univ Rochester, Dept Publ Hlth Sci, Sch Med & Dent, Rochester, NY 14642 USA; [Russell, Holly Ann] Univ Rochester, Med Ctr, Ctr Community Hlth & Prevent, Family Med Program, Rochester, NY 14642 USA; [Russell, Holly Ann] Univ Rochester, Med Ctr, Ctr Community Hlth & Prevent, Clin & Community Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Cullen, JP (corresponding author), Univ Rochester, Med Ctr, Clin & Translat Sci Inst, 601 Elmwood Ave,Box 708, Rochester, NY 14642 USA.	john_cullen@umc.rochester.edu	Cullen, John/GRR-9920-2022		Prevention Research Center Supplement from the Centers for Disease Control and Prevention [U48DP006394-02-01]; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002001]	Prevention Research Center Supplement from the Centers for Disease Control and Prevention; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this article was supported by a Prevention Research Center Supplement from the Centers for Disease Control and Prevention under award U48DP006394-02-01 and by the University of Rochester CTSA award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health.	Abdul-Mutakabbir J., 2021, OPEN FORUM INFECT DI, V8, pS339, DOI [10.1093/ofid/ofab466.674, DOI 10.1093/OFID/OFAB466.674]; Bradley Meredith, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc051; Manzi J, 2020, J MED HUMANIT, V41, P489, DOI 10.1007/s10912-020-09608-8; Patrick H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-18; Rizk Nina, 2020, MedEdPORTAL, V16, P11022, DOI 10.15766/mep_2374-8265.11022; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Sheeran P, 2021, HEALTH PSYCHOL, V40, P706, DOI 10.1037/hea0001111; Usher K, 2020, J CLIN NURS, V29, P2756, DOI 10.1111/jocn.15290	8	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1018	1019		10.1001/jama.2022.14864	http://dx.doi.org/10.1001/jama.2022.14864		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36053542				2022-12-28	WOS:000848898400003
J	Faltine-Gonzalez, DZ; Kebschull, JM				Faltine-Gonzalez, Dylan Z.; Kebschull, Justus M.			A mosaic of new and old cell types	SCIENCE			English	Editorial Material									[Faltine-Gonzalez, Dylan Z.; Kebschull, Justus M.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Kebschull, JM (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	kebschull@jhu.edu						Chen A, 2022, CELL, V185, P1777, DOI 10.1016/j.cell.2022.04.003; Colquitt BM, 2021, SCIENCE, V371, P695, DOI 10.1126/science.abd9704; Hain D, 2022, SCIENCE, V377, P1060, DOI 10.1126/science.abp8202; Jourjine N, 2021, NEURON, V109, P1084, DOI 10.1016/j.neuron.2021.02.002; Kebschull JM, 2020, SCIENCE, V370, DOI 10.1126/science.abd5059; Lust K, 2022, SCIENCE, V377, P1061, DOI 10.1126/science.abp9262; Marioni JC, 2017, ANNU REV CELL DEV BI, V33, P537, DOI 10.1146/annurev-cellbio-100616-060818; Norimoto H, 2020, NATURE, V578, P413, DOI 10.1038/s41586-020-1993-6; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Wei XY, 2022, SCIENCE, V377, P1062, DOI 10.1126/science.abp9444; Woych J, 2022, SCIENCE, V377, P1063, DOI 10.1126/science.abp9186; Zeng HK, 2022, CELL, V185, P2739, DOI 10.1016/j.cell.2022.06.031	12	0	0	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1043	1044		10.1126/science.add9465	http://dx.doi.org/10.1126/science.add9465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048955				2022-12-28	WOS:000887933200031
J	Florig, ST; Corby, S; Devara, T; Weiskopf, NG; Mohan, V; Gold, JA				Florig, Sarah T.; Corby, Sky; Devara, Tanuj; Weiskopf, Nicole G.; Mohan, Vishnu; Gold, Jeffrey A.			Medical Record Closure Practices of Physicians Before and After the Use of Medical Scribes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Florig, Sarah T.; Corby, Sky; Devara, Tanuj; Gold, Jeffrey A.] Oregon Hlth & Sci Univ, Div Pulmonol & Crit Care Med, Portland, OR 97201 USA; [Weiskopf, Nicole G.; Mohan, Vishnu] Oregon Hlth & Sci Univ, Dept Informat & Clin Epidemiol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Gold, JA (corresponding author), Oregon Hlth & Sci Univ, Div Pulmonol Allergy & Crit Care Med, 3181 SW Sam Jackson Pk Rd,Mail Code UHN 67, Portland, OR 97239 USA.	goldje@ohsu.edu		/0000-0001-6906-2689; Weiskopf, Nicole/0000-0003-0365-909X	AHRQ [R01 HS25141-05]; US Department of Health and Human Services	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services	This project was funded under grant No. R01 HS25141-05 (Dr Gold) from the AHRQ, US Department of Health and Human Services.	Florig ST., 2022, AMIA ANN S PROC, V2021, P457; Goldstein IH, 2019, OPHTHALMOLOGY, V126, P783, DOI 10.1016/j.ophtha.2019.01.011; Gottlieb M, 2021, ANN EMERG MED, V77, P180, DOI 10.1016/j.annemergmed.2020.07.031; Mishra P, 2018, JAMA INTERN MED, V178, P1467, DOI 10.1001/jamainternmed.2018.3956; Tran Brian, 2019, AMIA Jt Summits Transl Sci Proc, V2019, P136; Ullman K., 2020, 09009 VA ESP DEP VET	6	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2022	328	13					1350	1352		10.1001/jama.2022.13558	http://dx.doi.org/10.1001/jama.2022.13558		SEP 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5F6GU	36048452				2022-12-28	WOS:000848896700001
J	Chalkias, S; Harper, C; Vrbicky, K; Walsh, SR; Essink, B; Brosz, A; McGhee, N; Tomassini, JE; Chen, X; Chang, Y; Sutherland, A; Montefiori, DC; Girard, B; Edwards, DK; Feng, J; Zhou, HH; Baden, LR; Miller, JM; Das, R				Chalkias, Spyros; Harper, Charles; Vrbicky, Keith; Walsh, Stephen R.; Essink, Brandon; Brosz, Adam; McGhee, Nichole; Tomassini, Joanne E.; Chen, Xing; Chang, Ying; Sutherland, Andrea; Montefiori, David C.; Girard, Bethany; Edwards, Darin K.; Feng, Jing; Zhou, Honghong; Baden, Lindsey R.; Miller, Jacqueline M.; Das, Rituparna			A Bivalent Omicron-Containing Booster Vaccine against Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VARIANT; STATES	BACKGROUND The safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known. METHODS In this ongoing, phase 2-3 study, we compared the 50-mu g bivalent vaccine mRNA-1273.214 (25 mu g each of ancestral Wuhan-Hu-1 and omicron B.1.1.529 [BA.1] spike messenger RNAs) with the previously authorized 50-mu g mRNA-1273 booster. We administered mRNA-1273.214 or mRNA-1273 as a second booster in adults who had previously received a two-dose (100-mu g) primary series and first booster (50-mu g) dose of mRNA-1273 (>= 3 months earlier). The primary objectives were to assess the safety, reactogenicity, and immunogenicity of mRNA-1273.214 at 28 days after the booster dose. RESULTS Interim results are presented. Sequential groups of participants received 50 mu g of mRNA-1273.214 (437 participants) or mRNA-1273 (377 participants) as a second booster dose. The median time between the first and second boosters was similar for mRNA-1273.214 (136 days) and mRNA-1273 (134 days). In participants with no previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the geometric mean titers of neutralizing antibodies against the omicron BA.1 variant were 2372.4 (95% confidence interval [CI], 2070.6 to 2718.2) after receipt of the mRNA-1273.214 booster and 1473.5 (95% CI, 1270.8 to 1708.4) after receipt of the mRNA-1273 booster. In addition, 50-mu g mRNA-1273.214 and 50-mu g mRNA-1273 elicited geometric mean titers of 727.4 (95% CI, 632.8 to 836.1) and 492.1 (95% CI, 431.1 to 561.9), respectively, against omicron BA.4 and BA.5 (BA.4/5), and the mRNA-1273.214 booster also elicited higher binding antibody responses against multiple other variants (alpha, beta, gamma, and delta) than the mRNA-1273 booster. Safety and reactogenicity were similar with the two booster vaccines. Vaccine effectiveness was not assessed in this study; in an exploratory analysis, SARS-CoV-2 infection occurred in 11 participants after the mRNA-1273.214 booster and in 9 participants after the mRNA-1273 booster. CONCLUSIONS The bivalent omicron-containing vaccine mRNA-1273.214 elicited neutralizing antibody responses against omicron that were superior to those with mRNA-1273, without evident safety concerns.	[Chalkias, Spyros; McGhee, Nichole; Tomassini, Joanne E.; Chen, Xing; Chang, Ying; Sutherland, Andrea; Girard, Bethany; Edwards, Darin K.; Feng, Jing; Zhou, Honghong; Miller, Jacqueline M.; Das, Rituparna] Moderna, Cambridge, MA 02139 USA; [Walsh, Stephen R.; Baden, Lindsey R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Harper, Charles; Vrbicky, Keith] Meridian Clin Res, Norfolk, VA USA; [Essink, Brandon] Meridian Clin Res, Omaha, NE USA; [Brosz, Adam] Meridian Clin Res, Grand Isl, NE USA; [Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA; [Chalkias, Spyros] Moderna, 200 Technol Sq, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Duke University	Chalkias, S (corresponding author), Moderna, 200 Technol Sq, Cambridge, MA 02139 USA.	spyros.chalkias@modernatx.com		Walsh, Stephen/0000-0002-0817-9370	Moderna	Moderna	Supported by Moderna.	[Anonymous], 2021, EM US AUTH VACC PREV; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Cao YL, 2022, NATURE, V608, P593, DOI 10.1038/s41586-022-04980-y; Centers for Disease Control and Prevention, 2021, COVID DAT TRACK PROP; Centers for Disease Control and Prevention, 2022, STAY DAT COVID 19 VA; Chalkias S., NAT MED; Chu L, 2022, NAT MED, V28, P1042, DOI 10.1038/s41591-022-01739-w; CoVariants, 2021, OV VAR COUNTR; CoVariants, 2022, OV VAR MUT; El Sahly HM, 2021, NEW ENGL J MED, V385, P1774, DOI 10.1056/NEJMoa2113017; FDA Center for Biologics Evaluation and Research, 2022, EM US AUTH VACC PREV; FDA Center for Drug Evaluation and Research, 2017, MULT ENDP CLIN TRIAL; Ferdinands JM, 2022, MMWR-MORBID MORTAL W, V71, P255, DOI 10.15585/mmwr.mm7107e2; Food and Drug Administration (US), 2022, COR COVID 19 UPD FDA; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Pajon R, 2022, NEW ENGL J MED, V386, P1088, DOI 10.1056/NEJMc2119912; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Prasad N, 2022, MMWR-MORBID MORTAL W, V71, P633, DOI 10.15585/mmwr.mm7118a4; Pulliam JRC, 2022, SCIENCE, V376, P596, DOI 10.1126/science.abn4947; S. Carazo, 2022, medRxiv, DOI 10.1101/2022.04.29.22274455; Suryawanshi RK, 2022, NAT REV IMMUNOL, V22, P410, DOI 10.1038/s41586-022-04865-0; Tang JJ, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30649-1; Thompson Mark G, 2022, MMWR Morb Mortal Wkly Rep, V71, P139, DOI 10.15585/mmwr.mm7104e3; Tseng HF, 2022, NAT MED, V28, P1063, DOI 10.1038/s41591-022-01753-y; UK Health Security Agency, 2022, INV SARS COV 2 VAR T	27	12	12	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2022	387	14					1279	1291		10.1056/NEJMoa2208343	http://dx.doi.org/10.1056/NEJMoa2208343			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5I3II	36112399	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000868254300010
J	Sun, NN; Huang, JJ; Qian, JY; Zhou, TP; Guo, J; Tang, LY; Zhang, WT; Deng, YM; Zhao, WN; Wu, GJ; Liao, RZ; Chen, X; Zhong, FR; Wu, YZ				Sun, Ningning; Huang, Jianjian; Qian, Junyi; Zhou, Tai-Ping; Guo, Juan; Tang, Langyu; Zhang, Wentao; Deng, Yaming; Zhao, Weining; Wu, Guojiao; Liao, Rong-Zhen; Chen, Xi; Zhong, Fangrui; Wu, Yuzhou			Enantioselective [2+2]-cycloadditions with triplet photoenzymes	NATURE			English	Article							2+2 PHOTOCYCLOADDITION; ENERGY-TRANSFER; DERACEMIZATION; PHOTOCATALYSIS; CATALYSIS; ENZYMES	Naturally evolved enzymes, despite their astonishingly large variety and functional diversity, operate predominantly through thermochemical activation. Integrating prominent photocatalysis modes into proteins, such astriplet energy transfer, could create artificial photoenzymes that expand the scope of natural biocatalysis(1-3). Here, we exploit genetically reprogrammed, chemically evolved photoenzymes embedded with a synthetic triplet photosensitizer that are capable of excited-state enantio-induction(4-6). Structural optimization through four rounds of directed evolution afforded proficient variants for the enantioselective intramolecular [2+2]-photocycloaddition of indole derivatives with good substrate generality and excellent enantioselectivities (up to 99% enantiomeric excess). A crystal structure of the photoenzyme-substrate complex elucidated the non-covalent interactions that mediate the reaction stereochemistry. This study expands the energy transfer reactivity(7-10) of artificial triplet photoenzymes in a supramolecular protein cavity and unlocks an integrated approach to valuable enantioselective photochemical synthesisthat is not accessible with either the synthetic orthe biological world alone.	[Sun, Ningning; Huang, Jianjian; Zhou, Tai-Ping; Guo, Juan; Tang, Langyu; Zhang, Wentao; Deng, Yaming; Wu, Guojiao; Liao, Rong-Zhen; Zhong, Fangrui; Wu, Yuzhou] Huazhong Univ Sci & Technol HUST, Hubei Engn Res Ctr Biomat & Med Protect Mat, Sch Chem & Chem Engn,Minist Educ, Hubei Key Lab Bioinorgan Chem & Mat Med,Key Lab M, Wuhan, Peoples R China; [Qian, Junyi; Chen, Xi] Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol, Minist Educ, Xian, Peoples R China; [Zhao, Weining] Shenzhen Technol Univ, Coll Pharm, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Northwest University Xi'an; Shenzhen Technology University	Zhong, FR; Wu, YZ (corresponding author), Huazhong Univ Sci & Technol HUST, Hubei Engn Res Ctr Biomat & Med Protect Mat, Sch Chem & Chem Engn,Minist Educ, Hubei Key Lab Bioinorgan Chem & Mat Med,Key Lab M, Wuhan, Peoples R China.; Chen, X (corresponding author), Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol, Minist Educ, Xian, Peoples R China.	xchen@nwu.edu.cn; chemzfr@hust.edu.cn; wuyuzhou@hust.edu.cn			National Key R&D Program of China [2018YFA0903500]; National Natural Science Foundation of China [22077042, 22107075]; Natural Science Foundation of Top Talent of SZTU [20211061010013]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Top Talent of SZTU	We thank the National Key R&D Program of China (no. 2018YFA0903500), the National Natural Science Foundation of China (no. 22077042, 22107075) and the Natural Science Foundation of Top Talent of SZTU (20211061010013) for financial support. We thank the Analytical and Testing Centre of HUST, Analytical and Testing Centre of School of Chemistry and Chemical Engineering (HUST) and Research Core Facilities for Life Science (HUST) for instrument support. We thank X. Wan at the Shanghai Institute of Organic Chemistry for providing vibrational circular dichroism analysis, and the staff at beamlines BL02U1 and BL18U1 of the Shanghai Synchrotron Radiation Facility (SSRF) for assistance during X-ray crystal data collection. We thank T. Bach at Technical University of Munich and S. Xie at HUST for valuable discussions.	Alonso R, 2014, ANGEW CHEM INT EDIT, V53, P4368, DOI 10.1002/anie.201310997; Arnold FH, 2019, ANGEW CHEM INT EDIT, V58, P14420, DOI 10.1002/anie.201907729; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Becker MR, 2020, NAT CHEM, V12, P898, DOI 10.1038/s41557-020-0541-1; Biegasiewicz KF, 2019, SCIENCE, V364, P1166, DOI 10.1126/science.aaw1143; Black MJ, 2020, NAT CHEM, V12, P71, DOI 10.1038/s41557-019-0370-2; Blum TR, 2016, SCIENCE, V354, P1391, DOI 10.1126/science.aai8228; Brenninger C, 2018, ANGEW CHEM INT EDIT, V57, P14338, DOI 10.1002/anie.201804006; Brimioulle R, 2015, ANGEW CHEM INT EDIT, V54, P3872, DOI 10.1002/anie.201411409; Burke AJ, 2019, NATURE, V570, P219, DOI 10.1038/s41586-019-1262-8; Candish L, 2022, CHEM REV, V122, P2907, DOI 10.1021/acs.chemrev.1c00416; Chapman SJ, 2022, J AM CHEM SOC, V144, P4206, DOI 10.1021/jacs.2c00063; Chen K, 2020, NAT CATAL, V3, P203, DOI 10.1038/s41929-019-0385-5; COZZI F, 1995, ANGEW CHEM INT EDIT, V34, P1019, DOI 10.1002/anie.199510191; Drienovska I, 2018, NAT CHEM, V10, P946, DOI 10.1038/s41557-018-0082-z; Emmanuel MA, 2016, NATURE, V540, P414, DOI 10.1038/nature20569; Fu Y, 2021, J AM CHEM SOC, V143, P617, DOI 10.1021/jacs.0c10882; Gao X, 2021, J AM CHEM SOC, V143, P19643, DOI 10.1021/jacs.1c09828; Genzink MJ, 2022, CHEM REV, V122, P1654, DOI 10.1021/acs.chemrev.1c00467; Grosskopf J, 2022, CHEM REV, V122, P1626, DOI 10.1021/acs.chemrev.1c00272; Harrison W, 2022, ACCOUNTS CHEM RES, V55, P1087, DOI 10.1021/acs.accounts.1c00719; Holzl-Hobmeier A, 2018, NATURE, V564, P240, DOI 10.1038/s41586-018-0755-1; Huang MX, 2022, SCIENCE, V375, P869, DOI 10.1126/science.abl4922; Huang XQ, 2020, NATURE, V584, P69, DOI 10.1038/s41586-020-2406-6; Kang FY, 2021, ACS CATAL, V11, P5628, DOI 10.1021/acscatal.1c00287; Kleinmans R, 2022, NATURE, V605, P477, DOI 10.1038/s41586-022-04636-x; Li XY, 2021, ANGEW CHEM INT EDIT, V60, P2684, DOI 10.1002/anie.202013276; Liu XH, 2018, NAT CHEM, V10, P1201, DOI 10.1038/s41557-018-0150-4; Lovelock SL, 2022, NATURE, V606, P49, DOI 10.1038/s41586-022-04456-z; Madoori PK, 2009, EMBO J, V28, P156, DOI 10.1038/emboj.2008.263; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Munster N, 2017, ANGEW CHEM INT EDIT, V56, P9468, DOI 10.1002/anie.201705333; Pecho F, 2021, J AM CHEM SOC, V143, P9350, DOI 10.1021/jacs.1c05240; Plaza M, 2021, J AM CHEM SOC, V143, P11209, DOI 10.1021/jacs.1c05286; Poplata S, 2016, CHEM REV, V116, P9748, DOI 10.1021/acs.chemrev.5b00723; Roelfes G, 2019, ACCOUNTS CHEM RES, V52, P545, DOI 10.1021/acs.accounts.9b00004; Rui JY, 2022, SCIENCE, V376, P869, DOI 10.1126/science.abj2830; Silvi M, 2018, NATURE, V554, P40, DOI 10.1038/nature25175; Skubi KL, 2017, J AM CHEM SOC, V139, P17186, DOI 10.1021/jacs.7b10586; Skubi KL, 2016, CHEM REV, V116, P10035, DOI 10.1021/acs.chemrev.6b00018; Strieth-Kalthoff F, 2020, CHEM-US, V6, P1888, DOI 10.1016/j.chempr.2020.07.010; Strieth-Kalthoff F, 2018, CHEM SOC REV, V47, P7190, DOI 10.1039/c8cs00054a; Xu J, 2019, J AM CHEM SOC, V141, P7934, DOI 10.1021/jacs.9b02709; Zhou QQ, 2019, ANGEW CHEM INT EDIT, V58, P1586, DOI 10.1002/anie.201803102; Zhu M, 2019, J AM CHEM SOC, V141, P2636, DOI 10.1021/jacs.8b12965	45	0	0	50	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2022	611	7937					715	+		10.1038/s41586-022-05342-4	http://dx.doi.org/10.1038/s41586-022-05342-4		SEP 2022	10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EM	36130726	Green Submitted			2022-12-28	WOS:000880580400002
J	Saul, H; Gursul, D; Hoskin, L; Buckman, J				Saul, Helen; Gursul, Deniz; Hoskin, Lauren; Buckman, Joshua			Unemployment and insecure housing are linked to less successful treatment for depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Hoskin, Lauren] NIHR Ctr Engagement & Disseminat, Twickenham, England; [Buckman, Joshua] UCL, London, England; [Buckman, Joshua] Camden & Islington NHS Fdn Trust, London, England	University of London; University College London	Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk		Buckman, Joshua/0000-0002-2281-0907				Aubry T, 2015, PSYCHIAT SERV, V66, P463, DOI 10.1176/appi.ps.201400167; Bejerholm U, 2017, J AFFECT DISORDERS, V207, P212, DOI 10.1016/j.jad.2016.08.028; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Ridley M, 2020, SCIENCE, V370, P1289, DOI 10.1126/science.aay0214	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2022	378								o2182	10.1136/bmj.o2182	http://dx.doi.org/10.1136/bmj.o2182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V6QL	36113881	Green Submitted			2022-12-28	WOS:000877352500011
J	Coombes, R				Coombes, Rebecca			Stepping away from the formula milk industry: five minutes with ... Maeve Kelleher The paediatrician on her journey towards refusing funding from the formula milk industry	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								o2243	10.1136/bmj.o2243	http://dx.doi.org/10.1136/bmj.o2243			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109043				2022-12-28	WOS:000888774200010
J	De-Madaria, E; Buxbaum, JL; Maisonneuve, P; De Paredes, AGG; Zapater, P; Guilabert, L; Vaillo-Rocamora, A; Rodriguez-Gandia, MA; Donate-Ortega, J; Lozada-Hernandez, EE; Moreno, AJRC; Lira-Aguilar, A; Llovet, LP; Mehta, R; Tandel, R; Navarro, P; Sanchez-Pardo, AM; Sanchez-Marin, C; Cobreros, M; Fernandez-Cabrera, I; Casals-Seoane, F; Deza, DC; Lauret-Brana, E; Marti-Marques, E; Camacho-Montano, LM; Ubieto, V; Ganuza, M; Bolado, F				De-Madaria, E.; Buxbaum, J. L.; Maisonneuve, P.; Garcia de Paredes, A. Garcia; Zapater, P.; Guilabert, L.; Vaillo-Rocamora, A.; Rodriguez-Gandia, M. A.; Donate-Ortega, J.; Lozada-Hernandez, E. E.; Collazo Moreno, A. J. R.; Lira-Aguilar, A.; Llovet, L. P.; Mehta, R.; Tandel, R.; Navarro, P.; Sanchez-Pardo, A. M.; Sanchez-Marin, C.; Cobreros, M.; Fernandez-Cabrera, I; Casals-Seoane, F.; Deza, D. Casas; Lauret-Brana, E.; Marti-Marques, E.; Camacho-Montano, L. M.; Ubieto, V; Ganuza, M.; Bolado, F.		ERICA Consortium	Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE PERFUSION; ORGAN FAILURE; MANAGEMENT; MULTICENTER; MORTALITY; THERAPY; HEMOCONCENTRATION; HYDRATION; OUTCOMES; MARKER	Background Early aggressive hydration is widely recommended for the management of acute pancreatitis, but evidence for this practice is limited. Methods At 18 centers, we randomly assigned patients who presented with acute pancreatitis to receive goal-directed aggressive or moderate resuscitation with lactated Ringer's solution. Aggressive fluid resuscitation consisted of a bolus of 20 ml per kilogram of body weight, followed by 3 ml per kilogram per hour. Moderate fluid resuscitation consisted of a bolus of 10 ml per kilogram in patients with hypovolemia or no bolus in patients with normovolemia, followed by 1.5 ml per kilogram per hour in all patients in this group. Patients were assessed at 12, 24, 48, and 72 hours, and fluid resuscitation was adjusted according to the patient's clinical status. The primary outcome was the development of moderately severe or severe pancreatitis during the hospitalization. The main safety outcome was fluid overload. The planned sample size was 744, with a first planned interim analysis after the enrollment of 248 patients. Results A total of 249 patients were included in the interim analysis. The trial was halted owing to between-group differences in the safety outcomes without a significant difference in the incidence of moderately severe or severe pancreatitis (22.1% in the aggressive-resuscitation group and 17.3% in the moderate-resuscitation group; adjusted relative risk, 1.30; 95% confidence interval [CI], 0.78 to 2.18; P=0.32). Fluid overload developed in 20.5% of the patients who received aggressive resuscitation and in 6.3% of those who received moderate resuscitation (adjusted relative risk, 2.85; 95% CI, 1.36 to 5.94, P=0.004). The median duration of hospitalization was 6 days (interquartile range, 4 to 8) in the aggressive-resuscitation group and 5 days (interquartile range, 3 to 7) in the moderate-resuscitation group. Conclusions In this randomized trial involving patients with acute pancreatitis, early aggressive fluid resuscitation resulted in a higher incidence of fluid overload without improvement in clinical outcomes.	[De-Madaria, E.; Guilabert, L.; Vaillo-Rocamora, A.] Dr Balmis Gen Univ Hosp, Dept Gastroenterol, ISABIAL Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain; [Zapater, P.] Dr Balmis, Dept Clin Pharmacol, ISABIAL Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain; [De-Madaria, E.] Miguel Hernandez Univ, Fac Med, Dept Clin Med, Elche, Spain; [Garcia de Paredes, A. Garcia; Rodriguez-Gandia, M. A.; Donate-Ortega, J.] Univ Alcala, Inst Ramon y Cajal Invest Sanitaria, Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, Alcala De Henares, Spain; [Zapater, P.; Casals-Seoane, F.] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Casals-Seoane, F.] Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Gastroenterol Unit, Madrid, Spain; [Lira-Aguilar, A.; Llovet, L. P.; ERICA Consortium] Corp Sanitaria Parc Tauli, Gastroenterol & Digest Endoscopy Unit, Sabadell, Spain; [Navarro, P.; Sanchez-Pardo, A. M.] Hosp Clin Univ Valencia, Dept Gastroenterol, Valencia, Spain; [Sanchez-Marin, C.; Cobreros, M.] Marques de Valdecilla Univ Hosp, Dept Gastroenterol & Hepatol, Santander, Spain; [Fernandez-Cabrera, I] Hosp Dr Negrin, Dept Gastroenterol, Las Palmas Gran Canaria, Spain; [Deza, D. Casas; Camacho-Montano, L. M.] Miguel Servet Univ Hosp, Dept Gastroenterol, Zaragoza, Spain; [Deza, D. Casas; Camacho-Montano, L. M.] Hlth Res Inst Aragon, Zaragoza, Spain; [Lauret-Brana, E.] Cent Asturias Univ Hosp, Inst Invest Sanitaria Principado Asturias, Dept Gastroenterol, Oviedo, Spain; [Marti-Marques, E.] Lucus Augusti Univ Hosp, Dept Gastroenterol, Lugo, Spain; [Ubieto, V; Ganuza, M.; Bolado, F.] Univ Hosp Navarre, Dept Gastroenterol, Pamplona, Spain; [Buxbaum, J. L.] Univ Southern Calif, Div Gastroenterol, Los Angeles, CA 90007 USA; [Maisonneuve, P.] IRCSS European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Lozada-Hernandez, E. E.; Collazo Moreno, A. J. R.] Reg Hosp High Specialty Bajio, Gen Surg Unit, Dept Dis Digest Tract, Leon, Mexico; [Mehta, R.; Tandel, R.] Surat Inst Digest Sci Hosp & Res Ctr, Dept Gastroenterol, Surat, India	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Universidad Miguel Hernandez de Elche; Hospital Universitario Ramon y Cajal; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Clinic Universitari de Valencia; Hospital Universitario Marques de Valdecilla (HUMV); Miguel Servet University Hospital; Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); Hospital Universitario Lucus Augusti-Lugo; Servicio Navarro de Salud - Osasunbidea; University of Southern California	De-Madaria, E (corresponding author), Dr Balmis Gen Univ Hosp, Dept Gastroenterol, ISABIAL Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain.; De-Madaria, E (corresponding author), Miguel Hernandez Univ, Fac Med, Dept Clin Med, Elche, Spain.	emadaria@umh.es	Ezquerra, Alberto/HHM-5658-2022; Casas-Deza, Diego/AAB-3462-2020; Campos-Serra, Andrea/AAR-4148-2021; Pablo, Navarro/I-4329-2017; Maisonneuve, Patrick/U-9789-2018; de-Madaria, Enrique/F-5225-2013	Ezquerra, Alberto/0000-0002-1892-6317; Casas-Deza, Diego/0000-0001-6883-8940; Campos-Serra, Andrea/0000-0001-6970-7141; Pablo, Navarro/0000-0001-6228-3462; Maisonneuve, Patrick/0000-0002-5309-4704; de-Madaria, Enrique/0000-0002-2412-9541	Instituto de Salud Carlos III [PI19/01628]; European Commission, European Regional Development Funds; Spanish Association of Gastroenterology; ISABIAL (Instituto de Investigacion Sanitaria y Biomedica de Alicante) [UGP-20-117]; Italian Ministry of Health	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Commission, European Regional Development Funds; Spanish Association of Gastroenterology; ISABIAL (Instituto de Investigacion Sanitaria y Biomedica de Alicante); Italian Ministry of Health(Ministry of Health, Italy)	Supported by grants from Instituto de Salud Carlos III (PI19/01628, co-funded by the European Commission, European Regional Development Funds), the Spanish Association of Gastroenterology (Gonzalo-Mino 2019), and ISABIAL (Instituto de Investigacion Sanitaria y Biomedica de Alicante) (UGP-20-117). Mr. Maisonneuve was supported by the Italian Ministry of Health, Ricerca Corrente, and 5x1000 funds.	Acheampong A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0970-1; Baillargeon JD, 1998, AM J GASTROENTEROL, V93, P2130; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bolado F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00440; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brown A, 2000, PANCREAS, V20, P367, DOI 10.1097/00006676-200005000-00005; Buxbaum JL, 2017, AM J GASTROENTEROL, V112, P797, DOI 10.1038/ajg.2017.40; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de-Madaria E, 2021, GUT, V70, P139, DOI 10.1136/gutjnl-2020-320729; de-Madaria E, 2014, CLIN GASTROENTEROL H, V12, P997, DOI 10.1016/j.cgh.2013.10.017; de-Madaria E, 2011, AM J GASTROENTEROL, V106, P1843, DOI 10.1038/ajg.2011.236; Di Martino M, 2021, HPB, V23, P1629, DOI 10.1016/j.hpb.2021.06.426; En-Qiang M, 2009, CHINESE MED J-PEKING, V122, P169, DOI 10.3760/cma.j.issn.0366-6999.2009.02.011; Gardner TB, 2021, ANN INTERN MED, V174, pITC17, DOI 10.7326/AITC202102160; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Hjortrup PB, 2016, INTENS CARE MED, V42, P1695, DOI 10.1007/s00134-016-4500-7; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Juvonen PO, 1999, SCAND J GASTROENTERO, V34, P308; Kahan BC, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-99; Kinnala PJ, 2002, SCAND J GASTROENTERO, V37, P845, DOI 10.1080/713786530; KUSTERER K, 1991, AM J PHYSIOL, V260, pG346, DOI 10.1152/ajpgi.1991.260.2.G346; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P361, DOI 10.5603/AIT.2014.0060; Mao EQ, 2010, CHINESE MED J-PEKING, V123, P1639, DOI 10.3760/cmaj.issn.0366-6999.2010.13.005; Messmer AS, 2020, CRIT CARE MED, V48, P1862, DOI 10.1097/CCM.0000000000004617; NIEDERAU C, 1988, GASTROENTEROLOGY, V95, P1648, DOI 10.1016/S0016-5085(88)80091-X; Ramirez-Maldonado E, 2021, ANN SURG, V274, P255, DOI 10.1097/SLA.0000000000004596; Singh VK, 2017, UNITED EUR GASTROENT, V5, P491, DOI 10.1177/2050640616671077; Sternby H, 2019, ANN SURG, V270, P348, DOI 10.1097/SLA.0000000000002766; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Todd J, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-85; Vege SS, 2018, GASTROENTEROLOGY, V154, P1103, DOI 10.1053/j.gastro.2018.01.031; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702; Wu BU, 2011, ARCH INTERN MED, V171, P669, DOI 10.1001/archinternmed.2011.126	38	5	5	23	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					989	1000		10.1056/NEJMoa2202884	http://dx.doi.org/10.1056/NEJMoa2202884			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36103415				2022-12-28	WOS:000865415300010
J	Willingham, E				Willingham, Emily			THE FRAUGHT QUEST TO ACCOUNT FOR SEX IN STUDIES	NATURE			English	Editorial Material																		Buch T, 2019, J MOL MED, V97, P871, DOI 10.1007/s00109-019-01774-0; Doerre A, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0268119; Emont MP, 2022, NATURE, V603, P926, DOI 10.1038/s41586-022-04518-2; Feldman S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6700; Feridooni HA, 2017, AM J PHYSIOL-HEART C, V312, pH46, DOI 10.1152/ajpheart.00073.2016; Garcia-Sifuentes Y, 2021, ELIFE, V10, DOI [10.7554/eLife.70817, 10.7554/eLife.70817.sa1, 10.7554/eLife.70817.sa2]; Geller SE, 2018, ACAD MED, V93, P630, DOI 10.1097/ACM.0000000000002027; Ji HW, 2021, CIRCULATION, V143, P761, DOI 10.1161/CIRCULATIONAHA.120.049360; Obias-Manno D, 2007, J WOMENS HEALTH, V16, P807, DOI 10.1089/jwh.2006.0135; Peters SAE, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-007853; Shattuck-Heidorn H, 2021, NATURE, V597, pE7, DOI 10.1038/s41586-021-03644-7; Sylvester SV, 2022, CURR MED RES OPIN, V38, P1391, DOI 10.1080/03007995.2022.2081454; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; Tamargo J, 2017, EUR HEART J-CARD PHA, V3, P163, DOI 10.1093/ehjcvp/pvw042; Woitowich NC, 2020, ELIFE, V9, DOI 10.7554/eLife.56344	15	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					456	459						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M5CY	36100679	Bronze			2022-12-28	WOS:000853342100011
J	Tanne, JH				Tanne, Janice Hopkins			Polio emergency declared in New York State over virus found in wastewater	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		New York State, 2022, EX ORD 21 EX ORD DEC; New York State Department of Health, 2022, WAST SURV; New York State Department of Health, 2022, PROT NEW YORK IMM; Tanne JH, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o1864	4	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2211	10.1136/bmj.o2211	http://dx.doi.org/10.1136/bmj.o2211			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096510				2022-12-28	WOS:000863219000003
J	Suran, M				Suran, Melissa			Dr Fauci and the Art of Science Communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2022	328	13					1286	1287		10.1001/jama.2022.16280	http://dx.doi.org/10.1001/jama.2022.16280		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5F6GU	36083593	Bronze			2022-12-28	WOS:000851606500001
J	Andre, F; Filleron, T; Kamal, M; Mosele, F; Arnedos, M; Dalenc, F; Sablin, MP; Campone, M; Bonnefoi, H; Lefeuvre-Plesse, C; Jacot, W; Coussy, F; Ferrero, JM; Emile, G; Mouret-Reynier, MA; Thery, JC; Isambert, N; Mege, A; Barthelemy, P; You, B; Hajjaji, N; Lacroix, L; Rouleau, E; Tran-Dien, A; Boyault, S; Attignon, V; Gestraud, P; Servant, N; Le Tourneau, C; Cherif, LL; Soubeyran, I; Montemurro, F; Morel, A; Lusque, A; Jimenez, M; Jacquet, A; Goncalves, A; Bachelot, T; Bieche, I				Andre, Fabrice; Filleron, Thomas; Kamal, Maud; Mosele, Fernanda; Arnedos, Monica; Dalenc, Florence; Sablin, Marie-Paule; Campone, Mario; Bonnefoi, Herve; Lefeuvre-Plesse, Claudia; Jacot, William; Coussy, Florence; Ferrero, Jean-Marc; Emile, George; Mouret-Reynier, Marie-Ange; Thery, Jean-Christophe; Isambert, Nicolas; Mege, Alice; Barthelemy, Philippe; You, Benoit; Hajjaji, Nawale; Lacroix, Ludovic; Rouleau, Etienne; Tran-Dien, Alicia; Boyault, Sandrine; Attignon, Valery; Gestraud, Pierre; Servant, Nicolas; Le Tourneau, Christophe; Cherif, Linda Larbi; Soubeyran, Isabelle; Montemurro, Filippo; Morel, Alain; Lusque, Amelie; Jimenez, Marta; Jacquet, Alexandra; Goncalves, Anthony; Bachelot, Thomas; Bieche, Ivan			Genomics to select treatment for patients with metastatic breast cancer	NATURE			English	Article							PRECISION MEDICINE; MULTICENTER; ONCOLOGY; OLAPARIB; SOCIETY; ARRAY	Cancer progression is driven in part by genomic alterations(1). The genomic characterization of cancers has shown interpatient heterogeneity regarding driver alterations(2), leading to the concept that generation of genomic profiling in patients with cancer could allow the selection of effective therapies(3,4). Although DNA sequencing has been implemented in practice, it remains unclear how to use its results. A total of 1,462 patients with HER2-non-overexpressing metastatic breast cancer were enroled to receive genomic profiling in the SAFIR02-BREAST trial. Two hundred and thirty-eight of these patients were randomized in two trials (nos. NCT02299999 and NCT03386162) comparing the efficacy of maintenance treatment(5) with a targeted therapy matched to genomic alteration. Targeted therapies matched to genomics improves progression-free survival when genomic alterations are classified as level I/II according to the ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)(6) (adjusted hazards ratio (HR): 0.41, 90% confidence interval (CI): 0.27-0.61, P < 0.001), but not when alterations are unselected using ESCAT (adjusted HR: 0.77, 95% CI: 0.56-1.06, P = 0.109). No improvement in progression-free survival was observed in the targeted therapies arm (unadjusted HR: 1.15, 95% CI: 0.76-1.75) for patients presenting with ESCAT alteration beyond level I/II. Patients with germline BRCA1/2 mutations (n = 49) derived high benefit from olaparib (gBRCA1: HR = 0.36, 90% CI: 0.14-0.89; gBRCA2: HR = 0.37, 90% CI: 0.17-0.78). This trial provides evidence that the treatment decision led by genomics should be driven by a framework of target actionability in patients with metastatic breast cancer.	[Andre, Fabrice; Arnedos, Monica] Gustave Roussy, Dept Med Oncol, Villejuif, France; [Andre, Fabrice; Mosele, Fernanda; Tran-Dien, Alicia] Gustave Roussy, INSERM, U981, Villejuif, France; [Andre, Fabrice; Tran-Dien, Alicia] Gustave Roussy, PRISM Ctr Personalized Med, Villejuif, France; [Andre, Fabrice] Univ Paris Saclay, Med Sch, Le Kremlin Bicetre, France; [Filleron, Thomas; Lusque, Amelie] IUCT Oncopole, Inst Claudius Regaud, Dept Biostat, Toulouse, France; [Kamal, Maud; Sablin, Marie-Paule; Le Tourneau, Christophe; Cherif, Linda Larbi] Inst Curie, Dept Drug Dev & Innovat, St Cloud, France; [Dalenc, Florence] Inst Claudius Regaud IUCT Oncopole, Dept Med Oncol, Toulouse, France; [Dalenc, Florence] Univ Paul Sabatier, Toulouse, France; [Sablin, Marie-Paule] Inst Curie, Dept Med Oncol, Paris, France; [Campone, Mario] Univ Angers, Inst Cancerol Ouest Rene Gauducheau, Angers, France; [Bonnefoi, Herve] Inst Bergonie, Dept Med Oncol, INSERM, U1218, Bordeaux, France; [Bonnefoi, Herve] Univ Bordeaux, Bordeaux, France; [Lefeuvre-Plesse, Claudia] Ctr Eugene Marquis, Dept Med Oncol, Rennes, Ille & Vilaine, France; [Jacot, William] Inst Canc Montpellier, Inst Rech Cancerol Montpellier, Dept Med Oncol, INSERM,U1194, Montpellier, France; [Jacot, William] Montpellier Univ, Montpellier, France; [Coussy, Florence] Inst Curie, Dept Med Oncol, St Cloud, France; [Ferrero, Jean-Marc] Univ Cote Azur, Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France; [Emile, George] Ctr Frangois Baclesse, Dept Med Oncol, Caen, France; [Mouret-Reynier, Marie-Ange] Ctr Jean Perrin, Dept Med Oncol, Clermont Ferrand, France; [Thery, Jean-Christophe] Univ Med Rouen, Ctr Hennri Becquerel, Dept Med Oncol, Rouen, France; [Isambert, Nicolas] Ctr Georges Frangois Leclerc, Dept Med Oncol, Dijon, France; [Mege, Alice] Inst St Catherine, Avignon, France; [Barthelemy, Philippe] Inst Cancerol Strasbourg Europe, Strasbourg, France; [You, Benoit] Univ Claude Bernard Lyon 1, Inst Cancerol Hosp Civils Lyon, Dept Med Oncol, Lyon, France; [Hajjaji, Nawale] Ctr Oscar Lambret, INSERM, U1192, Dept Med Oncol,PRISM Lab, Lille, France; [Hajjaji, Nawale] Univ Lille, Lille, France; [Lacroix, Ludovic; Rouleau, Etienne] Gustave Roussy, Canc Genet Lab, Dept Pathol & Med Biol, Villejuif, France; [Tran-Dien, Alicia] Gustave Roussy, Bioinformat Core Facil, UMS AMMICA, Villejuif, France; [Boyault, Sandrine; Attignon, Valery] Ctr Leon Berard, Dept Translat Res & Innovat, Lyon, France; [Gestraud, Pierre; Servant, Nicolas] PSL Res Univ, INSERM U900, Mines Paris Tech, Bioinformat & Computat Syst Biol Canc, Paris, France; [Soubeyran, Isabelle] Inst Bergonie, Dept Biopathol, Unit Mol Pathol, Bordeaux, France; [Montemurro, Filippo] FPO IRCCS, Candid Canc Inst, Candiolo, Italy; [Morel, Alain] Inst Cancerol Ouest, Ctr Paul Papin, Dept Innate Immun & Immunotherapy, Angers, France; [Jimenez, Marta; Jacquet, Alexandra] Unicancer, Paris, France; [Goncalves, Anthony] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France; [Bachelot, Thomas] Ctr Leon Berard, Dept Med Oncol, Lyon, France; [Bieche, Ivan] Univ Paris Cite, Inst Curie, Dept Genet, INSERM,U1016, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut Claudius Regaud; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Centre Eugene Marquis; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Jean Perrin; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; IRCCS Fondazione del Piemonte per l'Oncologia; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Andre, F (corresponding author), Gustave Roussy, Dept Med Oncol, Villejuif, France.; Andre, F (corresponding author), Gustave Roussy, INSERM, U981, Villejuif, France.; Andre, F (corresponding author), Gustave Roussy, PRISM Ctr Personalized Med, Villejuif, France.; Andre, F (corresponding author), Univ Paris Saclay, Med Sch, Le Kremlin Bicetre, France.	fabrice.andre@gustaveroussy.fr	Jimenez, Marta/HCH-7687-2022	Jimenez, Marta/0000-0001-7940-4945; ARNEDOS, MONICA/0000-0001-5269-1251	Fondation ARC; AstraZeneca; IHU-B programme (PRISM); Breast Cancer Research Foundation	Fondation ARC; AstraZeneca(AstraZeneca); IHU-B programme (PRISM); Breast Cancer Research Foundation	We thank the patients and their families, as well as the investigators (especially V. Massard, T. l'Haridon, L. Venat-Bouvet, F. Del Piano, X. Tchiknavorian, N. Dohollou and C. Alliot) and their staff involved in SAFIR02-BREAST and SAFIR-PI3K. We also thank the UNICANCER team involved in both trials and C. Honfo Ga for data management. We also thank members of the IDMC (N. Turner, S. Loibl, S. Novello, E. Felip, S, Litiere and D. Beltram). The study was funded by Fondation ARC, AstraZeneca, the IHU-B programme (PRISM) and the Breast Cancer Research Foundation. AstraZeneca also supported targeted therapy (capivasertib, AZD2014, AZD8931, AZD4547, olaparib, selumetinib, bicalutamide and vandetanib) supply and distribution to the study sites. Novartis supported the supply of targeted therapy (alpelisib).	Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Arnedos M, 2015, NAT REV CLIN ONCOL, V12, P693, DOI 10.1038/nrclinonc.2015.123; Bachelot T, 2021, NAT MED, V27, P250, DOI 10.1038/s41591-020-01189-2; Carene D, 2020, BREAST CANCER RES TR, V179, P387, DOI 10.1007/s10549-019-05462-y; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Commo F, 2016, BIOINFORMATICS, V32, P1402, DOI 10.1093/bioinformatics/btv718; Condorelli R, 2019, ANN ONCOL, V30, P365, DOI 10.1093/annonc/mdz036; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Gennari A, 2021, ANN ONCOL, V32, P1475, DOI 10.1016/j.annonc.2021.09.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Johnson A, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00036; Kingston Belinda, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.19.00130; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Lee SH, 2018, CELL, V173, P515, DOI 10.1016/j.cell.2018.03.017; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Mateo J, 2018, ANN ONCOL, V29, P1895, DOI 10.1093/annonc/mdy263; Mosele F, 2020, ANN ONCOL, V31, P1491, DOI 10.1016/j.annonc.2020.07.014; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; Tung NM, 2020, J CLIN ONCOL, V38, P4274, DOI 10.1200/JCO.20.02151; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Yates LR, 2018, ANN ONCOL, V29, P30, DOI 10.1093/annonc/mdx707	29	2	2	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 13	2022	610	7931					343	+		10.1038/s41586-022-05068-3	http://dx.doi.org/10.1038/s41586-022-05068-3		SEP 2022	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5G9QP	36071165				2022-12-28	WOS:000852585300006
J	Griffin, CT; Wynd, BM; Munyikwa, D; Broderick, TJ; Zondo, M; Tolan, S; Langer, MC; Nesbitt, SJ; Taruvinga, HR				Griffin, Christopher T.; Wynd, Brenen M.; Munyikwa, Darlington; Broderick, Tim J.; Zondo, Michel; Tolan, Stephen; Langer, Max C.; Nesbitt, Sterling J.; Taruvinga, Hazel R.			Africa's oldest dinosaurs reveal early suppression of dinosaur distribution	NATURE			English	Article							FOUNDER-EVENT SPECIATION; EARLY EVOLUTION; ORIGIN; ANATOMY; MODELS; REASSESSMENT; BIOGEOGRAPHY; INSTABILITY; ARGENTINA; PARSIMONY	The vertebrate lineages that would shape Mesozoic and Cenozoic terrestrial ecosystems originated across Triassic Pangaea(1-11). By the Late Triassic (Carnian stage, similar to 235 million years ago), cosmopolitan 'disaster faunas' (refs. (12-14)) had given way to highly endemic assemblages(12,13) on the supercontinent. Testing the tempo and mode of the establishment of this endemism is challenging-there were few geographic barriers to dispersal across Pangaea during the Late Triassic. Instead, palaeolatitudinal climate belts, and not continental boundaries, are proposed to have controlled distribution(15-18). During this time of high endemism, dinosaurs began to disperse and thus offer an opportunity to test the timing and drivers of this biogeographic pattern. Increased sampling can test this prediction: if dinosaurs initially dispersed under palaeolatitudinal-driven endemism, then an assemblage similar to those of South America(4,19-21) and India(19,22)-including the earliest dinosaurs-should be present in Carnian deposits in south-central Africa. Here we report a new Carnian assemblage from Zimbabwe that includes Africa's oldest definitive dinosaurs, including a nearly complete skeleton of the sauropodomorph Mbiresaurus raathi gen. et sp. nov. This assemblage resembles other dinosaur-bearing Carnian assemblages, suggesting that a similar vertebrate fauna ranged high-latitude austral Pangaea. The distribution of the first dinosaurs is correlated with palaeolatitude-linked climatic barriers, and dinosaurian dispersal to the rest of the supercontinent was delayed until these barriers relaxed, suggesting that climatic controls influenced the initial composition of the terrestrial faunas that persist to this day.	[Griffin, Christopher T.; Wynd, Brenen M.; Nesbitt, Sterling J.] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [Griffin, Christopher T.] Yale Univ, Dept Earth & Planetary Sci, New Haven, CT 06520 USA; [Griffin, Christopher T.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA; [Munyikwa, Darlington] Natl Museums & Monuments Zimbabwe, Harare, Zimbabwe; [Munyikwa, Darlington; Zondo, Michel; Taruvinga, Hazel R.] Nat Hist Museum Zimbabwe, Dept Geol & Paleontol, Bulawayo, Zimbabwe; [Broderick, Tim J.] Makari, Harare, Zimbabwe; [Tolan, Stephen] Chipembele Wildlife Educ Ctr, Mfuwe, Zambia; [Langer, Max C.] Univ Sao Paulo, Dept Biol, Sao Paulo, Brazil; [Taruvinga, Hazel R.] Great Zimbabwe Univ, Sch Agr & Nat Sci, Masvingo, Zimbabwe	Virginia Polytechnic Institute & State University; Yale University; Yale University; Universidade de Sao Paulo	Griffin, CT (corresponding author), Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA.; Griffin, CT (corresponding author), Yale Univ, Dept Earth & Planetary Sci, New Haven, CT 06520 USA.; Griffin, CT (corresponding author), Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA.	chris.griffin@yale.edu	Langer, Max/F-7483-2012	Langer, Max/0000-0003-1009-4605; Griffin, Christopher/0000-0003-3201-1866	National Geographic Society Early Career Grant [CP-R004-17]; National Science Foundation Graduate Research Fellowship; Geological Society of America Graduate Student Research Grant; Paleontological Society Arthur J. Boucot Student Research Award; Virginia Tech Graduate School Graduate Research Development Program awards; Virginia Tech Department of Geosciences Summer Scholarship; National Geographic Society Exploration Grant [NGS-157R-18]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2020/07997-4]	National Geographic Society Early Career Grant(National Geographic Society); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Geological Society of America Graduate Student Research Grant; Paleontological Society Arthur J. Boucot Student Research Award; Virginia Tech Graduate School Graduate Research Development Program awards; Virginia Tech Department of Geosciences Summer Scholarship; National Geographic Society Exploration Grant(National Geographic Society); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We thank M. Fitzpatrick and the NHMZ for access to collections and for fieldwork logistics, National Museums and Monuments of Zimbabwe for field logistic assistance, the Research Council of Zimbabwe for foreign researcher permits and the Zimbabwe Geological Survey for mapping information. We acknowledge the Broderick family for help with field logistics. We thank local and regional Zimbabwean authorities (Communal Areas Management Programme for Indigenous Resources (CAMPFIRE), Mushumbi Pools Police, Mbire Rural Council, Mbire District Tsetse Control, Mbire District Development Coordinator) for accommodating fieldwork. We acknowledge the people of Dande, on whose Communal Land this research was conducted. We thank K. Rose, T. Oishi, B. Chermak, D. Chermak, G. Iannaccone and V. Yarborough for fossil preparation. We thank E. Mbambo, K. Madzana and G. Malunga for fieldwork assistance and Z. Murphy and L. Broderick for documentary assistance. We thank M. Stocker, S. Xiao, J. Uyeda, M. Raath, M. Landis, A. Bhullar, J. Gauthier, the Virginia Tech Paleobiology Research Group, J. Choiniere, W. Parker, K. Angielczyk, T. Melo, V. Paes-Neto, L. Corecco, C. Schultz, M. Bronzati, J. Marsola, M. Garcia, B. McPhee, F. Montefeltro and the other students/ postdocs of USP Ribeirao Preto and UFRGS for discussion. We thank the following collections managers and institutions: M. Bamford, B. Zipfel, BPI (now ESI); Z. Skosan Erasmus, N. Mtalana, SAM; C. Schultz, UFRGS; A.M. Ribeiro, MCN; M.B. de Andrade, MCP. The Willi Hennig Society provided TNT software free of charge. We acknowledge Advanced Research Computing at Virginia Tech (https://arc.vt.edu/) for providing computational resources and technical support that contributed to our results. This work was supported by a National Geographic Society Early Career Grant (CP-R004-17), a National Scie8nce Foundation Graduate Research Fellowship, a Geological Society of America Graduate Student Research Grant, a Paleontological Society Arthur J. Boucot Student Research Award, two Virginia Tech Graduate School Graduate Research Development Program awards, a Virginia Tech Department of Geosciences Summer Scholarship ( all to C.T.G.), a National Geographic Society Exploration Grant ( NGS-157R-18, to C.T.G. and S.J.N.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2020/07997-4, to M.C.L.).	Aberhan M, 2001, PALAEOGEOGR PALAEOCL, V165, P375, DOI 10.1016/S0031-0182(00)00172-3; Agnol?n FL., 2019, BREVIORA, V565, P1, DOI [10.3099/0006-9698-565.1.1, DOI 10.3099/0006-9698-565.1.1]; Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Angielczyk KD, 2017, J VERTEBR PALEONTOL, V37, P189, DOI 10.1080/02724634.2017.1395885; [Anonymous], 2021, MESQUITE MODULAR SYS; Apaldetti C, 2018, NAT ECOL EVOL, V2, P1227, DOI 10.1038/s41559-018-0599-y; Baron MG, 2019, HIST BIOL, V31, P967, DOI 10.1080/08912963.2017.1410705; Baron MG, 2017, NATURE, V551, pE4, DOI 10.1038/nature24012; Baron MG, 2017, NATURE, V543, P501, DOI 10.1038/nature21700; Benton MJ, 2010, EARTH ENV SCI T R SO, V101, P285, DOI 10.1017/S1755691011020081; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; BRINKMAN DB, 1987, PALAEONTOLOGY, V30, P493; Button DJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00827-7; Cabreira SF, 2016, CURR BIOL, V26, P3090, DOI 10.1016/j.cub.2016.09.040; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Colombi C, 2021, J S AM EARTH SCI, V111, DOI 10.1016/j.jsames.2021.103433; Debuysschere M, 2015, J SYST PALAEONTOL, V13, P825, DOI 10.1080/14772019.2014.960486; Desojo JB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67854-1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; Ezcurra MD, 2020, NATURE, V588, P445, DOI 10.1038/s41586-020-3011-4; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Ezcurra MD, 2010, P ROY SOC B-BIOL SCI, V277, P2547, DOI 10.1098/rspb.2010.0508; Fitch A. J., 2020, PROGRAM ABSTRACTS 80, P140; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2019, SYST BIOL, V68, P494, DOI 10.1093/sysbio/syy077; Goloboff PA, 2018, PALAEONTOLOGY, V61, P625, DOI 10.1111/pala.12353; Goloboff PA, 2018, CLADISTICS, V34, P407, DOI 10.1111/cla.12205; Goloboff PA, 2015, MOL PHYLOGENET EVOL, V88, P93, DOI 10.1016/j.ympev.2015.04.003; Griffin CT, 2018, J ANAT, V232, P604, DOI 10.1111/joa.12775; Griffin CT, 2021, BIOL REV, V96, P470, DOI 10.1111/brv.12666; Griffin CT, 2016, P NATL ACAD SCI USA, V113, P14757, DOI 10.1073/pnas.1613813113; Huttenlocker AK, 2018, NATURE, V558, P108, DOI 10.1038/s41586-018-0126-y; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Irmis RB, 2011, EARTH PLANET SC LETT, V309, P258, DOI 10.1016/j.epsl.2011.07.015; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Kammerer CF, 2020, P NATL ACAD SCI USA, V117, P17932, DOI 10.1073/pnas.1916631117; Kent DV, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020778118; Kligman B, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0631; Koch NM, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2021.0044; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Landis M, 2021, SYST BIOL, V70, P86, DOI 10.1093/sysbio/syaa045; Landis MJ, 2018, EVOLUTION, V72, P2343, DOI 10.1111/evo.13594; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2018, GONDWANA RES, V57, P133, DOI 10.1016/j.gr.2018.01.005; Langer MC, 2017, PEERJ, V5, DOI 10.7717/peerj.4038; Langer MC, 2017, NATURE, V551, pE1, DOI 10.1038/nature24011; Langer MC, 2010, EARTH ENV SCI T R SO, V101, P301, DOI 10.1017/S175569101102007X; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212543; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Lee MSY, 2019, EARTH ENV SCI T R SO, V109, P325, DOI 10.1017/S1755691018000920; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lyson TR, 2020, ANNU REV ECOL EVOL S, V51, P143, DOI 10.1146/annurev-ecolsys-110218-024746; Mao FY, 2021, NATURE, V592, P577, DOI 10.1038/s41586-021-03433-2; Marsola JCA, 2018, J VERTEBR PALEONTOL, V38, DOI 10.1080/02724634.2018.1531878; Martinez RN, 2021, NATURE, V597, P235, DOI 10.1038/s41586-021-03834-3; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Matzke NJ, 2013, FRONT BIOGEOGR, V5, P242, DOI DOI 10.21425/F5FBG19694; Melo TP, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.1002562; Montefeltro FC, 2010, EARTH ENV SCI T R SO, V101, P27, DOI 10.1017/S1755691010009060; Moro D, 2021, J ANAT, V238, P828, DOI 10.1111/joa.13356; Nesbitt SJ, 2021, ZOOL J LINN SOC-LOND, V191, P150, DOI 10.1093/zoolinnean/zlaa080; Nesbitt SJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0949; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Novas FE, 2010, EARTH ENV SCI T R SO, V101, P333, DOI 10.1017/S1755691011020093; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; Oesterlen PM., 1998, ZIMBABWE GEOLOGICAL, V98, P1; Pacheco C, 2019, PEERJ, V7, DOI 10.7717/peerj.7963; Parker WG, 2018, PEERJ, V6, DOI 10.7717/peerj.4291; Parker WG, 2016, PEERJ, V4, DOI 10.7717/peerj.1583; Parry LA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170833; Pol D, 2021, J S AM EARTH SCI, V107, DOI 10.1016/j.jsames.2020.103145; Pretto FA, 2019, ZOOL J LINN SOC-LOND, V185, P388, DOI 10.1093/zoolinnean/zly028; Prieto-Marquez A, 2011, AM MUS NOVIT, P1; R Development Core Team, 2009, R LANG ENV STAT COMP; Raath M. A., 1992, Palaeontologia Africana, V29, P1; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2018, J BIOGEOGR, V45, P741, DOI 10.1111/jbi.13173; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roberto-Da-Silva L, 2014, ZOOTAXA, V 3764, P240, DOI 10.11646/zootaxa.3764.3.1; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Schaller MF, 2015, GEOL SOC AM BULL, V127, P661, DOI 10.1130/B31107.1; Schoch RR, 2020, P NATL ACAD SCI USA, V117, P11584, DOI 10.1073/pnas.2001424117; Schollhorn I, 2020, GLOBAL PLANET CHANGE, V185, DOI 10.1016/j.gloplacha.2019.103096; Sciscio L, 2021, GEOL MAG, V158, P1035, DOI 10.1017/S0016756820001089; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Simoes TR, 2018, NATURE, V557, P706, DOI 10.1038/s41586-018-0093-3; Stefanic CM, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190258; Stocker MR, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0922; Wagner PJ, 1998, PALEOBIOLOGY, V24, P430, DOI 10.1017/S0094837300020091; Whiteside JH, 2015, P NATL ACAD SCI USA, V112, P7909, DOI 10.1073/pnas.1505252112; Whiteside JH, 2011, P NATL ACAD SCI USA, V108, P8972, DOI 10.1073/pnas.1102473108; Xiang Y, 2013, R J, V5, P13; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2003, PALAEONTOLOGY, V46, P317, DOI 10.1111/j.0031-0239.2003.00301.x	105	0	0	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					313	+		10.1038/s41586-022-05133-x	http://dx.doi.org/10.1038/s41586-022-05133-x		AUG 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36045297				2022-12-28	WOS:000848083000007
J	Nathan, DM; GRADE Study Res Grp; Lachin, JM; Balsubramanyam, A; Burch, HB; Buse, JB; Butera, NM; Cohen, RM; Crandall, JP; Kahn, SE; Krause-Steinrauf, H; Larkin, ME; Rasouli, N; Tiktin, M; Wexler, DJ; Younes, N				Nathan, David M.; GRADE Study Res Grp; Lachin, John M.; Balsubramanyam, Ashok; Burch, Henry B.; Buse, John B.; Butera, Nicole M.; Cohen, Robert M.; Crandall, Jill P.; Kahn, Steven E.; Krause-Steinrauf, Heidi; Larkin, Mary E.; Rasouli, Neda; Tiktin, Margaret; Wexler, Deborah J.; Younes, Naji			Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERGLYCEMIA; PREVENTION; MANAGEMENT	Glycemic Outcomes of Glycemia ReductionIn a trial of the glucose-lowering medications glargine, glimepiride, liraglutide, and sitagliptin added to metformin to maintain target glycated hemoglobin levels, all four decreased these levels. BACKGROUND The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain. METHODS In this trial involving participants with type 2 diabetes of less than 10 years' duration who were receiving metformin and had glycated hemoglobin levels of 6.8 to 8.5%, we compared the effectiveness of four commonly used glucose-lowering medications. We randomly assigned participants to receive insulin glargine U-100 (hereafter, glargine), the sulfonylurea glimepiride, the glucagon-like peptide-1 receptor agonist liraglutide, or sitagliptin, a dipeptidyl peptidase 4 inhibitor. The primary metabolic outcome was a glycated hemoglobin level, measured quarterly, of 7.0% or higher that was subsequently confirmed, and the secondary metabolic outcome was a confirmed glycated hemoglobin level greater than 7.5%. RESULTS A total of 5047 participants (19.8% Black and 18.6% Hispanic or Latinx) who had received metformin for type 2 diabetes were followed for a mean of 5.0 years. The cumulative incidence of a glycated hemoglobin level of 7.0% or higher (the primary metabolic outcome) differed significantly among the four groups (P < 0.001 for a global test of differences across groups); the rates with glargine (26.5 per 100 participant-years) and liraglutide (26.1) were similar and lower than those with glimepiride (30.4) and sitagliptin (38.1). The differences among the groups with respect to a glycated hemoglobin level greater than 7.5% (the secondary outcome) paralleled those of the primary outcome. There were no material differences with respect to the primary outcome across prespecified subgroups defined according to sex, age, or race or ethnic group; however, among participants with higher baseline glycated hemoglobin levels there appeared to be an even greater benefit with glargine, liraglutide, and glimepiride than with sitagliptin. Severe hypoglycemia was rare but significantly more frequent with glimepiride (in 2.2% of the participants) than with glargine (1.3%), liraglutide (1.0%), or sitagliptin (0.7%). Participants who received liraglutide reported more frequent gastrointestinal side effects and lost more weight than those in the other treatment groups. CONCLUSIONS All four medications, when added to metformin, decreased glycated hemoglobin levels. However, glargine and liraglutide were significantly, albeit modestly, more effective in achieving and maintaining target glycated hemoglobin levels. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; GRADE ClinicalTrials.gov number, .)	[Nathan, David M.; Larkin, Mary E.; Wexler, Deborah J.] Harvard Med Sch, Massachusetts Gen Hosp, Diabet Ctr, Boston, MA USA; [Lachin, John M.; Butera, Nicole M.; Krause-Steinrauf, Heidi; Younes, Naji] George Washington Univ, Milken Inst Sch Publ Hlth, Biostat Ctr, Dept Biostat & Bioinformat, Rockville, MD USA; [Burch, Henry B.] NIDDKD, NIH, Bethesda, MD USA; [Balsubramanyam, Ashok] Baylor Coll Med, Sect Endocrinol Diabet & Metab, Houston, TX USA; [Buse, John B.] Univ N Carolina, Dept Med, Div Endocrinol, Sch Med, Chapel Hill, NC USA; [Cohen, Robert M.] Univ Cincinnati, Cincinnati Vet Affairs VA Med Ctr, Coll Med, Cincinnati, OH USA; [Crandall, Jill P.] Albert Einstein Coll Med, Div Endocrinol & Diabet, Bronx, NY USA; [Crandall, Jill P.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY USA; [Kahn, Steven E.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Rasouli, Neda] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Aurora, CO, South Africa; [Rasouli, Neda] VA Eastern Colorado Hlth Care Syst, Aurora, CO, South Africa; [Tiktin, Margaret] Case Western Reserve Univ, Louis Stokes Cleveland VA Med Ctr, Cleveland Hts, OH USA; [Lachin, John M.] George Washington Univ, GRADE Coordinating Ctr, Biostat Ctr, 6110 Execut Blvd,Ste 750, Rockville, MD 20852 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; George Washington University	Lachin, JM (corresponding author), George Washington Univ, GRADE Coordinating Ctr, Biostat Ctr, 6110 Execut Blvd,Ste 750, Rockville, MD 20852 USA.	grademail@bsc.gwu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH); U34 planning grant [U01DK098246]; American Diabetes Association [U34-DK-088043]; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; NIH;  [P30 DK017047];  [P30 DK020541-44];  [P30 DK020572];  [P30 DK072476];  [P30 DK079626];  [P30 DK092926];  [U54 GM104940];  [UL1 TR000170];  [UL1 TR000439];  [UL1 TR000445];  [UL1 TR001102];  [UL1 TR001108];  [UL1 TR001409];  [2UL1TR001425];  [UL1 TR001449];  [UL1 TR002243];  [UL1 TR002345];  [UL1 TR002378];  [UL1 TR002489];  [UL1 TR002529];  [UL1 TR002535];  [UL1 TR002537];  [UL1 TR002541];  [UL1 TR002548]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U34 planning grant; American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	Supported by a grant (U01DK098246) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH); a U34 planning grant (U34-DK-088043) for the planning of the trial from the NIDDK; funding for the initial planning meeting regarding the U34 proposal from the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Centers for Disease Control and Prevention; resources and facilities from the Department of Veterans Affairs; grants (P30 DK017047, P30 DK020541-44, P30 DK020572, P30 DK072476, P30 DK079626, P30 DK092926, U54 GM104940, UL1 TR000170, UL1 TR000439, UL1 TR000445, UL1 TR001102, UL1 TR001108, UL1 TR001409, 2UL1TR001425, UL1 TR001449, UL1 TR002243, UL1 TR002345, UL1 TR002378, UL1 TR002489, UL1 TR002529, UL1 TR002535, UL1 TR002537, UL1 TR002541, and UL1 TR002548) from the NIH; educational materials from the National Diabetes Education Program; and donated medications and supplies from Becton Dickinson, Bristol Myers Squibb, Merck , Novo Nordisk, Roche Diagnostics, and Sanofi.	Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS73, DOI 10.2337/dc21-S006; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS111, DOI 10.2337/dc21-S009; Amod A, 2020, DIABETES THER, V11, P53, DOI [10.2337/dci19-0066, 10.1007/s13300-019-00715-x]; Centers for Disease Control Prevention, 2020, NAT DIAB STAT REP; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Hemmingsen B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub4; Houlden RL, 2018, CAN J DIABETES, V42, pS1, DOI 10.1016/j.jcjd.2017.10.001; International Diabetes Federation (IDF), 2015, IDF DIABETES ATLAS, V7th, DOI DOI 10.1214/AOMS/1177699147; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kayaniyil S, 2016, DIABETES THER, V7, P27, DOI 10.1007/s13300-016-0155-1; Khunti K, 2018, DIABETES OBES METAB, V20, P427, DOI 10.1111/dom.13088; Lachin JM., 2011, BIOSTATISTICAL METHO, V2nd; Lachin JM, 2020, CLIN TRIALS, V17, P77, DOI 10.1177/1740774519879932; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Mayberry LS, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0796-5; Nathan DM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257154; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; The GRADE Study Research Group, 2022, NEW ENGL J MED, V387, P1075; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Walker RJ, 2016, AM J MED SCI, V351, P366, DOI 10.1016/j.amjms.2016.01.008; Wexler DJ, 2019, DIABETES CARE, V42, P2098, DOI 10.2337/dc19-0901; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Zhao LH, 2016, BIOMETRICS, V72, P215, DOI 10.1111/biom.12384	24	1	1	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1063	1074		10.1056/NEJMoa2200433	http://dx.doi.org/10.1056/NEJMoa2200433			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36129996				2022-12-28	WOS:000865461700004
J	Fashoyin-Aje, LA; Mehta, GU; Beaver, JA; Pazdur, R				Fashoyin-Aje, Lola A.; Mehta, Gautam U.; Beaver, Julia A.; Pazdur, Richard			The On- and Off-Ramps of Oncology Accelerated Approval	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								On- and Off-Ramps of Oncology Accelerated Approval To address ongoing concerns about the implementation of the FDA's Accelerated Approval pathway in oncology, a comprehensive strategy is needed - one that equally emphasizes "on-ramp" and "off-ramp" considerations.	[Fashoyin-Aje, Lola A.; Mehta, Gautam U.; Beaver, Julia A.; Pazdur, Richard] US FDA, Off Oncol Dis, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Fashoyin-Aje, Lola A.; Beaver, Julia A.; Pazdur, Richard] US FDA, Oncol Ctr Excellence, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Fashoyin-Aje, LA (corresponding author), US FDA, Off Oncol Dis, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.; Fashoyin-Aje, LA (corresponding author), US FDA, Oncol Ctr Excellence, Silver Spring, MD 20993 USA.			Fashoyin-Aje, Lola/0000-0001-7328-7813; Mehta, Gautam/0000-0002-8009-6430				Beaver JA, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMp2104846; Murray JS, 1999, AIDS, V13, P797, DOI 10.1097/00002030-199905070-00008; Shah M, 2021, NEW ENGL J MED, V385, P1445, DOI 10.1056/NEJMp2109826; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9	4	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2022	387	16					1439	1442		10.1056/NEJMp2208954	http://dx.doi.org/10.1056/NEJMp2208954		SEP 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5Y0MZ	36129992				2022-12-28	WOS:000860238800001
J	Chew, DS; Whitelaw, S; Vaduganathan, M; Mark, DB; Van Spall, HGC				Chew, Derek S.; Whitelaw, Sera; Vaduganathan, Muthiah; Mark, Daniel B.; Van Spall, Harriette G. C.			Patient-Reported Outcomes Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; SYSTEMATIC REVIEWS; GUIDELINE	Background: Patient-reported outcomes (PROs) are important measures of treatment effect and can be used to inform the approval of cardiovascular drugs and devices by the U.S. Food and Drug Administration (FDA). Purpose: To catalogue the health status patient-reported outcome measures (PROMs) validated in cardiovascular diseases (CVDs), describe their psychometric properties, and assess adherence with both FDA recommendations and the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) framework. Data Sources: MEDLINE, EMBASE, CINAHL, and Allied and Complementary Medicine Database from inception to August 2022. Study Selection: Studies that developed and/or validated health status PROMs in CVD populations. Data Extraction: Two study authors extracted data on CVD type, PROM psychometric properties, and adherence to FDArecommendations. The risk of bias informing the development or validation of PROMs was assessed using the COSMIN framework. Data Synthesis: Fifty health status PROMs (described in 83 studies) were identified, of which 45 were disease specific and 5 were generic. Eleven (22%) of the 50 PROMs validated in CVDs had minimally important differences (MIDs) established, and 8 (16%) reported on the validation of all psychometric properties recommended by the FDA. By COSMIN standards, only 2 PROMs (4%) had all of their psychometric properties rated as sufficient in quality, and 32 PROMs (64%) had less than 50% of psychometric properties rated as sufficient. Limitation: The quality of reporting varied across included studies. Conclusion: Of 50 PROMs validated in CVDs, only a small minority reported on the validation of all FDA-recommended psychometric properties, had psychometric properties rated as sufficient by COSMIN, or had MIDs established. Given the use of PROMs to guide FDA approvals of drugs and devices in CVDs, there is a need for better adherence to quality standards in PROM validation. Primary Funding Source: None.	[Chew, Derek S.] Univ Calgary, OBrien Inst Publ Hlth, Dept Cardiac Sci, Libin Cardiovasc Inst, Calgary, AB, Canada; [Chew, Derek S.] Univ Calgary, Dept Community Hlth Sci, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Whitelaw, Sera] McGill Univ, Fac Med & Hlth Sci, Montreal, PQ, Canada; [Vaduganathan, Muthiah] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Vaduganathan, Muthiah] Harvard Med Sch, Boston, MA 02115 USA; [Mark, Daniel B.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Van Spall, Harriette G. C.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Populat Hlth Res Inst, Hamilton, ON, Canada; [Van Spall, Harriette G. C.] Res Inst St Josephs Hamilton, Hamilton, ON, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; McGill University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; McMaster University; Population Health Research Institute	Van Spall, HGC (corresponding author), 20 Copeland Ave,David Braley Res Bldg, Hamilton, ON L8L 0A3, Canada.	Harriette.VanSpall@phri.ca		Van Spall, Harriette Gillian Christine/0000-0002-8370-4569; Mark, Daniel/0000-0001-6340-8087				Anker SD, 2014, EUR HEART J, V35, P2001, DOI 10.1093/eurheartj/ehu205; Ara R, 2012, VALUE HEALTH, V15, P971, DOI 10.1016/j.jval.2012.05.003; Bennett SJ, 2002, QUAL LIFE RES, V11, P349, DOI 10.1023/A:1015547713061; Blumer V, 2021, EUR J HEART FAIL, V23, P1488, DOI 10.1002/ejhf.2312; Chen Y, 2020, EUR HEART J-QUAL CAR, V6, P234, DOI 10.1093/ehjqcco/qcaa022; DeFilippis EM, 2021, JACC-HEART FAIL, V9, P346, DOI 10.1016/j.jchf.2021.01.002; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; Eliya Y, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.022353; Goldfarb M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002204; Kosiborod MN, 2020, CIRCULATION, V141, P90, DOI 10.1161/CIRCULATIONAHA.119.044138; Lavallee DC, 2016, HEALTH AFFAIR, V35, P575, DOI 10.1377/hlthaff.2015.1362; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Ovretveit J, 2017, INT J QUAL HEALTH C, V29, P874, DOI 10.1093/intqhc/mzx108; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Rumsfeld JS, 2013, CIRCULATION, V127, P2233, DOI 10.1161/CIR.0b013e3182949a2e; Snapinn SM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-31; Terwee CB, 2018, QUAL LIFE RES, V27, P1159, DOI 10.1007/s11136-018-1829-0; U.S. Department of Health and Human Services U.S. Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2021, TREATM HEART FAIL EN; Venderbos LDF, 2015, PSYCHO-ONCOLOGY, V24, P348, DOI 10.1002/pon.3657; Weldring T, 2013, HEALTH SERV INSIGHTS, V6, P61, DOI 10.4137/HSI.S11093; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	24	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1431	+		10.7326/M22-2234	http://dx.doi.org/10.7326/M22-2234		SEP 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36122377				2022-12-28	WOS:000860851400001
J	MacGregor, R; Jain, V; Hillman, S; Lumsden, MA				MacGregor, R.; Jain, V; Hillman, S.; Lumsden, M. A.			Investigating abnormal uterine bleeding in reproductive aged women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTRAUTERINE SYSTEM; CLINICAL EFFECTIVENESS; COST-EFFECTIVENESS; MENORRHAGIA; MANAGEMENT; MIRENA; TRIAL		[MacGregor, R.; Hillman, S.] Univ Warwick, Unit Acad Primary Care, Coventry CV4 7AL, W Midlands, England; [Jain, V] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Lumsden, M. A.] Univ Glasgow, Reprod & Maternal Med Glasgow, Glasgow G4 0SF, Lanark, Scotland	University of Warwick; University of Edinburgh; University of Glasgow	MacGregor, R (corresponding author), Univ Warwick, Unit Acad Primary Care, Coventry CV4 7AL, W Midlands, England.	Becky.MacGregor@warwick.ac.uk						Amant F, 2018, INT J GYNECOL OBSTET, V143, P37, DOI 10.1002/ijgo.12612; American College of Obstetricians and Gynecologists, 2012, PRACTICE B, V128; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bhattacharya S, 2011, Health Technol Assess, V15, piii, DOI 10.3310/hta15190; Chodankar Rohan R, 2022, Front Reprod Health, V4, P820029, DOI 10.3389/frph.2022.820029; Chodankar RR, 2020, FEMALE REPROD DYSFUN, P16; Damey PD, 2018, CONTRACEPTION, V97, P210, DOI 10.1016/j.contraception.2017.10.005; Department of Health and Social Care, 2021, RES WOM HLTH LETS TA; Faculty of Sexual & Reproductive Healthcare, 2015, FSRH CLIN GUID PROBL; Fraser IS, 2015, INT J GYNECOL OBSTET, V128, P196, DOI 10.1016/j.ijgo.2014.09.027; Ghazizadeh S, 2011, INT J WOMENS HEALTH, V3, P207, DOI 10.2147/IJWH.S20999; Gupta JK, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19880; Henry C, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00986-8; Jain V, 2022, NAT REV ENDOCRINOL, V18, P290, DOI 10.1038/s41574-021-00629-4; Jensen J, 2013, CONTRACEPTION, V87, P107, DOI 10.1016/j.contraception.2012.08.022; Matteson KA, 2011, SEMIN REPROD MED, V29, P423, DOI 10.1055/s-0031-1287666; Maybin JA, 2016, WOMENS HEALTH, V12, P27, DOI 10.2217/whe.15.100; Munro MG, 2017, BJOG-INT J OBSTET GY, V124, P185, DOI 10.1111/1471-0528.14431; Munro MG, 2020, INT J GYNECOL OBSTET, V150, P275, DOI 10.1002/ijgo.13180; Munro MG, 2018, INT J GYNECOL OBSTET, V143, P393, DOI 10.1002/ijgo.12666; Munro MG, 2011, INT J GYNECOL OBSTET, V113, P3, DOI 10.1016/j.ijgo.2010.11.011; National Institute for Health and Care Excellence, 2007, HEAVY MENSTRUAL BLEE; National Institute for Health and Care Excellence, 2018, HEAVY MENSTRUAL BLEE; Percy L, 2017, OBSTET GYNAECOL, V19, P155, DOI 10.1111/tog.12368; Royal College of Obstetricians and Gynaecologists, 2014, NAT HEAV MENSTR BLEE; Royal College of Obstetricians and Gynaecologists, 2016, MANAGEMENT ENDOMETRI; Shankar M, 2004, BJOG-INT J OBSTET GY, V111, P734, DOI 10.1111/j.1471-0528.2004.00176.x; Wouk N, 2019, AM FAM PHYSICIAN, V99, P435	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2022	378								e070906	10.1136/bmj-2022-070906	http://dx.doi.org/10.1136/bmj-2022-070906			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V6QL	36113874				2022-12-28	WOS:000877352500008
J	Coller, BS				Coller, Barry S.			It's the water! The open and shut case of drug-induced integrin activation	CELL			English	Editorial Material							STRUCTURAL BASIS	Integrin receptors are established drug targets, but many of the drugs that have been developed act as partial agonists, inducing the receptor into a high-affinity, ligand-binding state. Lin et al. discovered a general mechanism to circumvent this problem-stabilizing a key water molecule that prevents receptor activation. Their findings are likely to impact future therapeutic development.	[Coller, Barry S.] Rockefeller Univ, Allen & Frances Adler Lab Blood & Vasc Biol, New York, NY 10065 USA	Rockefeller University	Coller, BS (corresponding author), Rockefeller Univ, Allen & Frances Adler Lab Blood & Vasc Biol, New York, NY 10065 USA.	collerb@rockefeller.edu		Oren, Deena/0000-0003-0074-2242	National Center for Advancing Translational Sciences (NCATS) [HL19278]; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [UL1TR001866]	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH), National Heart, Lung, and Blood Institute grant HL19278 and National Center for Advancing Translational Sciences (NCATS) grant UL1TR001866, National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program.	Aster RH, 2005, CHEST, V127, p53S, DOI 10.1378/chest.127.2_suppl.53S; Bosch X, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002130.pub3; Cox D, 2004, CURR PHARM DESIGN, V10, P1587, DOI 10.2174/1381612043384673; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li JH, 2014, ARTERIOSCL THROM VAS, V34, P2321, DOI 10.1161/ATVBAHA.114.303724; Lin FY, 2022, CELL, V185, P3533, DOI 10.1016/j.cell.2022.08.008; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976	12	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3463	3466		10.1016/j.cell.2022.08.015	http://dx.doi.org/10.1016/j.cell.2022.08.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4Z5ET	36113425	Green Accepted			2022-12-28	WOS:000862232500003
J	Jayne, D; Stone, JH; Rapalino, O; Stone, JR				Jayne, David; Stone, John H.; Rapalino, Otto; Stone, James R.			Case 28-2022: A 59-Year-Old Man with Headache and Progressive Neurologic Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IGG4-RELATED DISEASE; GRANULOMATOSIS; CONSENSUS; POLYANGIITIS; WEGENERS		[Jayne, David] Univ Cambridge, Dept Med, Cambridge, England; [Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stone, John H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	University of Cambridge; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Jayne, D (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.			Jayne, David/0000-0002-1712-0637				Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1136/annrheumdis-2018-214819, 10.1002/art.40930]; Bossuyt X, 2017, NAT REV RHEUMATOL, V13, P683, DOI 10.1038/nrrheum.2017.140; Cavazza A, 2014, AM J SURG PATHOL, V38, P1360, DOI 10.1097/PAS.0000000000000244; Chang SY, 2013, HUM PATHOL, V44, P2432, DOI 10.1016/j.humpath.2013.05.023; Danlos FX, 2017, AUTOIMMUN REV, V16, P1036, DOI 10.1016/j.autrev.2017.07.020; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Erden A, 2019, INT J RHEUM DIS, V22, P1926, DOI 10.1111/1756-185X.13693; Genereau T, 1999, ARTHRITIS RHEUM, V42, P2674, DOI 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A; Hamidou MA, 2003, J RHEUMATOL, V30, P2165; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennetti J., 2014, CELLULAR MOL PATHOBI, P197, DOI [10.1016/B978-0-12-405206-2.00011-9, DOI 10.1016/B978-0-12-405206-2.00011-9]; McDowell PJ, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.08.032; Mekinian A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011413; Merkel PA, 2008, NEW ENGL J MED, V359, P1603, DOI 10.1056/NEJMcpc0805310; Monach PA, 2017, NEW ENGL J MED, V376, P775, DOI 10.1056/NEJMcpc1613461; Perugino CA, 2020, NAT REV RHEUMATOL, V16, P702, DOI 10.1038/s41584-020-0500-7; Wallace ZS, 2020, ARTHRITIS RHEUMATOL, V72, P7, DOI [10.1002/art.41120, 10.1136/annrheumdis-2019-216561]; Wallace ZS, 2019, ANN RHEUM DIS, V78, P406, DOI 10.1136/annrheumdis-2018-214603; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35	21	0	0	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					1022	1032		10.1056/NEJMcpc2100271	http://dx.doi.org/10.1056/NEJMcpc2100271			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36103417				2022-12-28	WOS:000865415300014
J	Schuit, E; Venekamp, RP; Hooft, L; Veldhuijzen, IK; van den Bijllaardt, W; Pas, SD; Zwart, VF; Lodder, EB; Hellwich, M; Koppelman, M; Molenkamp, R; Wijers, CJH; Vroom, IH; Smeets, LC; Nagel-Imming, CRS; Han, WGH; van den Hof, S; Kluytmans, JAJW; van de Wijgert, JHHM; Moons, KGM				Schuit, Ewoud; Venekamp, Roderick P.; Hooft, Lotty; Veldhuijzen, Irene K.; van den Bijllaardt, Wouter; Pas, Suzan D.; Zwart, Vivian F.; Lodder, Esther B.; Hellwich, Marloes; Koppelman, Marco; Molenkamp, Richard; Wijers, Constantijn J. H.; Vroom, Irene H.; Smeets, Leonard C.; Nagel-Imming, Carla R. S.; Han, Wanda G. H.; van den Hof, Susan; Kluytmans, Jan A. J. W.; van de Wijgert, Janneke H. H. M.; Moons, Karel G. M.			Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SARS-COV-2	OBJECTIVE To assess the performance of rapid antigen tests with unsupervised nasal and combined oropharyngeal and nasal self-sampling during the omicron period. DESIGN Prospective cross sectional diagnostic test accuracy study.SETTING Three public health service covid-19 test sites in the Netherlands, 21 December 2021 to 10 February 2022.PARTICIPANTS 6497 people with covid-19 symptoms aged >= 16 years presenting for testing.INTERVENTIONS Participants had a swab sample taken for reverse transcription polymerase chain reaction (RT-PCR, reference test) and received one rapid antigen test to perform unsupervised using either nasal self-sampling (during the emergence of omicron, and when omicron accounted for >90% of infections, phase 1) or with combined oropharyngeal and nasal self-sampling in a subsequent (phase 2; when omicron accounted for >99% of infections). The evaluated tests were Flowflex (Acon Laboratories; phase 1 only), MPBio (MP Biomedicals), and Clinitest (Siemens-Healthineers).MAIN OUTCOME MEASURES The main outcomes were sensitivity, specificity, and positive and negative predictive values of each self -test, with RT-PCR testing as the reference standard. RESULTS During phase 1, 45.0% (n=279) of participants in the Flowflex group, 29.1% (n=239) in the MPBio group, and 35.4% ((n=257) in the Clinitest group were confirmatory testers (previously tested positive by a self-test at own initiative). Overall sensitivities with nasal self-sampling were 79.0% (95% confidence interval 74.7% to 82.8%) for Flowflex, 69.9% (65.1% to 74.4%) for MPBio, and 70.2% (65.6% to 74.5%) for Clinitest. Sensitivities were substantially higher in confirmatory testers (93.6%, 83.6%, and 85.7%, respectively) than in those who tested for other reasons (52.4%, 51.5%, and 49.5%, respectively). Sensitivities decreased from 87.0% to 80.9% (P=0.16 by chi 2 test), 80.0% to 73.0% (P=0.60), and 83.1% to 70.3% (P=0.03), respectively, when transitioning from omicron accounting for 29% of infections to >95% of infections. During phase 2, 53.0% (n=288) of participants in the MPBio group and 44.4% (n=290) in the Clinitest group were confirmatory testers. Overall sensitivities with combined oropharyngeal and nasal self-sampling were 83.0% (78.8% to 86.7%) for MPBio and 77.3% (72.9% to 81.2%) for Clinitest. When combined oropharyngeal and nasal self-sampling was compared with nasal self-sampling, sensitivities were found to be slightly higher in confirmatory testers (87.4% and 86.1%, respectively) and substantially higher in those testing for other reasons (69.3% and 59.9%, respectively).CONCLUSIONS Sensitivities of three rapid antigen tests with nasal self-sampling decreased during the emergence of omicron but was only statistically significant for Clinitest. Sensitivities appeared to be substantially influenced by the proportion of confirmatory testers. Sensitivities of MPBio and Clinitest improved after the addition of oropharyngeal to nasal self-sampling. A positive self-test result justifies prompt self-isolation without the need for confirmatory testing. Individuals with a negative self-test result should adhere to general preventive measures because a false negativeOBJECTIVE To assess the performance of rapid antigen tests with unsupervised nasal and combined oropharyngeal and nasal self-sampling during the omicron period. DESIGN Prospective cross sectional diagnostic test accuracy study.SETTING Three public health service covid-19 test sites in the Netherlands, 21 December 2021 to 10 February 2022. PARTICIPANTS 6497 people with covid-19 symptoms aged >= 16 years presenting for testing.INTERVENTIONS Participants had a swab sample taken for reverse transcription polymerase chain reaction (RT-PCR, reference test) and received one rapid antigen test to perform unsupervised using either nasal self-sampling (during the emergence of omicron, and when omicron accounted for >90% of infections, phase 1) or with combined oropharyngeal and nasal self-sampling in a subsequent (phase 2; when omicron accounted for >99% of infections). The evaluated tests were Flowflex (Acon Laboratories; phase 1 only), MPBio (MP Biomedicals), and Clinitest (Siemens-Healthineers).MAIN OUTCOME MEASURES The main outcomes were sensitivity, specificity, and positive and negative predictive values of each self -test, with RT-PCR testing as the reference standard. RESULTS During phase 1, 45.0% (n=279) of participants in the Flowflex group, 29.1% (n=239) in the MPBio group, and 35.4% ((n=257) in the Clinitest group were confirmatory testers (previously tested positive by a self-test at own initiative). Overall sensitivities with nasal self-sampling were 79.0% (95% confidence interval 74.7% to 82.8%) for Flowflex, 69.9% (65.1% to 74.4%) for MPBio, and 70.2% (65.6% to 74.5%) for Clinitest. Sensitivities were substantially higher in confirmatory testers (93.6%, 83.6%, and 85.7%, respectively) than in those who tested for other reasons (52.4%, 51.5%, and 49.5%, respectively). Sensitivities decreased from 87.0% to 80.9% (P=0.16 by chi 2 test), 80.0% to 73.0% (P=0.60), and 83.1% to 70.3% (P=0.03), respectively, when transitioning from omicron accounting for 29% of infections to >95% of infections. During phase 2, 53.0% (n=288) of participants in the MPBio group and 44.4% (n=290) in the Clinitest group were confirmatory testers. Overall sensitivities with combined oropharyngeal and nasal self-sampling were 83.0% (78.8% to 86.7%) for MPBio and 77.3% (72.9% to 81.2%) for Clinitest. When combined oropharyngeal and nasal self-sampling was compared with nasal self-sampling, sensitivities were found to be slightly higher in confirmatory testers (87.4% and 86.1%, respectively) and substantially higher in those testing for other reasons (69.3% and 59.9%, respectively).CONCLUSIONS Sensitivities of three rapid antigen tests with nasal self-sampling decreased during the emergence of omicron but was only statistically significant for Clinitest. Sensitivities appeared to be substantially influenced by the proportion of confirmatory testers. Sensitivities of MPBio and Clinitest improved after the addition of oropharyngeal to nasal self-sampling. A positive self-test result justifies prompt self-isolation without the need for confirmatory testing. Individuals with a negative self-test result should adhere to general preventive measures because a false negative result cannot be ruled out. Manufacturers of MPBio and Clinitest may consider extending their instructions for use to include combined oropharyngeal and nasal self-sampling, and other manufacturers of rapid antigen tests should consider evaluating this as well.	[Schuit, Ewoud; Venekamp, Roderick P.; Hooft, Lotty; Nagel-Imming, Carla R. S.; Kluytmans, Jan A. J. W.; van de Wijgert, Janneke H. H. M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Schuit, Ewoud; Hooft, Lotty] Univ Utrecht, Univ Med Ctr Utrecht, Cochrane Netherlands, Utrecht, Netherlands; [Veldhuijzen, Irene K.; Han, Wanda G. H.; van den Hof, Susan] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van den Bijllaardt, Wouter; Pas, Suzan D.; Zwart, Vivian F.] Amphia Hosp, Microvida Lab Med Microbiol, Breda, Netherlands; [van den Bijllaardt, Wouter] Amphia Hosp, Dept Infect Control, Breda, Netherlands; [Pas, Suzan D.] Bravis Hosp, Microvida Lab Med Microbiol, Roosendaal, Netherlands; [Lodder, Esther B.] Publ Hlth Serv West Brabant, Breda, Netherlands; [Hellwich, Marloes] Publ Hlth Serv Hart voor Brabant, Tilburg, Netherlands; [Koppelman, Marco] Sanquin Blood Supply Fdn, Natl Screening Lab Sanquin, Amsterdam, Netherlands; [Molenkamp, Richard] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Wijers, Constantijn J. H.; Vroom, Irene H.] Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands; [Smeets, Leonard C.; Moons, Karel G. M.] Reinier Haga Med Diagnost Ctr, Delft, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Amphia Hospital; Amphia Hospital; Erasmus University Rotterdam; Erasmus MC	Moons, KGM (corresponding author), Reinier Haga Med Diagnost Ctr, Delft, Netherlands.	k.g.m.moons@umcutrecht.nl	; Pas, Suzan/M-9863-2013	Molenkamp, Richard/0000-0002-9004-3850; Venekamp, Roderick P/0000-0002-1446-9614; Pas, Suzan/0000-0003-1943-1217; Veldhuijzen, Irene/0000-0002-3132-4070				Allen N, 2021, J INFECTION, V83, pE9, DOI 10.1016/j.jinf.2021.08.012; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brummer LE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003735; Centrum Infectieziektebestrijding RIVM, 2021, EP SIT SARS COV 2 NE; de Michelena P, 2022, MEDRXIV, DOI [10.1101/2022.02.02.22270295, DOI 10.1101/2022.02.02.22270295]; Deerain J, 2022, J CLIN MICROBIOL, V60, DOI 10.1128/jcm.02479-21; Schuit E, 2021, medRxiv, DOI 10.1101/2021.12.08.21267452; European Centre for Disease Prevention and Control (ECDC), 2021, COS US SELF TESTS CO; European Centre for Disease Prevention and Control (ECDC), COMB IND 14 DAY NOT; Igloi Z, 2021, EMERG INFECT DIS, V27, P1323, DOI 10.3201/eid2705.204688; Schrom J, 2022, medRxiv, DOI 10.1101/2022.01.08.22268954; Klein JAF, 2021, MED MICROBIOL IMMUN, V210, P181, DOI 10.1007/s00430-021-00710-9; Lindner AK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03961-2020; Molenkamp R., 2021, EVALUATION ANTIGEN R; Osterman A, 2022, MED MICROBIOL IMMUN, V211, P105, DOI 10.1007/s00430-022-00730-z; R Development Core Team, 2009, R LANG ENV STAT COMP; Rijksoverheid, VAR COR VIR 2021; RIVM Centrum Infectieziektebestrijding, 2021, STAT VAL SARS COV 2; Scheiblauer H, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.44.2100441; Schuit E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1676; van Kampen JJA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20568-4; Venekamp RP, 2022, BMC MED, V20, DOI 10.1186/s12916-022-02300-9; World Health Organization, 2022, US SARS COV 2 ANT DE; World Medical Association, 2013, JAMA-J AM MED ASSOC	24	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								e071215	10.1136/bmj-2022-071215	http://dx.doi.org/10.1136/bmj-2022-071215			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104069	Green Published, hybrid			2022-12-28	WOS:000862323900013
J	Parasidis, E; Fairchild, AL				Parasidis, Efthimios; Fairchild, Amy L.			Closing the Public Health Ethics Gap	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								During the Covid-19 pandemic, public health officials have rarely obtained systematic input from ethicists. Doing so could help avert ineffective public health campaigns and further polarization.	[Parasidis, Efthimios] Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA; [Parasidis, Efthimios; Fairchild, Amy L.] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Parasidis, E (corresponding author), Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA.; Parasidis, E (corresponding author), Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA.							Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; Fairchild AL, 2012, PUBLIC HEALTH REP, V127, P115, DOI 10.1177/003335491212700113; Jennings B, 2008, ETHICAL GUIDANCE PUB; Powell K., 2021, SLATE; Sisk BA, 2020, AM J BIOETHICS, V20, P62, DOI 10.1080/15265161.2020.1730483	5	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					961	963		10.1056/NEJMp2207543	http://dx.doi.org/10.1056/NEJMp2207543		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36094843	Bronze			2022-12-28	WOS:000852646700001
J	Mehra, MR; Goldstein, DJ; Cleveland, JC; Cowger, JA; Hall, S; Salerno, CT; Naka, Y; Horstmanshof, D; Chuang, J; Wang, AJ; Uriel, N				Mehra, Mandeep R.; Goldstein, Daniel J.; Cleveland, Joseph C.; Cowger, Jennifer A.; Hall, Shelley; Salerno, Christopher T.; Naka, Yoshifumi; Horstmanshof, Douglas; Chuang, Joyce; Wang, AiJia; Uriel, Nir			Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUMP	IMPORTANCE Although durable left ventricular assist device (LVAD) therapy has emerged as an important treatment option for patients with advanced heart failure refractory to pharmacological support, outcomes, including survival, beyond 2 years remain poorly characterized. OBJECTIVE To report the composite end point of survival to transplant, recovery, or LVAD support free of debilitating stroke (Modified Rankin Scale score >3) or reoperation to replace the pump 5 years after the implant in participants who received the fully magnetically levitated centrifugal-flow HeartMate 3 or axial-flow HeartMate II LVAD in the MOMENTUM 3 randomized trial and were still receiving LVAD therapy at the 2-year follow-up. DESIGN, SETTING, AND PARTICIPANTS This observational study was a 5-year follow-up of the MOMENTUM 3 trial, conducted in 69 US centers, that demonstrated superiority of the centrifugal-flow LVAD to the axial-flow pump with respect to survival to transplant, recovery, or LVAD support free of debilitating stroke or reoperation to replace the pump at 2 years. A total of 295 patients were enrolled between June 2019 to April 2021in the extended-phase study, with 5-year follow-up completed in September 2021. EXPOSURES Of 1020 patients in the investigational device exemption per-protocol population, 536 were still receiving LVAD support at 2 years, of whom 289 received the centrifugal-flow pump and 247 received the axial-flow pump. MAIN OUTCOMES AND MEASURES There were 10 end points evaluated at 5 years in the per-protocol population, including a composite of survival to transplant, recovery, or LVAD support free of debilitating stroke or reoperation to replace the pump between the centrifugal-flow and axial-flow pump groups and overall survival between the 2 groups. RESULTS A total of 477 patients (295 enrolled and 182 provided limited data) of 536 patients still receiving LVAD support at 2 years contributed to the extended-phase analysis (median age, 62 y; 86 [18%] women). The 5-year Kaplan-Meier estimate of survival to transplant, recovery, or LVAD support free of debilitating stroke or reoperation to replace the pump in the centrifugal-flow vs axial-flow group was 54.0% vs 29.7% (hazard ratio, 0.55 [95% CI, 0.45-0.67]; A < .001). Overall Kaplan-Meier survival was 58.4% in the centrifugal-flow group vs 43.7% in the axial-flow group (hazard ratio, 0.72 [95% CI, 0.58-0.89]; P = .003). Serious adverse events of stroke, bleeding, and pump thrombosis were less frequent in the centrifugal-flow pump group. CONCLUSIONS AND RELEVANCE In this observational follow-up study of patients from the MOMENTUM 3 randomized trial, per-protocol analyses found that receipt of a fully magnetically levitated centrifugal-flow LVAD vs axial-flow LVAD was associated with a better composite outcome and higher likelihood of overall survival at 5 years. These findings support the use of the fully magnetically levitated LVAD.	[Mehra, Mandeep R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Goldstein, Daniel J.] Montefiore Einstein Ctr Heart & Vasc Care, New York, NY USA; [Cleveland, Joseph C.] Univ Colorado, Sch Med, Aurora, CO USA; [Cowger, Jennifer A.] Henry Ford Hosp, Detroit, MI 48202 USA; [Hall, Shelley] Baylor Univ Hosp, Dallas, TX USA; [Salerno, Christopher T.] Univ Chicago, Chicago, IL 60637 USA; [Naka, Yoshifumi; Uriel, Nir] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Naka, Yoshifumi; Uriel, Nir] NewYork Presbyterian Hosp, New York, NY USA; [Naka, Yoshifumi] Weill Cornell Med Coll, New York, NY USA; [Horstmanshof, Douglas] INTEGRIS Baptist Med Ctr, Oklahoma City, OK USA; [Chuang, Joyce; Wang, AiJia] Abbott, Abbott Pk, IL USA	Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Henry Ford Health System; Henry Ford Hospital; Baylor University Medical Center; University of Chicago; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Abbott Laboratories; Abbott Vascular	Mehra, MR (corresponding author), Harvard Med Sch, Ctr Adv Heart Dis, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	mmehra@bwh.harvard.edu			Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	This study was sponsored by Abbott Laboratories.	Crespo-Leiro MG, 2018, EUR J HEART FAIL, V20, P1505, DOI 10.1002/ejhf.1236; Greene SJ, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007132; Heatley G, 2016, J HEART LUNG TRANSPL, V35, P528, DOI 10.1016/j.healun.2016.01.021; Jakus N, 2022, EUR J HEART FAIL, V24, P1305, DOI 10.1002/ejhf.2526; Lim HS, 2022, J HEART LUNG TRANSPL, V41, P174, DOI 10.1016/j.healun.2021.11.014; Mehra MR, 2019, NEW ENGL J MED, V380, P1618, DOI 10.1056/NEJMoa1900486; Mehra MR, 2021, J CARD FAIL, V27, P1291, DOI 10.1016/j.cardfail.2021.06.003; Mehra MR, 2018, CIRCULATION, V138, P1923, DOI 10.1161/CIRCULATIONAHA.118.035722; Mehra MR, 2019, EUR HEART J, V40, P673, DOI 10.1093/eurheartj/ehx036; Mehra MR, 2017, NEW ENGL J MED, V376, P440, DOI 10.1056/NEJMoa1610426; Mezzacappa C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242928; Milano CA, 2018, JACC-HEART FAIL, V6, P792, DOI 10.1016/j.jchf.2018.05.012; Patel CB, 2020, J HEART LUNG TRANSPL, V39, P774, DOI 10.1016/j.healun.2020.03.002; Rogers JG, 2017, NEW ENGL J MED, V376, P451, DOI 10.1056/NEJMoa1602954; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Shah P, 2022, ANN THORAC SURG, V113, P722, DOI 10.1016/j.athoracsur.2021.12.011; Sidhu K, 2020, TRENDS CARDIOVAS MED, V30, P223, DOI 10.1016/j.tcm.2019.05.013; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Starling RC, 2014, NEW ENGL J MED, V370, P33, DOI 10.1056/NEJMoa1313385; Uriel N, 2017, CIRCULATION, V135, P2003, DOI 10.1161/CIRCULATIONAHA.117.028303; Varshney AS, 2022, J AM COLL CARDIOL, V79, P1092, DOI 10.1016/j.jacc.2022.01.017; Vidula H, 2022, JACC-HEART FAIL, V10, P470, DOI 10.1016/j.jchf.2022.03.007	22	3	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2022	328	12					1233	1242		10.1001/jama.2022.16197	http://dx.doi.org/10.1001/jama.2022.16197		SEP 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E8TQ	36074476				2022-12-28	WOS:000851603800001
J	Larkin, HD				Larkin, Howard D.			First Therapy Targeting ERBB2-Low Breast Cancer Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					819	819						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066537				2022-12-28	WOS:000855171700009
J	Slomski, A				Slomski, Anita			Weekend Warriors Reap Same Benefits as the Regularly Active	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					817	818						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066529				2022-12-28	WOS:000855171700006
J	Sheu, SH; Upadhyayula, S; Dupuy, V; Pang, S; Deng, F; Wan, JX; Walpita, D; Pasolli, HA; Houser, J; Sanchez-Martinez, S; Brauchi, SE; Banala, S; Freeman, M; Xu, CS; Kirchhausen, T; Hess, HF; Lavis, L; Li, YL; Chaumont-Dubel, S; Clapham, DE				Sheu, Shu-Hsien; Upadhyayula, Srigokul; Dupuy, Vincent; Pang, Song; Deng, Fei; Wan, Jinxia; Walpita, Deepika; Pasolli, H. Amalia; Houser, Justin; Sanchez-Martinez, Silvia; Brauchi, Sebastian E.; Banala, Sambashiva; Freeman, Melanie; Xu, C. Shan; Kirchhausen, Tom; Hess, Harald F.; Lavis, Luke; Li, Yulong; Chaumont-Dubel, Severine; Clapham, David E.			A serotonergic axon-cilium synapse drives nuclear signaling to alter chromatin accessibility	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; MEMBRANE SKELETON; 5-HT6 RECEPTORS; NEURONAL CILIA; RHO; BINDING; ACTIVATION; CELL; RAT; PHOSPHORYLATION	Chemical synapses between axons and dendrites mediate neuronal intercellular communication. Here, we describe a synapse between axons and primary cilia: the axo-ciliary synapse. Using enhanced focused ion beam-scanning electron microscopy on samples with optimally preserved ultrastructure, we discovered synapses between brainstem serotonergic axons and the primary cilia of hippocampal CA1 pyramidal neurons. Functionally, these cilia are enriched in a ciliary-restricted serotonin receptor, the 5-hydroxytryptamine receptor 6 (5-HTR6). Using a cilia-targeted serotonin sensor, we show that opto-and chemogenetic stimulation of serotonergic axons releases serotonin onto cilia. Ciliary 5-HTR6 stimulation activates a non-canonical G(alpha q/11)-RhoA pathway, which modulates nuclear actin and increases histone acetylation and chromatin accessibility. Ablation of this pathway reduces chromatin accessibility in CA1 pyramidal neurons. As a signaling apparatus with proximity to the nucleus, axo-ciliary synapses short circuit neurotransmission to alter the postsynaptic neuron's epigenetic state.	[Sheu, Shu-Hsien; Pang, Song; Walpita, Deepika; Pasolli, H. Amalia; Sanchez-Martinez, Silvia; Brauchi, Sebastian E.; Banala, Sambashiva; Freeman, Melanie; Xu, C. Shan; Hess, Harald F.; Lavis, Luke; Li, Yulong; Clapham, David E.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Sheu, Shu-Hsien; Clapham, David E.] Harvard Med Sch, Boston, MA 02115 USA; [Sheu, Shu-Hsien] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Sheu, Shu-Hsien; Clapham, David E.] Boston Childrens Hosp, Howard Huges Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Upadhyayula, Srigokul] Univ Calif Berkeley, Adv Bioimaging Ctr, Berkeley, CA 94720 USA; [Upadhyayula, Srigokul] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Dupuy, Vincent; Chaumont-Dubel, Severine] Univ Montpellier, Inst Genom Fonctionnelle, INSERM, CNRS, Montpellier, France; [Deng, Fei; Wan, Jinxia] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Houser, Justin; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Brauchi, Sebastian E.] Univ Austral Chile, Dept Physiol, Fac Med, Valdivia, Chile; [Brauchi, Sebastian E.] Millennium Nucleus Ion Channel Associated Dis MiN, Valdivia, Chile; [Kirchhausen, Tom] Harvard Med Sch, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA; [Kirchhausen, Tom] Harvard Med Sch, Dept Pediat, 200 Longwood Ave, Boston, MA 02115 USA; [Upadhyayula, Srigokul] Chan Zuckerberg Biohub, San Francisco, CA USA; [Pasolli, H. Amalia] Rockefeller Univ, Electron Microscopy Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Houser, Justin] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Sanchez-Martinez, Silvia] Univ Wyoming, Laramie, WY 82071 USA; [Freeman, Melanie] 10x Genom, San Francisco, CA USA; [Pang, Song] Yale Sch Med, New Haven, CT USA; [Xu, C. Shan] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Peking University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Universidad Austral de Chile; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University; University of Texas System; University of Texas Austin; University of Wyoming; Yale University; Yale University	Sheu, SH; Clapham, DE (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.; Sheu, SH; Clapham, DE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Sheu, SH (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.; Sheu, SH; Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Huges Med Inst, Dept Cardiol, Boston, MA 02115 USA.	sheus@janelia.hhmi.org; claphamd@hhmi.org		Sheu, Shu-Hsien/0000-0003-0758-4654; Dupuy, Vincent/0000-0003-3449-470X	Howard Hughes Medical Institute; Foundation for Medical Research (FRM, France); ANR [ANR-11-BSV4-008, ANR-17-CE16-0010-01]; NIH BRAIN Initiative [1U01NS103558]; French Ministry of Research and Education; NIH [5T32HL110852-05]; ANID-Millennium Science Initiative Program [NCN19_168]; Philomathia Foundation and Chan Zuckerberg Initiative Imaging Scientist program; National Institute of General Medical Sciences Maximizing Investigators' Research [GM130386]; National Institutes of Health [R01 GM075252]; Biogen Sponsored Research Agreement	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for Medical Research (FRM, France); ANR(French National Research Agency (ANR)); NIH BRAIN Initiative; French Ministry of Research and Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANID-Millennium Science Initiative Program; Philomathia Foundation and Chan Zuckerberg Initiative Imaging Scientist program; National Institute of General Medical Sciences Maximizing Investigators' Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen Sponsored Research Agreement	We thank Liangqi Xie and James Liu for providing ATAC-see reagents and Joachim Goedhart (University of Amsterdam) and Kees Jalink (Netherlands Cancer Institute) for input on our RhoA analyses. This work was supported by Howard Hughes Medical Institute. The generation of Htr6-EGFP knockin mice and Htr6 KO mice were funded by the Foundation for Medical Research (FRM, France) and ANR contracts Sero6Cognet (ANR-11-BSV4-008) and Sero6Dev (ANR-17-CE16-0010-01). The development of the HTR6-based serotonin sensor was funded by the NIH BRAIN Initiative (1U01NS103558). V.D. was supported by the French Ministry of Research and Education, S.-H.S. by NIH 5T32HL110852-05, S.E.B. by the ANID-Millennium Science Initiative Program #NCN19_168 (National Agency of Research and Development, Chile), S.U. by the Philomathia Foundation and Chan Zuckerberg Initiative Imaging Scientist program, and T.K. by the National Institute of General Medical Sciences Maximizing Investigators' Research Award GM130386, National Institutes of Health R01 GM075252, and a Biogen Sponsored Research Agreement.	Aguet F, 2016, MOL BIOL CELL, V27, P3418, DOI 10.1091/mbc.E16-03-0164; Alvarez FJ, 1998, J COMP NEUROL, V393, P69; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Arellano JI, 2012, J COMP NEUROL, V520, P848, DOI 10.1002/cne.22793; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Baldi P, 2021, J NEUROSCI RES, V99, P2610, DOI 10.1002/jnr.24919; Barbeito P, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000746; Belmer A, 2017, BRAIN STRUCT FUNCT, V222, P1297, DOI 10.1007/s00429-016-1278-x; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Benzekhroufa K, 2009, GENE THER, V16, P681, DOI 10.1038/gt.2009.7; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berger DR, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00088; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boess FG, 1997, NEUROPHARMACOLOGY, V36, P713, DOI 10.1016/S0028-3908(97)00019-1; Bouquier N, 2009, CHEM BIOL, V16, P391, DOI 10.1016/j.chembiol.2009.02.006; Brodsky M, 2017, BRAIN RES, V1660, P10, DOI 10.1016/j.brainres.2017.01.010; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Chen XQ, 2016, NAT METHODS, V13, P1013, DOI [10.1038/NMETH.4031, 10.1038/nmeth.4031]; Chung M, 2021, MATLAB CENTRAL FILE; Cole DC, 2007, J MED CHEM, V50, P5535, DOI 10.1021/jm070521y; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Delgado T, 2019, BIOL OPEN, V8, DOI 10.1242/bio.044834; Deo C, 2019, J AM CHEM SOC, V141, P13734, DOI 10.1021/jacs.9b06092; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Douanne T, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202102089; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Feng J, 2019, NEURON, V102, P745, DOI 10.1016/j.neuron.2019.02.037; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Gao RX, 2019, SCIENCE, V363, P245, DOI 10.1126/science.aau8302; Goedhart J, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000581; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Hagen V, 2008, CHEM-EUR J, V14, P1621, DOI 10.1002/chem.200701142; Han BR, 2017, P NATL ACAD SCI USA, V114, pE6678, DOI 10.1073/pnas.1705043114; Hansen JN, 2021, EUR PHYS J E, V44, DOI 10.1140/epje/s10189-021-00031-y; Harkes R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00098-9; Hilgendorf KI, 2019, CELL, V179, P1289, DOI 10.1016/j.cell.2019.11.005; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Hirst WD, 2000, BRIT J PHARMACOL, V130, P1597, DOI 10.1038/sj.bjp.0703458; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hor CN, 2019, P NATL ACAD SCI USA, V116, P25773, DOI 10.1073/pnas.1910590116; Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001; Jiang JY, 2019, P NATL ACAD SCI USA, V116, P12066, DOI 10.1073/pnas.1819730116; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2837169; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kirschen Gregory W, 2017, Front Biol (Beijing), V12, P124, DOI 10.1007/s11515-017-1447-1; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kohli P, 2017, EMBO REP, V18, P1521, DOI 10.15252/embr.201643846; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; LEHMENKUHLER A, 1993, NEUROSCIENCE, V55, P339, DOI 10.1016/0306-4522(93)90503-8; Liu CM, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0333-0; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Marco A, 2020, NAT NEUROSCI, V23, P1606, DOI 10.1038/s41593-020-00717-0; Masyuk AI, 2013, AM J PHYSIOL-GASTR L, V304, pG1013, DOI 10.1152/ajpgi.00383.2012; Mirvis M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000381; MONSMA FJ, 1993, MOL PHARMACOL, V43, P320; Mullins N, 2021, NAT GENET, V53, P817, DOI 10.1038/s41588-021-00857-4; Muzerelle A, 2016, BRAIN STRUCT FUNCT, V221, P535, DOI 10.1007/s00429-014-0924-4; Nadim WD, 2016, P NATL ACAD SCI USA, V113, P12310, DOI 10.1073/pnas.1600914113; Nagai Y, 2020, NAT NEUROSCI, V23, P1157, DOI 10.1038/s41593-020-0661-3; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oikonomou G, 2019, NEURON, V103, P686, DOI 10.1016/j.neuron.2019.05.038; Oishi A, 2012, J BIOL CHEM, V287, P38705, DOI 10.1074/jbc.M112.401547; Park CS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-539; Park YG, 2019, NAT BIOTECHNOL, V37, P73, DOI 10.1038/nbt.4281; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Plessner M, 2019, CURR OPIN CELL BIOL, V56, P1, DOI 10.1016/j.ceb.2018.08.005; Postma M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000202; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rahman MA, 2017, MOL CELLS, V40, P495, DOI 10.14348/molcells.2017.0080; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Raschka S., 2018, J OPEN SOURCE SOFTW, V3, P638, DOI [10.21105/joss.00638, DOI 10.21105/JOSS.00638]; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Schechter LE, 2008, NEUROPSYCHOPHARMACOL, V33, P1323, DOI 10.1038/sj.npp.1301503; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Sosinsky GE, 2008, J STRUCT BIOL, V161, P359, DOI 10.1016/j.jsb.2007.09.002; Sun ZH, 2021, AGING CELL, V20, DOI 10.1111/acel.13369; Hai-Qing T, 2022, bioRxiv, DOI 10.1101/2022.01.26.477948; Tai YL, 2019, NEURON, V102, P358, DOI 10.1016/j.neuron.2019.02.009; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tereshko L, 2021, ELIFE, V10, DOI 10.7554/eLife.65427; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Ting JT, 2018, JOVE-J VIS EXP, DOI 10.3791/53825; Upton N, 2008, NEUROTHERAPEUTICS, V5, P458, DOI 10.1016/j.nurt.2008.05.008; Viita T, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226852; Wan JX, 2021, NAT NEUROSCI, V24, P746, DOI 10.1038/s41593-021-00823-7; Wan OW, 2016, SCI REP-UK, V6, DOI 10.1038/srep26285; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wong PT, 2017, ACS CHEM BIOL, V12, P1001, DOI 10.1021/acschembio.6b00999; Wu YM, 2017, P NATL ACAD SCI USA, V114, pE4859, DOI 10.1073/pnas.1701078114; Xu C.S., 2020, VOLUME MICROSCOPY MU, P221, DOI 10.1007/978-1-0716-0691-9_12; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173085; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zheng QS, 2019, ACS CENTRAL SCI, V5, P1602, DOI 10.1021/acscentsci.9b00676; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	107	3	3	15	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3390	+		10.1016/j.cell.2022.07.026	http://dx.doi.org/10.1016/j.cell.2022.07.026			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4M5EZ	36055200	Green Published, hybrid			2022-12-28	WOS:000853347900001
J	Yoon, JY; Klein, JP				Yoon, Joseph Y.; Klein, Joshua P.			Subacute Combined Degeneration from Nitrous Oxide Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yoon, Joseph Y.] Mt Sinai Hosp, New York, NY 10029 USA; [Klein, Joshua P.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital	Yoon, JY (corresponding author), Mt Sinai Hosp, New York, NY 10029 USA.	joseph.yoon@mountsinai.org							0	1	1	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					832	832		10.1056/NEJMicm2119871	http://dx.doi.org/10.1056/NEJMicm2119871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053508				2022-12-28	WOS:000849132700011
J	Crowther, CA; Samuel, D; McCowan, LME; Edlin, R; Tran, T; McKinlay, CJ				Crowther, Caroline A.; Samuel, Deborah; McCowan, Lesley M. E.; Edlin, Richard; Tran, Thach; McKinlay, Christopher J.		GEMS Trial Grp	Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL ASSOCIATION; PREGNANCY; HYPERGLYCEMIA; PREVALENCE; TRIAL; CLASSIFICATION; PREECLAMPSIA; MELLITUS; OUTCOMES; IMPACT	Background Treatment of gestational diabetes improves maternal and infant health, although diagnostic criteria remain unclear. Methods We randomly assigned women at 24 to 32 weeks' gestation in a 1:1 ratio to be evaluated for gestational diabetes with the use of lower or higher glycemic criteria for diagnosis. The lower glycemic criterion was a fasting plasma glucose level of at least 92 mg per deciliter (>= 5.1 mmol per liter), a 1-hour level of at least 180 mg per deciliter (>= 10.0 mmol per liter), or a 2-hour level of at least 153 mg per deciliter (>= 8.5 mmol per liter). The higher glycemic criterion was a fasting plasma glucose level of at least 99 mg per deciliter (>= 5.5 mmol per liter) or a 2-hour level of at least 162 mg per deciliter (>= 9.0 mmol per liter). The primary outcome was the birth of an infant who was large for gestational age (defined as a birth weight above the 90th percentile according to Fenton-World Health Organization standards). Secondary outcomes were maternal and infant health. Results A total of 4061 women underwent randomization. Gestational diabetes was diagnosed in 310 of 2022 women (15.3%) in the lower-glycemic-criteria group and in 124 of 2039 women (6.1%) in the higher-glycemic-criteria group. Among 2019 infants born to women in the lower-glycemic-criteria group, 178 (8.8%) were large for gestational age, and among 2031 infants born to women in the higher-glycemic-criteria group, 181 (8.9%) were large for gestational age (adjusted relative risk, 0.98; 95% confidence interval, 0.80 to 1.19; P=0.82). Induction of labor, use of health services, use of pharmacologic agents, and neonatal hypoglycemia were more common in the lower-glycemic-criteria group than in the higher-glycemic-criteria group. The results for the other secondary outcomes were similar in the two trial groups, and there were no substantial between-group differences in adverse events. Among the women in both groups who had glucose test results that fell between the lower and higher glycemic criteria, those who were treated for gestational diabetes (195 women), as compared with those who were not (178 women), had maternal and infant health benefits, including fewer large-for-gestational-age infants. Conclusions The use of lower glycemic criteria for the diagnosis of gestational diabetes did not result in a lower risk of a large-for-gestational-age infant than the use of higher glycemic criteria. (Funded by the Health Research Council of New Zealand and others; GEMS Australian New Zealand Clinical Trials Registry number, ACTRN12615000290594.)	[Crowther, Caroline A.; Samuel, Deborah; McKinlay, Christopher J.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [McCowan, Lesley M. E.] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand; [Edlin, Richard] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Tran, Thach] Garvan Inst Med Res, Osteoporosis & Bone Biol, Sydney, NSW, Australia	University of Auckland; University of Auckland; University of Auckland; Garvan Institute of Medical Research	Crowther, CA (corresponding author), Univ Auckland, Liggins Inst, Auckland, New Zealand.	c.crowther@auckland.ac.nz		Crowther, Caroline/0000-0002-9079-4451	Health Research Council of New Zealand [ID14/104]; Counties Manukau Health Tupu Fund; Liggins Institute Philanthropic Fund; New Zealand Society for the Study of Diabetes	Health Research Council of New Zealand(Health Research Council of New Zealand); Counties Manukau Health Tupu Fund; Liggins Institute Philanthropic Fund; New Zealand Society for the Study of Diabetes	Supported by a 3-year project grant (ID14/104) from the Health Research Council of New Zealand, and grants from Counties Manukau Health Tupu Fund, the Liggins Institute Philanthropic Fund, and the New Zealand Society for the Study of Diabetes.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; Anderson NH, 2012, AUST NZ J OBSTET GYN, V52, P552, DOI 10.1111/j.1479-828X.2012.01475.x; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1; Bilous RW, 2021, DIABETES CARE, V44, P858, DOI 10.2337/dc20-2941; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Davidson KW, 2021, JAMA-J AM MED ASSOC, V326, P531, DOI 10.1001/jama.2021.11922; Davis EM, 2021, OBSTET GYNECOL, V138, P6, DOI 10.1097/AOG.0000000000004431; Dodd JM, 2007, AUST NZ J OBSTET GYN, V47, P307, DOI 10.1111/j.1479-828X.2007.00743.x; Ekeroma AJ, 2015, AUST NZ J OBSTET GYN, V55, P34, DOI 10.1111/ajo.12267; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Hillier TA, 2021, NEW ENGL J MED, V384, P895, DOI 10.1056/NEJMoa2026028; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631; Kramer CK, 2019, DIABETOLOGIA, V62, P905, DOI 10.1007/s00125-019-4840-2; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lowe WL, 2018, JAMA-J AM MED ASSOC, V320, P1005, DOI 10.1001/jama.2018.11628; McKinlay CJD, 2017, JAMA PEDIATR, V171, P972, DOI 10.1001/jamapediatrics.2017.1579; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moses RG, 2011, MED J AUSTRALIA, V194, P338, DOI 10.5694/j.1326-5377.2011.tb03001.x; Nankervis A., 2014, AUSTRALASIAN DIABETE; National Institute for Health and Care Excellence, 2015, DIAB PREGN MAN PREC; New Zealand Ministry of Health, 2014, SCREEN DIAGN MAN GES; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Sacks DA, 2015, OBSTET GYNECOL, V126, P67, DOI 10.1097/AOG.0000000000000865; Saeedi M, 2021, DIABETES RES CLIN PR, V172, DOI 10.1016/j.diabres.2020.108642; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Vounzoulaki E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1361; Waters TP, 2016, DIABETES CARE, V39, P2204, DOI 10.2337/dc16-1194; Wong VW, 2017, DIABETES RES CLIN PR, V129, P148, DOI 10.1016/j.diabres.2017.04.018; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	37	4	4	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2022	387	7					587	598		10.1056/NEJMoa2204091	http://dx.doi.org/10.1056/NEJMoa2204091		AUG 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4D8EB	36070709				2022-12-28	WOS:000883681200007
J	Wouters, OJ; McKee, M; Luyten, J				Wouters, Olivier J.; McKee, Martin; Luyten, Jeroen			Errors in Source Data for Study of Drug Development Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wouters, Olivier J.] London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Luyten, Jeroen] Leuven Inst Healthcare Policy, Dept Publ Hlth & Primary Care, Leuven, Belgium	University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine	Wouters, OJ (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, Houghton St, London WC2A 2AE, England.	o.j.wouters@lse.ac.uk		Luyten, Jeroen/0000-0001-6398-4025				[Anonymous], 2022, JAMA, V328, P1111, DOI 10.1001/jama.2022.14733; Wong CH, 2019, BIOSTATISTICS, V20, P273, DOI 10.1093/biostatistics/kxx069; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166	3	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1110	1110		10.1001/jama.2022.14317	http://dx.doi.org/10.1001/jama.2022.14317			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125476				2022-12-28	WOS:000862909200030
J	Matta, S; Nicholas, LH				Matta, Sasmira; Nicholas, Lauren H.			Changes in Unemployment Among Health Care Workers Following the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Matta, Sasmira] Univ Penn Wharton Sch, Dept Hlth Care Management, Philadelphia, PA USA; [Nicholas, Lauren H.] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA	University of Pennsylvania; Colorado School of Public Health	Matta, S (corresponding author), Univ Penn, 3641 Locust Walk, Philadelphia, PA 19104 USA.	smatta@wharton.upenn.edu						Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bureau of Labor Statistics, 2022, HOUS EST SURV RESP R; Flood Sarah., 2021, INTEGRATED PUBLIC US; Himmelstein KEW, 2019, AM J PUBLIC HEALTH, V109, P198, DOI 10.2105/AJPH.2018.304801; Ochieng N., 2021, FUNDING HLTH CARE PR	6	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2022	328	16					1639	1641		10.1001/jama.2022.17608	http://dx.doi.org/10.1001/jama.2022.17608		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6C3UZ	36121675	Bronze			2022-12-28	WOS:000857175200002
J	Watts, G				Watts, Geoff			Mark Dransfield: breathing new ideas into COPD	LANCET			English	Biographical-Item																		DRANSFIELD M, PUBLICATION LIST	1	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					879	879		10.1016/S0140-6736(22)01701-9	http://dx.doi.org/10.1016/S0140-6736(22)01701-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36075253				2022-12-28	WOS:000890180700011
J	Suzuki, TA; Fitzstevens, JL; Schmidt, VT; Enav, H; Huus, KE; Ngwese, MM; Griesshammer, A; Pfleiderer, A; Adegbite, BR; Zinsou, JF; Esen, M; Velavan, TP; Adegnika, AA; Song, LH; Spector, TD; Muehlbauer, AL; Marchi, N; Kang, H; Maier, L; Blekhman, R; Seegurel, L; Ko, G; Youngblut, ND; Kremsner, P; Ley, RE				Suzuki, Taichi A.; Fitzstevens, J. Liam; Schmidt, Victor T.; Enav, Hagay; Huus, Kelsey E.; Ngwese, Mirabeau Mbong; Griesshammer, Anne; Pfleiderer, Anne; Adegbite, Bayode R.; Zinsou, Jeannot F.; Esen, Meral; Velavan, Thirumalaisamy P.; Adegnika, Ayola A.; Song, Le Huu; Spector, Timothy D.; Muehlbauer, Amanda L.; Marchi, Nina; Kang, Hyena; Maier, Lisa; Blekhman, Ran; Segurel, Laure; Ko, GwangPyo; Youngblut, Nicholas D.; Kremsner, Peter; Ley, Ruth E.			Codiversification of gut microbiota with humans	SCIENCE			English	Article								The gut microbiomes of human populations worldwide have many core microbial species in common. However, within a species, some strains can show remarkable population specificity. The question is whether such specificity arises from a shared evolutionary history (codiversification) between humans and their microbes. To test for codiversification of host and microbiota, we analyzed paired gut metagenomes and human genomes for 1225 individuals in Europe, Asia, and Africa, including mothers and their children. Between and within countries, a parallel evolutionary history was evident for humans and their gut microbes. Moreover, species displaying the strongest codiversification independently evolved traits characteristic of host dependency, including reduced genomes and oxygen and temperature sensitivity. These findings all point to the importance of understanding the potential role of population-specific microbial strains in microbiome-mediated disease phenotypes.	[Suzuki, Taichi A.; Fitzstevens, J. Liam; Schmidt, Victor T.; Enav, Hagay; Huus, Kelsey E.; Ngwese, Mirabeau Mbong; Youngblut, Nicholas D.; Ley, Ruth E.] Max Planck Inst Biol, Dept Microbiome Sci, Tubingen, Germany; [Griesshammer, Anne; Maier, Lisa] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Pfleiderer, Anne; Adegbite, Bayode R.; Zinsou, Jeannot F.; Esen, Meral; Velavan, Thirumalaisamy P.; Adegnika, Ayola A.; Kremsner, Peter] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Adegbite, Bayode R.; Zinsou, Jeannot F.; Adegnika, Ayola A.; Kremsner, Peter] Ctr Rech Med Lambarene, Lambarene, Gabon; [Esen, Meral; Adegnika, Ayola A.; Kremsner, Peter] German Ctr Infect Res, Tubingen, Germany; [Esen, Meral; Maier, Lisa; Kremsner, Peter; Ley, Ruth E.] Univ Tubingen, Cluster Excellence EXC Controlling Microbes Fight, Tubingen, Germany; [Velavan, Thirumalaisamy P.; Song, Le Huu] Vietnamese German Ctr Med Res, Hanoi, Vietnam; [Adegnika, Ayola A.] Fdn Rech Sci, Cotonou, Benin; [Song, Le Huu] 108 Mil Cent Hosp, Hanoi, Vietnam; [Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Muehlbauer, Amanda L.] Univ Minnesota, Dept Ecol Evolut & Behav, Minneapolis, MN USA; [Marchi, Nina; Segurel, Laure] Univ Paris, CNRS, Museum Natl Hist Nat, Ecoanthropol, Paris, France; [Kang, Hyena; Ko, GwangPyo] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul, South Korea; [Blekhman, Ran] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Segurel, Laure] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, Villeurbanne, France	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research; Eberhard Karls University of Tubingen; University of London; King's College London; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Seoul National University (SNU); University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Ley, RE (corresponding author), Max Planck Inst Biol, Dept Microbiome Sci, Tubingen, Germany.; Ley, RE (corresponding author), Univ Tubingen, Cluster Excellence EXC Controlling Microbes Fight, Tubingen, Germany.	rley@tuebingen.mpg.de	ADEGBITE, BAYODE ROMEO/AAE-1448-2020	ADEGBITE, BAYODE ROMEO/0000-0003-4208-6212; Mbong Ngwese, Mirabeau/0000-0001-7354-7128; Blekhman, Ran/0000-0003-3218-613X; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Pfleiderer, Anne/0000-0002-4147-0493	Max Planck Society; Medical Research Council; European Union; National Institute for Health Research; Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Agence Nationale de la Recherche [ANR-15CE02-0003]; NIH [R35-GM128716]; Wellcome Trust; Chronic Disease Research Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Chronic Disease Research Foundation	This work was supported by the Max Planck Society. T.D.S. was funded by the Wellcome Trust, Medical Research Council, European Union, Chronic Disease Research Foundation, Zoe Global Ltd., the National Institute for Health Research-funded BioResource, and the Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. L.S. was supported by an Agence Nationale de la Recherche grant (MICROREGAL, ANR-15CE02-0003). R.B. was supported by NIH grant R35-GM128716.	Abdill RJ, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001536; Asnicar F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16366-7; Barratt MJ, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abk1107; Brito IL, 2019, NAT MICROBIOL, V4, P964, DOI 10.1038/s41564-019-0409-6; Browne HP, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02428-6; Costea PI, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177589; Duda P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29890; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Enav H, 2022, CELL HOST MICROBE, V30, P627, DOI 10.1016/j.chom.2022.04.009; Even G, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.533528; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fitzstevens Liam, 2022, Zenodo, DOI 10.5281/ZENODO.6947454; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Groussin M, 2020, CELL HOST MICROBE, V28, P12, DOI 10.1016/j.chom.2020.06.013; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; H. Enav, 2021, bioRxiv, DOI 10.1101/2021.10.06.463341; Huus KE, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00707-21; Karcher N, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02042-y; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Lim MY, 2017, GUT, V66, P1031, DOI 10.1136/gutjnl-2015-311326; Lokmer A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211139; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Merrill B. D., 2022, BIORXIV, DOI [10.1101/2022.03.30.48647, DOI 10.1101/2022.03.30.48647]; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Moeller AH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500997; Moran NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002311; Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Nishida AH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25732-y; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olm MR, 2021, NAT BIOTECHNOL, V39, P727, DOI 10.1038/s41587-020-00797-0; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Suzuki Taichi, 2022, Dryad, DOI 10.5061/DRYAD.QRFJ6Q5K2; Suzuki TA, 2020, SCIENCE, V370, P1180, DOI 10.1126/science.aaz6827; Tett A, 2019, CELL HOST MICROBE, V26, P666, DOI 10.1016/j.chom.2019.08.018; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224; Wibowo MC, 2021, NATURE, V594, P234, DOI 10.1038/s41586-021-03532-0; Xie HL, 2016, CELL SYST, V3, P572, DOI 10.1016/j.cels.2016.10.004	42	1	1	35	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1328	1332		10.1126/science.abm7759	http://dx.doi.org/10.1126/science.abm7759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108023	Green Submitted			2022-12-28	WOS:000887933500042
J	King, A				King, Anthony			A persistent pursuit	NATURE			English	Editorial Material																		Fong L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju268; Graff JN, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000642; Guan XN, 2022, NATURE, V606, P791, DOI 10.1038/s41586-022-04522-6; Gulley J.L., 2019, J CLIN ONCOL, V37, P1051, DOI [10.1200/JCO.18.02031, DOI 10.1200/JCO.18.02031, DOI 10.1200/JCO.2019.37.15_SUPPL.8001]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Narayan V, 2022, NAT MED, V28, DOI 10.1038/s41591-022-01726-1; Redman JM, 2020, ANN ONCOL, V31, pS511, DOI 10.1016/j.annonc.2020.08.875; Tran B., 2020, ANN ONCOL, V31, pS507, DOI [10.1016/j.annonc.2021.09.021, DOI 10.1016/J.ANNONC.2020.06.007, 10.1016/j.annonc.2020.08.869, DOI 10.1016/J.ANNONC.2020.08.869]	8	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S42	S44		10.1038/d41586-022-02861-y	http://dx.doi.org/10.1038/d41586-022-02861-y			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104410	Bronze			2022-12-28	WOS:000855141600007
J	Manfrini, O; Bugiardini, R				Manfrini, Olivia; Bugiardini, Raffaele			Behavioural risk factors and cardiovascular disease: are women at higher risk?	LANCET			English	Editorial Material							COUNTRIES PURE; HEART-DISEASE; MEN; DEPRESSION; FAILURE		[Manfrini, Olivia; Bugiardini, Raffaele] Univ Bologna, Dept Expt Diagnost & Specialty Med, Lab Epidemiol & Clin Cardiol, I-40138 Bologna, Italy; [Manfrini, Olivia] St Orsola Hosp, IRCCS Azienda Osped Univ Bologna, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Manfrini, O (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Lab Epidemiol & Clin Cardiol, I-40138 Bologna, Italy.; Manfrini, O (corresponding author), St Orsola Hosp, IRCCS Azienda Osped Univ Bologna, Bologna, Italy.	olivia.manfrini@unibo.it						Bugiardini R, 2022, J AM COLL CARDIOL, V79, P2021, DOI 10.1016/j.jacc.2022.03.354; Cenko E, 2019, J AM COLL CARDIOL, V74, P2379, DOI 10.1016/j.jacc.2019.08.1047; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Manfrini O, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017235; McKenzie BL, 2020, NUTR J, V19, DOI 10.1186/s12937-019-0517-4; Miller V, 2017, LANCET, V390, P2037, DOI [10.1016/S0140-6736(17)32253-5, 10.1016/s0140-6736(17)32253-5]; Millett ERC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4247; Rajagopalan S, 2021, NEW ENGL J MED, V385, P1881, DOI 10.1056/NEJMra2030281; Walli-Attaei M, 2022, LANCET, V400, P811, DOI 10.1016/S0140-6736(22)01441-6; Walli-Attaei M, 2020, LANCET, V396, P97, DOI 10.1016/S0140-6736(20)30543-2	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					788	789						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088937				2022-12-28	WOS:000877580600003
J	Malgrange, B; Nguyen, L				Malgrange, Brigitte; Nguyen, Laurent			Scaling brain neurogenesis across evolution	SCIENCE			English	Editorial Material							NEOCORTEX		[Malgrange, Brigitte; Nguyen, Laurent] Univ Liege, GIGAStem Cells & GIGANeurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium	University of Liege	Malgrange, B (corresponding author), Univ Liege, GIGAStem Cells & GIGANeurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.	bmalgrange@uliege.be; lnguyen@uliege.be			Fonds National de la Recherche Scientifique (FNRS) [WELBIO CR-2022A-12, PDR -33666709]	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	The authors are supported by the Fonds National de la Recherche Scientifique (FNRS) (WELBIO CR-2022A-12 to L.N. and PDR -33666709 to B.M.).	Azzara A, 2021, CHILD NERV SYST, V37, P2589, DOI 10.1007/s00381-021-05153-4; Espinos A, 2022, DEV NEUROBIOL, V82, P428, DOI 10.1002/dneu.22891; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gould S J, 1977, Science, V196, P517, DOI 10.1126/science.196.4289.517-a; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Pinson A, 2022, SCIENCE, V377; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Trujillo CA, 2021, SCIENCE, V371, P694, DOI 10.1126/science.aax2537; VanSickle C, 2020, AM J PHYS ANTHROPOL, V173, P768, DOI 10.1002/ajpa.24124	12	0	0	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1155	1156		10.1126/science.ade4388	http://dx.doi.org/10.1126/science.ade4388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074827				2022-12-28	WOS:000887933400031
J	Todd, ET; Tonasso-Calviere, L; Chauvey, L; Schiavinato, S; Fages, A; Seguin-Orlando, A; Clavel, P; Khan, N; Pardal, LP; Rosa, LP; Librado, P; Ringbauer, H; Verdugo, M; Southon, J; Aury, JM; Perdereau, A; Vila, E; Marzullo, M; Prato, O; Tecchiati, U; Gianni, GB; Tagliacozzo, A; Tine, V; Alhaique, F; Cardoso, JL; Valente, MJ; Antunes, MT; Frantz, L; Shapiro, B; Bradley, DG; Boulbes, N; Gardeisen, A; Horwitz, LK; Oztan, A; Arbuckle, BS; Onar, V; Clavel, B; Lepetz, S; Vahdati, AA; Davoudi, H; Mohaseb, A; Mashkour, M; Bouchez, O; Donnadieu, C; Wincker, P; Brooks, SA; Beja-Pereira, A; Wu, DD; Orlando, L				Todd, Evelyn T.; Tonasso-Calviere, Laure; Chauvey, Lorelei; Schiavinato, Stephanie; Fages, Antoine; Seguin-Orlando, Andaine; Clavel, Pierre; Khan, Naveed; Pardal, Lucia Perez; Rosa, Laura Patterson; Librado, Pablo; Ringbauer, Harald; Verdugo, Marta; Southon, John; Aury, Jean-Marc; Perdereau, Aude; Vila, Emmanuelle; Marzullo, Matilde; Prato, Ornella; Tecchiati, Umberto; Gianni, Giovanna Bagnasco; Tagliacozzo, Antonio; Tine, Vincenzo; Alhaique, Francesca; Cardoso, Joao Luis; Valente, Maria Joao; Antunes, Miguel Telles; Frantz, Laurent; Shapiro, Beth; Bradley, Daniel G.; Boulbes, Nicolas; Gardeisen, Armelle; Horwitz, Liora Kolska; Oztan, Aliye; Arbuckle, Benjamin S.; Onar, Vedat; Clavel, Benoit; Lepetz, Sebastien; Vahdati, Ali Akbar; Davoudi, Hossein; Mohaseb, Azadeh; Mashkour, Marjan; Bouchez, Olivier; Donnadieu, Cecile; Wincker, Patrick; Brooks, Samantha A.; Beja-Pereira, Albano; Wu, Dong-Dong; Orlando, Ludovic			The genomic history and global expansion of domestic donkeys	SCIENCE			English	Article							GENE FLOW; INSIGHTS; ANCESTRY; EQUIDS; DNA	Donkeys transformed human history as essential beasts of burden for long-distance movement, especially across semi-arid and upland environments. They remain insufficiently studied despite globally expanding and providing key support to low- to middle-income communities. To elucidate their domestication history, we constructed a comprehensive genome panel of 207 modern and 31 ancient donkeys, as well as 15 wild equids. We found a strong phylogeographic structure in modern donkeys that supports a single domestication in Africa similar to 5000 BCE, followed by further expansions in this continent and Eurasia and ultimately returning to Africa. We uncover a previously unknown genetic lineage in the Levant similar to 200 BCE, which contributed increasing ancestry toward Asia. Donkey management involved inbreeding and the production of giant bloodlines at a time when mules were essential to the Roman economy and military.	[Todd, Evelyn T.; Tonasso-Calviere, Laure; Chauvey, Lorelei; Schiavinato, Stephanie; Fages, Antoine; Seguin-Orlando, Andaine; Clavel, Pierre; Khan, Naveed; Librado, Pablo; Orlando, Ludovic] Univ Paul Sabatier, CAGT, CNRS, UMR 5288, F-31000 Toulouse, France; [Khan, Naveed] Abdul Wali Khan Univ, Dept Biotechnol, Mardan 23200, Pakistan; [Pardal, Lucia Perez; Beja-Pereira, Albano] Univ Porto, InBIO Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Vairao, P-4485661 Vairao, Portugal; [Pardal, Lucia Perez; Beja-Pereira, Albano] Univ Porto, BIOPOLIS Program Genom Biodivers & Land Planning, Campus Vairao, P-4485661 Vairao, Portugal; [Rosa, Laura Patterson] Sul Ross State Univ, Dept Anim Sci, Alpine, TX 79830 USA; [Ringbauer, Harald] Max Planck Inst Evolutionary Anthropol, Dept Archaeogenet, D-04103 Leipzig, Germany; [Verdugo, Marta; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin D02 PN40, Ireland; [Southon, John] Univ Calif Irvine, Earth Syst Sci Dept, Irvine, CA 92697 USA; [Aury, Jean-Marc; Perdereau, Aude; Wincker, Patrick] Univ Paris Saclay, Univ Evry, CEA, Genoscope,Inst Biol Francois Jacob, F-91042 Evry, France; [Vila, Emmanuelle] Univ Lyon 2, Lab Archeorient, F-69007 Lyon, France; [Marzullo, Matilde; Prato, Ornella; Tecchiati, Umberto; Gianni, Giovanna Bagnasco] Univ Milan, Dipartimento Beni Culturali & Ambientali, I-20122 Milan, Italy; [Tagliacozzo, Antonio; Alhaique, Francesca] Museo Civilta, Bioarchaeol Serv, I-00144 Rome, Italy; [Tine, Vincenzo] Soprintendenza Archeol Belle Arti & Paesaggio Pro, I-37121 Verona, Italy; [Cardoso, Joao Luis] Univ Algarve, ICArEHB, Campus Gambelas, P-8005139 Faro, Portugal; [Cardoso, Joao Luis] Univ Aberta, P-1269001 Lisbon, Portugal; [Valente, Maria Joao] Univ Algarve, Ctr Estudos Arqueol Artes & Ciencias Patrimonio, P-8000117 Faro, Portugal; [Antunes, Miguel Telles] Univ Nova Lisboa, Ctr Res Sci & Geol Engn, P-1099085 Lisbon, Portugal; [Frantz, Laurent] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Palaeogen Grp, D-80539 Munich, Germany; [Frantz, Laurent] Queen Mary Univ London, Sch Biol & Behav Sci, London E1 4DQ, England; [Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Boulbes, Nicolas] UPVD, EPCC Ctr Europeen Rech Prehist, Inst Paleontol Humaine, Fdn Albert Ier Paris,UMR 7194,HNHP,MNHN, F-66720 Tautavel, France; [Gardeisen, Armelle] Univ Paul Valery Site St Charles 2, Archeol Soc Mediteraneennes, F-34090 Montpellier, France; [Horwitz, Liora Kolska] Hebrew Univ Jerusalem, Natl Nat Hist Collect, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Oztan, Aliye] Ankara Univ, Dept Archaeol, TR-06100 Ankara, Turkey; [Arbuckle, Benjamin S.] Univ N Carolina, Dept Anthropol, Chapel Hill, NC 27599 USA; [Onar, Vedat] Istanbul Univ Cerrahpasa, Fac Vet Med, Osteoarchaeol Practice & Res Ctr, TR-34320 Istanbul, Turkey; [Onar, Vedat] Istanbul Univ Cerrahpasa, Fac Vet Med, Dept Anat, TR-34320 Istanbul, Turkey; [Clavel, Benoit; Lepetz, Sebastien; Mohaseb, Azadeh; Mashkour, Marjan] Museum Natl Hist, Archeozool Archeobot Soc Prat & Environm, F-75005 Paris, France; [Vahdati, Ali Akbar] Iranian Ctr Cultural Heritage Handicrafts & Touri, Prov Off, Bojnord 9416745775, Iran; [Davoudi, Hossein; Mohaseb, Azadeh; Mashkour, Marjan] Univ Tehran, Archaezool Sect, Bioarchaeol Lab, Cent Lab, Tehran 1417634934, Iran; [Mashkour, Marjan] Natl Museum Iran, Dept Osteol, Tehran 1136918111, Iran; [Bouchez, Olivier; Donnadieu, Cecile] Inst Natl Rech Agr Alimentat & Environm, GeTPlaGe Genome & Transcriptome Plateforme Genom, F-31326 Castanet Tolosan, France; [Brooks, Samantha A.] Univ Florida, UF Genet Inst, Dept Anim Sci, Gainesville, FL 32610 USA; [Beja-Pereira, Albano] Univ Porto, Fac Sci, DGAOT, P-4169007 Porto, Portugal; [Beja-Pereira, Albano] Univ Porto, Sustainable Agrifood Prod Res Ctr GreenUPorto, P-4485646 Vairao, Portugal; [Wu, Dong-Dong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650201, Yunnan, Peoples R China; [Wu, Dong-Dong] Chinese Acad Sci, Kunming Inst Zool, Kunming Nat Hist Museum Zool, Kunming 650223, Yunnan, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Abdul Wali Khan University; Universidade do Porto; Universidade do Porto; Texas State University System; Max Planck Society; Trinity College Dublin; University of California System; University of California Irvine; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite Lyon 2; University of Milan; Universidade do Algarve; Universidade Aberta; Universidade do Algarve; Universidade Nova de Lisboa; University of Munich; University of London; Queen Mary University London; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Hebrew University of Jerusalem; Ankara University; University of North Carolina; University of North Carolina Chapel Hill; Istanbul University - Cerrahpasa; Istanbul University - Cerrahpasa; Museum National d'Histoire Naturelle (MNHN); University of Tehran; INRAE; State University System of Florida; University of Florida; Universidade do Porto; Universidade do Porto; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Orlando, L (corresponding author), Univ Paul Sabatier, CAGT, CNRS, UMR 5288, F-31000 Toulouse, France.	ludovic.orlando@univ-tlse3.fr	Patterson Rosa, Laura/GLU-7082-2022; Beja-Pereira, Albano/B-3681-2008; Khan, Naveed/GVT-1251-2022; Valente, Maria Joao/B-3313-2017	Patterson Rosa, Laura/0000-0001-5960-3883; Beja-Pereira, Albano/0000-0002-1607-7382; Khan, Naveed/0000-0002-6502-9774; Valente, Maria Joao/0000-0002-6137-5995; Cardoso, Joao Luis/0000-0003-2234-2266; Fages, Antoine/0000-0001-6985-4360; Perez Pardal, Lucia/0000-0002-9751-6550; Mohaseb, Azadeh/0000-0003-3130-6603; Todd, Evelyn/0000-0001-5885-754X; Tecchiati, Umberto/0000-0003-3215-0874; Librado, Pablo/0000-0001-5974-2189	European Union [857251]; FCT -Fundacao para a Ciencia e a Tecnologia, I.P.; France Genomique National infrastructure, "Investissement d'avenir" program [ANR-10-INBS-09]; "Grands Projets" funding instrument (BUCEPHALE); CNRS; University Paul Sabatier (AnimalFarm IRP); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [885729-AncestralWeave, 295729-CodeX, 853272-PALAEOFARM, 681605-PEGASUS]	European Union(European Commission); FCT -Fundacao para a Ciencia e a Tecnologia, I.P.(Portuguese Foundation for Science and Technology); France Genomique National infrastructure, "Investissement d'avenir" program(French National Research Agency (ANR)); "Grands Projets" funding instrument (BUCEPHALE); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier (AnimalFarm IRP); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	L.K.H. thanks the director of the Tel es-Safi/Gath excavation, A. Maeir, for facilitating sampling. The DonkeyBank collection of modern donkey DNA samples is supported by the European Union's Horizon 2020 Research and Innovation Programme (grant agreement no. 857251). L.P.P. is funded by national funds from FCT -Fundacao para a Ciencia e a Tecnologia, I.P. Genoscope and GeT-PlaGe sequencing platforms are partly funded by France Genomique National infrastructure, funded as part of "Investissement d'avenir" program managed by Agence Nationale pour la Recherche (contract ANR-10-INBS-09), and their "Grands Projets" funding instrument (BUCEPHALE). This project has received funding from the CNRS, University Paul Sabatier (AnimalFarm IRP), and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreements 885729-AncestralWeave, 295729-CodeX, 853272-PALAEOFARM, and 681605-PEGASUS).	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Amiri S., 2021, ARCH SW AS ADJ AR 13, P199; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Bennett EA, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm0218; Bennett EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174216; Boesneck J., 1990, OMARI NEOLITHIC SETT, P99; Boesneck J., 1989, MAADI 3 NONLITHIC SM, P87; BOESSNECK J., 1984, BAGHDADER MITTEILUNG, V15, P149; Bokonyi S., 1985, STUDI PALETNOLOGIA O, P495; Brewer D. J., 1994, DOMESTIC PLANTS ANIM; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Cardoso JL, 2013, J ARCHAEOL SCI, V40, P4483, DOI 10.1016/j.jas.2013.07.010; Cattani M., 2002, ESSAYS LATE PREHISTO, VXCIII; Cialowicz K. M., 1991, PALETTES EGYPTIENNES; CLUTTONBROCK J, 1992, MAMMAL REV, V22, P79, DOI 10.1111/j.1365-2907.1992.tb00122.x; Fages A, 2019, CELL, V177, P1419, DOI 10.1016/j.cell.2019.03.049; Felkel S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42640-w; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Frantz LAF, 2020, NAT REV GENET, V21, P449, DOI 10.1038/s41576-020-0225-0; Gaunitz C, 2018, SCIENCE, V360, P111, DOI 10.1126/science.aao3297; Haase B, 2015, ANIM GENET, V46, P321, DOI 10.1111/age.12282; Hildebrand EA, 2018, P NATL ACAD SCI USA, V115, P8942, DOI 10.1073/pnas.1721975115; Hui RY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75387-w; Johnstone C., 2008, FEEDING ROMAN ARMY A, P128; Jonsson H, 2014, P NATL ACAD SCI USA, V111, P18655, DOI 10.1073/pnas.1412627111; Kimura B, 2013, AFR ARCHAEOL REV, V30, P83, DOI 10.1007/s10437-012-9126-8; Kimura B, 2011, P ROY SOC B-BIOL SCI, V278, P50, DOI 10.1098/rspb.2010.0708; Knapp B. A, 1992, BIBLIC ARCHAEOL, V55, P52; Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121; Kunst G.K., 2000, ANTHROPOZOOLOGICA, V31, P109; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Legrand R, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0065-5; Lepetz S, 2021, J ARCHAEOL SCI-REP, V40, DOI 10.1016/j.jasrep.2021.103250; Lesur J, 2014, QUATERN INT, V343, P148, DOI 10.1016/j.quaint.2013.11.024; Librado P, 2021, NATURE, V598, P634, DOI 10.1038/s41586-021-04018-9; MacDonald K., 2000, ORIGINS DEV AFRICAN, P8; Marshall F., 2009, TRACKING ETHNOHISTOR, P59; Marshall F, 2007, RETHINKING AGR ARCHE; Marshall FB, 2014, P NATL ACAD SCI USA, V111, P6153, DOI 10.1073/pnas.1312984110; Meadow R. H., 1991, EQUIDS ANCIENT WORLD, V2; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Mitchell Peter, 2018, DONKEY HUMAN HIST AR; Norris SL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247830; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ratnagar S., 2004, TRADING ENCOUNTERS E; Reese DS, 2013, MEDITERR ARCHAEOL AR, V13, P289; Renaud G, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0392; Rosenbom S, 2015, MOL PHYLOGENET EVOL, V85, P88, DOI 10.1016/j.ympev.2015.01.005; Rossel S, 2008, P NATL ACAD SCI USA, V105, P3715, DOI 10.1073/pnas.0709692105; Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748; Vieira FG, 2016, BIOINFORMATICS, V32, P2096, DOI 10.1093/bioinformatics/btw212; Vila Emmanuelle, 2006, P101; Wang CF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19813-7; Wang LY, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.759831; Zarins J., 2014, CORNELL U STUDIES AS, V24, pXI + 432; Zeder M. A., 1986, EQUIDS ANCIENT WORLD, P164; Zeng L, 2021, ZOOL RES, V42, P450, DOI 10.24272/j.issn.2095-8137.2021.095	60	2	2	16	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1172	+		10.1126/science.abo3503	http://dx.doi.org/10.1126/science.abo3503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074859				2022-12-28	WOS:000887933400039
J	Venna, N; Schaefer, PW; Miloslavsky, EM				Venna, Nagagopal; Schaefer, Pamela W.; Miloslavsky, Eli M.			Case 27-2022: A 32-Year-Old Man with Confusion, Headache, and Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BEHCETS-DISEASE; DOUBLE-BLIND; TRIAL		[Venna, Nagagopal] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Miloslavsky, Eli M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Venna, Nagagopal] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Schaefer, Pamela W.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Miloslavsky, Eli M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Venna, N (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Venna, N (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.							Akman-Demir G, 1999, BRAIN, V122, P2171, DOI 10.1093/brain/122.11.2171; Armangue T, 2014, CURR OPIN NEUROL, V27, P361, DOI 10.1097/WCO.0000000000000087; Bertrand A, 2017, MED MALADIES INFECT, V47, P195, DOI 10.1016/j.medmal.2017.01.002; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chang AK, 2011, EMERG MED CLIN N AM, V29, P65, DOI 10.1016/j.emc.2010.08.006; Fromont A, 2009, CYTOKINE, V45, P55, DOI 10.1016/j.cyto.2008.11.002; Gerber S, 1996, NEURORADIOLOGY, V38, P761, DOI 10.1007/s002340050343; Greer DM, 2009, NEW ENGL J MED, V360, P2341, DOI 10.1056/NEJMcpc0810842; Hatemi G, 2019, NEW ENGL J MED, V381, P1918, DOI 10.1056/NEJMoa1816594; Hatemi G, 2018, ANN RHEUM DIS, V77, P808, DOI 10.1136/annrheumdis-2018-213225; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; Kurtuncu M, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0405-6; Melikoglu M, 2005, J RHEUMATOL, V32, P98; Pruitt AA, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01119-w; Sakakibara R, 2009, NEUROL SCI, V30, P405, DOI 10.1007/s10072-009-0109-8; Wallace ZS, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m421; Yurdakul S, 2001, ARTHRITIS RHEUM-US, V44, P2686, DOI 10.1002/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H	17	0	0	3	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					925	933		10.1056/NEJMcpc2201246	http://dx.doi.org/10.1056/NEJMcpc2201246			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069875				2022-12-28	WOS:000861634500014
J	Lamprea-Montealegre, JA; Madden, E; Tummalapalli, SL; Peralta, C; Neilands, TB; Garcia, PK; Muiru, A; Karliner, L; Shlipak, MG; Estrella, MM				Lamprea-Montealegre, Julio A.; Madden, Erin; Tummalapalli, Sri Lekha; Peralta, Carmen; Neilands, Torsten B.; Garcia, Paola K.; Muiru, Anthony; Karliner, Leah; Shlipak, Michael G.; Estrella, Michelle M.			Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTILEVEL LOGISTIC-REGRESSION; RACIAL-DIFFERENCES; CARE; DISPARITIES	IMPORTANCE Novel therapies for type 2 diabetes can reduce the risk of cardiovascular disease and chronic kidney disease progression. The equitability of these agents' prescription across racial and ethnic groups has not been well-evaluated. OBJECTIVE To investigate differences in the prescription of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) among adult patients with type 2 diabetes by racial and ethnic groups. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analysis of data from the US Veterans Health Administration's Corporate Data Warehouse. The sample included adult patients with type 2 diabetes and at least 2 primary care clinic visits from January 1, 2019, to December 31, 2020. EXPOSURES Self-identified race and self-identified ethnicity. MAIN OUTCOMES AND MEASURES The primary outcomes were prevalent SGLT2i or GLP-1 RA prescription, defined as any active prescription during the study period. RESULTS Among 1197 914 patients (mean age, 68 years; 96% men; 1% American Indian or Alaska Native, 2% Asian, Native Hawaiian, or Other Pacific Islander, 20% Black or African American, 71% White, and 7% of Hispanic or Latino ethnicity), 10.7% and 7.7% were prescribed an SGLT2i or a GLP-1 RA, respectively. Prescription rates for SGLT2i and GLP-1RA, respectively, were 11% and 8.4% among American Indian or Alaska Native patients; 11.8% and 8% among Asian, Native Hawaiian, or Other Pacific Islander patients; 8.8% and 6.1% among Black or African American patients; and 11.3% and 8.2% among White patients, respectively. Prescription rates for SGLT2i and GLP-1RA, respectively, were 11% and 7.1% among Hispanic or Latino patients and 10.7% and 7.8% among non-Hispanic or Latino patients. After accounting for patient- and system-level factors, all racial groups had significantly lower odds of SGLT2i and GLP-1RA prescription compared with White patients. Black patients had the lowest odds of prescription compared with White patients (adjusted odds ratio, 0.72 [95% CI, 0.71-0.74] for SGLT2i and 0.64 [95% CI, 0.63-0.66] for GLP-1 RA). Patients of Hispanic or Latino ethnicity had significantly lower odds of prescription (0.90 [95% CI, 0.88-0.93] for SGLT2i and 0.88 [95% CI, 0.85-0.91] for GLP-1 RA) compared with non-Hispanic or Latino patients. CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes in the Veterans Health Administration system during 2019 and 2020, prescription rates of SGLT2i and GLP-1 RA medications were low, and individuals of several different racial groups and those of Hispanic ethnicity had statistically significantly lower odds of receiving prescriptions for these medications compared with individuals of White race and non-Hispanic ethnicity. Further research is needed to understand the mechanisms underlying these differences in rates of prescribing and the potential relationship with differences in clinical outcomes.	[Lamprea-Montealegre, Julio A.; Peralta, Carmen; Neilands, Torsten B.; Muiru, Anthony; Karliner, Leah; Shlipak, Michael G.; Estrella, Michelle M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Lamprea-Montealegre, Julio A.; Madden, Erin; Tummalapalli, Sri Lekha; Peralta, Carmen; Muiru, Anthony; Shlipak, Michael G.; Estrella, Michelle M.] Univ Calif San Francisco, Kidney Hlth Res Collaborat, San Francisco, CA 94121 USA; [Lamprea-Montealegre, Julio A.; Madden, Erin; Peralta, Carmen; Shlipak, Michael G.; Estrella, Michelle M.] San Francisco VA Hlth Care Syst, San Francisco, CA USA; [Tummalapalli, Sri Lekha] Weill Cornell Med, Div Healthcare Delivery Sci & Innovat, Dept Populat Hlth Sci, New York, NY USA; [Peralta, Carmen] Cricket Hlth Inc, San Francisco, CA USA; [Neilands, Torsten B.; Karliner, Leah] Univ Calif San Francisco, San Francisco Ctr Aging Diverse Communities & Mul, San Francisco, CA 94121 USA; [Garcia, Paola K.] Pontificia Univ Javeriana, Dept Med, Div Nephrol, Sch Med, Bogota, Colombia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; University of California System; University of California San Francisco; Pontificia Universidad Javeriana	Lamprea-Montealegre, JA (corresponding author), Univ Calif San Francisco, 4150 Clement St,Bldg 2,Room 145, San Francisco, CA 94121 USA.	julio.lampreamontealegre@ucsf.edu	GARCIA, PAOLA/GXM-8600-2022		NIA/NIH [P30AG0115272]; National Heart, Lung, and Blood Institute [1K99HL157721-01A1]; Veterans Administration's Health Services Research and Development Service [SDR 20-387]; American Heart Association Established Investigator Award; National Kidney Foundation Young Investigator Grant; NIA [K24AG067003]	NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration's Health Services Research and Development Service; American Heart Association Established Investigator Award(American Heart Association); National Kidney Foundation Young Investigator Grant; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the NIA/NIH (award No. P30AG0115272). Dr Lamprea-Montealegre is supported by National Heart, Lung, and Blood Institute (grant 1K99HL157721-01A1). Ms Madden and Drs Shlipak and Estrella were supported by the Veterans Administration's Health Services Research and Development Service (grant SDR 20-387). Dr Peralta was supported by an American Heart Association Established Investigator Award. Dr Tummalapalli is supported by the National Kidney Foundation Young Investigator Grant. Dr Karliner is supported by NIA grant K24AG067003.	Al Rifai M, 2022, AM J CARDIOL, V172, P7, DOI 10.1016/j.amjcard.2022.02.013; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Cai C, 2022, J GEN INTERN MED, V37, P3501, DOI 10.1007/s11606-022-07428-1; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Cheng YLJ, 2019, JAMA-J AM MED ASSOC, V322, P2389, DOI 10.1001/jama.2019.19365; Churchwell K, 2020, CIRCULATION, V142, pE454, DOI 10.1161/CIR.0000000000000936; Citro CF, 2007, USING AM COMMUNITY S; Department of Veterans Affairs, 2021, VA FORM 10 10EZ APPL; Department of Veterans Affairs Veterans Health Administration, VHA DIR 1601A 01 REG; Eberly LA, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.4182; Eberly LA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6139; Essien UR, 2021, JAMA-J AM MED ASSOC, V326, P1793, DOI 10.1001/jama.2021.17764; Essien UR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.14234; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Jha AK, 2001, JAMA-J AM MED ASSOC, V285, P297, DOI 10.1001/jama.285.3.297; Jones C.P., 2002, PHYLON 1960, V50, P7, DOI [https://doi.org/10.2307/4149999, DOI 10.2307/4149999, 10.2307/4149999]; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mahtta D, 2022, DIABETES CARE, V45, P372, DOI 10.2337/dc21-1815; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Tummalapalli SL, 2021, JAMA-HEALTH FORUM, V2, DOI [10.1001/jamahealthforum, DOI 10.1001/JAMAHEALTHFORUM]; US Department of Veterans Affairs, VHA DIS RAT; US Renal Data System, 2021, ANN DAT REP; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Zhuo M, 2022, KIDNEY360, V3, P455, DOI 10.34067/KID.0007862021	31	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					861	871		10.1001/jama.2022.13885	http://dx.doi.org/10.1001/jama.2022.13885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066519				2022-12-28	WOS:000855171700022
J	Raber, L; Koskinas, KC				Raeber, Lorenz; Koskinas, Konstantinos C.			Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Raeber, Lorenz; Koskinas, Konstantinos C.] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Raber, L (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	lorenz.raeber@insel.ch						Aikawa M, 2001, CIRCULATION, V103, P276; Komukai K, 2014, J AM COLL CARDIOL, V64, P2207, DOI 10.1016/j.jacc.2014.08.045; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Raber L, 2022, JAMA-J AM MED ASSOC, V327, P1771, DOI 10.1001/jama.2022.5218; Schubert J, 2021, EUR HEART J, V42; Schuster S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47242-0	6	0	0	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					891	892						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066521				2022-12-28	WOS:000855171700032
J	Watson, K; Paul, M; Yanow, S; Baruch, J				Watson, Katie; Paul, Maureen; Yanow, Susan; Baruch, Jay			Supporting, Not Reporting - Emergency Department Ethics in a Post-Roe Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Watson, Katie] Northwestern Univ, Feinberg Sch Med, Dept Med Educ, Chicago, IL 60611 USA; [Watson, Katie] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Watson, Katie] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Paul, Maureen] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Paul, Maureen] Harvard Med Sch, Boston, MA 02115 USA; [Yanow, Susan] Women Help Women, Amsterdam, Netherlands; [Baruch, Jay] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Brown University	Watson, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Educ, Chicago, IL 60611 USA.; Watson, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA.; Watson, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.							[Anonymous], 2017, Ann Emerg Med, V70, pe17, DOI 10.1016/j.annemergmed.2017.04.029; Harris LH, 2020, NEW ENGL J MED, V382, P1029, DOI 10.1056/NEJMra1908412; Martinez F., 2022, LOS ANGELES TIMES; Upadhyay UD, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1072-0; Zink B., 2006, ANYONE ANYTHING ANYT	5	2	2	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					861	863		10.1056/NEJMp2209312	http://dx.doi.org/10.1056/NEJMp2209312		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36053234				2022-12-28	WOS:000849790600001
J	Omar, MM; El-Awady, JA				Omar, Mostafa M.; El-Awady, Jaafar A.			Foreseeing metal failure from its inception	SCIENCE			English	Editorial Material									[Omar, Mostafa M.; El-Awady, Jaafar A.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Johns Hopkins University	El-Awady, JA (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	jelawady@jhu.edu			Multiscale Structural Mechanics and Prognosis program at the Air Force Office of Scientific Research (AFOSR) [FA9550-21-1-0028]	Multiscale Structural Mechanics and Prognosis program at the Air Force Office of Scientific Research (AFOSR)	We acknowledge the support from the Multiscale Structural Mechanics and Prognosis program at the Air Force Office of Scientific Research (AFOSR), grant FA9550-21-1-0028.	Ho HS, 2017, INT J FATIGUE, V102, P1, DOI 10.1016/j.ijfatigue.2017.04.007; Lavenstein S, 2020, SCIENCE, V370, P190, DOI 10.1126/science.abb2690; Mughrabi H., 1983, FATIGUE MECH ADV QUA, V811, P1; Nicholas T, 2006, HIGH CYCLE FATIGUE M; Sola JF, 2019, INT J FATIGUE, V124, P70, DOI 10.1016/j.ijfatigue.2019.02.027; Stinville JC, 2022, SCIENCE, V377, P1065, DOI 10.1126/science.abn0392	6	0	0	18	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1047	1048		10.1126/science.add8259	http://dx.doi.org/10.1126/science.add8259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048961				2022-12-28	WOS:000887933200034
J	Wagen, CC; McMinn, SE; Kwan, EE; Jacobsen, EN				Wagen, Corin C.; McMinn, Spencer E.; Kwan, Eugene E.; Jacobsen, Eric N.			Screening for generality in asymmetric catalysis	NATURE			English	Article							PICTET-SPENGLER REACTIONS; ENANTIOMERIC EXCESS; KINETIC RESOLUTION; HYDROGENATION; SUPPRESSION	Research in the field of asymmetric catalysis over the past half century has resulted in landmark advances, enabling the efficient synthesis of chiral building blocks, pharmaceuticals and natural products(1-3). A small number of asymmetric catalytic reactions have been identified that display high selectivity across a broad scope of substrates; not coincidentally, these are the reactions that have the greatest impact on how enantioenriched compounds are synthesized(4-8). We postulate that substrate generality in asymmetric catalysis is rare not simply because it is intrinsically difficult to achieve, but also because of the way chiral catalysts are identified and optimized(9). Typical discovery campaigns rely on a single model substrate, and thus select for high performance in a narrow region of chemical space. Here we put forth a practical approach for using multiple model substratesto select simultaneously for both enantioselectivity and generality in asymmetric catalytic reactions from the outset(10,11). Multisubstrate screening is achieved by conducting high-throughput chiral analyses by supercritical fluid chromatography-mass spectrometry with pooled samples. When applied to Pictet-Spengler reactions, the multisubstrate screening approach revealed a promising and unexpected lead for the general enantioselective catalysis of this important transformation, which even displayed high enantioselectivity for substrate combinations outside of the screening set.	[Wagen, Corin C.; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [McMinn, Spencer E.] Merck & Co Inc, Discovery Chem, Boston, MA USA; [Kwan, Eugene E.] Merck & Co Inc, Proc Res & Dev, Boston, MA 02115 USA	Harvard University; Merck & Company; Merck & Company	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Kwan, EE (corresponding author), Merck & Co Inc, Proc Res & Dev, Boston, MA 02115 USA.	eugene.kwan@merck.com; jacobsen@chemistry.harvard.edu		Wagen, Corin/0000-0003-3315-3524	NIH [GM043214]; Harvard University; NSF predoctoral fellowship [DGE1745303]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NSF predoctoral fellowship(National Science Foundation (NSF))	We thank J. Gair, R. Klausen, R. Liu,A. Makarov, L. Nogle and E. Regalado for helpful discussions.This work was supported by a NIH grant GM043214 (E.N.J.), Dean's Competitive Fund, Harvard University(E.N.J.) and NSF predoctoral fellowship DGE1745303 (C.C.W.).	Abato P, 2001, J AM CHEM SOC, V123, P9206, DOI 10.1021/ja016177q; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Barhate CL, 2017, CHEM COMMUN, V53, P509, DOI 10.1039/c6cc08512a; Chan YC, 2021, ANGEW CHEM INT EDIT, V60, P24573, DOI 10.1002/anie.202109694; COX ED, 1995, CHEM REV, V95, P1797, DOI 10.1021/cr00038a004; Feagin TA, 2015, J AM CHEM SOC, V137, P4198, DOI 10.1021/jacs.5b00923; Gao X, 1998, CHIRALITY, V10, P120, DOI 10.1002/chir.19; George R, 2018, THER DRUG MONIT, V40, P1, DOI 10.1097/FTD.0000000000000471; Glinsky-Olivier N, 2019, ORG LETT, V21, P9446, DOI 10.1021/acs.orglett.9b03656; Guo JH, 1999, ANGEW CHEM INT EDIT, V38, P1755, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1755::AID-ANIE1755>3.0.CO;2-Q; Herrera BT, 2018, J AM CHEM SOC, V140, P10385, DOI 10.1021/jacs.8b06607; HIRAO A, 1981, J CHEM SOC CHEM COMM, P315, DOI 10.1039/c39810000315; HORNER L, 1968, ANGEW CHEM INT EDIT, V7, P942, DOI 10.1002/anie.196809422; Huang D, 2012, CHEM-EUR J, V18, P3148, DOI 10.1002/chem.201103207; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; JACOBSEN EN, 1988, J AM CHEM SOC, V110, P1968, DOI 10.1021/ja00214a053; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jang S, 2020, ORG LETT, V22, P7804, DOI 10.1021/acs.orglett.0c02620; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Kim H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08374-z; Klausen RS, 2009, ORG LETT, V11, P887, DOI 10.1021/ol802887h; KNOWLES WS, 1968, CHEM COMMUN, P1445, DOI 10.1039/c19680001445; Kondo M, 2021, ADV SYNTH CATAL, V363, P2648, DOI 10.1002/adsc.202001472; Korch KM, 2022, ACS CATAL, V12, P6737, DOI 10.1021/acscatal.2c01628; Kullmer CNP, 2022, SCIENCE, V376, P532, DOI 10.1126/science.abn1885; Lynch-Colameta T, 2021, CHEM SCI, V12, P6181, DOI 10.1039/d1sc00882j; Mittal N, 2014, ORG LETT, V16, P1012, DOI 10.1021/ol403773a; Muratore ME, 2009, J AM CHEM SOC, V131, P10796, DOI 10.1021/ja9024885; Nakamura S, 2022, ORG LETT, V24, P1072, DOI 10.1021/acs.orglett.1c04316; NOYORI R, 1987, J AM CHEM SOC, V109, P5856, DOI 10.1021/ja00253a051; Payne C, 2020, CHEMISTRYSELECT, V5, P1810, DOI 10.1002/slct.202000166; Qi L, 2018, ORG BIOMOL CHEM, V16, P566, DOI 10.1039/c7ob02606d; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Reetz MT, 1999, ANGEW CHEM INT EDIT, V38, P1758, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1758::AID-ANIE1758>3.0.CO;2-8; Satyanarayana T, 2005, ADV SYNTH CATAL, V347, P737, DOI 10.1002/adsc.200505057; Schmidt-Dannert Claudia, 1999, Trends in Biotechnology, V17, P135, DOI 10.1016/S0167-7799(98)01283-9; Seayad J, 2006, J AM CHEM SOC, V128, P1086, DOI 10.1021/ja057444l; Sewgobind NV, 2008, J ORG CHEM, V73, P6405, DOI 10.1021/jo8010478; Shen J, 2014, J CHROMATOGR A, V1363, P51, DOI 10.1016/j.chroma.2014.06.042; Stockigt J, 2011, ANGEW CHEM INT EDIT, V50, P8538, DOI 10.1002/anie.201008071; Taylor MS, 2004, J AM CHEM SOC, V126, P10558, DOI 10.1021/ja046259p; Tokunaga M, 1997, SCIENCE, V277, P936, DOI 10.1126/science.277.5328.936; Wanner MJ, 2007, ANGEW CHEM INT EDIT, V46, P7485, DOI 10.1002/anie.200701808; You L, 2015, CHEM REV, V115, P7840, DOI 10.1021/cr5005524; Zhao YN, 2003, J CHROMATOGR A, V1003, P157, DOI 10.1016/S0021-9673(03)00725-8	45	1	1	26	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					680	+		10.1038/s41586-022-05263-2	http://dx.doi.org/10.1038/s41586-022-05263-2		SEP 2022	8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36049504				2022-12-28	WOS:000864094000001
J	Chao, GR; Wannier, TM; Gutierrez, C; Borders, NC; Appleton, E; Chadha, A; Lebar, T; Church, GM				Chao, George; Wannier, Timothy M.; Gutierrez, Clair; Borders, Nathaniel C.; Appleton, Evan; Chadha, Anjali; Lebar, Tina; Church, George M.			helixCAM: A platform for programmable cellular assembly in bacteria and human cells	CELL			English	Article							COILED-COILS; IN-VITRO; ADHESION; IMAGE; COLI; CHALLENGES	Interactions between cells are indispensable for signaling and creating structure. The ability to direct precise cell-cell interactions would be powerful for engineering tissues, understanding signaling pathways, and di-recting immune cell targeting. In humans, intercellular interactions are mediated by cell adhesion molecules (CAMs). However, endogenous CAMs are natively expressed by many cells and tend to have cross-reactivity, making them unsuitable for programming specific interactions. Here, we showcase "helixCAM,"a platform for engineering synthetic CAMs by presenting coiled-coil peptides on the cell surface. helixCAMs were able to create specific cell-cell interactions and direct patterned aggregate formation in bacteria and human cells. Based on coiled-coil interaction principles, we built a set of rationally designed helixCAM libraries, which led to the discovery of additional high-performance helixCAM pairs. We applied this helixCAM toolkit for various multicellular engineering applications, such as spherical layering, adherent cell targeting, and surface patterning.	[Chao, George; Wannier, Timothy M.; Borders, Nathaniel C.; Appleton, Evan; Church, George M.] Harvard Med Sch, Genet Dept, Boston, MA 02115 USA; [Gutierrez, Clair] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chadha, Anjali] MIT, Dept Bioengn, Cambridge, MA 02139 USA; [Lebar, Tina; Church, George M.] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Chao, GR; Church, GM (corresponding author), Harvard Med Sch, Genet Dept, Boston, MA 02115 USA.; Church, GM (corresponding author), Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA.	gchao@hms.harvard.edu; gchurch@genetics.med.harvard.edu		Chao, George/0000-0001-7753-0323	DARPA Engineered Living Materials program [RM1HG008525]; NHGRI Centers of Excellence in Genomic Science [DE-FG02-02ER63445]; DoE;  [W911NF-17-2-0079]	DARPA Engineered Living Materials program; NHGRI Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DoE(United States Department of Energy (DOE)); 	We are extremely grateful to Dr. Roman Jerala for sharing the engineered coiled-coil pairs P3/AP4 and P9/AP10. We are grateful to Dr. Bridget Baum-gartner, Dr. Justin Gallivan, Dr. Jesse Dill, and Dr. Joseph Pomerening for helping to fund and shape the direction of our work. Thank you to Dr. Ron Raines at MIT for the use of LC-MS equipment for characterizing the CC-His and CC-GFP-His proteins. We thank Dr. Paula Montero Llopis and Ryan Stephansky from the HMS MicRoN core facility for their assistance in microscopy tech-niques and maintenance of microscopes. We also thank the HMS Immunology Flow Cytometry facility, particularly Chad Araneo, Jeffery Nelson, and Meegan Sleeper for training and maintenance of the FACS machines. Thank you to Songlei Liu for providing the v-bottom ULA plates for HCSRA experiments. We are extremely grateful to Dr. Tiffany Dill and John Aach for their help to edit the manuscript. Thank you to Emma Taddeo for all of her help with the lab's administrative work, and to Nicole DAleo for managing the grants. Plasmid design and map image generation was done in A Plasmid Editor (ApE) . A majority of schematic figures made in this work were created with BioRender. This work was supported in large part by the DARPA Engineered Living Materials program under contract W911NF-17-2-0079. G.C. was also supported by the NHGRI Centers of Excellence in Genomic Science (RM1HG008525) as well as a general gift from the Zhijun Yang Research Fund. T.M.W. was also supported by the DoE under the award DE-FG02-02ER63445.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Ansari AM, 2016, STEM CELL REV REP, V12, P553, DOI 10.1007/s12015-016-9670-8; Bagheri Y, 2019, CHEM SCI, V10, P11030, DOI 10.1039/c9sc04251b; Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Cachat E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20664; Campbell LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051270; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421; Chen EP, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.664188; Chen HJ, 2019, MATERIALS, V12, DOI 10.3390/ma12244099; Chen ZB, 2019, NATURE, V565, P106, DOI 10.1038/s41586-018-0802-y; Chesnut JD, 1996, J IMMUNOL METHODS, V193, P17, DOI 10.1016/0022-1759(96)00032-4; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Fink T, 2019, NAT CHEM BIOL, V15, P115, DOI 10.1038/s41589-018-0181-6; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Friedl P, 2004, TRENDS CELL BIOL, V14, P557, DOI 10.1016/j.tcb.2004.09.005; Frommel U, 2013, APPL ENVIRON MICROB, V79, P5814, DOI 10.1128/AEM.01384-13; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glass DS, 2018, CELL, V174, P649, DOI 10.1016/j.cell.2018.06.041; Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257; Gromiha MM, 2004, BIOPHYS CHEM, V111, P95, DOI 10.1016/j.bpc.2004.05.001; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo SQ, 2020, ACS SYNTH BIOL, V9, P475, DOI 10.1021/acssynbio.9b00404; Heller E, 2015, J CELL BIOL, V211, P219, DOI 10.1083/jcb.201506106; Hicks MR, 1997, FOLD DES, V2, P149, DOI 10.1016/S1359-0278(97)00021-7; Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kintaka R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31774; Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113; Kuo D, 2014, METHODS MOL BIOL, V1177, P71, DOI 10.1007/978-1-4939-1034-2_6; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lebar T, 2020, NAT CHEM BIOL, V16, P513, DOI 10.1038/s41589-019-0443-y; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Moroni L, 2018, NAT REV MATER, V3, P21, DOI 10.1038/s41578-018-0006-y; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Obana M, 2017, J AM CHEM SOC, V139, P14251, DOI 10.1021/jacs.7b07798; Ozbolat IT, 2013, IEEE T BIO-MED ENG, V60, P691, DOI 10.1109/TBME.2013.2243912; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pinero-Lambea C, 2015, ACS SYNTH BIOL, V4, P463, DOI 10.1021/sb500252a; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Romei MG, 2019, ANNU REV BIOPHYS, V48, P19, DOI 10.1146/annurev-biophys-051013-022846; Roohani-Esfahani SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19468; Roybal KT, 2017, ANNU REV IMMUNOL, V35, P229, DOI 10.1146/annurev-immunol-051116-052302; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Salema V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075126; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Song HHG, 2018, CELL STEM CELL, V22, P340, DOI 10.1016/j.stem.2018.02.009; Stevens KR, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5505; Stirling DR, 2021, BIOINFORMATICS, V37, P3992, DOI 10.1093/bioinformatics/btab634; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Todhunter ME, 2015, NAT METHODS, V12, P975, DOI [10.1038/NMETH.3553, 10.1038/nmeth.3553]; Truebestein L, 2016, BIOESSAYS, V38, P903, DOI 10.1002/bies.201600062; Trunk T, 2018, AIMS MICROBIOL, V4, P140, DOI 10.3934/microbiol.2018.1.140; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Veiga E, 2003, J BACTERIOL, V185, P5585, DOI 10.1128/JB.185.18.5585-5590.2003; Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132; Yu Y, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024575; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	73	0	0	20	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3551	+		10.1016/j.cell.2022.08.012	http://dx.doi.org/10.1016/j.cell.2022.08.012			57	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4V7YX	36055250	Green Submitted			2022-12-28	WOS:000859690800003
J	Li, Q; Cheng, B; Chen, MY; Xie, B; Xie, YQ; Wang, PF; Chen, FQ; Liu, ZL; Watanabe, K; Taniguchi, T; Liang, SJ; Wang, D; Wang, CJ; Wang, QH; Liu, JP; Miao, F				Li, Qiao; Cheng, Bin; Chen, Moyu; Xie, Bo; Xie, Yongqin; Wang, Pengfei; Chen, Fanqiang; Liu, Zenglin; Watanabe, Kenji; Taniguchi, Takashi; Liang, Shi-Jun; Wang, Da; Wang, Chenjie; Wang, Qiang-Hua; Liu, Jianpeng; Miao, Feng			Tunable quantum criticalities in an isospin extended Hubbard model simulator	NATURE			English	Article							CORRELATED STATES; MOIRE; INSULATOR; MOTT; SUPERCONDUCTIVITY; COLLOQUIUM; TRANSITION; BEHAVIOR	Studying strong electron correlations has been an essential driving force for pushing the frontiers of condensed matter physics. In particular, in the vicinity of correlation-driven quantum phase transitions (QPTs), quantum critical fluctuations of multiple degrees of freedom facilitate exotic many-body states and quantum critical behaviours beyond Landau's framework(1). Recently, moire heterostructures of van der Waals materials have been demonstrated as highly tunable quantum platforms for exploring fascinating, strongly correlated quantum physics(2-22). Here we report the observation of tunable quantum criticalities in an experimental simulator of the extended Hubbard model with spin-valley isospins arising in chiral-stacked twisted double bilayer graphene (cTDBG). Scaling analysis shows a quantum two-stage criticality manifesting two distinct quantum critical points as the generalized Wigner crystal transits to a Fermi liquid by varying the displacement field, suggesting the emergence of a critical intermediate phase. The quantum two-stage criticality evolves into a quantum pseudo criticality as a high parallel magnetic field is applied. In such a pseudo criticality, we find that the quantum critical scaling is only valid above a critical temperature, indicating a weak first-order QPT therein. Our results demonstrate a highly tunable solid-state simulator with intricate interplay of multiple degrees of freedom for exploring exotic quantum critical states and behaviours.	[Li, Qiao; Chen, Moyu; Xie, Yongqin; Wang, Pengfei; Chen, Fanqiang; Liu, Zenglin; Liang, Shi-Jun; Wang, Da; Wang, Qiang-Hua; Miao, Feng] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Inst Brain Inspired Intelligence, Sch Phys,Natl Lab Solid State Microstruct, Nanjing, Peoples R China; [Cheng, Bin] Nanjing Univ Sci & Technol, Sch Sci, Inst Interdisciplinary PhysicalSci, Nanjing, Peoples R China; [Xie, Bo; Liu, Jianpeng] ShanghaiTech Univ, ShanghaiTech Lab TopoL Phys, Sch Phys Sci & Technol, Shanghai, Peoples R China; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, Tsukuba, Ibaraki, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan; [Wang, Chenjie] Univ Hong Kong, Dept Phys & HKU UCAS Joint Inst Theoret & Computa, Hong Kong, Peoples R China	Nanjing University; Nanjing University of Science & Technology; ShanghaiTech University; National Institute for Materials Science; National Institute for Materials Science; University of Hong Kong	Miao, F (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Inst Brain Inspired Intelligence, Sch Phys,Natl Lab Solid State Microstruct, Nanjing, Peoples R China.; Cheng, B (corresponding author), Nanjing Univ Sci & Technol, Sch Sci, Inst Interdisciplinary PhysicalSci, Nanjing, Peoples R China.	bincheng@njust.edu.cn; miao@nju.edu.cn	Watanabe, Kenji/H-2825-2011	Watanabe, Kenji/0000-0003-3701-8119; Cheng, Bin/0000-0002-2932-4370; Xie, Bo/0000-0002-4765-7160; Wang, Pengfei/0000-0002-8827-0309	National Natural Science Foundation of China [62034004, 62122036, 61921005, 12074176, 61974176, 11874205]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB44000000]; National Key R&D program of China [2020YFA0309601]; ShanghaiTech University; Research Grant Council of Hong Kong [CRF C7012-21GF]; JSPS KAKENHI [19H05790, 20H00354, 21H05233]; A3 Foresight by JSPS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D program of China; ShanghaiTech University; Research Grant Council of Hong Kong(Hong Kong Research Grants Council); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); A3 Foresight by JSPS	This work was supported in part by the National Natural Science Foundation of China (62034004, 62122036, 61921005, 12074176, 61974176 and 11874205) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB44000000). J.L. was supported by National Key R&D program of China (grant no. 2020YFA0309601) and the start-up grant of ShanghaiTech University. C.W. was supported by the Research Grant Council of Hong Kong (CRF C7012-21GF). K.W. and T.T. acknowledge support from JSPS KAKENHI (grant numbers 19H05790, 20H00354 and 21H05233) and A3 Foresight by JSPS. Q.L. would like to thank M. Wang for valuable discussions.	Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Brussarski P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06332-9; Burg GW, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.197702; Cao Y, 2020, NATURE, V583, P215, DOI 10.1038/s41586-020-2260-6; Cao Y, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.076801; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2022, NANO LETT, V22, P238, DOI 10.1021/acs.nanolett.1c03699; Chen GR, 2020, NATURE, V579, P56, DOI 10.1038/s41586-020-2049-7; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; Continentino MA, 2007, J MAGN MAGN MATER, V310, P828, DOI 10.1016/j.jmmm.2006.10.765; Drummond ND, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126402; Ghiotto A, 2021, NATURE, V597, P345, DOI 10.1038/s41586-021-03815-6; GIULIANI GF, 1982, PHYS REV B, V26, P4421, DOI 10.1103/PhysRevB.26.4421; Hao ZY, 2021, SCIENCE, V371, P1133, DOI 10.1126/science.abg0399; Hatke AT, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aao2848; Huang X, 2021, NAT PHYS, V17, P715, DOI 10.1038/s41567-021-01171-w; HUBBARD J, 1978, PHYS REV B, V17, P494, DOI 10.1103/PhysRevB.17.494; Jaoui A, 2022, NAT PHYS, V18, P633, DOI 10.1038/s41567-022-01556-5; Kennes DM, 2021, NAT PHYS, V17, P155, DOI 10.1038/s41567-020-01154-3; Li HY, 2021, NATURE, V597, P650, DOI 10.1038/s41586-021-03874-9; Li TX, 2021, NATURE, V597, P350, DOI 10.1038/s41586-021-03853-0; Liu JP, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031021; Liu JP, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.155415; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Ma RC, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.020407; Moon P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205404; Musser S., PREPRINT; Nahum A, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041048; Padhi B, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.125146; Park JM, 2021, NATURE, V590, DOI 10.1038/s41586-021-03192-0; Paschen S, 2021, NAT REV PHYS, V3, P9, DOI 10.1038/s42254-020-00262-6; Polshyn H, 2022, NAT PHYS, V18, P42, DOI 10.1038/s41567-021-01418-6; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Shen C, 2020, NAT PHYS, V16, P520, DOI 10.1038/s41567-020-0825-9; Spivak B, 2010, REV MOD PHYS, V82, P1743, DOI 10.1103/RevModPhys.82.1743; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Varma CM, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.031001; Wang C, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031051; Wang L, 2020, NAT MATER, V19, P861, DOI 10.1038/s41563-020-0708-6; Xie YL, 2021, NATURE, V600, P439, DOI 10.1038/s41586-021-04002-3; Xu SG, 2021, NAT PHYS, V17, P619, DOI 10.1038/s41567-021-01172-9; Xu Y, 2020, NATURE, V587, P214, DOI 10.1038/s41586-020-2868-6; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zarenia M, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.115438	52	3	3	31	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927								10.1038/s41586-022-05106-0	http://dx.doi.org/10.1038/s41586-022-05106-0			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O5MH	36104555	hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000854741300001
J	Li, GG; Zhou, FH				Li, Guanggang; Zhou, Feihu			Early vs Standard Approach to Tracheostomy and Functional Outcome Among Patients With Severe Stroke Receiving Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Li, Guanggang] Peoples Liberat Army Gen Hosp, Seventh Med Ctr, Dept Crit Care Med, 5 Nanmencang St, Beijing 100700, Peoples R China; [Zhou, Feihu] Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Crit Care Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Li, GG (corresponding author), Peoples Liberat Army Gen Hosp, Seventh Med Ctr, Dept Crit Care Med, 5 Nanmencang St, Beijing 100700, Peoples R China.	leegangr@foxmail.com						Bosel J, 2022, JAMA-J AM MED ASSOC, V327, P1899, DOI 10.1001/jama.2022.4798; Schonenberger S, 2016, NEUROCRIT CARE, V25, P94, DOI 10.1007/s12028-015-0235-5	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10												3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098730				2022-12-28	WOS:000855222400027
J	Hannibal, ME				Hannibal, Mary Ellen			The Fishermen and the Dragon: Fear, Greed, and a Fight for Justice on the Gulf Coast	SCIENCE			English	Book Review												maryellenhannibal@gmail.com						JOHNSON KW, 2022, FISHERMEN DRAGON FEA	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1162	1162		10.1126/science.ade0604	http://dx.doi.org/10.1126/science.ade0604			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074857				2022-12-28	WOS:000887933400035
J	Arostegui, MC; Gaube, P; Woodworth-Jefcoats, PA; Kobayashi, DR; Braun, CD				Arostegui, Martin C.; Gaube, Peter; Woodworth-Jefcoats, Phoebe A.; Kobayashi, Donald R.; Braun, Camrin D.			Anticyclonic eddies aggregate pelagic predators in a subtropical gyre	NATURE			English	Article							NORTH PACIFIC; MESOSCALE EDDIES; FISHES; DEPTH; MODEL; DYNAMICS; ECOLOGY; CATCH; TUNA; TIME	Ocean eddies are coherent, rotating features that can modulate pelagic ecosystems across many trophic levels. These mesoscale features, which are ubiquitous at mid-latitudes(1), may increase productivity of nutrient-poor regions(2,3), accumulate prey(4) and modulate habitat conditions in the water column(5). However, in nutrient-poor subtropical gyres-the largest marine biome-the role of eddies in modulating behaviour throughout the pelagic predator community remains unknown despite predictions for these gyres to expand(6) and pelagic predators to become increasingly important for food security(7). Using a large-scale fishery dataset in the North Pacific Subtropical Gyre, we show a pervasive pattern of increased pelagic predator catch inside anticyclonic eddies relative to cyclones and non-eddy areas. Our results indicate that increased mesopelagic prey abundance in anticyclone cores(4,8) may be attracting diverse predators, forming ecological hotspots where these predators aggregate and exhibit increased abundance. In this energetically quiescent gyre, we expect that isolated mesoscale features (and the habitat conditions in them) exhibit primacy over peripheral submesoscale dynamics in structuring the foraging opportunities of pelagic predators. Our finding that eddies influence coupling of epi- to mesopelagic communities corroborates the growing evidence that deep scattering layer organisms are vital prey for a suite of commercially important predator species(9) and, thus, provide valuable ecosystem services.	[Arostegui, Martin C.; Gaube, Peter] Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98195 USA; [Arostegui, Martin C.; Braun, Camrin D.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Woodworth-Jefcoats, Phoebe A.; Kobayashi, Donald R.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI USA; [Braun, Camrin D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Arostegui, MC (corresponding author), Univ Washington, Appl Phys Lab, Air Sea Interact & Remote Sensing Dept, Seattle, WA 98195 USA.; Arostegui, MC (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	martin.arostegui@whoi.edu		Kobayashi, Donald/0000-0002-1582-1544; Woodworth-Jefcoats, Phoebe/0000-0001-9353-923X	NASA New Investigator Program [80NSSSC20K1132]; NOAA [NA15OAR4320063]; Postdoctoral Scholar Program at Woods Hole Oceanographic Institution; Dr. George D. Grice Postdoctoral Scholarship Fund; NASA Earth Science Research Program [80NSSC19K0187]; Woods Hole Oceanographic Institution; Investment in Science Program	NASA New Investigator Program(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Postdoctoral Scholar Program at Woods Hole Oceanographic Institution; Dr. George D. Grice Postdoctoral Scholarship Fund; NASA Earth Science Research Program(National Aeronautics & Space Administration (NASA)); Woods Hole Oceanographic Institution; Investment in Science Program	We thank L. Gallagher (Fishpics (R) and IMAR-DOP, University of the Azores) for producing fish artwork used in main text Figs. 1-3 and Extended Data Figs. 1-13 and 15, and K. Reading and M. LeDoux (UW APL) for producing main text Fig. 3. J. Brodziak (NOAA PIFSC) and R. Rykaczewski (NOAA PIFSC) reviewed a version of this manuscript before submission. M.C.A., C.D.B. and P.G. were supported by the NASA New Investigator Program grant no. 80NSSSC20K1132. M.C.A. and P.G. were also supported by NOAA project no. NA15OAR4320063. M.C.A. was also supported by the Postdoctoral Scholar Program at Woods Hole Oceanographic Institution with funding provided by the Dr. George D. Grice Postdoctoral Scholarship Fund, and C.D.B. was also supported by the NASA Earth Science Research Program no. 80NSSC19K0187 and The Investment in Science Program with funds from Woods Hole Oceanographic Institution.	Arostegui MC, 2019, FISH RES, V215, P21, DOI 10.1016/j.fishres.2019.03.005; Behrenfeld MJ, 2019, NATURE, V576, P257, DOI 10.1038/s41586-019-1796-9; Bell JD, 2015, MAR POLICY, V51, P584, DOI 10.1016/j.marpol.2014.10.005; BERNSTEIN RL, 1974, J PHYS OCEANOGR, V4, P613, DOI 10.1175/1520-0485(1974)004<0613:TALSOB>2.0.CO;2; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; BOGGS CH, 1992, FISH B-NOAA, V90, P642; Braun CD, 2022, ANNU REV MAR SCI, V14, P129, DOI 10.1146/annurev-marine-032521-103517; Braun CD, 2019, P NATL ACAD SCI USA, V116, P17187, DOI 10.1073/pnas.1903067116; Brodziak J, 2013, CAN J FISH AQUAT SCI, V70, P1723, DOI 10.1139/cjfas-2013-0111; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Chaigneau A, 2008, PROG OCEANOGR, V79, P106, DOI 10.1016/j.pocean.2008.10.013; Chambault P, 2019, PROG OCEANOGR, V175, P345, DOI 10.1016/j.pocean.2019.05.005; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chen YLL, 2015, DEEP-SEA RES PT I, V106, P68, DOI 10.1016/j.dsr.2015.10.006; Chow CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51989-x; Della Penna A, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00454; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; Duffy LM, 2017, DEEP-SEA RES PT II, V140, P55, DOI 10.1016/j.dsr2.2017.03.003; Dufois F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600282; Fennell S, 2015, DEEP-SEA RES PT I, V105, P132, DOI 10.1016/j.dsr.2015.09.002; Gaube P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25565-8; Gaube P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172839; Gaube P, 2014, J GEOPHYS RES-OCEANS, V119, P8195, DOI 10.1002/2014JC010111; Gilman E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235129; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Guidi L, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001984; Guo MX, 2019, GEOPHYS RES LETT, V46, P13217, DOI 10.1029/2019GL085278; Harke MJ, 2021, ENVIRON MICROBIOL, V23, P4807, DOI 10.1111/1462-2920.15677; Hartig F., 2019, DHARMA RESIDUAL DIAG; Hawco NJ, 2021, GLOBAL BIOGEOCHEM CY, V35, DOI 10.1029/2021GB007112; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Jackson CH, 2011, J STAT SOFTW, V38, P1; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; Klein P, 2019, EARTH SPACE SCI, V6, P795, DOI 10.1029/2018EA000492; Klevjer TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19873; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; Lenth R. V, 2022, EMMEANS ESTIMATED MA; Levy M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052756; Lima ID, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000jc000393; Liu Y, 2012, DEEP-SEA RES PT I, V68, P54, DOI 10.1016/j.dsr.2012.06.001; Lynham J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14588-3; Madigan DJ, 2021, ICES J MAR SCI, V78, P867, DOI 10.1093/icesjms/fsaa222; Martin A, 2020, NATURE, V580, P26, DOI 10.1038/d41586-020-00915-7; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; McGillicuddy DJ, 2016, ANNU REV MAR SCI, V8, P125, DOI 10.1146/annurev-marine-010814-015606; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Polovina JJ, 2009, FISH B-NOAA, V107, P523; Portner EJ, 2017, DEEP-SEA RES PT I, V125, P40, DOI 10.1016/j.dsr.2017.04.013; R Development Core Team, 2009, R LANG ENV STAT COMP; ROYER TC, 1978, SCIENCE, V199, P1063, DOI 10.1126/science.199.4333.1063-a; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Siegelman L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42117-w; Spall SA, 2000, DEEP-SEA RES PT I, V47, P1261, DOI 10.1016/S0967-0637(99)00081-3; St John MA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00031; Varghese SP, 2014, HYDROBIOLOGIA, V736, P99, DOI 10.1007/s10750-014-1895-4; Waga H, 2019, GEOPHYS RES LETT, V46, P13191, DOI 10.1029/2019GL085150; Walsh WA., 2016, APPL HAWAII LONGLINE, V57, P62; Walsh WA, 2015, FISH RES, V166, P151, DOI 10.1016/j.fishres.2014.07.015; Ward P, 2005, CAN J FISH AQUAT SCI, V62, P1130, DOI 10.1139/F05-021; Woodworth PA, 2012, MAR MAMMAL SCI, V28, P638, DOI 10.1111/j.1748-7692.2011.00509.x; Woodworth-Jefcoats PA, 2018, FISH B-NOAA, V116, P228, DOI 10.7755/FB.116.3.2	63	1	1	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					535	+		10.1038/s41586-022-05162-6	http://dx.doi.org/10.1038/s41586-022-05162-6		SEP 2022	35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36071164				2022-12-28	WOS:000852585300004
J	Maloney, TR; Dilkes-Hall, IE; Vlok, M; Oktaviana, AA; Setiawan, P; Priyatno, AAD; Ririmasse, M; Geria, IM; Effendy, MAR; Istiawan, B; Atmoko, FT; Adhityatama, S; Moffat, I; Joannes-Boyau, R; Brumm, A; Aubert, M				Maloney, Tim Ryan; Dilkes-Hall, India Ella; Vlok, Melandri; Oktaviana, Adhi Agus; Setiawan, Pindi; Priyatno, Andika Arief Drajat; Ririmasse, Marlon; Geria, I. Made; Effendy, Muslimin A. R.; Istiawan, Budi; Atmoko, Falentinus Triwijaya; Adhityatama, Shinatria; Moffat, Ian; Joannes-Boyau, Renaud; Brumm, Adam; Aubert, Maxime			Surgical amputation of a limb 31,000 years ago in Borneo	NATURE			English	Article							TOOTH; PROGRAM; BURIAL; CARE	The prevailing view regarding the evolution of medicine is that the emergence of settled agricultural societies around 10,000 years ago (the Neolithic Revolution) gave rise to a host of health problems that had previously been unknown among non-sedentary foraging populations, stimulating the first major innovations in prehistoric medical practices(1,2). Such changes included the development of more advanced surgical procedures, with the oldest known indication of an 'operation' formerly thought to have consisted of the skeletal remains of a European Neolithic farmer (found in Buthiers-Boulancourt, France) whose left forearm had been surgically removed and then partially healed(3). Dating to around 7,000 years ago, this accepted case of amputation would have required comprehensive knowledge of human anatomy and considerable technical skill, and has thus been viewed as the earliest evidence of a complex medical act(3). Here, however, we report the discovery of skeletal remains of a young individual from Borneo who had the distal third of their left lower leg surgically amputated, probably as a child, at least 31,000 years ago. The individual survived the procedure and lived for another 6-9 years, before their remains were intentionally buried in Liang Tebo cave, which is located in East Kalimantan, Indonesian Borneo, in a limestone karst area that contains some of the world's earliest dated rock art(4). This unexpectedly early evidence of a successful limb amputation suggests that at least some modern human foraging groups in tropical Asia had developed sophisticated medical knowledge and skills long before the Neolithic farming transition.	[Maloney, Tim Ryan; Aubert, Maxime] Griffith Univ, Griffith Ctr Social & Cultural Res, Gold Coast, Qld, Australia; [Maloney, Tim Ryan; Brumm, Adam; Aubert, Maxime] Griffith Univ, Australian Res Ctr Human Evolut, Nathan, Qld, Australia; [Dilkes-Hall, India Ella] Univ Western Australia, Sch Social Sci, Archaeol, Crawley, WA, Australia; [Vlok, Melandri] Univ Sydney, Sydney South East Asian Ctr, Sydney, NSW, Australia; [Oktaviana, Adhi Agus] BRIN, OR Arkeol Bahasa & Sastra, Pusat Riset Arkeometri, Jakarta, Indonesia; [Oktaviana, Adhi Agus; Adhityatama, Shinatria] Griffith Univ, Sch Humanities Languages & Social Sci, Gold Coast, Qld, Australia; [Setiawan, Pindi] Bandung Inst Technol, Fac Art & Design, Bandung, Indonesia; [Priyatno, Andika Arief Drajat; Effendy, Muslimin A. R.; Istiawan, Budi; Atmoko, Falentinus Triwijaya] Balai Perestarian Cagar Budaya Kalimantan Timur, Samarinda, Indonesia; [Ririmasse, Marlon; Geria, I. Made] BRIN, OR Arkeol Bahasa & Sastra, Pusat Riset Lingkungan Maritim & Budaya Berkelanj, Jakarta, Indonesia; [Moffat, Ian] Flinders Univ S Australia, Archaeol, Coll Humanities Arts & Social Sci, Bedford Pk, SA, Australia; [Joannes-Boyau, Renaud; Aubert, Maxime] Southern Cross Univ, Geoarchaeol & Archaeometry Res Grp GARG, Lismore, NSW, Australia; [Joannes-Boyau, Renaud] Univ Johannesburg, Palaeores Inst, Johannesburg, South Africa	Griffith University; Griffith University; University of Western Australia; University of Sydney; Griffith University; Institute Technology of Bandung; Flinders University South Australia; Southern Cross University; University of Johannesburg	Maloney, TR; Aubert, M (corresponding author), Griffith Univ, Griffith Ctr Social & Cultural Res, Gold Coast, Qld, Australia.; Maloney, TR; Brumm, A; Aubert, M (corresponding author), Griffith Univ, Australian Res Ctr Human Evolut, Nathan, Qld, Australia.; Dilkes-Hall, IE (corresponding author), Univ Western Australia, Sch Social Sci, Archaeol, Crawley, WA, Australia.; Vlok, M (corresponding author), Univ Sydney, Sydney South East Asian Ctr, Sydney, NSW, Australia.; Oktaviana, AA (corresponding author), BRIN, OR Arkeol Bahasa & Sastra, Pusat Riset Arkeometri, Jakarta, Indonesia.; Oktaviana, AA (corresponding author), Griffith Univ, Sch Humanities Languages & Social Sci, Gold Coast, Qld, Australia.; Setiawan, P (corresponding author), Bandung Inst Technol, Fac Art & Design, Bandung, Indonesia.; Priyatno, AAD (corresponding author), Balai Perestarian Cagar Budaya Kalimantan Timur, Samarinda, Indonesia.; Ririmasse, M (corresponding author), BRIN, OR Arkeol Bahasa & Sastra, Pusat Riset Lingkungan Maritim & Budaya Berkelanj, Jakarta, Indonesia.; Moffat, I (corresponding author), Flinders Univ S Australia, Archaeol, Coll Humanities Arts & Social Sci, Bedford Pk, SA, Australia.; Joannes-Boyau, R; Aubert, M (corresponding author), Southern Cross Univ, Geoarchaeol & Archaeometry Res Grp GARG, Lismore, NSW, Australia.; Joannes-Boyau, R (corresponding author), Univ Johannesburg, Palaeores Inst, Johannesburg, South Africa.	t.maroney@griffith.edu.au; India.dirkes-hall@uwa.edu.au; Merandri.vrok@sydney.edu.au; adhi.oktaviana@griffith.edu.au; pindisp@yahoo.com; andikaarief.priyatno@gmail.com; marl.010@brin.go.id; Ian.moffat@frinders.edu.au; Renaud.joannes-boyau@scu.edu.au; A.brumm@griffith.edu.au; M.aubert@griffith.edu.au	; Oktaviana, Adhi Agus/L-5630-2016	Maloney, Tim/0000-0002-1167-4743; Oktaviana, Adhi Agus/0000-0002-9140-497X; Vlok, Melandri/0000-0002-5259-3819; Dilkes-Hall, India Ella/0000-0002-6487-0043	Forrest Research Foundation; Australian Research Council [LE200100022, FT170100025]; Griffith University; Southern Cross University	Forrest Research Foundation; Australian Research Council(Australian Research Council); Griffith University(Griffith University); Southern Cross University	The director of the National Centre for Archaeology (ARKENAS; BRIN, OR Arkeologi) in Jakarta, Indonesia, and the director of the Balai Pelestarian Cagar Budaya Kalimantan Timur authorized the fieldwork. We acknowledge the Indonesian State Ministry of Research and Technology for facilitating the research; the field assistants, including S. Gung, U. Reski, P. Lampung, M. Mardhan, A. Gatz, A. Putra, Hendrick, Satriadi, Heldi, Johansyah, Y. Gung, Sugianoor, Su'ud, Rendi, Hendra, H. Ifan, Rusdi, Ali, Leo, Aping, Djoang and Syahdan; K. Westaway for assistance with the Bayesian model; and the Queensland X-Ray team at Southport for assistance. I.E.D.-H. is a Forrest Foundation Prospect Fellow supported by the Forrest Research Foundation. This research was supported by a fellowship from the Australian Research Council to M.A. (FT170100025) as well as additional financial support from Griffith University. This research was conducted using instruments supported by the Australian Research Council to R.J.-B. and colleagues (LE200100022) as well as additional financial support from Southern Cross University.	ACKERKNECHT E H, 1947, Bull Hist Med, V21, P135; Aubert M, 2018, NATURE, V564, P254, DOI 10.1038/s41586-018-0679-9; Aydin K, 2007, TURK NEUROSURG, V17, P155; Az-Zahra F. R., 2021, Biodiversitas: Journal of Biological Diversity, V22, P4633, DOI 10.13057/biodiv/d221057; Barber CG, 1929, ANN SURG, V90, P985, DOI 10.1097/00000658-192912000-00005; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brumm A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257273; Buckley, 2016, BRIT ARCHAEOLOGICAL, V2792; Buikstra Jane E., 1994, STANDARDS DATA COLLE, V44; Buquet-Marcon C., 2007, NAT PREC, DOI [10.1038/npre.2007.1278.1, DOI 10.1038/NPRE.2007.1278.1]; Burns KR, 2007, FORENSIC ANTHR TRAIN; Curnoe D, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00075; Donnally CJ, 2018, ORTHOP TRAUMATOL-SUR, V104, P267, DOI 10.1016/j.otsr.2018.01.004; Gargett RH, 1999, J HUM EVOL, V37, P27, DOI 10.1006/jhev.1999.0301; Gibbons, 2021, MED PLANTS BORNEO; Grun R, 2008, GEOCHIM COSMOCHIM AC, V72, P5278, DOI 10.1016/j.gca.2008.08.007; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; Jantz LM, 1999, AM J PHYS ANTHROPOL, V110, P57, DOI 10.1002/(SICI)1096-8644(199909)110:1<57::AID-AJPA5>3.0.CO;2-1; Joannes-Boyau R, 2018, QUAT GEOCHRONOL, V44, P13, DOI 10.1016/j.quageo.2017.11.003; Joannes-Boyau R, 2013, GEOCHRONOMETRIA, V40, P322, DOI 10.2478/s13386-013-0132-7; Joannes-Boyau R, 2011, QUAT GEOCHRONOL, V6, P82, DOI 10.1016/j.quageo.2010.09.001; Juengst SL, 2015, INT J PALEOPATHOL, V9, P20, DOI 10.1016/j.ijpp.2014.11.005; Littleton, 2008, FORENSIC APPROACHES, P155; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Martinon-Torres M, 2021, NATURE, V593, P95, DOI 10.1038/s41586-021-03457-8; Mavroforou A, 2014, CLIN ORTHOP RELAT R, V472, P3102, DOI 10.1007/s11999-014-3480-6; McKinley Jacqueline., 2004, GUIDELINES STANDARDS, P14; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Munsell AH., 1992, MUNSELL SOIL COLOR C; O'Connell JF, 2018, P NATL ACAD SCI USA, V115, P8482, DOI 10.1073/pnas.1808385115; Ortner D.J, 2003, IDENTIFICATION PATHO; Oxenham M., 2016, ROUTLEDGE HDB BIOARC; Oxenham MF, 2009, ANTHROPOL SCI, V117, P107, DOI 10.1537/ase.081114; Pennoyer, 1930, JAMA-J AM MED ASSOC, V95, P342, DOI [10.1001/jama.1930.27210050001009, DOI 10.1001/JAMA.1930.27210050001009]; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 2000, AM J PHYS ANTHROPOL, V113, P135; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Richards MP, 2002, EUR J CLIN NUTR, V56, DOI 10.1038/sj.ejcn.1601646; Roberts C. A., 2002, ARCHAEOLOGY MED, V1046, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Carro SCS, 2021, QUATERN INT, V603, P125, DOI 10.1016/j.quaint.2020.10.004; Schaefer Maureen, 2009, JUVENILE OSTEOLOGY L; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Sherk V, 2008, J BONE MINER RES, V23, P1449, DOI 10.1359/JBMR.080402; Sievanen H, 2010, ARCH BIOCHEM BIOPHYS, V503, P146, DOI 10.1016/j.abb.2010.07.008; Spikins P, 2019, QUATERNARY SCI REV, V217, P98, DOI 10.1016/j.quascirev.2018.08.011; Tilley L, 2011, INT J PALEOPATHOL, V1, P35, DOI 10.1016/j.ijpp.2011.02.003; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; Wamisho BL, 2009, MALAWI MED J, V21, P29; Wen APY, 2020, ARCH PLAST SURG-APS, V47, P182, DOI 10.5999/aps.2018.00514; Wendeberg B., 1961, ACTA ORTHOP SCAN S52, V32, P3, DOI 10.3109/ort.1961.32.suppl-52.01; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; Wurster CM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42670-4; Zhou YW, 2020, ARCHAEOL ANTHROP SCI, V12, DOI 10.1007/s12520-020-01151-w	56	2	2	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927								10.1038/s41586-022-05160-8	http://dx.doi.org/10.1038/s41586-022-05160-8		SEP 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O5MH	36071168	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000852585300014
J	Kalkavan, H; Chen, MJ; Crawford, JC; Quarato, G; Fitzgerald, P; Tait, SWG; Goding, CR; Green, DR				Kalkavan, Halime; Chen, Mark J.; Crawford, Jeremy C.; Quarato, Giovanni; Fitzgerald, Patrick; Tait, Stephen W. G.; Goding, Colin R.; Green, Douglas R.			Sublethal cytochrome c release generates drug-tolerant persister cells	CELL			English	Article							CANCER-CELLS; EIF2-ALPHA KINASE; HEME-BINDING; MOUSE MODELS; APOPTOSIS; ACTIVATION; RESISTANCE; INDUCTION; BCL-2; DEATH	Drug-tolerant persister cells (persisters) evade apoptosis upon targeted and conventional cancer therapies and represent a major non-genetic barrier to effective cancer treatment. Here, we show that cells that survive treatment with pro-apoptotic BH3 mimetics display a persister phenotype that includes colonization and metastasis in vivo and increased sensitivity toward ferroptosis by GPX4 inhibition. We found that sublethal mitochondrial outer membrane permeabilization (MOMP) and holocytochrome c release are key require-ments for the generation of the persister phenotype. The generation of persisters is independent of apoptosome formation and caspase activation, but instead, cytosolic cytochrome c induces the activation of heme-regulated inhibitor (HRI) kinase and engagement of the integrated stress response (ISR) with the consequent synthesis of ATF4, all of which are required for the persister phenotype. Our results reveal that sublethal cytochrome c release couples sublethal MOMP to caspase-independent initiation of an ATF4-dependent, drug-tolerant persister phenotype.	[Kalkavan, Halime; Chen, Mark J.; Crawford, Jeremy C.; Quarato, Giovanni; Fitzgerald, Patrick; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tait, Stephen W. G.] Canc Res UK Beatson Inst, Switchback Rd, Bearsden G61 1BD, Glasgow, Scotland; [Tait, Stephen W. G.] Univ Glasgow, Inst Canc Sci, Switchback Rd, Glasgow City, Scotland; [Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Clin Med, Oxford OX37DQ, England	St Jude Children's Research Hospital; Beatson Institute; University of Glasgow; Ludwig Institute for Cancer Research; University of Oxford	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Crawford, Jeremy Chase/G-5711-2013; Kalkavan, Halime/N-4989-2018; Chen, Mark/O-3937-2014	Crawford, Jeremy Chase/0000-0003-4096-6048; Kalkavan, Halime/0000-0002-0090-4080; Chen, Mark/0000-0003-1169-563X	SJCRH [NCI P30 CA021765, NCI R50 CA211481]; ALSAC (SJCRH); US National Cancer Institute [R35 CA231620]; German Research Foundation (DFG) [KA 4830/1-1]	SJCRH; ALSAC (SJCRH); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Richard Cross and Greig Lennon (SJCRH) for technical assistance and Aseem Ansari, Paul Thomas, Cliff Guy, Gustavo Palacios, Shelbi Christgen, Diego Rodriguez, Joelle Magne, Emilio Boada Romero (SJCRH), Jane-Jane Chen (MIT), and Cristina Munoz Pinedo (Idibell, Barce-lona) for thoughtful insights and discussions. We also thank the Hartwell Cen-ter for RNA sequencing and the Center for In Vivo Imaging and Therapeutics (supported by SJCRH, NCI R50 CA211481, and NCI P30 CA021765) for pre -clinical imaging (SJCRH). This work was supported by ALSAC (SJCRH), the US National Cancer Institute grant R35 CA231620 to D.R.G., and the German Research Foundation (DFG, KA 4830/1-1) to H.K. Original Piggybac vectors were provided by Kazuhiro Murakami (RIKEN, Kobe, Japan). As indicated, some of the results published here are based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berthenet K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107731; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Bialk P, 2018, MOL THER-ONCOLYTICS, V11, P75, DOI 10.1016/j.omto.2018.10.002; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brasacchio D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0470-8; Broad Institute, 2019, PIC TOOLK; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Condon KJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022120118; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Feng DR, 2018, J CLIN INVEST, V128, P3941, DOI 10.1172/JCI99217; Fessler E, 2020, NATURE, V579, P433, DOI 10.1038/s41586-020-2076-4; Fox DB, 2020, NAT METAB, V2, P318, DOI 10.1038/s42255-020-0191-z; Garcia-Jimenez C, 2019, CELL METAB, V29, P254, DOI 10.1016/j.cmet.2018.11.018; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Guan JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.546; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2021, COMPUT STRUCT BIOTEC, V19, P4101, DOI 10.1016/j.csbj.2021.07.014; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heimer S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1790-z; Hetz C, 2019, NAT CHEM BIOL, V15, P764, DOI 10.1038/s41589-019-0326-2; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Inguaggiato P, 2001, KIDNEY INT, V60, P2181, DOI 10.1046/j.1523-1755.2001.00046.x; Isobe T, 2013, J THORAC ONCOL, V8, P140, DOI 10.1097/JTO.0b013e3182725ff9; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Kalkavan H, 2018, CELL DEATH DIFFER, V25, P46, DOI 10.1038/cdd.2017.179; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Krueger F., 2021, TRIMGALORE; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lartigue L, 2009, MOL BIOL CELL, V20, P4871, DOI 10.1091/mbc.E09-07-0649; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lopez J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10538; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Maynard A, 2020, CELL, V182, P1232, DOI 10.1016/j.cell.2020.07.017; McStay Gavin P, 2014, Cold Spring Harb Protoc, V2014, P778, DOI 10.1101/pdb.prot080275; Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16; Merino D, 2018, CANCER CELL, V34, P879, DOI 10.1016/j.ccell.2018.11.004; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Miles MA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.454; Nagy A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84787-5; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Oberst A, 2016, CELL DEATH BIOL DIS, P213, DOI 10.1007/978-1-4939-3612-0_11; Okimoto RA, 2017, NAT GENET, V49, P87, DOI 10.1038/ng.3728; Oren Y, 2021, NATURE, V596, P576, DOI 10.1038/s41586-021-03796-6; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Popgeorgiev N, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00013; Rabouw HH, 2019, P NATL ACAD SCI USA, V116, P2097, DOI 10.1073/pnas.1815767116; Rafie-Kolpin M, 2003, BIOCHEMISTRY-US, V42, P6536, DOI 10.1021/bi034005v; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rehman SK, 2021, CELL, V184, P226, DOI 10.1016/j.cell.2020.11.018; Reme T, 2013, BIOINFORMATICS, V29, P1149, DOI 10.1093/bioinformatics/btt124; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen SS, 2020, CELL, V183, P860, DOI 10.1016/j.cell.2020.10.027; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tang DL, 2021, CELL RES, V31, P107, DOI 10.1038/s41422-020-00441-1; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Tian XB, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.747837; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Ubellacker JM, 2020, NATURE, V585, P113, DOI 10.1038/s41586-020-2623-z; Van den Berge K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14766-3; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Walter DM, 2017, CANCER RES, V77, P1719, DOI 10.1158/0008-5472.CAN-16-2159; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang CK, 2017, FREE RADICAL BIO MED, V113, P439, DOI 10.1016/j.freeradbiomed.2017.10.345; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; YANG JM, 1992, J BIOL CHEM, V267, P20519; Yang T, 2016, ANAL BIOANAL CHEM, V408, P7491, DOI 10.1007/s00216-016-9847-7; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang SP, 2019, ELIFE, V8, DOI 10.7554/eLife.46976; 2014, bioRxiv, DOI 10.1101/002832	105	5	5	40	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3356	+		10.1016/j.cell.2022.07.025	http://dx.doi.org/10.1016/j.cell.2022.07.025			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4U6ML	36055199				2022-12-28	WOS:000858905600003
J	Motter, AE				Motter, Adilson E.			The Biggest Ideas in the Universe	SCIENCE			English	Book Review									[Motter, Adilson E.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Northwestern University	Motter, AE (corresponding author), Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA.	motter@northwestern.edu						[Anonymous], US; Carroll S.M., 2019, SPACETIME GEOMETRY I; Strogatz S., 2019, INFINITE POWERS CALC, DOI [10.1126/science.add6308, DOI 10.1126/SCIENCE.ADD6308]	3	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1270	1270		10.1126/science.add6308	http://dx.doi.org/10.1126/science.add6308			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108010				2022-12-28	WOS:000887933500026
J	Mukherji, A				Mukherji, Aditi			The "water machine" of Bengal	SCIENCE			English	Editorial Material									[Mukherji, Aditi] Int Water Management Inst, New Delhi Off, New Delhi, India	CGIAR; International Water Management Institute (IWMI)	Mukherji, A (corresponding author), Int Water Management Inst, New Delhi Off, New Delhi, India.	a.mukherji@cgiar.org			SwissAgency for Development and Cooperation; TransformingAgri-Food Systems in South Asia, and Mitigate+: Research for Low-Emission Food Systems	SwissAgency for Development and Cooperation; TransformingAgri-Food Systems in South Asia, and Mitigate+: Research for Low-Emission Food Systems	The authoracknowledges the SwissAgency for Development and Cooperationfor their support of the project Solar Irrigation for Agricultural Resilience organizedby theInternational Water ManagementInstitute. Also acknowledged are support received fromTransformingAgri-Food Systems in South Asia, and Mitigate+: Research for Low-Emission Food Systems.	AHMED AU, 1992, AM J AGR ECON, V74, P144, DOI 10.2307/1242998; Asoka A, 2018, GEOPHYS RES LETT, V45, P5536, DOI 10.1029/2018GL078466; Bell AR, 2015, LAND USE POLICY, V48, P1, DOI 10.1016/j.landusepol.2015.05.019; Hossain M, 2009, 00917 INT FOOD POL R; Islam M. S, 2021, AUSTRAL J ASIAN LAW, V21, P47; Mitra A., 2021, SOLAR IRRIGATION BAN, DOI [10.5337/2021.216, DOI 10.5337/2021.216]; Mukherji A., 2021, ROLE GROUNDWATER AGR; REVELLE R, 1975, SCIENCE, V188, P611, DOI 10.1126/science.188.4188.611; Ritchie H., 2020, CO2 GREENHOUSE GAS E; Salim R, 2006, APPL ECON, V38, P2567, DOI 10.1080/00036840500427585; Shamsudduha M, 2022, SCIENCE, V377, P1315, DOI 10.1126/science.abm4730; Taylor RG, 2013, NAT CLIM CHANGE, V3, P374, DOI [10.1038/NCLIMATE1731, 10.1038/nclimate1731]	12	0	0	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1258	1259		10.1126/science.ade0393	http://dx.doi.org/10.1126/science.ade0393			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108015				2022-12-28	WOS:000887933500020
J	Xu, WX; Wu, LJ; Liu, SH; Liu, X; Cao, XL; Zhou, C; Zhang, JY; Fu, Y; Guo, Y; Wu, YR; Tan, QW; Wang, L; Liu, JL; Jiang, LQ; Fan, ZB; Pei, Y; Yu, JY; Cheng, JJ; Zhao, SW; Hao, XJ; Liu, ZJ; Hua, T				Xu, Weixiu; Wu, Lijie; Liu, Shenhui; Liu, Xiao; Cao, Xiaoling; Zhou, Cui; Zhang, Jinyi; Fu, You; Guo, Yu; Wu, Yiran; Tan, Qiwen; Wang, Ling; Liu, Junlin; Jiang, Longquan; Fan, Zhongbo; Pei, Yuan; Yu, Jingyi; Cheng, Jianjun; Zhao, Suwen; Hao, Xiaojiang; Liu, Zhi-Jie; Hua, Tian			Structural basis for strychnine activation of human bitter taste receptor TAS2R46	SCIENCE			English	Article							SWEET TASTE; MAMMALIAN SWEET; CELLS; FAMILY; RECOGNITION; GUSTDUCIN; BINDING; GENE	Taste sensing is a sophisticated chemosensory process, and bitter taste perception is mediated by type 2 taste receptors (TAS2Rs), or class T G protein-coupled receptors. Understanding the detailed molecular mechanisms behind taste sensation is hindered by a lack of experimental receptor structures. Here, we report the cryo-electron microscopy structures of human TAS2R46 complexed with chimeric mini-G protein gustducin, in both strychnine-bound and apo forms. Several features of TAS2R46 are disclosed, including distinct receptor structures that compare with known GPCRs, a new "toggle switch," activation-related motifs, and precoupling with mini-G protein gustducin. Furthermore, the dynamic extracellular and more-static intracellular parts of TAS2R46 suggest possible diverse ligand-recognition and activation processes. This study provides a basis for further exploration of other bitter taste receptors and their therapeutic applications.	[Xu, Weixiu; Wu, Lijie; Liu, Shenhui; Liu, Xiao; Cao, Xiaoling; Zhou, Cui; Zhang, Jinyi; Fu, You; Guo, Yu; Wu, Yiran; Tan, Qiwen; Wang, Ling; Liu, Junlin; Jiang, Longquan; Fan, Zhongbo; Pei, Yuan; Cheng, Jianjun; Zhao, Suwen; Liu, Zhi-Jie; Hua, Tian] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Xu, Weixiu; Liu, Shenhui; Liu, Xiao; Cao, Xiaoling; Zhou, Cui; Zhang, Jinyi; Fu, You; Jiang, Longquan; Fan, Zhongbo; Cheng, Jianjun; Zhao, Suwen; Liu, Zhi-Jie; Hua, Tian] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Yu, Jingyi] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai 201210, Peoples R China; [Hao, Xiaojiang] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resource West Chi, Kunming 650210, Peoples R China	ShanghaiTech University; ShanghaiTech University; ShanghaiTech University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Liu, ZJ; Hua, T (corresponding author), ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China.; Liu, ZJ; Hua, T (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	liuzhj@shanghaitech.edu.cn; huatian@shanghaitech.edu.cn		Zhang, Jinyi/0000-0002-0120-7455	CAS Strategic Priority Research Program [XDB37030104]; National Science Fund for Distinguished Young Scholars [32022038]; National Natural Science Foundation of China [31930060, 31870744]; National Key Research and Development Program of China [2018YFA0507000]; Shanghai Rising-Star Program [20QA1406500]	CAS Strategic Priority Research Program; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Shanghai Rising-Star Program	This work was supported by the CAS Strategic Priority Research Program XDB37030104 (Z.-J.L.), the National Science Fund for Distinguished Young Scholars 32022038 (T.H.), the National Natural Science Foundation of China grants 31930060 (Z.-J.L.) and 31870744 (T.H.), the National Key Research and Development Program of China grant 2018YFA0507000 (T.H.), and the Shanghai Rising-Star Program 20QA1406500 (T.H.).	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Behrens M, 2018, J AGR FOOD CHEM, V66, P2204, DOI 10.1021/acs.jafc.6b04835; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Caivo SSC, 2015, NAT REV ENDOCRINOL, V11, P213, DOI 10.1038/nrendo.2015.7; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Dagan-Wiener A, 2019, NUCLEIC ACIDS RES, V47, pD1179, DOI 10.1093/nar/gky974; Dagan-Wiener A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12359-7; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Duan J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17933-8; Fierro F, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00063; Guo RX, 2018, AM J CHINESE MED, V46, P1, DOI [10.1142/S0192415X18500015, 10.1142/s0192415x18500015]; Hua T, 2020, CELL, V180, P655, DOI 10.1016/j.cell.2020.01.008; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Jang W, 2020, P NATL ACAD SCI USA, V117, P30755, DOI 10.1073/pnas.2010801117; Kooistra AJ, 2021, NUCLEIC ACIDS RES, V49, pD335, DOI 10.1093/nar/gkaa1080; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liu KW, 2020, NATURE, V585, P135, DOI 10.1038/s41586-020-2492-5; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ping YQ, 2021, NATURE, V589, P620, DOI 10.1038/s41586-020-03083-w; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Sandal M, 2015, J CHEM THEORY COMPUT, V11, P4439, DOI 10.1021/acs.jctc.5b00472; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Topin J, 2021, CELL MOL LIFE SCI, V78, P7605, DOI 10.1007/s00018-021-03968-7; Tu YH, 2018, SCIENCE, V359, P1047, DOI 10.1126/science.aao3264; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	50	0	0	61	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1298	1303		10.1126/science.abo1633	http://dx.doi.org/10.1126/science.abo1633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108005				2022-12-28	WOS:000887933500036
J	Belkin, MN; Cifu, AS; Pinney, S				Belkin, Mark N.; Cifu, Adam S.; Pinney, Sean			Management of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								GUIDELINE TITLE 2022 American College of Cardiology (ACC)/American Heart Association AHA)/Heart Failure Society of America (HFSA) Guidelines for the Management of Heart Failure RELEASE DATE April 1, 2022 PRIOR VERSIONS 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure and 2013 ACCF/AHA Guideline for the Management of Heart Failure DEVELOPER AND FUNDING SOURCE ACC/AHA Joint Committee on Clinical Practice Guidelines TARGET POPULATION Adult patients with a diagnosis of or at risk for heart failure (HF) MAJOR RECOMMENDATIONS Classifications forHF are separated into 4 categories based on ejection fraction (EF) and disease history: HF with reduced EF (EF <= 40%), HF with mildly reduced EF (EF 41%-49%), HF with preserved EF (EF >= 50%), and HF with improved EF (EF previously <= 40% with improvement to >40%). In patients with chronic HF with reduced EF, angiotensin receptor-neprilysin inhibitors (ARNIs) are preferred over angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). If ARNI use is not feasible, ACEIs are preferred over ARBs, unless there is significant cough or angioedema (class 1, level of evidence [LOE] A). Sodium-glucose cotransporter 2 (SGLT2) inhibitors should be included across all HF categories (symptomatic HF with reduced EF [class 1, LOE A]; HF with mildly reduced EF and HF with preserved EF [class 2a, LOE B-R]). Patients with HF with improved EF should continue to receive medical therapy originally indicated for HF with reduced EF (class 1, LOE B-R). Evidence-based treatment of HF with preserved EF includes blood pressure control (class 1, LOE C-LD), SGLT2 inhibitors (class 2a, LOE B-R), mineralocorticoid antagonists, ARBs, and ARNIs (class 2b, LOE B-R).	[Belkin, Mark N.; Cifu, Adam S.; Pinney, Sean] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038; Bhagat AA, 2019, JACC-HEART FAIL, V7, P1, DOI 10.1016/j.jchf.2018.06.011; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; Heidenreich PA, 2022, J AM COLL CARDIOL, V79, pE253, DOI 10.1016/j.jacc.2021.12.012; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190; Rao VSN, 2021, J AM COLL CARDIOL, V78, P2004, DOI 10.1016/j.jacc.2021.08.064; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Zannad F, 2020, LANCET, V396, P819, DOI 10.1016/S0140-6736(20)31824-9	10	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2022	328	13					1346	1347		10.1001/jama.2022.16667	http://dx.doi.org/10.1001/jama.2022.16667		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5F6GU	36107415				2022-12-28	WOS:000854267800001
J	Fine-Edelstein, J				Fine-Edelstein, Judy			A Place Where I Belong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fine-Edelstein, Judy] Cambridge Hlth Alliance, Neurol, Lexington, MA USA	Harvard University; Cambridge Health Alliance	Fine-Edelstein, J (corresponding author), Cambridge Hlth Alliance, Neurol, 1493 Cambridge St, Cambridge, MA 02139 USA.	judyfine.edelstein@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					927	928		10.1001/jama.2022.15166	http://dx.doi.org/10.1001/jama.2022.15166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098722				2022-12-28	WOS:000855222400014
J	Hernandez, LE; Jadoo, A; Kirsner, RS				Hernandez, Loren E.; Jadoo, Arvin; Kirsner, Robert S.			Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat	LANCET			English	Editorial Material									[Hernandez, Loren E.; Jadoo, Arvin; Kirsner, Robert S.] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA	University of Miami	Hernandez, LE (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	loren.hernandez@med.miami.edu							0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355							e8					1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088950	Bronze, Green Published			2022-12-28	WOS:000877580600001
J	Teske, J				Teske, Johanna			Three types of planets orbit red dwarfs	SCIENCE			English	Editorial Material									[Teske, Johanna] Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Teske, J (corresponding author), Carnegie Inst Sci, Earth & Planets Lab, Washington, DC 20015 USA.	jteske@carnegiescience.edu						Alexander CMO, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2015.0384; Burn R, 2021, ASTRON ASTROPHYS, V656, DOI 10.1051/0004-6361/202140390; Cloutier R, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab8237; Luque R, 2022, SCIENCE, V377, P1211, DOI 10.1126/science.abl7164; Neil AR, 2022, ASTROPHYS J, V933, DOI 10.3847/1538-4357/ac609b; Nimmo F, 2016, J GEOPHYS RES-PLANET, V121, P1378, DOI 10.1002/2016JE005081; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Sabotta S, 2021, ASTRON ASTROPHYS, V653, DOI 10.1051/0004-6361/202140968; Schlecker M, 2021, ASTRON ASTROPHYS, V656, DOI 10.1051/0004-6361/202038554; Shields AL, 2016, PHYS REP, V663, P1, DOI 10.1016/j.physrep.2016.10.003; Tian F, 2015, NAT GEOSCI, V8, P177, DOI 10.1038/NGEO2372; Van Eylen V, 2021, MON NOT R ASTRON SOC, V507, P2154, DOI 10.1093/mnras/stab2143	15	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1156	1157		10.1126/science.add7175	http://dx.doi.org/10.1126/science.add7175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074836				2022-12-28	WOS:000887933400032
J	Bae, YJ; Wang, J; Scheie, A; Xu, JW; Chica, DG; Diederich, GM; Cenker, J; Ziebel, ME; Bai, YS; Ren, HW; Dean, CR; Delor, M; Xu, XD; Roy, X; Kent, AD; Zhu, XY				Bae, Youn Jue; Wang, Jue; Scheie, Allen; Xu, Junwen; Chica, Daniel G.; Diederich, Geoffrey M.; Cenker, John; Ziebel, Michael E.; Bai, Yusong; Ren, Haowen; Dean, Cory R.; Delor, Milan; Xu, Xiaodong; Roy, Xavier; Kent, Andrew D.; Zhu, Xiaoyang			Exciton-coupled coherent magnons in a 2D semiconductor	NATURE			English	Article							FERROMAGNETISM	The recent discoveries of two-dimensional (2D) magnets(1-6) and their stacking into van der Waals structures(7-11) have expanded the horizon of 2D phenomena. One exciting application is to exploit coherent magnons(12) as energy-efficient information carriers in spintronics and magnonics(13,14) or as interconnects in hybrid quantum systems(15-17). A particular opportunity arises when a 2D magnet is also a semiconductor, as reported recently for CrSBr (refs.(18-20)) and NiPS3 (refs.(21-23)) that feature both tightly bound excitons with a large oscillator strength and potentially long-lived coherent magnons owing to the bandgap and spatial confinement. Although magnons and excitons are energetically mismatched by orders of magnitude, their coupling can lead to efficient optical access to spin information. Here we report strong magnon-exciton coupling in the 2D A-type antiferromagnetic semiconductor CrSBr. Coherent magnons launched by above-gap excitation modulate the exciton energies. Time-resolved exciton sensing reveals magnons that can coherently travel beyond seven micrometres, with a coherence time of above five nanoseconds. We observe these exciton-coupled coherent magnons in both even and odd numbers of layers, with and without compensated magnetization, down to the bilayer limit. Given the versatility of van der Waals heterostructures, these coherent 2D magnons may be a basis for optically accessible spintronics, magnonics and quantum interconnects.	[Bae, Youn Jue; Wang, Jue; Chica, Daniel G.; Ziebel, Michael E.; Bai, Yusong; Delor, Milan; Roy, Xavier; Zhu, Xiaoyang] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Scheie, Allen] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN USA; [Xu, Junwen; Ren, Haowen; Kent, Andrew D.] NYU, Dept Phys, 4 Washington Pl, New York, NY 10003 USA; [Diederich, Geoffrey M.; Cenker, John; Xu, Xiaodong] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Diederich, Geoffrey M.] Univ Washington, Intelligence Community Postdoctoral Res Fellowshi, Seattle, WA 98195 USA; [Dean, Cory R.] Columbia Univ, Dept Phys & Astron, New York, NY USA	Columbia University; United States Department of Energy (DOE); Oak Ridge National Laboratory; New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University	Zhu, XY (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	xyzhu@columbia.edu		Scheie, Allen/0000-0002-7450-5138	Materials Science and Engineering Research Center (MRSEC) through NSF [DMR-2011738]; Vannevar Bush Faculty Fellowship through the Office of Naval Research [N00014-18-1-2080]; US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0019443]; Air Force Office of Scientific Research [FA9550-19-1-0307]; Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division [DE-SC0012509]; NSF [DMR-1751949]; Intelligence Community Postdoctoral Research Fellowship Program at University of Washington	Materials Science and Engineering Research Center (MRSEC) through NSF; Vannevar Bush Faculty Fellowship through the Office of Naval Research(Office of Naval Research); US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Intelligence Community Postdoctoral Research Fellowship Program at University of Washington	The spectroscopic and imaging work was supported by the Materials Science and Engineering Research Center (MRSEC) through NSF grant DMR-2011738, with partial support for experimental apparatus by the Vannevar Bush Faculty Fellowship through the Office of Naval Research grant number N00014-18-1-2080. The synthesis of the CrSBr crystals was supported as part of Programmable Quantum Materials, an Energy Frontier Research Center funded by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award DE-SC0019443. The magnetic resonance spectroscopy work was supported by the Air Force Office of Scientific Research under grant FA9550-19-1-0307. The magnetic-field-dependent experiment in Fig. 2c was supported by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division (DE-SC0012509). The vibrating sample magnetometry was purchased with financial support from the NSF through a supplement to award DMR-1751949. This research used resources at the Spallation Neutron Source, a DOE Office of Science User Facility operated by the Oak Ridge National Laboratory. This research was supported by an appointment to the Intelligence Community Postdoctoral Research Fellowship Program at University of Washington administered by Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the US Department of Energy and the Office of the Director of National Intelligence (ODNI). We are grateful to K. Lee, T. Handa and Y. Dai for providing help and discussions.	Awschalom David D., 2021, IEEE Transactions on Quantum Engineering, V2, DOI 10.1109/TQE.2021.3057799; Chumak AV, 2015, NAT PHYS, V11, P453, DOI [10.1038/nphys3347, 10.1038/NPHYS3347]; Gibertini M, 2019, NAT NANOTECHNOL, V14, P408, DOI 10.1038/s41565-019-0438-6; Gong C, 2019, SCIENCE, V363, P706, DOI 10.1126/science.aav4450; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Holstein T, 1940, PHYS REV, V58, P1098, DOI 10.1103/PhysRev.58.1098; Huang B, 2020, NAT MATER, V19, P1276, DOI 10.1038/s41563-020-0791-8; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Hwangbo K, 2021, NAT NANOTECHNOL, V16, P655, DOI 10.1038/s41565-021-00873-9; Kang S, 2020, NATURE, V583, P785, DOI 10.1038/s41586-020-2520-5; Kruglyak VV, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/26/264001; Kumar ATN, 2001, J CHEM PHYS, V114, P701, DOI 10.1063/1.1329640; Lachance-Quirion D, 2020, SCIENCE, V367, P425, DOI 10.1126/science.aaz9236; Lachance-Quirion D, 2019, APPL PHYS EXPRESS, V12, DOI 10.7567/1882-0786/ab248d; Lee JU, 2016, NANO LETT, V16, P7433, DOI 10.1021/acs.nanolett.6b03052; Lee K, 2021, NANO LETT, V21, P3511, DOI 10.1021/acs.nanolett.1c00219; Li Y, 2020, J APPL PHYS, V128, DOI 10.1063/5.0020277; Luer L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127401; MacNeill D, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.047204; Mak KF, 2019, NAT REV PHYS, V1, P646, DOI 10.1038/s42254-019-0110-y; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Nemec P, 2018, NAT PHYS, V14, P229, DOI 10.1038/s41567-018-0051-x; Ogawa N, 2015, P NATL ACAD SCI USA, V112, P8977, DOI 10.1073/pnas.1504064112; Scheie A., ADV SCI, DOI [10.1002/advs.202202467(2022), DOI 10.1002/ADVS.202202467(2022)]; Shen K, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aabd68; Shen K, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.197201; Shen X, 2021, J MAGN MAGN MATER, V528, DOI 10.1016/j.jmmm.2021.167772; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Tabuchi Y, 2015, SCIENCE, V349, P405, DOI 10.1126/science.aaa3693; Tang CL, 2020, ADV MATER, V32, DOI 10.1002/adma.201908498; Telford EJ, 2020, ADV MATER, V32, DOI 10.1002/adma.202003240; Tong QJ, 2018, NANO LETT, V18, P7194, DOI 10.1021/acs.nanolett.8b03315; Toth S, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/16/166002; Wang C, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.247201; Wang XZ, 2021, NAT MATER, V20, P964, DOI 10.1038/s41563-021-00968-7; Wilson NP, 2021, NAT MATER, V20, P1657, DOI 10.1038/s41563-021-01070-8; Zhang XX, 2020, NAT MATER, V19, P838, DOI 10.1038/s41563-020-0713-9; Zhong D, 2020, NAT NANOTECHNOL, V15, P187, DOI 10.1038/s41565-019-0629-1	39	1	1	59	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					282	+		10.1038/s41586-022-05024-1	http://dx.doi.org/10.1038/s41586-022-05024-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071189	Green Submitted			2022-12-28	WOS:000852469200023
J	Friml, J; Gallei, M; Gelova, Z; Johnson, A; Mazur, E; Monzer, A; Rodriguez, L; Roosjen, M; Verstraeten, I; Zivanovic, BD; Zou, MX; Fiedler, L; Giannini, C; Grones, P; Hrtyan, M; Kaufmann, WA; Kuhn, A; Narasimhan, M; Randuch, M; Rydza, N; Takahashi, K; Tan, ST; Teplova, A; Kinoshita, T; Weijers, D; Rakusova, H				Friml, Jiri; Gallei, Michelle; Gelova, Zuzana; Johnson, Alexander; Mazur, Ewa; Monzer, Aline; Rodriguez, Lesia; Roosjen, Mark; Verstraeten, Inge; Zivanovic, Branka D.; Zou, Minxia; Fiedler, Lukas; Giannini, Caterina; Grones, Peter; Hrtyan, Monika; Kaufmann, Walter A.; Kuhn, Andre; Narasimhan, Madhumitha; Randuch, Marek; Rydza, Nikola; Takahashi, Koji; Tan, Shutang; Teplova, Anastasia; Kinoshita, Toshinori; Weijers, Dolf; Rakusova, Hana			ABP1-TMK auxin perception for global phosphorylation and auxin canalization	NATURE			English	Article							BINDING PROTEIN-1; ARABIDOPSIS; TRANSPORT; GRADIENTS; COMPLEX; MODULE; GROWTH	The phytohormone auxin triggers transcriptional reprogramming through a well-characterized perception machinery in the nucleus. By contrast, mechanisms that underlie fast effects of auxin, such as the regulation of ion fluxes, rapid phosphorylation of proteins or auxin feedback on its transport, remain unclear(1-3). Whether auxin-binding protein 1 (ABP1) is an auxin receptor has been a source of debate for decades(1,4). Here we show that a fraction of Arabidopsis thaliana ABP1 is secreted and binds auxin specifically at an acidic pH that is typical of the apoplast. ABP1 and its plasma-membrane-localized partner, transmembrane kinase 1 (TMK1), are required for the auxin-induced ultrafast global phospho-response and for downstream processes that include the activation of H+-ATPase and accelerated cytoplasmic streaming. abp1 and tmk mutants cannot establish auxin-transporting channels and show defective auxin-induced vasculature formation and regeneration. An ABP1(M2X) variant that lacks the capacity to bind auxin is unable to complement these defects in abp1 mutants. These data indicate that ABP1 is the auxin receptor for TMK1-based cell-surface signalling, which mediates the global phospho-response and auxin canalization.	[Friml, Jiri; Gallei, Michelle; Gelova, Zuzana; Johnson, Alexander; Monzer, Aline; Rodriguez, Lesia; Verstraeten, Inge; Zou, Minxia; Fiedler, Lukas; Giannini, Caterina; Hrtyan, Monika; Kaufmann, Walter A.; Narasimhan, Madhumitha; Randuch, Marek; Tan, Shutang; Teplova, Anastasia] Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria; [Mazur, Ewa] Univ Silesia Katowice, Fac Nat Sci, Inst Biol Biotechnol & Environm Protect, Katowice, Poland; [Roosjen, Mark; Kuhn, Andre; Weijers, Dolf] Wageningen Univ, Lab Biochem, Wageningen, Netherlands; [Zivanovic, Branka D.] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Grones, Peter; Rakusova, Hana] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Grones, Peter; Rakusova, Hana] Univ Ghent, VIB Ctr Plant Syst Biol, Ghent, Belgium; [Rydza, Nikola] Masaryk Univ, Mendel Ctr Plant Genom & Prote, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Takahashi, Koji; Kinoshita, Toshinori] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Takahashi, Koji; Kinoshita, Toshinori] Nagoya Univ, Inst Transformat BioMol WPI ITbM, Nagoya, Aichi, Japan	Institute of Science & Technology - Austria; University of Silesia in Katowice; Wageningen University & Research; University of Belgrade; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Masaryk University Brno; Nagoya University; Nagoya University	Friml, J (corresponding author), Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria.	jiri.friml@ista.ac.at	Friml, Jiri/D-9511-2012; Rodríguez Solovey, Lesia Natacha/C-5498-2014; Grones, Peter/HFZ-9775-2022; Kinoshita, Toshinori/C-2891-2012	Friml, Jiri/0000-0002-8302-7596; Rodríguez Solovey, Lesia Natacha/0000-0002-7244-7237; Grones, Peter/0000-0003-4132-4151; Kinoshita, Toshinori/0000-0001-7621-1259; Fiedler, Lukas/0000-0002-2454-4665; Mazur, Ewa/0000-0003-0252-1427; Zivanovic, Branka/0000-0002-2300-7964; Kuhn, Andre/0000-0003-2144-8413; Gelova, Zuzana/0000-0003-4783-1752; Johnson, Alexander/0000-0002-2739-8843	European Research Council (ERC) under the European Union [742985, 833867]; Austrian Science Fund (FWF) [P29988]; Netherlands Organization for Scientific Research (NWO) [865.14.001, VI.Veni.212.003]; Ministry of Education, Science and Technological Development of the Republic of Serbia [451-03-68/2022-14/200053]; MEXT/JSPS KAKENHI [20K06685, 20H05687, 20H05910]	European Research Council (ERC) under the European Union(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge K. Kubiasova for excellent technical assistance, J. Neuhold, A. Lehner and A. Sedivy for technical assistance with protein production and purification at Vienna Biocenter Core Facilities; Creoptix for performing GCI; and the Bioimaging, Electron Microscopy and Life Science Facilities at ISTA, the Plant Sciences Core Facility of CEITEC Masaryk University, the Core Facility CELLIM (MEYS CR, LM2018129 Czech-BioImaging) and J. Sprakel for their assistance. J.F. is grateful to R. Napier for many insightful suggestions and support. We thank all past and present members of the Friml group for their support and for other contributions to this effort to clarify the controversial role of ABP1 over the past seven years. The project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 742985 to J.F. and 833867 to D.W.); the Austrian Science Fund (FWF; P29988 to J.F.); the Netherlands Organization for Scientific Research (NWO; VICI grant 865.14.001 to D.W. and VENI grant VI.Veni.212.003 to A.K.); the Ministry of Education, Science and Technological Development of the Republic of Serbia (contract no. 451-03-68/2022-14/200053 to B.D.Z.); and the MEXT/JSPS KAKENHI to K.T. (20K06685) and T.K. (20H05687 and 20H05910).	Adamowski M, 2015, PLANT CELL, V27, P20, DOI 10.1105/tpc.114.134874; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Cao M, 2019, NATURE, V568, P240, DOI 10.1038/s41586-019-1069-7; Dahlke RI, 2017, PLANT PHYSIOL, V175, P982, DOI 10.1104/pp.17.00733; Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060990; Dai XH, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.183; Dindas J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03582-5; Dubey SM, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a039891; Fendrych M, 2018, NAT PLANTS, V4, P453, DOI 10.1038/s41477-018-0190-1; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Friml J, 2022, CSH PERSPECT BIOL, V14, DOI 10.1101/cshperspect.a039859; Gallei M, 2020, CURR OPIN PLANT BIOL, V53, P43, DOI 10.1016/j.pbi.2019.10.003; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gelova Z, 2021, PLANT SCI, V303, DOI 10.1016/j.plantsci.2020.110750; Grones P, 2015, J EXP BOT, V66, P5055, DOI 10.1093/jxb/erv177; Hajny J, 2022, CURR OPIN PLANT BIOL, V65, DOI 10.1016/j.pbi.2022.102174; Hajny J, 2020, SCIENCE, V370, P550, DOI 10.1126/science.aba3178; Han H., 2021, RAPID AUXIN MEDIATED, DOI [10.1101/2021.04.13.439603, DOI 10.1101/2021.04.13.439603]; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; Jayakannan M, 2013, J EXP BOT, V64, P2255, DOI 10.1093/jxb/ert085; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Klode M, 2011, J PLANT GROWTH REGUL, V30, P416, DOI 10.1007/s00344-011-9203-2; Kuhn A, 2020, ELIFE, V9, DOI 10.7554/eLife.51787; Lavy M, 2016, DEVELOPMENT, V143, P3226, DOI 10.1242/dev.131870; Li LX, 2022, TRENDS PLANT SCI, V27, P440, DOI 10.1016/j.tplants.2021.11.006; Li LX, 2021, NATURE, V599, P273, DOI 10.1038/s41586-021-04037-6; Lin WW, 2021, NATURE, V599, P278, DOI 10.1038/s41586-021-03976-4; Mazur E, 2020, PLANT SCI, V293, DOI 10.1016/j.plantsci.2020.110414; Mazur E, 2020, NEW PHYTOL, V226, P1375, DOI 10.1111/nph.16446; Mazur E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33754; McLaughlin HM, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a039917; Michalko Jaroslav, 2015, F1000Res, V4, P1104, DOI 10.12688/f1000research.7143.1; Morffy N, 2022, CSH PERSPECT BIOL, V14, DOI 10.1101/cshperspect.a039883; Napier R, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a039909; Narasimhan M, 2021, PLANT PHYSIOL, V186, P1122, DOI 10.1093/plphys/kiab134; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Okumura M., 2016, BIO-PROTOCOL, V6, pe2044; Paponov IA, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01953; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; SACHS T, 1975, PLANTA, V127, P201, DOI 10.1007/BF00380716; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Serre NBC, 2021, NAT PLANTS, V7, P1229, DOI 10.1038/s41477-021-00969-z; Smakowska-Luzan E, 2018, NATURE, V553, P342, DOI 10.1038/nature25184; Tan ST, 2020, CURR BIOL, V30, P381, DOI 10.1016/j.cub.2019.11.058; TIAN HC, 1995, J BIOL CHEM, V270, P26962, DOI 10.1074/jbc.270.45.26962; Tominaga M, 2015, CURR OPIN PLANT BIOL, V27, P104, DOI 10.1016/j.pbi.2015.06.017; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wabnik K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.103; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; Yin K, 2009, ACTA BIOCH BIOPH SIN, V41, P478, DOI 10.1093/abbs/gmp036; Young G, 2018, SCIENCE, V360, P423, DOI 10.1126/science.aar5839; Zivanovic B, 2001, ELECTRO MAGNETOBIOL, V20, P343, DOI 10.1081/JBC-100108575	58	6	6	60	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927								10.1038/s41586-022-05187-x	http://dx.doi.org/10.1038/s41586-022-05187-x		SEP 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O5MH	36071161				2022-12-28	WOS:000851357500002
J	Larkin, HD				Larkin, Howard D.			Improving Patient Communication on LASIK Benefits and Risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					820	820						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066533				2022-12-28	WOS:000855171700012
J	Sekeres, MA; Taylor, J				Sekeres, Mikkael A.; Taylor, Justin			Diagnosis and Treatment of Myelodysplastic Syndromes A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEALTH-ORGANIZATION CLASSIFICATION; LOW-DOSE DECITABINE; CLONAL HEMATOPOIESIS; CELL TRANSPLANTATION; DARBEPOETIN-ALPHA; SCORING SYSTEM; OLDER PATIENTS; PHASE-II; RISK; AZACITIDINE	IMPORTANCE Myelodysplastic neoplasms (MDS), formerly known as myelodysplastic syndromes, are clonal hematopoietic malignancies that cause morphologic bone marrow dysplasia along with anemia, neutropenia, or thrombocytopenia. MDS are associated with an increased risk of acute myeloid leukemia (AML). The yearly incidence of MDS is approximately 4 per 100 000 people in the United States and is higher among patients with advanced age. OBSERVATIONS MDS are characterized by reduced numbers of peripheral blood cells, an increased risk of acute myeloid leukemia transformation, and reduced survival. The median age at diagnosis is approximately 70 years, and the yearly incidence rate increases to 25 per 100 000 in people aged 65 years and older. Risk factors associated with MDS include older age and prior exposures to toxins such as chemotherapy or radiation therapy. MDS are more common in men compared with women (with yearly incidence rates of approximately 5.4 vs 2.9 per 100 000). MDS typically has an insidious presentation, consisting of signs and symptoms associated with anemia, thrombocytopenia, and neutropenia. MDS can be categorized into subtypes that are associated with lower or higher risk for acute myeloid leukemia transformation and that help with therapy selection. Patients with lower-risk MDS have a median survival of approximately 3 to 10 years, whereas patients with higher-risk disease have a median survival of less than 3 years. Therapy for lower-risk MDS is selected based on whether the primary clinical characteristic is anemia, thrombocytopenia, or neutropenia. Management focuses on treating symptoms and reducing the number of required transfusions in patients with low-risk disease. For patients with lower-risk MDS, erythropoiesis stimulating agents, such as recombinant humanized erythropoietin or the longer-acting erythropoietin, darbepoetin alfa, can improve anemia in 15% to 40% of patients for a median of 8 to 23 months. For those with higher-risk MDS, hypomethylating agents such as azacitidine, decitabine, or decitabine/cedazuridine are first-line therapy. Hematopoietic cell transplantation is considered for higher-risk patients and represents the only potential cure. CONCLUSIONS AND RELEVANCE MDS are diagnosed in approximately 4 per 100 000 people in the United States and are associated with a 5-year survival rate of approximately 37%. Treatments are tailored to the patient's disease characteristics and comorbidities and range from supportive care with or without erythropoiesis-stimulating agents for patients with low-risk MDS to hypomethylating agents, such as azacitidine or decitabine, for patients with higher-risk MDS. Hematopoietic cell transplantation is potentially curative and should be considered for patients with higher-risk MDS at the time of diagnosis.	[Sekeres, Mikkael A.; Taylor, Justin] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Med, Div Hematol,Miller Sch Med, Miami, FL 33156 USA	University of Miami	Sekeres, MA (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Dept Med, Div Hematol, 1120 NW 14th St,Ste 610M, Miami, FL 33156 USA.	msekeres@med.miami.edu						Allampallam K, 2002, INT J HEMATOL, V75, P289, DOI 10.1007/BF02982044; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Atallah E, 2020, JAMA ONCOL, V6, P486, DOI 10.1001/jamaoncol.2019.5140; Bersanelli M, 2021, J CLIN ONCOL, V39, P1223, DOI 10.1200/JCO.20.01659; Bhatia S, 2013, SEMIN ONCOL, V40, P666, DOI 10.1053/j.seminoncol.2013.09.013; Bussel JB, 2021, DRUG DES DEV THER, V15, P2243, DOI 10.2147/DDDT.S299591; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; Cutler CS, 2004, BLOOD, V104, P579, DOI 10.1182/blood-2004-01-0338; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Duong VH, 2020, LEUKEMIA LYMPHOMA, V61, P1901, DOI 10.1080/10428194.2020.1751841; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Estey E, 2022, BLOOD, V139, P323, DOI 10.1182/blood.2021011304; Fenaux P, 2020, NEW ENGL J MED, V382, P140, DOI 10.1056/NEJMoa1908892; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Gabrilove J, 2008, BRIT J HAEMATOL, V142, P379, DOI 10.1111/j.1365-2141.2008.07181.x; Garcia-Manero G, 2020, BLOOD, V136, P674, DOI 10.1182/blood.2019004143; Garcia-Manero G, 2017, CANCER-AM CANCER SOC, V123, P994, DOI 10.1002/cncr.30533; Genovese G, 2015, NEW ENGL J MED, V372, P1071, DOI 10.1056/NEJMc1500684; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Giagounidis A, 2014, CANCER-AM CANCER SOC, V120, P1838, DOI 10.1002/cncr.28663; Golshayan AR, 2007, BRIT J HAEMATOL, V137, P125, DOI 10.1111/j.1365-2141.2007.06546.x; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Jabbour E, 2017, BLOOD, V130, P1514, DOI 10.1182/blood-2017-06-788497; Jadersten M, 2006, AM SOC HEMATOLOGY AN, V108, P521, DOI [10.1182/blood.V108.11.521.521, DOI 10.1182/BLOOD.V108.11.521.521]; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kantarjian H, 2007, CANCER-AM CANCER SOC, V109, P1705, DOI 10.1002/cncr.22602; Kantarjian HM, 2018, LANCET HAEMATOL, V5, pE117, DOI [10.1016/S2352-3026(18)30016-4, 10.1016/S2352-3026(18)30017-6]; Khoury JD, 2022, LEUKEMIA, V36, P1703, DOI 10.1038/s41375-022-01613-1; Komrokji R, 2018, ONCOLOGIST, V23, P159, DOI 10.1634/theoncologist.2017-0215; Komrokji RS, 2016, AM J HEMATOL, V91, pE280, DOI 10.1002/ajh.24333; Komrokji RS, 2014, HAEMATOLOGICA, V99, P1176, DOI 10.3324/haematol.2012.083345; Koreth J, 2013, J CLIN ONCOL, V31, P2662, DOI 10.1200/JCO.2012.46.8652; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; KURIYAMA K, 1986, BRIT J HAEMATOL, V63, P665, DOI 10.1111/j.1365-2141.1986.tb07550.x; Kwok B, 2015, BLOOD, V126, P2355, DOI 10.1182/blood-2015-08-667063; Lubbert M, 2011, J CLIN ONCOL, V29, P1987, DOI 10.1200/JCO.2010.30.9245; Madanat Y, 2017, SEMIN HEMATOL, V54, P147, DOI 10.1053/j.seminhematol.2017.06.001; Malcovati L, 2017, BLOOD, V129, P3371, DOI 10.1182/blood-2017-01-763425; Malcovati L, 2015, BLOOD, V126, P233, DOI 10.1182/blood-2015-03-633537; Nakamura R, 2021, J CLIN ONCOL, V39, P3328, DOI 10.1200/JCO.20.03380; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Nazha A, 2021, J CLIN ONCOL, V39, P3737, DOI 10.1200/JCO.20.02810; Negoro E, 2017, BLOOD, V130, P1953, DOI 10.1182/blood-2017-02-767731; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Oliva EN, 2017, LANCET HAEMATOL, V4, pE127, DOI 10.1016/S2352-3026(17)30012-1; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Passweg JR, 2011, J CLIN ONCOL, V29, P303, DOI 10.1200/JCO.2010.31.2686; Patnaik MM, 2010, LEUKEMIA, V24, P1283, DOI 10.1038/leu.2010.105; Pfeilstocker M, 2016, BLOOD, V128, P902, DOI 10.1182/blood-2016-02-700054; Platzbecker U, 2019, BLOOD, V133, P1020, DOI 10.1182/blood-2018-06-857102; Platzbecker U, 2017, LEUKEMIA, V31, P1944, DOI 10.1038/leu.2017.192; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Prebet T, 2014, J CLIN ONCOL, V32, P1242, DOI 10.1200/JCO.2013.50.3102; Prebet T, 2011, J CLIN ONCOL, V29, P3322, DOI 10.1200/JCO.2011.35.8135; Radakovich N, 2021, BLOOD ADV, V5, P4361, DOI 10.1182/bloodadvances.2021004755; Sanz GF, 1998, HAEMATOLOGICA, V83, P358; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Sekeres MA, 2021, LEUKEMIA, V35, P2119, DOI 10.1038/s41375-021-01125-4; Sekeres MA, 2019, HEMATOL-AM SOC HEMAT, P367, DOI 10.1182/hematology.2019000040; Sekeres MA, 2017, J CLIN ONCOL, V35, P2745, DOI 10.1200/JCO.2015.66.2510; Sekeres MA, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn349; Sekeres MA, 2008, J CLIN ONCOL, V26, P5943, DOI 10.1200/JCO.2007.15.5770; Shastri A, 2017, BLOOD, V129, P1586, DOI 10.1182/blood-2016-10-696062; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Stein EM, 2020, LANCET HAEMATOL, V7, pE309, DOI 10.1016/S2352-3026(19)30284-4; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Surveillance Research Program National Cancer Institute, ALL CANC SIT COMB RE; Toma A, 2012, HAEMATOL-HEMATOL J, V97, P1459, DOI 10.3324/haematol.2012.063420; Wei AH, 2019, J CLIN ONCOL, V37, P1277, DOI 10.1200/JCO.18.01600; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Zeidan AM, 2016, BRIT J HAEMATOL, V175, P829, DOI 10.1111/bjh.14305	75	1	1	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					872	880		10.1001/jama.2022.14578	http://dx.doi.org/10.1001/jama.2022.14578			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066514				2022-12-28	WOS:000855171700023
J	Greenwood, A				Greenwood, Anna			The art of medicine Diagnosing the medical history of British imperialism	LANCET			English	Editorial Material									[Greenwood, Anna] Univ Nottingham, Dept Hist, Nottingham NG7 2RD, England	University of Nottingham	Greenwood, A (corresponding author), Univ Nottingham, Dept Hist, Nottingham NG7 2RD, England.	anna.greenwood@nottingham.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					726	727						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058215				2022-12-28	WOS:000860483700012
J	Wei, XY; Fu, SL; Li, HB; Liu, Y; Wang, S; Feng, WM; Yang, YZ; Liu, XW; Zeng, YY; Cheng, MN; Lai, YW; Qiu, XJ; Wu, L; Zhang, NN; Jiang, YJ; Xu, JS; Su, XS; Peng, C; Han, L; Lou, WPK; Liu, CY; Yuan, Y; Ma, KL; Yang, T; Pan, XY; Gao, S; Chen, A; Esteban, MA; Yang, HM; Wang, J; Fan, GY; Liu, LQ; Chen, L; Xu, X; Fei, JF; Gu, Y				Wei, Xiaoyu; Fu, Sulei; Li, Hanbo; Liu, Yang; Wang, Shuai; Feng, Weimin; Yang, Yunzhi; Liu, Xiawei; Zeng, Yan-Yun; Cheng, Mengnan; Lai, Yiwei; Qiu, Xiaojie; Wu, Liang; Zhang, Nannan; Jiang, Yujia; Xu, Jiangshan; Su, Xiaoshan; Peng, Cheng; Han, Lei; Lou, Wilson Pak-Kin; Liu, Chuanyu; Yuan, Yue; Ma, Kailong; Yang, Tao; Pan, Xiangyu; Gao, Shang; Chen, Ao; Esteban, Miguel A.; Yang, Huanming; Wang, Jian; Fan, Guangyi; Liu, Longqi; Chen, Liang; Xu, Xun; Fei, Ji-Feng; Gu, Ying			Single-cell Stereo-seq reveals induced progenitor cells involved in axolotl brain regeneration	SCIENCE			English	Article							NEURAL STEM; NEURONS; NEUROGENESIS; READS; CYCLE; SOX1	The molecular mechanism underlying brain regeneration in vertebrates remains elusive. We performed spatial enhanced resolution omics sequencing (Stereo-seq) to capture spatially resolved single-cell transcriptomes of axolotl telencephalon sections during development and regeneration. Annotated cell types exhibited distinct spatial distribution, molecular features, and functions. We identified an injury-induced ependymoglial cell cluster at the wound site as a progenitor cell population for the potential replenishment of lost neurons, through a cell state transition process resembling neurogenesis during development. Transcriptome comparisons indicated that these induced cells may originate from local resident ependymoglial cells. We further uncovered spatially defined neurons at the lesion site that may regress to an immature neuron-like state. Our work establishes spatial transcriptome profiles of an anamniote tetrapod brain and decodes potential neurogenesis from ependymoglial cells for development and regeneration, thus providing mechanistic insights into vertebrate brain regeneration.	[Wei, Xiaoyu; Liu, Longqi; Gu, Ying] BGI Hangzhou, Hangzhou 310012, Peoples R China; [Wei, Xiaoyu; Li, Hanbo; Liu, Yang; Wang, Shuai; Feng, Weimin; Cheng, Mengnan; Wu, Liang; Jiang, Yujia; Xu, Jiangshan; Han, Lei; Liu, Chuanyu; Yuan, Yue; Ma, Kailong; Yang, Tao; Chen, Ao; Yang, Huanming; Wang, Jian; Fan, Guangyi; Liu, Longqi; Xu, Xun; Gu, Ying] BGI Shenzhen, Shenzhen 518103, Peoples R China; [Fu, Sulei; Zeng, Yan-Yun; Peng, Cheng; Lou, Wilson Pak-Kin; Pan, Xiangyu; Fei, Ji-Feng] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou 510080, Peoples R China; [Fu, Sulei; Zeng, Yan-Yun; Peng, Cheng; Lou, Wilson Pak-Kin] South China Normal Univ, Inst Brain Res & Rehabil, Minist Educ, Key Lab Brain Cognit & Educ Sci, Guangzhou 510631, Peoples R China; [Li, Hanbo; Liu, Xiawei; Zhang, Nannan; Su, Xiaoshan; Gao, Shang] BGI Qingdao, Qingdao 266555, Peoples R China; [Li, Hanbo] BGI Qingdao, Qingdao Europe Adv Inst Life Sci, Lars Bolund Inst Regenerat Med, Qingdao 266555, Peoples R China; [Wang, Shuai; Feng, Weimin; Cheng, Mengnan; Wu, Liang; Xu, Jiangshan; Yuan, Yue; Liu, Longqi; Gu, Ying] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Yang, Yunzhi; Jiang, Yujia] Zhengzhou Univ, BGI Coll, Zhengzhou 450000, Peoples R China; [Yang, Yunzhi; Jiang, Yujia] Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Zhengzhou 450000, Peoples R China; [Lai, Yiwei; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Integrat Biol, Guangzhou 510530, Peoples R China; [Qiu, Xiaojie] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Qiu, Xiaojie] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Han, Lei] BGI Shenzhen, Shenzhen Key Lab Single Cell Omics, Shenzhen 518120, Peoples R China; [Han, Lei; Liu, Chuanyu; Liu, Longqi] Shenzhen Bay Lab, Shenzhen 518000, Peoples R China; [Chen, Ao] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Esteban, Miguel A.] Chinese Acad Sci, Inst Stem Cells & Regenerat, Beijing 100101, Peoples R China; [Yang, Huanming; Wang, Jian] James D Watson Inst Genome Sci, Hangzhou 310058, Peoples R China; [Chen, Liang] Wuhan Univ, Coll Life Sci, RNA Inst, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Xu, Xun; Gu, Ying] BGI Shenzhen, Guangdong Prov Key Lab Genome Read & Write, Shenzhen 518120, Peoples R China	Beijing Genomics Institute (BGI); Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China Normal University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhengzhou University; Zhengzhou University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Beijing Genomics Institute (BGI); Shenzhen Bay Laboratory; University of Copenhagen; Chinese Academy of Sciences; Wuhan University; Beijing Genomics Institute (BGI)	Gu, Y (corresponding author), BGI Hangzhou, Hangzhou 310012, Peoples R China.; Li, HB; Xu, X; Gu, Y (corresponding author), BGI Shenzhen, Shenzhen 518103, Peoples R China.; Fei, JF (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou 510080, Peoples R China.; Li, HB (corresponding author), BGI Qingdao, Qingdao 266555, Peoples R China.; Li, HB (corresponding author), BGI Qingdao, Qingdao Europe Adv Inst Life Sci, Lars Bolund Inst Regenerat Med, Qingdao 266555, Peoples R China.; Gu, Y (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.; Chen, L (corresponding author), Wuhan Univ, Coll Life Sci, RNA Inst, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Xu, X; Gu, Y (corresponding author), BGI Shenzhen, Guangdong Prov Key Lab Genome Read & Write, Shenzhen 518120, Peoples R China.	lihanbo@genomics.cn; liang_chen@whu.edu.cn; xuxun@genomics.cn; jifengfei@gdph.org.cn; guying@genomics.cn	Fei, Ji-Feng/O-5160-2015	Fei, Ji-Feng/0000-0003-2426-9402; Li, Hanbo/0000-0001-8778-9988; yang, tao/0000-0003-4211-5183; Liu, Yang/0000-0001-7294-8763; feng, weimin/0000-0002-0862-1640; Wang, Shuai/0000-0002-7246-6980; Yang, Yunzhi/0000-0003-4957-071X; Fu, Sulei/0000-0002-6179-0929	National Key R&D Program of China [2019YFE0106700, 2021YFA0805000, 2021YFA1100500]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16010000]; Guangdong Provincial Key Laboratory of Genome Read and Write [2017B030301011]; Shenzhen Key Laboratory of Single-Cell Omics [ZDSYS20190902093613831]; National Natural Science Foundation of China [32171289, 31970619, 31970782]; Innovative Research Group Program of Hubei Province [2020CFA017]; High-level Hospital Construction Project of Guangdong Provincial People's Hospital [DFJHBF202103, KJ012021012]; Project of Department of Education of Guangdong Province [2018KZDXM027]; Key-Area Research and Development Program of Guangdong Province [2018B030332001, 2019B030335001]; Guangdong-Hong Kong-Macao-Joint Laboratory Program [2019B121205005]	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Guangdong Provincial Key Laboratory of Genome Read and Write; Shenzhen Key Laboratory of Single-Cell Omics; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Group Program of Hubei Province; High-level Hospital Construction Project of Guangdong Provincial People's Hospital; Project of Department of Education of Guangdong Province; Key-Area Research and Development Program of Guangdong Province; Guangdong-Hong Kong-Macao-Joint Laboratory Program	This work was supported by the National Key R&D Program of China (2019YFE0106700, 2021YFA0805000, 2021YFA1100500), Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA16010000), the Guangdong Provincial Key Laboratory of Genome Read and Write (2017B030301011), the Shenzhen Key Laboratory of Single-Cell Omics (No. ZDSYS20190902093613831), the National Natural Science Foundation of China (32171289, 31970619, 31970782), the Innovative Research Group Program of Hubei Province (2020CFA017), the High-level Hospital Construction Project of Guangdong Provincial People's Hospital (DFJHBF202103, KJ012021012), Project of Department of Education of Guangdong Province (2018KZDXM027), Key-Area Research and Development Program of Guangdong Province (2018B030332001, 2019B030335001), and Guangdong-Hong Kong-Macao-Joint Laboratory Program (2019B121205005).	Albors AR, 2015, ELIFE, V4, DOI 10.7554/eLife.10230; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Barna M, 2013, P NATL ACAD SCI USA, V110, P9, DOI 10.1073/pnas.1218764110; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; Burr HS, 1916, J COMP NEUROL, V26, P203, DOI 10.1002/cne.900260203; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Charni M, 2017, CELL DEATH DIFFER, V24, P8, DOI 10.1038/cdd.2016.117; Chen A, 2022, CELL, V185, P1777, DOI 10.1016/j.cell.2022.04.003; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Faissner A, 2017, MOL CELL NEUROSCI, V81, P22, DOI 10.1016/j.mcn.2016.11.003; Fu JP, 2021, NAT MATER, V20, P132, DOI 10.1038/s41563-020-00829-9; Gaidatzis D, 2015, NAT BIOTECHNOL, V33, P722, DOI 10.1038/nbt.3269; Gerber T, 2018, SCIENCE, V362, P421, DOI 10.1126/science.aaq0681; Gonzalez A., 2017, EVOLUTION NERVOUS SY, V1, P8; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Herrick C. J., 1948, BRAIN TIGER SALAMAND; Joven A, 2018, PROG NEUROBIOL, V170, P81, DOI 10.1016/j.pneurobio.2018.04.006; Joven A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160051; Kirkham M, 2014, STEM CELL REP, V2, P507, DOI 10.1016/j.stemcr.2014.01.018; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lazcano I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89357-3; Li HB, 2021, PROTEIN CELL, V12, P57, DOI 10.1007/s13238-020-00763-1; Li ZQ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abb6260; Liu Yang, 2022, Zenodo, DOI 10.5281/ZENODO.6792037; Lust K, 2019, DEV NEUROBIOL, V79, P424, DOI 10.1002/dneu.22665; Mademtzoglou D, 2018, ELIFE, V7, DOI 10.7554/eLife.33337; Maden M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-1; Marx V, 2021, NAT METHODS, V18, P9, DOI 10.1038/s41592-020-01033-y; Maynard KR, 2021, NAT NEUROSCI, V24, P425, DOI 10.1038/s41593-020-00787-0; Mouthon MA, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101784; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ortiz C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb3446; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Poplawski GHD, 2020, NATURE, V581, P77, DOI 10.1038/s41586-020-2200-5; Qiu XJ, 2022, CELL, V185, P690, DOI 10.1016/j.cell.2021.12.045; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Renthal W, 2020, NEURON, V108, P128, DOI 10.1016/j.neuron.2020.07.026; Roth G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019075; Ryczko D, 2020, TRENDS NEUROSCI, V43, P916, DOI 10.1016/j.tins.2020.08.006; SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Xia CL, 2019, P NATL ACAD SCI USA, V116, P19490, DOI 10.1073/pnas.1912459116	56	4	4	56	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1062	+	eabp9444	10.1126/science.abp9444	http://dx.doi.org/10.1126/science.abp9444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048929				2022-12-28	WOS:000887933200005
J	Kapadia, SR; Makkar, R; Leon, M; Abdel-Wahab, M; Waggoner, T; Massberg, S; Rottbauer, W; Horr, S; Sondergaard, L; Karha, J; Gooley, R; Satler, L; Stoler, RC; Messe, SR; Baron, SJ; Seeger, J; Kodali, S; Krishnaswamy, A; Thourani, VH; Harrington, K; Pocock, S; Modolo, R; Allocco, DJ; Meredith, IT; Linke, A; PROTECTED TAVR Investigators				Kapadia, Samir R. R.; Makkar, Raj; Leon, Martin; Abdel-Wahab, Mohamed; Waggoner, Thomas; Massberg, Steffen; Rottbauer, Wolfgang; Horr, Samuel; Sondergaard, Lars; Karha, Juhana; Gooley, Robert; Satler, Lowell; Stoler, Robert C.; Messe, Steven R.; Baron, Suzanne J.; Seeger, Julia; Kodali, Susheel; Krishnaswamy, Amar; Thourani, Vinod H.; Harrington, Katherine; Pocock, Stuart; Modolo, Rodrigo; Allocco, Dominic J.; Meredith, Ian T.; Linke, Axel; PROTECTED TAVR Investigators			Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH STATES; IMPLANTATION; RISK; STENOSIS; STROKE; OUTCOMES; DEATH; SCORE	BACKGROUND Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic stenosis can lead to embolization of debris. Capture of debris by devices that provide cerebral embolic protection (CEP) may reduce the risk of stroke. METHODS We randomly assigned patients with aortic stenosis in a 1:1 ratio to undergo transfemoral TAVR with CEP (CEP group) or without CEP (control group). The primary end point was stroke within 72 hours after TAVR or before discharge (whichever came first) in the intention-to-treat population. Disabling stroke, death, transient ischemic attack, delirium, major or minor vascular complications at the CEP access site, and acute kidney injury were also assessed. A neurology professional examined all the patients at baseline and after TAVR. RESULTS A total of 3000 patients across North America, Europe, and Australia underwent randomization; 1501 were assigned to the CEP group and 1499 to the control group. A CEP device was successfully deployed in 1406 of the 1489 patients (94.4%) in whom an attempt was made. The incidence of stroke within 72 hours after TAVR or before discharge did not differ significantly between the CEP group and the control group (2.3% vs. 2.9%; difference, -0.6 percentage points; 95% confidence interval, -1.7 to 0.5; P=0.30). Disabling stroke occurred in 0.5% of the patients in the CEP group and in 1.3% of those in the control group. There were no substantial differences between the CEP group and the control group in the percentage of patients who died (0.5% vs. 0.3%); had a stroke, a transient ischemic attack, or delirium (3.1% vs. 3.7%); or had acute kidney injury (0.5% vs. 0.5%). One patient (0.1%) had a vascular complication at the CEP access site. CONCLUSIONS Among patients with aortic stenosis undergoing transfemoral TAVR, the use of CEP did not have a significant effect on the incidence of periprocedural stroke, but on the basis of the 95% confidence interval around this outcome, the results may not rule out a benefit of CEP during TAVR.	[Kapadia, Samir R. R.] Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave, J2-3, Cleveland, OH 44195 USA; [Kapadia, Samir R. R.] Dept Cardiovasc Med, Cleveland, OH USA; [Krishnaswamy, Amar] Cleveland Clin Fdn, Cleveland, OH USA; [Makkar, Raj] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA USA; [Leon, Martin] Columbia Intervent Cardiovasc Care, New York, NY USA; [Kodali, Susheel] Columbia Univ, Med Ctr, New York, NY USA; [Abdel-Wahab, Mohamed] Univ Leipzig, Leipzig Heart Ctr, Leipzig, Germany; [Massberg, Steffen] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Massberg, Steffen] Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Rottbauer, Wolfgang] Univ Klinikum Ulm, Ulm, Germany; [Seeger, Julia] Med Campus Lake Constance, Friedrichshafen, Germany; [Linke, Axel] Tech Univ Dresden, Clin Internal Med & Cardiol, Herzzentrum, Dresden, Germany; [Waggoner, Thomas] Tucson Med Ctr Healthcare, Pima Heart & Vasc, Tucson, AZ USA; [Horr, Samuel] Centennial Med Ctr, Nashville, TN USA; [Sondergaard, Lars] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark; [Karha, Juhana] Heart Hosp Austin, Austin, TX USA; [Stoler, Robert C.] Baylor Heart & Vasc Hosp, Dallas, TX USA; [Harrington, Katherine] Baylor Scott & White Heart Hosp Plano, Plano, TX USA; [Gooley, Robert] Monash Med Ctr, Clayton, Vic, Australia; [Satler, Lowell] Washington Hosp Ctr, Washington, DC USA; [Massberg, Steffen] Univ Penn, Dept Neurol, Philadelphia, PA USA; [Baron, Suzanne J.] Lahey Hosp & Med Ctr, Burlington, MA USA; [Modolo, Rodrigo; Allocco, Dominic J.; Meredith, Ian T.] Boston Sci, Marlborough, MA USA; [Thourani, Vinod H.] Piedmont Heart Inst, Atlanta, GA USA; [Pocock, Stuart] London Sch Hyg & Trop Med, London, England	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cedars Sinai Medical Center; Columbia University; Heart Center Leipzig GMBH; Leipzig University; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; Technische Universitat Dresden; Rigshospitalet; University of Copenhagen; Monash University; MedStar Washington Hospital Center; University of Pennsylvania; Lahey Hospital & Medical Center; Boston Scientific; Piedmont Heart Institute; University of London; London School of Hygiene & Tropical Medicine	Kapadia, SR (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave, J2-3, Cleveland, OH 44195 USA.		Gómez-Escalonilla, Carlos/AAU-1050-2021; Gómez-Escalonilla, Carlos/HGD-6357-2022		Boston Scientific	Boston Scientific(Boston Scientific)	Supported by Boston Scientific.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Almarzooq ZI, 2022, EUROINTERVENTION, V18, pE335, DOI 10.4244/EIJ-D-21-00951; Butala NM, 2021, CIRCULATION, V143, P2229, DOI 10.1161/CIRCULATIONAHA.120.052874; Everett EA, 2021, NEUROL-CLIN PRACT, V11, P43, DOI 10.1212/CPJ.0000000000000856; Fanning JP, 2014, CIRCULATION, V129, P504, DOI 10.1161/CIRCULATIONAHA.113.004103; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Habertheuer A, 2020, ANN THORAC SURG, V110, P1294, DOI 10.1016/j.athoracsur.2020.01.074; Haussig S, 2016, JAMA-J AM MED ASSOC, V316, P592, DOI 10.1001/jama.2016.10302; Huded CP, 2019, JAMA-J AM MED ASSOC, V321, P2306, DOI 10.1001/jama.2019.7525; Isogai T, 2022, JACC-CARDIOVASC INTE, V15, P569, DOI 10.1016/j.jcin.2022.01.007; Kapadia S, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.002981; Kapadia SR, 2018, J AM COLL CARDIOL, V72, P2415, DOI 10.1016/j.jacc.2018.08.2172; Kapadia SR, 2017, J AM COLL CARDIOL, V69, P367, DOI 10.1016/j.jacc.2016.10.023; Lansky AJ, 2017, J AM COLL CARDIOL, V69, P679, DOI 10.1016/j.jacc.2016.11.045; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052; Ndunda PM, 2020, CARDIOVASC REVASCULA, V21, P717, DOI 10.1016/j.carrev.2019.04.023; Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Reardon MJ, 2016, JAMA CARDIOL, V1, P945, DOI 10.1001/jamacardio.2016.2257; Schaff HV, 2011, NEW ENGL J MED, V364, P2256, DOI 10.1056/NEJMe1103978; Seeger J, 2019, EUR HEART J, V40, P1334, DOI 10.1093/eurheartj/ehy847; Seeger J, 2017, JACC-CARDIOVASC INTE, V10, P2297, DOI 10.1016/j.jcin.2017.06.037; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014; Van Mieghem NM, 2016, EUROINTERVENTION, V12, P499, DOI 10.4244/EIJV12I4A84; Van Mieghem NM, 2013, CIRCULATION, V127, P2194, DOI 10.1161/CIRCULATIONAHA.112.001091; Vlastra W, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.118.007546; Winter MP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72453-1	32	3	3	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2022	387	14					1253	1263		10.1056/NEJMoa2204961	http://dx.doi.org/10.1056/NEJMoa2204961			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5I3II	36121045				2022-12-28	WOS:000868254300008
J	Bos, LDJ; Ware, LB				Bos, Lieuwe D. J.; Ware, Lorraine B.			Acute Respiratory Distress Syndrome 2022 1 Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	LANCET			English	Article							ACUTE LUNG INJURY; CIGARETTE-SMOKE EXPOSURE; MECHANICAL VENTILATION; ARDS SUBPHENOTYPES; PULMONARY-EDEMA; TIDAL VOLUME; TRANSFUSION; VALIDATION; SURFACTANT; RISK	Acute respiratory distress syndrome (ARDS) is a common clinical syndrome of acute respiratory failure as a result of diffuse lung inflammation and oedema. ARDS can be precipitated by a variety of causes. The pathophysiology of ARDS is complex and involves the activation and dysregulation of multiple overlapping and interacting pathways of injury, inflammation, and coagulation, both in the lung and systemically. Mechanical ventilation can contribute to a cycle of lung injury and inflammation. Resolution of inflammation is a coordinated process that requires downregulation of proinflammatory pathways and upregulation of anti-inflammatory pathways. The heterogeneity of the clinical syndrome, along with its biology, physiology, and radiology, has increasingly been recognised and incorporated into identification of phenotypes. A precision-medicine approach that improves the identification of more homogeneous ARDS phenotypes should lead to an improved understanding of its pathophysiological mechanisms and how they differ from patient to patient.	[Bos, Lieuwe D. J.] Univ Amsterdam, Intens Care, Amsterdam UMC Locat AMC, Amsterdam, Netherlands; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Med Ctr North, Nashville, TN USA; [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Med Ctr North, Nashville, TN 37232 USA	University of Amsterdam; Vanderbilt University; Vanderbilt University	Ware, LB (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr North, Nashville, TN 37232 USA.	lorraine.ware@vumc.org	Bos, Lieuwe/H-2578-2018	Bos, Lieuwe/0000-0003-2911-4549; Ware, Lorraine/0000-0002-9429-4702	Amsterdam UMC fellowship; Health Holland; Dutch Lung Foundation (Longfonds) through the Dirkje Postma Award	Amsterdam UMC fellowship; Health Holland; Dutch Lung Foundation (Longfonds) through the Dirkje Postma Award	LDB is supported by the Amsterdam UMC fellowship, Health Holland, and by the Dutch Lung Foundation (Longfonds) through the Dirkje Postma Award. We thank Diana Lim (Molecular Medicine Programme, University of Utah, Salt Lake City, Utah) for her assistance with illustrations.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; ASHBAUGH DG, 1967, LANCET, V2, P319; Aspal M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093188; BACHOFEN M, 1982, CLIN CHEST MED, V3, P35; Balczon R, 2021, FASEB J, V35, DOI 10.1096/fj.202100718R; Bastarache JA, 2008, AM J PHYSIOL-LUNG C, V294, pL874, DOI 10.1152/ajplung.00372.2007; Beitler Jeremy R, 2022, Lancet Respir Med, V10, P107, DOI 10.1016/S2213-2600(21)00157-0; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bos LD, 2017, THORAX, V72, P876, DOI 10.1136/thoraxjnl-2016-209719; Bos LDJ, 2022, INTENS CARE MED EXP, V10, DOI 10.1186/s40635-022-00435-w; Bos LDJ, 2021, LANCET RESP MED, V9, P1377, DOI 10.1016/S2213-2600(21)00365-9; Bos LDJ, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0317-2020; Bos LDJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01768-2020; Bos LDJ, 2019, AM J RESP CRIT CARE, V200, P42, DOI 10.1164/rccm.201809-1808OC; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2; Calfee CS, 2015, CRIT CARE MED, V43, P1790, DOI 10.1097/CCM.0000000000001089; Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Compagnone N, 2022, ACTA ANAESTH SCAND, V66, P223, DOI 10.1111/aas.13996; Constantin JM, 2019, LANCET RESP MED, V7, P870, DOI 10.1016/S2213-2600(19)30138-9; Constantin JM, 2010, CRIT CARE MED, V38, P1108, DOI 10.1097/CCM.0b013e3181d451ec; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Delucchi K, 2018, THORAX, V73, P439, DOI 10.1136/thoraxjnl-2017-211090; Duggal A, 2015, MINERVA ANESTESIOL, V81, P567; Eder AF, 2010, TRANSFUSION, V50, P1732, DOI 10.1111/j.1537-2995.2010.02652.x; Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC; Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Gajic O, 2007, CRIT CARE MED, V35, P1645, DOI 10.1097/01.CCM.0000269036.16398.0D; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 1998, AM J RESP CRIT CARE, V158, P3, DOI 10.1164/ajrccm.158.1.9708031; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433; Guerin C, 2015, INTENS CARE MED, V41, P222, DOI 10.1007/s00134-014-3583-2; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Heijnen NFL, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14693; Heijnen NFL, 2021, AM J RESP CRIT CARE, V203, P1503, DOI 10.1164/rccm.202006-2522OC; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976; Hough RF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124329; Husain-Syed F, 2016, AM J RESP CRIT CARE, V194, P402, DOI 10.1164/rccm.201602-0420CP; Ikegami M, 2008, J APPL PHYSIOL, V104, P1753, DOI 10.1152/japplphysiol.00875.2007; Juffermans NP, 2020, INTENS CARE MED, V46, P2450, DOI 10.1007/s00134-020-06303-z; Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994; Kerchberger VE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131206; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; Kneyber MCJ, 2014, AM J RESP CRIT CARE, V190, P258, DOI 10.1164/rccm.201401-0168CP; Lefrancais E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98178; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; Lin WC, 2021, CELL MOL LIFE SCI, V78, P4095, DOI 10.1007/s00018-021-03768-z; Livingstone SA, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.723217; Maddali MV, 2022, LANCET RESP MED, V10, P367, DOI 10.1016/S2213-2600(21)00461-6; Mart MF, 2020, EXPERT REV RESP MED, V14, P577, DOI 10.1080/17476348.2020.1743182; Martin TR, 2022, AM J RESP CELL MOL, V67, P284, DOI 10.1165/rcmb.2022-0089WS; Matsumoto S, 2020, AM J RESP CELL MOL, V63, P748, DOI 10.1165/rcmb.2020-0209OC; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Moazed F, 2022, AM J RESP CRIT CARE, V205, P927, DOI 10.1164/rccm.202105-1098OC; Moritz ED, 2019, MMWR-MORBID MORTAL W, V68, P985, DOI 10.15585/mmwr.mm6843e1; MULLIGAN MS, 1992, J CLIN INVEST, V90, P1600, DOI 10.1172/JCI116029; MURRAY JF, 1975, AM REV RESPIR DIS, V111, P716; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; NEWMAN W, 1993, J IMMUNOL, V150, P644; Nijmeh J, 2021, CELL BIOCHEM BIOPHYS, V79, P449, DOI 10.1007/s12013-021-01012-w; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pelosi P, 2003, EUR RESPIR J, V22, p48S, DOI 10.1183/09031936.03.00420803; Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI 10.1586/ERS.10.92; Petit M, 2022, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.797252; PETTY TL, 1975, AM REV RESPIR DIS, V111, P713; Peukert K, 2021, AM J RESP CRIT CARE, V204, P53, DOI 10.1164/rccm.202005-1916OC; Pierrakos C, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.730857; Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Reddy K, 2020, LANCET RESP MED, V8, P631, DOI 10.1016/S2213-2600(20)30124-7; Reilly JP, 2019, AM J RESP CRIT CARE, V199, P62, DOI 10.1164/rccm.201803-0435OC; Reilly JP, 2017, AM J RESP CRIT CARE, V196, P1113, DOI 10.1164/rccm.201702-0405CP; Reiss LK, 2018, CURR OPIN CRIT CARE, V24, P1, DOI 10.1097/MCC.0000000000000472; Reuss JE, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00920-z; Rizzo AN, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.154573; Sarma A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25040-5; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Shaver CM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98546; SIBBALD WJ, 1985, CHEST, V87, P585, DOI 10.1378/chest.87.5.585; Simou E, 2018, CHEST, V154, P58, DOI 10.1016/j.chest.2017.11.041; Sinha P, 2022, THORAX, V77, P13, DOI 10.1136/thoraxjnl-2021-217158; Sinha P, 2020, AM J RESP CRIT CARE, V202, P996, DOI 10.1164/rccm.202002-0347OC; Sinha P, 2020, LANCET RESP MED, V8, P247, DOI 10.1016/S2213-2600(19)30369-8; Sinha P, 2018, INTENS CARE MED, V44, P1859, DOI 10.1007/s00134-018-5378-3; Sommerfeld CG, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2016-3927; Thille AW, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1852-5; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tolle LB, 2013, J PATHOL, V229, P145, DOI 10.1002/path.4124; Toy P, 2022, ANN AM THORAC SOC, V19, P705, DOI 10.1513/AnnalsATS.202108-963CME; van Vught LA, 2022, AM J RESP CRIT CARE, V205, P483, DOI 10.1164/rccm.202112-2857ED; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Ware LB, 2020, INTENS CARE MED, V46, P2153, DOI 10.1007/s00134-020-06232-x; Ware LB, 2016, AM J RESP CRIT CARE, V193, P1143, DOI 10.1164/rccm.201507-1418OC; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Wendel Garcia PD, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03578-6; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wiersum-Osselton JC, 2011, TRANSFUSION, V51, P1278, DOI 10.1111/j.1537-2995.2010.02969.x; Yoshida T, 2019, CURR OPIN CRIT CARE, V25, P192, DOI 10.1097/MCC.0000000000000597; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	115	1	1	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1145	1156		10.1016/S0140-6736(22)01485-4	http://dx.doi.org/10.1016/S0140-6736(22)01485-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36070787	Bronze			2022-12-28	WOS:000877828800019
J	Manik, MK; Shi, Y; Li, SL; Zaydman, MA; Damaraju, N; Eastman, S; Smith, TG; Gu, WX; Masic, V; Mosaiab, T; Weagley, JS; Hancock, SJ; Vasquez, E; Hartley-Tassell, L; Kargios, N; Maruta, N; Lim, BYJ; Burdett, H; Landsberg, MJ; Schembri, MA; Prokes, I; Song, LJ; Grant, M; DiAntonio, A; Nanson, JD; Guo, M; Milbrandt, J; Ve, T; Kobe, B				Manik, Mohammad K.; Shi, Yun; Li, Sulin; Zaydman, Mark A.; Damaraju, Neha; Eastman, Samuel; Smith, Thomas G.; Gu, Weixi; Masic, Veronika; Mosaiab, Tamim; Weagley, James S.; Hancock, Steven J.; Vasquez, Eduardo; Hartley-Tassell, Lauren; Kargios, Nestoras; Maruta, Natsumi; Lim, Bryan Y. J.; Burdett, Hayden; Landsberg, Michael J.; Schembri, Mark A.; Prokes, Ivan; Song, Lijiang; Grant, Murray; DiAntonio, Aaron; Nanson, Jeffrey D.; Guo, Ming; Milbrandt, Jeffrey; Ve, Thomas; Kobe, Bostjan			Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling	SCIENCE			English	Article							NAD(+) CLEAVAGE ACTIVITY; TIR-DOMAIN; ASSEMBLY FORMATION; CRYSTAL-STRUCTURE; PROTEIN TCPB; CELL-DEATH; MECHANISMS; ENZYMES; REVEAL	Cyclic adenosine diphosphate (ADP)-ribose (cADPR) isomers are signaling molecules produced by bacterial and plant Toll/interleukin-1 receptor (TIR) domains via nicotinamide adenine dinucleotide (oxidized form) (NAD(+)) hydrolysis. We show that v-cADPR (2'cADPR) and v2-cADPR (3'cADPR) isomers are cyclized by O-glycosidic bond formation between the ribose moieties in ADPR. Structures of 2'cADPR-producing TIR domains reveal conformational changes that lead to an active assembly that resembles those of Toll-like receptor adaptor TIR domains. Mutagenesis reveals a conserved tryptophan that is essential for cyclization. We show that 3'cADPR is an activator of ThsA effector proteins from the bacterial antiphage defense system termed Thoeris and a suppressor of plant immunity when produced by the effector HopAM1. Collectively, our results reveal the molecular basis of cADPR isomer production and establish 3'cADPR in bacteria as an antiviral and plant immunity-suppressing signaling molecule.	[Manik, Mohammad K.; Li, Sulin; Gu, Weixi; Hancock, Steven J.; Maruta, Natsumi; Lim, Bryan Y. J.; Burdett, Hayden; Landsberg, Michael J.; Schembri, Mark A.; Nanson, Jeffrey D.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Manik, Mohammad K.; Li, Sulin; Gu, Weixi; Hancock, Steven J.; Maruta, Natsumi; Lim, Bryan Y. J.; Burdett, Hayden; Landsberg, Michael J.; Schembri, Mark A.; Nanson, Jeffrey D.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Shi, Yun; Masic, Veronika; Mosaiab, Tamim; Vasquez, Eduardo; Hartley-Tassell, Lauren; Ve, Thomas] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia; [Zaydman, Mark A.; DiAntonio, Aaron; Milbrandt, Jeffrey] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63100 USA; [Damaraju, Neha; DiAntonio, Aaron] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63100 USA; [Damaraju, Neha] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63100 USA; [Eastman, Samuel] Univ Nebraska Lincoln, Dept Plant Pathol, Lincoln, NE 68583 USA; [Smith, Thomas G.] Univ Nebraska Lincoln, Dept Chem, Lincoln, NE 68588 USA; [Weagley, James S.] Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63110 USA; [Kargios, Nestoras; Grant, Murray] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, England; [Prokes, Ivan; Song, Lijiang] Univ Warwick, Dept Chem, Coventry CV4 7AL, England; [Guo, Ming] Univ Nebraska Lincoln, Dept Agron & Hort, Lincoln, NE 68583 USA; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Manik, Mohammad K.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Manik, Mohammad K.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Smith, Thomas G.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Hancock, Steven J.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast BT12 6BA, North Ireland; [Burdett, Hayden] Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh EH9 3BF, Scotland	University of Queensland; University of Queensland; Griffith University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Washington University (WUSTL); University of Warwick; University of Warwick; University of Nebraska System; University of Nebraska Lincoln; University of Queensland; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Minnesota System; University of Minnesota Twin Cities; Queens University Belfast; University of Edinburgh	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.; Kobe, B (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Ve, T (corresponding author), Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia.; Kobe, B (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	t.ve@griffith.edu.au; b.kobe@uq.edu.au		Eastman, Samuel/0000-0003-1550-0828; Lim, Bryan Ying Jie/0000-0002-0554-909X; Gu, Weixi/0000-0002-1185-3557; Smith, Thomas/0000-0003-1366-8053; Shi, Yun/0000-0003-3365-4679; Mosaiab, Tamim/0000-0002-8251-0180; Li, Sulin/0000-0002-6116-4362	National Health and Medical Research Council (NHMRC) [1196590, 1107804, 1160570, 1071659, 1108859]; Australian Research Council (ARC) Future Fellowship [FT200100572]; ARC Laureate Fellowship [FL180100109]; ARC Discovery Early Career Researcher Award [DE170100783]; National Institutes of Health [R01NS087632]; Biotechnology and Biological Sciences Research Council [BB/V00400X/1]; Griffith University Postdoctoral Fellowship Scheme; Nebraska Soybean Board [1734]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); ARC Laureate Fellowship(Australian Research Council); ARC Discovery Early Career Researcher Award(Australian Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Griffith University Postdoctoral Fellowship Scheme; Nebraska Soybean Board	The work was supported by the National Health and Medical Research Council (NHMRC) (grants 1196590 to T.V., 1107804 and 1160570 to B.K. and T.V., 1071659 to B.K., and 1108859 to T.V.); an Australian Research Council (ARC) Future Fellowship (FT200100572 to T.V.); an ARC Laureate Fellowship (FL180100109 to B.K.); an ARC Discovery Early Career Researcher Award (DE170100783 to T.V.); the National Institutes of Health (R01NS087632 to J.M. and A.D.); and the Biotechnology and Biological Sciences Research Council (BB/V00400X/1 to M.Gr. and L.S.). Y.S. was a recipient of a Griffith University Postdoctoral Fellowship Scheme. Nebraska Soybean Board project no. 1734 funded the research assistantship for S.E.	Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Breen S, 2022, PLANT CELL ENVIRON, V45, P3001, DOI 10.1111/pce.14408; Burroughs AM, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00365-20; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104; Clabbers MTB, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22590-6; Coronas-Serna JM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1007979; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Drenichev MS, 2019, PHYTOCHEMISTRY, V157, P128, DOI 10.1016/j.phytochem.2018.10.016; Duxbury Z, 2020, P NATL ACAD SCI USA, V117, P18832, DOI 10.1073/pnas.2001185117; Eastman Samuel, 2022, Mol Plant Microbe Interact, V35, P964, DOI 10.1094/MPMI-06-22-0132-CR; Eastman S, 2022, NEW PHYTOL, V233, P890, DOI 10.1111/nph.17805; Essuman K, 2022, SCIENCE, V377, P486, DOI 10.1126/science.abo0001; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Felix C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0053-y; Figley MD, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.02.009; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Hogrel G, 2022, NATURE, V608, P808, DOI 10.1038/s41586-022-05070-9; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Huang SJ, 2022, SCIENCE, V377, P487, DOI 10.1126/science.abq3297; Jia AL, 2022, SCIENCE, V377, P488, DOI 10.1126/science.abq8180; Ka D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16703-w; Kaplan-Turkoz B, 2013, FEBS LETT, V587, P3412, DOI 10.1016/j.febslet.2013.09.007; Koopal B, 2022, CELL, V185, P1471, DOI 10.1016/j.cell.2022.03.012; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Leavitt A., 2022, BIORXIV, V2005, DOI [10.1101/2022.05.03.490397, DOI 10.1101/2022.05.03.490397]; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Hulin MT, 2022, bioRxiv, DOI 10.1101/2022.06.07.495176; Ma SC, 2020, SCIENCE, V370, P1184, DOI 10.1126/science.abe3069; Martin R, 2020, SCIENCE, V370, P1185, DOI 10.1126/science.abd9993; Maruta N, 2022, IMMUNOGENETICS, V74, P5, DOI 10.1007/s00251-021-01242-5; Morehouse BR, 2022, NATURE, V608, P803, DOI 10.1038/s41586-022-04999-1; Morehouse BR, 2020, NATURE, V586, P429, DOI 10.1038/s41586-020-2719-5; Nimma S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.784484; Nimma S, 2017, CURR OPIN STRUC BIOL, V43, P122, DOI 10.1016/j.sbi.2016.12.014; Ofir G, 2021, NATURE, V600, P116, DOI 10.1038/s41586-021-04098-7; Rana RR, 2013, MED MICROBIOL IMMUN, V202, P1, DOI 10.1007/s00430-012-0253-2; Shi Y, 2022, MOL CELL, V82, P1643, DOI 10.1016/j.molcel.2022.03.007; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Tal N, 2021, CELL, V184, P5728, DOI 10.1016/j.cell.2021.09.031; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Vajjhala PR, 2017, MOL IMMUNOL, V86, P23, DOI 10.1016/j.molimm.2017.02.012; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; Ve T, 2015, APOPTOSIS, V20, P250, DOI 10.1007/s10495-014-1064-2; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Weagley JS, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110738; Yu DL, 2022, CELL, V185, P2370, DOI 10.1016/j.cell.2022.04.032; Zabala MDT, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.74, 10.1038/nplants.2015.74]	54	0	0	21	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2022	377	6614					1510	+		10.1126/science.adc8969	http://dx.doi.org/10.1126/science.adc8969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6Q6HL	36048923	Green Published			2022-12-28	WOS:000891713300021
J	Perez-Carbonell, L; Mignot, E; Leschziner, G; Dauvilliers, Y				Perez-Carbonell, Laura; Mignot, Emmanuel; Leschziner, Guy; Dauvilliers, Yves			Understanding and approaching excessive daytime sleepiness	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; IDIOPATHIC HYPERSOMNIA; WAKE DISTURBANCES; COGNITIVE DECLINE; AMERICAN ACADEMY; NIGHTTIME SLEEP; APNEA PATIENTS; HEART-DISEASE; DOUBLE-BLIND	Excessive daytime sleepiness (EDS) is a public health issue. However, it remains largely undervalued, scarcely diagnosed, and poorly supported. Variations in the definition of EDS and limitations in clinical assessment lead to difficulties in its epidemiological study, but the relevance of this symptom from a socioeconomic perspective is inarguable. EDS might be a consequence of several behavioural issues leading to insufficient or disrupted sleep, as well as a consequence of sleep disorders including sleep apnoea syndrome, circadian disorders, central hypersomnolence disorders (narcolepsy and idiopathic hypersomnia), other medical or psychiatric conditions, or medications. Furthermore, EDS can have implications for health as it is thought to act as a risk factor for other conditions, such as cardiovascular and neurodegenerative disorders. Because of the heterogeneous causes of EDS and the complexity of its pathophysiology, management will largely depend on the cause, with the final aim of making treatment specific to the individual using precision medicine and personalised medicine.	[Perez-Carbonell, Laura; Leschziner, Guy] Guys & St Thomas NHS Fdn Trust, Sleep Disorders Ctr, London SE1 1UL, England; [Mignot, Emmanuel] Stanford Univ, Ctr Narcolepsy, Palo Alto, CA USA; [Leschziner, Guy] Kings Coll London, Inst Psychiat Psychol & Neurosci, Basic & Clin Neurosci, London, England; [Dauvilliers, Yves] Univ Montpellier, Ctr Natl Reference Narcolepsie Hypersomnies, Unite Troubles Sommeil, Dept Neurol,Hop Gui de Chauliac,Inserm INM, Montpellier, France	Guy's & St Thomas' NHS Foundation Trust; Stanford University; University of London; King's College London; Universite de Montpellier; CHU de Montpellier	Perez-Carbonell, L (corresponding author), Guys & St Thomas NHS Fdn Trust, Sleep Disorders Ctr, London SE1 1UL, England.	laura.perezcarbonell@gstt.nhs.uk						Alami YZ, 2018, J OCCUP MED TOXICOL, V13, DOI 10.1186/s12995-018-0203-z; Ambati A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005753118; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arand DL, 2019, HAND CLINIC, V160, P393, DOI 10.1016/B978-0-444-64032-1.00026-6; Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Auger RR, 2005, SLEEP, V28, P667, DOI 10.1093/sleep/28.6.667; Avis KT, 2015, J CLIN SLEEP MED, V11, P1281, DOI 10.5664/jcsm.5186; Baillieul S, 2022, LANCET NEUROL, V21, P78, DOI 10.1016/S1474-4422(21)00321-5; Barateau Lucie, 2021, Sleep, V44, DOI 10.1093/sleep/zsab012; Barateau L, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0763-0; Basille D, 2020, RESPIR MED RES-FRANC, V78, DOI 10.1016/j.resmer.2020.100787; Bassetti CLA, 2021, EUR J NEUROL, V28, P2815, DOI 10.1111/ene.14888; Bassetti CLA, 2019, NAT REV NEUROL, V15, P519, DOI 10.1038/s41582-019-0226-9; Benito-Leon J, 2013, J PSYCHIATR RES, V47, P1998, DOI 10.1016/j.jpsychires.2013.09.007; Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5; Berger M, 2021, J SLEEP RES, V30, DOI 10.1111/jsr.13069; Berkowski JA, 2016, SLEEP MED CLIN, V11, P365, DOI 10.1016/j.jsmc.2016.04.005; BILLIARD M, 1994, J PSYCHOSOM RES, V38, P41, DOI 10.1016/0022-3999(94)90134-1; Bisogni V, 2017, EXPERT REV RESP MED, V11, P711, DOI 10.1080/17476348.2017.1358619; Blachier M, 2012, ANN NEUROL, V71, P661, DOI 10.1002/ana.22656; Bosco A, 2018, NEUROLOGY, V90, pE479, DOI 10.1212/WNL.0000000000004911; Boscolo-Berto R, 2012, SLEEP MED REV, V16, P431, DOI 10.1016/j.smrv.2011.09.001; Bourgin P, 2008, LANCET NEUROL, V7, P649, DOI 10.1016/S1474-4422(08)70140-6; Brass SD, 2014, J CLIN SLEEP MED, V10, P1025, DOI 10.5664/jcsm.4044; Burks SV, 2016, SLEEP, V39, P967, DOI 10.5665/sleep.5734; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cortese S, 2006, SLEEP, V29, P504; Dauvilliers Y, 2009, J NEUROL NEUROSUR PS, V80, P636, DOI 10.1136/jnnp.2008.161588; Dauvilliers Y, 2022, LANCET NEUROL, V21, P53, DOI 10.1016/S1474-4422(21)00368-9; Dauvilliers Y, 2020, AM J RESP CRIT CARE, V201, P1135, DOI 10.1164/rccm.201907-1284OC; Dauvilliers Y, 2019, NEUROLOGY, V92, pE1754, DOI 10.1212/WNL.0000000000007264; Dauvilliers Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00350; Dauvilliers Y, 2017, NEUROLOGY, V88, P1358, DOI 10.1212/WNL.0000000000003787; Dauvilliers Y, 2013, LANCET NEUROL, V12, P1068, DOI 10.1016/S1474-4422(13)70225-4; Dauvilliers Yves A, 2012, Sleep Med Rev, V16, P539, DOI 10.1016/j.smrv.2012.01.001; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Edgar Dale M., 1996, V11, P253; Edgar DM, 1986, THESIS U CALIFORNIA, P360; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Empana JP, 2009, STROKE, V40, P1219, DOI 10.1161/STROKEAHA.108.530824; Evangelista E, 2022, SLEEP, V45, DOI 10.1093/sleep/zsab220; Evangelista E, 2018, ANN NEUROL, V83, P235, DOI 10.1002/ana.25141; Fernandez-Mendoza J, 2015, SLEEP, V38, P351, DOI 10.5665/sleep.4488; Gaig C, 2012, CURR NEUROL NEUROSCI, V12, P205, DOI 10.1007/s11910-011-0248-1; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; Gasa M, 2013, J SLEEP RES, V22, P389, DOI 10.1111/jsr.12039; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Harris AL, 2014, TRANSL STROKE RES, V5, P292, DOI 10.1007/s12975-013-0293-y; Hermann DM, 2008, STROKE, V39, P62, DOI 10.1161/STROKEAHA.107.494955; Hermann DM, 2016, NEUROLOGY, V87, P1407, DOI 10.1212/WNL.0000000000003037; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Iranzo A, 2016, SLEEP MED CLIN, V11, P1, DOI 10.1016/j.jsmc.2015.10.011; Jaumally BA, 2021, SLEEP BREATH, V25, P1063, DOI 10.1007/s11325-020-02151-9; Jaussent I, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz249; Jaussent I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01547-0; Jaussent I, 2012, SLEEP, V35, P1201, DOI 10.5665/sleep.2070; Jaussent I, 2011, SLEEP, V34, P1103, DOI 10.5665/SLEEP.1170; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaplan KA, 2009, SLEEP MED REV, V13, P275, DOI 10.1016/j.smrv.2008.09.001; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Khalsa SBS, 2002, J SLEEP RES, V11, P53, DOI 10.1046/j.1365-2869.2002.00276.x; Kornum BR, 2011, CURR OPIN NEUROBIOL, V21, P897, DOI 10.1016/j.conb.2011.09.003; Kushida CA, 2022, SLEEP, V45, DOI 10.1093/sleep/zsab200; Lammers GJ, 2020, SLEEP MED REV, V52, DOI 10.1016/j.smrv.2020.101306; Leger D, 2020, SLEEP MED REV, V51, DOI 10.1016/j.smrv.2020.101275; Leng Y, 2019, ALZHEIMERS DEMENT, V15, P1039, DOI 10.1016/j.jalz.2019.04.009; Leu-Semenescu S, 2017, REV NEUROL-FRANCE, V173, P32, DOI 10.1016/j.neurol.2016.09.015; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Liu YP, 2019, SLEEP MED, V53, P1, DOI 10.1016/j.sleep.2018.08.028; Lopez R, 2020, J ATTEN DISORD, V24, P555, DOI 10.1177/1087054718775826; Luppi PH, 2017, SLEEP MED REV, V32, P85, DOI 10.1016/j.smrv.2016.03.002; Mahowald ML, 2000, SLEEP MED, V1, P179, DOI 10.1016/S1389-9457(00)00029-0; Manconi M, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00311-z; Marinus J, 2018, LANCET NEUROL, V17, P559, DOI 10.1016/S1474-4422(18)30127-3; Maski K, 2022, J CLIN SLEEP MED, V18, P289, DOI 10.5664/jcsm.9638; Maski K, 2021, J CLIN SLEEP MED, V17, P1895, DOI 10.5664/jcsm.9326; Mazzotti DR, 2019, AM J RESP CRIT CARE, V200, P493, DOI 10.1164/rccm.201808-1509OC; Merdad RA, 2017, SLEEP MED CLIN, V12, P415, DOI 10.1016/j.jsmc.2017.03.014; Meyer N, 2022, LANCET, V400, P1061, DOI 10.1016/S0140-6736(22)00877-7; Moradi A, 2019, TRANSPORT RES F-TRAF, V65, P620, DOI 10.1016/j.trf.2018.09.013; Moreira GA, 2017, SLEEP MED CLIN, V12, P407, DOI 10.1016/j.jsmc.2017.03.013; Nakakubo S, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.05.020; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Nigam G, 2018, NAT SCI SLEEP, V10, P35, DOI 10.2147/NSS.S125839; NOFZINGER EA, 1991, AM J PSYCHIAT, V148, P1177; Ohayon MM, 2013, ANN NEUROL, V73, P785, DOI 10.1002/ana.23818; Ohayon MM, 2012, ARCH GEN PSYCHIAT, V69, P71, DOI 10.1001/archgenpsychiatry.2011.1240; Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001; Pepin JL, 2009, EUR RESPIR J, V33, P1062, DOI 10.1183/09031936.00016808; Pepin JL, 2021, CHEST, V159, P1598, DOI 10.1016/j.chest.2020.09.281; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Perez-Carbonell L, 2020, J THORAC DIS, V12, pS176, DOI 10.21037/jtd-cus-2020-002; Perlis ML, 2022, LANCET, V400, P1047, DOI 10.1016/S0140-6736(22)00879-0; Peter-Derex L, 2015, SLEEP MED REV, V19, P29, DOI 10.1016/j.smrv.2014.03.007; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pizza F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129386; Plante DT, 2017, SLEEP MED REV, V31, P48, DOI 10.1016/j.smrv.2016.01.004; Plante DT, 2016, J CLIN SLEEP MED, V12, P571, DOI 10.5664/jcsm.5694; Popp RFJ, 2017, SLEEP MED REV, V32, P95, DOI 10.1016/j.smrv.2016.03.004; Porez-Carbonell L, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0595-9; Quera-Salva MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012382; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Rocca FL, 2016, SLEEP, V39, P1389, DOI 10.5665/sleep.5970; Rotenberg BW, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0156-0; Roth T, 2020, J CLIN PSYCHIAT, V81; Royant-Parola S, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0236404, 10.1371/journal.pone.0236404.r001, 10.1371/journal.pone.0236404.r002, 10.1371/journal.pone.0236404.r003, 10.1371/journal.pone.0236404.r004]; Sagaspe P, 2010, J SLEEP RES, V19, P578, DOI 10.1111/j.1365-2869.2009.00818.x; Salva MAQ, 2014, SLEEP MED, V15, P23, DOI 10.1016/j.sleep.2013.06.018; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Saper CB, 2017, CURR OPIN NEUROBIOL, V44, P186, DOI 10.1016/j.conb.2017.03.021; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Schweitzer PK, 2019, AM J RESP CRIT CARE, V199, P1421, DOI 10.1164/rccm.201806-1100OC; Shah NM, 2018, CURR OPIN PULM MED, V24, P561, DOI 10.1097/MCP.0000000000000527; Shah NM, 2020, J THORAC DIS, V12, pS248, DOI 10.21037/jtd-cus-2020-012; Siegel JM, 2022, LANCET NEUROL, V21, P937, DOI 10.1016/S1474-4422(22)00210-1; So JY, 2020, AM J KIDNEY DIS, V75, P782, DOI 10.1053/j.ajkd.2019.09.010; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stepnowsky C, 2019, J CLIN SLEEP MED, V15, P235, DOI 10.5664/jcsm.7624; Theorell-Haglow J, 2015, SLEEP, V38, P1995, DOI 10.5665/sleep.5258; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thorpy MJ, 2019, ANN NEUROL, V85, P359, DOI 10.1002/ana.25423; Veasey SC, 2019, NEW ENGL J MED, V380, P1442, DOI 10.1056/NEJMcp1816152; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Ward KL, 2013, J CLIN SLEEP MED, V9, P1013, DOI 10.5664/jcsm.3072; Watson NF, 2015, J CLIN SLEEP MED, V11, P1335, DOI 10.5664/jcsm.5200; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2014, LANCET NEUROL, V13, P1017, DOI 10.1016/S1474-4422(14)70172-3; Zalai D, 2017, SLEEP MED CLIN, V12, P429, DOI 10.1016/j.jsmc.2017.03.015	134	5	5	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					1033	1046		10.1016/S0140-6736(22)01018-2	http://dx.doi.org/10.1016/S0140-6736(22)01018-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5S3JP	36115367				2022-12-28	WOS:000875091000004
J	Reardon, S				Reardon, Sara			DID THIS GENE GIVE MODERN HUMAN BRAINS THEIR EDGE?	NATURE			English	News Item						Brain; Genetics; Evolution		A mutation present in modern humans drives greater neuron growth than does an ancient hominin version.										Pinson A., 2022, SCIENCE, V377, peabl6422, DOI [10.1126/science.abl6422, DOI 10.1126/SCIENCE.ABL6422]; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886	2	0	0	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					665	666		10.1038/d41586-022-02895-2	http://dx.doi.org/10.1038/d41586-022-02895-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0SA	36076025	Bronze			2022-12-28	WOS:000855795500005
J	Roehr, B				Roehr, Bob			Long covid: protesters outside the White House demand better care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o2266	10.1136/bmj.o2266	http://dx.doi.org/10.1136/bmj.o2266			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126984	Bronze			2022-12-28	WOS:000869963500011
J	Tagg, A				Tagg, Andrew			The Shortest Stories and the Power of Parental Presence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a pediatrician describes his lingering questions about the care his daughter received during her very brief life while he was barred from operating room and compares it to being present when another daughter experienced a stressful birth.	[Tagg, Andrew] Western Hlth Melbourne, Melbourne, Vic, Australia; [Tagg, Andrew] Univ Melbourne, Melbourne, Vic, Australia	University of Melbourne	Tagg, A (corresponding author), Western Hlth, Emergency Dept, 160 Gordon St, Footscray, Vic 3040, Australia.	andrewjtagg@gmail.com							0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1045	1046		10.1001/jama.2022.15544	http://dx.doi.org/10.1001/jama.2022.15544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125469				2022-12-28	WOS:000862909200015
J	Technau, KG; Mazanderani, AH				Technau, Karl-Gunter; Mazanderani, Ahmad Haeri			Point-of-care HIV diagnosis for infants: the outcomes we need to achieve	LANCET			English	Editorial Material									[Technau, Karl-Gunter; Mazanderani, Ahmad Haeri] Univ Witwatersrand, Empilweni Serv & Res Unit, Rahima Moosa Mother & Child Hosp, Fac Hlth Sci, ZA-2093 Johannesburg, South Africa; [Technau, Karl-Gunter; Mazanderani, Ahmad Haeri] Univ Witwatersrand, Dept Paediat & Child Hlth, Rahima Moosa Mother & Child Hosp, Fac Hlth Sci, ZA-2093 Johannesburg, South Africa; [Mazanderani, Ahmad Haeri] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Technau, KG (corresponding author), Univ Witwatersrand, Empilweni Serv & Res Unit, Rahima Moosa Mother & Child Hosp, Fac Hlth Sci, ZA-2093 Johannesburg, South Africa.; Technau, KG (corresponding author), Univ Witwatersrand, Dept Paediat & Child Hlth, Rahima Moosa Mother & Child Hosp, Fac Hlth Sci, ZA-2093 Johannesburg, South Africa.	karl-gunter.technau@wits.ac.za						Drain PK, 2020, LANCET HIV, V7, pE229, DOI 10.1016/S2352-3018(19)30402-3; du Plooy E, 2020, PEDIATR INFECT DIS J, V39, P840, DOI 10.1097/INF.0000000000002684; Heerink F, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1630100; Kufa T, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25487; Luo R, 2022, LANCET, V400, P887, DOI 10.1016/S0140-6736(22)01492-1; Modi S, 2018, JAIDS-J ACQ IMM DEF, V78, pS107, DOI 10.1097/qai.0000000000001736; Moshoeshoe M, 2021, WOMENS HEALTH, V17, DOI 10.1177/17455065211058565; Mpinganjira S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8373-x; Nhampossa T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021410; Technau KG, 2018, LANCET HIV, V5, pE706, DOI 10.1016/S2352-3018(18)30251-0; Tellie M, 2020, AFR J NURS MIDWIFERY, V22, DOI 10.25159/2520-5293/6937; UNAIDS, 2020, 2020 WORLD AID DAY R; UNAIDS, 2020, GLOB AIDS STRAT 2021; UNAIDS, 2020, AIDSINFO	14	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					864	865						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116466				2022-12-28	WOS:000890180700002
J	Eisenstein, M				Eisenstein, Michael			A better way to biopsy	NATURE			English	Editorial Material																		Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Basourakos SP, 2022, EUR UROL OPEN SCI, V37, P53, DOI 10.1016/j.euros.2022.01.001; Kasivisvanathan V, 2018, NEW ENGL J MED, V378, P1767, DOI 10.1056/NEJMoa1801993; Liss MA, 2017, J UROLOGY, V198, P329, DOI 10.1016/j.juro.2017.01.103; Rosario DJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7894	5	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S34	S35		10.1038/d41586-022-02866-7	http://dx.doi.org/10.1038/d41586-022-02866-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104409	Bronze			2022-12-28	WOS:000855141600003
J	Ye, Y				Ye, Yvaine			'THREE-PERSON' EMBRYOS DEVELOP NORMALLY IN FIRST SAFETY STUDY	NATURE			English	News Item																		Kang E., 2016, NATURE, V540, P270, DOI [10.1038/nature20592, DOI 10.1038/NATURE20592]; Qi SY, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001741	2	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					449	450						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M5CY	36068410	Bronze			2022-12-28	WOS:000853342100004
J	Jonas, DE; Vander Schaaf, EB; Riley, S; Allison, BA; Middleton, JC; Baker, C; Ali, R; Voisin, CE; LeBlanc, ES				Jonas, Daniel E.; Vander Schaaf, Emily B.; Riley, Sean; Allison, Bianca A.; Middleton, Jennifer Cook; Baker, Claire; Ali, Rania; Voisin, Christiane E.; LeBlanc, Erin S.			Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							YOUTH; PREVALENCE	IMPORTANCE Of youths diagnosed with type 2 diabetes, many develop microvascular complications by young adulthood. OBJECTIVE To review the evidence on benefits and harms of screening children and adolescents for prediabetes and type 2 diabetes to inform the US Preventive Services Task Force (USPSTF). DATA SOURCES PubMed/MEDLINE, Cochrane Library, and trial registries through May 3, 2021; references; experts; literature surveillance through July 22, 2022. STUDY SELECTION English-language controlled studies evaluating screening or interventions for prediabetes or type 2 diabetes that was screen detected or recently diagnosed. DATA EXTRACTION AND SYNTHESIS Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. MAIN OUTCOMES AND MEASURES Mortality, cardiovascular morbidity, diabetes-related morbidity, development of diabetes, quality of life, and harms. RESULTS This review included 8 publications (856 participants; mean age, 14 years [range, 10-17 years]). Of those, 6 were from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study. No eligible studies directly evaluated the benefits or harms of screening. One randomized clinical trial (RCT) (TODAY; n = 699 adolescents with obesity; mean age, 14 years) comparing metformin, metformin plus rosiglitazone, and metformin plus lifestyle intervention reported that 2 youths with recently diagnosed diabetes developed kidney impairment (0 vs 1 vs 1, respectively; P > .99) and 11 developed diabetic ketoacidosis (5 vs 3 vs 3, respectively; P = .70). One RCT of 75 adolescents (mean age, 13 years) with obesity with prediabetes compared an intensive lifestyle intervention with standard care and reported that no participants in either group developed diabetes, although follow-up was only 6 months. Regarding harms of interventions, 2 RCTs assessing different comparisons enrolled youths with recently diagnosed diabetes. Major hypoglycemic events were reported by less than 1% of participants. Minor hypoglycemic events were more common among youths treated with metformin plus rosiglitazone than among those treated with metformin or metformin plus lifestyle intervention in TODAY (8.2% vs 4.3% vs 3.4%, P = .05). In 1 study, gastrointestinal adverse events were more commonly reported by those taking metformin than by those taking placebo (abdominal pain: 25% vs 12%; nausea/vomiting: 17% vs 10%; P not reported). CONCLUSIONS AND RELEVANCE No eligible studies directly evaluated the benefits or harms of screening for prediabetes and type 2 diabetes in children and adolescents. For youths with prediabetes or recently diagnosed (not screen-detected) diabetes, the only eligible trials reported few health outcomes and found no difference between groups, although evidence was limited by substantial imprecision and a duration of follow-up likely insufficient to assess health outcomes.	[Jonas, Daniel E.; Riley, Sean; Middleton, Jennifer Cook; Baker, Claire; Ali, Rania; Voisin, Christiane E.] Univ N Carolina, Evidence Based Practice Ctr, RTI Int, Chapel Hill, NC 27515 USA; [Jonas, Daniel E.; Riley, Sean; Voisin, Christiane E.] Ohio State Univ, Dept Internal Med, Columbus, OH 43221 USA; [Vander Schaaf, Emily B.; Allison, Bianca A.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27515 USA; [Allison, Bianca A.; Middleton, Jennifer Cook; Baker, Claire] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA; [Ali, Rania] RTI Int, Res Triangle Pk, NC USA; [LeBlanc, Erin S.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Kaiser Permanente	Jonas, DE (corresponding author), Ohio State Univ, Dept Internal Med, Div Gen Internal Med, 2050 Kenny Rd, Columbus, OH 43221 USA.	Daniel.Jonas@osumc.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA290201500007I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA290201500007I, Task Order 9, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Andes LJ, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2019.4498; Arslanian S, 2018, DIABETES CARE, V41, P2648, DOI 10.2337/dci18-0052; Bjornstad P, 2021, NEW ENGL J MED, V385, P416, DOI 10.1056/NEJMoa2100165; Copeland KC, 2013, DIABETES CARE, V36, P1742, DOI 10.2337/dc12-2534; Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642; Dabelea D, 2017, JAMA-J AM MED ASSOC, V317, P825, DOI 10.1001/jama.2017.0686; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Divers J, 2020, MMWR-MORBID MORTAL W, V69, P161, DOI 10.15585/mmwr.mm6906a3; Golden SH, 2019, DIABETOLOGIA, V62, P1751, DOI 10.1007/s00125-019-4968-0; Hirst K, 2015, PEDIATR DIABETES, V16, P39, DOI 10.1111/pedi.12119; Jonas DE, 2021, JAMA-J AM MED ASSOC, V326, P744, DOI 10.1001/jama.2021.10403; Jones KL, 2002, DIABETES CARE, V25, P89, DOI 10.2337/diacare.25.1.89; Kelsey MM, 2016, PEDIATR DIABETES, V17, P212, DOI 10.1111/pedi.12264; Marcus MD, 2017, PEDIATR OBES, V12, P337, DOI 10.1111/ijpo.12148; National Interagency Coordination Center (NICC), 2020, NAT DIAB STAT REP WE; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Pinhas-Hamiel O, 2007, PEDIATR DIABETES, V8, P16, DOI 10.1111/j.1399-5448.2007.00330.x; Savoye M, 2014, DIABETES CARE, V37, P317, DOI 10.2337/dc13-1571; United Nations Development Programme, 2019, INCOME AVERAGES TODA; US Preventive Services Task Force, 2021, US PREV SERV TASK FO; Vajravelu ME, 2020, PEDIATR DIABETES, V21, P743, DOI 10.1111/pedi.13028; Vander Schaff E., 2022, AHRQ PUBLICATION; West SL., 2010, COMP EFFECTIVENESS R; White NH, 2013, DIABETES CARE, V36, P1765, DOI 10.2337/dc12-2390; Wilfley DE, 2010, INT J OBESITY, V34, P217, DOI 10.1038/ijo.2009.195; Wolfsdorf JI, 2018, PEDIATR DIABETES, V19, P155, DOI 10.1111/pedi.12701; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	28	3	3	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					968	979		10.1001/jama.2022.7957	http://dx.doi.org/10.1001/jama.2022.7957			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098720				2022-12-28	WOS:000855222400022
J	Ilanges, A; Shiao, R; Shaked, J; Luo, JD; Yu, XF; Friedman, JM				Ilanges, Anoj; Shiao, Rani; Shaked, Jordan; Luo, Ji-Dung; Yu, Xiaofei; Friedman, Jeffrey M.			Brainstem ADCYAP1(+) neurons control multiple aspects of sickness behaviour	NATURE			English	Article							AREA POSTREMA; CIRCUMVENTRICULAR ORGANS; MECHANISMS; TOLERANCE; RECEPTOR; SYSTEM	Infections induce a set of pleiotropic responses in animals, including anorexia, adipsia, lethargy and changes in temperature, collectively termed sickness behaviours(1). Although these responses have been shown to be adaptive, the underlying neural mechanisms have not been elucidated(2-4). Here we use of a set of unbiased methodologies to show that a specific subpopulation of neurons in the brainstem can control the diverse responses to a bacterial endotoxin (lipopolysaccharide (LPS)) that potently induces sickness behaviour. Whole-brain activity mapping revealed that subsets of neurons in the nucleus of the solitary tract (NTS) and the area postrema (AP) acutely express FOS after LPS treatment, and we found that subsequent reactivation of these specific neurons in FOS2A-iCreERT2 (also known as TRAP2) mice replicates the behavioural and thermal component of sickness. In addition, inhibition of LPS-activated neurons diminished all of the behavioural responses to LPS. Single-nucleus RNA sequencing of the NTS-AP was used to identify LPS-activated neural populations, and we found that activation of ADCYAP1(+) neurons in the NTS-AP fully recapitulates the responses elicited by LPS. Furthermore, inhibition of these neurons significantly diminished the anorexia, adipsia and locomotor cessation seen after LPS injection. Together these studies map the pleiotropic effects of LPS to a neural population that is both necessary and sufficient for canonical elements of the sickness response, thus establishing a critical link between the brain and the response to infection.	[Ilanges, Anoj; Shiao, Rani; Shaked, Jordan] Rockefeller Univ, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA; [Luo, Ji-Dung] Rockefeller Univ, Bioinformat Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Yu, Xiaofei] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China; [Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Fudan University; Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu		Friedman, Jeffrey M./0000-0003-2152-0868; Shaked, Jordan/0000-0002-1704-2579	JBP Foundation; Howard Hughes Medical Institute	JBP Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank I. E.Araujo, L.Vosshall, P.Rajasethupathy and W.Freiwald for feedback on the work; members of the laboratory of J.M.F. for discussion and reagents; members of the laboratory of I.E.A. for feedback; H.Dong from the Rockefeller University Genomics Core for technical assistance with snRNA-seq experiments; and J.Petrillo from Rockefeller University Precision Fabrication Facility for design and technical assistance with the home-cage phenotyping systems. Elements of Figs. 2a, 3a,j and 4c and Extended Data Figs. 1a were created with BioRender.com. J.M.F. acknowledges support from the JBP Foundation and the Howard Hughes Medical Institute.	Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Barth SW, 2004, BRAIN RES, V997, P97, DOI 10.1016/j.brainres.2003.10.040; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Blatteis CM, 1998, ANN NY ACAD SCI, V840, P608, DOI 10.1111/j.1749-6632.1998.tb09600.x; BORISON HL, 1989, PROG NEUROBIOL, V32, P351, DOI 10.1016/0301-0082(89)90028-2; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Chi J, 2018, JOVE-J VIS EXP, DOI 10.3791/58271; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Dantzer R, 1998, ANN NY ACAD SCI, V856, P132, DOI 10.1111/j.1749-6632.1998.tb08321.x; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DeNardo LA, 2019, NAT NEUROSCI, V22, P460, DOI 10.1038/s41593-018-0318-7; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; Gaublomme JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10756-2; Grindberg RV, 2013, P NATL ACAD SCI USA, V110, P19802, DOI 10.1073/pnas.1319700110; Han WF, 2018, CELL, V175, P665, DOI [10.1016/j.cell.2018.08.049, 10.1016/j.cell.2018.10.018]; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kent S, 1996, NEUROSCI BIOBEHAV R, V20, P171, DOI 10.1016/0149-7634(95)00037-F; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Ludwig MQ, 2021, NAT METAB, V3, P530, DOI 10.1038/s42255-021-00363-1; Matikainen-Ankney BA, 2021, ELIFE, V10, DOI 10.7554/eLife.66173; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Nguyen KP, 2016, J NEUROSCI METH, V267, P108, DOI 10.1016/j.jneumeth.2016.04.003; Patel AR, 2022, AM J PHYSIOL-GASTR L, V322, pG247, DOI 10.1152/ajpgi.00146.2021; Price CJ, 2008, NEUROSCIENTIST, V14, P182, DOI 10.1177/1073858407311100; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; RITTER S, 1980, BRAIN RES, V201, P501, DOI 10.1016/0006-8993(80)91061-6; Rodriguez A, 2018, METHODS ECOL EVOL, V9, P460, DOI 10.1111/2041-210X.12874; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Takahashi Y, 1997, AM J PHYSIOL-REG I, V273, pR1690, DOI 10.1152/ajpregu.1997.273.5.R1690; Vanderburg C., 2020, FRESH FROZEN MOUSE B; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10715-x; Wess J, 2013, TRENDS PHARMACOL SCI, V34, P385, DOI 10.1016/j.tips.2013.04.006; WING EJ, 1980, INFECT IMMUN, V28, P771; Yao ZL, 2016, J IMMUNOL, V197, P2390, DOI 10.4049/jimmunol.1600702; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zhang CC, 2021, NEURON, V109, DOI 10.1016/j.neuron.2020.11.010	50	2	2	22	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					761	+		10.1038/s41586-022-05161-7	http://dx.doi.org/10.1038/s41586-022-05161-7		SEP 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U8YX	36071158	Green Published, hybrid			2022-12-28	WOS:000852585300013
J	Sammoud, S; Hammami, N				Sammoud, Skander; Hammami, Nadia			A posterior inferior cerebellar artery aneurysm ruptures during three-dimensional rotational angiography: need to think fast and act faster	LANCET			English	Editorial Material									[Sammoud, Skander; Hammami, Nadia] Natl Inst Neurol Mongi Ben Hamida, Dept Radiol, Tunis 1006, Tunisia; [Sammoud, Skander; Hammami, Nadia] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia	Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Sammoud, S (corresponding author), Natl Inst Neurol Mongi Ben Hamida, Dept Radiol, Tunis 1006, Tunisia.	skander119767@gmail.com							0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					768	768						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058224				2022-12-28	WOS:000860483700019
J	Zhang, J; Hansen, LG; Gudich, O; Viehrig, K; Lassen, LMM; Schrubbers, L; Adhikari, KB; Rubaszka, P; Carrasquer-Alvarez, E; Chen, L; D'Ambrosio, V; Lehka, B; Haidar, AK; Nallapareddy, S; Giannakou, K; Laloux, M; Arsovska, D; Jorgensen, MAK; Chan, LJG; Kristensen, M; Christensen, HB; Sudarsan, S; Stander, EA; Baidoo, E; Petzold, CJ; Wulff, T; O'Connor, SE; Courdavault, V; Jensen, MK; Keasling, JD				Zhang, Jie; Hansen, Lea G.; Gudich, Olga; Viehrig, Konrad; Lassen, Laerke M. M.; Schruebbers, Lars; Adhikari, Khem B.; Rubaszka, Paulina; Carrasquer-Alvarez, Elena; Chen, Ling; D'Ambrosio, Vasil; Lehka, Beata; Haidar, Ahmad K.; Nallapareddy, Saranya; Giannakou, Konstantina; Laloux, Marcos; Arsovska, Dushica; Jorgensen, Marcus A. K.; Chan, Leanne Jade G.; Kristensen, Mette; Christensen, Hanne B.; Sudarsan, Suresh; Stander, Emily A.; Baidoo, Edward; Petzold, Christopher J.; Wulff, Tune; O'Connor, Sarah E.; Courdavault, Vincent; Jensen, Michael K.; Keasling, Jay D.			A microbial supply chain for production of the anti-cancer drug vinblastine	NATURE			English	Article							CATHARANTHUS ALKALOIDS; DIPHOSPHATE SYNTHASE; MOLECULAR-CLONING; PLANT; STRICTOSIDINE; BIOSYNTHESIS; EXPRESSION; VINDOLINE; PATHWAY	Monoterpene indole alkaloids (MIAs) are a diverse family of complex plant secondary metabolites with many medicinal properties, including the essential anti-cancer therapeutics vinblastine and vincristine(1). As MIAs are difficult to chemically synthesize, the world's supply chain for vinblastine relies on low-yielding extraction and purification of the precursors vindoline and catharanthine from the plant Catharanthus roseus, which is then followed by simple in vitro chemical coupling and reduction to form vinblastine at an industrial scale(2,3). Here, we demonstrate the de novo microbial biosynthesis of vindoline and catharanthine using a highly engineered yeast, and in vitro chemical coupling to vinblastine. The study showcases a very long biosynthetic pathway refactored into a microbial cell factory, including 30 enzymatic steps beyond the yeast native metabolites geranyl pyrophosphate and tryptophan to catharanthine and vindoline. In total, 56 genetic edits were performed, including expression of 34 heterologous genes from plants, as well as deletions, knock-downs and overexpression of ten yeast genes to improve precursor supplies towards de novo production of catharanthine and vindoline, from which semisynthesis to vinblastine occurs. As the vinblastine pathway is one of the longest MIA biosynthetic pathways, this study positions yeast as a scalable platform to produce more than 3,000 natural MIAs and a virtually infinite number of new-to-nature analogues.	[Zhang, Jie; Hansen, Lea G.; Gudich, Olga; Viehrig, Konrad; Lassen, Laerke M. M.; Schruebbers, Lars; Adhikari, Khem B.; Rubaszka, Paulina; Carrasquer-Alvarez, Elena; Chen, Ling; D'Ambrosio, Vasil; Lehka, Beata; Haidar, Ahmad K.; Nallapareddy, Saranya; Giannakou, Konstantina; Laloux, Marcos; Arsovska, Dushica; Jorgensen, Marcus A. K.; Kristensen, Mette; Christensen, Hanne B.; Sudarsan, Suresh; Wulff, Tune; Jensen, Michael K.; Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark; [Chan, Leanne Jade G.; Baidoo, Edward; Petzold, Christopher J.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Chan, Leanne Jade G.; Baidoo, Edward; Petzold, Christopher J.; Keasling, Jay D.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Stander, Emily A.; Courdavault, Vincent] Univ Tours, EA2106 Biomol & Plant Biotechnol, Tours, France; [O'Connor, Sarah E.] Max Planck Inst Chem Ecol, Dept Nat Prod Biosynth, Jena, Germany; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Shenzhen Inst Adv Technol, Inst Synthet Biol, Ctr Synthet Biochem, Shenzhen, Peoples R China	Technical University of Denmark; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Universite de Tours; Max Planck Society; University of California System; University of California Berkeley; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Jensen, MK; Keasling, JD (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.; Keasling, JD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Keasling, JD (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Dept Bioengn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Shenzhen Inst Adv Technol, Inst Synthet Biol, Ctr Synthet Biochem, Shenzhen, Peoples R China.	mije@biosustain.dtu.dk; keasling@berkeley.edu	O'Connor, Sarah Ellen/X-2893-2019; Hansen, Lea/GYA-6008-2022	Jensen, Michael Krogh/0000-0001-7574-4707; Carrasquer-Alvarez, Elena/0000-0001-9292-9631; Hansen, Lea/0000-0002-8454-312X	Novo Nordisk Foundation [NNF10CC1016517]; Horizon 2020 (MIAMi) [814645]; BII Foundation [NNF19OC0055591, NNF20SA0067054]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Horizon 2020 (MIAMi); BII Foundation	This study was supported by grants from the Novo Nordisk Foundation (grant no. NNF10CC1016517), Horizon 2020 (MIAMi, grant no. 814645) and BII Foundation (grant nos. NNF19OC0055591 and NNF20SA0067054). We thank S. Rose (Axyntis Group, France) for providing the tabersonine standard. We thank P. Charusanti and L. Ding for technical assistance. Confocal microscopy analysis was carried out at Center for Advanced Bioimaging, University of Copenhagen.	Billingsley JM, 2017, METAB ENG, V44, P117, DOI 10.1016/j.ymben.2017.09.006; Boon BA, 2019, J AM CHEM SOC, V141, P14349, DOI 10.1021/jacs.9b06968; Brown S, 2015, P NATL ACAD SCI USA, V112, P3205, DOI 10.1073/pnas.1423555112; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caputi L, 2018, SCIENCE, V360, P1235, DOI 10.1126/science.aat4100; Chen Y., 2020, TARGETED PROTEOMIC L, DOI [10.17504/protocols.io.bf9xjr7n, DOI 10.17504/PROTOCOLS.IO.BF9XJR7N]; Costa MMR, 2008, PLANT PHYSIOL, V146, P403, DOI 10.1104/pp.107.107060; Courdavault V, 2014, CURR OPIN PLANT BIOL, V19, P43, DOI 10.1016/j.pbi.2014.03.010; Fernandez SMS, 2000, BIOCHEMISTRY-US, V39, P15316, DOI 10.1021/bi0014305; Ferreres F, 2010, J PHARMACEUT BIOMED, V51, P65, DOI 10.1016/j.jpba.2009.08.005; Fox ER, 2020, NAT REV CLIN ONCOL, V17, P128, DOI 10.1038/s41571-019-0318-x; Friedberg MW, 2017, JAMA INTERN MED, V177, P1058, DOI 10.1001/jamainternmed.2017.2142; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Geerlings A, 2000, J BIOL CHEM, V275, P3051, DOI 10.1074/jbc.275.5.3051; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gin J., 2020, CHLOROFORM METHANOL, DOI [10.17504/protocols.io.bhptj5nn, DOI 10.17504/PROTOCOLS.IO.BHPTJ5NN]; Gotoh H, 2011, ACS MED CHEM LETT, V2, P948, DOI 10.1021/ml200236a; Guirimand G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-182; Hirata K, 1997, BIOTECHNOL LETT, V19, P53, DOI 10.1023/A:1018367020754; Ignea C, 2014, ACS SYNTH BIOL, V3, P298, DOI 10.1021/sb400115e; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Jakociunas T, 2015, ACS SYNTH BIOL, V4, P1226, DOI 10.1021/acssynbio.5b00007; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Jeong WT, 2018, J CHROMATOGR B, V1080, P27, DOI 10.1016/j.jchromb.2018.02.018; Krengel F, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900175; Kulagina N, 2021, MICROB BIOTECHNOL, V14, P2693, DOI 10.1111/1751-7915.13898; KUTNEY JP, 1988, HETEROCYCLES, V27, P1845; Li YR, 2018, P NATL ACAD SCI USA, V115, pE3922, DOI 10.1073/pnas.1721469115; Lichman BR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0721; Lichman BR, 2019, NAT CHEM BIOL, V15, P71, DOI 10.1038/s41589-018-0185-2; Liu TF, 2022, BIOTECHNOL BIOENG, V119, P1314, DOI 10.1002/bit.28040; Luo XZ, 2019, NATURE, V567, P123, DOI 10.1038/s41586-019-0978-9; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Qu Y, 2019, PLANT J, V97, P257, DOI 10.1111/tpj.14111; Qua Y, 2015, P NATL ACAD SCI USA, V112, P6224, DOI 10.1073/pnas.1501821112; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Scalcinati G, 2012, METAB ENG, V14, P91, DOI 10.1016/j.ymben.2012.01.007; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Srinivasan P, 2020, NATURE, V585, P614, DOI 10.1038/s41586-020-2650-9; Stander EA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121595; Stavrinides A, 2015, CHEM BIOL, V22, P336, DOI 10.1016/j.chembiol.2015.02.006; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; US Food & Drug Administration, 2019, FDA DRUG SHORT ROOT; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Verma A, 2007, MOLECULES, V12, P1307, DOI 10.3390/12071307; Wright NR, 2020, BIOTECHNOL BIOENG, V117, P2074, DOI 10.1002/bit.27353; Zhu J, 2019, MBIO, V10, DOI 10.1128/mBio.01691-19	50	6	5	128	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					341	+		10.1038/s41586-022-05157-3	http://dx.doi.org/10.1038/s41586-022-05157-3		AUG 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36045295	hybrid, Green Published			2022-12-28	WOS:000848083000003
J	Rubin, R				Rubin, Rita			The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2022	328	15					1488	1489		10.1001/jama.2022.15062	http://dx.doi.org/10.1001/jama.2022.15062		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M9EQ	36129724	Bronze			2022-12-28	WOS:000857175500001
J	Limb, M				Limb, Matthew			Medical schools: More UK students choosing eastern Europe raises concerns over knowledge levels	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		General Medical Council, WELC UK PRACT; Moloney C, 2022, TIMES AUG	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o2248	10.1136/bmj.o2248	http://dx.doi.org/10.1136/bmj.o2248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126988				2022-12-28	WOS:000869963500001
J	Tomori, O; Ogoina, D				Tomori, Oyewale; Ogoina, Dimie			Monkeypox: The consequences of neglecting a disease, anywhere	SCIENCE			English	Editorial Material									[Tomori, Oyewale] Redeemers Univ, African Ctr Excellence Genom Infect Dis ACEGID, Ede, Osun State, Nigeria; [Ogoina, Dimie] Niger Delta Univ, Teaching Hosp, Yenagoa, Bayelsa State, Nigeria	Redeemers University	Tomori, O (corresponding author), Redeemers Univ, African Ctr Excellence Genom Infect Dis ACEGID, Ede, Osun State, Nigeria.	oyewaletomori@gmail.com						Barrett JW, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P431, DOI 10.1016/B978-0-12-374153-0.00019-9; Beer EM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007791; C. D. C. Africa, 2022, US; Falendysz EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004130; Isidro J, 2022, NAT MED, V28, DOI 10.1038/s41591-022-01907-y; LADNYJ ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Nguyen PY, 2021, EMERG INFECT DIS, V27, P1007, DOI 10.3201/eid2704.203569; Nigeria Centre for Disease Control, 2022, UPD MONK OUTBR NIG; Ogoina D, 2020, CLIN INFECT DIS, V71, pE210, DOI 10.1093/cid/ciaa143; Simpson K, 2020, VACCINE, V38, P5077, DOI 10.1016/j.vaccine.2020.04.062; UK Health Security Agency, 2022, US; VON MAGNUS P., 1959, Acta Pathologica et Microbiologica Scandinavica, V46, P156; WHO, 2022, US; World Health Organization, 2022, AFR REG	14	0	0	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1261	1263		10.1126/science.add3668	http://dx.doi.org/10.1126/science.add3668			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36107995				2022-12-28	WOS:000887933500022
J	Plackett, B				Plackett, Benjamin			The hunt for a better diagnosis	NATURE			English	Editorial Material																		Borkowetz A, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080578; De Visschere PJL, 2019, EUR UROL ONCOL, V2, P47, DOI 10.1016/j.euo.2018.09.010; Fredsoe J, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10040188; Ilic D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3519; Panigrahi GK, 2019, CANCER MED-US, V8, P1110, DOI 10.1002/cam4.1885	5	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S36	S37		10.1038/d41586-022-02858-7	http://dx.doi.org/10.1038/d41586-022-02858-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104412	Bronze			2022-12-28	WOS:000855141600004
J	Schmidt, C				Schmidt, Charlie			Matters of the heart	NATURE			English	Editorial Material																		Lopes R.D., 2021, CIRCULATION, V144, P1295, DOI [10.1161/CIRCULATIONAHA.121.056810, DOI 10.1161/CIRCULATIONAHA.117.028595]; Shore ND, 2020, NEW ENGL J MED, V382, P2187, DOI 10.1056/NEJMoa2004325; Wallach JD, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30587	3	0	0	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S46	S47		10.1038/d41586-022-02863-w	http://dx.doi.org/10.1038/d41586-022-02863-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104413	Bronze			2022-12-28	WOS:000855141600009
J	Schmidt, C				Schmidt, Charlie			A fresh chance of treatment	NATURE			English	Editorial Material																		Fendler W.P., 2019, JAMA ONCOL, V5, P856, DOI [10.1001/jamaoncol.2019.0096, DOI 10.1001/JAMAONCOL.2019.0096]; Ost P., 2018, J CLIN ONCOL, V36, P446, DOI [10.1200/JCO.2017.75.4853, DOI 10.1200/JCO.2017.75.4853]; Parker C, 2022, PLOS MED, V19, DOI 10.1371/journal.pmed.1003998; Phillips R, 2020, JAMA ONCOL, V6, P650, DOI 10.1001/jamaoncol.2020.0147; Reyes DK, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01385-7	5	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S38	S40		10.1038/d41586-022-02859-6	http://dx.doi.org/10.1038/d41586-022-02859-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104415	Bronze			2022-12-28	WOS:000855141600005
J	Pendrill, F; Gardner, TA; Meyfroidt, P; Persson, UM; Adams, J; Azevedo, T; Lima, MGB; Baumann, M; Curtis, PG; De Sy, V; Garrett, R; Godar, J; Goldman, ED; Hansen, MC; Heilmayr, R; Herold, M; Kuemmerle, T; Lathuilliere, MJ; Ribeiro, V; Tyukavina, A; Weisse, MJ; West, C				Pendrill, Florence; Gardner, Toby A.; Meyfroidt, Patrick; Persson, U. Martin; Adams, Justin; Azevedo, Tasso; Lima, Mairon G. Bastos; Baumann, Matthias; Curtis, Philip G.; De Sy, Veronique; Garrett, Rachael; Godar, Javier; Goldman, Elizabeth Dow; Hansen, Matthew C.; Heilmayr, Robert; Herold, Martin; Kuemmerle, Tobias; Lathuilliere, Michael J.; Ribeiro, Vivian; Tyukavina, Alexandra; Weisse, Mikaela J.; West, Chris			Disentangling the numbers behind agriculture-driven tropical deforestation	SCIENCE			English	Review							CONTENTIOUS LAND CHANGE; OIL PALM; SUPPLY-CHAIN; FOREST; BRAZIL; TRADE; DEFINITIONS; MANAGEMENT; LANDSCAPE; EXPANSION	Tropical deforestation continues at alarming rates with profound impacts on ecosystems, climate, and livelihoods, prompting renewed commitments to halt its continuation. Although it is well established that agriculture is a dominant driver of deforestation, rates and mechanisms remain disputed and often lack a clear evidence base. We synthesize the best available pantropical evidence to provide clarity on how agriculture drives deforestation. Although most (90 to 99%) deforestation across the tropics 2011 to 2015 was driven by agriculture, only 45 to 65% of deforested land became productive agriculture within a few years. Therefore, ending deforestation likely requires combining measures to create deforestation-free supply chains with landscape governance interventions. We highlight key remaining evidence gaps including deforestation trends, commodity-specific land-use dynamics, and data from tropical dry forests and forests across Africa.	[Pendrill, Florence; Persson, U. Martin] Chalmers Univ Technol, Dept Space Earth & Environm, Gothenburg, Sweden; [Gardner, Toby A.; Lima, Mairon G. Bastos; Godar, Javier; Lathuilliere, Michael J.; Ribeiro, Vivian] Stockholm Environm Inst SEI, Stockholm, Sweden; [Meyfroidt, Patrick] UCLouvain, Earth & Life Inst, Georges Lemaitre Earth & Climate Res Ctr, Louvain La Neuve, Belgium; [Meyfroidt, Patrick] Fonds Rech Sci FRS FNRS, Brussels, Belgium; [Adams, Justin] World Econ Forum, Trop Forest Alliance, Geneva, Switzerland; [Azevedo, Tasso] MapBiomas, Observ Clima, Sao Paulo, Brazil; [Baumann, Matthias] Humboldt Univ, Dept Geog, Berlin, Germany; [Curtis, Philip G.] Juniata Analyt LLC, Denver, CO USA; [De Sy, Veronique] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands; [Garrett, Rachael] Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Environm PolicyLab, Zurich, Switzerland; [Garrett, Rachael] Univ Cambridge, Dept Geog, Cambridge, England; [Garrett, Rachael] Univ Cambridge, Cambridge Conservat Initiat, Cambridge, England; [Goldman, Elizabeth Dow; Weisse, Mikaela J.] World Resources Inst, Global Forest Watch, Washington, DC USA; [Hansen, Matthew C.; Tyukavina, Alexandra] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Heilmayr, Robert] Univ Calif Santa Barbara, Environm Studies Program, Santa Barbara, CA 93106 USA; [Heilmayr, Robert] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Herold, Martin] Helmholz GFZ Res Ctr Geosci, Sect Remote Sensing & Geoinformat 1 4, Potsdam, Germany; [Kuemmerle, Tobias] Humboldt Univ, Integrated Res Inst Transformat Human Environm Sy, Berlin, Germany; [West, Chris] Univ York, Stockholm Environm Inst York, Dept Geog & Environm, York, England	Chalmers University of Technology; Stockholm Environment Institute; Universite Catholique Louvain; Fonds de la Recherche Scientifique - FNRS; Humboldt University of Berlin; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; University System of Maryland; University of Maryland College Park; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Humboldt University of Berlin; University of York - UK	Pendrill, F (corresponding author), Chalmers Univ Technol, Dept Space Earth & Environm, Gothenburg, Sweden.; Gardner, TA (corresponding author), Stockholm Environm Inst SEI, Stockholm, Sweden.	florence.pendrill@chalmers.se; toby.gardner@sei.org	Bastos Lima, Mairon/S-2012-2018; Meyfroidt, Patrick/G-7768-2012; Baumann, Matthias/K-4757-2014; De Sy, Veronique/P-6526-2014	Bastos Lima, Mairon/0000-0003-4235-8847; Ribeiro, Vivian/0000-0002-9592-3814; Meyfroidt, Patrick/0000-0002-1047-9794; Curtis, Philip/0000-0003-4958-9947; Baumann, Matthias/0000-0003-2375-3622; Pendrill, Florence/0000-0003-2492-3865; Persson, U. Martin/0000-0001-7069-6734; De Sy, Veronique/0000-0003-3647-7866	Formas grant [213:2014-1181, 2016-00351]; European Research Council (ERC) under the European Union [101001239, 677140]; Tropical Forest Alliance; Norway's International Climate and Forest Initiative under the Global Forest Watch Achieving Sustainability and Scaling Impact grant; UK Research and Innovation UKRI) Global Challenges Research Fund Trade, Development and the Environmental Hub project [ES/S008160/1]	Formas grant; European Research Council (ERC) under the European Union(European Research Council (ERC)); Tropical Forest Alliance; Norway's International Climate and Forest Initiative under the Global Forest Watch Achieving Sustainability and Scaling Impact grant; UK Research and Innovation UKRI) Global Challenges Research Fund Trade, Development and the Environmental Hub project	This work was supported by the following: Formas grant 213:2014-1181 (to F.P. and U.M.P.); Formas grant 2016-00351 within the LEAKAGE project (to T.A.G., J.G., and U.M.P.); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program Grant agreement 677140 MIDLAND (to P.M.); Tropical Forest Alliance (to E.D.G. and M.W.); Norway's International Climate and Forest Initiative under the Global Forest Watch Achieving Sustainability and Scaling Impact grant (to E.D.G. and M.W.); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program Grant agreement 101001239 SYSTEMSHIFT (to T.K.); and the UK Research and Innovation UKRI) Global Challenges Research Fund Trade, Development and the Environmental Hub project ES/S008160/1 (to C.W.).	Accountability Framework, 2020, TERMS DEF ACC FRAM I; ACTIAM Andra AP-fonden (AP2) Australian Ethical Investment Aviva PLC AXA Group Boston Common Asset Management Church Commissioners for England Church of England Pensions Board Comgest Caisse de Prevoyance de L'Etat de Geneve (CPEG) Domini Impact Investments LLC East Capital Group Fidelity International Generation Investment Management Grupo Bancolombia Impax Asset Management PLC International Business of Federated Hermes JGP Asset Management Legal and General Investment Management (LGIM) LGPS Central Limited Lombard Odier Menhaden PLC NEI Investments NN Investment Partners Robeco Schroders SCOR SE Skandia Sparebank 1 Forsikring Storebrand Asset Management Sumitomo Mitsui Trust Asset Management TCI Fund Management Ltd, 2021, LOC AUTH PENS FUND F; Aldrich S, 2012, ANN ASSOC AM GEOGR, V102, P103, DOI 10.1080/00045608.2011.620501; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; [Anonymous], 2020, GOVT RESPONSE RECOMM; [Anonymous], 2021, CONS GOODS FOR 2021; Austin KG, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf6db; Azevedo-Ramos C, 2018, LAND USE POLICY, V73, P125, DOI 10.1016/j.landusepol.2018.01.005; Barlow J, 2020, GLOBAL CHANGE BIOL, V26, P319, DOI 10.1111/gcb.14872; Bastin JF, 2017, SCIENCE, V356, P635, DOI 10.1126/science.aam6527; Bebbington A, 2020, P NATL ACAD SCI USA, V117, P21829, DOI 10.1073/pnas.2015636117; Bey A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100807; Borner J, 2020, ANNU REV RESOUR ECON, V12, P45, DOI 10.1146/annurev-resource-110119-025703; Brando PM, 2019, ANNU REV EARTH PL SC, V47, P555, DOI 10.1146/annurev-earth-082517-010235; Brito B, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab1e24; Brondizio E.S., 2019, GLOBAL ASSESSMENT RE, DOI [10.5281/zenodo.3831673, DOI 10.5281/ZENODO.3831673]; Buchadas A, 2022, NAT SUSTAIN, V5, P619, DOI 10.1038/s41893-022-00886-9; Busch J, 2017, REV ENV ECON POLICY, V11, P3, DOI 10.1093/reep/rew013; Caldas MM, 2015, J LAND USE SCI, V10, P1, DOI 10.1080/1747423X.2013.807314; Carter S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9ea4; Cattau ME, 2016, GLOBAL ENVIRON CHANG, V39, P205, DOI 10.1016/j.gloenvcha.2016.05.005; Chazdon RL, 2016, AMBIO, V45, P538, DOI 10.1007/s13280-016-0772-y; Chidumayo EN, 2013, ENERGY SUSTAIN DEV, V17, P86, DOI 10.1016/j.esd.2012.07.004; Cortner O, 2019, LAND USE POLICY, V82, P841, DOI 10.1016/j.landusepol.2019.01.006; Crippa M, 2021, NAT FOOD, V2, P198, DOI 10.1038/s43016-021-00225-9; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Cuypers D., 2013, EUROPEAN COMMISSION; De Sy V, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab3dc6; de Waroux YL, 2019, GEOFORUM, V105, P131, DOI 10.1016/j.geoforum.2019.05.016; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Descals A, 2021, EARTH SYST SCI DATA, V13, P1211, DOI 10.5194/essd-13-1211-2021; Dummett C., 2021, ILLICIT HARVEST COMP; Erb KH, 2018, NATURE, V553, P73, DOI 10.1038/nature25138; Espejo JC, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10121903; European Commission, 2021, DEF FOR DEGR RED IMP; FAO, 2018, FAOSTAT METH CROP PR; FAO, 2021, CROPS STAT CONC DEF; FAO, 2022, FRA 2020 REM SENS SU; FAO, 2017, FAOSTAT DAT; Faria WR, 2016, ECOL ECON, V121, P85, DOI 10.1016/j.ecolecon.2015.11.014; Feng Y, 2022, NAT SUSTAIN, V5, P444, DOI 10.1038/s41893-022-00854-3; de Oca AIFM, 2021, ENVIRON SCI POLICY, V115, P71, DOI 10.1016/j.envsci.2020.10.007; Food and Agriculture Organization, 2020, Global Forest Resources Assessment (FRA) 2020: main report, DOI 10.4060/ca9825en; Friedlingstein P, 2022, EARTH SYST SCI DATA, V14, P1917, DOI 10.5194/essd-14-1917-2022; Garrett RD, 2019, GLOBAL ENVIRON CHANG, V54, P135, DOI 10.1016/j.gloenvcha.2018.11.003; Garrett RD, 2017, ECOL SOC, V22, DOI 10.5751/ES-09364-220327; Gaveau DLA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266178; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Global Forest Watch, 2021, ASS TRENDS TREE COV; Goldman E. D., 2020, ESTIMATING ROLE 7 CO, DOI DOI 10.46830/WRITN.NA.00001; Greenpeace, 2021, AGR DEF; Guyana Forestry Commission, 2018, GUY REDD MON REP VER; Hamdan O, 2016, IOP C SER EARTH ENV, V37, DOI 10.1088/1755-1315/37/1/012028; Hansen M. C., 2021, HIGH RESOLUTION GLOB; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris N., 2019, SPATIAL DATABASE PLA; HECHT SB, 1993, BIOSCIENCE, V43, P687, DOI 10.2307/1312340; Heilmayr R, 2020, NAT FOOD, V1, P801, DOI 10.1038/s43016-020-00194-5; Heinimann A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184479; Hersperger AM, 2010, ECOL SOC, V15; Hoang NT, 2021, NAT ECOL EVOL, V5, P845, DOI 10.1038/s41559-021-01417-z; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Hubacek K, 2016, LAND USE POLICY, V50, P194, DOI 10.1016/j.landusepol.2015.09.022; Hunt DA, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12122041; Gasparri NI, 2015, CONSERV LETT, V8, P290, DOI 10.1111/conl.12121; Junquera V, 2020, ENVIRON SCI POLICY, V109, P103, DOI 10.1016/j.envsci.2020.04.013; Junquera V, 2019, GLOBAL ENVIRON CHANG, V57, DOI 10.1016/j.gloenvcha.2019.101929; Kissinger G, 2012, DRIVERS DEFORESTATIO; Kleinschmit D., 2016, IUFRO WORLD SERIES, V35; Lambin EF, 2018, NAT CLIM CHANGE, V8, P109, DOI 10.1038/s41558-017-0061-1; Latawiec AE, 2017, AGR ECOSYST ENVIRON, V240, P276, DOI 10.1016/j.agee.2017.01.043; Laue JE, 2016, J LAND USE SCI, V11, P48, DOI 10.1080/1747423X.2014.993341; Leblois A, 2017, WORLD DEV, V92, P82, DOI 10.1016/j.worlddev.2016.11.012; Lima MGB, 2020, FRONT FOR GLOB CHANG, V3, DOI 10.3389/ffgc.2020.00027; Lima MGB, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab4551; Luciano J., 2021, CLIMATE CHANGE C; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Masolele RN, 2021, REMOTE SENS ENVIRON, V264, DOI 10.1016/j.rse.2021.112600; Meyfroid P, 2018, GLOBAL ENVIRON CHANG, V53, P52, DOI 10.1016/j.gloenvcha.2018.08.006; Meyfroidt P, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab7397; Meyfroidt P, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2109217118; Meyfroidt P, 2016, J LAND USE SCI, V11, P501, DOI 10.1080/1747423X.2015.1117530; Miranda J, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab003a; Montanarella L., 2018, IPBES ASS REP LAND D; Mueller H, 2015, REMOTE SENS ENVIRON, V156, P490, DOI 10.1016/j.rse.2014.10.014; Nesha K, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/abd81b; Niether W, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abb053; Noojipady P, 2017, EARTH SYST DYNAM, V8, P749, DOI 10.5194/esd-8-749-2017; Oldekop JA, 2020, NAT PLANTS, V6, P1400, DOI 10.1038/s41477-020-00814-9; Oliveira J, 2020, INT J APPL EARTH OBS, V93, DOI 10.1016/j.jag.2020.102205; Ordway EM, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6509; Pearson TRH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034017; Pendrill F, 2019, GLOBAL ENVIRON CHANG, V56, P1, DOI 10.1016/j.gloenvcha.2019.03.002; Perez-Hoyos A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111118; Potapov P, 2022, NAT FOOD, V3, P19, DOI 10.1038/s43016-021-00429-z; Qin SY, 2022, CONSERV LETT, V15, DOI 10.1111/conl.12859; Rainforest Alliance, 2019, OUR MISS PROT WORLDS; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Rausch LL, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12671; Ravikumar A, 2017, CONSERV LETT, V10, P170, DOI 10.1111/conl.12264; Ribeiro N. S., 2020, MIOMBO WOODLANDS CHA; Richards P, 2015, ANN ASSOC AM GEOGR, V105, P1026, DOI 10.1080/00045608.2015.1060924; Richards P, 2015, ANN ASSOC AM GEOGR, V105, P806, DOI 10.1080/00045608.2015.1052337; Richards PD, 2014, GLOBAL ENVIRON CHANG, V29, P1, DOI 10.1016/j.gloenvcha.2014.06.011; Roebeling PC, 2010, LAND USE POLICY, V27, P489, DOI 10.1016/j.landusepol.2009.07.002; Romijn E, 2015, FOREST ECOL MANAG, V352, P109, DOI 10.1016/j.foreco.2015.06.003; Rufin P, 2022, INT J APPL EARTH OBS, V112, DOI 10.1016/j.jag.2022.102937; Samberg LH, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124010; Schroder JM, 2021, FOREST POLICY ECON, V122, DOI 10.1016/j.forpol.2020.102333; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Song XP, 2021, NAT SUSTAIN, V4, P784, DOI 10.1038/s41893-021-00729-z; Sonter LJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00557-w; Souza CM, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12172735; Spera SA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064010; STAFF OF H. COMM. ON OVERSIGHT & REFORM 117TH CONG., 2021, 117 CONG, P20; Strassburg BBN, 2014, GLOBAL ENVIRON CHANG, V28, P84, DOI 10.1016/j.gloenvcha.2014.06.001; Tarigan SD, 2015, PROCEDIA ENVIRON SCI, V24, P199, DOI 10.1016/j.proenv.2015.03.026; Thaler GM, 2017, J PEASANT STUD, V44, P1066, DOI 10.1080/03066150.2016.1243531; Tulbure MG, 2022, REMOTE SENS ECOL CON, V8, P272, DOI 10.1002/rse2.248; Turubanova S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacd1c; Tyukavina A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2993; U.S. Department of Agriculture's Forest Service (USFS) Spatial Informatics Group (SIG) World Agroforestry Centre (ICRAF) SERVIR-Mekong, 2021, COMM DRIV FOR LOSS S; UK Environment Act, 2021, SCHED 17 US FOR RISK; van Vliet J, 2019, NAT SUSTAIN, V2, P755, DOI 10.1038/s41893-019-0340-0; van Wees D, 2021, GLOBAL CHANGE BIOL, V27, P2377, DOI 10.1111/gcb.15591; Vancutsem C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1603; World Bank, 2010, 56719GLB WORLD BANK; Zalles V, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg1620; Zalles V, 2019, P NATL ACAD SCI USA, V116, P428, DOI 10.1073/pnas.1810301115; Zu Ermgassen EKHJ, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abn3132; zu Ermgassen EKHJ, 2020, P NATL ACAD SCI USA, V117, P31770, DOI 10.1073/pnas.2003270117; zu Ermgassen EKHJ, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab6497	135	2	2	9	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1168	+	eabm9267	10.1126/science.abm9267	http://dx.doi.org/10.1126/science.abm9267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074840	Green Accepted			2022-12-28	WOS:000887933400002
J	Lewis, D				Lewis, Dyani			WHAT SCIENTISTS HAVE LEARNT FROM COVID LOCKDOWNS	NATURE			English	Editorial Material																		Berry CR, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019706118; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; Broughel J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252729; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chen S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18168686; Department of Health and Social Care Office for National Statistics Government Actuary's Department Home Office, 2020, DIR IND IMP COVID 19; Flaxman S, 2020, NATURE, DOI [10.1038/s41586-020-2405-7, DOI 10.1038/S41586-020-2405-7]; Goes C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02096-3; Hale T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253116; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; Knock ES, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg4262; Meyerowitz-Katz G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02461-2; Phillips T, 2021, INTERFACE FOCUS, V11, DOI 10.1098/rsfs.2021.0041; Robinson LA, 2021, RISK ANAL, V41, P761, DOI 10.1111/risa.13561; Savaris RF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84092-1; Sharma M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26013-4; The Independent Panel for Pandemic Preparedness & Response, 2021, COVID 19 MAK IT LAST; Zhang HL, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.859751	18	1	1	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					236	239		10.1038/d41586-022-02823-4	http://dx.doi.org/10.1038/d41586-022-02823-4			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071184	Bronze			2022-12-28	WOS:000852469200016
J	Larkin, HD				Larkin, Howard D.			Paxlovid Expiration Dates Extended	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					819	819						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066535	Bronze			2022-12-28	WOS:000855171700010
J	Slomski, A				Slomski, Anita			Loss of Smell Associated With Prior Head Injuries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					818	818						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066530				2022-12-28	WOS:000855171700007
J	Mayes, KD; Schuur, JD; Chou, SC				Dickerson Mayes, Katherine; Schuur, Jeremiah D.; Chou, Shih-Chuan			Trends in Urinary Catheter Use by Indication in US Emergency Departments, 2002-2019	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Dickerson Mayes, Katherine] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Schuur, Jeremiah D.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chou, Shih-Chuan] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Brown University; Harvard University; Brigham & Women's Hospital	Chou, SC (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	schou2@bwh.harvard.edu						ABIM Foundation, CHOOS WISELY; [Anonymous], AMB HLTH CAR DAT; [Anonymous], 2017, EST ADD HOSP INP COS; Gould CV., 2009, GUIDELINE PREVENTION; Magill SS, 2018, NEW ENGL J MED, V379, P1732, DOI 10.1056/NEJMoa1801550; Schuur JD, 2014, ACAD EMERG MED, V21, P292, DOI 10.1111/acem.12334	6	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2022	328	15					1557	1559		10.1001/jama.2022.14378	http://dx.doi.org/10.1001/jama.2022.14378		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M9EQ	36053549				2022-12-28	WOS:000848898400002
J	Manfredi-Lozano, M; Leysen, V; Adamo, M; Paiva, I; Rovera, R; Pignat, JM; Timzoura, FE; Candlish, M; Eddarkaoui, S; Malone, SA; Silva, MSB; Trova, S; Imbernon, M; Decoster, L; Cotellessa, L; Tena-Sempere, M; Claret, M; Paoloni-Giacobino, A; Plassard, D; Paccou, E; Vionnet, N; Acierno, J; Maceski, AM; Lutti, A; Pfrieger, F; Rasika, S; Santoni, F; Boehm, U; Ciofi, P; Buee, L; Haddjeri, N; Boutillier, AL; Kuhle, J; Messina, A; Draganski, B; Giacobini, P; Pitteloud, N; Prevot, V				Manfredi-Lozano, Maria; Leysen, Valerie; Adamo, Michela; Paiva, Isabel; Rovera, Renaud; Pignat, Jean-Michel; Timzoura, Fatima Ezzahra; Candlish, Michael; Eddarkaoui, Sabiha; Malone, Samuel A.; Silva, Mauro S. B.; Trova, Sara; Imbernon, Monica; Decoster, Laurine; Cotellessa, Ludovica; Tena-Sempere, Manuel; Claret, Marc; Paoloni-Giacobino, Ariane; Plassard, Damien; Paccou, Emmanuelle; Vionnet, Nathalie; Acierno, James; Maceski, Aleksandra Maleska; Lutti, Antoine; Pfrieger, Frank; Rasika, S.; Santoni, Federico; Boehm, Ulrich; Ciofi, Philippe; Buee, Luc; Haddjeri, Nasser; Boutillier, Anne-Laurence; Kuhle, Jens; Messina, Andrea; Draganski, Bogdan; Giacobini, Paolo; Pitteloud, Nelly; Prevot, Vincent			GnRH replacement rescues cognition in Down syndrome	SCIENCE			English	Article							MOUSE MODEL; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; DOUBLE-BLIND; MEMORY; BRAIN; AGE; ADULTS; TRANSCRIPTOME; HYPOGONADISM	At the present time, no viable treatment exists for cognitive and olfactory deficits in Down syndrome (DS). We show in a DS model (Ts65Dn mice) that these progressive nonreproductive neurological symptoms closely parallel a postpubertal decrease in hypothalamic as well as extrahypothalamic expression of a master molecule that controls reproduction-gonadotropin-releasing hormone (GnRH)-and appear related to an imbalance in a microRNA-gene network known to regulate GnRH neuron maturation together with altered hippocampal synaptic transmission. Epigenetic, cellular, chemogenetic, and pharmacological interventions that restore physiological GnRH levels abolish olfactory and cognitive defects in Ts65Dn mice, whereas pulsatile GnRH therapy improves cognition and brain connectivity in adult DS patients. GnRH thus plays a crucial role in olfaction and cognition, and pulsatile GnRH therapy holds promise to improve cognitive deficits in DS.	[Manfredi-Lozano, Maria; Leysen, Valerie; Timzoura, Fatima Ezzahra; Eddarkaoui, Sabiha; Malone, Samuel A.; Silva, Mauro S. B.; Trova, Sara; Imbernon, Monica; Decoster, Laurine; Cotellessa, Ludovica; Rasika, S.; Buee, Luc; Giacobini, Paolo; Prevot, Vincent] Univ Lille, INSERM, CHU Lille, Lille Neurosci & Cognit,UMR S 1172,Labex DistAlz, Lille, France; [Manfredi-Lozano, Maria; Leysen, Valerie; Timzoura, Fatima Ezzahra; Malone, Samuel A.; Silva, Mauro S. B.; Trova, Sara; Imbernon, Monica; Decoster, Laurine; Cotellessa, Ludovica; Rasika, S.; Giacobini, Paolo; Prevot, Vincent] EGID, Lab Dev & Plast Neuroendocrine Brain, FHU Days Hlth 1000, Lille, France; [Adamo, Michela; Paccou, Emmanuelle; Vionnet, Nathalie; Acierno, James; Messina, Andrea; Pitteloud, Nelly] Lausanne Univ Hosp, Dept Endocrinol Diabetol & Metab, Lausanne, Switzerland; [Adamo, Michela; Santoni, Federico; Pitteloud, Nelly] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Paiva, Isabel; Boutillier, Anne-Laurence] Univ Strasbourg, CNRS, UMR 7364, Lab Neurosci Cognit & Adaptat LNCA, Strasbourg, France; [Rovera, Renaud; Haddjeri, Nasser] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM, U1208,Stem Cell & Brain Res Inst, Bron, France; [Pignat, Jean-Michel] Univ Hosp CHUV, Dept Clin Neurosci, Neurorehabil Unit, Lausanne, Switzerland; [Candlish, Michael; Boehm, Ulrich] Saarland Univ, Sch Med, Ctr Mol Signaling PZMS, Expt Pharmacol, Homburg, Germany; [Tena-Sempere, Manuel] Univ Cordoba, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, IMIBC HURS, Cordoba, Spain; [Claret, Marc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Neuronal Control Metab Lab, Barcelona, Spain; [Claret, Marc] Ctr Invest Biomed Red CIBER Diabet & Enfermedades, Barcelona, Spain; [Paoloni-Giacobino, Ariane] Univ Hosp Geneva, Dept Genet Med, Geneva, Switzerland; [Plassard, Damien] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire IGBMC, GenomEast Platform, INSERM,U1258,CNRS,UMR 7104, Illkirch Graffenstaden, France; [Maceski, Aleksandra Maleska; Kuhle, Jens] Univ Basel, Univ Basel Hosp, Neurol Clin & Polyclin, MS Ctr, Basel, Switzerland; [Maceski, Aleksandra Maleska; Kuhle, Jens] Univ Basel, Univ Basel Hosp, Res Ctr Clin Neuroimmunol & Neurosci Basel, Basel, Switzerland; [Lutti, Antoine] Univ Lausanne Hosp, Ctr Res Neurosci, Dept Clin Neurosci, Lab Res Neuroimaging LREN, Lausanne, Switzerland; [Lutti, Antoine] Univ Lausanne, Lausanne, Switzerland; [Pfrieger, Frank] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, Strasbourg, France; [Ciofi, Philippe] Univ Bordeaux, INSERM, U1215, Neuroctr Magendie, Bordeaux, France; [Draganski, Bogdan] Max Planck Inst Human Cognit & Brain Sci, Neurol Dept, Leipzig, Germany; [Candlish, Michael] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany; [Candlish, Michael] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany; [Silva, Mauro S. B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Trova, Sara] Ist Italiano Tecnol, Genoa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universitatsklinikum des Saarlandes; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Cordoba; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Basel; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Istituto Italiano di Tecnologia - IIT	Prevot, V (corresponding author), Univ Lille, INSERM, CHU Lille, Lille Neurosci & Cognit,UMR S 1172,Labex DistAlz, Lille, France.; Prevot, V (corresponding author), EGID, Lab Dev & Plast Neuroendocrine Brain, FHU Days Hlth 1000, Lille, France.; Pitteloud, N (corresponding author), Lausanne Univ Hosp, Dept Endocrinol Diabetol & Metab, Lausanne, Switzerland.; Pitteloud, N (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.	nelly.pitteloud@chuv.ch; vincent.prevot@inserm.fr	Giacobini, Paolo/P-9878-2019; Paiva, Isabel/GNP-7941-2022; BUEE, Luc/B-3126-2010; Draganski, Bogdan/C-3096-2016; Prevot, Vincent/E-5720-2016	Giacobini, Paolo/0000-0002-3075-1441; Paiva, Isabel/0000-0001-7607-9390; BUEE, Luc/0000-0002-6261-4230; Draganski, Bogdan/0000-0002-5159-5919; Imbernon, Monica/0000-0003-4359-4817; Manfredi-Lozano, Maria/0000-0003-3801-1955; Claret, Marc/0000-0001-7766-9296; Silva, Mauro/0000-0003-4447-6388; Adamo, Michela/0000-0002-9994-0945; Prevot, Vincent/0000-0001-7185-3615; Giacobino, Ariane/0000-0001-9432-1785; Eddarkaoui, Sabiha/0000-0002-5057-9335	European Research Council COST action [BM1105]; Agence Nationale de la Recherche [ANR-17-CE16-0015, ANR-11-LABEX-0009, I-SITE ULNE (ANR16-IDEX-0004)]; Swiss National Fund [310030B_201275]; European commission [656730]; Inserm; Region Hauts de France; European Union [874741]; Swiss National Science Foundation [320030_184784, 32003B_135679, 32003B_159780, 324730_192755, CRSK-3_190185]; ERA-NET iSEE project; SPHN-SACR project; ROGER DE SPOELBERCH Foundation; UNIL-EPFL CLIMACT program; Region Rhone-Alpes-SCUSI 2018 [R18119CC]	European Research Council COST action; Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss National Fund(Swiss National Science Foundation (SNSF)); European commission(European CommissionEuropean Commission Joint Research Centre); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Hauts de France(Region Hauts-de-France); European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERA-NET iSEE project; SPHN-SACR project; ROGER DE SPOELBERCH Foundation; UNIL-EPFL CLIMACT program; Region Rhone-Alpes-SCUSI 2018	This work has been supported by the European Research Council COST action BM1105 for the study of GnRH deficiency (to U.B., P.C., P.G., N.P., V.P., and M.T.-S.), Agence Nationale de la Recherche grants ANR-17-CE16-0015 (to V.P., P.C., and L.B.), DistAlz (ANR-11-LABEX-0009 to V.P. and L.B.), I-SITE ULNE (ANR16-IDEX-0004), and the Region Rhone-Alpes-SCUSI 2018#R18119CC and Swiss National Fund 310030B_201275 (to N.P.). M.M.-L. received a postdoctoral fellowship from the European commission (H2020-MSCA-IF-2014, no. 656730) and V.L. a doctoral fellowship from Inserm and the Region Hauts de France. P.G. is supported by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 874741. B.D. is supported by the Swiss National Science Foundation (project grant numbers 32003B_135679, 32003B_159780, 324730_192755, and CRSK-3_190185), the ERA-NET iSEE project, the UNIL-EPFL CLIMACT program, and the SPHN-SACR project. A.L. is supported by the Swiss National Science Foundation (project grant number 320030_184784) and the ROGER DE SPOELBERCH Foundation. The members of the Laboratory for Research in Neuroimaging (LREN) are grateful to the ROGER DE SPOELBERCH and Partridge Foundations for their generous financial support.	[Anonymous], 2013, LANCET NEUROL, V12, P931, DOI 10.1016/S1474-4422(13)70228-X; [Anonymous], 2013, AM J HUM GENET, V92, P725, DOI [10.1016/j.ajhg.2013.04.008, DOI 10.1016/J.AJHG.2013.04.008]; Antonarakis SE, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0143-7; Antonarakis SE, 2017, NAT REV GENET, V18, P147, DOI 10.1038/nrg.2016.154; Baburamani AA, 2019, DEV MED CHILD NEUROL, V61, P867, DOI 10.1111/dmcn.14260; Ballard C, 2016, LANCET NEUROL, V15, P622, DOI 10.1016/S1474-4422(16)00063-6; Banzhaf-Strathmann J, 2014, EMBO J, V33, P1667, DOI 10.15252/embj.201387576; Bayen E, 2018, JAMA NEUROL, V75, P1399, DOI 10.1001/jamaneurol.2018.2210; Begenisic T, 2014, NEUROBIOL DIS, V63, P12, DOI 10.1016/j.nbd.2013.11.010; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Benkert P, 2022, LANCET NEUROL, V21, P246, DOI 10.1016/S1474-4422(22)00009-6; Bianchi P, 2014, EXP NEUROL, V251, P1, DOI 10.1016/j.expneurol.2013.10.018; Boada R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.66; Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Bull MJ, 2020, NEW ENGL J MED, V382, P2344, DOI 10.1056/NEJMra1706537; Carr J, 2005, J INTELL DISABIL RES, V49, P915, DOI 10.1111/j.1365-2788.2005.00735.x; Casoni F, 2016, DEVELOPMENT, V143, P3969, DOI 10.1242/dev.139444; Chatterjee S, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708587; Chothani S, 2019, CIRCULATION, V140, P937, DOI 10.1161/CIRCULATIONAHA.119.039596; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Corrigan NM, 2021, NEUROIMAGE, V227, DOI 10.1016/j.neuroimage.2020.117678; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; de la Torre R, 2016, LANCET NEUROL, V15, P801, DOI 10.1016/S1474-4422(16)30034-5; Deidda G, 2015, NAT MED, V21, P318, DOI 10.1038/nm.3827; Deidda G, 2015, NAT NEUROSCI, V18, P87, DOI 10.1038/nn.3890; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; Figueroa-Jimenez MD, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11030311; Figueroa-Jimenez MD, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.1905; Fortea J, 2020, LANCET, V395, P1988, DOI 10.1016/S0140-6736(20)30689-9; Freeburn Aimee, 2021, Neuronal Signal, V5, pNS20200011, DOI 10.1042/NS20200011; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Goeldner C, 2022, J NEURODEV DISORD, V14, DOI 10.1186/s11689-022-09418-0; Grinspon RP, 2011, INT J ANDROL, V34, pE487, DOI 10.1111/j.1365-2605.2011.01210.x; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Hanney M, 2012, LANCET, V379, P528, DOI 10.1016/S0140-6736(11)61676-0; HIER DB, 1982, NEW ENGL J MED, V306, P1202, DOI 10.1056/NEJM198205203062003; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; HSIANG YHH, 1987, AM J MED GENET, V27, P449, DOI 10.1002/ajmg.1320270223; Huang CC, 2015, CNS NEUROSCI THER, V21, P817, DOI 10.1111/cns.12396; HURLEY DM, 1984, NEW ENGL J MED, V310, P1069, DOI 10.1056/NEJM198404263101702; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; KNOBIL E, 1990, AM J OBSTET GYNECOL, V163, P1721, DOI 10.1016/0002-9378(90)91435-F; Kola I, 1998, CURR OPIN GENET DEV, V8, P316, DOI 10.1016/S0959-437X(98)80088-9; Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009; KRIEGER DT, 1982, NATURE, V298, P468, DOI 10.1038/298468a0; Kwon D, 2020, BRAIN IMAGING BEHAV, V14, P242, DOI 10.1007/s11682-018-9980-3; Lanciotti L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00410; Lee NR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61799-1; Li ZZ, 2000, J NEUROSCI, V20, P4944; Liu YY, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134403; Lott IT, 2019, NAT REV NEUROL, V15, P135, DOI 10.1038/s41582-018-0132-6; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Messina A, 2016, NAT NEUROSCI, V19, P835, DOI 10.1038/nn.4298; Moenter SM, 2022, J NEUROENDOCRINOL, V34, DOI 10.1111/jne.13065; Moore CS, 2010, MAMM GENOME, V21, P543, DOI 10.1007/s00335-010-9300-8; Nelson L, 2005, PROG NEURO-PSYCHOPH, V29, P443, DOI 10.1016/j.pnpbp.2004.12.009; Nijjar RK, 2002, NEUROBIOL AGING, V23, P65, DOI 10.1016/S0197-4580(01)00263-9; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Pellegrino G, 2021, NAT NEUROSCI, V24, P1660, DOI 10.1038/s41593-021-00960-z; Pinto B, 2020, NEURON, V108, P887, DOI 10.1016/j.neuron.2020.09.010; Prevot V., 2020, Patent, Patent No. [2020/221821, 2020221821]; Pujol J, 2015, CORTEX, V64, P148, DOI 10.1016/j.cortex.2014.10.012; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Schafer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8200; Schang AL, 2011, ENDOCRINOLOGY, V152, P568, DOI 10.1210/en.2010-0840; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Schulz JM, 2019, J NEUROSCI, V39, P5210, DOI 10.1523/JNEUROSCI.2723-18.2019; SHAPIRO BL, 1983, AM J MED GENET, V14, P241, DOI 10.1002/ajmg.1320140206; Skrapits K, 2021, ELIFE, V10, DOI 10.7554/eLife.67714; Spatazza J, 2013, PHARMACOL REV, V65, P90, DOI 10.1124/pr.112.006577; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; Van der Jeugd A, 2013, J ALZHEIMERS DIS, V37, P777, DOI 10.3233/JAD-130110; Wang MH, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0355-3; Wang SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006463; Wang Z., 2021, NATURE AGING, V1, P904, DOI [10.1038/s43587-021-00116-5, DOI 10.1038/S43587-021-00116-5]; Xiong J, 2022, NATURE, V603, P470, DOI 10.1038/s41586-022-04463-0; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	82	0	0	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1064	+	eabq4515	10.1126/science.abq4515	http://dx.doi.org/10.1126/science.abq4515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048943				2022-12-28	WOS:000887933200006
J	Hanchard, NA; Choudhury, A				Hanchard, Neil A.; Choudhury, Ananyo			1000 Genomes Project phase 4: The gift that keeps on giving	CELL			English	Editorial Material								In this issue of Cell, Bryska-Bishop et al. report the release of the expanded, high-depth sequencing data that characterize the fourth phase of the 1000 Genomes Project. Using extensive comparisons and benchmarks, they demonstrate how this dataset is positioned to serve as a more comprehensive and accurate resource for global genomics.	[Hanchard, Neil A.] NHGRI, Childhood Complex Dis Genom Sect, Ctr Precis Hlth Res, NIH, Bethesda, MD 20892 USA; [Choudhury, Ananyo] Univ Witswaterand, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Witwatersrand	Hanchard, NA (corresponding author), NHGRI, Childhood Complex Dis Genom Sect, Ctr Precis Hlth Res, NIH, Bethesda, MD 20892 USA.	reil.hanchard@nih.gov						Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Byrska-Bishop M, 2022, CELL, V185, P3426, DOI 10.1016/j.cell.2022.08.004; Choudhury A, 2020, NATURE, V586, P741, DOI 10.1038/s41586-020-2859-7; Green ED, 2020, NATURE, V586, P683, DOI 10.1038/s41586-020-2817-4; Molnar-Gabor F, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911421; Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987; Sherman RM, 2019, NAT GENET, V51, P30, DOI 10.1038/s41588-018-0273-y; Wang T, 2022, NATURE, V604, P437, DOI 10.1038/s41586-022-04601-8; World Health Organization, 2022, REP WHO SCI COUNC	9	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3286	3289		10.1016/j.cell.2022.08.001	http://dx.doi.org/10.1016/j.cell.2022.08.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4V8AJ	36055197				2022-12-28	WOS:000859694600004
J	Rennert, K; Errickson, F; Prest, BC; Rennels, L; Newell, RG; Pizer, W; Kingdon, C; Wingenroth, J; Cooke, R; Parthum, B; Smith, D; Cromar, K; Diaz, D; Moore, FC; Muller, UK; Plevin, RJ; Raftery, AE; Sevcikova, H; Sheets, H; Stock, JH; Tan, T; Watson, M; Wong, TE; Anthoff, D				Rennert, Kevin; Errickson, Frank; Prest, Brian C.; Rennels, Lisa; Newell, Richard G.; Pizer, William; Kingdon, Cora; Wingenroth, Jordan; Cooke, Roger; Parthum, Bryan; Smith, David; Cromar, Kevin; Diaz, Delavane; Moore, Frances C.; Muller, Ulrich K.; Plevin, Richard J.; Raftery, Adrian E.; Sevcikova, Hana; Sheets, Hannah; Stock, James H.; Tan, Tammy; Watson, Mark; Wong, Tony E.; Anthoff, David			Comprehensive evidence implies a higher social cost of CO2	NATURE			English	Article							CLIMATE-CHANGE; IMPULSE-RESPONSE; GLOBAL VALUES; CARBON-CYCLE; TEMPERATURE; EMISSIONS; POLICY; UNCERTAINTY; FUTURE; MODEL	The social cost of carbon dioxide (SC-CO2) measures the monetized value of the damages to society caused by an incremental metric tonne of CO2 emissions and is a key metric informing climate policy. Used by governments and other decision-makers in benefit-cost analysis for over a decade, SC-CO2 estimates draw on climate science, economics, demography and other disciplines. However, a 2017 report by the US National Academies of Sciences, Engineering, and Medicine(1) (NASEM) highlighted that current SC-CO2 estimates no longer reflect the latest research. The report provided a series of recommendations for improving the scientific basis, transparency and uncertainty characterization of SC-CO2 estimates. Here we show that improved probabilistic socioeconomic projections, climate models, damage functions, and discounting methods that collectively reflect theoretically consistent valuation of risk, substantially increase estimates of the SC-CO2. Our preferred mean SC-CO2 estimate is $185 per tonne of CO2 ($44-$413 per tCO(2): 5%-95% range, 2020 US dollars) at a near-term risk-free discount rate of 2%, a value 3.6 times higher than the US government's current value of $51 per tCO(2). Our estimates incorporate updated scientific understanding throughout all components of SC-CO2 estimation in the new open-source Greenhouse Gas Impact Value Estimator (GIVE) model, in a manner fully responsive to the near-term NASEM recommendations. Our higher SC-CO2 values, compared with estimates currently used in policy evaluation, substantially increase the estimated benefits of greenhouse gas mitigation and thereby increase the expected net benefits of more stringent climate policies.	[Rennert, Kevin; Prest, Brian C.; Newell, Richard G.; Pizer, William; Wingenroth, Jordan; Cooke, Roger] Resources Future Inc, Washington, DC USA; [Errickson, Frank] Princeton Univ, Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Rennels, Lisa; Kingdon, Cora; Anthoff, David] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Parthum, Bryan; Smith, David; Tan, Tammy] Environm Protect Agcy, Washington, DC USA; [Cromar, Kevin] NYU, Marron Inst Urban Management, Brooklyn, NY USA; [Cromar, Kevin] NYU, Grossman Sch Med, New York, NY USA; [Diaz, Delavane] EPRI, Palo Alto, CA USA; [Moore, Frances C.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Muller, Ulrich K.; Watson, Mark] Princeton Univ, Dept Econ, Princeton, NJ 08544 USA; [Raftery, Adrian E.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Raftery, Adrian E.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Sevcikova, Hana] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Sheets, Hannah; Wong, Tony E.] Rochester Inst Technol, Sch Math Sci, Rochester, NY 14623 USA; [Stock, James H.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Resources for the Future; Princeton University; University of California System; University of California Berkeley; United States Environmental Protection Agency; New York University; New York University; Electric Power Research Institute (EPRI); University of California System; University of California Davis; Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rochester Institute of Technology; Harvard University	Anthoff, D (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	anthoff@berketey.edu	; Newell, Richard/I-3838-2015	Parthum, Bryan/0000-0002-9996-2183; Cromar, Kevin/0000-0002-7745-2780; Diaz, Delavane/0000-0001-8289-0980; Newell, Richard/0000-0002-3205-5562	Alfred P. Sloan Foundation; Hewlett Foundation; NIH [R01 HD070936]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Hewlett Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The views expressed in this paper are those of the authors and do not necessarily reflect the views or policies of the US Environmental Protection Agency. This work was supported by the Alfred P. Sloan Foundation, the Hewlett Foundation, and individual donations to RFF's Social Cost of Carbon Initiative. The work of A.E.R. and H.S. was supported by NIH grant R01 HD070936.	Aldy JE, 2021, SCIENCE, V373, P850, DOI 10.1126/science.abi7813; [Anonymous], 1984, WELFARE EC; Anthoff D., 2022, MIMI INTEGRATED ASSE, DOI [10.5281/zenodo.4321855, DOI 10.5281/ZENODO.4321855]; Anthoff D, 2019, J ASSOC ENVIRON RESO, V6, P29, DOI 10.1086/701900; Bauer M. D., 2021, REV ECON STAT, DOI [10.1162/rest_a_01109, DOI 10.1162/REST_A_01109]; Bauer MD, 2020, AM ECON REV, V110, P1316, DOI 10.1257/aer.20171822; Benveniste H, 2020, P NATL ACAD SCI USA, V117, P26692, DOI 10.1073/pnas.2007597117; Berger L, 2020, ENVIRON RESOUR ECON, V77, P475, DOI 10.1007/s10640-020-00503-3; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bressler RD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24487-w; Brooks WR, 2014, ECOL ECON, V105, P342, DOI 10.1016/j.ecolecon.2014.06.015; Burke M, 2016, AM ECON J-ECON POLIC, V8, P106, DOI 10.1257/pol.20130025; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Burke M, 2015, ANNU REV ECON, V7, P577, DOI 10.1146/annurev-economics-080614-115430; Carleton T, 2022, REV ENV ECON POLICY, V16, P196, DOI 10.1086/720988; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Christensen P, 2018, P NATL ACAD SCI USA, V115, P5409, DOI 10.1073/pnas.1713628115; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Clarke L, 2018, ENERG ECON, V72, P667, DOI 10.1016/j.eneco.2018.01.003; Clarke L, 2009, ENERG ECON, V31, pS63, DOI 10.1016/j.eneco.2009.10.014; Council of Economic Advisers, 2017, DISC PUBL POL THEOR; Cromar KR, 2022, ANN AM THORAC SOC, V19, P1203, DOI 10.1513/AnnalsATS.202110-1193OC; Del Negro M, 2017, BROOKINGS PAP ECO AC, P235; Desmet K, 2021, AM ECON J-MACROECON, V13, P444, DOI 10.1257/mac.20180366; Diaz DB, 2016, CLIMATIC CHANGE, V137, P143, DOI 10.1007/s10584-016-1675-4; Dietz S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103081118; Dietz S, 2021, J ASSOC ENVIRON RESO, V8, P895, DOI 10.1086/713977; Dietz S, 2019, J ENVIRON ECON MANAG, V96, P108, DOI 10.1016/j.jeem.2019.04.003; Dietz S, 2018, J ENVIRON ECON MANAG, V87, P258, DOI 10.1016/j.jeem.2017.07.005; Drupp MA, 2018, AM ECON J-ECON POLIC, V10, P109, DOI 10.1257/pol.20160240; Dyurgerov M., 2005, GLACIERS CHANGING EA; Edmonds J, 2004, ENERG ECON, V26, P517, DOI 10.1016/j.eneco.2004.04.025; Edmonds J., 1985, GLOBAL ENERGY ASSESS; Errickson FC, 2021, NATURE, V592, P564, DOI 10.1038/s41586-021-03386-6; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Forster P., 2021, IPCC 2021 CLIMATE CH; Gazzotti P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23613-y; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Giglio S, 2015, Q J ECON, V130, P1, DOI 10.1093/qje/qju036; Glanemann N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13961-1; Gollier C, 2002, J PUBLIC ECON, V85, P149, DOI 10.1016/S0047-2727(01)00079-2; Gollier C., 2001, EC RISK TIME; Gollier C, 2014, ANNU REV RESOUR ECON, V6, P273, DOI 10.1146/annurev-resource-100913-012516; Gollier C, 2014, AM ECON REV, V104, P534, DOI 10.1257/aer.104.5.534; Gollier Christian, 2013, PRICING PLANETS FUTU; Hansel MC, 2020, NAT CLIM CHANGE, V10, P781, DOI 10.1038/s41558-020-0833-x; Hausfather Z, 2020, P NATL ACAD SCI USA, V117, P27791, DOI 10.1073/pnas.2017124117; Hausfather Z, 2020, NATURE, V577, P618, DOI 10.1038/d41586-020-00177-3; Ho E, 2019, CLIMATIC CHANGE, V155, P545, DOI 10.1007/s10584-019-02500-y; Houser T., 2015, EC RISKS CLIMATE CHA; Howard PH, 2017, ENVIRON RESOUR ECON, V68, P197, DOI 10.1007/s10640-017-0166-z; Interagency Working Group on Social Cost of Carbon (IWG), 2010, 12866 IWG; Interagency Working Group on Social Cost of Greenhouse Gases (IWG), 2021, 13990 IWG; Jevrejeva S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacc76; Kalkuhl M, 2020, J ENVIRON ECON MANAG, V103, DOI 10.1016/j.jeem.2020.102360; Kikstra JS, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac1d0b; Kopp RE, 2012, ECONOMICS-KIEL, V6, DOI 10.5018/economics-ejournal.ja.2012-13; Kotz M, 2021, NAT CLIM CHANGE, V11, P319, DOI 10.1038/s41558-020-00985-5; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Leach NJ, 2021, GEOSCI MODEL DEV, V14, P3007, DOI 10.5194/gmd-14-3007-2021; Lemoine D, 2021, J ASSOC ENVIRON RESO, V8, P27, DOI 10.1086/710667; Liu PRR, 2021, COMMUN EARTH ENVIRON, V2, DOI 10.1038/s43247-021-00097-8; Masson-Delmotte V., 2021, CLIMATE CHANGE 2021; Masterman CJ, 2018, J BENEFIT-COST ANAL, V9, P407, DOI 10.1017/bca.2018.20; Meinshausen M, 2020, GEOSCI MODEL DEV, V13, P3571, DOI 10.5194/gmd-13-3571-2020; Millar RJ, 2017, ATMOS CHEM PHYS, V17, P7213, DOI 10.5194/acp-17-7213-2017; Moore FC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01792-x; Moore FC, 2015, NAT CLIM CHANGE, V5, P127, DOI [10.1038/nclimate2481, 10.1038/NCLIMATE2481]; Morgan MG, 2008, CLIMATIC CHANGE, V90, P189, DOI 10.1007/s10584-008-9458-1; Muller UK, 2022, REV ECON STAT, V104, P857, DOI 10.1162/rest_a_00997; National Academies of Sciences Engineering and Medicine, 2017, VAL CLIM DAM UPD EST; Newell RG, 2022, J ASSOC ENVIRON RESO, V9, P1017, DOI 10.1086/718145; Nicholls ZRJ, 2020, GEOSCI MODEL DEV, V13, P5175, DOI 10.5194/gmd-13-5175-2020; Nordhaus WD, 2017, P NATL ACAD SCI USA, V114, P1518, DOI 10.1073/pnas.1609244114; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Raftery Adrian E, 2023, Int J Forecast, V39, P73, DOI 10.1016/j.ijforecast.2021.09.001; Raftery AE, 2017, NAT CLIM CHANGE, V7, P637, DOI [10.1038/nclimate3352, 10.1038/NCLIMATE3352]; Ramsey FP, 1928, ECON J, V38, P543, DOI 10.2307/2224098; Rennert K, 2021, BROOKINGS PAP ECO AC, P223, DOI 10.1353/eca.2022.0003; Resources for the Future & New York State Energy Research and Development Authority (NYSERDA), 2020, EST VAL CARB 2 APPR; Robinson LA, 2019, J BENEFIT-COST ANAL, V10, P15, DOI 10.1017/bca.2018.26; Rode A, 2021, NATURE, V598, P308, DOI 10.1038/s41586-021-03883-8; Rose SK, 2017, CLIM CHANG ECON, V8, DOI 10.1142/S2010007817500099; Roy V, 2020, ANNU REV STAT APPL, V7, P387, DOI 10.1146/annurev-statistics-031219-041300; Ruckert KL, 2017, CLIMATIC CHANGE, V140, P349, DOI 10.1007/s10584-016-1858-z; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Schwalm CR, 2020, P NATL ACAD SCI USA, V117, P19656, DOI 10.1073/pnas.2007117117; Shepherd A, 2020, NATURE, V579, P233, DOI 10.1038/s41586-019-1855-2; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Slangen ABA, 2014, CLIMATIC CHANGE, V124, P317, DOI 10.1007/s10584-014-1080-9; Smith C., 2021, CLIMATE CHANGE 2021, DOI DOI 10.1017/9781009157896.009; Smith CJ, 2018, GEOSCI MODEL DEV, V11, P2273, DOI 10.5194/gmd-11-2273-2018; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Stokey E, 1978, PRIMER POLICY ANAL; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P135, DOI 10.1023/A:1014539414591; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Urban NM, 2010, TELLUS A, V62, P737, DOI 10.1111/j.1600-0870.2010.00471.x; US Environmental Protection Agency (US EPA), 2010, GUID PREP EC AN; Vafeidis AT, 2008, J COASTAL RES, V24, P917, DOI 10.2112/06-0725.1; Value Balancing Alliance, 2021, METH IMP STAT GEN PA; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P148, DOI 10.1016/j.gloenvcha.2016.10.009; Vega-Westhoff B, 2019, EARTHS FUTURE, V7, P677, DOI 10.1029/2018EF001082; Viscusi WK, 2017, J BENEFIT-COST ANAL, V8, P226, DOI 10.1017/bca.2017.12; Weitzman ML, 1998, J ENVIRON ECON MANAG, V36, P201, DOI 10.1006/jeem.1998.1052; Wong TE, 2017, CLIMATIC CHANGE, V144, P347, DOI 10.1007/s10584-017-2039-4; Wong TE, 2017, GEOSCI MODEL DEV, V10, P2741, DOI 10.5194/gmd-10-2741-2017; Zhang P, 2018, J ENVIRON ECON MANAG, V88, P1, DOI 10.1016/j.jeem.2017.11.001	109	4	4	29	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					687	+		10.1038/s41586-022-05224-9	http://dx.doi.org/10.1038/s41586-022-05224-9		SEP 2022	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36049503	Green Published, hybrid			2022-12-28	WOS:000864575000001
J	Gorman, EA; O'Kane, CM; McAuley, DF				Gorman, Ellen A.; O'Kane, Cecilia M.; McAuley, Daniel F.			Acute Respiratory Distress Syndrome 2022 2 Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management	LANCET			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; HIGH-FREQUENCY OSCILLATION; END-EXPIRATORY PRESSURE; FLOW NASAL OXYGEN; ACUTE LUNG INJURY; BERLIN DEFINITION; CLINICAL-TRIAL; CRITICAL-CARE; DOUBLE-BLIND; ARDS	Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by cardiac failure or fluid overload. ARDS is defined by the Berlin criteria. In this Series paper the diagnosis, management, outcomes, and long-term sequelae of ARDS are reviewed. Potential limitations of the ARDS definition and evidence that could inform future revisions are considered. Guideline recommendations, evidence, and uncertainties in relation to ARDS management are discussed. The future of ARDS strives towards a precision medicine approach, and the framework of treatable traits in ARDS diagnosis and management is explored.	[Gorman, Ellen A.; O'Kane, Cecilia M.; McAuley, Daniel F.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland; [McAuley, Daniel F.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, North Ireland	Queens University Belfast; Queens University Belfast	McAuley, DF (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland.; McAuley, DF (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, North Ireland.	d.f.mcauley@qub.ac.uk						Alhazzani W, 2022, JAMA-J AM MED ASSOC, V327, P2104, DOI 10.1001/jama.2022.7993; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Arabi YM, 2021, INTENS CARE MED, V47, P282, DOI 10.1007/s00134-021-06352-y; ASHBAUGH DG, 1967, LANCET, V2, P319; Auriemma CL, 2020, INTENS CARE MED, V46, P1222, DOI 10.1007/s00134-020-06010-9; Azevedo LCP, 2013, CRIT CARE, V17, DOI 10.1186/cc12594; Bain W, 2021, ANN AM THORAC SOC, V18, P1202, DOI 10.1513/AnnalsATS.202008-1026OC; Bakhru Rita N, 2019, Crit Care Explor, V1, pe0034, DOI 10.1097/CCE.0000000000000034; Bass CM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0995-5; Bastarache JA, 2021, AM J PHYSIOL-LUNG C, V320, pL785, DOI 10.1152/ajplung.00595.2020; Beitler Jeremy R, 2022, Lancet Respir Med, V10, P107, DOI 10.1016/S2213-2600(21)00157-0; Beitler JR, 2021, AM J RESP CRIT CARE, V204, P247, DOI 10.1164/rccm.202104-0839ED; Beitler JR, 2019, JAMA-J AM MED ASSOC, V321, P846, DOI 10.1001/jama.2019.0555; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bellingan G, 2022, INTENS CARE MED, V48, P36, DOI 10.1007/s00134-021-06570-4; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bos LDJ, 2022, INTENS CARE MED EXP, V10, DOI 10.1186/s40635-022-00435-w; Bosch NA, 2022, J CRIT CARE, V67, P85, DOI 10.1016/j.jcrc.2021.10.017; Bossuyt PMM, 2012, CLIN CHEM, V58, P1636, DOI 10.1373/clinchem.2012.182576; Boyle AJ, 2022, CRIT CARE, V26, DOI 10.1186/s13054-022-04025-w; Brault C, 2020, AM J RESP CRIT CARE, V202, P1301, DOI 10.1164/rccm.202005-2025LE; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown SM, 2021, ANN AM THORAC SOC, V18, P1948, DOI 10.1513/AnnalsATS.202105-534PS; Brown SM, 2017, THORAX, V72, P1094, DOI 10.1136/thoraxjnl-2017-210337; Calfee CS, 2022, NAT MED, V28, P9, DOI 10.1038/s41591-021-01617-x; Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Camporota L, 2021, LANCET RESP MED, V9, pE16, DOI 10.1016/S2213-2600(20)30581-6; Carsetti A, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0518-7; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; Chaudhuri D, 2021, INTENS CARE MED, V47, P521, DOI 10.1007/s00134-021-06394-2; Chiumello D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1446-7; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Combes A, 2020, INTENS CARE MED, V46, P2048, DOI 10.1007/s00134-020-06248-3; Combes A, 2014, AM J RESP CRIT CARE, V190, P488, DOI 10.1164/rccm.201404-0630CP; Connolly B, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052214; Connolly B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008632.pub2; Constantin JM, 2019, LANCET RESP MED, V7, P870, DOI 10.1016/S2213-2600(19)30138-9; Cook K, 2020, AUST CRIT CARE, V33, P533, DOI 10.1016/j.aucc.2020.03.005; Coppola S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02963-x; Cornet AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090983; Costa ELV, 2021, AM J RESP CRIT CARE, V204, P303, DOI 10.1164/rccm.202009-3467OC; Cui N, 2022, THROMB J, V20, DOI 10.1186/s12959-022-00386-y; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Dianti J, 2022, AM J RESP CRIT CARE, V205, P1300, DOI 10.1164/rccm.202108-1972OC; Dilogo IH, 2021, STEM CELL TRANSL MED, V10, P1279, DOI 10.1002/sctm.21-0046; Dinglas VD, 2017, CRIT CARE MED, V45, P446, DOI 10.1097/CCM.0000000000002208; Du ML, 2021, INTENS CARE MED, V47, P761, DOI 10.1007/s00134-021-06410-5; Eberst G, 2022, ANN INTENSIVE CARE, V12, DOI 10.1186/s13613-022-00997-8; Ehrmann S, 2021, LANCET RESP MED, V9, P1387, DOI 10.1016/S2213-2600(21)00356-8; Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Ferrando C, 2020, INTENS CARE MED, V46, P2200, DOI 10.1007/s00134-020-06192-2; Fuller BM, 2015, CHEST, V147, P1510, DOI 10.1378/chest.14-3161; Gates S, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17380; Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2; George M, 2020, ANN AM THORAC SOC, V17, P1, DOI 10.1513/AnnalsATS.201909-705ST; Goligher EC, 2018, JAMA-J AM MED ASSOC, V320, P2251, DOI 10.1001/jama.2018.14276; Goligher EC, 2014, AM J RESP CRIT CARE, V190, P70, DOI 10.1164/rccm.201404-0688OC; Gorman E, 2021, EXPERT REV RESP MED, V15, P301, DOI 10.1080/17476348.2021.1848555; Griffiths M, 2022, THORAX, V77, P129, DOI 10.1136/thoraxjnl-2021-216904; Griffiths MJD, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000420; Guerin C, 2018, INTENS CARE MED, V44, P22, DOI 10.1007/s00134-017-4996-5; Guerin C, 2020, INTENS CARE MED, V46, P2385, DOI 10.1007/s00134-020-06306-w; Guerin C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1556-2; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Gupta E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2646-8; Hashem MD, 2022, THORAX, V77, P22, DOI 10.1136/thoraxjnl-2020-216613; Heesakkers H, 2022, JAMA-J AM MED ASSOC, V327, P559, DOI 10.1001/jama.2022.0040; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hodgson CL, 2022, AM J RESP CRIT CARE, V205, P1159, DOI 10.1164/rccm.202110-2335OC; Hodgson CL, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03794-0; Hodgson CL, 2019, AM J RESP CRIT CARE, V200, P1363, DOI 10.1164/rccm.201901-0109OC; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hultstrom M, 2022, CRIT CARE, V26, DOI 10.1186/s13054-022-03933-1; Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996; I. Stewart, 2022, medRxiv, DOI 10.1101/2022.03.10.22272081; Ingraham NE, 2022, J INTENSIVE CARE MED, V37, P185, DOI 10.1177/0885066620982905; International Labour Organization, 2020, GUID MENT HLTH PROM; Iwata K, 2010, INTERNAL MED, V49, P2423, DOI 10.2169/internalmedicine.49.4010; Johnson Shelsey W, 2022, Crit Care Explor, V10, pe0638, DOI 10.1097/CCE.0000000000000638; Juschten J, 2021, INTENS CARE MED, V47, P422, DOI 10.1007/s00134-021-06370-w; Kamdar BB, 2017, AM J RESP CRIT CARE, V196, DOI 10.1164/rccm.201611-2327OC; Kamdar BB, 2018, THORAX, V73, P125, DOI 10.1136/thoraxjnl-2017-210217; Ketcham SW, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03108-w; Kwizera A, 2022, ANN AM THORAC SOC, V19, P691, DOI 10.1513/AnnalsATS.202103-270RL; Lanzoni G, 2021, STEM CELL TRANSL MED, V10, P660, DOI 10.1002/sctm.20-0472; Latronico N, 2022, THORAX, V77, P300, DOI 10.1136/thoraxjnl-2021-218064; Leopold SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204832; Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC; Maddali MV, 2022, LANCET RESP MED, V10, P367, DOI 10.1016/S2213-2600(21)00461-6; Magesh S, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.34147; Maslove DM, 2022, NAT MED, V28, P1141, DOI 10.1038/s41591-022-01843-x; Mason SE, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1201-0; Matthay MA, 2021, LANCET RESP MED, V9, P933, DOI 10.1016/S2213-2600(21)00105-3; Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McAuley DF, 2017, LANCET RESP MED, V5, P484, DOI 10.1016/S2213-2600(17)30171-6; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; McGroder CF, 2021, THORAX, V76, P1242, DOI 10.1136/thoraxjnl-2021-217031; McKelvey MC, 2022, AM J RESP CRIT CARE, V205, P769, DOI 10.1164/rccm.202107-1631OC; McNamee JJ, 2021, JAMA-J AM MED ASSOC, V326, P1013, DOI 10.1001/jama.2021.13374; McNeil JB, 2018, AM J RESP CRIT CARE, V197, P1027, DOI 10.1164/rccm.201707-1474OC; McPeake J, 2021, AM J CRIT CARE, V30, P145, DOI 10.4037/ajcc2021702; McPeake Joanne, 2020, Crit Care Explor, V2, pe0088, DOI 10.1097/CCE.0000000000000088; Mehta P, 2022, ERJ OPEN RES, V8, P118; Monsel A, 2022, CRIT CARE, V26, DOI 10.1186/s13054-022-03930-4; Moss M, 2019, NEW ENGL J MED, V380, P1997, DOI 10.1056/NEJMoa1901686; Needham DM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1532; Pais FM, 2018, RESP CARE, V63, P1060, DOI 10.4187/respcare.06034; Papazian L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0540-9; Parke RL, 2015, RESP CARE, V60, P1397, DOI 10.4187/respcare.04028; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pham T, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03317-2020; Pisani L, 2021, AM J TROP MED HYG, V104, P1022, DOI 10.4269/ajtmh.20-1177; Pisani L, 2021, AM J TROP MED HYG, V104, P478, DOI 10.4269/ajtmh.20-0996; Prescott HC, 2018, THORAX, V73, P618, DOI 10.1136/thoraxjnl-2017-210109; Ranieri VM, 2022, AM J RESP CRIT CARE, V205, P431, DOI 10.1164/rccm.202109-2163OC; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reddy K, 2021, AM J RESP CRIT CARE, V203, P1449, DOI 10.1164/rccm.202101-0218ED; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Romano SD, 2021, MMWR-MORBID MORTAL W, V70, P560, DOI [10.15585/mmwr.mm7015e2, 10.15585/mmwr.mm7015e2externalicon]; Roussel M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100291; Ruhl AP, 2017, INTENS CARE MED, V43, P980, DOI 10.1007/s00134-017-4827-8; Saha Rohit, 2022, Chest, V162, P1048, DOI 10.1016/j.chest.2022.05.018; Saha R, 2021, BRIT J ANAESTH, V127, P85, DOI 10.1016/j.bja.2021.02.027; Sarge T, 2021, AM J RESP CRIT CARE, V204, P1153, DOI 10.1164/rccm.202009-3539OC; Schofield-Robinson OJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012701.pub2; Neto AS, 2018, INTENS CARE MED, V44, P1914, DOI 10.1007/s00134-018-5375-6; Shaver CM, 2014, CLIN CHEST MED, V35, P639, DOI 10.1016/j.ccm.2014.08.004; Silva JD, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.02978-2020; Sinha P, 2020, LANCET RESP MED, V8, P1209, DOI 10.1016/S2213-2600(20)30366-0; Sjoding MW, 2021, LANCET DIGIT HEALTH, V3, pE340, DOI 10.1016/S2589-7500(21)00056-X; Sjoding MW, 2021, ANN AM THORAC SOC, V18, P1876, DOI 10.1513/AnnalsATS.202008-1076OC; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Su H, 2022, THORAX, V77, P123, DOI 10.1136/thoraxjnl-2020-216586; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Toner P, 2021, CHEST, V161, P1275; Torres LK, 2021, THORAX, V76, P1176, DOI 10.1136/thoraxjnl-2020-215950; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Tzotzos SJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03240-7; Urner M, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2021-068723; Valbuena VSM, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj-2021-069775; Vercesi V, 2018, INTENS CARE MED, V44, P523, DOI 10.1007/s00134-018-5048-5; Vijayakumar B, 2022, RADIOLOGY, V303, DOI 10.1148/radiol.2021211746; Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5; Wick KD, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03822-z; Wilcox ME, 2013, CHEST, V143, P920, DOI 10.1378/chest.12-0685; Willson DF, 2015, CHEST, V148, P356, DOI 10.1378/chest.14-1139; Xie Y, 2022, NAT MED, V28, P583, DOI 10.1038/s41591-022-01689-3; Xirouchaki N, 2011, INTENS CARE MED, V37, P1488, DOI 10.1007/s00134-011-2317-y; Yang CL, 2022, LANCET RESP MED, V10, pE81, DOI 10.1016/S2213-2600(22)00217-X; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Zangrillo A, 2022, J CARDIOTHOR VASC AN, V36, P1354, DOI 10.1053/j.jvca.2021.11.032; Zhang ZH, 2019, INTENS CARE MED, V45, P856, DOI 10.1007/s00134-019-05627-9; Zimatore C, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.672823	160	0	0	9	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1157	1170		10.1016/S0140-6736(22)01439-8	http://dx.doi.org/10.1016/S0140-6736(22)01439-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36070788	Bronze			2022-12-28	WOS:000877828800020
J	Saiag, P; Blom, A				Saiag, Philippe; Blom, Astrid			Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma	LANCET			English	Editorial Material									[Saiag, Philippe; Blom, Astrid] Paris Saclay Univ UVSQ, Ambroise Pare Hosp, Assistance Publ Hop Paris, Dept Gen & Oncol Dermatol,EA 4340,Biomarker Cance, F-92104 Boulogne Billancourt, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Saiag, P (corresponding author), Paris Saclay Univ UVSQ, Ambroise Pare Hosp, Assistance Publ Hop Paris, Dept Gen & Oncol Dermatol,EA 4340,Biomarker Cance, F-92104 Boulogne Billancourt, France.	philippe.saiag@uvsq.fr						D'Angelo SP, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002646; Gauci ML, 2022, EUR J CANCER, V171, P203, DOI 10.1016/j.ejca.2022.03.043; Kim S, 2022, LANCET, V400, P1008, DOI 10.1016/S0140-6736(22)01659-2; Nghiem P, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002478; Schadendorf D, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1338237; Shalhout SZ, 2022, J IMMUNOTHER, V45, P299, DOI 10.1097/CJI.0000000000000432	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					976	977		10.1016/S0140-6736(22)01749-4	http://dx.doi.org/10.1016/S0140-6736(22)01749-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3HP	36108656				2022-12-28	WOS:000888763000003
J	O'Dowd, A				O'Dowd, Adrian			Why I ... do calligraphy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o2231	10.1136/bmj.o2231	http://dx.doi.org/10.1136/bmj.o2231			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126972	Bronze			2022-12-28	WOS:000869963500003
J	Rubin, R				Rubin, Rita			Some Hearing Aids Will Soon Be Sold Over the Counter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1030	1030		10.1001/jama.2022.14714	http://dx.doi.org/10.1001/jama.2022.14714			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125482				2022-12-28	WOS:000862909200010
J	Shamsudduha, M; Taylor, RG; Haq, MI; Nowreen, S; Zahid, A; Ahmed, KMU				Shamsudduha, Mohammad; Taylor, Richard G.; Haq, Md Izazul; Nowreen, Sara; Zahid, Anwar; Ahmed, Kazi Matin Uddin			The Bengal Water Machine: Quantified freshwater capture in Bangladesh	SCIENCE			English	Article							GROUNDWATER DEPLETION; GANGES; BRAHMAPUTRA; ADAPTATION; SCARCITY; SECURITY; GROWTH; BASIN	Global food security depends on the sustainability of irrigated agriculture. Rising groundwater withdrawals from seasonally humid, alluvial plains across tropical Asia have enabled dry-season rice cultivation. This groundwater pumpage increases available subsurface storage that under favorable conditions amplifies groundwater replenishment during the subsequent monsoon. We empirically quantified this nature-based solution to seasonal freshwater storage capture described as the "Bengal Water Machine," revealing its potential and limitations. On the basis of a million piezometric observations from 465 monitoring wells, we show that the collective operation of similar to 16 million smallholder farmers in the Bengal Basin of Bangladesh from 1988 to 2018 has induced cumulative freshwater capture that volumetrically (75 to 90 cubic kilometers) is equivalent to twice the reservoir capacity of the Three Gorges Dam.	[Shamsudduha, Mohammad] UCL, Inst Risk & Disaster Reduct, London, England; [Shamsudduha, Mohammad] Univ Sussex, Dept Geog, Brighton, England; [Taylor, Richard G.; Haq, Md Izazul] UCL, Dept Geog, London, England; [Haq, Md Izazul] Univ Dhaka, Dept Disaster Sci & Climate Resilience, Dhaka, Bangladesh; [Nowreen, Sara] Bangladesh Univ Engn & Technol, Inst Water & Flood Management, Dhaka, Bangladesh; [Zahid, Anwar] Bangladesh Water Dev Board, Ground Water Hydrology Circle, Dhaka, Bangladesh; [Ahmed, Kazi Matin Uddin] Univ Dhaka, Dept Geol, Dhaka, Bangladesh	University of London; University College London; University of Sussex; University of London; University College London; University of Dhaka; Bangladesh University of Engineering & Technology (BUET); University of Dhaka	Shamsudduha, M (corresponding author), UCL, Inst Risk & Disaster Reduct, London, England.; Shamsudduha, M (corresponding author), Univ Sussex, Dept Geog, Brighton, England.	m.shamsudduha@ucl.ac.uk		Nowreen, Sara/0000-0001-8116-4020; Ahmed, Kazi Matin/0000-0001-5188-4385; Shamsudduha, Mohammad/0000-0002-9708-7223	DFID (UK government) [GA/11F/099/S2]; Commonwealth Split-Site Scholarship [BDCN-2014-4]; Commonwealth Scholarship [BDCS-2017-60]; Royal Society-Leverhulme Trust [LT170004]	DFID (UK government); Commonwealth Split-Site Scholarship; Commonwealth Scholarship; Royal Society-Leverhulme Trust(Royal Society of LondonLeverhulme Trust)	R.G.T. and M.S. acknowledge support from DFID (UK government) under grant GA/11F/099/S2, "Groundwater resources in the Indo-Gangetic Basin: Resilience to climate change and pumping." S.N., M.I.H., and R.G.T. acknowledge support of a Commonwealth Split-Site Scholarship (BDCN-2014-4), Commonwealth Scholarship (BDCS-2017-60), and The Royal Society-Leverhulme Trust Senior Fellowship (ref. LT170004), respectively.	Ahammed SJ, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10030819; Ahmed K. M., 2021, GLOBAL GROUNDWATER, P425; Alam K, 2015, AGR WATER MANAGE, V148, P196, DOI 10.1016/j.agwat.2014.10.011; Amarasinghe UA, 2016, HYDROL EARTH SYST SC, V20, P1085, DOI 10.5194/hess-20-1085-2016; [Anonymous], ESTIMATED RESERVOIR; Bandumula Nirmala, 2018, Proceedings of the Indian National Science Academy Part B Biological Sciences, V88, P1323, DOI 10.1007/s40011-017-0867-7; Bangladesh Agricultural Development Corporation (BADC), 2020, SURV REP IRR EQ IRR; Buchhorn M, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12061044; Dalin C, 2017, NATURE, V543, P700, DOI 10.1038/nature21403; Feng W, 2013, WATER RESOUR RES, V49, P2110, DOI 10.1002/wrcr.20192; Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021; Khan MR, 2014, WATER RESOUR MANAG, V28, P1235, DOI 10.1007/s11269-014-0537-y; Kinneburgh D. G., 2001, BRIT GEOLOGICAL SURV; MacDonald AM, 2016, NAT GEOSCI, V9, P762, DOI [10.1038/ngeo2791, 10.1038/NGEO2791]; Nowreen S, 2020, HYDROGEOL J, V28, P2917, DOI 10.1007/s10040-020-02238-3; Rasul G, 2015, INT J RIVER BASIN MA, V13, P387, DOI 10.1080/15715124.2015.1012518; REVELLE R, 1975, SCIENCE, V188, P611, DOI 10.1126/science.188.4188.611; Rodell M, 2018, NATURE, V557, P650, DOI 10.1038/s41586-018-0123-1; Rosa L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6031; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; Schneider P, 2020, J AGRON CROP SCI, V206, P491, DOI 10.1111/jac.12415; Shamsudduha M, 2009, HYDROL EARTH SYST SC, V13, P2373, DOI 10.5194/hess-13-2373-2009; Shamsudduha M, 2015, WATER RESOUR RES, V51, P685, DOI 10.1002/2013WR014572; Shamsudduha M, 2011, HYDROGEOL J, V19, P901, DOI 10.1007/s10040-011-0723-4; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Wada Y, 2014, EARTH SYST DYNAM, V5, P15, DOI 10.5194/esd-5-15-2014	26	1	1	9	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1315	+		10.1126/science.abm4730	http://dx.doi.org/10.1126/science.abm4730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108006	Green Submitted			2022-12-28	WOS:000887933500039
J	Vijayanarayanan, A; Menon, MP				Vijayanarayanan, Anjanaa; Menon, Madhu P.			Cholesterol Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Cholesterol Pericarditis A 64-year-old man with rheumatoid arthritis presented with fatigue and abdominal pain and was found to have a pericardial effusion. Pericardiocentesis was performed, and microscopy showed cholesterol crystals.	[Vijayanarayanan, Anjanaa] Henry Ford Hlth Syst, Detroit, MI USA; [Menon, Madhu P.] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA	Henry Ford Health System; Henry Ford Hospital; Utah System of Higher Education; University of Utah	Menon, MP (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.	madhu.menon@aruplab.com							0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					1021	1021		10.1056/NEJMicm2118193	http://dx.doi.org/10.1056/NEJMicm2118193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36094842				2022-12-28	WOS:000865415300013
J	Kozhimannil, KB; Hassan, A; Hardeman, RR				Kozhimannil, Katy Backes; Hassan, Asha; Hardeman, Rachel R.			Abortion Access as a Racial Justice Issue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access									[Kozhimannil, Katy Backes] Univ Minnesota, Ctr Antiracism Res Hlth Equ, Sch Publ Hlth, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kozhimannil, KB (corresponding author), Univ Minnesota, Ctr Antiracism Res Hlth Equ, Sch Publ Hlth, Minneapolis, MN 55455 USA.			Hassan, Asha/0000-0003-0097-3075				Gurr B., 2015, REPROD JUSTICE POLIT; McGregor Alecia J, 2021, Am J Obstet Gynecol MFM, V3, P100480, DOI 10.1016/j.ajogmf.2021.100480; Roberts DE, 1997, KILLING BLACK BODY R; Ross LJ., 2001, AM J HLTH STUD, V17, P79; Stevenson AJ, 2021, DEMOGRAPHY, V58, P2019, DOI 10.1215/00703370-9585908	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2209737	http://dx.doi.org/10.1056/NEJMp2209737		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6R7DY	36069823	Bronze			2022-12-28	WOS:000892460700001
J	Nichol, BC; Srinivas, R; Nadlinger, DP; Drmota, P; Main, D; Araneda, G; Ballance, CJ; Lucas, DM				Nichol, B. C.; Srinivas, R.; Nadlinger, D. P.; Drmota, P.; Main, D.; Araneda, G.; Ballance, C. J.; Lucas, D. M.			An elementary quantum network of entangled optical atomic clocks	NATURE			English	Article							PROJECTION NOISE; SPECTROSCOPY	Optical atomic clocks are our most precise tools to measure time and frequency(1-3). Precision frequency comparisons between clocks in separate locations enable one to probe the space-time variation of fundamental constants(4,5) and the properties of dark matter(6,7), to perform geodesy(8-10) and to evaluate systematic clock shifts. Measurements on independent systems are limited by the standard quantum limit; measurements on entangled systems can surpass the standard quantum limit to reach the ultimate precision allowed by quantum theory-the Heisenberg limit. Although local entangling operations have demonstrated this enhancement at microscopic distances(11-16), comparisons between remote atomic clocks require the rapid generation of high-fidelity entanglement between systems that have no intrinsic interactions. Here we report the use of a photonic link(17,18) to entangle two Sr-88(+) ions separated by a macroscopic distance(19) (approximately 2 m) to demonstrate an elementary quantum network of entangled optical clocks. For frequency comparisons between the ions, we find that entanglement reduces the measurement uncertainty by nearly root 2, the value predicted for the Heisenberg limit. Today's optical clocks are typically limited by dephasing of the probe laser(20); in this regime, we find that entanglement yields a factor of 2 reduction in the measurement uncertainty compared with conventional correlation spectroscopy techniques(20-22). We demonstrate this enhancement for the measurement of a frequency shift applied to one of the clocks. This two-node network could be extended to additional nodes(23), to other species of trapped particles or-through local operations-to larger entangled systems.	[Nichol, B. C.; Srinivas, R.; Nadlinger, D. P.; Drmota, P.; Main, D.; Araneda, G.; Ballance, C. J.; Lucas, D. M.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England	University of Oxford	Nichol, BC; Srinivas, R (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England.	raghavendra.srinivas@physics.ox.ac		Srinivas, Raghavendra/0000-0002-8462-6072; Ballance, Chris/0000-0002-9654-9510; Nadlinger, David P./0000-0003-0219-274X; Drmota, Peter/0000-0002-2241-885X	UK EPSRC Hub in Quantum Computing and Simulation [EP/T001062/1]; EU Quantum Technology Flagship Project AQTION [820495]; UK National Physical Laboratory; UKRI Fellowship [MR/S03238X/1]	UK EPSRC Hub in Quantum Computing and Simulation; EU Quantum Technology Flagship Project AQTION; UK National Physical Laboratory; UKRI Fellowship(UK Research & Innovation (UKRI))	We thank E. R. Clements, R. M. Godun, D. B. Hume and A. M. Steane for helpful discussions and insightful comments on the manuscript. We thank Sandia National Laboratories for supplying the HOA2 ion traps used in these experiments. This work was supported by the UK EPSRC Hub in Quantum Computing and Simulation (EP/T001062/1), the EU Quantum Technology Flagship Project AQTION (No. 820495) and C.J.B.'s UKRI Fellowship (MR/S03238X/1). B.C.N. acknowledges funding from the UK National Physical Laboratory.	Aharon N, 2019, NEW J PHYS, V21, DOI 10.1088/1367-2630/ab3871; Beloy K, 2021, NATURE, V591, P564, DOI 10.1038/s41586-021-03253-4; Bize S, 2000, IEEE T ULTRASON FERR, V47, P1253, DOI 10.1109/58.869073; Brewer SM, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.033201; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chwalla M, 2007, APPL PHYS B-LASERS O, V89, P483, DOI 10.1007/s00340-007-2867-4; Clements ER, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.243602; Degen CL, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.035002; Derevianko A, 2014, NAT PHYS, V10, P933, DOI 10.1038/NPHYS3137; GABRIELSE G, 1988, J APPL PHYS, V63, P5143, DOI 10.1063/1.340416; Gilmore KA, 2021, SCIENCE, V373, P673, DOI 10.1126/science.abi5226; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Hughes AC, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.080504; Hume DB, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.032138; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Kim, 2021, OPTICAL COHERENCE AT; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Lange R, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.011102; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Leroux ID, 2017, METROLOGIA, V54, DOI 10.1088/1681-7575/aa66e9; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Malnou M, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021023; Manovitz T, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.203001; Marti GE, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.103201; McGrew WF, 2018, NATURE, V564, P87, DOI 10.1038/s41586-018-0738-2; Megidish E, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.123605; Mehlstaubler TE, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab409; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Nadlinger DP, 2022, NATURE, V607, P682, DOI 10.1038/s41586-022-04941-5; Oelker E, 2019, NAT PHOTONICS, V13, P714, DOI 10.1038/s41566-019-0493-4; Pedrozo-Penafiel E, 2020, NATURE, V588, P414, DOI 10.1038/s41586-020-3006-1; Pezze L, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.035005; RAMSEY NF, 1957, REV SCI INSTRUM, V28, P57, DOI 10.1063/1.1715708; Riis E, 2004, J PHYS B-AT MOL OPT, V37, P4719, DOI 10.1088/0953-4075/37/24/001; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Ruster T, 2016, APPL PHYS B-LASERS O, V122, DOI 10.1007/s00340-016-6527-4; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; Sahoo BK, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.062504; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Stephenson L., 2019, THESIS U OXFORD; Stephenson LJ, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.110501; Tse M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.231107; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; Wolf F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10576-4; Wright TA, 2018, PHYS REV APPL, V10, DOI 10.1103/PhysRevApplied.10.044012; Young AW, 2020, NATURE, V588, P408, DOI 10.1038/s41586-020-3009-y	56	2	2	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					689	+		10.1038/s41586-022-05088-z	http://dx.doi.org/10.1038/s41586-022-05088-z		SEP 2022	7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36071166	Green Submitted			2022-12-28	WOS:000852585300001
J	Larkin, HD				Larkin, Howard D.			FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					819	819						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066536	Bronze			2022-12-28	WOS:000855171700008
J	Liu, SF; Hou, ZW; Lin, LH; Li, F; Zhao, Y; Li, XZ; Zhang, H; Fang, HH; Li, ZC; Sun, HB				Liu, Shao-Feng; Hou, Zheng-Wei; Lin, Linhan; Li, Fu; Zhao, Yao; Li, Xiao-Ze; Zhang, Hao; Fang, Hong-Hua; Li, Zhengcao; Sun, Hong-Bo			3D nanoprinting of semiconductor quantum dots by photoexcitation-induced chemical bonding	SCIENCE			English	Article							RESOLUTION; EFFICIENT	Three-dimensional (3D) laser nanoprinting allows maskless manufacturing of diverse nanostructures with nanoscale resolution. However, 3D manufacturing of inorganic nanostructures typically requires nanomaterial-polymer composites and is limited by a photopolymerization mechanism, resulting in a reduction of material purity and degradation of intrinsic properties. We developed a polymerization-independent, laser direct writing technique called photoexcitation-induced chemical bonding. Without any additives, the holes excited inside semiconductor quantum dots are transferred to the nanocrystal surface and improve their chemical reactivity, leading to interparticle chemical bonding. As a proof of concept, we printed arbitrary 3D quantum dot architectures at a resolution beyond the diffraction limit. Our strategy will enable the manufacturing of free-form quantum dot optoelectronic devices such as light-emitting devices or photodetectors.	[Liu, Shao-Feng; Lin, Linhan; Zhao, Yao; Li, Xiao-Ze; Fang, Hong-Hua; Sun, Hong-Bo] Tsinghua Univ, Dept Precis Instrument, State Key Lab Precis Measurement Technol & Instru, Beijing 100084, Peoples R China; [Hou, Zheng-Wei; Li, Zhengcao] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat MOE, Beijing 100084, Peoples R China; [Li, Fu; Zhang, Hao] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Sun, Hong-Bo] Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, Changchun 130012, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Jilin University	Lin, LH; Sun, HB (corresponding author), Tsinghua Univ, Dept Precis Instrument, State Key Lab Precis Measurement Technol & Instru, Beijing 100084, Peoples R China.; Sun, HB (corresponding author), Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, Changchun 130012, Peoples R China.	linlh2019@mail.tsinghua.edu.cn; hbsun@tsinghua.edu.cn	Lin, Linhan/W-4382-2017; Sun, Hongbo/D-3689-2012; Zhang, Hao/J-2858-2014	Lin, Linhan/0000-0003-0556-9143; Sun, Hongbo/0000-0003-2127-8610; Zhao, Yao/0000-0002-1772-9506; Xiao-Ze, Li/0000-0002-5805-5878; LI, FU/0000-0002-4710-9623; Zhang, Hao/0000-0003-4513-0813; Hou, Zhengwei/0000-0002-3514-6128	National Key Research and Development Program of China [2020YFA0715000]; National Natural Science Foundation of China [61960206003, 62075111]; TsinghuaFoshan Innovation Special Fund [2021THFS0206]; State Key Laboratory of Precision Measurement Technology and Instruments	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); TsinghuaFoshan Innovation Special Fund; State Key Laboratory of Precision Measurement Technology and Instruments	L.L. acknowledges support from the National Key Research and Development Program of China (grant 2020YFA0715000), the National Natural Science Foundation of China (grant 62075111), and L.L. acknowledges the TsinghuaFoshan Innovation Special Fund (grant 2021THFS0206). H.-B.S. acknowledges support from the National Natural Science Foundation of China (grant 61960206003). L.L. and H.-B.S. acknowledge support from the State Key Laboratory of Precision Measurement Technology and Instruments.	Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q; Desponds A, 2021, SMALL, V17, DOI 10.1002/smll.202102486; Dieleman CD, 2020, NANOSCALE, V12, P11306, DOI 10.1039/d0nr01077d; Gaidi M, 2018, J SOLID STATE ELECTR, V22, P3631, DOI 10.1007/s10008-018-4062-4; Gao JB, 2014, ACS NANO, V8, P12814, DOI 10.1021/nn506075s; Hahn V, 2021, NAT PHOTONICS, V15, P932, DOI 10.1038/s41566-021-00906-8; Hines DA, 2013, J PHYS CHEM C, V117, P14418, DOI 10.1021/jp404031s; Hitkari Gaurav, 2017, Nano-Structures & Nano-Objects, V12, P1, DOI 10.1016/j.nanoso.2017.08.007; Issa A, 2021, ACS APPL MATER INTER, V13, P41846, DOI 10.1021/acsami.1c03905; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kennehan ER, 2021, J AM CHEM SOC, V143, P13824, DOI 10.1021/jacs.1c06248; Kotz F, 2021, ADV MATER, V33, DOI 10.1002/adma.202006341; Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996; Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908; NATAN MJ, 1986, J PHYS CHEM-US, V90, P4089, DOI 10.1021/j100408a051; Peng Y, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800522; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Singhal P, 2016, NANOSCALE, V8, P1823, DOI 10.1039/c5nr07605f; Vyatskikh A, 2020, NANO LETT, V20, P3513, DOI 10.1021/acs.nanolett.0c00454; Wang LX, 2021, ACS APPL MATER INTER, V13, P17861, DOI 10.1021/acsami.1c02515; Wang YY, 2017, SCIENCE, V357, P385, DOI 10.1126/science.aan2958; Wen XW, 2021, NAT MATER, V20, P1506, DOI 10.1038/s41563-021-01111-2; Wuister SF, 2004, J PHYS CHEM B, V108, P17393, DOI 10.1021/jp047078c; Yee DW, 2019, ADV MATER, V31, DOI 10.1002/adma.201901345	24	2	2	113	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1112	1116		10.1126/science.abo5345	http://dx.doi.org/10.1126/science.abo5345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048954				2022-12-28	WOS:000887933200048
J	Lang, DM				Lang, David M.			Chronic Urticaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MANAGEMENT; DIAGNOSIS; GUIDELINE; ANGIOEDEMA; IMPACT	Chronic Urticaria Chronic urticaria differs from acute urticaria in characteristics and treatments. The chronic form is spontaneous or inducible, with the latter elicited by cold, heat, pressure, or other precipitants.	[Lang, David M.] Cleveland Clin, Resp Inst, Dept Allergy & Clin Immunol, Cleveland Hts, OH USA; [Lang, David M.] Cleveland Clin, Dept Allergy & Clin Immunol, 9500 Euclid Ave,A90, Cleveland Hts, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lang, DM (corresponding author), Cleveland Clin, Dept Allergy & Clin Immunol, 9500 Euclid Ave,A90, Cleveland Hts, OH 44195 USA.	langd@ccf.org						Agache I, 2021, ALLERGY, V76, P59, DOI 10.1111/all.14547; Asero R, 2010, J INVEST ALLERG CLIN, V20, P386; Bernstein JA, 2014, J ALLERGY CLIN IMMUN, V133, P1270, DOI 10.1016/j.jaci.2014.02.036; Carrillo-Martin I, 2019, J ALLER CL IMM-PRACT, V7, P2823, DOI 10.1016/j.jaip.2019.04.031; CHAMPION RH, 1969, BRIT J DERMATOL, V81, P588, DOI 10.1111/j.1365-2133.1969.tb16041.x; Choosing Wisely, 2012, AM AC ALL ASTHM IMM; Criado PR, 2019, AN BRAS DERMATOL, V94, pS56, DOI 10.1590/abd1806-4841.2019940209; Feldweg AM, 2017, J ALLER CL IMM-PRACT, V5, P283, DOI 10.1016/j.jaip.2016.11.022; Goncu EK, 2016, Turkderm-Turk Arch D, V50, P82, DOI 10.4274/turkderm.22438; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Katelaris CH, 2021, J ALLER CL IMM-PRACT, V9, P2151, DOI 10.1016/j.jaip.2021.02.026; Kolkhir P, 2020, ANN ALLERG ASTHMA IM, V124, P2, DOI 10.1016/j.anai.2019.08.014; Kozel MMA, 2001, J AM ACAD DERMATOL, V45, P387, DOI 10.1067/mjd.2001.116217; Kulthanan K, 2016, ASIAN PAC J ALLERGY, V34, P190; Lang DM, 2013, ANN ALLERG ASTHMA IM, V111, P235, DOI 10.1016/j.anai.2013.07.031; Losappio L, 2014, EUR J INTERN MED, V25, P147, DOI 10.1016/j.ejim.2013.11.003; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Ozkan M, 2007, ANN ALLERG ASTHMA IM, V99, P29; Powell RJ, 2015, CLIN EXP ALLERGY, V45, P547, DOI 10.1111/cea.12494; Price DB, 2018, J ASTHMA ALLERGY, V11, P193, DOI 10.2147/JAA.S176026; Puxeddu I, 2019, J ASTHMA ALLERGY, V12, P285, DOI 10.2147/JAA.S184986; Saini S, 2020, J ALLER CL IMM-PRACT, V8, P1866, DOI 10.1016/j.jaip.2020.03.030; Shah RH, 2022, IMMUNOL ALLERGY CLIN, V42, P121, DOI 10.1016/j.iac.2021.10.001; Shaker M, 2020, J ALLER CL IMM-PRACT, V8, P2360, DOI 10.1016/j.jaip.2019.11.004; Staevska M, 2010, J ALLERGY CLIN IMMUN, V125, P676, DOI 10.1016/j.jaci.2009.11.047; Straesser MD, 2018, J ALLER CL IMM-PRACT, V6, P1386, DOI 10.1016/j.jaip.2017.10.030; Tarbox JA, 2011, ANN ALLERG ASTHMA IM, V107, P239, DOI 10.1016/j.anai.2011.06.008; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Wertenteil S, 2019, J AM ACAD DERMATOL, V81, P152, DOI 10.1016/j.jaad.2019.02.064; Zuberbier T, 2022, ALLERGY, V77, P734, DOI 10.1111/all.15090	30	0	0	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					824	831		10.1056/NEJMra2120166	http://dx.doi.org/10.1056/NEJMra2120166			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053507				2022-12-28	WOS:000849132700010
J	Halling, AS; Thyssen, JP				Halling, Anne-Sofie; Thyssen, Jacob P.			Biological therapy for young children with atopic dermatitis	LANCET			English	Editorial Material									[Halling, Anne-Sofie; Thyssen, Jacob P.] Univ Copenhagen, Dept Dermatol & Venereol, Bispebjerg Hosp, DK-2400 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Halling, AS (corresponding author), Univ Copenhagen, Dept Dermatol & Venereol, Bispebjerg Hosp, DK-2400 Copenhagen, Denmark.	anne-sofie.halling-overgaard.01@regionh.dk		Halling, Anne-Sofie/0000-0003-0166-6560				Brunner PM, 2017, ALLERGY, V72, P2017, DOI 10.1111/all.13223; Cork MJ, 2021, BRIT J DERMATOL, V184, P857, DOI 10.1111/bjd.19460; Elsgaard Stine, 2021, Int J Womens Dermatol, V7, P708, DOI 10.1016/j.ijwd.2021.07.005; European Medicines Agency, DUP; Gerner T, 2021, PEDIAT ALLERG IMM-UK, V32, P331, DOI 10.1111/pai.13394; Halling AS, 2021, J AM ACAD DERMATOL, V84, P139, DOI 10.1016/j.jaad.2020.08.051; Lee HJ, 2015, J INVEST DERMATOL, V135, P3025, DOI 10.1038/jid.2015.333; Paller AS, 2022, LANCET, V400, P908, DOI 10.1016/S0140-6736(22)01539-2; Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P46, DOI 10.1016/j.jaci.2018.11.006; Regeneron Pharmaceuticals, DUP PRESCR INF; Ronnstad ATM, 2018, J AM ACAD DERMATOL, V79, P448, DOI 10.1016/j.jaad.2018.03.017; Schmidt SAJ, 2021, JAMA DERMATOL, V157, P667, DOI 10.1001/jamadermatol.2021.0009; Spekhorst LS, 2022, JAMA DERMATOL, V158, P1048, DOI 10.1001/jamadermatol.2022.3014	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					867	869						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116468				2022-12-28	WOS:000890180700004
J	El Moutamid, M				El Moutamid, Maryame			How Saturn got its tilt and its rings	SCIENCE			English	Editorial Material							SCALE		[El Moutamid, Maryame] Cornell Univ, Cornell Ctr Astrophys & Planetary Sci, Ithaca, NY 14853 USA	Cornell University	El Moutamid, M (corresponding author), Cornell Univ, Cornell Ctr Astrophys & Planetary Sci, Ithaca, NY 14853 USA.	maryame@astro.cornell.edu			NASACassini Data Analysis Program [80NSSC19K0893]	NASACassini Data Analysis Program(National Aeronautics & Space Administration (NASA))	M.E.M. is funded by the NASACassini Data Analysis Program, grant 80NSSC19K0893.	Boue G, 2009, ASTROPHYS J LETT, V702, pL19, DOI 10.1088/0004-637X/702/1/L19; Crida A, 2019, NAT ASTRON, V3, P967, DOI 10.1038/s41550-019-0876-y; French RG, 2017, ICARUS, V290, P14, DOI 10.1016/j.icarus.2017.02.007; Iess L, 2019, SCIENCE, V364, P1052, DOI 10.1126/science.aat2965; Saillenfest M, 2021, ASTRON ASTROPHYS, V647, DOI 10.1051/0004-6361/202039891; Saillenfest M, 2021, NAT ASTRON, V5, P345, DOI 10.1038/s41550-020-01284-x; Salmon J, 2010, ICARUS, V209, P771, DOI 10.1016/j.icarus.2010.05.030; Vokrouhlicky D, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/143; Ward WR, 2004, ASTRON J, V128, P2501, DOI 10.1086/424533; Wisdom J, 2022, SCIENCE, V377, P1285, DOI 10.1126/science.abn1234; Zhang Z, 2017, ICARUS, V294, P14, DOI 10.1016/j.icarus.2017.04.008; Zhang Z, 2017, ICARUS, V281, P297, DOI 10.1016/j.icarus.2016.07.020	12	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1264	1265		10.1126/science.abq3184	http://dx.doi.org/10.1126/science.abq3184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108002				2022-12-28	WOS:000887933500024
J	Soman, A; Wong, SY; Korolev, N; Surya, W; Lattmann, S; Vogirala, VK; Chen, QM; Berezhnoy, NV; van Noort, J; Rhodes, D; Nordenskiold, L				Soman, Aghil; Wong, Sook Yi; Korolev, Nikolay; Surya, Wahyu; Lattmann, Simon; Vogirala, Vinod K.; Chen, Qinming; Berezhnoy, Nikolay, V; van Noort, John; Rhodes, Daniela; Nordenskiold, Lars			Columnar structure of human telomeric chromatin	NATURE			English	Article							MOLECULE FORCE SPECTROSCOPY; NUCLEOSOME CORE PARTICLE; DNA-DAMAGE RESPONSE; REVEALS; FIBER; ORGANIZATION; EM; ULTRACENTRIFUGATION; RECONSTITUTION; COMPACT	Telomeres, the ends of eukaryotic chromosomes, play pivotal parts in ageing and cancer and are targets of DNA damage and the DNA damage response(1-5). Little is known about the structure of telomeric chromatin at the molecular level. Here we used negative stain electron microscopy and single-molecule magnetictweezers to characterize 3-kbp-longtelomeric chromatin fibres. We also obtained the cryogenic electron microscopy structure of the condensed telomerictetranucleosome and its dinucleosome unit. The structure displayed close stacking of nucleosomes with a columnar arrangement, and an unusually short nucleosome repeat length that comprised about 132 bp DNA wound in a continuous superhelix around histone octamers. This columnar structure is primarily stabilized by the H2A carboxy-terminal and histone amino-terminal tails in a synergistic manner. The columnar conformation results in exposure of the DNA helix, which may make it susceptible to both DNA damage and the DNA damage response. The conformation also exists in an alternative open state, in which one nucleosome is unstacked and flipped out, which exposesthe acidic patch of the histone surface. The structural features revealed in this work suggest mechanisms by which protein factors involved in telomere maintenance can access telomeric chromatin in its compact form.	[Soman, Aghil; Wong, Sook Yi; Korolev, Nikolay; Surya, Wahyu; Lattmann, Simon; Vogirala, Vinod K.; Chen, Qinming; Berezhnoy, Nikolay, V; van Noort, John; Rhodes, Daniela; Nordenskiold, Lars] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Lattmann, Simon; Rhodes, Daniela; Nordenskiold, Lars] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Berezhnoy, Nikolay, V] Nanyang Technol Univ, Singapore Ctr Environm Sci Engn SCELSE, Singapore, Singapore; [van Noort, John] Leiden Univ, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Rhodes, Daniela] MRC, Lab Mol Biol, Cambridge, England; [Wong, Sook Yi] Duke NUS, Dept Emerging Infect Dis, Med Sch, Singapore, Singapore; [Vogirala, Vinod K.] Electron Bioimaging Ctr eBIC, Diamond Light Source, Harwell Sci & Innovat Campus, Didcot, Oxon, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Leiden University; Leiden University - Excl LUMC; MRC Laboratory Molecular Biology; National University of Singapore; Diamond Light Source	Rhodes, D; Nordenskiold, L (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Rhodes, D; Nordenskiold, L (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore.; Rhodes, D (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	DRhodes@ntu.edu.sg; LarsNor@ntu.edu.sg	; Lattmann, Simon/G-2914-2010	Surya, Wahyu/0000-0001-9240-371X; Vogirala, VINOD/0000-0002-8534-3736; Lattmann, Simon/0000-0002-4639-4602	Singapore Ministry of Education (MOE) Academic Research Fund (AcRF) Tier 2 grant [MOE2018-T2-1-112]; Singapore Ministry of Education (MOE) Academic Research Fund (AcRF) Tier 3 grant [MOE2012-T3-1-001]	Singapore Ministry of Education (MOE) Academic Research Fund (AcRF) Tier 2 grant(Ministry of Education, Singapore); Singapore Ministry of Education (MOE) Academic Research Fund (AcRF) Tier 3 grant	We thank staff at the NTU Institute of Structural Biology (NISB), Nanyang Technological University, for providing access to facilities; staff at the Facility for Analysis, Characterisation, Testing and Simulation, Nanyang Technological University, for use of their electron microscope and A.Wong and E.Smith for assistance with data collection; staff at the Cryo-Electron Microscopy Facility at the Center for Bioimaging Science, Department of Biological Science, National University of Singapore, and J.Shi for scientific and technical assistance; W.Shum for assistance with the preparations of histone and DNA template constructs; and C.Davey and S.Sandin for their valuable discussions and suggestions. This work has been supported by the Singapore Ministry of Education (MOE) Academic Research Fund (AcRF) Tier 2 (MOE2018-T2-1-112) and Tier 3 (MOE2012-T3-1-001) grants.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2019, ORIGINPRO V 2019; Bedoyan JK, 1996, J BIOL CHEM, V271, P18485, DOI 10.1074/jbc.271.31.18485; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bowerman S, 2021, ELIFE, V10, DOI 10.7554/eLife.65587; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brouwer T, 2021, NUCLEIC ACIDS RES, V49, P2537, DOI 10.1093/nar/gkab058; Brouwer TB, 2020, BIOPHYS J, V118, P2245, DOI 10.1016/j.bpj.2020.01.015; Brouwer TB, 2018, METHODS MOL BIOL, V1837, P317, DOI 10.1007/978-1-4939-8675-0_17; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Burnley T, 2017, ACTA CRYSTALLOGR D, V73, P469, DOI 10.1107/S2059798317007859; Cacchione S, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1030-5; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Ekundayo B, 2017, J MOL BIOL, V429, P3031, DOI 10.1016/j.jmb.2017.09.002; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Fajkus J, 2001, BIOCHEM BIOPH RES CO, V280, P961, DOI 10.1006/bbrc.2000.4208; Garcia-Saez I, 2018, MOL CELL, V72, P902, DOI 10.1016/j.molcel.2018.09.027; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Huang YC, 2018, SOFT MATTER, V14, P9096, DOI 10.1039/c8sm00998h; Hubner B, 2022, NUCLEIC ACIDS RES, V50, P5047, DOI 10.1093/nar/gkac309; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Kaczmarczyk A, 2018, METHODS MOL BIOL, V1814, P297, DOI 10.1007/978-1-4939-8591-3_18; Kaczmarczyk A, 2017, J BIOL CHEM, V292, P17506, DOI 10.1074/jbc.M117.791830; Konrad SF, 2022, BIOPHYS J, V121, P841, DOI 10.1016/j.bpj.2022.01.014; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Korolev N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19875-0; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu WH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19018-y; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Mattiroli F, 2017, SCIENCE, V357, P609, DOI 10.1126/science.aaj1849; Meng H, 2015, NUCLEIC ACIDS RES, V43, P3578, DOI 10.1093/nar/gkv215; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pisano S, 2008, CELL MOL LIFE SCI, V65, P3553, DOI 10.1007/s00018-008-8307-8; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pope LH, 2005, BIOPHYS J, V88, P3572, DOI 10.1529/biophysj.104.053074; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Skrajna A, 2020, NUCLEIC ACIDS RES, V48, P9415, DOI 10.1093/nar/gkaa544; Soman A, 2020, NUCLEIC ACIDS RES, V48, P5383, DOI 10.1093/nar/gkaa289; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TATCHELL K, 1978, P NATL ACAD SCI USA, V75, P3583, DOI 10.1073/pnas.75.8.3583; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vancevska A, 2017, GENE DEV, V31, P567, DOI 10.1101/gad.294082.116; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Willhoft O, 2018, SCIENCE, V362, P199, DOI 10.1126/science.aat7716; Zhou BR, 2018, J MOL BIOL, V430, P3093, DOI 10.1016/j.jmb.2018.06.020; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	68	1	1	18	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					1048	+		10.1038/s41586-022-05236-5	http://dx.doi.org/10.1038/s41586-022-05236-5		SEP 2022	33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z2JJ	36104563	Green Submitted			2022-12-28	WOS:000854742900003
J	Torjesen, I				Torjesen, Ingrid			Sixty seconds on ... breaking lockdown rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BBC NEWS 0719; [Anonymous], 2022, GENDER INEQUALITIES; Public Health England, 2020, COVID 19 SUGG PRINC; Smith M, 2021, MIRROR ONLINE   1211	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2199	10.1136/bmj.o2199	http://dx.doi.org/10.1136/bmj.o2199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096513	Bronze			2022-12-28	WOS:000863219000006
J	Aishwarya, A; Cai, ZZ; Raghavan, A; Romanelli, M; Wang, XY; Li, X; Gu, GD; Hirsbrunner, M; Hughes, T; Liu, F; Jiao, L; Madhavan, V				Aishwarya, Anuva; Cai, Zhuozhen; Raghavan, Arjun; Romanelli, Marisa; Wang, Xiaoyu; Li, Xu; Gu, G. D.; Hirsbrunner, Mark; Hughes, Taylor; Liu, Fei; Jiao, Lin; Madhavan, Vidya			Spin-selective tunneling from nanowires of the candidate topological Kondo insulator SmB6	SCIENCE			English	Article							SURFACE-STATES; TORQUE; SCALE; BULK	Incorporating relativistic physics into quantum tunneling can lead to exotic behavior such as perfect transmission through Klein tunneling. Here, we probed the tunneling properties of spin-momentum-locked relativistic fermions by designing and implementing a tunneling geometry that uses nanowires of the topological Kondo insulator candidate samarium hexaboride. The nanowires are attached to the end of scanning tunneling microscope tips and used to image the bicollinear stripe spin order in the antiferromagnet Fe1.03Te with a Neel temperature of about 50 kelvin. The antiferromagnetic stripes become invisible above 10 kelvin concomitant with the suppression of the topological surface states in the tip. We further demonstrate that the direction of spin polarization is tied to the tunneling direction. Our technique establishes samarium hexaboride nanowires as ideal conduits for spin-polarized currents.	[Aishwarya, Anuva; Cai, Zhuozhen; Raghavan, Arjun; Romanelli, Marisa; Hirsbrunner, Mark; Hughes, Taylor; Jiao, Lin; Madhavan, Vidya] Univ Illinois, Dept Phys & Mat Res Lab, Urbana, IL 61801 USA; [Wang, Xiaoyu; Jiao, Lin] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Li, Xu; Liu, Fei] Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangdong Prov Key Lab Display Mat & Technol, Guangzhou 510275, Peoples R China; [Li, Xu; Liu, Fei] Sun Yat Sen Univ, Sch Elect & Informat Technol, Guangzhou 510275, Peoples R China; [Gu, G. D.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; Florida State University; Sun Yat Sen University; Sun Yat Sen University; United States Department of Energy (DOE); Brookhaven National Laboratory	Jiao, L; Madhavan, V (corresponding author), Univ Illinois, Dept Phys & Mat Res Lab, Urbana, IL 61801 USA.; Jiao, L (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA.; Liu, F (corresponding author), Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangdong Prov Key Lab Display Mat & Technol, Guangzhou 510275, Peoples R China.; Liu, F (corresponding author), Sun Yat Sen Univ, Sch Elect & Informat Technol, Guangzhou 510275, Peoples R China.	liufei@mail.sysu.edu.cn; lin.jiao@magnet.fsu.edu; vm1@illinois.edu		Li, Xu/0000-0002-8495-3807; Romanelli, Marisa/0000-0002-1745-2332; Wang, Xiaoyu/0000-0002-5035-5761; Aishwarya, Anuva/0000-0002-5639-5000; Jiao, Lin/0000-0002-8343-0190	National Science Foundation [DMR-1644779]; Army Research Office (ARO) under Multidisciplinary University Research Initiatives (MURI) [W911NF2020166]; Gordon and Betty Moore Foundation (EPiQS) [9465]; CIFAR; National Science Foundation of China [51872337]; National Project for the Development of Key Scientific Apparatus of China [2013YQ12034506]; State of Florida; PPG-Materials Research Laboratory Graduate assistantship 2020-2021; National MagLab - National Science Foundation [DMR-1644779]	National Science Foundation(National Science Foundation (NSF)); Army Research Office (ARO) under Multidisciplinary University Research Initiatives (MURI); Gordon and Betty Moore Foundation (EPiQS); CIFAR(Canadian Institute for Advanced Research (CIFAR)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Project for the Development of Key Scientific Apparatus of China; State of Florida; PPG-Materials Research Laboratory Graduate assistantship 2020-2021; National MagLab - National Science Foundation	The STM work at the University of Illinois was supported by the National Science Foundation through grant DMR-2003784. M.H and T.L.H thank the Army Research Office (ARO) under Multidisciplinary University Research Initiatives (MURI) grant W911NF2020166 for support. V.M acknowledges partial support from the Gordon and Betty Moore Foundation (EPiQS grant 9465) and the Materials Research Laboratory Central Research Facilities at the University of Illinois for use of the cleanroom. V.M is a CIFAR Fellow in the Quantum Materials Program and acknowledges CIFAR for support. A.A. was partially funded by PPG-Materials Research Laboratory Graduate assistantship 2020-2021. X.L and F.L. are very thankful for the support of the National Science Foundation of China (grant 51872337) and the National Project for the Development of Key Scientific Apparatus of China (grant 2013YQ12034506). L.J. and X.W. acknowledges financial support from National MagLab, which is funded by the National Science Foundation (grant DMR-1644779) and the State of Florida.	Aishwarya A, 2022, SPIN SELECTIVE TUNNE, DOI [10.13012/B2IDB-9971603_V1, DOI 10.13012/B2IDB-9971603_V1]; Alexandrov V, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.177202; B.I. Min, 2014, Arxiv, DOI arXiv:1312.6637; Casola F, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.88; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Chen F, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.205133; D.A. Bonn, 2017, Arxiv, DOI arXiv:1710.09089; Dzero M, 2016, ANNU REV CONDEN MA P, V7, P249, DOI 10.1146/annurev-conmatphys-031214-014749; Enayat M, 2014, THESIS SWISS FEDERAL; Fan YB, 2014, NAT MATER, V13, P699, DOI [10.1038/NMAT3973, 10.1038/nmat3973]; Gan HB, 2019, CRYST GROWTH DES, V19, P845, DOI 10.1021/acs.cgd.8b01412; Hanke T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13939; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hlawenka P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02908-7; Jiao L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13762; Lee SH, 2019, NATURE, V570, P344, DOI 10.1038/s41586-019-1305-1; Li L, 2020, NAT REV PHYS, V2, P463, DOI 10.1038/s42254-020-0210-8; Liu PZ, 2019, NAT REV MATER, V4, P479, DOI 10.1038/s41578-019-0113-4; Liu Q, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.156603; Liu T, 2018, PHYS REV LETT, V120; Lutchyn RM, 2018, NAT REV MATER, V3, P52, DOI 10.1038/s41578-018-0003-1; Manna S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14074; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Mito M, 2021, PHYS REV B, V104, DOI 10.1103/PhysRevB.104.054431; Nakajima Y, 2016, NAT PHYS, V12, P213, DOI 10.1038/NPHYS3555; Okada KN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12245; Park WK, 2016, P NATL ACAD SCI USA, V113, P6599, DOI 10.1073/pnas.1606042113; Pirie H, 2020, NAT PHYS, V16, P52, DOI 10.1038/s41567-019-0700-8; Rossler S, 2014, P NATL ACAD SCI USA, V111, P4798, DOI 10.1073/pnas.1402643111; Ruan W, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.136401; Smejkal L, 2018, NAT PHYS, V14, P242, DOI 10.1038/s41567-018-0064-5; Song Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13485; Tokura Y, 2019, NAT REV PHYS, V1, P126, DOI 10.1038/s42254-018-0011-5; Vasyukov D, 2013, NAT NANOTECHNOL, V8, P639, DOI [10.1038/nnano.2013.169, 10.1038/NNANO.2013.169]; Wang K. L., 2016, HDB SPINTRONICS; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; Wolgast S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.180405; Xu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5566; Zhang XH, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011011	43	0	0	17	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1218	1222		10.1126/science.abj8765	http://dx.doi.org/10.1126/science.abj8765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074835	Green Submitted			2022-12-28	WOS:000887933400047
J	Gouveia, B; Kim, Y; Shaevitz, JW; Petry, S; Stone, HA; Brangwynne, CP				Gouveia, Bernardo; Kim, Yoonji; Shaevitz, Joshua W.; Petry, Sabine; Stone, Howard A.; Brangwynne, Clifford P.			Capillary forces generated by biomolecular condensates	NATURE			English	Review							PROTEIN STORAGE VACUOLES; PHASE-SEPARATION; P GRANULES; LIQUID DROPLETS; CAJAL BODIES; RNA; BEHAVIOR; ORGANIZATION; TRANSITIONS; COMPARTMENTALIZATION	Liquid-liquid phase separation and related phase transitions have emerged as generic mechanisms in living cells for the formation of membraneless compartments or biomolecular condensates. The surface between two immiscible phases has an interfacial tension, generating capillary forces that can perform work on the surrounding environment. Here we present the physical principles of capillarity, including examples of how capillary forces structure multiphase condensates and remodel biological substrates. As with other mechanisms of intracellular force generation, for example, molecular motors, capillary forces can influence biological processes. Identifying the biomolecular determinants of condensate capillarity represents an exciting frontier, bridging soft matter physics and cell biology.	[Gouveia, Bernardo; Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Kim, Yoonji; Petry, Sabine] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.; Stone, HA (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.; Brangwynne, CP (corresponding author), Howard Hughes Med Inst, Princeton, NJ 08544 USA.	hastone@princeton.edu; cbrangwy@princeton.edu		Stone, Howard/0000-0002-9670-0639; Kim, Yoonji/0000-0003-1780-370X	Howard Hughes Medical Institute; Princeton Biomolecular Condensate Program; Princeton Center for Complex Materials; AFOSR MURI [FA9550-20-1-0241]; NSF GRFP [DGE-2039656]; MRSEC (NSF) [DMR-2011750]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Princeton Biomolecular Condensate Program; Princeton Center for Complex Materials; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); MRSEC (NSF)(National Science Foundation (NSF))	We thank members of our laboratories for helpful discussions; and M. Haataja for helpful comments on the manuscript. We acknowledge support from the Howard Hughes Medical Institute, the Princeton Biomolecular Condensate Program, and grants from the Princeton Center for Complex Materials, a MRSEC (NSF DMR-2011750), and the AFOSR MURI `Uncovering and applying the interfacial design principles of multiphasic natural and synthetic organelles' (FA9550-20-1-0241). B.G. acknowledges the PD Soros Foundation. Both B.G. and Y.K. are supported by the NSF GRFP (DGE-2039656).	Aarts DGAL, 2004, SCIENCE, V304, P847, DOI 10.1126/science.1097116; Abkarian M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188301; Agudo-Canalejo J, 2021, NATURE, V591, P142, DOI 10.1038/s41586-020-2992-3; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bergeron-Sandoval LP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2113789118; Berry J, 2018, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aaa61e; Binks BP, 2002, LANGMUIR, V18, P1270, DOI 10.1021/la011420k; Boddeker TJ, 2022, NAT PHYS, V18, P571, DOI 10.1038/s41567-022-01537-8; Boeynaems S, 2019, P NATL ACAD SCI USA, V116, P7889, DOI 10.1073/pnas.1821038116; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; BORUVKA L, 1977, J CHEM PHYS, V66, P5464, DOI 10.1063/1.433866; Bracha D, 2018, CELL, V175, P1467, DOI 10.1016/j.cell.2018.10.048; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Caragine CM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.148101; Cavallaro M, 2011, P NATL ACAD SCI USA, V108, P20923, DOI 10.1073/pnas.1116344108; Cochard A., 2022, BIOPHYS J, V121, P1675, DOI DOI 10.1101/2021.06.22.449254(2021; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Cuylen-Haering S, 2020, NATURE, V587, P285, DOI 10.1038/s41586-020-2672-3; De S, 2015, RSC ADV, V5, P65757, DOI 10.1039/c5ra11101c; Dill K., 2010, MOL DRIVING FORCES S; Dimova R, 2012, SOFT MATTER, V8, P6409, DOI 10.1039/c2sm25261a; Dine E, 2018, CELL SYST, V6, P655, DOI 10.1016/j.cels.2018.05.002; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Duprat C, 2011, J FLUID MECH, V679, P641, DOI 10.1017/jfm.2011.173; Eggers J, 1999, J FLUID MECH, V401, P293, DOI 10.1017/S002211209900662X; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Elettro H, 2016, P NATL ACAD SCI USA, V113, P6143, DOI 10.1073/pnas.1602451113; Falk M, 2019, NATURE, V570, P395, DOI 10.1038/s41586-019-1275-3; Feeney M, 2018, PLANT PHYSIOL, V177, P241, DOI 10.1104/pp.18.00010; Fei JY, 2017, J CELL SCI, V130, P4180, DOI 10.1242/jcs.206854; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Fisher RS, 2021, PROTEIN SCI, V30, P1482, DOI 10.1002/pro.4105; Fisher RS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18224-y; Folkmann AW, 2021, SCIENCE, V373, P1218, DOI 10.1126/science.abg7071; Frottin F, 2019, SCIENCE, V365, P342, DOI 10.1126/science.aaw9157; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gao YC, 2021, MOL CELL, V81, P4287, DOI 10.1016/j.molcel.2021.07.034; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hilbert L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21589-3; Ijavi M, 2021, SOFT MATTER, V17, P1655, DOI 10.1039/d0sm01319f; Jack A, 2022, DEV CELL, V57, P277, DOI 10.1016/j.devcel.2021.12.017; Jawerth LM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.258101; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Jijumon AS, 2022, NAT CELL BIOL, V24, P253, DOI 10.1038/s41556-021-00825-4; Kashchiev D., 2000, NUCL BASIC THEORY AP; Kaur T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21089-4; Keenen MM, 2021, ELIFE, V10, DOI 10.7554/eLife.64563; Kelley FM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109967118; Kilic S, 2019, EMBO J, V38, DOI 10.15252/embj.2018101379; King MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14087-0; Kumar N, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7779; Kusumaatmaja H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024109118; Kusumaatmaja H, 2011, SOFT MATTER, V7, P6914, DOI 10.1039/c1sm05499f; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lee DSW, 2021, NAT PHYS, V17, P531, DOI 10.1038/s41567-020-01125-8; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Mao S, 2019, SOFT MATTER, V15, P1297, DOI 10.1039/c8sm02045k; Marthelot J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06984-7; Martin EW, 2020, SCIENCE, V367, P694, DOI 10.1126/science.aaw8653; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morin JA, 2022, NAT PHYS, V18, P271, DOI 10.1038/s41567-021-01462-2; Narayanan A, 2019, ELIFE, V8, DOI 10.7554/eLife.39695; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pena E, 2001, J COMP NEUROL, V430, P250, DOI 10.1002/1096-9861(20010205)430:2<250::AID-CNE1029>3.0.CO;2-L; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Plys AJ, 2019, GENE DEV, V33, P799, DOI 10.1101/gad.326488.119; Putnam A, 2019, NAT STRUCT MOL BIOL, V26, P220, DOI 10.1038/s41594-019-0193-2; Quail T, 2021, NAT PHYS, V17, P1007, DOI 10.1038/s41567-021-01285-1; Roman B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/493101; Ronceray P, 2022, EPL-EUROPHYS LETT, V137, DOI 10.1209/0295-5075/ac56ac; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Rosowski KA, 2020, NAT PHYS, V16, P422, DOI 10.1038/s41567-019-0767-2; Rubinstein M., 2003, POLYM PHYS CHEM; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Sanchez-Burgos I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94309-y; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Setru SU, 2021, NAT PHYS, V17, P493, DOI 10.1038/s41567-020-01141-8; Seydoux G, 2018, J MOL BIOL, V430, P4702, DOI 10.1016/j.jmb.2018.08.007; Shimobayashi SF, 2021, NATURE, V599, P503, DOI 10.1038/s41586-021-03905-5; Shin Y, 2018, CELL, V175, P1481, DOI 10.1016/j.cell.2018.10.057; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Siahaan V, 2019, NAT CELL BIOL, V21, P1086, DOI 10.1038/s41556-019-0374-6; Simon JR, 2017, NAT CHEM, V9, P509, DOI [10.1038/NCHEM.2715, 10.1038/nchem.2715]; Snead WT, 2022, NAT CELL BIOL, V24, P461, DOI 10.1038/s41556-022-00882-3; Steinberg MS, 1996, DEV BIOL, V180, P377, DOI 10.1006/dbio.1996.0312; Stenstrom L, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209469; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Subramaniam AB, 2005, NATURE, V438, P930, DOI 10.1038/438930a; Tatavosian R, 2019, J BIOL CHEM, V294, P1451, DOI 10.1074/jbc.RA118.006620; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Wang H., 2021, BIOPHYS REP, V1, P100011; Wang HF, 2018, CELL, V175, P1405, DOI 10.1016/j.cell.2018.09.013; Wei MT, 2020, NAT CELL BIOL, V22, P1187, DOI 10.1038/s41556-020-00578-6; Weirich KL, 2019, P NATL ACAD SCI USA, V116, P11125, DOI 10.1073/pnas.1814854116; Weirich KL, 2017, P NATL ACAD SCI USA, V114, P2131, DOI 10.1073/pnas.1616133114; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wiegand T, 2020, EMERG TOP LIFE SCI, V4, P247, DOI 10.1042/ETLS20190174; Wurger A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041402; Yu HY, 2021, SCIENCE, V371, P585, DOI 10.1126/science.abb4309; Yuan F, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017435118; Zarzar LD, 2015, NATURE, V518, P520, DOI 10.1038/nature14168; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang YJ, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.258102; Zheng HQ, 2011, PLANT PHYSIOL, V155, P2023, DOI 10.1104/pp.110.170159; Zwicker D, 2017, NAT PHYS, V13, P408, DOI [10.1038/nphys3984, 10.1038/NPHYS3984]	117	1	1	39	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					255	264		10.1038/s41586-022-05138-6	http://dx.doi.org/10.1038/s41586-022-05138-6			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071192				2022-12-28	WOS:000852469200019
J	McCullough, J; Perera, RG				McCullough, Jocelyn; Perera, Rohan G.			Arrhythmogenic Right Ventricular Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McCullough, Jocelyn; Perera, Rohan G.] John T Mather Mem Hosp, Port Jefferson, NY 11777 USA		McCullough, J (corresponding author), John T Mather Mem Hosp, Port Jefferson, NY 11777 USA.	jmccullough1@northwell.edu							0	0	0	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10							e20	10.1056/NEJMicm2119255	http://dx.doi.org/10.1056/NEJMicm2119255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069874				2022-12-28	WOS:000861634500002
J	Wright, NJ; Fedor, JG; Zhang, H; Jeong, P; Suo, Y; Yoo, J; Hong, J; Im, W; Lee, SY				Wright, Nicholas J.; Fedor, Justin G.; Zhang, Han; Jeong, Pyeonghwa; Suo, Yang; Yoo, Jiho; Hong, Jiyong; Im, Wonpil; Lee, Seok-Yong			Methotrexate recognition by the human reduced folate carrier SLC19A1	NATURE			English	Article							POTENT NONPOLYGLUTAMATABLE ANTIFOLATE; MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; LEUKEMIA-CELLS; FOLIC-ACID; TRANSPORT; RESISTANCE; MUTATIONS; MECHANISM; GENE	Folates are essential nutrients with important roles as cofactors in one-carbon transfer reactions, being heavily utilized in the synthesis of nucleic acids and the metabolism of amino acids during cell division(1,2). Mammals lack de novo folate synthesis pathways and thus rely on folate uptake from the extracellular milieu(3). The human reduced folate carrier (hRFC, also known as SLC19A1) is the major importer of folates into the cell(1,3), as well as chemotherapeutic agents such as methotrexate(4-6). As an anion exchanger, RFC couples the import of folates and antifolates to anion export across the cell membrane and it is a major determinant in methotrexate (antifolate) sensitivity, as genetic variants and its depletion result in drug resistance(4-8). Despite its importance, the molecular basis of substrate specificity by hRFC remains unclear. Here we present cryo-electron microscopy structures of hRFC in the apo state and captured in complex with methotrexate. Combined with molecular dynamics simulations and functional experiments, our study uncovers key determinants of hRFC transport selectivity among folates and antifolate drugs while shedding light on important features of anion recognition by hRFC.	[Wright, Nicholas J.; Fedor, Justin G.; Suo, Yang; Yoo, Jiho; Lee, Seok-Yong] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA; [Zhang, Han; Im, Wonpil] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Zhang, Han; Im, Wonpil] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Zhang, Han; Im, Wonpil] Lehigh Univ, Dept Bioengn, Bethlehem, PA 18015 USA; [Yoo, Jiho] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Yoo, Jiho] Chung Ang Univ, Coll Pharm, Seoul, South Korea	Duke University; Lehigh University; Lehigh University; Lehigh University; Duke University; Chung Ang University	Lee, SY (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27706 USA.	seok-yonglee@duke.edu		Yoo, Jiho/0000-0002-0864-2142; Zhang, Han/0000-0002-5608-9185; Wright, Nicholas/0000-0002-7406-2015	National Institutes of Health [U24GM129547, R01GM137421]; American Heart Association fellowship [20PRE35210058]; National Science Foundation [ECCS-2025064, MCB-2111728]; Office of Biological and Environmental Research [grid.436923.9]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowship(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Cryo-EM data were screened and collected at the Duke University Shared Materials Instrumentation Facility (SMIF) and at the Pacific Northwest Center for Cryo-EM (PNCC) at Oregon Health & Science University (OHSU). We thank N. Bhattacharya at SMIF and J. Myers at the PNCC for assistance with microscope operation. This research was supported by National Institutes of Health grant R01GM137421 (S.-Y.L. and J.H.), American Heart Association fellowship 20PRE35210058 (N.J.W.) and National Science Foundation grant MCB-2111728 (W.I.). A portion of this research was supported by National Institutes of Health grant U24GM129547, performed at the PNCC at OHSU and accessed through EMSL (grid.436923.9), a Department of Energy Office of Science User Facility sponsored by the Office of Biological and Environmental Research. The Duke University SMIF is affiliated with the North Carolina Research Triangle Nanotechnology Network, which is in part supported by the National Science Foundation (ECCS-2025064).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam C, 2017, MOL PHARMACEUT, V14, P3848, DOI 10.1021/acs.molpharmaceut.7b00572; Aluri S, 2019, J BIOL CHEM, V294, P7245, DOI 10.1074/jbc.RA118.005533; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; Case D. A., 2021, AMBER 2022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Clare CE, 2019, ANNU REV ANIM BIOSCI, V7, P263, DOI 10.1146/annurev-animal-020518-115206; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng YJ, 2008, MOL PHARMACOL, V73, P1274, DOI 10.1124/mol.107.043190; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Di Francesco V, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13030332; Drew D, 2021, CHEM REV, V121, P5289, DOI 10.1021/acs.chemrev.0c00983; Drori S, 2000, J BIOL CHEM, V275, P30855, DOI 10.1074/jbc.M003988200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furst DE, 1997, BRIT J RHEUMATOL, V36, P1196; Gabler Felix, 2020, Curr Protoc Bioinformatics, V72, pe108, DOI 10.1002/cpbi.108; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao Y, 2021, J CHEM INF MODEL, V61, P831, DOI 10.1021/acs.jcim.0c01360; Gifford AJ, 2002, LEUKEMIA, V16, P2379, DOI 10.1038/sj.leu.2402655; Girardi E, 2020, NAT CHEM BIOL, V16, P469, DOI 10.1038/s41589-020-0483-3; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Guo W, 1999, CLIN CANCER RES, V5, P621; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; He XB, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0019056; HENDERSON GB, 1981, BIOCHEM BIOPH RES CO, V99, P163, DOI 10.1016/0006-291X(81)91727-7; HENDERSON GB, 1984, J BIOL CHEM, V259, P4558; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Hou ZJ, 2017, MOL CANCER THER, V16, P819, DOI 10.1158/1535-7163.MCT-16-0444; Hou ZJ, 2014, CURR TOP MEMBR, V73, P175, DOI 10.1016/B978-0-12-800223-0.00004-9; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen G, 2004, ARTHRITIS RHEUM-US, V50, P2130, DOI 10.1002/art.20375; Jansen G, 1998, J BIOL CHEM, V273, P30189, DOI 10.1074/jbc.273.46.30189; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kaufman Y, 2006, BLOOD, V107, P3288, DOI 10.1182/blood-2005-10-4048; Kaufman Y, 2004, CANCER-AM CANCER SOC, V100, P773, DOI 10.1002/cncr.20018; Kobayashi H, 1998, CANCER LETT, V124, P135, DOI 10.1016/S0304-3835(97)00464-3; Lee J, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0012280; Lee J, 2016, BIOPHYS J, V110, p641A, DOI 10.1016/j.bpj.2015.11.3431; Liu XY, 2001, BIOCHEM J, V358, P511, DOI 10.1042/0264-6021:3580511; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; O'Connor C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85818-x; Parker JL, 2021, NATURE, V595, P130, DOI 10.1038/s41586-021-03579-z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; RHEE MS, 1994, MOL PHARMACOL, V45, P783; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosowsky A, 2000, PHARMACOL THERAPEUT, V85, P191, DOI 10.1016/S0163-7258(99)00055-8; Rothem L, 2002, BIOCHEM J, V367, P741, DOI 10.1042/BJ20020801; Roy K, 1998, J BIOL CHEM, V273, P2526, DOI 10.1074/jbc.273.5.2526; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schroder O, 2003, AM J GASTROENTEROL, V98, P530, DOI 10.1016/S0002-9270(02)06027-6; Shinkarev VP, 2006, BBA-BIOENERGETICS, V1757, P67, DOI 10.1016/j.bbabio.2005.11.006; Straub MS, 2021, ELIFE, V10, DOI 10.7554/eLife.69800; Svaton M, 2020, BLOOD, V135, P2427, DOI 10.1182/blood.2019003178; Tian C, 2020, J CHEM THEORY COMPUT, V16, P528, DOI 10.1021/acs.jctc.9b00591; Tse A, 1998, J BIOL CHEM, V273, P25953, DOI 10.1074/jbc.273.40.25953; Yang R, 2003, CLIN CANCER RES, V9, P837; Yee SW, 2010, PHARMACOGENET GENOM, V20, P708, DOI 10.1097/FPC.0b013e32833eca92; Zhao R, 1998, J BIOL CHEM, V273, P19065, DOI 10.1074/jbc.273.30.19065; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 1998, J BIOL CHEM, V273, P7873, DOI 10.1074/jbc.273.14.7873; Zhao RB, 1999, MOL PHARMACOL, V56, P68, DOI 10.1124/mol.56.1.68; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; Zhao RB, 2001, J BIOL CHEM, V276, P10224, DOI 10.1074/jbc.C000905200; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng YX, 2019, J EXP MED, V216, P253, DOI 10.1084/jem.20181965; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	84	4	4	14	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					1056	+		10.1038/s41586-022-05168-0	http://dx.doi.org/10.1038/s41586-022-05168-0		SEP 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z2JJ	36071163				2022-12-28	WOS:000852585300005
J	Snyder, RA				Snyder, Rebecca A.			Together, we have learned the synchrony of operating as a pair, finding a measured rhythm and coordinated routine that makes sense to us bothE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Snyder, Rebecca A.] East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Snyder, RA (corresponding author), East Carolina Univ, Div Surg Oncol, Brody Sch Med, 600 Moye Blvd Surg Oncol Ste 4S-24, Greenville, NC 27834 USA.	snyderre19@ecu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					829	830						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066515				2022-12-28	WOS:000855171700016
J	Hassanpour, E; Zemp, Y; Tokunaga, Y; Taguchi, Y; Tokura, Y; Lottermoser, T; Fiebig, M; Weber, MC				Hassanpour, Ehsan; Zemp, Yannik; Tokunaga, Yusuke; Taguchi, Yasujiro; Tokura, Yoshinori; Lottermoser, Thomas; Fiebig, Manfred; Weber, Mads C.			Magnetoelectric transfer of a domain pattern	SCIENCE			English	Article								The utility of ferroic materials is determined by the formation of domains and their poling behavior under externally applied fields. For multiferroics, which exhibit several types of ferroic order at once, it is also relevant how the domains of the coexisting ferroic states couple and what kind of functionality this might involve. In this work, we demonstrate the reversible transfer of a domain pattern between magnetization and electric-polarization space in the multiferroic Dy0.7Tb0.3FeO3. A magnetic field transfers a ferromagnetic domain pattern into an identical ferroelectric domain pattern while erasing it at its magnetic origin. Reverse transfer completes the cycle. To assess the generality of our experiment, we elaborate on its conceptual origin and aspects of application.	[Hassanpour, Ehsan; Zemp, Yannik; Lottermoser, Thomas; Fiebig, Manfred; Weber, Mads C.] Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland; [Hassanpour, Ehsan] Swiss Fed Inst Technol, Dept Phys, CH-8093 Zurich, Switzerland; [Tokunaga, Yusuke] Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan; [Taguchi, Yasujiro; Tokura, Yoshinori; Fiebig, Manfred] RIKEN Ctr Emergent Matter Sci CEMS, Saitama 3510198, Japan; [Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Weber, Mads C.] Univ Tokyo, Tokyo Coll, Tokyo 1138656, Japan; [Hassanpour, Ehsan] Le Mans Univ, UMR 6283, Inst Mol & Mat Mans, CNRS, F-72085 Le Mans, France; Univ Bern, Univ Hosp Bern, Dept Diabet Endocrinol Nutrit Med & Metab, CH-3010 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Mans Universite; University of Bern; University Hospital of Bern	Fiebig, M (corresponding author), Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland.; Fiebig, M (corresponding author), RIKEN Ctr Emergent Matter Sci CEMS, Saitama 3510198, Japan.	manfred.fiebig@mat.ethz.ch	Tokura, Yoshinori/C-7352-2009; Lottermoser, Thomas/G-2828-2011	Tokura, Yoshinori/0000-0002-2732-4983; Weber, Mads C./0000-0002-8837-145X; Tokunaga, Yusuke/0000-0002-8913-9978; Fiebig, Manfred/0000-0003-4998-7179; Lottermoser, Thomas/0000-0002-2941-7446; Taguchi, Yasujiro/0000-0003-1896-699X; Hassanpour Yesaghi, Ehsan/0000-0002-4629-1558	SNSF [200021_178825/1]; European Research Council [694955-INSEETO]; JSPS [25707032]; Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology" (FIRST Program)	SNSF(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology" (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by SNSF (grant no. 200021_178825/1) and the European Research Council (advanced grant 694955-INSEETO). Y.Tokun. was supported by JSPS Grant-inAids for Young Scientists (A) (no. 25707032). Y.Tokun., Y.Ta., and Y.Tokur. were supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology" (FIRST Program). M.F. thanks CEMS at RIKEN and ETH for supporting his research sabbatical.	Birol T, 2012, CURR OPIN SOLID ST M, V16, P227, DOI 10.1016/j.cossms.2012.08.002; Bruck S, 2005, ADV MATER, V17, P2978, DOI 10.1002/adma.200500544; Chauleau JY, 2017, NAT MATER, V16, P803, DOI [10.1038/nmat4899, 10.1038/NMAT4899]; Chupis I. E., 2010, ARXIV10122024 CONDMA; Denev SA, 2011, J AM CERAM SOC, V94, P2699, DOI 10.1111/j.1551-2916.2011.04740.x; Fiebig M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144102; Fiebig M, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.46; Hassanpour E., 2022, DATA ANAL REPOSITORY, DOI [10.3929/ethz- b-000555414, DOI 10.3929/ETHZ-B-000555414]; Heron JT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217202; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Knizek K, 2014, SOLID STATE SCI, V28, P26, DOI 10.1016/j.solidstatesciences.2013.12.001; Lahtinen THE, 2011, ADV MATER, V23, P3187, DOI 10.1002/adma.201100426; Mundy JA, 2016, NATURE, V537, P523, DOI 10.1038/nature19343; Nolting F, 2000, NATURE, V405, P767, DOI 10.1038/35015515; PRELORENDJO LA, 1980, J PHYS C SOLID STATE, V13, P2567, DOI 10.1088/0022-3719/13/13/012; Tokunaga Y, 2012, NAT PHYS, V8, P838, DOI [10.1038/NPHYS2405, 10.1038/nphys2405]; Tokunaga Y, 2009, NAT MATER, V8, P558, DOI [10.1038/nmat2469, 10.1038/NMAT2469]; Wu LS, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.144407	18	0	0	11	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1109	+		10.1126/science.abm3058	http://dx.doi.org/10.1126/science.abm3058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048962				2022-12-28	WOS:000887933200047
J	Conradie, F; Bagdasaryan, TR; Borisov, S; Howell, P; Mikiashvili, L; Ngubane, N; Samoilova, A; Skornykova, S; Tudor, E; Variava, E; Yablonskiy, P; Everitt, D; Wills, GH; Sun, EGE; Olugbosi, M; Egizi, E; Li, MC; Holsta, A; Timm, J; Bateson, A; Crook, AM; Fabiane, SM; Hunt, R; McHugh, TD; Tweed, CD; Foraida, S; Mendel, CM; Spigelman, M; ZeNix Trial Team				Conradie, Francesca; Bagdasaryan, Tatevik R. R.; Borisov, Sergey; Howell, Pauline; Mikiashvili, Lali; Ngubane, Nosipho; Samoilova, Anastasia; Skornykova, Sergey; Tudor, Elena; Variava, Ebrahim; Yablonskiy, Petr; Everitt, Daniel; Wills, Genevieve H. H.; Sun, Eugene; Olugbosi, Morounfolu; Egizi, Erica; Li, Mengchun; Holsta, Alda; Timm, Juliano; Bateson, Anna; Crook, Angela M. M.; Fabiane, Stella M. M.; Hunt, Robert; McHugh, Timothy D. D.; Tweed, Conor D. D.; Foraida, Salah; Mendel, Carl M. M.; Spigelman, Melvin; ZeNix Trial Team			Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PA-824	BACKGROUND The bedaquiline-pretomanid-linezolid regimen has been reported to have 90% efficacy against highly drug-resistant tuberculosis, but the incidence of adverse events with 1200 mg of linezolid daily has been high. The appropriate dose of linezolid and duration of treatment with this agent to minimize toxic effects while maintaining efficacy against highly drug-resistant tuberculosis are unclear. METHODS We enrolled participants with extensively drug-resistant (XDR) tuberculosis (i.e., resistant to rifampin, a f luoroquinolone, and an aminoglycoside), pre-XDR tuber-culosis (i.e., resistant to rifampin and to either a f luoroquinolone or an aminogly-coside), or rifampin-resistant tuberculosis that was not responsive to treatment or for which a second-line regimen had been discontinued because of side effects. We randomly assigned the participants to receive bedaquiline for 26 weeks (200 mg daily for 8 weeks, then 100 mg daily for 18 weeks), pretomanid (200 mg daily for 26 weeks), and daily linezolid at a dose of 1200 mg for 26 weeks or 9 weeks or 600 mg for 26 weeks or 9 weeks. The primary end point in the modified intention-to-treat population was the incidence of an unfavorable outcome, defined as treat-ment failure or disease relapse (clinical or bacteriologic) at 26 weeks after comple-tion of treatment. Safety was also evaluated. RESULTS A total of 181 participants were enrolled, 88% of whom had XDR or pre-XDR tuber-culosis. Among participants who received bedaquiline-pretomanid-linezolid with linezolid at a dose of 1200 mg for 26 weeks or 9 weeks or 600 mg for 26 weeks or 9 weeks, 93%, 89%, 91%, and 84%, respectively, had a favorable outcome; peripheral neuropathy occurred in 38%, 24%, 24%, and 13%, respectively; myelo-suppression occurred in 22%, 15%, 2%, and 7%, respectively; and the linezolid dose was modified (i.e., interrupted, reduced, or discontinued) in 51%, 30%, 13%, and 13%, respectively. Optic neuropathy developed in 4 participants (9%) who had received linezolid at a dose of 1200 mg for 26 weeks; all the cases resolved. Six of the seven unfavorable microbiologic outcomes through 78 weeks of follow-up oc-curred in participants assigned to the 9-week linezolid groups. CONCLUSIONS A total of 84 to 93% of the participants across all four bedaquiline-pretomanid-linezolid treatment groups had a favorable outcome. The overall risk-benefit ratio favored the group that received the three-drug regimen with linezolid at a dose of 600 mg for 26 weeks, with a lower incidence of adverse events reported and fewer linezolid dose modifications.	[Conradie, Francesca; Howell, Pauline] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Klerksdorp Tshepong Hosp Complex, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Olugbosi, Morounfolu] TB Alliance, Pretori, South Africa; [Bagdasaryan, Tatevik R. R.] Fed Agcy Sci Org Moscow, Cent TB Res Inst, Moscow, Russia; [Borisov, Sergey] Moscow City Res & Practice TB Treatment Ctr, Moscow, Russia; [Samoilova, Anastasia] Natl Med Res Ctr Phthisiopulmonol & Infect Dis, Moscow, Russia; [Skornykova, Sergey] Ural Res Inst Phthisiopulmonol, Ekaterinburg, Russia; [Yablonskiy, Petr] St Petersburg Res Inst Phthisiopulmonol, St Petersburg, Russia; [Mikiashvili, Lali] Natl Ctr TB & Lung Dis, Tbilisi, Georgia; [Tudor, Elena] Chiril Draganiuc Inst Phthisiopneumol, Kishinev, Moldova; [Everitt, Daniel; Sun, Eugene; Egizi, Erica; Li, Mengchun; Holsta, Alda; Timm, Juliano; Fabiane, Stella M. M.; Mendel, Carl M. M.; Spigelman, Melvin] TB Alliance, New York, NY USA; [Wills, Genevieve H. H.; Crook, Angela M. M.; Fabiane, Stella M. M.; Tweed, Conor D. D.] UCL, Med Res Council Clin Trials Unit, London, England; [Bateson, Anna; Hunt, Robert; McHugh, Timothy D. D.] UCL, Univ Coll London Ctr Clin Microbiol, London, England; [Tweed, Conor D. D.] UCL, Inst Clin Trials & Methodol, Med Res Council Clin Trials Unit, 90 High Holborn,2nd Fl, London WC1V 6LJ, England	University of Witwatersrand; University of Witwatersrand; National Medical Research Center of Phthisiopulmonology & Infectious Diseases; National Medical Research Center of Phthisiopulmonology & Infectious Diseases; St. Petersburg State Research Institute of Phthisiopulmonology; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London	Tweed, CD (corresponding author), UCL, Inst Clin Trials & Methodol, Med Res Council Clin Trials Unit, 90 High Holborn,2nd Fl, London WC1V 6LJ, England.	c.tweed@ucl.ac.uk		Ortiz Canseco, Julio/0000-0002-8789-7919; McHugh, Timothy D/0000-0003-4658-8594; Mikiashvili, Lali/0000-0002-9569-7060	TB Alliance; Australia Department of Foreign Affairs and Trade; Bill and Melinda Gates Foundation; Federal Ministry of Education and Research of Germany through Kf W [OPP1129600]; Irish Aid; Netherlands Ministry of Foreign Affairs; U.K. Department of Health; U.K. Foreign, Commonwealth and Development Office; U.S. Agency for International Development; U.K. Research and Innovation Medical Research Council;  [MC_UU_00004/04]	TB Alliance; Australia Department of Foreign Affairs and Trade; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Federal Ministry of Education and Research of Germany through Kf W; Irish Aid(CGIAR); Netherlands Ministry of Foreign Affairs; U.K. Department of Health; U.K. Foreign, Commonwealth and Development Office; U.S. Agency for International Development(United States Agency for International Development (USAID)); U.K. Research and Innovation Medical Research Council; 	Supported by the TB Alliance with funding from the Australia Department of Foreign Affairs and Trade; the Bill and Melinda Gates Foundation (grant number, OPP1129600); the Federal Ministry of Education and Research of Germany through Kf W (a state-owned development bank that handles the grants to product development partnerships, such as the TB Alliance, for the German government); Irish Aid; the Netherlands Ministry of Foreign Affairs; the U.K. Department of Health; the U.K. Foreign, Commonwealth and Development Office; the U.S. Agency for International Development; and a grant (MC_UU_00004/04 Respiratory Infections, to Dr. Crook) from the U.K. Research and Innovation Medical Research Council.	Acquah R, 2019, LANCET INFECT DIS, V19, P224, DOI 10.1016/S1473-3099(18)30742-4; Bateson A, 2022, J ANTIMICROB CHEMOTH, V77, P1685, DOI 10.1093/jac/dkac070; Conradie F, 2020, NEW ENGL J MED, V382, P893, DOI 10.1056/NEJMoa1901814; Consalvi S, 2020, FUTURE MICROBIOL, V15, DOI 10.2217/fmb-2020-0089; Department of Health and Human Services, 2017, DIV AIDS DAIDS TABL; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Dou LJ, 2020, INT J INFECT DIS, V96, P105, DOI 10.1016/j.ijid.2020.03.054; Garrabou G, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00542-17, 10.1128/aac.00542-17]; Kilic EK, 2019, J INFECT DEV COUNTR, V13, P886, DOI 10.3855/jidc.10859; Lange C, 2019, LANCET, V394, P953, DOI 10.1016/S0140-6736(19)31882-3; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Olayanju O, 2019, INT J INFECT DIS, V85, P74, DOI 10.1016/j.ijid.2019.04.028; Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015; Singh B, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012836.pub2; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Thirot H, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10050530; Tyagi S, 2005, ANTIMICROB AGENTS CH, V49, P2289, DOI 10.1128/AAC.49.6.2289-2293.2005; Wasserman S, 2016, EXPERT REV ANTI-INFE, V14, P901, DOI 10.1080/14787210.2016.1225498; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Witney AA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0834-4; World Health Organization, 2018, WHOCDSTB20185	21	4	4	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					810	823		10.1056/NEJMoa2119430	http://dx.doi.org/10.1056/NEJMoa2119430			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053506	Green Accepted, Bronze			2022-12-28	WOS:000849132700009
J	Smithy, JW; Postow, MA				Smithy, James W.; Postow, Michael A.			Adjuvant checkpoint blockade following complete local therapy for melanoma metastases	LANCET			English	Editorial Material							STAGE IV MELANOMA; DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB		[Smithy, James W.; Postow, Michael A.] Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma Serv, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Postow, MA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Melanoma Serv, New York, NY 10065 USA.	postowm@mskcc.org			US National Institutes of Health/National Cancer Institute Cancer Center Support Grant [P30 CA008748]	US National Institutes of Health/National Cancer Institute Cancer Center Support Grant	MAP reports contracts for clinical trial research with payments going to his institution from RGenix, Infinity, Bristol-Myers Squibb, Merck, Array BioPharma, Novartis, and AstraZeneca unrelated to the topic commented on here, acknowledging that Bristol-Myers Squibb is the maker of nivolumab and ipilimumab as studied in the Article; royalties from Uptodate.com unrelated to the topic commented on here; and consulting fees for ad-hoc advisory board participation from Bristol-Myers Squibb, Merck, Array BioPharma, Novartis, Eisai, and Pfizer unrelated to the topic commented on here but acknowledging that Bristol-Myers Squibb is the maker of nivolumab and ipilimumab as studied in the Article. MAP and JWS acknowledge the US National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. JWS declares no competing interests. We would like to thank Hannah Rice, Memorial Sloan Kettering Cancer Center Editorial Service, for editorial support in the preparation of this Comment.	Ascierto PA, 2020, LANCET ONCOL, V21, P1465, DOI 10.1016/S1470-2045(20)30494-0; Faries MB, 2017, ANN SURG ONCOL, V24, P3991, DOI 10.1245/s10434-017-6072-3; Grossmann KF, 2022, CANCER DISCOV, V12, P644, DOI 10.1158/2159-8290.CD-21-1141; Long GV, 2021, CANCER RES, V81; National Comprehensive Cancer Network, 2022, NCCN PRACT GUID ONC; Wolchok JD, 2022, J CLIN ONCOL, V40, P127, DOI 10.1200/JCO.21.02229; Zimmer L, 2022, LANCET, V400, P1117, DOI 10.1016/S0140-6736(22)01654-3; Zimmer L, 2020, LANCET, V395, P1558, DOI 10.1016/S0140-6736(20)30417-7	8	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1082	1083		10.1016/S0140-6736(22)01748-2	http://dx.doi.org/10.1016/S0140-6736(22)01748-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36099925				2022-12-28	WOS:000877828800003
J	Colizzo, FP; Shroff, SG; High, FA; Chen, YB; Barmettler, S				Colizzo, Francis P.; Shroff, Stuti G.; High, Frances A.; Chen, Yi-Bin; Barmettler, Sara			Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; X-LINKED IPEX; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; FOXP3; GUIDELINES; MUTATIONS	A Man with Chronic Diarrhea and Autoimmune EnteropathyA 33-year-old man was evaluated for relapsing diarrhea, which had initially developed during infancy. Autoimmune enteropathy had been diagnosed, but symptoms recurred despite treatment. A diagnostic test was performed.	[Colizzo, Francis P.; Chen, Yi-Bin; Barmettler, Sara] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shroff, Stuti G.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [High, Frances A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA USA; [Colizzo, Francis P.; Chen, Yi-Bin; Barmettler, Sara] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shroff, Stuti G.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [High, Frances A.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Colizzo, FP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Colizzo, FP (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Bacchetta R, 2018, ANN NY ACAD SCI, V1417, P5, DOI 10.1111/nyas.13011; Barzaghi F, 2018, J ALLERGY CLIN IMMUN, V141, P1036, DOI 10.1016/j.jaci.2017.10.041; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Braskett MJ., 2022, IPEX IMMUNE DYSREGUL; Chae WJ, 2006, P NATL ACAD SCI USA, V103, P9631, DOI 10.1073/pnas.0600225103; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; DeZern AE, 2020, BLOOD ADV, V4, P1770, DOI 10.1182/bloodadvances.2020001729; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gentile Nicole M, 2012, Curr Gastroenterol Rep, V14, P380, DOI 10.1007/s11894-012-0276-2; Kamal A, 2019, GASTROENTEROL REP, V7, P162, DOI 10.1093/gastro/goz019; Kluger N, 2013, J CLIN GASTROENTEROL, V47, P112, DOI 10.1097/MCG.0b013e31827356e1; Leick M, 2020, BONE MARROW TRANSPL, V55, P758, DOI 10.1038/s41409-019-0725-8; Moran CJ, 2015, INFLAMM BOWEL DIS, V21, P1166, DOI 10.1097/MIB.0000000000000329; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seidelin JB, 2020, GASTROENTEROLOGY, V158, P58, DOI 10.1053/j.gastro.2019.09.012; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Verbsky JW, 2013, CURR OPIN PEDIATR, V25, P708, DOI 10.1097/MOP.0000000000000029; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	28	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1124	1134		10.1056/NEJMcpc2201236	http://dx.doi.org/10.1056/NEJMcpc2201236			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36130001				2022-12-28	WOS:000865461700009
J	Donohue, JM; Cole, ES; James, CV; Jarlenski, M; Michener, JD; Roberts, ET				Donohue, Julie M.; Cole, Evan S.; James, Cara V.; Jarlenski, Marian; Michener, Jamila D.; Roberts, Eric T.			The US Medicaid Program Coverage, Financing, Reforms, and Implications for Health Equity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MANAGED CARE; ETHNIC DISPARITIES; EXPANSIONS; IMPACT; ASSOCIATION; ACCESS; OREGON; POLICY; INSURANCE; POLITICS	IMPORTANCE Medicaid is the largest health insurance program by enrollment in the US and has an important role in financing care for eligible low-income adults, children, pregnant persons, older adults, people with disabilities, and people from racial and ethnic minority groups. Medicaid has evolved with policy reform and expansion under the Affordable Care Act and is at a crossroads in balancing its role in addressing health disparities and health inequities against fiscal and political pressures to limit spending. OBJECTIVE To describe Medicaid eligibility, enrollment, and spending and to examine areas of Medicaid policy, including managed care, payment, and delivery system reforms; Medicaid expansion; racial and ethnic health disparities; and the potential to achieve health equity. EVIDENCE REVIEW Analyses of publicly available data reported from 2010 to 2022 on Medicaid enrollment and program expenditures were performed to describe the structure and financing of Medicaid and characteristics of Medicaid enrollees. A search of PubMed for peer-reviewed literature and online reports from nonprofit and government organizations was conducted between August 1, 2021, and February 1, 2022, to review evidence on Medicaid managed care, delivery system reforms, expansion, and health disparities. Peer-reviewed articles and reports published between January 2003 and February 2022 were included. FINDINGS Medicaid covered approximately 80.6 million people (mean per month) in 2022 (24.2% of the US population) and accounted for an estimated $671.2 billion in health spending in 2020, representing 16.3% of US health spending. Medicaid accounted for an estimated 27.2% of total state spending and 7.6% of total federal expenditures in 2021. States enrolled 69.5% of Medicaid beneficiaries in managed care plans in 2019 and adopted 139 delivery system reforms from 2003 to 2019. The 38 states (and Washington, DC) that expanded Medicaid under the Affordable Care Act experienced gains in coverage, increased federal revenues, and improvements in health care access and some health outcomes. Approximately 56.4% of Medicaid beneficiaries were from racial and ethnic minority groups in 2019, and disparities in access, quality, and outcomes are common among these groups within Medicaid. Expanding Medicaid, addressing disparities within Medicaid, and having an explicit focus on equity in managed care and delivery system reforms may represent opportunities for Medicaid to advance health equity. CONCLUSIONS AND RELEVANCE Medicaid insures a substantial portion of the US population, accounts for a significant amount of total health spending and state expenditures, and has evolved with delivery system reforms, increased managed care enrollment, and state expansions. Additional Medicaid policy reforms are needed to reduce health disparities by race and ethnicity and to help achieve equity in access, quality, and outcomes.	[Donohue, Julie M.; Cole, Evan S.; Jarlenski, Marian; Roberts, Eric T.] Univ Pittsburgh, Dept Hlth Policy & Management, Sch Publ Hlth, 130 DeSoto St, Pittsburgh, PA 15261 USA; [James, Cara V.] Grantmakers Hlth, Washington, DC USA; [Michener, Jamila D.] Cornell Univ, Dept Govt, Ithaca, NY USA; [Michener, Jamila D.] Cornell Univ, Sch Publ Policy, Ithaca, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Cornell University	Donohue, JM (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Sch Publ Hlth, 130 DeSoto St, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu						Agniel D, 2021, J GEN INTERN MED, V36, P1847, DOI 10.1007/s11606-019-05473-x; Aizer A, 2007, REV ECON STAT, V89, P385, DOI 10.1162/rest.89.3.385; Albertson EM, 2020, AM J PUBLIC HEALTH, V110, P317, DOI 10.2105/AJPH.2019.305400; Allen HL, 2019, HEALTH AFFAIR, V38, P1451, DOI 10.1377/hlthaff.2018.05071; Artiga S., 2019, CHANGES HLTH COVERAG; Bailit Health, 2021, MED MANAGED CARE CON; Baker LC, 2005, HEALTH SERV RES, V40, P1466, DOI 10.1111/j.1475-6773.2005.00427.x; Barnett ML, 2018, HEALTH AFFAIR, V37, P1647, DOI 10.1377/hlthaff.2018.0505; Baumgartner JC, 2020, AFFORDABLE CARE ACT; Bindman AB, 2005, HEALTH SERV RES, V40, P19, DOI 10.1111/j.1475-6773.2005.00340.x; Brooks-LaSure C, 2021, INNOVATION CTR MED M, DOI DOI 10.1377/HBLOG20210812.211558/FULL/; Brown CC, 2019, JAMA-J AM MED ASSOC, V321, P1598, DOI 10.1001/jama.2019.3678; Callison K, 2021, AM J PUBLIC HEALTH, V111, P1523, DOI 10.2105/AJPH.2021.306316; Centers for Medicare & Medicaid Services, NAT HLTH EXP DAT TAB; Centers for Medicare & Medicaid Services, MED GOV; Centers for Medicare & Medicaid Services, 2019, MED MED COORD OFF FY; Centers for Medicare & Medicaid Services, MONTHL MED CHIP APPL; Centers for Medicare & Medicaid Services, BEN INF RAC ETHN; Centers for Medicare & Medicaid Services, 2020, LONG TERM SERV SUPP; Centers for Medicare & Medicaid Services, INN CTR STRAT DIR; Centers for Medicare & Medicaid Services, 2021, HLTH CAR INN AW; Centers for Medicare & Medicaid Services, 2020, FED FISC YEAR FFY 20; Change Healthcare, VAL BAS CAR AM STAT; Clemans-Cope L, 2016, MED SPENDING GROWTH; Colello HJ, 2022, MEDICAID ELIGIBILITY; Congressional Research Service, MED OV; Donohue JM, 2021, JAMA-J AM MED ASSOC, V326, P154, DOI 10.1001/jama.2021.7374; Draper DA, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.2.155; Figueroa JF, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.2007; Fording RC, 2019, POLICY STUD J, V47, P274, DOI 10.1111/psj.12311; Fry CE, 2020, RSF-RUS SAGE J SOC S, V6, P244, DOI [10.7758/rsf.2020.6.2.11, 10.7758/RSF.2020.6.2.11]; Gaskin DJ, 2012, HEALTH SERV RES, V47, P2353, DOI 10.1111/j.1475-6773.2012.01417.x; Gee RE, 2021, JAMA-J AM MED ASSOC, V325, P619, DOI 10.1001/jama.2021.0013; Goldman AL, 2020, HEALTH AFFAIR, V39, P85, DOI 10.1377/hlthaff.2019.00378; Goodman-Bacon A, 2018, J POLIT ECON, V126, P216, DOI 10.1086/695528; Grogan CM, 2017, J HEALTH POLIT POLIC, V42, P539, DOI 10.1215/03616878-3802977; Gruber J, 2020, NEW ENGL J MED, V382, P2280, DOI 10.1056/NEJMp2007124; Guth M., 2021, BUILDING EVIDENCE BA; Haeder SF, 2021, J HEALTH POLIT POLIC, V46, P305, DOI 10.1215/03616878-8802198; Hamel L., 2020, RACIAL DISPARITIES P; He QW, 2020, HEALTH ECON, V29, P261, DOI 10.1002/hec.3977; Hendryx M, 2018, MED CARE, V56, P944, DOI 10.1097/MLR.0000000000000984; Herring B, 2011, HEALTH ECON, V20, P446, DOI 10.1002/hec.1602; Hill SC, 2021, HEALTH SERV RES, V56, P84, DOI 10.1111/1475-6773.13603; Hinton E, 2021, MED AUTHORITIES OPTI; Holgash K, 2019, PHYS ACCEPTANCE NEW; Howell EA, 2020, OBSTET GYNECOL, V135, P285, DOI 10.1097/AOG.0000000000003667; Jarlenski M, 2017, J HEALTH POLIT POLIC, V42, P1039, DOI 10.1215/03616878-4193618; Kaiser Family Foundation, 2020, DAT NOT 5 CHARTS PUB; Kaiser Family Foundation, 2022, STAT STAT MED EXP DE; Kaiser Family Foundation, MED MED FEE INDEX; Kaiser Family Foundation, MED WAIV TRACK APPR; Kaiser Family Foundation, 2015, MED DEL SYST PAYM RE; Kangovi S, 2018, JAMA INTERN MED, V178, P1635, DOI 10.1001/jamainternmed.2018.4630; Kumar NR, 2021, AM J PUBLIC HEALTH, V111, P202, DOI 10.2105/AJPH.2020.306060; Kuziemko I, 2018, AM ECON J-ECON POLIC, V10, P255, DOI 10.1257/pol.20150262; Lanford D, 2016, SOCIOL PERSPECT, V59, P619, DOI 10.1177/0731121415587605; Le Cook B, 2007, HEALTH SERV RES, V42, P124, DOI 10.1111/j.1475-6773.2006.00611.x; Lee H, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/0046958021991293; Lee H, 2020, MED CARE RES REV, V77, P461, DOI 10.1177/1077558718808709; Lindrooth RC, 2018, HEALTH AFFAIR, V37, P111, DOI 10.1377/hlthaff.2017.0976; Maina IW, 2018, SOC SCI MED, V199, P219, DOI 10.1016/j.socscimed.2017.05.009; Marton J, 2016, HEALTH SERV RES, V51, P872, DOI 10.1111/1475-6773.12396; Marton J, 2014, J HEALTH ECON, V36, P47, DOI 10.1016/j.jhealeco.2014.03.001; McConnell KJ, 2018, HEALTH AFFAIR, V37, P386, DOI 10.1377/hlthaff.2017.1282; McConnell KJ, 2017, JAMA INTERN MED, V177, P538, DOI 10.1001/jamainternmed.2016.9098; McConnell KJ, 2016, JAMA-J AM MED ASSOC, V315, P869, DOI 10.1001/jama.2016.0206; McGinty EE, 2020, J GEN INTERN MED, V35, P3148, DOI 10.1007/s11606-020-05690-9; McGinty EE, 2018, GEN HOSP PSYCHIAT, V51, P54, DOI 10.1016/j.genhosppsych.2017.12.003; McGregor B, 2020, PSYCHIAT SERV, V71, P663, DOI 10.1176/appi.ps.201900407; McMorrow S, 2016, HEALTH SERV RES, V51, P1347, DOI 10.1111/1475-6773.12432; Medicaid and CHIP Payment and Access Commission, EXH 1 MED CHIP ENR P; Medicaid and CHIP Payment and Access Commission, 2021, RAC ETHN DISP MED AN; Medicaid and CHIP Payment and Access Commission, EXH 14 MED ENR STAT; Medicaid and CHIP Payment and Access Commission, 2015, MACSTATS MED CHIP DA; Medicaid and CHIP Payment and Access Commission, 2019, EXH 15 MED FULL YEAR; Medicaid and CHIP Payment and Access Commission, 2020, DEL SYST REF INC PAY; Medicaid and CHIP Payment and Access Commission, MAN LONG TERM SERV S; Medicaid and CHIP Payment and Access Commission, MED 101 FIN; Medicaid and CHIP Payment and Access Commission, 2021, MACSTATS MED CHIP DA; Medicaid and CHIP Payment and Access Commission, NURS FAC; Medicaid and CHIP Payment and Access Commission, 2019, EXH 19 MED BEN SPEND; Medicare Payment Advisory Commission; Medicaid and CHIP Payment and Access Commission, 2022, BEN DUALL EL MED MED; Michener J, 2018, FRAGMENTED DEMOCRACY, DOI [10.1017/9781108224987, DOI 10.1017/9781108224987]; Michener J, 2020, J HEALTH POLIT POLIC, V45, P547, DOI 10.1215/03616878-8255481; Michener JD, 2021, AM J PUBLIC HEALTH, V111, P643, DOI 10.2105/AJPH.2020.306126; Miller S, 2021, NATL BUREAU EC RES W; Miller S, 2021, Q J ECON, V136, P1783, DOI 10.1093/qje/qjab004; Mohamoud S, 2021, HLTH HOME PROGRAM EV; Montoya DF, 2020, ANNU REV PUBL HEALTH, V41, P537, DOI 10.1146/annurev-publhealth-040119-094345; Musumeci MB, 2021, MED PROVISIONS AM RE; National Academy for State Health Policy, STAT DEL SYST PAYM R; National Association of State Budget Officers, STAT EXP REP; Ndumele CD, 2017, JAMA INTERN MED, V177, P1445, DOI 10.1001/jamainternmed.2017.3766; Nguyen KH, 2022, HEALTH AFFAIR, V41, P256, DOI 10.1377/hlthaff.2021.01331; Office of Minority Health Centers for Medical & Medicaid Services, PAV WAY EQ PROGR REP; Omi M., 2015, RACIAL FORMATION US, DOI [https://doi.org/10.4324/9780203076804, DOI 10.4324/9780203076804, 10. 4324/9780203076804]; Parekh N, 2018, MATERN CHILD HLTH J, V22, P429, DOI 10.1007/s10995-017-2410-0; Pennsylvania Department of Human Services, 2021, PENNS REC GRANT FUND; Perez EO, 2021, DIVERSITYS CHILD PEO, DOI [10.7208/chicago/9780226799933.001. 0001, DOI 10.7208/CHICAG0/9780226799933.001.0001]; Primary Care Collaborative, PRIM CAR INN PCMH PR; Shane DM, 2016, MED CARE, V54, P752, DOI 10.1097/MLR.0000000000000555; Silver JK, 2019, HEALTH EQUITY, V3, P360, DOI 10.1089/heq.2019.0040; Simon K, 2017, J POLICY ANAL MANAG, V36, P390, DOI 10.1002/pam.21972; Smithey A, 2021, CTR HLTH CARE STRATE; Solomon J., 2021, FEDERAL ACTION NEEDE; Solomon J, 2020, CONTINUOUS COVERAGE; Soni A, 2018, AM J PUBLIC HEALTH, V108, P216, DOI 10.2105/AJPH.2017.304166; Sparer M., 2012, MEDICAID MANAGED CAR; State Health & Value Strategies, 2021, COLL RAC ETHN LANG R; Swaminathan S, 2020, JAMA INTERN MED, V180, P1672, DOI 10.1001/jamainternmed.2020.5408; Taylor E, 2021, PROMOTING HLTH EQUIT; Thielke A, 2021, ADDRESSING COVID 19; Thompson FJ, 2007, J HEALTH POLIT POLIC, V32, P971, DOI 10.1215/03616878-2007-039; US Census Bureau, 2021, CENS BUR REL AN REP; US Department of Health and Human Services Office of Minority Health, 2021, THINK CULT HLTH; US Government Accountability Office, 2017, FED LOW PROGR EL BEN; US Government Publishing Office, BUDG FY 2022 TABL 15; Vinekar K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMpv2113508; Vogler J., 2017, ACCESS HLTH CARE CRI, DOI [10.2139/ssrn.3042267, DOI 10.2139/SSRN.3042267]; Wallace J, 2019, WHAT DOES NETWORK EV; Wehby GL, 2018, HEALTH SERV RES, V53, P1248, DOI 10.1111/1475-6773.12711; Wherry LR, 2018, REV ECON STAT, V100, P287, DOI 10.1162/REST_a_00677; Wherry LR, 2016, J HUM RESOUR, V51, P556, DOI 10.3368/jhr.51.3.0913-5918R1; Williams E, 2022, FISCAL ENROLLMENT IM; Williams E, 2022, IMPACT COVID 19 RECE; Yeung R, 2020, J SCHOOL HEALTH, V90, P745, DOI 10.1111/josh.12937; Zewde N, 2019, AM J PUBLIC HEALTH, V109, P1379, DOI 10.2105/AJPH.2019.305230; Zewde N, 2019, HEALTH AFFAIR, V38, P132, DOI 10.1377/hlthaff.2018.05155; Zuckerman S, 2002, INQUIRY-J HEALTH CAR, V39, P221, DOI 10.5034/inquiryjrnl_39.3.221	130	2	2	5	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1085	1099		10.1001/jama.2022.14791	http://dx.doi.org/10.1001/jama.2022.14791			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125468				2022-12-28	WOS:000862909200022
J	Rubin, R				Rubin, Rita			Blood Donors Need Not Be Screened for Monkeypox	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1030	1030		10.1001/jama.2022.14715	http://dx.doi.org/10.1001/jama.2022.14715			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125481	Bronze			2022-12-28	WOS:000862909200011
J	Moeller, AH				Moeller, Andrew H.			Loyal gut microbes	SCIENCE			English	Editorial Material									[Moeller, Andrew H.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Moeller, AH (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	andrew.moeller@cornell.edu			National Institutes of Health [R35 GM138284]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.H.M. is funded by the National Institutes of Health (R35 GM138284).	Bennett GM, 2015, P NATL ACAD SCI USA, V112, P10169, DOI 10.1073/pnas.1421388112; Brito IL, 2019, NAT MICROBIOL, V4, P964, DOI 10.1038/s41564-019-0409-6; Browne HP, 2022, CURR OPIN MICROBIOL, V69, DOI 10.1016/j.mib.2022.102173; Duvallet C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222881; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Garud NR, 2020, TRENDS GENET, V36, P53, DOI 10.1016/j.tig.2019.10.010; Groussin M, 2020, CELL HOST MICROBE, V28, P12, DOI 10.1016/j.chom.2020.06.013; Karcher N, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02042-y; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Nishida AH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25732-y; Olesen SW, 2018, NAT REV GASTRO HEPAT, V15, P387, DOI 10.1038/s41575-018-0019-4; Perreau J, 2022, NAT REV GENET, V23, P23, DOI 10.1038/s41576-021-00395-z; Suzuki TA, 2022, SCIENCE, V377, P1328, DOI 10.1126/science.abm7759; Tett A, 2019, CELL HOST MICROBE, V26, P666, DOI 10.1016/j.chom.2019.08.018	14	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1263	1264		10.1126/science.ade2879	http://dx.doi.org/10.1126/science.ade2879			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108001				2022-12-28	WOS:000887933500023
J	Zhang, ZY; Fan, QW; Luo, XJ; Lou, K; Weiss, WA; Shokat, KM				Zhang, Ziyang; Fan, Qiwen; Luo, Xujun; Lou, Kevin; Weiss, William A.; Shokat, Kevan M.			Brain-restricted mTOR inhibition with binary pharmacology	NATURE			English	Article							MAMMALIAN PROTEIN; KINASE INHIBITOR; TARGET; CALCINEURIN; CELLS; ACTIVATION; MECHANISMS; REGRESSION; COMPLEXES; DESIGN	On-target-off-tissue drug engagement is an important source of adverse effects that constrains the therapeutic window of drug candidates(1,2). In diseases of the central nervous system, drugs with brain-restricted pharmacology are highly desirable. Here we report a strategy to achieve inhibition of mammalian target of rapamycin (mTOR) while sparing mTOR activity elsewhere through the use of the brain-permeable mTOR inhibitor RapaLink-1 and the brain-impermeable FKBP12 ligand RapaBlock. We show that this drug combination mitigates the systemic effects of mTOR inhibitors but retains the efficacy of RapaLink-1 in glioblastoma xenografts. We further present a general method to design cell-permeable, FKBP12-dependent kinase inhibitors from known drug scaffolds. These inhibitors are sensitive to deactivation by RapaBlock, enabling the brain-restricted inhibition of their respective kinase targets.	[Zhang, Ziyang; Lou, Kevin; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Fan, Qiwen; Luo, Xujun; Weiss, William A.] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Fan, Qiwen; Luo, Xujun; Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	kevan.shokat@ucsf.edu		Shokat, Kevan/0000-0001-8590-7741; Weiss, William/0000-0003-2230-9132; Zhang, Ziyang/0000-0003-0541-7211; Lou, Kevin/0000-0003-4939-4381	Damon Runyon Cancer Research Foundation [DRG-2281-17]; NIH [U01CA217864, F30CA2394761, R01CA221969]; Samuel Waxman Cancer Research Foundation; Cancer Research UK [A28592]; Michael J. Fox Foundation [P0536220]; Mark Foundation for Cancer Research; Howard Hughes Medical Institute	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Cancer Research UK(Cancer Research UK); Michael J. Fox Foundation; Mark Foundation for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Koach for help with data processing; D. Wassarman for discussions; our UCSF colleague M. Evans and his group for many discussions and mouse brain imaging studies; and L. Gilbert for the generous gift of K562 CRISPRi (dCas9-KRAB) cells. Z.Z. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2281-17). K.L. acknowledges NIH F30CA239476. K.M.S., Q.F. and W.A.W. acknowledge NIH 1R01CA221969. K.M.S. and W.A.W. acknowledge the Samuel Waxman Cancer Research Foundation. W.A.W. acknowledges NIH U01CA217864 and Cancer Research UK A28592. K.M.S. acknowledges the Michael J. Fox Foundation P0536220, The Mark Foundation for Cancer Research and the Howard Hughes Medical Institute.	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Baptista MAS, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aav0820; Barak S, 2013, NAT NEUROSCI, V16, P1111, DOI 10.1038/nn.3439; BARTHOLINI G, 1967, NATURE, V215, P852, DOI 10.1038/215852b0; Bos PH, 2019, CELL CHEM BIOL, V26, P1703, DOI 10.1016/j.chembiol.2019.10.005; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chase TN, 2017, NEUROTHERAPEUTICS, V14, P405, DOI 10.1007/s13311-016-0511-x; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clemons PA, 2002, CHEM BIOL, V9, P49, DOI 10.1016/S1074-5521(02)00085-6; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Ehinger Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24567-x; Estrada AA, 2014, J MED CHEM, V57, P921, DOI 10.1021/jm401654j; Fan QW, 2017, CANCER CELL, V31, P424, DOI 10.1016/j.ccell.2017.01.014; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Fuji RN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3634; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gaubitz C, 2015, MOL CELL, V58, P977, DOI 10.1016/j.molcel.2015.04.031; Gonzalez D, 2011, PEDIATR NEPHROL, V26, P961, DOI 10.1007/s00467-011-1811-3; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Komm BS, 2013, J CELL PHYSIOL, V228, P1423, DOI 10.1002/jcp.24324; Kozany C, 2009, CHEMBIOCHEM, V10, P1402, DOI 10.1002/cbic.200800806; Lapointe S, 2020, INVEST NEW DRUG, V38, P1137, DOI 10.1007/s10637-019-00875-4; Lassman AB, 2015, NEURO-ONCOLOGY, V17, P992, DOI 10.1093/neuonc/nov011; Lee BD, 2012, TRENDS PHARMACOL SCI, V33, P365, DOI 10.1016/j.tips.2012.04.001; Li M, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1012-x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Marinec PS, 2009, P NATL ACAD SCI USA, V106, P1336, DOI 10.1073/pnas.0805375106; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Morisot N, 2018, ADDICT BIOL, V23, P713, DOI 10.1111/adb.12528; Neasta J, 2010, P NATL ACAD SCI USA, V107, P20093, DOI 10.1073/pnas.1005554107; Orange DE, 2013, ELIFE, V2, DOI 10.7554/eLife.00105; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pallet N, 2013, EXPERT OPIN DRUG SAF, V12, P177, DOI 10.1517/14740338.2013.752814; Rageot D, 2018, J MED CHEM, V61, P10084, DOI 10.1021/acs.jmedchem.8b01262; Rankovic Z, 2015, J MED CHEM, V58, P2584, DOI 10.1021/jm501535r; REINER PB, 1994, NEUROSCIENCE, V59, P579, DOI 10.1016/0306-4522(94)90178-3; Rodrik-Outmezguine VS, 2016, NATURE, V534, P272, DOI 10.1038/nature17963; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Thiessen B, 2010, CANCER CHEMOTH PHARM, V65, P353, DOI 10.1007/s00280-009-1041-6; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; US National Library of Medicine, CT2 SHOW NCT04774952; Zhao Q, 2017, J AM CHEM SOC, V139, P680, DOI 10.1021/jacs.6b08536	51	2	2	18	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					822	+		10.1038/s41586-022-05213-y	http://dx.doi.org/10.1038/s41586-022-05213-y		SEP 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U8YX	36104566	Green Submitted, hybrid			2022-12-28	WOS:000854445600001
J	Jing, Y; Hu, JB; Luo, R; Mao, Y; Luo, ZX; Zhang, MJ; Yang, J; Song, Y; Feng, ZP; Wang, ZH; Cheng, QF; Ma, LQ; Yang, Y; Zhong, L; Du, ZP; Wang, Y; Luo, T; He, WW; Sun, Y; Lv, FJ; Li, QF; Yang, SM				Jing, Ying; Hu, Jinbo; Luo, Rong; Mao, Yun; Luo, Zhixiao; Zhang, Mingjun; Yang, Jun; Song, Ying; Feng, Zhengping; Wang, Zhihong; Cheng, Qingfeng; Ma, Linqiang; Yang, Yi; Zhong, Li; Du, Zhipeng; Wang, Yue; Luo, Ting; He, Wenwen; Sun, Yue; Lv, Fajin; Li, Qifu; Yang, Shumin			Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population A Cross-Sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY ALDOSTERONISM; INCIDENTALOMAS; MANAGEMENT; DIAGNOSIS; CONSENSUS; SOCIETY; CT	Background: With the widespread use of advanced imaging technology, adrenal tumors are increasingly being identified. Objective: To investigate the prevalence and characteristics of adrenal tumors in an unselected screening population in China. Design: Cross-sectional study. (ClinicalTrials.gov: NCT04682938) Setting: A health examination center in China. Patients: Adults having an annual checkup were invited to be screened for adrenal tumors by adrenal computed tomography. Measurements: The participants with adrenal tumors had further evaluation for malignancy risk and adrenal function. Results: A total of 25356 participants were screened, 351 of whom were found to have adrenal tumors, for a prevalence of 1.4%. The prevalence increased with age, from 0.2% in participants aged 18 to 25 years to 3.2% in those older than 65 years. Among 351 participants with adrenal tumors, 337 were diagnosed with an adrenocortical adenoma, 14 with another benign nodule, and none with a malignant mass. In 212 participants with an adenoma who completed endocrine testing, 69.3% were diagnosed with a nonfunctioning adenoma, 18.9% with cortisol autonomy, 11.8% with primary aldosteronism, and none with pheochromocytoma. Proportions of nonfunctioning adenomas were similarly high in various age groups (72.2%, 67.8%, and 72.2% in those aged <46, 46 to 65, and >= 66 years, respectively). Limitation: Only 212 of 337 participants with an adrenocortical adenoma had endocrine testing. Conclusion: The prevalence of adrenal tumors in the general adult screening population is 1.4%, and most of these tumors are nonfunctioning regardless of patient age. Cortisol and aldosterone secretion are the main causes of functional adenomas.	[Jing, Ying; Hu, Jinbo; Song, Ying; Feng, Zhengping; Wang, Zhihong; Cheng, Qingfeng; Ma, Linqiang; Yang, Yi; Du, Zhipeng; Wang, Yue; Luo, Ting; He, Wenwen; Sun, Yue; Li, Qifu; Yang, Shumin] Chongqing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Chongqing, Peoples R China; [Luo, Rong; Luo, Zhixiao; Zhang, Mingjun; Zhong, Li] Chongqing Med Univ, Med Examinat Ctr, Affiliated Hosp 1, Chongqing, Peoples R China; [Mao, Yun; Lv, Fajin] Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Jun] Monash Univ, Dept Med, Clayton, Vic, Australia; [Yang, Jun] Hudson Inst Med Res, Ctr Endocrinol & Metab, Clayton, Vic, Australia	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Monash University; Hudson Institute of Medical Research	Lv, FJ; Li, QF; Yang, SM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, 1 Youyi St, Chongqing 400016, Peoples R China.	fajinlv@163.com; liqifu@yeah.net; 443068494@qq.com		Yang, Jun/0000-0003-4620-4976; Hu, Jinbo/0000-0003-2925-0583	National Natural Science Foundation of China [82100833, U21A20355]; Joint Medical Research Project of Chongqing Science and Technology Commission [2022ZDXM003]; Chongqing Health and Family Planning Commission [2022ZDXM003]; National Key Research and Development Program of China, major project of prevention and treatment of common diseases [2021YFC2501600, 2021YFC2501603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Medical Research Project of Chongqing Science and Technology Commission; Chongqing Health and Family Planning Commission; National Key Research and Development Program of China, major project of prevention and treatment of common diseases	By the National Natural Science Foundation of China (82100833 and U21A20355); Joint Medical Research Project of Chongqing Science and Technology Commission and Chongqing Health and Family Planning Commission (major project 2022ZDXM003); and National Key Research and Development Program of China, major project of prevention and treatment of common diseases (2021YFC2501600; subproject: 2021YFC2501603).	Ahn SH, 2018, YONSEI MED J, V59, P501, DOI 10.3349/ymj.2018.59.4.501; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Bulow B, 2002, J INTERN MED, V252, P239, DOI 10.1046/j.1365-2796.2002.01028.x; Cyranska-Chyrek E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101872; Davenport C, 2011, ENDOCRINE, V40, P80, DOI 10.1007/s12020-011-9445-6; Davenport E, 2014, POSTGRAD MED J, V90, P365, DOI 10.1136/postgradmedj-2013-132386; Deutschbein T, 2022, LANCET DIABETES ENDO, V10, P499, DOI 10.1016/S2213-8587(22)00100-0; Di Dalmazi G, 2015, J CLIN ENDOCR METAB, V100, P3529, DOI 10.1210/JC.2015-1992; Ebbehoj A, 2020, LANCET DIABETES ENDO, V8, P894, DOI 10.1016/S2213-8587(20)30314-4; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Goh Z, 2018, INTERN MED J, V48, P173, DOI 10.1111/imj.13651; Grossman A, 2016, ENDOCR RES, V41, P98, DOI 10.3109/07435800.2015.1076455; Hammarstedt L, 2010, ACTA RADIOL, V51, P1149, DOI 10.3109/02841851.2010.516016; Hamrahian AH, 2005, J CLIN ENDOCR METAB, V90, P871, DOI 10.1210/jc.2004-1627; Hanna FWF, 2022, J ENDOCR SOC, V6, DOI 10.1210/jendso/bvab180; HERRERA MF, 1991, SURGERY, V110, P1014; Ichijo T, 2020, ENDOCR J, V67, P141, DOI 10.1507/endocrj.EJ18-0486; Iniguez-Ariza Nicole M, 2018, Mayo Clin Proc Innov Qual Outcomes, V2, P30, DOI 10.1016/j.mayocpiqo.2017.11.002; Kim Hee Young, 2005, Korean Journal of Internal Medicine, V20, P303; Kobayashi H, 2018, J HYPERTENS, V36, P2269, DOI 10.1097/HJH.0000000000001855; Ku EJ, 2021, ENDOCRINOL METAB, V36, P1131, DOI 10.3803/EnM.2021.1149; Maher DI, 2018, SURGERY, V164, P1360, DOI 10.1016/j.surg.2018.07.011; Monticone S, 2015, LANCET DIABETES ENDO, V3, P296, DOI 10.1016/S2213-8587(14)70069-5; Mulatero P, 2012, J CLIN ENDOCR METAB, V97, P881, DOI 10.1210/jc.2011-2384; Reimondo G, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz284; Rossi GP, 2014, HYPERTENSION, V63, P151, DOI 10.1161/HYPERTENSIONAHA.113.02097; Sadler C, 2014, WORLD J SURG, V38, P2019, DOI 10.1007/s00268-014-2524-0; Song JH, 2008, AM J ROENTGENOL, V190, P1163, DOI 10.2214/AJR.07.2799; Storbeck KH, 2019, ENDOCR REV, V40, P1605, DOI 10.1210/er.2018-00262; Studzinska D, 2021, VASC ENDOVASC SURG, V55, P793, DOI 10.1177/15385744211022603; Taya M, 2019, EUR RADIOL, V29, P6245, DOI 10.1007/s00330-019-06202-y; Williams TA, 2017, LANCET DIABETES ENDO, V5, P689, DOI 10.1016/S2213-8587(17)30135-3; Xu ZX, 2020, J AM COLL CARDIOL, V75, P1913, DOI 10.1016/j.jacc.2020.02.052; Yilmaz N, 2021, EXP CLIN ENDOCR DIAB, V129, P349, DOI 10.1055/a-1079-4915	35	2	2	8	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1383	+		10.7326/M22-1619	http://dx.doi.org/10.7326/M22-1619		SEP 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36095315				2022-12-28	WOS:000857104100005
J	Mangione, CM; Barry, MJ; Nicholson, WK; Cabana, M; Chelmow, D; Coker, TR; Davidson, KW; Davis, EM; Donahue, KE; Jaen, CR; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Ruiz, JM; Stevermer, J; Tseng, CW; Wong, JB				Mangione, Carol M.; Barry, Michael J.; Nicholson, Wanda K.; Cabana, Michael; Chelmow, David; Coker, Tumaini Rucker; Davidson, Karina W.; Davis, Esa M.; Donahue, Katrina E.; Jaen, Carlos Roberto; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Ruiz, John M.; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GLYCEMIC CONTROL; YOUTH	IMPORTANCE The Centers for Disease Control and Prevention estimates that 210 000 children and adolescents younger than 20 years had diabetes as of 2018; of these, approximately 23 000 had type 2 diabetes. Youth with type 2 diabetes have an increased prevalence of associated chronic comorbid conditions, including hypertension, dyslipidemia, and nonalcoholic fatty liver disease. Data indicate that the incidence of type 2 diabetes is rising; from 2002-2003 to 2014-2015, incidence increased from 9.0 cases per 100 000 children and adolescents to 13.8 cases per 100 000 children and adolescents. OBJECTIVE The US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on screening for prediabetes and type 2 diabetes in asymptomatic, nonpregnant persons younger than 18 years. This is a new recommendation. POPULATION Children and adolescents younger than 18 years without known diabetes or prediabetes or symptoms of diabetes or prediabetes. EVIDENCE ASSESSMENT The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for type 2 diabetes in children and adolescents. There is a lack of evidence on the effect of screening for, and early detection and treatment of, type 2 diabetes on health outcomes in youth, and the balance of benefits and harms cannot be determined. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for type 2 diabetes in children and adolescents. (I statement)	[Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Nicholson, Wanda K.; Donahue, Katrina E.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Chelmow, David] Virginia Commonwealth Univ, Richmond, VA USA; [Coker, Tumaini Rucker] Univ Washington, Seattle, WA 98195 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Jaen, Carlos Roberto] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Ruiz, John M.] Univ Arizona, Tucson, AZ USA; [Stevermer, James] Univ Missouri, Columbia, MO USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Yeshiva University; Virginia Commonwealth University; University of Washington; University of Washington Seattle; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; University of Arizona; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Tufts University	Mangione, CM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 10940 Wilshire Blvd,Ste 700, Los Angeles, CA 90024 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS32, DOI 10.2337/dc20-S003; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; American Diabetes Association, 2020, Diabetes Care, V43, pS163, DOI 10.2337/dc20-S013; AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Andes LJ, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2019.4498; [Anonymous], US PREV SERV TASK FO; Arslanian S, 2018, DIABETES CARE, V41, P2648, DOI 10.2337/dci18-0052; Ball GDC, 2006, J PEDIATR-US, V148, P16, DOI 10.1016/j.jpeds.2005.08.059; Centers for Disease Control and Prevention, 2021, PREV TYP 2 DIAB KIDS; Centers for Disease Control and Prevention, 2022, NAT DIAB STAT REP WE; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Davidson KW, 2021, JAMA-J AM MED ASSOC, V326, P736, DOI 10.1001/jama.2021.12531; Davidson KW, 2021, JAMA-J AM MED ASSOC, V326, P531, DOI 10.1001/jama.2021.11922; Divers J, 2020, MMWR-MORBID MORTAL W, V69, P161, DOI 10.15585/mmwr.mm6906a3; DuBose KD, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110213; Grossman DC, 2017, JAMA-J AM MED ASSOC, V317, P2417, DOI 10.1001/jama.2017.6803; Hannon TS, 2017, JAMA PEDIATR, V171, P327, DOI 10.1001/jamapediatrics.2016.4207; Jonas D., 2022, AHRQ PUBLICATION 21; Jonas DE, 2022, JAMA-J AM MED ASSOC, V328, P968, DOI 10.1001/jama.2022.7957; Jones KL, 2002, DIABETES CARE, V25, P89, DOI 10.2337/diacare.25.1.89; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Savoye M, 2014, DIABETES CARE, V37, P317, DOI 10.2337/dc13-1571; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	23	1	1	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					963	967		10.1001/jama.2022.14543	http://dx.doi.org/10.1001/jama.2022.14543			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098719	Bronze			2022-12-28	WOS:000855222400021
J	Shepherd, A				Shepherd, Alison			Medical world pays tribute to the Queen	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								o2212	10.1136/bmj.o2212	http://dx.doi.org/10.1136/bmj.o2212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100271				2022-12-28	WOS:000860470700013
J	Wise, J				Wise, Jacqui			Every pregnancy associated violent death should be considered preventable, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Modest AM, 2022, OBSTET GYNECOL, V140, P565, DOI 10.1097/AOG.0000000000004932; Wallace M, 2021, OBSTET GYNECOL, V138, P762, DOI 10.1097/AOG.0000000000004567	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								o2223	10.1136/bmj.o2223	http://dx.doi.org/10.1136/bmj.o2223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100270				2022-12-28	WOS:000860470700010
J	Pitcher, A; Spata, E; Emberson, J; Davies, K; Halls, H; Holland, L; Wilson, K; Reith, C; Child, AH; Clayton, T; Dodd, M; Flather, M; Jin, XY; Sandor, G; Groenink, M; Mulder, B; De Backer, J; Evangelista, A; Forteza, A; Teixido-Tura, G; Boileau, C; Jondeau, G; Milleron, O; Lacro, RV; Sleeper, LA; Chiu, HH; Wu, MH; Neubauer, S; Watkins, H; Dietz, H; Baigent, C				Pitcher, Alex; Spata, Enti; Emberson, Jonathan; Davies, Kelly; Halls, Heather; Holland, Lisa; Wilson, Kate; Reith, Christina; Child, Anne H.; Clayton, Tim; Dodd, Matthew; Flather, Marcus; Jin, Xu Yu; Sandor, George; Groenink, Maarten; Mulder, Barbara; De Backer, Julie; Evangelista, Arturo; Forteza, Alberto; Teixido-Tura, Gisela; Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier; Lacro, Ronald, V; Sleeper, Lynn A.; Chiu, Hsin-Hui; Wu, Mei-Hwan; Neubauer, Stefan; Watkins, Hugh; Dietz, Hal; Baigent, Colin		Marfan Treatment Trialists Collabo	Angiotensin receptor blockers and beta blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials	LANCET			English	Article							AORTIC-ROOT DILATION; LOSARTAN VS. ATENOLOL; DOUBLE-BLIND; ASCENDING AORTA; SURFACE-AREA; YOUNG-ADULTS; CHILDREN; PROGRESSION; PREVENTION; BLOCKADE	Background Angiotensin receptor blockers (ARBs) and beta blockers are widely used in the treatment of Marfan syndrome to try to reduce the rate of progressive aortic root enlargement characteristic of this condition, but their separate and joint effects are uncertain. We aimed to determine these effects in a collaborative individual patient data meta-analysis of randomised trials of these treatments. Methods In this meta-analysis, we identified relevant trials of patients with Marfan syndrome by systematically searching MEDLINE, Embase, and CENTRAL from database inception to Nov 2, 2021. Trials were eligible if they involved a randomised comparison of an ARB versus control or an ARB versus beta blocker. We used individual patient data from patients with no prior aortic surgery to estimate the effects of: ARB versus control (placebo or open control); ARB versus beta blocker; and indirectly, beta blocker versus control. The primary endpoint was the annual rate of change of body surface area-adjusted aortic root dimension Z score, measured at the sinuses of Valsalva. Findings We identified ten potentially eligible trials including 1836 patients from our search, from which seven trials and 1442 patients were eligible for inclusion in our main analyses. Four trials involving 676 eligible participants compared ARB with control. During a median follow-up of 3 years, allocation to ARB approximately halved the annual rate of change in the aortic root Z score (mean annual increase 0.07 [SE 0.02] ARB vs 0.13 [SE 0.02] control; absolute difference -0.07 [95% CI -0.12 to -0.01]; p=0.012). Prespecified secondary subgroup analyses showed that the effects of ARB were particularly large in those with pathogenic variants in fibrillin-1, compared with those without such variants (heterogeneity p=0.0050), and there was no evidence to suggest that the effect of ARB varied with beta-blocker use (heterogeneity p=0.54). Three trials involving 766 eligible participants compared ARBs with beta blockers. During a median follow-up of 3 years, the annual change in the aortic root Z score was similar in the two groups (annual increase -0.08 [SE 0.03] in ARB groups vs -0.11 [SE 0.02] in beta-blocker groups; absolute difference 0.03 [95% CI -0.05 to 0.10]; p=0.48). Thus, indirectly, the difference in the annual change in the aortic root Z score between beta blockers and control was -0.09 (95% CI -0.18 to 0.00; p=0.042). Interpretation In people with Marfan syndrome and no previous aortic surgery, ARBs reduced the rate of increase of the aortic root Z score by about one half, including among those taking a beta blocker. The effects of beta blockers were similar to those of ARBs. Assuming additivity, combination therapy with both ARBs and beta blockers from the time of diagnosis would provide even greater reductions in the rate of aortic enlargement than either treatment alone, which, if maintained over a number of years, would be expected to lead to a delay in the need for aortic surgery. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Pitcher, Alex; Jin, Xu Yu] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Heart Ctr, Oxford, England; [Spata, Enti; Emberson, Jonathan; Davies, Kelly; Halls, Heather; Holland, Lisa; Baigent, Colin] Univ Oxford, Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England; [Spata, Enti; Emberson, Jonathan; Davies, Kelly; Halls, Heather; Holland, Lisa; Wilson, Kate; Reith, Christina; Baigent, Colin] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Spata, Enti; Emberson, Jonathan; Davies, Kelly; Halls, Heather; Holland, Lisa; Wilson, Kate; Reith, Christina; Baigent, Colin] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Child, Anne H.] Imperial Coll London, Guys & St Thomas NHS Trust, Royal Brompton & Harefield Hosp Unit, London, England; [Child, Anne H.] Imperial Coll London, Dept Surg & Oncol, London, England; [Clayton, Tim; Dodd, Matthew] London Sch Hyg & Trop Med, Dept Med Stat, Clin Trials Unit, London, England; [Flather, Marcus] Univ East Anglia, Fac Med & Hlth Sci, Norwich, Norfolk, England; [Sandor, George] Univ British Columbia, Dept Paediat, Fac Med, Vancouver, BC, Canada; [Groenink, Maarten; Mulder, Barbara] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [De Backer, Julie] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [De Backer, Julie] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium; [Evangelista, Arturo] Hosp Univ Vall dHebron, Serv Cardiol, Barcelona, Spain; [Forteza, Alberto] Hosp Puerta de Hierro, Majadahonda, Spain; [Teixido-Tura, Gisela] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, Dept Cardiol,CIBER CV, Barcelona, Spain; [Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier] Univ Paris Cite, F-75018 Paris, France; [Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier] Univ Sorbonne Paris Nord, Inserrn U1148, LVTS, F-75018 Paris, France; [Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, F-75018 Paris, France; [Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier] Hop Bichat Claude Bernard, AP HP, CRMR Syndrome Marfan & Apparentes, F-75018 Paris, France; [Lacro, Ronald, V; Sleeper, Lynn A.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Lacro, Ronald, V; Sleeper, Lynn A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Chiu, Hsin-Hui] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Pediat, New Taipei, Taiwan; [Wu, Mei-Hwan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Mei-Hwan] Natl Taiwan Univ Hosp, Adult Congenital Heart Ctr, Taipei, Taiwan; [Neubauer, Stefan] Univ Oxford, Oxford Ctr Clin Magnet Resonance Res, Div Cardiovasc Med, Oxford, England; [Pitcher, Alex; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Dietz, Hal] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Dietz, Hal] Johns Hopkins Univ, Sch Med, Dept Genet Med, Baltimore, MD USA; [Groenink, Maarten; Mulder, Barbara] HTAD Rare Dis Working Grp, European Reference Network Rare Multisyst Vasc Di, Amsterdam, Netherlands; [De Backer, Julie] HTAD Rare Dis Working Grp, European Reference Network Rare Multisyst Vasc Di, Ghent, Belgium; [Evangelista, Arturo; Teixido-Tura, Gisela] HTAD Rare Dis Working Grp, European Reference Network Rare Multisyst Vasc Di, Barcelona, Spain; [Boileau, Catherine; Jondeau, Guillaume; Milleron, Olivier] HTAD Rare Dis Working Grp, European Reference Network Rare Multisyst Vasc Di, Paris, France	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of East Anglia; University of British Columbia; University of Amsterdam; Academic Medical Center Amsterdam; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Hospital Universitari Vall d'Hebron; Hospital Puerta de Hierro-Majadahonda; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; University of Oxford; University of Oxford; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Baigent, C (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.; Baigent, C (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England.; Baigent, C (corresponding author), Univ Oxford, Populat Hlth Res Unit, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.	m.flather@uea.ac.uk; gsandor@telus.net; Julie.DeBacker@UGent.be; guillaume.jondeau@aphp.fr; ron.lacro@cardio.chboston.org; colin.baigent@ndph.ox.ac.uk	De Backer, Julie/B-2897-2014	De Backer, Julie/0000-0001-8878-1507; Teixido-Tura, Gisela/0000-0003-4714-2420; Dodd, Matthew/0000-0002-6207-6604; Clayton, Tim/0000-0002-1266-3288; Emberson, Jonathan/0000-0001-7792-9422	Marfan Foundation; Oxford British Heart Foundation Centre for Research Excellence; UK Medical Research Council; British Heart Foundation; UK National Institute for Health and Care Research Biomedical Research Centre, Oxford; Gibson fund [MC_UU_00017/4]; Oxford University Hospitals Charitable Fund [RE/13/1/30181]; Academy of Medical Sciences Clinical Lecturer Starter Grant scheme	Marfan Foundation; Oxford British Heart Foundation Centre for Research Excellence; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK National Institute for Health and Care Research Biomedical Research Centre, Oxford; Gibson fund; Oxford University Hospitals Charitable Fund; Academy of Medical Sciences Clinical Lecturer Starter Grant scheme	The work of the MTT is supported by the Marfan Foundation, the Oxford British Heart Foundation Centre for Research Excellence, and the UK Medical Research Council (MC_UU_00017/4). AP acknowledges funding support from the Marfan Foundation, the British Heart Foundation, including from the Oxford British Heart Foundation Centre for Research Excellence (RE/13/1/30181), the UK National Institute for Health and Care Research Biomedical Research Centre, Oxford, the Gibson fund, Oxford University Hospitals Charitable Fund, and from an Academy of Medical Sciences Clinical Lecturer Starter Grant scheme, which is administered by the Academy on behalf of the Academy, the Wellcome Trust, the Medical Research Council, the British Heart Foundation, Arthritis Research UK, Prostate Cancer UK, and the Royal College of Physicians. We would like to thank all the participants who originally took part in the included trials, without whom this research would not have been possible. We would like to thank the clinicians, scientists, and all those who worked on the original trials. JDB would like to thank Laura Muino Mosquera for her contributions to the Ghent Marfan trial. We would also like to thank Samantha Briggs and Clare Mathewsfor their valuable administrative assistance in preparing this report	Al-abcha A, 2020, AM J CARDIOL, V128, P101, DOI 10.1016/j.amjcard.2020.04.034; Baetens M, 2011, HUM MUTAT, V32, P1053, DOI 10.1002/humu.21525; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bhatt AB, 2015, VASC MED, V20, P317, DOI 10.1177/1358863X15569868; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Campens L, 2014, AM J CARDIOL, V114, P914, DOI 10.1016/j.amjcard.2014.06.024; Chiu HH, 2013, MAYO CLIN PROC, V88, P271, DOI 10.1016/j.mayocp.2012.11.005; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Devereux RB, 2012, AM J CARDIOL, V110, P1189, DOI 10.1016/j.amjcard.2012.05.063; Di Toro A, 2019, EUR HEART J, V40, P3742, DOI DOI 10.1093/EURHEARTJ/EHZ746.0154; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Elbadawi A, 2019, CARDIOL THER, V8, P365, DOI 10.1007/s40119-019-00149-3; Forteza A, 2016, EUR HEART J, V37, P978, DOI 10.1093/eurheartj/ehv575; Gambarin FI, 2009, J CARDIOVASC MED, V10, P354, DOI 10.2459/JCM.0b013e3283232a45; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Groth KA, 2018, AM J CARDIOL, V122, P1231, DOI 10.1016/j.amjcard.2018.06.034; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALPERN BL, 1971, JOHNS HOPKINS MED J, V129, P123; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Kang YN, 2020, J FORMOS MED ASSOC, V119, P182, DOI 10.1016/j.jfma.2019.03.018; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Milleron O, 2015, EUR HEART J, V36, P2160, DOI 10.1093/eurheartj/ehv151; Mueller GC, 2014, HEART, V100, P214, DOI 10.1136/heartjnl-2013-304946; Muino-Mosquera L, 2017, ACTA CARDIOL, V72, P616, DOI 10.1080/00015385.2017.1314134; Mullen M, 2019, LANCET, V394, P2263, DOI 10.1016/S0140-6736(19)32518-8; Newitt David, 2016, TCIA, DOI 10.7937/K9/TCIA.2016.QHSYHJKY; Pees C, 2013, AM J CARDIOL, V112, P1477, DOI 10.1016/j.amjcard.2013.06.019; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Pitcher A, 2015, AM HEART J, V169, P605, DOI 10.1016/j.ahj.2015.01.011; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Sandor GGS, 2015, INT J CARDIOL, V179, P470, DOI 10.1016/j.ijcard.2014.11.082; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; The Marfan Foundation, MARFAN SYNDROME	38	2	2	12	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					822	831		10.1016/S0140-6736(22)01534-3	http://dx.doi.org/10.1016/S0140-6736(22)01534-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36049495	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000877580600021
J	Noble, S; Burgess, SM; Strauss, E				Noble, Suzanne; Burgess, Sean M.; Strauss, Evelyn			Christine Guthrie (1945-2022)	SCIENCE			English	Biographical-Item									[Noble, Suzanne] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Noble, Suzanne] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Burgess, Sean M.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Strauss, Evelyn] Univ Calif Santa Cruz, Sci Commun Program, Santa Cruz, CA 95064 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Santa Cruz	Noble, S (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Noble, S (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	suzanne.noble@ucsf.edu		Noble, Suzanne/0000-0001-9855-8448					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1049	1049		10.1126/science.ade2163	http://dx.doi.org/10.1126/science.ade2163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048934				2022-12-28	WOS:000887933200035
J	Duffett, L				Duffett, Lisa			In the Clinic Deep Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEMATOLOGY 2018 GUIDELINES; HOSPITALIZED MEDICAL PATIENTS; AMERICAN SOCIETY; THROMBOEMBOLISM PROPHYLAXIS; ANTITHROMBOTIC THERAPY; PULMONARY-EMBOLISM; POSTTHROMBOTIC SYNDROME; CHEST GUIDELINE; MANAGEMENT; RISK	Venous thromboembolism (VTE) is the third most common cardiovascular disorder, affecting up to 5% of the population. VTE commonly manifests as lower-extremity deep venous thrombosis (DVT) or pulmonary embolism. Half of these events are associated with a transient risk factor and may be preventable with prophylaxis. Direct oral anticoagulants are effective and safe and carry a lower risk for bleeding than vitamin K antagonists. Many patients with VTE will have a chronic disease requiring long-term anticoagulation. Postthrombotic syndrome affects 25% to 40% of patients with DVT and significantly impacts function and quality of life.	[Duffett, Lisa] Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Duffett, L (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.			Duffett, Lisa/0000-0002-6989-9224	American College of Physicians	American College of Physicians	American College of Physicians.	Ageno W, 2013, J THROMB HAEMOST, V11, P1597, DOI 10.1111/jth.12301; Ageno W, 2021, RES PRACT THROMB HAE, V5; American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics, 2018, Obstet Gynecol, V132, pe18, DOI 10.1097/AOG.0000000000002703; American College of Obstetricians and Gynecologists' Committee on Practice Bulletins -Obstetrics, 2018, OBSTET GYNECOL, V132, P1; Anderson DR, 2018, NEW ENGL J MED, V378, P699, DOI 10.1056/NEJMoa1712746; Anderson DR, 2019, BLOOD ADV, V3, P3898, DOI 10.1182/bloodadvances.2019000975; [Anonymous], 2018, Obstet Gynecol, V132, P243, DOI 10.1097/AOG.0000000000002707; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; Bates SM, 2018, BLOOD ADV, V2, P3317, DOI 10.1182/bloodadvances.2018024802; Bates SM, 2016, J THROMB THROMBOLYS, V41, P92, DOI 10.1007/s11239-015-1309-0; Bates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300; Bezemer ID, 2009, ARCH INTERN MED, V169, P610, DOI 10.1001/archinternmed.2008.589; Broderick C, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002783.pub5; Carrier M, 2018, CURR ONCOL, V25, P329, DOI 10.3747/co.25.4266; Carrier M, 2019, NEW ENGL J MED, V380, P711, DOI 10.1056/NEJMoa1814468; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; Chan NC, 2015, J THROMB THROMBOLYS, V40, P231, DOI 10.1007/s11239-014-1153-7; Chan WS, 2014, J OBSTET GYNAECOL CA, V36, P527, DOI 10.1016/S1701-2163(15)30569-7; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Cohen H, 2020, LUPUS, V29, P1571, DOI 10.1177/0961203320950461; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Connors JM, 2017, NEW ENGL J MED, V377, P1177, DOI 10.1056/NEJMra1700365; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Douxfils J, 2021, THROMB HAEMOSTASIS, V121, P1008, DOI 10.1055/a-1450-8178; Farge D, 2019, LANCET ONCOL, V20, pE566, DOI 10.1016/S1470-2045(19)30336-5; Franco L, 2017, J THROMB HAEMOST, V15, P1142, DOI 10.1111/jth.13677; Freund Y, 2021, JAMA-J AM MED ASSOC, V326, P2141, DOI 10.1001/jama.2021.20750; Geersing GJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1340; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Greene MT, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.03.031; Gynaecologists RCoOa, 2015, GREEN TOP GUIDELINE; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Kahn SR, 2014, CIRCULATION, V130, P1636, DOI 10.1161/CIR.0000000000000130; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461; Khan F, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4363; Khorana AA, 2019, NEW ENGL J MED, V380, P720, DOI 10.1056/NEJMoa1814630; Konstantinides SV, 2020, EUR HEART J, V41, P543, DOI 10.1093/eurheartj/ehz405; Kotaska A, 2018, BJOG-INT J OBSTET GY, V125, P1109, DOI 10.1111/1471-0528.15150; Kraaijpoel N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228788; Lim W, 2018, BLOOD ADV, V2, P3226, DOI 10.1182/bloodadvances.2018024828; Lyman GH, 2021, BLOOD ADV, V5, P927, DOI 10.1182/bloodadvances.2020003442; Middeldorp S, 2008, BRIT J HAEMATOL, V143, P321, DOI 10.1111/j.1365-2141.2008.07339.x; Mulder FI, 2020, BLOOD, V136, P1433, DOI 10.1182/blood.2020005819; Ordi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291; Ortel TL, 2020, BLOOD ADV, V4, P4693, DOI 10.1182/bloodadvances.2020001830; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pannucci CJ, 2014, CHEST, V145, P567, DOI 10.1378/chest.13-1553; Pengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333; Poller L, 2008, J THROMB HAEMOST, V6, P935, DOI 10.1111/j.1538-7836.2008.02959.x; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Quinlan DJ, 2007, J THROMB HAEMOST, V5, P1438, DOI 10.1111/j.1538-7836.2007.02571.x; Rabinovich A, 2018, BLOOD, V131, P2215, DOI 10.1182/blood-2018-01-785956; Rodger MA, 2019, THROMB RES, V180, P105, DOI 10.1016/j.thromres.2019.06.017; Rodger MA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1065; Schunemann HJ, 2018, BLOOD ADV, V2, P3198, DOI 10.1182/bloodadvances.2018022954; Siccama RN, 2011, AGEING RES REV, V10, P304, DOI 10.1016/j.arr.2010.10.005; Spyropoulos AC, 2011, CHEST, V140, P706, DOI 10.1378/chest.10-1944; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P1330, DOI 10.1001/jamainternmed.2014.2368; Stevens SM, 2021, CHEST, V160, pE545, DOI 10.1016/j.chest.2021.07.055; Sultan AA, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6253; Tektonidou MG, 2019, ANN RHEUM DIS, V78, P1296, DOI 10.1136/annrheumdis-2019-215213; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; van Es N, 2017, ANN INTERN MED, V167, P410, DOI 10.7326/M17-0868; Witt DM, 2018, BLOOD ADV, V2, P3257, DOI 10.1182/bloodadvances.2018024893; Wu C, 2014, THROMB RES, V134, P627, DOI 10.1016/j.thromres.2014.07.001; Zayed Y, 2020, INTERN MED J, V50, P192, DOI 10.1111/imj.14417	73	0	0	3	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	2022	175	9								10.7326/AITC202209200	http://dx.doi.org/10.7326/AITC202209200			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K5TA	36095313				2022-12-28	WOS:000869787900003
J	Zhang, JQ; Hu, YX; Yang, JX; Li, W; Zhang, MM; Wang, QC; Zhang, LJ; Wei, GQ; Tian, Y; Zhao, K; Chen, A; Tan, BH; Cui, JZ; Li, DQ; Li, Y; Qi, YL; Wang, DR; Wu, YX; Li, DL; Du, B; Liu, MY; Huang, H				Zhang, Jiqin; Hu, Yongxian; Yang, Jiaxuan; Li, Wei; Zhang, Mingming; Wang, Qingcan; Zhang, Linjie; Wei, Guoqing; Tian, Yue; Zhao, Kui; Chen, Ang; Tan, Binghe; Cui, Jiazhen; Li, Deqi; Li, Yi; Qi, Yalei; Wang, Dongrui; Wu, Yuxuan; Li, Dali; Du, Bing; Liu, Mingyao; Huang, He			Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL	NATURE			English	Article							CHIMERIC ANTIGEN RECEPTOR; SLEEPING-BEAUTY; IMMUNOTHERAPY; THERAPY	Recently, chimeric antigen receptor (CAR)-T cell therapy has shown great promise in treating haematological malignancies(1-7). However, CAR-T cell therapy currently has several limitations(8-12). Here we successfully developed a two-in-one approach to generate non-viral, gene-specific targeted CAR-T cells through CRISPR-Cas9. Using the optimized protocol, we demonstrated feasibility in a preclinical study by inserting an anti-CD19 CAR cassette into the AAVS1 safe-harbour locus. Furthermore, an innovative type of anti-CD19 CAR-T cell with PD1 integration was developed and showed superior ability to eradicate tumour cells in xenograft models. In adoptive therapy for relapsed/refractory aggressive B cell non-Hodgkin lymphoma (ClinicalTrials.gov, NCT04213469), we observed a high rate (87.5%) of complete remission and durable responses without serious adverse events in eight patients. Notably, these enhanced CAR-T cells were effective even at a low infusion dose and with a low percentage of CAR(+) cells. Single-cell analysis showed that the electroporation method resulted in a high percentage of memory T cells in infusion products, and PD1 interference enhanced anti-tumour immune functions, further validating the advantages of non-viral, PD1-integrated CAR-T cells. Collectively, our results demonstrate the high safety and efficacy of non-viral, gene-specific integrated CAR-T cells, thus providing an innovative technology for CAR-T cell therapy.	[Zhang, Jiqin; Yang, Jiaxuan; Zhang, Linjie; Tian, Yue; Chen, Ang; Tan, Binghe; Qi, Yalei; Wu, Yuxuan; Li, Dali; Du, Bing; Liu, Mingyao] East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China; [Zhang, Jiqin; Yang, Jiaxuan; Zhang, Linjie; Tian, Yue; Chen, Ang; Tan, Binghe; Qi, Yalei; Wu, Yuxuan; Li, Dali; Du, Bing; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Hu, Yongxian; Zhang, Mingming; Wei, Guoqing; Cui, Jiazhen; Li, Yi; Wang, Dongrui; Huang, He] Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Hu, Yongxian; Zhang, Mingming; Wei, Guoqing; Cui, Jiazhen; Li, Yi; Wang, Dongrui; Huang, He] Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China; [Hu, Yongxian; Zhang, Mingming; Wei, Guoqing; Cui, Jiazhen; Li, Yi; Wang, Dongrui; Huang, He] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China; [Hu, Yongxian; Zhang, Mingming; Wei, Guoqing; Cui, Jiazhen; Li, Yi; Wang, Dongrui; Huang, He] Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Peoples R China; [Li, Wei; Wang, Qingcan; Chen, Ang; Tan, Binghe; Li, Deqi; Wu, Yuxuan; Li, Dali; Du, Bing; Liu, Mingyao] BRL Med Inc, Shanghai, Peoples R China; [Zhao, Kui] Zhejiang Univ, Affiliated Hosp 1, PETCT Ctr, Sch Med, Hangzhou, Peoples R China	East China Normal University; East China Normal University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zhang, JQ; Li, DL; Du, B; Liu, MY (corresponding author), East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China.; Zhang, JQ; Li, DL; Du, B; Liu, MY (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, H (corresponding author), Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China.; Huang, H (corresponding author), Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou, Peoples R China.; Huang, H (corresponding author), Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China.; Huang, H (corresponding author), Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Peoples R China.; Li, DL; Du, B; Liu, MY (corresponding author), BRL Med Inc, Shanghai, Peoples R China.	zjqjeremy@163.com; dlli@bio.ecnu.edu.cn; bdu@bio.ecnu.edu.cn; myliu@bio.ecnu.edu.cn; huanghe@zju.edu.cn	ZHANG, LIN/GYD-9123-2022; Chen, Ang/HII-3354-2022	Du, Bing/0000-0002-5402-6527; Zhang, Jiqin/0000-0001-9545-9532	National Key R&D Program of China [2019YFA0802802, 2018YFA0507001]; National Natural Science Foundation of China [81772622, 81730008, 81770201, 91857116, 31871453]; Innovation Program of the Shanghai Municipal Education Commission [2017-01-07-00-05-E00011]; Key Project of the Science and Technology Department of Zhejiang Province [2019C03016]; Natural Science Foundation of Shanghai [18ZR1412300]; ECNU Public Platform for Innovation [011]; Instruments Sharing Platform of the School of Life Sciences, East China Normal University	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Key Project of the Science and Technology Department of Zhejiang Province; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); ECNU Public Platform for Innovation; Instruments Sharing Platform of the School of Life Sciences, East China Normal University	We thank S. Siwko for discussing and revising this manuscript. This study was supported by the National Key R&D Program of China (2019YFA0802802, 2018YFA0507001), the National Natural Science Foundation of China (81772622, 81730008, 81770201, 91857116, 31871453), the Innovation Program of the Shanghai Municipal Education Commission (2017-01-07-00-05-E00011), the Key Project of the Science and Technology Department of Zhejiang Province (2019C03016) and the Natural Science Foundation of Shanghai (18ZR1412300). It was also supported by the ECNU Public Platform for Innovation (011) and the Instruments Sharing Platform of the School of Life Sciences, East China Normal University.	Atianand MK, 2013, J IMMUNOL, V190, P1911, DOI 10.4049/jimmunol.1203162; Beatty GL, 2018, GASTROENTEROLOGY, V155, P29, DOI 10.1053/j.gastro.2018.03.029; Berdeja JG, 2021, LANCET, V398, P314, DOI 10.1016/S0140-6736(21)00933-8; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092; Dai XY, 2019, NAT METHODS, V16, P247, DOI 10.1038/s41592-019-0329-7; Russo-Carbolante EMD, 2011, BIOTECHNOL LETT, V33, P23, DOI 10.1007/s10529-010-0387-5; Deng Q, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1061-7; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Foster JB, 2019, HUM GENE THER, V30, P168, DOI 10.1089/hum.2018.145; Gandara C, 2018, HUM GENE THER METHOD, V29, P1, DOI 10.1089/hgtb.2017.098; Guo XL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01118; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Labanieh L, 2018, NAT BIOMED ENG, V2, P377, DOI 10.1038/s41551-018-0235-9; Larson RC, 2021, NAT REV CANCER, V21, P145, DOI 10.1038/s41568-020-00323-z; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin L, 2021, LEUKEMIA, V35, P752, DOI 10.1038/s41375-020-0951-5; Liu Q, 2019, SCI CHINA LIFE SCI, V62, P1, DOI 10.1007/s11427-018-9402-9; Lu Y, 2020, NAT MED, V26, P732, DOI 10.1038/s41591-020-0840-5; MacKay M, 2020, NAT BIOTECHNOL, V38, P233, DOI 10.1038/s41587-019-0329-2; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Michieletto D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08333-8; Monjezi R, 2017, LEUKEMIA, V31, P186, DOI 10.1038/leu.2016.180; Munshi NC, 2021, NEW ENGL J MED, V384, P705, DOI 10.1056/NEJMoa2024850; Nobles CL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1625-3; Patsoukis N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2712; Rafiq S, 2018, NAT BIOTECHNOL, V36, P847, DOI 10.1038/nbt.4195; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Tao JL, 2016, IUBMB LIFE, V68, P858, DOI 10.1002/iub.1566; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Yi M, 2022, MOL CANCER, V21, DOI 10.1186/s12943-021-01489-2	50	2	2	56	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					369	+		10.1038/s41586-022-05140-y	http://dx.doi.org/10.1038/s41586-022-05140-y		AUG 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36045296	Green Published, hybrid			2022-12-28	WOS:000848083000002
J	Zimmer, L; Livingstone, E; Hassel, JC; Fluck, M; Eigentler, T; Loquai, C; Haferkamp, S; Gutzmer, R; Meier, F; Mohr, P; Hauschild, A; Schilling, B; Menzer, C; Kieker, F; Dippel, E; Rosch, A; Simon, JC; Conrad, B; Korner, S; Windemuth-Kieselbach, C; Schwarz, L; Garbe, C; Becker, JC; Schadendorf, D				Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica C.; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp, Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild, Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel, Edgar; Rosch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Korner, Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus; Becker, Juergen C.; Schadendorf, Dirk		Dermatologic Cooperative Oncology	Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial	LANCET			English	Article							III MELANOMA; FREE SURVIVAL; THERAPY	Background The IMMUNED trial previously showed significant improvements in recurrence-free survival for adjuvant nivolumab plus ipilimumab as well as for adjuvant nivolumab alone in patients with stage IV melanoma with no evidence of disease after resection or radiotherapy. Here, we report the final analysis, including overall survival data. Methods IMMUNED was an investigator-sponsored, double-blind, placebo-controlled, three-arm, phase 2 trial conducted in 20 academic medical centres in Germany. Eligible patients were aged 18-80 years with stage IV melanoma with no evidence of disease after surgery or radiotherapy. Patients were randomly assigned (1:1:1) to either nivolumab plus ipilimumab (nivolumab 1 mg/kg plus ipilimumab 3 mg/kg every 3 weeks for four doses followed by nivolumab 3 mg/kg every 2 weeks), nivolumab monotherapy (nivolumab 3 mg/kg every 2 weeks), or matching placebo, for up to 1 year. The primary endpoint was recurrence-free survival in the intention-to-treat population. Secondary endpoints were time-to-recurrence, overall survival, progression-free survival or recurrence-free survival 2 (in patients in the placebo group who crossed over to nivolumab monotherapy after experiencing disease recurrence), and safety endpoints. This trial is registered on ClinicalTrials.gov (NCT02523313), and is complete. Findings Between Sept 2, 2015, and Nov 20, 2018, 175 patients were enrolled in the study, and 167 were randomly assigned to receive either nivolumab plus ipilimumab (n=56), nivolumab plus ipilimumab-matching placebo (n=59), or double placebo control (n=52). At a median follow-up of 49.2 months (IQR 34.9-58.1), 4-year recurrence-free survival was 64.2% (95% CI 49.2-75.9) in the nivolumab plus ipilimumab group, 31.4% (19.7-43.8) in the nivolumab alone group, and 15.0% (6.7-26.6) in the placebo group. The hazard ratio (HR) for recurrence for the nivolumab plus ipilimumab group versus placebo was 0.25 (97.5% CI 0.13-0.48; p<0.0001), and for the nivolumab group versus placebo was 0.60 (0.36-1.00; p=0.024). Median overall survival was not reached in any treatment group. The HR for overall survival was significantly in favour of the nivolumab plus ipilimumab group versus placebo (HR 0.41; 95% CI 0.17-0.99; p=0.040), but not for the nivolumab group versus placebo (HR 0.75; 0.36-1.56; p=0.44). 4-year overall survival was 83.8% (95% CI 68.8-91.9) in the nivolumab plus ipilimumab group, 72.6% (57.4-83.2) in the nivolumab alone group, and 63.1% (46.9-75.6) in the placebo group. The median progression -free survival or recurrence-free survival 2 of patients in the placebo group who crossed over to nivolumab monotherapy after experiencing disease recurrence was not reached (95% CI 21.2 months to not reached). Rates of grade 3-4 treatment-related adverse events remained largely unchanged compared with our previous report, occurring in 71% (95% CI 57-82) of the nivolumab plus ipilimumab group, and 29% (95% CI 17-42) of patients receiving nivolumab alone. There were no treatment-related deaths. Interpretation Both active regimens continued to show significantly improved recurrence-free survival compared with placebo in patients with stage IV melanoma with no evidence of disease who were at high risk of recurrence. Overall survival was significantly improved for patients receiving nivolumab plus ipilimumab compared with placebo. Use of subsequent anti-PD-1-based therapy was high in patients in the placebo group after recurrence and most likely impacted the overall survival comparison of nivolumab alone versus placebo. The recurrence-free and overall survival benefit of nivolumab plus ipilimumab over placebo reinforces the change of practice already initiated for the treatment of patients with stage IV melanoma with no evidence of disease. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Zimmer, Lisa; Livingstone, Elisabeth; Rosch, Alexander; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45147 Essen, Germany; [Hassel, Jessica C.; Menzer, Christian; Korner, Silvia] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany; [Fluck, Michael; Conrad, Beate] Fachklin Hornheide, Dept Oncol Hornheide, Munster, Germany; [Eigentler, Thomas; Garbe, Claus] Univ Hosp Tubingen, Dept Dermatol, Tubingen, Germany; [Eigentler, Thomas; Kieker, Felix] Charite Univ Med Berlin, Dept Dermatol Venereol & Allergol, Berlin, Germany; [Eigentler, Thomas; Kieker, Felix] Free Univ Berlin, Berlin, Germany; [Eigentler, Thomas; Kieker, Felix] Humboldt Univ, Berlin, Germany; [Loquai, Carmen] Univ Hosp Mainz, Dept Dermatol, Mainz, Germany; [Haferkamp, Sebastian] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Gutzmer, Ralf] Hannover Med Sch, Skin Canc Ctr Hannover, Dept Dermatol & Allergy, Hannover, Germany; [Gutzmer, Ralf] Ruhr Univ Bochum, Johannes Wesling Med Ctr, Dept Dermatol, Minden, Germany; [Meier, Friedegund] Univ Hosp Dresden, Dept Dermatol, Dresden, Germany; [Mohr, Peter] Elbe Kliniken, Dept Dermatol, Buxtehude, Germany; [Hauschild, Axel] Univ Hosp Schleswig Holstein, Dept Dermatol, Campus Kiel, Kiel, Germany; [Schilling, Bastian] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Kieker, Felix] Vivantes Klinikum Berlin Neukolln, Dept Dermatol & Venereol, Berlin, Germany; [Dippel, Edgar] Ludwigshafen Med Ctr, Dept Dermatol, Ludwigshafen, Germany; [Zimmer, Lisa] Leipzig Univ Hosp, Med Ctr, Dept Dermatol, Leipzig, Germany; [Windemuth-Kieselbach, Christine; Schwarz, Leonora] Alcedis, Giessen, Germany; [Becker, Juergen C.] Univ Med Duisburg Essen, Translat Skin Canc Res TSCR, Dept Dematol, Essen, Germany; [Becker, Juergen C.] Univ Med Duisburg Essen, West German Canc Ctr, Essen, Germany; [Becker, Juergen C.] German Canc Res Ctr, Heidelberg, Germany; [Rosch, Alexander; Becker, Juergen C.; Schadendorf, Dirk] Univ Duisburg Essen, Med Fac, German Canc Consortium DKTK, Partner Site Essen, Essen, Germany	University of Duisburg Essen; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; University Hospital Mainz; University of Regensburg; Hannover Medical School; Ruhr University Bochum; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Wurzburg; VIivantes Klinikum Neukolln; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Schadendorf, D (corresponding author), Univ Hosp Essen, Dept Dermatol, D-45147 Essen, Germany.	dirk.schadendorf@uk-essen.de		Menzer, Christian/0000-0002-1506-0191	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb.	Ascierto PA, 2020, LANCET ONCOL, V21, P1465, DOI 10.1016/S1470-2045(20)30494-0; Constantinou M, 2021, AM J CLIN ONCOL-CANC, V44, P254, DOI 10.1097/COC.0000000000000820; Dummer R, 2020, NEW ENGL J MED, V383, P1139, DOI 10.1056/NEJMoa2005493; Eggermont AMM, 2021, LANCET ONCOL, V22, P643, DOI 10.1016/S1470-2045(21)00065-6; Eggermont AMM, 2019, EUR J CANCER, V119, P1, DOI 10.1016/j.ejca.2019.07.001; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Grob JJ, 2018, LANCET ONCOL, V19, pE720, DOI 10.1016/S1470-2045(18)30596-5; Grossmann KF, 2022, CANCER DISCOV, V12, P644, DOI 10.1158/2159-8290.CD-21-1141; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Larkin J., SMR M 2021; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Long GV, 2021, CANCER RES, V81; Menzies AM, 2021, NAT MED, V27, P301, DOI 10.1038/s41591-020-01188-3; National Comprehensive Cancer Network, 2022, NCCN PRACT GUID CONC; Postow MA, 2022, J CLIN ONCOL, V40, P1059, DOI 10.1200/JCO.21.01570; Reijers ILM, 2022, NAT MED, V28, P1178, DOI 10.1038/s41591-022-01851-x; Ristl R, 2021, PHARM STAT, V20, P129, DOI 10.1002/pst.2062; Versluis JM, 2022, J CLIN ONCOL, V40; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Weber JS, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.9502; Wolchok JD, 2022, J CLIN ONCOL, V40, P127, DOI 10.1200/JCO.21.02229; Zhang LJ, 2013, THER INNOV REGUL SCI, V47, P95, DOI 10.1177/0092861512459180; Zimmer L, 2020, LANCET, V395, P1558, DOI 10.1016/S0140-6736(20)30417-7	24	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1117	1129		10.1016/S0140-6736(22)01654-3	http://dx.doi.org/10.1016/S0140-6736(22)01654-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36099927				2022-12-28	WOS:000877828800016
J	McQuaid, JR; Buelt, A; Capaldi, V; Fuller, M; Issa, F; Lang, AE; Hoge, C; Oslin, DW; Sall, J; Wiechers, IR; Williams, S				McQuaid, John R.; Buelt, Andrew; Capaldi, Vincent; Fuller, Matthew; Issa, Fuad; Lang, Adam Edward; Hoge, Charles; Oslin, David W.; Sall, James; Wiechers, Ilse R.; Williams, Scott			The Management of Major Depressive Disorder: Synopsis of the 2022 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; DOUBLE-BLIND; OLDER VETERANS; THETA BURST; THERAPY; PSYCHOTHERAPY; QUALITY; RECOMMENDATIONS; TELEMEDICINE	Description: In February 2022, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of major depressive disorder (MDD). This synopsis summarizes key recommendations. Methods: Senior leaders within the VA and the DoD assembled a team to update the 2016 CPG for the management of MDD that included clinical stakeholders and conformed to the National Academy of Medicine's tenets for trustworthy CPGs. The guideline panel developed key questions, systematically searched and evaluated the literature, created two 1-page algorithms, and distilled 36 recommendations for care using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Select recommendations that were identified by the authors to represent key changes from the prior CPG are presented in this synopsis. Recommendations: The scope of the CPG is diverse; however, this synopsis focuses on key recommendations that the authors identified as important new evidence and changes to prior recommendations on pharmacologic management, pharmacogenomics, psychotherapy, complementary and alternative therapies, and the use of telemedicine.	[McQuaid, John R.] San Francisco VA Hlth Care Syst, San Francisco, CA USA; [McQuaid, John R.; Wiechers, Ilse R.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Buelt, Andrew] CW Bill Young Vet Adm Med Ctr, Bay Pines, FL USA; [Capaldi, Vincent] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Fuller, Matthew] US Dept Vet Affairs, VHA Pharm Benefits Management Serv, Cleveland, OH USA; [Fuller, Matthew] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Issa, Fuad] Def Hlth Agcy, Silver Spring, MD USA; [Lang, Adam Edward] McDonald Army Hlth Ctr, Dept Primary Care, Ft Eustis, VA USA; [Lang, Adam Edward] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Sch Med, Richmond, VA USA; [Hoge, Charles] Walter Reed Army Inst Res, Silver Spring, MD USA; [Oslin, David W.] Univ Penn, Corporal Michael J Crescenz VA Med Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sall, James] Vet Adm Cent Off, Washington, DC USA; [Wiechers, Ilse R.] Univ Calif San Francisco, Off Mental Hlth & Suicide Prevent, Dept Vet Affairs, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Williams, Scott] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Williams, Scott] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	University of California System; University of California San Francisco; Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Case Western Reserve University; Virginia Commonwealth University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Case Western Reserve University	Sall, J (corresponding author), Vet Adm Cent Off, Qual & Patient Safety, 811 Vermont Ave NW, Washington, DC 20420 USA.	James.Sall@va.gov		Issa, Fuad/0000-0002-9081-6841; Lang, Adam/0000-0002-4347-6514; Sall, James/0000-0001-8564-1314	U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	Financial support for the development of the guideline was provided by the U.S. Department of Veterans Affairs.	American Psychological Association, 2020, PUBL MAN AM PSYCH AS, V7th; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Blumberger DM, 2018, LANCET, V391, P1683, DOI 10.1016/S0140-6736(18)30295-2; Callesen P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64577-1; Center for Connected Health Policy, 2021, STAT TEL LAWS MED PR; Chou PH, 2020, BRAIN BEHAV IMMUN, V88, P144, DOI 10.1016/j.bbi.2020.06.024; Daly EJ, 2019, JAMA PSYCHIAT, V76, P893, DOI 10.1001/jamapsychiatry.2019.1189; Davis AK, 2021, JAMA PSYCHIAT, V78, P481, DOI 10.1001/jamapsychiatry.2020.3285; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Driessen E, 2017, J CONSULT CLIN PSYCH, V85, P653, DOI 10.1037/ccp0000207; Egede LE, 2016, J CLIN PSYCHIAT, V77, P1704, DOI 10.4088/JCP.16m10951; Egede LE, 2015, LANCET PSYCHIAT, V2, P693, DOI 10.1016/S2215-0366(15)00122-4; Fond G, 2014, PSYCHOPHARMACOLOGY, V231, P3663, DOI 10.1007/s00213-014-3664-5; Fu Dong-Jing, 2020, J Clin Psychiatry, V81, DOI 10.4088/JCP.19m13191; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; Gibbons MBC, 2016, JAMA PSYCHIAT, V73, P904, DOI 10.1001/jamapsychiatry.2016.1720; Giosan C, 2020, J CLIN PSYCHOL, V76, P1818, DOI 10.1002/jclp.22991; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Greden JF, 2019, J PSYCHIATR RES, V111, P59, DOI 10.1016/j.jpsychires.2019.01.003; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Hay SI, 2017, LANCET, V389, pE1; Health Resources & Services Administration, BILL TEL COVID 19; Ionescu DF, 2021, INT J NEUROPSYCHOPH, V24, P22, DOI 10.1093/ijnp/pyaa068; Karyotaki E, 2021, JAMA PSYCHIAT, V78, P361, DOI 10.1001/jamapsychiatry.2020.4364; Kryst J, 2020, PHARMACOL REP, V72, P543, DOI 10.1007/s43440-020-00097-z; Lam RW, 2008, CAN J PSYCHIAT, V53, P621, DOI 10.1177/070674370805300909; Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183; Liu H, 2014, J NEUROL SCI, V341, P105, DOI 10.1016/j.jns.2014.04.012; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Luxton DD, 2016, J CONSULT CLIN PSYCH, V84, P923, DOI 10.1037/ccp0000135; McGregor B, 2020, PSYCHIAT SERV, V71, P663, DOI 10.1176/appi.ps.201900407; National Institute for Health and Care Excellence, 2022, DEPR AD TREATM MAN; Olfson M, 2016, JAMA INTERN MED, V176, P1482, DOI 10.1001/jamainternmed.2016.5057; Papakostas GI, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.OT19037COM5; Qaseem A, 2016, ANN INTERN MED, V164, P350, DOI 10.7326/M15-2570; Rosenblat JD, 2018, J AFFECT DISORDERS, V241, P484, DOI 10.1016/j.jad.2018.08.056; Tao L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113247; U.S. Department of Veterans Affairs; U.S. Department of Defense, 2022, VA DOD CLIN PRACT GU; U.S. Department of Veterans Affairs; U.S. Department of Defense, 2019, VA DOD CLIN PRACT GU; U.S. Department of Veterans Affairs; U.S. Department of Defense, 2016, VADOD CLIN PRACTICE; Wajs E, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.19m12891; Wirz-Justice A, 2011, J CLIN PSYCHIAT, V72, P986, DOI 10.4088/JCP.10m06188blu; Yesavage JA, 2018, JAMA PSYCHIAT, V75, P884, DOI 10.1001/jamapsychiatry.2018.1483	44	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1440	+		10.7326/M22-1603	http://dx.doi.org/10.7326/M22-1603		SEP 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36122380				2022-12-28	WOS:000860851400002
J	Luo, R; Fong, YY; Boeras, D; Jani, I; Vojnov, L				Luo, Robert; Fong, Youyi; Boeras, Debi; Jani, Ilesh; Vojnov, Lara			The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis	LANCET			English	Review							ANTIRETROVIRAL THERAPY; AGE; MORTALITY; QUALITY	Background Timely diagnosis and treatment of HIV is crucial in HIV-exposed infants to prevent the high rates of mortality seen during the first 2 years of life if HIV is untreated. However, challenges with sample transportation, testing, and result delivery to caregivers have led to long delays in treatment initiation. We aimed to compare the clinical effect of point-of-care HIV testing versus laboratory-based testing (standard of care) in HIV-exposed infants. Methods We did a systematic review and meta-analysis and searched PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, Embase, Conference Proceedings Citation Index-Science, and WHO Global Index Medicus, from Jan 1, 2014, to Aug 31, 2020. Studies were included if they pertained to the use of point-of-care nucleic acid testing for infant HIV diagnosis, had a laboratory-based nucleic acid test as the comparator or standard of care against the index test (same-day point-of-care testing), evaluated clinical outcomes when point-of-care testing was used, and included HIV-exposed infants aged younger than 2 years. Studies were excluded if they did not use a laboratory-based comparator, a nucleic acid test that had been approved by a stringent regulatory authority, or diagnostic-accuracy or performance evaluations (eg, no clinical outcomes included). Reviews, non-research letters, commentaries, and editorials were also excluded. The risk of bias was evaluated using the ROBINS-I framework. Data were extracted from published reports. Data from all studies were analysed using frequency statistics to describe the overall populations evaluated and their results. Key outcomes were time to result delivery and antiretroviral therapy initiation, and proportion of HIV-positive infants initiated on antiretroviral therapy within 60 days after sample collection. Findings 164 studies were identified by the search and seven were included in the analysis, comprising 37 377 infants in total across 15 countries, including 25 170 (67%) who had point-of-care HIV testing and 12 207 (33%) who had standard-of-care testing. The certainty of evidence was high. Same-day point-of-care testing led to a significantly shorter time between sample collection and result delivery to caregivers compared with standard-of-care testing (median 0 days [95% CI 0-0] vs 35 days [35-37]). Time from sample collection to antiretroviral therapy initiation in infants found to be HIV-positive was significantly lower with point-of-care testing compared with standard of care (median 0 days [95% CI 0-1] vs 40 days [36-44]). When each study's result was weighted equally, 90.3% (95% CI 76.7-96.5) of HIV-positive infants diagnosed using point-of-care testing had started antiretroviral therapy within 60 days of sample collection, compared with only 51.6% (27.1-75.7) who had standard-of-care testing (odds ratio 8.74 [95% CI 6.6-11.6]; p<0.0001). Interpretation Overall, the certainty of the evidence in this analysis was rated as high for the primary outcomes related to result delivery and treatment initiation, with no serious risk of bias, inconsistency, indirectness, or imprecision. In HIV-exposed infants, same-day point-of-care HIV testing was associated with significantly improved time to result delivery, time to antiretroviral therapy initiation, and proportion of HIV-positive infants starting antiretroviral therapy within 60 days compared with standard of care. Copyright (C) 2022 World Health Organization. Published by Elsevier Ltd.	[Luo, Robert; Boeras, Debi] Global Hlth Impact Grp, Atlanta, GA USA; [Fong, Youyi] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Jani, Ilesh] Inst Nacl Saude, Maputo, Mozambique; [Vojnov, Lara] World Hlth Org, Geneva, Switzerland	Fred Hutchinson Cancer Center; World Health Organization	Vojnov, L (corresponding author), World Hlth Org, CH-1211 Geneva, Switzerland.	vojnovl@who.int			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Bill & Melinda Gates Foundation.	Bianchi F, 2019, LANCET HIV, V6, pE373, DOI 10.1016/S2352-3018(19)30033-5; Boeke CE, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25677; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Burr IW, 1942, ANN MATH STAT, V13, P215, DOI 10.1214/aoms/1177731607; Chibwesha CJ, 2022, CLIN INFECT DIS, V75, P260, DOI 10.1093/cid/ciab923; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Cohn J, 2016, LANCET HIV, V3, pE473, DOI 10.1016/S2352-3018(16)30050-9; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Garcia-Broncano P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax7350; Goetghebuer T, 2012, CLIN INFECT DIS, V54, P878, DOI 10.1093/cid/cir950; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Iyun V, 2020, PEDIATR INFECT DIS J, V39, P127, DOI 10.1097/INF.0000000000002516; Jani IV, 2018, AIDS, V32, P1453, DOI [10.1097/QAD.0000000000001846, 10.1097/qad.0000000000001846]; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Kiyaga C, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25089; Kuhn Louise, 2018, PLoS One, V13, pe0195514, DOI 10.1371/journal.pone.0195514; Le Roux S, LANCET HIV; Lee K, 2009, GLOB INST, P1; Markby J, B WORLD HEALTH ORGAN; Massanella M, 2021, CLIN INFECT DIS, V73, P427, DOI 10.1093/cid/ciaa718; McCollum ED, 2014, JAIDS-J ACQ IMM DEF, V66, pE23, DOI 10.1097/QAI.0000000000000080; Moher D., 2009, PLOS MED, V6, DOI DOI 10.1371/JOURNAL.PMED.1000097; Mwenda R, 2018, CLIN INFECT DIS, V67, P701, DOI 10.1093/cid/ciy169; Ochodo EA, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013207.pub2; Odhiambo C, 2014, ASLM INT C; Page MJ, 2021, J CLIN EPIDEMIOL, V134, P103, DOI 10.1016/j.jclinepi.2021.02.003; Sacks E, 2020, JAIDS-J ACQ IMM DEF, V84, pS5, DOI 10.1097/QAI.0000000000002383; Shiau S, 2017, AIDS, V31, P355, DOI 10.1097/QAD.0000000000001312; Shiau S, 2013, J PEDIATR-US, V162, P1138, DOI 10.1016/j.jpeds.2012.11.025; Spooner E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6990-z; Tagarro A, 2020, C RETROVIRUSES OPPOR; Tagarro A, 2018, JAIDS-J ACQ IMM DEF, V79, P269, DOI [10.1097/QAI.0000000000001789, 10.1097/qai.0000000000001789]; Technau KG, 2017, LANCET HIV, V4, pE442, DOI 10.1016/S2352-3018(17)30097-8; UNAIDS, 2020, GLOB AIDS STRAT 2021; UNAIDS, 2020, AIDSINFO; Veldsman KA, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25368; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2013, CONSOLIDATED GUIDELI; WHO, 2020, WHO LIST PREQ IN VIT; WHO, 2017, NOV POINT OF CAR TOO	42	2	2	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					887	895						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116479				2022-12-28	WOS:000890180700021
J	Racioppi, F; Rutter, H; Nitzan, D; Borojevic, A; Carr, Z; Grygaski, TJ; Jarosinska, D; Netanyahu, S; Schmoll, O; Stuetzle, K; Van Den Akker, A; Kluge, HHP				Racioppi, Francesca; Rutter, Harry; Nitzan, Dorit; Borojevic, Anja; Carr, Zhanat; Grygaski, Tanya Jean; Jarosinska, Dorota; Netanyahu, Sinaia; Schmoll, Oliver; Stuetzle, Karien; Van Den Akker, Amber; Kluge, Hans Henri P.			The impact of war on the environment and health: implications for readiness, response, and recovery in Ukraine	LANCET			English	Editorial Material									[Racioppi, Francesca; Jarosinska, Dorota; Netanyahu, Sinaia; Schmoll, Oliver] World Hlth Org, European Ctr Environm & Hlth, D-53113 Bonn, Germany; [Nitzan, Dorit; Borojevic, Anja; Stuetzle, Karien; Kluge, Hans Henri P.] World Hlth Org, Reg Off Europe, Copenhagen, Denmark; [Carr, Zhanat] World Hlth Org, Geneva, Switzerland; [Rutter, Harry; Van Den Akker, Amber] Univ Bath, Bath, England; [Grygaski, Tanya Jean] United Nations Off Coordinat Humanitarian Affairs, Kiev, Ukraine; [Stuetzle, Karien] World Hlth Org, Country Off Ukraine, Kiev, Ukraine	World Health Organization; World Health Organization; World Health Organization; University of Bath; World Health Organization	Racioppi, F (corresponding author), World Hlth Org, European Ctr Environm & Hlth, D-53113 Bonn, Germany.	racioppif@who.int		Nitzan, Dorit/0000-0002-4280-2939; Rutter, Harry/0000-0002-9322-0656				Averin D, 2022, GREEN EUROPEAN J; Hook K, 2022, B ATOM SCI; ICRC, 2015, URB SERV PROTR ARM C; International Atomic Energy Agency, 2022, NUCL SAF SEC UKR; MedAct, 2014, HLTH IMPACT ASSESSME; PAX, 2015, AM DEBR DESKT STUD E; Polonsky JA, 2022, INFECT DIS POVERTY, V11, DOI 10.1186/s40249-022-00935-7; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Sowers J, 2021, CURR HIST, V120, P339; UN, 2022, UN WAR UKR KEY INF; UN Ukraine, 2022, WAR HAS CAUS FAST LA; UNECE, 2007, ENV PERF REV; UNICEF, 2019, WAT FIR; Weinthal E, 2022, ENV HLTH DIMENSIONS; Weir D, 2022, CONFLICT ENV OBSERVA; WHO, 2022, TECHN HAZ HLTH RISKS; WHO, 2020, WHO MAN HLTH REC COV; WHO, 2022, 19 WHO; WHO, 2022, UKR CRIS STRAT RESP; WHO, 2021, EUR PROGR WORK 2020; WHO Pan -European Commission on Health and Sustainable Development, 2021, DRAW LIGHT PAND NEW; Zaliska O, 2022, LANCET, V399, P1450, DOI 10.1016/S0140-6736(22)00615-8	23	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					871	873						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116469	Green Submitted			2022-12-28	WOS:000890180700006
J	Peycheva, M; Neumann, T; Malzl, D; Nazarova, M; Schoeberl, UE; Pavri, R				Peycheva, Mihaela; Neumann, Tobias; Malzl, Daniel; Nazarova, Mariia; Schoeberl, Ursula E.; Pavri, Rushad			DNA replication timing directly regulates the frequency of oncogenic chromosomal translocations	SCIENCE			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; GENOME-SCALE ANALYSIS; B-CELL GENOME; C-MYC; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; DORMANT ORIGINS; EXCESS MCM2-7; START SITES	Chromosomal translocations result from the joining of DNA double-strand breaks (DSBs) and frequently cause cancer. However, the steps linking DSB formation to DSB ligation remain undeciphered. We report that DNA replication timing (RT) directly regulates lymphomagenic Myc translocations during antibody maturation in B cells downstream of DSBs and independently of DSB frequency. Depletion of minichromosome maintenance complexes alters replication origin activity, decreases translocations, and deregulates global RT. Ablating a single origin at Myc causes an early-to-late RT switch, loss of translocations, and reduced proximity with the immunoglobulin heavy chain (Igh) gene, its major translocation partner. These phenotypes were reversed by restoring early RT. Disruption of early RT also reduced tumorigenic translocations in human leukemic cells. Thus, RT constitutes a general mechanism in translocation biogenesis linking DSB formation to DSB ligation.	[Peycheva, Mihaela; Neumann, Tobias; Malzl, Daniel; Nazarova, Mariia; Schoeberl, Ursula E.; Pavri, Rushad] Vienna Bioctr, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Neumann, Tobias] Univ Vienna, Doctoral Sch, Vienna BioCtr PhD Program, A-1030 Vienna, Austria; [Neumann, Tobias] Med Univ Vienna, Vienna Bioctr, A-1030 Vienna, Austria; [Neumann, Tobias] Vienna Bioctr, Quantro Therapeut, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Medical University of Vienna; Vienna Biocenter (VBC); Vienna Biocenter (VBC)	Pavri, R (corresponding author), Vienna Bioctr, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	rushad.pavri@imp.ac.at		Nazarova, Mariia/0000-0001-5293-4161; Peycheva, Mihaela/0000-0001-9268-0637; Malzl, Daniel/0000-0001-5765-6375; Neumann, Tobias/0000-0003-3908-4224; Pavri, Rushad/0000-0002-6191-6333	Boehringer Ingelheim; Austrian Industrial Research Promotion Agency [FFG-834223]; Austrian Science Fund [FWF P 29163-B26]	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Industrial Research Promotion Agency; Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by Boehringer Ingelheim, the Austrian Industrial Research Promotion Agency (headquarter grant FFG-834223), and the Austrian Science Fund (grant FWF P 29163-B26 to R.P.).	Akerman I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18527-0; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Casellas R, 2016, NAT REV IMMUNOL, V16, P164, DOI 10.1038/nri.2016.2; Cayrou C, 2015, GENOME RES, V25, P1873, DOI 10.1101/gr.192799.115; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chong SS, 2022, MOL CELL, V82, P2084, DOI 10.1016/j.molcel.2022.04.007; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Comoglio F, 2015, CELL REP, V11, P821, DOI 10.1016/j.celrep.2015.03.070; Courtot L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094959; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Du Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08302-1; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Fu H., 2014, CURR PROTOC CELL BIO, V65, P17, DOI [10.1002/0471143030.cb2220-65, DOI 10.1002/0471143030.CB2220-65]; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; Hu JZ, 2016, NAT PROTOC, V11, P853, DOI 10.1038/nprot.2016.043; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jankovic M, 2013, MOL CELL, V49, P623, DOI 10.1016/j.molcel.2012.11.029; Janoueix-Lerosey I, 2005, CELL CYCLE, V4, P1842, DOI 10.4161/cc.4.12.2257; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lombrana R, 2013, EMBO J, V32, P2631, DOI 10.1038/emboj.2013.195; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Marchal C, 2019, NAT REV MOL CELL BIO, V20, P721, DOI 10.1038/s41580-019-0162-y; Marchal C, 2018, NAT PROTOC, V13, P819, DOI 10.1038/nprot.2017.148; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Panchaksharia RA, 2018, P NATL ACAD SCI USA, V115, P762, DOI 10.1073/pnas.1719988115; Parker MW, 2019, ELIFE, V8, DOI 10.7554/eLife.48562; Pasqualucci L, 2000, CANCER RES, V60, P5644; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rocha PP, 2012, MOL CELL, V47, P873, DOI 10.1016/j.molcel.2012.06.036; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shugay M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002797; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Stavnezer J, 2014, J IMMUNOL, V193, P5370, DOI 10.4049/jimmunol.1401849; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wiedemann EM, 2016, CELL REP, V17, P2927, DOI 10.1016/j.celrep.2016.11.041; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	71	0	0	4	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1277	+	eabj5502	10.1126/science.abj5502	http://dx.doi.org/10.1126/science.abj5502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108018	Green Submitted			2022-12-28	WOS:000887933500001
J	Fenner, A				Fenner, Annette			Armoured immunotherapy	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S32	S32		10.1038/d41586-022-02857-8	http://dx.doi.org/10.1038/d41586-022-02857-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104418	Bronze			2022-12-28	WOS:000855141600002
J	Wise, J				Wise, Jacqui			Covid-19: WHO urges action as 17 million long covid cases are estimated in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Antonelli Michela, 2022, Lancet, V399, P2263, DOI 10.1016/S0140-6736(22)00941-2; Ballering AV, 2022, LANCET, V400, P61; Mahase Elisabeth, 2022, BMJ, V378, po1946, DOI 10.1136/bmj.o1946; Wise J, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o1500	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								o2232	10.1136/bmj.o2232	http://dx.doi.org/10.1136/bmj.o2232			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104031	Bronze			2022-12-28	WOS:000862323900015
J	Coemans, M; Verbeke, G; Dohler, B; Susal, C; Naesens, M				Coemans, Maarten; Verbeke, Geert; Doehler, Bernd; Suesal, Caner; Naesens, Maarten			Bias by censoring for competing events in survival analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISKS METHODS; MODELS	In survival analysis, competing events preclude the occurrence of the event of interest. The censoring of competing events is common in medical studies but leads to biased cumulative incidence estimators. Competing risks methods, such as the non-parametric Aalen-Johansen method or the semi -parametric Fine and Gray model, alleviate this bias and should be preferred above the Kaplan-Meier method and the Cox model, respectively. As an illustrative example, in a large European cohort, we report on the differences in the cumulative incidence estimates of graft failure after kidney transplantation, caused by censoring for recipient death.	[Coemans, Maarten; Naesens, Maarten] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Coemans, Maarten] Katholieke Univ Leuven, Leuven Biostat & Stat Bioinformat Ctr L Biostat, Leuven, Belgium; [Verbeke, Geert] Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat I Biost, Hasselt, Belgium; [Verbeke, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Doehler, Bernd; Suesal, Caner] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Suesal, Caner] Koc Univ, Transplant Immunol Res Ctr Excellence, Istanbul, Turkey; [Naesens, Maarten] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Leuven, Belgium	KU Leuven; KU Leuven; Hasselt University; KU Leuven; Ruprecht Karls University Heidelberg; Koc University; KU Leuven; University Hospital Leuven	Naesens, M (corresponding author), Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.	maarten.naesens@kuleuven.be	Verbeke, Geert/I-5587-2015; Naesens, Maarten/J-4766-2015	Verbeke, Geert/0000-0001-8430-7576; Susal, Caner/0000-0003-2521-8201; Naesens, Maarten/0000-0002-5625-0792	Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders); Applied Biomedical Research with a Primary Social Finality; Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders) [IWT.150199];  [1844019N]	Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders)(FWO); Applied Biomedical Research with a Primary Social Finality; Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders)(FWO); 	There was no specific funding provided for the study. MC had financial support from the Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders) and the Agency for Innovation and Entrepreneurship by an "Applied Biomedical Research with a Primary Social Finality" project grant IWT.150199; MN is senior clinical investigator of the Fonds Wetenschappelijk Onderzoek (Research Foundation-Flanders) (grant 1844019N). The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis	AALEN OO, 1978, SCAND J STAT, V5, P141; Abdel-Qadir H, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004580; Austin PC, 2021, STAT MED, V40, P4200, DOI 10.1002/sim.9023; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Cole SR, 2020, AM J EPIDEMIOL, V189, P1408, DOI 10.1093/aje/kwaa086; COX DR, 1972, J R STAT SOC B, V34, P187; El Ters M, 2021, TRANSPLANTATION, V105, P668, DOI 10.1097/TP.0000000000003285; Geskus RB, 2015, DATA ANAL COMPETING, DOI [10.1201/b18695, DOI 10.1201/B18695]; Grambauer N, 2010, STAT MED, V29, P875, DOI 10.1002/sim.3786; Grunkemeier GL, 2007, ANN THORAC SURG, V83, P1586, DOI 10.1016/j.athoracsur.2006.11.044; Lee D, 2019, NEPHROLOGY, V24, P591, DOI 10.1111/nep.13548; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Mozumder SI, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01213-0; Naesens M, 2022, TRANSPL INT, V35, DOI 10.3389/ti.2022.10136; Neumann A, 2016, COMPUT METH PROG BIO, V129, P63, DOI 10.1016/j.cmpb.2016.03.008; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Opelz G, 2013, TRANSPLANT REV-ORLAN, V27, P43, DOI 10.1016/j.trre.2013.01.004; Poguntke I, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0535-5; Ravani P, 2019, J AM SOC NEPHROL, V30, P2219, DOI 10.1681/ASN.2019060640; Royston P, 2011, FLEXIBLE PARAMETRIC; Saleh RR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61093-0; Sutradhar R, 2018, ANN EPIDEMIOL, V28, P54, DOI 10.1016/j.annepidem.2017.10.014; van Geloven N, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2021-069249; van Walraven C, 2016, J CLIN EPIDEMIOL, V69, P170, DOI 10.1016/j.jclinepi.2015.07.006; Warnock DG, 2016, NEPHROL DIAL TRANSPL, V31, P1033, DOI 10.1093/ndt/gfv455; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060	29	0	0	6	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								e071349	10.1136/bmj-2022-071349	http://dx.doi.org/10.1136/bmj-2022-071349			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100269	Bronze			2022-12-28	WOS:000860470700004
J	Tan, CY; Chiew, CJ; Lee, VJ; Ong, B; Lye, DC; Tan, KB				Tan, Celine Y.; Chiew, Calvin J.; Lee, Vernon J.; Ong, Benjamin; Lye, David Chien; Tan, Kelvin Bryan			Effectiveness of a Fourth Dose of COVID-19 mRNA Vaccine Against Omicron Variant Among Elderly People in Singapore	ANNALS OF INTERNAL MEDICINE			English	Letter; Early Access									[Tan, Celine Y.; Chiew, Calvin J.; Lee, Vernon J.; Ong, Benjamin; Tan, Kelvin Bryan] Minist Hlth, Singapore, Singapore; [Chiew, Calvin J.] Natl Ctr Infect Dis, Singapore, Singapore; [Lee, Vernon J.; Tan, Kelvin Bryan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Ong, Benjamin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Lye, David Chien] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Ctr Infect Dis, Singapore, Singapore; [Lye, David Chien] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Lye, David Chien] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore	Ministry of Health-Singapore; National Centre for Infectious Diseases Singapore; National University of Singapore; National University of Singapore; National Centre for Infectious Diseases Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital	Tan, CY (corresponding author), Minist Hlth, Communicable Dis Div, 12 Coll Rd, Singapore 169852, Singapore.	celine_ys_tan@moh.gov.sg		Tan, Celine/0000-0001-8799-7031; Lye, David/0000-0003-0324-0205; Chiew, Calvin J/0000-0002-8217-7971				Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]; Bar-On YM, 2022, NEW ENGL J MED, V386, P1712, DOI 10.1056/NEJMoa2201570; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Gazit S, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2022-071113; Ioannou GN, 2022, ANN INTERN MED, V175, P352, DOI 10.7326/M21-3256; Magen O, 2022, NEW ENGL J MED, V386, P1603, DOI 10.1056/NEJMoa2201688	6	0	0	5	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/M22-2042	http://dx.doi.org/10.7326/M22-2042		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4R9WH	36095316	Green Published			2022-12-28	WOS:000857104100006
J	Broughton, JM; Codding, BF; Faith, JT; Mohlenhoff, KA; Gruhn, R; Brenner-Coltrain, J; Hart, IA				Broughton, Jack M.; Codding, Brian F.; Faith, J. Tyler; Mohlenhoff, Kathryn A.; Gruhn, Ruth; Brenner-Coltrain, Joan; Hart, Isaac A.			El Nino frequency threshold controls coastal biotic communities	SCIENCE			English	Article							SOUTHERN OSCILLATION; DYNAMICS; DESERT	El Nino has profound influences on ecosystem dynamics. However, we know little about how it shapes vertebrate faunal community composition over centennial time scales, and this limits our ability to forecast change under projections of future El Nino events. On the basis of correlations between geological records of past El Nino frequency and the species composition of bird and fish remains from a Baja California bone deposit that spans the past 12,000 years, we documented marked faunal restructuring when major El Nino events occurred more than five times per century. This tipping point has implications for the past and future ecology of eastern Pacific coastal environments.	[Broughton, Jack M.; Codding, Brian F.; Faith, J. Tyler; Brenner-Coltrain, Joan; Hart, Isaac A.] Univ Utah, Department Anthropol, Salt Lake City, UT 84112 USA; [Broughton, Jack M.; Codding, Brian F.; Faith, J. Tyler; Brenner-Coltrain, Joan; Hart, Isaac A.] Univ Utah, Archaeol Ctr, Salt Lake City, UT 84112 USA; [Faith, J. Tyler] Nat Hist Museum Utah, Salt Lake City, UT USA; [Faith, J. Tyler] Univ Witwatersrand, Origins Ctr, Johannesburg, South Africa; [Mohlenhoff, Kathryn A.] Paleowest, Salt Lake City, UT USA; [Gruhn, Ruth] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Hart, Isaac A.] Univ Utah, Dept Geog, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Witwatersrand; University of Alberta; Utah System of Higher Education; University of Utah	Broughton, JM (corresponding author), Univ Utah, Department Anthropol, Salt Lake City, UT 84112 USA.; Broughton, JM (corresponding author), Univ Utah, Archaeol Ctr, Salt Lake City, UT 84112 USA.	jack.broughton@anthro.utah.edu		Faith, J. Tyler/0000-0002-1101-7161; Mohlenhoff, Kathryn/0000-0002-9912-6003; Coltrain, Joan/0000-0002-2461-5136; Hart, Isaac/0000-0002-9149-9307; Codding, Brian/0000-0001-7977-8568	National Science Foundation, Division of Behavioral and Cognitive Sciences, Archaeology [1624189]; University of Alberta	National Science Foundation, Division of Behavioral and Cognitive Sciences, Archaeology(National Science Foundation (NSF)); University of Alberta(University of Alberta)	This work was supported by the National Science Foundation, Division of Behavioral and Cognitive Sciences, Archaeology (grant 1624189 to J. M.B. and J.C.B.) and the University of Alberta (R.G.).	Ainley D. G., 1990, SEABIRDS FARALLON IS; Bertrand A, 2020, FAO FISHERIES AQUACU, DOI DOI 10.4060/CA8348EN; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Brown JH, 2002, BIOSCIENCE, V52, P979, DOI 10.1641/0006-3568(2002)052[0979:RARCDO]2.0.CO;2; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Elorriaga-Verplancken FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155034; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Fredriksen HB, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL090640; Gomez-Ocampo E., 2018, TOP STUD OCEANOGR, V151, P64; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Gruhn R., 2009, PAC COAST ARCHAEOL S, V42, P1; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hart IA, 2015, QUATERNARY RES, V84, P46, DOI 10.1016/j.yqres.2015.04.005; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Jenkins D. L., 2014, PALEOAMERICAN ODYSSE, P485; Jones TL, 2021, QUATERNARY SCI REV, V260, DOI 10.1016/j.quascirev.2021.106914; Kennett DJ, 2007, QUATERNARY SCI REV, V26, P351, DOI 10.1016/j.quascirev.2006.07.019; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; Lenton TM, 2013, ANNU REV ENV RESOUR, V38, P1, DOI 10.1146/annurev-environ-102511-084654; Liu ZY, 2014, NATURE, V515, P550, DOI 10.1038/nature13963; Marchitto TM, 2010, SCIENCE, V330, P1378, DOI 10.1126/science.1194887; Marshal JP, 2002, J WILDLIFE MANAGE, V66, P1283, DOI 10.2307/3802961; Martin P. S., 1967, P75; Meltzer DJ, 2020, P NATL ACAD SCI USA, V117, P28555, DOI 10.1073/pnas.2015032117; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Oro D, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00079; Sandweiss DH, 2020, P NATL ACAD SCI USA, V117, P8271, DOI 10.1073/pnas.1912242117; Shirasago-German B, 2015, ESTUAR COAST SHELF S, V154, P69, DOI 10.1016/j.ecss.2014.12.024; Terry RC, 2015, GEOLOGY, V43, P487, DOI 10.1130/G36483.1; Timmermann A, 2018, NATURE, V559, P535, DOI 10.1038/s41586-018-0252-6; White SM, 2018, GEOPHYS RES LETT, V45, P316, DOI 10.1002/2017GL075433; Wood S.N, 2017, GEN ADDITIVE MODELS	33	1	1	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1202	1205		10.1126/science.abm1033	http://dx.doi.org/10.1126/science.abm1033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074861				2022-12-28	WOS:000887933400043
J	Lyu, MZ; Suzuki, H; Kang, L; Gaspal, F; Zhou, WQ; Goc, J; Zhou, L; Zhou, J; Zhang, W; Shen, ZL; Fox, JG; Sockolow, RE; Laufer, TM; Fan, Y; Eberl, G; Withers, DR; Sonnenberg, GF				Lyu, Mengze; Suzuki, Hiroaki; Kang, Lan; Gaspal, Fabrina; Zhou, Wenqing; Goc, Jeremy; Zhou, Lei; Zhou, Jordan; Zhang, Wen; Shen, Zeli; Fox, James G.; Sockolow, Robbyn E.; Laufer, Terri M.; Fan, Yong; Eberl, Gerard; Withers, David R.; Sonnenberg, Gregory F.		JRI Live Cell Bank	ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut	NATURE			English	Article							INNATE LYMPHOID-CELLS; GROWTH-FACTOR-BETA; ROR-GAMMA-T; DENDRITIC CELLS; HOMEOSTASIS; DISTINCT; LINEAGE; POPULATION; INDUCE; TISSUE	Microbial colonization of the mammalian intestine elicits inflammatory or tolerogenic T cell responses, but the mechanisms controlling these distinct outcomes remain poorly understood, and accumulating evidence indicates that aberrant immunity to intestinal microbiota is causally associated with infectious, inflammatory and malignant diseases(1-8). Here we define a critical pathway controlling the fate of inflammatory versus tolerogenic T cells that respond to the microbiota and express the transcription factor ROR gamma t. We profiled all ROR gamma t(+) immune cells at single-cell resolution from the intestine-draining lymph nodes of mice and reveal a dominant presence of T regulatory (T-reg) cells and lymphoid tissue inducer-like group 3 innate lymphoid cells (ILC3s), which co-localize at interfollicular regions. These ILC3s are distinct from extrathymic AIRE-expressing cells, abundantly express major histocompatibility complex class II, and are necessary and sufficient to promote microbiota-specific ROR gamma t(+) T-reg cells and prevent their expansion as inflammatory T helper 17 cells. This occurs through ILC3-mediated antigen presentation, alpha V integrin and competition for interleukin-2. Finally, single-cell analyses suggest that interactions between ILC3s and ROR gamma t(+) T-reg cells are impaired in inflammatory bowel disease. Our results define a paradigm whereby ILC3s select for antigen-specific ROR gamma t(+) T-reg cells, and against T helper 17 cells, to establish immune tolerance to the microbiota and intestinal health.	[Lyu, Mengze; Suzuki, Hiroaki; Kang, Lan; Zhou, Wenqing; Goc, Jeremy; Zhou, Lei; Zhou, Jordan; Zhang, Wen; Sonnenberg, Gregory F.] Cornell Univ, Joan I Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Med, New York, NY 10021 USA; [Lyu, Mengze; Suzuki, Hiroaki; Kang, Lan; Zhou, Wenqing; Goc, Jeremy; Zhou, Lei; Zhou, Jordan; Zhang, Wen; Sonnenberg, Gregory F.] Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA; [Lyu, Mengze; Suzuki, Hiroaki; Kang, Lan; Zhou, Wenqing; Goc, Jeremy; Zhou, Lei; Zhou, Jordan; Zhang, Wen; Sonnenberg, Gregory F.] Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Gaspal, Fabrina; Withers, David R.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Shen, Zeli; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Sockolow, Robbyn E.] Cornell Univ, Weill Cornell Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, New York, NY 10021 USA; [Laufer, Terri M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Fan, Yong] Allegheny Hlth Network, Inst Cellular Therapeut, Pittsburgh, PA USA; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Suzuki, Hiroaki] EA Pharma, Kawasaki, Kanagawa, Japan	Cornell University; Cornell University; Cornell University; University of Birmingham; Massachusetts Institute of Technology (MIT); Cornell University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sonnenberg, GF (corresponding author), Cornell Univ, Joan I Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu	Lyu, Mengze/GXV-3779-2022	Zhang, Wen/0000-0002-9069-3773; Lyu, Mengze/0000-0002-8509-7969; Zhou, Wenqing/0000-0002-8800-3745; Kang, Lan/0000-0002-8643-9174	National Institutes of Health [R01AI143842, R01AI123368, R01AI145989, U01AI095608, R21CA249274, R01AI162936, R01CA274534]; Burroughs Wellcome Fund; Meyer Cancer Center Collaborative Research Initiative; Dalton Family Foundation; Linda and Glenn Greenberg; Crohn's and Colitis Foundation [831404, 519428, 608975, 901000]; Wellcome Trust [110199/Z/15/Z]; JRI; Jill Roberts Center for IBD, Cure for IBD; Rosanne H. Silbermann Foundation; Sanders Family and Weill Cornell Medicine Division of Pediatric Gastroenterology, Hepatology, and Nutrition;  [P30-ES002109];  [R35CA210088]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Meyer Cancer Center Collaborative Research Initiative; Dalton Family Foundation; Linda and Glenn Greenberg; Crohn's and Colitis Foundation; Wellcome Trust(Wellcome Trust); JRI; Jill Roberts Center for IBD, Cure for IBD; Rosanne H. Silbermann Foundation; Sanders Family and Weill Cornell Medicine Division of Pediatric Gastroenterology, Hepatology, and Nutrition; ; 	We thank members of the Sonnenberg Laboratory for discussions and critical reading of the manuscript. Research in the Sonnenberg Laboratory is supported by the National Institutes of Health (R01AI143842, R01AI123368, R01AI145989, U01AI095608, R21CA249274, R01AI162936 and R01CA274534), an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, the Meyer Cancer Center Collaborative Research Initiative, the Dalton Family Foundation and Linda and Glenn Greenberg. W.Zhou, J.G., L.Z. and W.Zhang are supported by fellowships from the Crohn's and Colitis Foundation (831404, 519428, 608975 and 901000, respectively). D.R.W. and F.G. are supported by a Senior Research Fellowship from the Wellcome Trust to D.R.W. (110199/Z/15/Z). J.G.F. is supported by P30-ES002109 and R35CA210088. G.F.S. is a CRI Lloyd J. Old STAR. We thank the Epigenomics Cores of Weill Cornell Medicine and G. Putzel for bioinformatics assistance, J. Conrad for administrative assistance, and S. Mozumder for technical assistance. The JRI IBD Live Cell Bank is supported by the JRI, the Jill Roberts Center for IBD, Cure for IBD, the Rosanne H. Silbermann Foundation, the Sanders Family and Weill Cornell Medicine Division of Pediatric Gastroenterology, Hepatology, and Nutrition.	Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boland BS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb4432; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cabeza-Cabrerizo M, 2021, ANNU REV IMMUNOL, V39, P131, DOI 10.1146/annurev-immunol-061020-053707; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dutton EE, 2020, METHODS MOL BIOL, V2121, P51, DOI 10.1007/978-1-0716-0338-3_5; Eberl G, 2017, MUCOSAL IMMUNOL, V10, P27, DOI 10.1038/mi.2016.86; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Goc J, 2021, CELL, V184, P5015, DOI 10.1016/j.cell.2021.07.029; Grigg JB, 2021, NATURE, V600, P707, DOI 10.1038/s41586-021-04136-4; Hadley Wickham, 2016, GGPLOT2 ELEGANT GRAP; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harrison OJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a018341; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Jaeger N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22164-6; Janney A, 2020, NATURE, V585, P509, DOI 10.1038/s41586-020-2729-3; Kim S, 2011, EUR J IMMUNOL, V41, P1563, DOI 10.1002/eji.201040915; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Popmihajlov Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00102; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russler-Germain EV, 2021, ELIFE, V10, DOI 10.7554/eLife.54792; Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Teng F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1215; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wells KL, 2020, ELIFE, V9, DOI 10.7554/eLife.60188; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Worthington JJ, 2011, GASTROENTEROLOGY, V141, P1802, DOI 10.1053/j.gastro.2011.06.057; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Zhou L, 2019, NATURE, V568, P405, DOI 10.1038/s41586-019-1082-x; Zhou L, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1605; Zhou WQ, 2022, NATURE, V609, P159, DOI 10.1038/s41586-022-04934-4	73	5	5	33	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					744	+		10.1038/s41586-022-05141-x	http://dx.doi.org/10.1038/s41586-022-05141-x		SEP 2022	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36071169	Green Submitted			2022-12-28	WOS:000851357500001
J	Kim, D; Yang, PS; You, SC; Jang, E; Yu, HT; Kim, TH; Pak, HN; Lee, MH; Lip, GYH; Sung, JH; Joung, B				Kim, Daehoon; Yang, Pil-Sung; You, Seng Chan; Jang, Eunsun; Yu, Hee Tae; Kim, Tae-Hoon; Pak, Hui-Nam; Lee, Moon-Hyoung; Lip, Gregory Y. H.; Sung, Jung-Hoon; Joung, Boyoung			Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients A Nationwide Propensity Score-Weighted Study	ANNALS OF INTERNAL MEDICINE			English	Article							CATHETER ABLATION; EVENTS; TRIAL	Background: Rhythm control is associated with lower risk for adverse cardiovascular outcomes compared with usual care among patients recently diagnosed with atrial fibrillation (AF) with a CHA2DS2-VASc score of approximately 2 or greater in EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial). Objective: To investigate whether the results can be generalized to patients with low stroke risk. Design: Population-based cohort study. Setting: Nationwide claims database of the Korean National Health Insurance Service. Participants: 54 216 patients with AF having early rhythm control (antiarrhythmic drugs or ablation) or rate control therapy that was initiated within 1 year of the AF diagnosis. Measurements: The effect of early rhythm control on the primary composite outcome of cardiovascular death, ischemic stroke, hospitalization for heart failure, or myocardial infarction was compared between eligible and ineligible patients for EAST-AFNET 4 (CHA2DS2-VASc score, approximately 0 to 1) using propensity overlap weighting. Results: In total, 37 557 study participants (69.3%) were eligible for the trial (median age, 70 years; median CHA2DS2-VASc score, 4), among whom early rhythm control was associated with lower risk for the primary composite outcome than rate control (hazard ratio, 0.86 [95% CI, 0.81 to 0.92]). Among the 16 659 low-risk patients (30.7%) who did not meet the inclusion criteria (median age, 54 years; median CHA2DS2-VASc score, 1), early rhythm control was consistently associated with lower risk for the primary outcome (hazard ratio, 0.81 [CI, 0.66 to 0.98]). No significant differences in safety outcomes were found between the rhythm and rate control strategies regardless of trial eligibility. Limitation: Residual confounding. Conclusion: In routine clinical practice, the beneficial association between early rhythm control and cardiovascular complications was consistent among low-risk patients regardless of trial eligibility. Primary Funding Source: The Ministry of Health and Welfare and the Ministry of Food and Drug Safety, Republic of Korea.	[Kim, Daehoon; Jang, Eunsun; Yu, Hee Tae; Kim, Tae-Hoon; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Severance Cardiovasc Hosp, Dept Internal Med, Div Cardiol,Coll Med, Seoul, South Korea; [Yang, Pil-Sung; Sung, Jung-Hoon] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Seongnam, South Korea; [You, Seng Chan] Yonsei Univ, Dept Biomed Syst Informat, Coll Med, Seoul, South Korea; [Lip, Gregory Y. H.] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England; [Lip, Gregory Y. H.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; University of Liverpool; Liverpool Heart & Chest Hospital	Joung, B (corresponding author), 50-1 Yonsei Ro, Seoul 03722, South Korea.; Sung, JH (corresponding author), 59 Yatap Ro, Seongnam 13496, Gyeonggi Do, South Korea.	atropin5@cha.ac.kr; cby6908@yuhs.ac		Kim, Daehoon/0000-0002-9736-450X	Patient-Centered Clinical Research Coordinating Center - Ministry of Health and Welfare, Republic of Korea [HC19C0130]; Ministry of Food and Drug Safety, Republic of Korea [22213MFDS486]	Patient-Centered Clinical Research Coordinating Center - Ministry of Health and Welfare, Republic of Korea; Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	By grant HC19C0130 from the Patient-Centered Clinical Research Coordinating Center funded by the Ministry of Health and Welfare, Republic of Korea, and by grant 22213MFDS486 from the Ministry of Food and Drug Safety, Republic of Korea.	Andrade JG, 2021, NEW ENGL J MED, V384, P305, DOI 10.1056/NEJMoa2029980; Camm AJ, 2016, EUR HEART J, V37, P1145, DOI 10.1093/eurheartj/ehv466; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Desai RJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5657; Eisen A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006035; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hindricks G, 2021, EUR HEART J, V42, P373, DOI [10.1093/eurheartj/ehaa612, 10.15829/1560-4071-2021-4701]; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kim D, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n991; Kirchhof P, 2020, NEW ENGL J MED, V383, P1305, DOI 10.1056/NEJMoa2019422; Kotecha D, 2020, JAMA-J AM MED ASSOC, V324, P2497, DOI 10.1001/jama.2020.23138; Lee SS, 2017, EUR HEART J, V38, P2599, DOI 10.1093/eurheartj/ehx316; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Mark DB, 2019, JAMA-J AM MED ASSOC, V321, P1275, DOI 10.1001/jama.2019.0692; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Washam JB, 2015, LANCET, V385, P2363, DOI 10.1016/S0140-6736(14)61836-5; Wazni OM, 2021, NEW ENGL J MED, V384, P316, DOI 10.1056/NEJMoa2029554; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Willems S, 2022, EUR HEART J, V43, P1219, DOI 10.1093/eurheartj/ehab593; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; You SC, 2020, JAMA-J AM MED ASSOC, V324, P1640, DOI 10.1001/jama.2020.16167	26	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1356	+		10.7326/M21-4798	http://dx.doi.org/10.7326/M21-4798		SEP 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36063552				2022-12-28	WOS:000868458800003
J	Thornton, J				Thornton, Jacqui			New centre for pandemic therapeutics A new Global Centre for Pandemic Therapeutics aims to accelerate the development of drugs thanks to an "astounding" AUS$250 million gift. Jacqui Thornton reports	LANCET			English	Editorial Material															National Science Foundation; CBET Catalysis Program [NSF CBET-2102238]; Oklahoma Center for the Advancement of Science and Technology [HR18-093]; National Science Foundation [1707008]	National Science Foundation(National Science Foundation (NSF)); CBET Catalysis Program; Oklahoma Center for the Advancement of Science and Technology; National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge Dr. M.A.'s awarded funding from the National Science Foundation, CBET Catalysis Program under Grant No. NSF CBET-2102238. The authors also acknowledge funding from the Oklahoma Center for the Advancement of Science and Technology under Project Number HR18-093. Dr. A.K.K. acknowledges National Science Foundation Award # 1707008. Some of the TEM images were acquired at the Oklahoma State University (OSU) Microscopy Laboratory. The authors thank Dr. James Puckette for helping them with using the XRD facility at the Noble Research Center, Oklahoma State University.		0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					722	722						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058214	Bronze, Green Published			2022-12-28	WOS:000860483700009
J	Wenzl, FA; Kraler, S; Ambler, G; Weston, C; Herzog, SA; Raber, L; Muller, O; Camici, GG; Roffi, M; Rickli, H; Fox, KAA; de Belder, M; Radovanovic, D; Deanfield, J; Luscher, TF				Wenzl, Florian A.; Kraler, Simon; Ambler, Gareth; Weston, Clive; Herzog, Sereina A.; Raber, Lorenz; Muller, Olivier; Camici, Giovanni G.; Roffi, Marco; Rickli, Hans; Fox, Keith A. A.; de Belder, Mark; Radovanovic, Dragana; Deanfield, John; Luscher, Thomas F.			Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; DELAYED INVASIVE INTERVENTION; PREDICTION; MANAGEMENT; IMMEDIATE; MEDICINE; OUTCOMES; SWEDEN; TRENDS	Background The Global Registry of Acute Coronary Events (GRACE) 2.0 score was developed and validated in predominantly male patient populations. We aimed to assess its sex-specific performance in non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and to develop an improved score (GRACE 3.0) that accounts for sex differences in disease characteristics. Methods We evaluated the GRACE 2.0 score in 420 781 consecutive patients with NSTE-ACS in contemporary nationwide cohorts from the UK and Switzerland. Machine learning models to predict in-hospital mortality were informed by the GRACE variables and developed in sex-disaggregated data from 386 591 patients from England, Wales, and Northern Ireland (split into a training cohort of 309 083 [80middot0%] patients and a validation cohort of 77 508 [20middot0%] patients). External validation of the GRACE 3.0 score was done in 20 727 patients from Switzerland. Findings Between Jan 1, 2005, and Aug 27, 2020, 400 054 patients with NSTE-ACS in the UK and 20 727 patients with NSTE-ACS in Switzerland were included in the study. Discrimination of in-hospital death by the GRACE 2.0 score was good in male patients (area under the receiver operating characteristic curve [AUC] 0middot86, 95% CI 0middot86-0middot86) and notably lower in female patients (0middot82, 95% CI 0middot81-0middot82; p < 0middot0001). The GRACE 2.0 score underestimated in-hospital mortality risk in female patients, favouring their incorrect stratification to the low-to-intermediate risk group, for which the score does not indicate early invasive treatment. Accounting for sex differences, GRACE 3.0 showed superior discrimination and good calibration with an AUC of 0middot91 (95% CI 0middot89-0middot92) in male patients and 0middot87 (95% CI 0middot84-0middot89) in female patients in an external cohort validation. GRACE 3middot0 led to a clinically relevant reclassification of female patients to the high-risk group. Interpretation The GRACE 2.0 score has limited discriminatory performance and underestimates in-hospital mortality in female patients with NSTE-ACS. The GRACE 3.0 score performs better in men and women and reduces sex inequalities in risk stratification. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Wenzl, Florian A.; Kraler, Simon; Camici, Giovanni G.; Luscher, Thomas F.] Univ Zurich, Ctr Mol Cardiol, Schlieren, Switzerland; [Camici, Giovanni G.] Univ Hosp Zurich, Dept Res & Educ, Zurich, Switzerland; [Ambler, Gareth] UCL, Dept Stat Sci, London, England; [Deanfield, John] UCL, Inst Cardiovasc Sci, London, England; [Weston, Clive] Glangwili Gen Hosp, Carmarthen, Wales; [Herzog, Sereina A.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Raber, Lorenz] Univ Bern, Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland; [Muller, Olivier] Univ Lausanne, Univ Hosp Lausanne, Dept Cardiol, Lausanne, Switzerland; [Roffi, Marco] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland; [Rickli, Hans] Kantonsspital St Gallen, Cardiol Div, St Gallen, Switzerland; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Scotland; [de Belder, Mark] Barts Hlth NHS Trust, Natl Inst Cardiovasc Outcomes Res, London, England; [Radovanovic, Dragana] Univ Zurich, Epidemiol Biostat & Prevent Inst, AMIS Plus Data Ctr, Zurich, Switzerland; [Luscher, Thomas F.] Royal Brompton & Harefield Hosp, London, England; [Luscher, Thomas F.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Luscher, Thomas F.] Kings Coll London, Sch Cardiovasc Med & Sci, London, England	University of Zurich; University Zurich Hospital; University of London; University College London; University of London; University College London; Medical University of Graz; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Kantonsspital St. Gallen; University of Edinburgh; Barts Health NHS Trust; University of Zurich; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; Imperial College London; University of London; King's College London	Luscher, TF (corresponding author), Royal Brompton & Harefield Hosp, London SW3 6NP, England.	cardio@tomluescher.ch		Kraler, Simon/0000-0002-8245-7287; Wenzl, Florian A./0000-0001-6654-9918	Swiss Heart Foundation; Abbot AG, in Switzerland; Amgen AG, in Switzerland; Bayer (Schweiz) AG, in Switzerland; Biotronik AG, in Switzerland; B Braun Medical AG, in Switzerland; Cordis Cardinal Health GmbH; Medtronic AG; Novartis Pharma Schweiz AG; Sanofi-Aventis (Schweiz) AG; Boston Scientific AG, in Switzerland; Swiss Working Group for Interventional Cardiology; Daiichi-Sankyo/Lilly AG, in Switzerland; Swiss National Science Foundation [SPUM 33CM30-124112, 32473B_163271]; SIS Medical AG, in Switzerland; Vascular Medical GmbH, in Switzerland; Roche Diagnostics (Boehringer Mannheim; Indianapolis, IN, USA); Eli Lilly (Indianapolis, IN, USA); AstraZeneca (Baar, Switzerland); Medtronic (Mnchenbuchsee, Switzerland); Merck Sharpe and Dohme (Lucerne, Switzerland); Sanofi-Aventis (Vernier, Switzerland); St Jude Medical AG (Zurich, Switzerland); Foundation for Cardiovascular Research-Zurich Heart House (through FAW, SK, GGC, and TFL); Lindenhofstiftung (through TFL and SK); Theodor Ida Herzog-Egli Stiftung (through SK)	Swiss Heart Foundation; Abbot AG, in Switzerland; Amgen AG, in Switzerland(Amgen); Bayer (Schweiz) AG, in Switzerland; Biotronik AG, in Switzerland; B Braun Medical AG, in Switzerland; Cordis Cardinal Health GmbH; Medtronic AG(Medtronic); Novartis Pharma Schweiz AG; Sanofi-Aventis (Schweiz) AG(Sanofi-Aventis); Boston Scientific AG, in Switzerland; Swiss Working Group for Interventional Cardiology; Daiichi-Sankyo/Lilly AG, in Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SIS Medical AG, in Switzerland; Vascular Medical GmbH, in Switzerland; Roche Diagnostics (Boehringer Mannheim; Indianapolis, IN, USA); Eli Lilly (Indianapolis, IN, USA)(Eli Lilly); AstraZeneca (Baar, Switzerland); Medtronic (Mnchenbuchsee, Switzerland); Merck Sharpe and Dohme (Lucerne, Switzerland); Sanofi-Aventis (Vernier, Switzerland); St Jude Medical AG (Zurich, Switzerland); Foundation for Cardiovascular Research-Zurich Heart House (through FAW, SK, GGC, and TFL); Lindenhofstiftung (through TFL and SK); Theodor Ida Herzog-Egli Stiftung (through SK)	The AMIS Plus registry is funded by unrestricted grants from the Swiss Heart Foundation and from Abbot AG, Amgen AG, AstraZeneca AG, Bayer (Schweiz) AG, Biotronik AG, Boston Scientific AG, B Braun Medical AG, Daiichi-Sankyo/Lilly AG, Cordis Cardinal Health GmbH, Medtronic AG, Novartis Pharma Schweiz AG, Sanofi-Aventis (Schweiz) AG, SIS Medical AG, Terumo AG, and Vascular Medical GmbH, all in Switzerland, and the Swiss Working Group for Interventional Cardiology. The SPUM-ACS registry is primarily supported by the Swiss National Science Foundation (SPUM 33CM30-124112 and 32473B_163271) and the Swiss Heart Foundation (through TFL) . Additional support for the SPUM-ACS registry was received from Roche Diagnostics (Boehringer Mannheim; Indianapolis, IN, USA) , Eli Lilly (Indianapolis, IN, USA) , AstraZeneca (Baar, Switzerland) , Medtronic (Mnchenbuchsee, Switzerland) , Merck Sharpe and Dohme (Lucerne, Switzerland) , Sanofi-Aventis (Vernier, Switzerland) , and St Jude Medical AG (Zurich, Switzerland) . This work was further supported by the Foundation for Cardiovascular Research-Zurich Heart House (through FAW, SK, GGC, and TFL) , the Lindenhofstiftung (through TFL and SK) , and the Theodor Ida Herzog-Egli Stiftung (through SK) . We gratefully acknowledge the invaluable contribution of all health-care professionals who participate in the conduct of the national registries this study is based on. We further express our gratitude towards all administrative personnel and IT personnel involved in data entry and management. Finally, we are grateful to the Epidemiology, Biostatistics and Prevention Institute (University of Zurich, Zurich, Switzerland) for the productive discussions.	Alabas OA, 2020, CARDIOVASC RES, V116, P149, DOI 10.1093/cvr/cvz197; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Badings EA, 2013, EUROINTERVENTION, V9, P54, DOI 10.4244/EIJV9I1A9; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Blom MT, 2019, EUR HEART J, V40, P3824, DOI 10.1093/eurheartj/ehz297; Champney KP, 2009, HEART, V95, P895, DOI 10.1136/hrt.2008.155804; Chen T., 2016, XGBOOST 22 ACM SIGKD; Chung SC, 2014, LANCET, V383, P1305, DOI 10.1016/S0140-6736(13)62070-X; Collet JP, 2021, EUR HEART J, V42, P1289, DOI 10.1093/eurheartj/ehaa575; D'Ascenzo F, 2021, LANCET, V397, P199, DOI 10.1016/S0140-6736(20)32519-8; de-Miguel-Balsa E, 2017, J WOMENS HEALTH, V26, P420, DOI 10.1089/jwh.2016.5940; Du Bois D, 1989, Nutrition, V5, P303; Faghri F, 2022, LANCET DIGIT HEALTH, V4, pE359, DOI 10.1016/S2589-7500(21)00274-0; Fox KAA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004425; Gong IY, 2017, INT J CARDIOL, V244, P24, DOI 10.1016/j.ijcard.2017.06.055; Gupta A, 2014, J AM COLL CARDIOL, V64, P337, DOI 10.1016/j.jacc.2014.04.054; Gupta T, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.005735; Haider A, 2020, EUR HEART J, V41, P1328, DOI 10.1093/eurheartj/ehz898; Hao YC, 2019, CIRCULATION, V139, P1776, DOI 10.1161/CIRCULATIONAHA.118.037655; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8; Hung J, 2021, EUR HEART J, V42, P2552, DOI 10.1093/eurheartj/ehaa375; Jobs A, 2017, LANCET, V390, P737, DOI 10.1016/S0140-6736(17)31490-3; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Katki HA, 2018, ANN INTERN MED, V169, P10, DOI [10.7326/M17-2701, 10.7326/m17-2701]; Kofoed KF, 2018, CIRCULATION, V138, P2741, DOI 10.1161/CIRCULATIONAHA.118.037152; Kraler S, 2022, EUR HEART J, V43, P1849, DOI 10.1093/eurheartj/ehac143; Laaksonen R, 2016, EUR HEART J, V37, P1967, DOI 10.1093/eurheartj/ehw148; Lee C, 2021, LANCET DIGIT HEALTH, V3, pE158, DOI 10.1016/S2589-7500(20)30314-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McNamara RL, 2014, INT J CARDIOL, V175, P240, DOI 10.1016/j.ijcard.2014.04.270; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Milosevic A, 2016, JACC-CARDIOVASC INTE, V9, P541, DOI 10.1016/j.jcin.2015.11.018; Mody P, 2021, CIRCULATION, V143, P641, DOI 10.1161/CIRCULATIONAHA.120.050427; Moledina SM, 2022, EUR HEART J, V43, P2289, DOI 10.1093/eurheartj/ehac052; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schoenenberger AW, 2016, EUR HEART J, V37, P1304, DOI 10.1093/eurheartj/ehv698; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418; van Loo HM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0242-y; Wilkinson C, 2019, HEART, V105, P516, DOI 10.1136/heartjnl-2018-313959; Yadaw AS, 2020, LANCET DIGIT HEALTH, V2, pE516, DOI 10.1016/S2589-7500(20)30217-X	43	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					744	756		10.1016/S0140-6736(22)01483-0	http://dx.doi.org/10.1016/S0140-6736(22)01483-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36049493	Green Published, hybrid			2022-12-28	WOS:000860483700017
J	Marra, CM; Rohatgi, S; Bloom, AK; Kahle, KT; Haj, AK				Marra, Christina M.; Rohatgi, Saurabh; Bloom, Allyson K.; Kahle, Kristopher T.; Haj, Amelia K.			Case 25-2022: A 25-Year-Old Woman with Headache and Blurred Vision	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANDIDAL MENINGITIS; HYDROCEPHALUS; SPECTRUM; MANIFESTATION; CANDIDIASIS		[Marra, Christina M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Rohatgi, Saurabh] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Bloom, Allyson K.] Harvard Med Sch, Dept Med, Boston, MA USA; [Kahle, Kristopher T.] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Bloom, Allyson K.; Haj, Amelia K.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Rohatgi, Saurabh] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Marra, CM (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.							Adada H, 2014, INT J TUBERC LUNG D, V18, P1516, DOI 10.5588/ijtld.14.0319; Anagnostou T, 2014, MEDICINE, V93, P19, DOI 10.1097/MD.0000000000000012; Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; Banerjee D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087246; Casado JL, 1997, CLIN INFECT DIS, V25, P673, DOI 10.1086/513746; Centers for Disease Control and Prevention, 2021, REP TUB US STAT 2020; Chaussade H, 2021, MED MYCOL, V59, P266, DOI 10.1093/mmy/myaa051; Chen TL, 2004, SCAND J INFECT DIS, V36, P124, DOI 10.1080/00365540310017573; Clancy CJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01909-17; Clardy SL, 2014, NEUROLOGY, V82, P1841, DOI 10.1212/WNL.0000000000000428; Dutra BG, 2018, RADIOGRAPHICS, V38, P169, DOI 10.1148/rg.2018170141; Hong SI, 2017, INFECT CHEMOTHER, V49, P123, DOI 10.3947/ic.2017.49.2.123; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Karimy JK, 2017, NAT MED, V23, P997, DOI 10.1038/nm.4361; Kulkarni AV, 2010, J NEUROSURG-PEDIATR, V6, P310, DOI 10.3171/2010.8.PEDS103; Narula N, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.594275; Nowak DA, 2001, J NEUROL, V248, P363, DOI 10.1007/s004150170175; Panackal AA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004884; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Peacock J E Jr, 1990, Infect Dis Clin North Am, V4, P747; PEACOCK JE, 1984, MEDICINE, V63, P379, DOI 10.1097/00005792-198411000-00004; RICHARDSON MD, 1991, MYCOSES, V34, P201, DOI 10.1111/j.1439-0507.1991.tb00644.x; Singh AK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1625-9; Thakur Kiran T, 2018, Continuum (Minneap Minn), V24, P1298, DOI 10.1212/CON.0000000000000664; VOICE RA, 1994, CLIN INFECT DIS, V19, P60, DOI 10.1093/clinids/19.1.60; Wang JY, 2013, MULT SCLER J, V19, P639, DOI 10.1177/1352458512459785; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	28	0	0	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2022	387	7					641	650		10.1056/NEJMcpc2201241	http://dx.doi.org/10.1056/NEJMcpc2201241		AUG 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4D8EB	36070713				2022-12-28	WOS:000883681200013
J	Tian, T; Hojman, H				Tian, Tina; Hojman, Horacio			Gallbladder Volvulus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Gallbladder Volvulus An 86-year-old woman presented with acute pain on the right side of her abdomen. Computed tomography revealed a distended gallbladder outside the gallbladder fossa and swirling of the cystic artery and duct.	[Tian, Tina; Hojman, Horacio] Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Tian, T (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.	ttian@tuftsmedicalcenter.org							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2022	387	7					640	640		10.1056/NEJMicm2118625	http://dx.doi.org/10.1056/NEJMicm2118625		AUG 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4D8EB	36070712				2022-12-28	WOS:000883681200012
J	Grossman, LA				Grossman, Lewis A.			Pushing Back with Pills - Enhancing Access to Reproductive Health Drugs after Dobbs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grossman, Lewis A.] American Univ, Washington Coll Law, Washington, DC 20016 USA	American University	Grossman, LA (corresponding author), American Univ, Washington Coll Law, Washington, DC 20016 USA.			Grossman, Lewis/0000-0001-6373-6419				Advancing New Standards in Reproductive Health, 2019, AN MED AB RISK FDA R; Aiken ARA, 2021, BJOG-INT J OBSTET GY, V128, P1464, DOI 10.1111/1471-0528.16668; Biggs MA, 2022, CONTRACEPTION, V109, P25, DOI 10.1016/j.contraception.2022.01.010; Cleland K., 2022, CONTRACEPTION; Jones RK., 2022, MED ABORTION NOW ACC	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1056	1058		10.1056/NEJMp2209377	http://dx.doi.org/10.1056/NEJMp2209377		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36121044				2022-12-28	WOS:000855978500001
J	Photopoulos, J				Photopoulos, Julianna			Let's talk about sex	NATURE			English	Editorial Material							PROSTATE-CANCER; MEN											Amarasekera C, 2019, J UROLOGY, V201, pE201; Gebert S., 2014, INT J UROLOG NURS, V8, P111, DOI [10.1111/ijun.12048, DOI 10.1111/IJUN.12048]; Nie I., 2020, J CLIN ENDOCR METAB, V105, pe3293, DOI [DOI 10.1210/clinem/dgaa341, 10.1210/clinem/dgaa412, DOI 10.1210/CLINEM/DGAA412]; Ralph S, 2021, CLIN ONCOL-UK, V33, P807, DOI 10.1016/j.clon.2021.07.010; Rosser BRS, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.812117; Rosser BRS, 2021, TRANSL ANDROL UROL, V10, P3208, DOI 10.21037/tau-20-1052; Ussher JM, 2017, ARCH SEX BEHAV, V46, P2043, DOI 10.1007/s10508-016-0728-0; Ussher JM, 2016, J SEX MED, V13, P425, DOI 10.1016/j.jsxm.2015.12.026; Wassersug RJ, 2013, UROLOGY, V82, P565, DOI 10.1016/j.urology.2013.04.022	9	0	0	56	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S48	S50		10.1038/d41586-022-02864-9	http://dx.doi.org/10.1038/d41586-022-02864-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104414	Bronze			2022-12-28	WOS:000855141600010
J	Sylwestrak, EL; Jo, Y; Vesuna, S; Wang, X; Holcomb, B; Tien, RH; Kim, DK; Fenno, L; Ramakrishnan, C; Allen, WE; Chen, R; Shenoy, KV; Sussillo, D; Deisseroth, K				Sylwestrak, Emily L.; Jo, YoungJu; Vesuna, Sam; Wang, Xiao; Holcomb, Blake; Tien, Rebecca H.; Kim, Doo Kyung; Fenno, Lief; Ramakrishnan, Charu; Allen, William E.; Chen, Ritchie; Shenoy, Krishna, V; Sussillo, David; Deisseroth, Karl			Cell-type-specific population dynamics of diverse reward computations	CELL			English	Article							REACTION-TIME-TASK; LATERAL HABENULA; DOPAMINE NEURONS; BEHAVIORAL STATE; GAUSSIAN-PROCESS; MEDIAL HABENULA; DISTINCT ROLES; BRAIN; NUCLEUS; INHIBITION	Computational analysis of cellular activity has developed largely independently of modern transcriptomic cell typology, but integrating these approaches may be essential for full insight into cellular-level mechanisms underlying brain function and dysfunction. Applying this approach to the habenula (a structure with diverse, intermingled molecular, anatomical, and computational features), we identified encoding of reward-predictive cues and reward outcomes in distinct genetically defined neural populations, including TH+ cells and Tac1(+) cells. Data from genetically targeted recordings were used to train an optimized nonlinear dynamical systems model and revealed activity dynamics consistent with a line attractor. High-density, cell-type-specific electrophysiological recordings and optogenetic perturbation provided supporting evidence for this model. Reverse-engineering predicted how Tac1(+) cells might integrate reward history, which was complemented by in vivo experimentation. This integrated approach describes a process by which data-driven computational models of population activity can generate and frame actionable hypotheses for cell-typespecific investigation in biological systems.	[Sylwestrak, Emily L.] Univ Oregon, Dept Biol, Eugene, OR 97403 USA; [Sylwestrak, Emily L.; Jo, YoungJu; Vesuna, Sam; Wang, Xiao; Tien, Rebecca H.; Kim, Doo Kyung; Fenno, Lief; Ramakrishnan, Charu; Allen, William E.; Chen, Ritchie; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Jo, YoungJu] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Vesuna, Sam; Fenno, Lief; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Sylwestrak, Emily L.; Holcomb, Blake] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Allen, William E.] Stanford Univ, Neurosci Interdept Program, Stanford, CA 94303 USA; [Shenoy, Krishna, V] Stanford Univ, Dept Neurobiol, Stanford, CA 94303 USA; [Shenoy, Krishna, V; Sussillo, David] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Shenoy, Krishna, V; Sussillo, David; Deisseroth, Karl] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Shenoy, Krishna, V; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Oregon; Stanford University; Stanford University; Stanford University; University of Oregon; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Sylwestrak, EL (corresponding author), Univ Oregon, Dept Biol, Eugene, OR 97403 USA.; Sylwestrak, EL; Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Sylwestrak, EL (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	emily@uoregon.edu; deissero@stanford.edu		Jo, YoungJu/0000-0002-2364-7160; Wang, Xiao/0000-0002-3090-9894; Kim, Doo Kyung/0000-0002-1181-3336; Sylwestrak, Emily/0000-0002-1172-6523; Tien, Rebecca/0000-0001-9590-953X	LIGHT-SPACE U19 of the NIH BRAIN initiative; NIMH; NIDA; NSF NeuroNex program; AE Foundation; BBRF; Bio-X Bowes Fellowship; Asan Foundation Biomedical Science Scholarship; Gatsby Foundation	LIGHT-SPACE U19 of the NIH BRAIN initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF NeuroNex program; AE Foundation; BBRF; Bio-X Bowes Fellowship; Asan Foundation Biomedical Science Scholarship; Gatsby Foundation	We thank Niles Pierce (Caltech) and Harry Choi (Molecular Technologies) for sharing HCR v3 probes and protocols with us; Tom Davidson for providing the initial code for processing photometry data; Yiming Chen for input; Dan O'Shea, Felicity Gore, Alex Attinger, and Jennifer Colonell (Janelia Research Campus) for electrophysiology advice; Ed Friedrich (New Scales Technologies) and Josh Siegle (Allen Institute) for sharing electrode mounts; Misha Raffiee for advice on light sheet imaging; Surya Ganguli for suggestions on modeling; and Deisseroth lab members for discussion. This work was supported by the LIGHT-SPACE U19 of the NIH BRAIN initiative (K.D., K.V.S., D.S.), NIMH (K.D.), NIDA (K.D.), the NSF NeuroNex program (K.D.), the AE and Gatsby Foundations (K.D.), BBRF (E.L.S.), the Bio-X Bowes Fellowship (Y.J.), and the Asan Foundation Biomedical Science Scholarship (Y.J.).	Ables JL, 2017, P NATL ACAD SCI USA, V114, P13012, DOI 10.1073/pnas.1717506114; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; Allen WE, 2019, SCIENCE, V364, P253, DOI 10.1126/science.aav3932; Andalman AS, 2019, CELL, V177, P970, DOI 10.1016/j.cell.2019.02.037; [Anonymous], SCIENCE, V372, DOI [10.1126/science.abf4588, DOI 10.1126/SCIENCE.ABF4588, 10.1126/science.1181675]; Barak O, 2013, PROG NEUROBIOL, V103, P214, DOI 10.1016/j.pneurobio.2013.02.002; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Bari Andrea, 2008, NAT PROTOC, V3, P759, DOI [DOI 10.1038/NPROT, 10.1038/nprot.2008.41, DOI 10.1038/NPROT.2008.41]; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bitra Venkata S.P., ATMOS ENVIRON, V106, P503, DOI [10.1016/j.biosystemseng.2010.05.016, DOI 10.1016/J.ATMOSENV.2017.04.029, 10.1016/J.MIB.2010.12.009, DOI 10.1016/J.BIORTECH.2010.05.094]; Boulos LJ, 2020, NEUROPSYCHOPHARMACOL, V45, P247, DOI 10.1038/s41386-019-0395-7; Boulos L. J., 2019, REP, V45, P247, DOI [10.1038/s41386-019-0395-7, DOI 10.1038/SREP45846, DOI https://doi.org/10.1038/srep39732]; Bromberg-Martin ES, 2011, NAT NEUROSCI, V14, P1209, DOI 10.1038/nn.2902; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Carrillo-Reid L, 2019, CELL, V178, P447, DOI 10.1016/j.cell.2019.05.045; Carter Stephen J., 2020, ADV THER-GERMANY, V28, P1176, DOI [10.1002/oby.22838, DOI 10.1002/ADTP.202000113, 10.1002/jrsm.5, DOI 10.1002/ACP.2350020209]; Chen R, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0679-9; Chen Ritchie, 2020, NAT BIOTECHNOL, V39, P161, DOI [DOI 10.1038/S41587-020-0581-5, 10.1038/s41587-020-0679-9, DOI 10.1038/S41587-020-0679-9]; Cho CH, 2020, EMBO REP, V21, DOI 10.15252/embr.201948097; Choi JH, 2021, ELIFE, V10, DOI [10.7554/eLife.72345, 10.7554/eLife.72345.sa0, 10.7554/eLife.72345.sa1, 10.7554/eLife.72345.sa2]; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; CONTESTABILE A, 1983, BRAIN RES, V275, P287, DOI 10.1016/0006-8993(83)90989-7; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Deisseroth K, 2017, EMBO REP, V18, P859, DOI 10.15252/embr.201744405; Diaz E, 2011, J COMP NEUROL, V519, P3727, DOI 10.1002/cne.22687; Diaz Eugenia, 2011, J COMP NEUROL, V519, P3727, DOI [DOI 10.1002/PROT.22687, 10.1002/cne.22687, DOI 10.1002/CNE.22687]; Fan LLZ, 2020, CELL, V180, P521, DOI 10.1016/j.cell.2020.01.001; Fenno LE, 2020, NEURON, V107, P836, DOI 10.1016/j.neuron.2020.06.003; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferreira J.G., EUR J MED CHEM, V426-427, P154, DOI [10.1016/j.aquaculture.2014.01.030, DOI 10.1016/J.EJMECH.2013.05.033]; Finkelstein A, 2021, NAT NEUROSCI, V24, P843, DOI 10.1038/s41593-021-00840-6; Finkelstein Arseny, 2021, NAT NEUROSCI, V24, P843, DOI [10.1038/s41593-021-00840-6, DOI 10.1038/S41593-021-00840-6]; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fuzesi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11937; HALLAM TG, 1981, BEHAV SCI, V26, P397, DOI 10.1002/bs.3830260412; Hashikawa Y, 2020, NEURON, V106, P743, DOI 10.1016/j.neuron.2020.03.011; Hattori R, 2019, CELL, V177, P1858, DOI 10.1016/j.cell.2019.04.027; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; Hong Simon, NEURON, V60, P720, DOI [10.1016/j.neuron.2008.09.035, DOI 10.1016/J.NEURON.2008.09.035, DOI 10.1016/J.BIOPSYCH.2008.09.035)]; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hsu Y.-W. A., 2013, J NEUROSCI, V33, P18022, DOI [10.1523/jneurosci.2927-13, DOI 10.1523/JNEUROSCI.3872-16, 10.1523/JNEUROSCI.4650-14, DOI 10.1523/JNEUROSCI.09-12-04355.1989]; Hsu Y.-W. A., 2014, J NEUROSCI, V34, P11366, DOI [10.1523/jneurosci.1861-14, DOI 10.1523/JNEUROSCI.1861-14]; Hsu YWA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0109-16.2016; Hsu YWA, 2014, J NEUROSCI, V34, P11366, DOI 10.1523/JNEUROSCI.1861-14.2014; Hsu YWA, 2013, J NEUROSCI, V33, P18022, DOI 10.1523/JNEUROSCI.2927-13.2013; Hwang EJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01356-z; Hyland John J., 2015, REV ENVIRON SCI BIO, V33, P323, DOI [10.1007/s10460-015-9608-9, DOI 10.1007/S11157-015-9363-9, 10.1038/s41420-021-00801-9, DOI https://doi.org/10.3390/met9010081]; Inagaki HK, 2019, NATURE, V566, P212, DOI 10.1038/s41586-019-0919-7; Jahangiri Mehdi, 2017, INT J PRECIS ENG MAN, V18, P1463, DOI [10.1007/s00737-011-0217-3, DOI 10.1007/978-3-030-27057-5, 10.1007/s12541-017-0174-5, DOI 10.1007/S12541-017-0174-5]; Jennings JH, 2019, NATURE, V565, P645, DOI 10.1038/s41586-018-0866-8; Kawai T, 2015, NEURON, V88, P792, DOI 10.1016/j.neuron.2015.09.030; Kebschull JM, 2020, SCIENCE, V370, DOI 10.1126/science.abd5059; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; Kim SS, 2017, SCIENCE, V356, P849, DOI 10.1126/science.aal4835; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kishi KE, 2022, CELL, V185, P672, DOI 10.1016/j.cell.2022.01.007; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Kohl J, 2018, NATURE, V556, P326, DOI 10.1038/s41586-018-0027-0; Kohl Johannes, 2018, NATURE, V556, P326, DOI [10.1038/s41586-018-0027-0, DOI 10.1038/S41586-018-0027-0, 10.1038/s41586-018-0686-x, DOI 10.1038/S41586-018-0088-0]; Konsman J. -P, 2001, PAXINOS FRANKLINS MO, P827; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lazaridis I, 2019, MOL PSYCHIATR, V24, P1351, DOI 10.1038/s41380-019-0369-5; Lazaridis Iakovos, 2019, MOL PSYCHIATR, V24, P1351, DOI [10.1038/s41380-019-0369-5, DOI 10.1038/S41380-019-0369-5]; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Liu LD, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0241-21.2021; Lovett-Barron M, 2020, NAT NEUROSCI, V23, P959, DOI 10.1038/s41593-020-0655-1; Lovett-Barron M, 2017, CELL, V171, P1411, DOI 10.1016/j.cell.2017.10.021; Lovett-Barron Matthew, 2020, NAT NEUROSCI, V23, P959, DOI [DOI 10.1038/S41593-020-00758-755, 10.1038/s41593-020-0655-1, DOI 10.1038/S41593-020-0655-1]; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Marshel JH, 2019, SCIENCE, V365, P558, DOI 10.1126/science.aaw5202; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mathuru Ajay S, 2013, Front Neural Circuits, V7, P99, DOI 10.3389/fncir.2013.00099; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mazzucato L, 2022, ELIFE, V11, DOI 10.7554/eLife.76577; McLaughlin I, 2017, J NEUROCHEM, V142, P130, DOI 10.1111/jnc.14008; Melani R, 2019, NEUROPSYCHOPHARMACOL, V44, P1828, DOI 10.1038/s41386-019-0396-6; Miri A, 2011, NAT NEUROSCI, V14, P1150, DOI 10.1038/nn.2888; Molas S, 2017, NAT NEUROSCI, V20, P1260, DOI 10.1038/nn.4607; Molas Susanna, 2017, NAT NEUROSCI, V20, P1260, DOI [10.1038/nn.4607, DOI 10.1038/NN.4607]; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Morcos AS, 2016, NAT NEUROSCI, V19, P1672, DOI 10.1038/nn.4403; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Morissette Marie-Claude, BEHAV BRAIN RES, V187, P17, DOI [10.1016/j.bbr.2007.08.021, DOI 10.1016/J.BBR.2007.08.021]; Morton G, 2018, J NEUROSCI, V38, P6900, DOI 10.1523/JNEUROSCI.0023-18.2018; Morton Glenn, 2018, J NEUROSCI, V38, P6900, DOI [DOI 10.1523/ENEURO.0265-18.2018, 10.1523/JNEUROSCI.0023-18, DOI 10.1523/JNEUROSCI.0023-18]; Namboodiri VMK, 2016, CURR BIOL, V26, pR873, DOI 10.1016/j.cub.2016.08.051; Ottenheimer D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06849-z; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Pandarinath C, 2018, J NEUROSCI, V38, P9390, DOI 10.1523/JNEUROSCI.1669-18.2018; Pandarinath C, 2018, NAT METHODS, V15, P805, DOI 10.1038/s41592-018-0109-9; Pandey S, 2018, CURR BIOL, V28, P1052, DOI 10.1016/j.cub.2018.02.040; Pang XY, 2016, NEUROPHARMACOLOGY, V107, P294, DOI 10.1016/j.neuropharm.2016.03.039; Pennekamp Frank, 2018, NATURE, V563, P109, DOI [DOI https://doi.org/10.1038/s41598-018-33723-1, 10.1038/s41586-018-0627-8, DOI 10.1038/S41586-018-0627-8]; Penteriani Vincenzo, 2016, NAT REV DRUG DISCOV, V6, DOI [DOI https://doi.org/10.1038/srep21762, 10.1038/SREP20552, DOI 10.1038/S41573-020-0068-6]; Piske Jacob Tyler, 2020, ARCH BIOCHEM BIOPHYS, V79, DOI [10.1007/s12665-020-08964-x, DOI 10.1016/0003-9861(61)90073-X]; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Prakash Rohit, 2012, NAT METHODS, V9, P1171, DOI [10.1038/nmeth.2215, DOI 10.1038/NMETH.3485]; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Quina LA, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0527-19.2020; Quina LA, 2015, J COMP NEUROL, V523, P32, DOI 10.1002/cne.23662; Remington ED, 2018, TRENDS COGN SCI, V22, P938, DOI 10.1016/j.tics.2018.07.010; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Roy NA, 2021, NEURON, V109, DOI 10.1016/j.neuron.2020.12.004; Sanchez-Roige S, 2012, PSYCHOPHARMACOLOGY, V219, P253, DOI 10.1007/s00213-011-2560-5; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott BB, 2017, NEURON, V95, P385, DOI 10.1016/j.neuron.2017.06.013; Seigneur E, 2018, P NATL ACAD SCI USA, V115, pE10235, DOI 10.1073/pnas.1811086115; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Siegle JH, 2021, NATURE, V592, P86, DOI 10.1038/s41586-020-03171-x; Siegle Joshua H., 2021, NATURE, V592, P86, DOI [10.1038/s41586-020-2095-1, DOI 10.1038/S41586-020-2452-0, 10.1038/s41586-020-03171-x, DOI 10.1038/S41586-020-2571-7]; Sohn H, 2019, NEURON, V103, P934, DOI 10.1016/j.neuron.2019.06.012; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Steinmetz NA, 2021, SCIENCE, V372, P258, DOI 10.1126/science.abf4588; Steinmetz NA, 2019, NATURE, V576, P266, DOI 10.1038/s41586-019-1787-x; Steinmetz Nicholas A., 2019, NATURE, V576, P266, DOI [10.1038/s41586-019-1787-x, DOI 10.1038/S41586-019-1787-X]; Sternson SM, 2020, CURR OPIN NEUROBIOL, V65, P20, DOI 10.1016/j.conb.2020.08.009; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Sutton R.S., 1990, TIME DERIVATIVE MODE; Swaney J., 2019, BIORXIV, DOI [10.1101/576595, DOI 10.1101/576595]; Tsutsui KI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12554; Vesuna S, 2020, NATURE, V586, P87, DOI 10.1038/s41586-020-2731-9; von Buchholtz LJ, 2020, PAIN, V161, P2212, DOI 10.1097/j.pain.0000000000001911; Vyas S, 2020, ANNU REV NEUROSCI, V43, P249, DOI 10.1146/annurev-neuro-092619-094115; Wagner F, 2016, BRAIN STRUCT FUNCT, V221, P39, DOI 10.1007/s00429-014-0891-9; Wallace ML, 2020, ELIFE, V9, DOI 10.7554/eLife.51271; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Weihe E, 2006, CELL MOL NEUROBIOL, V26, P659, DOI 10.1007/s10571-006-9053-9; Xie Chuanqi, 2015, EXPRESS POLYM LETT, V5, DOI [10.1038/srep16564, DOI 10.3144/EXPRESSPOLYMLETT.2008.11, 10.1038/nrc3262, DOI 10.17660/ACTAHORTIC.2008.795.30]; Yadav R. N. S., 2002, TROP ANIM HEALTH PRO, V4, P117, DOI [10.1007/s10653-008-9218-1, DOI 10.1007/S11528-015-0015-2, 10.1007/BF02942692, DOI 10.1007/S11250-020-02304-8]; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zalocusky KA, 2016, NATURE, V531, P642, DOI 10.1038/nature17400; Zhang G. -W., 2019, BIORXIV; Zhang GW, 2018, NEURON, V99, P1016, DOI 10.1016/j.neuron.2018.07.023; Zhang Qiang, ANIMAL, V37, P931, DOI [10.1016/j.jeurceramsoc.2016.09.031, DOI 10.1016/J.ANIMAL.2021.100367, 10.1016/j.apmr.2016.04.008, DOI 10.1016/J.SCITOTENV.2016.08.081]; Zhao Y, 2017, NEURAL COMPUT, V29, P1293, DOI 10.1162/NECO_a_00953; Zhao-Shea R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7770; Zhou Rong, 2018, HEAT MASS TRANSFER, V59, P499, DOI [10.1007/s13580-018-0050-y, DOI 10.1007/S00231-007-0323-Y]; Zoltowski D., 2020, GEN RECURRENT STATE, V119, P11680	157	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3568	+		10.1016/j.cell.2022.08.019	http://dx.doi.org/10.1016/j.cell.2022.08.019			47	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	6N0VS	36113428	hybrid			2022-12-28	WOS:000889280000001
J	Landy, JC; Dawson, GJ; Tsamados, M; Bushuk, M; Stroeve, JC; Howell, SEL; Krumpen, T; Babb, DG; Komarov, AS; Heorton, HDBS; Belter, HJ; Aksenov, Y				Landy, Jack C.; Dawson, Geoffrey J.; Tsamados, Michel; Bushuk, Mitchell; Stroeve, Julienne C.; Howell, Stephen E. L.; Krumpen, Thomas; Babb, David G.; Komarov, Alexander S.; Heorton, Harry D. B. S.; Belter, H. Jakob; Aksenov, Yevgeny			A year-round satellite sea-ice thickness record from CryoSat-2	NATURE			English	Article							INTERANNUAL VARIABILITY; RADAR; PREDICTABILITY; FREEBOARD; SURFACE; SAR; SUMMER; TRENDS; IMPACT; MODEL	Arctic sea ice is diminishing with climate warming(1) at a rate unmatched for at least 1,000 years(2). As the receding ice pack raises commercial interest in the Arctic(3), it has become more variable and mobile(4), which increases safety risks to maritime users(5). Satellite observations of sea-ice thickness are currently unavailable during the crucial melt period from May to September, when they would be most valuable for applications such as seasonal forecasting(6), owing to major challenges in the processing of altimetry data(7). Here we use deep learning and numerical simulations of the CryoSat-2 radar altimeter response to overcome these challenges and generate a pan-Arctic sea-ice thickness dataset for the Arctic melt period. CryoSat-2 observations capture the spatial and the temporal patterns of ice melting rates recorded by independent sensors and match the time series of sea-ice volume modelled by the Pan-Arctic Ice Ocean Modelling and Assimilation System reanalysis(8). Between 2011 and 2020, Arctic sea-ice thickness was 1.87 +/- 0.10 m at the start of the melting season in May and 0.82 +/- 0.11 m by the end of the melting season in August. Our year-round sea-ice thickness record unlocks opportunities for understanding Arctic climate feedbacks on different timescales. For instance, sea-ice volume observations from the early summer may extend the lead time of skilful August-October sea-ice forecasts by several months, at the peak of the Arctic shipping season.	[Landy, Jack C.] Univ Tromso, Ctr Integrated Remote Sensing & Forecasting Arcti, Dept Phys & Technol, Arctic Univ Norway, Tromso, Norway; [Landy, Jack C.; Dawson, Geoffrey J.] Univ Bristol, Bristol Glaciol Ctr, Sch GeographicalSci, Bristol, Avon, England; [Tsamados, Michel; Stroeve, Julienne C.; Heorton, Harry D. B. S.] UCL, Ctr Polar Observat & Modelling, Dept Earth Sci, London, England; [Bushuk, Mitchell] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Stroeve, Julienne C.; Babb, David G.] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Howell, Stephen E. L.] Environm & Climate Change Canada, Climate Res Div, Toronto, ON, Canada; [Krumpen, Thomas; Belter, H. Jakob] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Bremerhaven, Germany; [Komarov, Alexander S.] Environm & Climate Change Canada, Meteorol Res Div, Ottawa, ON, Canada; [Aksenov, Yevgeny] Natl Oceanog Ctr, Marine Syst Modelling Grp, Southampton, Hants, England	UiT The Arctic University of Tromso; University of Bristol; University of London; University College London; National Oceanic Atmospheric Admin (NOAA) - USA; University of Manitoba; Environment & Climate Change Canada; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Environment & Climate Change Canada; NERC National Oceanography Centre	Landy, JC (corresponding author), Univ Tromso, Ctr Integrated Remote Sensing & Forecasting Arcti, Dept Phys & Technol, Arctic Univ Norway, Tromso, Norway.; Landy, JC (corresponding author), Univ Bristol, Bristol Glaciol Ctr, Sch GeographicalSci, Bristol, Avon, England.	jack.c.landy@uit.no	; Krumpen, Thomas/D-5163-2011	Belter, H. Jakob/0000-0001-9383-911X; Krumpen, Thomas/0000-0001-6234-8756; Landy, Jack/0000-0002-7372-1007; Heorton, Harold/0000-0003-0447-7028	UKRI Natural Environment Research Council Project (NERC) 'PRE-MELT' under the split grant [NE/T001399/1, NE/T000546/1, NE/T000260/1]; European Space Agency Living Planet Fellowship 'Arctic-SummIT' [ESA/4000125582/18/I-NS]; CIRFA project through the Research Council of Norway (RCN) [237906]; Natural Sciences and Engineering Research Council of Canada (NSERC); Russian-German project CATS/Transdrift [63A0028B]; QUARCCS [03F0777A];  [NE/R000085/1]	UKRI Natural Environment Research Council Project (NERC) 'PRE-MELT' under the split grant; European Space Agency Living Planet Fellowship 'Arctic-SummIT'; CIRFA project through the Research Council of Norway (RCN); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Russian-German project CATS/Transdrift; QUARCCS; 	M.T., J.C.L., Y.A., G.J.D., J.C.S. and H.D.B.S.H. acknowledge financial support from the UKRI Natural Environment Research Council Project (NERC) 'PRE-MELT' under the split grant awards NE/T001399/1, NE/T000546/1 and NE/T000260/1. J.C.L. was also supported by the European Space Agency Living Planet Fellowship 'Arctic-SummIT' under grant ESA/4000125582/18/I-NS and the CIRFA project through the Research Council of Norway (RCN) under grant number 237906. D.G.B. acknowledges support from the Natural Sciences and Engineering Research Council of Canada (NSERC). M.T. and Y.A. acknowledge support from 'Towards a marginal Arctic sea ice cover' (NE/R000085/1). We thank the SARvatore (SAR Versatile Altimetric Toolkit for Ocean Research and Exploitation) service available through the ESA GPOD for providing Level-2 CryoSat-2 observations; and the WHOI Beaufort Gyre Exploration Programme and AWI IceBird Programme for providing essential observations for ground truthing new satellite datasets. ADCP and ULS moorings were deployed, recovered and processed within the framework of the Russian-German project CATS/Transdrift (grant 63A0028B) and QUARCCS (grant 03F0777A).	Aksenov Y, 2017, MAR POLICY, V75, P300, DOI 10.1016/j.marpol.2015.12.027; Alexandrov V, 2010, CRYOSPHERE, V4, P373, DOI 10.5194/tc-4-373-2010; Babb DG, 2019, J GEOPHYS RES-OCEANS, V124, P6575, DOI 10.1029/2019JC015053; Belter HJ, 2021, CRYOSPHERE, V15, P2575, DOI 10.5194/tc-15-2575-2021; Belter HJ, 2020, CRYOSPHERE, V14, P2189, DOI 10.5194/tc-14-2189-2020; Belter HJ, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13214335; Blanchard-Wrigglesworth E, 2011, J CLIMATE, V24, P231, DOI 10.1175/2010JCLI3775.1; Bonan DB, 2019, GEOPHYS RES LETT, V46, P5937, DOI 10.1029/2019GL082947; Bushuk M, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL088335; Bushuk M, 2017, GEOPHYS RES LETT, V44, P4953, DOI 10.1002/2017GL073155; Chevallier M, 2012, J CLIMATE, V25, P3025, DOI 10.1175/JCLI-D-11-00209.1; Dawson G, 2022, REMOTE SENS ENVIRON, V268, DOI 10.1016/j.rse.2021.112744; Day JJ, 2014, GEOPHYS RES LETT, V41, P7566, DOI 10.1002/2014GL061694; Dinardo S, 2018, ADV SPACE RES, V62, P1371, DOI 10.1016/j.asr.2017.12.018; Eicken H, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001989; EICKEN H, 1995, J GEOPHYS RES-OCEANS, V100, P22697, DOI 10.1029/95JC02188; Eicken H, 2013, NATURE, V497, P431, DOI 10.1038/497431a; Farrell SL, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL090708; Fetterer F, 2010, MULTISENSOR ANALYZED, DOI [10.7265/N5GT5K3K, DOI 10.7265/N5GT5K3K]; Fetterer F. M., 1992, MICROWAVE REMOTE SEN, P111; Fung AK, 2004, IEEE GEOSCI REMOTE S, V1, P75, DOI 10.1109/LGRS.2004.826564; Guemas V, 2016, Q J ROY METEOR SOC, V142, P546, DOI 10.1002/qj.2401; Haas C, 1997, GEOPHYSICS, V62, P749, DOI 10.1190/1.1444184; Hendricks S., 2012, AIRBORNE SEA ICE PLU, DOI [10.1594/PANGAEA.803312, DOI 10.1594/PANGAEA.803312]; Istomina L., 2020, AGU FALL M 2020; Kern M, 2020, CRYOSPHERE, V14, P2235, DOI 10.5194/tc-14-2235-2020; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Krishfield R., 2006, BGOS ULS DATA PROCES; Kurtz NT, 2014, CRYOSPHERE, V8, P1217, DOI 10.5194/tc-8-1217-2014; Kwok R, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae3ec; Kwok R, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.311; Kwok R, 2013, J GEOPHYS RES-OCEANS, V118, P2408, DOI 10.1002/jgrc.20191; Kwok R, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004753; Kwok R, 2015, GEOPHYS RES LETT, V42, P7598, DOI 10.1002/2015GL065462; Landy J, 2014, J GEOPHYS RES-OCEANS, V119, P3054, DOI 10.1002/2013JC009617; Landy JC, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015820; Landy JC, 2019, IEEE T GEOSCI REMOTE, V57, P4164, DOI 10.1109/TGRS.2018.2889763; Landy JC, 2015, GEOPHYS RES LETT, V42, P10714, DOI 10.1002/2015GL066712; Lavergne T, 2019, CRYOSPHERE, V13, P49, DOI 10.5194/tc-13-49-2019; Laxon S, 2003, NATURE, V425, P947, DOI 10.1038/nature02050; Laxon SW, 2013, GEOPHYS RES LETT, V40, P732, DOI 10.1002/grl.50193; Liston GE, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015913; Mallett RDC, 2020, CRYOSPHERE, V14, P251, DOI 10.5194/tc-14-251-2020; MELVILLE WK, 1991, J GEOPHYS RES-OCEANS, V96, P4915, DOI 10.1029/90JC02114; Mudryk LR, 2021, NAT CLIM CHANGE, V11, P673, DOI 10.1038/s41558-021-01087-6; Nandan V, 2017, GEOPHYS RES LETT, V44, P10419, DOI 10.1002/2017GL074506; Notz D, 2016, SCIENCE, V354, P747, DOI 10.1126/science.aag2345; Ordonez AC, 2018, J CLIMATE, V31, P9771, DOI 10.1175/JCLI-D-18-0348.1; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Perovich D, 2020, ANN GLACIOL, V61, P401, DOI 10.1017/aog.2020.62; Petty AA, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015764; Pfaffling A, 2007, GEOPHYSICS, V72, pF127, DOI 10.1190/1.2732551; Polashenski C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007231; Ray C, 2015, IEEE T GEOSCI REMOTE, V53, P911, DOI 10.1109/TGRS.2014.2330423; Renner AHH, 2014, GEOPHYS RES LETT, V41, P5029, DOI 10.1002/2014GL060369; Ricker R, 2014, CRYOSPHERE, V8, P1607, DOI 10.5194/tc-8-1607-2014; Roberts A., 2022, MATLAB CENTRAL FILE; Scharien RK, 2014, CRYOSPHERE, V8, P2147, DOI 10.5194/tc-8-2147-2014; Schroder D, 2019, CRYOSPHERE, V13, P125, DOI 10.5194/tc-13-125-2019; Schroder D, 2014, NAT CLIM CHANGE, V4, P353, DOI [10.1038/NCLIMATE2203, 10.1038/nclimate2203]; Schweiger A, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007084; Stoddard M. A., 2016, IOP Conference Series: Earth and Environmental Science, V34, DOI 10.1088/1755-1315/34/1/012034; Stroeve J, 2021, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.592337; Stroeve J, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015900; Stroeve J, 2020, CRYOSPHERE, V14, P4405, DOI 10.5194/tc-14-4405-2020; Tschudi MarkA, 2019, POLAR PATHFINDER DAI, DOI DOI 10.5067/INAWUWO7QH7B,2019B; Ulaby F. T., 1982, MICROWAVE REMOTE SEN; Willatt R, 2011, ANN GLACIOL, V52, P197, DOI 10.3189/172756411795931589; Willatt RC, 2010, IEEE T GEOSCI REMOTE, V48, P365, DOI 10.1109/TGRS.2009.2028237; Wingham DJ, 2006, ADV SPACE RES-SERIES, V37, P841, DOI 10.1016/j.asr.2005.07.027; Zhang JL, 2003, MON WEATHER REV, V131, P845, DOI 10.1175/1520-0493(2003)131<0845:MGSIWA>2.0.CO;2	71	0	0	44	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					517	+		10.1038/s41586-022-05058-5	http://dx.doi.org/10.1038/s41586-022-05058-5		SEP 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104558				2022-12-28	WOS:000854742300001
J	Han, H; Park, SJ; Sung, C; Kang, J; Lee, YH; Chung, J; Hahm, TS; Kim, B; Park, JK; Bak, JG; Cha, MS; Choi, GJ; Choi, MJ; Gwak, J; Hahn, SH; Jang, J; Lee, KC; Kim, JH; Kim, SK; Kim, WC; Ko, J; Ko, WH; Lee, CY; Lee, JH; Lee, JK; Lee, JP; Lee, KD; Park, YS; Seo, J; Yang, SM; Yoon, SW; Na, YS				Han, H.; Park, S. J.; Sung, C.; Kang, J.; Lee, Y. H.; Chung, J.; Hahm, T. S.; Kim, B.; Park, J-K; Bak, J. G.; Cha, M. S.; Choi, G. J.; Choi, M. J.; Gwak, J.; Hahn, S. H.; Jang, J.; Lee, K. C.; Kim, J. H.; Kim, S. K.; Kim, W. C.; Ko, J.; Ko, W. H.; Lee, C. Y.; Lee, J. H.; Lee, J. K.; Lee, J. P.; Lee, K. D.; Park, Y. S.; Seo, J.; Yang, S. M.; Yoon, S. W.; Na, Y-S			A sustained high-temperature fusion plasma regime facilitated by fast ions	NATURE			English	Article							INTERNAL TRANSPORT BARRIERS; REVERSED MAGNETIC SHEAR; IMPROVED CONFINEMENT; HIGH-BETA; H-MODE; ENHANCED CONFINEMENT; STABILITY; DISCHARGES; PHYSICS; TRANSITION	Nuclear fusion is one of the most attractive alternatives to carbon-dependent energy sources(1). Harnessing energy from nuclear fusion in a large reactor scale, however, still presents many scientific challenges despite the many years of research and steady advances in magnetic confinement approaches. State-of-the-art magnetic fusion devices cannot yet achieve a sustainable fusion performance, which requires a high temperature above 100 million kelvin and sufficient control of instabilities to ensure steady-state operation on the order of tens of seconds(2,3). Here we report experiments at the Korea Superconducting Tokamak Advanced Research(4) device producing a plasma fusion regime that satisfies most of the above requirements: thanks to abundant fast ions stabilizing the core plasma turbulence, we generate plasmas at a temperature of 100 million kelvin lasting up to 20 seconds without plasma edge instabilities or impurity accumulation. A low plasma density combined with a moderate input power for operation is key to establishing this regime by preserving a high fraction of fast ions. This regime is rarely subject to disruption and can be sustained reliably even without a sophisticated control, and thus represents a promising path towards commercial fusion reactors.	[Han, H.; Kang, J.; Lee, Y. H.; Chung, J.; Bak, J. G.; Choi, M. J.; Hahn, S. H.; Jang, J.; Lee, K. C.; Kim, J. H.; Kim, W. C.; Ko, J.; Ko, W. H.; Lee, J. H.; Lee, J. K.; Lee, K. D.; Yoon, S. W.] Korea Inst Fus Energy, Daejeon, South Korea; [Park, S. J.; Lee, Y. H.; Hahm, T. S.; Kim, B.; Cha, M. S.; Choi, G. J.; Gwak, J.; Lee, C. Y.; Seo, J.; Na, Y-S] Seoul Natl Univ, Dept Nucl Engn, Seoul, South Korea; [Sung, C.] Korea Adv Inst Sci & Technol, Dept Nucl & Quantum Engn, Daejeon, South Korea; [Park, J-K; Kim, S. K.; Yang, S. M.] Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA; [Kim, S. K.] Princeton Univ, Princeton, NJ 08544 USA; [Ko, J.; Ko, W. H.; Lee, J. H.; Lee, J. K.] Korean Univ Sci & Technol, Dept Accelerator & Nucl Fus Phys Engn, Daejeon, South Korea; [Lee, J. P.] Hanyang Univ, Dept Nucl Engn, Seoul, South Korea; [Park, Y. S.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Princeton University; United States Department of Energy (DOE); Princeton Plasma Physics Laboratory; Princeton University; University of Science & Technology (UST); Hanyang University; Columbia University	Na, YS (corresponding author), Seoul Natl Univ, Dept Nucl Engn, Seoul, South Korea.	ysna@snu.ac.kr		Seo, Jaemin/0000-0003-0635-0282; Lee, Kwan Chul/0000-0002-9214-8445; Han, Hyunsun/0000-0001-6506-9824; Sung, Choongki/0000-0002-8122-0018; Kim, SangKyeun/0000-0002-0701-8962	Ministry of Science and ICT under the Korea Institute of Fusion Energy R&D Program KSTAR Experimental Collaboration and Fusion Plasma Research [KFE-EN2101-12]; National R&D Program through the National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [NRF-2021M1A7A4091135]; National Supercomputing Center [KSC-2020-CRE-0364]; US Department of Energy [DE-AC02-09CH11466]	Ministry of Science and ICT under the Korea Institute of Fusion Energy R&D Program KSTAR Experimental Collaboration and Fusion Plasma Research; National R&D Program through the National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT)(National Research Foundation of Korea); National Supercomputing Center; US Department of Energy(United States Department of Energy (DOE))	We express our gratitude to R. Nazikian at Princeton Plasma Physics Laboratory, H.Zohm at Max-Plank-Institute for Plasma Physics, W.Choe at Korea Advanced Institute of Science and Technology and J. Candy and E.Belli at General Atomics for fruitful discussions. We also thank all members of the KSTAR centre for their support and assistance in our studies. This work was supported by the Ministry of Science and ICT under the Korea Institute of Fusion Energy R&D Program KSTAR Experimental Collaboration and Fusion Plasma Research (KFE-EN2101-12), the National R&D Program through the National Research Foundation of Korea (NRF) funded by the Korea government (Ministry of Science and ICT) (NRF-2021M1A7A4091135), and the National Supercomputing Center with supercomputing resources including technical support (KSC-2020-CRE-0364) and by the US Department of Energy under contract number DE-AC02-09CH11466 (Princeton Plasma Physics Laboratory). We gratefully acknowledge The Research Institute of Energy and Resources and The Institute of Engineering Research at Seoul National University.	Ahn JW, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/11/114001; Angioni C, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2913610; [Anonymous], 2018, ITR18003 ITER ORG; Bak J. G., 2010, P 37 EPS C PLASM PHY; Banacloche S, 2020, ENERGY, V209, DOI 10.1016/j.energy.2020.118460; Barbarino M, 2020, NAT PHYS, V16, P890, DOI 10.1038/s41567-020-0940-7; Bourdelle C, 2005, NUCL FUSION, V45, P110, DOI 10.1088/0029-5515/45/2/005; Burrell KH, 1997, PHYS PLASMAS, V4, P1499, DOI 10.1063/1.872367; Candy J, 2016, J COMPUT PHYS, V324, P73, DOI 10.1016/j.jcp.2016.07.039; Carlstrom TN, 2005, FUSION SCI TECHNOL, V48, P997, DOI 10.13182/FST05-A1055; Chapman IT, 2011, FUSION ENG DES, V86, P141, DOI 10.1016/j.fusengdes.2010.09.025; Chu MS, 1996, PHYS REV LETT, V77, P2710, DOI 10.1103/PhysRevLett.77.2710; Chung J, 2021, NUCL FUSION, V61, DOI 10.1088/1741-4326/ac3366; Chung J, 2018, NUCL FUSION, V58, DOI 10.1088/1741-4326/aa90c1; Chung J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891161; Citrin J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.155001; Connor JW, 2004, NUCL FUSION, V44, pR1, DOI 10.1088/0029-5515/44/4/R01; CONNOR JW, 1994, PLASMA PHYS CONTR F, V36, P719, DOI 10.1088/0741-3335/36/5/002; Conway GD, 2000, PHYS REV LETT, V84, P1463, DOI 10.1103/PhysRevLett.84.1463; Crisanti F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.145004; Degeling AW, 2003, PLASMA PHYS CONTR F, V45, P1637, DOI 10.1088/0741-3335/45/9/306; Di Siena A, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.025002; Diamond PH, 1997, PHYS REV LETT, V78, P1472, DOI 10.1103/PhysRevLett.78.1472; Doyle EJ, 2001, PLASMA PHYS CONTR F, V43, pA95, DOI 10.1088/0741-3335/43/12A/307; England AC, 2011, PHYS LETT A, V375, P3095, DOI 10.1016/j.physleta.2011.06.065; Evans TE, 2006, NAT PHYS, V2, P419, DOI 10.1038/nphys312; Fujita T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.245001; Garcia J, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/5/053007; Garofalo AM, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/12/123025; Gormezano C, 1998, PHYS REV LETT, V80, P5544, DOI 10.1103/PhysRevLett.80.5544; Gruber O, 2000, NUCL FUSION, V40, P1145, DOI 10.1088/0029-5515/40/6/312; GUO SC, 1993, PHYS FLUIDS B-PLASMA, V5, P520, DOI 10.1063/1.860537; HAHM TS, 1989, PHYS FLUIDS B-PLASMA, V1, P1185, DOI 10.1063/1.859197; Hahm TS, 2002, PLASMA PHYS CONTR F, V44, pA87, DOI 10.1088/0741-3335/44/5A/305; Houlberg WA, 1997, PHYS PLASMAS, V4, P3230, DOI 10.1063/1.872465; In Y, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/4/043004; Jeon YM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.035004; Jeong SH, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3660254; Joung M, 2020, FUSION ENG DES, V151, DOI 10.1016/j.fusengdes.2019.111395; Juhn JW, 2021, REV SCI INSTRUM, V92, DOI 10.1063/5.0043811; Kim HS, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083012; Kim K, 2005, NUCL FUSION, V45, P783, DOI 10.1088/0029-5515/45/8/003; Ko WH, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890402; KOIDE Y, 1994, PHYS REV LETT, V72, P3662, DOI 10.1103/PhysRevLett.72.3662; KOIDE Y, 1993, NUCL FUSION, V33, P251, DOI 10.1088/0029-5515/33/2/I06; Kwak JG, 2020, IEEE T PLASMA SCI, V48, P1388, DOI 10.1109/TPS.2020.2964776; Lang PT, 2003, NUCL FUSION, V43, P1110, DOI 10.1088/0029-5515/43/10/012; LAO LL, 1985, NUCL FUSION, V25, P1611, DOI 10.1088/0029-5515/25/11/007; LAO LL, 1993, PHYS REV LETT, V70, P3435, DOI 10.1103/PhysRevLett.70.3435; Lee CY, 2021, NUCL FUSION, V61, DOI 10.1088/1741-4326/ac1690; Lee GS, 2001, NUCL FUSION, V41, P1515, DOI 10.1088/0029-5515/41/10/318; Lee HJ, 2011, FUSION ENG DES, V86, P1993, DOI 10.1016/j.fusengdes.2011.03.058; Lee JH, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890258; Lee SG, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2953587; LEVINTON FM, 1995, PHYS REV LETT, V75, P4417, DOI 10.1103/PhysRevLett.75.4417; Li J, 2013, NAT PHYS, V9, P817, DOI [10.1038/NPHYS2795, 10.1038/nphys2795]; Liu ZX, 2016, PHYS PLASMAS, V23, DOI 10.1063/1.4972088; Luce TC, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/1/013015; Lutjens H, 1996, COMPUT PHYS COMMUN, V97, P219, DOI 10.1016/0010-4655(96)00046-X; MANICKAM J, 1987, NUCL FUSION, V27, P1461, DOI 10.1088/0029-5515/27/9/009; McDermott RM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3080721; Miller RL, 1998, PHYS PLASMAS, V5, P973, DOI 10.1063/1.872666; Na YS, 2020, NUCL FUSION, V60, DOI 10.1088/1741-4326/ab8b7a; Okabayashi M, 1998, NUCL FUSION, V38, P1149, DOI 10.1088/0029-5515/38/8/303; Pankin A, 2004, COMPUT PHYS COMMUN, V159, P157, DOI 10.1016/j.cpc.2003.11.002; Park JK, 2018, NAT PHYS, V14, P1223, DOI 10.1038/s41567-018-0268-8; Peeters AG, 2009, COMPUT PHYS COMMUN, V180, P2650, DOI 10.1016/j.cpc.2009.07.001; Pereverzev G., 2002, 598 IPP; Romanelli M, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/4/045007; Sarwar S, 2018, REV SCI INSTRUM, V89, DOI 10.1063/1.5004217; Shimada M, 2007, NUCL FUSION, V47, pS1, DOI 10.1088/0029-5515/47/6/S01; Sips ACC, 2005, PLASMA PHYS CONTR F, V47, pA19, DOI 10.1088/0741-3335/47/5A/003; STRACHAN JD, 1987, PHYS REV LETT, V58, P1004, DOI 10.1103/PhysRevLett.58.1004; STRAIT EJ, 1994, PHYS PLASMAS, V1, P1415, DOI 10.1063/1.870691; STRAIT EJ, 1995, PHYS REV LETT, V75, P4421, DOI 10.1103/PhysRevLett.75.4421; Sugama H, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3257907; WAGNER F, 1982, PHYS REV LETT, V49, P1408, DOI 10.1103/PhysRevLett.49.1408; Wakatani M, 1999, NUCL FUSION, V39, P2175, DOI 10.1088/0029-5515/39/12/302; Wang SJ, 2015, AIP CONF PROC, V1689, DOI 10.1063/1.4936479; Wesson J, 2011, TOKAMAKS, V4th, P764; Wesson J, 2004, TOKAMAKS, V3rd; Yoo MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05839-5; Yoon SW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113009; Yu DL, 2016, NUCL FUSION, V56, DOI 10.1088/0029-5515/56/5/056003; YUSHMANOV PN, 1990, NUCL FUSION, V30, P1999, DOI 10.1088/0029-5515/30/10/001; Zohm H, 1996, PLASMA PHYS CONTR F, V38, P105, DOI 10.1088/0741-3335/38/2/001	87	0	0	20	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					269	+		10.1038/s41586-022-05008-1	http://dx.doi.org/10.1038/s41586-022-05008-1			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071190	Green Submitted			2022-12-28	WOS:000852469200021
J	Rutz, C				Rutz, Christian			Register animal-tracking tags to boost conservation	NATURE			English	Editorial Material								The COVID-19 pandemic highlighted the value of pooling animal-tracking data a global tag registry would facilitate data discovery and collaboration.	[Rutz, Christian] Univ St Andrews, Int Biologging Soc, St Andrews, Fife, Scotland; [Rutz, Christian] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Rutz, C (corresponding author), Univ St Andrews, Int Biologging Soc, St Andrews, Fife, Scotland.; Rutz, C (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	christian.rutz@st-andrews.ac.uk		Rutz, Christian/0000-0001-5187-7417				Hindell MA, 2020, NATURE, V580, P87, DOI 10.1038/s41586-020-2126-y; Rutz C, 2020, NAT ECOL EVOL, V4, P1156, DOI 10.1038/s41559-020-1237-z	2	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					221	221		10.1038/d41586-022-02821-6	http://dx.doi.org/10.1038/d41586-022-02821-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071182	Bronze			2022-12-28	WOS:000852469200014
J	Sharp, C				Sharp, Carla			Personality Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROPOSED CHANGES; RISK-FACTORS; BORDERLINE; ADOLESCENTS; COMORBIDITY; PREVALENCE; COMMUNITY; SYMPTOMS; CLASSIFICATION; DIAGNOSIS		[Sharp, Carla] Univ Houston, Dept Psychol, 126 Heyne Bldg, Houston, TX 77204 USA	University of Houston System; University of Houston	Sharp, C (corresponding author), Univ Houston, Dept Psychol, 126 Heyne Bldg, Houston, TX 77204 USA.			Sharp, Carla/0000-0001-8349-4701				Alvarez-Tomas I, 2019, EUR PSYCHIAT, V56, P75, DOI 10.1016/j.eurpsy.2018.10.010; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2013, NHMRC CLIN PRACT GUI; [Anonymous], 1980, DIAGN STAT MAN MENT, V3rd; [Anonymous], 2009, BORDERLINE PERSONALI; Bateman AW., 2012, MENTALIZATION BASED; Belsky DW, 2012, DEV PSYCHOPATHOL, V24, P251, DOI 10.1017/S0954579411000812; Blashfield RK, 2000, AM J PSYCHIAT, V157, P472, DOI 10.1176/appi.ajp.157.3.472; Blum N, 2008, AM J PSYCHIAT, V165, P468, DOI 10.1176/appi.ajp.2007.07071079; Bohus M, 2021, LANCET, V398, P1528, DOI 10.1016/S0140-6736(21)00476-1; Boschen MJ, 2009, AUST PSYCHOL, V44, P136, DOI 10.1080/00050060802680598; Caligor E., 2018, PSYCHODYNAMIC THERAP, DOI DOI 10.1176/APPI.BOOKS.9781615371501.LR32; Chanen AM, 2004, J PERS DISORD, V18, P526, DOI 10.1521/pedi.18.6.526.54798; Chanen AM, 2017, WORLD PSYCHIATRY, V16, P215, DOI 10.1002/wps.20429; Choi-Kain LW, 2022, HDB GOOD PSYCHIAT MA; Clark LA, 2007, ANNU REV PSYCHOL, V58, P227, DOI 10.1146/annurev.psych.57.102904.190200; Clark LA, 2018, CURR OPIN PSYCHOL, V21, P117, DOI 10.1016/j.copsyc.2017.12.004; Crowell SE, 2009, PSYCHOL BULL, V135, P495, DOI 10.1037/a0015616; Drews E, 2019, NEUROSCI BIOBEHAV R, V96, P316, DOI 10.1016/j.neubiorev.2018.11.008; Eaton NR, 2018, CURR OPIN PSYCHOL, V21, P28, DOI 10.1016/j.copsyc.2017.09.001; Ellison WD, 2018, PSYCHIAT CLIN N AM, V41, P561, DOI 10.1016/j.psc.2018.07.008; Ferguson CJ, 2010, J PERS SOC PSYCHOL, V98, P659, DOI 10.1037/a0018770; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Gunderson JG., 2014, HDB GOOD PSYCHIAT MA; Ha C, 2014, J CLIN PSYCHIAT, V75, pE457, DOI 10.4088/JCP.13m08696; Hallquist MN, 2015, J ABNORM PSYCHOL, V124, P549, DOI 10.1037/abn0000058; Hastrup LH, 2019, ACTA PSYCHIAT SCAND, V140, P458, DOI 10.1111/acps.13094; Herpertz SC, 2018, CURR OPIN PSYCHOL, V21, P23, DOI 10.1016/j.copsyc.2017.08.032; Jorgensen MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245331; Kaess M, 2013, PSYCHOPATHOLOGY, V46, P55, DOI 10.1159/000338715; Kotov R, 2021, ANNU REV CLIN PSYCHO, V17, P83, DOI 10.1146/annurev-clinpsy-081219-093304; Krueger RF, 2018, WORLD PSYCHIATRY, V17, P282, DOI 10.1002/wps.20566; Linehan M., 1993, COGNITIVE BEHAV TREA; Ma GR, 2016, NEUROSCI BULL, V32, P286, DOI 10.1007/s12264-016-0027-8; Michonski JD, 2013, PERSONAL DISORD, V4, P15, DOI 10.1037/a0027948; Newton-Howes G, 2021, SOC PSYCH PSYCH EPID, V56, P679, DOI 10.1007/s00127-020-01876-y; Pedersen L, 2014, NORD J PSYCHIAT, V68, P543, DOI 10.3109/08039488.2014.884630; Rupel VP, 2021, QUAL LIFE RES, V30, P3485, DOI 10.1007/s11136-021-02870-w; Reed GM, 2018, WORLD PSYCHIATRY, V17, P227, DOI 10.1002/wps.20533; Reichborn-Kjennerud T, 2013, JAMA PSYCHIAT, V70, P1206, DOI 10.1001/jamapsychiatry.2013.1944; Reinelt E, 2014, PSYCHOPATHOLOGY, V47, P10, DOI 10.1159/000345857; Sansone RA, 2011, GEN HOSP PSYCHIAT, V33, P343, DOI 10.1016/j.genhosppsych.2011.04.006; Schulze L, 2019, BIOL PSYCHIAT-COGN N, V4, P220, DOI 10.1016/j.bpsc.2018.11.004; Sharp C, 2022, PERSONAL DISORD, V13, P301, DOI 10.1037/per0000595; Sharp C, 2022, PERSONAL DISORD, V13, P316, DOI 10.1037/per0000567; Sharp C, 2017, ARCH DIS CHILD, V102, P103, DOI 10.1136/archdischild-2015-310072; Sharp C, 2016, PERSONAL DISORD, V7, P334, DOI 10.1037/per0000199; Sharp C, 2015, J ABNORM PSYCHOL, V124, P387, DOI 10.1037/abn0000033; Sharp C, 2014, J ABNORM PSYCHOL, V123, P231, DOI 10.1037/a0035637; Sharp C, 2014, PERSONAL DISORD, V5, P70, DOI 10.1037/per0000057; Sharp C, 2012, COMPR PSYCHIAT, V53, P765, DOI 10.1016/j.comppsych.2011.12.003; Skodol AE, 2011, J PERS DISORD, V25, P136, DOI 10.1521/pedi.2011.25.2.136; Skodol AE, 2011, PERSONAL DISORD, V2, P4, DOI 10.1037/a0021891; Skodol AE, 2011, PERSONAL DISORD, V2, P23, DOI 10.1037/a0021892; Soeteman DI, 2008, J CLIN PSYCHIAT, V69, P259, DOI 10.4088/JCP.v69n0212; Stepp SD, 2016, PERSONAL DISORD, V7, P316, DOI 10.1037/per0000186; Stepp SD, 2014, DEV PSYCHOPATHOL, V26, P361, DOI 10.1017/S0954579413001041; Storebo OJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012955.pub2; Tomko RL, 2014, J PERS DISORD, V28, P734, DOI 10.1521/pedi_2012_26_093; Tyrer P, 2019, ANNU REV CLIN PSYCHO, V15, P481, DOI 10.1146/annurev-clinpsy-050718-095736; Wertz J, 2020, J AM ACAD CHILD PSY, V59, P1165, DOI 10.1016/j.jaac.2019.07.005; Widiger TA, 2007, AM PSYCHOL, V62, P71, DOI 10.1037/0003-066X.62.2.71; Winsper C, 2020, AUST NZ J PSYCHIAT, V54, P308, DOI 10.1177/0004867419882494; Winsper C, 2017, BORDER PERS DIS EMOT, V4, DOI 10.1186/s40479-017-0060-x; Young J.E., 2006, SCHEMA THERAPY PRACT, DOI DOI 10.1017/; Zanarini MC, 2011, J PERS DISORD, V25, P607, DOI 10.1521/pedi.2011.25.5.607; Zimmerman M, 2005, AM J PSYCHIAT, V162, P1911, DOI 10.1176/appi.ajp.162.10.1911; Zimmerman M, 2008, PSYCHIAT CLIN N AM, V31, P405, DOI 10.1016/j.psc.2008.03.015	68	0	0	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					916	923		10.1056/NEJMra2120164	http://dx.doi.org/10.1056/NEJMra2120164			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069872				2022-12-28	WOS:000861634500012
J	Kedmi, R; Najar, TA; Mesa, KR; Grayson, A; Kroehling, L; Hao, YH; Hao, S; Pokrovskii, M; Xu, M; Talbot, J; Wang, JX; Germino, J; Lareau, CA; Satpathy, AT; Anderson, MS; Laufer, TM; Aifantis, I; Bartleson, JM; Allen, PM; Paidassi, H; Gardner, JM; Stoeckius, M; Littman, DR				Kedmi, Ranit; Najar, Tariq A.; Mesa, Kailin R.; Grayson, Allyssa; Kroehling, Lina; Hao, Yuhan; Hao, Stephanie; Pokrovskii, Maria; Xu, Mo; Talbot, Jhimmy; Wang, Jiaxi; Germino, Joe; Lareau, Caleb A.; Satpathy, Ansuman T.; Anderson, Mark S.; Laufer, Terri M.; Aifantis, Iannis; Bartleson, Juliet M.; Allen, Paul M.; Paidassi, Helena; Gardner, James M.; Stoeckius, Marlon; Littman, Dan R.			A ROR gamma t(+) cell instructs gut microbiota-specific T-reg cell differentiation	NATURE			English	Article							DENDRITIC CELLS; TOLERANCE; POPULATION; COLITIS	The mutualistic relationship of gut-resident microbiota and the host immune system promotes homeostasis that ensures maintenance of the microbial community and of a largely non-aggressive immune cell compartment(1,2). The consequences of disturbing this balance include proximal inflammatory conditions, such as Crohn's disease, and systemic illnesses. This equilibrium is achieved in part through the induction of both effector and suppressor arms of the adaptive immune system. Helicobacter species induce T regulatory (T-reg) and T follicular helper (T-FH) cells under homeostatic conditions, but induce inflammatory T helper 17 (T(H)17) cells when induced T-reg (iT(reg)) cells are compromised(3,4). How Helicobacter and other gut bacteria direct T cells to adopt distinct functions remains poorly understood. Here we investigated the cells and molecular components required for iT(reg) cell differentiation. We found that antigen presentation by cells expressing ROR gamma t, rather than by classical dendritic cells, was required and sufficient for induction of T-reg cells. These ROR gamma t(+) cells-probably type 3 innate lymphoid cells and/or Janus cells(5)-require the antigen-presentation machinery, the chemokine receptor CCR7 and the TGF beta activator alpha(v) integrin. In the absence of any of these factors, there was expansion of pathogenic T(H)17 cells instead of iT(reg) cells, induced by CCR7-independent antigen-presenting cells. Thus, intestinal commensal microbes and their products target multiple antigen-presenting cells with pre-determined features suited to directing appropriate T cell differentiation programmes, rather than a common antigen-presenting cell that they endow with appropriate functions.	[Kedmi, Ranit; Najar, Tariq A.; Mesa, Kailin R.; Grayson, Allyssa; Kroehling, Lina; Pokrovskii, Maria; Xu, Mo; Talbot, Jhimmy; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10003 USA; [Grayson, Allyssa; Littman, Dan R.] Howard Hughes Med Inst, New York, NY 10065 USA; [Hao, Yuhan] NYU, Ctr Genom & Syst Biol, New York, NY USA; [Hao, Yuhan] New York Genome Ctr, New York, NY USA; [Hao, Stephanie; Stoeckius, Marlon] New York Genome Ctr, Technol Innovat Lab, New York, NY USA; [Wang, Jiaxi; Germino, Joe; Anderson, Mark S.; Gardner, James M.] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Lareau, Caleb A.; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Lareau, Caleb A.; Satpathy, Ansuman T.] Stanford Univ, Parker Inst Canc Immunotherapy, Stanford, CA 94305 USA; [Lareau, Caleb A.; Satpathy, Ansuman T.] Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA; [Laufer, Terri M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Laufer, Terri M.] C Michael Crescenz Vet Adm Med Ctr, Dept Med, Philadelphia, PA USA; [Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Bartleson, Juliet M.; Allen, Paul M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Paidassi, Helena] Univ Claude Bernard Lyon 1, Univ Lyon, CIRI,Ctr Int Rech Infectiol, INSERM U1111,CNRS UMR5308,ENS Lyon, Lyon, France; [Gardner, James M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Pokrovskii, Maria] Calico Life Sci LLC, San Francisco, CA USA; [Xu, Mo] Natl Inst Biol Sci, Beijing, Peoples R China; [Talbot, Jhimmy] Fred Hutchinson Canc Ctr, Seattle, WA USA; [Bartleson, Juliet M.] Federat Bio, San Francisco, CA USA; [Stoeckius, Marlon] 10X Genom, Stockholm, Sweden	New York University; Howard Hughes Medical Institute; New York University; University of California System; University of California San Francisco; Stanford University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; New York University; Washington University (WUSTL); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of California System; University of California San Francisco; National Institute of Biological Sciences, Beijing; Fred Hutchinson Cancer Center	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10003 USA.; Littman, DR (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	dan.littman@med.nyu.edu	Hao, Yuhan/AEN-2112-2022; HAO, YuHan/GWR-2654-2022; Najar, Tariq Ahmad/GYU-8021-2022	Najar, Tariq Ahmad/0000-0002-2693-5248; Lareau, Caleb/0000-0003-4179-4807; Paidassi, Helena/0000-0001-9915-4365; Gardner, James/0000-0003-3470-9520; Bartleson, Juliet/0000-0003-2342-1839	NYU Cancer Center Support Grant [NIH/NCI P30CA016087]; NIH [S10 ODO019974-01A1]; National Institutes of Health Shared Instrumentation grants [S10OD010584-01A1, S10OD018338-01]; IGVF award [UM1HG012076]; Irvington Institute fellowship from the Cancer Research Institute; Jane Coffin Childs Fund fellowship; Agence Nationale de la Recherche [ANR-20-CE15-0015]; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health grants [R01AI139540, R01AI158687]; Howard Hughes Medical Institute;  [S10 RR023704-01A1]	NYU Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrumentation grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IGVF award; Irvington Institute fellowship from the Cancer Research Institute; Jane Coffin Childs Fund fellowship; Agence Nationale de la Recherche(French National Research Agency (ANR)); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); 	We thank members of the Littman laboratory, J. J. Lafaille and S, Schwab for valuable discussion and critical reading of the manuscript and G. Romero-Meza for assistance with experiments; D. Sheppard for advice and providing ADWA-11 blocking antibody; S. Y. Kim and the NYU Rodent Genetic Engineering Laboratory (RGEL) for rederivation of mutant mice; and C. Loomis and the Experimental Pathology Research Laboratory of NYULMC for histology of intestine samples. The Microscopy Core and the Genome Technology Core are partially supported by NYU Cancer Center Support Grant NIH/NCI P30CA016087 at the Laura and Isaac Perlmutter Cancer Center, S10 RR023704-01A1 and NIH S10 ODO019974-01A1. The Experimental Pathology Research Laboratory is supported by National Institutes of Health Shared Instrumentation grants S10OD010584-01A1 and S10OD018338-01. C.A.L., A.T.S. and J.M.G. are recipients of the IGVF award UM1HG012076. This work was supported by an Irvington Institute fellowship from the Cancer Research Institute (R.K.) and a Jane Coffin Childs Fund fellowship (K.R.M.), the Agence Nationale de la Recherche (ANR-20-CE15-0015) (H.P.), the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.); National Institutes of Health grants R01AI139540 (P.M.A.) and R01AI158687 (D.R.L.) and the Howard Hughes Medical Institute (D.R.L.).	Anderson DA, 2021, NAT REV IMMUNOL, V21, P101, DOI 10.1038/s41577-020-00413-x; Ansaldo E, 2021, ANNU REV IMMUNOL, V39, P449, DOI 10.1146/annurev-immunol-093019-112348; Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; Bartleson JM, 2020, NAT IMMUNOL, V21, P1384, DOI 10.1038/s41590-020-0781-7; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kim MH, 2015, IMMUNITY, V43, P107, DOI 10.1016/j.immuni.2015.06.009; Koscso B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax0062; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lienart S, 2018, SCIENCE, V362, P952, DOI 10.1126/science.aau2909; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lopez R, 2018, NAT METHODS, V15, P1053, DOI 10.1038/s41592-018-0229-2; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Metzger TC, 2013, CELL REP, V5, P166, DOI 10.1016/j.celrep.2013.08.038; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Nakawesi J, 2021, MUCOSAL IMMUNOL, V14, P53, DOI 10.1038/s41385-020-0276-8; NUSSENZWEIG MC, 1980, J EXP MED, V152, P1070, DOI 10.1084/jem.152.4.1070; Paidassi H, 2011, GASTROENTEROLOGY, V141, P1813, DOI 10.1053/j.gastro.2011.06.076; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pool L, 2020, J IMMUNOL, V204, P1047, DOI 10.4049/jimmunol.1900775; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Russler-Germain EV, 2021, ELIFE, V10, DOI 10.7554/eLife.54792; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; van Buggenum JAGL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22675; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Wang JX, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5053; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wohn C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba1896; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430; Yin XY, 2021, ANNU REV IMMUNOL, V39, P759, DOI 10.1146/annurev-immunol-101819-025146	52	7	7	26	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					737	+		10.1038/s41586-022-05089-y	http://dx.doi.org/10.1038/s41586-022-05089-y		SEP 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36071167				2022-12-28	WOS:000852585300007
J	Li, YX; Watanabe, E; Kawashima, Y; Plichta, DR; Wang, ZJ; Ujike, M; Ang, QY; Wu, RR; Furuichi, M; Takeshita, K; Yoshida, K; Nishiyama, K; Kearney, SM; Suda, W; Hattori, M; Sasajima, S; Matsunaga, T; Zhang, XX; Watanabe, K; Fujishiro, J; Norman, JM; Olle, B; Matsuyama, S; Namkoong, H; Uwamino, Y; Ishii, M; Fukunaga, K; Hasegawa, N; Ohara, O; Xavier, RJ; Atarashi, K; Honda, K				Li, Youxian; Watanabe, Eiichiro; Kawashima, Yusuke; Plichta, Damian R.; Wang, Zhujun; Ujike, Makoto; Ang, Qi Yan; Wu, Runrun; Furuichi, Munehiro; Takeshita, Kozue; Yoshida, Koji; Nishiyama, Keita; Kearney, Sean M.; Suda, Wataru; Hattori, Masahira; Sasajima, Satoshi; Matsunaga, Takahiro; Zhang, Xiaoxi; Watanabe, Kazuto; Fujishiro, Jun; Norman, Jason M.; Olle, Bernat; Matsuyama, Shutoku; Namkoong, Ho; Uwamino, Yoshifumi; Ishii, Makoto; Fukunaga, Koichi; Hasegawa, Naoki; Ohara, Osamu; Xavier, Ramnik J.; Atarashi, Koji; Honda, Kenya			Identification of trypsin-degrading commensals in the large intestine	NATURE			English	Article							O-GLYCOSYLATION SYSTEM; TRYPTIC ACTIVITY; PANCREATIC ENDOPEPTIDASES; GUT MICROBIOME; HUMAN COLON; POLYSACCHARIDE; INACTIVATION; ACTIVATION; INDUCTION; SECRETION	Increased levels of proteases, such as trypsin, in the distal intestine have been implicated in intestinal pathological conditions(1-3). However, the players and mechanisms that underlie protease regulation in the intestinal lumen have remained unclear. Here we show that Paraprevotella strains isolated from the faecal microbiome of healthy human donors are potent trypsin-degrading commensals. Mechanistically, Paraprevotella recruit trypsin to the bacterial surface through type IX secretion system-dependent polysaccharide-anchoring proteins to promote trypsin autolysis. Paraprevotella colonization protects IgA from trypsin degradation and enhances the effectiveness of oral vaccines against Citrobacter rodentium. Moreover, Paraprevotella colonization inhibits lethal infection with murine hepatitis virus-2, a mouse coronavirus that is dependent on trypsin and trypsin-like proteases for entry into host cells(4,5). Consistently, carriage of putative genes involved in trypsin degradation in the gut microbiome was associated with reduced severity of diarrhoea in patients with SARS-CoV-2 infection. Thus, trypsin-degrading commensal colonization may contribute to the maintenance of intestinal homeostasis and protection from pathogen infection.	[Li, Youxian; Watanabe, Eiichiro; Kawashima, Yusuke; Wang, Zhujun; Suda, Wataru; Hattori, Masahira; Matsunaga, Takahiro; Zhang, Xiaoxi; Ohara, Osamu; Atarashi, Koji; Honda, Kenya] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Li, Youxian; Watanabe, Eiichiro; Wang, Zhujun; Furuichi, Munehiro; Takeshita, Kozue; Yoshida, Koji; Nishiyama, Keita; Kearney, Sean M.; Sasajima, Satoshi; Zhang, Xiaoxi; Atarashi, Koji; Honda, Kenya] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Li, Youxian] Univ Oslo, Fac Med, Inst Canc Res, Oslo, Norway; [Watanabe, Eiichiro; Fujishiro, Jun] Univ Tokyo, Fac Med, Dept Pediat Surg, Tokyo, Japan; [Kawashima, Yusuke; Ohara, Osamu] Kazusa DNA Res Inst, Dept Appl Genom, Kisarazu, Japan; [Plichta, Damian R.; Ang, Qi Yan; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Ujike, Makoto] Nippon Vet & Life Sci Univ, Fac Vet Med, Tokyo, Japan; [Wu, Runrun] Purdue Univ, Interdisciplinary Life Sci PULSe, W Lafayette, IN 47907 USA; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Cooperat Major Adv Hearth Sci, Tokyo, Japan; [Watanabe, Kazuto; Atarashi, Koji; Honda, Kenya] Keio Univ, Sch Med, JSR Keio Univ Med & Chem Innovat Ctr, Tokyo, Japan; [Norman, Jason M.; Olle, Bernat] Vedanta Biosci, Cambridge, MA USA; [Matsuyama, Shutoku] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Namkoong, Ho; Hasegawa, Naoki] Keio Univ, Sch Med, Dept Infect Dis, Tokyo, Japan; [Uwamino, Yoshifumi] Keio Univ, Sch Med, Dept Lab Med, Tokyo, Japan; [Ishii, Makoto; Fukunaga, Koichi] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo, Japan; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA	RIKEN; Keio University; University of Oslo; University of Tokyo; Kazusa DNA Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Nippon Veterinary & Life Science University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Waseda University; Keio University; National Institute of Infectious Diseases (NIID); Keio University; Keio University; Keio University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Atarashi, K; Honda, K (corresponding author), RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan.; Atarashi, K; Honda, K (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.; Atarashi, K; Honda, K (corresponding author), Keio Univ, Sch Med, JSR Keio Univ Med & Chem Innovat Ctr, Tokyo, Japan.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02115 USA.	xavier@molbio.mgh.harvard.edu; kojiatarashi@keio.jp; kenya@keio.jp	Atarashi, Koji/I-5363-2014	Atarashi, Koji/0000-0001-5422-0736; Plichta, Damian/0000-0002-6555-2557; Kawashima, Yusuke/0000-0002-9779-8199; Furuichi, Munehiro/0000-0001-7742-1135; Ujike, Makoto/0000-0002-7145-7126; Ishii, Makoto/0000-0003-4396-1664; Ang, Qi Yan/0000-0002-9788-1283	Japan Agency for Medical Research and Development (AMED) Project 'The next-generation drug discovery and development technology on regulating intestinal microbiome (NeDD Trim)' [JP21ae0121041]; AMED COVID-19-related RD project [JP20he0622002]; AMED LEAP [JP20gm0010003]; JSPS [20H05627]; Stand Up To Cancer (SU2C) Convergence Grant [3.1416]; Center for the Study of Inflammatory Bowel Disease [DK043351, AT009708]; RIKEN's SPDR programme; European Union's Horizon 2020 Research and Innovation programme under the Marie Sklodowska-Curie Actions Grant [80113]; AMED [JP20fk0108452, JP20fk0108415, JP20nk0101612, JP20ek0210154]; RIKEN's JRA programme	Japan Agency for Medical Research and Development (AMED) Project 'The next-generation drug discovery and development technology on regulating intestinal microbiome (NeDD Trim)'; AMED COVID-19-related RD project; AMED LEAP; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Stand Up To Cancer (SU2C) Convergence Grant; Center for the Study of Inflammatory Bowel Disease; RIKEN's SPDR programme; European Union's Horizon 2020 Research and Innovation programme under the Marie Sklodowska-Curie Actions Grant; AMED; RIKEN's JRA programme	We thank P. D. Burrows for comments; S. Narushima, T. Tanoue, T. Tanaka, S. Saegusa, M. Takekawa and M. Kumamoto for technical support and advice; H. Iseki and T. Matsui for coordinating and performing transmission electron microscopy experiments; and all of the staff members who supported us in the Keio University Hospital clinical COVID-19 Team, Keio Donner Project Team and the Japan COVID-19 Task Force. K.H. is funded through Japan Agency for Medical Research and Development (AMED) Project 'The next-generation drug discovery and development technology on regulating intestinal microbiome (NeDD Trim)' (JP21ae0121041), AMED COVID-19-related R&D project under grant number JP20he0622002, AMED LEAP under grant number JP20gm0010003, Grant-in-Aid for Specially Promoted Research from JSPS (no. 20H05627) and Stand Up To Cancer (SU2C) Convergence 3.1416 Grant. D.R.P. and R.J.X. were funded by Center for the Study of Inflammatory Bowel Disease (DK043351) and AT009708. Y.L. received funding from RIKEN's SPDR programme and the European Union's Horizon 2020 Research and Innovation programme under the Marie Sklodowska-Curie Actions Grant, agreement no. 80113 (Scientia Fellowship). This study was also supported by AMED grants JP20fk0108452, JP20fk0108415, JP20nk0101612 and JP20ek0210154. E.W. acknowledges support from RIKEN's JRA programme.	Afar DEH, 2001, CANCER RES, V61, P1686; Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3; Amodei D, 2019, J AM SOC MASS SPECTR, V30, P669, DOI 10.1007/s13361-018-2122-8; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; BOHE M, 1983, DIGESTION, V27, P8, DOI 10.1159/000198913; BORGSTROM A, 1977, SCAND J GASTROENTERO, V12, P525, DOI 10.3109/00365527709181329; Carroll IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078017; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Efimov BA, 2018, INT J SYST EVOL MICR, V68, P3818, DOI 10.1099/ijsem.0.003066; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4; Galvez EJC, 2020, CELL HOST MICROBE, V28, P838, DOI 10.1016/j.chom.2020.09.012; GENELL S, 1976, SCAND J GASTROENTERO, V11, P757; Gessulat S, 2019, NAT METHODS, V16, P509, DOI 10.1038/s41592-019-0426-7; Gonzalez-Dominguez J, 2016, BIOINFORMATICS, V32, P1562, DOI 10.1093/bioinformatics/btw038; Gorasia DG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005152; Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Jablaoui A, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00021; Jaimes JA, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101212; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kawashima Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235932; Kawashima Y, 2010, J PROTEOME RES, V9, P1694, DOI 10.1021/pr9008018; Kenny DJ, 2020, CELL HOST MICROBE, V28, P245, DOI 10.1016/j.chom.2020.05.013; Konno R, 2021, BIOCHEM BIOPH RES CO, V550, P37, DOI 10.1016/j.bbrc.2021.02.101; Krautkramer KA, 2021, NAT REV MICROBIOL, V19, P77, DOI 10.1038/s41579-020-0438-4; Kurilshikov A, 2019, CIRC RES, V124, P1808, DOI 10.1161/CIRCRESAHA.118.314642; Lasica AM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00215; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; Midtvedt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066074; Mirdita Milot, 2021, Zenodo, DOI [10.5281/ZENODO.5123297, 10.1038/s41592-022-01488-1]; Moor K, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00034; Morotomi M, 2009, INT J SYST EVOL MICR, V59, P1895, DOI 10.1099/ijs.0.008169-0; Namkoong H, 2022, NATURE, V609, P754, DOI 10.1038/s41586-022-05163-5; Ndongo S., 2016, New Microbes and New Infections, V13, P102, DOI 10.1016/j.nmni.2016.06.014; Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002; NORIN KE, 1986, LAB ANIM, V20, P234, DOI 10.1258/002367786780865656; NORIN KE, 1986, LAB ANIM, V20, P67, DOI 10.1258/002367786781062188; Onate FP, 2019, BIOINFORMATICS, V35, P1544, DOI 10.1093/bioinformatics/bty830; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Qin XF, 2007, GUT, V56, P1641, DOI 10.1136/gut.2007.132076; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Ramare F, 1996, APPL ENVIRON MICROB, V62, P1434, DOI 10.1128/AEM.62.4.1434-1436.1996; Rangarajan M, 2017, MOL ORAL MICROBIOL, V32, P365, DOI 10.1111/omi.12178; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Searle BC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15346-1; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Skelly AN, 2019, NAT REV IMMUNOL, V19, P305, DOI 10.1038/s41577-019-0144-5; Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; Veith PD, 2017, MOL MICROBIOL, V106, P35, DOI 10.1111/mmi.13752; Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0	67	0	0	30	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					582	+		10.1038/s41586-022-05181-3	http://dx.doi.org/10.1038/s41586-022-05181-3		SEP 2022	38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36071157	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000852585300015
J	Gottlieb, ER; Mendu, M				Gottlieb, Eric R.; Mendu, Mallika			Clinical Decision Support to Prevent Acute Kidney Injury After Cardiac Catheterization Moving Beyond Process to Improving Clinical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTRAST; IMPLEMENTATION		[Gottlieb, Eric R.] Mt Auburn Hosp, Dept Med, Cambridge, MA 02138 USA; [Gottlieb, Eric R.; Mendu, Mallika] Harvard Med Sch, Boston, MA 02115 USA; [Gottlieb, Eric R.] MIT, Lab Computat Physiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Mendu, Mallika] Brigham & Womens Hosp, Dept Med, Div Renal Med, 75 Francis St, Boston, MA 02115 USA; [Mendu, Mallika] Brigham & Womens Hosp, Off Chief Med Officer, 75 Francis St, Boston, MA 02115 USA	Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Gottlieb, ER (corresponding author), Mt Auburn Hosp, Hospitalist Phys Serv, 300 Mt Auburn St, Cambridge, MA 02138 USA.	eric.gottlieb@mah.org						Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Brillet G, 2015, VALUE HEALTH, V18, pA510, DOI 10.1016/j.jval.2015.09.1467; Camacho J, 2020, J MED INTERNET RES, V22, DOI 10.2196/18388; Cleland JGF, 2020, JACC-HEART FAIL, V8, P588, DOI 10.1016/j.jchf.2020.06.002; Gold M, 2016, MILBANK Q, V94, P654, DOI 10.1111/1468-0009.12214; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; James MT, 2022, JAMA-J AM MED ASSOC, V328, P839, DOI 10.1001/jama.2022.13382; Kelly YP, 2022, CLIN J AM SOC NEPHRO, V17, P194, DOI 10.2215/CJN.02060221; Lu Y, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2020-059818; National Institutes of Health, PAR22105 NIH; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P1614, DOI 10.1001/jama.2020.1816; Williams LMS, 2020, CHEST, V157, P866, DOI 10.1016/j.chest.2019.10.005; WuMY MY, 2022, FRONT MED-LAUSANNE, V9	15	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					831	832						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066539				2022-12-28	WOS:000855171700017
J	Schoemaecker, C; Carslaw, N				Schoemaecker, Coralie; Carslaw, Nicola			The "atmosphere" of the human body	SCIENCE			English	Editorial Material							OH; HO2		[Schoemaecker, Coralie] Univ Lille, CNRS, UMR 8522 PC2A Physicochimie Processus Combust, F-59000 Lille, France; [Carslaw, Nicola] Univ York, Dept Geog & Environm, York, N Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of York - UK	Schoemaecker, C (corresponding author), Univ Lille, CNRS, UMR 8522 PC2A Physicochimie Processus Combust, F-59000 Lille, France.	coralie.schoemaecker@univ-lille.fr						Arata C, 2018, ENVIRON SCI TECH LET, V5, P595, DOI 10.1021/acs.estlett.8b00415; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Brown SS, 2012, CHEM SOC REV, V41, P6405, DOI 10.1039/c2cs35181a; Carslaw N, 2017, INDOOR AIR, V27, P1091, DOI 10.1111/ina.12394; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Mendez M, 2017, INDOOR AIR, V27, P434, DOI 10.1111/ina.12316; Tan ZF, 2017, ATMOS CHEM PHYS, V17, P663, DOI 10.5194/acp-17-663-2017; Wang NJ, 2022, ENVIRON SCI TECHNOL, V56, P4838, DOI 10.1021/acs.est.1c08764; Weschler CJ, 2016, INDOOR AIR, V26, P6, DOI 10.1111/ina.12185; Weschler CJ, 1996, ENVIRON SCI TECHNOL, V30, P3250, DOI 10.1021/es960032f; Williams J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25464; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106; Yeoman AM, 2020, INDOOR AIR, V30, P459, DOI 10.1111/ina.12652; Zannoni N, 2022, SCIENCE, V377, P1071, DOI 10.1126/science.abn0340	15	0	0	13	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1045	1046		10.1126/science.add8461	http://dx.doi.org/10.1126/science.add8461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048941	Green Submitted			2022-12-28	WOS:000887933200032
J	Zeng, XF; Xing, X; Gupta, M; Keber, FC; Lopez, JG; Lee, YCJ; Roichman, A; Wang, L; Neinast, MD; Donia, MS; Wuhr, M; Jang, C; Rabinowitz, JD				Zeng, Xianfeng; Xing, Xi; Gupta, Meera; Keber, Felix C.; Lopez, Jaime G.; Lee, Ying-Chiang J.; Roichman, Asael; Wang, Lin; Neinast, Michael D.; Donia, Mohamed S.; Wuhr, Martin; Jang, Cholsoon; Rabinowitz, Joshua D.			Gut bacterial nutrient preferences quantified in vivo	CELL			English	Article							QUANTITATIVE PROTEOMICS; INTESTINAL MICROBIOTA; DIETARY FIBER; METABOLISM; CANCER; ACIDS; PHOSPHATIDYLCHOLINE; GLUCOSE	Great progress has been made in understanding gut microbiomes' products and their effects on health and disease. Less attention, however, has been given to the inputs that gut bacteria consume. Here, we quantitatively examine inputs and outputs of the mouse gut microbiome, using isotope tracing. The main input to microbial carbohydrate fermentation is dietary fiber and to branched-chain fatty acids and aromatic metabolites is dietary protein. In addition, circulating host lactate, 3-hydroxybutyrate, and urea (but not glucose or amino acids) feed the gut microbiome. To determine the nutrient preferences across bacteria, we traced into genus-specific bacterial protein sequences. We found systematic differences in nutrient use: most genera in the phylum Firmicutes prefer dietary protein, Bacteroides dietary fiber, and Akkermansia circulating host lactate. Such preferences correlate with microbiome composition changes in response to dietary modifications. Thus, diet shapes the microbiome by promoting the growth of bacteria that preferentially use the ingested nutrients.	[Zeng, Xianfeng; Xing, Xi; Roichman, Asael; Wang, Lin; Neinast, Michael D.; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gupta, Meera; Keber, Felix C.; Lee, Ying-Chiang J.; Donia, Mohamed S.; Wuhr, Martin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Gupta, Meera] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Zeng, Xianfeng; Xing, Xi; Gupta, Meera; Keber, Felix C.; Lopez, Jaime G.; Roichman, Asael; Wang, Lin; Neinast, Michael D.; Wuhr, Martin; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Jang, Cholsoon] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Wang, Lin] Chinese Acad Med Sci & Peking Union Med Coll, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Rabinowitz, Joshua D.] Princeton Univ, Ludwig Inst Canc Res, Princeton Branch, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University; University of California System; University of California Irvine; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Ludwig Institute for Cancer Research; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Wuhr, M (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Wuhr, M; Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Jang, C (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.; Rabinowitz, JD (corresponding author), Princeton Univ, Ludwig Inst Canc Res, Princeton Branch, Princeton, NJ 08544 USA.	wuhr@princeton.edu; choljang@uci.edu; joshr@princeton.edu		Jang, Cholsoon/0000-0001-6651-4213	NIH; Stand Up to Cancer Convergence Award; Ludwig Cancer Research; Princeton Catalysis Initiative [IDP1DK113643, R35GM128813, 1R01AA029124, T32GM007388]; Eric and Wendy Schmidt Transformative Technology Fund; Pew Biomedical Scholars Program; Harold W. Dodds Fellowship; EMBO; National Science Foundation; High Meadows Environmental Institute at Princeton University; Lisa Vanderzee Ford '82 Graduate Fellowship fund [5T32CA257957]; National Institute of General Medicine Sciences [ALTF 601-2018];  [2017249408]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Convergence Award; Ludwig Cancer Research; Princeton Catalysis Initiative; Eric and Wendy Schmidt Transformative Technology Fund; Pew Biomedical Scholars Program; Harold W. Dodds Fellowship; EMBO(European Molecular Biology Organization (EMBO)); National Science Foundation(National Science Foundation (NSF)); High Meadows Environmental Institute at Princeton University; Lisa Vanderzee Ford '82 Graduate Fellowship fund; National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 	This work is supported by the NIH Pioneer award IDP1DK113643 (J.D.R.) , Stand Up to Cancer Convergence Award 3.14.16 probing the cancer-micro-biome connection (J.D.R.) , Ludwig Cancer Research (J.D.R.) , NIH grant R35GM128813 (M.W.) , Princeton Catalysis Initiative (M.W.) , Eric and Wendy Schmidt Transformative Technology Fund (M.W) , NIH grant 1R01AA029124 (C.J.) , and the Pew Biomedical Scholars Program (M.S.D) . M.G. is funded by a Harold W. Dodds Fellowship. F.C.K is funded by EMBO ALTF 601-2018. J.G.L. is funded by a National Science Foundation Graduate Research Fellowship (2017249408) . Y.-C.J.L. is funded by the High Meadows Environmental Institute at Princeton University through the generous support of the William Clay Ford, Jr. '79 and Lisa Vanderzee Ford '82 Graduate Fellowship fund and by a training grant from the National Institute of General Medicine Sciences (T32GM007388) . M.D.N. is supported by NIH 5T32CA257957. We thank Sheng Hui, Michel Nofal, Yihui Shen, Lingfan Liang, Won Dong Lee, and other Rabinowitz lab members for their input and advice. We thank Seema Chatterjee for the assistance with DNA extraction. We thank Michael Stadlmeier, Thao Nguyen, and Alex Johnson for the assistance with proteomics. We thank Wei Wang and the Lewis-Sigler Institute sequencing core facility for assistance with HT sequencing.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Bartman CR, 2021, NAT METAB, V3, P896, DOI 10.1038/s42255-021-00419-2; Batani G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55049-2; Berry D, 2015, P NATL ACAD SCI USA, V112, pE194, DOI 10.1073/pnas.1420406112; Berry D, 2013, P NATL ACAD SCI USA, V110, P4720, DOI 10.1073/pnas.1219247110; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fernandez-Garcia J, 2020, TRENDS BIOCHEM SCI, V45, P185, DOI 10.1016/j.tibs.2019.12.002; Funabashi M, 2020, NATURE, V582, P566, DOI 10.1038/s41586-020-2396-4; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Gupta M, 2018, METHODS MOL BIOL, V1865, P175, DOI 10.1007/978-1-4939-8784-9_13; Gurdeep Singh R, 2019, J PROTEOME RES, V18, P606, DOI 10.1021/acs.jproteome.8b00716; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Han S, 2021, NATURE, V595, P415, DOI 10.1038/s41586-021-03707-9; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Holmes AJ, 2017, CELL METAB, V25, P140, DOI 10.1016/j.cmet.2016.10.021; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jang C, 2019, CELL METAB, V30, P594, DOI 10.1016/j.cmet.2019.06.002; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lai YJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26209-8; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Liu ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01687; Madsen L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01047; Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421; McCabe BJ, 2004, METAB ENG, V6, P25, DOI 10.1016/j.ymben.2003.09.003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKinney W., 2010, P 9 PYTH SCI C, P51, DOI [10.25080/majora-92bf1922-00a, 10.25080/Majora-92bf1922-00a]; Mora D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004472; Munukka Eveliina, 2018, Front Microbiol, V9, P2323, DOI 10.3389/fmicb.2018.02323; Nemet I, 2020, CELL, V180, P862, DOI 10.1016/j.cell.2020.02.016; Ni J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6888; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Oberbach A, 2017, J PROTEOME RES, V16, P1593, DOI 10.1021/acs.jproteome.6b00973; OBrien J.J., 2020, PRECISE ESTIMATION I, V2020, DOI [10.1101/2020.11.10.377440, DOI 10.1101/2020.11.10.377440]; Lund PJ, 2021, bioRxiv, DOI 10.1101/2021.07.05.450926; PURSER DB, 1966, J DAIRY SCI, V49, P81, DOI 10.3168/jds.S0022-0302(66)87791-3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quinn RA, 2020, NATURE, V579, P123, DOI 10.1038/s41586-020-2047-9; Reese AT, 2018, NAT MICROBIOL, V3, P1441, DOI 10.1038/s41564-018-0267-7; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Savitski MM, 2015, MOL CELL PROTEOMICS, V14, P2394, DOI 10.1074/mcp.M114.046995; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Sicard JF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00387; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Spinelli JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09993-6; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; ULLRICH KJ, 1982, PFLUG ARCH EUR J PHY, V395, P220, DOI 10.1007/BF00584813; Wali JA, 2021, NAT METAB, V3, P810, DOI 10.1038/s42255-021-00393-9; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wolfe R R, 1984, Lab Res Methods Biol Med, V9, P1; Wong JMW, 2007, J NUTR, V137, p2539S, DOI 10.1093/jn/137.11.2539S; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang X, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0176-z; Zhang X, 2016, ANAL CHEM, V88, P6120, DOI 10.1021/acs.analchem.6b01412; Zhao S, 2020, NATURE, V579, P586, DOI 10.1038/s41586-020-2101-7	71	2	2	36	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3441	+		10.1016/j.cell.2022.07.020	http://dx.doi.org/10.1016/j.cell.2022.07.020			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4L5NE	36055202	Green Submitted			2022-12-28	WOS:000852676300001
J	Dyer, O				Dyer, Owen			Hungary requires doctors to present women with fetal vital signs before abortion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Nash E., 2021, 26 STATES ARE CERTAI	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378									10.1136/bmj.o2260	http://dx.doi.org/10.1136/bmj.o2260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126970				2022-12-28	WOS:000869963500014
J	Rowlands, S; Holdsworth, R; Sowemimo, A				Rowlands, Sam; Holdsworth, Rebecca; Sowemimo, Annabel			How to recognise and respond to reproductive coercion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARTNER VIOLENCE; INTERVENTION; CARE		[Rowlands, Sam] Bournemouth Univ, Bournemouth, Dorset, England; [Holdsworth, Rebecca] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Holdsworth, Rebecca] Natl Inst Hlth & Care Res, London, England; [Sowemimo, Annabel] Kings Coll London, London, England; [Sowemimo, Annabel] Haymarket Hlth, Leicester, Leics, England	Bournemouth University; Newcastle University - UK; University of London; King's College London	Rowlands, S (corresponding author), Bournemouth Univ, Bournemouth, Dorset, England.	srowlands@boumemouth.ac.uk		Rowlands, Sam/0000-0001-5940-9079; Holdsworth, Rebecca/0000-0003-3238-6297				[Anonymous], 2013, Obstet Gynecol, V121, P411, DOI 10.1097/01.AOG.0000426427.79586.3b; [Anonymous], 2021, SPERM THEFT WIKIWAND; Barlow C, 2022, COERCIVE CONTROL, DOI [10.4324/9781003019114, DOI 10.4324/9781003019114]; BBC, 2022, BBC; Brooks M, 2018, AUST J GEN PRACT, V47, P370, DOI 10.31128/AJGP-11-17-4406; Burry K, 2020, AOTEAROA N Z SOC WOR, V32, P17, DOI 10.11157/anzswj-vol32iss1id701; Carter A, 2021, SEX HEALTH, V18, P436, DOI 10.1071/SH21116; Chang JC, 2005, PATIENT EDUC COUNS, V59, P141, DOI 10.1016/j.pec.2004.10.008; Cheng Y, 2021, SEX HEALTH, V18, P349, DOI 10.1071/SH21079; Department of Health and Social Care, 2017, RESPONDING DOMESTIC; Dimenstein NB, 2021, CONTRACEPTION, V104, P367, DOI 10.1016/j.contraception.2021.05.020; Fay KE, 2022, CONTRACEPTION, V115, P75, DOI 10.1016/j.contraception.2022.06.006; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Latimer RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209779; Miller E, 2017, PERSPECT SEX REPRO H, V49, P85, DOI 10.1363/psrh.12021; Miller E, 2016, CONTRACEPTION, V94, P58, DOI 10.1016/j.contraception.2016.02.009; Miller E, 2014, CONTRACEPTION, V89, P122, DOI 10.1016/j.contraception.2013.10.011; Moulton JE, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0261551; Neighbour R, 2021, CONSULTING NUTSHELL; Omole FS, 2011, AM FAM PHYSICIAN, V84, P780; Park J, 2016, AM J OBSTET GYNECOL, V214, P74, DOI 10.1016/j.ajog.2015.08.045; PATH, 2022, DMPA SC SELF INJ RES; Price E, 2022, J INTERPERS VIOLENCE, V37, pNP2823, DOI 10.1177/0886260519846851; Randell K, 2020, ADDRESSING REPROD CO; Rowlands S, 2022, EUR J CONTRACEP REPR, V27, P357, DOI 10.1080/13625187.2022.2092091; Rowlands S, 2019, BMJ SEX REPROD HEAL, V45, P61, DOI 10.1136/bmjsrh-2018-200156; Savanta ComRes, 2022, REPR COERC POLL BBC; Sheeran N, 2022, J FAM VIOLENCE, DOI 10.1007/s10896-022-00357-x; Silverman JG, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100484; Skracic I, 2021, J WOMENS HEALTH, V30, P1078, DOI 10.1089/jwh.2020.8784; Srinivasan S, 2020, CULT HEALTH SEX, V22, P489, DOI 10.1080/13691058.2019.1612094; Stark E, 2019, VIOLENCE AGAINST WOM, V25, P81, DOI 10.1177/1077801218816191; Tarzia L, 2021, REPROD HEALTH, V18, DOI 10.1186/s12978-021-01143-6; Tarzia L, 2022, CULT HEALTH SEX, V24, P466, DOI 10.1080/13691058.2020.1859617; Tarzia L, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-041339; Tarzia L, 2020, WOMEN HEALTH, V60, P1174, DOI 10.1080/03630242.2020.1804517; Tarzia L, 2021, J INTERPERS VIOLENCE, V36, P11704, DOI 10.1177/0886260519900298; Tarzia L, 2019, QUAL HEALTH RES, V29, P1395, DOI 10.1177/1049732318819839; Willie TC, 2021, WOMEN HEALTH ISS, V31, P157, DOI 10.1016/j.whi.2020.10.003; Zachor H, 2018, HEALTH EDUC RES, V33, P175, DOI 10.1093/her/cyy007	40	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								e069043	10.1136/bmj-2021-069043	http://dx.doi.org/10.1136/bmj-2021-069043			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126969	Green Accepted			2022-12-28	WOS:000869963500007
J	Rubin, R				Rubin, Rita			New Gene Therapy for beta-Thalassemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1030	1030		10.1001/jama.2022.14709	http://dx.doi.org/10.1001/jama.2022.14709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125483				2022-12-28	WOS:000862909200009
J	Jorge, AM; Mancini, C; Zhou, BJ; Ho, G; Zhang, YQ; Costenbader, K; Choi, HK				Jorge, April M.; Mancini, Christian; Zhou, Baijun; Ho, Gary; Zhang, Yuqing; Costenbader, Karen; Choi, Hyon K.			Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jorge, April M.; Mancini, Christian; Zhou, Baijun; Zhang, Yuqing; Choi, Hyon K.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Ho, Gary] NYU, Langone Hlth, Div Rheumatol, New York, NY USA; [Costenbader, Karen] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA	Harvard University; Massachusetts General Hospital; New York University; Harvard University; Brigham & Women's Hospital	Jorge, AM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, 100 Cambridge St,Ste 1600, Boston, MA 02114 USA.	amjorge@mgh.harvard.edu		Ho, Gary/0000-0003-1531-5147	Rheumatology Research Foundation Scientist Development Award	Rheumatology Research Foundation Scientist Development Award	Dr Jorge is supported by the Rheumatology Research Foundation Scientist Development Award.	Almeida-Brasil CC, 2022, ANN RHEUM DIS, V81, P370, DOI 10.1136/annrheumdis-2021-221295; Arora S, 2020, ARTHRIT CARE RES, V72, P27, DOI 10.1002/acr.24221; Fanouriakis A, 2019, ANN RHEUM DIS, V78, P736, DOI 10.1136/annrheumdis-2019-215089; Jorge A, 2018, NAT REV RHEUMATOL, V14, P693, DOI 10.1038/s41584-018-0111-8; Marmor MF, 2016, OPHTHALMOLOGY, V123, P1386, DOI 10.1016/j.ophtha.2016.01.058; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2022	328	14					1458	1460		10.1001/jama.2022.13591	http://dx.doi.org/10.1001/jama.2022.13591		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5L0OS	36112387				2022-12-28	WOS:000854267500002
J	Wisdom, J; Dbouk, R; Militzer, B; Hubbard, WB; Nimmo, F; Downey, BG; French, RG				Wisdom, Jack; Dbouk, Rola; Militzer, Burkhard; Hubbard, William B.; Nimmo, Francis; Downey, Brynna G.; French, Richard G.			Loss of a satellite could explain Saturn's obliquity and young rings	SCIENCE			English	Article							CHAOTIC OBLIQUITY; ORIGIN; DYNAMICS	The origin of Saturn's similar to 26.7 degrees obliquity and similar to 100-million-year-old rings is unknown. The observed rapid outward migration of Saturn's largest satellite, Titan, could have raised Saturn's obliquity through a spin-orbit precession resonance with Neptune. We use Cassini data to refine estimates of Saturn's moment of inertia, finding that it is just outside the range required for the resonance. We propose that Saturn previously had an additional satellite, which we name Chrysalis, that caused Saturn's obliquity to increase through the Neptune resonance. Destabilization of Chrysalis's orbit similar to 100 million years ago can then explain the proximity of the system to the resonance and the formation of the rings through a grazing encounter with Saturn.	[Wisdom, Jack; Dbouk, Rola] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Militzer, Burkhard] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Militzer, Burkhard] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Hubbard, William B.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Nimmo, Francis; Downey, Brynna G.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [French, Richard G.] Wellesley Coll, Dept Astron, Wellesley, MA 02481 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Arizona; University of California System; University of California Santa Cruz; Wellesley College	Wisdom, J (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	wisdom@mit.edu		French, Richard/0000-0002-9858-9532; Downey, Brynna/0000-0003-1751-5185; Hubbard, William/0000-0003-3185-4538	NASA's SSW program; NASA's extended Juno mission; National Nuclear Security Administration; NASA's CDAP program; NSF Graduate Research Fellowships Program	NASA's SSW program; NASA's extended Juno mission; National Nuclear Security Administration(National Nuclear Security Administration); NASA's CDAP program; NSF Graduate Research Fellowships Program(National Science Foundation (NSF))	Support for this work was provided by NASA's SSW program (J.W., F.N., and R.D.), NASA's extended Juno mission (W.B.H. and B.M.), the National Nuclear Security Administration (B.M.), NASA's CDAP program (R.G.F.), and the NSF Graduate Research Fellowships Program (B.D.).	Brasser R, 2015, ASTRON J, V150, DOI 10.1088/0004-6256/150/5/157; Cassini G, 1693, TRAITE ORIGINE EDE P; Crida A, 2019, NAT ASTRON, V3, P967, DOI 10.1038/s41550-019-0876-y; Cuk M, 2018, MON NOT R ASTRON SOC, V481, P5411, DOI 10.1093/mnras/sty2631; DONES L, 1991, ICARUS, V92, P194, DOI 10.1016/0019-1035(91)90045-U; GOLDREICH P, 1982, ANNU REV ASTRON ASTR, V20, P249, DOI 10.1146/annurev.aa.20.090182.001341; HARRIS AW, 1982, ANNU REV EARTH PL SC, V10, P61, DOI 10.1146/annurev.ea.10.050182.000425; Hubbard WB, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/43; Hubbard WB, 1999, ICARUS, V137, P357, DOI 10.1006/icar.1998.6064; Hyodo R, 2017, ICARUS, V282, P195, DOI 10.1016/j.icarus.2016.09.012; Iess L, 2019, SCIENCE, V364, P1052, DOI 10.1126/science.aat2965; Lainey V, 2020, NAT ASTRON, V4, P1053, DOI 10.1038/s41550-020-1120-5; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LINDAL GF, 1985, ASTRON J, V90, P1136, DOI 10.1086/113820; Militzer B, 2019, ASTROPHYS J, V879, DOI 10.3847/1538-4357/ab23f0; Militzer B, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/148; PEALE SJ, 1969, ASTRON J, V74, P483, DOI 10.1086/110825; Polycarpe W, 2018, ASTRON ASTROPHYS, V619, DOI 10.1051/0004-6361/201833930; SAGAN C, 1982, NATURE, V300, P731, DOI 10.1038/300731a0; Saillenfest M, 2021, ASTRON ASTROPHYS, V647, DOI 10.1051/0004-6361/202039891; Saillenfest M, 2021, NAT ASTRON, V5, P345, DOI 10.1038/s41550-020-01284-x; SINCLAIR AT, 1972, MON NOT R ASTRON SOC, V160, P169, DOI 10.1093/mnras/160.2.169; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; TREMAINE S, 1991, ICARUS, V89, P85, DOI 10.1016/0019-1035(91)90089-C; Tremaine S, 2009, ASTRON J, V137, P3706, DOI 10.1088/0004-6256/137/3/3706; Ward WR, 2004, ASTRON J, V128, P2501, DOI 10.1086/424533; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; Wisdom J, 2016, ICARUS, V267, P315, DOI 10.1016/j.icarus.2015.12.030; Wisdom Jack, 2022, HarvardDataverse, V1, DOI 10.7910/DVN/RJZXGW; Wisdom Jack, 2022, Zenodo, DOI 10.5281/ZENODO.6960630; Zhang Z, 2017, ICARUS, V294, P14, DOI 10.1016/j.icarus.2017.04.008	32	1	1	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1285	1289		10.1126/science.abn1234	http://dx.doi.org/10.1126/science.abn1234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36107998				2022-12-28	WOS:000887933500033
J	Frank, N; Nugent, J; Shire, BR; Pickford, HD; Rabe, P; Sterling, AJ; Zarganes-Tzitzikas, T; Grimes, T; Thompson, AL; Smith, RC; Schofield, CJ; Brennan, PE; Duarte, F; Anderson, EA				Frank, Nils; Nugent, Jeremy; Shire, Bethany R.; Pickford, Helena D.; Rabe, Patrick; Sterling, Alistair J.; Zarganes-Tzitzikas, Tryfon; Grimes, Thomas; Thompson, Amber L.; Smith, Russell C.; Schofield, Christopher J.; Brennan, Paul E.; Duarte, Fernanda; Anderson, Edward A.			Synthesis of meta-substituted arene bioisosteres from [3.1.1]propellane	NATURE			English	Article							DESIGN	Small-ring cage hydrocarbons are popular bioisosteres (molecular replacements) for commonly found para-substituted benzene rings in drug design(1). The utility of these cage structures derives from their superior pharmacokinetic properties compared with their parent aromatics, including improved solubility and reduced susceptibility to metabolism(2,3). A prime example is the bicyclo[1.1.1]pentane motif, which is mainly synthesized by ring-opening of the interbridgehead bond of the strained hydrocarbon [1.1.1]propellane with radicals or anions(4). By contrast, scaffolds mimicking meta-substituted arenes are lacking because of the challenge of synthesizing saturated isosteres that accurately reproduce substituent vectors(5). Here we show that bicyclo[3.1.1]heptanes (BCHeps), which are hydrocarbons for which the bridgehead substituents map precisely onto the geometry of meta-substituted benzenes, can be conveniently accessed from [3.1.1]propellane. We found that [3.1.1]propellane can be synthesized on a multigram scale, and readily undergoes a range of radical-based transformations to generate medicinally relevant carbon- and heteroatom-substituted BCHeps, including pharmaceutical analogues. Comparison of the absorption, distribution, metabolism and excretion (ADME) properties of these analogues reveals enhanced metabolic stability relative to their parent arene-containing drugs, validating the potential of this meta-arene analogue as an sp(3)-rich motif in drug design. Collectively, our results show that BCHeps can be prepared on useful scales using a variety of methods, offering a new surrogate for meta-substituted benzene rings for implementation in drug discovery programmes.	[Frank, Nils; Nugent, Jeremy; Shire, Bethany R.; Pickford, Helena D.; Rabe, Patrick; Sterling, Alistair J.; Thompson, Amber L.; Schofield, Christopher J.; Duarte, Fernanda; Anderson, Edward A.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Zarganes-Tzitzikas, Tryfon; Grimes, Thomas; Brennan, Paul E.] Nuffield Dept Med, Ctr Med Discovery, Alzheimers Res UK Oxford Drug Discovery Inst, Oxford, England; [Smith, Russell C.] Abbvie Drug Discovery Sci & Technol DDST, N Chicago, IL USA	University of Oxford; University of Oxford	Anderson, EA (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England.	edward.anderson@chem.ox.ac.uk		Frank, Nils/0000-0002-8512-6598; Rabe, Patrick/0000-0002-3448-9559; Nugent, Jeremy/0000-0001-7204-6161; Pickford, Helena/0000-0003-0941-7585	Studienstiftung des Deutschen Volkes e.V.; Marie Skodowska-Curie actions [786683]; EPSRC [EP/S013172/1, EP/T517811/1]; EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/ L015838/1]; Alzheimer's Research UK [ARUK-2021DDI-OX]; Deutsche Akademie fur Naturforscher Leopoldina	Studienstiftung des Deutschen Volkes e.V.; Marie Skodowska-Curie actions; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Deutsche Akademie fur Naturforscher Leopoldina	N.F. thanks Studienstiftung des Deutschen Volkes e.V. for a scholarship. J.N. thanks the Marie Skodowska-Curie actions for an Individual Fellowship (GA No 786683). E.A.A. and A.J.S. thank the EPSRC for support (grant nos EP/S013172/1 and EP/T517811/1). B.R.S., A.J.S. and H.D.P. thank the EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine for studentships (EP/ L015838/1). T.Z.-T., T.G. and P.E.B. thank Alzheimer's Research UK for support (grant no. ARUK-2021DDI-OX). P.R. thanks the Deutsche Akademie fur Naturforscher Leopoldina for a fellowship.	Agasti S., 2022, CHEMRXIV, DOI [10.26434/chemrxiv-22022-v26493kv, DOI 10.26434/CHEMRXIV-22022-V26493KV]; Anderson JM, 2021, ANGEW CHEM INT EDIT, V60, P24754, DOI 10.1002/anie.202106352; Auberson YP, 2017, CHEMMEDCHEM, V12, P590, DOI 10.1002/cmdc.201700082; Bar RM, 2019, BEILSTEIN J ORG CHEM, V15, P1172, DOI 10.3762/bjoc.15.114; Bar RM, 2018, CHEM-EUR J, V24, P1373, DOI 10.1002/chem.201704105; Caputo DFJ, 2018, CHEM SCI, V9, P5295, DOI 10.1039/c8sc01355a; Chalmers BA, 2016, ANGEW CHEM INT EDIT, V55, P3380, DOI 10.1002/anie.201510675; DELLA EW, 1995, AUST J CHEM, V48, P967, DOI 10.1071/CH9950967; Denisenko A, 2020, ANGEW CHEM INT EDIT, V59, P20515, DOI 10.1002/anie.202004183; Dhake K, 2022, ANGEW CHEM INT EDIT, V61, DOI 10.1002/anie.202204719; Dilmac AM, 2017, ANGEW CHEM INT EDIT, V56, P5684, DOI 10.1002/anie.201603951; FUCHS J, 1992, CHEM BER-RECL, V125, P2517, DOI 10.1002/cber.19921251126; GASSMAN PG, 1980, J AM CHEM SOC, V102, P6862, DOI 10.1021/ja00542a040; Guo RY, 2022, J AM CHEM SOC, V144, P7988, DOI 10.1021/jacs.2c02976; Harmata AS, 2021, J AM CHEM SOC, V143, P21223, DOI 10.1021/jacs.1c10541; Kleinmans R, 2022, NATURE, V605, P477, DOI 10.1038/s41586-022-04636-x; Kulinkovich OG, 2005, SYNTHESIS-STUTTGART, P1713, DOI 10.1055/s-2004-834869; Levterov VV, 2020, ANGEW CHEM INT EDIT, V59, P7161, DOI 10.1002/anie.202000548; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Ma XS, 2020, ASIAN J ORG CHEM, V9, P8, DOI 10.1002/ajoc.201900589; Meanwell NA, 2016, CHEM RES TOXICOL, V29, P564, DOI 10.1021/acs.chemrestox.6b00043; Measom ND, 2017, ACS MED CHEM LETT, V8, P43, DOI 10.1021/acsmedchemlett.6b00281; Mykhailiuk PK, 2019, ORG BIOMOL CHEM, V17, P2839, DOI 10.1039/c8ob02812e; Nilova A, 2020, J MED CHEM, V63, P13389, DOI 10.1021/acs.jmedchem.0c00915; Nugent J, 2020, ANGEW CHEM INT EDIT, V59, P11866, DOI 10.1002/anie.202004090; Nugent J, 2019, ACS CATAL, V9, P9568, DOI 10.1021/acscatal.9b03190; Pickford HD, 2021, J AM CHEM SOC, V143, P9729, DOI 10.1021/jacs.1c04180; Pu QL, 2020, ACS MED CHEM LETT, V11, P1548, DOI 10.1021/acsmedchemlett.0c00195; Stepan AF, 2012, J MED CHEM, V55, P3414, DOI 10.1021/jm300094u; Sterling A., 2022, CHEMRXIV, DOI [10.26434/chemrxiv-22021-n26430xm26439-v26432, DOI 10.26434/CHEMRXIV-22021-N26430XM26439-V26432]; Sterling AJ, 2020, CHEM SCI, V11, P4895, DOI 10.1039/d0sc01386b; Subbaiah MAM, 2021, J MED CHEM, V64, P14046, DOI 10.1021/acs.jmedchem.1c01215; Tokunaga K, 2020, J AM CHEM SOC, V142, P18522, DOI 10.1021/jacs.0c07490; WIBERG KB, 1989, CHEM REV, V89, P975, DOI 10.1021/cr00095a001; Wu Z, 2020, TETRAHEDRON, V76, DOI 10.1016/j.tet.2020.131692; Yang YY, 2021, NAT CHEM, V13, P950, DOI 10.1038/s41557-021-00786-z; Zarate C, 2021, ORG PROCESS RES DEV, V25, P642, DOI 10.1021/acs.oprd.0c00446; Zhang XH, 2020, NATURE, V580, P220, DOI 10.1038/s41586-020-2060-z; Zhao JX, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2108881118	39	4	4	29	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2022	611	7937					721	+		10.1038/s41586-022-05290-z	http://dx.doi.org/10.1038/s41586-022-05290-z		SEP 2022	11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EM	36108675	Green Submitted			2022-12-28	WOS:000869346300001
J	Lagoin, C; Bhattacharya, U; Grass, T; Chhajlany, RW; Salamon, T; Baldwin, K; Pfeiffer, L; Lewenstein, M; Holzmann, M; Dubin, F				Lagoin, C.; Bhattacharya, U.; Grass, T.; Chhajlany, R. W.; Salamon, T.; Baldwin, K.; Pfeiffer, L.; Lewenstein, M.; Holzmann, M.; Dubin, F.			Extended Bose-Hubbard model with dipolar excitons	NATURE			English	Article							MOTT INSULATOR; TRANSITION; SUPERFLUID	The Hubbard model constitutes one of the most celebrated theoretical frameworks of condensed-matter physics. It describes strongly correlated phases of interacting quantum particles confined in lattice potentials(1,)(2). For bosons, the Hubbard Hamiltonian has been deeply scrutinized for short-range on-site interactions(3-6). However, accessing longer-range couplings has remained elusive experimentally(7). This marks the frontier towards the extended Bose-Hubbard Hamiltonian, which enables insulating ordered phases at fractional lattice fillings(8-)(12). Here we implement this Hamiltonian by confining semiconductor dipolar excitons in an artificial two-dimensional square lattice. Strong dipolar repulsions between nearest-neighbour lattice sitesthen stabilize an insulating state at half filling. This characteristic feature of the extended Bose-Hubbard model exhibits the signatures theoretically expected for a chequerboard spatial order. Our work thus highlights that dipolar excitons enable controlled implementations of boson-like arrays with strong off-site interactions, in lattices with programmable geometries and more than 100 sites.	[Lagoin, C.; Dubin, F.] Inst Nanosci Paris, CNRS, Paris, France; [Lagoin, C.; Dubin, F.] Sorbonne Univ, Paris, France; [Bhattacharya, U.; Grass, T.; Salamon, T.; Lewenstein, M.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelidefels, Spain; [Chhajlany, R. W.] Adam Mickiewicz Univ, Fac Phys, Inst Spintron & Quantum Informat, Poznan, Poland; [Baldwin, K.; Pfeiffer, L.] Princeton Univ, Princeton Inst Sci & Technol Mat, PRISM, Princeton, NJ USA; [Lewenstein, M.] ICREA, Pg Luis Companys, Barcelona, Spain; [Holzmann, M.] Univ Grenoble Alpes, LPMMC, CNRS, Grenoble, France; [Dubin, F.] CRHEA, CNRS, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Adam Mickiewicz University; Princeton University; ICREA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Dubin, F (corresponding author), Inst Nanosci Paris, CNRS, Paris, France.; Dubin, F (corresponding author), Sorbonne Univ, Paris, France.	francois_dubin@icloud.com	Lewenstein, Maciej/I-1337-2014; Bhattacharya, Utso/AAB-4754-2021	Lewenstein, Maciej/0000-0002-0210-7800; Lagoin, Camille/0000-0001-6572-7751; Bhattacharya, Utso/0000-0002-1447-443X; Chhajlany, Ravindra/0000-0003-1069-7924; Dubin, Francois/0000-0001-6536-839X; Grass, Tobias/0000-0002-8163-9353	IXTASE from the French Agency for Research [ANR-20-CE30-0032-01]; Gordon and Betty Moore Foundation through the EPiQS initiative grant [GBMF 9545]; National Science Foundation MRSEC [DMR 1420541]; ERC AdG NOQIA; Agencia Estatal de Investigacion (MCIN/AEI) [CEX2019-000910-S, PID2019-106901GB-I00, MAQS PCI2019-111828-2, PCI2022-132919, RTC2019-007196-7]; MCIN via European Union NextGenerationEU (PRTR); Fundacio Cellex; Fundacio Mir-Puig; Generalitat de Catalunya through the European Social Fund FEDER; CERCA programme (AGAUR) (ERDF Operational Programme of Catalonia 2014-2020) [2017 SGR 134, U16-011424]; EU [899794]; National Science Centre, Poland [2016/20/W/ST4/00314]; European Union [101029393, 847648, ID100010434: LCF/BQ/PI19/11690013, LCF/BQ/PR20/11770012, LCF/BQ/PR21/11840013, LCF/BQ/PI20/11760031]; Polish National Science Centre (NCN) under Maestro grant [DEC2019/34/A/ST2/00081]; Barcelona Supercomputing Center MareNostrum [FI-2022-1-0042]	IXTASE from the French Agency for Research; Gordon and Betty Moore Foundation through the EPiQS initiative grant; National Science Foundation MRSEC(National Science Foundation (NSF)); ERC AdG NOQIA; Agencia Estatal de Investigacion (MCIN/AEI); MCIN via European Union NextGenerationEU (PRTR); Fundacio Cellex(Foundation CELLEX); Fundacio Mir-Puig; Generalitat de Catalunya through the European Social Fund FEDER; CERCA programme (AGAUR) (ERDF Operational Programme of Catalonia 2014-2020); EU(European Commission); National Science Centre, Poland(National Science Centre, Poland); European Union(European Commission); Polish National Science Centre (NCN) under Maestro grant; Barcelona Supercomputing Center MareNostrum	C.L. and F.D. thank S. Suffit for support during sample fabrication, together with A. Reserbat-Plantey and B. Urbaszek for a critical reading of the manuscript. Work at CNRS was funded by IXTASE from the French Agency for Research (ANR-20-CE30-0032-01). The work at Princeton University (L.P. and K.B.) was funded by the Gordon and Betty Moore Foundation through the EPiQS initiative grant GBMF 9545, and by the National Science Foundation MRSEC grant DMR 1420541. Research at ICFO acknowledges support from ERC AdG NOQIA; Agencia Estatal de Investigacion (R&D project CEX2019-000910-S, funded by MCIN/ AEI/10.13039/501100011033, Plan National FIDEUA PID2019-106901GB-I00, FPI, QUANTERA MAQS PCI2019-111828-2, QUANTERA DYNAMITE PCI2022-132919, Proyectos de I+D+I "Retos Colaboracion" QUSPIN RTC2019-007196-7); MCIN via European Union NextGenerationEU (PRTR); Fundacio Cellex; Fundacio Mir-Puig; Generalitat de Catalunya through the European Social Fund FEDER and CERCA programme (AGAUR grant no. 2017 SGR 134, QuantumCAT U16-011424, co-funded by ERDF Operational Programme of Catalonia 2014-2020); the computer resources and technical support at Barcelona Supercomputing Center MareNostrum (FI-2022-1-0042); EU Horizon 2020 FET-OPEN OPTOlogic (grant no 899794); National Science Centre, Poland (Symfonia grant no. 2016/20/W/ST4/00314); European Union's Horizon 2020 research and innovation programme under the Marie-Skodowska-Curie grant agreement no. 101029393 (STREDCH) and no. 847648 ('La Caixa' Junior Leaders fellowships ID100010434: LCF/BQ/PI19/11690013, LCF/BQ/PI20/11760031, LCF/BQ/PR20/11770012, LCF/BQ/PR21/11840013). R.W.C. acknowledges support from the Polish National Science Centre (NCN) under Maestro grant no. DEC2019/34/A/ST2/00081.	Alexeev EM, 2019, NATURE, V567, P81, DOI 10.1038/s41586-019-0986-9; Alloing M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245106; Arovas DP, 2022, ANNU REV CONDEN MA P, V13, P239, DOI 10.1146/annurev-conmatphys-031620-102024; Baier S, 2016, SCIENCE, V352, P201, DOI 10.1126/science.aac9812; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; BATROUNI GG, 1995, PHYS REV LETT, V74, P2527, DOI 10.1103/PhysRevLett.74.2527; Beian M, 2017, EPL-EUROPHYS LETT, V119, DOI 10.1209/0295-5075/119/37004; Bissbort U, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023617; Capogrosso-Sansone B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.125301; Combescot M, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa50e3; DeMarco B, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063601; Dutta O, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066001; Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; Gotting N, 2022, PHYS REV B, V105, DOI 10.1103/PhysRevB.105.165419; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; Gu J, 2022, NAT PHYS, V18, P395, DOI 10.1038/s41567-022-01532-z; Hebert F, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014513; High AA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.087403; Jin CH, 2021, NAT MATER, V20, P940, DOI 10.1038/s41563-021-00959-8; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Kennes DM, 2021, NAT PHYS, V17, P155, DOI 10.1038/s41567-020-01154-3; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Lackner L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24925-9; Lagoin C, 2022, NAT PHYS, V18, P149, DOI 10.1038/s41567-021-01440-8; Lagoin C, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.067404; Lagoin C, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.245428; Mahmud KW, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054302; Remeika M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3682302; Rosenberg I, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.195151; Salomon C., 2012, MANY BODY PHYS ULTRA, V94; Schmid G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167208; Scholl P, 2021, NATURE, V595, P233, DOI 10.1038/s41586-021-03585-1; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Trefzger C, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/19/193001; Winbow AG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196806; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021	41	1	1	14	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927								10.1038/s41586-022-05123-z	http://dx.doi.org/10.1038/s41586-022-05123-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O5MH	36104551	Green Submitted			2022-12-28	WOS:000854741300002
J	Wise, J				Wise, Jacqui			Most incidentally found adrenal tumours are non-functioning, regardless of age, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							MANAGEMENT											Bancos I, 2022, ANN INTERN MED, V175, P1481, DOI 10.7326/M22-2600; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Hanna FWF, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5674; Jing Y, 2022, ANN INTERN MED, V175, P1383, DOI 10.7326/M22-1619	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								o2233	10.1136/bmj.o2233	http://dx.doi.org/10.1136/bmj.o2233			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104071				2022-12-28	WOS:000862323900012
J	Yokomizo, T; Ideue, T; Morino-Koga, S; Tham, CY; Sato, T; Takeda, N; Kubota, Y; Kurokawa, M; Komatsu, N; Ogawa, M; Araki, K; Osato, M; Suda, T				Yokomizo, Tomomasa; Ideue, Takako; Morino-Koga, Saori; Tham, Cheng Yong; Sato, Tomohiko; Takeda, Naoki; Kubota, Yoshiaki; Kurokawa, Mineo; Komatsu, Norio; Ogawa, Minetaro; Araki, Kimi; Osato, Motomi; Suda, Toshio			Independent origins of fetal liver haematopoietic stem and progenitor cells	NATURE			English	Article							MYELOID PROGENITOR; TRANSGENIC MICE; MOUSE; LINEAGE; IDENTIFICATION; MATURATION; GENERATION; EXPANSION; DISTINCT	Self-renewal and differentiation are tightly controlled to maintain haematopoietic stem cell (HSC) homeostasis in the adult bone marrow(1,)(2). During fetal development, expansion of HSCs (self-renewal) and production of differentiated haematopoietic cells (differentiation) are both required to sustain the haematopoietic system for body growth(3,4). However, it remains unclear how these two seemingly opposing tasks are accomplished within the short embryonic period. Here we used in vivo genetic tracing in mice to analyse the formation of HSCs and progenitors from intra-arterial haematopoietic clusters, which contain HSC precursors and express the transcription factor hepatic leukaemia factor (HLF). Through kinetic study, we observed the simultaneous formation of HSCs and defined progenitors-previously regarded as descendants of HSCs5-from the HLF+ precursor population, followed by prompt formation of the hierarchical haematopoietic population structure in the fetal liver in an HSC-independent manner. The transcription factor EVI1 is heterogeneously expressed within the precursor population, with EVI1(hi) cells being predominantly localized to intra-embryonic arteries and preferentially giving rise to HSCs. By genetically manipulating EVI1 expression, we were able to alter HSC and progenitor output from precursors in vivo. Using fate tracking, we also demonstrated that fetal HSCs are slowly used to produce short-term HSCs at late gestation. These data suggest that fetal HSCs minimally contribute to the generation of progenitors and functional blood cells before birth. Stem cell-independent pathways during development thus offer a rational strategy for the rapid and simultaneous growth of tissues and stem cell pools.	[Yokomizo, Tomomasa; Ideue, Takako; Osato, Motomi; Suda, Toshio] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Yokomizo, Tomomasa] Tokyo Womens Med Univ, Microscop & Dev Anat, Tokyo, Japan; [Morino-Koga, Saori; Ogawa, Minetaro] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto, Japan; [Tham, Cheng Yong; Osato, Motomi; Suda, Toshio] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Sato, Tomohiko; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan; [Takeda, Naoki; Araki, Kimi] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan; [Kubota, Yoshiaki] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan; [Komatsu, Norio] Juntendo Univ, Grad Sch Med, Dept Hematol, Tokyo, Japan; [Araki, Kimi] Kumamoto Univ, Ctr Metab Regulat Hlth Aging, Kumamoto, Japan; [Osato, Motomi] Natl Univ Singapore, Dept Paediat, Singapore, Singapore	Kumamoto University; Tokyo Women's Medical University; Kumamoto University; National University of Singapore; University of Tokyo; Kumamoto University; Keio University; Juntendo University; Kumamoto University; National University of Singapore	Yokomizo, T; Suda, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.; Yokomizo, T (corresponding author), Tokyo Womens Med Univ, Microscop & Dev Anat, Tokyo, Japan.; Suda, T (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.	tomoyokomizo@gmail.com; csits@nus.edu.sg		Kubota, Yoshiaki/0000-0001-6672-4122; Sato, Tomohiko/0000-0002-8244-075X; Tham, Cheng Yong/0000-0002-7594-3025; Yokomizo, Tomomasa/0000-0001-6157-2852	JSPS Kakenhi Grant [20K08758, JP16H0627, 26221309]; SENSHIN Medical Research Foundation; Takeda Science Foundation; Japanese Society of Hematology; Sumitomo Foundation; National Medical Research Council grant of Singapore Translational Research Investigator Award [NMRC/STaR/0019/2014]; Inter-University Research Network for High Depth Omics, Institute of Molecular Embryology and Genetics, Kumamoto University	JSPS Kakenhi Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society of Hematology; Sumitomo Foundation; National Medical Research Council grant of Singapore Translational Research Investigator Award; Inter-University Research Network for High Depth Omics, Institute of Molecular Embryology and Genetics, Kumamoto University	We thank E. Dzierzak for critical comments on this manuscript; and T. Umemoto, M. Kataoka and R. Koitabashi for assistance with RNA sequencing. This work was supported by JSPS Kakenhi Grant (20K08758, JP16H0627 (AdAMS) to T.Y. and 26221309 to T. Suda), SENSHIN Medical Research Foundation (to T.Y.), Takeda Science Foundation (to T.Y.), Japanese Society of Hematology (to T.Y.), the Sumitomo Foundation (to T.Y.), the National Medical Research Council grant of Singapore Translational Research Investigator Award (NMRC/STaR/0019/2014 to T. Suda) and the programme of the Inter-University Research Network for High Depth Omics, Institute of Molecular Embryology and Genetics, Kumamoto University (to S.M.-K. and M. Ogawa).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapple RH, 2018, BLOOD ADV, V2, P1220, DOI 10.1182/bloodadvances.2018016295; Chen JY, 2020, AM J PATHOL, V190, P1565, DOI 10.1016/j.ajpath.2020.03.018; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dignum T, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109675; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Draper JE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007127; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Ema H, 2016, J THEOR BIOL, V394, P57, DOI 10.1016/j.jtbi.2016.01.010; Fadlullah MZH, 2022, BLOOD, V139, P343, DOI 10.1182/blood.2020007885; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Glass C, 2014, BLOOD CELL MOL DIS, V53, P67, DOI 10.1016/j.bcmd.2014.01.002; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Haas S, 2018, CELL STEM CELL, V22, P627, DOI 10.1016/j.stem.2018.04.003; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hayashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02866-0; Ishikawa E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12756; Ivanovs A, 2017, DEVELOPMENT, V144, P2323, DOI 10.1242/dev.134866; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsuo J, 2017, GASTROENTEROLOGY, V152, P218, DOI 10.1053/j.gastro.2016.09.018; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; Rybtsov S, 2016, DEVELOPMENT, V143, P1284, DOI 10.1242/dev.131193; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Sawen P, 2018, ELIFE, V7, DOI 10.7554/eLife.41258; Soares-da-Silva F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201729; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsukada M, 2017, STEM CELL REP, V9, P1024, DOI 10.1016/j.stemcr.2017.08.010; Ulloa BA, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109703; Vink CS, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107627; Warnes GR, 2020, GPLOTS VARIOUS R PRO; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yokomizo T, 2019, J EXP MED, V216, P1599, DOI 10.1084/jem.20181399; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	61	0	0	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					779	+		10.1038/s41586-022-05203-0	http://dx.doi.org/10.1038/s41586-022-05203-0		SEP 2022	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36104564				2022-12-28	WOS:000854788200002
J	Auer, RC; Ott, M; Karanicolas, P; Brackstone, MR; Ashamalla, S; Weaver, J; Tagalakis, V; Boutros, M; Stotland, P; Marulanda, AC; Moloo, H; Jayaraman, S; Patel, S; Le Gal, G; Spadafora, S; MacLellan, S; Trottier, D; Jonker, D; Asmis, T; Mallick, R; Pecarskie, A; Ramsay, T; Carrier, M				Auer, Rebecca C.; Ott, Michael; Karanicolas, Paul; Brackstone, Muriel Rebecca; Ashamalla, Shady; Weaver, Joel; Tagalakis, Vicky; Boutros, Marylise; Stotland, Peter; Marulanda, Antonio Caycedo; Moloo, Husein; Jayaraman, Shiva; Patel, Suni; Le Gal, Gregoire; Spadafora, Silvana; MacLellan, Steven; Trottier, Daniel; Jonker, Derek; Asmis, Timothy; Mallick, Ranjeeta; Pecarskie, Amanda; Ramsay, Tim; Carrier, Marc		PERIOP-01 Investigators	Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDIVIDUAL PATIENT DATA; COLON-CANCER; VENOUS THROMBOEMBOLISM; END-POINTS; METAANALYSIS	OBJECTIVETo determine the efficacy and safety of extended duration perioperative thromboprophylaxis by low molecular weight heparin when assessing disease -free survival in patients undergoing resection for colorectal cancer.DESIGNMulticentre, open label, randomised controlled trial.SETTINGS12 hospitals in Quebec and Ontario, Canada, between25 October 2011 and 31 December 2020.PARTICIPANTS614 adults (age s18 years) were eligible with pathologically confirmed invasive adenocarcinoma of the colon or rectum, no evidence of metastatic disease, a haemoglobin concentration of s8 g/dL, and were scheduled to undergo surgical resection.INTERVENTIONSRandom assignment to extended duration thromboprophylaxis using daily subcutaneous tinzaparin at 4500 IU, beginning at decision to operate and continuing for 56 days postoperatively, compared with in-patient postoperative thromboprophylaxis only. MAIN OUTCOME MEASURESPrimary outcome was disease-free survival at three years, defined as survival without locoregional recurrence, distant metastases, second primary (same cancer), second primary (other cancer), or death. Secondary outcomes included venous thromboembolism, postoperative major bleeding complications, and five year overall survival. Analyses were done in the intention-to-treat population.RESULTSThe trial stopped recruitment prematurely after the interim analysis for futility. The primary outcome occurred in 235 (77%) of 307 patients in the extended duration group and in 243 (79%) of 307 patients in the in-hospital thromboprophylaxis group (hazard ratio 1.1, 95% confidence interval 0.90 to 1.33; P=0.4). Postoperative venous thromboembolism occurred in five patients (2%) in the extended duration group and in four patients (1%) in the in-hospital thromboprophylaxis group (P=0.8). Major surgery related bleeding in the first postoperative week was reported in one person (<1%) in the extended duration and in six people (2%) in the in-hospital thromboprophylaxis group (P=0.1). No difference was noted for overall survival at five years in 272 (89%) patients in the extended duration group and 280 (91%) patients in the in-hospital thromboprophylaxis group (hazard ratio 1.12; 95% confidence interval 0.72 to 1.76; P=0.1).CONCLUSIONSExtended duration to perioperative anticoagulation with tinzaparin did not improve disease-free survival or overall survival in patients with colorectal cancer undergoing surgical resection compared with in-patient postoperative thromboprophylaxis alone. The incidences of venous thromboembolism and postoperative major bleeding were low and similar between groups.TRIAL REGISTRATIONClinicalTrials.gov NCT01455831.	[Auer, Rebecca C.; Moloo, Husein] Univ Ottawa, Ottawa Hosp, Dept Surg, Res Inst, Ottawa, ON, Canada; [Ott, Michael; Brackstone, Muriel Rebecca] London Hlth Sci Ctr, Dept Surg, London, ON, Canada; [Karanicolas, Paul; Ashamalla, Shady] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Weaver, Joel] Queensway Carleton Hosp, Dept Surg, Ottawa, ON, Canada; [Tagalakis, Vicky; Boutros, Marylise] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Stotland, Peter] North York Gen Hosp, Dept Surg, N York, ON, Canada; [Marulanda, Antonio Caycedo] Hlth Sci North, Dept Surg, Sudbury, ON, Canada; [Jayaraman, Shiva] St Josephs Hlth Ctr, Dept Surg, Toronto, ON, Canada; [Patel, Suni] Kingston Hlth Sci Ctr, Dept Surg, Kingston, ON, Canada; [Le Gal, Gregoire] Inst Savoir Montfort, Dept Med, Ottawa, ON, Canada; [Le Gal, Gregoire; Jonker, Derek; Asmis, Timothy; Pecarskie, Amanda; Carrier, Marc] Univ Ottawa, Ottawa Hosp, Dept Med, Res Inst, Ottawa, ON, Canada; [Spadafora, Silvana] Sault Area Hosp, Algoma Dist Canc Program, Sault Ste Marie, ON, Canada; [MacLellan, Steven] Humber River Hosp, Dept Surg, Toronto, ON, Canada; [Trottier, Daniel; Ramsay, Tim] Montfort Hosp, Dept Surg, Ottawa, ON, Canada; [Mallick, Ranjeeta] Ottawa Hosp, Method Ctr, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; London Health Sciences Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Lady Davis Institute; McGill University; University of Toronto; University Toronto Affiliates; North York General Hospital; Health Sciences North; Northern Ontario School of Medicine; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Carrier, M (corresponding author), Univ Ottawa, Ottawa Hosp, Dept Med, Res Inst, Ottawa, ON, Canada.	mcarrier@toh.ca			Ottawa Hospital Research Institute; Canadian Institute for Health Research; The Canada Foundation for Innovation; The Cancer Research Society; The Ottawa Hospital Academic Medical Organisation; Leo Pharma; The Ottawa Hospital Foundation.; Department of Surgery, University of Western Ontario; Canadian Institutes of Health Research;  [CDT-142654]	Ottawa Hospital Research Institute; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); The Canada Foundation for Innovation(Canada Foundation for Innovation); The Cancer Research Society; The Ottawa Hospital Academic Medical Organisation; Leo Pharma(LEO Pharma); The Ottawa Hospital Foundation.; Department of Surgery, University of Western Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 	Sponsored by the Ottawa Hospital Research Institute with funding from the Canadian Institute for Health Research, The Canada Foundation for Innovation, The Cancer Research Society, The Ottawa Hospital Academic Medical Organisation, and Leo Pharma, as well as through generous patient donations through The Ottawa Hospital Foundation. Patient recruitment at the London Health Sciences Center was subsidised through funds provided by the Department of Surgery, University of Western Ontario. MC, VT, TR, and GLG are investigators of the CanVECTOR Network; the Network receives grant funding from the Canadian Institutes of Health Research (funding reference: CDT-142654) . RA holds a T1 clinical research chair on Perioperative Cancer Therapeutics from the Department of Surgery, Division of General Surgery, and the University of Ottawa. MC holds a T1 clinical research chair on Cancer and Thrombosis from the Department of Medicine and the University of Ottawa. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Amirkhosravi A, 2003, J THROMB HAEMOST, V1, P1972, DOI 10.1046/j.1538-7836.2003.00341.x; Anderson DR, 2019, BLOOD ADV, V3, P3898, DOI 10.1182/bloodadvances.2019000975; Auer RAC, 2012, ANN SURG, V255, P963, DOI 10.1097/SLA.0b013e31824daccb; Clavien PA, 2009, ANN SURG, V250, P197, DOI 10.1097/SLA.0b013e3181b6dcab; Falanga A, 2007, SEMIN THROMB HEMOST, V33, P688, DOI 10.1055/s-2007-991536; Groen HJM, 2019, BRIT J CANCER, V121, P372, DOI 10.1038/s41416-019-0533-3; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Knoll W, 2021, THROMB RES, V204, P114, DOI 10.1016/j.thromres.2021.06.010; Laubli H, 2016, J CLIN ONCOL, V34, P2560, DOI 10.1200/JCO.2016.66.4607; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Lock JF, 2020, PERIOPER MED-LONDON, V9, DOI 10.1186/s13741-020-00170-4; Meyer G, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01220-2018; Montroy J, 2020, THROMB HAEMOSTASIS, V120, P832, DOI 10.1055/s-0040-1709712; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Sargent D, 2011, EUR J CANCER, V47, P990, DOI 10.1016/j.ejca.2010.12.015; Sargent DJ, 2007, J CLIN ONCOL, V25, P4569, DOI 10.1200/JCO.2006.10.4323; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Seth R, 2013, ANN SURG, V258, P158, DOI 10.1097/SLA.0b013e31826fcbdb; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122	20	0	0	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								e071375	10.1136/bmj-2022-071375	http://dx.doi.org/10.1136/bmj-2022-071375			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100263	Green Published, hybrid			2022-12-28	WOS:000860470700003
J	Roehr, B				Roehr, Bob			Texas judge rules against ObamaCare coverage of HIV prevention drugs on religious grounds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		affordablecareactlitigation.files.wordpress, US; [Anonymous], WASHINGTON POST	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2213	10.1136/bmj.o2213	http://dx.doi.org/10.1136/bmj.o2213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096512				2022-12-28	WOS:000863219000001
J	Dupont, SC; Galea, S				Dupont, Sarah C.; Galea, Sandro			Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dupont, Sarah C.] Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA 30322 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Emory University; Boston University	Dupont, SC (corresponding author), Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA 30322 USA.			dupont, sarah/0000-0001-8282-8984				Bannon A., 2020, IMPACT VIDEO P FAIRN; Lampe JR., 2020, COURTS COVID 19; Marsh SC, 2021, APPL PSYCHOL CRIM JU, V16, P242; Rho Hye Jin, 2020, BASIC DEMOGRAPHIC PR; Schoch-Spana Monica, 2020, J Particip Med, V12, pe18272, DOI 10.2196/18272	5	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					865	867		10.1056/NEJMp2207670	http://dx.doi.org/10.1056/NEJMp2207670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36053231	Bronze			2022-12-28	WOS:000861634500006
J	Taparra, K; Egan, A; Kanagusuku, L				Taparra, Kekoa; Egan, Alana; Kanagusuku, Leimomi			Mental Health and Substance Use Among US Homeless Adolescents RESPONSE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Taparra, Kekoa] Stanford Hlth Care, Dept Radiat Oncol, 875 Blake Wilbur Dr, Stanford, CA 94304 USA; [Egan, Alana] Univ Rhode Isl, Dept Clin Psychol, Kingston, RI 02881 USA; [Kanagusuku, Leimomi] Univ Hawai, Aiea, HI USA	Stanford University; University of Rhode Island	Taparra, K (corresponding author), Stanford Hlth Care, Dept Radiat Oncol, 875 Blake Wilbur Dr, Stanford, CA 94304 USA.	ktaparra@stanford.edu		Taparra, Kekoa/0000-0001-8493-3868				Liu M, 2022, JAMA-J AM MED ASSOC, V327, P1820, DOI 10.1001/jama.2022.4422; Mathieu S, 2021, LANCET REG HEALTH-W, V17, DOI 10.1016/j.lanwpc.2021.100283; Taparra K., 2021, JAMA-HEALTH FORUM, V2, DOI [10.1001/jamahealthforum.2021.0153, DOI 10.1001/JAMAHEALTHFORUM.2021.0153]; Taparra K, 2021, JAMA-J AM MED ASSOC, V326, P2432, DOI 10.1001/jama.2021.19243; Yuan S, STREET YOUTH STUDY	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					889	890						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066525				2022-12-28	WOS:000855171700028
J	Koo, BK; Hu, XY; Kang, JH; Zhang, JL; Jiang, J; Hahn, JY; Nam, CW; Doh, JH; Lee, BK; Kim, W; Huang, JY; Jiang, F; Zhou, H; Chen, P; Tang, LJ; Jiang, WB; Chen, XM; He, WM; Ahn, SG; Yoon, MH; Kim, U; Lee, JM; Hwang, D; Ki, YJ; Shin, ES; Kim, HS; Tahk, SJ; Wang, JA				Koo, Bon-Kwon; Hu, Xinyang; Kang, Jeehoon; Zhang, Jinlong; Jiang, Jun; Hahn, Joo-Yong; Nam, Chang-Wook; Doh, Joon-Hyung; Lee, Bong-Ki; Kim, Weon; Huang, Jinyu; Jiang, Fan; Zhou, Hao; Chen, Peng; Tang, Lijiang; Jiang, Wenbing; Chen, Xiaomin; He, Wenming; Ahn, Sung-Gyun; Yoon, Myeong-Ho; Kim, Ung; Lee, Joo-Myung; Hwang, Doyeon; Ki, You-Jeong; Shin, Eun-Seok; Kim, Hyo-Soo; Tahk, Seung-Jea; Wang, Jian'an			Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-OUTCOMES; ARTERY-DISEASE; PLAQUE CHARACTERISTICS; STENT IMPLANTATION; ANGIOGRAPHY; STENOSIS; DESIGN; SEVERITY; THERAPY	BACKGROUND In patients with coronary artery disease who are being evaluated for percutaneous coronary intervention (PCI), procedures can be guided by fractional flow reserve (FFR) or intravascular ultrasonography (IVUS) for decision making regarding revascularization and stent implantation. However, the differences in clinical outcomes when only one method is used for both purposes are unclear. METHODS We randomly assigned 1682 patients who were being evaluated for PCI for the treatment of intermediate stenosis (40 to 70% occlusion by visual estimation on coronary angiography) in a 1:1 ratio to undergo either an FFR-guided or IVUSguided procedure. FFR or IVUS was to be used to determine whether to perform PCI and to assess PCI success. In the FFR group, PCI was to be performed if the FFR was 0.80 or less. In the IVUS group, the criteria for PCI were a minimal lumen area measuring either 3 mm(2) or less or measuring 3 to 4 mm2 with a plaque burden of more than 70%. The primary outcome was a composite of death, myocardial infarction, or revascularization at 24 months after randomization. We tested the noninferiority of the FFR group as compared with the IVUS group (noninferiority margin, 2.5 percentage points). RESULTS The frequency of PCI was 44.4% among patients in the FFR group and 65.3% among those in the IVUS group. At 24 months, a primary-outcome event had occurred in 8.1% of the patients in the FFR group and in 8.5% of those in the IVUS group (absolute difference, -0.4 percentage points; upper boundary of the onesided 97.5% confidence interval, 2.2 percentage points; P = 0.01 for noninferiority). Patient-reported outcomes as reported on the Seattle Angina Questionnaire were similar in the two groups. CONCLUSIONS In patients with intermediate stenosis who were being evaluated for PCI, FFR guidance was noninferior to IVUS guidance with respect to the composite primary outcome of death, myocardial infarction, or revascularization at 24 months. (Funded by Boston Scientific; FLAVOUR ClinicalTrials.gov number, NCT02673424.) The grees, Appendix. wja@zju.edu.cn Cardiology, Zhejiang 88 Jiefang Tahk or Yeongtong-gu, *A equally This Copyright at	[Koo, Bon-Kwon; Kang, Jeehoon; Hwang, Doyeon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Seoul, South Korea; [Hahn, Joo-Yong; Lee, Joo-Myung] Samsung Med Ctr, Seoul, South Korea; [Kim, Weon] Kyung Hee Univ Hosp, Seoul, South Korea; [Nam, Chang-Wook] Keimyung Univ Dongsan Med Ctr, Daegu, South Korea; [Kim, Ung] Yeungnam Univ, Med Ctr, Daegu, South Korea; [Doh, Joon-Hyung] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea; [Lee, Bong-Ki] Kangwon Natl Univ Hosp, Chunchon, South Korea; [Ahn, Sung-Gyun] Wonju Severance Christian Hosp, Wonju, South Korea; [Yoon, Myeong-Ho; Tahk, Seung-Jea] Ajou Univ Hosp, Suwon, South Korea; [Ki, You-Jeong] Uijeongbu Eulji Med Ctr, Uijongbu, South Korea; [Shin, Eun-Seok] Ulsan Univ Hosp, Univ Ulsan Coll Med, Ulsan, South Korea; [Hu, Xinyang; Zhang, Jinlong; Jiang, Jun; Wang, Jian'an] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China; [Huang, Jinyu] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Hangzhou, Peoples R China; [Jiang, Fan] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Peoples R China; [Tang, Lijiang] Zhejiang Hosp, Hangzhou, Peoples R China; [Zhou, Hao] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China; [Chen, Peng] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China; [Jiang, Wenbing] Wenzhou Med Univ, Clin Inst 3, Wenzhou, Peoples R China; [Chen, Xiaomin] Ningbo First Hosp, Ningbo, Peoples R China; [He, Wenming] Ningbo Univ, Affiliated Hosp, Med Sch, Ningbo, Peoples R China	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Keimyung University; Yeungnam University; Inje University; Kangwon National University; Kangwon National University Hospital; Ajou University; Ajou University Hospital; University of Ulsan; Ulsan University Hospital; Zhejiang University; Zhejiang University; Hangzhou Normal University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Ningbo University	Koo, BK (corresponding author), Seoul Natl Univ Hosp, Seoul, South Korea.			Hahn, Joo-Yong/0000-0002-4412-377X				Buccheri S, 2017, JACC-CARDIOVASC INTE, V10, P2488, DOI 10.1016/j.jcin.2017.08.051; Burzotta F, 2020, JACC-CARDIOVASC INTE, V13, P49, DOI 10.1016/j.jcin.2019.09.034; Calvert PA, 2011, JACC-CARDIOVASC IMAG, V4, P894, DOI 10.1016/j.jcmg.2011.05.005; Collison D, 2021, EUR HEART J, V42, P4656, DOI 10.1093/eurheartj/ehab449; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Davies JE, 2017, NEW ENGL J MED, V376, P1824, DOI 10.1056/NEJMoa1700445; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Elgendy IY, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003700; Garzillo CL, 2019, JAMA INTERN MED, V179, P1345, DOI 10.1001/jamainternmed.2019.2227; Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540; Head SJ, 2012, EUR HEART J, V33, P1318, DOI 10.1093/eurheartj/ehs099; Hong SJ, 2022, JACC-CARDIOVASC INTE, V15, P208, DOI 10.1016/j.jcin.2021.10.020; Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454; Iannaccone M, 2020, CATHETER CARDIO INTE, V95, P1259, DOI 10.1002/ccd.28410; Jang HJ, 2013, EUR HEART J, V34, P2055, DOI 10.1093/eurheartj/eht040; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; Kang J, 2018, AM HEART J, V199, P7, DOI 10.1016/j.ahj.2017.11.001; Kedhi E, 2021, EUR HEART J, V42, P4671, DOI 10.1093/eurheartj/ehab433; Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013; Kumar A, 2018, J AM COLL CARDIOL, V72, P1926, DOI 10.1016/j.jacc.2018.07.075; Lee JM, 2019, J AM COLL CARDIOL, V73, P2413, DOI 10.1016/j.jacc.2019.02.060; Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922; Mauri L, 2017, NEW ENGL J MED, V377, P1357, DOI 10.1056/NEJMra1510063; Mintz GS, 2017, LANCET, V390, P793, DOI 10.1016/S0140-6736(17)31957-8; Nam CW, 2010, JACC-CARDIOVASC INTE, V3, P812, DOI 10.1016/j.jcin.2010.04.016; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Park KW, 2014, AM HEART J, V167, P384, DOI 10.1016/j.ahj.2013.09.015; Puymirat E, 2021, NEW ENGL J MED, V385, P297, DOI 10.1056/NEJMoa2104650; Rioufol G, 2021, J AM COLL CARDIOL, V78, P1875, DOI 10.1016/j.jacc.2021.08.061; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Waksman R, 2013, J AM COLL CARDIOL, V61, P917, DOI 10.1016/j.jacc.2012.12.012; Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Yang S, 2022, JACC-CARDIOVASC IMAG, V15, P1139, DOI 10.1016/j.jcmg.2021.10.009; Yang S, 2021, JACC-CARDIOVASC IMAG, V14, P1977, DOI 10.1016/j.jcmg.2021.04.004; Zhang JJ, 2018, J AM COLL CARDIOL, V72, P3126, DOI 10.1016/j.jacc.2018.09.013	36	3	3	18	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					779	789		10.1056/NEJMoa2201546	http://dx.doi.org/10.1056/NEJMoa2201546			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053504				2022-12-28	WOS:000849132700006
J	Capitanio, U; Montorsi, F				Capitanio, Umberto; Montorsi, Francesco			Identifying patients for adjuvant therapy after nephrectomy	LANCET			English	Editorial Material									[Capitanio, Umberto; Montorsi, Francesco] Ist Sci San Raffaele, Dept Urol, Milan, Italy; [Capitanio, Umberto; Montorsi, Francesco] IRCCS San Raffaele Hosp, Urol Res Inst, Div Expt Oncol, Unit Urol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Capitanio, U (corresponding author), Ist Sci San Raffaele, Dept Urol, Milan, Italy.	capitanio.umberto@hsr.it						Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Choueiri TK, 2021, NEW ENGL J MED, V385, P683, DOI 10.1056/NEJMoa2106391; Correa AF, 2021, EUR UROL, V80, P20, DOI 10.1016/j.eururo.2021.02.025; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Martini A, 2021, WORLD J UROL, V39, P1369, DOI 10.1007/s00345-020-03550-z; Pal SK, 2022, LANCET, V400, P1103, DOI 10.1016/S0140-6736(22)01658-0; Powles T, 2022, LANCET ONCOL, V23, P1133, DOI 10.1016/S1470-2045(22)00487-9; Procopio G, 2019, EUR UROL ONCOL, V2, P699, DOI 10.1016/j.euo.2019.08.011; Rosiello G, 2022, UROL ONCOL-SEMIN ORI, V40, DOI 10.1016/j.urolonc.2021.12.010; Yu KJ, 2018, CANCER-AM CANCER SOC, V124, P4023, DOI 10.1002/cncr.31661	10	0	0	11	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1080	1081		10.1016/S0140-6736(22)01747-0	http://dx.doi.org/10.1016/S0140-6736(22)01747-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36099928				2022-12-28	WOS:000877828800002
J	Shoamanesh, A; Mundl, H; Smith, EE; Masjuan, J; Milanov, I; Hirano, T; Agafina, A; Campbell, B; Caso, V; Mas, JL; Dong, Q; Turcani, P; Christensen, H; Ferro, JM; Veltkamp, R; Mikulik, R; Marchis, GMD; Robinson, T; Lemmens, R; Stepien, A; Greisenegger, S; Roine, R; Csiba, L; Khatri, P; Coutinho, J; Lindgren, AG; Demchuk, AM; Colorado, P; Kirsch, B; Neumann, C; Heenan, L; Xu, LZ; Connolly, SJ; Hart, RG; PACIFIC-Stroke Invest				Shoamanesh, Ashkan; Mundl, Hardi; Smith, Eric E.; Masjuan, Jaime; Milanov, Ivan; Hirano, Teruyuki; Agafina, Alina; Campbell, Bruce; Caso, Valeria; Mas, Jean-Louis; Dong, Qiang; Turcani, Peter; Christensen, Hanne; Ferro, Jose M.; Veltkamp, Roland; Mikulik, Robert; Marchis, Gian Marco De; Robinson, Thompson; Lemmens, Robin; Stepien, Adam; Greisenegger, Stefan; Roine, Risto; Csiba, Laszlo; Khatri, Pooja; Coutinho, Jonathan; Lindgren, Arne G.; Demchuk, Andrew M.; Colorado, Pablo; Kirsch, Bodo; Neumann, Christoph; Heenan, Laura; Xu, Lizhen; Connolly, Stuart J.; Hart, Robert G.; PACIFIC-Stroke Invest			Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo- controlled, phase 2b trial	LANCET			English	Article							BRAIN INFARCTS; RISK; ASPIRIN; CLASSIFICATION; RIVAROXABAN; PREVENTION	Background Asundexian (Bayer AG, Leverkusen, Germany), an oral small molecule factor XIa (FXIa) inhibitor, might prevent thrombosis without increasing bleeding. Asundexian's effect for secondary prevention of recurrent stroke is unknown. Methods In this randomised, double-blind, placebo-controlled, phase 2b dose-finding trial (PACIFIC-Stroke), patients with acute (within 48 h) non-cardioembolic ischaemic stroke were recruited from 196 hospitals in 23 countries. Patients were eligible if they were aged 45 years or older, to be treated with antiplatelet therapy, and able to have a baseline MRI (either before or within 72 h of randomisation). Eligible participants were randomly assigned (1:1:1:1), using an interactive web-based response system and stratified according to anticipated antiplatelet therapy (single vs dual), to once daily oral asundexian (BAY 2433334) 10 mg, 20 mg, or 50 mg, or placebo in addition to usual antiplatelet therapy, and were followed up during treatment for 26-52 weeks. Brain MRIs were obtained at study entry and at 26 weeks or as soon as possible after treatment discontinuation. The primary efficacy outcome was the dose-response effect on the composite of incident MRI-detected covert brain infarcts and recurrent symptomatic ischaemic stroke at or before 26 weeks after randomisation. The primary safety outcome was major or clinically relevant non-major bleeding as defined by International Society on Thrombosis and Haemostasis criteria. The efficacy outcome was assessed in all participants assigned to treatment, and the safety outcome was assessed in all participants who received at least one dose of study treatment. This study is registered with ClinicalTrials.gov, NCT04304508, and is now complete. Findings Between June 15, 2020, and July 22, 2021, 1880 patients were screened and 1808 participants were randomly assigned to asundexian 10 mg (n=455), 20 mg (n=450), or 50 mg (n=447), or placebo (n=456). Mean age was 67 years (SD 10) and 615 (34%) participants were women, 1193 (66%) were men, 1505 (83%) were White, and 268 (15%) were Asian. The mean time from index stroke to randomisation was 36 h (SD 10) and median baseline National Institutes of Health Stroke Scale score was 2.0 (IQR 1.0-4.0). 783 (43%) participants received dual antiplatelet treatment for a mean duration of 70.1 days (SD 113.4) after randomisation. At 26 weeks, the primary efficacy outcome was observed in 87 (19%) of 456 participants in the placebo group versus 86 (19%) of 455 in the asundexian 10 mg group (crude incidence ratio 0.99 [90% CI 0.79-1.24]), 99 (22%) of 450 in the asundexian 20 mg group (1.15 [0.93-1.43]), and 90 (20%) of 447 in the asundexian 50 mg group (1.06 [0.85-1.32]; t statistic -0.68; p=0 center dot 80). The primary safety outcome was observed in 11 (2%) of 452 participants in the placebo group versus 19 (4%) of 445 in the asundexian 10 mg group, 14 (3%) of 446 in the asundexian 20 mg group, and 19 (4%) of 443 in the asundexian 50 mg group (all asundexian doses pooled vs placebo hazard ratio 1.57 [90% CI 0.91-2.71]). Interpretation In this phase 2b trial, FXIa inhibition with asundexian did not reduce the composite of covert brain infarction or ischaemic stroke and did not increase the composite of major or clinically relevant non-major bleeding compared with placebo in patients with acute, non-cardioembolic ischaemic stroke. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Shoamanesh, Ashkan; Hart, Robert G.] McMaster Univ, Populat Hlth Res Inst, Div Neurol, Hamilton, ON, Canada; [Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Dept Med, Hamilton, ON, Canada; [Heenan, Laura; Xu, Lizhen] McMaster Univ, Populat Hlth Res Inst, Dept Stat, Hamilton, ON, Canada; [Mundl, Hardi] TA Thrombosis & Vasc Med Bayer AG, Wuppertal, Germany; [Smith, Eric E.; Demchuk, Andrew M.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Smith, Eric E.; Demchuk, Andrew M.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Radiol, Calgary, AB, Canada; [Masjuan, Jaime] Hosp Univ Ramon & Cajal, Neurol Dept, Madrid, Spain; [Masjuan, Jaime] Univ Alcala, Fac Med, IRYCIS,RICORS ICTUS, Dept Med, Madrid, Spain; [Milanov, Ivan] Med Univ, Univ Hosp Neurol & Psychiat St Naum, Sofia, Bulgaria; [Hirano, Teruyuki] Kyorin Univ, Sch Med, Dept Stroke & Cerebrovasc Med, Tokyo, Japan; [Agafina, Alina] City Hosp 40, Clin Res Dept, St Petersburg, Russia; [Campbell, Bruce] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med & Neurol, Parkville, Vic, Australia; [Caso, Valeria] Univ Perugia, St Maria Misericordia Hosp, Stroke Unit, Perugia, Italy; [Mas, Jean-Louis] Univ Paris Cite, GHU Paris, Hop St Anne, Dept Neurol, Paris, France; [Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Turcani, Peter] Comenius Univ, Med Fac, Dept Neurol 1, Bratislava, Slovakia; [Christensen, Hanne] Univ Hosp Copenhagen, Dept Neurol, Bispebjerg, Denmark; [Ferro, Jose M.] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Veltkamp, Roland] Alfried Krupp Hosp, Neurol Dept, Essen, Germany; [Mikulik, Robert] St Annes Univ Hosp, Int Clin Res Ctr, Neurol Dept, Brno, Czech Republic; [Mikulik, Robert] Masaryk Univ, Med Fac, Brno, Czech Republic; [Marchis, Gian Marco De] Univ Basel, Univ Hosp Basel, Stroke Ctr, Dept Neurol, Basel, Switzerland; [Robinson, Thompson] Univ Leicester, Coll Life Sci, Leicester, Leicestershire, England; [Lemmens, Robin] Univ Leuven, KU Leuven, Dept Neurosci Expt Neurol, Leuven, Belgium; [Lemmens, Robin] Katholieke Univ Leuven, Ctr Brain & Dis Res VIB, Leuven, Belgium; [Lemmens, Robin] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Stepien, Adam] Mil Inst Med, Dept Neurol, Warsaw, Poland; [Greisenegger, Stefan] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Roine, Risto] Univ Turku, Div Clin Neurosci, Turku, Finland; [Csiba, Laszlo] Univ Debrecen, Debrecen, Hungary; [Khatri, Pooja] Univ Cincinnati, Dept Neurol & Rehabil Sci, Cincinnati, OH USA; [Coutinho, Jonathan] Univ Amsterdam, Amsterdam UMC, Dept Neurol, Amsterdam, Netherlands; [Lindgren, Arne G.] Lund Univ, Dept Clin Sci Lund Neurol, Lund, Sweden; [Colorado, Pablo] Bayer US Pharmaceut, Whippany, NJ USA; [Kirsch, Bodo] Bayer AG, Stat & Data Insights, Berlin, Germany; [Shoamanesh, Ashkan] McMaster Univ, Populat Hlth Res Inst, Div Neurol, Hamilton, ON L9G 1J8, Canada	McMaster University; Population Health Research Institute; McMaster University; Population Health Research Institute; McMaster University; Population Health Research Institute; University of Calgary; University of Calgary; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Medical University Sofia; Kyorin University; Royal Melbourne Hospital; University of Melbourne; University of Perugia; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Fudan University; Comenius University Bratislava; University of Copenhagen; Universidade de Lisboa; Alfried Krupp Hospital; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; University of Basel; University of Leicester; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Military Institute of Aviation Medicine; Medical University of Vienna; University of Turku; University of Debrecen; University System of Ohio; University of Cincinnati; University of Amsterdam; Vrije Universiteit Amsterdam; Lund University; Bayer AG; McMaster University; Population Health Research Institute	Shoamanesh, A (corresponding author), McMaster Univ, Populat Hlth Res Inst, Div Neurol, Hamilton, ON, Canada.; Shoamanesh, A (corresponding author), McMaster Univ, Populat Hlth Res Inst, Div Neurol, Hamilton, ON L9G 1J8, Canada.	ashkan.shoamanesh@phri.ca		Neumann, Christoph/0000-0001-8765-2068; Robinson, Thompson/0000-0003-2144-2468; Roine, Risto/0000-0002-3824-3003	Bayer AG	Bayer AG(Bayer AG)	This trial was funded by Bayer AG.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Chen HT, 2021, J THROMB HAEMOST, V19, P2781, DOI 10.1111/jth.15486; Chong M, 2019, CIRCULATION, V140, P819, DOI 10.1161/CIRCULATIONAHA.119.040180; Dawson J, 2021, EUR STROKE J, V6, pCLXXXVII, DOI 10.1177/23969873211000877; Eikelboom JW., 2017, NEW ENGL J MED, V377, P1319, DOI DOI 10.1056/NEJMOA1709118; Fredenburgh JC, 2021, HAMOSTASEOLOGIE, V41, P104, DOI 10.1055/a-1384-3715; Ganor RS, 2016, ARTERIOSCL THROM VAS, V36, P475, DOI 10.1161/ATVBAHA.115.306954; Gill D, 2018, STROKE, V49, P2761, DOI 10.1161/STROKEAHA.118.022792; Gladstone DJ, 2022, CAN J NEUROL SCI, V49, P315, DOI 10.1017/cjn.2021.127; Hsu C, 2021, J AM COLL CARDIOL, V78, P625, DOI 10.1016/j.jacc.2021.06.010; Johnston SC, 2020, NEW ENGL J MED, V383, P207, DOI 10.1056/NEJMoa1916870; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Kargiotis O, 2021, CURR OPIN NEUROL, V34, P45, DOI 10.1097/WCO.0000000000000878; Kleindorfer DO, 2021, STROKE, V52, pE364, DOI 10.1161/STR.0000000000000375; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Perera KS, 2020, JAMA NEUROL, V77, P43, DOI 10.1001/jamaneurol.2019.2984; Piccini JP, 2022, LANCET, V399, P1383, DOI 10.1016/S0140-6736(22)00456-1; Sacco RL, 2004, NEUROLOGY, V62, pS7, DOI 10.1212/WNL.62.8_suppl_6.S7; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Santamaria A, 2007, INT J CLIN PRACT, V61, P1819, DOI 10.1111/j.1742-1241.2007.01388.x; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sharma M, 2022, STROKE, V53, P45, DOI 10.1161/STROKEAHA.120.032976; Sharma M, 2020, STROKE, V51, P2901, DOI 10.1161/STROKEAHA.120.029762; Siegerink B, 2014, J THROMB HAEMOST, V12, P606, DOI 10.1111/jth.12531; Verhamme P, 2021, NEW ENGL J MED, V385, P609, DOI 10.1056/NEJMoa2105872; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; von Kummer R, 2015, STROKE, V46, P2981, DOI 10.1161/STROKEAHA.115.010049; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Weitz JI, 2021, NEW ENGL J MED, V385, P2161, DOI 10.1056/NEJMoa2113194; Weitz JI, 2020, JAMA-J AM MED ASSOC, V323, P130, DOI 10.1001/jama.2019.20687	31	5	5	25	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					997	1007		10.1016/S0140-6736(22)01588-4	http://dx.doi.org/10.1016/S0140-6736(22)01588-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5S3JP	36063821				2022-12-28	WOS:000875091000001
J	Feinmann, J				Feinmann, Jane			Should "safe space" material be kept confidential?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						[Anonymous], 2022, THEY WORK YOU; [Anonymous], 2018, WHAT ROLE DID REFLEC; Crown Office Row, HIGH COURT RUL SHOR; Crown Prosecution Service, GROSS NEGL MANSL; Department of Health and Social Care, 2022, FIN REP OCK REV; Department of Health and Social Care, 2018, WILL REV GROSS NEGL; Dunn J, 2015, DAILY MAIL; General Medical Council, IND REV GROSS NEGL M; HSIB, US; Medical Defence Union, 2020, MED DEF UN LAUNCH NE	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o1944	10.1136/bmj.o1944	http://dx.doi.org/10.1136/bmj.o1944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126989				2022-12-28	WOS:000869963500015
J	Hussain, Z				Hussain, Zainab			Fossil fuels: Health professionals call for legally binding plan for global phase out	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		fossilfueltreaty, HLTH PROFESSIONALS C	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o2258	10.1136/bmj.o2258	http://dx.doi.org/10.1136/bmj.o2258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126987	Bronze			2022-12-28	WOS:000869963500009
J	Larkin, HD				Larkin, Howard D.			Backslide in Global Childhood Vaccinations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1029	1029		10.1001/jama.2022.14708	http://dx.doi.org/10.1001/jama.2022.14708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125465				2022-12-28	WOS:000862909200007
J	Boglaienko, D				Boglaienko, Daria			The meaning of home	SCIENCE			English	Editorial Material									[Boglaienko, Daria] Pacific Northwest Natl Lab, Richland, WA 99354 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Boglaienko, D (corresponding author), Pacific Northwest Natl Lab, Richland, WA 99354 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1354	1354						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36107994				2022-12-28	WOS:000887933500044
J	Popp, PF; Erhardt, M				Popp, Philipp F.; Erhardt, Marc			Supercoiled filaments propel them all	CELL			English	Editorial Material								In this issue of Cell, Kreutzberger and colleagues report the near-atomic-resolution, cryo-EM structures of the supercoiled filaments of both bacterial and archaeal motility machines. Despite the lack of homology, the supercoiled filament structures reveal shared fundamental features of prokaryotic locomotion and repre-sent a prime example of convergent evolution.	[Popp, Philipp F.; Erhardt, Marc] Humboldt Univ, Inst Biol Bacterial Physiol, Berlin, Germany; [Erhardt, Marc] Max Planck Unit Sci Pathogens, Berlin, Germany	Humboldt University of Berlin	Erhardt, M (corresponding author), Humboldt Univ, Inst Biol Bacterial Physiol, Berlin, Germany.; Erhardt, M (corresponding author), Max Planck Unit Sci Pathogens, Berlin, Germany.	marc.erhardt@hu-berlin.de		Popp, Philipp/0000-0002-7825-1550; Erhardt, Marc/0000-0001-6292-619X	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [864971]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	This work was supported in part by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant to M.E.; agreement no. 864971).	BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; Kreutzberger MAB, 2022, CELL, V185, P3487, DOI 10.1016/j.cell.2022.08.009	3	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3461	3463		10.1016/j.cell.2022.08.016	http://dx.doi.org/10.1016/j.cell.2022.08.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4Z5ET	36113424				2022-12-28	WOS:000862232500002
J	[Anonymous]				[Anonymous]			Update to living WHO guideline on drugs for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								o2224	10.1136/bmj.o2224	http://dx.doi.org/10.1136/bmj.o2224			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109041				2022-12-28	WOS:000888774200006
J	Larkin, HD				Larkin, Howard D.			Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					917	917		10.1001/jama.2022.14711	http://dx.doi.org/10.1001/jama.2022.14711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098737	Bronze			2022-12-28	WOS:000855222400006
J	Ro, I; Qi, J; Lee, S; Xu, MJ; Yan, XX; Xie, ZH; Zakem, G; Morales, A; Chen, JGG; Pan, XQ; Vlachos, DG; Caratzoulas, S; Christopher, P				Ro, Insoo; Qi, Ji; Lee, Seungyeon; Xu, Mingjie; Yan, Xingxu; Xie, Zhenhua; Zakem, Gregory; Morales, Austin; Chen, Jingguang G.; Pan, Xiaoqing; Vlachos, Dionisios G.; Caratzoulas, Stavros; Christopher, Phillip			Bifunctional hydroformylation on heterogeneous Rh-WOx pair site catalysts	NATURE			English	Article							WATER-GAS SHIFT; INTERFACIAL SITES; CO; SPECTROSCOPY; STABILITY; OXIDATION	Metal-catalysed reactions are often hypothesized to proceed on bifunctional active sites, whereby colocalized reactive species facilitate distinct elementary steps in a catalytic cycle(1-8). Bifunctional active sites have been established on homogeneous binuclear organometallic catalysts(9-11). Empirical evidence exists for bifunctional active sites on supported metal catalysts, for example, at metal-oxide support interfaces(2,6,7,12) . However, elucidating bifunctional reaction mechanisms on supported metal catalysts is challenging due to the distribution of potential active-site structures, their dynamic reconstruction and required non-mean-field kinetic descriptions(7,12,13) . We overcome these limitations by synthesizing supported, atomically dispersed rhodium-tungsten oxide (Rh-WOx) pair site catalysts. The relative simplicity of the pair site structure and sufficient description by mean-field modelling enable correlation of the experimental kinetics with first principles-based microkinetic simulations. The Rh-WOx pair sites catalyse ethylene hydroformylation through a bifunctional mechanism involving Rh-assisted WO(x )reduction, transfer of ethylene from WOx to Rh and H-2 dissociation at the Rh-WOx interface. The pair sites exhibited >95% selectivity at a product formation rate of 0.1g(propanal) CM-3 h(-l) in gas-phase ethylene hydroformylation. Our results demonstrate that oxide-supported pair sites can enable bifunctional reaction mechanisms with high activity and selectivity for reactionsthat are performed in industry using homogeneous catalysts.	[Ro, Insoo; Qi, Ji; Zakem, Gregory; Morales, Austin; Christopher, Phillip] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Ro, Insoo] Seoul Natl Univ Sci & Technol, Dept Chem & Biomol Engn, Seoul, South Korea; [Ro, Insoo; Qi, Ji; Lee, Seungyeon; Vlachos, Dionisios G.; Christopher, Phillip] Catalysis Ctr Energy Innovat, Newark, DE 19716 USA; [Lee, Seungyeon; Vlachos, Dionisios G.; Caratzoulas, Stavros] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA; [Xu, Mingjie; Yan, Xingxu; Pan, Xiaoqing] Univ Calif Irvine, Dept Mat Sci & Engn, Irvine, CA USA; [Xie, Zhenhua; Chen, Jingguang G.] Brookhaven Natl Lab, Div Chem, Upton, NY 11973 USA; [Xie, Zhenhua; Chen, Jingguang G.] Columbia Univ, Dept Chem Engn, New York, NY USA; [Pan, Xiaoqing] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA; [Pan, Xiaoqing] Univ Calif Irvine, Irvine Mat Res Inst, Irvine, CA USA	University of California System; University of California Santa Barbara; Seoul National University of Science & Technology; University of Delaware; University of California System; University of California Irvine; United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University; University of California System; University of California Irvine; University of California System; University of California Irvine	Christopher, P (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.; Christopher, P (corresponding author), Catalysis Ctr Energy Innovat, Newark, DE 19716 USA.	pchristopher@ucsb.edu	Pan, Xiaoqing/ABF-4088-2020	Pan, Xiaoqing/0000-0002-0965-8568	Catalysis Center for Energy Innovation - US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001004]; NSF [CBET-2031494, CHE-1955786]; DOE Office of Science [DE-SC0012704]; Synchrotron Catalysis Consortium (US DOE, Office of Basic Energy Sciences) [DE-SC0012335]; National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [NRF-2021R1F1A1054980]; NSF through the MRSEC program [DMR-2011967]	Catalysis Center for Energy Innovation - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); DOE Office of Science(United States Department of Energy (DOE)); Synchrotron Catalysis Consortium (US DOE, Office of Basic Energy Sciences)(United States Department of Energy (DOE)); National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); NSF through the MRSEC program(National Science Foundation (NSF))	I.R., J.Q., S.L., D.G.V., S.C. and P.C. acknowledge the Catalysis Center for Energy Innovation, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under award number DE-SC0001004. M.X., X.Y. and X.P. acknowledges the NSF awards under grant nos CBET-2031494 and CHE-1955786 for support for the microscopy. This research used 7-BM (QAS) beamline of the National Synchrotron Light Source II, a US DOE Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract no. DE-SC0012704. Beamline operations were supported in part by the Synchrotron Catalysis Consortium (US DOE, Office of Basic Energy Sciences, grant no. DE-SC0012335). I.R. acknowledges the National Research Foundation of Korea (NRF) grant funded by The Ministry of Science and ICT (MSIT) (NRF-2021R1F1A1054980). The authors acknowledge the use of facilities and instrumentation at the UC Irvine Materials Research Institute (IMRI) supported in part by the NSF through the MRSEC program (DMR-2011967). We acknowledge A. B. Getsoian for providing the 10% Rh/Al<INF>2</INF>O<INF>3</INF> Rh nanoparticle control sample. J. Resasco is acknowledged for his comments on the paper.	Alexeev O, 1996, J CATAL, V164, P1, DOI 10.1006/jcat.1996.0357; Andersen M, 2016, ANGEW CHEM INT EDIT, V55, P5210, DOI 10.1002/anie.201601049; Barton DG, 1999, J PHYS CHEM B, V103, P630, DOI 10.1021/jp983555d; Baz A, 2020, J CATAL, V384, P1, DOI 10.1016/j.jcat.2020.02.003; Blasco T, 2007, ANGEW CHEM INT EDIT, V46, P3938, DOI 10.1002/anie.200700029; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brundage MA, 1996, J CATAL, V164, P94, DOI 10.1006/jcat.1996.0366; Campos J, 2020, NAT REV CHEM, V4, P696, DOI 10.1038/s41570-020-00226-5; Cao LN, 2019, NATURE, V565, P631, DOI 10.1038/s41586-018-0869-5; Carrasquillo-Flores R, 2015, J AM CHEM SOC, V137, P10317, DOI 10.1021/jacs.5b05945; Chupas PJ, 2008, J APPL CRYSTALLOGR, V41, P822, DOI 10.1107/S0021889808020165; Coltrin M. E., 1996, SAND968217; Darby MT, 2018, J PHYS CHEM LETT, V9, P5636, DOI 10.1021/acs.jpclett.8b01888; Digne M, 2002, J CATAL, V211, P1, DOI 10.1006/jcat.2002.3741; Garland M, 2016, TOP ORGANOMETAL CHEM, V59, P187, DOI 10.1007/3418_2015_151; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hetterscheid DGH, 2013, CHEMCATCHEM, V5, P2785, DOI 10.1002/cctc.201300092; Hoffman A. J., 2021, J PHYS CHEM C, V2021, P19733; Kattel S, 2017, J AM CHEM SOC, V139, P9739, DOI 10.1021/jacs.7b05362; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kumar G, 2018, ACS CATAL, V8, P3202, DOI 10.1021/acscatal.8b00145; Lam E, 2019, ANGEW CHEM INT EDIT, V58, P13989, DOI 10.1002/anie.201908060; Lange JP, 2021, NAT CATAL, V4, P186, DOI 10.1038/s41929-021-00585-2; Lee S, 2021, ACS CATAL, V11, P9506, DOI 10.1021/acscatal.1c00705; Li CY, 2018, FRONT CHEM SCI ENG, V12, P113, DOI 10.1007/s11705-017-1672-9; Lwin S, 2016, ACS CATAL, V6, P3061, DOI 10.1021/acscatal.6b00389; Lwin S, 2015, ACS CATAL, V5, P1432, DOI 10.1021/cs5016518; Lym J, 2020, COMPUT PHYS COMMUN, V247, DOI 10.1016/j.cpc.2019.106864; Matsubu JC, 2017, NAT CHEM, V9, P120, DOI [10.1038/nchem.2607, 10.1038/NCHEM.2607]; Matsubu JC, 2015, J AM CHEM SOC, V137, P3076, DOI 10.1021/ja5128133; Mol JC, 2004, J MOL CATAL A-CHEM, V213, P39, DOI 10.1016/j.molcata.2003.10.049; Navidi N, 2014, APPL CATAL A-GEN, V469, P357, DOI 10.1016/j.apcata.2013.10.019; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Perez-Aguilar JE, 2020, J AM CHEM SOC, V142, P11474, DOI 10.1021/jacs.0c03730; Qi J, 2020, J AM CHEM SOC, V142, P14178, DOI 10.1021/jacs.0c05026; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; RICE CA, 1981, J CHEM PHYS, V74, P6487, DOI 10.1063/1.440987; Ro I, 2019, ACS CATAL, V9, P10899, DOI 10.1021/acscatal.9b02111; Ro I, 2018, J CATAL, V358, P19, DOI 10.1016/j.jcat.2017.11.021; Ross-Medgaarden EI, 2007, J PHYS CHEM C, V111, P15089, DOI 10.1021/jp074219c; Saavedra J, 2014, SCIENCE, V345, P1599, DOI 10.1126/science.1256018; Shekhar M, 2012, J AM CHEM SOC, V134, P4700, DOI 10.1021/ja210083d; Sheppard D, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3684549; Sheppard D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841941; Shylesh S, 2013, ACS CATAL, V3, P348, DOI 10.1021/cs3007445; Sirita J, 2007, ANAL CHEM, V79, P3912, DOI 10.1021/ac0702802; Sparta M, 2007, J AM CHEM SOC, V129, P8487, DOI 10.1021/ja070395n; Whittaker T, 2018, J AM CHEM SOC, V140, P16469, DOI 10.1021/jacs.8b04991; Zhao ZJ, 2017, J CATAL, V345, P157, DOI 10.1016/j.jcat.2016.11.008	49	4	4	78	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					287	+		10.1038/s41586-022-05075-4	http://dx.doi.org/10.1038/s41586-022-05075-4			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2BA	36071187				2022-12-28	WOS:000852437200001
J	Han, MK; Ye, W; Wang, D; White, E; Arjomandi, M; Barjaktarevic, IZ; Brown, SA; Buhr, RG; Comellas, AP; Cooper, CB; Criner, GJ; Dransfield, MT; Drescher, F; Folz, RJ; Hansel, NN; Kaner, RJ; Kanner, RE; Krishnan, JA; Lazarus, SC; Maddipati, V; Martinez, FJ; Mathews, A; Meldrum, C; McEvoy, C; Nyunoya, T; Rogers, L; Stringer, WW; Wendt, CH; Wise, RA; Wisniewski, SR; Sciurba, FC; Woodruff, PG; RETHINC Study Grp				Han, MeiLan K. K.; Ye, Wen; Wang, Di; White, Emily; Arjomandi, Mehrdad; Barjaktarevic, Igor Z.; Brown, Stacey-Ann; Buhr, Russell G.; Comellas, Alejandro P.; Cooper, Christopher B.; Criner, Gerard J.; Dransfield, Mark T.; Drescher, Frank; Folz, Rodney J.; Hansel, Nadia N.; Kaner, Robert J.; Kanner, Richard E.; Krishnan, Jerry A.; Lazarus, Stephen C.; Maddipati, Veeranna; Martinez, Fernando J.; Mathews, Anne; Meldrum, Catherine; McEvoy, Charlene; Nyunoya, Toru; Rogers, Linda; Stringer, William W.; Wendt, Christine H.; Wise, Robert A.; Wisniewski, Stephen R.; Sciurba, Frank C.; Woodruff, Prescott G.; RETHINC Study Grp			Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPD; SMOKERS; SPIROMETRY; DISEASE; CAT	BACKGROUND Many persons with a history of smoking tobacco have clinically significant respiratory symptoms despite an absence of airflow obstruction as assessed by spirometry. They are often treated with medications for chronic obstructive pulmonary disease (COPD), but supporting evidence for this treatment is lacking. METHODS We randomly assigned persons who had a tobacco-smoking history of at least 10 pack-years, respiratory symptoms as defined by a COPD Assessment Test score of at least 10 (scores range from 0 to 40, with higher scores indicating worse symptoms), and preserved lung function on spirometry (ratio of forced expiratory volume in 1 second [FEV1] to forced vital capacity [FVC] >= 0.70 and FVC >= 70% of the predicted value after bronchodilator use) to receive either indacaterol (27.5 mu g) plus glycopyrrolate (15.6 mu g) or placebo twice daily for 12 weeks. The primary outcome was at least a 4-point decrease (i.e., improvement) in the St. George's Respiratory Questionnaire (SGRQ) score (scores range from 1 to 100, with higher scores indicating worse health status) after 12 weeks without treatment failure (defined as an increase in lower respiratory symptoms treated with a long-acting inhaled bronchodilator, glucocorticoid, or antibiotic agent). RESULTS A total of 535 participants underwent randomization. In the modified intention-to-treat population (471 participants), 128 of 227 participants (56.4%) in the treatment group and 144 of 244 (59.0%) in the placebo group had a 4-point decrease in the SGRQ score (difference, -2.6 percentage points; 95% confidence interval [CI], -11.6 to 6.3; adjusted odds ratio, 0.91; 95% CI, 0.60 to 1.37; P=0.65). The mean change in the percent of predicted FEV1 was 2.48 percentage points (95% CI, 1.49 to 3.47) in the treatment group and -0.09 percentage points (95% CI, -1.06 to 0.89) in the placebo group, and the mean change in the inspiratory capacity was 0.12 liters (95% CI, 0.07 to 0.18) in the treatment group and 0.02 liters (95% CI, -0.03 to 0.08) in the placebo group. Four serious adverse events occurred in the treatment group, and 11 occurred in the placebo group; none were deemed potentially related to the treatment or placebo. CONCLUSIONS Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in symptomatic, tobacco-exposed persons with preserved lung function as assessed by spirometry.	[Han, MeiLan K. K.; Meldrum, Catherine] Univ Michigan, Div Pulm & Crit Care, Ann Arbor, MI USA; [Ye, Wen; Wang, Di; White, Emily] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA; [Arjomandi, Mehrdad; Lazarus, Stephen C.; Woodruff, Prescott G.] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA; [Lazarus, Stephen C.; Woodruff, Prescott G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Arjomandi, Mehrdad] San Francisco Vet Affairs VA Healthcare Syst, San Francisco, CA USA; [Barjaktarevic, Igor Z.; Buhr, Russell G.; Cooper, Christopher B.] UCLA, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA USA; [Stringer, William W.] UCLA, Lundquist Inst Biomed Innovat Harbor, Med Ctr, Los Angeles, CA USA; [Brown, Stacey-Ann; Hansel, Nadia N.; Wise, Robert A.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Comellas, Alejandro P.] Univ Iowa, Div Pulm Crit Care & Occupat Med, Iowa City, IA USA; [Criner, Gerard J.] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA USA; [Dransfield, Mark T.] Univ Alabama Birmingham, Heersink Sch Med, Div Pulm Allergy & Crit Care Med, Birmingham, Warwick, England; [Drescher, Frank] VA Med Ctr, Geisel Sch Med Dartmouth & Pulm & Crit Care Med, White River Jct, VT USA; [Folz, Rodney J.] Houston Methodist Acad Med Associates, Div Pulm Crit Care & Sleep Med, Houston, TX USA; [Kaner, Robert J.] Weill Cornell Med & New York Presbyterian Hosp, Dept Genet Med, New York, NY USA; [Kaner, Robert J.; Martinez, Fernando J.] Weill Cornell Med & New York Presbyterian Hosp, Joan & Sanford I Weill Dept Med, New York, NY USA; [Rogers, Linda] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY USA; [Kaner, Robert J.] Univ Utah, Sch Med, Div Resp Crit Care & Occupat Pulm Med, Salt Lake City, UT USA; [Krishnan, Jerry A.] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Breathe Chicago Ctr, Chicago, IL USA; [Maddipati, Veeranna] East Carolina Univ, Greenville, NC USA; [Mathews, Anne] Duke Univ, Sch Med, Durham, NC USA; [McEvoy, Charlene] HealthPartners Inst, Bloomington, MN USA; [Meldrum, Catherine] Minneapolis VA Healthcare Syst, Minneapolis, MN USA; [Nyunoya, Toru; Sciurba, Frank C.] Univ Pittsburgh, Div Pulm Allergy &Crit Care Med, Pittsburgh, PA USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Epidemiol Data Ctr, Pittsburgh, PA USA; [Han, MeiLan K. K.] Univ Michigan, Div Pulm & Crit Care, 1150 W Med Ctr Dr,6220 MSRB 3 SPC 5642, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; NewYork-Presbyterian Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar; NewYork-Presbyterian Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Icahn School of Medicine at Mount Sinai; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; East Carolina University; Duke University; HealthPartners Institute for Education & Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Han, MK (corresponding author), Univ Michigan, Div Pulm & Crit Care, 1150 W Med Ctr Dr,6220 MSRB 3 SPC 5642, Ann Arbor, MI 48109 USA.	mrking@umich.edu	Maddipati, Veeranna/ADO-4111-2022	Buhr, Russell/0000-0001-6159-7435; Maddipati, Veeranna/0000-0003-3412-5824; Comellas, Alejandro/0000-0003-1521-7520				[Anonymous], 1965, LANCET, V1, P775; Bateman ED, 2013, EUR RESPIR J, V42, P1484, DOI 10.1183/09031936.00200212; Choi JY, 2019, INT J CHRONIC OBSTR, V14, P3043, DOI 10.2147/COPD.S228307; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; Han MK, 2020, COPD-J COPD FDN, V7, DOI 10.15326/jcopdf.7.4.2020.0157; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Heffler E, 2018, RESP MED, V142, P48, DOI 10.1016/j.rmed.2018.07.015; Jones Paul W, 2005, COPD, V2, P75; Kesimer M, 2017, NEW ENGL J MED, V377, P911, DOI 10.1056/NEJMoa1701632; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; Mahler Donald A, 2005, COPD, V2, P99; Mahler DA, 2015, AM J RESP CRIT CARE, V192, P1068, DOI 10.1164/rccm.201505-1048OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NICE, 2004, CHRON OBSTR PULM DIS; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Rocha V., 2021, FRONT REHABILIT SCI, V2, P729190, DOI [10.3389/fresc.2021.729190/full, DOI 10.3389/FRESC.2021.729190/FULL]; Singh D, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0023-2021; Stott-Miller M, 2020, INT J CHRONIC OBSTR, V15, P2467, DOI 10.2147/COPD.S267002; Tan WC, 2015, THORAX, V70, P822, DOI 10.1136/thoraxjnl-2015-206938; Tan WC, 2014, THORAX, V69, P709, DOI 10.1136/thoraxjnl-2013-205048; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1111/resp.13012, 10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1164/rccm.201701-0218PP]; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971	23	1	1	17	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2022	387	13					1173	1184		10.1056/NEJMoa2204752	http://dx.doi.org/10.1056/NEJMoa2204752		SEP 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6F6WD	36066078				2022-12-28	WOS:000849836200001
J	Yan, H; Opachaloemphan, C; Carmona-Aldana, F; Mancini, G; Mlejnek, J; Descostes, N; Sieriebriennikov, B; Leibholz, A; Zhou, XF; Ding, L; Traficante, M; Desplan, C; Reinberg, D				Yan, Hua; Opachaloemphan, Comzit; Carmona-Aldana, Francisco; Mancini, Giacomo; Mlejnek, Jakub; Descostes, Nicolas; Sieriebriennikov, Bogdan; Leibholz, Alexandra; Zhou, Xiaofan; Ding, Long; Traficante, Maria; Desplan, Claude; Reinberg, Danny			Insulin signaling in the long-lived reproductive caste of ants	SCIENCE			English	Article							LIFE-SPAN; GROWTH; DROSOPHILA; METABOLISM; LONGEVITY; EVOLUTION; RECEPTOR; WORKERS; QUEENS; TARGET	In most organisms, reproduction is correlated with shorter life span. However, the reproductive queen in eusocial insects exhibits a much longer life span than that of workers. In Harpegnathos ants, when the queen dies, workers can undergo an adult caste switch to reproductive pseudo-queens (gamergates), exhibiting a five-times prolonged life span. To explore the relation between reproduction and longevity, we compared gene expression during caste switching. Insulin expression is increased in the gamergate brain that correlates with increased lipid synthesis and production of vitellogenin in the fat body, both transported to the egg. This results from activation of the mitogen-activated protein kinase (MAPK) branch of the insulin signaling pathway. By contrast, the production in the gamergate developing ovary of anti-insulin Imp-L2 leads to decreased signaling of the AKT/forkhead box O (FOXO) branch in the fat body, which is consistent with their extended longevity.	[Yan, Hua; Opachaloemphan, Comzit; Carmona-Aldana, Francisco; Descostes, Nicolas; Sieriebriennikov, Bogdan; Reinberg, Danny] New York Univ, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Yan, Hua; Reinberg, Danny] New York Univ, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA; [Yan, Hua] Univ Florida, Dept Biol, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Mancini, Giacomo; Mlejnek, Jakub; Sieriebriennikov, Bogdan; Leibholz, Alexandra; Ding, Long; Traficante, Maria; Desplan, Claude] New York Univ, Dept Biol, New York, NY 10003 USA; [Zhou, Xiaofan] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou 510642, Peoples R China; [Descostes, Nicolas] European Mol Biol Labs, I-00015 Monterotondo, Italy	New York University; Howard Hughes Medical Institute; New York University; State University System of Florida; University of Florida; New York University; South China Agricultural University; European Molecular Biology Laboratory (EMBL)	Reinberg, D (corresponding author), New York Univ, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA.; Reinberg, D (corresponding author), New York Univ, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA.; Desplan, C (corresponding author), New York Univ, Dept Biol, New York, NY 10003 USA.	cd38@nyu.edu; danny.reinberg@nyulangone.org	; Sieriebriennikov, Bogdan/AAG-5293-2021	Ding, Long/0000-0001-7877-6878; Mlejnek, Jakub/0000-0003-4997-2735; Carmona-Aldana, Francisco/0000-0001-6785-9504; Sieriebriennikov, Bogdan/0000-0002-2948-7292	Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award (CIA) [2009005, HCIA 2009005]; NIH [R21GM114457, R01EY13010, R01AG058762]; NIH Ruth L. Kirschstein NRSA postdoctoral fellowship [F32AG044971]; NSF I/UCRC CAMTech grant [IIP1821914]; Human Frontier Science Program long-term fellowship [LT000010/2020-L]	Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award (CIA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF I/UCRC CAMTech grant; Human Frontier Science Program long-term fellowship(Human Frontier Science Program)	This work was supported by Howard Hughes Medical Institute (HHMI) Collaborative Innovation Award (CIA) 2009005 and HCIA 2009005 to D.R. and C.D.; NIH grants R21GM114457 (to D.R.), R01EY13010 (to C.D.), and R01AG058762 (to D.R. and C.D.); NIH Ruth L. Kirschstein NRSA postdoctoral fellowship F32AG044971 and NSF I/UCRC CAMTech grant IIP1821914 to H.Y.; and Human Frontier Science Program long-term fellowship LT000010/2020-L to B.S.	Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Armstrong AR, 2018, DEV BIOL, V440, P31, DOI 10.1016/j.ydbio.2018.04.028; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brown KE, 2007, DEV BIOL, V307, P105, DOI 10.1016/j.ydbio.2007.04.025; Chandra V, 2018, SCIENCE, V361, P398, DOI 10.1126/science.aar5723; CHIN E, 1994, ENDOCRINOLOGY, V134, P2498, DOI 10.1210/en.134.6.2498; Decio P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154891; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Ghaninia M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03964-7; Gospocic J, 2017, CELL, V170, P748, DOI 10.1016/j.cell.2017.07.014; Holldobler B., 1990, pi; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hun LV, 2019, J INSECT PHYSIOL, V118, DOI 10.1016/j.jinsphys.2019.103932; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liebig J, 2004, ECOL ENTOMOL, V29, P203, DOI 10.1111/j.1365-2311.2004.00583.x; Liebig J, 2000, P NATL ACAD SCI USA, V97, P4124, DOI 10.1073/pnas.97.8.4124; Manning L, 2017, MECH DEVELOP, V148, P56, DOI 10.1016/j.mod.2017.06.003; Negroni MA, 2016, CURR OPIN INSECT SCI, V16, P51, DOI 10.1016/j.cois.2016.05.008; Opachaloemphan C, 2020, GENE DEV, V34, P410, DOI 10.1101/gad.343699.120; Opachaloemphan C, 2018, ANNU REV GENET, V52, P489, DOI 10.1146/annurev-genet-120116-024456; Parkhitko AA, 2020, ELIFE, V9, DOI 10.7554/eLife.58053; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Peeters C, 2000, INSECT SOC, V47, P325, DOI 10.1007/PL00001724; Penick CA, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2021.0141; Penick CA, 2014, J EXP BIOL, V217, P1496, DOI 10.1242/jeb.098301; Seite S, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-021-02974-6; Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 2011, EXP GERONTOL, V46, P363, DOI 10.1016/j.exger.2010.12.002; Tatar M, 2010, ANN NY ACAD SCI, V1204, P149, DOI 10.1111/j.1749-6632.2010.05522.x; Ueki I, 2000, P NATL ACAD SCI USA, V97, P6868, DOI 10.1073/pnas.120172697; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yan H, 2021, GENE DEV, V35, P470, DOI 10.1101/gad.346965.120	40	0	0	69	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1092	+		10.1126/science.abm8767	http://dx.doi.org/10.1126/science.abm8767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048960	Green Accepted			2022-12-28	WOS:000887933200044
J	Devauchelle-Pensec, V; Carvajal-Alegria, G; Dernis, E; Richez, C; Truchetet, ME; Wendling, D; Toussirot, E; Perdriger, A; Gottenberg, JE; Felten, R; Fautrel, BJ; Chiche, L; Hilliquin, P; Le Henaff, C; Dervieux, B; Direz, G; Chary-Valckenaere, I; Cornec, D; Guellec, D; Marhadour, T; Nowak, E; Saraux, A				Devauchelle-Pensec, Valerie; Carvajal-Alegria, Guillermo; Dernis, Emmanuelle; Richez, Christophe; Truchetet, Marie-Elise; Wendling, Daniel; Toussirot, Eric; Perdriger, Aleth; Gottenberg, Jacques-Eric; Felten, Renaud; Fautrel, Bruno Jean; Chiche, Laurent; Hilliquin, Pascal; Le Henaff, Catherine; Dervieux, Benjamin; Direz, Guillaume; Chary-Valckenaere, Isabelle; Cornec, Divi; Guellec, Dewi; Marhadour, Thierry; Nowak, Emmanuel; Saraux, Alain			Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GIANT-CELL ARTERITIS; ACTIVITY SCORE; RHEUMATISM/AMERICAN COLLEGE; EUROPEAN LEAGUE; DOUBLE-BLIND; PLACEBO; RECOMMENDATIONS; VALIDITY; CRITERIA	IMPORTANCE Few treatments are available for patients with glucocorticoid-dependent polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active glucocorticoid-dependent polymyalgia rheumatica. OBJECTIVE To compare the efficacy of tocilizumab vs placebo in patients with glucocorticoid-dependent polymyalgia rheumatica. DESIGN, SETTING, AND PARTICIPANTS This double-blind, parallel-group, placebo-controlled randomized clinical trial enrolled 101 patients with polymyalgia rheumatica at 17 hospitals in France from February 2017 to October 2019. Final follow-up occurred in November 2020. Inclusion criteria were persistent disease activity (polymyalgia rheumatica activity score computed using the C-reactive protein level [CRP PMR-AS] >10) and prednisone dose greater than or equal to 10mg per day. INTERVENTIONS Patients were randomly assigned to receive intravenous tocilizumab (8mg/kg; n = 51) or placebo (n = 50) every 4 weeks for 24 weeks, combined with predefined standardized tapering of oral prednisone. MAIN OUTCOMES AND MEASURES The primary efficacy end pointwas CRP PMR-AS less than 10 (range, 0-100; higher values indicate greater activity; no minimal clinically important difference defined) combined with either prednisone dose less than or equal to 5mg per day or a decrease in prednisone dose greater than or equal to 10mg from baseline at week 24. There were 11 secondary outcomes assessed at week 24 included in this report, including disease activity (measured by CRP PMR-AS) and the proportion of patients no longer taking prednisone. RESULTS Of the 101 randomized patients (mean age, 67.2 years; 68 [67.3%] women), 100 (99%) received at least 1 infusion and 100 completed the trial. The primary end point was achieved in 67.3% of patients in the tocilizumab group and 31.4% of patients in the placebo group (adjusted difference, 36.0% [95% CI, 19.4%-52.6%]; adjusted relative risk, 2.3 [95% CI, 1.5-3.6]; P <.001). Of 11 reported secondary end points at 24 weeks, 7 showed significant differences favoring tocilizumab, including mean CRP PMR-AS score (7.5 [95% CI, 5.4-9.6] vs 14.9 [95% CI, 11.4-18.4]; adjusted difference, -7.5 [95% CI, -11.2 to -3.8]; P <.001) and the percentage of patients no longer receiving prednisone (49.0% vs 19.6%; adjusted difference, 29.3%[95% CI, 18.9%-39.7%]; adjusted relative risk, 2.5 [95% CI, 1.8-3.5]; P <.001). The most frequent adverse events were infections, experienced by 23 patients (46.9%) in the tocilizumab group and 20 (39.2%) in the placebo group. CONCLUSIONS AND RELEVANCE Among patients with active polymyalgia rheumatica despite prednisone therapy, tocilizumab, compared with placebo, resulted in a significantly greater percentage of patients with a CRP PMR-AS less than 10 with reduced prednisone requirements at week 24. Further research is needed to confirm efficacy and to determine the balance of potential benefits and harms.	[Devauchelle-Pensec, Valerie; Carvajal-Alegria, Guillermo; Cornec, Divi; Marhadour, Thierry; Saraux, Alain] Brest Univ Hosp, Rheumatol Dept, Brest, France; [Devauchelle-Pensec, Valerie; Carvajal-Alegria, Guillermo; Cornec, Divi; Saraux, Alain] Brest Univ, INSERM 1227, Brest, France; [Dernis, Emmanuelle; Direz, Guillaume] Community Hosp, Dept Rheumatol, Le Mans, France; [Richez, Christophe; Truchetet, Marie-Elise] Bordeaux Univ, Bordeaux Univ Hosp, Rheumatol Dept, Bordeaux, France; [Richez, Christophe; Truchetet, Marie-Elise] Bordeaux Univ, Bordeaux, France; [Wendling, Daniel] Bourgogne Franche Comte Univ, Besancon Reg Univ Hosp, Dept Rheumatol, Besancon, France; [Wendling, Daniel] Bourgogne Franche Comte Univ, Besancon, France; [Toussirot, Eric] Besancon Univ Hosp Besancon, CIC1 431, INSERM, Clin Invest Ctr, Besancon, France; [Perdriger, Aleth] Univ 1 Rennes, Sch Med, Dept Rheumatol, South Hosp, Rennes, France; [Gottenberg, Jacques-Eric; Felten, Renaud] Strasbourg Univ Hosp, Dept Rheumatol, Strasbourg, France; [Fautrel, Bruno Jean] Sorbonne Univ, Pitie Salpetriere Hosp, Assistance Publ Hop Paris, Dept Rheumatol, Paris, France; [Chiche, Laurent] European Hosp, Internal Med Dept, Marseille, France; [Hilliquin, Pascal] Ctr Hosp Sud Francilien, Dept Rheumatol, Corbeil Essonnes, France; [Le Henaff, Catherine] Hosp Morlaix, Dept Rheumatol, Morlaix, France; [Dervieux, Benjamin] Hosp Mulhouse, Dept Internal Med, Mulhouse, France; [Chary-Valckenaere, Isabelle] Nancy Univ Hosp, Dept Rheumatol, Nancy, France; [Guellec, Dewi] Natl Hlth & Med Res Inst INSERM, Clin Invest Ctr CIC 1412, Brest, France; [Nowak, Emmanuel] Brest Univ Hosp, Publ Agcy Clin Res & Innovat DRCI, Brest, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Franche-Comte; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Centre Hospitalier Sud Francilien; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest	Devauchelle-Pensec, V (corresponding author), Hop Cavale Blanche, Rheumatol Unit, BP 824, F-29609 Brest, France.	valerie.devauchelle-pensec@chu-brest.fr			French National Program for Clinical Research; Roche-Chugai Pharmaceutical	French National Program for Clinical Research; Roche-Chugai Pharmaceutical(Johnson & Johnson)	The funders of this study were the French National Program for Clinical Research and the study sponsor (ie, the Brest University Hospital). Roche-Chugai Pharmaceutical provided an unconditional grant for the study and donated the tocilizumab used for the study.	Alegria GC, 2021, JOINT BONE SPINE, V88, DOI 10.1016/j.jbspin.2020.105117; Alegria GC, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102670; Alegria GC, 2017, RHEUMATOLOGY, V56, P1401, DOI 10.1093/rheumatology/kex169; Binard A, 2009, ANN RHEUM DIS, V68, P541, DOI 10.1136/ard.2008.088526; Binard A, 2008, ARTHRIT RHEUM-ARTHR, V59, P263, DOI 10.1002/art.23338; Binard A, 2007, ARTHRIT RHEUM-ARTHR, V57, P481, DOI 10.1002/art.22630; Buttgereit F, 2016, JAMA-J AM MED ASSOC, V315, P2442, DOI 10.1001/jama.2016.5444; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Alegria GC, 2021, RHEUMATOL THER, V8, P751, DOI 10.1007/s40744-021-00299-8; Chino K, 2019, INT J RHEUM DIS, V22, P2151, DOI 10.1111/1756-185X.13723; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Cleuziou C, 2012, J RHEUMATOL, V39, P310, DOI 10.3899/jrheum.110866; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Dejaco C, 2015, ANN RHEUM DIS, V74, P1799, DOI 10.1136/annrheumdis-2015-207492; Dejaco C, 2011, ANN RHEUM DIS, V70, P447, DOI 10.1136/ard.2010.133850; Devauchelle V, 2016, ANN RHEUM DIS, V75, pE48, DOI 10.1136/annrheumdis-2016-209607; Devauchelle-Pensec V, 2018, RHEUMATOLOGY, V57, P666, DOI 10.1093/rheumatology/kex477; Devauchelle-Pensec V, 2016, ANN RHEUM DIS, V75, P1506, DOI 10.1136/annrheumdis-2015-208742; Huwart A, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-017-1499-2; Kremers HM, 2005, J RHEUMATOL, V32, P65; Lally L, 2016, ARTHRITIS RHEUMATOL, V68, P2550, DOI 10.1002/art.39740; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; Leeb BF, 2004, ANN RHEUM DIS, V63, P1279, DOI 10.1136/ard.2003.011379; Leeb BF, 2003, ANN RHEUM DIS, V62, P1189, DOI 10.1136/ard.2002.002618; Marsman DE, 2021, LANCET RHEUMATOL, V3, pE758, DOI 10.1016/S2665-9913(21)00245-9; Miloslavsky EM, 2017, ANN RHEUM DIS, V76, P543, DOI 10.1136/annrheumdis-2016-210002; Palard-Novello X, 2016, EUR J NUCL MED MOL I, V43, P773, DOI 10.1007/s00259-015-3287-z; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P33, DOI 10.1002/art.20901; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Spiera R, 2021, SEMIN ARTHRITIS RHEU, V51, P469, DOI 10.1016/j.semarthrit.2021.03.006; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Strehl C, 2016, ANN RHEUM DIS, V75, P952, DOI 10.1136/annrheumdis-2015-208916; Twohig H, 2021, J RHEUMATOL, V48, P883, DOI 10.3899/jrheum.200248; van der Geest KSM, 2014, ARTHRITIS RHEUMATOL, V66, P1927, DOI 10.1002/art.38625; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; Yates M, 2020, J RHEUMATOL, V47, P1379, DOI 10.3899/jrheum.190575	37	1	1	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1053	1062		10.1001/jama.2022.15459	http://dx.doi.org/10.1001/jama.2022.15459			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125471				2022-12-28	WOS:000862909200019
J	de Lange, ME; Huirne, JAF				de lange, Maria E.; Huirne, Judith A. F.			Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding	LANCET			English	Editorial Material							ELAGOLIX		[Huirne, Judith A. F.] Vrije Univ Amsterdam, Dept Obstet & Gynaecol, Amsterdam UMC, Amsterdam Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [de lange, Maria E.] Amsterdam Reprod & Dev Res Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Huirne, JAF (corresponding author), Vrije Univ Amsterdam, Dept Obstet & Gynaecol, Amsterdam UMC, Amsterdam Med Ctr, NL-1105 AZ Amsterdam, Netherlands.	j.huirne@amsterdamumc.nl						Armer RE, 2004, CURR MED CHEM, V11, P3017, DOI 10.2174/0929867043363983; Donnez J, 2022, LANCET, V400, P896, DOI 10.1016/S0140-6736(22)01475-1; Frijlingh M, 2020, EUR J OBSTET GYN R B, V245, P186, DOI 10.1016/j.ejogrb.2019.08.002; Giuliani E, 2020, INT J GYNECOL OBSTET, V149, P3, DOI 10.1002/ijgo.13102; Huirne JAF, 2001, LANCET, V358, P1793, DOI 10.1016/S0140-6736(01)06797-6; Middelkoop MA, 2022, HUM REPROD, V37, P884, DOI 10.1093/humrep/deac009; Munro MG, 2011, FERTIL STERIL, V95, P2204, DOI 10.1016/j.fertnstert.2011.03.079; Ng J, 2017, J CLIN ENDOCR METAB, V102, P1683, DOI 10.1210/jc.2016-3845; Osuga Y, 2019, OBSTET GYNECOL, V133, P423, DOI 10.1097/AOG.0000000000003141; Rana D, 2021, BJOG-INT J OBSTET GY, V128, P1793, DOI 10.1111/1471-0528.16781; Simon JA, 2020, OBSTET GYNECOL, V135, P1313, DOI 10.1097/AOG.0000000000003869	11	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					866	867						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116467				2022-12-28	WOS:000890180700003
J	Faucon, AL; Messai, N; Pardon, A				Faucon, Anne-Laure; Messai, Nesrine; Pardon, Agathe			A sweet unilateral pleural effusion: pleuro-peritoneal communication in a patient on dialysis	LANCET			English	Editorial Material									[Faucon, Anne-Laure; Pardon, Agathe] Ctr Hosp Sud Francilien, Dept Nephrol, Corbeil Essonnes, France; [Messai, Nesrine] Ctr Hosp Sud Francilien, Dept Nucl Med, Corbeil Essonnes, France; [Faucon, Anne-Laure] Univ Paris Saclay, Ctr Res Epidemiol & Populat Hlth, Clin Epidemiol Unit, INSERM UMRS 1018, Paris, France	Centre Hospitalier Sud Francilien; Centre Hospitalier Sud Francilien; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Faucon, AL (corresponding author), Ctr Hosp Sud Francilien, Dept Nephrol, Corbeil Essonnes, France.; Faucon, AL (corresponding author), Univ Paris Saclay, Ctr Res Epidemiol & Populat Hlth, Clin Epidemiol Unit, INSERM UMRS 1018, Paris, France.	anne-laure.faucon@aphp.fr							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					920	920						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116482				2022-12-28	WOS:000890180700024
J	Chang, LL				Chang, Leslie L.			Management of Hyperglycemia in Hospitalized, Non-Critically Ill Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ASSOCIATION	Managing Hyperglycemia in Non-Critically Ill Adults This interactive feature about management of hyperglycemia in non-critically ill inpatients who had been receiving metformin at home offers a case vignette accompanied by two essays, one supporting continuing metformin in the hospital and the other stopping metformin and initiating insulin therapy.										Amod A, 2020, DIABETES THER, V11, P53, DOI [10.2337/dci19-0066, 10.1007/s13300-019-00715-x]; Haltmeier T, 2016, WORLD J SURG, V40, P1575, DOI 10.1007/s00268-016-3469-2; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Maynard G., 2015, GLYCEMIC CONTROL IMP; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Pasquel FJ, 2021, ANN INTERN MED, V174, pHO2, DOI 10.7326/M21-2789; Pasquel FJ, 2021, LANCET DIABETES ENDO, V9, P174, DOI 10.1016/S2213-8587(20)30381-8; Reitz KM, 2020, JAMA SURG, V155, DOI 10.1001/jamasurg.2020.0416; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub4; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098	10	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					1040	1042		10.1056/NEJMclde2204691	http://dx.doi.org/10.1056/NEJMclde2204691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36103419				2022-12-28	WOS:000865415300018
J	Christie, B				Christie, Bryan			Assisted dying: Legislation has widespread support in Scotland	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2205	10.1136/bmj.o2205	http://dx.doi.org/10.1136/bmj.o2205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096516				2022-12-28	WOS:000863219000002
J	Dyer, C				Dyer, Clare			Consultant caught by undercover police making plan to abuse girl is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Medical Practitioners Tribunal Service, RECORD DETERMINATION	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o2198	10.1136/bmj.o2198	http://dx.doi.org/10.1136/bmj.o2198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096511				2022-12-28	WOS:000863219000005
J	Boughton, CK; Allen, JM; Ware, J; Wilinska, ME; Hartnell, S; Thankamony, A; Randell, T; Ghatak, A; Besser, REJ; Elleri, D; Trevelyan, N; Campbell, FM; Sibayan, J; Calhoun, P; Bailey, R; Dunseath, G; Hovorka, R				Boughton, Charlotte K.; Allen, Janet M.; Ware, Julia; Wilinska, Malgorzata E.; Hartnell, Sara; Thankamony, Ajay; Randell, Tabitha; Ghatak, Atrayee; Besser, Rachel E. J.; Elleri, Daniela; Trevelyan, Nicola; Campbell, Fiona M.; Sibayan, Judy; Calhoun, Peter; Bailey, Ryan; Dunseath, Gareth; Hovorka, Roman		CLOuD Consortium	Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL FUNCTION; RANDOMIZED-TRIAL; COMPLICATIONS; VARIABILITY; ADOLESCENTS; CHILDREN; ADULTS	BACKGROUND Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. METHODS In a multicenter, open-label, parallel-group, randomized trial, we assigned youths 10.0 to 16.9 years of age within 21 days after a diagnosis of type 1 diabetes to receive hybrid closed-loop therapy or standard insulin therapy (control) for 24 months. The primary end point was the area under the curve (AUC) for the plasma C-peptide level (after a mixed-meal tolerance test) at 12 months after diagnosis. The analysis was performed on an intention-to-treat basis. RESULTS A total of 97 participants (mean [+/- SD] age, 12 +/- 2 years) underwent randomization: 51 were assigned to receive closed-loop therapy and 46 to receive control therapy. The AUC for the C-peptide level at 12 months (primary end point) did not differ significantly between the two groups (geometric mean, 0.35 pmol per milliliter (interquartile range, 0.16 to 0.49] with closed-loop therapy and 0.46 pmol per milliliter (interquartile range, 0.22 to 0.69) with control therapy; mean adjusted difference, -0.06 pmol per milliliter [95% confidence interval {CI}, -0.14 to 0.03]). There was not a substantial between-group difference in the AUC for the C-peptide level at 24 months (geometric mean, 0.18 pmol per milliliter (interquartile range, 0.06 to 0.22) with closed-loop therapy and 0.24 pmol per milliliter (interquartile range, 0.05 to 0.30) with control therapy; mean adjusted difference, -0.04 pmol per milliliter (95% CI, -0.14 to 0.06]). The arithmetic mean glycated hemoglobin level was lower in the closed-loop group than in the control group by 4 mmol per mole (0.4 percentage points; 95% CI, 0 to 8 mmol per mole [0.0 to 0.7 percentage points]) at 12 months and by 11 mmol per mole (1.0 percentage points; 95% CI, 7 to 15 mmol per mole [0.5 to 1.5 percentage points)) at 24 months. Five cases of severe hypoglycemia occurred in the closed-loop group (in 3 participants), and one occurred in the control group; one case of diabetic ketoacidosis occurred in the closed-loop group. CONCLUSIONS In youths with new-onset type 1 diabetes, intensive glucose control for 24 months did not appear to prevent the decline in residual C-peptide secretion.	[Boughton, Charlotte K.; Allen, Janet M.; Ware, Julia; Wilinska, Malgorzata E.; Hovorka, Roman] Univ Cambridge, Wellcome Med Res Council Inst Metab Sci, Cambridge, England; [Allen, Janet M.; Ware, Julia; Wilinska, Malgorzata E.; Thankamony, Ajay; Hovorka, Roman] Univ Cambridge, Dept Paediat, Cambridge, England; [Boughton, Charlotte K.; Hartnell, Sara] Cambridge Univ Hosp NHS Fdn Trust, Wolfson Diabet & Endocrine Clin, Cambridge, England; [Randell, Tabitha] Nottingham Childrens Hosp, Dept Paediat Diabet & Endocrinol, Nottingham, England; [Ghatak, Atrayee] Alder Hey Childrens NHS Fdn Trust, Dept Diabet, Liverpool, Merseyside, England; [Besser, Rachel E. J.] Univ Oxford, Dept Paediat, Oxford, England; [Besser, Rachel E. J.] John Radcliffe Hosp, Natl Inst Hlth, Oxford, England; [Besser, Rachel E. J.] John Radcliffe Hosp, Care Res Oxford Biomed Res Ctr, Oxford, England; [Elleri, Daniela] Royal Hosp Sick Children, Dept Diabet, Edinburgh, Midlothian, Scotland; [Trevelyan, Nicola] Southampton Childrens Hosp, Dept Paediat Diabet, Southampton, Hants, England; [Campbell, Fiona M.] Leeds Childrens Hosp, Dept Paediat Diabet, Leeds, W Yorkshire, England; [Dunseath, Gareth] Swansea Univ, Diabet Res Grp, Swansea, W Glam, Wales; [Sibayan, Judy; Calhoun, Peter; Bailey, Ryan] Jaeb Ctr Hlth Res, Tampa, FL USA	University of Cambridge; University of Cambridge; University of Cambridge; Alder Hey Children's NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; Swansea University; JAEB Center For Health Research	Hovorka, R (corresponding author), Addenbrookes Hosp, Wellcome Med Res Council Inst Metab Sci, Box 289,Hills Rd, Cambridge CB2 0QQ, England.	rh347@cam.ac.uk	; Hovorka, Roman/J-4123-2016	Besser, Rachel/0000-0002-4645-6324; Hovorka, Roman/0000-0003-2901-461X	National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation Programme [14/23/09]; Helmsley Charitable Trust [2016PG-T1D045, 2016PG-T1D046]; JDRF [22-2013-266, 2-RSC-2019-828-M-N]	National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation Programme; Helmsley Charitable Trust; JDRF(Juvenile Diabetes Research Foundation)	Supported by the National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation Programme (14/23/09), the Helmsley Charitable Trust (2016PG-T1D045 and 2016PG-T1D046), and JDRF (22-2013-266 and 2-RSC-2019-828-M-N). Additional support for the artificial pancreas work was provided by the NIHR Cambridge Biomedical Research Centre and the NIHR Oxford Biomedical Research Centre.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergenstal RM, 2021, LANCET, V397, P208, DOI 10.1016/S0140-6736(20)32514-9; Bluestone JA, 2021, SCIENCE, V373, P510, DOI 10.1126/science.abh1654; Boughton C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033500; Breton MD, 2020, NEW ENGL J MED, V383, P836, DOI 10.1056/NEJMoa2004736; Brown SA, 2019, NEW ENGL J MED, V381, P1707, DOI 10.1056/NEJMoa1907863; Brusko TM, 2021, SCIENCE, V373, P516, DOI 10.1126/science.abh1657; Buckingham B, 2013, DIABETES CARE, V36, P4030, DOI 10.2337/dc13-1074; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; DiMeglio LA., 2018, ISPAD CLIN PRACTICE; DiMeglio LA, 2018, LANCET, V391, P2449, DOI 10.1016/S0140-6736(18)31320-5; Dovc K, 2019, DIABETES CARE, V42, P1344, DOI 10.2337/dc18-2625; Greenbaum CJ, 2009, DIABETES CARE, V32, P1839, DOI 10.2337/dc08-2326; Kohnert KD, 2012, CURR DIABETES REV, V8, P345, DOI 10.2174/157339912802083513; Lachin JM, 2021, DIABETES CARE, V44, P2225, DOI 10.2337/dc21-1331; Lachin JM, 2014, DIABETES, V63, P739, DOI 10.2337/db13-0881; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; National Institute for Health and Care Excellence, 2015, DIAB TYP 1 TYP TYP 2; Ruan Y, 2016, DIABETES CARE, V39, P830, DOI 10.2337/dc15-2623; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tauschmann M, 2018, LANCET, V392, P1321, DOI 10.1016/S0140-6736(18)31947-0	22	1	1	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					882	893		10.1056/NEJMoa2203496	http://dx.doi.org/10.1056/NEJMoa2203496			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069870				2022-12-28	WOS:000861634500009
J	Poskett, J; Shaw, C				Poskett, James; Shaw, Claire			Scientists in Ukraine have long fought for scientific freedom	NATURE			English	Editorial Material								Researchers in the country have often shown creativity and resilience under threat. These strengths will be key to the future of science in Ukraine following Russia's invasion.	[Poskett, James] Univ Warwick, Hist Sci & Technol, Coventry, W Midlands, England; [Shaw, Claire] Univ Warwick, Hist Modern Russia, Coventry, W Midlands, England; [Shaw, Claire] Univ Warwick, European Hist Res Ctr, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Poskett, J (corresponding author), Univ Warwick, Hist Sci & Technol, Coventry, W Midlands, England.	j.poskett@warwick.ac.uk; c.shaw.2@warwick.ac.uk						Applebaum A., 2017, SIGNAL; Duszynski J, 2022, SCIENCE, V376, P1249, DOI 10.1126/science.add4088; Gerovitch Slava, 2002, NEWSPEAK CYBERSPEAK; Graham LR., 1993, SCI RUSSIA SOVIET UN; Kojevnikov A.B., 2004, STALINS GREAT SCI TI, DOI [10.1142/p307, DOI 10.1142/P307]; Krementsov Nikolai, 1997, STALINIST SCI; Martin Terry., 2001, AFFIRMATIVE ACTION E, DOI [10.7591/9781501713323, DOI 10.7591/9781501713323]; McCagg W. O., 1989, DISABLED SOVIET UNIO; Peters B., 2016, NOT NETWORK NATION U; Plokhy Serhii, 2015, GATES EUROPE HIST UK; Reinders L.J., 2018, LIFE SCI TIMES LEV V, DOI [10.1007/978-3-319-72098-2, DOI 10.1007/978-3-319-72098-2]; Smith J, 2011, BASEES-ROUT SER RUSS, V73, P1; Vikhanski Luba, 2016, IMMUNITY ELIE METCHN; Vucinich Alexander, 2001, EINSTEIN SOVIET IDEO, DOI DOI 10.1515/9780804764599	14	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					243	244		10.1038/d41586-022-02825-2	http://dx.doi.org/10.1038/d41586-022-02825-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H7TB	36064799	Bronze			2022-12-28	WOS:000850078900009
J	Chaaban, S; Carter, AP				Chaaban, Sami; Carter, Andrew P.			Structure of dynein-dynactin on microtubules shows tandem adaptor binding	NATURE			English	Article							CRYO-EM; CYTOPLASMIC DYNEIN; MOTOR DOMAIN; VISUALIZATION; ACTIVATION; MECHANISM; TRANSPORT; INSIGHTS; COMPLEX; RECRUITMENT	Cytoplasmic dynein is a microtubule motor that is activated by its cofactor dynactin and a coiled-coil cargo adaptor(1-3). Up to two dynein dimers can be recruited per dynactin, and interactions between them affect their combined motile behaviour(4-6). Different coiled-coil adaptors are linked to different cargos(7,8), and some share motifs known to contact sites on dynein and dynactin(4,9-13). There is limited structural information on how the resulting complex interacts with microtubules and how adaptors are recruited. Here we develop a cryo-electron microscopy processing pipeline to solve the high-resolution structure of dynein-dynactin and the adaptor BICDR1 bound to microtubules. This reveals the asymmetric interactions between neighbouring dynein motor domains and how they relate to motile behaviour. We found that two adaptors occupy the complex. Both adaptors make similar interactions with the dyneins but diverge in their contacts with each other and dynactin. Our structure has implications for the stability and stoichiometry of motor recruitment by cargos.	[Chaaban, Sami; Carter, Andrew P.] MRC, Div Struct Studies, Lab Mol Biol, Cambridge, England	MRC Laboratory Molecular Biology	Carter, AP (corresponding author), MRC, Div Struct Studies, Lab Mol Biol, Cambridge, England.	cartera@mrc-lmb.cam.ac.uk			Wellcome [210711/Z/18/Z]; Medical Research Council, as part of UK Research and Innovation (MRC) [MC_UP_A025_1011]; EMBO Postdoctoral Fellowship [ALTF 334-2020]	Wellcome; Medical Research Council, as part of UK Research and Innovation (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO Postdoctoral Fellowship(European Molecular Biology Organization (EMBO))	y We thank S. Scheres for help with micrograph-level signal subtraction in Relion; C. K. Lau for helpful discussions; the MRC Laboratory of Molecular Biology Electron Microscopy Facility for access and support of electron microscopy sample preparation and data collection; J. Grimmett and T. Darling for providing scientific computing resources; H. E. Foster and C. Ventura Santos for help with cryo-ET; and F. Abid Ali, K. Singh and C. K. Lau for critical reading of the manuscript. This work was supported by Wellcome (210711/Z/18/Z), the Medical Research Council, as part of UK Research and Innovation (MRC file reference number MC_UP_A025_1011), and the EMBO Postdoctoral Fellowship (ALTF 334-2020) to S.C. For the purpose of open access, the author has applied a CC BY public copyright license to any author-accepted manuscript version arising.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Belyy V, 2016, NAT CELL BIOL, V18, P1018, DOI 10.1038/ncb3393; Bhabha G, 2014, CELL, V159, P857, DOI 10.1016/j.cell.2014.10.018; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Canty J. T., 2021, BIORXIV, DOI [10.1101/2021.07.30.454553, DOI 10.1101/2021.07.30.454553]; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Celestino R, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000100; Chai P., BIORXIV, DOI [10.1101/2022.01.22.477366(2022, DOI 10.1101/2022.01.22.477366(2022]; Cook AD, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.10.004; dAmico E., 2022, BIORXIV, DOI [10.1101/2022.02.02.478874, DOI 10.1101/2022.02.02.478874]; DeSantis ME, 2017, CELL, V170, P1197, DOI 10.1016/j.cell.2017.08.037; DeWitt MA, 2015, NAT STRUCT MOL BIOL, V22, P73, DOI 10.1038/nsmb.2930; Elshenawy MM, 2020, NAT CELL BIOL, V22, P570, DOI 10.1038/s41556-020-0501-4; Elshenawy MM, 2019, NAT CHEM BIOL, V15, P1093, DOI 10.1038/s41589-019-0352-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans R., 2022, BIORXIV, DOI [10.1101/2021.10.04.463034, DOI 10.1101/2021.10.04.463034]; Fenton AR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24862-7; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goldtzvik Y, 2018, STRUCTURE, V26, P1664, DOI 10.1016/j.str.2018.08.005; Grotjahn DA, 2018, NAT STRUCT MOL BIOL, V25, P203, DOI 10.1038/s41594-018-0027-7; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Htet ZM, 2020, NAT CELL BIOL, V22, P518, DOI 10.1038/s41556-020-0506-z; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kellogg EH, 2017, J MOL BIOL, V429, P633, DOI 10.1016/j.jmb.2017.01.001; Kimanius D, 2021, BIOCHEM J, V478, P4169, DOI 10.1042/BCJ20210708; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kubo S, 2021, EMBO REP, V22, DOI 10.15252/embr.202152911; Lacey SE, 2019, ELIFE, V8, DOI 10.7554/eLife.47145; Lau CK, 2021, EMBO J, V40, DOI 10.15252/embj.2020106164; Lee IG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19538-7; Lee IG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03412-8; Ma MS, 2019, CELL, V179, P909, DOI 10.1016/j.cell.2019.09.030; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Mirdita Milot, 2021, Zenodo, DOI [10.5281/ZENODO.5123297, 10.1038/s41592-022-01488-1]; Mirdita M, 2019, BIOINFORMATICS, V35, P2856, DOI 10.1093/bioinformatics/bty1057; Nicholas MP, 2015, P NATL ACAD SCI USA, V112, P6371, DOI 10.1073/pnas.1417422112; Olenick MA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.227132; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIERSON GB, 1978, J CELL BIOL, V76, P223, DOI 10.1083/jcb.76.1.223; Qiu RD, 2021, CURR BIOL, V31, P4486, DOI 10.1016/j.cub.2021.07.081; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Rao QH, 2021, NAT STRUCT MOL BIOL, V28, P799, DOI 10.1038/s41594-021-00656-9; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sacristan C, 2018, NAT CELL BIOL, V20, P800, DOI 10.1038/s41556-018-0130-3; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Schroeder CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03351; Shibata K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042990; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Suzuki Y, 1997, FEBS LETT, V409, P29, DOI 10.1016/S0014-5793(97)00472-9; Urnavicius L, 2018, NATURE, V554, P202, DOI 10.1038/nature25462; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Wagner T, 2020, ACTA CRYSTALLOGR D, V76, P613, DOI 10.1107/S2059798320007342; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Walton T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20735-7; Warshamanage R, 2022, J STRUCT BIOL, V214, DOI 10.1016/j.jsb.2021.107826; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong ED, 2021, NAT METHODS, V18, P176, DOI 10.1038/s41592-020-01049-4; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	76	2	2	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2022	610	7930					212	+		10.1038/s41586-022-05186-y	http://dx.doi.org/10.1038/s41586-022-05186-y		SEP 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5C6KA	36071160				2022-12-28	WOS:000852464800001
J	James, MT; Har, BJ; Tyrrell, BD; Faris, PD; Tan, Z; Spertus, JA; Wilton, SB; Ghali, WA; Knudtson, ML; Sajobi, TT; Pannu, NI; Klarenbach, SW; Graham, MM				James, Matthew T.; Har, Bryan J.; Tyrrell, Benjamin D.; Faris, Peter D.; Tan, Zhi; Spertus, John A.; Wilton, Stephen B.; Ghali, William A.; Knudtson, Merril L.; Sajobi, Tolulope T.; Pannu, Neesh, I; Klarenbach, Scott W.; Graham, Michelle M.			Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STEPPED WEDGE; PERFORMANCE; VALIDITY; METAANALYSIS; MULTICENTER; DISEASE	IMPORTANCE Contrast-associated acute kidney injury (AKI) is a common complication of coronary angiography and percutaneous coronary intervention (PCI) that has been associated with high costs and adverse long-term outcomes. OBJECTIVE To determine whether a multifaceted intervention is effective for the prevention of AKI after coronary angiography or PCI. DESIGN, SETTING, AND PARTICIPANTS A stepped-wedge, cluster randomized clinical trial was conducted in Alberta, Canada, that included all invasive cardiologists at 3 cardiac catheterization laboratories who were randomized to various start dates for the intervention between January 2018 and September 2019. Eligible patients were aged 18 years or older who underwent nonemergency coronary angiography, PCI, or both; who were not undergoing dialysis; and who had a predicted AKI risk of greater than 5%. Thirty-four physicians performed 7820 procedures among 7106 patients who met the inclusion criteria. Participant follow-up ended in November 2020. INTERVENTIONS During the intervention period, cardiologists received educational outreach, computerized clinical decision support on contrast volume and hemodynamic-guided intravenous fluid targets, and audit and feedback. During the control (preintervention) period, cardiologists provided usual care and did not receive the intervention. MAIN OUTCOMES AND MEASURES The primary outcome was AKI. There were 12 secondary outcomes, including contrast volume, intravenous fluid administration, and major adverse cardiovascular and kidney events, The analyses were conducted using time-adjusted models. RESULTS Of the 34 participating cardiologists who were divided into 8 clusters by practice group and center, the intervention group included 31 who performed 4327 procedures among 4032 patients (mean age, 70.3 [SD, 10.7] years; 1384 were women [32.0%]) and the control group included 34 who performed 3493 procedures among 3251 patients (mean age, 70.2 [SD, 10.8] years; 1151 were women [33.0%]). The incidence of AKI was 7.2% (310 events after 4327 procedures) during the intervention period and 8.6% (299 events after 3493 procedures) during the control period (between-group difference, -23% [95% CI, -0.6% to -4.1%]; odds ratio [OR], 0.72 [95% CI, 0.56 to 0.93]; P = .01). Of 12 prespecified secondary outcomes, 8 showed no significant difference. The proportion of procedures in which excessive contrast volumes were used was reduced to 38.1% during the intervention period from 51.7% during the control period (between-group difference, -12.0% [95% CI, -14.4% to -9.4%]; OR, 0.77 [95% CI, 0.65 to 0.90]; P = .002). The proportion of procedures in eligible patients in whom insufficient intravenous fluid was given was reduced to 60.8% during the intervention period from 75.1% during the control period (between-group difference, -15.8% [95% CI, -19.7% to -12.0%]; OR, 0.68 [95% CI, 0.53 to 0.87]; P = .002). There were no significant between-group differences in major adverse cardiovascular events or major adverse kidney events. CONCLUSIONS AND RELEVANCE Among cardiologists randomized to an intervention including clinical decision support with audit and feedback, patients undergoing coronary procedures during the intervention period were less likely to develop AKI compared with those treated during the control period, with a time-adjusted absolute risk reduction of 2.3%. Whether this intervention would show efficacy outside this study setting requires further investigation.	[James, Matthew T.; Tan, Zhi; Ghali, William A.; Sajobi, Tolulope T.] Univ Calgary, Cumming Sch Med, Dept Med, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada; [James, Matthew T.; Wilton, Stephen B.; Ghali, William A.; Sajobi, Tolulope T.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada; [James, Matthew T.; Har, Bryan J.; Wilton, Stephen B.; Ghali, William A.; Knudtson, Merril L.; Sajobi, Tolulope T.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [James, Matthew T.; Ghali, William A.; Sajobi, Tolulope T.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Har, Bryan J.; Wilton, Stephen B.; Knudtson, Merril L.] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB, Canada; [Tyrrell, Benjamin D.; Pannu, Neesh, I; Klarenbach, Scott W.; Graham, Michelle M.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Tyrrell, Benjamin D.] Univ Alberta, CK Hui Heart Ctr, Edmonton, AB, Canada; [Faris, Peter D.] Alberta Hlth Serv, Calgary, AB, Canada; [Spertus, John A.] Univ Missouri, Dept Biomed, Kansas City, MO 64110 USA; [Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Graham, Michelle M.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Calgary; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; University of Alberta	James, MT (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.; James, MT (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	mjames@ucalgary.ca			Alberta Innovates [201600425]; Alberta Health Services; Canadian Institutes of Health Research; Alberta Health Services (Cardiac Sciences); Libin Cardiovascular Institute; Mazankowski Alberta Heart Institute	Alberta Innovates; Alberta Health Services; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health Services (Cardiac Sciences); Libin Cardiovascular Institute; Mazankowski Alberta Heart Institute	Supported by partnership for research and innovation in the health system grant 201600425 from Alberta Innovates and Alberta Health Services. Dr James was supported by a Canadian Institutes of Health Research new investigator award. The Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease was supported by the Alberta Health Services (Cardiac Sciences), the Libin Cardiovascular Institute, and the Mazankowski Alberta Heart Institute.	Amin AP, 2020, AM J CARDIOL, V125, P29, DOI 10.1016/j.amjcard.2019.09.042; Amin AP, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004961; Amin AP, 2017, JAMA CARDIOL, V2, P1007, DOI 10.1001/jamacardio.2017.2156; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Azzalini L, 2017, CAN J CARDIOL, V33, P1225, DOI 10.1016/j.cjca.2017.07.482; Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Brown JR, 2014, CIRC-CARDIOVASC QUAL, V7, P693, DOI 10.1161/CIRCOUTCOMES.114.000903; Brown JR, 2012, BMJ QUAL SAF, V21, P54, DOI 10.1136/bmjqs-2011-000041; Carless D, 2011, STUD HIGH EDUC, V36, P395, DOI 10.1080/03075071003642449; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; De Coster C, 2008, MED CARE, V46, P627, DOI 10.1097/MLR.0b013e3181649439; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hemming K, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k1614; Hemming K, 2016, J CLIN EPIDEMIOL, V69, P137, DOI 10.1016/j.jclinepi.2015.08.015; Huang CX, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16021; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Hysong SJ, 2009, MED CARE, V47, P356, DOI 10.1097/MLR.0b013e3181893f6b; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; James MT, 2019, CAN J CARDIOL, V35, P1124, DOI 10.1016/j.cjca.2019.06.002; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Ma Bryan, 2022, CJC Open, V4, P271, DOI 10.1016/j.cjco.2021.10.006; Malik AO, 2021, AM HEART J, V234, P51, DOI 10.1016/j.ahj.2020.12.013; Mansouri M, 2007, J CONTIN EDUC HEALTH, V27, P6, DOI 10.1002/chp.88; Mehran R, 2019, NEW ENGL J MED, V380, P2146, DOI 10.1056/NEJMra1805256; Myla M, 2020, CATHETER CARDIO INTE, V96, P1198, DOI 10.1002/ccd.29354; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Overeem K, 2010, MED EDUC, V44, P140, DOI 10.1111/j.1365-2923.2009.03580.x; Qian G, 2016, JACC-CARDIOVASC INTE, V9, P89, DOI 10.1016/j.jcin.2015.09.026; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Sargeant J, 2015, ACAD MED, V90, P1698, DOI 10.1097/ACM.0000000000000809; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; Tsai TT, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001380; Valdenor C, 2021, CURR PROB CARDIOLOGY, V46, DOI 10.1016/j.cpcardiol.2021.100851; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	40	1	1	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					839	849		10.1001/jama.2022.13382	http://dx.doi.org/10.1001/jama.2022.13382			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066520				2022-12-28	WOS:000855171700020
J	Korenstein, D; Gillespie, EF				Korenstein, Deborah; Gillespie, Erin F.			Audit and Feedback-Optimizing a Strategy to Reduce Low-Value Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10017 USA; [Korenstein, Deborah] Weill Cornell Med, Dept Med, New York, NY USA; [Gillespie, Erin F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10017 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Korenstein, D (corresponding author), Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	korenstd@mskcc.org						Colla CH, 2017, MED CARE RES REV, V74, P507, DOI 10.1177/1077558716656970; Ebell Mark H, 2017, Evid Based Med, V22, P88, DOI 10.1136/ebmed-2017-110704; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; Ganguli I, 2022, JAMA INTERN MED, V182, P127, DOI 10.1001/jamainternmed.2021.6911; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jenkins HJ, 2015, CAN MED ASSOC J, V187, P401, DOI 10.1503/cmaj.141183; Mafi JN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37328; Morgan DJ, 2021, JAMA INTERN MED, V181, P747, DOI 10.1001/jamainternmed.2021.0269; Navathe AS, 2016, JAMA-J AM MED ASSOC, V316, P1759, DOI 10.1001/jama.2016.13739; O'Connor DA, 2022, JAMA-J AM MED ASSOC, V328, P850, DOI 10.1001/jama.2022.14587; Roos-Blom MJ, 2019, BMJ QUAL SAF, V28, P1007, DOI 10.1136/bmjqs-2019-009588; Takada T, 2020, BRIT J GEN PRACT, V70, pE858, DOI 10.3399/bjgp20X713693; Whittington MD, 2019, AM J MED QUAL, V34, P409, DOI 10.1177/1062860618824153	14	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					833	835						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066538				2022-12-28	WOS:000855171700018
J	Tzahor, E; Dimmeler, S				Tzahor, Eldad; Dimmeler, Stefanie			A coalition to heal-the impact of the cardiac microenvironment	SCIENCE			English	Review							ENDOTHELIAL PROGENITOR CELLS; REGULATORY T-CELLS; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; CELLULAR SENESCENCE; IMMUNE-MECHANISMS; REPAIR; MACROPHAGES; GROWTH; PERIOSTIN	Heart regenerative medicine has been gradually evolving from a view of the heart as a nonregenerative organ with terminally differentiated cardiac muscle cells. Understanding the biology of the heart during homeostasis and in response to injuries has led to the realization that cellular communication between all cardiac cell types holds great promise for treatments. Indeed, recent studies highlight new disease-reversion concepts in addition to cardiomyocyte renewal, such as matrix- and vascular-targeted therapies, and immunotherapy with a focus on inflammation and fibrosis. In this review, we will discuss the crosstalk within the cardiac microenvironment and how specific therapies aim to target the hostile cardiac milieu under pathological conditions.	[Tzahor, Eldad] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, D-60594 Frankfurt, Germany; [Dimmeler, Stefanie] Goethe Univ Frankfurt, Cardiopulm Inst, Frankfurt, Germany; [Dimmeler, Stefanie] RheinMain, German Ctr Cardiovasc Res, Frankfurt, Germany	Weizmann Institute of Science; Goethe University Frankfurt; Goethe University Frankfurt; German Centre for Cardiovascular Research	Tzahor, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.; Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Ctr Mol Med, D-60594 Frankfurt, Germany.; Dimmeler, S (corresponding author), Goethe Univ Frankfurt, Cardiopulm Inst, Frankfurt, Germany.; Dimmeler, S (corresponding author), RheinMain, German Ctr Cardiovasc Res, Frankfurt, Germany.	eldad.tzahor@weizmann.ac.il; dimmeler@em.uni-frankfurt.de		Tzahor, Eldad/0000-0002-5212-9426	Dr. Robert M. Schwiete Foundation; German Research Foundation [SFB834, SFB1366, TRR267, Exc2026/1]; European Research Council [ERC AdG 788194, ERC AdG 101053352]; European Union [874764]; Israel Science Foundation (ISF)	Dr. Robert M. Schwiete Foundation; German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Israel Science Foundation (ISF)(Israel Science Foundation)	S.D. is supported by the Dr. Robert M. Schwiete Foundation, the German Research Foundation (SFB834, SFB1366, TRR267, Exc2026/1), and the European Research Council (ERC AdG 101053352). E.T. is supported by the European Research Council (ERC AdG 788194), the European Union's Horizon 2020 research and innovation program (874764), and the Israel Science Foundation (ISF).	Abplanalp WT, 2020, NUCLEIC ACID THER, V30, P335, DOI 10.1089/nat.2020.0871; Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Aharonov A, 2020, NAT CELL BIOL, V22, P1346, DOI 10.1038/s41556-020-00588-4; Alexanian M, 2021, NATURE, V595, P438, DOI 10.1038/s41586-021-03674-1; Allanki S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg6497; Andrade J, 2021, NAT CELL BIOL, V23, P413, DOI 10.1038/s41556-021-00637-6; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Baehr A, 2020, CIRCULATION, V142, P868, DOI 10.1161/CIRCULATIONAHA.119.045116; Bar C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6863; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Bednarek D, 2015, CELL REP, V12, P1691, DOI 10.1016/j.celrep.2015.07.064; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bibli SI, 2021, CIRCULATION, V143, P935, DOI 10.1161/CIRCULATIONAHA.120.051877; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Chen MS, 2022, CARDIOVASC RES, V118, P1173, DOI 10.1093/cvr/cvab161; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Chothani S, 2019, CIRCULATION, V140, P937, DOI 10.1161/CIRCULATIONAHA.119.039596; Collen A, 2022, NAT REV DRUG DISCOV, V21, P79, DOI 10.1038/s41573-021-00355-6; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Mora-Ruiz MD, 2019, MOL IMMUNOL, V107, P71, DOI 10.1016/j.molimm.2019.01.008; Das S, 2019, CELL, V176, P1128, DOI 10.1016/j.cell.2018.12.023; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Dorsheimer L, 2019, JAMA CARDIOL, V4, P25, DOI 10.1001/jamacardio.2018.3965; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Eroglu E, 2017, DEV CELL, V42, P7, DOI 10.1016/j.devcel.2017.06.017; Farbehi N, 2019, ELIFE, V8, DOI 10.7554/eLife.43882; Faust HJ, 2020, J CLIN INVEST, V130, P5493, DOI 10.1172/JCI134091; Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530; Forte E, 2020, CELL REP, V30, P3149, DOI 10.1016/j.celrep.2020.02.008; Frangogiannis NG, 2017, J CLIN INVEST, V127, P1600, DOI 10.1172/JCI87491; Fu X, 2018, J CLIN INVEST, V128, P2127, DOI 10.1172/JCI98215; Fung THW, 2020, THERANOSTICS, V10, P8924, DOI 10.7150/thno.47118; Gancz D, 2019, ELIFE, V8, DOI 10.7554/eLife.44153; Gladka MM, 2018, CIRCULATION, V138, P166, DOI 10.1161/CIRCULATIONAHA.117.030742; Gomez-Salinero JM, 2021, DEV CELL, V56, P3042, DOI 10.1016/j.devcel.2021.10.020; Gopalkrishna S, 2022, CARDIOVASC RES, V118, P2596, DOI 10.1093/cvr/cvab302; Grunewald M, 2021, SCIENCE, V373, P533, DOI 10.1126/science.abc8479; Hinkel R, 2020, J AM COLL CARDIOL, V75, P1788, DOI 10.1016/j.jacc.2020.02.041; Hoffmann J, 2020, CIRC RES, V127, P699, DOI 10.1161/CIRCRESAHA.120.316619; Hofmann U, 2016, EUR HEART J, V37, P873, DOI 10.1093/eurheartj/ehv639; Hortells L, 2020, P NATL ACAD SCI USA, V117, P21469, DOI 10.1073/pnas.2009119117; Hui SP, 2017, DEV CELL, V43, P659, DOI 10.1016/j.devcel.2017.11.010; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Jabs M, 2018, CIRCULATION, V137, P2592, DOI 10.1161/CIRCULATIONAHA.117.029733; Kallikourdis M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14680; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; Klaourakis K, 2021, NAT REV CARDIOL, V18, P368, DOI 10.1038/s41569-020-00489-x; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Korf-Klingebiel M, 2015, NAT MED, V21, P140, DOI 10.1038/nm.3778; Krishnasamy K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00953-2; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lee SJ, 2018, J CLIN INVEST, V128, P5018, DOI 10.1172/JCI99659; Li HT, 2021, HEART FAIL REV, V26, P1231, DOI 10.1007/s10741-020-09953-9; Li S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI149711; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Liu XL, 2020, NATURE, V588, P705, DOI 10.1038/s41586-020-2998-x; Lorchner H, 2015, NAT MED, V21, P353, DOI 10.1038/nm.3816; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Luxan G, 2022, CARDIOVASC RES, V118, P53, DOI 10.1093/cvr/cvab047; Luxan G, 2019, ELIFE, V8, DOI 10.7554/eLife.45863; Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nicin L., 2022, NATURE CARDIOVASCULA, V1, P174, DOI [DOI 10.1038/S44161-022-00019-7, 10.1038/s44161-022-00019-7]; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Notari M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5553; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Owens WA, 2021, MECH AGEING DEV, V198, DOI 10.1016/j.mad.2021.111540; Paramos-de-Carvalho D, 2021, ELIFE, V10, DOI 10.7554/eLife.72449; Patra C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02461-1; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pruijt JFM, 2002, P NATL ACAD SCI USA, V99, P6228, DOI 10.1073/pnas.092112999; Rasanen M, 2021, CIRCULATION, V143, P65, DOI 10.1161/CIRCULATIONAHA.120.050635; Reboll MR, 2017, CIRCULATION, V136, P1809, DOI 10.1161/CIRCULATIONAHA.117.029980; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rurik JG, 2022, SCIENCE, V375, P91, DOI 10.1126/science.abm0594; Rurik JG, 2021, CIRC RES, V128, P1766, DOI 10.1161/CIRCRESAHA.121.318005; Sadek H, 2020, CELL STEM CELL, V26, P7, DOI 10.1016/j.stem.2019.12.004; Sarig R, 2019, CIRCULATION, V139, P2491, DOI 10.1161/CIRCULATIONAHA.119.040125; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sicklinger F, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136778; Silva AC, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.621644; Simoes FC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14263-2; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Swirski FK, 2018, NAT REV IMMUNOL, V18, P733, DOI 10.1038/s41577-018-0065-8; Tatin F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93887; Tempel D, 2012, CIRC RES, V111, P585, DOI 10.1161/CIRCRESAHA.111.262097; Thum T, 2014, NAT REV CARDIOL, V11, P655, DOI 10.1038/nrcardio.2014.125; Todorova D, 2017, CIRC RES, V120, P1658, DOI 10.1161/CIRCRESAHA.117.309681; Tombor LS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20905-1; Trincot CE, 2019, CIRC RES, V124, P101, DOI 10.1161/CIRCRESAHA.118.313835; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vagnozzi RJ, 2020, NATURE, V577, P405, DOI 10.1038/s41586-019-1802-2; Valiente-Alandi I, 2016, J MOL CELL CARDIOL, V91, P228, DOI 10.1016/j.yjmcc.2016.01.011; Valussi M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi6648; Vidal R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131092; Walters HE, 2020, CURR OPIN GENET DEV, V64, P94, DOI 10.1016/j.gde.2020.06.002; Wolfien M, 2020, CARDIOVASC RES, V116, P1249, DOI 10.1093/cvr/cvaa054; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Wu CC, 2020, CIRC RES, V127, P896, DOI 10.1161/CIRCRESAHA.119.316303; Wu XK, 2021, CARDIOVASC RES, V117, P1257, DOI 10.1093/cvr/cvaa287; Wysoczynski M, 2014, STEM CELLS, V32, P2502, DOI 10.1002/stem.1743; Xiao Y, 2018, DEV CELL, V45, P153, DOI 10.1016/j.devcel.2018.03.019; Xue GL, 2021, ACTA PHARMACOL SIN, V42, P1780, DOI 10.1038/s41401-020-00580-6; Yahalom-Ronen Y, 2015, ELIFE, V4, DOI [10.7554/eLife.07455.001, 10.7554/eLife.07455]; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yang ZQ, 2000, CIRCULATION, V101, P1019, DOI 10.1161/01.CIR.101.9.1019; Yokota T, 2020, CELL, V182, P545, DOI 10.1016/j.cell.2020.06.030; Zacchigna S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04908-z; Zaman R, 2021, IMMUNITY, V54, P2057, DOI 10.1016/j.immuni.2021.07.006; Zhang YY, 2017, EUR J HEART FAIL, V19, P1379, DOI 10.1002/ejhf.942; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202	131	1	1	11	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1059	+	eabm4443	10.1126/science.abm4443	http://dx.doi.org/10.1126/science.abm4443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048959				2022-12-28	WOS:000887933200001
J	Page, KA				Page, Kathleen A.			A gut reaction: Microbiome-driven glycemic effects of non-nutritive sweeteners	CELL			English	Editorial Material							CONSUMPTION	Non-nutritive sweeteners are increasingly consumed to satisfy cravings for sweet taste without the associ-ated calories. Paradoxically, non-nutritive sweeteners have been linked to metabolic risks, but the underlying mechanisms are not understood. In this issue of Cell, Suez and colleagues pinpoint changes in the gut micro -biome as a mechanism for non-nutritive sweetener-induced glycemic impairments in healthy adults.	[Page, Kathleen A.] Univ Southern Calif, Keck Sch Med, Div Endocrinol, Dept Internal Med, Los Angeles, CA 90033 USA	University of Southern California	Page, KA (corresponding author), Univ Southern Calif, Keck Sch Med, Div Endocrinol, Dept Internal Med, Los Angeles, CA 90033 USA.	katie.page@usc.edu						Azad MB, 2017, CAN MED ASSOC J, V189, pE929, DOI 10.1503/cmaj.161390; Dalenberg JR, 2020, CELL METAB, V31, P493, DOI 10.1016/j.cmet.2020.01.014; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Hossain Md Delowar, 2020, J EC STRUCTURES, V11, DOI [10.1038/s41579-020-0433-9, DOI https://doi.org/10.2478/s11756-020-00662-0, 10.1038/s41467-020-16119-6, DOI 10.1186/S40008-020-00195-4]; Ruiz-Ojeda FJ, 2019, ADV NUTR, V10, pS31, DOI 10.1093/advances/nmy037; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Kolodziejczyk Aleksandra A., 2019, NAT REV MICROBIOL, V17, P742, DOI [10.1038/s41579-019-0256-8, DOI 10.1038/S41563-019-0463-8]; Suez J, 2022, CELL, V185, P3307, DOI 10.1016/j.cell.2022.07.016; Sylvetsky AC, 2017, J ACAD NUTR DIET, V117, P441, DOI 10.1016/j.jand.2016.11.004	9	1	1	21	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3282	3284		10.1016/j.cell.2022.08.007	http://dx.doi.org/10.1016/j.cell.2022.08.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4V8AJ	36055195				2022-12-28	WOS:000859694600002
J	Nathan, DM; GRADE Study Res Grp; Lachin, JM; Bebu, I; Burch, HB; Buse, JB; Cherrington, AL; Fortmann, SP; Green, JB; Kahn, SE; Kirkman, MS; Krause-Steinrauf, H; Larkin, ME; Phillips, LS; Pop-Busui, R; Steffes, M; Tiktin, M; Tripputi, M; Wexle, DJ; Younes, N				Nathan, David M.; GRADE Study Res Grp; Lachin, John M.; Bebu, Ionut; Burch, Henry B.; Buse, John B.; Cherrington, Andrea L.; Fortmann, Stephen P.; Green, Jennifer B.; Kahn, Steven E.; Kirkman, M. Sue; Krause-Steinrauf, Heidi; Larkin, Mary E.; Phillips, Lawrence S.; Pop-Busui, Rodica; Steffes, Michael; Tiktin, Margaret; Tripputi, Mark; Wexle, Deborah J.; Younes, Naji			Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION	BACKGROUND Data are lacking on the comparative effectiveness of commonly used glucose-lowering medications, when added to metformin, with respect to microvascular and cardiovascular disease outcomes in persons with type 2 diabetes. METHODS We assessed the comparative effectiveness of four commonly used glucose-lowering medications, added to metformin, in achieving and maintaining a glycated hemoglobin level of less than 7.0% in participants with type 2 diabetes. The randomly assigned therapies were insulin glargine U-100 (hereafter, glargine), glimepiride, liraglutide, and sitagliptin. Prespecified secondary outcomes with respect to microvascular and cardiovascular disease included hypertension and dyslipidemia, confirmed moderately or severely increased albuminuria or an estimated glomerular filtration rate of less than 60 ml per minute per 1.73 m(2) of body-surface area, diabetic peripheral neuropathy assessed with the Michigan Neuropathy Screening Instrument, cardiovascular events (major adverse cardiovascular events [MACE], hospitalization for heart failure, or an aggregate outcome of any cardiovascular event), and death. Hazard ratios are presented with 95% confidence limits that are not adjusted for multiple comparisons. RESULTS During a mean 5.0 years of follow-up in 5047 participants, there were no material differences among the interventions with respect to the development of hypertension or dyslipidemia or with respect to microvascular outcomes; the mean overall rate (i.e., events per 100 participant-years) of moderately increased albuminuria levels was 2.6, of severely increased albuminuria levels 1.1, of renal impairment 2.9, and of diabetic peripheral neuropathy 16.7. The treatment groups did not differ with respect to MACE (overall rate, 1.0), hospitalization for heart failure (0.4), death from cardiovascular causes (0.3), or all deaths (0.6). There were small differences with respect to rates of any cardiovascular disease, with 1.9, 1.9, 1.4, and 2.0 in the glargine, glimepiride, liraglutide, and sitagliptin groups, respectively. When one treatment was compared with the combined results of the other three treatments, the hazard ratios for any cardiovascular disease were 1.1 (95% confidence interval [CI], 0.9 to 1.3) in the glargine group, 1.1 (95% CI, 0.9 to 1.4) in the glimepiride group, 0.7 (95% CI, 0.6 to 0.9) in the liraglutide group, and 1.2 (95% CI, 1.0 to 1.5) in the sitagliptin group. CONCLUSIONS In participants with type 2 diabetes, the incidences of microvascular complications and death were not materially different among the four treatment groups. The findings indicated possible differences among the groups in the incidence of any cardiovascular disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; GRADE ClinicalTrials.gov number, .)	[Lachin, John M.] George Washington Univ, Biostat Ctr, GRADE Coordinating Ctr, 6110 Execut Blvd,Ste 750, Rockville, MD 20852 USA; [Nathan, David M.; Larkin, Mary E.; Wexle, Deborah J.] Harvard Med Sch, Massachusetts Gen Hosp, Diabet Ctr, Boston, MA USA; [Lachin, John M.; Bebu, Ionut; Krause-Steinrauf, Heidi; Tripputi, Mark; Younes, Naji] George Washington Univ, Milken Inst Sch Publ Hlth, Biostat Ctr, Dept Biostat & Bioinformat, Rockville, MD USA; [Burch, Henry B.] Natl Inst Diabet & Digest & Kidney Dis, NIH, Bethesda, MD USA; [Buse, John B.; Kirkman, M. Sue] Univ N Carolina, Dept Med, Div Endocrinol & Metab, Sch Med, Chapel Hill, NC USA; [Green, Jennifer B.] Duke Univ, Dept Med, Duke Div Endocrinol Metab & Nutr, Med Ctr, Durham, NC USA; [Cherrington, Andrea L.] Univ Alabama Birmingham, Birmingham, AL USA; [Fortmann, Stephen P.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Kahn, Steven E.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Vet Affairs VA Puget Sound Health Care Syst, Seattle, WA USA; [Phillips, Lawrence S.] Atlanta VA Med Ctr, Decatur, GA USA; [Pop-Busui, Rodica] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA; [Steffes, Michael] Univ Minnesota, Dept Lab Med & Pathol, Adv Res & Diagnost Lab, Minneapolis, MN USA; [Tiktin, Margaret] Case Western Reserve Univ, Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA	George Washington University; Harvard University; Harvard Medical School; Massachusetts General Hospital; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Lachin, JM (corresponding author), George Washington Univ, Biostat Ctr, GRADE Coordinating Ctr, 6110 Execut Blvd,Ste 750, Rockville, MD 20852 USA.	grademail@bsc.gwu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) [U01DK098246]; NIDDK [U34-DK-088043]; American Diabetes Association; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; Department of Veterans Affairs; NIH [P30 DK017047, P30 DK020541-44, P30 DK020572, P30 DK072476, P30 DK079626, P30 DK092926, U54 GM104940, UL1 TR000170]; the NIH [UL1 TR000439, UL1 TR000445, UL1 TR001102, UL1 TR001108, UL1 TR001409, 2UL1TR001425, UL1 TR001449, UL1 TR002243, UL1 TR002345, UL1 TR002378, UL1 TR002489, UL1 TR002529, UL1 TR002535, UL1 TR002537, UL1 TR002541, UL1 TR002548]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a grant (U01DK098246) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH); a U34 planning grant (U34-DK-088043) from the NIDDK; funding for the initial planning meeting regarding the U34 proposal from the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Centers for Disease Control and Prevention; resources and facilities from the Department of Veterans Affairs; grants (P30 DK017047, P30 DK020541-44, P30 DK020572, P30 DK072476, P30 DK079626, P30 DK092926, U54 GM104940, UL1 TR000170, UL1 TR000439, UL1 TR000445, UL1 TR001102, UL1 TR001108, UL1 TR001409, 2UL1TR001425, UL1 TR001449, UL1 TR002243, UL1 TR002345, UL1 TR002378, UL1 TR002489, UL1 TR002529, UL1 TR002535, UL1 TR002537, UL1 TR002541, and UL1 TR002548) from the NIH; educational materials from the National Diabetes Education Program; and donated medications and supplies from Becton Dickinson, Bristol Myers Squibb, Merck, Novo Nordisk, Roche Diagnostics, and Sanofi.	Amod A, 2020, DIABETES THER, V11, P53, DOI [10.2337/dci19-0066, 10.1007/s13300-019-00715-x]; Davies MJ, 2018, DIABETES CARE, V41, P2669, DOI 10.2337/dci18-0033; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Gerstein HC, 2019, LANCET, V394, P121, DOI 10.1016/S0140-6736(19)31149-3; GRADE Study Research Group, 2022, NEW ENGL J MED, V387, P1067; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hemmingsen B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub3; Hicks KA, 2018, J AM COLL CARDIOL, V71, P1021, DOI 10.1016/j.jacc.2017.12.048; Holman Rury, 1998, BMJ, V317, P713; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Marso SP, 2016, NEW ENGL J MED, V375, P1834, DOI 10.1056/NEJMoa1607141; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mather KJ, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108235; Nathan DM, 2019, DIABETOLOGIA, V62, P1319, DOI 10.1007/s00125-019-4928-8; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Sarafidis PA, 2007, AM J NEPHROL, V27, P44, DOI 10.1159/000098955; Sarafidis PA, 2016, NEW ENGL J MED, V374, P1092, DOI 10.1056/NEJMc1600827; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wexler DJ, 2019, DIABETES CARE, V42, P2098, DOI 10.2337/dc19-0901; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1	23	0	0	5	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1075	1088		10.1056/NEJMoa2200436	http://dx.doi.org/10.1056/NEJMoa2200436			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36129997				2022-12-28	WOS:000865461700005
J	Gonsalves, G				Gonsalves, Gregg			Monkeypox, COVID-19, AIDS: have we progressed so little?	NATURE			English	Editorial Material									[Gonsalves, Gregg] Yale Sch Publ Hlth, New Haven, CT USA	Yale University	Gonsalves, G (corresponding author), Yale Sch Publ Hlth, New Haven, CT USA.	gonsalves@yale.edu							0	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					443	443						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M5CY	36100678	Bronze			2022-12-28	WOS:000853342100003
J	Lin, FY; Lin, J; Xie, YH; Zhu, JH; Nguyen, TTH; Zhang, YH; Zhu, JQ; Springer, TA				Lin, Fu-Yang-; Lin, Jing; Xie, Yonghua; Zhu, Jiangha; Nguyen, Thi Thu Huong; Zhang, Yonghui; Zhu, Jieqing; Springer, Timothy A.			A general chemical principle for creating closure inhibitors	CELL			English	Article							GLYCOPROTEIN IIB/IIIA ANTAGONIST; FIBRINOGEN-RECEPTOR ANTAGONIST; INJURED CAROTID-ARTERY; ORALLY-ACTIVE PRODRUG; PLATELET ACTIVATION; MONOCLONAL-ANTIBODY; INTEGRIN HEADPIECE; CRYSTAL-STRUCTURE; DOUBLE-BLIND; GPIIB/IIIA	Integrins are validated drug targets with six approved therapeutics. However, small-molecule inhibitors to three integrins failed in late-stage clinical trials for chronic indications. Such unfavorable outcomes may in part be caused by partial agonism, i.e., the stabilization of the high-affinity, extended-open integrin conforma-tion. Here, we show that the failed, small-molecule inhibitors of integrins ccIIb(33 and cc4(31 stabilize the high -affinity conformation. Furthermore, we discovered a simple chemical feature present in multiple ccIIb(33 antag-onists that stabilizes integrins in their bent-closed conformation. Closing inhibitors contain a polar nitrogen atom that stabilizes, via hydrogen bonds, a water molecule that intervenes between a serine residue and the metal in the metal-ion-dependent adhesion site (MIDAS). Expulsion of this water is a requisite for transition to the open conformation. This change in metal coordination is general to integrins, suggesting broad appli-cability of the drug-design principle to the integrin family, as validated with a distantly related integrin, cc4(31.	[Lin, Fu-Yang-; Lin, Jing; Zhu, Jiangha; Zhu, Jieqing; Springer, Timothy A.] Harvard Med Sch, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xie, Yonghua; Zhang, Yonghui] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China; [Nguyen, Thi Thu Huong; Zhu, Jieqing] Versiti, Blood Res Inst, Milwaukee, WI 53226 USA; [Nguyen, Thi Thu Huong; Zhu, Jieqing] Med Coll Wisconsin, Biochem, Milwaukee, WI 53226 USA; [Lin, Fu-Yang-] Morph Therapeut, 35 Gatehouse Dr, Waltham, MA 02451 USA; [Zhu, Jiangha] Natl Inst Allergy & Infect Dis, Res Technol Dev Sect, 5625 Fishers LN, Rockville, MD 20852 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Tsinghua University; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JQ; Springer, TA (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol, Program Cellular & Mol Med, Boston, MA 02115 USA.; Zhang, YH (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.; Zhu, JQ (corresponding author), Versiti, Blood Res Inst, Milwaukee, WI 53226 USA.; Zhu, JQ (corresponding author), Med Coll Wisconsin, Biochem, Milwaukee, WI 53226 USA.	zhangyonghui@tsinghua.edu.cn; jieqing.zhu@versiti.org; springer@crystal.harvard.edu		Springer, Timothy/0000-0001-6627-2904	NIH [HL131729, HL131836]; DOE Office of Science by Ar-gonne National Laboratory [DE-AC02-06CH11357]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science by Ar-gonne National Laboratory(United States Department of Energy (DOE))	We thank Rui Qiu and Christine Hwang for experimental work early in this project. Supported by NIH grants HL131729 (T.A.S.) and HL131836 (Jieqing Zhu).We thank the Advanced Photon Source, a U.S. Department of Energy (DOE)Office of Science user facility operated for the DOE Office of Science by Ar-gonne National Laboratory under contract no. DE-AC02-06CH11357 for beamline support	Adair BD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13928-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aga Y, 2004, CURR PHARM DESIGN, V10, P1597, DOI 10.2174/1381612043384592; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Anderson JM, 2022, MOL BIOL CELL, V33, DOI 10.1091/mbc.E21-11-0536; Arimori T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24184-8; Ault KA, 1999, J AM COLL CARDIOL, V33, P634, DOI 10.1016/S0735-1097(98)00635-4; Baba K, 2001, CARDIOVASC DRUG REV, V19, P25; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bosco A, 2005, J THROMB HAEMOST, V3, P1109, DOI 10.1111/j.1538-7836.2005.01296.x; Bougie DW, 2012, BLOOD, V119, P6317, DOI 10.1182/blood-2012-01-406322; Breth L, 2005, J IMMUNOL METHODS, V301, P11, DOI 10.1016/j.jim.2005.02.008; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Campbell MG, 2020, CELL, V180, P490, DOI 10.1016/j.cell.2019.12.030; Chew DP, 2001, CIRCULATION, V103, P201; Chiba J, 2005, BIOORG MED CHEM LETT, V15, P41, DOI 10.1016/j.bmcl.2004.10.041; Cox D, 1996, THROMB HAEMOSTASIS, V75, P503; Cox D, 2000, J AM COLL CARDIOL, V36, P1514, DOI 10.1016/S0735-1097(00)00919-0; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dickfeld T, 2001, THROMB RES, V101, P53, DOI 10.1016/S0049-3848(00)00385-6; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; ELDRED CD, 1994, J MED CHEM, V37, P3882, DOI 10.1021/jm00049a006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; Gante J, 1995, LETT PEPT SCI, V2, P135, DOI 10.1007/BF00119139; Gante J, 1996, BIOORG MED CHEM LETT, V6, P2425, DOI 10.1016/0960-894X(96)00445-3; Himmelsbach F., 1996, US patent, Patent No. 5576444; Jansen EE, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9081064; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEKOMAKI R, 1991, J CLIN INVEST, V88, P847, DOI 10.1172/JCI115386; Kereiakes DJ, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016552; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Ley K, 2016, NAT REV DRUG DISCOV, V15, P173, DOI 10.1038/nrd.2015.10; Li JH, 2019, ACS PHARMACOL TRANSL, V2, P387, DOI 10.1021/acsptsci.9b00041; Li JH, 2014, ARTERIOSCL THROM VAS, V34, P2321, DOI 10.1161/ATVBAHA.114.303724; Li J, 2018, J CELL BIOL, V217, P397, DOI 10.1083/jcb.201701169; Li J, 2017, P NATL ACAD SCI USA, V114, P4685, DOI 10.1073/pnas.1704171114; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Ma DW, 2001, ORG LETT, V3, P2583, DOI 10.1021/ol016258r; Matsuno H, 1998, J CARDIOVASC PHARM, V32, P191, DOI 10.1097/00005344-199808000-00004; Matsuno H, 1997, BRIT J PHARMACOL, V122, P1099, DOI 10.1038/sj.bjp.0701500; Miller DH, 2012, LANCET NEUROL, V11, P131, DOI 10.1016/S1474-4422(11)70299-X; MITJANS F, 1995, J CELL SCI, V108, P2825; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Mould D, 2001, CLIN PHARMACOL THER, V69, P210, DOI 10.1067/mcp.2001.114925; Muller TH, 1997, CIRCULATION, V96, P1130, DOI 10.1161/01.CIR.96.4.1130; Muro F, 2009, J MED CHEM, V52, P7974, DOI 10.1021/jm901154c; Murphy NP, 1998, J PHARMACOL EXP THER, V286, P945; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; NEWMAN PJ, 1985, BLOOD, V65, P227; Nomoto M, 2009, J PHARM SCI-US, V98, P1532, DOI 10.1002/jps.21510; Onitilo AA, 2006, AM J HEMATOL, V81, P984, DOI 10.1002/ajh.20609; Peter K, 2001, THROMB RES, V103, pS21, DOI 10.1016/S0049-3848(01)00300-0; Pieniaszek HJ, 2002, J CLIN PHARMACOL, V42, P738, DOI 10.1177/009127002401102687; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Schumacher S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe9716; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Smallheer J.M., 2001, US patent, Patent No. [6303609B1, 6303609]; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tilley JW, 2013, BIOORG MED CHEM LETT, V23, P1036, DOI 10.1016/j.bmcl.2012.12.019; Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Wang JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13248-5; Weller T, 1996, J MED CHEM, V39, P3139, DOI 10.1021/jm9509298; Wittke B, 1999, BRIT J CLIN PHARMACO, V47, P521, DOI 10.1046/j.1365-2125.1999.00931.x; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang CM, 2013, J CELL SCI, V126, P5735, DOI 10.1242/jcs.137828; Zhang LH, 1997, J ORG CHEM, V62, P2466, DOI 10.1021/jo9612537; Zhu J., 2012, SCI TRANSL MED, V4, P125; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	88	2	2	14	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3533	+		10.1016/j.cell.2022.08.008	http://dx.doi.org/10.1016/j.cell.2022.08.008			46	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4V7YX	36113427				2022-12-28	WOS:000859690800002
J	Feinstein, MJ				Feinstein, Matthew J.			HIV, Subclinical Cardiovascular Disease, and Clinical Progression Insights From Immunologic Heterogeneity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MYOCARDIAL-INFARCTION; RISK; IMMUNODEFICIENCY; INFECTION; INDIVIDUALS		[Feinstein, Matthew J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 300 E Super St,Tarry 3-703, Chicago, IL 60611 USA; [Feinstein, Matthew J.] Northwestern Med, Bluhm Cardiovasc Inst, Clin & Translat Immunocardiol Program, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Feinstein, MJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, 300 E Super St,Tarry 3-703, Chicago, IL 60611 USA.	matthewjfeinstein@northwestern.edu						Barnett CF, 2013, CLIN CHEST MED, V34, P283, DOI 10.1016/j.ccm.2013.01.009; Drozd DR, 2017, JAIDS-J ACQ IMM DEF, V75, P568, DOI [10.1097/QAI.0000000000001450, 10.1097/qai.0000000000001450]; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Feinstein MJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009985; Freiberg MS, 2017, JAMA CARDIOL, V2, P536, DOI 10.1001/jamacardio.2017.0264; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Hudson JA, 2022, JAMA-J AM MED ASSOC, V328, P951, DOI 10.1001/jama.2022.15078; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Smit M, 2018, CLIN INFECT DIS, V66, P743, DOI 10.1093/cid/cix858; Tarr PE, 2018, EUR HEART J, V39, P2147, DOI 10.1093/eurheartj/ehy163; Thompson MA, 2021, CLIN INFECT DIS, V73, pE3572, DOI 10.1093/cid/ciaa1391; Tseng ZH, 2021, NEW ENGL J MED, V384, P2306, DOI 10.1056/NEJMoa1914279	14	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					931	932		10.1001/jama.2022.15226	http://dx.doi.org/10.1001/jama.2022.15226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098735				2022-12-28	WOS:000855222400016
J	Rasmussen, SA; Jamieson, DJ				Rasmussen, Sonja A.; Jamieson, Denise J.			Protecting Pregnant People and Babies from the Health Effects of Climate Change	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rasmussen, Sonja A.] Johns Hopkins Univ, Dept Genet Med, Baltimore, MD 21218 USA; [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA	Johns Hopkins University; Emory University	Rasmussen, SA (corresponding author), Johns Hopkins Univ, Dept Genet Med, Baltimore, MD 21218 USA.			Rasmussen, Sonja/0000-0002-0574-4928				Abdo M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193720; Ha S, 2022, CURR ENV HLTH REP, V9, P263, DOI 10.1007/s40572-022-00345-9; Mendola P, 2022, FERTIL STERIL, V118, P224, DOI 10.1016/j.fertnstert.2022.06.007; Rasmussen SA, 2022, BJOG-INT J OBSTET GY, V129, P188, DOI 10.1111/1471-0528.16859; Xu RB, 2020, NEW ENGL J MED, V383, P2173, DOI 10.1056/NEJMsr2028985	5	0	0	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					957	959		10.1056/NEJMp2210221	http://dx.doi.org/10.1056/NEJMp2210221		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36094840	Bronze			2022-12-28	WOS:000859604000001
J	Webster, P				Webster, Paul			Worries grow about medically assisted dying in Canada	LANCET			English	Editorial Material																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					801	802						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088940				2022-12-28	WOS:000877580600010
J	Heyland, DK; Wibbenmeyer, L; Pollack, JA; Friedman, B; Turgeon, AF; Eshraghi, N; Jeschke, MG; Belisle, S; Grau, D; Mandell, S; Velamuri, SR; Hundeshagen, G; Moiemen, N; Shokrollahi, K; Foster, K; Huss, F; Collins, D; Savetamal, A; Gurney, JM; Depetris, N; Stoppe, C; Ortiz-Reyes, L; Garrel, D; Day, AG				Heyland, Daren K.; Wibbenmeyer, Lucy; Pollack, Jonathan A.; Friedman, Bruce; Turgeon, Alexis F.; Eshraghi, Niknam; Jeschke, Marc G.; Belisle, Sylvain; Grau, Daisy; Mandell, Samuel; Velamuri, Sai R.; Hundeshagen, Gabriel; Moiemen, Naiem; Shokrollahi, Kayvan; Foster, Kevin; Huss, Fredrik; Collins, Declan; Savetamal, Alisa; Gurney, Jennifer M.; Depetris, Nadia; Stoppe, Christian; Ortiz-Reyes, Luis; Garrel, Dominique; Day, Andrew G.			A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION; DEPLETION; TESTS; MODEL; ICU	BACKGROUNDGlutamine is thought to have beneficial effects on the metabolic and stress response to severe injury. Clinical trials involving patients with burns and other critically ill patients have shown conflicting results regarding the benefits and risks of glutamine supplementation. METHODS In a double-blind, randomized, placebo-controlled trial, we assigned patients with deep second-or third-degree burns (affecting >= 10% to >= 20% of total body-surface area, depending on age) within 72 hours after hospital admission to receive 0.5 g per kilogram of body weight per day of enterally delivered glutamine or placebo. Trial agents were given every 4 hours through a feeding tube or three or four times a day by mouth until 7 days after the last skin grafting procedure, discharge from the acute care unit, or 3 months after admission, whichever came first. The primary outcome was the time to discharge alive from the hospital, with data censored at 90 days. We calculated subdistribution hazard ratios for discharge alive, which took into account death as a competing risk. RESULTS A total of 1209 patients with severe burns (mean burn size, 33% of total body-surface area) underwent randomization, and 1200 were included in the analysis (596 patients in the glutamine group and 604 in the placebo group). The median time to discharge alive from the hospital was 40 days (interquartile range, 24 to 87) in the glutamine group and 38 days (interquartile range, 22 to 75) in the placebo group (subdistribution hazard ratio for discharge alive, 0.91; 95% confidence interval [CI], 0.80 to 1.04; P = 0.17). Mortality at 6 months was 17.2% in the glutamine group and 16.2% in the placebo group (hazard ratio for death, 1.06; 95% CI, 0.80 to 1.41). No substantial between-group differences in serious adverse events were observed. CONCLUSIONS In patients with severe burns, supplemental glutamine did not reduce the time to discharge alive from the hospital.	[Heyland, Daren K.; Ortiz-Reyes, Luis] Queens Univ, Clin Evaluat Res Unit, Kingston, ON, Canada; [Heyland, Daren K.; Ortiz-Reyes, Luis] Queens Univ, Res Inst, Kingston Hlth Sci Ctr, Kingston, ON, Canada; [Heyland, Daren K.; Ortiz-Reyes, Luis] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; [Heyland, Daren K.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Turgeon, Alexis F.] Univ Laval, Fac Med, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval Res Ctr, Populat Hlth & Optimal Hlth Pract Unit Trauma Emer, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval Res Ctr, Canada Res Chair Crit Care Neurol & Trauma, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Jeschke, Marc G.] Univ Toronto, Ross Tilley Burn Ctr, Sunnybrook Hlth Sci Ctr, Dept Surg,Dept Immunol,Div Plast Surg, Toronto, ON, Canada; [Jeschke, Marc G.] Univ Toronto, Inst Med Sci, Ross Tilley Burn Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Jeschke, Marc G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Belisle, Sylvain] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Belisle, Sylvain] Univ Montreal, Dept Anesthesiol, Montreal, PQ, Canada; [Garrel, Dominique] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ, Canada; [Wibbenmeyer, Lucy] Univ Iowa, Iowa City, IA USA; [Pollack, Jonathan A.] Mercy Hosp, Burn Ctr, St. Louis, MO USA; [Friedman, Bruce] Joseph M Still Res Fdn, Augusta, GA USA; [Eshraghi, Niknam] Legacy Oregon Burn Ctr, Portland, OR USA; [Eshraghi, Niknam] Oregon Hlth & Sci Univ, Portland, OR USA; [Grau, Daisy] Ctr Nacl Quemaduras & Cirugia Reconstruct, Internal Med, Asuncion, Paraguay; [Mandell, Samuel] UT Southwestern Med Ctr, Dallas, TX USA; [Gurney, Jennifer M.] Joint Base San Antonio Ft Sam Houston, San Antonio, TX USA; [Velamuri, Sai R.] Univ Tennessee Hlth Sci Ctr, Knoxville, TN USA; [Velamuri, Sai R.] Firefighters Burn Ctr, Memphis, TN USA; [Hundeshagen, Gabriel] Heidelberg Univ, Burn Trauma Ctr, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Heidelberg, Germany; [Stoppe, Christian] Univ Hosp Wurzburg, Dept Anesthesiol Intens Care Med & Pain Therapy, Wurzburg, Germany; [Moiemen, Naiem] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Birmingham, England; [Shokrollahi, Kayvan] Whiston Hosp, Mersey Reg Burn Ctr, St Helens & Knowesley NHS Trust, Prescot, England; [Shokrollahi, Kayvan] Manchester Metropolitan Univ, Manchester, England; [Collins, Declan] Chelsea & Westminster Hosp London, Plast Surg & Burns, London, England; [Foster, Kevin] Arizona Burn Ctr Valleywise Hlth, Maricopa Med Ctr, Phoenix, AZ USA; [Huss, Fredrik] Uppsala Univ, Dept Surg Sci, Plast Surg, Uppsala, Sweden; [Huss, Fredrik] Uppsala Univ Hosp, Burn Ctr, Dept Plast & Maxillofacial Surg, Uppsala, Sweden; [Savetamal, Alisa] Yale New Haven Hlth Bridgeport Hosp, Connecticut Burn Ctr, Bridgeport, CT USA; [Depetris, Nadia] Azienda Osped Univ, Ctr Traumatol Ortoped, Citta Salute & Sci Torino, Turin, Italy	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Laval University; Laval University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Iowa; Saint Johns Mercy Medical Center; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tennessee Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Birmingham; Whiston Hospital; Manchester Metropolitan University; Uppsala University; Uppsala University; Uppsala University Hospital; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Heyland, DK (corresponding author), Queens Univ, Clin Evaluat Res Unit, Kingston, ON, Canada.; Heyland, DK (corresponding author), Queens Univ, Res Inst, Kingston Hlth Sci Ctr, Kingston, ON, Canada.; Heyland, DK (corresponding author), Queens Univ, Dept Crit Care Med, Kingston, ON, Canada.; Heyland, DK (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.		; Jeschke, Marc/D-3501-2019; galet, colette/C-4620-2011	Collins, Declan/0000-0003-3191-3606; Jeschke, Marc/0000-0003-0870-1664; galet, colette/0000-0002-5931-2143				Sanchez JLA, 2007, ARCH SURG-CHICAGO, V142, P50, DOI 10.1001/archsurg.142.1.50; [Anonymous], 2021, COMP PAR NUTR GLUT S; Bessey PQ, 2014, J BURN CARE RES, V35, pS218, DOI 10.1097/BCR.0000000000000080; Czapran A, 2015, BURNS, V41, P510, DOI 10.1016/j.burns.2014.09.013; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Duchateau L, 2002, COMPUT STAT DATA AN, V40, P603, DOI 10.1016/S0167-9473(02)00057-9; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Greenhalgh DG, 2019, NEW ENGL J MED, V380, P2349, DOI 10.1056/NEJMra1807442; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Heyland Daren K, 2017, Scars Burn Heal, V3, p2059513117745241, DOI 10.1177/2059513117745241; Heyland DK, 2010, JPEN-PARENTER ENTER, V34, P697, DOI 10.1177/0148607110362993; James SL, 2020, INJURY PREV, V26, P36, DOI 10.1136/injuryprev-2019-043299; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kieser M, 2003, STAT MED, V22, P3571, DOI 10.1002/sim.1585; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Matsuyama T, 2021, CELL DEATH DIFFER, V28, P3199, DOI 10.1038/s41418-021-00892-y; Oehler R, 2002, BRIT J NUTR, V87, pS17, DOI 10.1079/BJN2001453; Oudemans-van Straaten HM, 2001, INTENS CARE MED, V27, P84, DOI 10.1007/s001340000703; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Peck MD, 2012, BURNS, V38, P630, DOI 10.1016/j.burns.2011.12.028; PLANAS M, 1993, JPEN-PARENTER ENTER, V17, P299, DOI 10.1177/0148607193017003299; Pritchett YL, 2015, STAT BIOPHARM RES, V7, P309, DOI 10.1080/19466315.2015.1098564; Roth E, 1982, Clin Nutr, V1, P25, DOI 10.1016/0261-5614(82)90004-8; Rousseau AF, 2013, CLIN NUTR, V32, P497, DOI 10.1016/j.clnu.2013.02.012; van Zanten ARH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1002-x; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Ware DL, 1996, QUALITY LIFE PHARMAC, P337; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; Zhou YP, 2003, JPEN-PARENTER ENTER, V27, P241, DOI 10.1177/0148607103027004241	30	0	0	8	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					1001	1010		10.1056/NEJMoa2203364	http://dx.doi.org/10.1056/NEJMoa2203364		SEP 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36082909				2022-12-28	WOS:000852749800001
J	Kumar, C; Birkbeck, J; Sulpizio, JA; Perello, D; Taniguchi, T; Watanabe, K; Reuven, O; Scaffidi, T; Stern, A; Geim, AK; Ilani, S				Kumar, C.; Birkbeck, J.; Sulpizio, J. A.; Perello, D.; Taniguchi, T.; Watanabe, K.; Reuven, O.; Scaffidi, T.; Stern, Ady; Geim, A. K.; Ilani, S.			Imaging hydrodynamic electrons flowing without Landauer-Sharvin resistance	NATURE			English	Article								Electrical resistance usually originates from lattice imperfections. However, even a perfect lattice has a fundamental resistance limit, given by the Landauer(1) conductance caused by a finite number of propagating electron modes. This resistance, shown by Sharvin(2) to appear at the contacts of electronic devices, sets the ultimate conduction limit of non-interacting electrons. Recent years have seen growing evidence of hydrodynamic electronic phenomena(3-18), prompting recent theories(19,20) to ask whether an electronic fluid can radically break the fundamental Landauer-Sharvin limit. Here, we use single-electron-transistor imaging of electronic flow in high-mobility graphene Corbino disk devices to answer this question. First, by imaging ballistic flows at liquid-helium temperatures, we observe a Landauer-Sharvin resistance that does not appear at the contacts but is instead distributed throughout the bulk. This underpins the phase-space origin of this resistance-as emerging from spatial gradients in the number of conduction modes. At elevated temperatures, by identifying and accounting for electron-phonon scattering, we show the details of the purely hydrodynamic flow. Strikingly, we find that electron hydrodynamics eliminates the bulk Landauer-Sharvin resistance. Finally, by imaging spiralling magneto-hydrodynamic Corbino flows, we show the key emergent length scale predicted by hydrodynamic theories-the Gurzhi length. These observations demonstrate that electronic fluids can dramatically transcend the fundamental limitations of ballistic electrons, with important implications for fundamental science and future technologies.	[Kumar, C.; Birkbeck, J.; Sulpizio, J. A.; Reuven, O.; Stern, Ady; Ilani, S.] Weizmann Inst Sci, Dept Condensed Matter Phys, Rehovot, Israel; [Perello, D.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Perello, D.; Geim, A. K.] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Taniguchi, T.; Watanabe, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Scaffidi, T.] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Scaffidi, T.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA	Weizmann Institute of Science; University of Manchester; University of Manchester; National Institute for Materials Science; University of Toronto; University of California System; University of California Irvine	Ilani, S (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, Rehovot, Israel.	shaha.ilani@weizmann.ac.il	Watanabe, Kenji/H-2825-2011	Watanabe, Kenji/0000-0003-3701-8119; Stern, Ady/0000-0002-9493-268X; Kumar, Chandan/0000-0003-3493-2597	Leona M. and Harry B. Helmsley Charitable Trust grant; ISF [1182/21]; Minerva [713237]; Hydrotronics [873028]; ERC-Cog (See-1D-Qmatter) [647413]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2020-05842, RGPAS-2020-00060, DGECR-2020-00222]	Leona M. and Harry B. Helmsley Charitable Trust grant; ISF(Israel Science Foundation); Minerva; Hydrotronics; ERC-Cog (See-1D-Qmatter); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank L. Ella, G. Falkovich, L. Levitov, M. Polini, M. Shavit, A. Rozen, A. V. Shytov and U. Zondiner for useful discussions. Work was supported by the Leona M. and Harry B. Helmsley Charitable Trust grant, ISF grant (no. 1182/21), Minerva grant (no. 713237), Hydrotronics (no. 873028) and the ERC-Cog (See-1D-Qmatter, no. 647413). T.S. acknowledges the support of the Natural Sciences and Engineering Research Council of Canada (NSERC), in particular the Discovery Grant (no. RGPIN-2020-05842), the Accelerator Supplement (no. RGPAS-2020-00060) and the Discovery Launch Supplement (no. DGECR-2020-00222). During the preparation of this manuscript, we became aware of a partially related STM work17, which images voltage drops in flows across a constriction.	Andreev AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256804; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Ben Shalom M, 2016, NAT PHYS, V12, P318, DOI 10.1038/NPHYS3592; Berdyugin AI, 2019, SCIENCE, V364, P163, DOI 10.1126/science.aau0685; Braem BA, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.241304; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; DEJONG MJM, 1995, PHYS REV B, V51, P13389, DOI 10.1103/PhysRevB.51.13389; Efetov DK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.256805; Ella L, 2019, NAT NANOTECHNOL, V14, P480, DOI 10.1038/s41565-019-0398-x; Gooth J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06688-y; Guo HY, 2017, P NATL ACAD SCI USA, V114, P3068, DOI 10.1073/pnas.1612181114; Gupta A, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.076803; GURZHI RN, 1963, SOV PHYS JETP-USSR, V17, P521; Holder T, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.245305; Hong Q., 2020, SUPERSCREENING RETRO; Jenkins A, 2020, IMAGING BREAKDOWN OH; Keser AC, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.031030; Krebs Z. J, 2021, IMAGING BREAKING ELE; Ku MJH, 2020, NATURE, V583, P537, DOI 10.1038/s41586-020-2507-2; Kumar RK, 2017, NAT PHYS, V13, P1182, DOI 10.1038/NPHYS4240; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; Levchenko A, 2020, ANN PHYS-NEW YORK, V419, DOI 10.1016/j.aop.2020.168218; Levitov L, 2016, NAT PHYS, V12, P672, DOI [10.1038/NPHYS3667, 10.1038/nphys3667]; Moll PJW, 2016, SCIENCE, V351, P1061, DOI 10.1126/science.aac8385; Nagaev KE, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125316; Nagaev KE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.216807; Narozhny BN, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201700043; Scaffidi T, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.226601; SHARVIN YV, 1965, SOV PHYS JETP-USSR, V21, P655; Shavit M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.026801; Stern A, 2021, SPREAD ERASE ELECT H; Sulpizio JA, 2019, NATURE, V576, P75, DOI 10.1038/s41586-019-1788-9; Tan C., SCI ADV, V8; Torre I, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.165433; Vool U, 2021, NAT PHYS, V17, P1216, DOI 10.1038/s41567-021-01341-w; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358	38	1	1	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					276	+		10.1038/s41586-022-05002-7	http://dx.doi.org/10.1038/s41586-022-05002-7			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071191	Green Submitted			2022-12-28	WOS:000852469200022
J	Tang, HR; Liang, YY; Liu, CC; Hu, ZC; Deng, YF; Guo, H; Yu, ZD; Song, A; Zhao, HY; Zhao, DK; Zhang, YZ; Guo, XG; Pei, J; Ma, YG; Cao, Y; Huang, F				Tang, Haoran; Liang, Yuanying; Liu, Chunchen; Hu, Zhicheng; Deng, Yifei; Guo, Han; Yu, Zidi; Song, Ao; Zhao, Haiyang; Zhao, Duokai; Zhang, Yuanzhu; Guo, Xugang; Pei, Jian; Ma, Yuguang; Cao, Yong; Huang, Fei			A solution-processed n-type conducting polymer with ultrahigh conductivity	NATURE			English	Article							CHARGE-TRANSPORT; CRITICAL REGIME; THIN-FILMS; C-H; POLYACETYLENE; TRANSITION; POLARONS; DOPANT; STATE	Conducting polymers (CPs) with high conductivity and solution processability have made great advances since the pioneering work on doped polyacetylene(1-3), thus creating the new field of 'organic synthetic metals,(4). Various high-performance CPs have been realized, which enable the applications of several organic electronic devices(5,6). Nevertheless, most CPs exhibit hole-dominant (p-type) transport behaviour(7,8), whereas the development of n-type analogues lags far behind and only a few exhibit metallic state, typically limited by low doping efficiency and ambient instability. Here we present a facilely synthesized highly conductive n-type polymer poly(benzodifurandione) (PBFDO). The reaction combines oxidative polymerization and in situ reductive n-doping, greatly increasing the doping efficiency, and a doping level of almost 0.9 charges per repeating unit can be achieved. The resultant polymer exhibits a breakthrough conductivity of more than 2,000 S cm(-1) with excellent stability and an unexpected solution processability without extra side chains or surfactants. Furthermore, detailed investigations on PBFDO show coherent charge-transport properties and existence of metallic state. The benchmark performances in electrochemical transistors and thermoelectric generators are further demonstrated, thus paving the way for application of the n-type CPs in organic electronics.	[Tang, Haoran; Liang, Yuanying; Liu, Chunchen; Hu, Zhicheng; Song, Ao; Zhao, Haiyang; Zhao, Duokai; Ma, Yuguang; Cao, Yong; Huang, Fei] South China Univ Technol SCUT, Inst Polymer Optoelect Mat & Devices, State Key Lab Luminescent Mat & Devices, Guangzhou, Peoples R China; [Deng, Yifei; Zhang, Yuanzhu] Southern Univ Sci & Technol SUSTech, Dept Chem, Shenzhen, Peoples R China; [Guo, Han; Guo, Xugang] Southern Univ Sci & Technol SUSTech, Dept Mat Sci & Engn, Shenzhen, Peoples R China; [Yu, Zidi; Pei, Jian] Peking Univ, Beijing Natl Lab Mol Sci BNLMS, Minist Educ,Coll Chem & Mol Engn, Ctr Soft Matter Sci & Engn,Key Lab Polymer Chem &, Beijing, Peoples R China	South China University of Technology; Southern University of Science & Technology; Southern University of Science & Technology; Peking University	Huang, F (corresponding author), South China Univ Technol SCUT, Inst Polymer Optoelect Mat & Devices, State Key Lab Luminescent Mat & Devices, Guangzhou, Peoples R China.	msfhuang@scut.edu.cn	Zhang, Yuan-Zhu/AAD-5208-2019	Zhang, Yuan-Zhu/0000-0002-1676-2427; Tang, Haoran/0000-0002-0963-7230	National Key Research and Development Program of China [2019YFA0705900]; MOST; Basic and Applied Basic Research Major Program of Guangdong Province [2019B030302007]; National Natural Science Foundation of China [U21A6002]	National Key Research and Development Program of China; MOST; Basic and Applied Basic Research Major Program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Key Research and Development Program of China (no. 2019YFA0705900) funded by MOST, the Basic and Applied Basic Research Major Program of Guangdong Province (no. 2019B030302007) and the National Natural Science Foundation of China (no. U21A6002).	Ahlskog M, 1997, J PHYS-CONDENS MAT, V9, P4145, DOI 10.1088/0953-8984/9/20/014; Aleshin AN, 2003, SYNTHETIC MET, V135, P303, DOI 10.1016/S0379-6779(02)00566-0; BASESCU N, 1987, NATURE, V327, P403, DOI 10.1038/327403a0; Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003; Bharti M, 2018, PROG MATER SCI, V93, P270, DOI 10.1016/j.pmatsci.2017.09.004; Chen ZX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26173-3; Cheng DP, 2008, J ORG CHEM, V73, P6881, DOI 10.1021/jo8010039; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; EMIN D, 1993, PHYS REV B, V48, P13691, DOI 10.1103/PhysRevB.48.13691; Feng K, 2022, ADV MATER, V34, DOI 10.1002/adma.202201340; Fischer H, 2001, CHEM REV, V101, P3581, DOI 10.1021/cr990124y; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Gueye MN, 2020, PROG MATER SCI, V108, DOI 10.1016/j.pmatsci.2019.100616; Guha S, 2012, J AM CHEM SOC, V134, P13679, DOI 10.1021/ja303173n; Guo H, 2021, NATURE, V599, P67, DOI 10.1038/s41586-021-03942-0; Guo S, 2012, ADV MATER, V24, P699, DOI 10.1002/adma.201103238; Guo XG, 2020, NAT MATER, V19, P922, DOI 10.1038/s41563-020-0778-5; Han JF, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202005901; Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0; Ji XZ, 2020, J AM CHEM SOC, V142, P641, DOI 10.1021/jacs.9b12626; Jin EQ, 2017, SCIENCE, V357, P673, DOI 10.1126/science.aan0202; Kang K, 2016, NAT MATER, V15, P896, DOI [10.1038/nmat4634, 10.1038/NMAT4634]; Kiefer D, 2018, ACS ENERGY LETT, V3, P278, DOI 10.1021/acsenergylett.7b01146; Kobayashi Y, 2009, J AM CHEM SOC, V131, P9995, DOI 10.1021/ja809425b; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; Li FH, 2004, J PHYS CHEM B, V108, P17076, DOI 10.1021/jp0478615; Li ZP, 2008, ORG LETT, V10, P803, DOI 10.1021/ol702934k; Liu J, 2018, ADV MATER, V30, DOI 10.1002/adma.201704630; Lu Y, 2021, ADV MATER, V33, DOI 10.1002/adma.202005946; Lu Y, 2020, J AM CHEM SOC, V142, P15340, DOI 10.1021/jacs.0c05699; Lu Y, 2019, ANGEW CHEM INT EDIT, V58, P11390, DOI 10.1002/anie.201905835; Lussem B, 2016, CHEM REV, V116, P13714, DOI 10.1021/acs.chemrev.6b00329; MACDIARMID AG, 1980, SYNTHETIC MET, V1, P101, DOI 10.1016/0379-6779(80)90002-8; MENON R, 1993, PHYS REV B, V48, P17685, DOI 10.1103/PhysRevB.48.17685; MORAES F, 1985, SYNTHETIC MET, V10, P169, DOI 10.1016/0379-6779(85)90188-2; Mukherjee AK, 2005, J PHYS-CONDENS MAT, V17, P1947, DOI 10.1088/0953-8984/17/12/017; MULLER P, 1972, J AM CHEM SOC, V94, P2716; Naab BD, 2014, ADV MATER, V26, P4268, DOI 10.1002/adma.201400668; Noriega R, 2013, NAT MATER, V12, P1038, DOI [10.1038/nmat3722, 10.1038/NMAT3722]; Rivnay J, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.86; Rivnay J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045203; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Suh DS, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165210; Sun YH, 2016, ADV MATER, V28, P3351, DOI 10.1002/adma.201505922; Tanaka H, 2014, ADV MATER, V26, P2376, DOI 10.1002/adma.201304691; Tang CG, 2019, NATURE, V573, P519, DOI 10.1038/s41586-019-1575-7; Wei P, 2012, J AM CHEM SOC, V134, P3999, DOI 10.1021/ja211382x; Wu HY, 2022, ADV MATER, V34, DOI 10.1002/adma.202106235; Yang CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22528-y; Yang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17063-1; Zanettini S, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4908526; Zhang YH, 2006, J AM CHEM SOC, V128, P4242, DOI 10.1021/ja060050p; Zhao XG, 2017, ADV MATER, V29, DOI 10.1002/adma.201606928; Zozoulenko I, 2019, ACS APPL POLYM MATER, V1, P83, DOI 10.1021/acsapm.8b00061	56	6	6	225	225	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 10	2022	611	7935					271	+		10.1038/s41586-022-05295-8	http://dx.doi.org/10.1038/s41586-022-05295-8		SEP 2022	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6H0KM	36070797				2022-12-28	WOS:000867593700001
J	Horton, R				Horton, Richard			Offline: The slow death of human civilisations	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					718	718						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058211	Bronze			2022-12-28	WOS:000860483700007
J	Jaffe, S				Jaffe, Susan			Health organisations welcome US climate crisis law The recently passed Inflation Reduction Act will provide billions of dollars of incentives to reduce greenhouse gas emissions. Susan Jaffe reports	LANCET			English	Editorial Material																			0	0	0	5	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					719	720						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058212				2022-12-28	WOS:000860483700001
J	Akkerman, QA; Nguyen, TPT; Boehme, SC; Montanarella, F; Dirin, DN; Wechsler, P; Beiglbock, F; Raino, G; Erni, R; Katan, C; Even, J; Kovalenko, MV				Akkerman, Quinten A.; Nguyen, Tan P. T.; Boehme, Simon C.; Montanarella, Federico; Dirin, Dmitry N.; Wechsler, Philipp; Beiglbock, Finn; Raino, Gabriele; Erni, Rolf; Katan, Claudine; Even, Jacky; Kovalenko, Maksym V.			Controlling the nucleation and growth kinetics of lead halide perovskite quantum dots	SCIENCE			English	Article							SINGLE-PHOTON EMISSION; NANOCRYSTALS; CSPBX3; SIZE; BR	Colloidal lead halide perovskite nanocrystals are of interest as photoluminescent quantum dots (QDs) whose properties depend on the size and shape. They are normally synthesized on subsecond time scales through hard-to-control ionic metathesis reactions. We report a room-temperature synthesis of monodisperse, isolable, spheroidal APbBr(3) QDs ("A" indicates cesium, formamidinium, and methylammonium) that are size tunable from 3 to >13 nanometers. The kinetics of both nucleation and growth are temporally separated and substantially slowed down by the intricate equilibrium between the precursor (PbBr2) and the A[PbBr3] solute, with the latter serving as a monomer. QDs of all these compositions exhibit up to four excitonic transitions in their linear absorption spectra, and we demonstrate that the size-dependent confinement energy for all transitions is independent of the A-site cation.	[Akkerman, Quinten A.; Boehme, Simon C.; Montanarella, Federico; Dirin, Dmitry N.; Wechsler, Philipp; Raino, Gabriele; Kovalenko, Maksym V.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Akkerman, Quinten A.; Boehme, Simon C.; Montanarella, Federico; Dirin, Dmitry N.; Beiglbock, Finn; Raino, Gabriele; Kovalenko, Maksym V.] Empa Swiss Fed Labs Mat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Nguyen, Tan P. T.; Katan, Claudine] Univ Rennes, CNRS, ENSCR, INSA Rennes,ISCR UMR 6226, F-35000 Rennes, France; [Erni, Rolf] Empa Swiss Fed Labs Mat Sci & Technol, Electron Microscopy Ctr, Dubendorf, Switzerland; [Even, Jacky] Univ Rennes, CNRS, Inst FOTON UMR 6082, INSA Rennes, F-35000 Rennes, France; [Akkerman, Quinten A.] Ludwig Maximilians Univ LMU, Nanoinst Munchen, Lehrstuhl Photon & Optoelekt, Koniginstr 10, D-80539 Munich, Germany; [Akkerman, Quinten A.] Ludwig Maximilians Univ LMU, Fak Phys, Koniginstr 10, D-80539 Munich, Germany; [Montanarella, Federico] Seaborough BV, Matrix Innovat Ctr 7, Sci Pk 106, NL-1098 XG Amsterdam, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Nationale Superieure de Chimie de Rennes (ENSCR); Institut National des Sciences Appliquees de Rennes; Universite de Rennes; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Rennes; Universite de Rennes; University of Munich; University of Munich	Kovalenko, MV (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.; Kovalenko, MV (corresponding author), Empa Swiss Fed Labs Mat Sci & Technol, CH-8600 Dubendorf, Switzerland.	mvkovalenko@ethz.ch	Akkerman, Quinten/B-8518-2018; even, jacky/C-6212-2008; KATAN, Claudine/I-9446-2012; Erni, Rolf/P-7435-2014; Dirin, Dmitry/K-1599-2016	Akkerman, Quinten/0000-0002-8699-9390; Nguyen, Tan/0000-0003-2883-4464; even, jacky/0000-0002-4607-3390; Boehme, Simon C./0000-0002-8399-5773; Montanarella, Federico/0000-0002-9057-7414; KATAN, Claudine/0000-0002-2017-5823; Erni, Rolf/0000-0003-2391-5943; Dirin, Dmitry/0000-0002-5187-4555; Raino, Gabriele/0000-0002-2395-4937; Beiglboeck, Finn/0000-0001-9158-1338	European Union through the Horizon 2020 Research and Innovation Programme through the European Research Commission (ERCCoG) [819740]; Air Force Office of Scientific Research; Office of Naval Research [FA8655-21-1-7013]; Institute Universitaire de France; project CALIPSOplus from the EU Framework Programme for Research and Innovation Horizon 2020 [730872]; European Union through the FET Open Research and Innovation Action [899141]	European Union through the Horizon 2020 Research and Innovation Programme through the European Research Commission (ERCCoG); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); Institute Universitaire de France; project CALIPSOplus from the EU Framework Programme for Research and Innovation Horizon 2020; European Union through the FET Open Research and Innovation Action	This work was financially supported by the European Union through the Horizon 2020 Research and Innovation Programme through the European Research Commission (ERCCoG, agreement no. 819740, project SCALE-HALO) and FET Open Research and Innovation Action (grant agreement no. 899141, project PoLLoC) and by the Air Force Office of Scientific Research and the Office of Naval Research (award no. FA8655-21-1-7013), and the Institute Universitaire de France. SAXS and WAXS measurements were carried out at beamline P21.2 at PETRA III at DESY, a member of the Helmholtz Association (HGF); the research leading to this result has been supported by the project CALIPSOplus (grant agreement 730872) from the EU Framework Programme for Research and Innovation Horizon 2020.	Akkerman QA, 2018, NAT MATER, V17, P394, DOI 10.1038/s41563-018-0018-4; Almeida G, 2018, J AM CHEM SOC, V140, P14878, DOI 10.1021/jacs.8b08978; Almeida G, 2018, ACS NANO, V12, P1704, DOI 10.1021/acsnano.7b08357; Andreev AD, 1999, PHYS REV B, V59, P15402, DOI 10.1103/PhysRevB.59.15402; Avantama, US; Becker MA, 2018, NANO LETT, V18, P7546, DOI 10.1021/acs.nanolett.8b03027; Brennan MC, 2017, J AM CHEM SOC, V139, P12201, DOI 10.1021/jacs.7b05683; Chen QS, 2018, NATURE, V561, P88, DOI 10.1038/s41586-018-0451-1; Cherniukh I, 2021, NATURE, V593, P535, DOI 10.1038/s41586-021-03492-5; Cho K, 2021, NANO LETT, V21, P7206, DOI 10.1021/acs.nanolett.1c02122; De Roo J, 2016, ACS NANO, V10, P2071, DOI 10.1021/acsnano.5b06295; Dey A, 2021, ACS NANO, V15, P10775, DOI 10.1021/acsnano.0c08903; Dong YT, 2018, NANO LETT, V18, P3716, DOI 10.1021/acs.nanolett.8b00861; Gandini M, 2020, NAT NANOTECHNOL, V15, P462, DOI 10.1038/s41565-020-0683-8; Hassan Y, 2021, NATURE, V591, P72, DOI 10.1038/s41586-021-03217-8; Hendricks MP, 2015, SCIENCE, V348, P1226, DOI 10.1126/science.aaa2951; Hui J, 2020, CHEM MATER, V32, P4574, DOI 10.1021/acs.chemmater.0c00661; Imran M, 2018, NANO LETT, V18, P7822, DOI 10.1021/acs.nanolett.8b03598; Kim YH, 2021, NAT PHOTONICS, V15, P148, DOI 10.1038/s41566-020-00732-4; Krieg F, 2021, ACS CENTRAL SCI, V7, P135, DOI 10.1021/acscentsci.0c01153; Krieg F, 2019, J AM CHEM SOC, V141, P19839, DOI 10.1021/jacs.9b09969; Krieg F, 2018, ACS ENERGY LETT, V3, P641, DOI 10.1021/acsenergylett.8b00035; Mattiotti F, 2020, NANO LETT, V20, P7382, DOI 10.1021/acs.nanolett.0c02784; Nguyen TPT, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.195414; Norris DJ, 1996, PHYS REV B, V53, P16338, DOI 10.1103/PhysRevB.53.16338; Park YS, 2015, ACS NANO, V9, P10386, DOI 10.1021/acsnano.5b04584; Protesescu L, 2015, NANO LETT, V15, P3692, DOI 10.1021/nl5048779; Raino G, 2018, NATURE, V563, P671, DOI 10.1038/s41586-018-0683-0; Raino G, 2016, ACS NANO, V10, P2485, DOI 10.1021/acsnano.5b07328; Sakuma T, 2002, SOLID STATE IONICS, V154, P237, DOI 10.1016/S0167-2738(02)00438-1; Sercel PC, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5127528; Shcherbakov-Wu W, 2021, J PHYS CHEM LETT, V12, P8088, DOI 10.1021/acs.jpclett.1c01822; Shynkarenko Y, 2019, ACS ENERGY LETT, V4, P2703, DOI 10.1021/acsenergylett.9b01915; Tamarat P, 2019, NAT MATER, V18, P717, DOI 10.1038/s41563-019-0364-x; Traore B, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.035139; Utzat H, 2019, SCIENCE, V363, P1068, DOI 10.1126/science.aau7392; Wei MY, 2019, NAT ENERGY, V4, P197, DOI 10.1038/s41560-018-0313-y; Wu JJ, 2020, ANGEW CHEM INT EDIT, V59, P7738, DOI 10.1002/anie.201911638; Yin CY, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.026401; Yoon SJ, 2016, J PHYS CHEM LETT, V7, P1368, DOI 10.1021/acs.jpclett.6b00433; Zhang P, 2018, J PHYS CHEM LETT, V9, P5040, DOI 10.1021/acs.jpclett.8b01945; Zhang Q, 2021, NANO LETT, V21, P1903, DOI 10.1021/acs.nanolett.0c03593	42	3	3	78	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2022	377	6613					1406	1412		10.1126/science.abq3616	http://dx.doi.org/10.1126/science.abq3616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1FA	36074820	Green Submitted			2022-12-28	WOS:000887934300034
J	Kozlov, M				Kozlov, Max			HOW DEADLY IS MONKEYPOX? WHAT SCIENTISTS KNOW	NATURE			English	Editorial Material																		Badenoch JB, 2022, ECLINICALMEDICINE, V52, DOI 10.1016/j.eclinm.2022.101644; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880	2	2	2	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					663	663						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O1XO	36100744	Bronze			2022-12-28	WOS:000854500100008
J	Lebwohl, MG; Kircik, LH; Moore, AY; Gold, LS; Draelos, ZD; Gooderham, MJ; Papp, KA; Bagel, J; Bhatia, N; Del Rosso, JQ; Ferris, LK; Green, LJ; Hebert, AA; Jones, T; Kempers, SE; Pariser, DM; Yamauchi, PS; Zirwas, M; Albrecht, L; Devani, AR; Lomaga, M; Feng, A; Snyder, S; Burnett, P; Higham, RC; Berk, DR				Lebwohl, Mark G.; Kircik, Leon H.; Moore, Angela Y.; Stein Gold, Linda; Draelos, Zoe D.; Gooderham, Melinda J.; Papp, Kim A.; Bagel, Jerry; Bhatia, Neal; Del Rosso, James Q.; Ferris, Laura K.; Green, Lawrence J.; Hebert, Adelaide A.; Jones, Terry; Kempers, Steven E.; Pariser, David M.; Yamauchi, Paul S.; Zirwas, Matthew; Albrecht, Lorne; Devani, Alim R.; Lomaga, Mark; Feng, Amy; Snyder, Scott; Burnett, Patrick; Higham, Robert C.; Berk, David R.			Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis The DERMIS-1 and DERMIS-2 Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUMERIC RATING-SCALE; PSYCHOMETRIC PROPERTIES; MODERATE	IMPORTANCE Once-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis. OBJECTIVE To evaluate the efficacy of roflumilast cream, 0.3%, applied once daily for 8 weeks in 2 trials of patients with plaque psoriasis. DESIGN, SETTING, AND PARTICIPANTS Two phase 3, randomized, double-blind, controlled, multicenter trials (DERMIS-1 [trial 1; n = 439] and DERMIS-2 [trial 2; n = 442]) were conducted at 40 centers (trial 1) and 39 centers (trial 2) in the US and Canada between December 9, 2019, and November 16, 2020, and between December 9, 2019, and November 23, 2020, respectively. Patients aged 2 years or older with plaque psoriasis involving 2% to 20% of body surface area were enrolled. The dates of final follow-up were November 20, 2020, and November 23, 2020, for trial 1 and trial 2, respectively. INTERVENTIONS Patientswere randomized 2:1 to receive roflumilast cream, 0.3%(trial 1: n = 286; trial 2: n = 290), or vehicle cream (trial 1: n = 153; trial 2: n = 152) once daily for 8weeks. MAIN OUTCOMES AND MEASURES The primary efficacy end point was Investigator Global Assessment (IGA) success (clear or almost clear status plus >= 2-grade improvement from baseline [score range, 0-4]) at week 8, analyzed using a Cochran-Mantel-Haenszel test stratified by site, baseline IGA score, and intertriginous involvement. There were 9 secondary outcomes, including intertriginous IGA success, 75% reduction in Psoriasis Area and Severity Index (PASI) score, andWorst Itch Numeric Rating Scale score of 4 or higher at baseline achieving 4-point reduction (WI-NRS success) at week 8 (scale: 0 [no itch] to 10 [worst imaginable itch]; minimum clinically important difference, 4 points). RESULTS Among 881 participants (mean age, 47.5 years; 320 [36.3%] female), mean IGA scores in trial 1were 2.9 [SD, 0.52] for roflumilast and 2.9 [SD, 0.45] for vehicle and in trial 2 were 2.9 [SD, 0.48] for roflumilast and 2.9 [SD, 0.47]) for vehicle. Statistically significantly greater percentages of roflumilast-treated patients than vehicle-treated patients had IGA success at week 8 (trial 1: 42.4% vs 6.1%; difference, 39.6% [95% CI, 32.3%-46.9%]; trial 2: 37.5% vs 6.9%; difference, 28.9%[95% CI, 20.8%-36.9%]; P <.001 for both). Of 9 secondary end points, statistically significant differences favoring roflumilast vs vehiclewere observed for 8 in trial 1 and 9 in trial 2, including intertriginous IGA success (71.2% vs 13.8%; difference, 66.5%[95% CI, 47.1%-85.8%] and 68.1% vs 18.5%; difference, 51.6% [95% CI, 29.3%-73.8%]; P <.001 for both), 75% reduction in PASI score (41.6% vs 7.6%; difference, 36.1% [95% CI, 28.5%-43.8%] and 39.0% vs 5.3%; difference, 32.4% [95% CI, 24.9%-39.8%]; P <.001 for both), WI-NRS success (67.5% vs 26.8%; difference, 42.6% [95% CI, 31.3%-53.8%] and 69.4% vs 35.6%; difference, 30.2% [95% CI, 18.2%-42.2%]; P <.001 for both). The incidence of treatment-emergent adverse events was 25.2% with roflumilast vs 23.5% with vehicle in trial 1 and 25.9% with roflumilast vs 18.4% with vehicle in trial 2. The incidence of serious adverse eventswas 0.7% with roflumilast vs 0.7% with vehicle in trial 1 and 0% with roflumilast vs 0.7% with vehicle in trial 2. CONCLUSIONS AND RELEVANCE Among patients with chronic plaque psoriasis, treatment with roflumilast cream, 0.3%, compared with vehicle cream resulted in better clinical status at 8 weeks. Further research is needed to assess efficacy compared with other active treatments and to assess longer-term efficacy and safety.	[Lebwohl, Mark G.; Kircik, Leon H.] Icahn Sch Med Mt Sinai, 5 98th St,5th Floor, New York, NY 10029 USA; [Kircik, Leon H.] Indiana Med Ctr, Indianapolis, IN USA; [Kircik, Leon H.] Phys Skin Care PLLC, Louisville, KY USA; [Kircik, Leon H.] Skin Sci PLLC, Louisville, KY USA; [Moore, Angela Y.] Arlington Res Ctr, Arlington, TX USA; [Moore, Angela Y.] Baylor Univ, Med Ctr, Dallas, TX USA; [Stein Gold, Linda] Henry Ford Med Ctr, Detroit, MI USA; [Draelos, Zoe D.] Dermatol Consulting Serv, High Point, NC USA; [Gooderham, Melinda J.] SkiN Ctr Dermatol, Peterborough, ON, Canada; [Gooderham, Melinda J.] Prob Med Res, Peterborough, ON, Canada; [Gooderham, Melinda J.] Queens Univ, Peterborough, ON, Canada; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Papp, Kim A.] K Papp Clin Res, Waterloo, ON, Canada; [Bagel, Jerry] Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA; [Bhatia, Neal] Therapeut Clin Res, San Diego, CA USA; [Del Rosso, James Q.] JDR Dermatol Res Ctr LLC, Las Vegas, NV USA; [Del Rosso, James Q.] Adv Dermatol & Cosmet Surg, Maitland, FL USA; [Ferris, Laura K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Green, Lawrence J.] George Washington Univ, Sch Med, Rockville, MD USA; [Hebert, Adelaide A.] UT Hlth McGovern Med Sch, Houston, TX USA; [Jones, Terry] US Dermatol Partners Bryan, Bryan, TX USA; [Kempers, Steven E.] Minnesota Clin Study Ctr, Fridley, MN USA; [Pariser, David M.] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Pariser, David M.] Virginia Clin Res Inc, Norfolk, VA USA; [Yamauchi, Paul S.] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Yamauchi, Paul S.] Skin Care Ctr Inc, Inst Dermatol, Santa Monica, CA USA; [Yamauchi, Paul S.] Skin Care Ctr Inc, Santa Monica, CA USA; [Zirwas, Matthew] Dermatol Cent States, Bexley, OH USA; [Zirwas, Matthew] Prob Med Res, Bexley, OH USA; [Zirwas, Matthew] Ohio Univ, Bexley, OH USA; [Albrecht, Lorne] Enverus Med Res, Surrey, BC, Canada; [Albrecht, Lorne] Prob Med Res, Surrey, BC, Canada; [Devani, Alim R.] Dermatol Res Inst, Calgary, AB, Canada; [Devani, Alim R.] Prob Med Res, Calgary, AB, Canada; [Lomaga, Mark] DermEdge Res, Mississauga, ON, Canada; [Lomaga, Mark] Prob Med Res, Mississauga, ON, Canada; [Feng, Amy; Snyder, Scott; Burnett, Patrick; Higham, Robert C.; Berk, David R.] Arcutis Biotherapeut Inc, Westlake Village, CA USA	Icahn School of Medicine at Mount Sinai; Baylor University; Baylor University Medical Center; Henry Ford Health System; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Eastern Virginia Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Ohio University	Lebwohl, MG (corresponding author), Icahn Sch Med Mt Sinai, 5 98th St,5th Floor, New York, NY 10029 USA.	lebwohl@aol.com			Arcutis Biotherapeutics Inc.	Arcutis Biotherapeutics Inc.	This work was supported by Arcutis Biotherapeutics Inc.	Dong C, 2016, J PHARMACOL EXP THER, V358, P413, DOI 10.1124/jpet.116.232819; Dopytalska Klaudia, 2018, Reumatologia (Warsaw), V56, P392, DOI 10.5114/reum.2018.80718; Elewski B, 2019, J EUR ACAD DERMATOL, V33, P1465, DOI 10.1111/jdv.15450; Elmets CA, 2021, J AM ACAD DERMATOL, V84, P432, DOI 10.1016/j.jaad.2020.07.087; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Globe D, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-62; Khosravi H, 2017, J DRUGS DERMATOL, V16, P760; Kimball AB, 2016, BRIT J DERMATOL, V175, P157, DOI 10.1111/bjd.14464; Kivelevitch D, 2018, EXPERT OPIN PHARMACO, V19, P561, DOI 10.1080/14656566.2018.1448788; Langley RGB, 2015, J DERMATOL TREAT, V26, P23, DOI 10.3109/09546634.2013.865009; Lebwohl MG, 2020, NEW ENGL J MED, V383, P229, DOI 10.1056/NEJMoa2000073; Naegeli AN, 2015, INT J DERMATOL, V54, P715, DOI 10.1111/ijd.12645; Papp KA, 2020, J DRUGS DERMATOL, V19, P734, DOI 10.36849/JDD.2020.5370; Strober BE, 2013, VALUE HEALTH, V16, P1014, DOI 10.1016/j.jval.2013.07.002; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	15	3	3	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1073	1084		10.1001/jama.2022.15632	http://dx.doi.org/10.1001/jama.2022.15632			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125472				2022-12-28	WOS:000862909200021
J	Daniels, JP				Daniels, Joe Parkin			COPD in Colombia	LANCET			English	Editorial Material								Huge numbers of Colombian's have chronic obstructive pulmonary disease (COPD), driven by tobacco use and air pollution. Joe Parkin Daniels reports from Bogota											0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					875	876						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116471				2022-12-28	WOS:000890180700008
J	Samarasekera, U				Samarasekera, Udani			Daiana Stolz: transforming the agenda for lung health	LANCET			English	Biographical-Item																		STOLZ D, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					878	878		10.1016/S0140-6736(22)01702-0	http://dx.doi.org/10.1016/S0140-6736(22)01702-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36075256				2022-12-28	WOS:000890180700010
J	Chang, EH				Chang, Edward H.			Getting to Diversity: What Works and What Doesn't	SCIENCE			English	Book Review									[Chang, Edward H.] Harvard Sch Business, Boston, MA 02163 USA	Harvard University	Chang, EH (corresponding author), Harvard Sch Business, Boston, MA 02163 USA.	ehchang@hbs.edu						DOBBIN F, 2022, GETTING DIVERSITY WH	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1271	1271		10.1126/science.add8064	http://dx.doi.org/10.1126/science.add8064			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108003				2022-12-28	WOS:000887933500027
J	Dance, A				Dance, Amber			Community science draws on the power of the crowd	NATURE			English	Editorial Material						Careers; Society; Education; Research data												Allf BC, 2022, BIOSCIENCE, V72, P651, DOI 10.1093/biosci/biac035; Durso AM, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.201273; Freitag A., 2016, CITIZEN SCI THEORY P, V1, P12, DOI DOI 10.5334/CSTP.6; Pauly G.B., 2019, HERPETOL REV, V50, P103; Perry T, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.687115; Usuda-Sato K, 2019, P INT ASTRON UNION, V15, P218, DOI [10.1017/S1743921321000764, DOI 10.1017/S1743921321000764]	6	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					641	643		10.1038/d41586-022-02921-3	http://dx.doi.org/10.1038/d41586-022-02921-3			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M1LB	36097058				2022-12-28	WOS:000853088800009
J	Kravchuk, V; Petrova, O; Kampjut, D; Wojciechowska-Bason, A; Breese, Z; Sazanov, L				Kravchuk, Vladyslav; Petrova, Olga; Kampjut, Domen; Wojciechowska-Bason, Anna; Breese, Zara; Sazanov, Leonid			A universal coupling mechanism of respiratory complex I	NATURE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; BEAM-INDUCED MOTION; PARACOCCUS-DENITRIFICANS; MEMBRANE DOMAIN; GENOME; PREDICTION; MODEL; SITE	Complex I is the first enzyme in the respiratory chain, which is responsible for energy production in mitochondria and bacteria(1). Complex I couples the transfer of two electrons from NADH to quinone and the translocation of four protons across the membrane(2), but the coupling mechanism remains contentious. Here we present cryo-electron microscopy structures of Escherichia coli complex I (EcCI) in different redox states, including catalytic turn over.EcCI exists mostly in the open state, in which the quinone cavity is exposed to the cytosol, allowing access for water molecules, which enable quinone movements. Unlike the mammalian paralogues(3), EcCI can convert to the closed state only during turnover, showing that closed and open states are genuine turnover intermediates. The open-to-closed transition results in the tightly engulfed quinone cavity being connected to the central axis of the membrane arm, a source of substrate protons. Consistently, the proportion of the closed state increases with increasing pH. We propose a detailed but straightforward and robust mechanism comprising a 'domino effect' series of proton transfers and electrostatic interactions: the forward wave ('dominoes stacking') primes the pump, and the reverse wave ('dominoes falling') results in the ejection of all pumped protons from the distal subunit NuoL. This mechanism explains why protons exit exclusively from the NuoL subunit and is supported by our mutagenesis data. We contend that this is a universal coupling mechanism of complex I and related enzymes.	[Kravchuk, Vladyslav; Petrova, Olga; Kampjut, Domen; Sazanov, Leonid] IST Austria, Klosterneuburg, Austria; [Wojciechowska-Bason, Anna; Breese, Zara] MRC Mitochondrial Biol Unit, Cambridge, England; [Kampjut, Domen] MRC Lab Mol Biol, Cambridge, England; [Wojciechowska-Bason, Anna] Warsaw Med Univ, Warsaw, Poland; [Breese, Zara] Sosei Heptares, Cambridge, England	Institute of Science & Technology - Austria; MRC Laboratory Molecular Biology; Medical University of Warsaw; Heptares Therapeutics Ltd.	Sazanov, L (corresponding author), IST Austria, Klosterneuburg, Austria.	sazanov@ist.ac.at		Sazanov, Leonid/0000-0002-0977-7989	Scientific Service Units (SSU) of IST Austria; DOC Fellowship of the Austrian Academy of Sciences at the Institute of Science and Technology, Austria; ERC [101020697 RESPICHAIN]	Scientific Service Units (SSU) of IST Austria; DOC Fellowship of the Austrian Academy of Sciences at the Institute of Science and Technology, Austria; ERC(European Research Council (ERC)European Commission)	This research was supported by the Scientific Service Units (SSU) of IST Austria through resources provided by the Electron Microscopy Facility (EMF), the Life Science Facility (LSF) and the IST high-performance computing cluster. We thank V.-V. Hodirnau from IST Austria EMF, M. Babiak from CEITEC for assistance with collecting cryo-EM data and A. Charnagalov for the assistance with protein purification. V.K. was a recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Institute of Science and Technology, Austria. V.K. and O.P. are funded by the ERC Advanced Grant 101020697 RESPICHAIN to L.S.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Belevich N, 2017, BIOCHEMISTRY-US, V56, P5691, DOI 10.1021/acs.biochem.7b00727; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Grba DN, 2020, NAT STRUCT MOL BIOL, V27, P892, DOI 10.1038/s41594-020-0473-x; Gu JK, 2022, NAT STRUCT MOL BIOL, V29, P172, DOI 10.1038/s41594-022-00722-w; Gutierrez-Fernandez J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17957-0; Holt PJ, 2016, BBA-BIOENERGETICS, V1857, P1777, DOI 10.1016/j.bbabio.2016.08.008; Jones AJY, 2017, J BIOL CHEM, V292, P4987, DOI 10.1074/jbc.M116.771899; Kaila VRI, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0916; Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klusch N, 2021, PLANT CELL, V33, P2072, DOI 10.1093/plcell/koab092; Kolata P, 2021, ELIFE, V10, DOI 10.7554/eLife.68710; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Kotlyar AB, 1998, BBA-BIOENERGETICS, V1365, P53, DOI 10.1016/S0005-2728(98)00042-5; Laughlin TG, 2019, NATURE, V566, P411, DOI 10.1038/s41586-019-0921-0; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Masuya T, 2021, BIOCHEMISTRY-US, V60, P813, DOI 10.1021/acs.biochem.0c00991; Muhlbauer ME, 2020, J AM CHEM SOC, V142, P13718, DOI 10.1021/jacs.0c02789; Nuber F, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.672969; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Pan XW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14456-0; Parey K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj3221; Parey K, 2020, CURR OPIN STRUC BIOL, V63, P1, DOI 10.1016/j.sbi.2020.01.004; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2020, NAT METHODS, V17, P328, DOI 10.1038/s41592-020-0731-1; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Prisant MG, 2020, PROTEIN SCI, V29, P315, DOI 10.1002/pro.3786; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Roessler MM, 2010, P NATL ACAD SCI USA, V107, P1930, DOI 10.1073/pnas.0908050107; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Schulte M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10429-0; Steiner J, 2020, ELIFE, V9, DOI 10.7554/eLife.59407; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; Wikstrom M, 2015, CHEM REV, V115, P2196, DOI 10.1021/cr500448t; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yu HJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100740; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	56	2	2	15	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					808	+		10.1038/s41586-022-05199-7	http://dx.doi.org/10.1038/s41586-022-05199-7		SEP 2022	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36104567				2022-12-28	WOS:000854788200001
J	Isganaitis, E; Laffel, L				Isganaitis, Elvira; Laffel, Lori			Recommendations for Screening Children and Adolescents for Prediabetes and Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUTH; PREVALENCE; US		[Isganaitis, Elvira; Laffel, Lori] Harvard Med Sch, Pediat Adolescent & Young Adult Sect, Boston, MA 02115 USA; [Isganaitis, Elvira; Laffel, Lori] Harvard Med Sch, Sect Clin Behav & Outcomes Res, Boston, MA 02115 USA; [Isganaitis, Elvira; Laffel, Lori] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Laffel, L (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	lori.laffel@joslin.harvard.edu						American Diabetes Association Professional Practice Committee, 2022, Diabetes Care, V45, pS208, DOI 10.2337/dc22-S014; Barrett CE, 2022, MMWR-MORBID MORTAL W, V71, P59, DOI 10.15585/mmwr.mm7102e2; Bjornstad P, 2021, NEW ENGL J MED, V385, P416, DOI 10.1056/NEJMoa2100165; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Casagrande S, 2018, DIABETES, V67, DOI 10.2337/db18-1478-P; Dabelea D, 2017, JAMA-J AM MED ASSOC, V317, P825, DOI 10.1001/jama.2017.0686; Jonas DE, 2022, JAMA-J AM MED ASSOC, V328, P968, DOI 10.1001/jama.2022.7957; Kahn SE, 2018, DIABETES CARE, V41, P1696, DOI 10.2337/dc18-0244; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawrence JM, 2021, JAMA-J AM MED ASSOC, V326, P717, DOI 10.1001/jama.2021.11165; Magge Sheela N, 2022, J Pediatr, V251, P51, DOI 10.1016/j.jpeds.2022.08.010; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; RISE Consortium, 2019, DIABETES, V68, P1670, DOI 10.2337/db19-0299; Savoye M, 2014, DIABETES CARE, V37, P317, DOI 10.2337/dc13-1571; US Preventive Services Task Force, 2022, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2022.14543, DOI 10.1001/JAMA.2022.14543]; Utzschneider KM, 2020, PEDIATR DIABETES, V21, P1421, DOI 10.1111/pedi.13113; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	17	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					933	934						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098736				2022-12-28	WOS:000855222400017
J	Bracic, A; Callier, SL; Price, WN				Bracic, Ana; Callier, Shawneequa L.; Price, W. Nicholson, II			Exclusion cycles: Reinforcing disparities in medicine	SCIENCE			English	Editorial Material							RACIAL BIAS; DIVERSITY		[Bracic, Ana] Michigan State Univ, Dept Polit Sci, E Lansing, MI 48824 USA; [Callier, Shawneequa L.] George Washington Univ, Dept Clin Res & Leadership, Sch Med & Hlth Sci, Washington, DC USA; [Callier, Shawneequa L.] Natl Human Genome Res Inst, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD USA; [Price, W. Nicholson, II] Univ Michigan, Law Sch, Ann Arbor, MI USA; [Price, W. Nicholson, II] Univ Copenhagen, Ctr Adv Studies Biomed Innovat Law, Copenhagen, Denmark	Michigan State University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Copenhagen	Bracic, A (corresponding author), Michigan State Univ, Dept Polit Sci, E Lansing, MI 48824 USA.	bracic@msu.edu; wnp@umich.edu		Bracic, Ana/0000-0002-1738-4210	Novo Nordisk Foundation [NNF17SA0027784]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	W.N.P. is supported by Novo Nordisk Foundation grant NNF17SA0027784. We thank S.Bender and P. Bugga for research assistance and E. Trapecar for design assistance.	Adamson AS, 2018, JAMA DERMATOL, V154, P1247, DOI 10.1001/jamadermatol.2018.2348; Babic B, 2019, SCIENCE, V366, P1202, DOI 10.1126/science.aay9547; Bracic A., 2020, BREAKING EXCLUSION C; Callier S, 2020, J LAW MED ETHICS, V48, P115, DOI 10.1177/1073110520917036; Crawley LM, 2001, J NATL MED ASSOC, V93, p14S; Fair MA, 2021, SCIENCE, V372, P348, DOI 10.1126/science.abf6738; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Jipguep-Akhtar M, 2020, SOC FORCES, V98, DOI 10.1093/sf/soz162; Matthew D. B., 2018, JUST MED CURE RACIAL; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Pierson E, 2021, NAT MED, V27, P136, DOI 10.1038/s41591-020-01192-7; Rotimi CN, 2021, SCIENCE, V371, P565; Smedley B.D, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Spector-Bagdady K, 2021, HEALTH AFFAIR, V40, P1892, DOI 10.1377/hlthaff.2021.01197	15	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1158	1160		10.1126/science.abo2788	http://dx.doi.org/10.1126/science.abo2788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074837				2022-12-28	WOS:000887933400033
J	Pinson, A; Xing, L; Namba, T; Kalebic, N; Peters, J; Oegema, CE; Traikov, S; Reppe, K; Riesenberg, S; Maricic, T; Derihaci, R; Wimberger, P; Paabo, S; Huttner, WB				Pinson, Anneline; Xing, Lei; Namba, Takashi; Kalebic, Nereo; Peters, Jula; Oegema, Christina Eugster; Traikov, Sofia; Reppe, Katrin; Riesenberg, Stephan; Maricic, Tomislav; derihaci, RazVan; Wimberger, Pauline; Paabo, Svante; Huttner, Wieland B.			Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals	SCIENCE			English	Article							OUTER SUBVENTRICULAR ZONE; RADIAL GLIA; PROGENITOR-CELL; EVOLUTION; PRIMATE; EXPANSION; ORIGIN	Neanderthal brains were similar in size to those of modern humans. We sought to investigate potential differences in neurogenesis during neocortex development. Modern human transketolase-like 1 (TKTL1) differs from Neanderthal TKTL1 by a lysine-to-arginine amino acid substitution. Using overexpression in developing mouse and ferret neocortex, knockout in fetal human neocortical tissue, and genome-edited cerebral organoids, we found that the modern human variant, hTKTL1, but not the Neanderthal variant, increases the abundance of basal radial glia (bRG) but not that of intermediate progenitors (bIPs). bRG generate more neocortical neurons than bIPs. The hTKTL1 effect requires the pentose phosphate pathway and fatty acid synthesis. Inhibition of these metabolic pathways reduces bRG abundance in fetal human neocortical tissue. Our data suggest that neocortical neurogenesis in modern humans differs from that in Neanderthals.	[Pinson, Anneline; Xing, Lei; Namba, Takashi; Kalebic, Nereo; Peters, Jula; Oegema, Christina Eugster; Traikov, Sofia; Reppe, Katrin; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Riesenberg, Stephan; Maricic, Tomislav; Paabo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [derihaci, RazVan; Wimberger, Pauline] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, D-01307 Dresden, Germany; [Namba, Takashi] Univ Helsinki, HiLIFE Helsinki Inst Life Sci, Neurosci Ctr, Helsinki, Finland; [Kalebic, Nereo] Human Technopole, Milan, Italy	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Helsinki; Human Technopole	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	huttner@mpi-cbg.de		Eugster Oegema, Christina/0000-0002-8895-0726; Xing, Lei/0000-0003-0542-4083; Maricic, Tomislav/0000-0003-3267-0474; Namba, Takashi/0000-0003-4875-666X; Riesenberg, Stephan/0000-0001-8171-1717; Kalebic, Nereo/0000-0002-8445-2906	NOMIS Foundation; ERA-NET NEURON (MicroKin); Max Planck Society	NOMIS Foundation; ERA-NET NEURON (MicroKin); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Supported by the NOMIS Foundation (S.P.), a grant from ERA-NET NEURON (MicroKin) (W.B.H.), and the Max Planck Society (S.P and W.B.H.). Author contributions: Conceptualization: A.P., W.B.H.; formal analysis: A.P., L.X.; C.E.O., S.T., T.M.; investigation: A.P., L.X., T.N., N.K., J.P., C.E.O., S.T., K.R., S.R., T.M.; resources: S.R., S.P., R.D., P.W.; writing-original draft: A.P., W.B.H.; writing-review and editing: A.P., W.B.H. with comments from N.K, T.N., L.X., S.P.; project administration and supervision: W.B.H.	Martinez-Martinez MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11812; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007; Breyl M, 2021, WIRES COGN SCI, V12, DOI 10.1002/wcs.1545; Coy JF, 2005, CLIN LAB, V51, P257; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; Diaz-Moralli S, 2016, ONCOTARGET, V7, P51875, DOI 10.18632/oncotarget.10429; Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Florio M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601941; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gunz P, 2019, CURR BIOL, V29, P120, DOI 10.1016/j.cub.2018.10.065; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kalebic N, 2019, CELL STEM CELL, V24, P535, DOI 10.1016/j.stem.2019.02.017; Kalebic N, 2018, ELIFE, V7, DOI 10.7554/eLife.41241; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Leder D, 2021, NAT ECOL EVOL, V5, P1273, DOI 10.1038/s41559-021-01487-z; Long KR, 2018, NEURON, V99, P702, DOI 10.1016/j.neuron.2018.07.013; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Maricic T, 2021, SCIENCE, V374, DOI 10.1126/science.abi6060; Matsumoto N, 2017, ELIFE, V6, DOI 10.7554/eLife.29285; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683; Namba T, 2021, NEURON, V109, P408, DOI 10.1016/j.neuron.2020.11.014; Namba T, 2020, NEURON, V105, P867, DOI 10.1016/j.neuron.2019.11.027; Peltonen R, 2020, CANCER BIOL THER, V21, P826, DOI 10.1080/15384047.2020.1803008; Pinson A, 2021, CURR OPIN CELL BIOL, V73, P9, DOI 10.1016/j.ceb.2021.04.008; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Stepanova V, 2021, ELIFE, V10, DOI 10.7554/eLife.58741; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Trujillo CA, 2021, SCIENCE, V371, P694, DOI 10.1126/science.aax2537; Vaid S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.169276; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Yuan WJ, 2010, CANCER BIOL THER, V9, P710, DOI 10.4161/cbt.9.9.11431	48	2	2	47	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1170	+	eabl6422	10.1126/science.abl6422	http://dx.doi.org/10.1126/science.abl6422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074851				2022-12-28	WOS:000887933400001
J	Weber, JN; Steinel, NC; Peng, F; Shim, KC; Lohman, BK; Fuess, LE; Subramanian, S; De Lisle, SP; Bolnick, DI				Weber, Jesse N.; Steinel, Natalie C.; Peng, Foen; Shim, Kum Chuan; Lohman, Brian K.; Fuess, Lauren E.; Subramanian, Swapna; De Lisle, Stephen P.; Bolnick, Daniel I.			Evolutionary gain and loss of a pathological immune response to parasitism	SCIENCE			English	Article							ECOLOGICAL IMMUNOLOGY; TRADE-OFFS; STICKLEBACK; ADAPTATION; RESISTANCE; TOLERANCE; FITNESS; HOST	Parasites impose fitness costs on their hosts. Biologists often assume that natural selection favors infection-resistant hosts. Yet, when the immune response itself is costly, theory suggests that selection may sometimes favor loss of resistance, which may result in alternative stable states where some populations are resistant and others are tolerant. Intraspecific variation in immune costs is rarely surveyed in a manner that tests evolutionary patterns, and there are few examples of adaptive loss of resistance. Here, we show that when marine threespine stickleback colonized freshwater lakes, they gained resistance to the freshwater-associated cestode Schistocephalus solidus. Extensive peritoneal fibrosis and inflammation are a commonly observed phenotype that contributes to suppression of cestode growth and viability but also imposes a substantial cost on fecundity. Combining genetic mapping and population genomics, we find that opposing selection generates immune system differences between tolerant and resistant populations, consistent with divergent optimization.	[Weber, Jesse N.; Steinel, Natalie C.; Shim, Kum Chuan; Lohman, Brian K.; Bolnick, Daniel I.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Peng, Foen; Fuess, Lauren E.; Subramanian, Swapna; De Lisle, Stephen P.; Bolnick, Daniel I.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Peng, Foen] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Lohman, Brian K.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Fuess, Lauren E.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [De Lisle, Stephen P.] Lund Univ, Dept Biol, Evolutionary Ecol Unit, S-22362 Lund, Sweden	University of Texas System; University of Texas Austin; University of Connecticut; Haverford College; Utah System of Higher Education; University of Utah; Texas State University System; Texas State University San Marcos; Lund University	Bolnick, DI (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Bolnick, DI (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.; Weber, JN (corresponding author), Univ Wisconsin Madison, Dept Integrat Biol, Madison, WI 53706 USA.; Steinel, NC (corresponding author), Univ Massachusetts Lowell, Dept Biol Sci, Lowell, MA 01854 USA.	jnweber2@wisc.edu; natalie_steinel@uml.edu; daniel.bolnick@uconn.edu	Fuess, Lauren E/S-6456-2019; Bolnick, Daniel/G-4440-2015	Fuess, Lauren E/0000-0003-0197-7326; Weber, Jesse/0000-0003-4839-6684; Bolnick, Daniel/0000-0003-3148-6296; Subramanian, Swapna/0000-0002-6809-1717; Steinel, Natalie/0000-0002-7585-8402	Howard Hughes Medical Institute Early Career Scientist fellowship; National Institutes of Health [1R01AI123659-01A1, 1R01AI146168, 1R35GM142891]	Howard Hughes Medical Institute Early Career Scientist fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by a Howard Hughes Medical Institute Early Career Scientist fellowship (D. I.B.) and by National Institutes of Health grants 1R01AI123659-01A1 (D.I.B.), 1R01AI146168 (N.C.S.), and 1R35GM142891 (J.N.W.).	Best A, 2014, EVOLUTION, V68, P1426, DOI 10.1111/evo.12368; Bolnick Daniel, 2022, Dryad, DOI 10.5061/DRYAD.D51C5B060; Bonneaud C, 2012, MOL ECOL, V21, P4787, DOI 10.1111/j.1365-294X.2012.05736.x; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; De Lisle SP, 2021, EVOLUTION, V75, P2509, DOI 10.1111/evo.14266; Ebert D, 2020, NAT REV GENET, V21, P754, DOI 10.1038/s41576-020-0269-1; Fuess LE, 2021, MOL ECOL, V30, P6791, DOI 10.1111/mec.16197; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Graham AL, 2022, TRENDS IMMUNOL, V43, P117, DOI 10.1016/j.it.2021.12.002; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harer A, 2021, MOL ECOL, V30, P451, DOI 10.1111/mec.15746; Hund AK, 2022, EVOL LETT, V6, P162, DOI 10.1002/evl3.274; Leung JM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004108; Lohman BK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01071; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Nystrand M, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00856-7; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Seal S, 2021, ELIFE, V10, DOI 10.7554/eLife.68874; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; TIERNEY JF, 1993, ANIM BEHAV, V46, P603, DOI 10.1006/anbe.1993.1229; Veith Alex, 2018, Current Opinion in Toxicology, V7, P44, DOI 10.1016/j.cotox.2017.10.003; Vrtilek M, 2021, EVOLUTION, V75, P2600, DOI 10.1111/evo.14316; Watt S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22548-8; Weber JN, 2017, P NATL ACAD SCI USA, V114, P6575, DOI 10.1073/pnas.1620095114; Weber JN, 2017, AM NAT, V189, P43, DOI 10.1086/689597; Wohlfahrt T, 2019, NATURE, V566, P344, DOI 10.1038/s41586-019-0896-x; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yeh MM, 2019, WORLD J GASTROENTERO, V25, P4074, DOI 10.3748/wjg.v25.i30.4074	32	1	1	10	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1206	+		10.1126/science.abo3411	http://dx.doi.org/10.1126/science.abo3411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074841				2022-12-28	WOS:000887933400044
J	Lust, K; Maynard, A; Gomes, T; Fleck, JS; Camp, JG; Tanaka, EM; Treutlein, B				Lust, Katharina; Maynard, Ashley; Gomes, Tomas; Fleck, Jonas Simon; Camp, J. Gray; Tanaka, Elly M.; Treutlein, Barbara			Single-cell analyses of axolotl telencephalon organization, neurogenesis, and regeneration	SCIENCE			English	Article							NEURAL STEM-CELLS; ADULT; CONNECTIVITY; ARCHITECTURE; EVOLUTION; DYNAMICS; PALLIUM; COMPLEX; CORTEX; ZONE	Salamanders are tetrapod models to study brain organization and regeneration; however, the identity and evolutionary conservation of brain cell types are largely unknown. We delineated the cell populations in the axolotl telencephalon during homeostasis and regeneration using single-cell genomic profiling. We identified glutamatergic neurons with similarities to amniote neurons of hippocampus, dorsal and lateral cortex, and conserved gamma-aminobutyric acid-releasing (GABAergic) neuron classes. We inferred transcriptional dynamics and gene regulatory relationships of postembryonic, region-specific neurogenesis and unraveled conserved differentiation signatures. After brain injury, ependymoglia activate an injury-specific state before reestablishing lost neuron populations and axonal connections. Together, our analyses yield insights into the organization, evolution, and regeneration of a tetrapod nervous system.	[Lust, Katharina; Tanaka, Elly M.] Vienna Bioctr VBC, Res Inst Mol Pathol, Campus Vienna Bioctr, A-1030 Vienna, Austria; [Maynard, Ashley; Gomes, Tomas; Fleck, Jonas Simon; Treutlein, Barbara] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Camp, J. Gray] Roche Innovat Ctr Basel, Roche Inst Translat Bioengn ITB, Roche Pharma Res & Early Dev, Basel, Switzerland; [Camp, J. Gray] Univ Basel, CH-4001 Basel, Switzerland	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Swiss Federal Institutes of Technology Domain; ETH Zurich; Roche Holding; University of Basel	Lust, K; Tanaka, EM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol, Campus Vienna Bioctr, A-1030 Vienna, Austria.; Treutlein, B (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	katharina.lust@imp.ac.at; elly.tanaka@imp.ac.at; barbara.treutlein@bsse.ethz.ch		Camp, Jarrett/0000-0003-3295-1225; Tanaka, Elly/0000-0003-4240-2158; Treutlein, Barbara/0000-0002-3299-5597	Human Frontier Science Program [LT000605/2018-L]; EMBO LongTerm Fellowship [ALTF 738-2019]; European Research Council RegGeneMems [742046]; Special research program of the Austrian Science Fund [F78]; European Research Council Organomics [758877]; European Research Council Braintime [874606]; Swiss National Science Foundation Project Grant [310030_192604]	Human Frontier Science Program(Human Frontier Science Program); EMBO LongTerm Fellowship(European Molecular Biology Organization (EMBO)); European Research Council RegGeneMems; Special research program of the Austrian Science Fund(Austrian Science Fund (FWF)); European Research Council Organomics; European Research Council Braintime; Swiss National Science Foundation Project Grant(Swiss National Science Foundation (SNSF))	This work was supported by a Long-Term Fellowship from the Human Frontier Science Program LT000605/2018-L (K.L.); EMBO LongTerm Fellowship ALTF 738-2019 (T.G.); European Research Council RegGeneMems 742046 (E.M.T.); Special research program of the Austrian Science Fund project F78 (E.M.T.); European Research Council Organomics 758877 (A.M. and B.T.); European Research Council Braintime 874606 (B.T.); and Swiss National Science Foundation Project Grant 310030_192604 (B.T.).	Albors AR, 2015, ELIFE, V4, DOI 10.7554/eLife.10230; Almasi Z, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00045; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bachy I, 2002, MECH DEVELOP, V117, P163, DOI 10.1016/S0925-4773(02)00199-5; Bandler RC, 2022, NATURE, V601, P404, DOI 10.1038/s41586-021-04237-0; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Carrera I, 2008, BRAIN RES BULL, V75, P405, DOI 10.1016/j.brainresbull.2007.10.013; Cebrian-Silla A, 2021, ELIFE, V10, DOI 10.7554/eLife.67436; Colquitt BM, 2021, SCIENCE, V371, P695, DOI 10.1126/science.abd9704; Di Bella DJ, 2021, NATURE, V595, P554, DOI 10.1038/s41586-021-03670-5; Diodato A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12238; Doetsch F, 1997, J NEUROSCI, V17, P5046; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Furlan G, 2017, CURR BIOL, V27, P3288, DOI 10.1016/j.cub.2017.09.052; Garcia-Moreno F, 2020, PROG NEUROBIOL, V194, DOI 10.1016/j.pneurobio.2020.101865; Gerber T, 2018, SCIENCE, V362, P421, DOI 10.1126/science.aaq0681; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Hartenstein V, 2015, DEV CELL, V32, P390, DOI 10.1016/j.devcel.2015.02.004; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Sotelo MI, 2016, BRAIN BEHAV EVOLUT, V88, P149, DOI 10.1159/000447441; Fleck JS, 2021, bioRxiv, DOI 10.1101/2021.08.24.457460; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Joven A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160051; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kirkham M, 2014, STEM CELL REP, V2, P507, DOI 10.1016/j.stemcr.2014.01.018; Lange M, 2022, NAT METHODS, V19, P159, DOI 10.1038/s41592-021-01346-6; Lin TY, 2021, DEV CELL, V56, P1541, DOI 10.1016/j.devcel.2021.04.016; Lust Katharina, 2022, Zenodo, DOI 10.5281/ZENODO.6390083; Maden M, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-1; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Maynard Ashley, 2022, Zenodo, DOI 10.5281/ZENODO.6627781; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Naef V, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.549533; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; Roth G, 1999, EUR J MORPHOL, V37, P166, DOI 10.1076/ejom.37.2.166.4759; Sugahara F, 2016, NATURE, V531, P97, DOI 10.1038/nature16518; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; ULINSKI PS, 1980, J MORPHOL, V165, P85, DOI 10.1002/jmor.1051650108; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhao E, 2021, NAT BIOTECHNOL, V39, P1375, DOI 10.1038/s41587-021-00935-2	45	3	3	5	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1061	+	eabp9262	10.1126/science.abp9262	http://dx.doi.org/10.1126/science.abp9262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048956				2022-12-28	WOS:000887933200004
J	Lee, CD; Shirey, E; Guttadauria, B; Kenyon, CC				Lee, Clement D.; Shirey, Evan; Guttadauria, Brittany; Kenyon, Chen C.			Telescoping the Diagnostic Process	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HENOCH-SCHONLEIN PURPURA; FOLLOW-UP		[Lee, Clement D.; Shirey, Evan; Guttadauria, Brittany; Kenyon, Chen C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lee, CD (corresponding author), 10 Shattuck St, Boston, MA 02115 USA.	clee@nejm.org		Lee, Clement/0000-0002-2963-4731				Aalberse J, 2007, ANN RHEUM DIS, V66, P1648, DOI 10.1136/ard.2006.069187; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Dudley J, 2013, ARCH DIS CHILD, V98, P756, DOI 10.1136/archdischild-2013-303642; GOLDSTEIN AR, 1992, LANCET, V339, P280, DOI 10.1016/0140-6736(92)91341-5; Jauhola O, 2010, ARCH DIS CHILD, V95, P871, DOI 10.1136/adc.2009.167874; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Oni L, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00257; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Reamy BV, 2009, AM FAM PHYSICIAN, V80, P697; Reid-Adam J, 2014, PEDIATR REV, V35, P447, DOI 10.1542/pir.35-10-447; Wang H, 2019, INT J RHEUM DIS, V22, P1271, DOI 10.1111/1756-185X.13552; Wang XH, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0080-x; Weiss PF, 2007, PEDIATRICS, V120, P1079, DOI 10.1542/peds.2007-0667	13	0	0	4	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					833	838		10.1056/NEJMcps2205676	http://dx.doi.org/10.1056/NEJMcps2205676			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053509				2022-12-28	WOS:000849132700012
J	Zhao, JY; Gu, XN				Zhao, Jiyu; Gu, Xianen			Jackstone Calculus in the Bladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhao, Jiyu; Gu, Xianen] Chuiyangliu Hosp Beijing, Beijing, Peoples R China		Zhao, JY (corresponding author), Chuiyangliu Hosp Beijing, Beijing, Peoples R China.	yu_19821@163.com							0	0	0	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1123	1123		10.1056/NEJMicm2119095	http://dx.doi.org/10.1056/NEJMicm2119095			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36121048				2022-12-28	WOS:000865461700008
J	Gupta, R; Levine, RL; Cepeda, JA; Holtgrave, DR				Gupta, Rahul; Levine, Rachel L.; Cepeda, Javier A.; Holtgrave, David R.			Transforming Management of Opioid Use Disorder with Universal Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Rahul; Cepeda, Javier A.; Holtgrave, David R.] US Dept HHS, White House Off Natl Drug Control Policy, Washington, DC 20201 USA; [Levine, Rachel L.] US Dept HHS, Off Assistant Secretary Hlth, Off Secretary, Washington, DC USA; [Levine, Rachel L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gupta, R (corresponding author), US Dept HHS, White House Off Natl Drug Control Policy, Washington, DC 20201 USA.							Evans EA, 2022, DRUG ALCOHOL DEPEN, V231, DOI 10.1016/j.drugalcdep.2021.109254; Keyes KM., 2022, DRUG ALCOHOL DEPEN, V3, P100052; Krawczyk N, 2020, ADDICTION, V115, P1683, DOI 10.1111/add.14991; National Institute on Drug Abuse, 2021, MED TREAT OP US DIS; Weintraub E, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.18487	5	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2022	387	15					1341	1344		10.1056/NEJMp2210121	http://dx.doi.org/10.1056/NEJMp2210121		SEP 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6B8KB	36129991				2022-12-28	WOS:000856581100001
J	Bennell, KL; Schwartz, S; Teo, PL; Hawkins, S; Mackenzie, D; McManus, F; Lamb, KE; Kimp, AJ; Metcalf, B; Hunter, DJ; Hinman, RS				Bennell, Kim L.; Schwartz, Sarah; Teo, Pek Ling; Hawkins, Stephanie; Mackenzie, Dave; McManus, Fiona; Lamb, Karen E.; Kimp, Alexander J.; Metcalf, Ben; Hunter, David J.; Hinman, Rana S.			Effectiveness of an Unsupervised Online Yoga Program on Pain and Function in People With Knee Osteoarthritis A Randomized Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOWER-EXTREMITY OSTEOARTHRITIS; CONSENSUS DEVELOPMENT; PHYSICAL-ACTIVITY; OUTCOME MEASURES; HIP; EXERCISE; SCALE; RECOMMENDATIONS; ADHERENCE; FEASIBILITY	Background: Yoga is a mind-body exercise typically done in groups in person, but this delivery method can be inconvenient, inaccessible, and costly. Effective online programs may increase access to exercise for knee osteoarthritis. Objective: To evaluate the effectiveness of an unsupervised 12-week online yoga program. Design: Two-group superiority randomized trial. (Australian New Zealand Clinical Trials Registry: ACTRN12620000012976) Setting: Community. Participants: 212 adults with symptomatic knee osteoarthritis. Intervention: Both groups received online osteoarthritis information (control). The yoga group also received access to an unsupervised online yoga program delivered via prerecorded videos over 12 weeks (1 video per week, with each session to be performed 3 times per week), with optional continuation thereafter. Measurements: Primary outcomes were changes in knee pain during walking (0 to 10 on a numerical rating scale) and physical function (0 to 68 on the Western Ontario and McMaster Universities Osteoarthritis Index) at 12 weeks (primary time point) and 24 weeks, analyzed using mixed-effects linear regression models. Secondary outcomes were self-reported overall knee pain, stiffness, depression, anxiety, stress, global change, quality of life, self-efficacy, fear of movement, and balance confidence. Adverse events were also collected. Results: A total of 195 (92%) and 189 (89%) participants provided 12- and 24-week primary outcomes, respectively. Compared with control at 12 weeks, yoga improved function (between-group mean difference in change, -4.0 [95% CI, -6.8 to -1.3]) but not knee pain during walking (between-group mean difference in change, -0.6 [CI, -1.2 to 0.1]), with more yoga participants than control participants achieving the minimal clinically important difference (MCID) for both outcomes. At 12 weeks, knee stiffness, quality of life, and arthritis self-efficacy improved more with yoga than the control intervention. Benefits were not maintained at 24 weeks. Adverse events were minor. Limitation: Participants were unblinded. Conclusion: Compared with online education, an unsupervised online yoga program improved physical function but not knee pain at 12 weeks in people with knee osteoarthritis, although the improvement did not reach the MCID and was not sustained at 24 weeks.	[Bennell, Kim L.; Schwartz, Sarah; Teo, Pek Ling; Hawkins, Stephanie; Mackenzie, Dave; Kimp, Alexander J.; Metcalf, Ben; Hinman, Rana S.] Univ Melbourne, Ctr Hlth, Dept Physiotherapy, Melbourne, Vic, Australia; [McManus, Fiona] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Lamb, Karen E.] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Lamb, Karen E.] Univ Melbourne, Methods & Implementat Support Clin Hlth Res Hub, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Hunter, David J.] Univ Sydney, Sydney Musculoskeletal Hlth, Sydney, NSW, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Sydney	Bennell, KL (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Dept Physiotherapy, Sch Hlth Sci,Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia.	k.bennell@unimelb.edu.au	; Lamb, Karen/P-4988-2016	Teo, Pek Ling/0000-0003-1657-1820; Lamb, Karen/0000-0001-9782-8450; Kimp, Alexander/0000-0003-2757-2239; Metcalf, Ben/0000-0002-4945-3217; McManus, Fiona/0000-0002-1001-8146; Mackenzie, David/0000-0003-3604-9378	National Health and Medical Research Council [1091302]; National Health and Medical Research Council Centres of Research Excellence [1079078]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Centres of Research Excellence	By a National Health and Medical Research Council Program Grant (#1091302) and the Centres of Research Excellence (#1079078).	Alaiti RK, 2022, CLIN J PAIN, V38, P502, DOI 10.1097/AJP.0000000000001047; Allen KD, 2018, OSTEOARTHR CARTILAGE, V26, P383, DOI 10.1016/j.joca.2017.12.008; [Anonymous], AD PREEX SCREEN SYST; Australian Bureau of Statistics, 2018, HOUS US INF TECHN; Bannuru RR, 2019, OSTEOARTHR CARTILAGE, V27, P1578, DOI 10.1016/j.joca.2019.06.011; Bellamy N, 1997, J RHEUMATOL, V24, P768; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1992, J RHEUMATOL, V19, P451; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bennell KL, 2017, ARTHRIT CARE RES, V69, P84, DOI 10.1002/acr.22915; Bossen D, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2662; Brinsley J, 2021, J ALTERN COMPLEM MED, V27, P893, DOI 10.1089/acm.2021.0062; Brosnan P, 2021, COMPLEMENT THER MED, V60, DOI 10.1016/j.ctim.2021.102742; Carpenter JR, 2013, J WILEY, DOI [10.1002/9781119942283, DOI 10.1002/9781119942283]; Cheung C, 2016, J AGING PHYS ACTIV, V24, P181, DOI 10.1123/japa.2015-0048; Delbaere K, 2010, BRIT J SPORT MED, V44, P1029, DOI 10.1136/bjsm.2009.060350; Dobson F, 2016, AM J PHYS MED REHAB, V95, P372, DOI 10.1097/PHM.0000000000000448; Dore AL, 2015, ARTHRIT CARE RES, V67, P633, DOI 10.1002/acr.22499; Elwy AR, 2014, AM J PREV MED, V47, P220, DOI 10.1016/j.amepre.2014.03.012; Eyles JP, 2020, AUST J GEN PRACT, V49, P438, DOI 10.31128/AJGP-08-19-5051-02; Fitzmaurice G, 2011, APPL LONGITUDINAL AN; Fransen M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-095424; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hay SI, 2017, LANCET, V389, pE1; Huberty J, 2018, INTEGR CANCER THER, V17, P1150, DOI 10.1177/1534735418808595; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; Lauche R, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0846-5; Liao CD, 2020, ARTHRIT CARE RES, V72, P1703, DOI 10.1002/acr.24097; Lima YL, 2022, ARTHRIT CARE RES, DOI 10.1002/acr.24983; Lin CWC, 2010, PHYS THER, V90, P839, DOI 10.2522/ptj.20100084; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; Manlapaz DG, 2019, PM&R, V11, P745, DOI 10.1002/pmrj.12066; Martin AC, 2019, INT J YOGA, V12, P37, DOI 10.4103/ijoy.IJOY_5_18; McAlindon TE, 2015, OSTEOARTHR CARTILAGE, V23, P747, DOI 10.1016/j.joca.2015.03.005; McHugh M, 2020, ARTHRIT CARE RES, V72, P219, DOI 10.1002/acr.24235; Meade LB, 2018, MUSCULOSKELET CARE, V16, P409, DOI 10.1002/msc.1240; Meade LB, 2019, BRIT J HEALTH PSYCH, V24, P10, DOI 10.1111/bjhp.12324; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Moonaz S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045812; Moustgaard H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6802; National Institute for Health and Care Excellence, 2014, OST CAR MAN; Nicolson PJA, 2018, ARTHRIT CARE RES, V70, P388, DOI 10.1002/acr.23297; Osborne RH, 2003, J CLIN EPIDEMIOL, V56, P138, DOI 10.1016/S0895-4356(02)00601-7; Osteoarthritis Action Alliance; CDC; Arthritis Foundation, 2020, NAT PUBL HLTH AG OST; Park J, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110886; Pisters MF, 2010, ARTHRIT CARE RES, V62, P1087, DOI 10.1002/acr.20182; Quicke J G, 2020, Osteoarthr Cartil Open, V2, P100113, DOI 10.1016/j.ocarto.2020.100113; Sakellariou G, 2017, ANN RHEUM DIS, V76, P1484, DOI 10.1136/annrheumdis-2016-210815; Shelby RA, 2012, ARTHRIT CARE RES, V64, P862, DOI 10.1002/acr.21626; Stubbs B, 2016, AGE AGEING, V45, P228, DOI 10.1093/ageing/afw001; Talley KMC, 2008, J AM GERIATR SOC, V56, P328, DOI 10.1111/j.1532-5415.2007.01550.x; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; Uebelacker L, 2018, J PSYCHIATR PRACT, V24, P60, DOI 10.1097/PRA.0000000000000286; van Schoor NM, 2020, SEMIN ARTHRITIS RHEU, V50, P380, DOI 10.1016/j.semarthrit.2020.02.006; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Zernicke KA, 2014, PSYCHOSOM MED, V76, P257, DOI 10.1097/PSY.0000000000000053; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang Y, 2021, J ALTERN COMPLEM MED, V27, P778, DOI 10.1089/acm.2020.0506	58	0	0	7	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1345	+		10.7326/M22-1761	http://dx.doi.org/10.7326/M22-1761		SEP 2022	15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36122378				2022-12-28	WOS:000860851400004
J	Eisenberg, MD; Eddelbuettel, JCP; McGinty, EE				Eisenberg, Matthew D.; Eddelbuettel, Julia C. P.; McGinty, Emma E.			Employment in Office-Based and Intensive Behavioral Health Settings in the US, 2016-2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Eisenberg, Matthew D.; Eddelbuettel, Julia C. P.; McGinty, Emma E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Hampton House 406, Baltimore, MD 21205 USA; [McGinty, Emma E.] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University	Eisenberg, MD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Hampton House 406, Baltimore, MD 21205 USA.	eisenberg@jhu.edu						[Anonymous], 2020, Q CENS EMPL WAG; Brabson LA, 2020, CLIN CHILD FAM PSYCH, V23, P297, DOI 10.1007/s10567-020-00313-5; Druss BG, 2021, PSYCHIAT SERV, V72, P1222, DOI 10.1176/appi.ps.202000509; Nguyen T, 2021, J SUBST ABUSE TREAT, V130, DOI 10.1016/j.jsat.2021.108482; Substance Abuse and Mental Health Services Administration, 2021, KEY SUBST US MENT HL; Zhu JM, 2022, HEALTH AFFAIR, V41, P573, DOI 10.1377/hlthaff.2021.01297	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2022	328	16					1642	U17		10.1001/jama.2022.17613	http://dx.doi.org/10.1001/jama.2022.17613		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6C3UZ	36121674	Bronze			2022-12-28	WOS:000857175200001
J	Booth, A				Booth, Amy			Chile abolishes copayments in step towards UHC	LANCET			English	Editorial Material								Public health experts have welcomed the Chilean Government's extension of free care to around 6 million people. Amy Booth reports.											0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					877	877						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116472				2022-12-28	WOS:000890180700009
J	Rajkumar, K; Saint-Jacques, G; Bojinov, I; Brynjolfsson, E; Aral, S				Rajkumar, Karthik; Saint-Jacques, Guillaume; Bojinov, Iavor; Brynjolfsson, Erik; Aral, Sinan			A causal test of the strength of weak ties	SCIENCE			English	Article							SOCIAL NETWORKS; STRUCTURAL HOLES; DIVERSITY; IDENTIFICATION; COOPERATION; PERFORMANCE	The authors analyzed data from multiple large-scale randomized experiments on LinkedIn's People You May Know algorithm, which recommends new connections to LinkedIn members, to test the extent to which weak ties increased job mobility in the world's largest professional social network. The experiments randomly varied the prevalence of weak ties in the networks of over 20 million people over a 5-year period, during which 2 billion new ties and 600,000 new jobs were created. The results provided experimental causal evidence supporting the strength of weak ties and suggested three revisions to the theory. First, the strength of weak ties was nonlinear. Statistical analysis found an inverted U-shaped relationship between tie strength and job transmission such that weaker ties increased job transmission but only to a point, after which there were diminishing marginal returns to tie weakness. Second, weak ties measured by interaction intensity and the number of mutual connections displayed varying effects. Moderately weak ties (measured by mutual connections) and the weakest ties (measured by interaction intensity) created the most job mobility. Third, the strength of weak ties varied by industry. Whereas weak ties increased job mobility in more digital industries, strong ties increased job mobility in less digital industries.	[Rajkumar, Karthik; Saint-Jacques, Guillaume] LinkedIn Corp, 700 E Middlefield Rd, Mountain View, CA 94043 USA; [Bojinov, Iavor] Harvard Sch Business, Soldiers Field, Boston, MA 02163 USA; [Brynjolfsson, Erik] Stanford Univ, 353 Jane Stanford Way, Stanford, CA 94305 USA; [Brynjolfsson, Erik] Natl Bur Econ Res, 1050 Massachusetts Ave, Cambridge, MA 02138 USA; [Aral, Sinan] MIT, MIT Sloan Sch Management, 100 Main St, Cambridge, MA 02142 USA	Harvard University; Stanford University; National Bureau of Economic Research; Massachusetts Institute of Technology (MIT)	Aral, S (corresponding author), MIT, MIT Sloan Sch Management, 100 Main St, Cambridge, MA 02142 USA.	sinan@mit.edu						Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2011, AM J SOCIOL, V117, P90, DOI 10.1086/661238; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brynjolfsson E, 2018, AEA PAP P, V108, P43, DOI 10.1257/pandp.20181019; Burt R. S, 1992, STRUCTURAL HOLES; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Gee LK, 2017, J LABOR ECON, V35, P485, DOI 10.1086/686225; Gee LK, 2017, J ECON BEHAV ORGAN, V133, P362, DOI 10.1016/j.jebo.2016.12.004; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hargadon A, 1997, ADMIN SCI QUART, V42, P716, DOI 10.2307/2393655; Kempe D., 2003, P 9 ACM SIGKDD INT C, P137, DOI DOI 10.1145/956750.956769; Lazer D, 2007, ADMIN SCI QUART, V52, P667, DOI 10.2189/asqu.52.4.667; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MONTGOMERY JD, 1991, AM ECON REV, V81, P1408; Park PS, 2018, SCIENCE, V362, P1410, DOI 10.1126/science.aau9735; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Rajkumar K., 2022, RAJKUMARKARTHIK WEA; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637; Rodan S, 2004, STRATEGIC MANAGE J, V25, P541, DOI 10.1002/smj.398; RUBIN DB, 1980, J AM STAT ASSOC, V75, P591, DOI 10.2307/2287653; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Walker G, 1997, ORGAN SCI, V8, P109, DOI 10.1287/orsc.8.2.109; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Webb M., 2020, IMPACT ARTIFICIAL IN	34	2	2	77	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1304	1310		10.1126/science.abl4476	http://dx.doi.org/10.1126/science.abl4476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36107999				2022-12-28	WOS:000887933500037
J	Engrand, N; Barrovecchio, B; Da Costa, I				Engrand, Nicolas; Barrovecchio, Boris; Da Costa, Ines			Early vs Standard Approach to Tracheostomy and Functional Outcome Among Patients With Severe Stroke Receiving Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Engrand, Nicolas; Barrovecchio, Boris; Da Costa, Ines] Rothschild Hosp Fdn, Neurointens Care Unit, 29 rue Manin, F-75019 Paris, France		Engrand, N (corresponding author), Rothschild Hosp Fdn, Neurointens Care Unit, 29 rue Manin, F-75019 Paris, France.	nengrand@for.paris						Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Bosel J, 2022, JAMA-J AM MED ASSOC, V327, P1899, DOI 10.1001/jama.2022.4798; Chotirmall SH, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.08.007; Godet T, 2017, ANESTHESIOLOGY, V126, P104, DOI 10.1097/ALN.0000000000001379; Zhao CW, 2021, NEUROCRIT CARE, V34, P669, DOI 10.1007/s12028-020-01127-7	5	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10												3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098728				2022-12-28	WOS:000855222400029
J	Tanne, JH				Tanne, Janice Hopkins			Roe v Wade: patients struggle to access drugs as doctors forced to take legal advice	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		AMA APhA ASHP, 2022, AMA APHA ASHP NCPA S; Tanne JH, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o1575	2	0	0	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								o2218	10.1136/bmj.o2218	http://dx.doi.org/10.1136/bmj.o2218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100275				2022-12-28	WOS:000860470700012
J	Thiagarajan, K				Thiagarajan, Kamala			Doctors call for report of new "tomato flu" outbreak in India to be retracted	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chavda VP, 2022, LANCET RESP MED; flu, US; Thiagarajan K, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o2101	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2022	378								o2217	10.1136/bmj.o2217	http://dx.doi.org/10.1136/bmj.o2217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9JJ	36100268				2022-12-28	WOS:000860470700002
J	Lane, R				Lane, Richard			Dinesh Palipana: clinician and leading disability rights advocate	LANCET			English	Biographical-Item																		PALIPANA D, PUBLICATION LIST	1	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					803	803		10.1016/S0140-6736(22)01697-X	http://dx.doi.org/10.1016/S0140-6736(22)01697-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088941				2022-12-28	WOS:000877580600011
J	Alderton, GK				Alderton, Gemma K.			COVID-19 and children	SCIENCE			English	Editorial Material																			0	0	0	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1144	1144						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074833				2022-12-28	WOS:000887933400021
J	Cui, ZH; Zhai, HC; Zhang, X; Chan, GKL				Cui, Zhi-Hao; Zhai, Huanchen; Zhang, Xing; Chan, Garnet Kin-Lic			Systematic electronic structure in the cuprate parent state from quantum many-body simulations	SCIENCE			English	Article							RENORMALIZATION; CHEMISTRY	The quantitative description of correlated electron materials remains a modern computational challenge. We demonstrate a numerical strategy to simulate correlated materials at the fully ab initio level beyond the solution of effective low-energy models and apply it to gain a detailed microscopic understanding across a family of cuprate superconducting materials in their parent undoped states. We uncover microscopic trends in the electron correlations and reveal the link between the material composition and magnetic energy scales through a many-body picture of excitation processes involving the buffer layers. Our work illustrates a path toward a quantitative and reliable understanding of more complex states of correlated materials at the ab initio many-body level.	[Cui, Zhi-Hao; Zhai, Huanchen; Zhang, Xing; Chan, Garnet Kin-Lic] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Chan, GKL (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	gkc1000@gmail.com		Cui, Zhi-Hao/0000-0002-7389-4063; Zhai, Huanchen/0000-0003-0086-0388	US Department of Energy, Office of Science [DE-SC0018140]; US National Science Foundation [CHE-2102505]; Center for Molecular Magnetic Quantum Materials, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0019330]; Eddleman Quantum Institute; Resnick Sustainability Institute at Caltech; National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility at Lawrence Berkeley National Laboratory	US Department of Energy, Office of Science(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Center for Molecular Magnetic Quantum Materials, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Eddleman Quantum Institute; Resnick Sustainability Institute at Caltech; National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility at Lawrence Berkeley National Laboratory	This work was primarily supported by the US Department of Energy, Office of Science, through grant DE-SC0018140. The DMRG calculations were performed using the BLOCK2 code, which was developed with funding from the US National Science Foundation through grant CHE-2102505. This work also relied on improvements to the PYSCF density fitting and integral transformation modules, carried out as part of work supported by the Center for Molecular Magnetic Quantum Materials, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Basic Energy Sciences, under award DE-SC0019330. G.K.-L.C. is a Simons Investigator in Physics and is part of the Simons Collaboration on the ManyElectron Problem. Z.-H.C. acknowledges support from the Eddleman Quantum Institute through a graduate fellowship. Calculations were conducted in the Resnick High Performance Computing Center, supported by the Resnick Sustainability Institute at Caltech, and National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility located at Lawrence Berkeley National Laboratory.	Antipov EV, 2002, SUPERCOND SCI TECH, V15, pR31, DOI 10.1088/0953-2048/15/7/201; Bartlett RJ, 2007, REV MOD PHYS, V79, P291, DOI 10.1103/RevModPhys.79.291; Choi S, 2016, NPJ QUANTUM MATER, V1, DOI 10.1038/npjquantmats.2016.1; Cui ZH, 2020, J CHEM THEORY COMPUT, V16, P119, DOI 10.1021/acs.jctc.9b00933; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Delannoy JYP, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235130; Foyevtsova K, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031003; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; HYBERTSEN MS, 1990, PHYS REV B, V41, P11068, DOI 10.1103/PhysRevB.41.11068; Kan D, 2004, PHYSICA C, V412, P298, DOI 10.1016/j.physc.2003.12.040; Kananenka AA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.121111; Karp J, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021061; Kent PRC, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035132; Kim S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.157001; Knizia G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186404; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Lane C, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.125140; Lokshin KA, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.064511; Mai P, 2021, NPJ QUANTUM MATER, V6, DOI 10.1038/s41535-021-00326-5; Martin R. M., 2016, INTERACTING ELECT; Munoz D, 2000, PHYS REV LETT, V84, P1579, DOI 10.1103/PhysRevLett.84.1579; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Pavarini E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047003; Peng YY, 2017, NAT PHYS, V13, P1201, DOI 10.1038/NPHYS4248; Plakida N, 2010, SPRINGER SER SOLID-S, V166, P1, DOI 10.1007/978-3-642-12633-8; Qin MP, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.031016; Sakakibara H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057003; SCHILLING A, 1993, NATURE, V363, P56, DOI 10.1038/363056a0; Shee A, 2019, J CHEM THEORY COMPUT, V15, P6010, DOI 10.1021/acs.jctc.9b00603; Sun QM, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0006074; Sun QM, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4998644; Sun QN, 2016, ACCOUNTS CHEM RES, V49, P2705, DOI 10.1021/acs.accounts.6b00356; Wagner LK, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125129; Wang Liyuan, 2022, Nat Commun, V13, P12, DOI 10.1038/s41467-021-27609-6; Weber C, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/37001; Weber C, 2010, NAT PHYS, V6, P574, DOI 10.1038/NPHYS1706; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Werner P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146401; White SR, 1999, J CHEM PHYS, V110, P4127, DOI 10.1063/1.478295; White SR, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205112; Wouters S, 2016, J CHEM THEORY COMPUT, V12, P2706, DOI 10.1021/acs.jctc.6b00316; Yu B, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021059; Zhai H, 2021, J CHEM PHYS, V154, DOI 10.1063/5.0050902; Zheng BX, 2017, SCIENCE, V358, P1155, DOI 10.1126/science.aam7127; Cui ZH, 2021, Arxiv, DOI arXiv:2112.09735; Zhou XJ, 2021, NAT REV PHYS, V3, P462, DOI 10.1038/s42254-021-00324-3; Zhu TY, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.021006; Zhu TY, 2020, J CHEM THEORY COMPUT, V16, P141, DOI 10.1021/acs.jctc.9b00934; Zhu T, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.115154	51	2	2	7	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1192	+		10.1126/science.abm2295	http://dx.doi.org/10.1126/science.abm2295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074839	Green Accepted, Green Submitted			2022-12-28	WOS:000887933400041
J	Forbes, A				Forbes, Andrew			Chiral light sources get a helping hand	SCIENCE			English	Editorial Material									[Forbes, Andrew] Univ Witwatersrand, Sch Phys, Johannesburg, South Africa	University of Witwatersrand	Forbes, A (corresponding author), Univ Witwatersrand, Sch Phys, Johannesburg, South Africa.	andrew.forbes@wits.ac.za						Abdollahramezani S, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29374-6; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Chen Y, 2022, NAT REV PHYS, V4, P113, DOI 10.1038/s42254-021-00391-6; Forbes A, 2021, NAT PHOTONICS, V15, P253, DOI 10.1038/s41566-021-00780-4; Franke-Arnold S, 2022, NAT REV PHYS, V4, P361, DOI 10.1038/s42254-022-00467-x; Hentschel M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602735; Jana K, 2021, NAT PHOTONICS, V15, P622, DOI 10.1038/s41566-021-00832-9; Ji ZR, 2020, SCIENCE, V368, P763, DOI 10.1126/science.aba9192; Marinica DC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.183902; Sroor H, 2020, NAT PHOTONICS, V14, P498, DOI 10.1038/s41566-020-0623-z; Zambon NC, 2019, NAT PHOTONICS, V13, P283, DOI 10.1038/s41566-019-0380-z; Zhang XD, 2022, SCIENCE, V377, P1215, DOI 10.1126/science.abq7870; Zhang ZF, 2020, SCIENCE, V368, P760, DOI 10.1126/science.aba8996	13	0	0	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1152	1153		10.1126/science.add5065	http://dx.doi.org/10.1126/science.add5065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074853				2022-12-28	WOS:000887933400029
J	Bhavani, SV; Wiley, Z; Verhoef, PA; Coopersmith, CM; Ofotokun, I				Bhavani, Sivasubramanium V.; Wiley, Zanthia; Verhoef, Philip A.; Coopersmith, Craig M.; Ofotokun, Ighovwerha			Racial Differences in Detection of Fever Using Temporal vs Oral Temperature Measurements in Hospitalized Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bhavani, Sivasubramanium V.; Wiley, Zanthia; Ofotokun, Ighovwerha] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Verhoef, Philip A.] Univ Hawai, Dept Med, John A Burns Sch Med, Honolulu, HI USA; [Coopersmith, Craig M.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University; Emory University	Bhavani, SV (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.	sbhava2@emory.edu			National Institutes of Health/National Institute of General Medical Sciences [K23GM144867, GM072808]; National Institute of General Medical Sciences [AA027396]; National Institute on Alcohol Abuse and Alcoholism	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Dr Bhavani is supported by National Institutes of Health/National Institute of General Medical Sciences grant K23GM144867 and Dr Coopersmith is supported by grant GM072808 from the National Institute of General Medical Sciences and grant AA027396 from the National Institute on Alcohol Abuse and Alcoholism.	Allyn Welch., ACCURACY STUDY THEWE; Carleton E, 2012, CAN J EMERG MED, V14, P7, DOI 10.2310/8000.2011.110484; Exergen, ART HEAT BAL THERM E; Pompei F, NONINVASIVE TEMPORAL; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Sjoding MW, 2020, NEW ENGL J MED, V383, P2477, DOI 10.1056/NEJMc2029240	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					885	886						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066526				2022-12-28	WOS:000855171700026
J	Slomski, A				Slomski, Anita			Uterus Transplant a Clinical Reality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					817	817						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066531				2022-12-28	WOS:000855171700005
J	Symes, O				Symes, Oliver			Looking for a change	SCIENCE			English	Editorial Material									[Symes, Oliver] Imperial Coll London, London, England	Imperial College London	Symes, O (corresponding author), Imperial Coll London, London, England.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1122	1122						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048947				2022-12-28	WOS:000887933200049
J	Bramante, CT; Huling, JD; Tignanelli, CJ; Buse, JB; Liebovitz, DM; Nicklas, JM; Cohen, K; Puskarich, MA; Belani, HK; Proper, JL; Siegel, LK; Klatt, NR; Odde, DJ; Luke, DG; Anderson, B; Karger, AB; Ingraham, NE; Hartman, KM; Rao, V; Hagen, AA; Patel, B; Fenno, SL; Avula, N; Reddy, NV; Erickson, SM; Lindberg, S; Fricton, R; Lee, S; Zaman, A; Saveraid, HG; Tordsen, WJ; Pullen, MF; Biros, M; Sherwood, NE; Thompson, JL; Boulware, DR; Murray, TA				Bramante, C. T.; Huling, J. D.; Tignanelli, C. J.; Buse, J. B.; Liebovitz, D. M.; Nicklas, J. M.; Cohen, K.; Puskarich, M. A.; Belani, H. K.; Proper, J. L.; Siegel, L. K.; Klatt, N. R.; Odde, D. J.; Luke, D. G.; Anderson, B.; Karger, A. B.; Ingraham, N. E.; Hartman, K. M.; Rao, V; Hagen, A. A.; Patel, B.; Fenno, S. L.; Avula, N.; Reddy, N., V; Erickson, S. M.; Lindberg, S.; Fricton, R.; Lee, S.; Zaman, A.; Saveraid, H. G.; Tordsen, W. J.; Pullen, M. F.; Biros, M.; Sherwood, N. E.; Thompson, J. L.; Boulware, D. R.; Murray, T. A.		COVID-OUT Trial Team	Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C; PHARMACOKINETICS; REPLICATION; INHIBITION; MORTALITY	Background Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Methods In this phase 3, double-blind, randomized, placebo-controlled trial, we used a 2-by-3 factorial design to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine - in preventing serious SARS-CoV-2 infection in nonhospitalized adults who had been enrolled within 3 days after a confirmed diagnosis of infection and less than 7 days after the onset of symptoms. The patients were between the ages of 30 and 85 years, and all had either overweight or obesity. The primary composite end point was hypoxemia (<= 93% oxygen saturation on home oximetry), emergency department visit, hospitalization, or death. All analyses used controls who had undergone concurrent randomization and were adjusted for SARS-CoV-2 vaccination and receipt of other trial medications. Results A total of 1431 patients underwent randomization; of these patients, 1323 were included in the primary analysis. The median age of the patients was 46 years; 56% were female (6% of whom were pregnant), and 52% had been vaccinated. The adjusted odds ratio for a primary event was 0.84 (95% confidence interval [CI], 0.66 to 1.09; P=0.19) with metformin, 1.05 (95% CI, 0.76 to 1.45; P=0.78) with ivermectin, and 0.94 (95% CI, 0.66 to 1.36; P=0.75) with fluvoxamine. In prespecified secondary analyses, the adjusted odds ratio for emergency department visit, hospitalization, or death was 0.58 (95% CI, 0.35 to 0.94) with metformin, 1.39 (95% CI, 0.72 to 2.69) with ivermectin, and 1.17 (95% CI, 0.57 to 2.40) with fluvoxamine. The adjusted odds ratio for hospitalization or death was 0.47 (95% CI, 0.20 to 1.11) with metformin, 0.73 (95% CI, 0.19 to 2.77) with ivermectin, and 1.11 (95% CI, 0.33 to 3.76) with fluvoxamine. Conclusions None of the three medications that were evaluated prevented the occurrence of hypoxemia, an emergency department visit, hospitalization, or death associated with Covid-19. (Funded by the Parsemus Foundation and others; COVID-OUT ClinicalTrials.gov number, NCT04510194.)	[Bramante, C. T.; Ingraham, N. E.; Hartman, K. M.; Hagen, A. A.; Patel, B.; Fenno, S. L.; Avula, N.; Reddy, N., V; Erickson, S. M.; Saveraid, H. G.; Pullen, M. F.; Boulware, D. R.] Univ Minnesota, Dept Med, Fairview, MN USA; [Tignanelli, C. J.; Klatt, N. R.] Univ Minnesota, Dept Surg, Fairview, MN USA; [Puskarich, M. A.; Biros, M.] Univ Minnesota, Dept Emergency Med, Fairview, MN USA; [Karger, A. B.] Univ Minnesota, Lab Med & Pathol, Fairview, MN USA; [Huling, J. D.; Proper, J. L.; Siegel, L. K.; Rao, V; Lindberg, S.; Murray, T. A.] Univ Minnesota, Med Sch, Div Biostat, Fairview, MN USA; [Sherwood, N. E.] Univ Minnesota, Div Epidemiol & Community Hlth, Fairview, MN USA; [Odde, D. J.] Univ Minnesota, Sch Publ Hlth, Fairview, MN USA; [Odde, D. J.] Univ Minnesota, Dept Biomed Engn, Fairview, MN USA; [Puskarich, M. A.; Tordsen, W. J.; Biros, M.] Univ Minnesota, Dept Emergency Med, Hennepin Cty Med Ctr, Fairview, MN USA; [Luke, D. G.] Univ Minnesota, Invest Drug Serv Pharm, Fairview, MN USA; [Cohen, K.] Optum Labs, United Hlth Grp, Minnetonka, MN USA; [Buse, J. B.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Liebovitz, D. M.; Fricton, R.; Lee, S.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL USA; [Nicklas, J. M.; Zaman, A.] Univ Colorado, Dept Med, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Belani, H. K.] Olive View Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA; [Anderson, B.] Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Atlanta, GA USA; [Anderson, B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Thompson, J. L.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA	University of Minnesota System; University of Minnesota System; University of Minnesota System; University of Minnesota System; University of Minnesota System; University of Minnesota System; University of Minnesota System; University of Minnesota System; Hennepin County Medical Center; University of Minnesota System; University of Minnesota System; UnitedHealth Group Incorporated; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Vanderbilt University	Bramante, CT (corresponding author), Univ Minnesota, Div Gen Internal Med & Pediat, MMC 1932, Minneapolis, MN 55414 USA.	bramante@umn.edu	; Liebovitz, David/AAI-9398-2020; Puskarich, Michael/N-7849-2014	Avula, Nandini/0000-0001-5323-2639; Pullen, Matthew/0000-0002-4644-7487; Liebovitz, David/0000-0002-2518-5940; Boulware, David/0000-0002-4715-0060; Ingraham, Nicholas/0000-0002-0292-0594; Sherwood, Nancy/0000-0002-3365-9018; Puskarich, Michael/0000-0001-6358-4670; Tignanelli, Christopher/0000-0002-8079-5565; Bramante, Carolyn T./0000-0001-5858-2080; Karger, Amy/0000-0002-2781-3824; Buse, John/0000-0002-9723-3876	Parsemus Foundation; Rainwater Charitable Foundation; UnitedHealth Group Foundation; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [KL2TR002492, UL1TR002494]; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH [K23 DK124654-01-A1]; NCATS [UL1TR002489]; National Heart, Lung, and Blood Institute of the NIH [K23HL133604]; Institute for Engineering in Medicine; Medtronic Professorship for Engineering in Medicine; National Cancer Institute of the NIH [U54 CA210190, P01 CA254849]; Medtronic Faculty Fellowship; Fast Grants	Parsemus Foundation; Rainwater Charitable Foundation; UnitedHealth Group Foundation; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute for Engineering in Medicine; Medtronic Professorship for Engineering in Medicine; National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medtronic Faculty Fellowship; Fast Grants	Supported by the Parsemus Foundation, Rainwater Charitable Foundation, Fast Grants, and UnitedHealth Group Foundation. The fluvoxamine placebo tablets were donated by Apotex Pharmaceuticals. The ivermectin placebo and active tablets were donated by Edenbridge Pharmaceuticals. Dr. Bramante was supported by grants (KL2TR002492 and UL1TR002494) from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and by a grant (K23 DK124654-01-A1) from the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH. Dr. Buse was supported by a grant (UL1TR002489) from NCATS. Dr. Nicklas was supported by a grant (K23HL133604) from the National Heart, Lung, and Blood Institute of the NIH. Dr. Odde was supported by the Institute for Engineering in Medicine, the Medtronic Professorship for Engineering in Medicine, and by grants (U54 CA210190 and P01 CA254849) from the National Cancer Institute of the NIH. Dr. Murray was supported in part by the Medtronic Faculty Fellowship.	A.Haase, 2020, bioRxiv, DOI 10.1101/2020.05.22.111237; Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044; Blitzer AL, 2021, JAMA OPHTHALMOL, V139, P302, DOI 10.1001/jamaophthalmol.2020.6331; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Bramante CT, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofac066; Bramante CT, 2021, J MED VIROL, V93, P4273, DOI 10.1002/jmv.26873; Bramante CT, 2021, LANCET HEALTH LONGEV, V2, pE34, DOI 10.1016/S2666-7568(20)30033-7; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Cheng F, 2016, J VIROL, V90, P6515, DOI 10.1128/JVI.00624-16; Connors JM, 2021, JAMA-J AM MED ASSOC, V326, P1703, DOI 10.1001/jama.2021.17272; Crouse AB, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.600439; del Campo JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191805; Dodds MG, 2022, LANCET GLOB HEALTH, V10, pE332, DOI 10.1016/S2214-109X(22)00006-7; Facente SN, 2021, DRUGS, V81, P2081, DOI 10.1007/s40265-021-01636-5; Farfan-Morales CN, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.749770; FDA, 2020, J CLIN MED, DOI DOI 10.3390/JCM11206138; FDA, 2022, FDA NEWS RELEAS 0211; Ferdinands JM, 2022, MMWR-MORBID MORTAL W, V71, P255, DOI 10.15585/mmwr.mm7107e2; Food and Drug Administration, 2017, MULT ENDP CLIN TRIAL; Food and Drug Administration, 2021, PULS OX ACC LIM FDA; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Hales Craig M, 2017, NCHS Data Brief, P1; Hammond J, 2022, NEW ENGL J MED, V386, P1397, DOI 10.1056/NEJMoa2118542; Karam BS, 2021, J MED VIROL, V93, P1843, DOI 10.1002/jmv.26728; Keehner J, 2021, NEW ENGL J MED, V385, P1330, DOI 10.1056/NEJMc2112981; Lee TC, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.6269; Lenze EJ, 2020, JAMA-J AM MED ASSOC, V324, P2292, DOI 10.1001/jama.2020.22760; Li Y, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.704666; Lopez-Medina E, 2021, JAMA-J AM MED ASSOC, V325, P1426, DOI 10.1001/jama.2021.3071; Luo P, 2020, AM J TROP MED HYG, V103, P69, DOI 10.4269/ajtmh.20-0375; Marzolini C, 2022, ANN INTERN MED, V175, P744, DOI 10.7326/M22-0281; MENG XL, 1992, BIOMETRIKA, V79, P103, DOI 10.1093/biomet/79.1.103; Nakashima K, 2011, MICROBIOL IMMUNOL, V55, P774, DOI 10.1111/j.1348-0421.2011.00382.x; Newberry AM, 2005, CHEST, V128, P3681, DOI 10.1378/chest.128.5.3681; O'Brien MP, 2021, NEW ENGL J MED, V385, P1184, DOI 10.1056/NEJMoa2109682; Oldenburg CE, 2021, JAMA-J AM MED ASSOC, V326, P490, DOI 10.1001/jama.2021.11517; Popp M, 2021, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD015017.pub2, 10.1002/14651858.CD015017]; Portmann-Baracco A, 2020, ARCH BRONCONEUMOL, V56, P831, DOI 10.1016/j.arbres.2020.06.011; Postler TS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97441-x; Reis Gilmar, 2022, Lancet Reg Health Am, V6, P100142, DOI 10.1016/j.lana.2021.100142; Reis G, 2022, LANCET GLOB HEALTH, V10, pE36, DOI 10.1016/S2214-109X(21)00448-4; Schaller MA, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.148003; Seftel D, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab050; Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207; Stauffer WM, 2020, JAMA-J AM MED ASSOC, V324, P623, DOI 10.1001/jama.2020.13170; Thompson Mark G, 2022, MMWR Morb Mortal Wkly Rep, V71, P139, DOI 10.15585/mmwr.mm7104e3; Timmins P, 2005, CLIN PHARMACOKINET, V44, P721, DOI 10.2165/00003088-200544070-00004; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004; Xin G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36222; Yu JW, 2012, INT J INFECT DIS, V16, pE436, DOI 10.1016/j.ijid.2012.02.004	52	9	9	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2022	387	7					599	610		10.1056/NEJMoa2201662	http://dx.doi.org/10.1056/NEJMoa2201662		AUG 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4D8EB	36070710	Bronze			2022-12-28	WOS:000883681200008
J	Trimble, JS; Crawshaw, R; Hardy, FJ; Levy, CW; Brown, MJB; Fuerst, DE; Heyes, DJ; Obexer, R; Green, AP				Trimble, Jonathan S.; Crawshaw, Rebecca; Hardy, Florence J.; Levy, Colin W.; Brown, Murray J. B.; Fuerst, Douglas E.; Heyes, Derren J.; Obexer, Richard; Green, Anthony P.			A designed photoenzyme for enantioselective [2+2] cycloadditions	NATURE			English	Article							PHOTOCYCLOADDITION REACTIONS; PHOTOCATALYSIS; ACID	The ability to program new modes of catalysis into proteins would allow the development of enzyme families with functions beyond those found in nature. To this end, genetic code expansion methodology holds particular promise, as it allows the site-selective introduction of new functional elements into proteins as noncanonical amino acid side chains(1-4). Here we exploit an expanded genetic code to develop a photoenzyme that operates by means oftriplet energy transfer (EnT) catalysis, a versatile mode of reactivity in organic synthesis that is not accessible to biocatalysis at present(5-)(12). Installation of a genetically encoded photosensitizer into the beta-propeller scaffold of DA_20_00 (ref.(13)) converts a de novo Diels-Alderase into a photoenzyme for [2+2] cycloadditions (EnT1.0). Subsequent development and implementation of a platform for photoenzyme evolution afforded an efficient and enantioselective enzyme (EnT1.3, up to 99% enantiomeric excess (e.e.)) that can promote intramolecular and bimolecular cycloadditions, including transformations that have proved challenging to achieve selectively with small-molecule catalysts. EnT1.3 performs >300 turnovers and, in contrast to small-molecule photocatalysts, can operate effectively under aerobic conditions and at ambient temperatures. An X-ray crystal structure of an EnT1.3-product complex shows how multiple functional components work in synergy to promote efficient and selective photocatalysis. This study opens up a wealth of new excited-state chemistry in protein active sites and establishes the framework for developing a new generation of enantioselective photocatalysts.	[Trimble, Jonathan S.; Crawshaw, Rebecca; Hardy, Florence J.; Levy, Colin W.; Heyes, Derren J.; Obexer, Richard; Green, Anthony P.] Univ Manchester, Dept Chem, Manchester, Lancs, England; [Trimble, Jonathan S.; Crawshaw, Rebecca; Hardy, Florence J.; Levy, Colin W.; Heyes, Derren J.; Obexer, Richard; Green, Anthony P.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Brown, Murray J. B.] GlaxoSmithKline Med Res Ctr, Synthet Biochem Med Dev & Supply, Stevenage, Herts, England; [Fuerst, Douglas E.] GlaxoSmithKline, Synthet Biochem Med Dev & Supply, Collegeville, PA USA	University of Manchester; University of Manchester; GlaxoSmithKline; GlaxoSmithKline	Green, AP (corresponding author), Univ Manchester, Dept Chem, Manchester, Lancs, England.; Green, AP (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	anthony.green@manchester.ac.uk		Green, Anthony/0000-0003-0454-1798; Obexer, Richard/0000-0002-4940-3543; Brown, Murray/0000-0002-2393-7686; Hardy, Florence/0000-0003-0671-0209	European Research Council (ERC) [757991]; Biotechnology and Biological Sciences Research Council (David Phillips Fellowship) [BB/M027023/1, BB/W014483/1]; integrated catalysis Doctoral Training Programme [EP/023755/1]; BBSRC Flexible Talent Mobility Account Award [BB/S507969/1]; EPSRC [EP/R00661X/1, EP/S019367/1, EP/P025021/1, EP/P025498/1]	European Research Council (ERC)(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council (David Phillips Fellowship)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); integrated catalysis Doctoral Training Programme; BBSRC Flexible Talent Mobility Account Award; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the European Research Council (ERC Starting Grant no. 757991 to A.P.G.) and the Biotechnology and Biological Sciences Research Council (David Phillips Fellowship BB/M027023/1 to A.P.G. and Transition Award BB/W014483/1). J.S.T. was supported by an integrated catalysis Doctoral Training Programme (EP/023755/1). R.C. was supported by a BBSRC Flexible Talent Mobility Account Award (BB/S507969/1). We are grateful to Diamond Light Source for time on beamline I03 under proposal MX24447, to the Manchester SYNBIOCHEM Centre (BB/M017702/1), the Future Biomanufacturing Hub (EP/S01778X/1) and the Henry Royce Institute for Advanced Materials (financed through EPSRC grant nos. EP/R00661X/1, EP/S019367/1, EP/P025021/1 and EP/P025498/1) for access to their facilities and to M. Dunstan (Manchester Institute of Biotechnology) for guidance on automating directed-evolution workflows. We thank R. Spiess and R. Sung (Manchester Institute of Biotechnology) for acquiring protein mass spectra and for assistance with UPLC method development and Reach Separations (Nottingham) for supplying individual enantiomers of the product <BOLD>1a</BOLD>. We thank S. Lovelock and R. Jamagne for their assistance in preparing DNA constructs and modified proteins. We are grateful to GlaxoSmithKline for access to their facilities and to J. Hosford and L. J. Edwards (GlaxoSmithKline, Stevenage) for helpful discussions. We are also grateful to D. Leonori for helpful discussions throughout the project.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso R, 2014, ANGEW CHEM INT EDIT, V53, P4368, DOI 10.1002/anie.201310997; Becker M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09609-9; Black MJ, 2020, NAT CHEM, V12, P71, DOI 10.1038/s41557-019-0370-2; Blum TR, 2016, SCIENCE, V354, P1391, DOI 10.1126/science.aai8228; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Burke AJ, 2019, NATURE, V570, P219, DOI 10.1038/s41586-019-1262-8; Chin JW, 2017, NATURE, V550, P53, DOI 10.1038/nature24031; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Daub ME, 2019, J AM CHEM SOC, V141, P9543, DOI 10.1021/jacs.9b04643; Drienovska I, 2018, NAT CHEM, V10, P946, DOI 10.1038/s41557-018-0082-z; Emmanuel MA, 2016, NATURE, V540, P414, DOI 10.1038/nature20569; Fu Y, 2021, J AM CHEM SOC, V143, P617, DOI 10.1021/jacs.0c10882; Gao X, 2021, J AM CHEM SOC, V143, P19643, DOI 10.1021/jacs.1c09828; Godfrey TS, 1967, CHEM PHYS LETT, V1, P490, DOI 10.1016/0009-2614(67)85085-1; Grosskopf J, 2022, CHEM REV, V122, P1626, DOI 10.1021/acs.chemrev.1c00272; Heyes DJ, 2021, NAT PLANTS, V7, P268, DOI 10.1038/s41477-021-00866-5; Heyes DJ, 2020, ACS CATAL, V10, P6691, DOI 10.1021/acscatal.0c01684; Hormann FM, 2020, ANGEW CHEM INT EDIT, V59, P9659, DOI 10.1002/anie.202001634; Huang MX, 2022, SCIENCE, V375, P869, DOI 10.1126/science.abl4922; Huang XQ, 2022, NAT CATAL, V5, P586, DOI 10.1038/s41929-022-00777-4; Huang XQ, 2020, NATURE, V584, P69, DOI 10.1038/s41586-020-2406-6; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kang FY, 2021, ACS CATAL, V11, P5628, DOI 10.1021/acscatal.1c00287; Kleinmans R, 2022, NATURE, V605, P477, DOI 10.1038/s41586-022-04636-x; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu XH, 2018, NAT CHEM, V10, P1201, DOI 10.1038/s41557-018-0150-4; Lovelock SL, 2022, NATURE, V606, P49, DOI 10.1038/s41586-022-04456-z; Maturi MM, 2015, AUST J CHEM, V68, P1682, DOI 10.1071/CH15280; Maturi MM, 2013, CHEM-EUR J, V19, P7461, DOI 10.1002/chem.201300203; Mayr F, 2016, J ORG CHEM, V81, P6965, DOI 10.1021/acs.joc.6b01039; Muller C, 2011, J AM CHEM SOC, V133, P16689, DOI 10.1021/ja207480q; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Munster N, 2017, ANGEW CHEM INT EDIT, V56, P9468, DOI 10.1002/anie.201705333; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sorigue D, 2017, SCIENCE, V357, P903, DOI 10.1126/science.aan6349; Strieth-Kalthoff F, 2020, CHEM-US, V6, P1888, DOI 10.1016/j.chempr.2020.07.010; Tan C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8302; Troster A, 2019, ANGEW CHEM INT EDIT, V58, P3538, DOI 10.1002/anie.201814193; Troster A, 2016, J AM CHEM SOC, V138, P7808, DOI 10.1021/jacs.6b03221; Vogt F., 2009, SYNTHESIS-STUTTGART, V24, P4268	41	2	2	32	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2022	611	7937					709	+		10.1038/s41586-022-05335-3	http://dx.doi.org/10.1038/s41586-022-05335-3		SEP 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EM	36130727	Green Submitted			2022-12-28	WOS:000880580400001
J	Antiochos, B				Antiochos, Brendan			Tocilizumab as a Novel Therapy for Steroid-Dependent Polymyalgia Rheumatica	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GIANT-CELL ARTERITIS		[Antiochos, Brendan] Johns Hopkins, 5200 Eastern Ave,Ste 5000,Mason Lord Bldg,Ctr Tow, Baltimore, MD 21218 USA	Johns Hopkins University	Antiochos, B (corresponding author), Johns Hopkins, 5200 Eastern Ave,Ste 5000,Mason Lord Bldg,Ctr Tow, Baltimore, MD 21218 USA.	bantioc1@jh.edu						BAGRATUNI L, 1953, ANN RHEUM DIS, V12, P98, DOI 10.1136/ard.12.2.98; BARBER HS, 1957, ANN RHEUM DIS, V16, P230, DOI 10.1136/ard.16.2.230; Buttgereit F, 2016, JAMA-J AM MED ASSOC, V315, P2442, DOI 10.1001/jama.2016.5444; Crowson CS, 2017, SEMIN ARTHRITIS RHEU, V47, P253, DOI 10.1016/j.semarthrit.2017.04.001; Devauchelle-Pensec V, 2022, JAMA-J AM MED ASSOC, V328, P1053, DOI 10.1001/jama.2022.15459; Devauchelle-Pensec V, 2016, ANN RHEUM DIS, V75, P1506, DOI 10.1136/annrheumdis-2015-208742; Kersley GD., 1951, 2 CONGRESO EUROPEO R; Kremers HM, 2005, J RHEUMATOL, V32, P65; Leeb BF, 2004, ANN RHEUM DIS, V63, P1279, DOI 10.1136/ard.2003.011379; Partington R, 2021, ARTHRIT CARE RES, V73, P1853, DOI 10.1002/acr.24403; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Sondag M, 2016, RHEUMATOLOGY, V55, P1452, DOI 10.1093/rheumatology/kew202; Spiera R, 2021, SEMIN ARTHRITIS RHEU, V51, P469, DOI 10.1016/j.semarthrit.2021.03.006; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Weigand S, 2014, J RHEUMATOL, V41, P730, DOI 10.3899/jrheum.130946	15	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1047	1048		10.1001/jama.2022.11526	http://dx.doi.org/10.1001/jama.2022.11526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125486				2022-12-28	WOS:000862909200016
J	Arabi, YM; Aldekhyl, S; Al Qahtani, S; Al-Dorzi, HM; Abdukahil, SA; Al Harbi, MK; Al Qasim, E; Kharaba, A; Albrahim, T; Alshahrani, MS; Al-Fares, AA; Al Bshabshe, A; Mady, A; Al Duhailib, Z; Algethamy, H; Jose, J; Al Mutairi, M; Al Zumai, O; Al Haji, H; Alaqeily, A; Al Aseri, Z; Al-Omari, A; Al-Dawood, A; Tlayjeh, H				Arabi, Yaseen M.; Aldekhyl, Sara; Al Qahtani, Saad; Al-Dorzi, Hasan M.; Abdukahil, Sheryl Ann; Al Harbi, Mohammed Khulaif; Al Qasim, Eman; Kharaba, Ayman; Albrahim, Talal; Alshahrani, Mohammed S.; Al-Fares, Abdulrahman A.; Al Bshabshe, Ali; Mady, Ahmed; Al Duhailib, Zainab; Algethamy, Haifa; Jose, Jesna; Al Mutairi, Mohammed; Al Zumai, Omar; Al Haji, Hussain; Alaqeily, Ahmed; Al Aseri, Zohair; Al-Omari, Awad; Al-Dawood, Abdulaziz; Tlayjeh, Haytham		Saudi Critical Care Trials Grp	Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19 The HELMET-COVID Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTCOMES	IMPORTANCE Helmet noninvasive ventilation has been used in patients with COVID-19 with the premise that helmet interface is more effective than mask interface in delivering prolonged treatments with high positive airway pressure, but data about its effectiveness are limited. OBJECTIVE To evaluate whether helmet noninvasive ventilation compared with usual respiratory support reduces mortality in patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. DESIGN, SETTING, AND PARTICIPANTS Thiswas a multicenter, pragmatic, randomized clinical trial that was conducted in 8 sites in Saudi Arabia and Kuwait between February 8, 2021, and November 16, 2021. Adult patients with acute hypoxemic respiratory failure (n = 320) due to suspected or confirmed COVID-19 were included. The final follow-up date for the primary outcome was December 14, 2021. INTERVENTIONS Patients were randomized to receive helmet noninvasive ventilation (n = 159) or usual respiratory support (n = 161), which included mask noninvasive ventilation, high-flow nasal oxygen, and standard oxygen. MAIN OUTCOMES AND MEASURES The primary outcomewas 28-day all-cause mortality. There were 12 prespecified secondary outcomes, including endotracheal intubation, barotrauma, skin pressure injury, and serious adverse events. RESULTS Among 322 patients who were randomized, 320 were included in the primary analysis, all of whom completed the trial. Median age was 58 years, and 187 were men (58.4%). Within 28 days, 43 of 159 patients (27.0%) died in the helmet noninvasive ventilation group compared with 42 of 161 (26.1%) in the usual respiratory support group (risk difference, 1.0%[95% CI, -8.7% to 10.6%]; relative risk, 1.04 [95% CI, 0.72-1.49]; P =.85). Within 28 days, 75 of 159 patients (47.2%) required endotracheal intubation in the helmet noninvasive ventilation group compared with 81 of 161 (50.3%) in the usual respiratory support group (risk difference, -3.1% [95% CI, -14.1% to 7.8%]; relative risk, 0.94 [95% CI, 0.75-1.17]). There were no significant differences between the 2 groups in any of the prespecified secondary end points. Barotrauma occurred in 30 of 159 patients (18.9%) in the helmet noninvasive ventilation group and 25 of 161 (15.5%) in the usual respiratory support group. Skin pressure injury occurred in 5 of 159 patients (3.1%) in the helmet noninvasive ventilation group and 10 of 161 (6.2%) in the usual respiratory support group. There were 2 serious adverse events in the helmet noninvasive ventilation group and 1 in the usual respiratory support group. CONCLUSIONS AND RELEVANCE Results of this study suggest that helmet noninvasive ventilation did not significantly reduce 28-day mortality compared with usual respiratory support among patients with acute hypoxemic respiratory failure due to COVID-19 pneumonia. However, interpretation of the findings is limited by imprecision in the effect estimate, which does not exclude potentially clinically important benefit or harm.	[Arabi, Yaseen M.; Aldekhyl, Sara; Al Qahtani, Saad; Al-Dorzi, Hasan M.; Abdukahil, Sheryl Ann; Al Qasim, Eman; Jose, Jesna; Al-Dawood, Abdulaziz; Tlayjeh, Haytham] Minist Natl Guard Hlth Affairs, Dept Intens Care, Riyadh, Saudi Arabia; [Arabi, Yaseen M.; Aldekhyl, Sara; Al Qahtani, Saad; Al-Dorzi, Hasan M.; Abdukahil, Sheryl Ann; Al Harbi, Mohammed Khulaif; Al Qasim, Eman; Al Mutairi, Mohammed; Al Zumai, Omar; Al Haji, Hussain; Alaqeily, Ahmed; Al-Dawood, Abdulaziz; Tlayjeh, Haytham] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Arabi, Yaseen M.; Aldekhyl, Sara; Al Qahtani, Saad; Al-Dorzi, Hasan M.; Abdukahil, Sheryl Ann; Al Harbi, Mohammed Khulaif; Al Qasim, Eman; Jose, Jesna; Al Mutairi, Mohammed; Al Zumai, Omar; Al Haji, Hussain; Alaqeily, Ahmed; Al-Dawood, Abdulaziz; Tlayjeh, Haytham] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Al Harbi, Mohammed Khulaif] Minist Natl Guard Hlth Affairs, Dept Anesthesia, Riyadh, Saudi Arabia; [Kharaba, Ayman] King Fahad Hosp, Dept Pulm, Madinah, Saudi Arabia; [Kharaba, Ayman] King Fahad Hosp, Crit Care Dept, Madinah, Saudi Arabia; [Albrahim, Talal] Imam Abdulrahman Bin Faisal Univ, King Fahad Hosp Univ, Dept Crit Care, Al Khobar, Saudi Arabia; [Alshahrani, Mohammed S.] Imam Abdulrahman Bin Faisal Univ, King Fahad Hosp Univ, Dept Emergency & Crit Care, Al Khobar, Saudi Arabia; [Al-Fares, Abdulrahman A.] Al Amiri Hosp, Minist Hlth, Dept Anesthesia Crit Care Med & Pain Med, Kuwait, Kuwait; [Al Bshabshe, Ali] King Khalid Univ, Aseer Cent Hosp, Dept Crit Care Med, Abha, Saudi Arabia; [Mady, Ahmed] King Saud Med City, Dept Intens Care, Riyadh, Saudi Arabia; [Mady, Ahmed] Tanta Univ, Coll Med, Tanta, Egypt; [Al Duhailib, Zainab] King Faisal Specialist Hosp & Res Ctr, Adult Crit Care Med Dept, Riyadh, Saudi Arabia; [Algethamy, Haifa] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Dept Anesthesia & Crit Care, Jeddah, Saudi Arabia; [Jose, Jesna] King Abdullah Int Med Res Ctr, Dept Bioinformat & Biostat, Riyadh, Saudi Arabia; [Al Mutairi, Mohammed; Al Zumai, Omar; Al Haji, Hussain; Alaqeily, Ahmed] Minist Natl Guard Hlth Affairs, Resp Serv Dept, Riyadh, Saudi Arabia; [Al Aseri, Zohair] King Saud Univ, Coll Med, Emergency Dept, Riyadh, Saudi Arabia; [Al Aseri, Zohair] King Saud Univ, Coll Med, Dept Intens Care, Riyadh, Saudi Arabia; [Al-Omari, Awad] Alfaisal Univ, Crit Care & Infect Dis Dept, Dr Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia; [Al-Omari, Awad] Alfaisal Univ, Infect Control Dept, Dr Sulaiman Al Habib Med Grp, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; Ministry of National Guard - Health Affairs; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; Ministry of National Guard - Health Affairs; Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; Amiri Hospital; Assir Central Hospital; King Khalid University; King Saud Medical City; Egyptian Knowledge Bank (EKB); Tanta University; King Faisal Specialist Hospital & Research Center; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; Ministry of National Guard - Health Affairs; King Saud University; King Saud University; Alfaisal University; Alfaisal University	Arabi, YM (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Intens Care, Coll Med,Minist Natl Guard Hlth Affairs, ICU 1425,POB 22490, Riyadh 11426, Saudi Arabia.	yaseenarabi@yahoo.com	al bshabshe, ali/CAI-2698-2022; Al Aseri, Zohair/A-6098-2018	al bshabshe, ali/0000-0003-0974-7226; Al Aseri, Zohair/0000-0001-9869-7544; Al-Dorzi, Hasan M/0000-0002-3772-8949	King Abdullah International Medical Research Center, Riyadh, Saudi Arabia [RC20/306R]	King Abdullah International Medical Research Center, Riyadh, Saudi Arabia	The trial was funded by King Abdullah International Medical Research Center (grant RC20/306R), Riyadh, Saudi Arabia.	Arabi Y, 2022, TRIALS, V23, DOI 10.1186/s13063-021-05988-x; Arabi YM, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052169; Avari H, 2021, AM J RESP CRIT CARE, V203, P1112, DOI 10.1164/rccm.202008-3070OC; Bellani G, 2021, ANN AM THORAC SOC, V18, P1020, DOI 10.1513/AnnalsATS.202008-1080OC; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Chaudhuri D, 2022, EUR RESPIR J, V59, DOI 10.1183/13993003.01269-2021; Reyes LF, 2022, ERJ OPEN RES, V8, DOI 10.1183/23120541.00552-2021; Ferreyro BL, 2020, JAMA-J AM MED ASSOC, V324, P57, DOI 10.1001/jama.2020.9524; Grieco DL, 2021, INTENS CARE MED, V47, P851, DOI 10.1007/s00134-021-06459-2; Grieco DL, 2021, JAMA-J AM MED ASSOC, V325, P1731, DOI 10.1001/jama.2021.4682; Grieco DL, 2020, AM J RESP CRIT CARE, V201, P303, DOI 10.1164/rccm.201904-0841OC; Hasan SS, 2020, EXPERT REV RESP MED, V14, P1149, DOI 10.1080/17476348.2020.1804365; Nava S, 2009, CRIT CARE MED, V37, P2111, DOI 10.1097/CCM.0b013e3181a5e6b5; Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338; Perkins GD, 2022, JAMA-J AM MED ASSOC, V327, P546, DOI 10.1001/jama.2022.0028; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schmidt M, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03784-2; Serafim RB, 2021, CLIN MICROBIOL INFEC, V27, P47, DOI 10.1016/j.cmi.2020.10.017; U.S. Food & Drug Administration, 2020, COR COVID 19 UPD DAI; UteMuti-Schuenemann GE, 2022, ANN INTERN MED, V175, pW6, DOI 10.7326/L21-0424; Vargas F, 2009, CRIT CARE MED, V37, P1921, DOI 10.1097/CCM.0b013e31819fff93; Winck JC, 2021, PULMONOLOGY, V27, P305, DOI 10.1016/j.pulmoe.2020.12.005	23	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1063	1072		10.1001/jama.2022.15599	http://dx.doi.org/10.1001/jama.2022.15599			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125473				2022-12-28	WOS:000862909200020
J	Larkin, HD				Larkin, Howard D.			Transport and Unintentional Injuries Among Adolescents and Young Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1029	1029		10.1001/jama.2022.14712	http://dx.doi.org/10.1001/jama.2022.14712			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125464				2022-12-28	WOS:000862909200006
J	Mahase, E				Mahase, Elisabeth			Monkeypox: NHS offers tecovirimat for severe or complicated cases	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], CLIN FEAT MAN HUM MO; [Anonymous], TEC TREATM PAT HOSP; Grosenbach DW, 2018, NEW ENGL J MED, V379, P44, DOI [10.1056/nejmoa1705688, 10.1056/NEJMoa1705688]; Mahase E, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o2080	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2022	378								o2272	10.1136/bmj.o2272	http://dx.doi.org/10.1136/bmj.o2272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5K8IF	36126983	Bronze			2022-12-28	WOS:000869963500002
J	Cortez, N				Cortez, Nathan			The Law of Licensure and Quality Regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								The Law of Licensure and Quality Regulation U.S. federal and state laws, licensing requirements, payers' conditions of participation, and the standards set by accreditors all regulate the quality of medical practice.	[Cortez, Nathan] Southern Methodist Univ, Dedman Sch Law, Dallas, TX 75205 USA	Southern Methodist University	Cortez, N (corresponding author), Southern Methodist Univ, Dedman Sch Law, Dallas, TX 75205 USA.							[Anonymous], 1965, DARLING CHARLESTON C; Centers for Medicare and Medicaid Services, FIND COMP NURS HOM H; Jost TS., 1995, ARIZ LAW REV, V37, P825; Madison K., 2013, INDIANA HLTH LAW REV, V10, P325; Studdert DM., 2019, DEPAUL LAW REV, V68, P421	5	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2201802	http://dx.doi.org/10.1056/NEJMp2201802		SEP 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4T9IC	36121060				2022-12-28	WOS:000858420100001
J	Constantin, T; Gorski, B; Tilby, MJ; Chelli, S; Julia, F; Llaveria, J; Gillen, KJ; Zipse, H; Lakhdar, S; Leonori, D				Constantin, Timothee; Gorski, Bartosz; Tilby, Michael J.; Chelli, Saloua; Julia, Fabio; Llaveria, Josep; Gillen, Kevin J.; Zipse, Hendrik; Lakhdar, Sami; Leonori, Daniele			Halogen-atom and group transfer reactivity enabled by hydrogen tunneling	SCIENCE			English	Article							SILYLATED CYCLOHEXADIENES; RATE CONSTANTS; RADICALS; ACTIVATION; REAGENTS; HYDRIDE	The generation of carbon radicals by halogen-atom and group transfer reactions is generally achieved using tin and silicon reagents that maximize the interplay of enthalpic (thermodynamic) and polar (kinetic) effects. In this work, we demonstrate a distinct reactivity mode enabled by quantum mechanical tunneling that uses the cyclohexadiene derivative g-terpinene as the abstractor under mild photochemical conditions. This protocol activates alkyl and aryl halides as well as several alcohol and thiol derivatives. Experimental and computational studies unveiled a noncanonical pathway whereby a cyclohexadienyl radical undergoes concerted aromatization and halogen-atom or group abstraction through the reactivity of an effective H atom. This activation mechanism is seemingly thermodynamically and kinetically unfavorable but is rendered feasible through quantum tunneling.	[Constantin, Timothee; Gorski, Bartosz; Tilby, Michael J.; Julia, Fabio] Univ Manchester, Dept Chem, Manchester M13 9PL, England; [Chelli, Saloua; Lakhdar, Sami] Univ Toulouse III Paul Sabatier, Lab Heterochim Fondamentale & Appl, LHFA UMR 5069, CNRS, F-31062 Toulouse 09, France; [Llaveria, Josep] Janssen Cilag SA, Global Discovery Chem, Therapeut Discovery, Janssen Res & Dev, Toledo 45007, Spain; [Gillen, Kevin J.] LifeArc, Accelerator Bldg,Open Innovation Campus, Stevenage SG1 2FX, England; [Zipse, Hendrik] LMU Munchen, Dept Chem, D-81377 Munich, Germany; [Leonori, Daniele] Rhein Westfal TH Aachen, Inst Organ Chem, D-52056 Aachen, Germany	University of Manchester; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Johnson & Johnson; University of Munich; RWTH Aachen University	Lakhdar, S (corresponding author), Univ Toulouse III Paul Sabatier, Lab Heterochim Fondamentale & Appl, LHFA UMR 5069, CNRS, F-31062 Toulouse 09, France.; Leonori, D (corresponding author), Rhein Westfal TH Aachen, Inst Organ Chem, D-52056 Aachen, Germany.	sami.lakhdar@univ-tlse3.fr; daniele.leonori@rwth-aachen.de	; Lakhdar, Sami/D-7496-2017; Julia, Fabio/E-7414-2012	Gillen, Kevin/0000-0001-5563-0470; Lakhdar, Sami/0000-0002-1168-7472; Julia, Fabio/0000-0001-8903-4482; Llaveria Cros, Josep/0000-0003-2260-3657; Leonori, Daniele/0000-0002-7692-4504; Constantin, Timothee/0000-0001-5376-1557	EPSRC [EP/P004997/1]; European Research Council [758427]; Leverhulme Trust; CNRS; ANR [220424]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Leverhulme Trust(Leverhulme Trust); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	D.L. thanks EPSRC for a fellowship (EP/P004997/1), the European Research Council for a research grant (758427), and the Leverhulme Trust for additional support (Philip Leverhulme Prize). S.L. thanks CNRS and ANR (PhotoFlat N degrees 220424) for financial support. N. S. Sheikh is kindly acknowledged for initial calculations.	Andrieux CP, 2003, J AM CHEM SOC, V125, P14801, DOI 10.1021/ja0374574; Bae SH, 2019, J AM CHEM SOC, V141, P7675, DOI 10.1021/jacs.9b02272; Baguley PA, 1998, ANGEW CHEM INT EDIT, V37, P3073, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3072::AID-ANIE3072>3.0.CO;2-9; BALLESTRI M, 1991, J ORG CHEM, V56, P678, DOI 10.1021/jo00002a035; Bhunia A, 2021, CHEM-US, V7, P2060, DOI 10.1016/j.chempr.2021.03.023; BINMORE G, 1995, J CHEM SOC CHEM COMM, P27, DOI 10.1039/c39950000027; CHATGILIALOGLU C, 1992, ACCOUNTS CHEM RES, V25, P188, DOI 10.1021/ar00016a003; Chatgilialoglu C, 2018, CHEM REV, V118, P6516, DOI 10.1021/acs.chemrev.8b00109; Chen TQ, 2019, ANGEW CHEM INT EDIT, V58, P14584, DOI 10.1002/anie.201909072; Cowper NGW, 2020, J AM CHEM SOC, V142, P2093, DOI 10.1021/jacs.9b12328; Crespi S, 2020, CHEM REV, V120, P9790, DOI 10.1021/acs.chemrev.0c00278; Denes F, 2013, CHEM SOC REV, V42, P7900, DOI 10.1039/c3cs60143a; EFFIO A, 1980, J AM CHEM SOC, V102, P6063, DOI 10.1021/ja00539a015; Ghosh I, 2014, SCIENCE, V346, P725, DOI 10.1126/science.1258232; Greer EM, 2016, TETRAHEDRON, V72, P7357, DOI 10.1016/j.tet.2016.09.029; Gutz C, 2015, ORG PROCESS RES DEV, V19, P1428, DOI 10.1021/acs.oprd.5b00272; Hendy CM, 2021, J AM CHEM SOC, V143, P8987, DOI 10.1021/jacs.1c04427; Ho JM, 2013, J ORG CHEM, V78, P6677, DOI 10.1021/jo400927y; INGOLD KU, 1984, J AM CHEM SOC, V106, P343, DOI 10.1021/ja00314a016; Julia F, 2022, CHEM REV, V122, P2292, DOI 10.1021/acs.chemrev.1c00558; KRECH RH, 1977, J AM CHEM SOC, V99, P8402, DOI 10.1021/ja00468a005; Le C, 2018, SCIENCE, V360, P1010, DOI 10.1126/science.aat4133; Ley D, 2012, ORG BIOMOL CHEM, V10, P3781, DOI 10.1039/c2ob07170c; Luo Y-R., 2007, COMPREHENSIVE HDB CH, DOI DOI 10.1201/9781420007282; MacKenzie IA, 2020, NATURE, V580, P76, DOI 10.1038/s41586-020-2131-1; Meisner J, 2016, ANGEW CHEM INT EDIT, V55, P5400, DOI 10.1002/anie.201511028; Nandi A, 2021, ACS CATAL, V11, P14836, DOI 10.1021/acscatal.1c04475; NEUMANN WP, 1987, SYNTHESIS-STUTTGART, P665; NEWCOMB M, 1986, J AM CHEM SOC, V108, P4132, DOI 10.1021/ja00274a046; Pitre SP, 2019, J AM CHEM SOC, V141, P2800, DOI 10.1021/jacs.8b11790; Plesniak MP, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0077; Sakai HA, 2020, J AM CHEM SOC, V142, P11691, DOI 10.1021/jacs.0c04812; Salamone M, 2011, J AM CHEM SOC, V133, P16625, DOI 10.1021/ja206890y; Schreiner PR, 2020, TRENDS CHEM, V2, P980, DOI 10.1016/j.trechm.2020.08.006; Schreiner PR, 2017, J AM CHEM SOC, V139, P15276, DOI 10.1021/jacs.7b06035; Schreiner PR, 2011, SCIENCE, V332, P1300, DOI 10.1126/science.1203761; Schweitzer-Chaput B, 2019, NAT CHEM, V11, P129, DOI 10.1038/s41557-018-0173-x; SKODJE RT, 1981, J PHYS CHEM-US, V85, P3019, DOI 10.1021/j150621a001; Studer A, 2003, J AM CHEM SOC, V125, P5726, DOI 10.1021/ja0341743; Studer A, 2000, ANGEW CHEM INT EDIT, V39, P3080, DOI 10.1002/1521-3773(20000901)39:17<3080::AID-ANIE3080>3.0.CO;2-E; Studer A, 2011, ANGEW CHEM INT EDIT, V50, P5018, DOI 10.1002/anie.201101597; Taylor JW, 2004, J PHYS CHEM A, V108, P7193, DOI 10.1021/jp0379547; Walton JC, 2005, ACCOUNTS CHEM RES, V38, P794, DOI 10.1021/ar050089j; Wu JJ, 2019, ANGEW CHEM INT EDIT, V58, P18830, DOI 10.1002/anie.201910051; Yan M, 2016, J AM CHEM SOC, V138, P12692, DOI 10.1021/jacs.6b08856; Young IS, 2016, ORG PROCESS RES DEV, V20, P2108, DOI 10.1021/acs.oprd.6b00334; Zarate C, 2021, ORG PROCESS RES DEV, V25, P642, DOI 10.1021/acs.oprd.0c00446; Zard SZ, 2017, ORG LETT, V19, P1257, DOI 10.1021/acs.orglett.7b00531	48	0	0	22	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1323	+		10.1126/science.abq8663	http://dx.doi.org/10.1126/science.abq8663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108027	Green Submitted			2022-12-28	WOS:000887933500041
J	Pagel, C; Yates, CA				Pagel, Christina; Yates, Christian A.			Role of mathematical modelling in future pandemic response policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Christina Pagel and Christian Yates consider what the pandemic has taught us about mathematical modelling in the UK and how it can be used more effectively	[Pagel, Christina] UCL, Clin Operat Res Unit, London, England; [Yates, Christian A.] Univ Bath, Bath, Avon, England	University of London; University College London; University of Bath	Pagel, C (corresponding author), UCL, Clin Operat Res Unit, London, England.	c.pagel@ucl.ac.uk	Yates, Christian/A-8863-2014	Yates, Christian/0000-0003-0461-7297				[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, INDEPENDENT 0531; [Anonymous], 2020, SAGE 58 MINUTES CORO; [Anonymous], 2021, UK RESPONSE COVID 19; [Anonymous], 2020, HUFFPOST UK 0523; [Anonymous], 2020, TIMES 1213; [Anonymous], 2021, PRESS RELEASE; [Anonymous], 2020, HUFFPOST UK 0522; [Anonymous], 2021, DAILY MAIL 1219; [Anonymous], 2022, INDEPENDENT 0124; [Anonymous], 2022, INDEPENDENT 0123; Banerjee R, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113473; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540; Birrell P, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0279; Brink B, 2001, Prehosp Disaster Med, V16, P39; Brooks-Pollock E, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2021.0001; C.Thompson, 2020, medRxiv, DOI 10.1101/2020.03.24.20042291; Challen R, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0280; Clark A., 2022, TELEGRAPH 0119; Covid UK, 2022, INDEPENDENT 0422; Crowe S, 2017, BMJ QUAL SAF, V26, P641, DOI 10.1136/bmjqs-2016-005636; Donnelly L., 2020, TELEGRAPH 1119; E. Brooks-Pollock, 2022, medRxiv, DOI 10.1101/2022.01.26.22269540; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Evans-Pritchard A., 2021, TELEGRAPH 1223; Ge Y, 2021, RISK ANAL, V41, P1145, DOI 10.1111/risa.13280; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; GISAID, 2022, HCOV19 VAR; Gog JR, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0263; Hall I, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0269; Institute for Government, 2020, SCI ADV CRIS; Ismail M, 2020, OXFORD I POPULA 0930; Keeling M, 2021, EARLY OMICRON RESULT; Knapton S, 2022, TELEGRAPH 0118; Lahiri S, 2021, INT J DISAST RISK RE, V61, DOI 10.1016/j.ijdrr.2021.102369; Lesh M, 2021, TELEGRAPH 1221; Marshall GC., 2022, F1000 RES, V11, DOI [10.12688/f1000research.124627.1, DOI 10.12688/F1000RESEARCH.124627.1]; Moore S, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008849; Morgan ALK, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0282; Nuffield Trust, 2018, A E WAITING TIMES; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; ONS, DEATHS INV COVID 19; Panovska-Griffiths J, 2020, CONVERSATION 0403; SAGE, 17 18 MARCH DISC LON; Sayburn A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1216; SPI-M_O, 2020, MED TERM PRED; SPI-M-O, 2021, SUMM MOD EAS RESTR; SPI-M-O, 2022, CONS STAT COV 19; SPI-M-O, 2021, CONS STAT COVID 19; SPI-M-O Working Group on Scenario Planning, 2020, CONS VIEW COV 19; Stewart E, 2015, EVID POLICY, V11, P415, DOI 10.1332/174426415X14381786400158; UK Covid-19 Inquiry, 2022, DRAFT TERMS REF; UK Government, 2021, COVID 19 RESP; Vallance P, 2020, HIST ACCESS SAGE MOD; Yong E, 2020, ATLANTIC MAR; Zhu SS, 2009, OPER RES, V57, P1155, DOI 10.1287/opre.1080.0684	57	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								e070615	10.1136/bmj-2022-070615	http://dx.doi.org/10.1136/bmj-2022-070615			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109042	Green Submitted, Bronze			2022-12-28	WOS:000888774200001
J	Tollefson, J				Tollefson, Jeff			THE SUPREME COURT'S WAR ON SCIENCE	NATURE			English	Editorial Material																			0	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					460	462						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104405	Bronze			2022-12-28	WOS:000855141600013
J	Kan, MJ; Doudna, JA				Kan, Matthew J.; Doudna, Jennifer A.			Treatment of Genetic Diseases With CRISPR Genome Editing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BASE; DNA		[Kan, Matthew J.] Univ Calif San Francisco, Dept Pediat, Div Allergy Immunol & Bone Marrow Transplantat, San Francisco, CA USA; [Kan, Matthew J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Scientist Dev Program, San Francisco, CA USA; [Kan, Matthew J.; Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA USA; [Doudna, Jennifer A.] Gladstone UCSF Inst Genom Immunol, San Francisco, CA USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), 2151 Berkeley Way, Berkeley, CA 94704 USA.	doudna@berkeley.edu						Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; intelliatx.com, 2022, INT REG PRES UPD INT; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Locatelli F, 2022, EFFICACY SAFETY SING; Lu Y, 2020, NAT MED, V26, P732, DOI 10.1038/s41591-020-0840-5; Musunuru K, 2021, NATURE, V593, P429, DOI 10.1038/s41586-021-03534-y; Pickar-Oliver A, 2019, NAT REV MOL CELL BIO, V20, P490, DOI 10.1038/s41580-019-0131-5; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004	10	1	1	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					980	981						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098733				2022-12-28	WOS:000855222400023
J	Reimann, SP				Reimann, Stanley P.			Significant Trends in Cancer Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					990	990		10.1001/jama.2021.17125	http://dx.doi.org/10.1001/jama.2021.17125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098732				2022-12-28	WOS:000855222400032
J	Lheritier, P; Torello, A; Usui, T; Nouchokgwe, Y; Aravindhan, A; Li, JN; Prah, U; Kovacova, V; Bouton, O; Hirose, S; Defay, E				Lheritier, Pierre; Torello, Alvar; Usui, Tomoyasu; Nouchokgwe, Youri; Aravindhan, Ashwath; Li, Junning; Prah, Uros; Kovacova, Veronika; Bouton, Olivier; Hirose, Sakyo; Defay, Emmanuel			Large harvested energy with non-linear pyroelectric modules	NATURE			English	Article							ELECTRICAL ENERGY; CALORIC MATERIALS; PERFORMANCE; EFFICIENCY; CONVERSION	Coming up with sustainable sources of electricity is one of the grand challenges of this century. The research field of materials for energy harvesting stems from this motivation, including thermoelectrics(1), photovoltaics(2) and thermophotovoltaics(3). Pyroelectric materials, converting temperature periodic variations in electricity, have been considered as sensors(4) and energy harvesters(5-7), although we lack materials and devices able to harvest in the joule range. Here we develop a macroscopic thermal energy harvester made of42 g of lead scandium tantalate in the form of multilayer capacitors that produces11.2 J of electricity per thermodynamic cycle. Each pyroelectric module can generate up to 4.43 J cm(-3) of electric energy density per cycle. We also show that two of these modules weighing 0.3 g are sufficient to sustainably supply an autonomous energy harvester embedding microcontrollers and temperature sensors. Finally, we show that for a 10 K temperature span these multilayer capacitors can reach 40% of Carnot efficiency. These performances stem from (1) a ferroelectric phase transition enabling large efficiency, (2) low leakage current preventing losses and (3) high breakdown voltage. These macroscopic, scalable and highly efficient pyroelectric energy harvesters enable the reconsideration of the production of electricity from heat.	[Lheritier, Pierre; Torello, Alvar; Nouchokgwe, Youri; Aravindhan, Ashwath; Li, Junning; Prah, Uros; Kovacova, Veronika; Bouton, Olivier; Defay, Emmanuel] Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept, Belvaux, Luxembourg; [Torello, Alvar; Nouchokgwe, Youri; Aravindhan, Ashwath] Univ Luxembourg, Esch Sur Alzette, Luxembourg; [Usui, Tomoyasu; Hirose, Sakyo] Murata Mfg Co Ltd, Nagaokakyo, Japan	Luxembourg Institute of Science & Technology; University of Luxembourg; Murata Manufacturing Co Ltd	Torello, A; Defay, E (corresponding author), Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept, Belvaux, Luxembourg.; Torello, A (corresponding author), Univ Luxembourg, Esch Sur Alzette, Luxembourg.	alvar.torello@list.lu; emmanuel.defay@list.lu	Massana, Alvar Torello/AAV-4487-2020	Massana, Alvar Torello/0000-0002-4173-2529; Nouchokgwe Kamgue, Youri Dilan/0000-0003-3594-694X; Li, Junning/0000-0001-6012-8258; Kovacova, Veronika/0000-0002-9281-3732; Prah, Uros/0000-0003-1226-9819; Bouton, Olivier/0000-0003-3321-9394; Usui, Tomoyasu/0000-0001-7073-6169; Aravindhan, Ashwath/0000-0001-6769-9176	Fonds National de la Recherche (FNR) of Luxembourg [C17/MS/11703691, MASSENA PRIDE/15/10935404, THERMODIMAT C20/MS/14718071, BRIDGES2021/MS/16282302/CEC0HA]	Fonds National de la Recherche (FNR) of Luxembourg(Luxembourg National Research Fund)	We thank N. Furusawa, Y. Inoue and K. Honda for their assistance in fabricating the MLCs. P.L., A.T., Y.N., A.A., J.L., U.P., V.K., O.B. and E.D. acknowledge the Fonds National de la Recherche (FNR) of Luxembourg for supporting this work through the projects CAMELHEAT C17/MS/11703691/Defay, MASSENA PRIDE/15/10935404/Defay-Siebentritt, THERMODIMAT C20/MS/14718071/Defay and BRIDGES2021/MS/16282302/CEC0HA/Defay.	Alpay SP, 2014, MRS BULL, V39, P1099, DOI 10.1557/mrs.2014.256; Ando OH, 2018, RENEW SUST ENERG REV, V91, P376, DOI 10.1016/j.rser.2018.03.052; Crossley S, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.041002; HOH SR, 1963, P IEEE, V51, P838, DOI 10.1109/PROC.1963.2277; LaPotin A, 2022, NATURE, V604, P287, DOI 10.1038/s41586-022-04473-y; Meng Y, 2020, NAT ENERGY, V5, P996, DOI 10.1038/s41560-020-00715-3; Moya X, 2020, SCIENCE, V370, P797, DOI 10.1126/science.abb0973; Moya X, 2014, NAT MATER, V13, P439, DOI [10.1038/NMAT3951, 10.1038/nmat3951]; Nair B, 2019, NATURE, V575, P468, DOI [10.1038/s41586-019-1634-0, 10.1038/s41586-019-1634]; Nouchokgwe Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23354-y; OLSEN RB, 1984, FERROELECTRICS, V59, P205, DOI 10.1080/00150198408240091; OLSEN RB, 1982, FERROELECTRICS, V40, P17, DOI 10.1080/00150198208210592; Pandya S, 2018, NAT MATER, V17, P432, DOI 10.1038/s41563-018-0059-8; Polman A, 2016, SCIENCE, V352, DOI 10.1126/science.aad4424; Sebald G, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015012; SHEBANOV L, 1992, FERROELECTRICS, V127, P143, DOI 10.1080/00150199208223361; Smith AN, 2020, J APPL PHYS, V128, DOI 10.1063/5.0003301; Song K, 2019, ADV MATER, V31, DOI 10.1002/adma.201902831; Torello A, 2020, SCIENCE, V370, P125, DOI 10.1126/science.abb8045; Torello A, 2022, ADV ELECTRON MATER, V8, DOI 10.1002/aelm.202101031; Wang YD, 2020, SCIENCE, V370, P129, DOI 10.1126/science.aba2648; Zhang KW, 2019, NANO ENERGY, V55, P534, DOI 10.1016/j.nanoen.2018.11.020	22	1	1	30	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					718	+		10.1038/s41586-022-05069-2	http://dx.doi.org/10.1038/s41586-022-05069-2		SEP 2022	6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36097191	hybrid, Green Published			2022-12-28	WOS:000852902700001
J	Collaborat, CTTC; Reith, C; Baigent, C; Blackwell, L; Emberson, J; Spata, E; Davies, K; Halls, H; Holland, L; Wilson, K; Armitage, J; Harper, C; Preiss, D; Roddick, A; Keech, A; Simes, J; Collins, R; Fulcher, J; Herrington, WG; Kirby, A; Mihaylova, B; O'Connell, R; Banks, E; Blastland, M; Evans, S; Temple, R; Weissberg, P; Wittes, J; Blazing, M; Braunwald, E; de Lemos, J; Murphy, S; Pedersen, TR; Pfeffer, M; White, H; Wiviott, S; Clearfield, M; Downs, JR; Jr, AG; Weis, S; Fellstroem, B; Holdaas, H; Jardine, A; Gordon, D; Davis, B; Furberg, C; Grimm, R; Pressel, S; Probstfield, J; Rahman, M; Simpson, L				Collaborat, Cholesterol Treatment Trialists' Collaborators; Reith, Christina; Baigent, Colin; Blackwell, Lisa; Emberson, Jonathan; Spata, Enti; Davies, Kelly; Halls, Heather; Holland, Lisa; Wilson, Kate; Armitage, Jane; Harper, Charlie; Preiss, David; Roddick, Alistair; Keech, Anthony; Simes, John; Collins, Rory; Fulcher, Jordan; Herrington, William G.; Kirby, Adrienne; Mihaylova, Borislava; O'Connell, Rachel; Banks, Emily; Blastland, Michael; Evans, Stephen; Temple, Robert; Weissberg, Peter; Wittes, Janet; Blazing, Michael; Braunwald, Eugene; de Lemos, James; Murphy, Sabina; Pedersen, Terje R.; Pfeffer, Marc; White, Harvey; Wiviott, Stephen; Clearfield, Michael; Downs, John R.; Gotto Jr, Antonio; Weis, Stephen; Fellstroem, Bengt; Holdaas, Hallvard; Jardine, Alan; Gordon, David; Davis, Barry; Furberg, Curt; Grimm, Richard; Pressel, Sara; Probstfield, Jeffrey; Rahman, Mahboob; Simpson, Lara			Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; CORONARY-HEART-DISEASE; LDL CHOLESTEROL; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; DIABETES-MELLITUS; CARDIAC OUTCOMES; ATORVASTATIN; EVENTS; PLACEBO	Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular disease and is widely prescribed, but there are persisting concerns that statin therapy might frequently cause muscle pain or weakness. We aimed to address these through an individual participant data meta-analysis of all recorded adverse muscle events in large, long-term, randomised, double-blind trials of statin therapy.Methods Randomised trials of statin therapy were eligible if they aimed to recruit at least 1000 participants with a scheduled treatment duration of at least 2 years, and involved a double-blind comparison of statin versus placebo or of a more intensive versus a less intensive statin regimen. We analysed individual participant data from 19 double-blind trials of statin versus placebo (n=123 940) and four double-blind trials of a more intensive versus a less intensive statin regimen (n=30 724). Standard inverse-variance-weighted meta-analyses of the effects on muscle outcomes were conducted according to a prespecified protocol.Findings Among 19 placebo-controlled trials (mean age 63 years [SD 8], with 34 533 [27-9%] women, 59 610 [48-1%] participants with previous vascular disease, and 22 925 [18-5%] participants with diabetes), during a weighted average median follow-up of 4-3 years, 16 835 (27-1%) allocated statin versus 16 446 (26-6%) allocated placebo reported muscle pain or weakness (rate ratio [RR] 1-03; 95% CI 1-01-1-06). During year 1, statin therapy produced a 7% relative increase in muscle pain or weakness (1-07; 1-04-1-10), corresponding to an absolute excess rate of 11 (6-16) events per 1000 person-years, which indicates that only one in 15 ([1-07-1-00]/1-07) of these muscle-related reports by participants allocated to statin therapy were actually due to the statin. After year 1, there was no significant excess in first reports of muscle pain or weakness (0-99; 0-96-1-02). For all years combined, more intensive statin regimens (ie, 40-80 mg atorvastatin or 20-40 mg rosuvastatin once per day) yielded a higher RR than less intensive or moderate-intensity regimens (1-08 [1-04-1-13] vs 1-03 [1-00-1-05]) compared with placebo, and a small excess was present (1-05 [0-99-1-12]) for more intensive regimens after year 1. There was no clear evidence that the RR differed for different statins, or in different clinical circumstances. Statin therapy yielded a small, clinically insignificant increase in median creatine kinase values of approximately 0-02 times the upper limit of normal. Interpretation Statin therapy caused a small excess of mostly mild muscle pain. Most (> 90%) of all reports of muscle symptoms by participants allocated statin therapy were not due to the statin. The small risks of muscle symptoms are much lower than the known cardiovascular benefits. There is a need to review the clinical management of muscle symptoms in patients taking a statin.	[Collaborat, Cholesterol Treatment Trialists' Collaborators] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Collaborat, Cholesterol Treatment Trialists' Collaborators] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Collaborat, CTTC (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.; Collaborat, CTTC (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford OX3 7LF, England.	ctt@ndph.ox.ac.uk	Wiviott, Stephen/HIK-2534-2022; Bosch, Jackie/N-2816-2013	Gupta, Ajay/0000-0001-5807-8503; Mihaylova, Borislava/0000-0002-0951-1304; Bosch, Jackie/0000-0001-6292-4207; Nicolis, Enrico Bjorn/0000-0001-9246-2533	British Heart Foundation [PG/18/16/33570, CH/1996001/9454]; UK Medical Research Council [MC_UU_00017/4]; Australian National Health and Medical Research Council [GNT1037786, GNT1150467]	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work of the Cholesterol Treatment Trialists Collaboration was funded by the British Heart Foundation (PG/18/16/33570 and CH/1996001/9454) , UK Medical Research Council (MC_UU_00017/4) , and Australian National Health and Medical Research Council (GNT1037786 and GNT1150467) . Although individual trials that were contributing data to the analyses were funded by the pharmaceutical industry, as well as by charities and government organisations, the Cholesterol Treatment Trialists Collaboration has not received grant funding from industry. Further details are available at: www.cttcollaboration.org. We thank all participants who originally took part in the included trials, as well as the investigators who conducted those trials, without whom this research would not be possible. We also thank Samantha Briggs and Clare Mathews for their valuable administrative assistance in preparing this report.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Buettner C, 2012, AM J MED, V125, P176, DOI 10.1016/j.amjmed.2011.08.007; Bytyci I, 2022, EUR HEART J, V43, P3213, DOI 10.1093/eurheartj/ehac015; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Clinical Data Interchange Standards Consortium, STUD DAT TAB MOD; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Davis JW, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043714; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Gupta A, 2017, LANCET, V389, P2473, DOI 10.1016/S0140-6736(17)31075-9; Herrett E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n135; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moriarty PM, 2015, J CLIN LIPIDOL, V9, P758, DOI 10.1016/j.jacl.2015.08.006; Newman CB, 2019, ARTERIOSCL THROM VAS, V39, pE38, DOI 10.1161/ATV.0000000000000073; Nissen SE, 2017, ANN INTERN MED, V167, P281, DOI 10.7326/M17-1566; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P1580, DOI 10.1001/jama.2016.3608; PEDERSEN TR, 1994, LANCET, V344, P1383; Penson PE, 2022, J CACHEXIA SARCOPENI, V13, P1596, DOI 10.1002/jcsm.12960; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Reith C, 2016, AM HEART J, V176, P63, DOI 10.1016/j.ahj.2016.01.016; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Spata E, 2022, CLIN TRIALS, DOI 10.1177/17407745221105509; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tobert JA, 2016, J CLIN LIPIDOL, V10, P739, DOI 10.1016/j.jacl.2016.05.002; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Welsh C, 2019, CIRCULATION, V140, P542, DOI 10.1161/CIRCULATIONAHA.119.041149; Wood FA, 2020, NEW ENGL J MED, V383, P2182, DOI 10.1056/NEJMc2031173; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	52	8	8	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					832	845		10.1016/S0140-6736(22)01545-8	http://dx.doi.org/10.1016/S0140-6736(22)01545-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36049498	Green Published, hybrid			2022-12-28	WOS:000877580600022
J	Lieberman, M				Lieberman, Matthew			Belonging	SCIENCE			English	Book Review									[Lieberman, Matthew] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Lieberman, Matthew] Resonance Inc, Los Angeles, CA 94134 USA	University of California System; University of California Los Angeles	Lieberman, M (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.; Lieberman, M (corresponding author), Resonance Inc, Los Angeles, CA 94134 USA.	lieber@ucla.edu						Lieberman MD, 2022, PSYCHOL REV, V129, P830, DOI 10.1037/rev0000362; Walton GM, 2011, SCIENCE, V331, P1447, DOI 10.1126/science.1198364	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1161	1161		10.1126/science.add2900	http://dx.doi.org/10.1126/science.add2900			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074844				2022-12-28	WOS:000887933400034
J	Sandweiss, DH; Maasch, KA				Sandweiss, Daniel H.; Maasch, Kirk A.			El Nino's role in changing fauna	SCIENCE			English	Editorial Material							NINO/SOUTHERN-OSCILLATION; HOLOCENE; VARIABILITY		[Sandweiss, Daniel H.; Maasch, Kirk A.] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Orono, ME 04469 USA; [Maasch, Kirk A.] Univ Maine, Dept Earth & Climate Sci, Orono, ME 04469 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Sandweiss, DH (corresponding author), Univ Maine, Climate Change Inst, Orono, ME 04469 USA.	dan.sandweiss@maine.edu						Andrus CFT, 2002, SCIENCE, V295, P1508, DOI 10.1126/science.1062004; Broughton JM, 2022, SCIENCE, V377, P1202, DOI 10.1126/science.abm1033; Carre M, 2014, SCIENCE, V345, P1045, DOI 10.1126/science.1252220; Cashin P., 2016, FINANC DEV, V53, P30; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Lindsey R., 2016, STATE CLIMATE NINO C; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; McPhaden M. J., 2021, NINO SO OSCILLATION, V253; Mendi V., 2015, INT J EARTH SCI ENG, V8, P130; Minnich RA, 2000, ATMOSFERA, V13, P1; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Reitz E.J., 2008, ZOOARCHAEOLOGY, V2nd; Sandweiss DH, 2020, P NATL ACAD SCI USA, V117, P8271, DOI 10.1073/pnas.1912242117; Takesue RK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001856	15	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1153	1154		10.1126/science.add8890	http://dx.doi.org/10.1126/science.add8890			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074856				2022-12-28	WOS:000887933400030
J	Patel, K; Huo, YL; Jao, J; Powis, KM; Williams, PL; Kacanek, D; Yee, LM; Chadwick, EG; Shiau, S; Jacobson, DL; Brummel, SS; Sultan-Beyer, L; Kahlert, CR; Zash, R; Seage, GR				Patel, Kunjal; Huo, Yanling; Jao, Jennifer; Powis, Kathleen M.; Williams, Paige L.; Kacanek, Deborah; Yee, Lynn M.; Chadwick, Ellen G.; Shiau, Stephanie; Jacobson, Denise L.; Brummel, Sean S.; Sultan-Beyer, Leila; Kahlert, Christian R.; Zash, Rebecca; Seage, George R., III		Pediat HIV AIDS Cohort Study; Swiss Mother Child HIV Cohort Stud	Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ONCE-DAILY DOLUTEGRAVIR; TENOFOVIR DISOPROXIL FUMARATE; ANTIRETROVIRAL-NAIVE ADULTS; DARUNAVIR PLUS RITONAVIR; OPEN-LABEL; NON-INFERIORITY; INFECTION; THERAPY; WOMEN; EFAVIRENZ	Antiretroviral HIV Treatment in PregnancyIn this study involving 1257 pregnancies among persons treated for HIV-1 infection during pregnancy, dolutegravir was better at suppressing viral loads than other regimens, without evident safety concerns. BackgroundData on the effectiveness and safety of dolutegravir-based antiretroviral therapy (ART) for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy as compared with other ART regimens commonly used in the United States and Europe, particularly when initiated before conception, are limited. MethodsWe conducted a study involving pregnancies in persons with HIV-1 infection in the Pediatric HIV/AIDS Cohort Study whose initial ART in pregnancy included dolutegravir, atazanavir-ritonavir, darunavir-ritonavir, oral rilpivirine, raltegravir, or elvitegravir-cobicistat. Viral suppression at delivery and the risks of infants being born preterm, having low birth weight, and being small for gestational age were compared between each non-dolutegravir-based ART regimen and dolutegravir-based ART. Supplementary analyses that included participants in the Swiss Mother and Child HIV Cohort Study were conducted to improve the precision of our results. ResultsOf the pregnancies in the study, 120 were in participants who received dolutegravir, 464 in those who received atazanavir-ritonavir, 185 in those who received darunavir-ritonavir, 243 in those who received rilpivirine, 86 in those who received raltegravir, and 159 in those who received elvitegravir-cobicistat. The median age at conception was 29 years; 51% of the pregnancies were in participants who started ART before conception. Viral suppression was present at delivery in 96.7% of the pregnancies in participants who received dolutegravir; corresponding percentages were 84.0% for atazanavir-ritonavir, 89.2% for raltegravir, and 89.8% for elvitegravir-cobicistat (adjusted risk differences vs. dolutegravir, -13.0 percentage points [95% confidence interval {CI}, -17.0 to -6.1], -17.0 percentage points [95% CI, -27.0 to -2.4], and -7.0 percentage points [95% CI, -13.3 to -0.0], respectively). The observed risks of preterm birth were 13.6 to 17.6%. Adjusted risks of infants being born preterm, having low birth weight, or being small for gestational age did not differ substantially between non-dolutegravir-based ART and dolutegravir. Results of supplementary analyses were similar. ConclusionsAtazanavir-ritonavir and raltegravir were associated with less frequent viral suppression at delivery than dolutegravir. No clear differences in adverse birth outcomes were observed with dolutegravir-based ART as compared with non-dolutegravir-based ART, although samples were small. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.)	[Patel, Kunjal; Williams, Paige L.; Seage, George R., III] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Patel, Kunjal; Huo, Yanling; Williams, Paige L.; Kacanek, Deborah; Jacobson, Denise L.; Brummel, Sean S.; Seage, George R., III] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Powis, Kathleen M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zash, Rebecca] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Jao, Jennifer; Chadwick, Ellen G.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Yee, Lynn M.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Shiau, Stephanie] Rutgers Sch Publ Hlth, Dept Biostat & Epidemiol, Piscataway, NJ USA; [Sultan-Beyer, Leila] Univ Hosp Zurich, Dept Gynecol, Zurich, Switzerland; [Kahlert, Christian R.] Childrens Hosp Eastern Switzerland, Dept Infect Dis & Hosp Epidemiol, St Gallen, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Zurich; University Zurich Hospital	Patel, K (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	kpatel@hsph.harvard.edu	; Ritz, Nicole/G-2924-2015	Kahlert, Christian R./0000-0002-0784-3276; Abela, Irene/0000-0002-5566-8628; Ritz, Nicole/0000-0002-1498-1685	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of the Director, National Institutes of Health; National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases; National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Institute on Drug Abuse; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; National Heart, Lung, and Blood Institute; Harvard T.H. Chan School of Public Health; Tulane University School of Medicine [HD052102, HD052104]; Westat [P01HD103133]; Swiss National Science Foundation;  [201369]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Harvard T.H. Chan School of Public Health; Tulane University School of Medicine; Westat; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 	The Pediatric HIV/AIDS Cohort Study (PHACS) was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of the Director, National Institutes of Health; National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases; National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; National Institute of Mental Health; National Institute on Drug Abuse; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; and National Heart, Lung, and Blood Institute through cooperative agreements with the Harvard T.H. Chan School of Public Health (HD052102; principal investigator, George R. Seage III; program director, Liz Salomon) and the Tulane University School of Medicine (HD052104; principal investigator, Russell Van Dyke; co-princi-pal investigator, Ellen Chadwick; project director, Patrick Davis), and through the Harvard T.H. Chan School of Public Health for PHACS 2020 (P01HD103133; multiple principal investigators: Ellen Chadwick, Sonia Hernandez-Diaz, Jennifer Jao, and Paige Williams; program director, Liz Salomon). Data-management services were provided by Frontier Science (data management center director, Suzanne Siminski), and regulatory services and logistic support were provided by Westat (project directors, Julie Davidson and Tracy Wolbach). The Swiss Mother and Child HIV Cohort Study has been financed within the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant 201369).	[Anonymous], 2019, UPDATE RECOMMENDATIO; Bell JF, 2006, SOC SCI MED, V63, P3030, DOI 10.1016/j.socscimed.2006.08.011; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Davey S, 2020, JAIDS-J ACQ IMM DEF, V84, P235, DOI 10.1097/QAI.0000000000002338; Dominguez TP, 2008, CLIN OBSTET GYNECOL, V51, P360, DOI 10.1097/GRF.0b013e31816f28de; Kintu K, 2020, LANCET HIV, V7, pE332, DOI 10.1016/S2352-3018(20)30050-3; Lockman S, 2021, LANCET, V397, P1276, DOI 10.1016/S0140-6736(21)00314-7; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Molina JM, 2015, LANCET HIV, V2, pE127, DOI 10.1016/S2352-3018(15)00027-2; Molina JM, 2014, J INT AIDS SOC, V17, P6, DOI 10.7448/IAS.17.4.19490; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Orrell C, 2017, LANCET HIV, V4, pE536, DOI 10.1016/S2352-3018(17)30095-4; Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission, 2022, RECOMMENDATIONS USE; Pediatric HIV/AIDS Cohort Study (PHACS), 2020, SMARTT ANN ADM REP; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Scherrer AU, 2022, INT J EPIDEMIOL, V51, P33, DOI 10.1093/ije/dyab141; Sibiude J, 2021, AIDS, V35, P219, DOI 10.1097/QAD.0000000000002719; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; Van Dyke RB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00199; Waitt C, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002895; Walmsley S, 2015, JAIDS-J ACQ IMM DEF, V70, P515, DOI 10.1097/QAI.0000000000000790; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Zash R, 2019, NEW ENGL J MED, V381, P827, DOI 10.1056/NEJMoa1905230; Zash R, 2018, NEW ENGL J MED, V379, P979, DOI 10.1056/NEJMc1807653; Zash R, 2018, LANCET GLOB HEALTH, V6, pE804, DOI 10.1016/S2214-109X(18)30218-3; Zash RM, 2016, EXPERT OPIN DRUG SAF, V15, P1501, DOI 10.1080/14740338.2016.1226281	26	1	1	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					799	809		10.1056/NEJMoa2200600	http://dx.doi.org/10.1056/NEJMoa2200600			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053505				2022-12-28	WOS:000849132700008
J	Laine, C; Cotton, D				Laine, Christine; Cotton, Deborah			Current Clinical Challenges in the Prevention and Management of COVID-19	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Laine, Christine; Cotton, Deborah] Annals Internal Med, 190 N Independence Mall West, Philadelphia, PA 19106 USA		Laine, C (corresponding author), Annals Internal Med, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	claine@acponline.org						[Anonymous], 2022, SEPT 1 2022 ACIP M W	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1475	1475		10.7326/M22-2684	http://dx.doi.org/10.7326/M22-2684			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36084312	Green Published			2022-12-28	WOS:000870976800036
J	Larkin, HD				Larkin, Howard D.			COVID-19 Health Policies and Economies in Nordic Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1029	1029		10.1001/jama.2022.14713	http://dx.doi.org/10.1001/jama.2022.14713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125463	Bronze			2022-12-28	WOS:000862909200008
J	Tanne, JH				Tanne, Janice Hopkins			Ig Nobel prize 2022: it's better to be lucky than smart, how heart rate reveals romantic feelings, and why ice cream works as cryotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DESMET PAGM, 1986, J ETHNOPHARMACOL, V16, P213, DOI 10.1016/0378-8741(86)90091-7; Fish FE, 1994, MECH PHYSL ANIMAL SW, DOI [10.1017/CBO9780511983641.014, DOI 10.1017/CBO9780511983641.014]; Garcia-hernandez S, 2022, INTEGR ZOOL, V17, P672, DOI 10.1111/1749-4877.12604; Gens M., 2001, THESIS KTH ROYAL I T; Jasinski M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02002-x; Martinez E, 2022, COGNITION, V224, DOI 10.1016/j.cognition.2022.105070; Matsuzaki G, 1999, B JAPANESE SOC SCI D, V45, P76; Matsuzaki G, 1998, P 3 ASIA DESIGN C, P37; Pluchino A, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S0219525918500145; Prochazkova E, 2022, NAT HUM BEHAV, V6, P269, DOI 10.1038/s41562-021-01197-3; Wu JH, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0300; Yuan ZM, 2021, J FLUID MECH, V928, DOI 10.1017/jfm.2021.820	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2022	378								o2255	10.1136/bmj.o2255	http://dx.doi.org/10.1136/bmj.o2255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V6QL	36113872				2022-12-28	WOS:000877352500012
J	Sigmundsson, F; Parks, M; Hooper, A; Geirsson, H; Vogfjord, KS; Drouin, V; Ofeigsson, BG; Hreinsdottir, S; Hjaltadottir, S; Jonsdottir, K; Einarsson, P; Barsotti, S; Horalek, J; Agustsdottir, T				Sigmundsson, Freysteinn; Parks, Michelle; Hooper, Andrew; Geirsson, Halldor; Vogfjord, Kristin S.; Drouin, Vincent; Ofeigsson, Benedikt G.; Hreinsdottir, Sigrun; Hjaltadottir, Sigurlaug; Jonsdottir, Kristin; Einarsson, Pall; Barsotti, Sara; Horalek, Josef; Agustsdottir, Thorbjorg			Deformation and seismicity decline before the 2021 Fagradalsfjall eruption	NATURE			English	Article							NORTHERN VOLCANIC ZONE; REYKJANES PENINSULA; CRUSTAL DEFORMATION; SURFACE DEFORMATION; EARTHQUAKE CATALOG; PLATE BOUNDARY; ICELAND; MAGNITUDE; INTRUSION; EVENTS	Increased rates of deformation and seismicity are well-established precursors to volcanic eruptions, and their interpretation forms the basis for eruption warnings worldwide. Rates of ground displacement and the number of earthquakes escalate before many eruptions(1-3), as magma forces its way towards the surface. However, the pre-eruptive patterns of deformation and seismicity vary widely. Here we show how an eruption beginning on 19 March 2021 at Fagradalsfjall, Iceland, was preceded by a period of tectonic stress release ending with a decline in deformation and seismicity over several days preceding the eruption onset. High rates of deformation and seismicity occurred from 24 February to mid-March in relation to gradual emplacement of an approximately 9-km-long magma-filled dyke, between the surface and 8 km depth (volume approximately 34 x 10(6) m(3)), as well as the triggering of strike-slip earthquakes up to magnitude M-W 5.64. As stored tectonic stress was systematically released, there was less lateral migration of magma and a reduction in both the deformation rates and seismicity. Weaker crust near the surface may also have contributed to reduced seismicity, as the depth of active magma emplacement progressively shallowed. This demonstrates that the interaction between volcanoes and tectonic stress as well as crustal layering need to be fully considered when forecasting eruptions.	[Sigmundsson, Freysteinn; Geirsson, Halldor; Einarsson, Pall] Univ Iceland, Nordic Volcanol Ctr, Inst Earth Sci, Reykjavik, Iceland; [Parks, Michelle; Vogfjord, Kristin S.; Drouin, Vincent; Ofeigsson, Benedikt G.; Hjaltadottir, Sigurlaug; Jonsdottir, Kristin; Barsotti, Sara] Icelandic Meteorol Off, Reykjavik, Iceland; [Hooper, Andrew] Univ Leeds, Ctr Observat & Modelling Earthquakes & Tecton COM, Sch Earth & Environm, Leeds, W Yorkshire, England; [Hreinsdottir, Sigrun] GNS Sci, Lower Hutt, New Zealand; [Horalek, Josef] Czech Acad Sci, Inst Geophys, Prague 4, Czech Republic; [Agustsdottir, Thorbjorg] Iceland GeoSurvey, ISOR, Uroarhvarf 6, Kopavogur, Iceland	University of Iceland; University of Leeds; GNS Science - New Zealand; Czech Academy of Sciences; Institute of Geophysics of the Czech Academy of Sciences	Sigmundsson, F (corresponding author), Univ Iceland, Nordic Volcanol Ctr, Inst Earth Sci, Reykjavik, Iceland.	fs@hi.is	Sigmundsson, Freysteinn/F-7160-2015	Sigmundsson, Freysteinn/0000-0001-9052-4665; Vogfjord, Kristin S./0000-0003-2658-1838; Hooper, Andrew/0000-0003-4244-6652	European Commission [731070, 821115]; Natural Environmental Research Council through the Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics (COMET); IS-TREMOR Rannis grant [217738]; MaDRe RanniS grant [228933-051]; University of Iceland Research Fund; Committee on Earth Observing Satellites	European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environmental Research Council through the Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics (COMET); IS-TREMOR Rannis grant; MaDRe RanniS grant; University of Iceland Research Fund; Committee on Earth Observing Satellites	This research was supported by the H2020 projects EUROVOLC and RISE funded by the European Commission (grant numbers 731070 and 821115, respectively), the Natural Environmental Research Council through the Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics (COMET), a IS-TREMOR Rannis grant (number 217738) and a MaDRe RanniS grant (number 228933-051). We thank IMO technicians and the Operations department, the IMO seismological monitoring team, the CAS as well as the iSOR for connecting eight of their seismic stations (currently running under the NASPMON project) to IMO's monitoring system to improve the detection and location of earthquakes and the University of Cambridge for access to data from seismic station odf. We thank the University of Iceland technicians for support and operation of the GNSS stations. We also thank the National Commissioner of the Icelandic Police and their Department of Civil Protection for organizing science-board meetings in connection with the unrest on Reykjanes Peninsula, and participants in these meetings for discussions and evaluations of the monitoring data. F.S. and H.G. acknowledge support from the University of Iceland Research Fund. We acknowledge reviews by D. Roman and F. Amelung that helped to significantly improve the paper. The GSNL Icelandic Volcanoes Supersite project supported by the Committee on Earth Observing Satellites is acknowledged for providing support to the InSAR monitoring/research in Iceland. The GMT open access software was used to produce a number of the figures in this paper.	Argus DF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003751; Bagnardi M, 2018, GEOCHEM GEOPHY GEOSY, V19, P2194, DOI 10.1029/2018GC007585; Bell AF, 2018, GEOPHYS RES LETT, V45, P1339, DOI 10.1002/2017GL076429; Bevilacqua A, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00135; Boovarsson R, 1999, PHYS EARTH PLANET IN, V113, P89, DOI 10.1016/S0031-9201(99)00032-1; Boue A, 2015, J GEOPHYS RES-SOL EA, V120, P2143, DOI 10.1002/2014JB011637; Budi-Santoso A, 2013, J VOLCANOL GEOTH RES, V261, P153, DOI 10.1016/j.jvolgeores.2013.03.024; Buurman H, 2013, J VOLCANOL GEOTH RES, V259, P16, DOI 10.1016/j.jvolgeores.2012.04.024; Cervelli P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000602; CHOUET BA, 1994, J VOLCANOL GEOTH RES, V62, P95, DOI 10.1016/0377-0273(94)90030-2; Clifton AE, 2006, TECTONOPHYSICS, V419, P27, DOI 10.1016/j.tecto.2006.03.016; Cubuk-Sabuncu Y, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2020GL092265; Drouin V, 2019, GEOPHYS RES LETT, V46, P8046, DOI 10.1029/2019GL082629; Drouin V, 2017, J GEOPHYS RES-SOL EA, V122, P3158, DOI 10.1002/2016JB013206; Ebinger C, 2010, ANNU REV EARTH PL SC, V38, P439, DOI 10.1146/annurev-earth-040809-152333; Einarsson P, 2021, FRONT EARTH SC-SWITZ, V9, DOI 10.3389/feart.2021.628967; Einarsson P, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00045; Geirsson H., 2021, 2020 VOLCANO TECTONI, DOI [10.5194/egusphere-egu21-7534(2021, DOI 10.5194/EGUSPHERE-EGU21-7534(2021]; Gorelchik VI., 1980, B VOLCANOL, V43, P73, DOI [10.1007/BF02597612, DOI 10.1007/BF02597612]; Gudmundsson MT, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8988; Halldorsson S. A, NATURE, DOI [10.1038/s41586-022-04981-x(2022), DOI 10.1038/S41586-022-04981-X(2022)]; HANKS TC, 1979, J GEOPHYS RES, V84, P2348, DOI 10.1029/JB084iB05p02348; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Heimisson ER, 2015, GEOPHYS RES LETT, V42, P7958, DOI 10.1002/2015GL065680; Hjaltadottir S., 2010, 2010003 VI U IC; Hreinsdottir S, 2001, J GEOPHYS RES-SOL EA, V106, P13803, DOI 10.1029/2001JB000428; Jakobsdottir SS, 2008, JOKULL, V58, P75; Jonasson K, 2021, NAT HAZARD EARTH SYS, V21, P2197, DOI 10.5194/nhess-21-2197-2021; Jonsdottir L. S., 2022, RAUNTIMAUTREIKNINGAR; Keiding M, 2008, GEOPHYS J INT, V172, P861, DOI 10.1111/j.1365-246X.2007.03655.x; Keir D, 2013, TECTONOPHYSICS, V607, P98, DOI 10.1016/j.tecto.2012.10.015; Kjartansson E., 2010, DEV IMPLEMENTATION S, P47; Lowenstern J.B., 2022, J APPL VOLCANOL, V11, P3, DOI [10.1186/s13617-021-00112-9, DOI 10.1186/S13617-021-00112-9]; McNutt S.R., 1996, MONITORING MITIGATIO, P99, DOI [DOI 10.1007/978-3-642-80087-0_3, 10.1007/978-3-642-80087-0]; MOSEGAARD K, 1995, J GEOPHYS RES-SOL EA, V100, P12431, DOI 10.1029/94JB03097; Nishimura T, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0779-1; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Owen S, 2000, GEOPHYS RES LETT, V27, P2757, DOI 10.1029/1999GL008454; Pallister J., 2019, J APPL VOLCANOL, V8, P1, DOI [10.1186/s13617-019-0082-8, DOI 10.1186/S13617-019-0082-8]; Pallister JS, 2010, NAT GEOSCI, V3, P705, DOI 10.1038/NGEO966; Panzera F, 2017, J SEISMOL, V21, P615, DOI 10.1007/s10950-016-9623-3; Pedersen GBM, 2022, GEOPHYS RES LETT, V49, DOI 10.1029/2021GL097125; Peltier A, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00104; Petursson G. G., 2009, SW ICELAND ICELANDIC; Rodgers M, 2013, J VOLCANOL GEOTH RES, V265, P39, DOI 10.1016/j.jvolgeores.2013.08.010; ROGNVALDSSON ST, 1993, B SEISMOL SOC AM, V83, P1232; Roman DC, 2016, EARTH PLANET SC LETT, V450, P20, DOI 10.1016/j.epsl.2016.06.020; Saemundsson K, 2020, J VOLCANOL GEOTH RES, V391, DOI 10.1016/j.jvolgeores.2018.11.022; Samundsson K., 2016, GEOLOGICAL MAP SW IC, V2; Sigmundsson F., 2021, FORECASTING PLANNING, V2, P413; Sigmundsson F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16054-6; Sigmundsson F, 2020, J VOLCANOL GEOTH RES, V391, DOI 10.1016/j.jvolgeores.2018.08.014; Sigmundsson F, 2015, NATURE, V517, P191, DOI 10.1038/nature14111; Sigmundsson F, 2010, NATURE, V468, P426, DOI 10.1038/nature09558; SLUNGA R, 1995, GEOPHYS J INT, V123, P409, DOI 10.1111/j.1365-246X.1995.tb06862.x; Thelen W. A., 2017, EOS T AM GEOPHYS UN, DOI [10.1029/2017EO083937, DOI 10.1029/2017EO083937]; Tilling RI., 2008, ADV GEOSCI, V14, P3, DOI [DOI 10.5194/ADGEO-14-3-2008, 10.5194/adgeo-14-3-2008]; Toda S., 2011, US GEOL SURV OPEN FI; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Vadon H, 1997, SCIENCE, V275, P193, DOI 10.1126/science.275.5297.194; Vogfjord K. S.=, 2002, AGU FALL M ABSTRACT; VOIGHT B, 1988, NATURE, V332, P125, DOI 10.1038/332125a0; Weir NRW, 2001, J GEOPHYS RES-SOL EA, V106, P6347, DOI 10.1029/2000JB900358	64	2	2	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					523	+		10.1038/s41586-022-05083-4	http://dx.doi.org/10.1038/s41586-022-05083-4		SEP 2022	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104559	hybrid, Green Accepted			2022-12-28	WOS:000854788200004
J	Banach, M				Banach, Maciej			Statin intolerance: time to stop letting it get in the way of treating patients	LANCET			English	Editorial Material							THERAPY; RISK		[Banach, Maciej] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland; [Banach, Maciej] Polish Mothers Mem Hosp Res Inst, PL-90419 Lodz, Poland; [Banach, Maciej] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland	Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; University of Zielona Gora	Banach, M (corresponding author), Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland.; Banach, M (corresponding author), Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland.	maciej.banach@umed.lodz.pl	Banach, Maciej/A-1271-2009	Banach, Maciej/0000-0001-6690-6874				Banach M, 2021, ARCH MED SCI, V17, P1447, DOI 10.5114/aoms/141941; Banach M, 2016, INT J CARDIOL, V225, P184, DOI 10.1016/j.ijcard.2016.09.075; Bytyci I, 2022, EUR HEART J, V43, P3213, DOI 10.1093/eurheartj/ehac015; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Collaborat CTTC, 2022, LANCET, V400, P832, DOI 10.1016/S0140-6736(22)01545-8; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Gupta A, 2017, LANCET, V389, P2473, DOI 10.1016/S0140-6736(17)31075-9; Penson PE, 2022, J CACHEXIA SARCOPENI, V13, P1596, DOI 10.1002/jcsm.12960; Penson PE, 2018, J CACHEXIA SARCOPENI, V9, P1023, DOI 10.1002/jcsm.12344; Ray KK, 2021, EUR J PREV CARDIOL, V28, P1279, DOI 10.1093/eurjpc/zwaa047; Ruscica M, 2022, CARDIOVASC RES, DOI 10.1093/cvr/cvac020; Serban MC, 2017, J AM COLL CARDIOL, V69, P1386, DOI 10.1016/j.jacc.2016.12.036	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					791	793		10.1016/S0140-6736(22)01643-9	http://dx.doi.org/10.1016/S0140-6736(22)01643-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36049497				2022-12-28	WOS:000877580600005
J	Jorstad, SG; Marscher, AP; Raiteri, CM; Villata, M; Weaver, ZR; Zhang, H; Dong, L; Gomez, JL; Perel, MV; Savchenko, SS; Larionov, VM; Carosati, D; Chen, WP; Kurtanidze, OM; Marchini, A; Matsumoto, K; Mortari, F; Aceti, P; Acosta-Pulido, JA; Andreeva, T; Apolonio, G; Arena, C; Arkharov, A; Bachev, R; Bonnoli, G; Borman, GA; Bozhilov, V; Carnerero, MI; Damljanovic, G; Ehgamberdiev, SA; Elsasser, D; Frasca, A; Gabellini, D; Grishina, TS; Gupta, AC; Hagen-Thorn, VA; Hallum, MK; Hart, M; Hasuda, K; Hemrich, F; Hsiao, HY; Ibryamov, S; Irsmambetova, TR; Ivanov, DV; Joner, MD; Kimeridze, GN; Klimanov, SA; Knott, J; Kopatskaya, EN; Kurtanidze, SO; Kurtenkov, A; Kuutma, T; Larionova, EG; Leonini, S; Lin, HC; Lorey, C; Mannheim, K; Marino, G; Minev, M; Mirzaqulov, DO; Morozova, DA; Nikiforova, AA; Nikolashvili, MG; Ovcharov, E; Papini, R; Pursimo, T; Rahimov, I; Reinhart, D; Sakamoto, T; Salvaggio, F; Semkov, E; Shakhovskoy, DN; Sigua, LA; Steineke, R; Stojanovic, M; Strigachev, A; Troitskaya, YV; Troitskiy, IS; Tsai, A; Valcheva, A; Vasilyev, AA; Vince, O; Waller, L; Zaharieva, E; Chatterjee, R				Jorstad, S. G.; Marscher, A. P.; Raiteri, C. M.; Villata, M.; Weaver, Z. R.; Zhang, H.; Dong, L.; Gomez, J. L.; Perel, M., V; Savchenko, S. S.; Larionov, V. M.; Carosati, D.; Chen, W. P.; Kurtanidze, O. M.; Marchini, A.; Matsumoto, K.; Mortari, F.; Aceti, P.; Acosta-Pulido, J. A.; Andreeva, T.; Apolonio, G.; Arena, C.; Arkharov, A.; Bachev, R.; Bonnoli, G.; Borman, G. A.; Bozhilov, V; Carnerero, M., I; Damljanovic, G.; Ehgamberdiev, S. A.; Elsasser, D.; Frasca, A.; Gabellini, D.; Grishina, T. S.; Gupta, A. C.; Hagen-Thorn, V. A.; Hallum, M. K.; Hart, M.; Hasuda, K.; Hemrich, F.; Hsiao, H. Y.; Ibryamov, S.; Irsmambetova, T. R.; Ivanov, D., V; Joner, M. D.; Kimeridze, G. N.; Klimanov, S. A.; Knoett, J.; Kopatskaya, E. N.; Kurtanidze, S. O.; Kurtenkov, A.; Kuutma, T.; Larionova, E. G.; Leonini, S.; Lin, H. C.; Lorey, C.; Mannheim, K.; Marino, G.; Minev, M.; Mirzaqulov, D. O.; Morozova, D. A.; Nikiforova, A. A.; Nikolashvili, M. G.; Ovcharov, E.; Papini, R.; Pursimo, T.; Rahimov, I; Reinhart, D.; Sakamoto, T.; Salvaggio, F.; Semkov, E.; Shakhovskoy, D. N.; Sigua, L. A.; Steineke, R.; Stojanovic, M.; Strigachev, A.; Troitskaya, Y., V; Troitskiy, I. S.; Tsai, A.; Valcheva, A.; Vasilyev, A. A.; Vince, O.; Waller, L.; Zaharieva, E.; Chatterjee, R.			Rapid quasi-periodic oscillations in the relativistic jet of BL Lacertae	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; BLAZAR 3C 279; GAMMA-RAY; VARIABILITY; SIMULATIONS; INSTABILITY; SPECTRA; LONG	Blazars are active galactic nuclei (AGN) with relativistic jets whose non-thermal radiation is extremely variable on various timescales(1-3). This variability seems mostly random, although some quasi-periodic oscillations (QPOs), implying systematic processes, have been reported in blazars and other AGN. QPOs with timescales of days or hours are especially rare(4) in AGN and their nature is highly debated, explained by emitting plasma moving helically inside the jet(5), plasma instabilities(6,7) or orbital motion in an accretion disc(7,8). Here we report results of intense optical and gamma-ray flux monitoring of BL Lacertae (BL Lac) during a dramatic outburst in 2020 (ref. (9)). BL Lac, the prototype of a subclass of blazars(10), is powered by a 1.7 x 10(8) M-Sun (ref. (11)) black hole in an elliptical galaxy (distance = 313 megaparsecs (ref. (12))). Our observations show QPOs of optical flux and linear polarization, and gamma-ray flux, with cycles as short as approximately 13 h during the highest state of the outburst. The QPO properties match the expectations of current-driven kink instabilities(6) near a recollimation shock about 5 parsecs (pc) from the black hole in the wake of an apparent superluminal feature moving down the jet. Such a kink is apparent in a microwave Very Long Baseline Array (VLBA) image.	[Jorstad, S. G.; Marscher, A. P.; Weaver, Z. R.; Hallum, M. K.; Hart, M.] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Jorstad, S. G.; Savchenko, S. S.; Larionov, V. M.; Grishina, T. S.; Hagen-Thorn, V. A.; Kopatskaya, E. N.; Larionova, E. G.; Morozova, D. A.; Nikiforova, A. A.; Troitskaya, Y., V; Troitskiy, I. S.; Vasilyev, A. A.] St Petersburg State Univ, Astron Inst, St Petersburg, Russia; [Raiteri, C. M.; Villata, M.; Carnerero, M., I] Osservatorio Astrofis Torino, INAF, Turin, Italy; [Zhang, H.] NASA Postdoctoral Program, Greenbelt, MD USA; [Zhang, H.] NASA Goddard Space Flight Ctr, Greenbelt, MD USA; [Dong, L.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Gomez, J. L.; Bonnoli, G.] Inst Astrofis Andalucia CSIC, Granada, Spain; [Perel, M., V] St Petersburg State Univ, St Petersburg, Russia; [Savchenko, S. S.] Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz, Russia; [Savchenko, S. S.; Larionov, V. M.; Arkharov, A.; Klimanov, S. A.; Nikiforova, A. A.] Pulkovo Observ, St Petersburg, Russia; [Carosati, D.] EPT Observ, Tijarafe, La Palma, Spain; [Carosati, D.] TNG Fdn Galileo Galilei, INAF, La Palma, Spain; [Chen, W. P.; Hsiao, H. Y.; Lin, H. C.; Tsai, A.] Natl Cent Univ, Grad Inst Astron, Taoyuan, Taiwan; [Kurtanidze, O. M.; Kimeridze, G. N.; Kurtanidze, S. O.; Nikolashvili, M. G.; Sigua, L. A.] Abastumani Observ, Mt Kanobili, Abastumani, Georgia; [Kurtanidze, O. M.] Kazan Fed Univ, Engelhardt Astron Observ, Tatarstan, Russia; [Kurtanidze, O. M.; Kurtanidze, S. O.; Nikolashvili, M. G.] Heidelberg Univ, Landessternwarte, Zentrum Astron, Heidelberg, Germany; [Marchini, A.; Bonnoli, G.] Univ Siena, Dept Phys Sci Earth & Environm, Astron Observ, Siena, Italy; [Matsumoto, K.] Osaka Kyoiku Univ, Astron Inst, Kashiwara, Japan; [Mortari, F.; Gabellini, D.] Hypatia Observ, Rimini, Italy; [Aceti, P.] Osservatorio Astron Citta Seveso, Seveso, Italy; [Aceti, P.] Politecn Milan, Dept Aerosp Sci & Technol, Milan, Italy; [Acosta-Pulido, J. A.] Univ La Laguna, Inst Astrofis Canarias, Tenerife, Spain; [Acosta-Pulido, J. A.] Univ La Laguna, Dept Astrofis, Tenerife, Spain; [Andreeva, T.; Ivanov, D., V; Rahimov, I] Russian Acad Sci, Inst Appl Astron, St Petersburg, Russia; [Apolonio, G.; Joner, M. D.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Arena, C.; Marino, G.; Salvaggio, F.] Grp Astrofili Catanesi GAC, Catania, Italy; [Bachev, R.; Kurtenkov, A.; Semkov, E.; Strigachev, A.] Bulgarian Acad Sci, Inst Astron, Sofia, Bulgaria; [Bachev, R.; Kurtenkov, A.; Semkov, E.; Strigachev, A.] Bulgarian Acad Sci, Natl Astron Observ, Sofia, Bulgaria; [Bonnoli, G.] INAF Osservatorio Astron Brera, Merate, Italy; [Borman, G. A.; Shakhovskoy, D. N.] Crimean Astrophys Observ RAS, Bakhchisaray, Crimea, Ukraine; [Bozhilov, V; Minev, M.; Ovcharov, E.; Valcheva, A.; Zaharieva, E.] Univ Sofia, Fac Phys, Dept Astron, Sofia, Bulgaria; [Damljanovic, G.; Stojanovic, M.; Vince, O.] Astron Observ Belgrade, Belgrade, Serbia; [Ehgamberdiev, S. A.; Mirzaqulov, D. O.] Ulugh Beg Astron Inst, Tashkent, Uzbekistan; [Ehgamberdiev, S. A.] Natl Univ Uzbekistan, Tashkent, Uzbekistan; [Elsasser, D.; Hemrich, F.; Knoett, J.; Lorey, C.; Mannheim, K.; Reinhart, D.; Steineke, R.; Waller, L.] Nat Wissensch Lab Schuler FKG, Hans Haffner Sternwarte, W Rzburg, Germany; [Elsasser, D.] TU Dortmund Univ, Dept Phys, Dortmund, Germany; [Frasca, A.] INAF Osservatorio Astrofis Catania, Catania, Italy; [Gupta, A. C.] Aryabhatta Res Inst Observat Sci ARIES, Naini Tal, India; [Hasuda, K.; Sakamoto, T.] Aoyama Gakuin Univ, Dept Phys Sci, Tokyo, Japan; [Ibryamov, S.] Univ Shumen, Fac Nat Sci, Dept Phys & Astron, Shumen, Bulgaria; [Irsmambetova, T. R.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Kuutma, T.] Ctr Estudios Fis Cosmos Aragon, Teruel, Spain; [Leonini, S.] Montarrenti Observ, Siena, Italy; [Mannheim, K.] Univ Wurzburg, Lehrstuhl Astron, Wurzburg, Germany; [Marino, G.; Papini, R.; Salvaggio, F.] Wild Boar Remote Observ, Florence, Italy; [Pursimo, T.] Nordic Opt Telescope, Santa Cruz De Tenerife, Spain; [Pursimo, T.] Aarhus Univ, Dept Phys & Astron, Aarhus C, Denmark; [Chatterjee, R.] Presidency Univ, Dept Phys, Kolkata, India	Boston University; Saint Petersburg State University; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Saint Petersburg State University; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Pulkovo Observatory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); National Central University; Ilia State University; Kazan Federal University; Ruprecht Karls University Heidelberg; University of Siena; Osaka University of Education; Polytechnic University of Milan; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Universidad de la Laguna; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Brigham Young University; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Istituto Nazionale Astrofisica (INAF); Bulgarian Academy of Sciences; University of Sofia; Academy of Sciences of Uzbekistan; Ulugh Beg Astronomical Institute (UBAI); National University of Uzbekistan; Dortmund University of Technology; Istituto Nazionale Astrofisica (INAF); Department of Science & Technology (India); Aryabhatta Research Institute of Observational Sciences (ARIES); Aoyama Gakuin University; University of Shumen; Lomonosov Moscow State University; University of Wurzburg; Aarhus University; Presidency University, Kolkata	Jorstad, SG (corresponding author), Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA.; Jorstad, SG (corresponding author), St Petersburg State Univ, Astron Inst, St Petersburg, Russia.	jorstad@bu.edu	Klimanov, Sergei/O-7827-2017; Ibryamov, Sunay/HDN-8575-2022; Zaharieva, Evelina/AAK-8416-2021; Gomez, Jose L./C-4195-2008; Perel, Maria/K-6605-2013; Vasilyev, Andrey/H-9121-2013	Zaharieva, Evelina/0000-0001-7663-4489; Ibryamov, Sunay/0000-0002-4618-1201; Villata, Massimo/0000-0003-1743-6946; Dong, Lingyi/0000-0002-7751-8639; Gomez, Jose L./0000-0003-4190-7613; Perel, Maria/0000-0001-8025-9722; Weaver, Zachary/0000-0001-6314-0690; Klimanov, Sergei/0000-0001-5062-0644; Jorstad, Svetlana/0000-0001-6158-1708; Vasilyev, Andrey/0000-0002-8293-0214; MARCHINI, ALESSANDRO/0000-0003-3779-6762; Raiteri, Claudia Maria/0000-0003-1784-2784				Abdollahi S., 2020, ASTROPHYS J SUPPL S, V247, P33, DOI [DOI 10.3847/1538-4365/AB6BCB, 10.3847/1538-4365/ab6bcb]; Acharya S., 2021, MON NOT R ASTRON SOC, V506, P1862, DOI [DOI 10.1093/mnras/stab1775, 10.1093/mnras/stab1775]; Albert J, 2007, ASTROPHYS J, V666, pL17, DOI 10.1086/521550; Alexander T, 1997, ASTROPHYS SPACE SC L, V218, P163; Alexander T., 2013, PREPRINT; An T, 2013, MON NOT R ASTRON SOC, V434, P3487, DOI 10.1093/mnras/stt1265; [Anonymous], 2022, BEAM ME PROGRAM BLAZ; Ashton DI., 2021, MON NOT R ASTRON SOC, V501, P5478, DOI [10.1093/mnras/staa4024, DOI 10.1093/MNRAS/STAA4024]; Bach U, 2006, ASTRON ASTROPHYS, V456, P105, DOI 10.1051/0004-6361:20065235; Bennett CL, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/135; Bodo G, 2021, MON NOT R ASTRON SOC, V501, P2836, DOI 10.1093/mnras/staa3620; Chatterjee R, 2008, ASTROPHYS J, V689, P79, DOI 10.1086/592598; Cohen MH, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/3; Cohen MH, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/151; DONE C, 1992, ASTROPHYS J, V400, P138, DOI 10.1086/171979; Dong LY, 2020, MON NOT R ASTRON SOC, V494, P1817, DOI 10.1093/mnras/staa773; Duran RB, 2017, MON NOT R ASTRON SOC, V469, P4957, DOI 10.1093/mnras/stx1165; Emmanoulopoulos D, 2013, MON NOT R ASTRON SOC, V433, P907, DOI 10.1093/mnras/stt764; Fiorucci M, 1996, ASTRON ASTROPHYS SUP, V116, P403, DOI 10.1051/aas:1996123; Foster G, 1996, ASTRON J, V112, P1709, DOI 10.1086/118137; Fuentes A, 2018, ASTROPHYS J, V860, DOI 10.3847/1538-4357/aac091; Gomez JL, 1997, ASTROPHYS J, V482, pL33, DOI 10.1086/310671; Grishina T. S., 2020, ASTRONOMERS TELEGRAM; Gupta AC, 2018, GALAXIES, V6, DOI 10.3390/galaxies6010001; Holschneider M, 1989, WAVELETS TIME FREQUE; Hong SW, 2018, ASTRON J, V155, DOI 10.3847/1538-3881/aa9d89; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Jorstad SG, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa8407; Larionov VM, 2020, MON NOT R ASTRON SOC, V492, P3829, DOI 10.1093/mnras/staa082; Lister ML, 2021, ASTROPHYS J, V923, DOI 10.3847/1538-4357/ac230f; MILLER JS, 1978, ASTROPHYS J, V219, pL85, DOI 10.1086/182612; Mizuno Y, 2009, ASTROPHYS J, V700, P684, DOI 10.1088/0004-637X/700/1/684; Nolan PL, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/31; O'Neill S, 2022, ASTROPHYS J LETT, V926, DOI 10.3847/2041-8213/ac504b; O'Sullivan SP, 2009, MON NOT R ASTRON SOC, V400, P26, DOI 10.1111/j.1365-2966.2009.15428.x; Raiteri CM, 2017, NATURE, V552, P374, DOI 10.1038/nature24623; Roy A, 2022, MON NOT R ASTRON SOC, V510, P3641, DOI 10.1093/mnras/stab3701; Sarkar A, 2020, ASTRON ASTROPHYS, V642, DOI 10.1051/0004-6361/202038052; SCARGLE JD, 1990, ASTROPHYS J, V359, P469, DOI 10.1086/169079; SCHMIDT GD, 1992, ASTRON J, V104, P1563, DOI 10.1086/116341; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Shepherd MC, 1997, ASTR SOC P, V125, P77; STICKEL M, 1991, ASTROPHYS J, V374, P431, DOI 10.1086/170133; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Villata M, 2002, ASTRON ASTROPHYS, V390, P407, DOI 10.1051/0004-6361:20020662; Weaver ZR, 2020, ASTROPHYS J, V900, DOI 10.3847/1538-4357/aba693; Wehrle AE, 2016, ASTROPHYS J, V816, DOI 10.3847/0004-637X/816/2/53; Woo JH, 2002, ASTROPHYS J, V579, P530, DOI 10.1086/342878; Zhang HC, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/125	52	0	0	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					265	+		10.1038/s41586-022-05038-9	http://dx.doi.org/10.1038/s41586-022-05038-9			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071186				2022-12-28	WOS:000852469200020
J	Simner, PJ; Salzberg, SL				Simner, Patricia J.; Salzberg, Steven L.			The Human "Contaminome" and Understanding Infectious Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Simner, Patricia J.] Johns Hopkins Univ, Dept Pathol, Div Med Microbiol, Baltimore, MD 21218 USA; [Simner, Patricia J.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Comp Sci, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Ctr Computat Biol, Whiting Sch Engn, Baltimore, MD 21218 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Simner, PJ (corresponding author), Johns Hopkins Univ, Dept Pathol, Div Med Microbiol, Baltimore, MD 21218 USA.; Simner, PJ (corresponding author), Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD 21218 USA.		Salzberg, Steven/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432				Breitwieser FP, 2019, GENOME RES, V29, P954, DOI 10.1101/gr.245373.118; Chrisman B, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-13269-z; Nurk Sergey, 2022, Science, V376, P44, DOI 10.1126/science.abj6987; Simner PJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00472-18; Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					943	946		10.1056/NEJMcibr2208625	http://dx.doi.org/10.1056/NEJMcibr2208625			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069879				2022-12-28	WOS:000861634500019
J	Akagbosu, B; Tayyebi, Z; Shibu, G; Iza, YAP; Deep, D; Parisotto, YF; Fisher, L; Pasolli, HA; Thevin, V; Elmentaite, R; Knott, M; Hemmers, S; Jahn, L; Friedrich, C; Verter, J; Wang, ZM; van den Brink, M; Gasteiger, G; Grunewald, TGP; Marie, JC; Leslie, C; Rudensky, AY; Brown, CC				Akagbosu, Blossom; Tayyebi, Zakieh; Shibu, Gayathri; Iza, Yoselin A. Paucar; Deep, Deeksha; Parisotto, Yollanda Franco; Fisher, Logan; Pasolli, H. Amalia; Thevin, Valentin; Elmentaite, Rasa; Knott, Maximilian; Hemmers, Saskia; Jahn, Lorenz; Friedrich, Christin; Verter, Jacob; Wang, Zhong-Min; van den Brink, Marcel; Gasteiger, Georg; Gruenewald, Thomas G. P.; Marie, Julien C.; Leslie, Christina; Rudensky, Alexander Y.; Brown, Chrysothemis C.			Novel antigen-presenting cell imparts T-reg-dependent tolerance to gut microbiota	NATURE			English	Article							INNATE LYMPHOID-CELLS; MHC CLASS-II; DENDRITIC CELLS; AIRE; IMMUNITY; EXPRESSION; SELECTION; COLITIS; LIFE; P63	Establishing and maintaining tolerance to self-antigens or innocuous foreign antigens is vital for the preservation of organismal health. Within the thymus, medullary thymic epithelial cells (mTECs) expressing autoimmune regulator (AIRE) have a critical role in self-tolerance through deletion of autoreactive T cells and promotion of thymic regulatory T (T-reg) cell development(1-4). Within weeks of birth, a separate wave of T-reg cell differentiation occurs in the periphery upon exposure to antigens derived from the diet and commensal microbiota(5-8), yet the cell types responsible for the generation of peripheral T-reg (pT(reg)) cells have not been identified. Here we describe the identification of a class of ROR gamma t(+) antigen-presenting cells called Thetis cells, with transcriptional features of both mTECs and dendritic cells, comprising four major sub-groups (TC I-TC IV). We uncover a developmental wave of Thetis cells within intestinal lymph nodes during a critical window in early life, coinciding with the wave of pT(reg) cell differentiation. Whereas TC I and TC III expressed the signature mTEC nuclear factor AIRE, TC IV lacked AIRE expression and was enriched for molecules required for pT(reg) generation, including the TGF-beta-activating integrin alpha v beta 8. Loss of either major histocompatibility complex class II (MHCII) or ITGB8 by Thetis cells led to a profound impairment in intestinal pT(reg) differentiation, with ensuing colitis. By contrast, MHCII expression by ROR gamma t(+) group 3 innate lymphoid cells (ILC3) and classical dendritic cells was neither sufficient nor required for pT(reg) generation, further implicating TC IV as the tolerogenic ROR gamma t(+) antigen-presenting cell with an essential function in early life. Our studies reveal parallel pathways for the establishment of tolerance to self and foreign antigens in the thymus and periphery, respectively, marked by the involvement of shared cellular and transcriptional programmes.	[Akagbosu, Blossom; Shibu, Gayathri; Iza, Yoselin A. Paucar; Parisotto, Yollanda Franco; Fisher, Logan; Brown, Chrysothemis C.] Mem Sloan Kettering Canc Ctr, Immunooncol Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Tayyebi, Zakieh; Leslie, Christina] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Tayyebi, Zakieh] Weill Cornell Grad Sch, Triinst Program Computat Biol & Med, New York, NY USA; [Shibu, Gayathri; Iza, Yoselin A. Paucar; Deep, Deeksha; Fisher, Logan; Hemmers, Saskia; van den Brink, Marcel; Rudensky, Alexander Y.; Brown, Chrysothemis C.] Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Grad Sch Med Sci, New York, NY 10021 USA; [Deep, Deeksha; Hemmers, Saskia; Verter, Jacob; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Deep, Deeksha; Hemmers, Saskia; Verter, Jacob; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Deep, Deeksha; Hemmers, Saskia; Verter, Jacob; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Deep, Deeksha] Rockefeller Univ, Triinst MD PhD Program, Weill Cornell Med, 1230 York Ave, New York, NY 10021 USA; [Deep, Deeksha] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Pasolli, H. Amalia] Rockefeller Univ, Electron Microscopy Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Thevin, Valentin; Marie, Julien C.] Univ Lyon, Ctr Leon Berard, Tumor Escape Resistance Immun Dept, CRCL,INSERM U1052,CNRS 5286, Lyon, France; [Thevin, Valentin; Marie, Julien C.] Equipe Labellisee Ligue Natl Canc, Lyon, France; [Elmentaite, Rasa] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Knott, Maximilian] Ludwig Maximilians Univ Munchen, Inst Pathol, Fac Med, Munich, Germany; [Jahn, Lorenz; van den Brink, Marcel] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA; [Friedrich, Christin; Gasteiger, Georg] Julius Maximilians Univ Wurzburg, Wurzburg Inst Syst Immunol, Max Planck Res Grp, Wurzburg, Germany; [van den Brink, Marcel] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Gruenewald, Thomas G. P.] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany; [Gruenewald, Thomas G. P.] German Canc Res Ctr, Div Translat Pediat Sarcoma Res, German Canc Consortium DKTK, Heidelberg, Germany; [Gruenewald, Thomas G. P.; Brown, Chrysothemis C.] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Gruenewald, Thomas G. P.; Brown, Chrysothemis C.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Brown, Chrysothemis C.] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA; [Hemmers, Saskia] Duke Univ, Dept Immunol, Durham, NC USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Wellcome Trust Sanger Institute; University of Munich; Memorial Sloan Kettering Cancer Center; Max Planck Society; University of Wurzburg; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Duke University	Brown, CC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunooncol Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY; Brown, CC (corresponding author), Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Grad Sch Med Sci, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.; Brown, CC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.; Brown, CC (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA.	rudenska@mskcc.org; brownc10@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	Elmentaite, Rasa/0000-0001-7366-5466; Franco, Yollanda/0000-0003-4598-8000; Fisher, Logan/0000-0003-4680-1527; Tayyebi, Zakieh/0000-0002-7821-9905; Gasteiger, Georg/0000-0001-6986-127X	NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Parker Institute for Cancer Immunotherapy; Ludwig Center at Memorial Sloan Kettering, NCI Cancer Center Support Grant [P30 CA08748]; NCI [U54 CA209975]; NIAID [R01AI034206]; Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); MSTP grant from NIGMS of the NIH [T32GM007739]; NIAID F30 Predoctoral Fellowship [F30AI154660-01]; Barbara and Wilfried Mohr foundation; French Ministry of Research; Wellcome Trust Fellowship [WT201483/Z/16/Z]; Parker Institute for Cancer Immunotherapy Senior Fellowship; Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research)	NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parker Institute for Cancer Immunotherapy; Ludwig Center at Memorial Sloan Kettering, NCI Cancer Center Support Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation); MSTP grant from NIGMS of the NIH; NIAID F30 Predoctoral Fellowship; Barbara and Wilfried Mohr foundation; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Wellcome Trust Fellowship(Wellcome Trust); Parker Institute for Cancer Immunotherapy Senior Fellowship; Hilton-Ludwig Cancer Prevention Initiative (Ludwig Cancer Research)	We thank J. van der Veeken, C. Campbell and members of the Rudensky laboratory for their technical support and helpful discussions; the Single Cell Core Facility at MSK for sample processing; J. Gardner for discussions, M. Anderson for the provision of AireGFP mice; C. Reis e Sousa for Clec9acre mice; D. Sheppard for Itgb8fl/fl mice; L. Denzin for H2-Dma-/-mice; M. Glickman for C7 mice; and S. Teichmann for assistance with human single-cell datasets. We acknowledge the use of the Integrated Genomics Operation Core, funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. Elements of cartoons in Figs. 2a and 5j and Extended Data Fig. 4c were created with BioRender.com. This work was supported by the Parker Institute for Cancer Immunotherapy (C.C.B. and A.Y.R.), Ludwig Center at Memorial Sloan Kettering, NCI Cancer Center Support Grant P30 CA08748, NCI grant U54 CA209975 (A.Y.R. and C.L.), NIAID grant R01AI034206 (A.Y.R.) and the Hilton-Ludwig Cancer Prevention Initiative (Conrad N. Hilton Foundation and Ludwig Cancer Research) (A.Y.R.). D.D. was supported by a MSTP grant from NIGMS of the NIH under award number T32GM007739 to the Tri-Institutional MD-PhD Program and by a NIAID F30 Predoctoral Fellowship (F30AI154660-01). The laboratory of T.G.P.G. is supported by the Barbara and Wilfried Mohr foundation. V.T. is supported by the French Ministry of Research. A.Y.R. is an HHMI investigator. C.C.B. was supported by a Wellcome Trust Fellowship (WT201483/Z/16/Z), a Josie Robertson Investigator Award and a Parker Institute for Cancer Immunotherapy Senior Fellowship.	Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barton GM, 2002, P NATL ACAD SCI USA, V99, P6937, DOI 10.1073/pnas.102645699; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BILLINGHAM RE, 1956, PHILOS T R SOC B, V239, P357, DOI 10.1098/rstb.1956.0006; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Choi J, 2019, NUCLEIC ACIDS RES, V47, pD780, DOI 10.1093/nar/gky1020; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Dobes J, 2022, NAT IMMUNOL, V23, P1098, DOI 10.1038/s41590-022-01247-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elmentaite Rasa, 2021, Nature, V597, P250, DOI 10.1038/s41586-021-03852-1; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Fergusson JR, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02902; Fiancette R, 2021, NAT IMMUNOL, V22, P1245, DOI 10.1038/s41590-021-01024-x; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Herzig Y, 2017, NAT IMMUNOL, V18, P161, DOI 10.1038/ni.3638; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kedmi R, 2022, NATURE, V610, P737, DOI 10.1038/s41586-022-05089-y; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Lyu MZ, 2022, NATURE, V610, P744, DOI 10.1038/s41586-022-05141-x; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Michelson DA, 2022, CELL, V185, P2542, DOI 10.1016/j.cell.2022.05.018; Nakawesi J, 2021, MUCOSAL IMMUNOL, V14, P53, DOI 10.1038/s41385-020-0276-8; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Papaioannou NE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20659-2; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Salvermoser J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00699; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Stehle C, 2021, NAT IMMUNOL, V22, P1231, DOI 10.1038/s41590-021-01029-6; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suo CQ, 2022, SCIENCE, V376, P1069, DOI 10.1126/science.abo0510; Taddy M., 2012, P 15 INT C ART INT S, V22, P1184; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Wang JX, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5053; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamano T, 2019, J EXP MED, V216, P1027, DOI 10.1084/jem.20181430; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Zembrzycki A, 2013, NAT NEUROSCI, V16, P1060, DOI 10.1038/nn.3454; Zhou WQ, 2022, NATURE, V609, P159, DOI 10.1038/s41586-022-04934-4	71	3	3	13	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					752	+		10.1038/s41586-022-05309-5	http://dx.doi.org/10.1038/s41586-022-05309-5		SEP 2022	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36070798	hybrid, Green Published			2022-12-28	WOS:000866403900001
J	Venkataramani, M; Ogunwole, SM; Caulfield, LE; Sharma, R; Zhang, AE; Gross, SM; Hurley, KM; Lerman, JL; Bass, EB; Bennett, WL				Venkataramani, Maya; Ogunwole, S. Michelle; Caulfield, Laura E.; Sharma, Ritu; Zhang, Allen; Gross, Susan M.; Hurley, Kristen M.; Lerman, Jennifer L.; Bass, Eric B.; Bennett, Wendy L.			Maternal, Infant, and Child Health Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants, and Children A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							BIRTH OUTCOMES; PREGNANCY; IMPACT; WEIGHT; CARE	Background: The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) is intended to improve maternal and child health outcomes. In 2009, the WIC food package changed to better align with national nutrition recommendations. Purpose: To determine whether WIC participation was associated with improved maternal, neonatal-birth, and infant-child health outcomes or differences in outcomes by subgroups and WIC enrollment duration. Data Sources: Search (January 2009 to April 2022) included PubMed, Embase, CINAHL, ERIC, Scopus, PsycInfo, and the Cochrane Central Register of Controlled Trials. Study Selection: Included studies had a comparator of WIC-eligible nonparticipants or comparison before and after the 2009 food package change. Data Extraction: Paired team members independently screened articles for inclusion and evaluated risk of bias. Data Synthesis: We identified 20 observational studies. We found: moderate strength of evidence (SOE) that maternal WIC participation during pregnancy is likely associated with lower risk for preterm birth, low birthweight infants, and infant mortality; low SOE that maternal WIC participation may be associated with a lower likelihood of inadequate gestational weight gain, as well as increased well-child visits and childhood immunizations; and low SOE that child WIC participation may be associated with increased childhood immunizations. We found low SOE for differences in some outcomes by race and ethnicity but insufficient evidence for differences by WIC enrollment duration. We found insufficient evidence related to maternal morbidity and mortality outcomes. Limitation: Data are from observational studies with high potential for selection bias related to the choice to participate in WIC, and participation status was self-reported in most studies. Conclusion: Participation in WIC was likely associated with improved birth outcomes and lower infant mortality, and also may be associated with increased child preventive service receipt. Primary Funding Source: Agency for Healthcare Research and Quality. (PROSPERO: CRD42020222452)	[Venkataramani, Maya; Ogunwole, S. Michelle; Bass, Eric B.; Bennett, Wendy L.] Johns Hopkins Univ, Div Gen Internal Med, Sch Med, Baltimore, MD 21205 USA; [Caulfield, Laura E.; Hurley, Kristen M.; Lerman, Jennifer L.] Johns Hopkins Univ, Ctr Human Nutr, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sharma, Ritu; Zhang, Allen; Bass, Eric B.] Johns Hopkins Univ, Sch Med, Ctr Evidence Based Practice, Baltimore, MD 21205 USA; [Gross, Susan M.; Bennett, Wendy L.] Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ogunwole, SM (corresponding author), Johns Hopkins Univ, Sch Med, 2024 East Monument St,Suite 2-638, Baltimore, MD 21205 USA.	sogunwo1@jhmi.edu			AHRQ, HHS [75Q80120D00003, 75Q80120F32003]	AHRQ, HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract number 75Q80120D00003 task order 75Q80120F32003 from the AHRQ, HHS.	Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10; Amutah-Onukagha Ndidiamaka, 2022, J Int Assoc Provid AIDS Care, V21, p23259582211069767, DOI 10.1177/23259582211069767; Angley M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1920-0; Baer RJ, 2019, J MATERN-FETAL NEO M, V32, P3336, DOI 10.1080/14767058.2018.1463366; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bersak T, 2018, HEALTH SERV RES, V53, P2952, DOI 10.1111/1475-6773.12810; Bitler MP, 2005, J POLICY ANAL MANAG, V24, P73, DOI 10.1002/pam.20070; Black MM, 2012, ARCH PEDIAT ADOL MED, V166, P444, DOI 10.1001/archpediatrics.2012.1; Blakeney EL, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2486-1; Bornstein E, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100657; Brown CC, 2019, JAMA-J AM MED ASSOC, V321, P1598, DOI 10.1001/jama.2019.3678; Carlson S, 2021, CBPP POLICY FUTURES; Casillas SM, 2017, J PEDIATR-US, V187, P265, DOI 10.1016/j.jpeds.2017.04.001; Caswell JA., 2013, SUPPLEMENTAL NUTR AS; Caulfield LE, 2022, COMP EFFECTIVENESS R, DOI [10.23970/AHRQEPCCER253, DOI 10.23970/AHRQEPCCER253]; Claiborne DM, 2022, J PUBLIC HEALTH DENT, V82, P72, DOI 10.1111/jphd.12487; Colman S, 2012, EFFECTS SPECIAL SUPP; de Cuba SE, 2022, J ACAD NUTR DIET, V122, P1514, DOI 10.1016/j.jand.2022.02.005; Effective Public Healthcare Panacea Project, 2021, QUAL ASS TOOL QUANT; El-Bastawissi AY, 2007, MATERN CHILD HLTH J, V11, P611, DOI 10.1007/s10995-007-0212-5; Fingar KR, 2017, MATERN CHILD HLTH J, V21, P825, DOI 10.1007/s10995-016-2176-9; Fox MK, 2004, LITERARY REV, V3; Gamblin MD, APPLYING RACIAL EQUI; Gray K, 2019, NATIONALAND STATE LE, V1; Hamad R, 2019, JAMA PEDIATR, V173, P845, DOI 10.1001/jamapediatrics.2019.1706; Kasim MT, 2021, CONTEMP ECON POLICY, V39, P608, DOI 10.1111/coep.12525; Kline N, 2018, WIC PARTICIPANT PROG; National Academies of Sciences Engineering and Medicine, 2017, REV WIC FOOD PACK IM; National Research Council, 2005, WIC FOOD PACK TIM CH; National WIC Association, 2022, ROL WIC PUBL HLTH; National WIC Association, 2020, ROL WIC RED MAT MORT; Nianogo RA, 2019, PREV MED, V124, P42, DOI 10.1016/j.ypmed.2019.04.011; Nuyt AM, 2017, CLIN PERINATOL, V44, P315, DOI 10.1016/j.clp.2017.01.010; Oliveira V, 2009, 73 DEP AGR EC RES RE, P59; Oropesa RS, 2001, SOC BIOL, V48, P44; Petersen EE, 2019, MMWR-MORBID MORTAL W, V68, P762, DOI 10.15585/mmwr.mm6835a3; PRISMA, 2021, EPIDEMIOLOGY; Rhee J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214154; Singh Gopal K, 2021, Int J MCH AIDS, V10, P29, DOI 10.21106/ijma.444; Smock L, 2020, J PUBLIC HEALTH MAN, V26, P71, DOI 10.1097/PHH.0000000000000995; Sonchak L, 2017, CHILD YOUTH SERV REV, V79, P115, DOI 10.1016/j.childyouth.2017.05.024; Sonchak L, 2016, MATERN CHILD HLTH J, V20, P1518, DOI 10.1007/s10995-016-1951-y; Soneji S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16722; Testa A, 2020, J PEDIATR-US, V226, P251, DOI 10.1016/j.jpeds.2020.06.055; Thomas TN, 2014, AM J PREV MED, V47, P624, DOI 10.1016/j.amepre.2014.06.017; US Department of Agriculture, 2021, WIC DAT TABL; US Department of Agriculture Food and Nutrition Service, 2007, SPEC SUPPL NUTR PROG; US Department of Health and Human Services US Department of Agriculture, 2005, DIET GUID AM 2005	48	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					1411	+		10.7326/M22-0604	http://dx.doi.org/10.7326/M22-0604		SEP 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36063550				2022-12-28	WOS:000868458800001
J	Lai, YT; Wu, PH				Lai, Yuan Tao; Wu, Po Hsuan			Gallstone Ileus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lai, Yuan Tao; Wu, Po Hsuan] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lai, YT (corresponding author), Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan.	m06wlx94@gmail.com		Wu, Po Hsuan/0000-0003-3775-831X					0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					924	924		10.1056/NEJMicm2204208	http://dx.doi.org/10.1056/NEJMicm2204208		SEP 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36053241				2022-12-28	WOS:000882828700001
J	Gould, F; Amasino, RM; Brossard, D; Buell, CR; Dixon, RA; Falck-Zepeda, JB; Gallo, MA; Giller, KE; Glenna, LL; Griffin, T; Magraw, D; Mallory-Smith, C; Pixley, KV; Ransom, EP; Stelly, DM; Stewart, CN				Gould, Fred; Amasino, Richard M.; Brossard, Dominique; Buell, C. Robin; Dixon, Richard A.; Falck-Zepeda, Jose B.; Gallo, Michael A.; Giller, Ken E.; Glenna, Leland L.; Griffin, Timothy; Magraw, Daniel; Mallory-Smith, Carol; Pixley, Kevin V.; Ransom, Elizabeth P.; Stelly, David M.; Stewart, C. Neal, Jr.			Toward product-based regulation of crops	SCIENCE			English	Editorial Material												fred_gould@ncsu.edu		Buell, C Robin/0000-0002-6727-4677	GrasslaNZTechnologies, New Zealand; Forage Genetics International, USA	GrasslaNZTechnologies, New Zealand; Forage Genetics International, USA	Some of the ideas for this article emerged from discussions during deliberations of the NASEM Committee on Genetically Engineered Crops: Past Experiences and Future Prospects. K.E.G.is a member of the Sustainable Sourcing Advisory Board of Unilever and of the Scientific Advisory Committee of theAfrican Plant Nutrition Institute. R.A.D. holds patents in the field of metabolic engineering for improvement of forage crops and has received funding for research on the above topic from GrasslaNZTechnologies, New Zealand, and Forage Genetics International, USA. C.N.S. and C.R.B.hold patents in plant biotechnology. C.M.-S.has received research funding from agrichemical companies and has been retained by counsel for defendants as an expert in litigation related to glyphosate-based herbicides.	bch.cbd, CARTAGENA PROTOCOL B; Benevenuto RF, 2022, TRENDS FOOD SCI TECH, V120, P325, DOI 10.1016/j.tifs.2022.01.002; Buttel FH, 2005, ENVIRON POLIT, V14, P309, DOI 10.1080/09644010500151602; Canadian Food Inspection Agency, 2021, DRAFT GUID WHETH PLA; Dryzek JS, 2019, SCIENCE, V363, P1144, DOI 10.1126/science.aaw2694; Enfissi E.M. A, 2021, J PLANT PHYSIOL, V258-259; Entine J, 2021, TRANSGENIC RES, V30, P551, DOI 10.1007/s11248-021-00257-8; EPA, 2020, PEST EX CERT PLANT I; European Commission, 2021, STUD STAT NEW GEN TE; Gordon DR, 2021, NAT BIOTECHNOL, V39, P1055, DOI 10.1038/s41587-021-01023-1; Herman RA, 2021, GM CROPS FOOD, V12, P376, DOI 10.1080/21645698.2021.1934353; National Academies of Sciences Engineering and Medicine, 2016, GENETICALLY ENG CROP; USDA-Animal and Plant Health Inspection Service, 2020, FED REGISTER, V85, P29790; USDA-NMS, 2018, FED REG, V83, P65814; Varshney RK, 2021, TRENDS PLANT SCI, V26, P631, DOI 10.1016/j.tplants.2021.03.010	15	2	2	4	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1051	1053		10.1126/science.abo3034	http://dx.doi.org/10.1126/science.abo3034			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048940				2022-12-28	WOS:000887933200036
J	Woych, J; Gurrola, AO; Deryckere, A; Jaeger, ECB; Gumnit, E; Merello, G; Gu, JC; Araus, AJ; Leigh, ND; Yun, M; Simon, A; Tosches, MA				Woych, Jamie; Gurrola, Alonso Ortega; Deryckere, Astrid; Jaeger, Eliza C. B.; Gumnit, Elias; Merello, Gianluca; Gu, Jiacheng; Araus, Alberto Joven; Leigh, Nicholas D.; Yun, Maximina; Simon, Andras; Tosches, Maria Antonietta			Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution	SCIENCE			English	Article							DORSAL VENTRICULAR RIDGE; AMYGDALOID COMPLEX; TELENCEPHALON; EXPRESSION; TETRAPODS; PATTERNS; LIZARD; SYSTEM; BRAIN	The evolution of advanced cognition in vertebrates is associated with two independent innovations in the forebrain: the six-layered neocortex in mammals and the dorsal ventricular ridge (DVR) in sauropsids (reptiles and birds). How these innovations arose in vertebrate ancestors remains unclear. To reconstruct forebrain evolution in tetrapods, we built a cell-type atlas of the telencephalon of the salamander Pleurodeles waltl. Our molecular, developmental, and connectivity data indicate that parts of the sauropsid DVR trace back to tetrapod ancestors. By contrast, the salamander dorsal pallium is devoid of cellular and molecular characteristics of the mammalian neocortex yet shares similarities with the entorhinal cortex and subiculum. Our findings chart the series of innovations that resulted in the emergence of the mammalian six-layered neocortex and the sauropsid DVR.	[Woych, Jamie; Gurrola, Alonso Ortega; Deryckere, Astrid; Jaeger, Eliza C. B.; Gumnit, Elias; Merello, Gianluca; Gu, Jiacheng; Tosches, Maria Antonietta] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Gurrola, Alonso Ortega] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Araus, Alberto Joven; Simon, Andras] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Leigh, Nicholas D.] Lund Univ, Mol Med & Gene Therapy, Wallenberg Ctr Mol Med, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Yun, Maximina] Tech Univ Dresden, CRTD Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Yun, Maximina] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Columbia University; Columbia University; Karolinska Institutet; Lund University; Technische Universitat Dresden; Max Planck Society	Tosches, MA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mt3353@columbia.edu	Deryckere, Astrid/AAU-6858-2021	Deryckere, Astrid/0000-0001-6227-7759; Leigh, Nicholas/0000-0002-6978-6254; Yun, Maximina/0000-0001-9019-2453; Jaeger, Eliza/0000-0003-3708-7923; Joven Araus, Alberto/0000-0002-0926-4665	McKnight Foundation; NIH [NHGRI RM1HG011014]; National Science Foundation [DGE 2036197]; Knut and Alice Wallenberg Foundation; European Research Council	McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the McKnight Foundation (M.A.T.), the NIH (grant NHGRI RM1HG011014 to M.A.T.), the National Science Foundation (Graduate Research Fellowship DGE 2036197 to E.C.J.B.), the Knut and Alice Wallenberg Foundation (A.S.), and the European Research Council (A.S.).	[Anonymous], 2014, FRONT NEUROANAT, V8, P59, DOI 10.3389/; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Bloch S, 2020, ELIFE, V9, DOI 10.7554/eLife.54945; Bormuth I, 2013, J NEUROSCI, V33, P641, DOI 10.1523/JNEUROSCI.0899-12.2013; Brox A, 2004, J COMP NEUROL, V474, P562, DOI 10.1002/cne.20152; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Butler AB, 2002, BRAIN RES BULL, V57, P475, DOI 10.1016/S0361-9230(01)00679-7; Butler AB, 2011, ANN NY ACAD SCI, V1225, P14, DOI 10.1111/j.1749-6632.2011.06006.x; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Colquitt BM, 2021, SCIENCE, V371, P695, DOI 10.1126/science.abd9704; Cordery P, 1999, J COMP NEUROL, V413, P26; Deryckere A., 2022, BIORXIV; Diodato A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12238; Endepols H, 2005, J COMP NEUROL, V483, P437, DOI 10.1002/cne.20455; Faedo A, 2002, MECH DEVELOP, V116, P157, DOI 10.1016/S0925-4773(02)00114-4; Fishell G, 2020, ANNU REV NEUROSCI, V43, P1, DOI 10.1146/annurev-neuro-070918-050421; Fournier J, 2018, NEURON, V97, P164, DOI 10.1016/j.neuron.2017.11.017; Garcia-Moreno F, 2020, PROG NEUROBIOL, V194, DOI 10.1016/j.pneurobio.2020.101865; Gonzalez A., 2020, EVOLUTIONARY NEUROSC, P125; Gouwens NW, 2020, CELL, V183, P935, DOI 10.1016/j.cell.2020.09.057; Hain D, 2022, SCIENCE, V377, P1060, DOI 10.1126/science.abp8202; J. Woych, 2022, bioRxiv, DOI 10.1101/2022.03.28.485354; Jabaudon D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16042; Jarvis E.D., 2007, P213; Johnston JB, 1916, J COMP NEUROL, V26, P481, DOI 10.1002/cne.900260504; Joven A, 2018, PROG NEUROBIOL, V170, P81, DOI 10.1016/j.pneurobio.2018.04.006; Joven A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160051; Joven A, 2013, BRAIN STRUCT FUNCT, V218, P969, DOI 10.1007/s00429-012-0442-1; Karten HJ, 2013, CURR BIOL, V23, pR12, DOI 10.1016/j.cub.2012.11.013; Laberge F, 2006, BRAIN BEHAV EVOLUT, V67, P177, DOI 10.1159/000091119; Laberge F, 2005, J COMP NEUROL, V482, P176, DOI 10.1002/cne.20430; Lanuza E, 1998, EUR J NEUROSCI, V10, P3517, DOI 10.1046/j.1460-9568.1998.00363.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leitner FC, 2016, NAT NEUROSCI, V19, P935, DOI 10.1038/nn.4303; Luzzati F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00162; MacIver MA, 2022, PHILOS T R SOC B, V377, DOI 10.1098/rstb.2020.0523; Manger PR, 2002, J COMP NEUROL, V453, P226, DOI 10.1002/cne.10373; Medina L, 2022, BRAIN BEHAV EVOLUT, V96, P181, DOI 10.1159/000519260; Moreno N, 2006, PROG NEUROBIOL, V78, P61, DOI 10.1016/j.pneurobio.2005.12.005; Moreno N., 2017, EVOLUTION NERVOUS SY, P409, DOI DOI 10.1016/b978-0-12-804042-3.00017-8; Moreno N, 2008, DEV NEUROBIOL, V68, P504, DOI 10.1002/dneu.20603; Moreno N, 2007, J ANAT, V211, P151, DOI 10.1111/j.1469-7580.2007.00780.x; Moreno N, 2007, FRONT NEUROANAT, V1, DOI [10.3389/neuro.05/001.2007, 10.3389/neuro.05.001.2007]; Neary T.J., 1990, Cerebral Cortex, V8A, P107; Nomura T, 2018, CELL REP, V22, P3142, DOI 10.1016/j.celrep.2018.02.086; Norimoto H, 2020, NATURE, V578, P413, DOI 10.1038/s41586-020-1993-6; O'Leary TP, 2020, ELIFE, V9, DOI 10.7554/eLife.59003; Puelles L, 2019, J COMP NEUROL, V527, P1731, DOI 10.1002/cne.24650; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Striedter GF, 2022, BRAIN BEHAV EVOLUT, V96, P200, DOI 10.1159/000516563; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suryanarayana SM, 2017, CURR BIOL, V27, P3264, DOI 10.1016/j.cub.2017.09.034; Tosches MA, 2021, ANNU REV CELL DEV BI, V37, P495, DOI 10.1146/annurev-cellbio-120319-112654; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; VONEIDA TJ, 1979, J COMP NEUROL, V186, P43, DOI 10.1002/cne.901860104; Witter MP, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00046; Yao ZZ, 2021, CELL, V184, P3222, DOI 10.1016/j.cell.2021.04.021; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	62	3	3	8	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1063	+	eabp9186	10.1126/science.abp9186	http://dx.doi.org/10.1126/science.abp9186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048957	Green Submitted			2022-12-28	WOS:000887933200003
J	Park, SK; Mohr, G; Yao, J; Russell, R; Lambowitz, AM				Park, Seung Kuk; Mohr, Georg; Yao, Jun; Russell, Rick; Lambowitz, Alan M.			Group II intron-like reverse transcriptases function in double-strand break repair	CELL			English	Article							PSEUDOMONAS-AERUGINOSA; READ ALIGNMENT; SIGMA-FACTOR; DNA-DAMAGE; RNA; RETROELEMENTS; BROAD; RETROTRANSPOSITION; IDENTIFICATION; GENERATION	Bacteria encode reverse transcriptases (RTs) of unknown function that are closely related to group II intron-encoded RTs. We found that a Pseudomonas aeruginosa group II intron-like RT (G2L4 RT) with YIDD instead of YADD at its active site functions in DNA repair in its native host and when expressed in Escherichia coli. G2L4 RT has biochemical activities strikingly similar to those of human DNA repair polymerase q and uses them for translesion DNA synthesis and double-strand break repair (DSBR) via microhomology-mediated end-joining (MMEJ). We also found that a group II intron RT can function similarly in DNA repair, with recip-rocal active-site substitutions showing isoleucine favors MMEJ and alanine favors primer extension in both enzymes. These DNA repair functions utilize conserved structural features of non-LTR-retroelement RTs, including human LINE-1 and other eukaryotic non-LTR-retrotransposon RTs, suggesting such enzymes may have inherent ability to function in DSBR in a wide range of organisms.	[Park, Seung Kuk; Mohr, Georg; Yao, Jun; Russell, Rick; Lambowitz, Alan M.] Univ Texas Austin, Dept Mol Biosci & Oncol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Mol Biosci & Oncol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			Welch Foundation [R35 GM136216]; NIH;  [F-1607]	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by Welch Foundation grant F-1607 and NIH grant R35 GM136216 to A.M.L. R.R. is supported by NIH grant R35 GM131777. We thank Kyle Miller for use of his X-ray generator, Jennifer Stamos for comments on the manuscript, and Douglas Wu for help with whole-genome sequence analysis.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Black SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12272-9; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Chandramouly G, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1771; Chen WZ, 2018, ISCIENCE, V6, P222, DOI 10.1016/j.isci.2018.07.024; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Silva SDE, 2011, J THEOR BIOL, V287, P92, DOI 10.1016/j.jtbi.2011.07.017; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Erik Garrison, 2012, Arxiv, DOI arXiv:1207.3907; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gabler Felix, 2020, Curr Protoc Bioinformatics, V72, pe108, DOI 10.1002/cpbi.108; Gao LY, 2020, SCIENCE, V369, P1077, DOI 10.1126/science.aba0372; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gu SQ, 2010, RNA, V16, P732, DOI 10.1261/rna.2007310; Himeno H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00066; Hutfilz CR, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00426-19; Jaishankar J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02000; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Katibah GE, 2014, P NATL ACAD SCI USA, V111, P12025, DOI 10.1073/pnas.1412842111; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; Kolde Raivo, 2019, CRAN; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Kreuzer KN, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012674; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leclercq S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052268; Lee G, 2018, P NATL ACAD SCI USA, V115, P12465, DOI 10.1073/pnas.1807709115; Lentzsch AM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100971; Lentzsch AM, 2019, J BIOL CHEM, V294, P19764, DOI 10.1074/jbc.RA119.011337; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovett Susan T, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.4.4.7; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin-Alonso S, 2021, TRENDS BIOTECHNOL, V39, P194, DOI 10.1016/j.tibtech.2020.06.008; Merrikh H, 2009, P NATL ACAD SCI USA, V106, P611, DOI 10.1073/pnas.0803665106; Millman A, 2020, CELL, V183, P1551, DOI 10.1016/j.cell.2020.09.065; Mohr G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000391; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Muller C, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.652980; Nottingham RM, 2016, RNA, V22, P597, DOI 10.1261/rna.055558.115; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Poetsch AR, 2020, COMPUT STRUCT BIOTEC, V18, P207, DOI 10.1016/j.csbj.2019.12.013; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramsden DA, 2022, NAT REV MOL CELL BIO, V23, P125, DOI 10.1038/s41580-021-00405-2; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schurr MJ, 1997, MOL MICROBIOL, V24, P411, DOI 10.1046/j.1365-2958.1997.3411711.x; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Stamos JL, 2017, MOL CELL, V68, P926, DOI 10.1016/j.molcel.2017.10.024; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang C, 2011, NUCLEIC ACIDS RES, V39, P7620, DOI 10.1093/nar/gkr397; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wu L, 2018, NUCLEIC ACIDS RES, V46, P11, DOI 10.1093/nar/gkx1150; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu HY, 2021, BIO-PROTOCOL, V11, DOI 10.21769/BioProtoc.4239; Xu HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44457-z; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zimmerly S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0058-2014; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zubradt M, 2017, NAT METHODS, V14, P75, DOI [10.1038/nmeth.4057, 10.1038/NMETH.4057]	85	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2022	185	20					3671	+		10.1016/j.cell.2022.08.014	http://dx.doi.org/10.1016/j.cell.2022.08.014			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	5W1JY	36113466				2022-12-28	WOS:000877678500006
J	Kim, S; Wuthrick, E; Blakaj, D; Eroglu, Z; Verschraegen, C; Thapa, R; Mills, M; Dibs, K; Liveringhouse, C; Russell, J; Caudell, JJ; Tarhini, A; Markowitz, J; Kendra, K; Wu, RC; Chen, DT; Berglund, A; Michael, L; Aoki, M; Wang, MH; Hamaidi, I; Cheng, PY; de la Iglesia, J; Slebos, RJ; Chung, CH; Knepper, TC; Moran-Segura, CM; Nguyen, JV; Perez, BA; Rose, T; Harrison, L; Messina, JL; Sondak, VK; Tsai, KY; Khushalani, NI; Brohl, AS				Kim, Sungjune; Wuthrick, Evan; Blakaj, Dukagjin; Eroglu, Zeynep; Verschraegen, Claire; Thapa, Ram; Mills, Matthew; Dibs, Khaled; Liveringhouse, Casey; Russell, Jeffery; Caudell, Jimmy J.; Tarhini, Ahmad; Markowitz, Joseph; Kendra, Kari; Wu, Richard; Chen, Dung-Tsa; Berglund, Anders; Michael, Lauren; Aoki, Mia; Wang, Min-Hsuan; Hamaidi, Imene; Cheng, Pingyan; de la Iglesia, Janis; Slebos, Robbert J.; Chung, Christine H.; Knepper, Todd C.; Moran-Segura, Carlos M.; Nguyen, Jonathan, V; Perez, Bradford A.; Rose, Trevor; Harrison, Louis; Messina, Jane L.; Sondak, Vernon K.; Tsai, Kenneth Y.; Khushalani, Nikhil, I; Brohl, Andrew S.			Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial	LANCET			English	Article							PLUS IPILIMUMAB; LUNG-CANCER; RADIOTHERAPY; MULTICENTER; BLOCKADE	Background Merkel cell carcinoma is among the most aggressive and lethal of primary skin cancers, with a high rate of distant metastasis. Anti-programmed death receptor 1 (anti-PD-1) and programmed death ligand 1 (PD-L1) monotherapy is currently standard of care for unresectable, recurrent, or metastatic Merkel cell carcinoma. We assessed treatment with combined nivolumab plus ipilimumab, with or without stereotactic body radiotherapy (SBRT) in patients with advanced Merkel cell carcinoma as a first-line therapy or following previous treatment with anti-PD-1 and PD-L1 monotherapy.Methods In this randomised, open label, phase 2 trial, we randomly assigned adults from two cancer sites in the USA (one in Florida and one in Ohio) to group A (combined nivolumab and ipilimumab) or group B (combined nivolumab and ipilimumab plus SBRT) in a 1:1 ratio. Eligible patients were aged at least 18 years with histologically proven advanced stage (unresectable, recurrent, or stage IV) Merkel cell carcinoma, a minimum of two tumour lesions measureable by CT, MRI or clinical exam, and tumour tissue available for exploratory biomarker analysis. Patients were stratified by previous immune-checkpoint inhibitor (ICI) status to receive nivolumab 240 mg intravenously every 2 weeks plus ipilimumab 1 mg/kg intravenously every 6 weeks (group A) or the same schedule of combined nivolumab and ipilimumab with the addition of SBRT to at least one tumour site (24 Gy in three fractions at week 2; group B). Patients had to have at least two measurable sites of disease so one non-irradiated site could be followed for response. The primary endpoint was objective response rate (ORR) in all randomly assigned patients who received at least one dose of combined nivolumab and ipilimumab. ORR was defined as the proportion of patients with a complete response or partial response per immune-related Response Evaluation Criteria in Solid Tumours. Response was assessed every 12 weeks. Safety was assessed in all patients. This trial is registered with ClinicalTrials.gov, NCT03071406.Findings 50 patients (25 in both group A and group B) were enrolled between March 14, 2017, and Dec 21, 2021, including 24 ICI-naive patients (13 [52%] of 25 group A patients and 11 [44%] of 25 group B patients]) and 26 patients with previous ICI (12 [48%] of 25 group A patients and 14 [56%] of 25 group B patients]). One patient in group B did not receive SBRT due to concerns about excess toxicity. Median follow-up was 14middot6 months (IQR 9middot1-26middot5). Two patients in group B were excluded from the analysis of the primary endpoint because the target lesions were irradiated and so the patients were deemed non-evaluable. Of the ICI-naive patients, 22 (100%) of 22 (95% CI 82-100) had an objective response, including nine (41% [95% CI 21-63]) with complete response. Of the patients who had previously had ICI exposure, eight (31%) of 26 patients (95% CI 15-52) had an objective response and four (15% [5-36]) had a complete response. No significant differences in ORR were observed between groups A (18 [72%] of 25 patients) and B (12 [52%] of 23 patients; p=0middot26). Grade 3 or 4 treatment-related adverse events were observed in 10 (40%) of 25 patients in group A and 8 (32%) of 25 patients in group B.Interpretation First-line combined nivolumab and ipilimumab in patients with advanced Merkel cell carcinoma showed a high ORR with durable responses and an expected safety profile. Combined nivolumab and ipilimumab also showed clinical benefit in patients with previous anti-PD-1 and PD-L1 treatment. Addition of SBRT did not improve efficacy of combined nivolumab and ipilimumab. The combination of nivolumab and ipilimumab represents a new first-line and salvage therapeutic option for advanced Merkel cell carcinoma.Funding Bristol Myers Squibb Rare Population Malignancy Program.Copyright (c) 2022 Published by Elsevier Ltd. All rights reserved.	[Kim, Sungjune; Wuthrick, Evan; Mills, Matthew; Liveringhouse, Casey; Caudell, Jimmy J.; Michael, Lauren; Aoki, Mia; Perez, Bradford A.; Harrison, Louis] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA; [Eroglu, Zeynep; Tarhini, Ahmad; Markowitz, Joseph; Sondak, Vernon K.; Khushalani, Nikhil, I; Brohl, Andrew S.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Thapa, Ram; Chen, Dung-Tsa; Berglund, Anders] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [de la Iglesia, Janis; Moran-Segura, Carlos M.; Nguyen, Jonathan, V; Messina, Jane L.; Tsai, Kenneth Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL USA; [Slebos, Robbert J.; Chung, Christine H.] H Lee Moffitt Canc Ctr & Res Inst, Dept Head & Neck Endocrine Oncol, Tampa, FL USA; [Rose, Trevor] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA; [Kim, Sungjune; Wang, Min-Hsuan; Hamaidi, Imene; Cheng, Pingyan] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Knepper, Todd C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Precis Med, Tampa, FL USA; [Russell, Jeffery] Univ Utah, Huntsman Canc Inst, Dept Head & Neck & Cutaneous Oncol, Salt Lake City, UT USA; [Blakaj, Dukagjin; Dibs, Khaled] Ohio State Univ, James Canc Hosp, Solove Res Inst, Dept Radiat Oncol, Columbus, OH USA; [Verschraegen, Claire; Kendra, Kari; Wu, Richard] Ohio State Univ, James Canc Hosp, Solove Res Inst, Dept Med Oncol, Columbus, OH USA; [Kim, Sungjune] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33647 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; H Lee Moffitt Cancer Center & Research Institute	Kim, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33647 USA.	sungjune.kim@moffitt.org			Bristol Myers Squibb Rare Population Malignancy Program;  [K08 CA194273];  [R37CA248298];  [P30-CA076292]	Bristol Myers Squibb Rare Population Malignancy Program; ; ; 	Bristol Myers Squibb Rare Population Malignancy Program	Altorki NK, 2021, LANCET ONCOL, V22, P824, DOI 10.1016/S1470-2045(21)00149-2; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Baas P, 2021, LANCET, V397, P375, DOI 10.1016/S0140-6736(20)32714-8; Chen DT, 2017, ONCOTARGET, V8, P88376, DOI 10.18632/oncotarget.19088; Chiou VL, 2015, J CLIN ONCOL, V33, P3541, DOI 10.1200/JCO.2015.61.6870; D'Angelo SP, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002646; D'Angelo SP, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000674; D'Angelo SP, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0077; Demaria S, 2015, JAMA ONCOL, V1, P1325, DOI 10.1001/jamaoncol.2015.2756; DINSE GE, 1982, BIOMETRICS, V38, P921, DOI 10.2307/2529872; Glutsch V, 2021, CANCER IMMUNOL IMMUN, V70, P2087, DOI 10.1007/s00262-020-02832-0; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Harms PW, 2018, NAT REV CLIN ONCOL, V15, P763, DOI 10.1038/s41571-018-0103-2; Hellmann MD, 2019, NEW ENGL J MED, V381, P2020, DOI 10.1056/NEJMoa1910231; Iyer JG, 2015, CANCER MED-US, V4, P1161, DOI 10.1002/cam4.458; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Knepper TC, 2019, CLIN CANCER RES, V25, P5961, DOI 10.1158/1078-0432.CCR-18-4159; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; LoPiccolo J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0661-6; McBride S, 2021, J CLIN ONCOL, V39, P30, DOI 10.1200/JCO.20.00290; National Institutes of Health; National Cancer Institute; US Department of Health and Human Services, 2009, COMMON TERMINOLOGY C; Nghiem P, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002478; Nghiem P, 2017, FUTURE ONCOL, V13, P1263, DOI 10.2217/fon-2017-0072; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Rabinowits G, 2018, ONCOLOGIST, V23, P814, DOI 10.1634/theoncologist.2017-0552; Samlowski WE, 2010, AM J CLIN ONCOL-CANC, V33, P495, DOI 10.1097/COC.0b013e3181b9cf04; Schadendorf D, 2017, EUR J CANCER, V71, P53, DOI 10.1016/j.ejca.2016.10.022; Shalhout SZ, 2022, J IMMUNOTHER, V45, P299, DOI 10.1097/CJI.0000000000000432; Stege HM, 2021, CANCER IMMUNOL IMMUN, V70, P3313, DOI 10.1007/s00262-021-02925-4; Strom T, 2017, HEAD NECK-J SCI SPEC, V39, P48, DOI 10.1002/hed.24527; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Verma V, 2019, NAT IMMUNOL, V20, P1231, DOI 10.1038/s41590-019-0441-y; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	34	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					1008	1019		10.1016/S0140-6736(22)01659-2	http://dx.doi.org/10.1016/S0140-6736(22)01659-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5S3JP	36108657				2022-12-28	WOS:000875091000002
J	Callaway, E				Callaway, Ewen			SCIENTISTS ARE USING AI TO DREAM UP REVOLUTIONARY NEW PROTEINS	NATURE			English	News Item						Structural biology; Proteomics		Huge advances in artificial intelligence mean researchers can design completely original molecules in seconds instead of months.										Anishchenko I, 2021, NATURE, V600, P547, DOI 10.1038/s41586-021-04184-w; Dauparas J, 2022, Science, V378, P49, DOI 10.1126/science.add2187; Ferruz N, BIORXIV, DOI [10.1101/2022.08.31.505981(2022, DOI 10.1101/2022.08.31.505981(2022]; Ferruz N, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32007-7; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Hsu C, BIORXIV, DOI [10.1101/2022.04.10.487779v2(2022, DOI 10.1101/2022.04.10.487779V2(2022]; Wang J, 2022, SCIENCE, V377, P387, DOI 10.1126/science.abn2100; Wicky B I M, 2022, Science, V378, P56, DOI 10.1126/science.add1964	8	0	0	9	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					661	662		10.1038/d41586-022-02947-7	http://dx.doi.org/10.1038/d41586-022-02947-7			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0SA	36109683	Bronze			2022-12-28	WOS:000855795500003
J	Roschewski, M; Staudt, LM; Wilson, WH				Roschewski, Mark; Staudt, Louis M. M.; Wilson, Wyndham H. H.			Burkitt's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MODIFIED CODOX-M/IVAC; NON-HODGKINS-LYMPHOMA; LEUKEMIA GROUP-B; CELL LYMPHOMA; C-MYC; ADULT BURKITT; CHEMOTHERAPY; RITUXIMAB; OUTCOMES; CANCER	Burkitt's LymphomaBurkitt's lymphoma is a rapidly proliferating lymphoma of germinal-center B cells. Most patients are cured with chemotherapy and prevention of tumor lysis. Relapse and CNS involvement carry a poor prognosis.	[Roschewski, Mark; Staudt, Louis M. M.; Wilson, Wyndham H. H.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD USA; [Roschewski, Mark] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N115,MSC1374,9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roschewski, M (corresponding author), NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bldg 10,Rm 4N115,MSC1374,9000 Rockville Pike, Bethesda, MD 20892 USA.	mark.roschewski@nih.gov		Roschewski, Mark/0000-0003-0278-2635				Alderuccio JP, 2021, BLOOD ADV, V5, P2852, DOI 10.1182/bloodadvances.2021004458; BURKITT D, 1962, NATURE, V194, P232, DOI 10.1038/194232a0; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Cairo M, 2018, BRIT J HAEMATOL, V182, P859, DOI 10.1111/bjh.15491; Chamuleau M., 2022, 27 C EUROPEAN HEMATO; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Evens AM, 2021, BLOOD, V137, P374, DOI 10.1182/blood.2020006926; Frazer JK, 2019, BRIT J HAEMATOL, V185, P374, DOI 10.1111/bjh.15520; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Gong C, 2021, MOL CELL, V81, P4059, DOI 10.1016/j.molcel.2021.07.041; Gonzalez-Farre B, 2019, HAEMATOLOGICA, V104, P1822, DOI 10.3324/haematol.2018.207928; Gopal S, 2018, BLOOD, V132, P254, DOI 10.1182/blood-2018-04-844472; Grande BM, 2019, BLOOD, V133, P1313, DOI 10.1182/blood-2018-09-871418; HENLE W, 1967, SCIENCE, V157, P1064, DOI 10.1126/science.157.3792.1064; Hoelzer D, 2014, BLOOD, V124, P3870, DOI 10.1182/blood-2014-03-563627; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Kabrani E, 2018, BLOOD, V132, P2670, DOI 10.1182/blood-2018-06-856203; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; Kaymaz Y, 2017, MOL CANCER RES, V15, P563, DOI 10.1158/1541-7786.MCR-16-0305; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lim ST, 2005, J CLIN ONCOL, V23, P4430, DOI 10.1200/JCO.2005.11.973; Lopez C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08578-3; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; MANOLOV G, 1972, NATURE, V237, P33, DOI 10.1038/237033a0; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mbulaiteye SM, 2010, INT J CANCER, V126, P1732, DOI 10.1002/ijc.24934; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Minard-Colin V, 2020, NEW ENGL J MED, V382, P2207, DOI 10.1056/NEJMoa1915315; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; MURPHY SB, 1986, J CLIN ONCOL, V4, P1732, DOI 10.1200/JCO.1986.4.12.1732; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Noy A, 2015, BLOOD, V126, P160, DOI 10.1182/blood-2015-01-623900; OCONOR GT, 1960, J PEDIATR-US, V56, P526, DOI 10.1016/S0022-3476(60)80369-1; Olszewski AJ, 2021, J CLIN ONCOL, V39, P1129, DOI 10.1200/JCO.20.03288; Ozuah NW, 2020, BLOOD ADV, V4, P4007, DOI 10.1182/bloodadvances.2020002178; Panea RI, 2019, BLOOD, V134, P1598, DOI 10.1182/blood.2019001880; PATTE C, 1986, J CLIN ONCOL, V4, P1219, DOI 10.1200/JCO.1986.4.8.1219; Piccaluga PP, 2011, BLOOD, V117, P3596, DOI 10.1182/blood-2010-08-301556; Pighi C, 2021, BLOOD ADV, V5, P5239, DOI 10.1182/bloodadvances.2021005682; Pui CH, 2001, J CLIN ONCOL, V19, P697, DOI 10.1200/JCO.2001.19.3.697; Reiter A, 1999, BLOOD, V94, P3294; Reutter K, 2021, LEUKEMIA, V35, P639, DOI 10.1038/s41375-020-0862-5; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rizzieri DA, 2004, CANCER-AM CANCER SOC, V100, P1438, DOI 10.1002/cncr.20143; Rizzieri DA, 2014, BRIT J HAEMATOL, V165, P102, DOI 10.1111/bjh.12736; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roschewski M, 2020, J CLIN ONCOL, V38, P2519, DOI 10.1200/JCO.20.00303; Rosolen A, 2015, J CLIN ONCOL, V33, P2112, DOI 10.1200/JCO.2014.59.7203; Samra B, 2021, BLOOD ADV, V5, P3913, DOI 10.1182/bloodadvances.2021004427; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Short NJ, 2017, AM J HEMATOL, V92, pE114, DOI 10.1002/ajh.24720; Swerdlow SH., 2017, WHO CLASSIFICATION T, VRevised 4th ed.; Teras LR, 2016, CA-CANCER J CLIN, V66, P443, DOI 10.3322/caac.21357; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Wagener R, 2020, HAEMATOLOGICA, V105, DOI [10.3324/haematol.2018.208140, 10.3324/haematol.2019.2058440]; Wagener R, 2019, BLOOD, V133, P962, DOI 10.1182/blood-2018-07-864025; Wilke AC, 2022, BLOOD, V139, P538, DOI 10.1182/blood.2021012081; Wilson WH, 2014, HAEMATOLOGICA, V99, P1228, DOI 10.3324/haematol.2013.101741; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zayac AS, 2021, HAEMATOLOGICA, V106, P1932, DOI 10.3324/haematol.2020.270876; Zhang WQ, 2020, BLOOD, V135, P2425, DOI 10.1182/blood.2019002008; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; ZIEGLER JL, 1982, LANCET, V2, P631	75	0	0	6	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1111	1122		10.1056/NEJMra2025746	http://dx.doi.org/10.1056/NEJMra2025746			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36129999				2022-12-28	WOS:000865461700007
J	Cordoro, KM				Cordoro, Kelly M.			Roflumilast for Chronic Plaque Psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEVERITY; SCALE		[Cordoro, Kelly M.] Univ Calif San Francisco, Dept Dermatol, 1701 Divisadero St, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Cordoro, KM (corresponding author), Univ Calif San Francisco, Dept Dermatol, 1701 Divisadero St, San Francisco, CA 94115 USA.	kelly.cordoro@ucsf.edu						Ahn CS, 2017, J DERMATOL TREAT, V28, P94, DOI 10.1080/09546634.2016.1181256; Carlin CS, 2004, J AM ACAD DERMATOL, V50, P859, DOI 10.1016/j.jaad.2003.09.014; Danby SG, 2022, J DERMATOL TREAT, V33, P685, DOI 10.1080/09546634.2020.1789050; Elmets CA, 2021, J AM ACAD DERMATOL, V84, P432, DOI 10.1016/j.jaad.2020.07.087; Elmets CA, 2019, J AM ACAD DERMATOL, V80, P1073, DOI 10.1016/j.jaad.2018.11.058; Jensen P, 2016, DERMATOLOGY, V232, P633, DOI 10.1159/000455840; Kimball AB, 2016, BRIT J DERMATOL, V175, P157, DOI 10.1111/bjd.14464; Langley RGB, 2015, J DERMATOL TREAT, V26, P23, DOI 10.3109/09546634.2013.865009; Lebwohl M, 2014, INT J DERMATOL, V53, P714, DOI 10.1111/j.1365-4632.2012.05798.x; Lebwohl MG, 2022, JAMA-J AM MED ASSOC, V328, P1073, DOI 10.1001/jama.2022.15632; Lebwohl MG, 2020, NEW ENGL J MED, V383, P229, DOI 10.1056/NEJMoa2000073; Menter A, 2019, J AM ACAD DERMATOL, V80, P1029, DOI 10.1016/j.jaad.2018.11.057; Miller J, 2021, JAMA DERMATOL, V157, P597, DOI 10.1001/jamadermatol.2021.0356; Omar Deega, 2022, J Am Acad Dermatol, DOI 10.1016/j.jaad.2022.03.052	14	0	0	4	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1049	1050		10.1001/jama.2022.14663	http://dx.doi.org/10.1001/jama.2022.14663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125485				2022-12-28	WOS:000862909200017
J	Hodkinson, A; Zhou, AL; Johnson, J; Geraghty, K; Riley, R; Zhou, AD; Panagopoulou, E; Chew-Graham, CA; Peters, D; Esmail, A; Panagioti, M				Hodkinson, Alexander; Zhou, Anli; Johnson, Judith; Geraghty, Keith; Riley, Ruth; Zhou, Andrew; Panagopoulou, Efharis; Chew-Graham, Carolyn A.; Peters, David; Esmail, Aneez; Panagioti, Maria			Associations of physician burnout with career engagement and quality of patient care: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WORK-LIFE BALANCE; HEALTH-CARE; SATISFACTION; INTERVENTIONS; OUTCOMES; STRESS; SAFETY	OBJECTIVE To examine the association of physician burnout with the career engagement and the quality of patient care globally.DESIGN Systematic review and meta-analysis.DATA SOURCES Medline, PsycINFO, Embase, and CINAHL were searched from database inception until May 2021.ELIGIBILITY CRITERIA FOR SELECTING STUDIES Observational studies assessing the association of physician burnout (including a feeling of overwhelming emotional exhaustion, feelings of cynicism and detachment from job defined as depersonalisation, and a sense of ineffectiveness and little personal accomplishment) with career engagement (job satisfaction, career choice regret, turnover intention, career development, and productivity loss) and the quality of patient care (patient safety incidents, low professionalism, and patient satisfaction). Data were double extracted by independent reviewers and checked through contacting all authors, 84 (49%) of 170 of whom confirmed their data. Random-effect models were used to calculate the pooled odds ratio, prediction intervals expressed the amount ofheterogeneity, and meta-regressions assessed for potential moderators with significance set using a conservative level of P<0.10. RESULTS 4732 articles were identified, of which 170 observational studies of 239 246 physicians were included in the meta-analysis. Overall burnout in physicians was associated with an almost four times decrease in job satisfaction compared with increased job satisfaction (odds ratio 3.79, 95% confidence interval 3.24 to 4.43, I2=97%, k=73 studies, n=146 980 physicians). In the presence of increased burnout, career choice regret increased by more than threefold compared with being satisfied with career choice (3.49, 2.43 to 5.00, I2=97%, k=16, n=33 871). Turnover intention also increased by more than threefold compared with retention (3.10, 2.30 to 4.17, I2=97%, k=25, n=32 271). Productivity had a small but significant association with burnout (1.82, 1.08 to 3.07, I2=83%, k=7, n=9581) and burnout also affected career development (3.77, 2.77 to 5.14, I2=0%, n=3411). Overall physician burnout doubled patient safety incidents compared with no patient safety incidents (2.04, 1.69 to 2.45, I2=87%, k=35, n=41 059). As burnout increased, low professionalism was twice as likely compared with maintained professionalism (2.33, 1.96 to 2.70, I2=96%, k=40, n=32 321), as was patient dissatisfaction compared with patient satisfaction (2.22, 1.38 to 3.57, I2=75%, k=8, n=1002). Burnout and poorer job satisfaction was greatest in hospital settings (1.88, 0.91 to 3.86, P=0.09), physicians aged 31-50 years (2.41, 1.02 to 5.64, P=0.04), and working in emergency medicine and intensive care (2.16, 0.98 to 4.76, P=0.06); burnout was lowest in general practitioners (0.16, 0.03 to 0.88, P=0.04). However, these associations did not remain significant in the multivariable regressions. The association between burnout and patient safety incidents was greatest in physicians aged 20-30 years (1.88, 1.07 to 3.29, P=0.03), and people working in emergency medicine (2.10, 1.09 to 3.56, P=0.02). The association of burnout with low professionalism was smallest in physicians older than 50 years (0.36, 0.19 to 0.69, P=0.003) and greatest in physicians still in training or residency (2.27, 1.45 to 3.60, P=0.001), in those who worked in a hospital (2.16, 1.46 to 3.19, P<0.001), specifically in emergency medicine specialty (1.48, 1.01 to 2.34, P=0.042), or situated in a low to middle income country (1.68, 0.94 to 2.97, P=0.08). CONCLUSIONS This meta-analysis provides compelling evidence that physician burnout is associated with poor function and sustainability of healthcare organisations primarily by contributing to the career disengagement and turnover of physicians and secondarily by reducing the quality of patient care. Healthcare organisations should invest more time and effort in implementing evidence-based strategies to mitigate physician burnout across specialties, and particularly in emergency medicine and for physicians in training or residency.	[Hodkinson, Alexander; Zhou, Anli; Geraghty, Keith; Esmail, Aneez; Panagioti, Maria] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Natl Inst Hlth & Care Res NIHR,Sch Primary Care Re, Manchester, England; [Johnson, Judith] Univ Leeds, Sch Psychol, Leeds, England; [Johnson, Judith] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford, England; [Riley, Ruth] Univ Surrey, Fac Hlth & Med Sci, Sch Hlth Sci, Guildford, England; [Zhou, Andrew] Univ Cambridge, Sch Clin Med, Cambridge, England; [Panagopoulou, Efharis] Aristotle Univ Thessaloniki, Aristotle Med Sch, Lab Hyg, Thessaloniki, Greece; [Chew-Graham, Carolyn A.] Keele Univ, Sch Med, Newcastle Upon Tyne, England; [Peters, David] Univ Westminster, Fac Sci & Technol, Westminster Ctr Resilience, London, England; [Hodkinson, Alexander; Panagioti, Maria] Univ Manchester, Natl Inst Hlth Res Greater Manchester Patient Safe, Hlth Serv Res & Primary Care, Div Populat Hlth, Manchester, Engalnd	University of Manchester; University of Leeds; Bradford Royal Infirmary; University of Surrey; University of Cambridge; Aristotle University of Thessaloniki; Keele University; University of Westminster	Hodkinson, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Natl Inst Hlth & Care Res NIHR,Sch Primary Care Re, Manchester, England.; Hodkinson, A (corresponding author), Univ Manchester, Natl Inst Hlth Res Greater Manchester Patient Safe, Hlth Serv Res & Primary Care, Div Populat Hlth, Manchester, Engalnd.	alexander.hodkinson@manchester.ac.uk		Riley, Ruth/0000-0001-8774-5344; Johnson, Judith/0000-0003-0431-013X				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Medical Association (AMA), 2021, NAT COMP REP PREP; [Anonymous], 2019, LANCET, V394, P93, DOI 10.1016/S0140-6736(19)31573-9; [Anonymous], 2003, EPIDEMIOLOGY UNINITI; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Block L, 2013, POSTGRAD MED J, V89, P495, DOI 10.1136/postgradmedj-2012-131743; Bourne T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030968; Bourne T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017856; Bourne T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006687; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; Coleman DM, 2021, J VASC SURG, V73, P1841, DOI 10.1016/j.jvs.2020.10.065; Conner KR, 2011, SUICIDE LIFE-THREAT, V41, P594, DOI 10.1111/j.1943-278X.2011.00057.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dewa CS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015141; Dinibutun SR, 2020, J HEALTHC LEADERSH, V12, P85, DOI 10.2147/JHL.S270440; Estryn-Behar M, 2011, EMERG MED J, V28, P397, DOI 10.1136/emj.2009.082594; Gergen K. J., 2011, PSYCHOL STUD, V56, P108, DOI [10.1007/s12646-011-0066-1, DOI 10.1007/S12646-011-0066-1]; Gunzler DD, 2021, STRUCTURAL EQUATION, V1st, DOI [10.1201/9780203701133, DOI 10.1201/9780203701133]; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Hall LH, 2019, BRIT J GEN PRACT, V69, pE507, DOI 10.3399/bjgp19X702713; Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015; Han S, 2019, ANN INTERN MED, V170, P784, DOI 10.7326/M18-1422; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hartzband P, 2020, NEW ENGL J MED, V382, P2485, DOI 10.1056/NEJMp2003149; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodkinson A, 2021, PROSPERO; Hodkinson A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01774-9; Holm AL, 2011, INT J MENT HEALTH NU, V20, P165, DOI 10.1111/j.1447-0349.2010.00713.x; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kaiser S, 2018, RES NURS HEALTH, V41, P265, DOI 10.1002/nur.21858; Kanter Michael H, 2013, Perm J, V17, P87, DOI 10.7812/TPP/12-120; Kassam AF, 2021, AM J TRANSPLANT, V21, P307, DOI 10.1111/ajt.16075; Kaushik D, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100808; Kelker H, 2021, BMC EMERG MED, V21, DOI 10.1186/s12873-021-00425-3; Khan A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018720; Kirch DG, 2017, JAMA-J AM MED ASSOC, V317, P1947, DOI 10.1001/jama.2017.2714; Lather P., 2007, GETTING LOST FEMINIS; Makara-Studzinska M, 2020, ANN AGR ENV MED, V27, P456, DOI 10.26444/aaem/110846; Marsh Ian, 2010, SUICIDE FOUCAULT HIS; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 2015, INT ENCY SOCIAL BEHA, P929, DOI 10.1016/B978-0-08-097086-8.26009-1; McAbee JH, 2015, J NEUROSURG, V123, P161, DOI 10.3171/2014.12.JNS141348; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; National Academy of Medicine (NAM), 2019, ANNU REP PROG CHEM; Ochoa P, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00662; Olson KD, 2017, MAYO CLIN PROC, V92, P1608, DOI 10.1016/j.mayocp.2017.09.008; Owoc J, 2022, J PATIENT SAF, V18, pE180, DOI 10.1097/PTS.0000000000000724; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Palthe ODRV, 2016, CLIN ORTHOP RELAT R, V474, P1857, DOI 10.1007/s11999-016-4848-6; Panagioti M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4185; Panagioti M, 2017, JAMA INTERN MED, V177, P195, DOI 10.1001/jamainternmed.2016.7674; Panagioti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135947; Parliament UK. House of Commons Health and Social Care Committee, HOUS COMM HLTH SOC C; Pei P, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05593-9; Pit SW, 2014, OCCUP MED-OXFORD, V64, P297, DOI 10.1093/occmed/kqu028; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Prudenzi A, 2022, PSYCHOL HEALTH MED, V27, P1130, DOI 10.1080/13548506.2021.1898651; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Scanlan JN, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3841-z; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1286; Shanafelt TD, 2017, JAMA-J AM MED ASSOC, V317, P901, DOI 10.1001/jama.2017.0076; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2014, J CLIN ONCOL, V32, P678, DOI 10.1200/JCO.2013.51.8480; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Sharma A, 2008, PSYCHO-ONCOLOGY, V17, P570, DOI 10.1002/pon.1269; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Smaggus A, 2019, BMJ QUAL SAF, V28, P667, DOI 10.1136/bmjqs-2018-009147; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tawfik DS, 2019, ANN INTERN MED, V171, P555, DOI 10.7326/M19-1152; Thiese MS, 2016, J THORAC DIS, V8, pE928, DOI 10.21037/jtd.2016.08.16; Van Gerven E, 2016, MED CARE, V54, P937, DOI 10.1097/MLR.0000000000000582; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Welle D, 2020, MAYO CLIN PROC, V95, P719, DOI 10.1016/j.mayocp.2019.09.025; Wells G., 2000, NEWCASTLE OTTAWA SCA; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; Wright T, 2021, B WORLD HEALTH ORGAN, V100, P385, DOI 10.2471/BLT.22.288300; Yates SW, 2020, AM J MED, V133, P160, DOI 10.1016/j.amjmed.2019.08.034; Yuguero O, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0214-9	83	2	2	7	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								e070442	10.1136/bmj-2022-070442	http://dx.doi.org/10.1136/bmj-2022-070442			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104064	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000862323900006
J	Mckay, DIA; Staal, A; Abrams, JF; Winkelmann, R; Sakschewski, B; Loriani, S; Fetzer, I; Cornell, SE; Rockstrom, J; Lenton, TM				Mckay, David I. Armstrong; Staal, Arie; Abrams, Jesse F.; Winkelmann, Ricarda; Sakschewski, Boris; Loriani, Sina; Fetzer, Ingo; Cornell, Sarah E.; Rockstrom, Johan; Lenton, Timothy M.			Exceeding 1.5 degrees C global warming could trigger multiple climate tipping points	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; EARLY-WARNING SIGNALS; SEA-LEVEL; MASS-LOSS; CARBON; THRESHOLDS; COLLAPSE; THWAITES; ELEMENTS; CO2	Climate tipping points occur when change in a part of the climate system becomes self-perpetuating beyond a warming threshold, leading to substantial Earth system impacts. Synthesizing paleoclimate, observational, and model-based studies, we provide a revised shortlist of global "core" tipping elements and regional "impact" tipping elements and their temperature thresholds. Current global warming of similar to 1.1 degrees C above preindustrial temperatures already lies within the lower end of some tipping point uncertainty ranges. Several tipping points may be triggered in the Paris Agreement range of 1.5 to <2 degrees C global warming, with many more likely at the 2 to 3 degrees C of warming expected on current policy trajectories. This strengthens the evidence base for urgent action to mitigate climate change and to develop improved tipping point risk assessment, early warning capability, and adaptation strategies.	[Mckay, David I. Armstrong; Staal, Arie; Fetzer, Ingo; Cornell, Sarah E.; Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Mckay, David I. Armstrong; Staal, Arie; Fetzer, Ingo; Cornell, Sarah E.] Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden; [Mckay, David I. Armstrong; Abrams, Jesse F.; Lenton, Timothy M.] Univ Exeter, Global Syst Inst, Exeter, England; [Mckay, David I. Armstrong] Georesilience Analyt, Leatherhead, England; [Staal, Arie] Univ Utrecht, Copernicus Inst Sustainable Dev, Utrecht, Netherlands; [Winkelmann, Ricarda; Sakschewski, Boris; Loriani, Sina; Rockstrom, Johan] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Winkelmann, Ricarda] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany	Stockholm University; University of Exeter; Utrecht University; Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Mckay, DIA (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Mckay, DIA (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, Stockholm, Sweden.; Mckay, DIA; Lenton, TM (corresponding author), Univ Exeter, Global Syst Inst, Exeter, England.; Mckay, DIA (corresponding author), Georesilience Analyt, Leatherhead, England.	d.mckay@exeter.ac.uk; m.lenton@exeter.ac.uk		Armstrong McKay, David/0000-0002-0020-7461	European Research Council Advanced Investigator project "Earth Resilience in the Anthropocene" [ERC-2016-ADG-743080]; Oak Foundation, MAVA; Gordon and Betty Moore Foundation; Global Environment Facility; Leverhulme Trust [RPG-2018-046]; Herlin Foundation; Turing Fellowship	European Research Council Advanced Investigator project "Earth Resilience in the Anthropocene"; Oak Foundation, MAVA; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Global Environment Facility; Leverhulme Trust(Leverhulme Trust); Herlin Foundation; Turing Fellowship	This work was initiated and supported by the European Research Council Advanced Investigator project "Earth Resilience in the Anthropocene" ERC-2016-ADG-743080 (to D.I.A.M., A.S., S.C., I.F., and J.R.). This work is part of the Earth Commission which is hosted by Future Earth and is the science component of the Global Commons Alliance. The Global Commons Alliance is a sponsored project of Rockefeller Philanthropy Advisors, with support from Oak Foundation, MAVA, Porticus, Gordon and Betty Moore Foundation, Herlin Foundation, and the Global Environment Facility. (to D.I.A.M., J.F.A., R.W., B.S., S.L., and J.R.). This work was also supported by the Leverhulme Trust RPG-2018-046 (to T.M.L. and D.I.A.M.) and the Turing Fellowship (to T.M.L.).	Abis B, 2017, BIOGEOSCIENCES, V14, P511, DOI 10.5194/bg-14-511-2017; Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Allison I, 2009, COPENHAGEN DIAGNOSIS; Arthern RJ, 2017, GEOPHYS RES LETT, V44, P2352, DOI 10.1002/2017GL072514; Boers N, 2021, NAT CLIM CHANGE, V11, P680, DOI 10.1038/s41558-021-01097-4; Boers N, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2024192118|1of7, 10.1073/pnas.2024192118]; Boos WR, 2016, P NATL ACAD SCI USA, V113, P1510, DOI 10.1073/pnas.1517143113; Boulton CA, 2022, NAT CLIM CHANGE, V12, P271, DOI 10.1038/s41558-022-01287-8; Bozbiyik A, 2011, CLIM PAST, V7, P319, DOI 10.5194/cp-7-319-2011; Bury TM, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2106140118|1of9, 10.1073/pnas.2106140118]; Caesar L, 2018, NATURE, V556, P191, DOI 10.1038/s41586-018-0006-5; Cai YY, 2016, NAT CLIM CHANGE, V6, P520, DOI [10.1038/nclimate2964, 10.1038/NCLIMATE2964]; Canadell J. G., 2021, CLIMATE CHANGE 2021, DOI DOI 10.1260/095830507781076194; Christ AJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021442118; Clark PU, 2020, NATURE, V577, P660, DOI 10.1038/s41586-020-1931-7; Clark PU, 2016, NAT CLIM CHANGE, V6, P360, DOI 10.1038/NCLIMATE2923; Collins M., 2019, EXTREMES ABRUPT CHAN, P589, DOI [10.1017/9781009157964.008, DOI 10.1017/9781009157964.008]; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; DeConto RM, 2021, NATURE, V593, P83, DOI 10.1038/s41586-021-03427-0; Docquier D, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00172; Dosio A, 2021, CLIM DYNAM, V57, P3135, DOI 10.1007/s00382-021-05859-w; Douville H., 2021, CLIMATE CHANGE 2021, P73; Drijfhout S, 2015, P NATL ACAD SCI USA, V112, pE5777, DOI 10.1073/pnas.1511451112; Drijfhout S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14877; Edwards TL, 2019, NATURE, V566, P58, DOI 10.1038/s41586-019-0901-4; Erfanian A, 2016, J ADV MODEL EARTH SY, V8, P1411, DOI 10.1002/2016MS000660; Feldmann J, 2015, P NATL ACAD SCI USA, V112, P14191, DOI 10.1073/pnas.1512482112; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Fox-Kemper B., 2021, IPCC 2021 SUMMARY PO; Fox-Kemper B., 2021, CLIMATE CHANGE 2021, P1211, DOI [10.5285/77B64C55-7166-4A06-9DEF-2E400398E452, 10.1017/9781009157896.011, DOI 10.1109/OCEANSE.2009.5278204]; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Garbe J, 2020, NATURE, V585, P538, DOI 10.1038/s41586-020-2727-5; Gasson E, 2016, P NATL ACAD SCI USA, V113, P3459, DOI 10.1073/pnas.1516130113; Gatti LV, 2021, NATURE, V595, P388, DOI 10.1038/s41586-021-03629-6; Gerten D, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034032; Gregory JM, 2020, CRYOSPHERE, V14, P4299, DOI 10.5194/tc-14-4299-2020; Hankel C, 2021, J CLIMATE, V34, P4435, DOI 10.1175/JCLI-D-20-0558.1; Hezel PJ, 2014, CRYOSPHERE, V8, P1195, DOI 10.5194/tc-8-1195-2014; Hock R., 2019, IPCC SPECIAL REPORT, DOI [10.1017/9781009157964.004, DOI 10.1017/9781009157964.004]; Hoegh-Guldberg O., 2018, GLOBAL WARMING 15, P175, DOI [10.1017/9781009157940.005, DOI 10.1093/AJE/KWP410]; Hollesen J, 2015, NAT CLIM CHANGE, V5, P574, DOI 10.1038/nclimate2590; Hopcroft PO, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2108783118; Hubau W, 2020, NATURE, V579, P80, DOI 10.1038/s41586-020-2035-0; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Huss M, 2018, NAT CLIM CHANGE, V8, P135, DOI 10.1038/s41558-017-0049-x; IPCC, 2021, CONTRIBUTION WORKING, DOI DOI 10.1007/S10584-021-03233-7; Jackson LC, 2015, CLIM DYNAM, V45, P3299, DOI 10.1007/s00382-015-2540-2; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; King MD, 2020, COMMUN EARTH ENVIRON, V1, DOI 10.1038/s43247-020-0001-2; Kopp RE, 2016, EARTHS FUTURE, V4, P346, DOI 10.1002/2016EF000362; Koven CD, 2013, NAT GEOSCI, V6, P452, DOI [10.1038/NGEO1801, 10.1038/ngeo1801]; Kriegler E, 2009, P NATL ACAD SCI USA, V106, P5041, DOI 10.1073/pnas.0809117106; Lehner F, 2013, J CLIMATE, V26, P7586, DOI 10.1175/JCLI-D-12-00690.1; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Lenton TM, 2012, AMBIO, V41, P10, DOI 10.1007/s13280-011-0221-x; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; Levermann A, 2012, CLIMATIC CHANGE, V110, P845, DOI 10.1007/s10584-011-0126-5; Liu W, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601666; Lohmann J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017989118; Lovejoy TE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2340; Luke CM, 2011, EUR J SOIL SCI, V62, P5, DOI 10.1111/j.1365-2389.2010.01312.x; Lynch-Stieglitz J, 2017, ANNU REV MAR SCI, V9, P83, DOI 10.1146/annurev-marine-010816-060415; Meinshausen M, 2022, NATURE, V604, P304, DOI 10.1038/s41586-022-04553-z; National Research Council, 2002, ABRUPT CLIMATE CHANG; Nobre C., 2021, SCI PANEL AMAZON SPA; Nobre CA, 2016, P NATL ACAD SCI USA, V113, P10759, DOI 10.1073/pnas.1605516113; Noel B, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2020GL090471; Notz D, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL086749; Osman MB, 2021, NATURE, V599, P239, DOI 10.1038/s41586-021-03984-4; Pausata FSR, 2020, ONE EARTH, V2, P235, DOI 10.1016/j.oneear.2020.03.002; Ranasinghe R., 2021, CLIMATE CHANGE 2021, P73; Rietkerk M, 2021, EVASION TIPPING COMP, V374, DOI [DOI 10.1038/S41561-019-0310-1, 10.1038/s41561-019-0310-1]; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Ritchie PDL, 2021, NATURE, V592, P517, DOI 10.1038/s41586-021-03263-2; Robinson A, 2012, NAT CLIM CHANGE, V2, P429, DOI 10.1038/NCLIMATE1449; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schellnhuber HJ, 2016, NAT CLIM CHANGE, V6, P649, DOI 10.1038/nclimate3013; Schmidt MW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15637-6; Schneider T, 2019, NAT GEOSCI, V12, P163, DOI 10.1038/s41561-019-0310-1; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Sgubin G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14375; Shepherd A, 2020, NATURE, V579, P233, DOI 10.1038/s41586-019-1855-2; Staal A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18728-7; Staal A, 2018, NAT CLIM CHANGE, V8, P539, DOI 10.1038/s41558-018-0177-y; Steffen W, 2018, P NATL ACAD SCI USA, V115, P8252, DOI 10.1073/pnas.1810141115; Strauss J, 2017, EARTH-SCI REV, V172, P75, DOI 10.1016/j.earscirev.2017.07.007; Swingedouw D, 2021, ANN NY ACAD SCI, V1504, P187, DOI 10.1111/nyas.14659; Terrer C, 2019, NAT CLIM CHANGE, V9, P684, DOI 10.1038/s41558-019-0545-2; Teufel B, 2019, NAT CLIM CHANGE, V9, P858, DOI 10.1038/s41558-019-0614-6; Turetsky MR, 2020, NAT GEOSCI, V13, P138, DOI 10.1038/s41561-019-0526-0; Turney CSM, 2020, P NATL ACAD SCI USA, V117, P3996, DOI 10.1073/pnas.1902469117; Vaks A, 2013, SCIENCE, V340, P183, DOI 10.1126/science.1228729; Van Breedam J, 2020, EARTH SYST DYNAM, V11, P953, DOI 10.5194/esd-11-953-2020; Waibel MS, 2018, GEOPHYS RES LETT, V45, P809, DOI 10.1002/2017GL076470; Wilson DJ, 2018, NATURE, V561, P383, DOI 10.1038/s41586-018-0501-8; Wunderling N, 2021, EARTH SYST DYNAM, V12, P601, DOI 10.5194/esd-12-601-2021; Yu HJ, 2019, GEOPHYS RES LETT, V46, P14539, DOI 10.1029/2019GL084066; Zemp DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14681	100	1	1	74	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1171	+	eabn7950	10.1126/science.abn7950	http://dx.doi.org/10.1126/science.abn7950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074831	Green Accepted			2022-12-28	WOS:000887933400003
J	Zhang, BX; Kubis, C; Franke, R				Zhang, Baoxin; Kubis, Christoph; Franke, Robert			Hydroformylation catalyzed by unmodified cobalt carbonyl under mild conditions	SCIENCE			English	Article							ANTI-MARKOVNIKOV HYDROFORMYLATION; PHOSPHORUS LIGANDS; DECOMPOSITION; MONOXIDE; ALKENES	Hydroformylation with unmodified cobalt carbonyl catalyst plays a crucial role in industrial production of surfactants and plasticizers. However, syngas pressures of 100 to 400 bar with reaction temperatures of 100 degrees to 250 degrees C are typically applied. We report here that unmodified cobalt carbonyl is a stable hydroformylation catalyst at 140 degrees C under 30 bar of syngas. The activity was comparable to that of recently reported bisphosphine-coordinated cobalt(II) catalysts, which we could not reproduce under the reported conditions. Kinetic and in situ infrared spectroscopic studies confirmed the stability of the unmodified cobalt tetracarbonyl hydride [HCo(CO)(4)]. Branched internal olefins were converted to aldehydes with high regioselectivity under low syngas pressures without phosphorus ligands. Bisphosphines had a small promotional effect on the catalyst at phosphorus-to-cobalt loading ratios below 0.6.	[Zhang, Baoxin; Kubis, Christoph] Leibniz Inst Catalysis eV, Albert Einstein Str 29a, D-18059 Rostock, Germany; [Franke, Robert] Evonik Operat GmbH, Paul Baumann Str 1, D-45772 Marl, Germany; [Franke, Robert] Ruhr Univ Bochum, Lehrstuhl Theoret Chem, D-44780 Bochum, Germany	Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT); Ruhr University Bochum	Zhang, BX (corresponding author), Leibniz Inst Catalysis eV, Albert Einstein Str 29a, D-18059 Rostock, Germany.; Franke, R (corresponding author), Evonik Operat GmbH, Paul Baumann Str 1, D-45772 Marl, Germany.; Franke, R (corresponding author), Ruhr Univ Bochum, Lehrstuhl Theoret Chem, D-44780 Bochum, Germany.	baoxin.zhang@catalysis.de; robert.franke@evonik.com	Zhang, Baoxin/HGU-2483-2022	Zhang, Baoxin/0000-0002-0372-0252	Evonik Operations GmbH	Evonik Operations GmbH	The authors gratefully acknowledge the financial support from Evonik Operations GmbH.	Achonduh G, 2015, TETRAHEDRON, V71, P1241, DOI 10.1016/j.tet.2015.01.006; ALVILA L, 1992, J MOL CATAL, V73, P325, DOI 10.1016/0304-5102(92)80085-U; [Anonymous], 1956, German Patent, Patent No. [DE1218428, 1218428]; Arias JL, 2013, TRANSIT METAL CHEM, V38, P787, DOI 10.1007/s11243-013-9750-4; BANERJEE TK, 1981, J CHEM TECHNOL BIOT, V31, P737, DOI 10.1002/jctb.280310199; Behr A., 2012, APPL HOMOGENEOUCAT; Borner A., 2016, HYDROFORMYLATION FUN; Borole YL, 2005, IND ENG CHEM RES, V44, P9601, DOI 10.1021/ie050272g; Brezny AC, 2018, ACCOUNTS CHEM RES, V51, P2344, DOI 10.1021/acs.accounts.8b00335; Cornils B., 1980, NEW SYNTHESES CARBON, P1; Dengler JE, 2011, J ORGANOMET CHEM, V696, P3831, DOI 10.1016/j.jorganchem.2011.07.035; Franke R, 2012, CHEM REV, V112, P5675, DOI 10.1021/cr3001803; GHOLAP RV, 1992, IND ENG CHEM RES, V31, P1597, DOI 10.1021/ie00007a003; Haumann M, 2004, DALTON T, P1679, DOI 10.1039/b403033h; Hebrard F, 2009, CHEM REV, V109, P4272, DOI 10.1021/cr8002533; HECK RF, 1960, J AM CHEM SOC, V82, P4438, DOI 10.1021/ja01501a088; HECK RF, 1961, J AM CHEM SOC, V83, P4023, DOI 10.1021/ja01480a017; Hood DM, 2020, SCIENCE, V367, P542, DOI 10.1126/science.aaw7742; Huo CF, 2003, ORGANOMETALLICS, V22, P4665, DOI 10.1021/om0304863; Janssen M, 2010, ANGEW CHEM INT EDIT, V49, P7738, DOI 10.1002/anie.201001926; Jia XF, 2012, CHEM-EUR J, V18, P15288, DOI 10.1002/chem.201203042; KLINGLER RJ, 1994, J AM CHEM SOC, V116, P4772, DOI 10.1021/ja00090a025; Klingler RJ, 2007, ORGANOMETALLICS, V26, P352, DOI 10.1021/om060768d; Kubis C, 2014, CHEM-EUR J, V20, P11921, DOI 10.1002/chem.201402515; Li SL, 2020, ORG LETT, V22, P1108, DOI 10.1021/acs.orglett.9b04624; Meijboom R, 2005, HELV CHIM ACTA, V88, P676, DOI 10.1002/hlca.200590047; Neymeyr K, 2010, J CHEMOMETR, V24, P67, DOI 10.1002/cem.1273; Roelen O., 1952, German Patent, Patent No. [DE849548, 849548]; Rosi L, 1996, J MOL CATAL A-CHEM, V112, P367, DOI 10.1016/1381-1169(96)00135-5; Sawall M, 2016, J IRAN CHEM SOC, V13, P191, DOI 10.1007/s13738-015-0727-4; SLAUGH LH, 1968, J ORGANOMET CHEM, V13, P469, DOI 10.1016/S0022-328X(00)82775-8; UNGVARY F, 1969, J ORGANOMET CHEM, V20, P205, DOI 10.1016/S0022-328X(00)80107-2; UNGVARY F, 1980, J ORGANOMET CHEM, V193, P383, DOI 10.1016/S0022-328X(00)90298-5; van Leeuwen P.W.N.M., 2002, RHODIUM CATALYZED HY; vanRooy A, 1996, ORGANOMETALLICS, V15, P835, DOI 10.1021/om950549k; VELECKIS E, 1984, J CHEM ENG DATA, V29, P36, DOI 10.1021/je00035a013; Vilches-Herrera M, 2014, ACS CATAL, V4, P1706, DOI 10.1021/cs500273d; WEGMAN RW, 1980, J AM CHEM SOC, V102, P2494, DOI 10.1021/ja00527a077; You C, 2018, J AM CHEM SOC, V140, P4977, DOI 10.1021/jacs.8b00275	39	1	1	30	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1223	+		10.1126/science.abm4465	http://dx.doi.org/10.1126/science.abm4465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074860				2022-12-28	WOS:000887933400048
J	Rosenbaum, S; Somodevilla, A; Casoni, M				Rosenbaum, Sara; Somodevilla, Alexander; Casoni, Maria			Will EMTALA Be There for People with Pregnancy-Related Emergencies?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara; Casoni, Maria] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC 20037 USA; [Somodevilla, Alexander] Foley Hoag, Washington, DC USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC 20037 USA.							Becerra X., 2022, COMMUNICATION 0711; Guttmacher Institute, 2022, AB POL ABS ROE; Rosenbaum Sara, 2012, LAW AM HLTH CARE SYS, V2d, P3; The White House, 2022, FACT SHEET PRES BID; US Food and Drug Administration, 2021, REINF EMTALA OBL SPE	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					863	865		10.1056/NEJMp2209893	http://dx.doi.org/10.1056/NEJMp2209893		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36053229				2022-12-28	WOS:000849787000001
J	Anderegg, WRL; Wu, C; Acil, N; Carvalhais, N; Pugh, TAM; Sadler, JP; Seidl, R				Anderegg, William R. L.; Wu, Chao; Acil, Nezha; Carvalhais, Nuno; Pugh, Thomas A. M.; Sadler, Jon P.; Seidl, Rupert			A climate risk analysis of Earth's forests in the 21st century	SCIENCE			English	Article							MORTALITY; DROUGHT; MODELS	Earth's forests harbor extensive biodiversity and are currently a major carbon sink. Forest conservation and restoration can help mitigate climate change; however, climate change could fundamentally imperil forests in many regions and undermine their ability to provide such mitigation. The extent of climate risks facing forests has not been synthesized globally nor have different approaches to quantifying forest climate risks been systematically compared. We combine outputs from multiple mechanistic and empirical approaches to modeling carbon, biodiversity, and disturbance risks to conduct a synthetic climate risk analysis for Earth's forests in the 21st century. Despite large uncertainty in most regions we find that some forests are consistently at higher risk, including southern boreal forests and those in western North America and parts of the Amazon.	[Anderegg, William R. L.; Wu, Chao] Univ Utah, Wilkes Ctr Climate Sci & Policy, Salt Lake City, UT 84103 USA; [Anderegg, William R. L.; Wu, Chao] Univ Utah, Sch Biol Sci, Salt Lake City, UT 84103 USA; [Acil, Nezha; Pugh, Thomas A. M.; Sadler, Jon P.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, England; [Acil, Nezha; Pugh, Thomas A. M.; Sadler, Jon P.] Univ Birmingham, Birmingham Inst Forest Res, Birmingham, England; [Carvalhais, Nuno] Max Planck Inst Biogeochem, Jena, Germany; [Carvalhais, Nuno] Univ Nova Lisboa, Dept Ciencias & Engn Ambiente DCEA, Fac Ciencias Tecnol FCT, P-2829516 Caparica, Portugal; [Pugh, Thomas A. M.] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Seidl, Rupert] Tech Univ Munich, Sch Life Sci, Freising Weihenstephan, Germany; [Seidl, Rupert] Berchtesgaden Natl Pk, Berchtesgaden, Germany	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Birmingham; University of Birmingham; Max Planck Society; Universidade Nova de Lisboa; Lund University; Technical University of Munich	Anderegg, WRL (corresponding author), Univ Utah, Wilkes Ctr Climate Sci & Policy, Salt Lake City, UT 84103 USA.; Anderegg, WRL (corresponding author), Univ Utah, Sch Biol Sci, Salt Lake City, UT 84103 USA.	anderegg@utah.edu	Pugh, Thomas A M/A-3790-2010	Pugh, Thomas A M/0000-0002-6242-7371; Acil, Nezha/0000-0002-4043-0414; Sadler, Jonathan/0000-0003-0443-4458; Seidl, Rupert/0000-0002-3338-3402; Wu, Chao/0000-0003-3233-856X	David and Lucille Packard Foundation; US National Science Foundation [1802880, 2003017, 2044937]; USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Programme, Ecosystem Services and Agro-Ecosystem Management [2018-67019-27850]; European Research Council (ERC) under the European Union [101001905, 758873]	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); US National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Programme, Ecosystem Services and Agro-Ecosystem Management; European Research Council (ERC) under the European Union(European Research Council (ERC))	W.R.L.A. acknowledges support from the David and Lucille Packard Foundation, US National Science Foundation grants 1802880, 2003017, and 2044937, and USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Programme, Ecosystem Services and Agro-Ecosystem Management, grant 2018-67019-27850. C.W. acknowledges support from the David and Lucille Packard Foundation. R.S., N.A., and T.P. acknowledge support from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 101001905, FORWARD, to R.S.; grant agreement 758873, TreeMort, to N.A. and T.P.) This study contributes to the strategic research areas BECC and MERGE.	Albrich K, 2020, GLOBAL ECOL BIOGEOGR, V29, P2082, DOI 10.1111/geb.13197; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2020, SCIENCE, V368, P1327, DOI 10.1126/science.aaz7005; [Anonymous], MAT METHODS ARE AVAI; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brodribb TJ, 2020, SCIENCE, V368, P261, DOI 10.1126/science.aat7631; Coffield SR, 2021, AGU ADV, V2, DOI 10.1029/2021AV000384; Dobrowski SZ, 2021, COMMUN EARTH ENVIRON, V2, DOI 10.1038/s43247-021-00270-z; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elsen PR, 2022, GLOBAL CHANGE BIOL, V28, P918, DOI 10.1111/gcb.15962; FAO and UNEP, 2020, STAT WORLDS FOR 2020, DOI [DOI 10.4060/CA8642-N, DOI 10.4060/CA8642EN]; Fisher RA, 2018, GLOBAL CHANGE BIOL, V24, P35, DOI 10.1111/gcb.13910; Friedlingstein P, 2014, J CLIMATE, V27, P511, DOI 10.1175/JCLI-D-12-00579.1; Gatti LV, 2021, NATURE, V595, P388, DOI 10.1038/s41586-021-03629-6; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Hantson S, 2020, GEOSCI MODEL DEV, V13, P3299, DOI 10.5194/gmd-13-3299-2020; Koch A, 2021, EARTHS FUTURE, V9, DOI 10.1029/2020EF001874; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lecina-Diaz J, 2021, FRONT ECOL ENVIRON, V19, P126, DOI 10.1002/fee.2278; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mori AS, 2021, NAT CLIM CHANGE, V11, P543, DOI 10.1038/s41558-021-01062-1; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Pugh TAM, 2019, NAT GEOSCI, V12, P730, DOI 10.1038/s41561-019-0427-2; Roe S, 2019, NAT CLIM CHANGE, V9, P817, DOI 10.1038/s41558-019-0591-9; Saatchi S, 2021, ONE EARTH, V4, P988, DOI 10.1016/j.oneear.2021.06.002; Sanderson BM, 2020, NAT CLIM CHANGE, V10, P175, DOI 10.1038/s41558-020-0707-2; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Seidl R, 2020, ECOGRAPHY, V43, P967, DOI 10.1111/ecog.04995; Seidl R, 2017, NAT CLIM CHANGE, V7, P395, DOI [10.1038/NCLIMATE3303, 10.1038/nclimate3303]; Wang JA, 2021, NAT CLIM CHANGE, V11, P435, DOI 10.1038/s41558-021-01027-4	31	3	3	26	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1099	1103		10.1126/science.abp9723	http://dx.doi.org/10.1126/science.abp9723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048937				2022-12-28	WOS:000887933200045
J	Nayak, S; Taatjes, DJ				Nayak, Shraddha; Taatjes, Dylan J.			SnapShot: Mediator complex structure	CELL			English	Editorial Material									[Nayak, Shraddha] MRC Lab Mol Biol, Cambridge, England; [Taatjes, Dylan J.] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA	MRC Laboratory Molecular Biology; University of Colorado System; University of Colorado Boulder	Nayak, S (corresponding author), MRC Lab Mol Biol, Cambridge, England.				NIH [R01AI156739, R35GM139550]; NSF [MCB-1818147]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	Acknowledgments The Taatjes lab is supported in part by the NIH (R01AI156739 and R35GM139550) and the NSF (MCB-1818147) .	Abdella R, 2021, SCIENCE, V372, P52, DOI 10.1126/science.abg3074; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Chen XZ, 2021, SCIENCE, V372, P1055, DOI 10.1126/science.abg0635; Currie SL, 2017, J MOL BIOL, V429, P2975, DOI 10.1016/j.jmb.2017.06.024; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Rengachari S, 2021, NATURE, V594, P129, DOI 10.1038/s41586-021-03555-7; Schilbach S, 2017, NATURE, V551, P204, DOI 10.1038/nature24282; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Zhao HY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21601-w	10	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3458	+		10.1016/j.cell.2022.07.011	http://dx.doi.org/10.1016/j.cell.2022.07.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4L5NE	36055203				2022-12-28	WOS:000852676300002
J	Simon, DJ; Levitz, J				Simon, David J.; Levitz, Joshua			A ciliary synapse for ?short-circuit?neuromodulation	CELL			English	Editorial Material							CILIUM	Nearly all neurons contain a primary cilium, but little is known about how this compartment contributes to neuromodulatory signaling. In a new study, Sheu et al. use cutting-edge electron microscopy and fluores-cence imaging techniques to reveal a new type of synapse that enables chemical transmission between sero-tonergic axons and the primary cilia of hippocampal neurons.	[Simon, David J.; Levitz, Joshua] Weill Cornell Med Coll, Dept Biochem, New York, NY 10024 USA	Cornell University	Simon, DJ; Levitz, J (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10024 USA.	djs4002@med.cornell.edu; jtl2003@med.cornell.edu						Abdullah Fazil, NEURAL NETWORKS, V63, P75, DOI [10.1016/j.neuroimage.2016.10.047, DOI 10.1016/J.IJHYDENE.2012.08.006, 10.1016/j.chb.2016.05.014, DOI 10.1016/J.NEUNET.2008.03.014]; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Avet C, 2022, ELIFE, V11, DOI 10.7554/eLife.74101; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Guo J, 2019, DEV CELL, V51, P759, DOI 10.1016/j.devcel.2019.11.005; Haddad SA, 2018, NEURON, V100, P609, DOI 10.1016/j.neuron.2018.08.035; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Martin-Ramos Pablo, 2022, NJAS-WAGEN J LIFE SC, V80, P420, DOI [10.1016/j.neuroscience.2009.06.040, DOI 10.1016/J.NEUROSCIENCE.2009.06.040, 10.1016/j.chb.2017.12.011, DOI 10.1016/J.NJAS.2015.09.001, 10.1016/j.cell.2013.08.001, DOI 10.1016/J.ANNEPIDEM.2013.07.021.QUANTIFYING]; Mullins N, 2021, NAT GENET, V53, P817, DOI 10.1038/s41588-021-00857-4; Ravotto L, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00067; Sheu SH, 2022, CELL, V185, P3390, DOI 10.1016/j.cell.2022.07.026	11	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3284	3286		10.1016/j.cell.2022.08.006	http://dx.doi.org/10.1016/j.cell.2022.08.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4V8AJ	36055196				2022-12-28	WOS:000859694600003
J	Pal, SK; Uzzo, R; Karam, JA; Master, VA; Donskov, F; Suarez, C; Albiges, L; Rini, B; Tomita, Y; Kann, AG; Procopio, G; Massari, F; Zibelman, M; Antonyan, I; Huseni, M; Basu, D; Ci, B; Leung, W; Khan, O; Dubey, S; Bex, A				Pal, Sumanta Kumar; Uzzo, Robert; Karam, Jose Antonio; Master, Viraj A.; Donskov, Frede; Suarez, Cristina; Albiges, Laurence; Rini, Brian; Tomita, Yoshihiko; Kann, Ariel Galapo; Procopio, Giuseppe; Massari, Francesco; Zibelman, Matthew; Antonyan, Igor; Huseni, Mahrukh; Basu, Debasmita; Ci, Bo; Leung, William; Khan, Omara; Dubey, Sarita; Bex, Axel			Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial	LANCET			English	Article							SUNITINIB; NEPHRECTOMY; THERAPY	Background The standard of care for locoregional renal cell carcinoma is surgery, but many patients experience recurrence. The objective of the current study was to determine if adjuvant atezolizumab (vs placebo) delayed recurrence in patients with an increased risk of recurrence after resection. Methods IMmotion010 is a randomised, double-blind, multicentre, phase 3 trial conducted in 215 centres in 28 countries. Eligible patients were patients aged 18 years or older with renal cell carcinoma with a clear cell or sarcomatoid component and increased risk of recurrence. After nephrectomy with or without metastasectomy, patients were randomly assigned (1:1) to receive atezolizumab (1200 mg) or placebo (both intravenous) once every 3 weeks for 16 cycles or 1 year. Randomisation was done with an interactive voice-web response system. Stratification factors were disease stage (T2 or T3a vs T3b-c or T4 or N+ vs M1 no evidence of disease), geographical region (north America [excluding Mexico] vs rest of the world), and PD-L1 status on tumour-infiltrating immune cells (<1% vs >= 1% expression). The primary endpoint was investigator-assessed disease-free survival in the intention-to-treat population, defined as all patients who were randomised, regardless of whether study treatment was received. The safety-evaluable population included all patients randomly assigned to treatment who received any amount of study drug (ie, atezolizumab or placebo), regardless of whether a full or partial dose was received. This trial is registered with ClinicalTrials.gov, NCT03024996, and is closed to further accrual. Findings Between Jan 3, 2017, and Feb 15, 2019, 778 patients were enrolled; 390 (50%) were assigned to the atezolizumab group and 388 (50%) to the placebo group. At data cutoff (May 3, 2022), the median follow-up duration was 44.7 months (IQR 39.1-51.0). Median investigator-assessed disease-free survival was 57.2 months (95% CI 44.6 to not evaluable) with atezolizumab and 49.5 months (47.4 to not evaluable) with placebo (hazard ratio 0.93, 95% CI 0.75-1.15, p=0.50). The most common grade 3-4 adverse events were hypertension (seven [2%] patients who received atezolizumab vs 15 [4%] patients who received placebo), hyperglycaemia (ten [3%] vs six [2%]), and diarrhoea (two [1%] vs seven [2%]). 69 (18%) patients who received atezolizumab and 46 (12%) patients who received placebo had a serious adverse event. There were no treatment-related deaths. Interpretation Atezolizumab as adjuvant therapy after resection for patients with renal cell carcinoma with increased risk of recurrence showed no evidence of improved clinical outcomes versus placebo. These study results do not support adjuvant atezolizumab for treatment of renal cell carcinoma. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Pal, Sumanta Kumar] City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA 91010 USA; [Uzzo, Robert] Fox Chase Canc Ctr, Dept Urol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Zibelman, Matthew] Fox Chase Canc Ctr, Dept Hematol & Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Karam, Jose Antonio] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Karam, Jose Antonio] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Master, Viraj A.] Emory Univ, Dept Urol, Atlanta, GA 30322 USA; [Master, Viraj A.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Donskov, Frede] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark; [Donskov, Frede] Univ Hosp Southern Denmark, Esbjerg, Denmark; [Suarez, Cristina] Vall dHebron Barcelona Hosp Campus, Hosp Univ Vall dHebron, Vall dHebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain; [Albiges, Laurence] Univ Paris Saclay, Gustave Roussy, Dept Canc Med, Villejuif, France; [Rini, Brian] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Tomita, Yoshihiko] Niigata Univ, Niigita Univ Med & Dent Hosp, Dept Urol, Niigata, Japan; [Kann, Ariel Galapo] Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil; [Procopio, Giuseppe] Fdn IRCCS Ist Nazl Tumori Milano, Dept Med Oncol, Milan, Italy; [Massari, Francesco] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy; [Antonyan, Igor] VI Shapoval Reg Med Clin Ctr Urol & Nephrol, Kharkiv, Ukraine; [Huseni, Mahrukh; Ci, Bo; Leung, William; Dubey, Sarita] Genentech Inc, San Francisco, CA USA; [Basu, Debasmita; Khan, Omara] Roche Prod, Welwyn Garden City, Herts, England; [Bex, Axel] Univ Coll London, Royal Free London NHS Fdn Trust, Div Surge & Intervent Sci, Dept Urol, Amsterdam, Netherlands; [Bex, Axel] Netherlands Canc Inst, Amsterdam, Netherlands	City of Hope; Fox Chase Cancer Center; Fox Chase Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Emory University; Emory University; Aarhus University; University of Southern Denmark; Odense University Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Vanderbilt University; Niigata University; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Roche Holding; Genentech; Roche Holding; Netherlands Cancer Institute	Pal, SK (corresponding author), City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA 91010 USA.	spal@coh.org		Donskov, Frede/0000-0002-8449-863X	F Hoffmann -La Roche; Genentech; Roche group	F Hoffmann -La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); Roche group	F Hoffmann -La Roche and Genentech, a member of the Roche group.	Allaf ME, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.TPS4596; [Anonymous], 2022, TECENTRIQ ATEZOLIZUM; Bedke J, 2021, EUR UROL, V79, P339, DOI 10.1016/j.eururo.2020.12.005; Bex A, 2020, J CLIN ONCOL, V38; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bristol Myers Squibb, 2022, BRIST MYERS SQUIBB P; Choueiri TK, 2021, NEW ENGL J MED, V385, P683, DOI 10.1056/NEJMoa2106391; Choueiri TK, 2022, J CLIN ONCOL, V40, DOI 10.1200/JCO.2022.40.6_suppl.290; Eisen T, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01800; Gross-Goupil M, 2018, ANN ONCOL, V29, P2371, DOI 10.1093/annonc/mdy454; Haas NB, 2016, LANCET, V387, P2008, DOI 10.1016/S0140-6736(16)00559-6; Lalani AKA, 2022, THER ADV MED ONCOL, V14, DOI 10.1177/17588359221108685; Lam JS, 2005, UROLOGY, V66, P1, DOI 10.1016/j.urology.2005.06.112; Lawrence L, CLIN CHALLENGES USE; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Marconi L, 2021, CLIN GENITOURIN CANC, V19, pE92, DOI 10.1016/j.clgc.2020.12.005; McDermott DF, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.20.02365; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2018, EUR UROL, V73, P62, DOI 10.1016/j.eururo.2017.09.008; Motzer RJ, 2017, J CLIN ONCOL, V35, P3916, DOI 10.1200/JCO.2017.73.5324; Oza B, 2021, CONTEMP CLIN TRIALS, V108, DOI 10.1016/j.cct.2021.106482; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Powles T, 2021, ANN ONCOL, V32, P1511, DOI 10.1016/j.annonc.2021.09.014; Powles T, 2021, NATURE, V595, P432, DOI 10.1038/s41586-021-03642-9; Ravaud A, 2016, NEW ENGL J MED, V375, P2246, DOI 10.1056/NEJMoa1611406; Rini BI, 2021, EUR UROL, V79, P659, DOI 10.1016/j.eururo.2020.06.021; Ryan CW., 2022, J CLIN ONCOL, V40, DOI DOI 10.1200/JCO.2022.40.17_SUPPL.LBA4500; SEER, 2022, CAMC STAT FACTS KIDN; Staehler M, 2018, ANN ONCOL, V29, P2098, DOI 10.1093/annonc/mdy329	29	4	4	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2022	400	10358					1103	1116		10.1016/S0140-6736(22)01658-0	http://dx.doi.org/10.1016/S0140-6736(22)01658-0			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5W3OW	36099926				2022-12-28	WOS:000877828800015
J	Knox, RP; Sarpatwari, A				Knox, Ryan P.; Sarpatwari, Ameet			Risks to the 340B Drug Pricing Program Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Knox, Ryan P.] Harvard Med Sch, Harvard MIT Ctr Regulatory Sci, Boston, MA 02115 USA; [Sarpatwari, Ameet] Harvard Med Sch, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sarpatwari, A (corresponding author), Harvard Med Sch, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	asarpatwari@bwh.harvard.edu			Arnold Ventures	Arnold Ventures	Dr Sarpatwari's work is supported by Arnold Ventures.	[Anonymous], 2022, 340B CRIT PROGR HLTH; [Anonymous], 2021, SANOFI AVENTIS US LL; [Anonymous], 2022, CONTR PHARM RESTR RE; [Anonymous], 2021, NOVARTIS PHARM CORP; Knox RP, 2022, JAMA-J AM MED ASSOC, V327, P1647, DOI 10.1001/jama.2022.5959; Nikpay S, 2022, AM J MANAG CARE, V28, P133, DOI 10.37765/ajmc.2022.88840	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1109	1110		10.1001/jama.2022.12756	http://dx.doi.org/10.1001/jama.2022.12756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125474				2022-12-28	WOS:000862909200029
J	Hluchy, M; Gajduskova, P; de los Mozos, IR; Rajecky, M; Kluge, M; Berger, BT; Slaba, Z; Potesil, D; Weiss, E; Ule, J; Zdrahal, Z; Knapp, S; Paruch, K; Friedel, CC; Blazek, D				Hluchy, Milan; Gajduskova, Pavla; Ruiz de los Mozos, Igor; Rajecky, Michal; Kluge, Michael; Berger, Benedict-Tilman; Slaba, Zuzana; Potesil, David; Weiss, Elena; Ule, Jernej; Zdrahal, Zbynek; Knapp, Stefan; Paruch, Kamil; Friedel, Caroline C.; Blazek, Dalibor			CDK11 regulates pre-mRNA splicing by phosphorylation ofSF3B1	NATURE			English	Article							HUMAN SPLICEOSOME; IN-VIVO; P-TEFB; PROTEIN; TARGET; DESIGN; SNRNP; INHIBITION; DISCOVERY; ISOFORMS	RNA splicing, the process of intron removal from pre-mRNA, is essential for the regulation of gene expression. It is controlled by the spliceosome, a megadalton RNA-protein complex that assembles de novo on each pre-mRNA intron through an ordered assembly of intermediate complexes(1,2). Spliceosome activation is a major control step that requires substantial protein and RNA rearrangements leading to a catalytically active complex(1-5). Splicing factor 3B subunit 1 (SF3B1) protein-a subunit of the U2 small nuclear ribonucleoprotein(6)-is phosphorylated during spliceosome activation(7-)(10), but the kinase that is responsible has not been identified. Here we show that cyclin-dependent kinase 11 (CDK11) associates with SF3B1 and phosphorylates threonine residues at its N terminus during spliceosome activation. The phosphorylation is important for the association between SF3B1 and U5 and U6 snRNAs in the activated spliceosome, termed the B(act )complex, and the phosphorylation can be blocked by OTS964, a potent and selective inhibitor of CDK11. Inhibition of CDK11 prevents spliceosomal transition from the precatalytic complex B to the activated complex B-act and leads to widespread intron retention and accumulation of non-functional spliceosomes on pre-mRNAs and chromatin. We demonstrate a central role of CDK11 in spliceosome assembly and splicing regulation and characterize OTS964 as a highly selective CDK11 inhibitor that suppresses spliceosome activation and splicing.	[Hluchy, Milan; Gajduskova, Pavla; Rajecky, Michal; Slaba, Zuzana; Potesil, David; Zdrahal, Zbynek; Blazek, Dalibor] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Ruiz de los Mozos, Igor; Ule, Jernej] Francis Crick Inst, London, England; [Ruiz de los Mozos, Igor] Govt Navarra, Dept Personalized Med, NASERTIC, Pamplona, Spain; [Ruiz de los Mozos, Igor] Univ Navarra, Ctr Appl Med Res, Pamplona, Spain; [Kluge, Michael; Weiss, Elena; Friedel, Caroline C.] Ludwig Maximilians Univ Munchen, Inst Informat, Munich, Germany; [Berger, Benedict-Tilman; Knapp, Stefan] Goethe Univ Frankfurt Main, Buchmann Inst Life Sci BMLS, Struct Genom Consortium SGC, Frankfurt, Germany; [Berger, Benedict-Tilman; Knapp, Stefan] Goethe Univ Frankfurt Main, Inst Pharmazeut Chem, Frankfurt, Germany; [Ule, Jernej] Kings Coll London, UK Dementia Res Inst, London, England; [Paruch, Kamil] Masaryk Univ, Fac Sci, Dept Chem, Brno, Czech Republic; [Paruch, Kamil] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic	Masaryk University Brno; Francis Crick Institute; University of Navarra; University of Munich; Goethe University Frankfurt; Goethe University Frankfurt; University of London; King's College London; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Blazek, D (corresponding author), Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic.	dalibor.blazek@ceitec.muni.cz	de los Mozos, Igor Ruiz/Q-6269-2019; Potesil, David/D-9696-2012; Ule, Jernej/C-6315-2013	de los Mozos, Igor Ruiz/0000-0003-4097-6422; Potesil, David/0000-0003-0390-0904; Zdrahal, Zbynek/0000-0003-3044-5548; Weiss, Elena/0000-0001-9252-5629; Rajecky, Michal/0000-0002-0865-4012; Ule, Jernej/0000-0002-2452-4277; Hluchy, Milan/0000-0002-1231-5208; Berger, Benedict-Tilman/0000-0002-3314-2617	Czech Science Foundation [21-19266S]; CEITEC (Project CEITEC-Central-European Institute of Technology) [CZ.1.05/1.1.00/02.0068]; GAMU [MUNI/G/1129/2021]; Deutsche Forschungsgemeinschaft (DFG) [FR2938/9-1, FR2938/10-1]; European Union's Horizon 2020 research and innovation programme [835300-RNPdynamics]; European Structural and Investment Funds, Operational Programme Research, Development and Education-"Preclinical Progression of New Organic Compounds with Targeted Biological Activity" (Preclinprogress) from the National Program of Sustainability II (MEYS [CZ.02.1.01/0.0/0.0/16_025/0007381, LQ1605]; project CZ-OPENSCREEN: National Infrastructure for Chemical Biology [LM2018130]; Bader Philanthropies; CIISB, Instruct-CZ Centre of Instruct-ERIC EU consortium - MEYS CR infrastructure project [LM2018127]; Ministry of Education, Youth and Sports of the Czech Republic [90140]; AbbVie; Bayer; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genentech; Genome Canada through Ontario Genomics Institute [OGI-196]; EU/EFPIA/OICR/McGill/KTH/Diamond; Innovative Medicines Initiative 2 Joint Undertaking (EUbOPEN grant) [875510]; Janssen; Merck; Merck Co; Pfizer; Takeda; Wellcome; German translational cancer network (DKTK); Frankfurt Cancer Institute (FCI); collaborative research center 1399 "Mechanisms of drug sensitivity and resistance in small cell lung cancer"	Czech Science Foundation(Grant Agency of the Czech Republic); CEITEC (Project CEITEC-Central-European Institute of Technology); GAMU; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation programme; European Structural and Investment Funds, Operational Programme Research, Development and Education-"Preclinical Progression of New Organic Compounds with Targeted Biological Activity" (Preclinprogress) from the National Program of Sustainability II (MEYS; project CZ-OPENSCREEN: National Infrastructure for Chemical Biology; Bader Philanthropies; CIISB, Instruct-CZ Centre of Instruct-ERIC EU consortium - MEYS CR infrastructure project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genentech(Roche HoldingGenentech); Genome Canada through Ontario Genomics Institute(Genome Canada); EU/EFPIA/OICR/McGill/KTH/Diamond; Innovative Medicines Initiative 2 Joint Undertaking (EUbOPEN grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Merck Co(Merck & Company); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome; German translational cancer network (DKTK); Frankfurt Cancer Institute (FCI); collaborative research center 1399 "Mechanisms of drug sensitivity and resistance in small cell lung cancer"	We thank all of the members of the Blazek laboratory for discussions throughout the project and comments on the manuscript; M. Hallegger for protocols and advice regarding in vitro splicing assays; M. Sebesta for providing GST-RNAPII<SUP>CTD</SUP>, T. Barta for providing anti-CDK2 antibodies; K. Hanakova for assistance with proteomic experiments; and the staff at Life Science Editors for editing services. This research was supported by grants from the Czech Science Foundation (21-19266S); the CEITEC (Project CEITEC-Central-European Institute of Technology (CZ.1.05/1.1.00/02.0068)); GAMU MUNI/G/1129/2021 to D.B.; the Deutsche Forschungsgemeinschaft (DFG; grants FR2938/9-1 and FR2938/10-1) to C.C.F.; the European Union's Horizon 2020 research and innovation programme (835300-RNPdynamics) to J.U; European Structural and Investment Funds, Operational Programme Research, Development and Education-"Preclinical Progression of New Organic Compounds with Targeted Biological Activity" (Preclinprogress)-CZ.02.1.01/0.0/0.0/16_025/0007381, project no. LQ1605 from the National Program of Sustainability II (MEYS CR); the project CZ-OPENSCREEN: National Infrastructure for Chemical Biology (LM2018130); Bader Philanthropies; and GAMU MUNI/G/1129/2021 to K.P. CIISB, Instruct-CZ Centre of Instruct-ERIC EU consortium, funded by MEYS CR infrastructure project LM2018127, is acknowledged for the financial support of the measurements at the CEITEC Proteomics Core Facility. Computational resources were supplied by the project "e-Infrastruktura CZ" (e-INFRA CZ ID: 90140) supported by the Ministry of Education, Youth and Sports of the Czech Republic. S.K. and B.-T.B. are grateful for support from the SGC, a registered charity (no. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, Eshelman Institute for Innovation, Genentech, Genome Canada through Ontario Genomics Institute (OGI-196), EU/EFPIA/OICR/McGill/KTH/Diamond, Innovative Medicines Initiative 2 Joint Undertaking (EUbOPEN grant 875510), Janssen, Merck, Merck & Co, Pfizer, Takeda and Wellcome; S.K. from the German translational cancer network (DKTK) and the Frankfurt Cancer Institute (FCI); and S.K. and B.-T.B. from the collaborative research center 1399 "Mechanisms of drug sensitivity and resistance in small cell lung cancer".	Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Asquith CRM, 2019, J MED CHEM, V62, P2830, DOI 10.1021/acs.jmedchem.8b01213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Bonfert T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0557-5; Briese M, 2019, NAT STRUCT MOL BIOL, V26, P930, DOI 10.1038/s41594-019-0300-4; Caizzi L, 2021, MOL CELL, V81, P1920, DOI 10.1016/j.molcel.2021.02.016; Carrocci Tucker J, 2019, Cold Spring Harb Symp Quant Biol, V84, P11, DOI 10.1101/sqb.2019.84.040402; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duffy Erin E, 2016, Curr Protoc Chem Biol, V8, P234, DOI 10.1002/cpch.12; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Gajduskova P, 2020, NAT STRUCT MOL BIOL, DOI 10.1038/s41594-020-0406-8; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Greifenberg AK, 2016, CELL REP, V14, P320, DOI 10.1016/j.celrep.2015.12.025; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu QF, 2019, EUR J MED CHEM, V162, P407, DOI 10.1016/j.ejmech.2018.11.007; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Kluge M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2107-4; Koga M, 2015, NUCLEIC ACIDS RES, V43, P8258, DOI 10.1093/nar/gkv740; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kramer A, 2020, EUR J MED CHEM, V208, DOI 10.1016/j.ejmech.2020.112770; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8412; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Loyer P, 1998, J CELL SCI, V111, P1495; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Loyer P, 2011, J BIOL CHEM, V286, P147, DOI 10.1074/jbc.M110.192518; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Manavalan APC, 2019, EMBO REP, V20, DOI 10.15252/embr.201847592; Matsuo Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010277; Mukherjee P, 2021, METHOD ENZYMOL, V658, P137, DOI 10.1016/bs.mie.2021.06.005; Murthy T, 2018, J BIOL CHEM, V293, P10220, DOI 10.1074/jbc.RA118.001654; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Pak V, 2015, CELL HOST MICROBE, V18, P560, DOI 10.1016/j.chom.2015.10.012; Paruch K, 2010, ACS MED CHEM LETT, V1, P204, DOI 10.1021/ml100051d; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Pilarova Kveta, 2020, NAR Cancer, V2, pzcaa003, DOI 10.1093/narcan/zcaa003; Quaresma AJC, 2016, NUCLEIC ACIDS RES, V44, P7527, DOI 10.1093/nar/gkw585; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanso M, 2016, GENE DEV, V30, P117, DOI 10.1101/gad.269589.115; Schneider-Poetsch T, 2021, J ANTIBIOT, V74, P603, DOI 10.1038/s41429-021-00450-1; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Stejskal K, 2013, J PROTEOME RES, V12, P3057, DOI 10.1021/pr400183v; Sun CF, 2020, CELL MOL LIFE SCI, V77, P3583, DOI 10.1007/s00018-020-03493-z; Teng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15522; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Townsend C, 2020, SCIENCE, V370, P1433, DOI 10.1126/science.abc3753; Trembley JH, 2003, J BIOL CHEM, V278, P2265, DOI 10.1074/jbc.M207518200; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Van Nostrand EL, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01982-9; Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wells CI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16559-0; Wilkinson ME, 2020, ANNU REV BIOCHEM, V89, P359, DOI 10.1146/annurev-biochem-091719-064225; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14	80	0	0	23	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					829	+		10.1038/s41586-022-05204-z	http://dx.doi.org/10.1038/s41586-022-05204-z		SEP 2022	36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4U9VA	36104565				2022-12-28	WOS:000854742900002
J	Teng, XK; Chen, LB; Ye, F; Rosenberg, E; Liu, ZY; Yin, JX; Jiang, YX; Oh, JS; Hasan, MZ; Neubauer, KJ; Gao, B; Xie, YF; Hashimoto, M; Lu, DH; Jozwiak, C; Bostwick, A; Rotenberg, E; Birgeneau, RJ; Chu, JH; Yi, M; Dai, PC				Teng, Xiaokun; Chen, Lebing; Ye, Feng; Rosenberg, Elliott; Liu, Zhaoyu; Yin, Jia-Xin; Jiang, Yu-Xiao; Oh, Ji Seop; Hasan, M. Zahid; Neubauer, Kelly J.; Gao, Bin; Xie, Yaofeng; Hashimoto, Makoto; Lu, Donghui; Jozwiak, Chris; Bostwick, Aaron; Rotenberg, Eli; Birgeneau, Robert J.; Chu, Jiun-Haw; Yi, Ming; Dai, Pengcheng			Discovery of charge density wave in a kagome lattice antiferromagnet	NATURE			English	Article							STRIPES; PHASE; MODEL	A hallmark of strongly correlated quantum materials is the rich phase diagram resulting from competing and intertwined phases with nearly degenerate ground-state energies(1,2). A well-known example is the copper oxides, in which a charge density wave (CDW) is ordered well above and strongly coupled to the magnetic order to form spin-charge-separated stripes that compete with superconductivity(1,2). Recently, such rich phase diagrams have also been shown in correlated topological materials. In 2D kagome lattice metals consisting of corner-sharing triangles, the geometry of the lattice can produce flat bands with localized electrons(3,4), non-trivial topology(5-7), chiral magnetic order(8,9), superconductivity and CDW order(10-15). Although CDW has been found in weakly electron-correlated non-magnetic AV(3)Sb(5) (A = K, Rb, Cs)(10-15), it has not yet been observed in correlated magnetic-ordered kagome lattice metals(4,16-21). Here we report the discovery of CDW in the antiferromagnetic (AFM) ordered phase of kagome lattice FeGe (refs. (16-19)). The CDW in FeGe occurs at wavevectors identical to that of AV(3)Sb(5) (refs. (10-15)), enhances the AFM ordered moment and induces an emergent anomalous Hall effect(22,23). Our findings suggest that CDW in FeGe arises from the combination of electron-correlations-driven AFM order and van Hove singularities (vHSs)-driven instability possibly associated with a chiral flux phase(24-28), in stark contrast to strongly correlated copper oxides(1,2) and nickelates(29-31), in which the CDW precedes or accompanies the magnetic order.	[Teng, Xiaokun; Chen, Lebing; Oh, Ji Seop; Neubauer, Kelly J.; Gao, Bin; Xie, Yaofeng; Yi, Ming; Dai, Pengcheng] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Ye, Feng] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN USA; [Rosenberg, Elliott; Liu, Zhaoyu; Chu, Jiun-Haw] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Yin, Jia-Xin; Jiang, Yu-Xiao; Hasan, M. Zahid] Princeton Univ, Dept Phys, Lab TopoL Quantum Matter & Adv Spect, Princeton, NJ 08544 USA; [Oh, Ji Seop; Birgeneau, Robert J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Hashimoto, Makoto; Lu, Donghui] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Jozwiak, Chris; Bostwick, Aaron; Rotenberg, Eli] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA USA; [Birgeneau, Robert J.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA USA	Rice University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Washington; University of Washington Seattle; Princeton University; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Yi, M; Dai, PC (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.	mingyi@rice.edu; pdai@rice.edu	Ye, Feng/B-3210-2010; Yin, Jia-Xin/AAA-8548-2019; liu, zhao/GXV-6141-2022; Dai, Pengcheng/C-9171-2012; Chu, Jiun-Haw/B-1613-2012	Ye, Feng/0000-0001-7477-4648; Yin, Jia-Xin/0000-0003-2661-4206; Teng, Xiaokun/0000-0002-7185-085X; Dai, Pengcheng/0000-0002-6088-3170; Liu (liu zhao yu), Zhaoyu/0000-0002-9894-9622; Chu, Jiun-Haw/0000-0001-6222-1210; Chen, Lebing/0000-0002-9829-8428; Neubauer, Kelly/0000-0002-4852-1230	US NSF [DMR-2100741]; Robert A. Welch Foundation [C-2024, C-1839]; U.S. Department Of Energy (DOE) [DE-SC0021421]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF9470]; Air Force Office of Scientific Research [FA9550-21-1-0068]; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation [GBMF4547, GBMF9461]; U.S. DOE under the Basic Energy Sciences programme [DOE/BES DE-FG-02-05ER46200]; U.S. DOE [DE-AC02-05-CH11231, KC2202]; U.S. DOE Office of Science User Facilities [DE-AC02-05CH11231, AC02-76SF00515]	US NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); U.S. Department Of Energy (DOE)(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. DOE under the Basic Energy Sciences programme(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); U.S. DOE Office of Science User Facilities(United States Department of Energy (DOE))	We thank D. Xiao, Q. Si and C. Setty for helpful discussions. The neutron scattering and single-crystal synthesis work at Rice was supported by US NSF-DMR-2100741 and by the Robert A. Welch Foundation under grant no. C-1839, respectively. The ARPES work at Rice was supported by the U.S. Department Of Energy (DOE) grant no. DE-SC0021421, the Gordon and Betty Moore Foundation's EPiQS Initiative through grant no. GBMF9470 and the Robert A. Welch Foundation grant no. C-2024. The transport experiment at the University of Washington was supported by the Air Force Office of Scientific Research under grant FA9550-21-1-0068 and the David and Lucile Packard Foundation. Experimental and theoretical work at Princeton University was supported by the Gordon and Betty Moore Foundation (GBMF4547 and GBMF9461; M.Z.H.) and the U.S. DOE under the Basic Energy Sciences programme (grant no. DOE/BES DE-FG-02-05ER46200). The work at the University of California, Berkeley was supported by the U.S. DOE under contract no. DE-AC02-05-CH11231 in the Quantum Materials Program (KC2202). This research used resources of the Advanced Light Source and the Stanford Synchrotron Radiation Lightsource, both U.S. DOE Office of Science User Facilities under contract nos. DE-AC02-05CH11231 and AC02-76SF00515, respectively. A portion of this research used resources at the Spallation Neutron Source, a DOE Office of Science User Facility operated by Oak Ridge National Laboratory.	BECKMAN O, 1972, PHYS SCRIPTA, V6, P151, DOI 10.1088/0031-8949/6/2-3/009; BERNHARD J, 1988, J PHYS F MET PHYS, V18, P539, DOI 10.1088/0305-4608/18/3/023; BERNHARD J, 1984, J PHYS F MET PHYS, V14, P2379, DOI 10.1088/0305-4608/14/10/017; Chen H, 2021, NATURE, V599, P222, DOI 10.1038/s41586-021-03983-5; Denner MM, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.217601; Feng XL, 2021, SCI BULL, V66, P1384, DOI 10.1016/j.scib.2021.04.043; Ghimire NJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe2680; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Huang L, 2020, PHYS REV B, V102, DOI 10.1103/PhysRevB.102.125130; Jiang YX, 2021, NAT MATER, V20, P1353, DOI 10.1038/s41563-021-01034-y; Kang MG, 2022, NAT PHYS, V18, P301, DOI 10.1038/s41567-021-01451-5; Kang MG, 2020, NAT MATER, V19, P163, DOI 10.1038/s41563-019-0531-0; Khalaniya RA, 2019, J SOLID STATE CHEM, V270, P118, DOI 10.1016/j.jssc.2018.10.030; Larsson AK, 1998, J SOLID STATE CHEM, V141, P199, DOI 10.1006/jssc.1998.7951; Lee SH, 1997, PHYS REV LETT, V79, P2514, DOI 10.1103/PhysRevLett.79.2514; Liang ZW, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.031026; Liu ZH, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.041010; Mazin II, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5261; Mielke C, 2022, NATURE, V602, P245, DOI 10.1038/s41586-021-04327-z; Neupert T, 2022, NAT PHYS, V18, P137, DOI 10.1038/s41567-021-01404-y; OHOYAMA T, 1963, J PHYS SOC JPN, V18, P589, DOI 10.1143/JPSJ.18.589; Ortiz BR, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.247002; Petricek V, 2014, Z KRIST-CRYST MATER, V229, P345, DOI 10.1515/zkri-2014-1737; RICHARDS.M, 1967, ACTA CHEM SCAND, V21, P2305, DOI 10.3891/acta.chem.scand.21-2305; Sales BC, 2019, PHYS REV MATER, V3, DOI 10.1103/PhysRevMaterials.3.114203; Setty C., PREPRINT; Si QM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076401; Suzuki T, 2016, NAT PHYS, V12, P1119, DOI [10.1038/nphys3831, 10.1038/NPHYS3831]; Tranquada JM, 2020, ADV PHYS, V69, P437, DOI 10.1080/00018732.2021.1935698; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Wang Q, 2021, PHYS REV B, V103, DOI 10.1103/PhysRevB.103.014416; Wu WY, 2018, CRYSTENGCOMM, V20, P2916, DOI 10.1039/c8ce00211h; Xie YF, 2021, COMMUN PHYS-UK, V4, DOI 10.1038/s42005-021-00736-8; Yang SY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb6003; Ye F, 2018, J APPL CRYSTALLOGR, V51, P315, DOI 10.1107/S160057671800403X; Ye LD, 2018, NATURE, V555, P638, DOI 10.1038/nature25987; Yin JX, 2020, NATURE, V583, P533, DOI 10.1038/s41586-020-2482-7; Yin JX, 2018, NATURE, V562, P91, DOI 10.1038/s41586-018-0502-7; Yu FH, 2021, PHYS REV B, V104, DOI 10.1103/PhysRevB.104.L041103; Zhang JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19836-0; Zhao H, 2021, NATURE, V599, P216, DOI 10.1038/s41586-021-03946-w	45	4	4	79	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					490	+		10.1038/s41586-022-05034-z	http://dx.doi.org/10.1038/s41586-022-05034-z		SEP 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O8AF	36104552	Green Submitted			2022-12-28	WOS:000854742300005
J	Kuehn, BM				Kuehn, Bridget M.			Most Insured People With Hepatitis C Don't Get Timely Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					919	919		10.1001/jama.2022.14706	http://dx.doi.org/10.1001/jama.2022.14706			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098717				2022-12-28	WOS:000855222400010
J	Kutscher, E				Kutscher, Eric			Erasing Shame in Sexuality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kutscher, Eric] NYU Langone Hlth, Dept Internal Med, New York, NY 10016 USA; [Kutscher, Eric] Bellevue Hosp Ctr, Dept Internal Med, New York, NY 10016 USA	NYU Langone Medical Center; Bellevue Hospital Center	Kutscher, E (corresponding author), NYU Langone Hlth, Dept Internal Med, New York, NY 10016 USA.; Kutscher, E (corresponding author), Bellevue Hosp Ctr, Dept Internal Med, New York, NY 10016 USA.	eric.kutscher@nyulangone.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2022	328	14					1397	1398		10.1001/jama.2022.17156	http://dx.doi.org/10.1001/jama.2022.17156		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5L0OS	36094525	Bronze			2022-12-28	WOS:000854267400001
J	Lok, P				Lok, Pat			Clinicians in the 21st century-caring for the people and the planet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Bandyopadhyay A, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o1258; Chakravorty T, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2830; Chedid G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o19; Davey P, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2020-055084; Doherty Patrick, 2022, BMJ, V376, po131, DOI 10.1136/bmj.o131; Duric B, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o1744; Ho T, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o896; Kaminskaite V, 2022, BMJ-BRIT MED J, V378, DOI 10.1136/bmj.o1398; Kusi-Appiah Adjoa E, 2022, BMJ, V378, po1898, DOI 10.1136/bmj.o1898; Lok P, 2022, BMJ; Lok P, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o1108; Lok P, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o649; Lynch-Kelly K, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2970; Moore A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2385; Osborne R, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o947; Rao M., 2021, BMJ OPINION; Shepherd Alison, 2022, BMJ, V377, po1450, DOI 10.1136/bmj.o1450; Sherman Jodi D, 2022, BMJ, V377, po1301, DOI 10.1136/bmj.o1301; Singh H, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2021-068044; Smith C, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o920; Sucharitkul PPJ, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o561; Wilkinson E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o421	22	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2022	378								o1954	10.1136/bmj.o1954	http://dx.doi.org/10.1136/bmj.o1954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A9SO	36096519				2022-12-28	WOS:000863219000007
J	Eisenhauer, N				Eisenhauer, Nico			A walk in the office	SCIENCE			English	Editorial Material									[Eisenhauer, Nico] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Eisenhauer, Nico] Univ Leipzig, Leipzig, Germany	Leipzig University	Eisenhauer, N (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.; Eisenhauer, N (corresponding author), Univ Leipzig, Leipzig, Germany.								0	0	0	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1232	1232						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074848				2022-12-28	WOS:000887933400050
J	Wang, T; Zhang, Y; Kong, WY; Qiao, L; Peng, BG; Shen, ZC; Han, QF; Chen, H; Yuan, ZL; Zheng, RK; Yang, XD				Wang, Tao; Zhang, Yao; Kong, Weiyu; Qiao, Liang; Peng, Bingguo; Shen, Zhichao; Han, Qifeng; Chen, Han; Yuan, Zhiliang; Zheng, Rongkun; Yang, Xudong			Transporting holes stably under iodide invasion in efficient perovskite solar cells	SCIENCE			English	Article							ION MIGRATION; SEMICONDUCTORS; DEGRADATION; INTERLAYERS; STABILITY	Highly efficient halide perovskite solar cells generally rely on lithium-doped organic hole transporting layers that are thermally and chemically unstable, in part because of migration of iodide anions from the perovskite layer. We report a solution strategy to stabilize the hole transport in organic layers by ionic coupling positive polymer radicals and molecular anions through an ion-exchange process. The target layer exhibited a hole conductivity that was 80 times higher than that of the conventional lithium-doped layer. Moreover, after extreme iodide invasion caused by light-soaking at 85 degrees C for 200 hours, the target layer maintained high hole conductivity and well-matched band alignment. This ion-exchange strategy enabled fabrication of perovskite solar cells with a certified power conversion efficiency of 23.9% that maintained 92% under standard illumination at 85 degrees C after 1000 hours.	[Wang, Tao; Zhang, Yao; Kong, Weiyu; Qiao, Liang; Peng, Bingguo; Shen, Zhichao; Han, Qifeng; Chen, Han; Yang, Xudong] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China; [Wang, Tao; Kong, Weiyu; Qiao, Liang; Peng, Bingguo; Yang, Xudong] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Ctr Hydrogen Sci, Shanghai 200240, Peoples R China; [Wang, Tao; Kong, Weiyu; Qiao, Liang; Peng, Bingguo; Yang, Xudong] Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study, Shanghai 201210, Peoples R China; [Yuan, Zhiliang] Beijing Acad Quantum Informat Sci, Beijing 100193, Peoples R China; [Zheng, Rongkun] Univ Sydney, Sydney Nano Inst, Sch Phys, Sydney, NSW 2006, Australia	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Sydney	Yang, XD (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.; Yang, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Ctr Hydrogen Sci, Shanghai 200240, Peoples R China.; Yang, XD (corresponding author), Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study, Shanghai 201210, Peoples R China.	yang.xudong@sjtu.edu.cn	Zheng, Rongkun/A-7923-2008; Yang, Xudong/S-4750-2017; Yuan, Zhiliang/HHZ-6646-2022	Zheng, Rongkun/0000-0002-7860-2023; Yang, Xudong/0000-0002-3877-7830; Yuan, Zhiliang/0000-0001-5276-9151	National Key Research and Development Program of China [2018YFB1500104]; National Natural Science Foundation of China [11574199, 11911530142]; Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	This work was funded by the National Key Research and Development Program of China (grant no. 2018YFB1500104), the National Natural Science Foundation of China (grant nos. 11574199 and 11911530142), the Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University, and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.	Bi EB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15330; Carrillo J, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502246; Dawson JA, 2017, ACS ENERGY LETT, V2, P1818, DOI 10.1021/acsenergylett.7b00437; FORSTERLING HD, 1992, J PHYS CHEM-US, V96, P3067; Jeon NJ, 2018, NAT ENERGY, V3, P682, DOI 10.1038/s41560-018-0200-6; Jeong J, 2021, NATURE, V592, P381, DOI 10.1038/s41586-021-03406-5; Jeong M, 2020, SCIENCE, V369, P1615, DOI 10.1126/science.abb7167; Jiang Q, 2017, NAT ENERGY, V2, P1, DOI [10.1038/nenergy.2016.177, 10.1038/NENERGY.2016.177]; KIM Y, 1992, SCIENCE, V257, P375, DOI 10.1126/science.257.5068.375; Kong J, 2021, NATURE, V594, P51, DOI 10.1038/s41586-021-03518-y; Kung PK, 2018, ADV MATER INTERFACES, V5, DOI 10.1002/admi.201800882; Lee HK, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42891; Lee I, 2017, ACS APPL MATER INTER, V9, P7029, DOI 10.1021/acsami.6b14089; Li NX, 2020, CHEM SOC REV, V49, P8235, DOI 10.1039/d0cs00573h; Li WZ, 2014, J MATER CHEM A, V2, P13587, DOI 10.1039/c4ta01550a; Li Z, 2017, ENERG ENVIRON SCI, V10, P1234, DOI 10.1039/c7ee00358g; Liu J, 2018, ADV MATER, V30, DOI 10.1002/adma.201704630; Mansour AE, 2022, PHYS CHEM CHEM PHYS, V24, P3109, DOI 10.1039/d1cp04985b; Min H, 2021, NATURE, V598, P444, DOI 10.1038/s41586-021-03964-8; Polat M, 2004, FOOD RES INT, V37, P293, DOI 10.1016/j.foodres.2004.01.002; Rakstys K, 2019, CHEM SCI, V10, P6748, DOI 10.1039/c9sc01184f; Sakai N, 2021, NAT MATER, V20, P1248, DOI 10.1038/s41563-021-00980-x; Schloemer TH, 2019, CHEM SCI, V10, P1904, DOI 10.1039/c8sc05284k; Wang S, 2016, NANO LETT, V16, P5594, DOI 10.1021/acs.nanolett.6b02158; Wang YB, 2019, SCIENCE, V365, P687, DOI 10.1126/science.aax8018; Yamashita Y, 2019, NATURE, V572, P634, DOI 10.1038/s41586-019-1504-9; Ye TL, 2019, ACS APPL MATER INTER, V11, P14004, DOI 10.1021/acsami.8b18663; Yin XX, 2020, ENERG ENVIRON SCI, V13, P4057, DOI 10.1039/d0ee02337j; Yoo JJ, 2021, NATURE, V590, DOI 10.1038/s41586-021-03285-w; Zhao WR, 2020, CHEM SOC REV, V49, P7210, DOI 10.1039/d0cs00204f	30	2	2	96	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1227	1231		10.1126/science.abq6235	http://dx.doi.org/10.1126/science.abq6235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074838				2022-12-28	WOS:000887933400049
J	Furie, RA; van Vollenhoven, RF; Kalunian, K; Navarra, S; Romero-Diaz, J; Werth, VP; Huang, XB; Clark, G; Carroll, H; Meyers, A; Musselli, C; Barbey, C; Franchimont, N				Furie, Richard A.; van Vollenhoven, Ronald F.; Kalunian, Kenneth; Navarra, Sandra; Romero-Diaz, Juanita; Werth, Victoria P.; Huang, Xiaobi; Clark, George; Carroll, Hua; Meyers, Adam; Musselli, Cristina; Barbey, Catherine; Franchimont, Nathalie		LILAC Trial Investigators	Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; DISEASE-ACTIVITY INDEX; ALPHA PRODUCING CELLS; MONOCLONAL-ANTIBODY; REVISED CRITERIA; I INTERFERONS; CLASSIFICATION; ANIFROLUMAB; INHIBITOR; BDCA-2	BACKGROUND Antibody-binding of blood dendritic cell antigen 2 (BDCA2), which is expressed exclusively on plasmacytoid dendritic cells, suppresses the production of type I interferon that is involved in the pathogenesis of systemic lupus erythematosus (SLE). The safety and efficacy of subcutaneous litifilimab, a humanized monoclonal antibody that binds to BDCA2, in patients with SLE have not been extensively studied. METHODS We conducted a phase 2 trial of litifilimab involving participants with SLE. The initial trial design called for randomly assigning participants to receive litifilimab (at a dose of 50, 150, or 450 mg) or placebo administered subcutaneously at weeks 0, 2, 4, 8, 12, 16, and 20, with the primary end point of evaluating cutaneous lupus activity. The trial design was subsequently modified; adults with SLE, arthritis, and active skin disease were randomly assigned to receive either litifilimab at a dose of 450 mg or placebo. The revised primary end point was the change from baseline in the total number of active joints (defined as the sum of the swollen joints and the tender joints) at week 24. Secondary end points were changes in cutaneous and global disease activity. Safety was also assessed. RESULTS A total of 334 adults were assessed for eligibility, and 132 underwent randomization (64 were assigned to receive 450-mg litifilimab, 6 to receive 150-mg litifilimab, 6 to receive 50-mg litifilimab, and 56 to receive placebo). The primary analysis was conducted in the 102 participants who had received 450-mg litifilimab or placebo and had at least four tender and at least four swollen joints. The mean (+/- SD) baseline number of active joints was 19.0 +/- 8.4 in the litifilimab group and 21.6 +/- 8.5 in the placebo group. The least-squares mean (+/- SE) change from baseline to week 24 in the total number of active joints was -15.0 +/- 1.2 with litifilimab and -11.6 +/- 1.3 with placebo (mean difference, -3.4; 95% confidence interval, -6.7 to -0.2; P=0.04). Most of the secondary end points did not support the results of the analysis of the primary end point. Receipt of litifilimab was associated with adverse events, including two cases of herpes zoster and one case of herpes keratitis. CONCLUSIONS In a phase 2 trial involving participants with SLE, litifilimab was associated with a greater reduction from baseline in the number of swollen and tender joints than placebo over a period of 24 weeks. Longer and larger trials are required to determine the safety and efficacy of litifilimab for the treatment of SLE.	[Furie, Richard A.] Northwell Hlth, Great Neck, NY USA; [van Vollenhoven, Ronald F.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Kalunian, Kenneth] Univ Calif San Diego, La Jolla, CA 92093 USA; [Navarra, Sandra] Univ Santo Tomas, Manila, Philippines; [Romero-Diaz, Juanita] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Werth, Victoria P.] Univ Penn, Philadelphia, PA 19104 USA; [Werth, Victoria P.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Huang, Xiaobi; Clark, George; Carroll, Hua; Meyers, Adam; Musselli, Cristina; Franchimont, Nathalie] Biogen, 225 Binney St, Cambridge, MA 02142 USA; [Barbey, Catherine] Biogen, Baar, Switzerland	Northwell Health; University of Amsterdam; University of California System; University of California San Diego; University of Santo Tomas; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Pennsylvania; Biogen	Franchimont, N (corresponding author), Biogen, 225 Binney St, Cambridge, MA 02142 USA.	nathalie.franchimont@biogen.com	GOSPODINOV, DIMITAR/T-3064-2018	GOSPODINOV, DIMITAR/0000-0001-6800-4671; Werth, Victoria/0000-0003-3030-5369; Kalunian, Kenneth/0000-0003-0261-3102	Biogen	Biogen(Biogen)	Supported by Biogen.	Albrecht J, 2005, J INVEST DERMATOL, V125, P889, DOI 10.1111/j.0022-202X.2005.23889.x; Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1136/annrheumdis-2018-214819, 10.1002/art.40930]; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Blomberg S, 2001, LUPUS, V10, P484, DOI 10.1191/096120301678416042; Chakka S, 2021, J AM ACAD DERMATOL, V84, P1562, DOI 10.1016/j.jaad.2020.07.047; Dorner T, 2019, LANCET, V393, P2344, DOI 10.1016/S0140-6736(19)30546-X; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Furie R, 2019, J CLIN INVEST, V129, P1359, DOI 10.1172/JCI124466; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Furie RA, 2019, LANCET RHEUMATOL, V1, pE208, DOI 10.1016/S2665-9913(19)30076-1; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Jegalian AG, 2009, ADV ANAT PATHOL, V16, P392, DOI 10.1097/PAP.0b013e3181bb6bc2; Kalunian KC, 2018, RHEUMATOLOGY, V57, P125, DOI 10.1093/rheumatology/kex368; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Morand EF, 2020, NEW ENGL J MED, V382, P211, DOI 10.1056/NEJMoa1912196; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Pellerin A, 2015, EMBO MOL MED, V7, P464, DOI 10.15252/emmm.201404719; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Ronnblom L, 2002, HUM IMMUNOL, V63, P1181, DOI 10.1016/S0198-8859(02)00757-7; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tomasini D, 2010, J CUTAN PATHOL, V37, P1132, DOI 10.1111/j.1600-0560.2010.01587.x; Tucci M, 2008, ARTHRITIS RHEUM-US, V58, P251, DOI 10.1002/art.23186; Werth VP, 2022, NEW ENGL J MED, V387, P321, DOI 10.1056/NEJMoa2118024	31	1	1	4	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					894	904		10.1056/NEJMoa2118025	http://dx.doi.org/10.1056/NEJMoa2118025			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069871				2022-12-28	WOS:000861634500010
J	Musen, MA				Musen, Mark A.			Demand standards to sort FAIR data from foul	NATURE			English	Editorial Material									[Musen, Mark A.] Stanford Univ Calif, Med Biomed Informat & Biomed Data Sci, Stanford, CA 94305 USA		Musen, MA (corresponding author), Stanford Univ Calif, Med Biomed Informat & Biomed Data Sci, Stanford, CA 94305 USA.	musen@stanford.edu		Musen, Mark/0000-0003-3325-793X					0	2	2	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					222	222		10.1038/d41586-022-02820-7	http://dx.doi.org/10.1038/d41586-022-02820-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H7TB	36064801	Bronze			2022-12-28	WOS:000850078900001
J	Stinville, JC; Charpagne, MA; Cervellon, A; Hemery, S; Wang, F; Section, PGC; Valle, V; Pollock, TM				Stinville, J. C.; Charpagne, M. A.; Cervellon, A.; Hemery, S.; Wang, F.; Callahan, P. G.; Valle, V.; Pollock, T. M.			On the origins of fatigue strength in crystalline metallic materials	SCIENCE			English	Article							HIGH-CYCLE FATIGUE; NICKEL-BASED SUPERALLOY; CRACK INITIATION; TENSILE-STRENGTH; BEHAVIOR; ALLOY; TEMPERATURE; MECHANISMS; STRAIN; LOCALIZATION	Metallic materials experience irreversible deformation with increasing applied stress, manifested in localized slip events that result in fatigue failure upon repeated cycling. We discerned the physical origins of fatigue strength in a large set of face-centered cubic, hexagonal close-packed, and body-centered cubic metallic materials by considering cyclic deformation processes at nanometer resolution over large volumes of individual materials at the earliest stages of cycling. We identified quantitative relations between the yield strength and the ultimate tensile strength, fatigue strength, and physical characteristics of early slip localization events. The fatigue strength of metallic alloys that deform by slip could be predicted by the amplitude of slip localization during the first cycle of loading. Our observations provide a physical basis for well-known empirical fatigue laws and enable a rapid method of predicting fatigue strength as reflected by measurement of slip localization amplitude.	[Stinville, J. C.; Charpagne, M. A.] Univ Illinois, Chicago, IL 60680 USA; [Stinville, J. C.; Charpagne, M. A.; Cervellon, A.; Wang, F.; Callahan, P. G.; Pollock, T. M.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Hemery, S.; Valle, V.] Univ Poitiers, CNRS, Inst PPRIME, ISAE ENSMA,UPR 3346, F-86962 Chasseneuil 86962, France; [Cervellon, A.] Safran Aircraft Engines, Chatellerault, France; [Wang, F.] Shanghai Jiao Tong Univ, Shanghai, Peoples R China; [Callahan, P. G.] US Naval Res Lab, Washington, DC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Nationale Superieure de Mecanique et d'Aerotechnique (ISAE-ENSMA); Universite de Poitiers; Shanghai Jiao Tong University; United States Department of Defense; United States Navy; Naval Research Laboratory	Stinville, JC (corresponding author), Univ Illinois, Chicago, IL 60680 USA.; Stinville, JC (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	jcstinv@illinois.edu		Valle, Valery/0000-0002-3776-6945; Callahan, Patrick/0000-0002-6904-8171	Vannevar Bush DoD Faculty Fellowship; ONR [N00014-18-13031]; Naval Research Laboratory under the Office of Naval Research; Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign	Vannevar Bush DoD Faculty Fellowship; ONR(Office of Naval Research); Naval Research Laboratory under the Office of Naval Research; Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign	Supported by a Vannevar Bush DoD Faculty Fellowship, ONR grant N00014-18-13031; the Naval Research Laboratory under the auspices of the Office of Naval Research (P.G.C.); and startup funds from the Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign (J.C.S.).	Bathias C, 1999, FATIGUE FRACT ENG M, V22, P559, DOI 10.1046/j.1460-2695.1999.00183.x; Bathias C, 2004, GIGACYCLE FATIGUE ME; Bourdin F, 2018, ACTA MATER, V157, P307, DOI 10.1016/j.actamat.2018.07.013; BRECHET Y, 1989, ACTA METALL MATER, V37, P2469, DOI 10.1016/0001-6160(89)90044-8; Chai G, 2015, FATIGUE FRACT ENG M, V38, P1315, DOI 10.1111/ffe.12345; Charpagne MA, 2021, ACTA MATER, V215, DOI 10.1016/j.actamat.2021.117037; Charpagne MA, 2020, MATER CHARACT, V163, DOI 10.1016/j.matchar.2020.110245; Charpagne MA, 2019, MATER CHARACT, V150, P184, DOI 10.1016/j.matchar.2019.01.033; Chen Q, 2005, INT J FATIGUE, V27, P1227, DOI 10.1016/j.ijfatigue.2005.07.022; Chen SY, 2022, J MATER SCI TECHNOL, V114, P191, DOI 10.1016/j.jmst.2021.10.026; Cogez L, 2017, CNL NUCL REV, V6, P221, DOI 10.12943/CNR.2017.00011; Cui YA, 2020, INT J PLASTICITY, V124, P117, DOI 10.1016/j.ijplas.2019.08.008; FATEMI A, 1988, FATIGUE FRACT ENG M, V11, P149, DOI 10.1111/j.1460-2695.1988.tb01169.x; FERRO A, 1965, PHILOS MAG, V12, P867, DOI 10.1080/14786436508218923; FLECK NA, 1994, ACTA METALL MATER, V42, P365, DOI 10.1016/0956-7151(94)90493-6; Gazizov M, 2017, T NONFERR METAL SOC, V27, P1215, DOI 10.1016/S1003-6326(17)60142-0; Ghomsheh MZ, 2020, MAT SCI ENG A-STRUCT, V777, DOI 10.1016/j.msea.2020.139034; HEINZ A, 1990, ACTA METALL MATER, V38, P1933, DOI 10.1016/0956-7151(90)90305-Z; Heinz S, 2016, INT J FATIGUE, V93, P301, DOI 10.1016/j.ijfatigue.2016.04.026; Hemery S, 2021, ACTA MATER, V219, DOI 10.1016/j.actamat.2021.117227; Ho HS, 2015, ACTA MATER, V85, P155, DOI 10.1016/j.actamat.2014.11.020; Karolczuk A, 2019, FATIGUE FRACT ENG M, V42, P197, DOI 10.1111/ffe.12895; Khireddine D, 2000, INT J FATIGUE, V22, P585, DOI 10.1016/S0142-1123(00)00028-1; Kolyshkin A, 2016, INT J FATIGUE, V93, P272, DOI 10.1016/j.ijfatigue.2016.03.017; Lavogiez C, 2020, SCRIPTA MATER, V183, P117, DOI 10.1016/j.scriptamat.2020.03.031; Li P, 2017, ACTA MATER, V129, P98, DOI 10.1016/j.actamat.2017.02.057; Li ZM, 2015, INT J FATIGUE, V80, P468, DOI 10.1016/j.ijfatigue.2015.07.001; Lukas P, 2004, PHILOS MAG, V84, P317, DOI 10.1080/14786430310001610339; Marti N, 2020, MAT SCI ENG A-STRUCT, V772, DOI 10.1016/j.msea.2019.138619; Mayer H, 1999, INT MATER REV, V44, P1, DOI 10.1179/095066099771048801; Miao JS, 2008, SUPERALLOYS 2008, P589, DOI 10.7449/2008/Superalloys_2008_589_597; Mughrabi H, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0132; Mughrabi H, 2013, PROCEDIA ENGINEER, V55, P636, DOI 10.1016/j.proeng.2013.03.307; Mughrabi H, 2009, METALL MATER TRANS A, V40A, P1257, DOI 10.1007/s11661-009-9839-8; Murakami Y., 2002, METAL FATIGUE EFFECT; Nascimento MP, 2011, J MATER PROCESS TECH, V211, P1126, DOI 10.1016/j.jmatprotec.2011.01.016; Nikitin A, 2016, INT J FATIGUE, V93, P318, DOI 10.1016/j.ijfatigue.2016.05.030; Pang JC, 2014, FATIGUE FRACT ENG M, V37, P958, DOI 10.1111/ffe.12158; Pang JC, 2013, MAT SCI ENG A-STRUCT, V564, P331, DOI 10.1016/j.msea.2012.11.103; Papakyriacou M, 2001, MAT SCI ENG A-STRUCT, V308, P143, DOI 10.1016/S0921-5093(00)01978-X; PARK JH, 1995, INT J FATIGUE, V17, P365, DOI 10.1016/0142-1123(95)99737-U; Polak J, 2015, PROCEDIA ENGINEER, V101, P386, DOI 10.1016/j.proeng.2015.02.047; Qi Zhang, 2020, Nature Communications, V11, DOI 10.1038/s41467-020-19071-7; Stanzl-Tschegg SE, 2010, INT J FATIGUE, V32, P886, DOI 10.1016/j.ijfatigue.2009.03.016; Stinville JC, 2020, ACTA MATER, V186, P172, DOI 10.1016/j.actamat.2019.12.009; Stinville JC, 2016, EXP MECH, V56, P197, DOI 10.1007/s11340-015-0083-4; Stinville JC, 2018, ACTA MATER, V152, P16, DOI 10.1016/j.actamat.2018.03.035; Stocker C, 2011, INT J FATIGUE, V33, P2, DOI 10.1016/j.ijfatigue.2010.04.008; Stocker C, 2011, ACTA MATER, V59, P5288, DOI 10.1016/j.actamat.2011.05.005; Thomas R, 2019, MATERIALIA, V5, DOI 10.1016/j.mtla.2019.100248; Torabian N, 2017, ACTA MATER, V134, P40, DOI 10.1016/j.actamat.2017.05.064; Wang C, 2019, FATIGUE FRACT ENG M, V42, P2183, DOI 10.1111/ffe.13104; Weinberger CR, 2013, INT MATER REV, V58, P296, DOI 10.1179/1743280412Y.0000000015; WILLIAMS JC, 1974, SCRIPTA METALL MATER, V8, P625, DOI 10.1016/0036-9748(74)90009-X; Xu ZQ, 2017, INT J FATIGUE, V95, P156, DOI 10.1016/j.ijfatigue.2016.10.013; Yaghoobi M, 2021, NPJ COMPUT MATER, V7, DOI 10.1038/s41524-021-00506-8; Yu DL, 2018, MAT SCI ENG A-STRUCT, V711, P624, DOI 10.1016/j.msea.2017.10.082; Zhao P, 2018, MAT SCI ENG A-STRUCT, V712, P406, DOI 10.1016/j.msea.2017.11.119; Zuo JH, 2008, MAT SCI ENG A-STRUCT, V473, P147, DOI 10.1016/j.msea.2007.04.062	60	3	3	98	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1065	+		10.1126/science.abn0392	http://dx.doi.org/10.1126/science.abn0392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048948				2022-12-28	WOS:000887933200040
J	South, E; Venkataramani, A; Dalembert, G				South, Eugenia; Venkataramani, Atheendar; Dalembert, George			Building Black Wealth - The Role of Health Systems in Closing the Gap	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISPARITIES; MORTALITY; OUTCOMES	Building Black Wealth Since wealth is a fundamental driver of health, health equity strategies that fail to close the racial wealth gap may be ineffective. What can health systems do to help address this major social determinant of health?	[South, Eugenia] Univ Penn, Penn Urban Hlth Lab, Perelman Sch Med, Philadelphia, PA 19104 USA; [South, Eugenia] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Venkataramani, Atheendar] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dalembert, George] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [South, Eugenia; Venkataramani, Atheendar; Dalembert, George] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Dalembert, George] Childrens Hosp Philadelphia, Possibilities Project, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	South, E (corresponding author), Univ Penn, Penn Urban Hlth Lab, Perelman Sch Med, Philadelphia, PA 19104 USA.; South, E (corresponding author), Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA.							Akbar P.A., 2019, RACIAL SEGREGATION H; [Anonymous], 2018, SAMUEL DUBOIS COOK C, V3; Bassett MT, 2020, NEW ENGL J MED, V383, P2101, DOI 10.1056/NEJMp2026170; Blakemore E, 2021, GI BILLS PROMISE WAS; Boen C, 2020, J HEALTH SOC BEHAV, V61, P153, DOI 10.1177/0022146520924811; Brandolini A, 2010, J POLICY ANAL MANAG, V29, P267, DOI 10.1002/pam.20491; Case A, 2020, DEATHS OF DESPAIR AND THE FUTURE OF CAPITALISM, P1; Center on Budget and Policy Priorities, 2019, POL BAS EARN INC TAX; Chetty R, 2018, Q J ECON, V133, P1107, DOI 10.1093/qje/qjy007; COATES K., 2016, NO INDIGENOUS PEOPLE; Cooper Zack, 2021, Health Aff (Millwood), V40, P1830, DOI 10.1377/hlthaff.2021.01130; Dalembert G., 2021, NEJM CATALYST, V2, DOI [10.1056/CAT.20.0594, DOI 10.1056/CAT.20.0594]; Derenoncourt E., 2022, W30101 NAT BUR EC RE; Dill J, 2022, HEALTH AFFAIR, V41, P265, DOI 10.1377/hlthaff.2021.01400; Elliott W, 2013, CHILD YOUTH SERV REV, V35, P560, DOI 10.1016/j.childyouth.2012.12.003; Ettman CK, 2020, ANN EPIDEMIOL, V43, P25, DOI 10.1016/j.annepidem.2020.02.001; Faber JW, 2013, HOUS POLICY DEBATE, V23, P328, DOI 10.1080/10511482.2013.771788; Fuller AE, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-1975; Gibson-Davis C, 2021, J MARRIAGE FAM, V83, P667, DOI 10.1111/jomf.12742; Green Kaye-Alese, 2021, Acad Pediatr, V21, pS194, DOI 10.1016/j.acap.2021.08.018; Hamilton Darrick, 2010, REV BLACK POLIT ECON, V37, P207, DOI DOI 10.1007/S12114-010-9063-1; Harris K., 2011, CLGH REV, V45, P74; Himmelstein KEW, 2019, AM J PUBLIC HEALTH, V109, P198, DOI 10.2105/AJPH.2018.304801; Khanani I, 2010, AM J PUBLIC HEALTH, V100, pS204, DOI 10.2105/AJPH.2009.168922; Makaroun LK, 2017, JAMA INTERN MED, V177, P1745, DOI 10.1001/jamainternmed.2017.3903; Marcil Lucy E, 2021, Acad Pediatr, V21, pS169, DOI 10.1016/j.acap.2021.03.017; Matta S, 2021, J GEN INTERN MED, V36, P2870, DOI 10.1007/s11606-020-05989-7; Misera L., 2020, UPHILL BATTLE COVID; Parolin Z., 2021, POVERTY SOCIAL POLIC; Pew Research Center, 2018, PHIL POOR EXP POV LI; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Pollack CE, 2013, J EPIDEMIOL COMMUN H, V67, P439, DOI 10.1136/jech-2012-200999; Pool LR, 2018, JAMA-J AM MED ASSOC, V319, P1341, DOI 10.1001/jama.2018.2055; Prager E, 2021, AM ECON REV, V111, P397, DOI 10.1257/aer.20190690; Rothstein R., 2017, COLOR LAW FORGOTTEN; Rugh JS, 2015, SOC PROBL, V62, P186, DOI 10.1093/socpro/spv002; Schwandt H, 2018, AM ECON J-APPL ECON, V10, P349, DOI 10.1257/app.20140499; Sullivan L., 2016, RACIAL WEALTH GAP WH; Sykes Bryan L, 2016, RUSSELL SAGE FDN J S, V2, P129, DOI [10.7758/RSF.2016.2.6.07, 10.7758/rsf.2016.2.6.07, DOI 10.7758/RSF.2016.2.6.07]; Tamborini CR, 2015, DEMOGRAPHY, V52, P1383, DOI 10.1007/s13524-015-0407-0	40	0	0	3	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 1	2022	387	9					844	849		10.1056/NEJMms2209521	http://dx.doi.org/10.1056/NEJMms2209521			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4G3XB	36053512	Bronze			2022-12-28	WOS:000849132700015
J	Witze, A				Witze, Alexandra			NASA'S MARS ROVER MAKES 'FANTASTIC' FIND IN SEARCH FOR PAST LIFE	NATURE			English	Editorial Material						Planetary science; Geology; Geochemistry													0	0	0	32	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					885	886		10.1038/d41586-022-02968-2	http://dx.doi.org/10.1038/d41586-022-02968-2			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4X3BY	36114424	Bronze			2022-12-28	WOS:000860722600003
J	Ostendorf, BN; Patel, MA; Bilanovic, J; Hoffmann, HH; Carrasco, SE; Rice, CM; Tavazoie, SF				Ostendorf, Benjamin N.; Patel, Mira A.; Bilanovic, Jana; Hoffmann, H-Heinrich; Carrasco, Sebastian E.; Rice, Charles M.; Tavazoie, Sohail F.			Common human genetic variants of APOE impact murine COVID-19 mortality	NATURE			English	Article							APOLIPOPROTEIN-E; LIVER-DISEASE; SARS-COV-2; GENOTYPE; HYPERCHOLESTEROLEMIA; ASSOCIATION; SUPPRESSION; ALLELE	Clinical outcomes of severe acute respiratory syndrome 2 (SARS-CoV-2) infection are highly heterogeneous, ranging from asymptomatic infection to lethal coronavirus disease 2019 (COVID-19). The factors underlying this heterogeneity remain insufficiently understood. Genetic association studies have suggested that genetic variants contribute to the heterogeneity of COVID-19 outcomes, but the underlying potential causal mechanisms are insufficiently understood. Here we show that common variants of the apolipoprotein E (APOE) gene, homozygous in approximately 3% of the world's population(1) and associated with Alzheimer's disease, atherosclerosis and anti-tumour immunity(2-5), affect COVID-19 outcome in a mouse model that recapitulates increased susceptibility conferred by male sex and advanced age. Mice bearing the APOE2 or APOE4 variant exhibited rapid disease progression and poor survival outcomes relative to mice bearing the most prevalent APOE3 allele. APOE2 and APOE4 mice exhibited increased viral loads as well as suppressed adaptive immune responses early after infection. In vitro assays demonstrated increased infection in the presence of APOE2 and APOE4 relative to APOE3, indicating that differential outcomes are mediated by differential effects of APOE variants on both viral infection and antiviral immunity. Consistent with these in vivo findings in mice, our results also show that APOE genotype is associated with survival in patients infected with SARS-CoV-2 in the UK Biobank (candidate variant analysis, P = 2.6 x 10(-7)). Our findings suggest APOE genotype to partially explain the heterogeneity of COVID-19 outcomes and warrant prospective studies to assess APOE genotyping as a means of identifying patients at high risk for adverse outcomes.	[Ostendorf, Benjamin N.; Patel, Mira A.; Bilanovic, Jana; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA; [Ostendorf, Benjamin N.] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany; [Ostendorf, Benjamin N.] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany; [Ostendorf, Benjamin N.] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol BIMSB, Berlin, Germany; [Hoffmann, H-Heinrich; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Carrasco, Sebastian E.] Mem Sloan Kettering Canc Ctr, Weill Cornell Med, Lab Comparat Pathol, 1275 York Ave, New York, NY 10021 USA; [Carrasco, Sebastian E.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Rockefeller University; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University	Ostendorf, BN; Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA.; Ostendorf, BN (corresponding author), Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany.; Ostendorf, BN (corresponding author), Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany.; Ostendorf, BN (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol BIMSB, Berlin, Germany.	bostendorf@rockefeller.edu; sohail.tavazoie@rockefeller.edu		Ostendorf, Benjamin Nils/0000-0003-4492-9252; Bilanovic, Jana/0000-0002-0143-9694; Patel, Mira/0000-0002-4926-5128	NIH [P30 CA008748]; Pershing Square Innovation Fund; Max Eder grant of the German Cancer Aid [70114327]; David Rockefeller Graduate Program in Bioscience; German National Academic Foundation; National Center for Advancing Translational Sciences, NIH, through Rockefeller University [UL1 TR001866]; Black Family Foundation; Rockefeller Center for Human Metastasis Research; Breast Cancer Research Foundation; G.Harold and LeilaY.Mathers Charitable Foundation; Bawd Foundation; Fast Grants, a part of Emergent Ventures at the Mercatus Center, George Mason University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pershing Square Innovation Fund(Pershing Square Foundation); Max Eder grant of the German Cancer Aid; David Rockefeller Graduate Program in Bioscience; German National Academic Foundation; National Center for Advancing Translational Sciences, NIH, through Rockefeller University; Black Family Foundation; Rockefeller Center for Human Metastasis Research; Breast Cancer Research Foundation; G.Harold and LeilaY.Mathers Charitable Foundation; Bawd Foundation; Fast Grants, a part of Emergent Ventures at the Mercatus Center, George Mason University	We are grateful to members of the laboratory of S.F.T. and to D.Mucida for comments on previous versions of the manuscript. We thank Rockefeller University Resource Centers for assistance: V.Francis and other veterinary staff of the Comparative Bioscience Center for animal husbandry and care, C.Zhao, C.Lai and staff at the Genomics Resource Center for assistance with RNA sequencing, and G.McNab for advice on biosafety measures. We thank the Laboratory of Comparative Pathology for histopathology support (with funding from NIH Core Grant P30 CA008748), the group of R.Baric for generating the mouse-adapted SARS-CoV-2 MA10 strain and making it available to the scientific community, and R.Yamin for experimental advice. We thank the NIH Tetramer Core Facility for providing BV421-labelled SARS-CoV-2 S 539-546 tetramer (H-2K(b)). This work was supported by the Pershing Square Innovation Fund. B.N.O. was supported by a Max Eder grant of the German Cancer Aid (reference 70114327) and the David Rockefeller Graduate Program in Bioscience, and is a fellow of the Digital Clinician Scientist Program at BIH-Charite. J.B. was supported by a scholarship from the German National Academic Foundation. M.A.P. was supported in part by the National Center for Advancing Translational Sciences, NIH, through Rockefeller University, Grant UL1 TR001866. S.F.T. was supported by the Black Family Foundation, The Rockefeller Center for Human Metastasis Research and The Breast Cancer Research Foundation. C.M.R. was supported by the G.Harold and LeilaY.Mathers Charitable Foundation, the Bawd Foundation and Fast Grants, a part of Emergent Ventures at the Mercatus Center, George Mason University. Human data analyses were conducted using the UK Biobank Resource under application number 62709.	Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Blair CK, 2005, NEUROLOGY, V64, P268, DOI 10.1212/01.WNL.0000149643.91367.8A; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bonacina F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05322-1; Burt TD, 2008, P NATL ACAD SCI USA, V105, P8718, DOI 10.1073/pnas.0803526105; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; del Ser T, 2021, GERONTOLOGY, V67, P281, DOI 10.1159/000513182; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Hoffmann H-Heinrich, 2021, Cell Host Microbe, V29, P267, DOI [10.1101/2020.09.11.291716, 10.1016/j.chom.2020.12.009]; Hurskainen M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21865-2; Kosmicki JA, 2021, AM J HUM GENET, V108, P1350, DOI [10.1016/j.ajhg.2021.05.017, 10.1016/j.ajhg.2021.017]; Kousathanas A, 2022, NATURE, V607, P97, DOI 10.1038/s41586-022-04576-6; Kuo CL, 2020, J GERONTOL A-BIOL, V75, P2231, DOI 10.1093/gerona/glaa131; Kurki SN, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01302-7; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laskowitz DT, 2000, J LIPID RES, V41, P613; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Ludewig B, 2001, J IMMUNOL, V166, P3369, DOI 10.4049/jimmunol.166.5.3369; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Melms JC, 2021, NATURE, V595, P114, DOI 10.1038/s41586-021-03569-1; Nakanishi T, 2021, J CLIN INVEST, V131, DOI [10.1172/JCI152386, 10.1101/2021.03.07.21252875]; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Ostendorf BN, 2020, NAT MED, V26, P1048, DOI 10.1038/s41591-020-0879-3; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Pathak GA, 2022, NATURE, V608, pE1, DOI 10.1038/s41586-022-04826-7; Perico L, 2021, NAT REV NEPHROL, V17, P46, DOI 10.1038/s41581-020-00357-4; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Toledo A, 2015, P NATL ACAD SCI USA, V112, P5491, DOI 10.1073/pnas.1502561112; van Exel E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179497; Wang C, 2021, CELL STEM CELL, V28, P331, DOI 10.1016/j.stem.2020.12.018; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wozniak MA, 2002, HEPATOLOGY, V36, P456, DOI 10.1053/jhep.2002.34745; Yin YW, 2021, NANOSCALE, V13, P12865, DOI 10.1039/d1nr02687a; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Q, 2022, NATURE, V603, P587, DOI 10.1038/s41586-022-04447-0; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z	49	2	2	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 10	2022	611	7935					346	+		10.1038/s41586-022-05344-2	http://dx.doi.org/10.1038/s41586-022-05344-2		SEP 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6H0KM	36130725	Bronze			2022-12-28	WOS:000874441400001
J	Donnez, J; Taylor, HS; Stewart, EA; Bradley, L; Marsh, E; Archer, D; Al-Hendy, A; Petraglia, F; Watts, N; Gotteland, JP; Bestel, E; Terrill, P; Loumaye, E; Humberstone, A; Garner, E				Donnez, Jacques; Taylor, Hugh S.; Stewart, Elizabeth A.; Bradley, Linda; Marsh, Erica; Archer, David; Al-Hendy, Ayman; Petraglia, Felice; Watts, Nelson; Gotteland, Jean-Pierre; Bestel, Elke; Terrill, Paul; Loumaye, Ernest; Humberstone, Andrew; Garner, Elizabeth			Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials	LANCET			English	Article							EPIDEMIOLOGY; ESTRADIOL; ELAGOLIX; QUALITY; RISK	Background Uterine fibroids are common non-cancerous neoplasm that cause heavy menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone receptor antagonist taken once per day that dose-dependently suppresses gonadal steroids and might reduce uterine-fibroid-associated signs. Two phase 3 trials were conducted to confirm the efficacy and safety of linzagolix at full-suppression (200 mg) and partial-suppression (100 mg) doses with or without hormonal add-back therapy (1 mg oestradiol and 0.5 mg norethisterone acetate) compared with placebo for the treatment of symptomatic uterine fibroids. Methods PRIMROSE 1 and PRIMROSE 2 were identical 52-week, randomised, parallel, double-blind, placebo-controlled, phase 3 trials conducted at clinics in the USA (PRIMROSE 1) and Europe and the USA (PRIMROSE 2). Eligible women with uterine fibroid-associated heavy menstrual bleeding (menstrual blood loss >80 mL per cycle) were randomly assigned in a 1:1:1:1:1 ratio to one of five masked treatments: (1) placebo, (2) 100 mg linzagolix per day alone, (3) 100 mg linzagolix per day with once-per-day hormonal add-back therapy (1 mg oestradiol and 0.5 mg norethisterone acetate), (4) 200 mg linzagolix per day alone, or (5) 200 mg linzagolix per day with once-per-day hormonal add-back therapy (1 mg oestradiol and 0.5 mg norethisterone acetate).The primary endpoint was a response (menstrual blood loss <= 80 mL and >= 50% reduction from baseline) at 24 weeks in women who received at least one dose of treatment and did not meet any exclusion criteria based on predosing assessments. These trials are registered with ClinicalTrials.gov (NCT03070899 and NCT03070951). The trials have been completed. Findings Between May, 2017, and October, 2020, in PRIMROSE 1, 574 women were enrolled, of which 48 discontinued and 15 were excluded; therefore, 511 women were included in the full analysis set; and in PRIMROSE 2, 535 women were enrolled, of which 24 did not receive the study drug and ten women were excluded from the study, resulting in 501 women being included in the full analysis set. In both trials, a significantly higher proportion of women had a reduction in heavy menstrual bleeding in all linzagolix (with or without add-back therapy) treatment groups compared with the placebo group (p=0.003). In PRIMROSE 1, the response rates were 56.4% (95% CI 45.8-66.6%) in the 100 mg group, 66.4% (56.6-75.2%) in the 100 mg plus add-back therapy group, 71.4% (61.8-79.8%) in the 200 mg group, and 75.5% (66.0-83.5%) in the 200 mg plus add-back therapy group, compared with 35.0% (25.8-45.0%) in the placebo group. In PRIMROSE 2, the response rates were 56.7% (46.3-66.7%) in the 100 mg group, 77.2% (67.8-85.0%) in the 100 mg plus add-back therapy group, 77.7% (68.4-85.3%) in the 200 mg group, and 93.9% (87.1-97.7%) in the 200 mg plus add-back therapy group, compared with 29.4% (20.8-39.3%) with placebo. The most common adverse events up to 24 weeks were hot flushes (35% of participants in PRIMROSE 1 and 32% in PRIMROSE 2 with linzagolix [200 mg] alone and 3-14% in all other groups). Interpretation Linzagolix (100 mg or 200 mg) with or without add-back therapy significantly reduced heavy menstrual bleeding. Partial suppression with once-per-day linzagolix (100 mg) without add-back therapy potentially provides a unique option for the chronic treatment of symptomatic uterine fibroids in women who cannot or do not want to take concomitant hormonal add-back therapy. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Donnez, Jacques] Catholic Univ Louvain, Soc Rech linfertilite, Brussels, Belgium; [Taylor, Hugh S.] Yale Univ, Sch Med, New Haven, CT USA; [Stewart, Elizabeth A.] Mayo Clin, Div Reprod Endocrinol, Rochester, MN USA; [Stewart, Elizabeth A.] Mayo Clin, Alix Sch Med, Rochester, MN USA; [Bradley, Linda] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH USA; [Marsh, Erica] Univ Michigan, Med Sch, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Ann Arbor, MI USA; [Archer, David] Eastern Virginia Med Sch, Dept Obstet & Gynecol, Norfolk, VA USA; [Al-Hendy, Ayman] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL USA; [Petraglia, Felice] Univ Florence, Obstet & Gynecol, Dept Expt & Clin Biomed Sci, Florence, Italy; [Watts, Nelson] Mercy Hlth Osteoporosis & Bone Hlth Serv, Cincinnati, OH USA; [Gotteland, Jean-Pierre; Bestel, Elke; Loumaye, Ernest; Humberstone, Andrew] ObsEva, Geneva, Switzerland; [Terrill, Paul] Cytel, London, England; [Garner, Elizabeth] Ferring Pharmaceut, Parsippanny, NJ USA	Universite Catholique Louvain; Yale University; Mayo Clinic; Mayo Clinic; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Eastern Virginia Medical School; University of Chicago; University of Florence; Ferring Pharmaceuticals	Garner, E (corresponding author), Ferring Pharmaceut, Parsippany, NJ 07054 USA.	elizabeth.garner@ferring.com			ObsEva	ObsEva	ObsEva.	Al-Hendy A, 2021, NEW ENGL J MED, V384, P630, DOI 10.1056/NEJMoa2008283; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Carr BR, 2018, OBSTET GYNECOL, V132, P1252, DOI 10.1097/AOG.0000000000002933; Chotiyarnwong P, 2020, NAT REV ENDOCRINOL, V16, P437, DOI 10.1038/s41574-020-0341-0; Dolmans MM, 2021, J CLIN MED, V10, DOI 10.3390/jcm10194389; Donnez J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123948; Donnez J, 2018, EXPERT OPIN EMERG DR, V23, P17, DOI 10.1080/14728214.2018.1446943; Donnez J, 2017, FERTIL STERIL, V107, P568, DOI 10.1016/j.fertnstert.2017.01.013; Donnez J, 2016, HUM REPROD UPDATE, V22, P665, DOI 10.1093/humupd/dmw023; El Sabeh Malak, 2021, F S Sci, V2, P114, DOI 10.1016/j.xfss.2021.02.002; Fraser IS, 2011, EUR J CONTRACEP REPR, V16, P258, DOI 10.3109/13625187.2011.591456; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Islam MS, 2018, HUM REPROD UPDATE, V24, P59, DOI 10.1093/humupd/dmx032; Lumsden MA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4887; Magnay JL, 2011, FERTIL STERIL, V96, P394, DOI 10.1016/j.fertnstert.2011.05.096; Manyonda IT, 2012, CARDIOVASC INTER RAD, V35, P530, DOI 10.1007/s00270-011-0228-5; Pavone D, 2018, BEST PRACT RES CL OB, V46, P3, DOI 10.1016/j.bpobgyn.2017.09.004; Schlaff WD, 2020, NEW ENGL J MED, V382, P328, DOI 10.1056/NEJMoa1904351; Spies JB, 2002, OBSTET GYNECOL, V99, P290, DOI 10.1016/S0029-7844(01)01702-1; Stewart EA, 2020, NEW ENGL J MED, V383, P489, DOI 10.1056/NEJMe2017266; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Taylor HS, 2017, NEW ENGL J MED, V377, P28, DOI 10.1056/NEJMoa1700089; Winter EM, 2020, ENDOCR CONNECT, V9, pR143, DOI 10.1530/EC-20-0055; Wise LA, 2004, HUM REPROD, V19, P1746, DOI 10.1093/humrep/deh309; Wise LA, 2016, CLIN OBSTET GYNECOL, V59, P2, DOI 10.1097/GRF.0000000000000164	25	2	2	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					896	907						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116480				2022-12-28	WOS:000890180700022
J	Wang, DS; Uzzi, B				Wang, Dashun; Uzzi, Brian			Weak ties, failed tries, and success	SCIENCE			English	Editorial Material									[Wang, Dashun] Northwestern Univ, Ctr Sci Sci & Innovat, Evanston, IL 60208 USA; [Wang, Dashun; Uzzi, Brian] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Wang, Dashun; Uzzi, Brian] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Wang, Dashun] Northwestern Univ, McCormick Sch Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Wang, DS (corresponding author), Northwestern Univ, Ctr Sci Sci & Innovat, Evanston, IL 60208 USA.; Wang, DS (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA.; Wang, DS (corresponding author), Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA.; Wang, DS (corresponding author), Northwestern Univ, McCormick Sch Engn, Evanston, IL 60208 USA.	dashun.wang@northwestern.edu						Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Barabasi AL, 2016, NETWORK SCIENCE, P1; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Burger JM, 2004, PERS SOC PSYCHOL B, V30, P35, DOI 10.1177/0146167203258838; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Centola D, 2018, SCIENCE, V360, P1116, DOI 10.1126/science.aas8827; Chetty R, 2022, NATURE, V608, P108, DOI 10.1038/s41586-022-04996-4; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Rajkumar K, 2022, SCIENCE, V377, P1304, DOI 10.1126/science.abl4476; Romero D. M., 2016, P 25 INT C WORLDWIDE; Smith EB, 2012, ORGAN SCI, V23, P67, DOI 10.1287/orsc.1100.0643; Tang SJ, 2022, SCI CHINA LIFE SCI, V65, P753, DOI 10.1007/s11427-021-1974-7; Wang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12189-3; Yang Y, 2019, P NATL ACAD SCI USA, V116, P2033, DOI 10.1073/pnas.1721438116; Yin Y, 2019, NATURE, V575, P190, DOI 10.1038/s41586-019-1725-y	15	0	0	13	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1256	1258		10.1126/science.add0692	http://dx.doi.org/10.1126/science.add0692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108030				2022-12-28	WOS:000887933500019
J	Acharya, D; Reis, R; Volcic, M; Liu, GQ; Wang, MK; Chia, BS; Nchioua, R; Gross, R; Munch, J; Kirchhoff, F; Sparrer, KMJ; Gack, MU				Acharya, Dhiraj; Reis, Rebecca; Volcic, Meta; Liu, GuanQun; Wang, May K.; Chia, Bing Shao; Nchioua, Rayhane; Gross, Rudiger; Munch, Jan; Kirchhoff, Frank; Sparrer, Konstantin M. J.; Gack, Michaela U.			Actin cytoskeleton remodeling primes RIG-I-like receptor activation	CELL			English	Article							RNA SENSORS; INHIBITS ACTIVATION; UBIQUITIN LIGASE; CORTICAL ACTIN; RHO GTPASES; VIRUS; PHOSPHORYLATION; INTERFERON; RECOGNITION; SELF	The current dogma of RNA-mediated innate immunity is that sensing of immunostimulatory RNA ligands is sufficient for the activation of intracellular sensors and induction of interferon (IFN) responses. Here, we report that actin cytoskeleton disturbance primes RIG-I-like receptor (RLR) activation. Actin cytoskeleton rearrangement induced by virus infection or commonly used reagents to intracellularly deliver RNA triggers the relocalization of PPP1R12C, a regulatory subunit of the protein phosphatase-1 (PP1), from filamentous actin to cytoplasmic RLRs. This allows dephosphorylation-mediated RLR priming and, together with the RNA agonist, induces effective RLR downstream signaling. Genetic ablation of PPP1R12C impairs antiviral responses and enhances susceptibility to infection with several RNA viruses including SARS-CoV-2, influenza virus, picomavirus, and vesicular stomatitis virus. Our work identifies actin cytoskeleton disturbance as a priming signal for RLR-mediated innate immunity, which may open avenues for antiviral or adjuvant design.	[Acharya, Dhiraj; Liu, GuanQun; Gack, Michaela U.] Cleveland Clin, Florida Res & Innovat Ctr, Port St Lucie, FL 34987 USA; [Acharya, Dhiraj; Reis, Rebecca; Liu, GuanQun; Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Volcic, Meta; Nchioua, Rayhane; Gross, Rudiger; Munch, Jan; Kirchhoff, Frank; Sparrer, Konstantin M. J.] Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany; [Wang, May K.; Chia, Bing Shao] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Wang, May K.] Skylark Bio, Cambridge, MA 02139 USA; [Chia, Bing Shao] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore	Cleveland Clinic Foundation; University of Chicago; Ulm University; Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Gack, MU (corresponding author), Cleveland Clin, Florida Res & Innovat Ctr, Port St Lucie, FL 34987 USA.; Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.; Sparrer, KMJ (corresponding author), Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.	konstantin.sparrer@uni-ulm.de; gackm@ccf.org		Jan, Munch/0000-0001-7316-7141; Liu, GuanQun/0000-0003-2520-7625; Chia, Bing Shao/0000-0003-0101-5805; Gross, Rudiger Martin/0000-0003-0355-7915; Sparrer, Konstantin MJ/0000-0002-8682-1779	US National Institutes of Health [AI087846, AI127774]; Federal Ministry of Education and Research Germany (BMBF junior research group [IMMUNOMOD-01KI2014]; German Research Foundation [SPP 1923, CRC 1279]; International Graduate School in Molecular Medicine, Ulm (IGradU)	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Federal Ministry of Education and Research Germany (BMBF junior research group; German Research Foundation(German Research Foundation (DFG)); International Graduate School in Molecular Medicine, Ulm (IGradU)	We greatly thank B.R. tenOever (New York University), K.-K. Conzelmann (Ludwig Maximilians University of Munich), F.J.M. van Kuppeveld (Utrecht University), and J. Rehwinkel (Oxford University) for providing key reagents. We are grateful to Kerstin Regensburger, Jana-Romana Fischer, and Regina Burger (all Ulm University) for technical assistance. We thank Steffen Stenger (Ulm University) for providing BSL3 facilities to conduct SARS-CoV-2 experiments. This work was supported by US National Institutes of Health grants AI087846 and AI127774 (to M.U.G.), the Federal Ministry of Education and Research Germany (BMBF junior research group IMMUNOMOD-01KI2014 to K.M.J.S.), the German Research Foundation (SPP 1923 to K.M.J.S. and F.K. and CRC 1279 to J.M., K.M.J.S., and F.K.). R.G. is enrolled in and was supported by the International Graduate School in Molecular Medicine, Ulm (IGradU).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Bielig H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004351; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Braun E, 2019, CELL REP, V27, P2092, DOI 10.1016/j.celrep.2019.04.063; Cardarelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25879; Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393; Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Coppola S, 2013, THER DELIV, V4, P191, DOI [10.4155/tde.12.151, 10.4155/TDE.12.151]; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Dohner K, 2005, CURR TOP MICROBIOL, V285, P67; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gardet A, 2006, J VIROL, V80, P3947, DOI 10.1128/JVI.80.8.3947-3956.2006; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hato SV, 2007, CELL MICROBIOL, V9, P2921, DOI 10.1111/j.1462-5822.2007.01006.x; Hayn M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109126; Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483; Hotter D, 2019, CELL HOST MICROBE, V25, P858, DOI 10.1016/j.chom.2019.05.002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Koepke L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68607-w; Li CF, 2022, NAT IMMUNOL, V23, P543, DOI 10.1038/s41590-022-01163-9; Li T, 2021, SCIENCE, V371, P1221, DOI 10.1126/science.abc5386; Liu GQ, 2021, NAT MICROBIOL, V6, P467, DOI 10.1038/s41564-021-00884-1; Liu GQ, 2020, IMMUNITY, V53, P26, DOI 10.1016/j.immuni.2020.03.017; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Moulding DA, 2013, IMMUNOL REV, V256, P282, DOI 10.1111/imr.12114; Nchioua R, 2020, MBIO, V11, DOI 10.1128/mBio.01930-20; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Niu TT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26142-w; Papa R, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.604206; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Spalinger MR, 2016, J CLIN INVEST, V126, P1783, DOI 10.1172/JCI83669; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tang J, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abe3410; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tolar P, 2017, NAT REV IMMUNOL, V17, P621, DOI 10.1038/nri.2017.67; van Gent M, 2022, J VIROL, V96, DOI 10.1128/JVI.01510-21; Volcic M, 2020, NAT MICROBIOL, V5, P1247, DOI 10.1038/s41564-020-0753-6; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhong L, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0162-2	69	2	2	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3588	+		10.1016/j.cell.2022.08.011	http://dx.doi.org/10.1016/j.cell.2022.08.011			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	6N0VS	36113429				2022-12-28	WOS:000889280000002
J	Looi, MK				Looi, Mun-Keat			Is covid-19 settling into a pattern?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								SARS-CoV-2 is here to stay, with an increasing array of questions for science and medicine. In the first of a new series on Covid Unanswered Questions, The BMJ asks about our current understanding of waves and variants-and what they might mean for "living with the virus"										A. M. Hahn, 2022, medRxiv, DOI 10.1101/2022.06.29.22276868; Callaway E, 2022, NATURE, V606, P848, DOI 10.1038/d41586-022-01730-y; Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o792; T. I. Vasylyeva, 2022, medRxiv, DOI 10.1101/2022.04.15.22273909; World Health Organization, TRACK SARS COV 2 VAR	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								o2183	10.1136/bmj.o2183	http://dx.doi.org/10.1136/bmj.o2183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109015	Bronze			2022-12-28	WOS:000888774200004
J	Yang, Y; Shi, Y; Schweighauser, M; Zhang, XJ; Kotecha, A; Murzin, AG; Garringer, HJ; Cullinane, PW; Saito, Y; Foroud, T; Warner, TT; Hasegawa, K; Vidal, R; Murayama, S; Revesz, T; Ghetti, B; Hasegawa, M; Lashley, T; Scheres, SHW; Goedert, M				Yang, Yang; Shi, Yang; Schweighauser, Manuel; Zhang, Xianjun; Kotecha, Abhay; Murzin, Alexey G.; Garringer, Holly J.; Cullinane, Patrick W.; Saito, Yuko; Foroud, Tatiana; Warner, Thomas T.; Hasegawa, Kazuko; Vidal, Ruben; Murayama, Shigeo; Revesz, Tamas; Ghetti, Bernardino; Hasegawa, Masato; Lashley, Tammaryn; Scheres, Sjors H. W.; Goedert, Michel			Structures of alpha-synuclein filaments from human brains with Lewy pathology	NATURE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; DEMENTIA; BODIES; MUTATION; PHOSPHORYLATION; AGGREGATION; INCLUSIONS; COMPONENT; TAU	Parkinson's disease (PD) is the most common movement disorder, with resting tremor, rigidity, bradykinesia and postural instability being major symptoms(1). Neuropathologically, it is characterized by the presence of abundant filamentous inclusions of alpha-synuclein in the form of Lewy bodies and Lewy neurites in some brain cells, including dopaminergic nerve cells of the substantia nigra(2). PD is increasingly recognised as a multisystem disorder, with cognitive decline being one of its most common non-motor symptoms. Many patients with PD develop dementia more than 10 years after diagnosis(3). PD dementia (PDD) is clinically and neuropathologically similar to dementia with Lewy bodies (DLB), which is diagnosed when cognitive impairment precedes parkinsonian motor signs or begins within one year from their onset(4). In PDD, cognitive impairment develops in the setting of well-established PD. Besides PD and DLB, multiple system atrophy (MSA) is the third major synucleinopathy(5). It is characterized by the presence of abundant filamentous alpha-synuclein inclusions in brain cells, especially oligodendrocytes (Papp-Lantos bodies). We previously reported the electron cryo-microscopy structures of two types of alpha-synuclein filament extracted from the brains of individuals with MSA(6). Each filament type is made of two different protofilaments. Here we report that the cryo-electron microscopy structures of alpha-synuclein filaments from the brains of individuals with PD, PDD and DLB are made of a single protofilament (Lewy fold) that is markedly different from the protofilaments of MSA. These findings establish the existence of distinct molecular conformers of assembled alpha-synuclein in neurodegenerative disease.	[Yang, Yang; Shi, Yang; Schweighauser, Manuel; Murzin, Alexey G.; Scheres, Sjors H. W.; Goedert, Michel] Med Res Council Lab Mol Biol, Cambridge, England; [Zhang, Xianjun; Kotecha, Abhay] Thermo Fisher Sci, Eindhoven, Netherlands; [Garringer, Holly J.; Vidal, Ruben; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Cullinane, Patrick W.; Warner, Thomas T.] UCL, Dept Clin & Movement Neurosci, Queen Sq Inst Neurol, London, England; [Cullinane, Patrick W.; Warner, Thomas T.; Revesz, Tamas; Lashley, Tammaryn] UCL, Inst Neurol, Queen Sq Brain Bank Neurol Disorders, London, England; [Saito, Yuko] Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; [Foroud, Tatiana] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN USA; [Hasegawa, Kazuko] Sagamihara Natl Hosp, Div Neurol, Sagamihara, Kanagawa, Japan; [Murayama, Shigeo] Univ Osaka, Mol Res Ctr Childrens Mental Dev, United Sch Child Dev, Osaka, Japan; [Revesz, Tamas; Lashley, Tammaryn] UCL, Dept Neurodegenerat Dis, Queen Sq Inst Neurol, London, England; [Hasegawa, Masato] Metropolitan Inst Med Sci, Dept Brain & Neurosci, Tokyo, Japan	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Thermo Fisher Scientific; Indiana University System; Indiana University Bloomington; University of London; University College London; University of London; University College London; Tokyo Metropolitan Institute of Gerontology; Indiana University System; Indiana University Bloomington; Osaka University; University of London; University College London; Tokyo Metropolitan Institute of Medical Science	Scheres, SHW; Goedert, M (corresponding author), Med Res Council Lab Mol Biol, Cambridge, England.	scheres@mrc-tmb.cam.ac.uk; mg@mrc-tmb.cam.ac.uk		Lashley, Tammaryn/0000-0001-7389-0348; Yang, Yang/0000-0003-2238-6437	Wellcome Trust [bi23268]; MRC [MC_UP_A025_1013, MC_U105184291]; Biotechnology and Biological Sciences Research Council (BBSRC); Alzheimer's Research UK Senior Fellowship; National Institute for Health Research Queen Square Biomedical Research Unit in Dementia; Rita Lila Weston Institute for Neurological Studies; Japan Agency for Science and Technology (CREST) [JPMJCR18H3]; Japan Agency for Medical Research and Development (AMED) [JP20dm0207072]; US National Institutes of Health [P30-AG010133, U01-NS110437, RF1-AG071177, R01NS037167]; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; MRC	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer's Research UK Senior Fellowship; National Institute for Health Research Queen Square Biomedical Research Unit in Dementia; Rita Lila Weston Institute for Neurological Studies; Japan Agency for Science and Technology (CREST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients' families for donating brain tissues, T. Darling and J. Grimmett for help with high-performance computing and the EM facility of the Medical Research Council (MRC) Laboratory of Molecular Biology for help with cryo-EM data acquisition. We thank H. Braak, R.A. Crowther, K. Del Tredici, S. Lovestam, W. Poewe, M.G. Spillantini and E. Tolosa for helpful discussions. We acknowledge Diamond Light Source for access and support of the cryo-EM facilities at the UK's Electron Bio-imaging Centre (under proposal bi23268), funded by the Wellcome Trust, the MRC and the Biotechnology and Biological Sciences Research Council (BBSRC). This work was supported by the MRC (MC_UP_A025_1013 to S.H.W.S. and MC_U105184291 to M.G.). T.L. holds an Alzheimer's Research UK Senior Fellowship. T.R. is supported by the National Institute for Health Research Queen Square Biomedical Research Unit in Dementia. The Queen Square Brain Bank is supported by the Rita Lila Weston Institute for Neurological Studies. This work was also supported by the Japan Agency for Science and Technology (CREST) (JPMJCR18H3 to M.H.), the Japan Agency for Medical Research and Development (AMED) (JP20dm0207072 to M.H.), the US National Institutes of Health (P30-AG010133, U01-NS110437 and RF1-AG071177, to R.V. and B.G., and R01NS037167, to T.F.) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (to R.V. and B.G.).	Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Ayers JI, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2113489119; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; Burger D., 2021, CRYO EM STRUCTURE AL, DOI [10.1101/2021.07.08.451588, DOI 10.1101/2021.07.08.451588]; Candelise N, 2019, ANN NEUROL, V85, P691, DOI 10.1002/ana.25446; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Frieg, 2021, ALPHA SYNUCLEIN POLY, DOI [10.1101/2021.07.09.451731, DOI 10.1101/2021.07.09.451731]; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Guerrero-Ferreira R, 2019, ELIFE, V8, DOI 10.7554/eLife.48907; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Holec SAM, 2022, ACTA NEUROPATHOL, V143, P311, DOI 10.1007/s00401-022-02403-w; Klingstedt T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0840-1; Lau A, 2020, NAT NEUROSCI, V23, P21, DOI 10.1038/s41593-019-0541-x; Lavenir I, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0804-5; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Lovestam S, 2022, ELIFE, V11, DOI 10.7554/eLife.76494; Lovestam S, 2021, FEBS OPEN BIO, V11, P999, DOI 10.1002/2211-5463.13110; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; McGlinchey RP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023487118; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Poggiolini I, 2022, BRAIN, V145, P584, DOI 10.1093/brain/awab431; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Schweighauser M, 2022, NATURE, V605, P310, DOI 10.1038/s41586-022-04650-z; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shahnawaz M, 2020, NATURE, V578, P273, DOI 10.1038/s41586-020-1984-7; Shi Y, 2021, NATURE, V598, P359, DOI 10.1038/s41586-021-03911-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sokratian, 2022, BIORXIV, DOI [10.1101/2022.07.13.499896, DOI 10.1101/2022.07.13.499896]; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Tsuboi Y, 2005, PARKINSONISM RELAT D, V11, pS47, DOI 10.1016/j.parkreldis.2004.10.014; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Van der Perren A, 2020, ACTA NEUROPATHOL, V139, P977, DOI 10.1007/s00401-020-02157-3; Woerman AL, 2018, P NATL ACAD SCI USA, V115, P409, DOI 10.1073/pnas.1719369115; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471; Yamashita Keitaro, 2021, Acta Crystallogr D Struct Biol, V77, P1282, DOI 10.1107/S2059798321009475; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhao K, 2020, P NATL ACAD SCI USA, V117, P20305, DOI 10.1073/pnas.1922741117; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	66	1	1	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2022	610	7933					791	+		10.1038/s41586-022-05319-3	http://dx.doi.org/10.1038/s41586-022-05319-3		SEP 2022	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5Q8QG	36108674	Green Accepted			2022-12-28	WOS:000870206900001
J	Hussain, Z				Hussain, Zainab			Climate crisis: scorecard reveals UK health organisations' response	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], US; Cooke E, 2022, J CLIMATE CHANGE HLT, V8, DOI [10.1016/j.joclim.2022.100164, DOI 10.1016/J.JOCLIM.2022.100164]	2	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								o2238	10.1136/bmj.o2238	http://dx.doi.org/10.1136/bmj.o2238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104066	Bronze			2022-12-28	WOS:000862323900011
J	Freeman, NW; Keuroghlian, AS				Freeman, Nicolas W.; Keuroghlian, Alex S.			The art of medicine Supporting transgender and gender diverse medical students	LANCET			English	Editorial Material									[Freeman, Nicolas W.; Keuroghlian, Alex S.] Harvard Med Sch, Boston, MA 02115 USA; [Keuroghlian, Alex S.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Keuroghlian, Alex S.] Fenway Inst, Natl LGBTQIA Hlth Educ Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Keuroghlian, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Keuroghlian, AS (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Keuroghlian, AS (corresponding author), Fenway Inst, Natl LGBTQIA Hlth Educ Ctr, Boston, MA 02215 USA.	akeuroghlian@partners.org		Keuroghlian, Alex/0000-0002-6624-8354					0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					804	805						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088942				2022-12-28	WOS:000877580600012
J	Heidari, SN				Heidari, Shireen N.			Finding a New Mantra	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heidari, Shireen N.] Stanford Univ, Sch Med, Dept Med, Sect Palliat Care,Div Primary Care & Populat Hlth, Palo Alto, CA 94304 USA	Stanford University	Heidari, SN (corresponding author), Stanford Univ, Sch Med, Dept Med, Sect Palliat Care,Div Primary Care & Populat Hlth, Palo Alto, CA 94304 USA.			Heidari, Shireen/0000-0002-0127-3719					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2022	387	11					964	965		10.1056/NEJMp2206851	http://dx.doi.org/10.1056/NEJMp2206851		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E1UZ	36094841	Bronze			2022-12-28	WOS:000859601300001
J	Dutta, B; Umansky, V; Banerjee, M; Heiblum, M				Dutta, Bivas; Umansky, Vladimir; Banerjee, Mitali; Heiblum, Moty			Isolated ballistic non-abelian interface channel	SCIENCE			English	Article							QUANTUM HALL; FLOW	The topological order of a quantum Hall state is mirrored by the gapless edge modes owing to bulk-edge correspondence. The state at the filling of nu = 5/2, predicted to host non-abelian anyons, supports a variety of edge modes (integer, fractional, neutral). To ensure thermal equilibration between the edge modes and thus accurately determine the state's nature, it is advantageous to isolate the fractional channel (1/2 and neutral modes). In this study, we gapped out the integer modes by interfacing the nu = 5/2 state with integer states nu = 2 and nu = 3 and measured the thermal conductance of the isolated-interface channel. Our measured half-quantized thermal conductance confirms the non-abelian nature of the nu = 5/2 state and its particle-hole Pfaffian topological order. Such an isolated channel may be more amenable to braiding experiments.	[Dutta, Bivas; Umansky, Vladimir; Heiblum, Moty] Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel; [Banerjee, Mitali] Ecole Polytech Fed Lausanne, Inst Phys, Fac Basic Sci, CH-1015 Lausanne, Switzerland	Weizmann Institute of Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Heiblum, M (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, Braun Ctr Submicron Res, IL-76100 Rehovot, Israel.	moty.heiblum@weizmann.ac.il	Dutta, Bivas/F-2277-2018	Dutta, Bivas/0000-0002-5354-3426; Umansky, Vladimir/0000-0001-5727-2064	Clore Foundation; European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC [713351]; Minerva Foundation [713534]; SNSF Eccellenza grant [PCEGP2_194528]	Clore Foundation; European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC; Minerva Foundation; SNSF Eccellenza grant	B.D. acknowledges support from the Clore Foundation. M.H. acknowledges the continuous support of the Submicron Center staff, the support of the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC under grant 713351, and the partial support of the Minerva Foundation under grant 713534. M.B. acknowledges the support of SNSF Eccellenza grant PCEGP2_194528.	Banerjee M, 2018, NATURE, V559, P205, DOI 10.1038/s41586-018-0184-1; Banerjee M, 2017, NATURE, V545, P75, DOI 10.1038/nature22052; Dutta Bivas, 2022, Zenodo, DOI 10.5281/ZENODO.6559780; Dutta B, 2022, SCIENCE, V375, P193, DOI 10.1126/science.abg6116; Feldman DE, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.167401; Fulga IC, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.236802; Goerbig MO, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.241302; Gromov A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.016805; Heiblum M, 2020, INT J MOD PHYS A, V35, DOI 10.1142/S0217751X20300094; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Kane CL, 1997, PHYS REV B, V55, P15832, DOI 10.1103/PhysRevB.55.15832; Lee SS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236807; Levin M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236806; Lian BA, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.165124; Ma KKW, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.016801; Ma KKW, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.035302; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Morf RH, 1998, PHYS REV LETT, V80, P1505, DOI 10.1103/PhysRevLett.80.1505; Mross DF, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.026801; PENDRY JB, 1983, J PHYS A-MATH GEN, V16, P2161, DOI 10.1088/0305-4470/16/10/012; Rezayi EH, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.026801; Rosales KAV, 2021, PHYS REV LETT, V127, DOI 10.1103/PhysRevLett.127.056801; Simon SH, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.126801; Simon SH, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.121406; Storni M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076803; Umansky V, 2013, MOLECULAR BEAM EPITAXY: FROM RESEARCH TO MASS PRODUCTION, P121, DOI 10.1016/B978-0-12-387839-7.00006-3; Wang C, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.045112; WEN XG, 1991, PHYS REV LETT, V66, P802, DOI 10.1103/PhysRevLett.66.802; Zaletel MP, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045115; Zucker PT, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.096802	30	0	0	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1198	1201		10.1126/science.abm6571	http://dx.doi.org/10.1126/science.abm6571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074847	Green Submitted			2022-12-28	WOS:000887933400042
J	Byron, J; Kreuzwieser, J; Purser, G; van Haren, J; Ladd, SN; Meredith, LK; Werner, C; Williams, J				Byron, Joseph; Kreuzwieser, Juergen; Purser, Gemma; van Haren, Joost; Ladd, S. Nemiah; Meredith, Laura K.; Werner, Christiane; Williams, Jonathan			Chiral monoterpenes reveal forest emission mechanisms and drought responses	NATURE			English	Article							TROPICAL RAIN-FOREST; VOLATILE ORGANIC-COMPOUNDS; ISOPRENE; PINE; PHOTOSYNTHESIS; STRESS; MODEL	Monoterpenes (C10H16) are emitted in large quantities by vegetation to the atmosphere (>100 TgC year(-1)), where they readily react with hydroxyl radicals and ozone to form new particles and, hence, clouds, affecting the Earth's radiative budget and, thereby, climate change(1-3). Although most monoterpenes exist in two chiral mirror-image forms termed enantiomers, these (+) and (-) forms are rarely distinguished in measurement or modelling studies(4-6). Therefore, the individual formation pathways of monoterpene enantiomers in plants and their ecological functions are poorly understood. Here we present enantiomerically separated atmospheric monoterpene and isoprene data from an enclosed tropical rainforest ecosystem in the absence of ultraviolet light and atmospheric oxidation chemistry, during a four-month controlled drought and rewetting experiment(7). Surprisingly, the emitted enantiomers showed distinct diel emission peaks, which responded differently to progressive drying. Isotopic labelling established that vegetation emitted mainly de novo-synthesized (-)-alpha-pinene, whereas (+)-alpha-pinene was emitted from storage pools. As drought progressed, the source of (-)-alpha-pinene emissions shifted to storage pools, favouring cloud formation. Pre-drought mixing ratios of both alpha-pinene enantiomers correlated better with other monoterpenes than with each other, indicating different enzymatic controls. These results show that enantiomeric distribution is key to understanding the underlying processes driving monoterpene emissions from forest ecosystems and predicting atmospheric feedbacks in response to climate change.	[Byron, Joseph; Williams, Jonathan] Max Planck Inst Chem, Atmospher Chem, Mainz, Germany; [Kreuzwieser, Juergen; Ladd, S. Nemiah; Werner, Christiane] Albert Ludwig Univ Freiburg, Fac Environm & Nat Resources, Ecosyst Physiol, Freiburg, Germany; [Purser, Gemma] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Purser, Gemma] UK Ctr EcoL & Hydrol, Edinburgh, Midlothian, Scotland; [van Haren, Joost; Meredith, Laura K.] Univ Arizona, Biosphere 2, Oracle, AZ USA; [van Haren, Joost] Univ Arizona, Honors Coll, Tucson, AZ USA; [Ladd, S. Nemiah] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Meredith, Laura K.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Williams, Jonathan] Cyprus Inst, Climate & Atmosphere Res Ctr, Nicosia, Cyprus	Max Planck Society; University of Freiburg; University of Edinburgh; UK Centre for Ecology & Hydrology (UKCEH); University of Arizona; University of Arizona; University of Basel; University of Arizona	Williams, J (corresponding author), Max Planck Inst Chem, Atmospher Chem, Mainz, Germany.	jonathan.williams@mpic.de	Werner, Christiane/B-2948-2009; Meredith, Laura/J-2331-2014	Werner, Christiane/0000-0002-7676-9057; Meredith, Laura/0000-0003-4244-4366; Ladd, S. Nemiah/0000-0002-0132-5785	European Research Council (ERC) [647008]; Philecology Foundation; Max Planck Graduate Center; Johannes Gutenberg-Universitat Mainz (MPGC); European Commission [FETOPEN-737071]	European Research Council (ERC)(European Research Council (ERC)European Commission); Philecology Foundation; Max Planck Graduate Center(Max Planck Society); Johannes Gutenberg-Universitat Mainz (MPGC); European Commission(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge financial support from the European Research Council (ERC consolidator grant #647008 (VOCO<INF>2</INF>) to C.W.) and from the Philecology Foundation to Biosphere 2 to L.K.M. We would like to thank all members of the B2WALD team for their valuable support, as detailed in the B2WALD contribution list . J.B. was supported by the Max Planck Graduate Center with the Johannes Gutenberg-Universitat Mainz (MPGC). This work was supported by the European Commission Horizon 2020 ULTRACHIRAL project (grant no. FETOPEN-737071). We are very grateful to J. Birks from 2B Technologies for providing an ozone instrument for post-campaign tests.	Abbott TH, 2021, SCIENCE, V371, P83, DOI 10.1126/science.abc5181; Asensio D, 2007, PLANT SOIL, V291, P249, DOI 10.1007/s11104-006-9190-4; Bellcross A, 2021, J AM CHEM SOC, V143, P16653, DOI 10.1021/jacs.1c07509; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Engelhart GJ, 2008, ATMOS CHEM PHYS, V8, P3937, DOI 10.5194/acp-8-3937-2008; Finn M, 1996, ECOL ENG, V6, P21, DOI 10.1016/0925-8574(95)00050-X; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; Guenther A, 1997, ECOL APPL, V7, P34, DOI 10.1890/1051-0761(1997)007[0034:SASVIN]2.0.CO;2; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; IPCC, 2014, CLIMATE CHANGE 2014, P59; Jardine KJ, 2017, PLANT CELL ENVIRON, V40, P441, DOI 10.1111/pce.12879; Jokinen T, 2015, P NATL ACAD SCI USA, V112, P7123, DOI 10.1073/pnas.1423977112; KAINULAINEN P, 1992, CAN J BOT, V70, P1613, DOI 10.1139/b92-203; Karl T, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008539; Lambers H, 2019, PLANT PHYSIOLOGICAL ECOLOGY, 3RD EDITION, P187, DOI 10.1007/978-3-030-29639-1_5; Langford B, 2022, ENVIRON SCI-ATMOS, V2, P230; Laothawornkitkul J, 2009, NEW PHYTOL, V183, P27, DOI 10.1111/j.1469-8137.2009.02859.x; Lavoir AV, 2009, BIOGEOSCIENCES, V6, P1167, DOI 10.5194/bg-6-1167-2009; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Lupke M, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx045; Messina P, 2016, ATMOS CHEM PHYS, V16, P14169, DOI 10.5194/acp-16-14169-2016; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Niinemets U, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001927; Pazouki L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01019; Pegoraro E, 2006, GLOBAL CHANGE BIOL, V12, P456, DOI 10.1111/j.1365-2486.2006.01112.x; Pegoraro E, 2005, GLOBAL CHANGE BIOL, V11, P1234, DOI 10.1111/j.1365-2486.2005.00986.x; Phillips MA, 1999, ARCH BIOCHEM BIOPHYS, V372, P197, DOI 10.1006/abbi.1999.1467; Rascher U, 2004, PLANT CELL ENVIRON, V27, P1239, DOI 10.1111/j.1365-3040.2004.01231.x; Restrepo-Coupe N, 2013, AGR FOREST METEOROL, V182, P128, DOI 10.1016/j.agrformet.2013.04.031; RICCI MP, 1994, ORG GEOCHEM, V21, P561, DOI 10.1016/0146-6380(94)90002-7; Sander R, 2015, ATMOS CHEM PHYS, V15, P4399, DOI 10.5194/acp-15-4399-2015; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Song W, 2014, BIOGEOSCIENCES, V11, P1435, DOI 10.5194/bg-11-1435-2014; Staudt M, 2019, SCI TOTAL ENVIRON, V654, P1158, DOI 10.1016/j.scitotenv.2018.11.146; Turtola S, 2003, J CHEM ECOL, V29, P1981, DOI 10.1023/A:1025674116183; Werner C, 2021, SCIENCE, V374, P1514, DOI 10.1126/science.abj6789; Williams J, 2007, ATMOS CHEM PHYS, V7, P973, DOI 10.5194/acp-7-973-2007; Yanez-Serrano AM, 2018, ATMOS CHEM PHYS, V18, P3403, DOI 10.5194/acp-18-3403-2018; Zannoni N, 2020, COMMUN EARTH ENVIRON, V1, DOI 10.1038/s43247-020-0007-9	42	0	0	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					307	+		10.1038/s41586-022-05020-5	http://dx.doi.org/10.1038/s41586-022-05020-5			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2NE	36071188	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000852469200025
J	Benson, VM				Benson, Victor M.			Alirocumab Added to High-Intensity Statin Therapy and Coronary Atherosclerosis in Patients With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Benson, Victor M.] 3200 Rotonda Dr,Unit 314, Rancho Palos Verdes, CA 90275 USA		Benson, VM (corresponding author), 3200 Rotonda Dr,Unit 314, Rancho Palos Verdes, CA 90275 USA.	vbenson100@gmail.com						Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Raber L, 2022, JAMA-J AM MED ASSOC, V327, P1771, DOI 10.1001/jama.2022.5218	3	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					890	891						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066523				2022-12-28	WOS:000855171700030
J	Slomski, A				Slomski, Anita			Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					817	817						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066528				2022-12-28	WOS:000855171700004
J	Byrska-Bishop, M; Evani, US; Zhao, XF; Basile, AO; Abel, HJ; Regier, AA; Corvelo, A; Clarke, WE; Musunuri, R; Nagulapalli, K; Fairley, S; Runnels, A; Winterkorn, L; Lowy, E; Flicek, P; Germer, S; Brand, H; Hall, IM; Talkowski, ME; Narzisi, G; Zody, MC				Byrska-Bishop, Marta; Evani, Uday S.; Zhao, Xuefang; Basile, Anna O.; Abel, Haley J.; Regier, Allison A.; Corvelo, Andre; Clarke, Wayne E.; Musunuri, Rajeeva; Nagulapalli, Kshithija; Fairley, Susan; Runnels, Alexi; Winterkorn, Lara; Lowy, Ernesto; Flicek, Paul; Germer, Soren; Brand, Harrison; Hall, Ira M.; Talkowski, Michael E.; Narzisi, Giuseppe; Zody, Michael C.		Human Genome Struct Variation Cons	High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios	CELL			English	Article							STRUCTURAL VARIATION; WIDE ASSOCIATION; FRAMEWORK; VARIANTS; DIVERSITY; DISCOVERY; INFERENCE; MUTATION; FORMAT; TOOL	The 1000 Genomes Project (1kGP) is the largest fully open resource of whole-genome sequencing (WGS) data consented for public distribution without access or use restrictions. The final, phase 3 release of the 1kGP included 2,504 unrelated samples from 26 populations and was based primarily on low-coverage WGS. Here, we present a high-coverage 3,202-sample WGS 1kGP resource, which now includes 602 complete trios, sequenced to a depth of 30X using Illumina. We performed single-nucleotide variant (SNV) and short insertion and deletion (INDEL) discovery and generated a comprehensive set of structural variants (SVs) by integrating multiple analytic methods through a machine learning model. We show gains in sensitivity and precision of variant calls compared to phase 3, especially among rare SNVs as well as INDELs and SVs spanning frequency spectrum. We also generated an improved reference imputation panel, making variants discovered here accessible for association studies.	[Byrska-Bishop, Marta; Evani, Uday S.; Basile, Anna O.; Corvelo, Andre; Clarke, Wayne E.; Musunuri, Rajeeva; Nagulapalli, Kshithija; Runnels, Alexi; Winterkorn, Lara; Germer, Soren; Narzisi, Giuseppe; Zody, Michael C.] New York Genome Ctr, New York, NY 10013 USA; [Brand, Harrison; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Zhao, Xuefang; Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brand, Harrison; Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02114 USA; [Abel, Haley J.; Regier, Allison A.; Hall, Ira M.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA; [Abel, Haley J.; Regier, Allison A.; Hall, Ira M.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [Clarke, Wayne E.] Outlier Informat Inc, Saskatoon, SK S7H 1L4, Canada; [Fairley, Susan; Lowy, Ernesto; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Brand, Harrison; Talkowski, Michael E.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Hall, Ira M.] Yale Univ, Ctr Genom Hlth, Sch Med, New Haven, CT 06510 USA; [Hall, Ira M.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL); European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Yale University	Byrska-Bishop, M; Zody, MC (corresponding author), New York Genome Ctr, New York, NY 10013 USA.	mbyrska-bishop@nygenome.org; mczody@nygenome.org	; Alkan, Can/D-2982-2009	Chen, Yu/0000-0002-2037-7337; Fairley, Susan/0000-0001-9425-0788; Alkan, Can/0000-0002-5443-0706	NHGRI [UM1HG008853]; NHGRI [UM1HG008853, 3UM1HG008901-03S1, 3UM1HG008901-04S1, WT104947/Z/14/Z, MH115957]; Wellcome Trust [UM1HG008901]; European Molecular Biology Laboratory; NIMH [UM1HG008895]; NICHD [UM1HG008853]; National Library of Medicine, National Institutes of Health; National Institutes of Health [HD081256];  [U24HG007497]	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	The WGS data were generated at the New York Genome Center with funds pro- vided by NHGRI grants 3UM1HG008901-03S1 and 3UM1HG008901-04S1. A.C., W.E.C., and M.C.Z. were partially supported by the NHGRI grant UM1HG008901. S.F., E.L., and P.F. were partially supported by the Wellcome Trust (WT104947/Z/14/Z) and the European Molecular Biology Laboratory. Support for analyses by X.Z. and M.E.T. was provided in part by NIMH MH115957, NICHD HD081256, and NHGRI UM1HG008895. I.M.H., H.J.A. and A.A.R. were supported in part by the NHGRI grant UM1HG008853. C.X. was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health. The HGSVC was supported in part by a grant from the National Institutes of Health U24HG007497 (to C.L., E.E.E., J.O.K., and T.M.) . We thank Justin Zook from the GIAB Consortium for his feed- back and manual curation of a subset of singleton calls in the NA12878 sample across the technologies employed by the GIAB v4.2.1 truth set.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; 1000 Genomes Project Consortium, 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Abel HJ, 2020, NATURE, V583, P83, DOI 10.1038/s41586-020-2371-0; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Almeida R, 2014, HUM MOL GENET, V23, P2481, DOI 10.1093/hmg/ddt619; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andrews S., 2019, FASTQC; [Anonymous], AM J HUM GENET, V91, P839, DOI [10.1016/j.ajhg.2012.09.004, DOI 10.1016/J.AJHG.2012.09.004]; Broad Institute, 2019, POL; Broad Institute Picard Toolkit; Broad Institute, 2019, PICARD TOOLKIT BROAD; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1909-7; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Collins RL, 2020, NATURE, V581, P444, DOI 10.1038/s41586-020-2287-8; Corvelo A., 2021, ABSINTHE; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dashnow H, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1505-2; Delaneau O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13225-y; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dolzhenko E, 2019, BIOINFORMATICS, V35, P4754, DOI 10.1093/bioinformatics/btz431; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; Ebert P, 2021, SCIENCE, V372, P48, DOI 10.1126/science.abf7117; Ebler J, 2022, NAT GENET, V54, P518, DOI 10.1038/s41588-022-01043-w; Fairley S, 2020, NUCLEIC ACIDS RES, V48, pD941, DOI 10.1093/nar/gkz836; Gardner EJ, 2017, GENOME RES, V27, P1916, DOI 10.1101/gr.218032.116; Halldorsson BV, 2022, NATURE, V607, P732, DOI 10.1038/s41586-022-04965-x; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7821; Ng JK, 2021, bioRxiv, DOI 10.1101/2021.05.27.445979; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ke GL, 2017, ADV NEUR IN, V30; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kronenberg ZN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004572; Krusche P, 2019, NAT BIOTECHNOL, V37, P555, DOI 10.1038/s41587-019-0054-x; Larson DE, 2019, BIOINFORMATICS, V35, P4782, DOI 10.1093/bioinformatics/btz492; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Martin M., 2016, BIORXIV, DOI [10.1101/085050, DOI 10.1101/085050]; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Mousavi N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz501; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Poplin R., 2018, BIORXIV, DOI [10.1101/201178, DOI 10.1101/201178, DOI 10.1101/201178V3]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sherry ST, 1999, GENOME RES, V9, P677; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Taliun Daniel, 2021, Nature, V590, P290, DOI 10.1038/s41586-021-03205-y; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Van der Auwera G.A., 2020, GENOMICS CLOUD USING; Wagner Justin, 2022, Cell Genom, V2, DOI 10.1016/j.xgen.2022.100128; Werling DM, 2018, NAT GENET, V50, P727, DOI 10.1038/s41588-018-0107-y; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zhao XF, 2021, AM J HUM GENET, V108, P919, DOI 10.1016/j.ajhg.2021.03.014; Zhao Xuefang, 2017, GigaScience, V6, P1, DOI 10.1093/gigascience/gix061; Zheng-Bradley X, 2017, BRIEF FUNCT GENOMICS, V16, P163, DOI 10.1093/bfgp/elw027; Zook JM, 2019, NAT BIOTECHNOL, V37, P561, DOI 10.1038/s41587-019-0074-6; 2015, bioRxiv, DOI 10.1101/023754	82	9	9	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3426	+		10.1016/j.cell.2022.08.004	http://dx.doi.org/10.1016/j.cell.2022.08.004			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4M5EZ	36055201	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000853347900003
J	Honda, S; Kawasaki, T				Honda, Sakiko; Kawasaki, Tatsuya			Wellens' Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Honda, Sakiko; Kawasaki, Tatsuya] Matsushita Mem Hosp, Moriguchi, Osaka, Japan		Honda, S (corresponding author), Matsushita Mem Hosp, Moriguchi, Osaka, Japan.	honda.sakiko@jp.panasonic.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12							e25	10.1056/NEJMicm2201699	http://dx.doi.org/10.1056/NEJMicm2201699			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36130000				2022-12-28	WOS:000865461700002
J	Kallbekken, S; Victor, DG				Kallbekken, Steffen; Victor, David G.			A cleaner future for flight - aviation needs a radical redesign	NATURE			English	Editorial Material								Efficiency and clean fuels won't be enough. Governments and industry must experiment with other approaches to bring the climate impact of aviation close to zero.	[Kallbekken, Steffen] CICERO Ctr Int Climate Res, Climate Econ Grp, Oslo, Norway; [Victor, David G.] Univ Calif San Diego, Innovat & Publ Policy, San Diego, CA 92103 USA; [Victor, David G.] Brookings Inst, Washington, DC 20036 USA	University of California System; University of California San Diego; Brookings Institution	Kallbekken, S (corresponding author), CICERO Ctr Int Climate Res, Climate Econ Grp, Oslo, Norway.	steffen.kallbekken@cicero.oslo.no						Badgley G, 2022, GLOBAL CHANGE BIOL, V28, P1433, DOI 10.1111/gcb.15943; Cullenward D., 2020, MAKING CLIMATE POLIC; Digby RAR, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2021GL095882; Hiselius LW, 2021, EUR TRANSP RES REV, V13, DOI 10.1186/s12544-021-00471-9; IPCC, 2022, CLIMATE CHANGE 2022, DOI [DOI 10.1017/9781009325844, DOI 10.1017/9781009157926.001]; Klower M, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/ac286e; Lee DS, 2021, ATMOS ENVIRON, V244, DOI 10.1016/j.atmosenv.2020.117834; Sabel C.F., 2022, FIXING CLIMATE STRAT, DOI [10.2307/j.ctv279500j, DOI 10.2307/J.CTV279500J]; Scheelhaase J, 2018, J AIR TRANSP MANAG, V67, P55, DOI 10.1016/j.jairtraman.2017.11.007; Ueckerdt F, 2021, NAT CLIM CHANGE, V11, P384, DOI 10.1038/s41558-021-01032-7; Victor D. G., 2019, ACCELERATING LOW CAR	11	1	1	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					673	675						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O1XO	36114304	Bronze			2022-12-28	WOS:000854500100010
J	[Anonymous]				[Anonymous]			Summary for Patients: Effectiveness of an Online Yoga Program on Pain and Function in Participants With Knee Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT	2022	175	10					I32	I32		10.7326/P22-0017	http://dx.doi.org/10.7326/P22-0017		SEP 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5M3CC	36122379				2022-12-28	WOS:000860851400003
J	Hudson, JA; Majonga, ED; Ferrand, RA; Perel, P; Alam, SR; Shah, ASV				Hudson, Jonathan A.; Majonga, Edith D.; Ferrand, Rashida A.; Perel, Pablo; Alam, Shirjel R.; Shah, Anoop S., V			Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMMUNODEFICIENCY-VIRUS-INFECTION; RISK CORONARY PLAQUE; ARTERIAL INFLAMMATION; ANTIRETROVIRAL THERAPY; MYOCARDIAL FIBROSIS; HEART-FAILURE; PEOPLE; INDIVIDUALS; PREVALENCE; ATHEROSCLEROSIS	IMPORTANCE HIV-associated cardiovascular disease is increasing in prevalence, but its mechanisms remain poorly understood. OBJECTIVE To systematically review data from advanced cardiovascular imaging studies evaluating computed tomographic coronary angiography, positron emission tomography (PET), and cardiac magnetic resonance (MR), in people living with HIV compared with uninfected individuals. DATA SOURCES Three databases and Google Scholar were searched for studies assessing cardiovascular pathology using computed tomographic coronary angiography, cardiac MR, PET, and HIV from inception to February 11, 2022. STUDY SELECTION Two reviewers selected original studies without any restrictions on design, date, or language, investigating HIV and cardiovascular pathology. Data Extraction and Synthesis One investigator extracted data checked by a second investigator. Prevalence ratios (PRs) and differences in inflammation among people living with HIV and uninfected individuals were qualitatively synthesized in terms of cardiovascular pathology. Study quality was assessed using the National Heart, Lung, and Blood Institute quality assessment tool for observational studies. MAIN OUTCOMES AND MEASURES Primary outcomes were computed tomographic coronary angiography-defined moderate to severe (>= 50%) coronary stenosis, cardiac MR-defined myocardial fibrosis identified by late gadolinium enhancement, and PET-defined vascular and myocardial target to background ratio. Prevalence of moderate to severe coronary disease, as well as myocardial fibrosis, and PRs compared with uninfected individuals were reported alongside difference in vascular target to background ratio. RESULTS Forty-five studies including 5218 people living with HIV (mean age, 48.5 years) and 2414 uninfected individuals (mean age, 49.1 years) were identified. Sixteen studies (n = 5107 participants) evaluated computed tomographic coronary angiography; 16 (n = 1698), cardiac MRs; 10 (n = 681), vascular PET scans; and 3 (n = 146), both computed tomographic coronary angiography and vascular PET scans. No studies originated from low-income countries. Regarding risk of bias, 22% were classified as low; 47% moderate; and 31% high. Prevalence of moderate to severe coronary disease among those with vs without HIV ranged from 0% to 52% and 0% to 27%, respectively, with PRs ranging from 0.33 (95% CI, 0.01-15.90) to 5.19 (95% CI, 1.26-21.42). Prevalence of myocardial fibrosis among those with vs without HIV ranged from 5% to 84% and 0% to 68%, respectively, with PRs ranging from 1.01 (95% CI, 0.85-1.21) to 17.35 (95% CI, 1.10-274.28). Differences in vascular target to background ratio among those with vs without HIV ranged from 0.06 (95% CI, 0.01-0.11) to 0.37 (95% CI, 0.02-0.72). CONCLUSIONS AND RELEVANCE In this systematic review of studies of advanced cardiovascular imaging, the estimates of the associations between HIV and cardiovascular pathologies demonstrated large amounts of heterogeneity. The findings provide a summary of the available data but may not be representative of all individuals living with HIV, including those from low-income countries with higher HIV endemicity.	[Hudson, Jonathan A.] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, British Heart Fdn Ctr, London, England; [Hudson, Jonathan A.] Epsom & St Helier Univ Hosp Trust, Dept Cardiol, London, England; [Majonga, Edith D.; Ferrand, Rashida A.] Biomed Res & Training Inst, Harare, Zimbabwe; [Majonga, Edith D.] Univ Zimbabwe, Fac Med & Hlth Sci, Dept Med Phys & Imaging Sci, Harare, Zimbabwe; [Ferrand, Rashida A.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Perel, Pablo; Alam, Shirjel R.; Shah, Anoop S., V] London Sch Hyg & Trop Med, Dept Noncommunicable Dis, Keppel St,Room 249, London WC1E 7HT, England; [Alam, Shirjel R.] North Bristol NHS Trust, Dept Cardiol, London, England; [Shah, Anoop S., V] Imperial Coll NHS Trust, Dept Cardiol, London, England	University of London; King's College London; Biomedical Research Training Institute; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; North Bristol NHS Trust	Shah, ASV (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis, Keppel St,Room 249, London WC1E 7HT, England.	anoop.shah@lshtm.ac.uk		Majonga, Edith/0000-0002-9021-0698; Shah, Anoop/0000-0002-2825-3419; Hudson, Jonathan/0000-0002-5128-8388	British Heart Foundation through an Intermediate Clinical Research Fellowship [FS/19/17/34172]	British Heart Foundation through an Intermediate Clinical Research Fellowship	This study was funded by grant FS/19/17/34172 from the British Heart Foundation through an Intermediate Clinical Research Fellowship.	Abd-Elmoniem KZ, 2014, CLIN INFECT DIS, V59, P1779, DOI 10.1093/cid/ciu672; Alencherry B, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2019-001046; [Anonymous], 2021, STUD QUAL ASS TOOLS; [Anonymous], 2021, CONFR IN LESS PAND R; Boldeanu I, 2021, RADIOLOGY, V299, P571, DOI 10.1148/radiol.2021203297; Breuckmann F, 2007, EUR J MED RES, V12, P185; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Butler J, 2020, J CARD FAIL, V26, P371, DOI 10.1016/j.cardfail.2019.10.011; Caceres BA, 2020, CIRCULATION, V142, pE321, DOI 10.1161/CIR.0000000000000914; Chareonthaitawee P, 2017, J NUCL CARDIOL, V24, P1741, DOI 10.1007/s12350-017-0978-9; Chen YQ, 2021, JAIDS-J ACQ IMM DEF, V87, P741, DOI 10.1097/QAI.0000000000002629; Chew KW, 2017, J INT MED RES, V45, P1693, DOI 10.1177/0300060517708919; Crane HM, 2017, JAMA CARDIOL, V2, P260, DOI 10.1001/jamacardio.2016.5139; Cury RC, 2016, J AM COLL RADIOL, V13, P1458, DOI 10.1016/j.jacr.2016.04.024; D'Abramo Alessandra, 2013, ISRN AIDS, V2013, P737083, DOI 10.1155/2013/737083; D'Ascenzo F, 2015, ATHEROSCLEROSIS, V240, P197, DOI 10.1016/j.atherosclerosis.2015.03.019; d'Ettorre G, 2012, J INFECTION, V64, P82, DOI 10.1016/j.jinf.2011.09.007; Davis K, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01978-7; de Leuw P, 2021, JACC-CARDIOVASC IMAG, V14, P1548, DOI 10.1016/j.jcmg.2021.01.042; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Duarte H, 2012, ANTIVIR THER, V17, P763, DOI 10.3851/IMP1994; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Fitch KV, 2016, AIDS, V30, P2205, DOI 10.1097/QAD.0000000000001186; Freiberg MS, 2017, JAMA CARDIOL, V2, P536, DOI 10.1001/jamacardio.2017.0264; Frustaci A, 2014, AIDS, V28, P2541, DOI 10.1097/QAD.0000000000000426; Germain P, 2014, CLIN MED INSIGHTS-CA, V8, P1, DOI 10.4137/CMC.S19005; Grinspoon SK, 2019, AM HEART J, V212, P23, DOI 10.1016/j.ahj.2018.12.016; Guaraldi G, 2020, ATHEROSCLEROSIS, V297, P127, DOI 10.1016/j.atherosclerosis.2020.02.014; Haaf P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0308-4; Hoffmann U, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.14923; Hsue PY, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004427; Jeudy J, 2022, AIDS, V36, P399, DOI 10.1097/QAD.0000000000003125; Johnston PI, 2021, AIDS, V35, P957, DOI 10.1097/QAD.0000000000002815; Kapelios CJ, 2021, AIDS RES HUM RETROV, V37, P343, DOI [10.1089/aid.2021.0015, 10.1089/AID.2021.0015]; Knudsen A, 2015, J NUCL CARDIOL, V22, P372, DOI 10.1007/s12350-014-0032-0; Lai H, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002529; Lawal IO, 2019, J NUCL CARDIOL, V26, P1258, DOI 10.1007/s12350-018-1207-x; [李培杰 Li Peijie], 2020, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V36, P391; Lo J, 2015, LANCET HIV, V2, pE52, DOI 10.1016/S2352-3018(14)00032-0; Longenecker CT, 2018, AIDS, V32, P89, DOI 10.1097/QAD.0000000000001682; Luetkens Julian A, 2016, Circ Cardiovasc Imaging, V9, pe004091, DOI 10.1161/CIRCIMAGING.115.004091; Menacho K, 2020, JACC-CARDIOVASC IMAG, V13, P1278, DOI 10.1016/j.jcmg.2019.12.005; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Mugisha JO, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31098; Nadel J, 2016, J CARDIOVASC COMPUT, V10, P391, DOI 10.1016/j.jcct.2016.07.018; Ntusi N, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004430; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Patterson AJ, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-00664-6; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950; Pineirua-Menendez A, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa297; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Raggi P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051183; Remick J, 2014, CIRCULATION, V129, P1781, DOI 10.1161/CIRCULATIONAHA.113.004574; Scholtz MEL, 2019, DISSERTATION; Schuster C, 2018, J INFECT DIS, V218, P466, DOI 10.1093/infdis/jiy183; Senoner T, 2019, AIDS, V33, P1853, DOI 10.1097/QAD.0000000000002297; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Shuldiner SR, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofaa600; So-Armah K, 2020, LANCET HIV, V7, pE279, DOI 10.1016/S2352-3018(20)30036-9; Soares C, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019291; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Taglieri N, 2022, J NUCL CARDIOL, V29, P1566, DOI 10.1007/s12350-020-02522-5; Tarr PE, 2018, EUR HEART J, V39, P2147, DOI 10.1093/eurheartj/ehy163; Tawakol A, 2017, JAMA CARDIOL, V2, P163, DOI 10.1001/jamacardio.2016.4728; Tawakol A, 2014, JAIDS-J ACQ IMM DEF, V66, P164, DOI 10.1097/QAI.0000000000000138; Thiara DK, 2015, J INFECT DIS, V212, P1544, DOI 10.1093/infdis/jiv274; Trickey A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160460; Tseng ZH, 2021, NEW ENGL J MED, V384, P2306, DOI 10.1056/NEJMoa1914279; UNAIDS, 2021, GLOB HIV AIDS STAT 2; van der Valk FM, 2016, JACC-CARDIOVASC IMAG, V9, P1198, DOI 10.1016/j.jcmg.2016.04.007; Vos AG, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013466; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; World Bank country and lending groups, US; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Wu KC, 2021, EUR HEART J-CARD IMG, V22, P888, DOI 10.1093/ehjci/jeab037; Yan CX, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.756162; Yarasheski KE, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-26; Zanni MV, 2020, J INFECT DIS, V221, P1315, DOI 10.1093/infdis/jiz184; Zanni MV, 2016, JAMA CARDIOL, V1, P474, DOI 10.1001/jamacardio.2016.0846; Zhang LL, 2021, JAIDS-J ACQ IMM DEF, V87, P706, DOI 10.1097/QAI.0000000000002630	81	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					951	962		10.1001/jama.2022.15078	http://dx.doi.org/10.1001/jama.2022.15078			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098725				2022-12-28	WOS:000855222400020
J	Devi, S				Devi, Sharmila			Pakistan floods: impact on food security and health systems	LANCET			English	Editorial Material																			0	1	1	4	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					799	800						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36088939				2022-12-28	WOS:000877580600009
J	Xu, SQ; Wang, R; Gasser, T; Ciais, P; Penuelas, J; Balkanski, Y; Boucher, O; Janssens, IA; Sardans, J; Clark, JH; Cao, JJ; Xing, XF; Chen, JM; Wang, L; Tang, X; Zhang, RH				Xu, Siqing; Wang, Rong; Gasser, Thomas; Ciais, Philippe; Penuelas, Josep; Balkanski, Yves; Boucher, Olivier; Janssens, Ivan A.; Sardans, Jordi; Clark, James H.; Cao, Junji; Xing, Xiaofan; Chen, Jianmin; Wang, Lin; Tang, Xu; Zhang, Renhe			Delayed use of bioenergy crops might threaten climate and food security	NATURE			English	Article							GLOBAL FIRE EMISSIONS; CARBON CAPTURE; NITROUS-OXIDE; BIOFUEL; CHINA; MANAGEMENT; FERTILIZER; EFFICIENCY; RESOURCES; SCENARIOS	The potential of mitigation actions to limit global warming within 2 degrees C (ref.(1)) might rely on the abundant supply of biomass for large-scale bioenergy with carbon capture and storage (BECCS) that is assumed to scale up markedly in the future(2-5). However, the detrimental effects of climate change on crop yields may reduce the capacity of BECCS and threaten food security(6-8), thus creating an unrecognized positive feedback loop on global warming. We quantified the strength of this feedback by implementing the responses of crop yields to increases in growing season temperature, atmospheric CO2 concentration and intensity of nitrogen (N) fertilization in a compact Earth system model(9). Exceeding a threshold of climate change would cause transformative changes in social-ecological systems by jeopardizing climate stability and threatening food security. If global mitigation alongside large-scale BECCS is delayed to 2060 when global warming exceeds about 2.5 degrees C, then the yields of agricultural residues for BECCS would be too low to meet the Paris goal of 2 degrees C by 2200. This risk of failure is amplified by the sustained demand for food, leading to an expansion of cropland or intensification of N fertilization to compensate for climate-induced yield losses. Our findings there by reinforce the urgency of early mitigation, preferably by 2040, to avoid irreversible climate change and serious food crises unless other negative-emission technologies become available in the near future to compensate for the reduced capacity of BECCS.	[Xu, Siqing; Wang, Rong; Clark, James H.; Xing, Xiaofan; Chen, Jianmin; Wang, Lin] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai, Peoples R China; [Wang, Rong; Chen, Jianmin; Wang, Lin; Tang, Xu; Zhang, Renhe] Fudan Univ, IRDR Int Ctr Excellence Risk Interconnect & Gover, Shanghai, Peoples R China; [Wang, Rong; Chen, Jianmin; Wang, Lin; Tang, Xu; Zhang, Renhe] Fudan Univ, Inst Atmospher Sci, Shanghai, Peoples R China; [Wang, Rong; Zhang, Renhe] Shanghai Frontiers Sci Ctr Atmosphere Ocean Inter, Shanghai, Peoples R China; [Wang, Rong; Zhang, Renhe] Fudan Univ, MOE Lab Natl Dev & Intelligent Governance, Shanghai, Peoples R China; [Wang, Rong] Inst Eco Chongming IEC, Shanghai, Peoples R China; [Gasser, Thomas] Int Inst Appl Syst Anal IIASA, Laxenburg, Austria; [Ciais, Philippe; Balkanski, Yves] CEA CNRS UVSQ, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Ciais, Philippe] Cyprus Inst, Climate & Atmosphere Res Ctr CARE C, Nicosia, Cyprus; [Penuelas, Josep; Sardans, Jordi] CREAF CSIC UAB, Global Ecol Unit, CSIC, Berraterra, Spain; [Penuelas, Josep; Sardans, Jordi] CREAF, Cerdanyola Del Valles, Spain; [Boucher, Olivier] Sorbonne Univ, Inst Pierre Simon Laplace, CNRS, Paris, France; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Clark, James H.] Univ York, Green Chem Ctr Excellence, York, N Yorkshire, England; [Cao, Junji] Chinese Acad Sci, Inst Atmospher Phys, Beijing, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; International Institute for Applied Systems Analysis (IIASA); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Antwerp; University of York - UK; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Wang, R (corresponding author), Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai, Peoples R China.; Wang, R (corresponding author), Fudan Univ, IRDR Int Ctr Excellence Risk Interconnect & Gover, Shanghai, Peoples R China.; Wang, R (corresponding author), Fudan Univ, Inst Atmospher Sci, Shanghai, Peoples R China.; Wang, R (corresponding author), Shanghai Frontiers Sci Ctr Atmosphere Ocean Inter, Shanghai, Peoples R China.; Wang, R (corresponding author), Fudan Univ, MOE Lab Natl Dev & Intelligent Governance, Shanghai, Peoples R China.; Wang, R (corresponding author), Inst Eco Chongming IEC, Shanghai, Peoples R China.	rongwang@fudan.edu.cn	Penuelas, Josep/D-9704-2011; Wang, Lin/E-8546-2010; Zhang, Renhe/AAA-6301-2020; Janssens, Ivan/P-1331-2014	Penuelas, Josep/0000-0002-7215-0150; Wang, Lin/0000-0002-4905-3432; Zhang, Renhe/0000-0001-7750-8679; Clark, James/0000-0002-5860-2480; Janssens, Ivan/0000-0002-5705-1787; Wang, Rong/0000-0003-1962-0165	National Natural Science Foundation of China [41877506]; Chinese Thousand Youth Talents Program; Shanghai International Science and Technology Partnership Project [21230780200]; Fudan-Sinar Mas Think Tank Fund [JGSXK2014]; ANR CLAND Convergence Institute [16-CONV-0003]; Catalan Government [SGR 2017-1005, AGAUR-2020PANDE00117]; Spanish Government [PID2019-110521GB-I00]; Fundacion Ramon Areces grant ELEMENTAL-CLIMATE; Austrian Science Fund (FWF) [P31796-N29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Thousand Youth Talents Program; Shanghai International Science and Technology Partnership Project; Fudan-Sinar Mas Think Tank Fund; ANR CLAND Convergence Institute(French National Research Agency (ANR)); Catalan Government; Spanish Government(Spanish GovernmentEuropean Commission); Fundacion Ramon Areces grant ELEMENTAL-CLIMATE; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	R.W. appreciates the provision of funds from the National Natural Science Foundation of China (41877506) and the Chinese Thousand Youth Talents Program. R.Z., X.T., J. Chen and R.W. acknowledge support from the Shanghai International Science and Technology Partnership Project (21230780200). X.T. and R.W. acknowledge support from the Fudan-Sinar Mas Think Tank Fund (JGSXK2014). P.C. acknowledges support from the ANR CLAND Convergence Institute 16-CONV-0003. J.P. and J.S. acknowledge the financial support from the Catalan Government grants SGR 2017-1005 and AGAUR-2020PANDE00117, the Spanish Government grant PID2019-110521GB-I00 and the Fundacion Ramon Areces grant ELEMENTAL-CLIMATE. T.G. acknowledges support from the Austrian Science Fund (FWF) under grant agreement P31796-N29 (ERM project).	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ardebili SMS, 2018, J CLEAN PROD, V204, P819, DOI 10.1016/j.jclepro.2018.09.031; Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Asseng S, 2021, LANCET PLANET HEALTH, V5, pE378, DOI 10.1016/S2542-5196(21)00079-6; Bajzelj B, 2014, NAT CLIM CHANGE, V4, P924, DOI [10.1038/NCLIMATE2353, 10.1038/nclimate2353]; Boas I, 2019, NAT CLIM CHANGE, V9, P901, DOI 10.1038/s41558-019-0633-3; Boden Thomas, 2013, AmeriFlux, DOI 10.3334/CDIAC/00001_V2013; Brander M, 2011, TECHNICAL PAPER ELEC, DOI DOI 10.13044/J.SDEWES.2014.02.0030; Broberg MC, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9050243; Cai XM, 2011, ENVIRON SCI TECHNOL, V45, P334, DOI 10.1021/es103338e; Calories.info, 2021, CAL FOOD CAL CHART; Creutzig F, 2021, GCB BIOENERGY, V13, P510, DOI 10.1111/gcbb.12798; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Dawson IGJ, 2017, RISK ANAL, V37, P65, DOI 10.1111/risa.12576; Drouet L, 2021, NAT CLIM CHANGE, V11, P1070, DOI 10.1038/s41558-021-01218-z; EC-JRC/PBL, 2011, EM DAT GLOB ATM RES; Erb KH, 2018, NATURE, V553, P73, DOI 10.1038/nature25138; Fajardy M, 2019, 28 GRANTH I; Fajardy M, 2017, ENERG ENVIRON SCI, V10, P1389, DOI [10.1039/c7ee00465f, 10.1039/C7EE00465F]; FAO, 2020, FAOSTAT STAT DAT, DOI DOI 10.4060/CA8642EN; FAO Food and Agriculture Organization of the United Nations, 2021, FOOD AGR DAT; Food and Agriculture Organization of the United Nations (FAO), 2014, REP 31 SESS COMM FIS; Food and Agriculture Organization of the United Nations (FAO), 2020, ANN POP; Friedlingstein P, 2020, EARTH SYST SCI DATA, V12, P3269, DOI 10.5194/essd-12-3269-2020; Fu B, 2020, NAT CLIM CHANGE, V10, P851, DOI 10.1038/s41558-020-0841-x; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gao J, 2016, GCB BIOENERGY, V8, P880, DOI 10.1111/gcbb.12305; Gasser T, 2018, NAT GEOSCI, V11, P830, DOI 10.1038/s41561-018-0227-0; Gasser T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8958; Gasser T, 2017, GEOSCI MODEL DEV, V10, P271, DOI 10.5194/gmd-10-271-2017; Ghugare SB, 2017, J ENERGY INST, V90, P476, DOI 10.1016/j.joei.2016.03.002; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Graus WHJ, 2007, ENERG POLICY, V35, P3936, DOI 10.1016/j.enpol.2007.01.016; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hanssen SV, 2020, CLIMATIC CHANGE, V163, P1569, DOI 10.1007/s10584-019-02539-x; Hao H, 2018, RENEW SUST ENERG REV, V82, P645, DOI 10.1016/j.rser.2017.09.045; Hasegawa T, 2021, NAT SUSTAIN, V4, P1052, DOI 10.1038/s41893-021-00772-w; Hausfather Z, 2020, NATURE, V577, P618, DOI 10.1038/d41586-020-00177-3; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Hyrchenko Yevhenii, 2021, E3S Web of Conferences, V280, DOI 10.1051/e3sconf/202128005005; IPCC, 2021, CLIM CHANG WID RAP I, DOI DOI 10.1017/9781009157896; Ji LQ, 2015, RENEW SUST ENERG REV, V44, P561, DOI 10.1016/j.rser.2015.01.011; Johansson DJA, 2021, NAT CLIM CHANGE, V11, P1021, DOI 10.1038/s41558-021-01229-w; Jones MB, 2020, GLOBAL CHANGE BIOL, V26, P5358, DOI 10.1111/gcb.15296; Kukal MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21848-2; Kumar A, 2003, BIOMASS BIOENERG, V24, P445, DOI 10.1016/S0961-9534(02)00149-6; Lade SJ, 2020, NAT SUSTAIN, V3, P119, DOI 10.1038/s41893-019-0454-4; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Li BG, 2016, NATURE, V531, P357, DOI 10.1038/nature17165; Li W, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.169; Lipinski B., 2013, WORKING PAPER INSTAL; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lu X, 2019, P NATL ACAD SCI USA, V116, P8206, DOI 10.1073/pnas.1812239116; Makowski D, 2015, AGR FOREST METEOROL, V214, P483, DOI 10.1016/j.agrformet.2015.09.013; Meinshausen M, 2022, NATURE, V604, P304, DOI 10.1038/s41586-022-04553-z; Milkoreit M, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaaa75; Moore CE, 2021, J EXP BOT, V72, P2822, DOI 10.1093/jxb/erab090; Muratori M, 2020, CLIMATIC CHANGE, V163, P1621, DOI 10.1007/s10584-020-02784-5; Muratori M, 2017, INT J GREENH GAS CON, V57, P34, DOI 10.1016/j.ijggc.2016.11.026; Penuelas J, 2022, SCIENCE, V375, P266, DOI 10.1126/science.abl4827; Potapov P, 2022, NAT FOOD, V3, P19, DOI 10.1038/s43016-021-00429-z; Riahi K, 2021, NAT CLIM CHANGE, V11, P1063, DOI 10.1038/s41558-021-01215-2; Rickels W, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab3ab4; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; RTE France, 2022, ECO 2 MIX CO2 EM KWH; Schakel W, 2014, APPL ENERG, V131, P441, DOI 10.1016/j.apenergy.2014.06.045; Schyns JF, 2019, P NATL ACAD SCI USA, V116, P4893, DOI 10.1073/pnas.1817380116; Sharma S, 2019, FRONT ENERGY RES, V7, DOI 10.3389/fenrg.2019.00143; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Spinoni J., 2021, GLOBAL PLANET CHANGE, V205, P103597, DOI DOI 10.1016/J.GLOPLACHA.2021.103597; Su Y, 2021, NAT CLIM CHANGE, V11, P628, DOI 10.1038/s41558-021-01075-w; Thilakarathna SK, 2020, SOIL SCI SOC AM J, V84, P1910, DOI 10.1002/saj2.20145; U.S. Department of Agriculture (USDA), 2021, WORLD AGR PROD WAP C; United Nations Framework Convention on Climate Change (UNFCCC), 2021, PAR AGR STAT RAT; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; van Vuuren DP, 2018, NAT CLIM CHANGE, V8, P391, DOI 10.1038/s41558-018-0119-8; Van Zeist WJ, 2020, GLOBAL ENVIRON CHANG, V64, DOI 10.1016/j.gloenvcha.2020.102120; Wang D, 2011, ACTA AGR SCAND B-S P, V61, P681, DOI 10.1080/09064710.2010.534108; Wang R, 2019, JOULE, V3, P2103, DOI 10.1016/j.joule.2019.07.024; Wang SH, 2020, SCIENCE, V370, P1295, DOI 10.1126/science.abb7772; Wolf J, 2015, GLOBAL BIOGEOCHEM CY, V29, P1617, DOI 10.1002/2015GB005119; World Health Organization, 2021, FOOD AGR ORG UN SAF; Xing XF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23282-x; Yang YL, 2010, RENEW SUST ENERG REV, V14, P3050, DOI 10.1016/j.rser.2010.07.054; Ye YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101776; Yoshida R, 2015, CLIM RES, V64, P275, DOI 10.3354/cr01320; Zhang X, 2015, NATURE, V528, P51, DOI 10.1038/nature15743; Zhao C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13530; Zhao G, 2015, GCB BIOENERGY, V7, P479, DOI 10.1111/gcbb.12145; Zhou F, 2014, ENVIRON SCI TECHNOL, V48, P8538, DOI 10.1021/es5018027	98	2	2	140	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					299	+		10.1038/s41586-022-05055-8	http://dx.doi.org/10.1038/s41586-022-05055-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4L2BA	36071193				2022-12-28	WOS:000852437200002
J	Vodicka, M				Vodicka, Marie			The Song of the Cell: An Exploration of Medicine and the New Human	SCIENCE			English	Book Review																		SCRIBNER M, 2022, SONG THE CELL EXPLOR	1	0	0	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1036	1037						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048936				2022-12-28	WOS:000887933200021
J	Meyer, N; Harvey, AG; Lockley, SW; Dijk, DJ				Meyer, Nicholas; Harvey, Allison G.; Lockley, Steven W.; Dijk, Derk-Jan			Circadian rhythms and disorders of the timing of sleep	LANCET			English	Review							PHASE RESPONSE CURVE; NIGHT-SHIFT WORK; SOCIAL JETLAG; WAKE SYNDROME; NONPHOTIC ENTRAINMENT; MELATONIN SECRETION; INTRINSIC PERIOD; MISTIMED SLEEP; LIGHT EXPOSURE; CANCER RISK	The daily alternation between sleep and wakefulness is one of the most dominant features of our lives and is a manifestation of the intrinsic 24 h rhythmicity underlying almost every aspect of our physiology. Circadian rhythms are generated by networks of molecular oscillators in the brain and peripheral tissues that interact with environmental and behavioural cycles to promote the occurrence of sleep during the environmental night. This alignment is often disturbed, however, by contemporary changes to our living environments, work or social schedules, patterns of light exposure, and biological factors, with consequences not only for sleep timing but also for our physical and mental health. Characterised by undesirable or irregular timing of sleep and wakefulness, in this Series paper we critically examine the existing categories of circadian rhythm sleep-wake disorders and the role of the circadian system in their development. We emphasise how not all disruption to daily rhythms is driven solely by an underlying circadian disturbance, and take a broader, dimensional approach to explore how circadian rhythms and sleep homoeostasis interact with behavioural and environmental factors. Very few high-quality epidemiological and intervention studies exist, and wider recognition and treatment of sleep timing disorders are currently hindered by a scarcity of accessible and objective tools for quantifying sleep and circadian physiology and environmental variables. We therefore assess emerging wearable technology, transcriptomics, and mathematical modelling approaches that promise to accelerate the integration of our knowledge in sleep and circadian science into improved human health.	[Meyer, Nicholas] Univ Coll London Hosp NHS Fdn Trust, Insomnia & Behav Sleep Med Clin, London, England; [Meyer, Nicholas] Inst Psychol Psychiat & Neurosci, Kings Coll London, Dept Psychosis Studies, London, England; [Harvey, Allison G.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA USA; [Lockley, Steven W.] Brigham & Womens Hosp, Dept Med, Div Sleep & Circadian Disorders, Boston, MA USA; [Lockley, Steven W.] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Lockley, Steven W.] Harvard Med Sch, Div Sleep Med, Boston, MA USA; [Lockley, Steven W.; Dijk, Derk-Jan] Univ Surrey, Surrey Sleep Res Ctr, Dept Clin & Expt Med, Guildford, England; [Dijk, Derk-Jan] Imperial Coll London, UK Dementia Res Inst, Care Res & Technol Ctr, Guildford, England; [Dijk, Derk-Jan] Univ Surrey, Guildford, England; [Dijk, Derk-Jan] Univ Surrey, Surrey Sleep Res Ctr, Dept Clin & Expt Med, Guildford GU2 7XP, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; King's College London; University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Surrey; Imperial College London; University of Surrey; University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Surrey Sleep Res Ctr, Dept Clin & Expt Med, Guildford GU2 7XP, England.	d.j.dijk@surrey.ac.uk	Meyer, Nicholas/O-6310-2015	Meyer, Nicholas/0000-0002-7640-0284				Abbott SM, 2015, SLEEP MED CLIN, V10, P517, DOI 10.1016/j.jsmc.2015.08.005; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Allada R, 2021, NEW ENGL J MED, V384, P550, DOI 10.1056/NEJMra1802337; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Archer SN, 2015, J SLEEP RES, V24, P476, DOI 10.1111/jsr.12307; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Archer SN, 2010, SLEEP, V33, P695, DOI 10.1093/sleep/33.5.695; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Arendt J, 2005, J BIOL RHYTHM, V20, P291, DOI 10.1177/0748730405277492; Ashbrook LH, 2020, NEUROPSYCHOPHARMACOL, V45, P45, DOI 10.1038/s41386-019-0476-7; Auger RR, 2015, J CLIN SLEEP MED, V11, P1199, DOI 10.5664/jcsm.5100; Barger LK, 2012, SLEEP, V35, P1693, DOI 10.5665/sleep.2246; Barnes RG, 1998, NEUROSCI LETT, V241, P9, DOI 10.1016/S0304-3940(97)00965-8; Baron KG, 2014, INT REV PSYCHIATR, V26, P139, DOI 10.3109/09540261.2014.911149; Bauer M, 2006, BIPOLAR DISORD, V8, P160, DOI 10.1111/j.1399-5618.2006.00294.x; Boivin DB, 2014, PATHOL BIOL, V62, P292, DOI 10.1016/j.patbio.2014.08.001; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Borbely A A, 1982, Hum Neurobiol, V1, P195; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Brown TM, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001571; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Carskadon MA, 1999, NEUROSCI LETT, V260, P129, DOI 10.1016/S0304-3940(98)00971-9; Cederroth CR, 2019, CELL METAB, V30, P238, DOI 10.1016/j.cmet.2019.06.019; Chang AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41712-1; Chang AM, 2015, P NATL ACAD SCI USA, V112, P1232, DOI 10.1073/pnas.1418490112; Chellappa SL, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa214; Cheng P, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa180; Coogan AN, 2013, BIOL PSYCHIAT, V74, P333, DOI 10.1016/j.biopsych.2012.11.021; Cortesi F, 2010, SLEEP MED, V11, P659, DOI 10.1016/j.sleep.2010.01.010; Crouse JJ, 2021, LANCET PSYCHIAT, V8, P813, DOI 10.1016/S2215-0366(21)00034-1; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Curtis BJ, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz148; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; CZEISLER CA, 1980, SCIENCE, V210, P1264, DOI 10.1126/science.7434029; CZEISLER CA, 1981, SLEEP, V4, P1; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Danielsson K, 2016, BEHAV SLEEP MED, V14, P212, DOI 10.1080/15402002.2014.981817; Dannerfjord AA, 2021, METHODS MOL BIOL, V2130, P233, DOI 10.1007/978-1-0716-0381-9_18; de Bree LCJ, 2020, J CLIN INVEST, V130, P5603, DOI 10.1172/JCI133934; Depner CM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz254; Dijk DJ, 2020, J BIOL RHYTHM, V35, P421, DOI 10.1177/0748730420940483; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Duffy JF, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa281; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Duncan MJ, 2020, EUR J NEUROSCI, V51, P310, DOI 10.1111/ejn.14358; Ekirch AR, 2015, PAST PRESENT, P149, DOI 10.1093/pastj/gtu040; Emens JS, 2022, J CLIN SLEEP MED, V18, P453, DOI 10.5664/jcsm.9612; Facer-Childs ER, 2019, SLEEP MED, V60, P236, DOI 10.1016/j.sleep.2019.05.001; Faulkner SM, 2019, SLEEP MED REV, V46, P108, DOI 10.1016/j.smrv.2019.04.012; Fischer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178782; Flynn-Evans EE, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx163; Flynn-Evans EE, 2016, J CLIN SLEEP MED, V12, P703, DOI 10.5664/jcsm.5800; Flynn-Evans EE, 2014, J BIOL RHYTHM, V29, P215, DOI 10.1177/0748730414536852; Folkard S, 2006, CHRONOBIOL INT, V23, P1181, DOI 10.1080/07420520601096443; Ganesan S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40914-x; Garbazza C, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00017; Gaus SE, 2002, NEUROSCIENCE, V115, P285, DOI 10.1016/S0306-4522(02)00308-1; Geoffroy PA, 2021, PROG NEURO-PSYCHOPH, V106, DOI 10.1016/j.pnpbp.2020.110158; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hablitz LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18115-2; Hansen Johnni, 2017, Curr Environ Health Rep, V4, P325, DOI 10.1007/s40572-017-0155-y; Harvey AG, 2021, J CONSULT CLIN PSYCH, V89, P537, DOI 10.1037/ccp0000650; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Hastings MH, 2018, NAT REV NEUROSCI, V19, P453, DOI 10.1038/s41583-018-0026-z; Hayakawa T, 2005, SLEEP, V28, P945, DOI 10.1093/sleep/28.8.945; He CL, 2015, INT ARCH OCC ENV HEA, V88, P533, DOI 10.1007/s00420-014-0986-x; Hida A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06309; Hjetland GJ, 2020, SLEEP MED REV, V52, DOI 10.1016/j.smrv.2020.101310; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huang YT, 2021, SLEEP, V44, DOI 10.1093/sleep/zsab126; Hughey JJ, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0406-4; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kalmbach DA, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw048; Kelley P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00588; Kennaway DJ, 2015, J PAEDIATR CHILD H, V51, P584, DOI 10.1111/jpc.12840; Kervezee L, 2020, EUR J NEUROSCI, V51, P396, DOI 10.1111/ejn.14216; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Klerman EB, 1998, AM J PHYSIOL-REG I, V274, pR991; Koronowski KB, 2021, SCIENCE, V371, P690, DOI 10.1126/science.abd0951; Lack L, 2005, SLEEP, V28, P616, DOI 10.1093/sleep/28.5.616; Laing EE, 2017, ELIFE, V6, DOI 10.7554/eLife.20214; Lazar AS, 2015, NEUROIMAGE, V116, P123, DOI 10.1016/j.neuroimage.2015.05.012; Lazar AS, 2013, J SLEEP RES, V22, P155, DOI 10.1111/jsr.12001; Lee A, 2017, J KOREAN MED SCI, V32, P1091, DOI 10.3346/jkms.2017.32.7.1091; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Leng Y, 2020, JAMA NEUROL, V77, P1270, DOI 10.1001/jamaneurol.2020.1623; Leng Y, 2019, LANCET NEUROL, V18, P307, DOI 10.1016/S1474-4422(18)30461-7; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Lockley SW, 2008, J SLEEP RES, V17, P207, DOI 10.1111/j.1365-2869.2008.00656.x; Lockley Steven W, 2007, Dialogues Clin Neurosci, V9, P301; Lockley SW, 2015, LANCET, V386, P1754, DOI 10.1016/S0140-6736(15)60031-9; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1999, SLEEP, V22, P616, DOI 10.1093/sleep/22.5.616; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Lockley SW, 2013, ENCY SLEEP, P138; Lyall LM, 2018, LANCET PSYCHIAT, V5, P507, DOI 10.1016/S2215-0366(18)30139-1; Magee M, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12684; Malkani RG, 2018, J CLIN SLEEP MED, V14, P603, DOI 10.5664/jcsm.7054; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Matsui K, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071513; McCleery J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009178.pub3; Meaklim H, 2021, AUST PSYCHOL, V56, P485, DOI 10.1080/00050067.2021.1955614; Merikangas KR, 2019, JAMA PSYCHIAT, V76, P190, DOI 10.1001/jamapsychiatry.2018.3546; Merikanto I, 2022, SLEEP, V45, DOI 10.1093/sleep/zsab216; Micic G, 2021, SLEEP, V44, P1; Micic G, 2017, SLEEP MED, V30, P128, DOI 10.1016/j.sleep.2016.04.002; Micic G, 2016, J BIOL RHYTHM, V31, P387, DOI 10.1177/0748730416650069; Micic G, 2016, SLEEP MED REV, V27, P29, DOI 10.1016/j.smrv.2015.06.004; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOLDOFSKY H, 1986, SLEEP, V9, P61, DOI 10.1093/sleep/9.1.61; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Moon JH, 2016, EBIOMEDICINE, V11, P285, DOI 10.1016/j.ebiom.2016.08.019; Moreira J, 2016, CHRONOBIOL INT, V33, P351, DOI 10.3109/07420528.2016.1151026; Morgan L, 2003, CHRONOBIOL INT, V20, P795, DOI 10.1081/CBI-120024218; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Murray JM, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw002; Musiek ES, 2018, JAMA NEUROL, V75, P582, DOI 10.1001/jamaneurol.2017.4719; Muto V, 2016, SCIENCE, V353, P687, DOI 10.1126/science.aad2993; Nassan M, 2022, NAT REV NEUROL, V18, P7, DOI 10.1038/s41582-021-00577-7; Nota JA, 2015, NEUROSCI BIOBEHAV R, V51, P100, DOI 10.1016/j.neubiorev.2015.01.002; Ong JL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40156-x; OREN DA, 1992, NEW ENGL J MED, V327, P1762; Paine SJ, 2014, CHRONOBIOL INT, V31, P627, DOI 10.3109/07420528.2014.885036; Pallesen S, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.638252; Palmer Christopher R, 2003, Behav Sleep Med, V1, P213, DOI 10.1207/S15402010BSM0104_4; Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201; Patke A, 2017, CELL, V169, P203, DOI 10.1016/j.cell.2017.03.027; Perez-Carbonell L, 2022, LANCET, V400, P1033, DOI 10.1016/S0140-6736(22)01018-2; Perlis ML, 2022, LANCET, V400, P1047, DOI 10.1016/S0140-6736(22)00879-0; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2019, P NATL ACAD SCI USA, V116, P12019, DOI 10.1073/pnas.1901824116; Phillips AJK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03171-4; Qian JY, 2016, TRENDS ENDOCRIN MET, V27, P282, DOI 10.1016/j.tem.2016.03.005; Rahman SA, 2009, SLEEP MED, V10, P549, DOI 10.1016/j.sleep.2008.03.020; Rajaratnam SMW, 2015, SLEEP HEALTH, V1, P121, DOI 10.1016/j.sleh.2015.03.001; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; Rijo-Ferreira F, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0704-0; Rivkees SA, 2003, PEDIATRICS, V112, P373, DOI 10.1542/peds.112.2.373; Robillard R, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0255-y; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; ROSENTHAL NE, 1990, SLEEP, V13, P354; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Salas RME, 2018, NEUROLOGY, V91, P597, DOI 10.1212/WNL.0000000000006239; Santhi N, 2016, P NATL ACAD SCI USA, V113, pE2730, DOI 10.1073/pnas.1521637113; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SCHRADER H, 1993, J SLEEP RES, V2, P51, DOI 10.1111/j.1365-2869.1993.tb00061.x; Shan ZL, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4641; Siegel JM, 2022, LANCET NEUROL, V21, P937, DOI 10.1016/S1474-4422(22)00210-1; Skeldon AC, 2022, SCHIZOPHRENIA BULL, V48, P447, DOI 10.1093/schbul/sbab124; Skeldon AC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45158; Skeldon AC, 2016, SLEEP MED REV, V28, P96, DOI 10.1016/j.smrv.2015.05.011; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; Sletten TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128273; Spera V, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113162; St Hilaire MA, 2012, J PHYSIOL-LONDON, V590, P3035, DOI 10.1113/jphysiol.2012.227892; Steinan MK, 2016, J AFFECT DISORDERS, V191, P156, DOI 10.1016/j.jad.2015.11.025; Stone JE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47290-6; Takaesu Y, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11565; Takaesu Y, 2018, PSYCHIAT CLIN NEUROS, V72, P673, DOI 10.1111/pcn.12688; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Uchiyama M, 2000, NEUROSCI LETT, V294, P101, DOI 10.1016/S0304-3940(00)01551-2; Uchiyama M, 2002, SLEEP, V25, P83, DOI 10.1093/sleep/25.1.83; Uchiyama M, 2015, SLEEP MED CLIN, V10, P495, DOI 10.1016/j.jsmc.2015.07.006; Vadnie CA, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1504507; Veatch OJ, 2017, LANCET NEUROL, V16, P158, DOI 10.1016/S1474-4422(16)30339-8; Verhoeven G, 2021, J SLEEP RES, V30, DOI 10.1111/jsr.13099; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Wang JL, 2015, ANN NEUROL, V78, P317, DOI 10.1002/ana.24432; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737; Wendeu-Foyet MG, 2017, CANCER EPIDEM BIOMAR, V26, P985, DOI [10.1158/1055-9965.EPI-16-1030, 10.1158/1055-9965.epi-16-1030]; Wirz-Justice A, 2019, EUR ARCH PSY CLIN N, V269, P833, DOI 10.1007/s00406-018-0921-3; Wittenbrink N, 2018, J CLIN INVEST, V128, P3826, DOI 10.1172/JCI120874; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Woelders T, 2017, J BIOL RHYTHM, V32, P274, DOI 10.1177/0748730417696787; Wong PM, 2015, J CLIN ENDOCR METAB, V100, P4612, DOI 10.1210/jc.2015-2923; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265; Wyatt JK, 2006, SLEEP, V29, P609, DOI 10.1093/sleep/29.5.609; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Xu P, 2021, NEURON, V109, P3268, DOI 10.1016/j.neuron.2021.07.026; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yetish G, 2015, CURR BIOL, V25, P2862, DOI 10.1016/j.cub.2015.09.046; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	198	4	4	7	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					1061	1078		10.1016/S0140-6736(22)00877-7	http://dx.doi.org/10.1016/S0140-6736(22)00877-7			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5S3JP	36115370				2022-12-28	WOS:000875091000006
J	Fineberg, HV; Song, SS; Wang, T				Fineberg, Harvey V.; Song, Susan; Wang, Tommy			The Future of Diagnostic Excellence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fineberg, Harvey V.; Song, Susan; Wang, Tommy] Gordon & Betty Moore Fdn, 1661 Page Mill Rd, Palo Alto, CA 94304 USA		Fineberg, HV (corresponding author), Gordon & Betty Moore Fdn, 1661 Page Mill Rd, Palo Alto, CA 94304 USA.	harvey.fineberg@moore.org						Bani-Hani AH, 2005, J UROLOGY, V173, P391, DOI 10.1097/01.ju.0000148951.71353.8b; Cercek A, 2022, NEW ENGL J MED, DOI 10.1056/NEJMoa2201445; Maitra A, 2021, JAMA-J AM MED ASSOC, V326, P1907, DOI 10.1001/jama.2021.19496; Medigus, SCOUTCAM ACH BREAKTH; NHS England, NHS ROLLS OUT CAPS T; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Yang D, 2021, JAMA-J AM MED ASSOC, V326, P1905, DOI 10.1001/jama.2021.19493	7	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1039	1040		10.1001/jama.2022.12205	http://dx.doi.org/10.1001/jama.2022.12205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125466				2022-12-28	WOS:000862909200012
J	An, ZY; Peng, D; Shi, YJ; Zhang, CH				An, Zhuo-Yu; Peng, Ding; Shi, Ya-Juan; Zhang, Chuan-Hai			Dyspnoea with diffuse T wave inversion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE PULMONARY-EMBOLISM		[An, Zhuo-Yu] Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China; [Peng, Ding] Guangzhou Med Univ, Affiliated Hosp 6, Dept Electrocardiog, Qingyuan Peoples Hosp, Guangzhou, Peoples R China; [Shi, Ya-Juan] Nantong Univ, Affiliated Qidong Hosp, Qidong Peoples Hosp, Qidong, Jiangsu, Peoples R China; [Zhang, Chuan-Hai] Jinzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Jinzhou, Peoples R China	Peking University; Guangzhou Medical University; Nantong University; Jinzhou Medical University	Zhang, CH (corresponding author), Jinzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Jinzhou, Peoples R China.	zch8598145@yeah.net						DEZWAAN C, 1982, AM HEART J, V103, P730, DOI 10.1016/0002-8703(82)90480-X; Imazio M, 2008, INT J CARDIOL, V127, P17, DOI 10.1016/j.ijcard.2007.10.053; Kosuge M, 2012, EUR HEART J-ACUTE CA, V1, P349, DOI 10.1177/2048872612466790; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Stein PD, 2012, AM J CARDIOL, V110, P1836, DOI 10.1016/j.amjcard.2012.08.019	5	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								e070894	10.1136/bmj-2022-070894	http://dx.doi.org/10.1136/bmj-2022-070894			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109047				2022-12-28	WOS:000888774200002
J	Bai, XM; Bjorn, A; Kilkis, S; Munoz, OS; Whiteman, G; Hoff, H; Andersen, LS; Rockstrom, J				Bai, Xuemei; Bjorn, Anders; Kilkis, Siir; Sabag Munoz, Oscar; Whiteman, Gail; Hoff, Holger; Seaby Andersen, Lauren; Rockstrom, Johan			How to stop cities and companies causing planetary harm	NATURE			English	Editorial Material						Sustainability; Environmental sciences; Sociology; Policy	IMPACTS		[Bai, Xuemei] Australian Natl Univ, Urban Environm & humane ecol, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Bjorn, Anders] Tech Univ Denmark, Dept Environm & Resource Engn, Lyngby, Denmark; [Kilkis, Siir] Council Turkey, Sci & Technol Res, Ankara, Turkey; [Kilkis, Siir] Sci Based Targets Network, New York, NY USA; [Whiteman, Gail] Univ Exeter, Business Sch, Exeter, Devon, England; [Hoff, Holger] Karl Franzens Univ Graz, Field Excellence Climate Change Graz, Graz, Austria; [Seaby Andersen, Lauren] Potsdam Inst Climate Impact Res PIK, Earth Syst Anal Dept, Potsdam, Germany; [Rockstrom, Johan] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Rockstrom, Johan] Univ Potsdam, Earth Syst Sci, Inst Environm Sci & Geog, Potsdam, Germany	Australian National University; Technical University of Denmark; University of Exeter; University of Graz; Potsdam Institut fur Klimafolgenforschung; Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Bai, XM (corresponding author), Australian Natl Univ, Urban Environm & humane ecol, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	xuemei.bai@anu.edu.au	Kilkis, Siir/E-5934-2015; Bai, Xuemei/A-5443-2012	Kilkis, Siir/0000-0003-3466-3593; Bai, Xuemei/0000-0001-6556-8041				Andersen I, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa186; Bai XM, 2017, ANNU REV ENV RESOUR, V42, P215, DOI 10.1146/annurev-environ-102016-061128; Bjorn A, 2022, CURR CLIM CHANGE REP, V8, P53, DOI 10.1007/s40641-022-00182-w; Boers N, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2024192118|1of7, 10.1073/pnas.2024192118]; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Kilkis S, 2022, RENEW SUST ENERG REV, V167, DOI 10.1016/j.rser.2022.112733; Lade SJ, 2020, NAT SUSTAIN, V3, P119, DOI 10.1038/s41893-019-0454-4; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Li GD, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29324-2; Liu JG, 2018, CURR OPIN ENV SUST, V33, P58, DOI 10.1016/j.cosust.2018.04.009; Lucas PL, 2020, GLOBAL ENVIRON CHANG, V60, DOI 10.1016/j.gloenvcha.2019.102017; Obura DO, 2021, SCIENCE, V373, P746, DOI 10.1126/science.abh2234; Rockstrom J, 2021, EARTHS FUTURE, V9, DOI 10.1029/2020EF001866; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Whiteman G, 2013, J MANAGE STUD, V50, P307, DOI 10.1111/j.1467-6486.2012.01073.x	16	0	0	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					463	466		10.1038/d41586-022-02894-3	http://dx.doi.org/10.1038/d41586-022-02894-3			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4M1LB	36097057	Bronze			2022-12-28	WOS:000853088800008
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... the woman who can smell Parkinson's	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, PARK BREAKTHR CAN DI; Sarkar D, 2022, JACS AU, DOI 10.1021/jacsau.2c00300	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2022	378								o2247	10.1136/bmj.o2247	http://dx.doi.org/10.1136/bmj.o2247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6M3LX	36109018				2022-12-28	WOS:000888774200011
J	Webber, C; Myran, DT; Milani, C; Turcotte, L; Imsirovic, H; Li, WS; Tanuseputro, P				Webber, Colleen; Myran, Daniel T.; Milani, Christina; Turcotte, Luke; Imsirovic, Haris; Li, Wenshan; Tanuseputro, Peter			Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Webber, Colleen; Myran, Daniel T.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Milani, Christina] Bruyere Res Inst, Ottawa, ON, Canada; [Turcotte, Luke] Univ Waterloo, Waterloo, ON, Canada; [Imsirovic, Haris] ICES, Ottawa, ON, Canada; [Li, Wenshan] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Tanuseputro, Peter] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Waterloo; University of Ottawa; University of Ottawa	Webber, C (corresponding author), 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	cowebber@ohri.ca		Turcotte, Luke/0000-0001-5678-7234	ICES - Ontario Ministry of Health; Ministry of Long-Term Care; Bruyere Academic Medical Organization; Canadian Institutes of Health Research project grant [177916]; PSI Knowledge Translation Fellowship	ICES - Ontario Ministry of Health; Ministry of Long-Term Care; Bruyere Academic Medical Organization; Canadian Institutes of Health Research project grant(Canadian Institutes of Health Research (CIHR)); PSI Knowledge Translation Fellowship	This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and the Ministry of Long-Term Care. This study was also supported by grants from the Bruyere Academic Medical Organization and the Canadian Institutes of Health Research project grant (funding #177916). Dr Tanuseputro is supported by a PSI Knowledge Translation Fellowship.	Abbasi J, 2020, JAMA-J AM MED ASSOC, V324, P619, DOI 10.1001/jama.2020.13484; [Anonymous], RIS COVID 19 CRIS PO; [Anonymous], 2021, CHANGES HLTH END STA; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174	6	0	0	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2022	328	14					1456	1458		10.1001/jama.2022.17214	http://dx.doi.org/10.1001/jama.2022.17214		SEP 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5L0OS	36094572	Bronze			2022-12-28	WOS:000854267400002
J	Perkel, JM				Perkel, Jeffrey M.			GENE CIRCUITS MADE SIMPLE	NATURE			English	Editorial Material																		Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Avsec Z, 2021, NAT GENET, V53, P354, DOI 10.1038/s41588-021-00782-6; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Cazares T. A., BIORXIV, DOI [10.1101/2022.01.28.478235(2022, DOI 10.1101/2022.01.28.478235(2022]; Deshpande A, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110333; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Gibbs CS, 2022, BIOINFORMATICS, V38, P2519, DOI 10.1093/bioinformatics/btac117; Handzlik J, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1009779; Herpelinck T., BIORXIV, DOI [10.1101/2022.03.14.484345(2022, DOI 10.1101/2022.03.14.484345(2022]; Kamimoto K., BIORXIV, DOI [10.1101/2022.07.01.497374(2022, DOI 10.1101/2022.07.01.497374(2022]; Miraldi ER, 2019, GENOME RES, V29, P449, DOI 10.1101/gr.238253.118; Ozel M. N., BIORXIV, DOI [10.1101/2022.05.01.490216(2022, DOI 10.1101/2022.05.01.490216(2022]; Pratapa A, 2020, NAT METHODS, V17, P147, DOI 10.1038/s41592-019-0690-6; Replogle Joseph M, 2022, Cell, V185, P2559, DOI 10.1016/j.cell.2022.05.013; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Weighill D, 2022, GENOME RES, V32, P524, DOI 10.1101/gr.275107.120	16	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2022	609	7926					428	431		10.1038/d41586-022-02826-1	http://dx.doi.org/10.1038/d41586-022-02826-1			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4H7TB	36064802	Bronze			2022-12-28	WOS:000850078900015
J	Pan, JA; Talapin, DV				Pan, Jia-Ahn; Talapin, Dmitri V.			3D-printing nanocrystals with light	SCIENCE			English	Editorial Material									[Talapin, Dmitri V.] Univ Chicago, James Franck Inst, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Mol Engn, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Talapin, DV (corresponding author), Univ Chicago, James Franck Inst, Dept Chem, Chicago, IL 60637 USA.	dvtalapin@uchicago.edu			National Science Foundation [CHE-1905290]	National Science Foundation(National Science Foundation (NSF))	We thank A. Nelson for helpful suggestions and the National Science Foundation for financial support under award no. CHE-1905290.	Kagan CR, 2016, SCIENCE, V353, DOI 10.1126/science.aac5523; Kotz F, 2017, NATURE, V544, P337, DOI 10.1038/nature22061; Liu SF, 2022, SCIENCE, V377, P1112, DOI 10.1126/science.abo5345; Llordes A, 2013, NATURE, V500, P323, DOI 10.1038/nature12398; Losch P, 2019, NANO TODAY, V24, P15, DOI 10.1016/j.nantod.2018.12.002; Montanarella F, 2022, ACS NANO, V16, P5085, DOI 10.1021/acsnano.1c11159; Park JJ, 2010, NANO LETT, V10, P2310, DOI 10.1021/nl101609s; Wang YY, 2017, SCIENCE, V357, P385, DOI 10.1126/science.aan2958; Yee DW, 2021, POLYM INT, V70, P964, DOI 10.1002/pi.6165	9	0	0	18	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1046	1047		10.1126/science.add8382	http://dx.doi.org/10.1126/science.add8382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048942				2022-12-28	WOS:000887933200033
J	Reisenbauer, JC; Green, O; Franchino, A; Finkelstein, P; Morandi, B				Reisenbauer, Julia C.; Green, Ori; Franchino, Allegra; Finkelstein, Patrick; Morandi, Bill			Late-stage diversification of indole skeletons through nitrogen atom insertion	SCIENCE			English	Article							CARBON-CARBON BONDS; RING EXPANSION; QUINAZOLINES; HETEROCYCLES; DELETION	Compared with peripheral late-stage transformations mainly focusing on carbon-hydrogen functionalizations, reliable strategies to directly edit the core skeleton of pharmaceutical lead compounds still remain scarce despite the recent flurry of activity in this area. Herein, we report the skeletal editing of indoles through nitrogen atom insertion, accessing the corresponding quinazoline or quinoxaline bioisosteres by trapping of an electrophilic nitrene species generated from ammonium carbamate and hypervalent iodine. This reactivity relies on the strategic use of a silyl group as a labile protecting group that can facilitate subsequent product release. The utility of this highly functional group-compatible methodology in the context of late-stage skeletal editing of several commercial drugs is demonstrated.	[Reisenbauer, Julia C.; Green, Ori; Franchino, Allegra; Finkelstein, Patrick; Morandi, Bill] Swiss Fed Inst Technol, Lab Organ Chem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Morandi, B (corresponding author), Swiss Fed Inst Technol, Lab Organ Chem, CH-8093 Zurich, Switzerland.	bill.morandi@org.chem.ethz.ch		Franchino, Allegra/0000-0001-6955-5651; Morandi, Bill/0000-0003-3968-1424; Reisenbauer, Julia/0000-0001-5995-5619	European Research Council under the European Union [757608]; ETH Zurich; Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI); International Human Frontier Science Program Organization [LT000861/2020-L]	European Research Council under the European Union(European Research Council (ERC)); ETH Zurich(ETH Zurich); Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI); International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the European Research Council under the European Union's Horizon 2020 research and innovation program (Shuttle Cat, project ID: 757608) and by ETH Zurich. J.C.R. acknowledges a fellowship from the Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI). O.G. acknowledges a fellowship from the International Human Frontier Science Program Organization (grant LT000861/2020-L).	AELLIG WH, 1982, BRIT J CLIN PHARMACO, V13, pS187, DOI 10.1111/j.1365-2125.1982.tb01909.x; Alagarsamy V, 2018, EUR J MED CHEM, V151, P628, DOI 10.1016/j.ejmech.2018.03.076; Baeyer A., 1899, CHEM BER, V32, P3625; Beckmann E., 1886, CHEM BER, V19, P988; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Bols M, 2017, BEILSTEIN J ORG CHEM, V13, P93, DOI 10.3762/bjoc.13.12; Bolteau R, 2020, EUR J MED CHEM, V189, DOI 10.1016/j.ejmech.2020.112078; Bouz G, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14080768; Cao ZC, 2017, J AM CHEM SOC, V139, P6546, DOI 10.1021/jacs.7b02326; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chaabouni S, 2018, CHEM-EUR J, V24, P17006, DOI 10.1002/chem.201805055; Chen W, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28535-x; Dherange BD, 2021, J AM CHEM SOC, V143, P11337, DOI 10.1021/jacs.1c06287; Faisal M, 2021, FRONT CHEM, V8, DOI 10.3389/fchem.2020.594717; Feng YD, 2015, J ORG CHEM, V80, P7099, DOI 10.1021/acs.joc.5b00957; Glachet T, 2019, J AM CHEM SOC, V141, P13689, DOI 10.1021/jacs.9b07035; Gribble G. W., 2016, INDOLE RING SYNTHESI, P1, DOI [10.1002/9781118695692.ch1, DOI 10.1002/9781118695692, 10.1002/9781118695692]; Guillemard L, 2021, NAT REV CHEM, V5, P522, DOI 10.1038/s41570-021-00300-6; Heravi MM, 2020, RSC ADV, V10, P44247, DOI 10.1039/d0ra09198g; Hu Y, 2017, J MED CHEM, V60, P1238, DOI 10.1021/acs.jmedchem.6b01437; Hui CG, 2021, J AM CHEM SOC, V143, P18864, DOI 10.1021/jacs.1c10175; Im JK, 2021, SYNTHESIS-STUTTGART, V53, P1760, DOI 10.1055/s-0040-1706639; Jurczyk Justin, 2022, Nat Synth, V1, P352, DOI 10.1038/s44160-022-00052-1; Jurczyk J, 2021, SCIENCE, V373, P1004, DOI 10.1126/science.abi7183; Kennedy SH, 2021, NATURE, V593, P223, DOI 10.1038/s41586-021-03448-9; Klare HFT, 2021, CHEM REV, V121, P5889, DOI 10.1021/acs.chemrev.0c00855; KUMAR PR, 1987, HETEROCYCLES, V26, P1257; Kumar SN, 2014, WORLD J MICROB BIOT, V30, P439, DOI 10.1007/s11274-013-1461-7; Liu B, 2019, J AGR FOOD CHEM, V67, P1795, DOI 10.1021/acs.jafc.8b06175; Liu S, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28099-w; Lyu HR, 2021, SCIENCE, V372, P175, DOI 10.1126/science.abg5526; MAEDA K, 1974, B CHEM SOC JPN, V47, P334, DOI 10.1246/bcsj.47.334; Montalban AG, 2015, TETRAHEDRON LETT, V56, P378, DOI 10.1016/j.tetlet.2014.11.101; MORICONI EJ, 1963, J ORG CHEM, V28, P2215, DOI 10.1021/jo01044a015; Narancic T, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2642-9; Neese F, 2022, WIRES COMPUT MOL SCI, V12, DOI 10.1002/wcms.1606; NOLAND WE, 1962, J ORG CHEM, V27, P341, DOI 10.1021/jo01048a601; Qin HT, 2021, ANGEW CHEM INT EDIT, V60, P20678, DOI 10.1002/anie.202107356; Roque JB, 2018, NATURE, V564, P244, DOI 10.1038/s41586-018-0700-3; Sattler A, 2010, NATURE, V463, P523, DOI 10.1038/nature08730; Smaligo AJ, 2019, SCIENCE, V364, P681, DOI 10.1126/science.aaw4212; Smits RA, 2008, J MED CHEM, V51, P7855, DOI 10.1021/jm800876b; SOMEI M, 1979, CHEM LETT, P127, DOI 10.1246/cl.1979.127; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wang Y, 2021, J MED CHEM, V64, P17115, DOI 10.1021/acs.jmedchem.1c01139; Wang ZF, 2019, J AM CHEM SOC, V141, P15509, DOI 10.1021/jacs.9b08632; Woo J, 2022, SCIENCE, V376, P527, DOI 10.1126/science.abo4282; Wynberg H., 1982, ORGANIC REACTIONS, P1; Xia Y, 2019, J AM CHEM SOC, V141, P13038, DOI 10.1021/jacs.9b07445; Xu MM, 2018, CHEM COMMUN, V54, P12602, DOI 10.1039/c8cc07721e; Xu Y, 2019, NATURE, V567, P373, DOI 10.1038/s41586-019-0926-8; Zenzola M, 2016, ANGEW CHEM INT EDIT, V55, P7203, DOI 10.1002/anie.201602320	52	2	2	17	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1104	+		10.1126/science.add1383	http://dx.doi.org/10.1126/science.add1383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048958	Green Accepted			2022-12-28	WOS:000887933200046
J	Damania, B; Kenney, SC; Raab-Traub, N				Damania, Blossom; Kenney, Shannon C.; Raab-Traub, Nancy			Epstein-Barr virus: Biology and clinical disease	CELL			English	Review							MEMBRANE-PROTEIN 1; NF-KAPPA-B; REED-STERNBERG CELLS; EPHRIN RECEPTOR A2; TOLL-LIKE RECEPTOR; RIG-I; NASOPHARYNGEAL CARCINOMA; LYMPHOPROLIFERATIVE DISEASE; GENE-EXPRESSION; GROWTH-FACTOR	Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of different human malignancies as well as autoimmune disorders. The expression of EBV viral proteins and non-coding RNAs contribute to EBV-mediated disease pathologies. The virus establishes life-long latency in the human host and is adept at evading host innate and adaptive immune responses. In this review, we discuss the life cycle of EBV, the various functions of EBV-encoded proteins and RNAs, the ability of the virus to activate and evade immune responses, as well as the neoplastic and autoimmune diseases that are associated with EBV infec-tion in the human population.	[Damania, Blossom; Raab-Traub, Nancy] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Damania, Blossom; Raab-Traub, Nancy] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Kenney, Shannon C.] Univ Wisconsin Madison, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA; [Kenney, Shannon C.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Damania, B (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Damania, B (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	damania@med.unc.edu			NIH [CA019014, DE028211, CA163217, CA228172, CA239583, CA232616, AI147060, CA229673, CA022443]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We sincerely apologize for omitting many important references in the field due to space restrictions. B.D. is supported by NIH grants DE028211, CA163217, CA228172, and CA239583; S.C.K. is supported by NIH grants CA232616, AI147060, CA229673, and CA022443; N.R.-T. is supported by NIH grant CA019014. The authors dedicate this review article to Dr. Joseph S. Pagano in recognition of his scientific contributions, insightful guidance, and unwavering support.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Albanese M, 2016, P NATL ACAD SCI USA, V113, pE6467, DOI 10.1073/pnas.1605884113; Alexander FE, 2003, INT J CANCER, V107, P298, DOI 10.1002/ijc.11156; Anderson LJ, 2009, BLOOD, V113, P108, DOI 10.1182/blood-2008-06-160937; Aubry V, 2014, J VIROL, V88, P12825, DOI 10.1128/JVI.02139-14; Balandraud N, 2018, JOINT BONE SPINE, V85, P165, DOI 10.1016/j.jbspin.2017.04.011; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Bentz GL, 2014, VIROLOGY, V448, P293, DOI 10.1016/j.virol.2013.10.018; Bentz GL, 2011, J VIROL, V85, P10144, DOI 10.1128/JVI.05035-11; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Bourbon E, 2021, BLOOD ADV, V5, P3227, DOI 10.1182/bloodadvances.2021004515; Brauninger A, 2006, INT J CANCER, V118, P1853, DOI 10.1002/ijc.21716; Bristol JA, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1010453; Bristol JA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007179; Bruce JP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24348-6; Bu W, 2019, IMMUNITY, V50, P1305, DOI 10.1016/j.immuni.2019.03.010; Burton EM, 2020, P NATL ACAD SCI USA, V117, P1722, DOI 10.1073/pnas.1919133117; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Callan MFC, 2004, CURR OPIN RHEUMATOL, V16, P399, DOI 10.1097/01.bor.0000126149.96627.82; Chen J, 2019, FEMS MICROBIOL REV, V43, P674, DOI 10.1093/femsre/fuz023; Chen J, 2018, NAT MICROBIOL, V3, P172, DOI 10.1038/s41564-017-0081-7; Cheng AZ, 2019, NAT MICROBIOL, V4, P78, DOI 10.1038/s41564-018-0284-6; Chesnokova LS, 2014, J VIROL, V88, P12193, DOI 10.1128/JVI.01597-14; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Chijioke O, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00323; Chiu YF, 2013, CELL HOST MICROBE, V14, P607, DOI 10.1016/j.chom.2013.11.009; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung BK, 2013, BLOOD, V122, P2600, DOI 10.1182/blood-2013-01-480665; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Cohen JI, 2020, LEUKEMIA LYMPHOMA, V61, P808, DOI 10.1080/10428194.2019.1699080; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; DEACON EM, 1993, J EXP MED, V177, P339, DOI 10.1084/jem.177.2.339; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; Djaoud Z, 2017, J EXP MED, V214, P1827, DOI 10.1084/jem.20161017; Djavadian R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005718; Duan YM, 2015, CANCER LETT, V361, P67, DOI 10.1016/j.canlet.2015.02.037; Edwards RH, 2015, MBIO, V6, DOI 10.1128/mBio.00441-15; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Farrell PJ, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12010017; Fathallah I, 2010, J IMMUNOL, V185, P6439, DOI 10.4049/jimmunol.0903459; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON EK, 1992, J VIROL, V66, P922, DOI 10.1128/JVI.66.2.922-929.1992; Fotheringham JA, 2015, J VIROL, V89, P6940, DOI 10.1128/JVI.03371-14; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; Gaudreault E, 2007, J VIROL, V81, P8016, DOI 10.1128/JVI.00403-07; Gewurz B.L., 2021, FIELDS VIROLOGY, P324; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; GILLIGAN KJ, 1991, J VIROL, V65, P6252, DOI 10.1128/JVI.65.11.6252-6259.1991; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Griffin BD, 2013, J IMMUNOL, V190, P1672, DOI 10.4049/jimmunol.1102462; Guo R, 2020, MOL CELL, V78, P653, DOI 10.1016/j.molcel.2020.03.025; Guo R, 2020, NAT MICROBIOL, V5, P1051, DOI 10.1038/s41564-020-0724-y; Gupta S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008146; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harley JB, 2018, NAT GENET, V50, P699, DOI 10.1038/s41588-018-0102-3; Hatzivassiliou E, 1998, J IMMUNOL, V160, P1116; He YL, 2009, CANCER RES, V69, P7935, DOI 10.1158/0008-5472.CAN-09-0828; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; Heslop HE, 2010, BLOOD, V115, P925, DOI 10.1182/blood-2009-08-239186; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Hochberg D, 2004, J VIROL, V78, P5194, DOI 10.1128/JVI.78.10.5194-5204.2004; Hong GK, 2005, J VIROL, V79, P13984, DOI 10.1128/JVI.79.22.13984-13992.2005; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Hoshino Y, 2009, J VIROL, V83, P11857, DOI 10.1128/JVI.01005-09; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Jones RJ, 2007, INT J CANCER, V121, P1274, DOI 10.1002/ijc.22839; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Kalchschmidt JS, 2016, J EXP MED, V213, P921, DOI 10.1084/jem.20160120; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kataoka K, 2019, LEUKEMIA, V33, P1687, DOI 10.1038/s41375-019-0380-5; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; Kenney SC, 2014, SEMIN CANCER BIOL, V26, P60, DOI 10.1016/j.semcancer.2014.01.002; Kim BK, 2019, TRANSPL INFECT DIS, V21, DOI 10.1111/tid.13182; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Kimura H, 2003, J INFECT DIS, V187, P527, DOI 10.1086/367988; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kraus RJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006404; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lange PT, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167214; Lanz Tobias V, 2022, Nature, V603, P321, DOI 10.1038/s41586-022-04432-7; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Li CR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008590; Li XF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006249; Li Z, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2115508118; Li Z, 2019, NAT MICROBIOL, V4, P2475, DOI 10.1038/s41564-019-0546-y; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Liu XQ, 2020, J VIROL, V94, DOI 10.1128/JVI.00258-20; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; Lu YJ, 2017, J INNATE IMMUN, V9, P574, DOI 10.1159/000479749; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Luftig M, 2003, P NATL ACAD SCI USA, V100, P15595, DOI 10.1073/pnas.2136756100; Lunn RM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0266; Ma SD, 2011, J VIROL, V85, P165, DOI 10.1128/JVI.01512-10; Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010; Magrath I, 2012, BRIT J HAEMATOL, V156, P744, DOI 10.1111/j.1365-2141.2011.09013.x; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; Mainou BA, 2007, J VIROL, V81, P9680, DOI 10.1128/JVI.01001-07; Malpica L, 2022, AM J HEMATOL, V97, P951, DOI 10.1002/ajh.26579; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; MANNICK JB, 1991, J VIROL, V65, P6826, DOI 10.1128/JVI.65.12.6826-6837.1991; Marquitz AR, 2015, J VIROL, V89, P11256, DOI 10.1128/JVI.01492-15; Marquitz AR, 2014, J VIROL, V88, P1389, DOI 10.1128/JVI.02662-13; Mathas S, 2016, SEMIN HEMATOL, V53, P139, DOI 10.1053/j.seminhematol.2016.05.007; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Messick TE, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5612; MILLER N, 1992, J VIROL, V66, P3409, DOI 10.1128/JVI.66.6.3409-3414.1992; Miller WE, 1998, MOL CELL BIOL, V18, P2835, DOI 10.1128/MCB.18.5.2835; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; Morrison JA, 2004, CANCER RES, V64, P5251, DOI 10.1158/0008-5472.CAN-04-0538; Moss WN, 2014, RNA BIOL, V11, P10, DOI 10.4161/rna.27488; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murer A, 2019, MBIO, V10, DOI 10.1128/mBio.01941-18; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Ok CY, 2014, CLIN CANCER RES, V20, P2338, DOI 10.1158/1078-0432.CCR-13-3157; Okuno Y, 2019, NAT MICROBIOL, V4, P404, DOI 10.1038/s41564-018-0334-0; Pagano JS, 2018, CANCERS, V10, DOI 10.3390/cancers10060197; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pei YG, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006500; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pisano G, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0891-5; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Price AM, 2017, ELIFE, V6, DOI 10.7554/eLife.22509; Prockop S, 2020, J CLIN INVEST, V130, P733, DOI 10.1172/JCI121127; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Quinn LL, 2016, J VIROL, V90, P356, DOI 10.1128/JVI.02183-15; Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60; Raab-Traub N, 2015, CURR TOP MICROBIOL, V390, P339, DOI 10.1007/978-3-319-22822-8_14; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rickinson AB, 2014, TRENDS IMMUNOL, V35, P159, DOI 10.1016/j.it.2014.01.003; Robertson ES, 1996, J VIROL, V70, P3068, DOI 10.1128/JVI.70.5.3068-3074.1996; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; Rostgaard K, 2014, CLIN INFECT DIS, V58, P1684, DOI 10.1093/cid/ciu204; Saito S, 2013, J VIROL, V87, P4060, DOI 10.1128/JVI.02020-12; Saldana BJD, 2022, BLOOD ADV, V6, P452, DOI 10.1182/bloodadvances.2021005291; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serafini B, 2019, J VIROL, V93, DOI 10.1128/JVI.00980-19; Shah KM, 2009, ONCOGENE, V28, P3903, DOI 10.1038/onc.2009.249; Simone O, 2011, ACTA TROP, V119, P144, DOI 10.1016/j.actatropica.2011.05.005; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Smith C, 2009, BLOOD, V113, P6148, DOI 10.1182/blood-2009-02-203687; Smith DW, 2021, MBIO, V12, DOI 10.1128/mBio.02243-21; Smith NA, 2020, J VIROL, V94, DOI 10.1128/JVI.00428-20; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Stanland LJ, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12111222; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Styles CT, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001992; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Temple RM, 2014, P NATL ACAD SCI USA, V111, P16544, DOI 10.1073/pnas.1400818111; Tiacci E, 2018, BLOOD, V131, P2454, DOI 10.1182/blood-2017-11-814913; Torgbor C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004170; Tsai K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002376; Tzellos S, 2014, J VIROL, V88, P8743, DOI 10.1128/JVI.01000-14; Ungerleider NA, 2019, MBIO, V10, DOI 10.1128/mBio.00071-19; van Gent M, 2011, J IMMUNOL, V186, P1694, DOI 10.4049/jimmunol.0903120; Van Sciver N, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1010045; Van Sciver N, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009783; Vedham V, 2015, CANCER MED-US, V4, P1908, DOI 10.1002/cam4.538; Vereide DT, 2014, ONCOGENE, V33, P1258, DOI 10.1038/onc.2013.71; Vereide DT, 2011, BLOOD, V117, P1977, DOI 10.1182/blood-2010-05-285791; Verma D, 2020, P NATL ACAD SCI USA, V117, P13044, DOI 10.1073/pnas.2000625117; Vilmen G, 2021, AUTOPHAGY, V17, P1296, DOI 10.1080/15548627.2020.1758416; Wang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7240; Wei CJ, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abf3685; WEISS LM, 1989, NEW ENGL J MED, V320, P502, DOI 10.1056/NEJM198902233200806; Wen KW, 2021, FEBS J, DOI 10.1111/febs.16206; Weniger MA, 2021, LEUKEMIA, V35, P968, DOI 10.1038/s41375-021-01204-6; Wille CK, 2015, P NATL ACAD SCI USA, V112, pE7257, DOI 10.1073/pnas.1513432112; Wille CK, 2013, J VIROL, V87, P935, DOI 10.1128/JVI.01790-12; Wongwiwat W, 2022, J VIROL, V96, DOI 10.1128/jvi.00394-22; WU TC, 1990, INT J CANCER, V46, P801, DOI 10.1002/ijc.2910460509; Xing JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00101-w; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194; Zhang H, 2018, NAT MICROBIOL, V3, P164, DOI 10.1038/s41564-017-0080-8	187	1	1	11	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 29	2022	185	20					3652	3670		10.1016/j.cell.2022.08.026	http://dx.doi.org/10.1016/j.cell.2022.08.026			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	5W1JY	36113467				2022-12-28	WOS:000877678500005
J	Perlis, ML; Posner, D; Riemann, D; Bastien, CH; Teel, J; Thase, M				Perlis, Michael L.; Posner, Donn; Riemann, Dieter; Bastien, Celyne H.; Teel, Joseph; Thase, Michael			Insomnia	LANCET			English	Review							COGNITIVE-BEHAVIORAL THERAPY; SHORT-SLEEP DURATION; CLINICAL-PRACTICE GUIDELINE; RANDOMIZED CONTROLLED-TRIAL; LATE-LIFE INSOMNIA; QUALITY-OF-LIFE; SEVERITY INDEX; CBT-I; PSYCHOPHYSIOLOGICAL INSOMNIA; RESTRICTION THERAPY	Insomnia is highly prevalent in clinical practice, occurring in up to 50% of primary care patients. Insomnia can present independently or alongside other medical conditions or mental health disorders and is a risk factor for the development and exacerbation of these other disorders if not treated. In 2016, the American College of Physicians recommended that insomnia be specifically targeted for treatment. The recommended first-line treatment for insomnia, whether the underlying cause has been identified or not, is cognitive behavioural therapy for insomnia (CBT-I). Currently, there is no global consensus regarding which pharmacological treatment has the best efficacy or risk-benefit ratio. Both CBT-I and pharmacological intervention are thought to have similar acute effects, but only CBT-I has shown durable long-term effects after treatment discontinuation. Administering a combined treatment of CBT-I and medication could decrease the latency to treatment response, but might diminish the durability of the positive treatment effects of CBT-I.	[Perlis, Michael L.; Thase, Michael] Univ Penn, Dept Psychiat, Philadelphia, PA USA; [Posner, Donn] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA USA; [Riemann, Dieter] Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Bastien, Celyne H.] Laval Univ, Sch Psychol, Quebec City, PQ, Canada; [Teel, Joseph] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA USA; [Perlis, Michael L.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Pennsylvania; Stanford University; University of Freiburg; Laval University; University of Pennsylvania; University of Pennsylvania	Perlis, ML (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	mperlis@upenn.edu			National Institutes of Health?s National Institute on Aging;  [R01AG054521];  [K24AG055602]	National Institutes of Health?s National Institute on Aging; ; 	Acknowledgments Preparation of this paper was partly supported by grants from the National Institutes of Health?s National Institute on Aging (R01AG054521 and K24AG055602) .	Abbasi Samira Ms, 2016, Int J Community Based Nurs Midwifery, V4, P320; American Medical Association, 2021, EVALUATION MANAGEMEN; [Anonymous], 2014, SUVOREXANT PACKAGE I; [Anonymous], 2019, LEMBOREXANT PACKAGE; [Anonymous], 2007, ZALEPLON PACKAGE INS; [Anonymous], 2008, ZOLPIDEM PACKAGE INS; [Anonymous], 2014, TASIMELTEON PACKAGE; [Anonymous], 2016, TEMAZEPAM PACKAGE IN; [Anonymous], 2008, ZOPICLONE PACKAGE IN; [Anonymous], 2010, RAMELTEON PACKAGE IN; [Anonymous], 2016, TRIAZOLAM PACKAGE IN; Arnedt JT, 2011, BEHAV RES THER, V49, P227, DOI 10.1016/j.brat.2011.02.003; Atkin T, 2018, PHARMACOL REV, V70, P197, DOI 10.1124/pr.117.014381; Auld F, 2017, SLEEP MED REV, V34, P10, DOI 10.1016/j.smrv.2016.06.005; Baglioni C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061949; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx002; Belleville G, 2016, J CLIN PSYCHOL, V72, P880, DOI 10.1002/jclp.22300; Blanken TF, 2019, LANCET PSYCHIAT, V6, P151, DOI 10.1016/S2215-0366(18)30464-4; Blanken TF, 2019, LANCET PSYCHIAT, V6, P285, DOI 10.1016/S2215-0366(19)30079-3; Bootzin R, 1972, P AM PSYCHOL ASS, V7, P395, DOI DOI 10.1037/E465522008-198; Bootzin RR, 2011, PRACT RESOUR MENT, P21, DOI 10.1016/B978-0-12-381522-4.00002-X; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 2016, J SLEEP RES, V25, P131, DOI 10.1111/jsr.12371; Boullin P, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010001; Buysse Daniel J, 2011, Drug Discov Today Dis Models, V8, P129; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Buysse DJ, 2010, SLEEP MED, V11, P56, DOI 10.1016/j.sleep.2009.02.010; Castelnovo A, 2019, SLEEP MED REV, V44, P70, DOI 10.1016/j.smrv.2018.12.007; Castronovo V, 2018, SLEEP MED, V47, P54, DOI 10.1016/j.sleep.2018.03.017; Chakravorty S, 2019, ALCOHOL CLIN EXP RES, V43, P1244, DOI 10.1111/acer.14030; Cheng P, 2020, J CLIN SLEEP MED, V16, P193, DOI 10.5664/jcsm.8164; Chinoy ED, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa291; Chiu HY, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa260; Chiu VW, 2018, PSYCHIAT RES, V268, P279, DOI 10.1016/j.psychres.2018.07.027; Clancy Megan, 2015, Int J MS Care, V17, P261, DOI 10.7224/1537-2073.2014-071; Cronlein T, 2019, BEHAV THER, V50, P994, DOI 10.1016/j.beth.2019.03.002; Edinger JD, 2008, OVERCOMING INSOMNIA; Espie CA, 2006, SLEEP MED REV, V10, P215, DOI 10.1016/j.smrv.2006.03.002; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Fernando S, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0098-y; Finan PH, 2014, SLEEP MED CLIN, V9, P261, DOI 10.1016/j.jsmc.2014.02.007; Freeman D, 2015, LANCET PSYCHIAT, V2, P975, DOI 10.1016/S2215-0366(15)00314-4; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Germain A, 2006, J CLIN SLEEP MED, V2, P403; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Grima NA, 2019, AUST J GEN PRACT, V48, P198; Hammerschlag AR, 2017, NAT GENET, V49, P1584, DOI 10.1038/ng.3888; Harris J, 2012, SLEEP, V35, P49, DOI 10.5665/sleep.1584; Harvey AG, 2005, CLIN PSYCHOL REV, V25, P593, DOI 10.1016/j.cpr.2005.04.005; Harvey AG, 2015, J CONSULT CLIN PSYCH, V83, P564, DOI 10.1037/a0038655; Hauri P, 1982, CURRENT CONCEPTS SCO, P22; Hertenstein E, 2014, PSYCHOTHER PSYCHOSOM, V83, P371, DOI 10.1159/000365173; Jansson-Frojmark M, 2021, BEHAV COGN PSYCHOTH, V49, P540, DOI 10.1017/S1352465821000023; Jungquist CR, 2010, SLEEP MED, V11, P302, DOI 10.1016/j.sleep.2009.05.018; Kanady JC, 2018, J CLIN SLEEP MED, V14, P1193, DOI 10.5664/jcsm.7224; Kapella MC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1334-0; Kapella MC, 2011, INT J CHRONIC OBSTR, V6, P625, DOI 10.2147/COPD.S24858; Kaplan KA, 2013, AM J PSYCHIAT, V170, P716, DOI 10.1176/appi.ajp.2013.12050708; Kerkhof GA, 2013, J SLEEP RES, V22, P104, DOI 10.1111/j.1365-2869.2012.01041.x; Klingman K.J., 2017, SLEEP MED RES, V8, P17, DOI DOI 10.17241/SMR.2017.00010; Klingman KJ, 2019, SLEEP HEALTH, V5, P658, DOI 10.1016/j.sleh.2019.07.004; Klingman KJ, 2017, SLEEP MED REV, V32, P37, DOI 10.1016/j.smrv.2016.02.004; Kyle SD, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2012-6; Kyle SD, 2015, SLEEP MED REV, V23, P83, DOI 10.1016/j.smrv.2015.02.003; Lack L, 2005, SLEEP, V28, P616, DOI 10.1093/sleep/28.5.616; Lack L, 2019, SLEEP MED CLIN, V14, P245, DOI 10.1016/j.jsmc.2019.01.005; Lack LC, 2007, SLEEP MED, V8, P637, DOI 10.1016/j.sleep.2006.10.003; Liley DTJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051906; Low TL, 2020, J PSYCHIATR RES, V121, P10, DOI 10.1016/j.jpsychires.2019.10.022; Ma Y, 2021, SLEEP MED REV, V55, DOI 10.1016/j.smrv.2020.101376; Manber R, 2015, TREATMENT PLANS INTE; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Meyer N, 2022, LANCET, V400, P1061, DOI 10.1016/S0140-6736(22)00877-7; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2014, SLEEP MED, V15, P701, DOI 10.1016/j.sleep.2014.02.004; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2011, PRACT RESOUR MENT, P107, DOI 10.1016/B978-0-12-381522-4.00011-0; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 2003, INSOMNIA CLIN GUIDE; Muench A, 2021, ADAPTING COGNITIVE B, P1; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Ong Jason C, 2017, Curr Sleep Med Rep, V3, P57, DOI 10.1007/s40675-017-0068-1; Ong JC, 2014, SLEEP, V37, P1553, DOI 10.5665/sleep.4010; Pchelina P V, 2017, Zh Nevrol Psikhiatr Im S S Korsakova, V117, P48, DOI 10.17116/jnevro20171174248-55; Peoples AR, 2017, J CANCER SURVIV, V11, P401, DOI 10.1007/s11764-017-0597-0; Perez-Carbonell L, 2022, LANCET, V400, P1033, DOI 10.1016/S0140-6736(22)01018-2; Perlis M, 2000, J BEHAV MED, V23, P149, DOI 10.1023/A:1005413117932; Perlis M.L., 2005, COGNITIVE BEHAV TREA; Perlis M, 2015, SLEEP MED, V16, P1160, DOI 10.1016/j.sleep.2015.06.015; Perlis Michael L, 2021, J Prim Care Community Health, V12, p21501327211014084, DOI 10.1177/21501327211014084; Perlis ML, 2014, J SLEEP RES, V23, P499, DOI 10.1111/jsr.12150; Perlis ML, 2011, PRACT RESOUR MENT, P119, DOI 10.1016/B978-0-12-381522-4.00012-2; Perlis ML, 2010, J SLEEP RES, V19, P31, DOI 10.1111/j.1365-2869.2009.00768.x; Perlis ML, 2004, SLEEP, V27, P715, DOI 10.1093/sleep/27.4.715; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Posner D, 2011, PRACT RESOUR MENT, P31, DOI 10.1016/B978-0-12-381522-4.00003-1; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Randall C, 2019, BEHAV SLEEP MED, V17, P827, DOI 10.1080/15402002.2018.1518227; Redeker NS, 2022, SLEEP, V45, DOI 10.1093/sleep/zsab252; Redeker NS, 2020, BEHAV SLEEP MED, V18, P190, DOI 10.1080/15402002.2018.1546709; Ree M, 2017, SLEEP MED, V36, pS43, DOI 10.1016/j.sleep.2017.03.017; Richardson G, 2009, HUM PSYCHOPHARM CLIN, V24, P103, DOI 10.1002/hup.993; Riemann D, 2017, J SLEEP RES, V26, P675, DOI 10.1111/jsr.12594; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Rouse B, 2017, INTERN EMERG MED, V12, P103, DOI 10.1007/s11739-016-1583-7; Samara MT, 2020, ACTA PSYCHIAT SCAND, V142, P6, DOI 10.1111/acps.13201; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Scott H, 2022, J CLIN SLEEP MED, V18, P1823, DOI 10.5664/jcsm.10004; Selvanathan J, 2021, SLEEP MED REV, V60, DOI 10.1016/j.smrv.2021.101460; Sheaves B, 2018, PSYCHOL MED, V48, P1694, DOI 10.1017/S0033291717003191; Sheaves B, 2018, BEHAV COGN PSYCHOTH, V46, P661, DOI 10.1017/S1352465817000789; Siegel JM, 2022, LANCET NEUROL, V21, P937, DOI 10.1016/S1474-4422(22)00210-1; Silenor D, 2010, SIL D PACK INS; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; Snyder E, 2018, J CLIN SLEEP MED, V14, P1849, DOI 10.5664/jcsm.7478; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; SPIELMAN AJ, 1987, SLEEP, V10, P45; Spielman AJ, 2011, PRACT RESOUR MENT, P9, DOI 10.1016/B978-0-12-381522-4.00001-8; Squires Lauren R, 2022, Sleep Med Rev, V63, P101615, DOI 10.1016/j.smrv.2022.101615; Stein MB, 2018, MOL PSYCHIATR, V23, P2238, DOI 10.1038/s41380-018-0033-5; Sweetman A, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa002; Sweetman A, 2017, SLEEP MED, V39, P38, DOI 10.1016/j.sleep.2017.09.003; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Trockel M, 2015, SLEEP, V38, P259, DOI 10.5665/sleep.4410; Vallieres A, 2011, SLEEP, V34, P609, DOI 10.1093/sleep/34.5.609; van der Zweerde T, 2019, SLEEP MED REV, V48, DOI 10.1016/j.smrv.2019.08.002; van Straten A, 2018, SLEEP MED REV, V38, P3, DOI 10.1016/j.smrv.2017.02.001; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Walsh JK, 2016, PRINCIPLES PRACTICE, P832; Waters F, 2020, SCHIZOPHR RES, V221, P57, DOI 10.1016/j.schres.2020.03.054; Wilson S, 2019, J PSYCHOPHARMACOL, V33, P923, DOI 10.1177/0269881119855343; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	142	4	4	14	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2022	400	10357					1047	1060		10.1016/S0140-6736(22)00879-0	http://dx.doi.org/10.1016/S0140-6736(22)00879-0			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5S3JP	36115372				2022-12-28	WOS:000875091000005
J	Miller, TM; Cudkowicz, ME; Genge, A; Shaw, PJ; Sobue, G; Bucelli, RC; Chio, A; Van Damme, P; Ludolph, AC; Glass, JD; Andrews, JA; Babu, S; Benatar, M; McDermott, CJ; Cochrane, T; Chary, S; Chew, S; Zhu, H; Wu, F; Nestorov, I; Graham, D; Sun, P; McNeill, M; Fanning, L; Ferguson, TA; Fradette, S				Miller, Timothy M.; Cudkowicz, Merit E.; Genge, Angela; Shaw, Pamela J.; Sobue, Gen; Bucelli, Robert C.; Chio, Adriano; Van Damme, Philip; Ludolph, Albert C.; Glass, Jonathan D.; Andrews, Jinsy A.; Babu, Suma; Benatar, Michael; McDermott, Christopher J.; Cochrane, Thos; Chary, Sowmya; Chew, Sheena; Zhu, Han; Wu, Fan; Nestorov, Ivan; Graham, Danielle; Sun, Peng; McNeill, Manjit; Fanning, Laura; Ferguson, Toby A.; Fradette, Stephanie		VALOR OLE Working Grp	Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROFILAMENT LIGHT-CHAIN; MUTATION; BIOMARKERS; SURVIVAL	BackgroundThe intrathecally administered antisense oligonucleotide tofersen reduces synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with amyotrophic lateral sclerosis (ALS) associated with mutations in SOD1 (SOD1 ALS).MethodsIn this phase 3 trial, we randomly assigned adults with SOD1 ALS in a 2:1 ratio to receive eight doses of tofersen (100 mg) or placebo over a period of 24 weeks. The primary end point was the change from baseline to week 28 in the total score on the ALS Functional Rating Scale-Revised (ALSFRS-R; range, 0 to 48, with higher scores indicating better function) among participants predicted to have faster-progressing disease. Secondary end points included changes in the total concentration of SOD1 protein in cerebrospinal fluid (CSF), in the concentration of neurofilament light chains in plasma, in slow vital capacity, and in handheld dynamometry in 16 muscles. A combined analysis of the randomized component of the trial and its open-label extension at 52 weeks compared the results in participants who started tofersen at trial entry (early-start cohort) with those in participants who switched from placebo to the drug at week 28 (delayed-start cohort).ResultsA total of 72 participants received tofersen (39 predicted to have faster progression), and 36 received placebo (21 predicted to have faster progression). Tofersen led to greater reductions in concentrations of SOD1 in CSF and of neurofilament light chains in plasma than placebo. In the faster-progression subgroup (primary analysis), the change to week 28 in the ALSFRS-R score was -6.98 with tofersen and -8.14 with placebo (difference, 1.2 points; 95% confidence interval [CI], -3.2 to 5.5; P=0.97). Results for secondary clinical end points did not differ significantly between the two groups. A total of 95 participants (88%) entered the open-label extension. At 52 weeks, the change in the ALSFRS-R score was -6.0 in the early-start cohort and -9.5 in the delayed-start cohort (difference, 3.5 points; 95% CI, 0.4 to 6.7); non-multiplicity-adjusted differences favoring early-start tofersen were seen for other end points. Lumbar puncture-related adverse events were common. Neurologic serious adverse events occurred in 7% of tofersen recipients.ConclusionsIn persons with SOD1 ALS, tofersen reduced concentrations of SOD1 in CSF and of neurofilament light chains in plasma over 28 weeks but did not improve clinical end points and was associated with adverse events. The potential effects of earlier as compared with delayed initiation of tofersen are being further evaluated in the extension phase. (Funded by Biogen; VALOR and OLE ClinicalTrials.gov numbers, and ; EudraCT numbers, 2015-004098-33 and 2016-003225-41.)	[Miller, Timothy M.; Bucelli, Robert C.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Cudkowicz, Merit E.; Babu, Suma] Harvard Med Sch, Sean M Healey & AMG Ctr ALS, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Cochrane, Thos; Chary, Sowmya; Chew, Sheena; Zhu, Han; Wu, Fan; Nestorov, Ivan; Graham, Danielle; Sun, Peng; Fanning, Laura; Ferguson, Toby A.; Fradette, Stephanie] Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA; [Genge, Angela] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Natl Inst Hlth & Care Res Sheffield Biomed Res Ct, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Univ Sheffield, Clin Res Facil, Sheffield, S Yorkshire, England; [Shaw, Pamela J.; McDermott, Christopher J.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [McNeill, Manjit] Biogen, Maidenhead, Berks, England; [Sobue, Gen] Aichi Med Univ, Nagakute, Aichi, Japan; [Chio, Adriano] Univ Turin, Turin, Italy; [Van Damme, Philip] Katholieke Univ Leuven, VIB Ctr Brain & Dis Res, Univ Hosp Leuven, Leuven, Belgium; [Ludolph, Albert C.] Univ Ulm, Ulm, Germany; [Ludolph, Albert C.] Deutsch Zentrum Neurodegenerat Erkrankungen, Bonn, Germany; [Glass, Jonathan D.] Emory Univ, Atlanta, GA 30322 USA; [Andrews, Jinsy A.] Columbia Univ, Irving Med Ctr, Neurol Inst, New York, NY USA; [Benatar, Michael] Univ Miami, Dept Neurol, Miami, FL USA	Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Biogen; McGill University; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Aichi Medical University; University of Turin; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Ulm University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Emory University; Columbia University; NewYork-Presbyterian Hospital; University of Miami	Miller, TM (corresponding author), Washington Univ, Dept Neurol, Sch Med, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.; Fradette, S (corresponding author), Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA.	miller.t@wustl.edu; stephanie.fradette@biogen.com	Van Damme, Philip/A-6464-2009; McDermott, Christopher/AAU-4988-2020	Van Damme, Philip/0000-0002-4010-2357; McDermott, Christopher/0000-0002-1269-9053				Abu-Rumeileh S, 2020, J NEUROL, V267, P1699, DOI 10.1007/s00415-020-09761-z; Amyotrophic Lateral Sclerosis online Database, SOD1 GEN SUMM; Bali T, 2017, J NEUROL NEUROSUR PS, V88, P99, DOI 10.1136/jnnp-2016-313521; Benatar M, 2022, NEUROTHERAPEUTICS, V19, P1248, DOI 10.1007/s13311-022-01237-4; Benatar M, 2020, NEUROLOGY, V95, pE59, DOI 10.1212/WNL.0000000000009559; Benatar M, 2018, NEUROLOGY, V90, pE565, DOI 10.1212/WNL.0000000000004960; Bidhendi EE, 2018, ACTA NEUROPATHOL, V136, P939, DOI 10.1007/s00401-018-1915-y; Bunton-Stasyshyn RKA, 2015, NEUROSCIENTIST, V21, P519, DOI 10.1177/1073858414561795; Coppede F, 2018, AMYOTROPH LAT SCL FR, V19, P93, DOI 10.1080/21678421.2017.1367401; De Schaepdryver M, 2020, J NEUROL NEUROSUR PS, V91, P436, DOI 10.1136/jnnp-2019-322309; Gaiani A, 2017, JAMA NEUROL, V74, P525, DOI 10.1001/jamaneurol.2016.5398; Hayashi Yuki, 2015, Advances in Biological Regulation, V60, P95, DOI 10.1016/j.jbior.2015.10.006; Huai JS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00527; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Ludolph AC, 2020, ANN NEUROL, V87, P206, DOI 10.1002/ana.25661; Ludolph AC, 2018, LANCET NEUROL, V17, P681, DOI 10.1016/S1474-4422(18)30176-5; McCampbell A, 2018, J CLIN INVEST, V128, P3558, DOI 10.1172/JCI99081; Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715; Muller K, 2018, J NEUROL NEUROSUR PS, V89, P817, DOI 10.1136/jnnp-2017-317611; Poesen K, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01167; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; Thompson AG, 2022, BRAIN COMMUN, V4, DOI 10.1093/braincomms/fcac029; Verde F, 2019, J NEUROL NEUROSUR PS, V90, P157, DOI 10.1136/jnnp-2018-318704	28	7	7	13	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2022	387	12					1099	1110		10.1056/NEJMoa2204705	http://dx.doi.org/10.1056/NEJMoa2204705			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5E2MR	36129998				2022-12-28	WOS:000865461700006
J	Paller, AS; Simpson, EL; Siegfried, EC; Cork, MJ; Wollenberg, A; Arkwright, PD; Soong, W; Gonzalez, ME; Schneider, LC; Sidbury, R; Lockshin, B; Meltzer, S; Wang, ZX; Mannent, LP; Amin, N; Sun, YP; Laws, E; Akinlade, B; Dillon, M; Kosloski, MP; Kamal, MA; Dubost-Brama, A; Patel, N; Weinreich, DM; Yancopoulos, GD; O'Malley, JT; Bansal, A				Paller, Amy S.; Simpson, Eric L.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Soong, Weily; Gonzalez, Mercedes E.; Schneider, Lynda C.; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P.; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Dubost-Brama, Ariane; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; O'Malley, John T.; Bansal, Ashish		Participating Investigators	Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							MANAGEMENT; HUMANIZATION; POPULATION; GUIDELINES; ECZEMA; RISK; CARE	Background Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis that is uncontrolled with topical therapies might have suboptimal efficacy and safety. Dupilumab is approved for older children and adults with atopic dermatitis and for other type 2 inflammatory conditions. We aimed to evaluate efficacy and safety of dupilumab with concomitant low-potency topical corticosteroids in children aged 6 months to younger than 6 years with moderate-to-severe atopic dermatitis. Methods This randomised, double-blind, placebo-controlled, parallel-group, phase 3 trial was conducted in 31 hospitals, clinics, and academic institutions in Europe and North America. Eligible patients were aged 6 months to younger than 6 years, with moderate-to-severe atopic dermatitis (Investigator's Global Assessment [IGA] score 3-4) diagnosed according to consensus criteria of the American Academy of Dermatology, and an inadequate response to topical corticosteroids. Patients were randomly assigned (1:1) to subcutaneous placebo or dupilumab (bodyweight >= 5 kg to <15 kg: 200 mg; bodyweight >= 15 kg to <30 kg: 300 mg) every 4 weeks plus low-potency topical corticosteroids (hydrocortisone acetate 1% cream) for 16 weeks. Randomisation was stratified by age, baseline bodyweight, and region. Patient allocation was done via a central interactive web response system, and treatment allocation was masked. The primary endpoint at week 16 was the proportion of patients with IGA score 0-1 (clear or almost clear skin). The key secondary endpoint (coprimary endpoint for the EU and EU reference market) at week 16 was the proportion of patients with at least a 75% improvement from baseline in Eczema Area and Severity Index (EASI-75). Primary analyses were done in the full analysis set (ie, all randomly assigned patients, as randomly assigned) and safety analyses were done in all patients who received any study drug. This study was registered with ClinicalTrials.gov, NCT03346434. Findings Between June 30, 2020, and Feb 12, 2021, 197 patients were screened for eligibility, 162 of whom were randomly assigned to receive dupilumab (n=83) or placebo (n=79) plus topical corticosteroids. At week 16, significantly more patients in the dupilumab group than in the placebo group had IGA 0-1 (23 [28%] vs three [4%], difference 24% [95% CI 13-34]; p<0.0001) and EASI-75 (44 [53%] vs eight [11%], difference 42% [95% CI 29-55]; p<0.0001). Overall prevalence of adverse events was similar in the dupilumab group (53 [64%] of 83 patients) and placebo group (58 [74%] of 78 patients). Conjunctivitis incidence was higher in the dupilumab group (four [5%]) than the placebo group (none). No dupilumab-related adverse events were serious or led to treatment discontinuation. Interpretation Dupilumab significantly improved atopic dermatitis signs and symptoms versus placebo in children younger than 6 years. Dupilumab was well tolerated and showed an acceptable safety profile, similar to results in older children and adults. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Paller, Amy S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Paller, Amy S.] Ann & Robert H Lurie Childrens Hosp, Dept Dermatol, Chicago, IL USA; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA; [Siegfried, Elaine C.] St Louis Univ, Dept Pediat, St Louis, MO USA; [Siegfried, Elaine C.] Cardinal Glennon Childrens Hosp, Dept Pediat Dermatol, St Louis, MO USA; [Cork, Michael J.] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England; [Wollenberg, Andreas] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Dermatol & Allergol, Munich, Germany; [Wollenberg, Andreas] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Brussels, Belgium; [Arkwright, Peter D.] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester, England; [Soong, Weily] AllerVie Hlth, Alabama Allergy & Asthma Ctr, Birmingham, AL USA; [Gonzalez, Mercedes E.] Univ Miami, Phillip Frost Dept Dermatol, Miller Sch Med, Miami, FL USA; [Schneider, Lynda C.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA; [Sidbury, Robert] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA; [Lockshin, Benjamin] US Dermatol Partners, Rockville, MD USA; [Meltzer, Steven] Beach Allergy & Asthma Specialty Grp, Long Beach, CA USA; [Wang, Zhixiao; Amin, Nikhil; Sun, Yiping; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Weinreich, David M.; Yancopoulos, George D.; Bansal, Ashish] Regeneron Pharmaceut, Tarrytown, NY USA; [Mannent, Leda P.; Dubost-Brama, Ariane] Sanofi, Chilly Mazarin, France; [Laws, Elizabeth] Sanofi, Bridgewater, NJ USA; [Patel, Naimish; O'Malley, John T.] Sanofi, Cambridge, MA USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Oregon Health & Science University; Saint Louis University; University of Sheffield; University of Munich; University Hospital Brussels; Vrije Universiteit Brussel; University of Manchester; University of Miami; Harvard University; Boston Children's Hospital; Seattle Children's Hospital; Regeneron; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi-Aventis	Bansal, A (corresponding author), Regeneron Pharmaceut, Tarrytown, NY 10591 USA.	ashish.bansal@regeneron.com		Cork, Michael/0000-0003-4428-2428	Sanofi; Regeneron Pharmaceuticals	Sanofi; Regeneron Pharmaceuticals(Regeneron)	Sanofi and Regeneron Pharmaceuticals	Akinlade B, 2019, BRIT J DERMATOL, V181, P459, DOI 10.1111/bjd.17869; Al Shobaili HA, 2010, PEDIATR DERMATOL, V27, P618, DOI 10.1111/j.1525-1470.2010.01215.x; Bansal A, 2021, AM J CLIN DERMATOL, V22, P101, DOI 10.1007/s40257-020-00577-1; Beck Lisa A, 2022, JID Innov, V2, P100131, DOI 10.1016/j.xjidi.2022.100131; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Cork MJ, 2020, BRIT J DERMATOL, V182, P85, DOI 10.1111/bjd.18476; Di Lernia V, 2020, J DTSCH DERMATOL GES, V18, P1016, DOI 10.1111/ddg.14257; Eichenfield LF, 2019, AM J CLIN DERMATOL, V20, P443, DOI 10.1007/s40257-019-00445-7; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eichenfield LF, 2003, PEDIATRICS, V111, P608, DOI 10.1542/peds.111.3.608; European Medicines Agency, 2022, DUP EUR PUBL ASS REP; Ferrucci S, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3565; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Haddad E, 2022, DERMATOLOGY THER, V12, P1501, DOI 10.1007/s13555-022-00737-7; Hamilton JD, 2021, CLIN EXP ALLERGY, V51, P915, DOI 10.1111/cea.13954; Hansen PM, 2022, ALLERGY, V77, P2555, DOI 10.1111/all.15326; Kamal MA, 2021, CLIN PHARMACOL THER, V110, P1318, DOI 10.1002/cpt.2366; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Langan SM, 2017, J INVEST DERMATOL, V137, P1375, DOI 10.1016/j.jid.2017.01.030; Macdonald LE, 2014, P NATL ACAD SCI USA, V111, P5147, DOI 10.1073/pnas.1323896111; Martin PE, 2015, CLIN EXP ALLERGY, V45, P255, DOI 10.1111/cea.12406; Martinez-Cabriales SA, 2021, AM J CLIN DERMATOL, V22, P443, DOI 10.1007/s40257-021-00607-6; Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111; Paller AS, 2021, J EUR ACAD DERMATOL, V35, P464, DOI 10.1111/jdv.16928; Paller AS, 2022, PEDIATR DERMATOL, V39, P187, DOI 10.1111/pde.14909; Paller AS, 2021, PEDIATR DRUGS, V23, P515, DOI 10.1007/s40272-021-00459-x; Paller AS, 2020, J AM ACAD DERMATOL, V83, P1282, DOI 10.1016/j.jaad.2020.06.054; Regeneron Pharmaceuticals, 2022, DUP PACK INS; Rothenberg M, 2022, J ALLERGY CLIN IMMUN, V149, pAB312; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Siegfried EC, 2021, AM J CLIN DERMATOL, V22, P243, DOI 10.1007/s40257-020-00583-3; Silverberg JI, 2021, ANN ALLERG ASTHMA IM, V126, P417, DOI 10.1016/j.anai.2020.12.020; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2020, JAMA DERMATOL, V156, P44, DOI 10.1001/jamadermatol.2019.3336; Swiecki M, 2011, J INVEST DERMATOL, V131, P288, DOI 10.1038/jid.2010.368; Wollenberg A, 2020, BRIT J DERMATOL, V182, P1120, DOI 10.1111/bjd.18434; Yosipovitch G, 2022, AM ACAD DERMATOLOGY	37	2	2	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					908	919						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36116481				2022-12-28	WOS:000890180700023
J	Davidson, MR; Karplus, VJ; Lewis, JI; Nahm, J; Wang, A				Davidson, Michael R.; Karplus, Valerie J.; Lewis, Joanna I.; Nahm, Jonas; Wang, Alex			Risks of decoupling from China on low-carbon technologies	SCIENCE			English	Editorial Material									[Davidson, Michael R.] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA USA; [Davidson, Michael R.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA USA; [Karplus, Valerie J.] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA USA; [Lewis, Joanna I.] Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Sci Technol & Int Affairs Program, Washington, DC USA; [Nahm, Jonas] Johns Hopkins Univ, Sch Adv Int Studies, Washington, DC USA; [Wang, Alex] Univ Calif Los Angeles, Sch Law, Los Angeles, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Carnegie Mellon University; Georgetown University; Johns Hopkins University; University of California System; University of California Los Angeles	Davidson, MR (corresponding author), Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA USA.; Davidson, MR (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA USA.	mrdavidson@ucsd.edu		Lewis, Joanna I./0000-0002-5362-1308				Bezdek RH, 2019, RENEWABLE ENERGY ENV, V4, P1; Bowen R, 2021, ROLE TRADE ADDRESSIN; Cohen MA, 2021, WORLD TRADE REV, V20, P238, DOI 10.1017/S1474745620000531; Commission on the Theft of American Intellectual Property, 2017, UPD IP COMM REP THE; Freund C., 2021, POLICY RES WORKING P; IEA, 2021, PAT EN TRANS GLOB TR; Jolley GJ, 2019, REG SCI POLICY PRACT, V11, P403, DOI 10.1111/rsp3.12191; Karplus VJ, 2021, ISSUES SCI TECHNOL, V38, P76; Lewis JI, 2014, GLOBAL ENVIRON POLIT, V14, P10, DOI 10.1162/GLEP_a_00255; Nahm J, 2021, COLLABORATIVE ADVANT; TheWhite House, 2021, INT NAT SEC STRAT GU; TheWhite House, 2021, BUILD RES SUPPL CHAI; US Department of Energy (DOE), 2022, 1871491 DOE; Watts J., 2010, CRITICAL TECHNOLOGY; Yu S., 2021, FINANCIAL TIMES FEB	15	1	1	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1266	1269		10.1126/science.abq5446	http://dx.doi.org/10.1126/science.abq5446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36108004				2022-12-28	WOS:000887933500025
J	Aizawa, N; Pu, YJ; Harabuchi, Y; Nihonyanagi, A; Ibuka, R; Inuzuka, H; Dhara, B; Koyama, Y; Nakayama, KI; Maeda, S; Araoka, F; Miyajima, D				Aizawa, Naoya; Pu, Yong-Jin; Harabuchi, Yu; Nihonyanagi, Atsuko; Ibuka, Ryotaro; Inuzuka, Hiroyuki; Dhara, Barun; Koyama, Yuki; Nakayama, Ken-ichi; Maeda, Satoshi; Araoka, Fumito; Miyajima, Daigo			Delayed fluorescence from inverted singlet and triplet excited states	NATURE			English	Article							LIGHT-EMITTING-DIODES; HIGH-EFFICIENCY; MOLECULES; HEPTAZINES; ENERGIES; EMISSION; EMITTERS; GAP	Hund's multiplicity rule states that a higher spin state has a lower energy for a given electronic configuration(1). Rephrasing this rule for molecular excited states predicts a positive energy gap between spin-singlet and spin-triplet excited states, as has been consistent with numerous experimental observations over almost a century. Here we report a fluorescent molecule that disobeys Hund's rule and has a negative singlet-triplet energy gap of -11 +/- 2 meV. The energy inversion of the singlet and triplet excited states results in delayed fluorescence with short time constants of 0.2 mu s, which anomalously decrease with decreasing temperature owing to the emissive singlet character of the lowest-energy excited state. Organic light-emitting diodes (OLEDs) using this molecule exhibited a fast transient electroluminescence decay with a peak external quantum efficiency of 17%, demonstrating its potential implications for optoelectronic devices, including displays, lighting and lasers.	[Aizawa, Naoya; Pu, Yong-Jin; Nihonyanagi, Atsuko; Ibuka, Ryotaro; Inuzuka, Hiroyuki; Dhara, Barun; Koyama, Yuki; Araoka, Fumito; Miyajima, Daigo] RIKEN, Ctr Emergent Matter Sci CEMS, Wako, Saitama, Japan; [Aizawa, Naoya; Nakayama, Ken-ichi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka, Japan; [Aizawa, Naoya] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Pu, Yong-Jin; Koyama, Yuki] Yamagata Univ, Grad Sch Organ Mat Sci, Yonezawa, Yamagata, Japan; [Harabuchi, Yu; Maeda, Satoshi] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido, Japan; [Harabuchi, Yu; Maeda, Satoshi] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan	RIKEN; Osaka University; Japan Science & Technology Agency (JST); Yamagata University; Hokkaido University; Hokkaido University	Aizawa, N; Pu, YJ; Miyajima, D (corresponding author), RIKEN, Ctr Emergent Matter Sci CEMS, Wako, Saitama, Japan.	aizawa@chem.eng.osaka-u.ac.jp; yongjin.pu@riken.jp; daigo.miyajima@riken.jp	Pu, Yong-Jin/B-5269-2008; Aizawa, Naoya/R-6189-2016	Pu, Yong-Jin/0000-0003-3841-2417; Aizawa, Naoya/0000-0003-4673-4512; Dhara, Barun/0000-0003-1648-8824	New Energy and Industrial Technology Development Organization (NEDO) [09151455]; JST PRESTO [13417316, JPMJPR17N1]; JSPS KAKENHI [24685029, 17H03103, 20H02554, 20K15252, 21H05413, 22H02051]	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); JST PRESTO(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by an Industrial Technology Research Grant for Young Researchers from the New Energy and Industrial Technology Development Organization (NEDO) (grant no. 09151455 to Y.-J.P.), JST PRESTO (grant nos. 13417316 to Y.-J.P. and JPMJPR17N1 to N.A.) and JSPS KAKENHI (grant nos. 24685029, 17H03103, 20H02554 to Y.-J.P. and 20K15252, 21H05413, 22H02051 to N.A.). The authors thank M. Kim at RIKEN CEMS, T. Chiba, and M. Hirasawa at Yamagata University for their support with the OLED fabrication and evaluation. The computations were partially performed using the HOKUSAI Big Waterfall system at RIKEN.	ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; Audebert P, 2021, CHEM REV, V121, P2515, DOI 10.1021/acs.chemrev.0c00955; Baer R, 2010, ANNU REV PHYS CHEM, V61, P85, DOI 10.1146/annurev.physchem.012809.103321; Baldo MA, 2000, PHYS REV B, V62, P10967, DOI 10.1103/PhysRevB.62.10967; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Cui LS, 2020, NAT PHOTONICS, V14, P636, DOI 10.1038/s41566-020-0668-z; de Silva P, 2019, J PHYS CHEM LETT, V10, P5674, DOI 10.1021/acs.jpclett.9b02333; Di DW, 2017, SCIENCE, V356, P159, DOI 10.1126/science.aah4345; dos Santos PL, 2018, ADV SCI, V5, DOI 10.1002/advs.201700989; Ehrmaier J, 2019, J PHYS CHEM A, V123, P8099, DOI 10.1021/acs.jpca.9b06215; Elliott P, 2011, CHEM PHYS, V391, P110, DOI 10.1016/j.chemphys.2011.03.020; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Galmiche L, 2019, CHEM SCI, V10, P5513, DOI 10.1039/c9sc00665f; Goushi K, 2012, NAT PHOTONICS, V6, P253, DOI 10.1038/nphoton.2012.31; Haase N, 2018, J PHYS CHEM C, V122, P29173, DOI 10.1021/acs.jpcc.8b11020; Hamze R, 2019, SCIENCE, V363, P601, DOI 10.1126/science.aav2865; Hatakeyama T, 2016, ADV MATER, V28, P2777, DOI 10.1002/adma.201505491; Hund F, 1925, Z PHYS, V33, P345, DOI 10.1007/BF01328319; Kim JU, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-15558-5, 10.1038/s41467-020-18842-6]; Kondo Y, 2019, NAT PHOTONICS, V13, P678, DOI 10.1038/s41566-019-0476-5; Le T, 2020, CHEM COMMUN, V56, P10742, DOI 10.1039/d0cc05118g; Lee MT, 2004, APPL PHYS LETT, V85, P3301, DOI 10.1063/1.1804232; LEUPIN W, 1986, J AM CHEM SOC, V108, P17, DOI 10.1021/ja00261a004; LEUPIN W, 1980, J AM CHEM SOC, V102, P6068, DOI 10.1021/ja00539a016; Li J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4887346; Li J, 2013, ADV MATER, V25, P3319, DOI 10.1002/adma.201300575; Liu YC, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2018.20; Martin RL, 2003, J CHEM PHYS, V118, P4775, DOI 10.1063/1.1558471; Murawski C, 2013, ADV MATER, V25, P6801, DOI 10.1002/adma.201301603; Nakagawa T, 2016, OPT LETT, V41, P1498, DOI 10.1364/OL.41.001498; Nowy S, 2008, J APPL PHYS, V104, DOI 10.1063/1.3043800; PARKER CA, 1963, PROC R SOC LON SER-A, V276, P125, DOI 10.1098/rspa.1963.0197; PARKER CA, 1961, T FARADAY SOC, V57, P1894, DOI 10.1039/tf9615701894; Pershin A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08495-5; Pollice R, 2021, MATTER-US, V4, P1654, DOI 10.1016/j.matt.2021.02.017; Pu YJ, 2019, J MATER CHEM C, V7, P2541, DOI 10.1039/c8tc05817b; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Ricci G, 2021, CHEMPHYSCHEM, V22, P553, DOI 10.1002/cphc.202000926; Sanz-Rodrigo J, 2021, J PHYS CHEM A, V125, P513, DOI 10.1021/acs.jpca.0c08029; SCHIRMER J, 1982, PHYS REV A, V26, P2395, DOI 10.1103/PhysRevA.26.2395; Schmidbauer S, 2013, ADV MATER, V25, P2114, DOI 10.1002/adma.201205022; Slater JC, 1929, PHYS REV, V34, P1293, DOI 10.1103/PhysRev.34.1293; Sobolewski AL, 2021, J PHYS CHEM LETT, V12, P6852, DOI 10.1021/acs.jpclett.1c01926; STANTON JF, 1993, J CHEM PHYS, V98, P7029, DOI 10.1063/1.464746; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Wada Y, 2020, NAT PHOTONICS, V14, P643, DOI 10.1038/s41566-020-0667-0; Wu TL, 2018, NAT PHOTONICS, V12, P235, DOI 10.1038/s41566-018-0112-9; Zeng WX, 2018, ADV MATER, V30, DOI 10.1002/adma.201704961; ZIEGLER T, 1977, THEOR CHIM ACTA, V43, P261, DOI 10.1007/BF00551551	50	1	1	51	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927								10.1038/s41586-022-05132-y	http://dx.doi.org/10.1038/s41586-022-05132-y			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4O5MH	36104553	Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000854741300003
J	Sachs, JD; Karim, SSA; Aknin, L; Allen, J; Brosbol, K; Colombo, F; Barron, GC; Espinosa, MF; Gaspar, V; Gaviria, A; Haines, A; Hotez, PJ; Koundouri, P; Bascunan, FL; Lee, JK; Pate, MA; Ramos, G; Reddy, KS; Serageldin, I; Thwaites, J; Vike-Freiberga, V; Wang, C; Were, MK; Xue, L; Bahadur, C; Bottazzi, ME; Bullen, C; Laryea-Adjei, G; Ben Amor, Y; Karadag, O; Lafortune, G; Torres, E; Barredo, L; Bartels, JGE; Joshi, N; Hellard, M; Huynh, UK; Khandelwal, S; Lazarus, JV; Michie, S				Sachs, Jeffrey D.; Karim, Salim S. Abdool; Aknin, Lara; Allen, Joseph; Brosbol, Kirsten; Colombo, Francesca; Barron, Gabriela Cuevas; Espinosa, Maria Fernanda; Gaspar, Vitor; Gaviria, Alejandro; Haines, Andy; Hotez, Peter J.; Koundouri, Phoebe; Larrain Bascunan, Felipe; Lee, Jong-Koo; Pate, Muhammad Ali; Ramos, Gabriela; Reddy, K. Srinath; Serageldin, Ismail; Thwaites, John; Vike-Freiberga, Vaira; Wang, Chen; Were, Miriam Khamadi; Xue, Lan; Bahadur, Chandrika; Bottazzi, Maria Elena; Bullen, Chris; Laryea-Adjei, George; Ben Amor, Yanis; Karadag, Ozge; Lafortune, Guillaume; Torres, Emma; Barredo, Lauren; Bartels, Juliana G. E.; Joshi, Neena; Hellard, Margaret; Huynh, Uyen Kim; Khandelwal, Shweta; Lazarus, Jeffrey V.; Michie, Susan			The Lancet Commission on lessons for the future from the COVID-19 pandemic	LANCET			English	Review							AIRBORNE TRANSMISSION; MENTAL-HEALTH; INCOME INEQUALITY; PARADIGM SHIFT; SARS-COV-2; CORONAVIRUS; VENTILATION; AIR; OUTBREAK; AEROSOLS		[Sachs, Jeffrey D.; Ben Amor, Yanis; Karadag, Ozge; Bartels, Juliana G. E.] Columbia Univ, Ctr Sustainable Dev, New York, NY 10115 USA; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Aknin, Lara] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Pate, Muhammad Ali] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Allen, Joseph] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Brosbol, Kirsten] Parliamentarians Global Goals, Copenhagen, Denmark; [Colombo, Francesca] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Barron, Gabriela Cuevas] UHC2030, Geneva, Switzerland; [Espinosa, Maria Fernanda] Robert Bosch Acad, Berlin, Germany; [Gaspar, Vitor] Int Monetary Fund, Fiscal Affairs Dept, Washington, DC 20431 USA; [Gaviria, Alejandro] Minist Natl Educ, Bogota, Colombia; [Haines, Andy] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Hotez, Peter J.; Bottazzi, Maria Elena] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Koundouri, Phoebe] Athens Univ Econ & Business, Dept Int & European Econ Studies, Athens, Greece; [Koundouri, Phoebe] Tech Univ Denmark, Dept Technol Management & Econ, Lyngby, Denmark; [Koundouri, Phoebe] European Assoc Environm & Resource Economists, Athens, Greece; [Larrain Bascunan, Felipe] Pontificia Univ Catolica Chile, Dept Econ & Adm, Santiago, Chile; [Lee, Jong-Koo] Natl Acad Med Korea, Seoul, South Korea; [Ramos, Gabriela] UNESCO, Social & Human Sci Ctr, Paris, France; [Reddy, K. Srinath; Khandelwal, Shweta] Publ Hlth Fdn India, New Delhi, India; [Serageldin, Ismail] Bibliotheca Alexandrina, Alexandria, Egypt; [Thwaites, John] Monash Univ, Monash Sustainable Dev Inst, Clayton, Vic, Australia; [Vike-Freiberga, Vaira] Nizami Ganjavi Int Ctr, Baku, Azerbaijan; [Wang, Chen] Chinese Acad Med Sci, Natl Clin Res Ctr Resp Dis, Peking Union Med Coll Beijing, Beijing, Peoples R China; [Were, Miriam Khamadi] Champ AIDS Free Generat, Nairobi, Kenya; [Xue, Lan] Tsinghua Univ, Schwarzman Coll, Beijing, Peoples R China; [Bahadur, Chandrika] Lancet COVID 19 Commiss Reg Task Force India, New Delhi, India; [Bullen, Chris] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Laryea-Adjei, George] UNICEF Reg Off South Asia, Kathmandu, Nepal; [Lafortune, Guillaume] United Nations Sustainable Dev Solut Network, Paris, France; [Torres, Emma; Barredo, Lauren] United Nations Sustainable Dev Solut Network, New York, NY USA; [Hellard, Margaret] Burnet Inst, Melbourne, Vic, Australia; [Huynh, Uyen Kim] UNICEF, Evaluat Off, New York, NY USA; [Lazarus, Jeffrey V.] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Michie, Susan] UCL, Ctr Behav Change, London, England	Columbia University; Columbia University; Simon Fraser University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Organisation for Economic Co-operation & Development (OECD); International Monetary Fund; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; Athens University of Economics & Business; Technical University of Denmark; Pontificia Universidad Catolica de Chile; Public Health Foundation of India; Monash University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; University of Auckland; Burnet Institute; UNICEF; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of London; University College London	Sachs, JD (corresponding author), Columbia Univ, Ctr Sustainable Dev, New York, NY 10115 USA.	sachs@columbia.edu	Koundouri, Phoebe/AAI-2160-2021; Lazarus, Jeffrey V./R-6248-2018; Michie, Susan/A-1745-2010	Koundouri, Phoebe/0000-0001-5979-6128; Lazarus, Jeffrey V./0000-0001-9618-2299; Michie, Susan/0000-0003-0063-6378; Haines, Andy/0000-0002-8053-4605				Abaluck J, 2022, SCIENCE, V375, P160, DOI 10.1126/science.abi9069; Adenaiye OO, 2022, CLIN INFECT DIS, V75, pE241, DOI 10.1093/cid/ciab797; Adetifa IMO, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24062-3; Adhikari A, 2020, INDIAN J LABOUR ECON, V63, P969, DOI 10.1007/s41027-020-00282-x; Agarwal R., 2022, IMFBLOG 0203; Agren D, 2020, GUARDIAN 0325; Airport Cooperative Research Program, 2013, INF DIS MIT AIRP AIR, DOI [10.17226/22512, DOI 10.17226/22512]; Aiyegbusi OL, 2021, J ROY SOC MED, V114, P428, DOI 10.1177/01410768211032850; Aizenman N., 2021, NPR 1230; Aknin LB, 2022, LANCET PUBLIC HEALTH, V7, pE417, DOI 10.1016/S2468-2667(22)00060-3; Aknin LB, 2022, PERSPECT PSYCHOL SCI, V17, P915, DOI 10.1177/17456916211029964; Aknin LB, 2019, WORLD HAPPINESS REPO; Allam Z, 2020, SURVEYING COVID 19 P, P1; Allen JG, 2021, JAMA-J AM MED ASSOC, V325, P2112, DOI 10.1001/jama.2021.5053; Allen JG, 2020, INDOOR AIR, V30, P557, DOI 10.1111/ina.12697; Amaratunga D, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100133; Amendola A, 2021, EMERG INFECT DIS, V27, P648, DOI 10.3201/eid2702.204632; Anand JC, 2022, EUR J SOC WORK, V25, P804, DOI 10.1080/13691457.2021.1954886; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Anglemyer A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013699; [Anonymous], 2020, LANCET INFECT DIS, V20, P875, DOI 10.1016/S1473-3099(20)30565-X; [Anonymous], 1946, PUBLIC HEALTH REP, V61, P1268; [Anonymous], 2021, FRANCE 24 0619; [Anonymous], 2021, ECONOMIST 1102; [Anonymous], 2021, GLOB DEAL OUR PAND A; ANSI/ASHRAE, 2019, 6212019 ANSIASHRAE; Apolone G, 2021, TUMORI J, V107, P446, DOI 10.1177/0300891620974755; ASHRAE, 2017, 522 ASHRAE; Assaf G, 2020, ANAL PROLONGED COVID; Assefa Y, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004882; Ayoubkhani D, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2021-069676; Ayouni I, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11111-1; Azimi P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015482118; Bacon SL, 2021, CHANGE LEVEL VACCINE; Bai F, 2022, CLIN MICROBIOL INFEC, V28, DOI 10.1016/j.cmi.2021.11.002; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Ballard M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002550; Barron GC, 2022, LANCET PUBLIC HEALTH, V7, pE86, DOI 10.1016/S2468-2667(21)00235-8; Basavaraju SV, 2021, CLIN INFECT DIS, V72, pE1004, DOI 10.1093/cid/ciaa1785; Behsudi A, 2020, WISH YOU WERE HERE T; Belluz J, 2022, NY TIMES 0208; Benedek D, 2021, POSTPANDEMIC ASSESSM; bessi, BEH ENV SOC SYST INT; Bhaumik S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002769; Bian LL, 2021, EXPERT REV VACCINES, V20, P1201, DOI 10.1080/14760584.2021.1976153; BioNTech, 2020, BIONTECH REC 375M FU; Bloom JD, 2021, SCIENCE, V372, P694, DOI 10.1126/science.abj0016; Bloomberg UK, BLOOMBERG UK; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Boniol M., 2019, GENDER EQUITY HLTH W; Bourdrel T, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0242-2020; Bourouiba L, 2021, ANNU REV FLUID MECH, V53, P473, DOI [10.1146/annurev-fluid-060220113712, 10.1146/annurev-fluid-060220-113712]; Brackel CLH, 2021, PEDIATR PULM, V56, P2495, DOI 10.1002/ppul.25521; Bragge Peter, 2022, Discov Sustain, V3, P7, DOI 10.1007/s43621-022-00074-x; Brethel-Haurwitz KM, 2014, PSYCHOL SCI, V25, P762, DOI 10.1177/0956797613516148; Breuninger K., 2020, CNBC 0324; Brown G, 2020, OXFORD REV ECON POL, V36, pS64, DOI 10.1093/oxrep/graa025; Bucciarelli V, 2022, TRENDS CARDIOVAS MED, V32, P12, DOI 10.1016/j.tcm.2021.09.009; Buckley C, 2021, NY TIMES 1131; Bulfone TC, 2021, J INFECT DIS, V223, P550, DOI 10.1093/infdis/jiaa742; Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Buonanno G, 2020, ENVIRON INT, V145, DOI 10.1016/j.envint.2020.106112; Burns J, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013717; Byrne EA, 2022, BRAIN BEHAV IMMUN, V99, P17, DOI 10.1016/j.bbi.2021.09.012; Campos-Mercade P, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2021.104367; Caparros A, 2020, ENVIRON RESOUR ECON, V76, P913, DOI 10.1007/s10640-020-00475-4; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Carnegie Endowment for International Peace, GLOB PROT TRACK; Carrat F, 2021, EUR J EPIDEMIOL, V36, P219, DOI 10.1007/s10654-020-00716-2; Center for Countering Digital Hate, 2021, DIS DOZ WHY PLATF MU; Centers for Disease Control and Prevention, 2019, 2009 H1N1 PAND H1N1; Centers for Disease Control and Prevention, 2019, 1968 PAND H3N2 VIR; Centers for Disease Control and Prevention, 2020, HIST QUAR; Centers for Disease Control and Prevention, 2019, 1957 1958 PAND H2N2; Centers for Medicare and Medicaid Services, NAT HLTH EXP TYP SER; Chamary J, 2021, FORBES 0504; Chen JF, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101816; Chen WZ, 2020, BUILD ENVIRON, V176, DOI 10.1016/j.buildenv.2020.106859; Chmielewska B, 2021, LANCET GLOB HEALTH, V9, pE759, DOI 10.1016/S2214-109X(21)00079-6; Choi EM, 2020, EMERG INFECT DIS, V26, P2713, DOI 10.3201/eid2611.203254; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Chu IYH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa192; Claeson M, 2021, LANCET, V397, P259, DOI 10.1016/S0140-6736(20)32750-1; Collins FS, 2021, COMMUNICATION 0519; Companies Market Cap, MARK CAP MOD MRNA; Cooper RN, 1989, CAN NATIONS AGREE IS; Cooper RN, 1985, B AM ACAD ARTS SCI, V39, P11; Corsi R, 2021, DESIGNING INFECT DIS; Cortellessa G, 2021, SCI TOTAL ENVIRON, V794, DOI 10.1016/j.scitotenv.2021.148749; COVID-NMA, COVID NMA IN; COVID19 Bharat, US; Crawshaw J, 2021, FACTORS AFFECTING HE; Crook H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1648; Cukier A, 2021, CAN MED ASSOC J, V193, pE1896, DOI 10.1503/cmaj.1095980; Czypionka T, 2021, ANN INTERN MED, V174, P511, DOI 10.7326/M20-6625; Dada S, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-003910; Dalberg, 2021, ACT ACC STRAT REV; Dalsania AK, 2022, J RACIAL ETHN HEALTH, V9, P288, DOI 10.1007/s40615-020-00952-y; Daugirdas K, 2019, INT ORGAN LAW REV, V16, P299, DOI 10.1163/15723747-01602005; Decary S, 2021, CARE MODELS LONG COV; Desjardins J, 2019, MAPPED MEDIAN AGE PO; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Development Initiatives, 2020, AID SPENT HLTH ODA D; Dinic BM, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.647710; Dorjee K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243191; Drinka PJ, 1996, J AM GERIATR SOC, V44, P910, DOI 10.1111/j.1532-5415.1996.tb01859.x; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Edwards NJ, 2021, AEROSOL SCI TECH, V55, P1378, DOI 10.1080/02786826.2021.1966376; Espiner T, 2021, BBC NEWS 1112; EuroNews AP, 2022, EURONEWS 0128; EuroNews AP, 2021, EURONEWS 0517; European Commission, 2022, INV PLAN EUR EUR INV; European Commission, 2020, TOUR TRANSP PACK; Falahi S, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100812; Falk G, 2021, UNEMPLOYMENT RATES C; Feldman JM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.35967; Finance for Biodiversity Initiative, GREENN STIM IND; Flaherty GT, 2020, TROP DIS TRAVEL MED, V6, DOI 10.1186/s40794-020-00118-y; Flor LS, 2022, LANCET, V399, P2381, DOI 10.1016/S0140-6736(22)00008-3; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Friebel R, 2019, LANCET, V393, P2006, DOI 10.1016/S0140-6736(18)33055-1; Frumkin H, 2019, ANNU REV PUBL HEALTH, V40, P261, DOI 10.1146/annurev-publhealth-040218-043706; Frutos R, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.591535; Gabarron E, 2021, B WORLD HEALTH ORGAN, V99, P455, DOI 10.2471/BLT.20.276782; Gaffney AW, 2021, J GEN INTERN MED, V36, P3647, DOI 10.1007/s11606-021-07078-9; Garijo B, 2020, COVID 19 HIGHLIGHTS; Gaspar V, 2019, FISCAL POLICY DEV HU; Gelfand MJ, 2021, LANCET PLANET HEALTH, V5, pe135, DOI 10.1016/S2542-5196(20)30301-6; Germani F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247642; Gianotti R, 2021, BRIT J DERMATOL, V184, P970, DOI 10.1111/bjd.19804; Gibb R, 2020, NATURE, V584, P398, DOI 10.1038/s41586-020-2562-8; Gillard E-C., 2020, COVID 19 VACCINE REA; Girum T, 2021, ARCH PUBLIC HEALTH, V79, DOI 10.1186/s13690-021-00663-8; Gisondi MA, 2022, J MED INTERNET RES, V24, DOI 10.2196/35552; Global Commission on Evidence to Address Societal Challenges, 2022, EV COMM REP WAK UP C; Global Health 50/50 International Center for Research on Women African Population and Health Research Center, 2021, SEX GEND COVID 19 PR; Global Preparedness Monitoring Board, 2020, WORLD DIS; Godeau D, 2021, SCAND J WORK ENV HEA, V47, P408, DOI 10.5271/sjweh.3960; Gold JE, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10060763; Goldman N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256085; Goldstein JR, 2020, P NATL ACAD SCI USA, V117, P22035, DOI 10.1073/pnas.2006392117; Gostin LO, 2022, LANCET, V399, P1445, DOI 10.1016/S0140-6736(22)00533-5; Gover AR, 2020, AM J CRIM JUSTICE, V45, P647, DOI 10.1007/s12103-020-09545-1; Government of India Ministry of Information and Broadcasting, 2020, IND RESP COVID OUTBR; Graafland J, 2019, J HAPPINESS STUD, V20, P1717, DOI 10.1007/s10902-018-0021-0; Grady D., 2020, NY TIMES 0117; Gragnani L, 2021, EUR REV MED PHARMACO, V25, P3342, DOI 10.26355/eurrev_202104_25746; Graham EL, 2021, ANN CLIN TRANSL NEUR, V8, P1073, DOI 10.1002/acn3.51350; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Greenstone M., 2020, DOES SOCIAL DISTANCI; Grillo I., 2020, NY TIMES 0323; Groves LM, 2021, MMWR-MORBID MORTAL W, V70, P316, DOI [10.15585/mmwr.mm7009, 10.15585/mmwr.mm7009e1]; Guo H, 2021, EMERG MICROBES INFEC, V10, P1507, DOI 10.1080/22221751.2021.1956373; H.Nishiura, 2020, medRxiv, DOI 10.1101/2020.02.28.20029272; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Han Q, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001306; Hansen J, 2022, GLOBAL TEMPERATURE 2; Hansen N-JH, 2021, MASK MANDATES SAVE L; Hasan A, 2021, J BIOMOL STRUCT DYN, V39, P3025, DOI 10.1080/07391102.2020.1754293; Himmels JPW, 2021, COVID 19 COVID 19 RI; Hodcroft EB, 2021, NATURE, V595, P707, DOI [10.1038/s41586-021-03677-y, 10.1101/2020.10.25.20219063]; Hoffmann C, 2021, INFECTION, V49, P111, DOI 10.1007/s15010-020-01538-w; Holmes EC, 2021, CELL, V184, P4848, DOI 10.1016/j.cell.2021.08.017; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horton R, 2020, LANCET, V395, P1330, DOI 10.1016/S0140-6736(20)30969-7; Hotez PJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001369; Hotez PJ, 2020, MICROBES INFECT, V22, P505, DOI 10.1016/j.micinf.2020.09.005; Hotez PJ, 2021, SCI AM 1230; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inglesby TV, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00990-19; Institute for Health Metrics and Evaluation, 2022, COVID 19 PROJ; Institute for Health Metrics and Evaluation, COVID 19 PROJ UN AR; InterAcademy Partnership, 2021, STRENGTH RES COVID 1; International Energy Agency, 2022, SUSTAINABLE RECOVERY; International Institute for Sustainable Development, EN POL TRACK; International Labour Organization, 2020, ILO MON COVID 19 WOR; International Labour Organization, 2021, BUILD FORW FAIR WOM; International Monetary Fund, COVID 19 GLOB TARG P; International Monetary Fund, WORLD EC OUTL UPD JA; International Monetary Fund, 2021, COMMUNICATION 0407; International Monetary Fund, 2022, ADV EC DAT; International Monetary Fund, 2022, G 20 SURV NOT; International Monetary Fund, 2021, STRENGTH CRED PUBL F; International Monetary Fund, 2022, WORLD EC OUTL APR 20; International Monetary Fund, 2021, FISC MON; International Monetary Fund, 2021, WORLD EC OUTL OCT 20; International Monetary Fund, 2019, WORLD EC OUTL OCT 20; International Society for Infectious Diseases, SURV; Iosifidis P, 2021, DIGITAL DEMOCRACY SO; Iyengar KP, 2021, ADV RESPIR MED, V89, P234, DOI 10.5603/ARM.a2021.0040; Izcovich A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241955; Jenniskens K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050519; Jensen K, 2016, CURR BIOL, V26, pR748, DOI 10.1016/j.cub.2016.07.025; Jha P, 2022, SCIENCE, V375, P667, DOI 10.1126/science.abm5154; Jia KM, 2022, MEDRXIV; Johnson C, 2020, POLIT GENDER, V16, P943, DOI 10.1017/S1743923X2000029X; Kagumire R, 2021, JAZEERA 1206; Keaton J., 2021, ASS PRESS 0121; Khamsi R, 2021, NATURE, V590, P29, DOI 10.1038/d41586-021-00149-1; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kiszewski AE, 2021, VACCINE, V39, P2458, DOI 10.1016/j.vaccine.2021.03.022; Kola L, 2022, LANCET, V399, P1851, DOI 10.1016/S0140-6736(22)00523-2; Kourti A, 2021, TRAUMA VIOLENCE ABUS, DOI 10.1177/15248380211038690; Krause R, 2006, EMERG INFECT DIS, V12, P40, DOI 10.3201/eid1201.051132; Kulldorf M, 2020, GREAT BARRINGTON DEC; Kutter JS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21918-6; Lafortune G, 2021, EUROPE SUSTAINABLE D; Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5; Lamb LE, 2022, INT UROL NEPHROL, V54, P17, DOI 10.1007/s11255-021-03030-2; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Lee JS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260487; Lee S, 2020, INDIAN J LABOUR ECON, V63, P11, DOI 10.1007/s41027-020-00249-y; Lendacki FR, 2021, MMWR-MORBID MORTAL W, V70, P321, DOI 10.15585/mmwr.mm7009e2; Lerner S., 2022, INTERCEPT 0220; Lessler J, 2021, SCIENCE, V372, P1092, DOI 10.1126/science.abh2939; Levinson M, 2021, LANCET REG HLTH AM, V2; Li HOY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002604; Li TG, 2011, J CLIN VIROL, V50, P235, DOI 10.1016/j.jcv.2010.11.012; Li XY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250602; Li YG, 2022, INDOOR AIR, V32, DOI 10.1111/ina.12946; Linthicum K, 2020, LOS ANGELES TIM 0319; Liu XT, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.649314; Lobaloba Ingoba Line, 2022, IJID Reg, V2, P130, DOI 10.1016/j.ijregi.2022.01.002; Lotta Gabriela, 2022, Health Policy Open, V3, P100065, DOI 10.1016/j.hpopen.2021.100065; Lotta G, 2020, LANCET, V396, P365, DOI 10.1016/S0140-6736(20)31521-X; M. Gates, 2021, medRxiv, DOI 10.1101/2021.04.23.21256014; Ma JX, 2021, CLIN INFECT DIS, V72, pE652, DOI 10.1093/cid/ciaa1283; Mallapaty S, 2021, NATURE, V600, P199, DOI 10.1038/d41586-021-03608-x; Mallapaty S, 2020, NATURE, V588, P15, DOI 10.1038/d41586-020-03217-0; Mandavilli A, 2020, NY TIMES 0605; Mandolo J, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02187-y; Margolin J, 2020, ABC NEWS 0409; Marr LC, 2021, CLIN INFECT DIS, V73, P1747, DOI 10.1093/cid/ciab722; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Maxmen A, 2021, NATURE, V589, P499, DOI 10.1038/d41586-021-00162-4; McKee M, 2021, DRAWING LIGHT PANDEM; mcmasterforum, COVID END INV EV SYN; Megnin-Viggars O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241473; Mendel A, 2021, ANN RHEUM DIS, V80, P272, DOI 10.1136/annrheumdis-2020-218164; Mendelson M, 2021, LANCET, V398, P2211, DOI 10.1016/S0140-6736(21)02752-5; Mendez-Brito A, 2021, J INFECTION, V83, P281, DOI 10.1016/j.jinf.2021.06.018; Micah AE, 2021, LANCET, V398, P1317, DOI 10.1016/S0140-6736(21)01258-7; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Miller SL, 2021, INDOOR AIR, V31, P314, DOI 10.1111/ina.12751; Milton DK, 2020, J PEDIAT INF DIS SOC, V9, P413, DOI 10.1093/jpids/piaa079; Moayyedi P., 2022, EFFECTS VACCINATION; Moderna, 2021, MRNA STRAT COLL GOV; Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0; Mooney H, 2021, CARIBBEAN Q B FRAGIL; Morawska L, 2021, SCIENCE, V372, P689, DOI 10.1126/science.abg2025; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Morgan R, 2022, LANCET, V399, P2327, DOI 10.1016/S0140-6736(22)00278-1; Muehlschlegel PA, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.05008; Mulenga LB, 2021, LANCET GLOB HEALTH, V9, pE773, DOI 10.1016/S2214-109X(21)00053-X; Murhekar MV, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003877; Murray CJL, 2022, LANCET, V399, P417, DOI 10.1016/S0140-6736(22)00100-3; Nabavi N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3489; Nachega JB, 2021, AM J TROP MED HYG, V104, P1179, DOI 10.4269/ajtmh.21-0033; Nadeau SA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012008118; Nagaraj A, 2021, REUTERS 0505; Nahm JM, 2022, NATURE, V603, P28, DOI 10.1038/d41586-022-00540-6; National Bureau of Economic Research, 2021, US BUS CYCL EXP CONT; National Collaborating Centre for Methods and Tools, 2020, WHAT IS KNOWN IMP CO; National Collaborating Centre for Methods and Tools, 2022, RAP REV UPD 1 WHAT A; National Collaborating Centre for Methods and Tools, 2022, LIV RAP REV UPD 4 WH; National Collaborating Centre for Methods and Tools, 2021, LIV RAP REV UPD 16 W; National Intelligence Council, 2021, UPD ASS COVID 19 OR; Nebehay S., 2020, REUTERS 0203; Nelson JQ, 2020, FOX NEWS; Ng OW, 2017, HUM VACC IMMUNOTHER, V13, P186, DOI 10.1080/21645515.2016.1228500; Khanh NC, 2020, EMERG INFECT DIS, V26, P2617, DOI 10.3201/eid2611.203299; Nishiura H, 2022, J CLIN MED, V11, DOI 10.3390/jcm11010030; Nit Buntongyi, 2021, Public Health Pract (Oxf), V2, P100073, DOI 10.1016/j.puhip.2020.100073; Njoku A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189904; Nkuba AN, 2022, CLIN INFECT DIS, V74, P882, DOI 10.1093/cid/ciab515; Nuclear Threat Initiative Johns Hopkins Center for Health Security, 2019, GLOB HLTH SEC IND BU; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013574.pub2, 10.1002/14651858.CD013574]; Office for Health Improvement and Disparities, 2021, COVID 19 MENTAL HLTH; Okonjo-Iweala N, 2021, RETHINKING MULTILATE; Oliu-Barton M, 2021, LANCET, V397, P2234, DOI 10.1016/S0140-6736(21)00978-8; Organisation for Economic Co-operation and Development, 2021, TACKL MENT HLTH IMP; Organisation for Economic Co-operation and Development, 2021, HLTH GLANC; Organisation for Economic Co-operation and Development, 2021, RIS COVID 19 CRIS PO; Organisation for Economic Co-operation and Development, 2021, HLTH EXP; Organisation for Economic Co-operation and Development, 2020, AID DAC MEMB INCR 20; Organisation for Economic Co-operation and Development, 2021, NEW BENCHM MENT HLTH, DOI [10.1787/4ed890f6-en, DOI 10.1787/4ED890F6-EN]; Organisation for Economic Co-operation and Development, 2021, OECD GREEN REC DAT E; Organisation for Economic Co-operation and Development, 2020, FLATT COVID 19 PEAK; Organisation for Economic Co-operation and Development EU, 2020, HLTH GLANC EUR 2020, DOI [10.1787/82129230-en, DOI 10.1787/82129230-EN]; Organization WH., 2020, WHO DIR GEN OP REM M; Orru G, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9050575; Ou CY, 2022, BUILD ENVIRON, V207, DOI 10.1016/j.buildenv.2021.108414; Our world in data, COR COVID 19 VACC; Oxfam, 2022, 10 RICH MEN DOUBL TH; Oxford Economics, 2021, TOUR REL EMPL REP SE; Oxford University Economic Recovery Project, GLOB REC OBS; Paget J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020421; Paremoer L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n129; Parhizkar H, 2021, RISK ANAL, DOI 10.1111/risa.13844; Parmet WE, 2020, AM J PUBLIC HEALTH, V110, P945, DOI 10.2105/AJPH.2020.305721; Parthasarathi A, 2022, WELLCOME OPEN RES, V7, P17; Paskov M, 2012, RES SOC STRAT MOBIL, V30, P415, DOI 10.1016/j.rssm.2012.06.002; Pavli A, 2020, TRAVEL MED INFECT DI, V38, DOI 10.1016/j.tmaid.2020.101882; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pekar J, 2021, SCIENCE, V372, P412, DOI 10.1126/science.abf8003; Peretz PJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2022641; Perry HB, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-021-00755-5; Pew Research Centre, 2022, PUBL TRUST GOV 1958; Pieraccini M, 2020, LEGAL PERSPECTIVES ON SUSTAINABILITY, P1, DOI 10.1016/S2215-0366(20)30308-4; Piquero AR, 2021, J CRIM JUST, V74, DOI 10.1016/j.jcrimjus.2021.101806; Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128; Port JR, 2021, BIORXIV, DOI [10.1101/2021.07.26.453518, DOI 10.1101/2021.07.26.453518]; Power K, 2020, SUSTAINABILITY-SCI P, V16, P67, DOI 10.1080/15487733.2020.1776561; Pozzer A, 2020, CARDIOVASC RES, V116, P2247, DOI 10.1093/cvr/cvaa288; PRINCIPLE, HELP FIND TREATM COV; PRNewswire, 2013, PRNEWSWIRE 1002; Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057; Qian H, 2021, INDOOR AIR, V31, P639, DOI 10.1111/ina.12766; Qian H, 2018, J THORAC DIS, V10, pS2295, DOI 10.21037/jtd.2018.01.24; Ralli M, 2020, EUR REV MED PHARMACO, V24, P9765, DOI [10.26355/eurrev_202009_3071, 10.26355/eurrev_202009_23071]; Randall K, 2021, INTERFACE FOCUS, V11, DOI 10.1098/rsfs.2021.0049; Raut AP, 2021, AM J PUBLIC HEALTH, V111, P2100, DOI 10.2105/AJPH.2021.306544; Raveendran AV, 2021, DIABETES METAB SYND, V15, P869, DOI 10.1016/j.dsx.2021.04.007; Regmi K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084274; Reuters, REUTERS; Reuters Staff, 2020, REUTERS 0124; Reuters Staff, 2020, REUTERS 0609; Rhoads SA, 2021, PSYCHOL SCI, V32, P1247, DOI 10.1177/0956797621994767; Ricard J, 2020, HARVARD KENNEDY SCH, DOI 10.37016/mr-2020-013; Risko N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240503; Roberts DL, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009620; Robinson E, 2022, J AFFECT DISORDERS, V296, P567, DOI 10.1016/j.jad.2021.09.098; Rocha ICN, 2021, AM J TROP MED HYG, V105, P868, DOI 10.4269/ajtmh.21-0601; Rogers K, 2020, NY TIMES 0707; Rothstein B, 2005, WORLD POLIT, V58, P41, DOI 10.1353/wp.2006.0022; Thuluva S, 2022, medRxiv, DOI 10.1101/2022.03.20.22271891; Sachs J, 2022, FINANCING JOINT IMPL; Sachs J, 2020, LANCET, V396, P1102, DOI 10.1016/S0140-6736(20)31927-9; Sachs JD, 2021, ASIAN ECON PAP, V20, P30, DOI 10.1162/asep_a_00795; Sachs JD, 2021, LANCET, V397, P947, DOI 10.1016/S0140-6736(21)00388-3; Sachs JD, 2020, LANCET, V396, P454, DOI 10.1016/S0140-6736(20)31494-X; Sagan A, 2021, HLTH SYSTEMS RESILIE; Sandler T, 2020, PEACE ECON PEACE SCI, V26, DOI 10.1515/peps-2020-0023; Sangeetha K, 2019, THESIS U TEXAS AUSTI; Santamaria-Garcia H, 2022, HUM SOC SCI COMMUN, V9, DOI 10.1057/s41599-021-01022-2; Santarpia JL, 2022, J EXPO SCI ENV EPID, V32, P706, DOI 10.1038/s41370-021-00376-8; Santomauro DF, 2021, LANCET, V398, P1700, DOI 10.1016/S0140-6736(21)02143-7; Saxena Saket, 2021, Cleve Clin J Med, DOI 10.3949/ccjm.88a.ccc080; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; Scientific Advisory Group for Emergencies, 2021, SPI B SUST BEH RED S; Sen P, 2021, NATURE, V598, P338, DOI 10.1038/s41586-021-03914-4; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sepulveda J, 2021, US RESPONSE COVID 19; Shah H, 2021, ACTA DIABETOL, V58, P831, DOI 10.1007/s00592-020-01636-z; Shear MD, 2020, NY TIMES 0407; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Shiraef MA, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05482-7; Shuren J, 2021, HLTH AFFAIRS 0525, DOI [10.1377/forefront.20210521.255232, DOI 10.1377/FOREFRONT.20210521.255232]; Siddalingaiah SV, 2021, C RES SERVICE; Silver A, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o994; Silver A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2756; Sim D, 2020, S CHINA MORNING POST; Sims KM, 2021, AM J PUBLIC HEALTH, V111, P1534, DOI 10.2105/AJPH.2021.306352; Singh S, 2020, INTERNET PLATFORMS A; Singh S, 2021, LANCET, V398, P2109, DOI 10.1016/S0140-6736(21)01897-3; Sivan M, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj.o988; Solinas-Saunders M, 2020, AM REV PUBLIC ADM, V50, P713, DOI 10.1177/0275074020942408; South Carolina Department of Health and Environmental Control, DANG US HYDR IV PREV; Speake H, 2020, EMERG INFECT DIS, V26, P2872, DOI 10.3201/eid2612.203910; Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178; Srivastava S, 2021, BLOOMBERG 1201; Stefano GB, 2021, MED SCI MONITOR, V27, DOI 10.12659/MSM.931447; Stevens L, 2021, GALLUP BLOG 1217; Stevis-Gridneff M, 2021, NY TIMES 0609; Su ZH, 2022, NURS OUTLOOK, V70, P89, DOI 10.1016/j.outlook.2021.08.004; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; Summers J, 2020, NPR 1002; Sun Y, 2021, MEDRXIV, DOI [10.1101/2021.05.10.21256920(preprint, DOI 10.1101/2021.05.10.21256920(PREPRINT]; Tagliabue Fabio, 2020, SN Compr Clin Med, V2, P1287, DOI 10.1007/s42399-020-00439-1; Tang JW, 2021, J HOSP INFECT, V115, P131, DOI 10.1016/j.jhin.2021.05.007; Tang JW, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n913; Tang V, 2021, GENDER EQUALITY COVI; Tangkitvanich P, 2021, ASIAN ECON PAP, V20, P175, DOI 10.1162/asep_a_00799; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Thakur B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88130-w; The Global Fund, 2021, RES REP 2021; The Global Fund, OUR RESP COVID 19; The Independent Panel for Pandemic Preparedness & Response, 2021, COVID 19 MAK IT LAST; The Lancet COVID-19 Commission Global Health Diplomacy Task Force, 2021, GLOB DIPL COOP PAND; The Lancet COVID-19 Commission India Task Force, 2021, REOP SCH COVID 19 CL; The Lancet COVID-19 Commission Regional Task Force: Latin America and the Caribbean, 2021, REG COORD STRENGTH P; The Lancet COVID-19 Commission Task Force on Safe Work Safe School and Safe Travel, 2021, BUILD REL RISK FACT; The Lancet COVID-19 Commission Task Force on Safe Work Safe School and Safe Travel, LANCET; The Lancet COVID-19 Commissioners and Commission Secretariat, 2021, STAT OCC G20 LEAD SU; The Royal Society, 2020, REPR NUMB R GROWTH R; The World Bank, 2021, URG EFF ACT REQ QUEI; The World Bank, 2022, WORLD BANK GROUPS OP; The World Bank, GDP GROWTH ANN IND; The World Bank, 2022, DEBT SERV SUSP IN; Thiagarajan K, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1124; Thunstrom L, 2020, J BENEFIT-COST ANAL, V11, P179, DOI 10.1017/bca.2020.12; Tso FY, 2021, INT J INFECT DIS, V102, P577, DOI 10.1016/j.ijid.2020.10.104; UK Health Security Agency COVID-19 Evidence Team, 2022, EFF VACC LONG COVID; UN, 2021, OUR COMM AG REP SECR; UN, 2020, UN NEWS 0123; UN, 2020, GLOB HLTH FOR POL ST; UN, 2022, SECR GEN REM GEN ASS; UN High Commissioner for Refugees, 2020, 1 PERC HUM DISPL UNH; UN Population Fund, 2020, IMPACT COVID 19 PAND; UN Women, 2020, ADDR EC FALL COVID 1; UN Women, 2020, COVID 19 EM GEND DAT; UNAIDS, GLOB HIV AIDS STAT F; UNDP, 2020, POL BRIEF ED COV 19; UNESCO, 2020, 1 3 BILL LEARN AR ST; UNESCO, 2021, UNESCO SCI REPORT RA; UNESCO, 2019, LEARN POV; UNICEF, 2021, NUTR CRIS LOOMS MOR; UNICEF, 2021, ENG COMM ENS SAF WEL; UNICEF, 2022, WHO COR COVID 19 DAS; United Nations Children's Fund World Health Organization World Bank Group, 2021, LEVELS TRENDS CHILD; United States Trade Representative, 2021, COMMUNICATION 0505; Universidad de Antioquia McMaster University COVID-END, 2022, COVID 19 LIV EV SYNT; Unnithan S., 2021, INDIA TODAY 0501; US Census Bureau, 2021, TRACK JOB LOSS MOTH; Usher AD, 2021, LANCET, V397, P2322, DOI 10.1016/S0140-6736(21)01367-2; Usuf E, 2021, LANCET GLOB HEALTH, V9, pE724, DOI 10.1016/S2214-109X(21)00092-9; van Der Linden S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566790; van Helden J, 2021, LANCET, V398, P1402, DOI 10.1016/S0140-6736(21)02019-5; von Tigerstrom B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002629; Vyas M, 2020, INDIAN J LABOUR ECON, V63, P73, DOI 10.1007/s41027-020-00259-w; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Walsh KA, 2022, REV MED VIROL, V32, DOI 10.1002/rmv.2285; Walton H, 2021, INVESTIGATING LINKS; Wang MM, 2021, HEALTH ECON REV, V11, DOI 10.1186/s13561-021-00319-x; Wang XY, 2022, J ASSOC INF SCI TECH, V73, P726, DOI 10.1002/asi.24576; Wardeh M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21034-5; Weiland N, 2020, NY TIMES 0328; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; Wells WF, 1942, AM J HYG, V35, P97, DOI 10.1093/oxfordjournals.aje.a118789; WHO, 2020, PULSE SURVEY CONTINU; WHO, 2021, CLIN CAS DEF POSTCOV; WHO, 2020, ADV US MASKS CONT CO; WHO, 2020, WHO COR COVID 19 DAS; WHO, INT CLIN TRIALS REG; WHO, 2020, LEAST 80 MILL CHILDR; WHO, 2022, STRAT ACH GLOB COVID; WHO, 2005, INT HLTH REG, V3rd; WHO, 2019, DEL WOM LED MEN GEND; WHO, 2022, JOINT STAT PRIOR MON; WHO, 2017, AS PAC EM DIS PUBL H; WHO, ONE HEALTH-AMSTERDAM; WHO, 2021, WORLD HLTH ASS AGR L; WHO, 2020, MISS SUMM WHO FIELD; WHO, 2020, UPD WHO ADV INT TRAF; WHO, 2021, MOR MAL CAS DEATHS 2; WHO, 2020, WHO ADV INT TRAV TRA; WHO, 2020, COVID 19 CHIN; WHO, 2022, 2 YEARS WE COULD BE; Wolfe D, 2020, THE CNN; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Women in Global Health, 2021, FIT WOM SAF DEC PPE; Women in Informal Employment: Globalizing and Organizing, 2021, COVID 19 INF EC ROUN; World Health Organization, 2020, UPD WHO REC INT TRAF; World Health Organization, 2021, WHOS WORK HLTH EM ST; World Health Organization, 2020, GUIDING PRINCIPLES I; World Health Organization (WHO), 2019, TUBERCULOSIS; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Wu YR, 2021, STEM CELL RES, V50, DOI 10.1016/j.scr.2020.102115; Wu ZQ, 2021, LANCET, V398, P1299, DOI 10.1016/S0140-6736(21)02020-1; Wuppertal Institute, E3G; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xiao X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91470-2; Xu W, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.10004; Yao Y, 2020, ENVIRON RES, V189, DOI 10.1016/j.envres.2020.109941; Yong SJ, 2021, INFECT DIS-NOR, V53, P737, DOI 10.1080/23744235.2021.1924397; YouGov, YOUGOV COVID 19 BEH; Yu XY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00759-3; Zerhouni E, 2019, CELL, V179, P13, DOI 10.1016/j.cell.2019.08.026; Zhang Y, 2022, AM J CRIM JUSTICE, V47, P441, DOI 10.1007/s12103-020-09602-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zimmerman KO, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-048090	489	9	9	59	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2022	400	10359					1224	1280		10.1016/S0140-6736(22)01585-9	http://dx.doi.org/10.1016/S0140-6736(22)01585-9			57	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5Q7FC	36115368	Green Published, Bronze			2022-12-28	WOS:000873991600024
J	Gross, ND; Miller, DM; Khushalani, NI; Divi, V; Ruiz, ES; Lipson, EJ; Meier, F; Su, YB; Swiecicki, PL; Atlas, J; Geiger, JL; Hauschild, A; Choe, JH; Hughes, BGM; Schadendorf, D; Patel, VA; Homsi, J; Taube, JM; Lim, AM; Ferrarotto, R; Kaufman, HL; Seebach, F; Lowy, I; Yoo, SY; Mathias, M; Fenech, K; Han, H; Fury, MG; Rischin, D				Gross, N. D.; Miller, D. M.; Khushalani, N., I; Divi, V; Ruiz, E. S.; Lipson, E. J.; Meier, F.; Su, Y. B.; Swiecicki, P. L.; Atlas, J.; Geiger, J. L.; Hauschild, A.; Choe, J. H.; Hughes, B. G. M.; Schadendorf, D.; Patel, V. A.; Homsi, J.; Taube, J. M.; Lim, A. M.; Ferrarotto, R.; Kaufman, H. L.; Seebach, F.; Lowy, I; Yoo, S-Y; Mathias, M.; Fenech, K.; Han, H.; Fury, M. G.; Rischin, D.			Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Early Access							IMMUNOTHERAPY; HEAD	BACKGROUND In a pilot study involving patients with cutaneous squamous-cell carcinoma, a high percentage of patients had a pathological complete response with the use of two doses of neoadjuvant cemiplimab before surgery. Data from a phase 2 study are needed to confirm these findings. METHODS We conducted a phase 2, confirmatory, multicenter, nonrandomized study to evaluate cemiplimab as neoadjuvant therapy in patients with resectable stage II, III, or IV (M0) cutaneous squamous-cell carcinoma. Patients received cemiplimab, administered at a dose of 350 mg every 3 weeks for up to four doses, before undergoing surgery with curative intent. The primary end point was a pathological complete response (the absence of viable tumor cells in the surgical specimen) on independent review at a central laboratory, with a null hypothesis that a pathological complete response would be observed in 25% of patients. Key secondary end points included a pathological major response (the presence of viable tumor cells that constitute <= 10% of the surgical specimen) on independent review, a pathological complete response and a pathological major response on investigator assessment at a local laboratory, an objective response on imaging, and adverse events. RESULTS A total of 79 patients were enrolled and received neoadjuvant cemiplimab. On independent review, a pathological complete response was observed in 40 patients (51%; 95% confidence interval [CI], 39 to 62) and a pathological major response in 10 patients (13%; 95% CI, 6 to 22). These results were consistent with the pathological responses determined on investigator assessment. An objective response on imaging was observed in 54 patients (68%; 95% CI, 57 to 78). Adverse events of any grade that occurred during the study period, regardless of whether they were attributed to the study treatment, were observed in 69 patients (87%). Grade 3 or higher adverse events that occurred during the study period were observed in 14 patients (18%). CONCLUSIONS Neoadjuvant therapy with cemiplimab was associated with a pathological complete response in a high percentage of patients with resectable cutaneous squamous-cell carcinoma. (Funded by Regeneron Pharmaceuticals and Sanofi; ClinicalTrials.gov number, .)	[Gross, N. D.] MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Ferrarotto, R.] MD Anderson Canc Ctr, Dept Thorac & Head & Neck Med Oncol, Houston, TX 77030 USA; [Homsi, J.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX USA; [Miller, D. M.] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Boston, MA USA; [Miller, D. M.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kaufman, H. L.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Ruiz, E. S.] Harvard Med Sch, Boston, MA 02115 USA; [Ruiz, E. S.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA; [Khushalani, N., I] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Divi, V] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford Canc Inst, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA USA; [Lipson, E. J.; Taube, J. M.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA; [Lipson, E. J.; Taube, J. M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Taube, J. M.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Meier, F.] Univ Canc Ctr, Skin Canc Ctr, Dresden, Germany; [Meier, F.] Univ Hosp Carl Gustav Carus, Natl Ctr Tumor Dis Dresden, Dept Dermatol, Dresden, Germany; [Meier, F.] Tech Univ Dresden, Dresden, Germany; [Hauschild, A.] Schleswig Holstein Univ Hosp, Dept Dermatol, Kiel, Germany; [Schadendorf, D.] Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Schadendorf, D.] German Canc Consortium, Partner Site Essen, Essen, Germany; [Su, Y. B.] Nebraska Canc Specialists, Head & Neck Med Oncol, Omaha, NE USA; [Swiecicki, P. L.] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA; [Atlas, J.] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA; [Choe, J. H.] Duke Canc Inst, Durham, NC USA; [Geiger, J. L.] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH USA; [Hughes, B. G. M.] Royal Brisbane & Womens Hosp, Dept Canc Care Serv, Brisbane, Qld, Australia; [Hughes, B. G. M.] Univ Queensland, Brisbane, Qld, Australia; [Lim, A. M.; Rischin, D.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; [Lim, A. M.; Rischin, D.] Univ Melbourne, Melbourne, Vic, Australia; [Patel, V. A.] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA; [Patel, V. A.] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Washington, DC USA; [Patel, V. A.] George Washington Univ, Sch Med & Hlth Sci, Dept Oncol, Washington, DC USA; [Seebach, F.; Lowy, I; Yoo, S-Y; Mathias, M.; Fenech, K.; Han, H.; Fury, M. G.] Regeneron Pharmaceut, Tarrytown, NY USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; H Lee Moffitt Cancer Center & Research Institute; Stanford Cancer Institute; Stanford University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Kiel; Schleswig Holstein University Hospital; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Michigan System; University of Michigan; Duke University; Cleveland Clinic Foundation; Royal Brisbane & Women's Hospital; University of Queensland; Peter Maccallum Cancer Center; University of Melbourne; George Washington University; George Washington University; George Washington University; Regeneron	Gross, ND (corresponding author), MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ngross@mdanderson.org		Hughes, Brett/0000-0002-1811-0537; Miller, David/0000-0001-9736-9119; Gross, Neil/0000-0002-9427-0743	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	We thank the patients, their families, and all staff members at the study sites who were involved in this study; and Atif Riaz, Ph.D., of Prime (Knutsford, United Kingdom) for medical-writing support, funded by Regeneron Pharmaceuticals.	Amin MB, 2017, AJCC CANC STAGING MA; Chabrillac E, 2022, EUR ARCH OTO-RHINO-L, V279, P2069, DOI 10.1007/s00405-021-06972-6; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Cottrell TR, 2018, ANN ONCOL, V29, P1853, DOI 10.1093/annonc/mdy218; D'heygere V, 2021, J PLAST RECONSTR AES, V74, P625, DOI 10.1016/j.bjps.2020.10.013; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferrarotto R, 2021, CLIN CANCER RES, V27, P4557, DOI 10.1158/1078-0432.CCR-21-0585; Forde PM, 2022, NEW ENGL J MED, V386, P1973, DOI 10.1056/NEJMoa2202170; Gerring RC, 2017, EYE, V31, P379, DOI 10.1038/eye.2016.218; Grob JJ, 2020, J CLIN ONCOL, V38, P2916, DOI 10.1200/JCO.19.03054; Gross ND, 2022, J CLIN ONCOL, V40; Institute for Health Metrics and Evaluation, GLOBAL BURDEN DIS 20; Jubran J, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-229940; Menzies AM, 2021, NAT MED, V27, P301, DOI 10.1038/s41591-020-01188-3; Migden MR, 2018, NEW ENGL J MED, V379, P341, DOI 10.1056/NEJMoa1805131; Migden MR, 2020, LANCET ONCOL, V21, P294, DOI 10.1016/S1470-2045(19)30728-4; Mukoyama N, 2020, J NEUROL SURG PART B, V81, P585, DOI 10.1055/s-0039-1694010; Nehal KS, 2018, NEW ENGL J MED, V379, P363, DOI 10.1056/NEJMra1708701; O'Sullivan BBJ, 2015, UICC MANUAL CLIN ONC, DOI [10.1002/9781119013143, DOI 10.1002/9781119013143]; Que SKT, 2018, J AM ACAD DERMATOL, V78, P249, DOI 10.1016/j.jaad.2017.08.058; Rischin D, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002757; Shalhout SZ, 2021, CURR ONCOL REP, V23, DOI 10.1007/s11912-021-01120-z; Sweeny L, 2014, OTOLARYNG HEAD NECK, V150, P610, DOI 10.1177/0194599814520686; Uprety D, 2020, J THORAC ONCOL, V15, P1281, DOI 10.1016/j.jtho.2020.05.020; Xu V, 2022, ENT-EAR NOSE THROAT, V101, P663, DOI 10.1177/0145561320980179	25	1	1	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMoa2209813	http://dx.doi.org/10.1056/NEJMoa2209813		SEP 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4M3SZ	36094839				2022-12-28	WOS:000853246600001
J	Bavli, I; Jones, DS				Bavli, Itai; Jones, David S.			Race Correction and the X-Ray Machine - The Controversy over Increased Radiation Doses for Black Americans in 1968	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bavli, Itai; Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Jones, David S.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Bavli, Itai] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	Harvard University; Harvard University; Harvard Medical School; University of British Columbia	Bavli, I (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.; Bavli, I (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.			Bavli, Itai/0000-0002-7323-0435; Jones, David/0000-0003-0039-7784				American Academy of Clinical Neuropsychology, 2021, POS STAT US RAC FACT; American College of Radiology, RAD DOS AD COMM IM E; [Anonymous], 1968, NEW YORK TIMES 0518; [Anonymous], 1968, RAD CONTROL HLTH S 2; [Anonymous], 1968, NEW YORK TIMES 0516, P26; [Anonymous], 1911, EVENING WORLD 0322, P14; [Anonymous], 1996, FINAL REPORT ADVISOR; Bhakta NR, 2022, CHEST, V161, P288, DOI 10.1016/j.chest.2021.08.053; Braun Lundy, 2014, BREATHING RACE MACHI, DOI DOI 10.5749/MINNESOTA/9780816683574.001.0001; DUMMETT CO, 1968, J AM DENT ASSOC, V77, P507, DOI 10.14219/jada.archive.1968.0284; Duster T., 2003, GENETIC NATURE CULTU, P273; Eneanya ND, 2019, JAMA-J AM MED ASSOC, V322, P113, DOI 10.1001/jama.2019.5774; Ettinger B, 1997, J CLIN ENDOCR METAB, V82, P429, DOI 10.1210/jc.82.2.429; Fawzy A, 2022, JAMA INTERN MED, V182, P730, DOI 10.1001/jamainternmed.2022.1906; Goodman AH., 2000, KROEBER ANTHR SOC PA, V84, P28; Graves JL., 2022, RACISM NOT RACE ANSW; GYSS E E, 1957, Xray Tech, V29, P76; Hammonds EM, 2008, NATURE OF DIFFERENCE: SCIENCES OF RACE IN THE UNITED STATES FROM JEFFERSON TO GENOMICS, P1; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Howell JD, 1995, TECHNOLOGY HOSP TRAN; Jacobi CA., 1964, XRAY TECHNOLOGY, V3rd; Jacobi CA, 1960, XRAY TECHNOLOGY, V2nd; Jipguep-Akhtar M, 2020, SOC FORCES, V98, DOI 10.1093/sf/soz162; Jones DS, 2021, ANN INTERN MED, V174, P1745, DOI 10.7326/M21-3804; Kahn J., 2012, RACE BOTTLE STORY BI; Lardner GJ, 1968, WASHINGTON POST 0516; Madden P, 2021, ABC NEWS 1202; Magio KN, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00022; Meschan I., 1959, ATLAS NORMAL RADIOGR; Meschan I., 1956, ROENTGEN SIGNS CLIN; Mintz M, 1968, WASHINGTON POST 0523; NADER C, 1975, HEALTH PHYS, V29, P181, DOI 10.1097/00004032-197507000-00023; National Center for Radiological Health, 1969, J NATL MED ASSOC, V61, P282; Owens Deirdre Cooper, 2017, MED BONDAGE RACE GEN; Perlman D, 1968, SAN FRANCISCO CHRONI, P2; Reverby SM, 2009, JOHN HOPE FRANK SER, P1; Roberts Dorothy E., 2011, FATAL INVENTION SCI; Shapiro R., 1960, NORMAL SKULL ROENTGE; Tirak LM, 2021, RIJKSMUS BULL, V69, P27; Tirak LM, 2016, THESIS WILLIAM MARY; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Waitz T., 1863, INTRO ANTHR; Washington H. A., 2006, DOUBLEDAY	43	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10					947	952		10.1056/NEJMms2206281	http://dx.doi.org/10.1056/NEJMms2206281			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069880	Bronze			2022-12-28	WOS:000861634500020
J	Larkin, HD				Larkin, Howard D.			FDA Warns Against Certain UV Disinfection Wands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2022	328	9					819	820						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P1QZ	36066534				2022-12-28	WOS:000855171700011
J	Devi, S				Devi, Sharmila			Condemnation after Palestinian NGOs closed Several groups, including the Palestinian Health Work Committees, have been shut down by Israeli authorities. Sharmila Devi reports	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 3	2022	400	10354					721	721						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4W9OJ	36058213				2022-12-28	WOS:000860483700008
J	Hain, D; Gallego-Flores, T; Klinkmann, M; Macias, A; Ciirdaeva, E; Arends, A; Thum, C; Tushev, G; Kretschmer, F; Tosches, MA; Laurent, G				Hain, David; Gallego-Flores, Tatiana; Klinkmann, Michaela; Macias, Angeles; Ciirdaeva, Elena; Arends, Anja; Thum, Christina; Tushev, Georgi; Kretschmer, Friedrich; Tosches, Maria Antonietta; Laurent, Gilles			Molecular diversity and evolution of neuron types in the amniote brain	SCIENCE			English	Article							LIZARD PODARCIS-HISPANICA; THALAMIC NUCLEUS; DORSAL THALAMUS; TELENCEPHALON; ORGANIZATION; AFFERENT; RECEPTOR; IDENTIFICATION; CONSERVATION; ARCHITECTURE	The existence of evolutionarily conserved regions in the vertebrate brain is well established. The rules and constraints underlying the evolution of neuron types, however, remain poorly understood. To compare neuron types across brain regions and species, we generated a cell type atlas of the brain of a bearded dragon and compared it with mouse datasets. Conserved classes of neurons could be identified from the expression of hundreds of genes, including homeodomain-type transcription factors and genes involved in connectivity. Within these classes, however, there are both conserved and divergent neuron types, precluding a simple categorization of the brain into ancestral and novel areas. In the thalamus, neuronal diversification correlates with the evolution of the cortex, suggesting that developmental origin and circuit allocation are drivers of neuronal identity and evolution.	[Hain, David; Gallego-Flores, Tatiana; Klinkmann, Michaela; Macias, Angeles; Ciirdaeva, Elena; Arends, Anja; Thum, Christina; Tushev, Georgi; Kretschmer, Friedrich; Tosches, Maria Antonietta; Laurent, Gilles] Max Planck Inst Brain Res, Frankfurt, Germany; [Hain, David; Gallego-Flores, Tatiana] Goethe Univ, Fac Biol Sci, Frankfurt, Germany; [Tosches, Maria Antonietta] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Max Planck Society; Goethe University Frankfurt; Columbia University	Hain, D; Gallego-Flores, T; Tosches, MA; Laurent, G (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.; Hain, D; Gallego-Flores, T (corresponding author), Goethe Univ, Fac Biol Sci, Frankfurt, Germany.; Tosches, MA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	david.hain@brain.mpg.de; maria-tatiana.gallego-flores@brain.mpg.de; mt3353@columbia.edu; gilles.laurent@brain.mpg.de		Gallego, Tatiana/0000-0003-0773-0578	Max Planck Society; European Research Council (ERC) under the European Union [834446]; McKnight Foundation; National Institutes of Health [NHGRI RM1 HG011014]; International Max Planck Research School for Neural Circuits; DFG-CRC [1080]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council (ERC) under the European Union(European Research Council (ERC)); McKnight Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Max Planck Research School for Neural Circuits; DFG-CRC	This work was funded by the Max Planck Society (G.L.), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant 834446) (G.L.), the DFG-CRC 1080 (G.L.), the McKnight Foundation (M.A.T.), National Institutes of Health grant NHGRI RM1 HG011014 (M.A.T.), and the International Max Planck Research School for Neural Circuits (D.H.).	Aruga J, 1998, J NEUROSCI, V18, P284; Bachy I, 2002, MECH DEVELOP, V117, P163, DOI 10.1016/S0925-4773(02)00199-5; Bakken TE, 2021, NATURE, V598, P111, DOI 10.1038/s41586-021-03465-8; BRUCE LL, 1984, J COMP NEUROL, V229, P585, DOI 10.1002/cne.902290411; BUTLER AB, 1994, BRAIN RES REV, V19, P29, DOI 10.1016/0165-0173(94)90003-5; Butler Ann B., 2008, Thalamus & Related Systems, V4, P35, DOI 10.1017/S1472928808000356; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; Colquitt BM, 2021, SCIENCE, V371, P695, DOI 10.1126/science.abd9704; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Davila JC, 2002, EUR J NEUROSCI, V16, P267, DOI 10.1046/j.1460-9568.2002.02091.x; Desfilis E, 2002, BRAIN RES BULL, V57, P447, DOI 10.1016/S0361-9230(01)00727-4; Desfilis E, 2018, J COMP NEUROL, V526, P166, DOI 10.1002/cne.24329; DIAZ C, 1994, J COMP NEUROL, V343, P193, DOI 10.1002/cne.903430202; Font C, 1997, J COMP NEUROL, V383, P489; FOSTER RE, 1978, J COMP NEUROL, V178, P783, DOI 10.1002/cne.901780412; Freudenmacher L, 2020, J COMP NEUROL, V528, P705, DOI 10.1002/cne.24777; Gobron S, 1999, NEUROSCIENCE, V88, P655, DOI 10.1016/S0306-4522(98)00252-8; Hain D, 2022, M PLANCK COMPUTING D, DOI [10.17617/1.91, DOI 10.17617/1.91]; Halley AC, 2019, CURR OPIN NEUROBIOL, V56, P78, DOI 10.1016/j.conb.2018.12.003; Heredia R, 2002, BRAIN RES BULL, V57, P443, DOI 10.1016/S0361-9230(01)00712-2; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Katz PS, 2016, CURR OPIN NEUROBIOL, V41, P8, DOI 10.1016/j.conb.2016.07.004; Kebschull JM, 2020, SCIENCE, V370, DOI 10.1126/science.abd5059; Kenigfest N, 2005, J CHEM NEUROANAT, V30, P129, DOI 10.1016/j.jchemneu.2005.07.001; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Kumamoto T, 2017, DEV GROWTH DIFFER, V59, P258, DOI 10.1111/dgd.12367; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leung RF, 2022, FRONT NEUROSCI-SWITZ, V16, DOI 10.3389/fnins.2022.843794; Li YQ, 2020, NATURE, V583, P819, DOI 10.1038/s41586-020-2504-5; Love CE, 2012, DEV DYNAM, V241, P1603, DOI 10.1002/dvdy.23838; Nagalski A, 2016, BRAIN STRUCT FUNCT, V221, P2493, DOI 10.1007/s00429-015-1052-5; Nieuwenhuys R., 2016, NEW NEUROMORPHOLOGY, DOI 10.1007/978-3-319-25693-1; Nieuwenhuys R., 2016, NEW NEUROMORPHOLOGY, P273; Nieuwenhuys R, 2017, BRAIN BEHAV EVOLUT, V90, P117, DOI 10.1159/000460237; Norimoto H, 2020, NATURE, V578, P413, DOI 10.1038/s41586-020-1993-6; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Phillips JW, 2019, NAT NEUROSCI, V22, P1925, DOI 10.1038/s41593-019-0483-3; PRITZ MB, 1990, BRAIN RES, V525, P330, DOI 10.1016/0006-8993(90)90885-F; PRITZ MB, 1994, BRAIN BEHAV EVOLUT, V43, P107, DOI 10.1159/000113628; Pritz MB, 2021, J COMP NEUROL, V529, P3785, DOI 10.1002/cne.25194; Puelles L, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P187, DOI 10.1016/B978-0-12-397265-1.00118-0; Puelles L, 2001, PHILOS T R SOC B, V356, P1583, DOI 10.1098/rstb.2001.0973; Puelles L, 2013, TRENDS NEUROSCI, V36, P570, DOI 10.1016/j.tins.2013.06.004; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; Rueda-Alana E, 2022, BRAIN BEHAV EVOLUT, V97, P33, DOI 10.1159/000519068; Sarropoulos I, 2021, SCIENCE, V373, P983, DOI 10.1126/science.abg4696; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Shafer MER, 2022, NAT ECOL EVOL, V6, P63, DOI 10.1038/s41559-021-01580-3; Shein-Idelson M, 2016, SCIENCE, V352, P590, DOI 10.1126/science.aaf3621; Smith SJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47889; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suryanarayana SM, 2022, BRAIN BEHAV EVOLUT, V96, P318, DOI 10.1159/000517492; Tarashansky AJ, 2021, ELIFE, V10, DOI 10.7554/eLife.66747; Taylor SR, 2021, CELL, V184, P4329, DOI 10.1016/j.cell.2021.06.023; Tosches MA, 2021, ANNU REV CELL DEV BI, V37, P495, DOI 10.1146/annurev-cellbio-120319-112654; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Xie ZY, 2021, ELIFE, V10, DOI 10.7554/eLife.69825; YANES C, 1990, J COMP NEUROL, V295, P559, DOI 10.1002/cne.902950405; Yao ZZ, 2021, CELL, V184, P3222, DOI 10.1016/j.cell.2021.04.021; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	67	3	3	2	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1060	+	eabp8202	10.1126/science.abp8202	http://dx.doi.org/10.1126/science.abp8202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048944				2022-12-28	WOS:000887933200002
J	Ravindran, S				Ravindran, Sandeep			FIVE WAYS DEEP LEARNING HAS TRANSFORMED IMAGE ANALYSIS	NATURE			English	Editorial Material																		Shapson-Coe A, 2021, bioRxiv, DOI 10.1101/2021.05.29.446289; Bai B, BMEF FRONT; Greenwald NF, 2022, NAT BIOTECHNOL, V40, P555, DOI 10.1038/s41587-021-01094-0; Lauer J, 2022, NAT METHODS, V19, DOI 10.1038/s41592-022-01443-0; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Ouyang W, 2019, NAT METHODS, V16, P1254, DOI 10.1038/s41592-019-0658-6; Rivenson Y, 2019, NAT BIOMED ENG, V3, P466, DOI 10.1038/s41551-019-0362-y; Sullivan DP, 2018, NAT BIOTECHNOL, V36, P820, DOI 10.1038/nbt.4225; von Chamier L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22518-0	9	2	2	27	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2022	609	7928					864	866						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Q0SA	36127440	hybrid			2022-12-28	WOS:000855795500011
J	Chen, AH; Ghaly, MA				Chen, Alice Hm; Ghaly, Mark A.			Medicaid as a Driver of Health Equity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chen, Alice Hm] Covered Calif, 7677 Oakport St,Ste 800, Sacramento, CA 94621 USA; [Chen, Alice Hm] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ghaly, Mark A.] Calif Hlth & Human Serv Agcy, Sacramento, CA USA	University of California System; University of California San Francisco; California Health & Human Services Agency	Chen, AH (corresponding author), Covered Calif, 7677 Oakport St,Ste 800, Sacramento, CA 94621 USA.	alice.chen@covered.ca.gov						Agarwal SD, 2020, NEW ENGL J MED, V383, P1603, DOI 10.1056/NEJMp2023312; Agrawal S., 2022, HLTH AFFAIRS FOREFRO, DOI [10.1377/forefront.20220628.771279, DOI 10.1377/FOREFRONT.20220628.771279]; Bailit Health, MEDICAID MANAGED CAR; Brooks-LaSure C., HEALTHAFFAIRS; Buettgens M., 37 MILLION PEOPLE WO; California Department of Health Care Services, TRANSF MED MAN CAR T; California Department of Health Care Services, CALAIM; California Department of Health Care Services, DEP HLTH CAR SERV CO; Donohue JM, 2022, JAMA-J AM MED ASSOC, V328, P1085, DOI 10.1001/jama.2022.14791; Guth M., MEDICAID RACIAL HLTH; Lee A., NATL UNINSURED RATE; Medicaid and CHIP Payment and Access Commission, FED LEG MIL MED CHIP; Migration Policy Institute, PROF UN POP CAL; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; Yee A., 2021, SCI AM, V6	15	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2022	328	11					1051	1052		10.1001/jama.2022.14911	http://dx.doi.org/10.1001/jama.2022.14911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A5DY	36125484				2022-12-28	WOS:000862909200018
J	Brusselle, GG; Humbert, M				Brusselle, Guy G.; Humbert, Marc			Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPD	LANCET			English	Editorial Material									[Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands; [Humbert, Marc] Univ Paris Saclay, Serv Pneumol & Soins Intensifs Resp, INSERM UMR S 999, Hop Bicetre,Assistance Publ Hop Paris, Le Kremlin Bicetre, France	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Brusselle, GG (corresponding author), Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium.; Brusselle, GG (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Brusselle, GG (corresponding author), Erasmus MC, Dept Resp Med, Rotterdam, Netherlands.	guy.brusselle@ugent.be						Agusti A, 2019, NEW ENGL J MED, V381, P1248, DOI 10.1056/NEJMra1900475; Brusselle GG, 2022, NEW ENGL J MED, V386, P157, DOI 10.1056/NEJMra2032506; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis m. and Prevention of CHRONIC obstructive Pulmonary Disease, 2020, PNEUMOLOGIE; Hoffmann B, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.1604465; Humbert Marc, 2022, Eur Respir J, DOI 10.1183/13993003.00879-2022; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Martinez FJ, 2022, AM J RESP CRIT CARE, V205, P275, DOI 10.1164/rccm.202107-1663SO; Safiri Saeid, 2022, BMJ, V378, pe069679, DOI 10.1136/bmj-2021-069679; Stolz D, 2022, LANCET, V400, P921, DOI 10.1016/S0140-6736(22)01273-9	11	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2022	400	10356					869	871		10.1016/S0140-6736(22)01660-9	http://dx.doi.org/10.1016/S0140-6736(22)01660-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	6O3YZ	36075257				2022-12-28	WOS:000890180700005
J	Trinajstic, K; Long, JA; Sanchez, S; Boisvert, CA; Snitting, D; Tafforeau, P; Dupret, V; Clement, AM; Currie, PD; Roelofs, B; Bevitt, JJ; Lee, MSY; Ahlberg, PE				Trinajstic, Kate; Long, John A.; Sanchez, Sophie; Boisvert, Catherine A.; Snitting, Daniel; Tafforeau, Paul; Dupret, Vincent; Clement, Alice M.; Currie, Peter D.; Roelofs, Brett; Bevitt, Joseph J.; Lee, Michael S. Y.; Ahlberg, Per E.			Exceptional preservation of organs in Devonian placoderms from the Gogo lagerstatte	SCIENCE			English	Article							EVOLUTION; LUNGS; FISH	The origin and early diversification of jawed vertebrates involved major changes to skeletal and soft anatomy. Skeletal transformations can be examined directly by studying fossil stem gnathostomes; however, preservation of soft anatomy is rare. We describe the only known example of a three-dimensionally mineralized heart, thick-walled stomach, and bilobed liver from arthrodire placoderms, stem gnathostomes from the Late Devonian Gogo Formation in Western Australia. The application of synchrotron and neutron microtomography to this material shows evidence of a flat S-shaped heart, which is well separated from the liver and other abdominal organs, and the absence of lungs. Arthrodires thus show the earliest phylogenetic evidence for repositioning of the gnathostome heart associated with the evolution of the complex neck region in jawed vertebrates.	[Trinajstic, Kate; Boisvert, Catherine A.; Roelofs, Brett] Curtin Univ, Sch Mol & Life Sci, Bentley, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Welshpool, WA 6106, Australia; [Long, John A.; Clement, Alice M.; Lee, Michael S. Y.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA 5001, Australia; [Long, John A.] Museum Victoria, Melbourne, Vic 3001, Australia; [Sanchez, Sophie; Snitting, Daniel; Dupret, Vincent; Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38000 Grenoble, France; [Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Currie, Peter D.] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia; [Bevitt, Joseph J.] Australian Nucl Sci & Technol Org ANSTO, Lucas Heights, NSW 2234, Australia; [Lee, Michael S. Y.] South Australian Museum, Earth Sci Sect, Adelaide, SA 5000, Australia	Curtin University; Western Australian Museum; Flinders University South Australia; Museum Victoria; Uppsala University; European Synchrotron Radiation Facility (ESRF); Australian Regenerative Medicine Institute; Monash University; European Molecular Biology Laboratory (EMBL); Monash University; Australian Nuclear Science & Technology Organisation; South Australian Museum	Trinajstic, K (corresponding author), Curtin Univ, Sch Mol & Life Sci, Bentley, WA 6102, Australia.; Trinajstic, K (corresponding author), Western Australian Museum, Welshpool, WA 6106, Australia.	k.trinajstic@curtin.edu.au	; Dupret, Vincent/L-2306-2015	Sanchez, Sophie/0000-0002-3611-6836; Long, John/0000-0001-8012-0114; Dupret, Vincent/0000-0002-6859-1041	Australian Research Council [DP1092870, ARC-DP140104161, DP1096002, ARC-DP110101127, ARC-DP200103219]; European Research Council [233111]; Knut and Alice Wallenberg Foundation; European Synchrotron proposal [EC-203]; Australian Neutron [P5203]	Australian Research Council(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Synchrotron proposal; Australian Neutron	Supported by Australian Research Council grants DP1092870 and ARC-DP140104161 (J.A.L., K.T.), DP1096002 (C.A.B., P.D.C.), ARC-DP110101127 (K.T.), and ARC-DP200103219 (P.D.C., K.T.); European Research Council Advanced Investigator grant 233111 (P.E.A., V.D., S.S.); the Knut and Alice Wallenberg Foundation (P.E.A.); European Synchrotron proposal EC-203 (P.E.A., S.S., K.T.); and Australian Neutron proposal P5203 (A.M.C., J.A.L., K.T.).	Adachi N, 2018, ZOOL LETT, V4, DOI 10.1186/s40851-018-0087-x; Arsenault M., 2004, RECENT ADV ORIGIN EA, P439; Briggs DEG, 2011, J SYST PALAEONTOL, V9, P399, DOI 10.1080/14772019.2010.493050; DENISON ROBERT H., 1941, JOUR PALEONTOL, V15, P553; Ericsson R, 2013, J ANAT, V222, P67, DOI 10.1111/j.1469-7580.2012.01530.x; Frey L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01394-2; Gabbott SE, 2021, PALAEONTOLOGY, V64, P789, DOI 10.1111/pala.12571; Goujet D, 2011, CR PALEVOL, V10, P323, DOI 10.1016/j.crpv.2011.03.008; Heude E, 2018, ELIFE, V7, DOI 10.7554/eLife.40179; Higashiyama H, 2016, J MORPHOL, V277, P1146, DOI 10.1002/jmor.20563; JANVIER P, 1991, J ZOOL, V223, P567, DOI 10.1111/j.1469-7998.1991.tb04388.x; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2007, J VERTEBR PALEONTOL, V27, P709, DOI 10.1671/0272-4634(2007)27[709:NEFTCL]2.0.CO;2; King B, 2017, SYST BIOL, V66, P499, DOI 10.1093/sysbio/syw107; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Lopez SA, 2013, TROP CONSERV SCI, V6, P126, DOI 10.1177/194008291300600103; Maldanis L, 2016, ELIFE, V5, DOI 10.7554/eLife.14698; Tatsumi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30580; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Wang YJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4808; Wilby P.R., 1992, Historical Biology, V6, P25; Zhu YA, 2021, CURR BIOL, V31, P1112, DOI 10.1016/j.cub.2020.12.046	23	1	1	3	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2022	377	6612					1311	1314		10.1126/science.abf3289	http://dx.doi.org/10.1126/science.abf3289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ES	36107996				2022-12-28	WOS:000887933500038
J	Baranzini, SE; iMSMS Consortium				Baranzini, Sergio E.; iMSMS Consortium			Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course	CELL			English	Article							FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL BARRIER; METABOLIC PATHWAYS; METACYC DATABASE; EATING INDEX; IDENTIFICATION; BACTERIA; IMPACT; PROGRESSION; TRANSPORTER	Changes in gut microbiota have been associated with several diseases. Here, the International Multiple Scle-rosis Microbiome Study (iMSMS) studied the gut microbiome of 576 MS patients (36% untreated) and genet-ically unrelated household healthy controls (1,152 total subjects). We observed a significantly increased proportion of Akkermansia muciniphila, Ruthenibacterium lactatiformans, Hungatella hathewayi, and Eisen-bergiella tayi and decreased Faecalibacterium prausnitzii and Blautia species. The phytate degradation pathway was over-represented in untreated MS, while pyruvate-producing carbohydrate metabolism path-ways were significantly reduced. Microbiome composition, function, and derived metabolites also differed in response to disease-modifying treatments. The therapeutic activity of interferon-b may in part be associated with upregulation of short-chain fatty acid transporters. Distinct microbial networks were observed in un-treated MS and healthy controls. These results strongly support specific gut microbiome associations with MS risk, course and progression, and functional changes in response to treatment.				sergio.baranzini@ucsf.edu			Valhalla Foundation; Salah Foundation; UCSF Benioff Center for Microbiome Medicine; National MS Society USA [RFA-2104-37464]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy) [390857198]; Gemeinnatzige Hertie Stiftung; Bavarian association; national association of the German MS society (DMSG); Dr. Leopold And Carmen Ellinger Foundation; association "Verein zurTher-apieforschung far MS Kranke e.V."; National Institutes of Health and the Department of Defense; Race to Erase MS Early Investigator Award; NIH/NINDS award;  [R01NS087226];  [5R35NS111644]	Valhalla Foundation; Salah Foundation; UCSF Benioff Center for Microbiome Medicine; National MS Society USA(National Multiple Sclerosis Society); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy)(German Research Foundation (DFG)); Gemeinnatzige Hertie Stiftung; Bavarian association; national association of the German MS society (DMSG); Dr. Leopold And Carmen Ellinger Foundation; association "Verein zurTher-apieforschung far MS Kranke e.V."; National Institutes of Health and the Department of Defense; Race to Erase MS Early Investigator Award; NIH/NINDS award; ; 	Major funding for this work was provided by the Valhalla Foundation. This work was also supported by the Salah Foundation and the UCSF Benioff Center for Microbiome Medicine. R.H. and L.A.G. are supported by the National MS Society USA (RFA-2104-37464), Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy - ID 390857198), the Gemeinnatzige Hertie Stiftung, Bavarian association and national association of the German MS society (DMSG), Dr. Leopold And Carmen Ellinger Foundation, and the association "Verein zurTher-apieforschung far MS Kranke e.V."Z.X. has received research support from the National Institutes of Health and the Department of Defense. L.M.C. is supported by the Race to Erase MS Early Investigator Award. H.L.W. is supported by NIH/NINDS award R01NS087226. S.L.H. is supported by NIH/NINDS award 5R35NS111644. S.E.B. holds the Heidrich Family and Friends endowed chair in Neurology at UCSF. S.E.B. holds the Professorship in Neurology I at UCSF.	Amini ME, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.107024; Arabshahi S, 2011, J NUTR, V141, P1871, DOI 10.3945/jn.111.140822; Baranzini SE, 2017, TRENDS GENET, V33, P960, DOI 10.1016/j.tig.2017.09.004; Becken B, 2021, MBIO, V12, DOI 10.1128/mBio.00478-21; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Blacher E, 2019, NATURE, V572, P474, DOI 10.1038/s41586-019-1443-5; Block G., 2005, BLOCK ADULT QUESTION; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Camara-Lemarroy CR, 2018, WORLD J GASTROENTERO, V24, P4217, DOI 10.3748/wjg.v24.i37.4217; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Cani PD, 2014, NAT REV ENDOCRINOL, V10, P74, DOI 10.1038/nrendo.2013.240; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsson AH, 2013, SCAND J GASTROENTERO, V48, P1136, DOI 10.3109/00365521.2013.828773; Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Castillo-Alvarez F, 2021, NEUROLOGIA, V36, P495, DOI 10.1016/j.nrl.2018.04.006; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; CHAO A, 1984, SCAND J STAT, V11, P265; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Chen LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17840-y; Cheng J, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113214; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; Cox LM, 2021, ANN NEUROL, V89, P1195, DOI 10.1002/ana.26084; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Didion JP, 2017, PEERJ, V5, DOI 10.7717/peerj.3720; Duscha A, 2020, CELL, V180, P1067, DOI 10.1016/j.cell.2020.02.035; Enders M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051663; Espina MD, 2019, FEMS MICROBIOL REV, V43, P1, DOI 10.1093/femsre/fuy035; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Flandroy L, 2018, SCI TOTAL ENVIRON, V627, P1018, DOI 10.1016/j.scitotenv.2018.01.288; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Garcia-Ribera S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041063; Gaulke CA, 2018, NAT MED, V24, P1495, DOI 10.1038/s41591-018-0210-8; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; GOLDBERG P, 1986, MED HYPOTHESES, V21, P193, DOI 10.1016/0306-9877(86)90010-1; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Gonzalez-Uarquin F, 2020, POULTRY SCI, V99, P893, DOI 10.1016/j.psj.2019.10.014; Guo X, 2004, EUR J CLIN NUTR, V58, P1580, DOI 10.1038/sj.ejcn.1601989; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hatton GB, 2018, INT J PHARMACEUT, V548, P408, DOI 10.1016/j.ijpharm.2018.06.054; Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18; Himmelstein DS, 2017, ELIFE, V6, DOI 10.7554/eLife.26726; HOLM V, 1978, ARCH NEUROL-CHICAGO, V35, P478, DOI 10.1001/archneur.1978.00500310080018; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Kadowaki A, 2020, TRENDS NEUROSCI, V43, P622, DOI 10.1016/j.tins.2020.06.002; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karcher N, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02427-7; Kirmiz N, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02117-19; Kozhieva M, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1685-2; Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langer-Gould A, 2013, NEUROLOGY, V80, P1734, DOI 10.1212/WNL.0b013e3182918cc2; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Lazzarino G, 2017, MOL NEUROBIOL, V54, P7520, DOI 10.1007/s12035-016-0257-9; Leite AZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01107; Liu SR, 2019, CELL HOST MICROBE, V26, P779, DOI 10.1016/j.chom.2019.10.008; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Lopez-Almela I, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1865706; Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176; Louis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149564; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McMurdie PJ, 2022, BMC MICROBIOL, V22, DOI 10.1186/s12866-021-02415-8; Miller PG, 2015, J IMMUNOL, V195, P4668, DOI 10.4049/jimmunol.1501664; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2011, MULT SCLER J, V17, P1405, DOI 10.1177/1352458511425366; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; Nelson CA, 2021, LIFE-BASEL, V11, DOI 10.3390/life11010042; Nerurkar SN, 2020, CANCERS, V12, DOI 10.3390/cancers12092572; Olsson A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.661493; Ottoboni L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004186; Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Pintaudi B, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/9132052; Probstel AK, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc7191; Probstel AK, 2018, NEUROTHERAPEUTICS, V15, P126, DOI 10.1007/s13311-017-0587-y; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Reynders T, 2020, ANN CLIN TRANSL NEUR, V7, P406, DOI 10.1002/acn3.51004; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sand IK, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000517; Sanna A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010068; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Shannon CE, 1997, M D COMPUT, V14, P306; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shokrpour M, 2019, GYNECOL ENDOCRINOL, V35, P406, DOI 10.1080/09513590.2018.1540570; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Storm-Larsen C, 2019, MULT SCLER J-EXP TRA, V5, DOI 10.1177/2055217319888767; Takewaki D, 2020, P NATL ACAD SCI USA, V117, P22402, DOI 10.1073/pnas.2011703117; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Tasnim N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01935; Thingholm LB, 2019, CELL HOST MICROBE, V26, P252, DOI 10.1016/j.chom.2019.07.004; Thorpe MG, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0495-6; Villoslada Pablo, 2017, Neurol Neuroimmunol Neuroinflamm, V4, pe321, DOI 10.1212/NXI.0000000000000321; Vujkovic-Cvijin I, 2020, NATURE, V587, P448, DOI 10.1038/s41586-020-2881-9; Wang J, 2020, CELL, V183, P1264, DOI 10.1016/j.cell.2020.09.054; Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028; YOUNG GB, 1986, J NEUROL NEUROSUR PS, V49, P265, DOI 10.1136/jnnp.49.3.265; Zahoor I, 2021, CELL MOL LIFE SCI, V78, P3181, DOI 10.1007/s00018-020-03733-2; Ferreira KPZ, 2017, J NEUROL SCI, V373, P236, DOI 10.1016/j.jns.2016.12.039; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zeng Q, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104468; Zhang CY, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109043; Zhou XY, 2021, MULT SCLER J, V27, P366, DOI 10.1177/1352458520924594; Zhu QY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13443-4	123	4	4	17	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3467	+		10.1016/j.cell.2022.08.021	http://dx.doi.org/10.1016/j.cell.2022.08.021			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4Z5ET	36113426	Green Accepted			2022-12-28	WOS:000862232500004
J	Kreutzberger, MAB; Sonani, RR; Liu, JF; Chatterjee, S; Wang, FB; Sebastian, AL; Biswas, P; Ewing, C; Zheng, WL; Poly, F; Frankel, G; Luisi, BF; Calladine, CR; Krupovic, M; Scharf, BE; Egelman, EH				Kreutzberger, Mark A. B.; Sonani, Ravi R.; Liu, Junfeng; Chatterjee, Sharanya; Wang, Fengbin; Sebastian, Amanda L.; Biswas, Priyanka; Ewing, Cheryl; Zheng, Weili; Poly, Frederic; Frankel, Gad; Luisi, B. F.; Calladine, Chris R.; Krupovic, Mart; Scharf, Birgit E.; Egelman, Edward H.			Convergent evolution in the supercoiling of prokaryotic flagellar filaments	CELL			English	Article							CRYO-EM; OUTER DOMAIN; 3-DIMENSIONAL RECONSTRUCTION; MOTILITY; VISUALIZATION; BACTERIA; BINDING; LACKING; FORMS; RHO	The supercoiling of bacterial and archaeal flagellar filaments is required for motility. Archaeal flagellar fila-ments have no homology to their bacterial counterparts and are instead homologs of bacterial type IV pili. How these prokaryotic flagellar filaments, each composed of thousands of copies of identical subunits, can form stable supercoils under torsional stress is a fascinating puzzle for which structural insights have been elusive. Advances in cryoelectron microscopy (cryo-EM) make it now possible to directly visualize the basis for supercoiling, and here, we show the atomic structures of supercoiled bacterial and archaeal flagellar filaments. For the bacterial flagellar filament, we identify 11 distinct protofilament conformations with three broad classes of inter-protomer interface. For the archaeal flagellar filament, 10 protofilaments form a supercoil geometry supported by 10 distinct conformations, with one inter-protomer discontinuity creating a seam inside of the curve. Our results suggest that convergent evolution has yielded stable super -helical geometries that enable microbial locomotion.	[Kreutzberger, Mark A. B.; Sonani, Ravi R.; Wang, Fengbin; Zheng, Weili; Egelman, Edward H.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Liu, Junfeng; Krupovic, Mart] Univ Paris Cite, Inst Pasteur, Archaeal Virol Unit, CNRS UMR 6047, F-75015 Paris, France; [Chatterjee, Sharanya; Biswas, Priyanka; Frankel, Gad] Imperial Coll London, Ctr Mol Microbiol & Infect, Dept Life Sci, London, England; [Sebastian, Amanda L.; Scharf, Birgit E.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ewing, Cheryl] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Luisi, B. F.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England; [Calladine, Chris R.] Univ Cambridge, Dept Engn, Trumpington St, Cambridge CB2 1PZ, England	University of Virginia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Imperial College London; Virginia Polytechnic Institute & State University; Naval Medical Research Center (NMRC); University of Cambridge; University of Cambridge	Egelman, EH (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	egelman@virginia.edu	Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Wang, Fengbin/0000-0003-1008-663X; , Junfeng/0000-0003-1062-2404	NIH [T32 GM080186, 6000.RAD1.DA3.A0308]; U.S. Navy Work Unit [GM122150]; Robert R. Wagner Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Navy Work Unit; Robert R. Wagner Fellowship	This work was supported by NIH GM122150 (to E.H.E.) . This work was also supported by U.S. Navy Work Unit (program 6000.RAD1.DA3.A0308, to F.P.) . M.A.K.B. was supported by the Robert R. Wagner Fellowship and NIH grant T32 GM080186. The views expressed in this article reflect the results of research conducted by the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. F.P. is a federal employee of the US Government, and this work was prepared as part of his official duties. Title 17 U.S.C. 105 provides that copyright protection under this title is not available for any work of the US Government. Title 17 U.S.C. 101 defines a US Government work as work prepared by a military service member or employee of the US Government as part of that person's official duties. Electron microscopy was performed at the Molecular Electron Microscopy Core at the University of Virginia.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Asakura S, 1970, Adv Biophys, V1, P99; Bardy SL, 2002, J BACTERIOL, V184, P5223, DOI 10.1128/JB.184.19.5223-5233.2002; Bayley DP, 1998, J MOL EVOL, V46, P370; Blum TB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51440-1; Calladine CR, 2013, J MOL BIOL, V425, P914, DOI 10.1016/j.jmb.2012.12.007; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0; Cohen-Krausz S, 2002, J MOL BIOL, V321, P383, DOI 10.1016/S0022-2836(02)00616-2; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaffney EAA, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.710825; Gambelli L, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28337-1; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; KAMIYA R, 1982, SYM SOC EXP BIOL, P53; KAMIYA R, 1976, J MOL BIOL, V106, P167, DOI 10.1016/0022-2836(76)90306-5; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; Kato T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13252-9; Khan S, 2018, CURR BIOL, V28, pR278, DOI 10.1016/j.cub.2018.01.085; Kinosita Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.148, 10.1038/nmicrobiol.2016.148]; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kreutzberger MAB, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29069-y; Kreutzberger MAB, 2020, P NATL ACAD SCI USA, V117, P16985, DOI 10.1073/pnas.2010996117; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; MACNAB RM, 1976, J CLIN MICROBIOL, V4, P258; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Makarova KS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00667; Maki-Yonekura S, 2010, NAT STRUCT MOL BIOL, V17, P417, DOI 10.1038/nsmb.1774; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Meshcheryakov VA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846340; Montemayor EJ, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00399-20; Nedeljkovic M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147521; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Ortega D, 2022, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.803720; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Poweleit N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.222; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rice WJ, 2018, J STRUCT BIOL, V204, P38, DOI 10.1016/j.jsb.2018.06.007; Shibata S, 2019, NAT STRUCT MOL BIOL, V26, P941, DOI 10.1038/s41594-019-0301-3; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Subramaniam S, 2016, CURR OPIN STRUC BIOL, V41, P194, DOI 10.1016/j.sbi.2016.07.009; Thomas NA, 2001, FEMS MICROBIOL REV, V25, P147, DOI 10.1016/S0168-6445(00)00061-9; TRACHTENBERG S, 1988, J MOL BIOL, V202, P787, DOI 10.1016/0022-2836(88)90559-1; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Wang FB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17268-4; Wang FB, 2019, NAT MICROBIOL, V4, P1401, DOI 10.1038/s41564-019-0458-x; Wang F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01075-5; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wirth R, 2012, TRENDS MICROBIOL, V20, P511, DOI 10.1016/j.tim.2012.07.007; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	69	1	1	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 15	2022	185	19					3487	+		10.1016/j.cell.2022.08.009	http://dx.doi.org/10.1016/j.cell.2022.08.009			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4Z5ET	36057255				2022-12-28	WOS:000862232500005
J	Madhusoodanan, J				Madhusoodanan, Jyoti			Joseph Ravenell: Tackling disparities	NATURE			English	Editorial Material								Prostate cancer is more common in Black men than in white men - one in six Black men in the United States will develop the disease, compared with one in eight white men. Not only that, but Black men are also twice as likely to die of the disease (A. N. Giaquinto et al. CA Cancer J. Clin. 72, 2022-29; 2022). Joseph Ravenell, a populationhealth researcher at New York University Grossman School of Medicine in New York City, spoke to Nature about the causes of disparities in prostate cancer outcomes, and why important work to provide equal access to care might not eliminate racial inequity by itself.											0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S51	S51		10.1038/d41586-022-02865-8	http://dx.doi.org/10.1038/d41586-022-02865-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104416	Bronze			2022-12-28	WOS:000855141600011
J	Makin, S				Makin, Simon			Tools of destruction	NATURE			English	Editorial Material							AR PROTAC DEGRADER; CANCER; CASTRATION; ARV-110											Ahmed OK., 2020, J CLIN ONCOL, V38, P4599, DOI [10.1200/JCO.2020.38.15_suppl.4599, DOI 10.1200/JCO.2020.38.15_SUPPL.4599]; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Gao X., 2022, J CLIN ONCOL, V40, P17, DOI [10.1200/JCO.2022.40.6_suppl.017, DOI 10.1200/JCO.2022.40.6_SUPPL.017]; Huggins C, 1941, CANCER RES, V1, P293; Kregel S, 2020, NEOPLASIA, V22, P111, DOI 10.1016/j.neo.2019.12.003; Salami J, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0105-8	6	0	0	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 15	2022	609	7927					S41	S41		10.1038/d41586-022-02860-z	http://dx.doi.org/10.1038/d41586-022-02860-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4P1FN	36104417	Bronze			2022-12-28	WOS:000855141600006
J	Miura, SK; Scanziani, M				Miura, Satoru K.; Scanziani, Massimo			Distinguishing externally from saccade-induced motion in visual cortex	NATURE			English	Article							EYE-MOVEMENTS; RECEPTIVE-FIELDS; COROLLARY DISCHARGE; SUPERIOR COLLICULUS; SUPPRESSION; MECHANISMS; INTERNEURONS; DIRECTION; CIRCUIT; NUCLEUS	Distinguishing sensory stimuli caused by changes in the environment from those caused by an animal's own actions is a hallmark of sensory processing(1). Saccades are rapid eye movements that shift the image on the retina. How visual systems differentiate motion of the image induced by saccades from actual motion in the environment is not fully understood(2). Here we discovered that in mouse primary visual cortex (V1) the two types of motion evoke distinct activity patterns. This is because, during saccades, V1 combines the visual input with a strong non-visual input arriving from the thalamic pulvinar nucleus. The non-visual input triggers responses that are specific to the direction of the saccade and the visual input triggers responses that are specific to the direction of the shift of the stimulus on the retina, yet the preferred directions of these two responses are uncorrelated. Thus, the pulvinar input ensures differential V1 responsesto external and self-generated motion. Integration of external sensory information with information about body movement may be a general mechanism for sensory cortices to distinguish between self-generated and external stimuli.	[Miura, Satoru K.; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Miura, Satoru K.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Miura, Satoru K.; Scanziani, Massimo] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Miura, Satoru K.; Scanziani, Massimo] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Miura, SK; Scanziani, M (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.; Miura, SK; Scanziani, M (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Miura, SK; Scanziani, M (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.; Miura, SK; Scanziani, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	smiura@ucla.edu; massimo@ucsf.edu	Miura, Satoru/GZH-1685-2022	Miura, Satoru/0000-0002-6698-9435	Jane Coffin Childs Memorial Fund for Medical Research; Japan Society for the Promotion of Science; NIH [U19NS107613]	Jane Coffin Childs Memorial Fund for Medical Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Bao, J. Evora, N. Kim, Y. Li, M. Mukundan and B. Wong for technical assistance; R. Beltramo, E.J. Chichilnisky, B. Liu, R. Nicoll, N. Rochefort and S. Ruediger for critical reading of the manuscript; and all members of the Scanziani laboratory for discussion. This investigation has been aided by a grant from the Jane Coffin Childs Memorial Fund for Medical Research and the Japan Society for the Promotion of Science to S.K.M. and NIH grant U19NS107613 to M.S. M.S. is an investigator of the Howard Hughes Medical Institute.	BEELER GW, 1967, VISION RES, V7, P769, DOI 10.1016/0042-6989(67)90039-9; Bennett C, 2019, NEURON, V102, P477, DOI 10.1016/j.neuron.2019.02.010; Bouvier G, 2020, NEURON, V108, P500, DOI 10.1016/j.neuron.2020.07.004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bremmer F, 2009, J NEUROSCI, V29, P12374, DOI 10.1523/JNEUROSCI.2908-09.2009; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 2000, NAT NEUROSCI, V3, P177, DOI 10.1038/72124; Castet E, 2010, DYNAMICS OF VISUAL MOTION PROCESSING: NEURONAL, BEHAVIORAL, AND COMPUTATIONAL APPROACHES, P213, DOI 10.1007/978-1-4419-0781-3_10; Chen CY, 2017, J NEUROPHYSIOL, V117, P1657, DOI 10.1152/jn.00911.2016; CORAZZA R, 1971, BRAIN RES, V34, P345, DOI 10.1016/0006-8993(71)90286-1; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Crowder NA, 2009, J NEUROPHYSIOL, V101, P3100, DOI 10.1152/jn.91254.2008; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; DUFFY FH, 1968, NATURE, V218, P1074, DOI 10.1038/2181074a0; FELDMAN M, 1968, J NEUROPHYSIOL, V31, P455, DOI 10.1152/jn.1968.31.3.455; Fredes F, 2012, J COMP NEUROL, V520, P1800, DOI 10.1002/cne.23014; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Guillery RW, 2011, BRAIN RES REV, V66, P205, DOI 10.1016/j.brainresrev.2010.08.001; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Idrees S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15890-w; JEANNEROD M, 1971, EXP BRAIN RES, V13, P533; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jordan R, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.024; Kleiner M, 2007, PERCEPTION, V36, P14; Land M, 2019, VISION RES, V162, P1, DOI 10.1016/j.visres.2019.06.004; Land MF, 2019, CURR TOP BEHAV NEURO, V41, P3, DOI 10.1007/7854_2018_60; Leinweber M, 2017, NEURON, V95, P1420, DOI 10.1016/j.neuron.2017.08.036; Liu BH, 2016, NATURE, V538, P383, DOI 10.1038/nature19818; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; Meyer AF, 2020, CURR BIOL, V30, P2116, DOI 10.1016/j.cub.2020.04.042; Meyer AF, 2018, NEURON, V100, P46, DOI 10.1016/j.neuron.2018.09.020; Michaiel AM, 2020, ELIFE, V9, DOI 10.7554/eLife.57458; MOONEY RD, 1984, J NEUROPHYSIOL, V51, P407, DOI 10.1152/jn.1984.51.3.407; Nakamura H, 2015, EUR J NEUROSCI, V41, P1294, DOI 10.1111/ejn.12882; Nestvogel DB, 2022, NEURON, V110, P120, DOI 10.1016/j.neuron.2021.10.005; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2021, ANNU REV NEUROSCI, V44, P517, DOI 10.1146/annurev-neuro-102320-085825; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; ROBINSON DL, 1986, EXP BRAIN RES, V62, P625; Roth MM, 2016, NAT NEUROSCI, V19, P299, DOI 10.1038/nn.4197; Sakatani T, 2007, NEUROSCI RES, V58, P324, DOI 10.1016/j.neures.2007.04.003; Samonds JM, 2018, NAT NEUROSCI, V21, P1591, DOI 10.1038/s41593-018-0255-5; Sato TK, 2014, NAT NEUROSCI, V17, P30, DOI 10.1038/nn.3585; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Usrey WM, 2019, J COMP NEUROL, V527, P640, DOI 10.1002/cne.24423; VOLKMANN FC, 1986, VISION RES, V26, P1401, DOI 10.1016/0042-6989(86)90164-1; Watson T, 2011, J NEUROSCI, V31, P6535, DOI 10.1523/JNEUROSCI.6255-10.2011; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Yu JN, 2016, NAT NEUROSCI, V19, P1647, DOI 10.1038/nn.4412; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zhou N, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000050; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	59	1	1	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2022	610	7930					135	+		10.1038/s41586-022-05196-w	http://dx.doi.org/10.1038/s41586-022-05196-w		SEP 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5C6KA	36104560	hybrid			2022-12-28	WOS:000854788200006
J	Suran, M				Suran, Melissa			QUICK UPTAKES New Guidance From the American Academy of Pediatrics on Protecting Children From Sexual Abuse in Health Care Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2022	328	14					1385	1386		10.1001/jama.2022.16787	http://dx.doi.org/10.1001/jama.2022.16787		SEP 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5L0OS	36103202				2022-12-28	WOS:000854267300001
J	Thacker, PD				Thacker, Paul D.			Stealing from the tobacco playbook, fossil fuel companies pour money into elite American universities	BMJ-BRITISH MEDICAL JOURNAL			English	Article												thackerpd@gmail.com						Abdulla A, 2021, ENVIRON RES LETT, V16, DOI 10.1088/1748-9326/abd19e; American Petroleum Institute, 1998, GLOB CLIM SCI COMM T; [Anonymous], 2000, PRINCETON RECEIVES 2; [Anonymous], OPEN LETT STANFORD D; Barnum RE., 1981, SCOPING STUDY CO2; Berkeley College of Chemistry, 2021, EXXONMOBIL COLL DISC; Bonneuil C, 2021, GLOBAL ENVIRON CHANG, V71, DOI 10.1016/j.gloenvcha.2021.102386; Brandt AM, 2012, AM J PUBLIC HEALTH, V102, P63, DOI 10.2105/AJPH.2011.300292; Carter A, 2021, CORRECTING CANADAS O; Clean Air Canada Partnership, 2022, YOUTUBE; Committee on Campus Climate Change, 2021, DISCL FOSS FUEL IND; From the Community, 2021, STANFORD DAILY 0330; Frontline PBS, 2022, YOUTUBE; House KZ, 2011, P NATL ACAD SCI USA, V108, P20428, DOI 10.1073/pnas.1012253108; Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5; Landrigan PJ, 2020, NEW ENGL J MED, V382, P104, DOI 10.1056/NEJMp1913663; Levine DG., 1989, POTENTIAL ENHANCED G; MIT Energy Initiative, 2011, FUTURE NATURAL GAS I; Oreskes N, 2022, SCI AM; Sekera J, 2021, CONVERSATION 1123; Sekera J., 2020, BIOPHYS EC SUSTAIN, V5, P1, DOI [10.1007/s41247-020-00080-5, DOI 10.1007/S41247-020-00080-5]; Servick K, 2012, STANF GLOB CLIM EN P; Stanford Center for Carbon Storage, AFF OPP; Stanford University, GLOB CLIM EN PROJ; Stanford University, 2018, STANFORD NEWS 0301; Thacker PD, 2021, DISINFORMATION 1102; Thacker PD, 2020, INTEGRITY TRANSPAREN, P3, DOI [10.1007/978-981-15-1424-1_1, DOI 10.1007/978-981-15-1424-1_1]	27	1	1	5	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2022	378								o2095	10.1136/bmj.o2095	http://dx.doi.org/10.1136/bmj.o2095			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Z6NX	36104039				2022-12-28	WOS:000862323900009
J	Xu, C; Martin, N; Li, M; Mann, S				Xu, Can; Martin, Nicolas; Li, Mei; Mann, Stephen			Living material assembly of bacteriogenic protocells	NATURE			English	Article							VITRO GENE-EXPRESSION; MEMBRANE; MICRODROPLETS; CATALYSIS; BACTERIAL; ASSAY; STEP; ATP	Advancing the spontaneous bottom-up construction of artificial cells with high organizational complexity and diverse functionality remains an unresolved issue at the interface between living and non-living matter(1-4). Here, to address this challenge, we developed a living material assembly process based on the capture and on-site processing of spatially segregated bacterial colonies within individual coacervate microdroplets for the endogenous construction of membrane-bounded, molecularly crowded, and compositionally, structurally and morphologically complex synthetic cells. The bacteriogenic protocells inherit diverse biological components, exhibit multifunctional cytomimetic properties and can be endogenously remodelled to include a spatially partitioned DNA-histone nucleus-like condensate, membranized water vacuoles and a three-dimensional network of F-actin proto-cytoskeletal filaments. The ensemble is biochemically energized by ATP production derived from implanted live Escherichia coli cells to produce a cellular bionic system with amoeba-like external morphology and integrated life-like properties. Our results demonstrate a bacteriogenic strategy for the bottom-up construction of functional protoliving microdevices and provide opportunities for the fabrication of new synthetic cell modules and augmented living/synthetic cell constructs with potential applications in engineered synthetic biology and biotechnology.	[Xu, Can; Li, Mei; Mann, Stephen] Univ Bristol, Sch Chem, Ctr Protolife Res, Bristol, Avon, England; [Xu, Can; Li, Mei; Mann, Stephen] Univ Bristol, Sch Chem, Ctr Organized Matter Chem, Bristol, Avon, England; [Martin, Nicolas] Univ Bordeaux, CNRS, Ctr Rech Paul Pascal, UMR5031, Pessac, France; [Li, Mei; Mann, Stephen] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Shanghai, Peoples R China; [Mann, Stephen] Univ Bristol, Max Planck Bristol Ctr Minimal Biol, Sch Chem, Bristol, Avon, England; [Mann, Stephen] Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study ZIAS, Shanghai, Peoples R China	University of Bristol; University of Bristol; Centre de Recherche Paul Pascal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Shanghai Jiao Tong University; University of Bristol; Shanghai Jiao Tong University	Li, M; Mann, S (corresponding author), Univ Bristol, Sch Chem, Ctr Protolife Res, Bristol, Avon, England.; Li, M; Mann, S (corresponding author), Univ Bristol, Sch Chem, Ctr Organized Matter Chem, Bristol, Avon, England.; Li, M; Mann, S (corresponding author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, Shanghai, Peoples R China.; Mann, S (corresponding author), Univ Bristol, Max Planck Bristol Ctr Minimal Biol, Sch Chem, Bristol, Avon, England.; Mann, S (corresponding author), Shanghai Jiao Tong Univ, Zhangjiang Inst Adv Study ZIAS, Shanghai, Peoples R China.	mei.li@bristol.ac.uk; s.mann@bristol.ac.uk	Mann, Stephen/D-1332-2012; Martin, Nicolas/N-9990-2017	Mann, Stephen/0000-0003-3012-8964; Martin, Nicolas/0000-0003-1367-4330	Marie Curie Skodowska Postdoctoral Fellowship [8082 H2020 PROTOBAC ERC 670 837197]; BBSRC [BB/P017320/1]; ERC Advanced Grant Scheme [EC-2016-674 ADG 740235]	Marie Curie Skodowska Postdoctoral Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC Advanced Grant Scheme	We thank Y. Takebayashi and J. Spencer for help with bacterial cultures; H. Sun, C. Berger-Schaffitzel and E. Bragginton for help with gel electrophoresis and western blot analysis; and A. Coutable and J. L. R. Anderson for providing the plasmid pEXP5-NT/deGFP. C.X. was funded by a Marie Curie Skodowska Postdoctoral Fellowship (8082 H2020 PROTOBAC ERC 670 837197) and the BBSRC (BB/P017320/1). N.M. and S.M. were funded by the ERC Advanced Grant Scheme (EC-2016-674 ADG 740235).	Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; Bosnea LA, 2014, FOOD BIOPROCESS TECH, V7, P2767, DOI 10.1007/s11947-014-1317-7; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Costales MG, 2019, J AM CHEM SOC, V141, P2960, DOI 10.1021/jacs.8b10558; Deng NN, 2017, J AM CHEM SOC, V139, P587, DOI 10.1021/jacs.6b10977; Donau C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18815-9; Dou HJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00465-z; Drescher HK, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051106; Drobot B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06072-w; Engelhart AE, 2016, NAT CHEM, V8, P448, DOI [10.1038/NCHEM.2475, 10.1038/nchem.2475]; Faust JE, 2017, BIOPHYS J, V112, P1663, DOI 10.1016/j.bpj.2017.03.003; Florea M, 2016, P NATL ACAD SCI USA, V113, pE3431, DOI 10.1073/pnas.1522985113; FUNG BM, 1983, ARCH BIOCHEM BIOPHYS, V220, P370, DOI 10.1016/0003-9861(83)90426-5; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Huang X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3239; Jeong S, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201907182; Jung Y, 2013, MOL CELLS, V35, P335, DOI 10.1007/s10059-013-2319-4; Koga S, 2011, NAT CHEM, V3, P720, DOI [10.1038/NCHEM.1110, 10.1038/nchem.1110]; Kuchler A, 2016, NAT NANOTECHNOL, V11, P409, DOI 10.1038/nnano.2016.54; Kumar BVVSP, 2018, NAT CHEM, V10, P1154, DOI 10.1038/s41557-018-0119-3; Lee KY, 2018, NAT BIOTECHNOL, V36, P530, DOI 10.1038/nbt.4140; Li M, 2013, NAT CHEM, V5, P529, DOI [10.1038/NCHEM.1644, 10.1038/nchem.1644]; Li M, 2011, CHEM SCI, V2, P1739, DOI 10.1039/c1sc00183c; Alvarez CL, 2017, BIOCHEM J, V474, P1395, DOI 10.1042/BCJ20160879; Linger JG, 2010, APPL ENVIRON MICROB, V76, P6360, DOI 10.1128/AEM.00230-10; Marguet M, 2013, CHEM SOC REV, V42, P512, DOI 10.1039/c2cs35312a; Martin N, 2019, CHEMBIOCHEM, V20, P2553, DOI 10.1002/cbic.201900183; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Moreau NG, 2020, CHEM COMMUN, V56, P12717, DOI 10.1039/d0cc05399f; Mukwaya V, 2020, ACS NANO, V14, P7899, DOI 10.1021/acsnano.0c02127; Nakashima KK, 2018, SOFT MATTER, V14, P361, DOI 10.1039/c7sm01897e; Niederholtmeyer H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07473-7; Silverman AD, 2020, NAT REV GENET, V21, P151, DOI 10.1038/s41576-019-0186-3; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Spoelstra WK, 2020, LANGMUIR, V36, P1956, DOI 10.1021/acs.langmuir.9b02719; Strulson CA, 2012, NAT CHEM, V4, P941, DOI [10.1038/NCHEM.1466, 10.1038/nchem.1466]; Tang TYD, 2015, CHEM COMMUN, V51, P11429, DOI 10.1039/c5cc04220h; Tang TYD, 2014, NAT CHEM, V6, P527, DOI [10.1038/nchem.1921, 10.1038/NCHEM.1921]; Thakur S, 2016, MOL PLANT MICROBE IN, V29, P243, DOI 10.1094/MPMI-01-16-0013-TA; Toparlak OD, 2019, EXP BIOL MED, V244, P304, DOI 10.1177/1535370218816657; van Stevendaal MHME, 2021, CHEMSYSTEMSCHEM, V3, DOI 10.1002/syst.202100009; Weiss M, 2018, NAT MATER, V17, P89, DOI [10.1038/nmat5005, 10.1038/NMAT5005]; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; WITTRUP KD, 1988, CYTOMETRY, V9, P394, DOI 10.1002/cyto.990090418; Yewdall NA, 2018, INTERFACE FOCUS, V8, DOI 10.1098/rsfs.2018.0023; Zhang YW, 2021, J AM CHEM SOC, V143, P2866, DOI 10.1021/jacs.0c12494	46	1	1	80	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					1029	+		10.1038/s41586-022-05223-w	http://dx.doi.org/10.1038/s41586-022-05223-w		SEP 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z0HD	36104562	Green Submitted			2022-12-28	WOS:000854742900001
J	Ye, RQ; Wang, MY; Du, H; Chhajed, S; Koh, J; Liu, KH; Shin, J; Wu, Y; Shi, L; Xu, L; Chen, SX; Zhang, YJ; Sheen, J				Ye, Ruiqiang; Wang, Meiyue; Du, Hao; Chhajed, Shweta; Koh, Jin; Liu, Kun-hsiang; Shin, Jinwoo; Wu, Yue; Shi, Lin; Xu, Lin; Chen, Sixue; Zhang, Yijing; Sheen, Jen			Glucose-driven TOR-FIE-PRC2 signalling controls plant development	NATURE			English	Article							REPRESSIVE COMPLEX 2; GENE-EXPRESSION; HISTONE H3; RAPAMYCIN KINASE; POLYCOMB; TOR; GROWTH; PROTEIN; TARGET; MTOR	Nutrients and energy have emerged as central modulators of developmental programmes in plants and animals(1-3). The evolutionarily conserved target of rapamycin (TOR) kinase is a master integrator of nutrient and energy signalling that controls growth. Despite its key regulatory roles in translation, proliferation, metabolism and autophagy(2-5), little is known about how TOR shapes developmental transitions and differentiation. Here we show that glucose-activated TOR kinase controls genome-wide histone H3 trimethylation at K27 (H3K27me3) in Arabidopsis thaliana, which regulates cell fate and development(6-10). We identify FERTILIZATION-INDEPENDENT ENDOSPERM (FIE), an indispensable component of Polycomb repressive complex 2 (PRC2), which catalyses H3K27me3 (refs. (6-8,10-12)), as a TOR target. Direct phosphorylation by TOR promotes the dynamic translocation of FIE from the cytoplasm to the nucleus. Mutation of the phosphorylation site on FIE abrogates the global H3K27me3 landscape, reprogrammes the transcriptome and disrupts organogenesis in plants. Moreover, glucose-TOR-FIE-PRC2 signalling modulates vernalization-induced floral transition. We propose that this signalling axis serves as a nutritional checkpoint leading to epigenetic silencing of key transcription factor genes that specify stem cell destiny in shoot and root meristems and control leaf, flower and silique patterning, branching and vegetative-to-reproduction transition. Our findings reveal a fundamental mechanism of nutrient signalling in direct epigenome reprogramming, with broad relevance for the developmental control of multicellular organisms.	[Ye, Ruiqiang; Du, Hao; Liu, Kun-hsiang; Shin, Jinwoo; Wu, Yue; Shi, Lin; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ye, Ruiqiang; Du, Hao; Liu, Kun-hsiang; Shin, Jinwoo; Wu, Yue; Shi, Lin; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ye, Ruiqiang; Du, Hao; Liu, Kun-hsiang; Shin, Jinwoo; Wu, Yue; Shi, Lin; Sheen, Jen] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Wang, Meiyue; Xu, Lin; Zhang, Yijing] Chinese Acad Sci, Ctr Excellence Mol Kant Sci, Shanghai Inst Kant Physiol & Ecol, Natl Key Lab Kant Mol Genet, Shanghai, Peoples R China; [Wang, Meiyue] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Meiyue; Zhang, Yijing] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Inst Plant Biol,State Key Lab Genet Engn, Sch Life Sci,Dept Biochem, Shanghai, Peoples R China; [Chhajed, Shweta; Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL USA; [Koh, Jin; Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Prote & Mass Spectrometry, Gainesville, FL USA; [Liu, Kun-hsiang] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Kun-hsiang] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Liu, Kun-hsiang] Northwest Agr & Forestry Univ, Inst Future Agr, Yangling, Shaanxi, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Ye, RQ; Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Ye, RQ; Sheen, J (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Ye, RQ; Sheen, J (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	ye@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu		Shin, Jinwoo/0000-0002-8750-0491	NIH [GM060493, GM129093]; Agriculture and Food Research Initiative from the USDA-NIFA [2020-67013-31615]; National Natural Science Foundation of China [31770285]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agriculture and Food Research Initiative from the USDA-NIFA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank A. von Arnim, D. Anwesha, S. H. Wu, and C. Meyer for sharing pRPS6(S237), pRPS6(S240) and RPS6 antibodies with detailed protocols; C. Meyer, J. Brunkard, C. Dean, D. Bouyer, Y. H. Cui, J. Goodrich, S. Brady, M. de Lucas and ABRC for providing Arabidopsis lines; H. Y. Qi for supplying the human 293T cells; J. Bush for plant management; S. Jiang and F. Marchan for help with insect cell expression system; B. Ardehali, C. Tsokos, F. K. Hsieh and C. H. Yang for sharing reagents and discussions; C. Dufresne from Thermo Scientific Training Institute for advice on LC-MS/MS analysis; X. Fang, A. Diener, L. Li, J. Bush, T. C. Chen and H. Y. Cho for critical reading of the manuscript. This work was supported by the NIH grants GM060493 and GM129093 to J. Sheen and R.Y., the Agriculture and Food Research Initiative (2020-67013-31615) from the USDA-NIFA to S. Chen, and National Natural Science Foundation of China (31770285) to Y.Z.	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Arur S, 2014, NAT PROTOC, V9, P375, DOI 10.1038/nprot.2014.017; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Barbier FF, 2019, TRENDS PLANT SCI, V24, P220, DOI 10.1016/j.tplants.2018.12.001; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bieluszewski T, 2021, TRENDS PLANT SCI, V26, P1186, DOI 10.1016/j.tplants.2021.06.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Cervera M, 2005, METH MOL B, V286, P203; Chen GH, 2018, P NATL ACAD SCI USA, V115, P12823, DOI 10.1073/pnas.1809526115; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; de Lucas M, 2016, PLANT CELL, V28, P2616, DOI 10.1105/tpc.15.00744; Denyer T, 2019, DEV CELL, V48, P840, DOI 10.1016/j.devcel.2019.02.022; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Dong Y., 2021, BIORXIV, DOI [10.1101/2021.03.28.437410, DOI 10.1101/2021.03.28.437410]; Enganti R, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02210; Forzani C, 2019, CELL REP, V27, P3696, DOI 10.1016/j.celrep.2019.05.074; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jacob Y, 2014, SCIENCE, V343, P1249, DOI 10.1126/science.1248357; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klotke J, 2004, PLANT CELL ENVIRON, V27, P1395, DOI 10.1111/j.1365-3040.2004.01242.x; Krejci A, 2017, DEVELOPMENT, V144, P3193, DOI 10.1242/dev.150573; Li JF, 2013, PLANT CELL, V25, P1507, DOI 10.1105/tpc.113.112235; Li L, 2021, ANNU REV CELL DEV BI, V37, P341, DOI 10.1146/annurev-cellbio-010521-015047; Li XJ, 2017, P NATL ACAD SCI USA, V114, P2765, DOI 10.1073/pnas.1618782114; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1746-8; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu C, 2009, DEVELOPMENT, V136, P3379, DOI 10.1242/dev.033076; Liu KH, 2017, NATURE, V545, P311, DOI 10.1038/nature22077; Liu Q, 2018, NAT METHODS, V15, P715, DOI 10.1038/s41592-018-0100-5; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Liu QS, 2012, ACS CHEM BIOL, V7, P982, DOI 10.1021/cb300058v; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Menon G, 2021, CURR OPIN PLANT BIOL, V61, DOI 10.1016/j.pbi.2021.102012; Montane MH, 2013, J EXP BOT, V64, P4361, DOI 10.1093/jxb/ert242; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Mozgova I, 2015, ANNU REV PLANT BIOL, V66, P269, DOI 10.1146/annurev-arplant-043014-115627; Niu Yajie, 2012, Methods Mol Biol, V876, P195, DOI 10.1007/978-1-61779-809-2_16; Oliva M, 2016, J EXP BOT, V67, P6111, DOI 10.1093/jxb/erw373; Ori N, 2000, DEVELOPMENT, V127, P5523; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Pang QY, 2020, PLANTA, V252, DOI 10.1007/s00425-020-03474-3; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Petricka JJ, 2008, PLANT J, V56, P251, DOI 10.1111/j.1365-313X.2008.03595.x; Pierre-Jerome E, 2018, ANNU REV CELL DEV BI, V34, P289, DOI 10.1146/annurev-cellbio-100617-062459; Pu L, 2015, TRENDS GENET, V31, P252, DOI 10.1016/j.tig.2015.03.004; Purvis ON, 1940, NATURE, V145, P462, DOI 10.1038/145462a0; Questa JI, 2016, SCIENCE, V353, P485, DOI 10.1126/science.aaf7354; Ren MZ, 2012, PLANT CELL, V24, P4850, DOI 10.1105/tpc.112.107144; Ruelens P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3280; Ryabova LA, 2019, J EXP BOT, V70, P2211, DOI 10.1093/jxb/erz108; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Shi L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160887; Shu J, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.100; Tie F, 2005, BIOCHEM BIOPH RES CO, V332, P622, DOI 10.1016/j.bbrc.2005.04.157; Wang H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005771; Wang L, 2020, NATURE, V583, P277, DOI 10.1038/s41586-020-2382-x; Wu Y, 2019, J EXP BOT, V70, P2227, DOI 10.1093/jxb/erz028; Xiao J, 2017, NAT GENET, V49, P1546, DOI 10.1038/ng.3937; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yang HC, 2017, SCIENCE, V357, P1142, DOI 10.1126/science.aan1121; Yang Y, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007296; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu S, 2015, CURR OPIN PLANT BIOL, V27, P1, DOI 10.1016/j.pbi.2015.05.009; Zhang T, 2017, METHODS MOL BIOL, V1578, P133, DOI 10.1007/978-1-4939-6859-6_10; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YS, 2020, NATURE, V583, P825, DOI 10.1038/s41586-020-2485-4; Zhou Y, 2018, NAT GENET, V50, P638, DOI 10.1038/s41588-018-0109-9	86	1	1	44	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 29	2022	609	7929					986	+		10.1038/s41586-022-05171-5	http://dx.doi.org/10.1038/s41586-022-05171-5		SEP 2022	32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	4Z2JJ	36104568				2022-12-28	WOS:000854788200005
J	Kuehn, BM				Kuehn, Bridget M.			CDC Streamlines COVID-19 Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					918	919		10.1001/jama.2022.15126	http://dx.doi.org/10.1001/jama.2022.15126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098716	Bronze			2022-12-28	WOS:000855222400008
J	Kuehn, BM				Kuehn, Bridget M.			Most Insured People With Hepatitis C Don't Get Timely Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2022	328	10					919	919		10.1001/jama.2022.14705	http://dx.doi.org/10.1001/jama.2022.14705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4P2JT	36098718				2022-12-28	WOS:000855222400009
J	Pees, C				Pees, Christiane			Marfan syndrome meta-analysis: individual patient data analysis reduces heterogeneity	LANCET			English	Editorial Material							LOSARTAN		[Pees, Christiane] Med Univ Vienna, Univ Childrens Hosp, Pediat Heart Ctr, Div Pediat Cardiol, A-1090 Vienna, Austria	Medical University of Vienna	Pees, C (corresponding author), Med Univ Vienna, Univ Childrens Hosp, Pediat Heart Ctr, Div Pediat Cardiol, A-1090 Vienna, Austria.	christiane.pees@meduniwien.ac.at						Dietz HC, 2015, CIRC-CARDIOVASC GENE, V8, DOI 10.1161/CIRCGENETICS.115.001040; Falvella Felicia Stefania, 2016, Drug Metabolism and Personalized Therapy, V31, P157, DOI 10.1515/dmpt-2016-0006; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; Pitcher A, 2022, LANCET, V400, P822, DOI 10.1016/S0140-6736(22)01534-3; Weinsaft JW, 2016, J AM COLL CARDIOL, V67, P2744, DOI 10.1016/j.jacc.2016.03.570	6	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2022	400	10355					790	791		10.1016/S0140-6736(22)01642-7	http://dx.doi.org/10.1016/S0140-6736(22)01642-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5V9YX	36049496				2022-12-28	WOS:000877580600004
J	Luque, R; Palle, E				Luque, Rafael; Palle, Enric			Density, not radius, separates rocky and water-rich small planets orbiting M dwarf stars	SCIENCE			English	Article							SUPER-EARTH; BIOSIGNATURES; HABITABILITY; MIGRATION; EXOPLANET; SYSTEMS	Exoplanets smaller than Neptune are common around red dwarf stars (M dwarfs), with those that transit their host star constituting the bulk of known temperate worlds amenable for atmospheric characterization. We analyze the masses and radii of all known small transiting planets around M dwarfs, identifying three populations: rocky, water-rich, and gas-rich. Our results are inconsistent with the previously known bimodal radius distribution arising from atmospheric loss of a hydrogen/helium envelope. Instead, we propose that a density gap separates rocky from water-rich exoplanets. Formation models that include orbital migration can explain the observations: Rocky planets form within the snow line, whereas water-rich worlds form outside it and later migrate inward.	[Luque, Rafael] CSIC, Inst Astrofis Andalucia, Granada 18008, Spain; [Luque, Rafael] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Palle, Enric] Inst Astrofis Canarias, Tenerife 38205, Spain; [Palle, Enric] Univ La Laguna, Dept Astrofis, Tenerife 38206, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Chicago; Instituto de Astrofisica de Canarias; Universidad de la Laguna	Luque, R (corresponding author), CSIC, Inst Astrofis Andalucia, Granada 18008, Spain.; Luque, R (corresponding author), Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA.	rluque@uchicago.edu		Palle, Enric/0000-0003-0987-1593; Luque, Rafael/0000-0002-4671-2957	Spanish Ministerio de Ciencia e Innovacion [PID2019109522GB-C52]; Centre of Excellence "Severo Ochoa" award [SEV-2017-0709]; University of La Laguna through the Margarita Salas Fellowship from the Spanish Ministry of Universities [UNI/551/2021-May-26]; EU Next Generation funds; Spanish Ministry of Economics and Competitiveness [PGC2018-098153-B-C31]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centre of Excellence "Severo Ochoa" award; University of La Laguna through the Margarita Salas Fellowship from the Spanish Ministry of Universities; EU Next Generation funds; Spanish Ministry of Economics and Competitiveness(Spanish Government)	Supported by the Spanish Ministerio de Ciencia e Innovacion, through project PID2019109522GB-C52, the Centre of Excellence "Severo Ochoa" award SEV-2017-0709 to the Instituto de Astrofisica de Andalucia, and the University of La Laguna through the Margarita Salas Fellowship from the Spanish Ministry of Universities ref. UNI/551/2021-May-26 and under EU Next Generation funds (R.L.) and by the Spanish Ministry of Economics and Competitiveness through grant PGC2018-098153-B-C31 (E.P.).	Benneke B, 2019, ASTROPHYS J LETT, V887, DOI 10.3847/2041-8213/ab59dc; Brugger N, 2020, ASTRON ASTROPHYS, V640, DOI 10.1051/0004-6361/202038042; Burn R, 2021, ASTRON ASTROPHYS, V656, DOI 10.1051/0004-6361/202140390; Cloutier R, 2020, ASTRON J, V159, DOI 10.3847/1538-3881/ab8237; Espinoza N, 2019, MON NOT R ASTRON SOC, V490, P2262, DOI 10.1093/mnras/stz2688; Fulton BJ, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa80eb; Jin S, 2018, ASTROPHYS J, V853, DOI 10.3847/1538-4357/aa9f1e; Kreidberg L., 2020, ARXIV; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Loyd ROP, 2020, ASTROPHYS J, V890, DOI 10.3847/1538-4357/ab6605; Madhusudhan N, 2021, ASTROPHYS J, V918, DOI 10.3847/1538-4357/abfd9c; Mordasini C, 2009, ASTRON ASTROPHYS, V501, P1139, DOI 10.1051/0004-6361/200810301; Mousis O, 2020, ASTROPHYS J LETT, V896, DOI 10.3847/2041-8213/ab9530; Munoz AG, 2021, ASTROPHYS J LETT, V907, DOI 10.3847/2041-8213/abd9b8; Rauer H, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201014368; Raymond SN, 2018, MON NOT R ASTRON SOC, V479, pL81, DOI 10.1093/mnrasl/sly100; Rogers J. G., 2021, MON NOT R ASTRON SOC, V503, P1526, DOI [10.1093/mnras/stab529, DOI 10.1093/mnras/stab529]; Segura A, 2005, ASTROBIOLOGY, V5, P706, DOI 10.1089/ast.2005.5.706; Trifonov T, 2021, SCIENCE, V371, P1038, DOI 10.1126/science.abd7645; Tsiaras A, 2019, NAT ASTRON, V3, P1086, DOI 10.1038/s41550-019-0878-9; Van Eylen V, 2021, MON NOT R ASTRON SOC, V507, P2154, DOI 10.1093/mnras/stab2143; Venturini J, 2020, ASTRON ASTROPHYS, V643, DOI 10.1051/0004-6361/202039141; Zeng L, 2019, P NATL ACAD SCI USA, V116, P9723, DOI 10.1073/pnas.1812905116	29	3	3	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1211	1214		10.1126/science.abl7164	http://dx.doi.org/10.1126/science.abl7164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074855	Green Submitted			2022-12-28	WOS:000887933400045
J	Marshall-Gradisnik, S; Eaton-Fitch, N				Marshall-Gradisnik, Sonya; Eaton-Fitch, Natalie			Understanding myalgic encephalomyelitis	SCIENCE			English	Editorial Material							FATIGUE-SYNDROME		[Marshall-Gradisnik, Sonya; Eaton-Fitch, Natalie] Griffith Univ, Natl Ctr Neuroimmunol & Emerging Dis, MHIQ, Gold Coast, Australia	Griffith University; Menzies Health Institute Queensland	Marshall-Gradisnik, S (corresponding author), Griffith Univ, Natl Ctr Neuroimmunol & Emerging Dis, MHIQ, Gold Coast, Australia.	s.marshall-gradisnik@griffith.edu.au		Eaton-Fitch, Natalie/0000-0002-0815-3162	National Health and Medical Research Council; Stafford Fox Medical Research Foundation; McCusker Charitable Foundation; Buxton Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Stafford Fox Medical Research Foundation; McCusker Charitable Foundation; Buxton Foundation	The authors are funded by the National Health and Medical Research Council,the Stafford Fox Medical Research Foundation,McCusker Charitable Foundation, and the Buxton Foundation.The authors disclose Patent Cooperation Treaty (PCT) patent application no.WO2016176726A1 and PCT provisional application no. 2022902253.	Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Eaton-Fitch N, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1202-6; Konig RS, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.628741; Lim EJ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02269-0; Maksoud R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232475; Mensah FKF, 2017, NEUROPHYSIOL CLIN, V47, P131, DOI 10.1016/j.neucli.2017.02.002; Missailidis D, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030080; National Institute for Health and Care Excellence (NICE), 2021, GUIDANCE, V87; Nelson T, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.769511; Paul BD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024358118; Polo O, 2019, FATIGUE, V7, P207, DOI 10.1080/21641846.2019.1692770; Sukocheva OA, 2022, J ADV RES, V40, P179, DOI 10.1016/j.jare.2021.11.013; Toogood PL, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2021.105465; Varesi A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10215077; Wong TL, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57050418	15	0	0	4	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2022	377	6611					1150	1151		10.1126/science.abo1261	http://dx.doi.org/10.1126/science.abo1261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1ER	36074854				2022-12-28	WOS:000887933400028
J	Conley, C; Brook, K; Louca, J; Haber, A; Nozari, A; Ortega, R				Conley, Christopher; Brook, Karolina; Louca, Joseph; Haber, Amy; Nozari, Ala; Ortega, Rafael			Inhalational Induction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Conley, Christopher; Brook, Karolina; Louca, Joseph; Haber, Amy; Nozari, Ala; Ortega, Rafael] Boston Med Ctr, Dept Anesthesiol, 750 Albany St, Boston, MA 02118 USA	Boston Medical Center	Ortega, R (corresponding author), Boston Med Ctr, Dept Anesthesiol, 750 Albany St, Boston, MA 02118 USA.	rafael.ortega@bmc.org		Conley, Christopher/0000-0002-6446-2832				Hartigan PM, 2022, ANESTHESIOLOGY, V136, P104, DOI 10.1097/ALN.0000000000004011; Jo JY, 2019, JAMA OTOLARYNGOL, V145, P117, DOI 10.1001/jamaoto.2018.3097; Manso MA, 2019, PEDIATR ANESTH, V29, P1094, DOI 10.1111/pan.13747; Ortega RA, 2006, ANESTHESIOLOGY, V105, P838, DOI 10.1097/00000542-200610000-00030; Ramgolam A, 2018, ANESTHESIOLOGY, V128, P1065, DOI 10.1097/ALN.0000000000002152	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2022	387	10							e19	10.1056/NEJMvcm2202144	http://dx.doi.org/10.1056/NEJMvcm2202144			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	4Y6KL	36069873				2022-12-28	WOS:000861634500001
J	Zannoni, N; Lakey, PSJ; Won, Y; Shiraiwa, M; Rim, D; Weschler, CJ; Wang, NJ; Ernle, L; Li, MZ; Beko, G; Wargocki, P; Williams, J				Zannoni, Nora; Lakey, Pascale S. J.; Won, Youngbo; Shiraiwa, Manabu; Rim, Donghyun; Weschler, Charles J.; Wang, Nijing; Ernle, Lisa; Li, Mengze; Beko, Gabriel; Wargocki, Pawel; Williams, Jonathan			The human oxidation field	SCIENCE			English	Article							INDOOR; OZONE; PRODUCTS; IMPACT; OH; RADICALS	Hydroxyl (OH) radicals are highly reactive species that can oxidize most pollutant gases. In this study, high concentrations of OH radicals were found when people were exposed to ozone in a climate-controlled chamber. OH concentrations calculated by two methods using measurements of total OH reactivity, speciated alkenes, and oxidation products were consistent with those obtained from a chemically explicit model. Key to establishing this human-induced oxidation field is 6-methyl-5-hepten-2-one (6-MHO), which forms when ozone reacts with the skin-oil squalene and subsequently generates OH efficiently through gas-phase reaction with ozone. A dynamic model was used to show the spatial extent of the human-generated OH oxidation field and its dependency on ozone influx through ventilation. This finding has implications for the oxidation, lifetime, and perception of chemicals indoors and, ultimately, human health.	[Zannoni, Nora; Wang, Nijing; Ernle, Lisa; Li, Mengze; Williams, Jonathan] Max Planck Inst Chem, Atmospher Chem Dept, Jena, Germany; [Lakey, Pascale S. J.; Shiraiwa, Manabu] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Won, Youngbo; Rim, Donghyun] Penn State Univ, Dept Architectural Engn, University Pk, PA 16802 USA; [Weschler, Charles J.; Beko, Gabriel; Wargocki, Pawel] Tech Univ Denmark, Int Ctr Indoor Environm & Energy Environm & Resou, DTU Sustain, Lyngby, Denmark; [Weschler, Charles J.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Williams, Jonathan] Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus	Max Planck Society; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Technical University of Denmark; Rutgers State University New Brunswick	Zannoni, N; Williams, J (corresponding author), Max Planck Inst Chem, Atmospher Chem Dept, Jena, Germany.; Shiraiwa, M (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.; Rim, D (corresponding author), Penn State Univ, Dept Architectural Engn, University Pk, PA 16802 USA.; Williams, J (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus.	nora.zannoni@mpic.de; m.shiraiwa@uci.edu; dxr51@psu.edu; jonathan.williams@mpic.de	Shiraiwa, Manabu/A-6246-2010; Beko, Gabriel/C-8684-2009; Wargocki, Pawel/B-4632-2017	Shiraiwa, Manabu/0000-0003-2532-5373; Beko, Gabriel/0000-0001-6107-8336; Lakey, Pascale/0000-0003-2923-4073; WANG, Nijing/0000-0003-3197-8151; Wargocki, Pawel/0000-0003-3865-3560; Ernle, Lisa/0000-0001-7641-4347; Li, Mengze/0000-0003-0620-6301; Zannoni, Nora/0000-0003-2721-5362	Alfred P. Sloan Foundation [G-2018-11233, G-2019-12306, G-2020-13912]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was funded by Alfred P. Sloan Foundation grants G-2018-11233 (J.W., G.B., and P.W.), G-2019-12306 (M.S. and D.R.), and G-2020-13912 (M.S. and D.R.).	Abbatt JPD, 2020, ENVIRON SCI-PROC IMP, V22, P25, DOI 10.1039/c9em00386j; Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Ault AP, 2020, CHEM-US, V6, P3203, DOI 10.1016/j.chempr.2020.08.023; Beko G, 2020, INDOOR AIR, V30, P1213, DOI 10.1111/ina.12687; Blocquet M., 2016, 14 INT C IND AIR QUA, V1, P1310; Carslaw N, 2017, INDOOR AIR, V27, P1091, DOI 10.1111/ina.12394; Carslaw N, 2007, ATMOS ENVIRON, V41, P1164, DOI 10.1016/j.atmosenv.2006.09.038; Committee on Emerging Science on Indoor Chemistry Board on Chemical Sciences and Technology Division on Earth and Life Studies National Academies of Sciences Engineering and Medicine, 2022, WHY IND CHEM MATT; Corsi RL, 2007, ATMOS ENVIRON, V41, P3161, DOI 10.1016/j.atmosenv.2006.07.054; European Commission, PRESS CORN; Farmer DK, 2019, ENVIRON SCI-PROC IMP, V21, P1280, DOI 10.1039/c9em00228f; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lakey PSJ, 2017, INDOOR AIR, V27, P816, DOI 10.1111/ina.12360; Lakey PSJ, 2021, COMMUN CHEM, V4, DOI 10.1038/s42004-021-00548-5; Lakey PSJ, 2019, COMMUN CHEM, V2, DOI 10.1038/s42004-019-0159-7; Liu YJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018140118; Nazaroff WW, 2015, INDOOR AIR, V25, P357, DOI 10.1111/ina.12219; Nazaroff WW, 2022, INDOOR AIR, V32, DOI 10.1111/ina.12942; Nazaroff WW, 2021, INDOOR AIR, V31, P282, DOI 10.1111/ina.12785; New Jersey Department of Health, WORKPLACE HLTH SAFET; Nielsen P. V., 2021, INDOOR BUILT ENVIRON, V31; Pitts Jr J. N., 2000, CHEM UPPER LOWER ATM; Rim D, 2018, BUILD ENVIRON, V130, P40, DOI 10.1016/j.buildenv.2017.12.012; Rivera-Rios JC, 2014, GEOPHYS RES LETT, V41, P8645, DOI 10.1002/2014GL061919; Roberts SC, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0258; Sarwar G, 2002, ATMOS ENVIRON, V36, P3973, DOI 10.1016/S1352-2310(02)00278-9; Shen GF, 2020, ENVIRON POLLUT, V267, DOI 10.1016/j.envpol.2020.115493; Singer BC, 2006, ATMOS ENVIRON, V40, P6696, DOI 10.1016/j.atmosenv.2006.06.005; Smith AM, 1996, ENVIRON SCI TECHNOL, V30, P1781, DOI 10.1021/es950871m; Wang NJ, 2021, ENVIRON SCI TECHNOL, V55, P149, DOI 10.1021/acs.est.0c04206; Weschler CJ, 2016, INDOOR AIR, V26, P6, DOI 10.1111/ina.12185; Weschler CJ, 2006, ENVIRON HEALTH PERSP, V114, P1489, DOI 10.1289/ehp.9256; Weschler CJ, 2018, ENVIRON SCI TECHNOL, V52, P2419, DOI 10.1021/acs.est.7b06387; Weschler CJ, 1996, ENVIRON SCI TECHNOL, V30, P3250, DOI 10.1021/es960032f; Weschler CJ, 1997, ENVIRON SCI TECHNOL, V31, P3719, DOI 10.1021/es970669e; White IR, 2010, ENVIRON SCI TECHNOL, V44, P6269, DOI 10.1021/es901699a; Williams J, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0274; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106; Won Y, 2020, INDOOR AIR, V30, P1229, DOI 10.1111/ina.12700; Yang S, 2021, ENVIRON SCI TECHNOL, V55, P14536, DOI 10.1021/acs.est.1c03379; Zannoni N, 2021, ENVIRON SCI TECHNOL, V55, P13614, DOI 10.1021/acs.est.1c01831; Zhang MX, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132772	43	2	2	33	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2022	377	6610					1071	1076		10.1126/science.abn0340	http://dx.doi.org/10.1126/science.abn0340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6L1EP	36048928	Green Submitted			2022-12-28	WOS:000887933200041
J	Zhao, HT; Lee, J; Chen, J				Zhao, Hongtu; Lee, James; Chen, Jue			The hemolysin A secretion system is a multi-engine pump containing three ABC transporters	CELL			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; I SECRETION; CRYO-EM; PROTEIN SECRETION; TRIPARTITE EFFLUX; ALPHA-HEMOLYSIN; ATPASE ACTIVITY; SUBSTRATE; EXPORT	Type 1 secretion systems (T1SSs) are widespread in pathogenic Gram-negative bacteria, extruding protein substrates following synthesis of the entire polypeptide. The Escherichia coli hemolysin A secretion system has long been considered a prototype in structural and mechanistic studies of T1SSs. Three membrane pro-teins-an inner membrane ABC transporter HlyB, an adaptor protein HlyD, and an outer membrane porin TolC-are required for secretion. However, the stoichiometry and structure of the complex are unknown. Here, cryo-electron microscopy (cryo-EM) structures determined in two conformations reveal that the inner membrane complex is a hetero-dodecameric assembly comprising three HlyB homodimers and six HlyD subunits. Functional studies indicate that oligomerization of HlyB and HlyD is essential for protein secretion and that polypeptides translocate through a canonical ABC transporter pathway in HlyB. Our data suggest that T1SSs entail three ABC transporters, one that functions as a protein channel and two that allosterically power the translocation process.	[Zhao, Hongtu; Lee, James; Chen, Jue] Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA; [Lee, James; Chen, Jue] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhao, Hongtu] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; St Jude Children's Research Hospital	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biol & Biophys, New York, NY 10065 USA.; Chen, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	juechen@rockefeller.edu			Human Frontier Science Program	Human Frontier Science Program(Human Frontier Science Program)	We thank Mark Ebrahim, Honkit Ng, and Johanna Sotiris at the Evelyn Gruss Lipper Cryo-EM Resource Center of The Rockefeller University for help with microscope operation and Misha Kopylov and Edward Eng at the Simons Electron Microscopy Center (New York Structural Biology Center) for assis- tance in data collection. We also thank Yixiao Zhang in the Walz laboratory for helping with carbon -coated grids and Donna Tallent for editing the manuscript. H.Z. was supported by a postdoctoral fellowship from Human Frontier Science Program. J.L. is a fellow of the Helen Hay Whitney Foundation. J.C. is an investigator of the Howard Hughes Medical Institute.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alav I, 2021, CHEM REV, V121, P5479, DOI 10.1021/acs.chemrev.1c00055; Bakkes PJ, 2010, J BIOL CHEM, V285, P40573, DOI 10.1074/jbc.M110.173658; Balakrishnan L, 2001, J MOL BIOL, V313, P501, DOI 10.1006/jmbi.2001.5038; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzpatrick AWP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.70; GHIGO JM, 1994, J BIOL CHEM, V269, P8979; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo I, 2019, J MICROBIOL, V57, P185, DOI 10.1007/s12275-019-8520-1; Kanonenberg K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44812-0; Kieuvongngam V, 2020, ELIFE, V9, DOI 10.7554/eLife.51492; Kim JS, 2016, STRUCTURE, V24, P477, DOI 10.1016/j.str.2015.12.012; KORONAKIS E, 1995, MOL MICROBIOL, V16, P87, DOI 10.1111/j.1365-2958.1995.tb02394.x; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KORONAKIS V, 1989, EMBO J, V8, P595, DOI 10.1002/j.1460-2075.1989.tb03414.x; Lecher J, 2012, STRUCTURE, V20, P1778, DOI 10.1016/j.str.2012.08.005; Lee M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040460; Lenders MHH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12470; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Madeira F, 2022, NUCLEIC ACIDS RES, V50, pW276, DOI 10.1093/nar/gkac240; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miyazaki R, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.03.003; Morgan JLW, 2017, STRUCTURE, V25, P522, DOI 10.1016/j.str.2017.01.010; NICAUD JM, 1986, FEBS LETT, V204, P331, DOI 10.1016/0014-5793(86)80838-9; NOEGEL A, 1979, MOL GEN GENET, V175, P343, DOI 10.1007/BF00397234; OSTOLAZA H, 1995, EUR J BIOCHEM, V228, P39, DOI 10.1111/j.1432-1033.1995.tb20225.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimenta AL, 1999, MOL GEN GENET, V261, P122, DOI 10.1007/s004380050949; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Reimann S, 2016, BIOCHEM J, V473, P2471, DOI 10.1042/BCJ20160154; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Spitz KKO, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny094; Spitz O, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0003-2018; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	54	1	1	9	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 1	2022	185	18					3329	+		10.1016/j.cell.2022.07.017	http://dx.doi.org/10.1016/j.cell.2022.07.017			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	4U6ML	36055198	hybrid			2022-12-28	WOS:000858905600001
